PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Takada, K; Van Laethem, F; Xing, Y; Akane, K; Suzuki, H; Murata, S; Tanaka, K; Jameson, SC; Singer, A; Takahama, Y				Takada, Kensuke; Van Laethem, Francois; Xing, Yan; Akane, Kazuyuki; Suzuki, Haruhiko; Murata, Shigeo; Tanaka, Keiji; Jameson, Stephen C.; Singer, Alfred; Takahama, Yousuke			TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							CORTICAL EPITHELIAL-CELLS; CLASS-I MOLECULES; MHC CLASS-I; NEGATIVE SELECTION; DEVELOPING THYMOCYTES; MEMORY PHENOTYPE; SELF-PEPTIDES; MICE; REPERTOIRE; RECOGNITION	In the thymus, low-affinity T cell antigen receptor (TCR) engagement facilitates positive selection of a useful T cell repertoire. Here we report that TCR responsiveness of mature CD8(+) T cells is fine tuned by their affinity for positively selecting peptides in the thymus and that optimal TCR responsiveness requires positive selection on major histocompatibility complex class I-associated peptides produced by the thymoproteasome, which is specifically expressed in the thymic cortical epithelium. Thymoproteasome-independent positive selection of monoclonal CD8(+) T cells results in aberrant TCR responsiveness, homeostatic maintenance and immune responses to infection. These results demonstrate a novel aspect of positive selection, in which TCR affinity for positively selecting peptides produced by thymic epithelium determines the subsequent antigen responsiveness of mature CD8(+) T cells in the periphery.	[Takada, Kensuke; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima, Tokushima, Japan; [Van Laethem, Francois; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Xing, Yan; Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; [Akane, Kazuyuki; Suzuki, Haruhiko] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Tokushima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; Nagoya University; University of Tokyo; Tokyo Metropolitan Institute of Medical Science	Takahama, Y (corresponding author), Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima, Tokushima, Japan.	takahama@genome.tokushima-u.ac.jp	Murata, Shigeo/A-1426-2010; Takahama, Yousuke/A-5863-2010; Jameson, Stephen C/D-9892-2013	Murata, Shigeo/0000-0002-3177-3503; Takahama, Yousuke/0000-0002-4992-9174; Jameson, Stephen C/0000-0001-9137-1146	MEXT-JSPS [24111004, 23249025, 24790475, 26460576]; Naito Foundation; Takeda Science Foundation; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [ZIABC011113, ZIABC011114, ZIABC011106, ZIABC009273, ZIABC011112, ZIABC011117, ZIABC011111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038903, R01AI038903, R01AI075168] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24111004, 26000014] Funding Source: KAKEN	MEXT-JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Kosako, I. Ohigashi, M. Kozai and B. Kim for helpful discussion and reading the manuscript. This work was supported by grants from MEXT-JSPS (24111004 and 23249025 to Y.T. and 24790475 and 26460576 to K. Takada), Naito Foundation (to Y.T. and K. Takada), Takeda Science Foundation (to K. Takada), and Uehara Memorial Foundation (to K. Takada).	ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BEVAN MJ, 1981, IMMUNOL TODAY, V2, P216, DOI 10.1016/0167-5699(81)90050-5; BRANDLE D, 1991, EUR J IMMUNOL, V21, P2195, DOI 10.1002/eji.1830210930; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Capone M, 2001, BLOOD, V97, P1336, DOI 10.1182/blood.V97.5.1336; Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lee JY, 2013, P NATL ACAD SCI USA, V110, P13498, DOI 10.1073/pnas.1307572110; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; MORSE HC, 1987, IMMUNOGENETICS, V25, P71, DOI 10.1007/BF00364270; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sasaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8484; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Takada K, 2015, ADV IMMUNOL, V125, P87, DOI 10.1016/bs.ai.2014.09.003; Takahama Y, 2012, CURR OPIN IMMUNOL, V24, P92, DOI 10.1016/j.coi.2012.01.006; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	46	47	48	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1069	+		10.1038/ni.3237	http://dx.doi.org/10.1038/ni.3237			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26301566	Green Accepted			2022-12-18	WOS:000361686500012
J	Klammt, C; Novotna, L; Li, DT; Wolf, M; Blount, A; Zhang, K; Fitchett, JR; Lillemeier, BF				Klammt, Christian; Novotna, Lucie; Li, Dongyang T.; Wolf, Miriam; Blount, Amy; Zhang, Kai; Fitchett, Jonathan R.; Lillemeier, Bjoern F.			T cell receptor dwell times control the kinase activity of Zap70	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE KINASE; TANDEM SH2 DOMAINS; ANTIGEN RECEPTOR; MASS-SPECTROMETRY; ACTIVATION MOTIFS; STRUCTURAL BASIS; TCR-ZETA; ZAP-70; PHOSPHORYLATION; SPECIFICITY	Kinase recruitment to membrane receptors is essential for signal transduction. However, the underlying regulatory mechanisms are poorly understood. We investigated how conformational changes control T cell receptor (TCR) association and activity of the kinase Zap70. Structural analysis showed that TCR binding or phosphorylation of Zap70 triggers a transition from a closed, autoinhibited conformation to an open conformation. Using Zap70 mutants with defined conformations, we found that TCR dwell times controlled Zap70 activity. The closed conformation minimized TCR dwell times and thereby prevented activation by membrane-associated kinases. Parallel recruitment of coreceptor-associated Lck kinase to the TCR ensured Zap70 phosphorylation and stabilized Zap70 TCR binding. Our study suggests that the dynamics of cytosolic enzyme recruitment to the plasma membrane regulate the activity and function of receptors lacking intrinsic catalytic activity.	[Klammt, Christian; Novotna, Lucie; Li, Dongyang T.; Wolf, Miriam; Blount, Amy; Lillemeier, Bjoern F.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Klammt, Christian; Novotna, Lucie; Li, Dongyang T.; Wolf, Miriam; Blount, Amy; Lillemeier, Bjoern F.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Zhang, Kai; Fitchett, Jonathan R.] Eli Lilly Inc, Lilly Biotechnol Ctr, San Diego, CA USA	Salk Institute; Salk Institute; Eli Lilly	Lillemeier, BF (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	blillemeier@salk.edu		Li, Dongyang/0000-0003-2728-4843; Lillemeier, Bjorn/0000-0002-9425-6327	Nomis Foundation; Waitt Foundation; James B. Pendleton Charitable Trust; National Institutes of Health [1DP2GM105455-01]; Salk Institute Cancer Center core facilities - National Cancer Institute [CA014195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105455, R01GM110397] Funding Source: NIH RePORTER	Nomis Foundation; Waitt Foundation; James B. Pendleton Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salk Institute Cancer Center core facilities - National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Komives, I. Masslenikov, C. Beuck and M. Harber for valuable discussions. We thank B.E. Jones (Eli Lilly) for access to the HDX-MS platform, J. Williamson (the Scripps Research Institute) for use of the BLI instrument and B. Varsanofieva for assistance with FRAP data acquisition. We thank S. Chalasani, M. Hetzer and T. Hunter for critical reading of the manuscript. Stable Jurkat cell lines were a gift from A. Weiss (University of California San Francisco, San Francisco, California, USA). HEK293T cells were a gift from M.M. Davis (Stanford University Stanford, California). We thank the Nomis Foundation, the Waitt Foundation and the James B. Pendleton Charitable Trust for their support. This work was supported by the National Institutes of Health (1DP2GM105455-01) and the Salk Institute Cancer Center core facilities (CA014195) funded by the National Cancer Institute.	ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Goda S, 2004, J IMMUNOL, V172, P5379, DOI 10.4049/jimmunol.172.9.5379; Gong Q, 2001, J EXP MED, V194, P507, DOI 10.1084/jem.194.4.507; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Huby RDJ, 1997, J CELL BIOL, V137, P1639, DOI 10.1083/jcb.137.7.1639; Hughes CA, 2001, J MOL BIOL, V307, P967, DOI 10.1006/jmbi.2001.4523; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; Magnan A, 2001, J EXP MED, V194, P491, DOI 10.1084/jem.194.4.491; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Wu J, 1997, J EXP MED, V185, P1877, DOI 10.1084/jem.185.10.1877; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12	41	47	47	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					961	969		10.1038/ni.3231	http://dx.doi.org/10.1038/ni.3231			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26237552	Green Accepted			2022-12-18	WOS:000359876900014
J	Castello, A; Gaya, M; Tucholski, J; Oellerich, T; Lu, KH; Tafuri, A; Pawson, T; Wienands, J; Engelke, M; Batista, FD				Castello, Angelo; Gaya, Mauro; Tucholski, Johannes; Oellerich, Thomas; Lu, Kun-Hui; Tafuri, Anna; Pawson, Tony; Wienands, Juergen; Engelke, Michael; Batista, Facundo D.			Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells	NATURE IMMUNOLOGY			English	Article							NON-ITAM TYROSINE; ANTIGEN RECEPTOR; LINKER PROTEIN; ACTIVATION; BLNK; PROLIFERATION; EXPRESSION; REQUIRES; ALPHA; GRB2	The adaptor Nck links receptor signaling to cytoskeleton regulation. Here we found that Nck also controlled the phosphatidylinositol-3-OH kinase (PI(3)K)-kinase Akt pathway by recruiting the adaptor BCAP after activation of B cells. Nck bound directly to the B cell antigen receptor (BCR) via the non-immunoreceptor tyrosine-based activation motif (ITAM) phosphorylated tyrosine residue at position 204 in the tail of the immunoglobulin-a component. Genetic ablation of Nck resulted in defective BCR signaling, which led to hampered survival and proliferation of B cells in vivo. Indeed, antibody responses in Nck-deficient mice were also considerably impaired. Thus, we demonstrate a previously unknown adaptor function for Nck in recruiting BCAP to sites of BCR signaling and thereby modulating the PI(3) K-Akt pathway in B cells.	[Castello, Angelo; Gaya, Mauro; Batista, Facundo D.] London Res Inst Canc Res UK, Lymphocyte Interact Lab, London, England; [Tucholski, Johannes; Wienands, Juergen; Engelke, Michael] Univ Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Oellerich, Thomas] Goethe Univ Frankfurt, Dept Med 2, D-60054 Frankfurt, Germany; [Lu, Kun-Hui; Tafuri, Anna] German Canc Res Ctr, Dept Mol Immunol, Heidelberg, Germany; [Pawson, Tony] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of London; Institute of Cancer Research - UK; University of Gottingen; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Castello, A (corresponding author), London Res Inst Canc Res UK, Lymphocyte Interact Lab, London, England.	angelo.castello@cancer.org.uk; mengelk@gwdg.de; facundo.batista@cancer.org.uk	Pawson, Tony J/E-4578-2013		Cancer Research UK; Royal Society; Cancer Research UK [15691] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK)	We thank M. Way (Cancer Research UK) for constructs expressing His-Nck1 and His-Nck2; N. Engels (Georg-August-Universitat Gottingen) for the CD8-immunoglobulin-alpha chimeric construct; M. Reth (Max Planck Institute of Immunobiology and Epigenetics) for the mouse expressing Cre from the promoter of the gene encoding MB-1 and the Syk-GFP-pcDNA3 plasmid; F. Bladt (Merck) and B. Arnold (German Cancer Research Centre and Institute of Molecular Biology) for mice with conditional deficiency in Nck1 or Nck1-Nck2; T. Kurosaki (Osaka University) for antibodies M1 and M4 (each anti-IgM); B. Montaner for help with breeding and maintenance of the mouse colony; S. Kjaer of the Protein Purification Facility (Cancer Research UK) for help with the expression of recombinant proteins; A. Weston and L. Collins of the Electron Microscopy Unit (Cancer Research UK) for assistance in the imaging of DT40 cells by electron microscopy; N. O'Reilly of the Peptide Synthesis Unit (Cancer Research UK) for help in the production of biotinylated peptides and peptide arrays; D. McCarthy of the Electron Microscopy Division (Cancer Research UK) for help in imaging naive B cells by electron microscopy; and all members of the Lymphocyte Interaction Laboratory (Cancer Research UK) for discussions and comments. Supported by Cancer Research UK and the Royal Society (F.D.B.).	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Donnelly SK, 2013, CURR BIOL, V23, P999, DOI 10.1016/j.cub.2013.04.051; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Roy E, 2010, J IMMUNOL, V185, P7518, DOI 10.4049/jimmunol.1000008; Roy E, 2010, P NATL ACAD SCI USA, V107, P15529, DOI 10.1073/pnas.1009743107; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Siemasko K, 2002, J IMMUNOL, V168, P2127, DOI 10.4049/jimmunol.168.5.2127; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Stork B, 2007, EMBO J, V26, P1140, DOI 10.1038/sj.emboj.7601557; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	48	47	49	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					966	+		10.1038/ni.2685	http://dx.doi.org/10.1038/ni.2685			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23913047				2022-12-18	WOS:000323377700014
J	Colonna, M				Colonna, Marco			Skin function for human CD1a-reactive T cells	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN PRESENTATION; LANGERHANS CELLS; INTERLEUKIN 22; DISTINCT	Human CD4(+) T cells that produce interleukin 22 are an essential component of skin defense and repair. New evidence shows that these T cells recognize CD1a-lipid complexes on Langerhans cells.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@wustl.edu	; Watzl, Carsten/B-4911-2013; Jonjic, Stipan/C-5657-2016	Colonna, Marco/0000-0001-5222-4987; Watzl, Carsten/0000-0001-5195-0995; Jonjic, Stipan/0000-0001-5003-3108				Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; De Libero G, 2009, EUR J IMMUNOL, V39, P2648, DOI 10.1002/eji.200939425; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kronenberg M, 2009, CURR OPIN IMMUNOL, V21, P391, DOI 10.1016/j.coi.2009.07.002; Moody DB, 2006, ADV IMMUNOL, V89, P87, DOI 10.1016/S0065-2776(05)89003-0; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Strid J, 2009, SEMIN IMMUNOL, V21, P110, DOI 10.1016/j.smim.2009.03.002; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002	16	47	51	3	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1079	1080		10.1038/ni1210-1079	http://dx.doi.org/10.1038/ni1210-1079			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21079630				2022-12-18	WOS:000284262200005
J	Maltais, LJ; Lovering, RC; Taranin, AV; Colonna, M; Ravetch, JV; Dalla-Favera, R; Burrows, PD; Cooper, MD; Davis, RS				Maltais, LJ; Lovering, RC; Taranin, AV; Colonna, M; Ravetch, JV; Dalla-Favera, R; Burrows, PD; Cooper, MD; Davis, RS			New nomenclature for Fc receptor-like molecules	NATURE IMMUNOLOGY			English	Letter							B-CELL EXPRESSION; FAMILY; HOMOLOGS		Jackson Lab, Mouse Genome Informat Resource, Nomenclature Grp, Bar Harbor, ME 04609 USA; UCL, Galton Lab, Human Genome Org Gene Nomenclature Comm, London NW1 2HE, England; Inst Cytol & Genet, Novosibirsk 630090, Russia; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Univ Alabama, Div Dev & Clin Immunol, Birmingham, AL 35294 USA	Jackson Laboratory; University of London; University College London; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Washington University (WUSTL); Rockefeller University; Columbia University; University of Alabama System; University of Alabama Birmingham	Maltais, LJ (corresponding author), Jackson Lab, Mouse Genome Informat Resource, Nomenclature Grp, 600 Main St, Bar Harbor, ME 04609 USA.	rsdavis@uab.edu	Ravetch, Jeffrey/Z-1596-2019; Taranin, Alexander/N-5136-2015	Ravetch, Jeffrey/0000-0003-2024-9041; Taranin, Alexander/0000-0002-9184-4238; Lovering, Ruth/0000-0002-9791-0064; Colonna, Marco/0000-0001-5222-4987	MRC [G0000107] Funding Source: UKRI; Medical Research Council [G0000107] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Davis RS, 2004, INT IMMUNOL, V16, P1343, DOI 10.1093/intimm/dxh137; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Guselnikov SV, 2002, IMMUNOGENETICS, V54, P87, DOI 10.1007/s00251-002-0436-x; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Mechetina LV, 2002, EUR J IMMUNOL, V32, P87, DOI 10.1002/1521-4141(200201)32:1<87::AID-IMMU87>3.0.CO;2-#	5	47	49	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					431	432		10.1038/ni0506-431	http://dx.doi.org/10.1038/ni0506-431			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622424				2022-12-18	WOS:000237008800002
J	Herzenberg, LA; Tung, JW				Herzenberg, LA; Tung, JW			B cell lineages: documented at last!	NATURE IMMUNOLOGY			English	Editorial Material							B-1B CELLS		Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University	Herzenberg, LA (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	leeherz@stanford.edu						Alugupalli KR, 2005, IMMUNITY, V23, P1, DOI 10.1016/j.immuni.2005.07.001; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; Kawikova I, 2004, IMMUNOLOGY, V113, P234, DOI 10.1111/j.1365-2567.2004.01936.x; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; TUNG JW, IN PRESS P NATL ACAD	12	47	47	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					225	226		10.1038/ni0306-225	http://dx.doi.org/10.1038/ni0306-225			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482166				2022-12-18	WOS:000235360400003
J	Holt, PG; Thomas, WR				Holt, PG; Thomas, WR			Sensitization to airborne environmental allergens: unresolved issues	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; IMMUNE-RESPONSES; ASTHMA; IGE; ANTIGEN; CONTRIBUTE; MECHANISM; PATTERNS; CHILDREN; POLLEN	Despite considerable advances in identifying the environmental agents that trigger allergy and the immunological mechanisms involved, progress in developing effective treatments remains frustratingly slow. Is it time to rethink some of the paradigms guiding this research?	Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Holt, PG (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	patrick@ichr.uwa.edu.au	Holt, Patrick G/H-1548-2011	Holt, Patrick G/0000-0003-1193-0935				Asero R, 2004, J INVEST ALLERG CLIN, V14, P208; BJORKSTEN F, 1981, ACTA MED SCAND, V209, P299; CHAPMAN MD, 1983, J ALLERGY CLIN IMMUN, V72, P27, DOI 10.1016/0091-6749(83)90048-9; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Cullinan P, 2004, THORAX, V59, P855, DOI 10.1136/thx.2003.019877; Epton MJ, 2002, CLIN EXP ALLERGY, V32, P1341, DOI 10.1046/j.1365-2222.2002.01473.x; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Heaton T, 2005, LANCET, V365, P142, DOI 10.1016/S0140-6736(05)17704-6; Hjern A, 1999, PEDIATR ALLERGY IMMU, V10, P101, DOI 10.1034/j.1399-3038.1999.00023.x; Holt PG, 1999, NATURE, V402, pB12; HOLT PG, 1987, IMMUNOL TODAY, V8, P14, DOI 10.1016/0167-5699(87)90825-5; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Mark PG, 1996, CLIN EXP ALLERGY, V26, P1316, DOI 10.1111/j.1365-2222.1996.tb00529.x; Niederberger V, 1998, J ALLERGY CLIN IMMUN, V102, P579, DOI 10.1016/S0091-6749(98)70273-8; Niederberger V, 2001, J INVEST DERMATOL, V117, P848, DOI 10.1046/j.0022-202x.2001.01470.x; O'Sullivan S, 2001, AM J RESP CRIT CARE, V164, P560, DOI 10.1164/ajrccm.164.4.2102018; Peat JK, 2004, J ALLERGY CLIN IMMUN, V114, P807, DOI 10.1016/j.jaci.2004.06.057; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Rogers PR, 1999, J IMMUNOL, V163, P1205; Rottem M, 2005, INT ARCH ALLERGY IMM, V136, P198, DOI 10.1159/000083894; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; SEDGWICK JD, 1985, IMMUNOLOGY, V56, P635; Seneviratne SL, 2002, J CLIN INVEST, V110, P1283, DOI 10.1172/JCI200215753; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Thornton CA, 2004, J IMMUNOL, V173, P3084, DOI 10.4049/jimmunol.173.5.3084; Trombone APF, 2002, CLIN EXP ALLERGY, V32, P1323, DOI 10.1046/j.1365-2745.2002.01455.x; Woodcock A, 2004, AM J RESP CRIT CARE, V170, P433, DOI 10.1164/rccm.200401-083OC; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	30	47	52	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					957	960		10.1038/ni1005-957	http://dx.doi.org/10.1038/ni1005-957			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16177798				2022-12-18	WOS:000232027200002
J	Chakraborty, AK; Dustin, ML; Shaw, AS				Chakraborty, AK; Dustin, ML; Shaw, AS			In silico models for cellular and molecular immunology: successes, promises and challenges	NATURE IMMUNOLOGY			English	Editorial Material							SYNAPSE		Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; New York University; New York University; Washington University (WUSTL)	Chakraborty, AK (corresponding author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.	arup@uclink.berkeley.edu	Dustin, Michael/AAM-4611-2020	Shaw, Andrey/0000-0001-5685-0272; Dustin, Michael/0000-0003-4983-6389				AFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; LEE K, 2003, SCIENCE         0925, DOI DOI 10.1126/SCIENCE.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Ritchie L. I., 2002, IMMUNITY, V16, P595; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944	23	47	47	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					933	936		10.1038/ni1003-933	http://dx.doi.org/10.1038/ni1003-933			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515121				2022-12-18	WOS:000185590100004
J	Sakaguchi, S				Sakaguchi, S			Policing the regulators	NATURE IMMUNOLOGY			English	News Item							IMMUNOLOGICAL SELF-TOLERANCE; IMMUNOREGULATORY T-CELLS; AUTOIMMUNE-DISEASE; SELECTION; THYMUS; REPERTOIRE		Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Kyoto University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.		Sakaguchi, Shimon/C-9535-2009					Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; Peterson P, 1998, IMMUNOL TODAY, V19, P384, DOI 10.1016/S0167-5699(98)01293-6; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287	18	47	49	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					283	284		10.1038/86283	http://dx.doi.org/10.1038/86283			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276194				2022-12-18	WOS:000167982900005
J	Jacquelot, N; Seillet, C; Wang, MY; Pizzolla, A; Liao, Y; Hediyeh-zadeh, S; Grisaru-Tal, S; Louis, C; Huang, QT; Schreuder, J; Souza-Fonseca-Guimaraes, F; de Graaf, CA; Thia, K; Macdonald, S; Camilleri, M; Luong, K; Zhang, SB; Chopin, M; Molden-Hauer, T; Nutt, SL; Umansky, V; Ciric, B; Groom, JR; Foster, PS; Hansbro, PM; McKenzie, ANJ; Gray, DHD; Behren, A; Cebon, J; Vivier, E; Wicks, IP; Trapani, JA; Munitz, A; Davis, MJ; Shi, W; Neeson, PJ; Belz, GT				Jacquelot, Nicolas; Seillet, Cyril; Wang, Minyu; Pizzolla, Angela; Liao, Yang; Hediyeh-zadeh, Soroor; Grisaru-Tal, Sharon; Louis, Cynthia; Huang, Qiutong; Schreuder, Jaring; Souza-Fonseca-Guimaraes, Fernando; de Graaf, Carolyn A.; Thia, Kevin; Macdonald, Sean; Camilleri, Mary; Luong, Kylie; Zhang, Shengbo; Chopin, Michael; Molden-Hauer, Tristan; Nutt, Stephen L.; Umansky, Viktor; Ciric, Bogoljub; Groom, Joanna R.; Foster, Paul S.; Hansbro, Philip M.; McKenzie, Andrew N. J.; Gray, Daniel H. D.; Behren, Andreas; Cebon, Jonathan; Vivier, Eric; Wicks, Ian P.; Trapani, Joseph A.; Munitz, Ariel; Davis, Melissa J.; Shi, Wei; Neeson, Paul J.; Belz, Gabrielle T.			Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; COLONY-STIMULATING FACTOR; ROR-GAMMA-T; GM-CSF; EXPRESSION; AMPHIREGULIN; CONTRIBUTES; ANTIGEN; ILC2S; LEADS	Group 2 innate lymphoid cells (ILC2s) are generally considered to have pro-tumor functions. However, Belz and colleagues demonstrate that ILC2s have anti-melanoma effects due to their high production of the inflammatory cytokine granulocyte-macrophage colony-stimulating factor in the tumor microenvironment. Group 2 innate lymphoid cells (ILC2s) are essential to maintain tissue homeostasis. In cancer, ILC2s can harbor both pro-tumorigenic and anti-tumorigenic functions, but we know little about their underlying mechanisms or whether they could be clinically relevant or targeted to improve patient outcomes. Here, we found that high ILC2 infiltration in human melanoma was associated with a good clinical prognosis. ILC2s are critical producers of the cytokine granulocyte-macrophage colony-stimulating factor, which coordinates the recruitment and activation of eosinophils to enhance antitumor responses. Tumor-infiltrating ILC2s expressed programmed cell death protein-1, which limited their intratumoral accumulation, proliferation and antitumor effector functions. This inhibition could be overcome in vivo by combining interleukin-33-driven ILC2 activation with programmed cell death protein-1 blockade to significantly increase antitumor responses. Together, our results identified ILC2s as a critical immune cell type involved in melanoma immunity and revealed a potential synergistic approach to harness ILC2 function for antitumor immunotherapies.	[Jacquelot, Nicolas; Seillet, Cyril; Liao, Yang; Hediyeh-zadeh, Soroor; Louis, Cynthia; Huang, Qiutong; de Graaf, Carolyn A.; Camilleri, Mary; Luong, Kylie; Zhang, Shengbo; Chopin, Michael; Nutt, Stephen L.; Groom, Joanna R.; Gray, Daniel H. D.; Wicks, Ian P.; Davis, Melissa J.; Shi, Wei; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Jacquelot, Nicolas; Seillet, Cyril; Liao, Yang; Hediyeh-zadeh, Soroor; Louis, Cynthia; Huang, Qiutong; de Graaf, Carolyn A.; Camilleri, Mary; Luong, Kylie; Zhang, Shengbo; Chopin, Michael; Nutt, Stephen L.; Groom, Joanna R.; Gray, Daniel H. D.; Wicks, Ian P.; Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Wang, Minyu; Pizzolla, Angela; Thia, Kevin; Macdonald, Sean; Molden-Hauer, Tristan; Trapani, Joseph A.; Neeson, Paul J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Wang, Minyu; Pizzolla, Angela; Trapani, Joseph A.; Neeson, Paul J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Liao, Yang; Behren, Andreas; Cebon, Jonathan; Shi, Wei] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Liao, Yang; Behren, Andreas; Cebon, Jonathan; Shi, Wei] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia; [Grisaru-Tal, Sharon; Munitz, Ariel] Tel Aviv Univ, Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Huang, Qiutong; Schreuder, Jaring; Souza-Fonseca-Guimaraes, Fernando; Belz, Gabrielle T.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Umansky, Viktor] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Umansky, Viktor] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Ciric, Bogoljub] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Foster, Paul S.; Hansbro, Philip M.] Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; [Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Newcastle, NSW, Australia; [Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Sydney, NSW, Australia; [Hansbro, Philip M.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [McKenzie, Andrew N. J.] Med Res Council Lab Mol Biol, Cambridge, England; [Behren, Andreas; Cebon, Jonathan] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Cebon, Jonathan] Ludwig Inst Canc Res, Melbourne Austin Branch, Melbourne, Vic, Australia; [Vivier, Eric] Innate Pharma Res Labs, Marseille, France; [Vivier, Eric] Aix Marseille Univ, CIML, INSERM, CNRS, Marseille, France; [Vivier, Eric] Hop La Timone, AP HM, Marseille Immunopole, Serv Immunol, Marseille, France; [Wicks, Ian P.] Royal Melbourne Hosp, Rheumatol Unit, Melbourne, Vic, Australia; [Davis, Melissa J.; Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia; [Jacquelot, Nicolas] Princess Margaret Canc Ctr, Toronto, ON, Canada	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; Tel Aviv University; University of Queensland; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Jefferson University; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Melbourne; Ludwig Institute for Cancer Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Melbourne Hospital; University of Melbourne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Jacquelot, N; Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.; Jacquelot, N; Belz, GT (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.; Belz, GT (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.; Jacquelot, N (corresponding author), Princess Margaret Canc Ctr, Toronto, ON, Canada.	nicolas.jacquelot@uhnresearch.ca; g.belz@uq.edu.au	Foster, Paul/G-5057-2013; Jacquelot, Nicolas/AAY-6937-2020; Belz, Gabrielle T/C-9350-2013; Hansbro, Phil/G-7486-2013; zhang, shengbo/GQA-8220-2022; Vivier, Eric/F-8939-2010; Behren, Andreas/ABZ-2615-2022; Nutt, Stephen/C-9256-2013	Belz, Gabrielle T/0000-0002-9660-9587; Hansbro, Phil/0000-0002-4741-3035; Vivier, Eric/0000-0001-7022-8287; Huang, Qiutong/0000-0002-4556-0605; Cebon, Jonathan/0000-0002-3898-950X; , Yang/0000-0002-9746-2839; , Paul/0000-0002-0827-8299; LOUIS, CYNTHIA/0000-0001-8382-6358; Nutt, Stephen/0000-0002-0020-6637; Jacquelot, Nicolas/0000-0003-0282-1892; Hediyeh-zadeh, Soroor/0000-0001-7513-6779; Davis, Melissa/0000-0003-4864-7033; Macdonald, Sean/0000-0002-7575-681X; Zhang, Shengbo/0000-0003-3870-0590	National Health and Medical Research Council (NHMRC) of Australia [1122277, 1054925, 1135898, 1165443, 1123000, 1175134, 1113577, 1154325, 1158024, 1140406, 1155342, 1196235]; Reid Charitable Trusts; Cancer Council NSW [RG21-05]; Cure Cancer Australia and Cancer Australia through the Cancer Australia Priority-driven Cancer Research Scheme [1163990, 1158085]; Foundation ARC pour la recherche sur le cancer; Walter and Eliza Hall Institute (CSL); Victorian Government Department of Health and Human Services through the Victorian Cancer Agency; Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) [259332240/RTG 2099]; Australian Government Research Training Program; Melbourne Research Scholarship; UK Medical Research Council [U105178805]; US-Israel Binational Science Foundation [2015163]; Israel Science Foundation [886/15, 542/20]; Israel Cancer Research Fund; Richard Eimert Research Fund on Solid Tumors; Israel Cancer Association Avraham Rotstein Donation; Cancer Biology Research Center; Emerson Collective; Australian Government; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIIS	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Reid Charitable Trusts; Cancer Council NSW(Cancer Council New South Wales); Cure Cancer Australia and Cancer Australia through the Cancer Australia Priority-driven Cancer Research Scheme; Foundation ARC pour la recherche sur le cancer; Walter and Eliza Hall Institute (CSL); Victorian Government Department of Health and Human Services through the Victorian Cancer Agency; Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)(German Research Foundation (DFG)); Australian Government Research Training Program(Australian Government); Melbourne Research Scholarship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Richard Eimert Research Fund on Solid Tumors; Israel Cancer Association Avraham Rotstein Donation; Cancer Biology Research Center; Emerson Collective; Australian Government(Australian GovernmentCGIAR); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIIS(National Health and Medical Research Council (NHMRC) of Australia)	We thank J. Janssen, S. Cree, S. Shaw, E. Mettes, J. Leahy, F. Almeida, E. Pan, A. Johnston, D. Tantalo, members of the Belz, Neeson and Nutt laboratories, and members of the Flow Cytometry, Histology and Bioservices facilities at the Walter and Eliza Hall Institute of Medical Research for technical assistance and for helpful discussions. We express our gratitude to J. Cockwill, our long-term consumer representative, for fruitful discussions and significant consumer input. We are grateful to S. Wilcox and the Genomics platform for their technical help with scRNA-seq. The results published here are in part based upon data generated by the TCGA Research Network (https://www.cancer.gov/tcga/).This work was supported by grants and fellowships from the National Health and Medical Research Council (NHMRC) of Australia (1165443, 1122277, 1054925 and 1135898 to G.T.B.; 1165443 and 1123000 to C.S.; 1175134 to P.M.H.; 1113577 and 1154325 to I.W.; 1158024 to D.H.D.G.; 1140406 to F.S.-F.-G.; 1155342 to S.L.N.; and 1196235 to M. Chopin), Reid Charitable Trusts (I.W.), a grant to The University of Queensland Chair of Immunology (Diamantina Institute, to G.T.B.), Cancer Council NSW (RG21-05 to G.T.B. and N.J.), Cure Cancer Australia and Cancer Australia through the Cancer Australia Priority-driven Cancer Research Scheme (1163990 to N.J., 1158085 to F.S-F.-G.), a fellowship from the Foundation ARC pour la recherche sur le cancer (to N.J.), Centenary Fellowships of the Walter and Eliza Hall Institute (sponsored by CSL, to J.G. and W.S.), a fellowship from the Victorian Government Department of Health and Human Services acting through the Victorian Cancer Agency (to A.B.), and the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation, 259332240/RTG 2099 to V.U.) and scholarships of the Australian Government Research Training Program (to Q.H.) and Melbourne Research Scholarship (to S.Z.). A.N.J.M. was supported by the UK Medical Research Council (U105178805). A.M. is supported by the US-Israel Binational Science Foundation (grant no. 2015163), the Israel Science Foundation (grant nos. 886/15 and 542/20), the Israel Cancer Research Fund, the Richard Eimert Research Fund on Solid Tumors (TAU), the Israel Cancer Association Avraham Rotstein Donation, the Cancer Biology Research Center (TAU) and the Emerson Collective. This research was carried out in part at the Translational Research Institute, Australia. The Translational Research Institute is supported by a grant from the Australian Government. This work was supported through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bie QL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/923135; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Bruggen MC, 2016, J INVEST DERMATOL, V136, P2396, DOI 10.1016/j.jid.2016.07.017; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chesney J, 2018, J CLIN ONCOL, V36, P1658, DOI 10.1200/JCO.2017.73.7379; Chevalier MF, 2017, J CLIN INVEST, V127, P2916, DOI 10.1172/JCI89717; Choi J, 2019, NUCLEIC ACIDS RES, V47, pD780, DOI 10.1093/nar/gky1020; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Ercolano G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02801; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Grisaru-Tal S, 2020, NAT REV CANCER, V20, P594, DOI 10.1038/s41568-020-0283-9; Helou DG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17813-1; Hoeller C, 2016, CANCER IMMUNOL IMMUN, V65, P1015, DOI 10.1007/s00262-016-1860-3; Hollande C, 2019, NAT IMMUNOL, V20, P257, DOI 10.1038/s41590-019-0321-5; Huang QT, 2021, CANCERS, V13, DOI 10.3390/cancers13030559; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jacquelot N, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1299303; Jacquelot N, 2016, J INVEST DERMATOL, V136, P994, DOI 10.1016/j.jid.2015.12.042; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lee NA, 1997, J IMMUNOL, V158, P1332; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; Liu XT, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-001460; Long A, 2018, J IMMUNOL, V201, P3456, DOI 10.4049/jimmunol.1800173; Louis C, 2020, J EXP MED, V217, DOI 10.1084/jem.20191421; Lucarini V, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1317420; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Moreira A, 2017, IMMUNOTHERAPY-UK, V9, P115, DOI 10.2217/imt-2016-0138; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Park SL, 2019, NATURE, V565, P366, DOI 10.1038/s41586-018-0812-9; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Putz EM, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1267892; Reichman H, 2019, CANCER IMMUNOL RES, V7, P388, DOI 10.1158/2326-6066.CIR-18-0494; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Salimi M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4262-4; Saranchova I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20608-6; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Seremet T, 2019, MELANOMA RES, V29, P85, DOI 10.1097/CMR.0000000000000501; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Trabanelli S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00678-2; Wagner M, 2020, CELL REP, V30, P2743, DOI 10.1016/j.celrep.2020.01.103; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540	68	46	46	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					851	+		10.1038/s41590-021-00943-z	http://dx.doi.org/10.1038/s41590-021-00943-z		JUN 2021	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34099918	Green Accepted			2022-12-18	WOS:000658651000001
J	Buszko, M; Park, JH; Verthelyi, D; Sen, R; Young, HA; Rosenberg, AS				Buszko, Maja; Park, Jung-Hyun; Verthelyi, Daniela; Sen, Ranjan; Young, Howard A.; Rosenberg, Amy S.			The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge	NATURE IMMUNOLOGY			English	Editorial Material								"The role of cytokines in COVID-19" online symposium was presented on 18 June 2020 by the NIH/FDA Immunology and Cytokine Interest Groups and was purposed to discuss our rapidly changing understanding of COVID-19-related cytokine responses in different stages of infection, including the etiologies, downstream consequences and possible mitigation strategies. The recording is available at.	[Buszko, Maja] NIAID, Cellular Immunol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Park, Jung-Hyun] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Verthelyi, Daniela] US FDA, Ctr Drug Evaluat & Res, Div Biotechnol Review & Res 3, Lab Innate Immun,Off Biotechnol Prod, Silver Spring, MD USA; [Sen, Ranjan] NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Young, Howard A.] NCI, Ctr Canc Res, Lab Canc Immunometab, Frederick, MD 21701 USA; [Rosenberg, Amy S.] US FDA, Ctr Drug Evaluat & Res, Div Biotechnol Review & Res 3, Lab Immunol,Off Biotechnol Prod, Silver Spring, MD 20993 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Rosenberg, AS (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Biotechnol Review & Res 3, Lab Immunol,Off Biotechnol Prod, Silver Spring, MD 20993 USA.	amy.rosenberg@fda.hhs.gov	Park, Jung Hyun/B-5712-2015; Young, Howard/A-6350-2008	Park, Jung Hyun/0000-0002-9547-9055; Reis, AlessanRSS/0000-0001-8486-7469; Verthelyi, Daniela/0000-0002-5450-3071; Young, Howard/0000-0002-3118-5111				[Anonymous], 2020, NAT MED 0618; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Chatham WW, 2020, J RHEUMATOL, V47, P1590, DOI 10.3899/jrheum.200679; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273, DOI 10.1101/2020.06.22.20137273, DOI 10.1056/NEJMOA2021436, 10.1056/NEJMoa2021436]; Jordan Michael B, 2004, Blood, V104, P735; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Moratto D, 2020, J CLIN IMMUNOL, V40, P970, DOI 10.1007/s10875-020-00806-6; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Roschewski M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd0110; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Zhou Q, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00295	17	46	46	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1146	1151		10.1038/s41590-020-0779-1	http://dx.doi.org/10.1038/s41590-020-0779-1		AUG 2020	6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32855555	Bronze, Green Published			2022-12-18	WOS:000563237600003
J	Wolf, T; Jin, WJ; Zoppi, G; Vogel, IA; Akhmedov, M; Bleck, CKE; Beltraminelli, T; Rieckmann, JC; Ramirez, NJ; Benevento, M; Notarbartolo, S; Bumann, D; Meissner, F; Grimbacher, B; Mann, M; Lanzavecchia, A; Sallusto, F; Kwee, I; Geiger, R				Wolf, Tobias; Jin, Wenjie; Zoppi, Giada; Vogel, Ian A.; Akhmedov, Murodzhon; Bleck, Christopher K. E.; Beltraminelli, Tim; Rieckmann, Jan C.; Ramirez, Neftali J.; Benevento, Marco; Notarbartolo, Samuele; Bumann, Dirk; Meissner, Felix; Grimbacher, Bodo; Mann, Matthias; Lanzavecchia, Antonio; Sallusto, Federica; Kwee, Ivo; Geiger, Roger			Dynamics in protein translation sustaining T cell preparedness	NATURE IMMUNOLOGY			English	Article							REAL-TIME; NAIVE; METABOLISM; DIFFERENTIATION; QUANTIFICATION; CHROMATIN; SURVIVAL	In response to pathogenic threats, naive T cells rapidly transition from a quiescent to an activated state, yet the underlying mechanisms are incompletely understood. Using a pulsed SILAC approach, we investigated the dynamics of mRNA translation kinetics and protein turnover in human naive and activated T cells. Our datasets uncovered that transcription factors maintaining T cell quiescence had constitutively high turnover, which facilitated their depletion following activation. Furthermore, naive T cells maintained a surprisingly large number of idling ribosomes as well as 242 repressed mRNA species and a reservoir of glycolytic enzymes. These components were rapidly engaged following stimulation, promoting an immediate translational and glycolytic switch to ramp up the T cell activation program. Our data elucidate new insights into how T cells maintain a prepared state to mount a rapid immune response, and provide a resource of protein turnover, absolute translation kinetics and protein synthesis rates in T cells (https://www.immunomics.ch).	[Wolf, Tobias; Jin, Wenjie; Zoppi, Giada; Vogel, Ian A.; Akhmedov, Murodzhon; Beltraminelli, Tim; Benevento, Marco; Notarbartolo, Samuele; Lanzavecchia, Antonio; Sallusto, Federica; Kwee, Ivo; Geiger, Roger] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Wolf, Tobias; Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Bleck, Christopher K. E.; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland; [Rieckmann, Jan C.; Meissner, Felix] Max Planck Inst Biochem, Expt Syst Immunol, Munich, Germany; [Ramirez, Neftali J.; Grimbacher, Bodo] Albert Ludwigs Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency, Med Ctr,Inst Immunodeficiency, Freiburg, Germany; [Ramirez, Neftali J.] Collaborat Res Ctr 992, Integrated Res Training Grp IRTG Med Epigenet, D-992 Freiburg, Germany; [Meissner, Felix] Univ Bonn, Med Fac, Inst Innate Immun, Dept Syst Immunol & Prote, Bonn, Germany; [Grimbacher, Bodo] DZIF German Ctr Infect Res, Satellite Ctr Freiburg, Freiburg, Germany; [Grimbacher, Bodo] Albert Ludwigs Univ, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Germany; [Grimbacher, Bodo] Hanover Med Sch, RESIST Cluster Excellence 2155, Satellite Ctr Freiburg, Freiburg, Germany; [Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Munich, Germany	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Max Planck Society; University of Freiburg; University of Bonn; German Center for Infection Research; University of Freiburg; Hannover Medical School; Max Planck Society	Geiger, R (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland.	roger.geiger@irb.usi.ch	Notarbartolo, Samuele/X-9697-2019; , Wenjie/HHS-6700-2022; Meissner, Felix/C-8767-2015	Notarbartolo, Samuele/0000-0001-5910-4910; , Wenjie/0000-0002-7527-6357; Ramirez, Neftali/0000-0002-7942-6762; Beltraminelli, Tim/0000-0002-1183-8736; Vogel, Ian/0000-0001-6593-3598; Bleck, Christopher/0000-0003-1029-3444; Geiger, Roger/0000-0002-8016-1669; Meissner, Felix/0000-0003-1000-7989	Swiss SystemsX.ch initiative; Swiss National Science Foundation [142032, 170213]; European Research Council [803150]; Federal Ministry of Education and Research [GAIN_01GM1910A]; German Research Foundation [SFB1160/2_B5, RESIST-EXC 2155, 39087428]; Helmut Horten Foundation	Swiss SystemsX.ch initiative; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Helmut Horten Foundation	We thank D. Jarrossay for cell sorting. This work was supported by a grant from the Swiss SystemsX.ch initiative, evaluated by the Swiss National Science Foundation (grant no. 142032 to R.G.), the European Research Council (grant no. 803150 to R.G.), the Swiss National Science Foundation (grant no 170213 to F.S.), the Federal Ministry of Education and Research (GAIN_01GM1910A to B.G.) and the German Research Foundation (SFB1160/2_B5, RESIST-EXC 2155-Project ID 39087428 to B.G). The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Akat K, 2003, ACTA NEUROPATHOL, V106, P337, DOI 10.1007/s00401-003-0736-8; Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Barozzi I, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-51; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Froehlich J, 2016, ONCOTARGET, V7, P63215, DOI 10.18632/oncotarget.11438; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Harndahl M, 2011, J IMMUNOL METHODS, V374, P5, DOI 10.1016/j.jim.2010.10.012; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liebmann M, 2018, P NATL ACAD SCI USA, V115, pE8017, DOI 10.1073/pnas.1721049115; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morisaki T, 2016, SCIENCE, V352, P1425, DOI 10.1126/science.aaf0899; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ricciardi S, 2018, CELL METAB, V28, P895, DOI 10.1016/j.cmet.2018.08.009; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Scheltema RA, 2014, MOL CELL PROTEOMICS, V13, P3698, DOI 10.1074/mcp.M114.043489; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Tan TCJ, 2017, P NATL ACAD SCI USA, V114, pE6117, DOI 10.1073/pnas.1700939114; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Zheng C, 2017, CELL, V169, pe1316	59	46	46	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					927	+		10.1038/s41590-020-0714-5	http://dx.doi.org/10.1038/s41590-020-0714-5		JUL 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32632289	Green Accepted			2022-12-18	WOS:000547687000004
J	Park, YH; Remmers, EF; Lee, W; Ombrello, AK; Chung, LK; Zhao, SL; Stone, DL; Ivanov, MI; Loeven, NA; Barron, KS; Hoffmann, P; Nehrebecky, M; Akkaya-Ulum, YZ; Sag, E; Balci-Peynircioglu, B; Aksentijevich, I; Gul, A; Rotimi, CN; Chen, H; Bliska, JB; Ozen, S; Kastner, DL; Shriner, D; Chae, JJ				Park, Yong Hwan; Remmers, Elaine F.; Lee, Wonyong; Ombrello, Amanda K.; Chung, Lawton K.; Zhao Shilei; Stone, Deborah L.; Ivanov, Maya I.; Loeven, Nicole A.; Barron, Karyl S.; Hoffmann, Patrycja; Nehrebecky, Michele; Akkaya-Ulum, Yeliz Z.; Sag, Erdal; Balci-Peynircioglu, Banu; Aksentijevich, Ivona; Gul, Ahmet; Rotimi, Charles N.; Chen, Hua; Bliska, James B.; Ozen, Seza; Kastner, Daniel L.; Shriner, Daniel; Chae, Jae Jin			Ancient familial Mediterranean fever mutations in human pyrin and resistance toYersinia pestis	NATURE IMMUNOLOGY			English	Article							RECENT POSITIVE SELECTION; YERSINIA-PESTIS; HOST KINASES; HUMAN GENOME; PROTEIN; YOPM; ACTIVATION; CARRIER; MEFV; GENE	Familial Mediterranean fever is an autoinflammatory disease caused by gain-of-function mutations in the pyrin inflammasome. Kastner and colleagues show that mutant pyrin better resists suppression by the plague bacteriumYersinia pestisand may have been positively selected in human Middle Eastern populations. Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations inMEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multipleMEFVmutations are high in several Mediterranean populations, suggesting that they confer selective advantage. Among 2,313 Turkish people, we found extended haplotype homozygosity flanking FMF-associated mutations, indicating evolutionarily recent positive selection of FMF-associated mutations. Two pathogenic pyrin variants independently arose >1,800 years ago. Mutant pyrin interacts less avidly withYersinia pestisvirulence factor YopM than with wild-type human pyrin, thereby attenuating YopM-induced interleukin (IL)-1 beta suppression. Relative to healthy controls, leukocytes from patients with FMF harboring homozygous or compound heterozygous mutations and from asymptomatic heterozygous carriers released heightened IL-1 beta specifically in response toY. pestis.Y. pestis-infectedMefv(M680I/M680I)FMF knock-in mice exhibited IL-1-dependent increased survival relative to wild-type knock-in mice. Thus, FMF mutations that were positively selected in Mediterranean populations confer heightened resistance toY. pestis.	[Park, Yong Hwan; Remmers, Elaine F.; Lee, Wonyong; Ombrello, Amanda K.; Stone, Deborah L.; Hoffmann, Patrycja; Nehrebecky, Michele; Aksentijevich, Ivona; Kastner, Daniel L.; Chae, Jae Jin] NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, Bethesda, MD 20892 USA; [Chung, Lawton K.; Ivanov, Maya I.; Loeven, Nicole A.; Bliska, James B.] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Zhao Shilei; Chen, Hua] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Zhao Shilei; Chen, Hua] China Natl Ctr Bioinformat, Beijing, Peoples R China; [Zhao Shilei; Chen, Hua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao Shilei; Chen, Hua] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Barron, Karyl S.] NIAID, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Akkaya-Ulum, Yeliz Z.; Balci-Peynircioglu, Banu] Hacettepe Univ, Dept Med Biol, Fac Med, Ankara, Turkey; [Sag, Erdal; Ozen, Seza] Hacettepe Univ, Dept Pediat, Div Rheumatol, Fac Med, Ankara, Turkey; [Gul, Ahmet] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey; [Rotimi, Charles N.; Shriner, Daniel] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Park, Yong Hwan] Ctr Genom Integr, Inst Basic Sci, Ulsan, South Korea; [Loeven, Nicole A.; Bliska, James B.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hacettepe University; Hacettepe University; Istanbul University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Institute for Basic Science - Korea (IBS); Dartmouth College	Kastner, DL; Chae, JJ (corresponding author), NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, Bethesda, MD 20892 USA.	dan.kastner@nih.gov; chaej@mail.nih.gov	Sag, Erdal/Q-5119-2017; PEYNIRCIOGLU, BANU/I-8337-2013; Gul, Ahmet/AAT-7787-2020	Sag, Erdal/0000-0002-6542-2656; Gul, Ahmet/0000-0001-8219-3720; Chen, Hua/0000-0002-9829-6561; Shriner, Daniel/0000-0003-1928-5520; Ombrello, Amanda/0000-0001-5563-9416	Intramural Research Programs of the National Human Genome Research Institute; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Center for Research on Genomics and Global Health; National Institute of Allergy and Infectious Diseases [R01AI099222]	Intramural Research Programs of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Research on Genomics and Global Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the patients enrolled in our clinical protocols for providing research specimens, A. Jones, T. Romeo, L. Poe and R. Laird for help with caring for patients and A. Schaffer for thoughtful discussions. This work was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Allergy and Infectious Diseases, the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Center for Research on Genomics and Global Health. This research was also supported by the National Institute of Allergy and Infectious Diseases award R01AI099222 (to J.B.B.) and utilized the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0990; Aksentijevich I, 1997, CELL, V90, P797; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aubert DF, 2016, CELL HOST MICROBE, V19, P664, DOI 10.1016/j.chom.2016.04.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Chetrit E, 1998, LANCET, V351, P659, DOI 10.1016/S0140-6736(97)09408-7; Ben-Chetrit E, 2009, ARTHRIT CARE RES, V61, P1447, DOI 10.1002/art.24458; Bernot A, 1997, NAT GENET, V17, P25; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2000, MAMM GENOME, V11, P428, DOI 10.1007/s003350010082; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen H, 2015, THEOR POPUL BIOL, V99, P18, DOI 10.1016/j.tpb.2014.11.001; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Gandolfo LC, 2014, GENETICS, V197, P1315, DOI 10.1534/genetics.114.164616; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kogan A, 2001, AM J MED GENET, V102, P272, DOI 10.1002/ajmg.1438; Koshy R, 2018, CLIN GENET, V93, P92, DOI 10.1111/cge.13070; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; McPhee JB, 2010, INFECT IMMUN, V78, P3529, DOI 10.1128/IAI.00269-10; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; Osei-Owusu P, 2019, NATURE, V574, P57, DOI 10.1038/s41586-019-1570-z; Papadopoulos VP, 2008, ANN HUM GENET, V72, P752, DOI 10.1111/j.1469-1809.2008.00471.x; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Ratner D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006035; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shahraki AH, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016033; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Szpiech ZA, 2014, MOL BIOL EVOL, V31, P2824, DOI 10.1093/molbev/msu211; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Voight BF, 2006, PLOS BIOL, V4, P659, DOI 10.1371/journal.pbio.0040072; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674; Zhao Y, 2016, CURR OPIN MICROBIOL, V29, P37, DOI 10.1016/j.mib.2015.10.003; Zvereff VV, 2014, GENET MED, V16, P539, DOI 10.1038/gim.2013.188	45	46	45	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					857	+		10.1038/s41590-020-0705-6	http://dx.doi.org/10.1038/s41590-020-0705-6		JUN 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32601469	Green Accepted			2022-12-18	WOS:000544172900002
J	Schwerk, J; Soveg, FW; Ryan, AP; Thomas, KR; Hatfield, LD; Ozarkar, S; Forero, A; Kell, AM; Roby, JA; So, L; Hyde, JL; Gale, M; Daugherty, MD; Savan, R				Schwerk, Johannes; Soveg, Frank W.; Ryan, Andrew P.; Thomas, Kerri R.; Hatfield, Lauren D.; Ozarkar, Snehal; Forero, Adriana; Kell, Alison M.; Roby, Justin A.; So, Lomon; Hyde, Jennifer L.; Gale, Michael, Jr.; Daugherty, Matthew D.; Savan, Ram			RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions	NATURE IMMUNOLOGY			English	Article							VIRAL MESSENGER-RNAS; FACTOR CSTF-64; SINDBIS-VIRUS; RIG-I; REPLICATION; EXPRESSION; INHIBITION; INDUCTION; DOMAIN	The initial response to viral infection is anticipatory, with host antiviral restriction factors and pathogen sensors constantly surveying the cell to rapidly mount an antiviral response through the synthesis and downstream activity of interferons. After pathogen clearance, the host's ability to resolve this antiviral response and return to homeostasis is critical. Here, we found that isoforms of the RNA-binding protein ZAP functioned as both a direct antiviral restriction factor and an interferon-resolution factor. The short isoform of ZAP bound to and mediated the degradation of several host interferon messenger RNAs, and thus acted as a negative feedback regulator of the interferon response. In contrast, the long isoform of ZAP had antiviral functions and did not regulate interferon. The two isoforms contained identical RNA-targeting domains, but differences in their intracellular localization modulated specificity for host versus viral RNA, which resulted in disparate effects on viral replication during the innate immune response.	[Schwerk, Johannes; Soveg, Frank W.; Thomas, Kerri R.; Hatfield, Lauren D.; Ozarkar, Snehal; Forero, Adriana; Kell, Alison M.; Roby, Justin A.; So, Lomon; Gale, Michael, Jr.; Savan, Ram] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Ryan, Andrew P.; Daugherty, Matthew D.] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [So, Lomon] Virginia Mason, Benaroya Res Inst, Immunol Program, Seattle, WA USA; [Hyde, Jennifer L.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Gale, Michael, Jr.; Savan, Ram] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Savan, R (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.; Daugherty, MD (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA.; Savan, R (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.	mddaugherty@ucsd.edu; savanram@uw.edu	Schwerk, Johannes/AAN-2937-2020; Daugherty, Matthew/AAT-4418-2020	Roby, Justin/0000-0003-2434-4273; Hatfield, Lauren D/0000-0003-0095-9863; Savan, Ram/0000-0002-3087-1355; Schwerk, Johannes/0000-0002-5964-7162; Kell, Alison/0000-0001-5550-1038	National Institutes of Health [AI108765, AI135437, AI119017, AI104002, AI118916, AI127463]; Pew Biomedical Scholars program [32011]; German Research Foundation [SCHW 1881/1-1]; T32 training grants [AI106677, GM007270, GM007240]; UW Proteomics Resource [UWPR95794]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106677, R21AI135437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM133633] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Biomedical Scholars program; German Research Foundation(German Research Foundation (DFG)); T32 training grants; UW Proteomics Resource; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by National Institutes of Health grants (nos. AI108765 and AI135437 to R.S.; no. AI119017 to M.D.D.; and nos. AI104002, AI118916 and AI127463 to M.G.); the Pew Biomedical Scholars program (no. 32011 to M.D.D.); a Research Fellowship from the German Research Foundation (no. SCHW 1881/1-1 to J.S.); T32 training grants (nos. AI106677 and GM007270 to F.W.S.); and T32 training grant (no. GM007240 to A.P.R.). This work was supported in part by the UW Proteomics Resource (UWPR95794). We thank P. von Haller and J. Eng (UW Proteomics Resource) for expert technical assistance with mass spectrometry. We are thankful for the support of W. P. Chang (UW Biology Imaging Facility) for help with super-resolution microscopy. We thank M. A. Davis (UW Immunology) for help with confocal laser scanning microscopy, D. B. Stetson and K. Burleigh (UW Immunology) for providing the IRF3 CRISPR construct, S. N. Sarkar (University of Pittsburgh) for providing STAT1 KO PH5CH8 cells and members of the Savan, Daugherty and Gale laboratories for helpful discussions.	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Charron G, 2013, P NATL ACAD SCI USA, V110, P11085, DOI 10.1073/pnas.1302564110; Chen SD, 2012, NAT STRUCT MOL BIOL, V19, P430, DOI 10.1038/nsmb.2243; Chiu HP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007166; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Glasker S, 2014, J GEN VIROL, V95, P816, DOI 10.1099/vir.0.060988-0; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Huang Z, 2010, PROTEIN CELL, V1, P752, DOI 10.1007/s13238-010-0096-9; Jarret A, 2016, NAT MED, V22, P1475, DOI 10.1038/nm.4211; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; Liu CH, 2015, P NATL ACAD SCI USA, V112, P14048, DOI 10.1073/pnas.1509745112; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Olenych S. G., 2006, CURR PROTOC CELL BIO, V33; Rosengren AT, 2005, PROTEOMICS, V5, P371, DOI 10.1002/pmic.200400967; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Savan R, 2014, J INTERF CYTOK RES, V34, P318, DOI 10.1089/jir.2013.0117; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwerk J, 2015, J IMMUNOL, V195, P2963, DOI 10.4049/jimmunol.1500756; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vogt D. A, 2015, BIO PROTOC, V5, pe1435; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang XL, 2016, J VIROL, V90, P10247, DOI 10.1128/JVI.01487-16; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044; Zhu YP, 2012, EMBO J, V31, P4236, DOI 10.1038/emboj.2012.271; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	46	46	47	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1610	+		10.1038/s41590-019-0527-6	http://dx.doi.org/10.1038/s41590-019-0527-6			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31740798	Green Accepted			2022-12-18	WOS:000497949800016
J	Voisinne, G; Kersse, K; Chaoui, K; Lu, LX; Chaix, J; Zhang, LC; Menoita, MG; Girard, L; Ounoughene, Y; Wang, H; Burlet-Schiltz, O; Luche, H; Fiore, F; Malissen, M; de Peredo, AG; Liang, YM; Roncagalli, R; Malissen, B				Voisinne, Guillaume; Kersse, Kristof; Chaoui, Karima; Lu, Liaoxun; Chaix, Julie; Zhang, Lichen; Menoita, Marisa Goncalves; Girard, Laura; Ounoughene, Youcef; Wang, Hui; Burlet-Schiltz, Odile; Luche, Herve; Fiore, Frederic; Malissen, Marie; de Peredo, Anne Gonzalez; Liang, Yinming; Roncagalli, Romain; Malissen, Bernard			Quantitative interactomics in primary T cells unveils TCR signal diversification extent and dynamics	NATURE IMMUNOLOGY			English	Article							ACTIVATION; SLP-76; LAT; INHIBITION; COMPLEXES; REQUIRES; BINDING; THEMIS; BTLA	The activation of T cells by the T cell antigen receptor (TCR) results in the formation of signaling protein complexes (signalosomes), the composition of which has not been analyzed at a systems level. Here, we isolated primary CD4(+) T cells from 15 gene-targeted mice, each expressing one tagged form of a canonical protein of the TCR-signaling pathway. Using affinity purification coupled with mass spectrometry, we analyzed the composition and dynamics of the signalosomes assembling around each of the tagged proteins over 600 s of TCR engagement. We showed that the TCR signal-transduction network comprises at least 277 unique proteins involved in 366 high-confidence interactions, and that TCR signals diversify extensively at the level of the plasma membrane. Integrating the cellular abundance of the interacting proteins and their interaction stoichiometry provided a quantitative and contextual view of each documented interaction, permitting anticipation of whether ablation of a single interacting protein can impinge on the whole TCR signal-transduction network.	[Voisinne, Guillaume; Kersse, Kristof; Chaix, Julie; Menoita, Marisa Goncalves; Girard, Laura; Ounoughene, Youcef; Malissen, Marie; Roncagalli, Romain; Malissen, Bernard] Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France; [Chaoui, Karima; Burlet-Schiltz, Odile; de Peredo, Anne Gonzalez] CNRS, Prote Genopole Toulouse Midi Pyrenees UMR 5089, Dept Biol Struct Biophys, Inst Pharmacol & Biol Struct, Toulouse, France; [Lu, Liaoxun; Zhang, Lichen; Wang, Hui; Liang, Yinming] Xinxiang Med Univ, Sch Lab Med, Xinxiang, Henan, Peoples R China; [Lu, Liaoxun] Xinxiang Med Univ, Inst Psychiat & Neurosci, Lab Mouse Genet, Xinxiang, Henan, Peoples R China; [Girard, Laura; Luche, Herve; Fiore, Frederic; Malissen, Marie; Malissen, Bernard] Aix Marseille Univ, CNRS, UMR, Ctr Immunophenom,INSERM, Marseille, France; [Luche, Herve; Malissen, Marie; Liang, Yinming; Malissen, Bernard] Xinxiang Med Univ, Sch Lab Med, Lab Immunophen, Xinxiang, Henan, Peoples R China	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Xinxiang Medical University; Xinxiang Medical University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Xinxiang Medical University	Roncagalli, R; Malissen, B (corresponding author), Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France.; Liang, YM (corresponding author), Xinxiang Med Univ, Sch Lab Med, Xinxiang, Henan, Peoples R China.; Malissen, B (corresponding author), Aix Marseille Univ, CNRS, UMR, Ctr Immunophenom,INSERM, Marseille, France.; Liang, YM; Malissen, B (corresponding author), Xinxiang Med Univ, Sch Lab Med, Lab Immunophen, Xinxiang, Henan, Peoples R China.	yinming.liang@foxmail.com; roncagalli@ciml.univ-mrs.fr; bernardm@ciml.univ-mrs.fr	Roncagalli, Romain/ABB-8786-2020; LUCHE, Herve/GLT-1401-2022; Liang, Yinming/AAM-6226-2020; Malissen, Bernard/AAK-4659-2020	Liang, Yinming/0000-0001-9174-4037; Gonzalez de Peredo, Anne/0000-0001-6152-6311; Malissen, Bernard/0000-0003-1340-9342; Roncagalli, Romain/0000-0001-7554-0552; Zhang, Lichen/0000-0002-7810-9941; Voisinne, Guillaume/0000-0003-3922-2121; FIORE, FREDERIC/0000-0001-7955-6594; Lu, Liaoxun/0000-0002-5342-2720; Wang, Hui/0000-0002-2454-3814; Malissen, Marie/0000-0003-2331-1445; Schiltz, Odile/0000-0002-3606-2356	CNRS; INSERM; European Research Council (ERC) [322465]; European Union [787300]; Agence Nationale de la Recherche; MSDAVENIR Fund; Investissement d'Avenir program of the French Ministry of Research ProFI [ANR-10-INBS-08]; PHENOMIN (French National Infrastructure) [ANR-10-INBS-07]; National Natural Science Foundation of China [81471595, 31400759]; Education Department of Henan Province, China [16HASTIT030]; INTEGRATE; MSDAVENIR; PHENOMIN	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); MSDAVENIR Fund; Investissement d'Avenir program of the French Ministry of Research ProFI(French National Research Agency (ANR)); PHENOMIN (French National Infrastructure); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Henan Province, China; INTEGRATE; MSDAVENIR; PHENOMIN	We thank D. Mori, C. Wulfing (University of Bristol) and A. Zarubica for discussions and E. Bergot, S. Li, T. Chao, S. Durand and the late F. Danjan for technical help. This work was supported by CNRS, INSERM, the European Research Council (ERC) under FP7 program (grant agreement no. 322465 (INTEGRATE), to B.M.) and the European Union's Horizon 2020 research and innovation program (grant agreement no. 787300 (BASILIC), to B.M.), Agence Nationale de la Recherche (BASILIC project, to M.M.), the MSDAVENIR Fund (to B.M.), the Investissement d'Avenir program of the French Ministry of Research ProFI (Proteomics French Infrastructure, ANR-10-INBS-08, to O.B.-S.), and PHENOMIN (French National Infrastructure for mouse Phenogenomics; ANR-10-INBS-07, to B.M.), the National Natural Science Foundation of China (grant nos 81471595 and 31400759, to Y.L.) and the Education Department of Henan Province, China (16HASTIT030, to Y.L.) and by fellowships from the INTEGRATE (to M.G.M, G.V., K.K. and K.C.), MSDAVENIR (to Y.O.) and PHENOMIN (to L.G.) projects.	Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Bouchet J, 2017, J IMMUNOL, V198, P2967, DOI 10.4049/jimmunol.1600671; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Caron E, 2017, CELL REP, V18, P3219, DOI 10.1016/j.celrep.2017.03.019; Celis-Gutierrez J, 2019, CELL REP, V27, P3315, DOI 10.1016/j.celrep.2019.05.041; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Choi S, 2017, NAT IMMUNOL, V18, P433, DOI 10.1038/ni.3692; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; de Kreuk BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073962; Ditlev JA, 2019, ELIFE, V8, DOI 10.7554/eLife.42695; Gaud G, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3083; Geng LP, 1999, J IMMUNOL, V163, P5753; Giuriato S, 2003, BIOCHEM J, V376, P199, DOI 10.1042/BJ20030581; Goulden BD, 2019, J CELL BIOL, V218, P1066, DOI 10.1083/jcb.201809026; Hashimoto-Tane A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00255; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Huang YP, 2005, J BIOL CHEM, V280, P23576, DOI 10.1074/jbc.M413201200; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Lasserre R, 2011, J CELL BIOL, V195, P839, DOI 10.1083/jcb.201103105; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Marcos T, 2014, FEBS J, V281, P3844, DOI 10.1111/febs.12912; Mehta M, 2018, P NATL ACAD SCI USA, V115, pE11331, DOI 10.1073/pnas.1720209115; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Seki A, 2018, J EXP MED, V215, P985, DOI 10.1084/jem.20171626; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Stanford SM, 2010, SEMIN IMMUNOPATHOL, V32, P127, DOI 10.1007/s00281-010-0201-4; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Voisinne G, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166837; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Xu Q, 2019, P NATL ACAD SCI USA, V116, P982, DOI 10.1073/pnas.1807484116; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Yi J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08064-2; Zvezdova E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1576	41	46	46	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1530	+		10.1038/s41590-019-0489-8	http://dx.doi.org/10.1038/s41590-019-0489-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591574	Green Accepted, Green Submitted			2022-12-18	WOS:000492309600022
J	Zhou, XF; Yu, JY; Cheng, XH; Zhao, BY; Manyam, GC; Zhang, L; Schluns, K; Li, PW; Wang, J; Sun, SC				Zhou, Xiaofei; Yu, Jiayi; Cheng, Xuhong; Zhao, Baoyu; Manyam, Ganiraju C.; Zhang, Li; Schluns, Kimberly; Li, Pingwei; Wang, Jing; Sun, Shao-Cong			The deubiquitinase Otub1 controls the activation of CD8(+) T cells and NK cells by regulating IL-15-mediated priming	NATURE IMMUNOLOGY			English	Article							ADOPTIVE IMMUNOTHERAPY; MEMORY; CANCER; IL-15; HOMEOSTASIS; NAIVE; UBIQUITINATION; PROLIFERATION; INHIBITION; EXPRESSION	CD8(+) T cells and natural killer (NK) cells are central cellular components of immune responses against pathogens and cancer, which rely on interleukin (IL)-15 for homeostasis. Here we show that IL-15 also mediates homeostatic priming of CD8(+) T cells for antigen-stimulated activation, which is controlled by a deubiquitinase, Otub1. IL-15 mediates membrane recruitment of Otub1, which inhibits ubiquitin-dependent activation of AKT, a kinase that is pivotal for T cell activation and metabolism. Otub1 deficiency in mice causes aberrant responses of CD8(+) T cells to IL-15, rendering naive CD8(+) T cells hypersensitive to antigen stimulation characterized by enhanced metabolic reprograming and effector functions. Otub1 also controls the maturation and activation of NK cells. Deletion of Otub1 profoundly enhances anticancer immunity by unleashing the activity of CD8(+) T cells and NK cells. These findings suggest that Otub1 controls the activation of CD8(+) T cells and NK cells by functioning as a check-point of IL-15-mediated priming.	[Zhou, Xiaofei; Yu, Jiayi; Cheng, Xuhong; Schluns, Kimberly; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Zhao, Baoyu; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Manyam, Ganiraju C.; Zhang, Li; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Schluns, Kimberly; Wang, Jing; Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 78229 USA; [Yu, Jiayi] Therapeut Tumor Microenvironm Strategies, Pittsburgh, PA USA; [Zhang, Li] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; University of Cincinnati	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sun, SC (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 78229 USA.	ssun@mdanderson.org		Li, Pingwei/0000-0002-1815-3107; Sun, Shao-Cong/0000-0001-7353-9400	NIH [AI64639]; National Institutes of Health [AI057555, GM84459, AI121458-01A1, AI145287]; Cancer Prevention & Research Institute of Texas [RP160188]; Bridge Biotherapeutics; Nektar Therapeutics; NIH/NCI [P30 CA016672]; Mission Therapeutics; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064639, R01AI057555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas; Bridge Biotherapeutics; Nektar Therapeutics; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mission Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Dubois (NCI/NIH) and Q. Yi (Cleveland Clinic) for cell lines and D. Durocher (Lunenfeld-Tanenbaum Research Institute) and P. Martin (University of Nice Sophia Antipolis) for plasmids. This study was supported by NIH grant AI64639 (to S.-C. S.) and partially supported by the following grants: National Institutes of Health grants AI057555 and GM84459 (to S.-C.S.), AI121458-01A1 (to K.S.) and AI145287 (to P.L.); Cancer Prevention & Research Institute of Texas grant RP160188 (to K.S.); Bridge Biotherapeutics (to S.-C.S.); Mission Therapeutics (to S.-C.S.); and Nektar Therapeutics (to K.S.). This study was also supported by NIH/NCI grant P30 CA016672 and used the flow cytometry, sequencing and microarray, and animal facility of the Cancer Center Support Grant-shared resources at the MD Anderson Cancer Center.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cammann C, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0104-x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Crouse J, 2015, TRENDS IMMUNOL, V36, P49, DOI 10.1016/j.it.2014.11.001; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Durgeau A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00014; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Huang PL, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0058-2; Jethwa N, 2015, J CELL SCI, V128, P3456, DOI 10.1242/jcs.172775; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kim EH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00020; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Lodolce JP, 2002, CYTOKINE GROWTH F R, V13, P429, DOI 10.1016/S1359-6101(02)00029-1; Maueroder C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00212; McKinney EF, 2018, NAT IMMUNOL, V19, P213, DOI 10.1038/s41590-018-0045-y; Mishra A, 2014, CLIN CANCER RES, V20, P2044, DOI 10.1158/1078-0432.CCR-12-3603; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Polansky JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19699; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Rosenberg J, 2018, CURR OPIN CHEM ENG, V19, P9, DOI 10.1016/j.coche.2017.11.006; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Waldmann TA, 2015, CANCER IMMUNOL RES, V3, P219, DOI 10.1158/2326-6066.CIR-15-0009; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yu JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7074; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	53	46	47	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					879	+		10.1038/s41590-019-0405-2	http://dx.doi.org/10.1038/s41590-019-0405-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31182807	Green Accepted			2022-12-18	WOS:000471891900018
J	Singhania, A; Wilkinson, RJ; Rodrigue, M; Haldar, P; O'Garra, A				Singhania, Akul; Wilkinson, Robert J.; Rodrigue, Marc; Haldar, Pranabashis; O'Garra, Anne			The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis	NATURE IMMUNOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; I IFN; RECURRENT TUBERCULOSIS; CYNOMOLGUS MACAQUES; LUNG INFLAMMATION; HOST-RESISTANCE; EXPRESSION; INFECTION; DISEASE	Blood transcriptomics analysis of tuberculosis has revealed an interferon-inducible gene signature that diminishes in expression after successful treatment; this promises improved diagnostics and treatment monitoring, which are essential for the eradication of tuberculosis. Sensitive radiography revealing lung abnormalities and blood transcriptomics have demonstrated heterogeneity in patients with active tuberculosis and exposed asymptomatic people with latent tuberculosis, suggestive of a continuum of infection and immune states. Here we describe the immune response to infection with Mycobacterium tuberculosis revealed through the use of transcriptomics, as well as differences among clinical phenotypes of infection that might provide information on temporal changes in host immunity associated with evolving infection. We also review the diverse blood transcriptional signatures, composed of small sets of genes, that have been proposed for the diagnosis of tuberculosis and the identification of at-risk asymptomatic people and suggest novel approaches for the development of such biomarkers for clinical use.	[Singhania, Akul; O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, London, England; [Wilkinson, Robert J.] Francis Crick Inst, Lab TB, London, England; [Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England; [Wilkinson, Robert J.] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, ZA-7925 Cape Town, South Africa; [Rodrigue, Marc] BioMerieux SA, Med Diagnost Discovery Dept, Marcy Letoile, France; [Haldar, Pranabashis] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Resp Biomed Res Ctr, Leicester, Leics, England; [O'Garra, Anne] Imperial Coll London, Natl Heart & Lung Inst, London, England	Francis Crick Institute; Francis Crick Institute; Imperial College London; University of Cape Town; bioMerieux; University of Leicester; Imperial College London	O'Garra, A (corresponding author), Francis Crick Inst, Lab Immunoregulat & Infect, London, England.; O'Garra, A (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	anne.ogarra@crick.ac.uk	Singhania, Akul/I-4633-2019	Singhania, Akul/0000-0002-6941-3618; O'Garra, Anne/0000-0001-9845-6134; Haldar, Pranabashis/0000-0002-1572-5421; Wilkinson, Robert/0000-0002-2753-1800	Francis Crick Institute [Crick 10126, Crick 10468, Crick 10128]; Cancer Research UK; UK Medical Research Council; Wellcome Trust [104803, 203135]; MRC South Africa under strategic health innovation partnerships [EDCTP SR1A 2015-1065]; US National Institutes of Health [019 AI 111276, UO1AI115940]; NIHR Leicester Biomedical Research Centre; University of Leicester; Medical Diagnostic Discovery Department, bioMerieux SA, Marcy l'Etoile, France; MRC [MC_U117565642, MC_U117588499] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111276, U01AI115940] Funding Source: NIH RePORTER	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC South Africa under strategic health innovation partnerships; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Leicester Biomedical Research Centre; University of Leicester; Medical Diagnostic Discovery Department, bioMerieux SA, Marcy l'Etoile, France; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.S., R.J.W. and A.O.G. were funded by The Francis Crick Institute (Crick 10126 and Crick 10468 for A.O.G. and A.S., and Crick 10128 for R.J.W.), which receives its core funding from Cancer Research UK, the UK Medical Research Council and the Wellcome Trust. R.J.W. was supported by the Wellcome Trust (104803 and 203135); MRC South Africa under strategic health innovation partnerships EDCTP SR1A 2015-1065 and the US National Institutes of Health (019 AI 111276 and UO1AI115940). P.H. was supported by NIHR Leicester Biomedical Research Centre and the University of Leicester. M.R. was supported by Medical Diagnostic Discovery Department, bioMerieux SA, Marcy l'Etoile, France. The views expressed are those of the author(s) and not necessarily those of the NHS the NIHR or the Department of Health.	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Berry MPR, 2013, CURR OPIN IMMUNOL, V25, P579, DOI 10.1016/j.coi.2013.08.003; Blankley S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162220; Blankley S, 2016, EUR RESPIR J, V47, P1873, DOI 10.1183/13993003.02121-2015; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Cadena AM, 2017, NAT REV IMMUNOL, V17, P691, DOI 10.1038/nri.2017.69; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Carmona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067277; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; Chen DY, 2008, BIOCHEMISTRY-MOSCOW+, V73, P702, DOI 10.1134/S0006297908060114; Clayton K, 2017, AM J RESP CRIT CARE, V196, P655, DOI 10.1164/rccm.201706-1248LE; Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cox H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002238; Cox HS, 2015, B WORLD HEALTH ORGAN, V93, P491, DOI 10.2471/BLT.14.138925; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Divangahi M, 2015, TRENDS IMMUNOL, V36, P307, DOI 10.1016/j.it.2015.03.005; Domaszewska T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11812-x; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426; Elkington P, 2016, TRENDS IMMUNOL, V37, P815, DOI 10.1016/j.it.2016.09.007; Esmail H, 2018, ANNU REV IMMUNOL, V36, P603, DOI 10.1146/annurev-immunol-042617-053420; Esmail H, 2018, P NATL ACAD SCI USA, V115, pE964, DOI 10.1073/pnas.1711853115; Esmail H, 2016, NAT MED, V22, P1090, DOI 10.1038/nm.4161; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Gideon HP, 2016, J IMMUNOL, V197, P4817, DOI 10.4049/jimmunol.1601138; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Leong S, 2018, TUBERCULOSIS, V109, P41, DOI 10.1016/j.tube.2018.01.002; Lin PL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005739; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Llewelyn M, 2000, THORAX, V55, P129, DOI 10.1136/thorax.55.2.129; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2016, EMBO MOL MED, V8, P86, DOI 10.15252/emmm.201505790; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; McNab FW, 2014, J IMMUNOL, V193, P3600, DOI 10.4049/jimmunol.1401088; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; Moreira-Teixeira L, 2018, J EXP MED, V215, P1273, DOI 10.1084/jem.20180325; Moreira-Teixeira L, 2017, J IMMUNOL, V199, P613, DOI 10.4049/jimmunol.1601340; Moreira-Teixeira L, 2016, J IMMUNOL, V197, P4714, DOI 10.4049/jimmunol.1600584; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Namasivayam S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0286-2; Bang ND, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1923-2; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; PAN L, 2017, ONCOTARGET, V0008; Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P2229, DOI 10.1128/JCM.35.9.2229-2234.1997; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Roe JK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87238; Sambarey A, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0005-4; Scriba TJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006687; Singhania A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04579-w; Suliman S., 2018, AM J RESP CRIT CARE; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; Uys P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144487; van Helden PD, 2008, J INFECT DIS, V197, P172, DOI 10.1086/523829; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; van Rie A, 1999, J INFECT DIS, V180, P1608, DOI 10.1086/315054; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Walter Nicholas D, 2016, Lancet Respir Med, V4, pe28, DOI 10.1016/S2213-2600(16)30038-8; Walter ND, 2016, J CLIN MICROBIOL, V54, P274, DOI 10.1128/JCM.01990-15; Ward CM, 2007, EUR J PEDIATR, V166, P981, DOI 10.1007/s00431-006-0339-1; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; WHO, 2017, GLOB TUB REP; Wiens KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005809; Wipperman MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10346-6; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1; Zhang GL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02611-z; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	100	46	49	5	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1159	1168		10.1038/s41590-018-0225-9	http://dx.doi.org/10.1038/s41590-018-0225-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333612	Green Accepted, Green Submitted			2022-12-18	WOS:000447632200011
J	Salerno, F; Engels, S; van den Biggelaar, M; van Alphen, FPJ; Guislain, A; Zhao, WQ; Hodge, DL; Bell, SE; Medema, JP; von Lindern, M; Turner, M; Young, HA; Wolkers, MC				Salerno, Fiamma; Engels, Sander; van den Biggelaar, Maartje; van Alphen, Floris P. J.; Guislain, Aurelie; Zhao, Wanqi; Hodge, Deborah L.; Bell, Sarah E.; Medema, Jan Paul; von Lindern, Marieke; Turner, Martin; Young, Howard A.; Wolkers, Monika C.			Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells	NATURE IMMUNOLOGY			English	Article							BINDING PROTEINS ZFP36L1; AU-RICH ELEMENT; CD8(+) T; POSTTRANSCRIPTIONAL REGULATION; HOMEOSTATIC PROLIFERATION; IFN-GAMMA; EFFECTOR; EXPRESSION; INNATE; RESPONSES	Memory T cells are critical for the immune response to recurring infections. Their instantaneous reactivity to pathogens is empowered by the persistent expression of cytokine-encoding mRNAs. How the translation of proteins from pre-formed cytokine-encoding mRNAs is prevented in the absence of infection has remained unclear. Here we found that protein production in memory T cells was blocked via a 3' untranslated region (3' UTR)-mediated process. Germline deletion of AU-rich elements (AREs) in the Ifng-3' UTR led to chronic cytokine production in memory T cells. This aberrant protein production did not result from increased expression and/or half-life of the mRNA. Instead, AREs blocked the recruitment of cytokine-encoding mRNA to ribosomes; this block depended on the ARE-binding protein ZFP36L2. Thus, AREs mediate repression of translation in mouse and human memory T cells by preventing undesirable protein production from pre-formed cytokine-encoding mRNAs in the absence of infection.	[Salerno, Fiamma; Engels, Sander; Guislain, Aurelie; Zhao, Wanqi; von Lindern, Marieke; Wolkers, Monika C.] Univ Amsterdam, AMC, Dept Hematopoiesis, Sanquin Res, Amsterdam, Netherlands; [Salerno, Fiamma; Engels, Sander; Guislain, Aurelie; Zhao, Wanqi; von Lindern, Marieke; Wolkers, Monika C.] Univ Amsterdam, AMC, Landsteiner Lab, Amsterdam, Netherlands; [van den Biggelaar, Maartje; van Alphen, Floris P. J.] Sanquin Res, Dept Plasma Prot, Amsterdam, Netherlands; [Hodge, Deborah L.; Young, Howard A.] NCI, Lab Expt Immunol, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Bell, Sarah E.; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham, England; [Medema, Jan Paul] Univ Amsterdam, AMC, CEMM, Lab Expt Oncol & Radiobiol LEXOR, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Amsterdam; Academic Medical Center Amsterdam	Wolkers, MC (corresponding author), Univ Amsterdam, AMC, Dept Hematopoiesis, Sanquin Res, Amsterdam, Netherlands.; Wolkers, MC (corresponding author), Univ Amsterdam, AMC, Landsteiner Lab, Amsterdam, Netherlands.	m.wolkers@sanquin.nl	von Lindern, Marieke/AAH-2350-2020; Young, Howard/R-5140-2019; Young, Howard/A-6350-2008; Turner, Martin/N-9976-2014	Young, Howard/0000-0002-3118-5111; Salerno, Fiamma/0000-0002-8595-4051; von Lindern, Marieke/0000-0001-6162-6320; Turner, Martin/0000-0002-3801-9896; Medema, Jan Paul/0000-0003-3045-2924	Biotechnology and Biological Sciences Research Council; Dutch Science Foundation (VENI grant) [916.76.127]; Dutch Science Foundation (VIDI grant) [917.14.314]; intramural research program of the US NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC009283] Funding Source: NIH RePORTER; BBSRC [BBS/E/B/000C0428, BBS/E/B/000C0407, BBS/E/B/000C0427, BB/J00152X/1, BBS/E/B/0000H322] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dutch Science Foundation (VENI grant); Dutch Science Foundation (VIDI grant); intramural research program of the US NCI, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the animal caretakers of the NKI and the FACS facility of Sanquin Research and the Babraham Institute for excellent assistance. We thank D. Zehn (TU Munich) for the LM-OVA strain, J. Rohr (University of Freiburg) for Listeria cultures; H. Meijer for sharing the sucrose cushion protocol; G. Stoecklin (University of Heidelberg) for the 4xS1m aptamer construct; R. Arens (Leiden University), T. Schumacher (Netherlands Cancer Institute) and J. den Haan (Free University, Amsterdam) for providing mice; S. Libregts, B. van Steensel, K. Moore and B. Nicolet for technical help and advice; and D. Amsen, M. Nolte and R. van Lier for critical reading of the manuscript. M.T. and S.E.B. are supported by the Biotechnology and Biological Sciences Research Council. D.L.H. and H.A.Y. are funded through the intramural research program of the US NCI, NIH. The use of materials and reagents does not imply any endorsement of these products by the US government. This research was supported by the Dutch Science Foundation (VENI grant 916.76.127/VIDI grant 917.14.314, to M.C.W.).	Abdelsamed HA, 2017, J EXP MED, V214, P1593, DOI 10.1084/jem.20161760; Beisang D, 2012, WIRES RNA, V3, P719, DOI 10.1002/wrna.1125; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Galloway A, 2016, SCIENCE, V352, P453, DOI 10.1126/science.aad5978; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grammatikakis I, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1372; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; Hodge DL, 2014, J AUTOIMMUN, V53, P33, DOI 10.1016/j.jaut.2014.02.003; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/nmeth.2834, 10.1038/NMETH.2834]; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Salerno F, 2017, P NATL ACAD SCI USA, V114, P9677, DOI 10.1073/pnas.1704227114; Salerno F, 2016, J IMMUNOL, V196, P3695, DOI 10.4049/jimmunol.1501997; Salerno F, 2015, BIOCHEM SOC T, V43, P1201, DOI 10.1042/BST20150154; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Swamy M, 2016, IMMUNITY, V44, P1091, DOI 10.1016/j.immuni.2016.04.011; Swanson BJ, 2002, IMMUNITY, V17, P605, DOI 10.1016/S1074-7613(02)00456-9; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Turner M, 2012, CURR OPIN IMMUNOL, V24, P160, DOI 10.1016/j.coi.2012.01.011; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Vlasova-St Louis I, 2014, J INTERF CYTOK RES, V34, P233, DOI 10.1089/jir.2013.0108; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215	64	46	47	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					828	+		10.1038/s41590-018-0155-6	http://dx.doi.org/10.1038/s41590-018-0155-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ6CZ	29988089	Green Accepted, Green Submitted			2022-12-18	WOS:000457272600002
J	Ryu, H; Lim, H; Choi, G; Park, YJ; Cho, M; Na, H; Ahn, CW; Kim, YC; Kim, WU; Lee, SH; Chung, Y				Ryu, Heeju; Lim, Hoyong; Choi, Garam; Park, Young-Jun; Cho, Minkyoung; Na, Hyeongjin; Ahn, Chul Won; Kim, Young Chul; Kim, Wan-Uk; Lee, Sang-Hak; Chung, Yeonseok			Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; INTERFERON-GAMMA; LIPID-METABOLISM; TNF-ALPHA; LUPUS; ATHEROSCLEROSIS; INTERLEUKIN-27; PATHOGENESIS; INDUCTION; ARTHRITIS	The incidence of atherosclerosis is higher among patients with systemic lupus erythematosus (SLE); however, the mechanism by which an atherogenic environment affects autoimmunity remains unclear. We found that reconstitution of atherosclerosis-prone Apoe(-/-) and Ldlr(-/-) mice with bone marrow from lupus-prone BXD2 mice resulted in increased autoantibody production and glomerulonephritis. This enhanced disease was associated with an increase in CXCR3(+) follicular helper T cells (T-FH cells). T-FH cells isolated from Apoe(-/-) mice had higher expression of genes associated with inflammatory responses and SLE and were more potent in inducing production of the immunoglobulin IgG2c. Mechanistically, the atherogenic environment induced the cytokine IL-27 from dendritic cells in a Toll-like receptor 4 (TLR4)-dependent manner, which in turn triggered the differentiation of CXCR3(+) T-FH cells while inhibiting the differentiation of follicular regulatory T cells. Blockade of IL-27 signals diminished the increased T-FH cell responses in atherogenic mice. Thus, atherogenic dyslipidemia augments autoimmune T-FH cell responses and subsequent IgG2c production in a TLR4- and IL-27-dependent manner.	[Ryu, Heeju; Lim, Hoyong; Choi, Garam; Park, Young-Jun; Cho, Minkyoung; Na, Hyeongjin; Chung, Yeonseok] Seoul Natl Univ, Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea; [Ryu, Heeju; Choi, Garam; Park, Young-Jun; Na, Hyeongjin; Ahn, Chul Won; Kim, Young Chul; Chung, Yeonseok] Seoul Natl Univ, Coll Pharm, Plus Program BK21, Seoul, South Korea; [Ahn, Chul Won; Kim, Young Chul] Seoul Natl Univ, Coll Pharm, Lab Toxicol, Seoul, South Korea; [Kim, Wan-Uk] Catholic Univ Korea, Ctr Integrat Rheumatoid Transcript & Dynam, Seoul, South Korea; [Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Yonsei University; Yonsei University Health System	Chung, Y (corresponding author), Seoul Natl Univ, Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea.; Chung, Y (corresponding author), Seoul Natl Univ, Coll Pharm, Plus Program BK21, Seoul, South Korea.	yeonseok@snu.ac.kr	Kim, Wan-Uk/AAO-8502-2020; Park, Youngjun/AAK-2026-2020	Kim, Wan-Uk/0000-0001-8224-8496	National Research Foundation of Korea [2014R1A2A1A11054364, 2017R1A2B3007392, 2017K1A1A2004511, 2015R1D1A1A01059719]	National Research Foundation of Korea(National Research Foundation of Korea)	We thank K.-W. Kim and S.-J. Bae for support in flow cytometry; S. Akira (Osaka University) and S-Y. Sung (Seoul National University) for Stat3<SUP>fl/fl</SUP> and Tlr4<SUP>-/-</SUP> mice; H. S. Kim (Ulsan University) for Stat1<SUP>-/-</SUP> mice; J.-H. Choi (Hanyang University) for Apoe<SUP>-/-</SUP> mice; S-A. Yoo (The Catholic University of Korea) for animal models; the entire Chung lab for suggestion and discussion; and J. Reynolds, G. Martinez and D.-S. Kuen for proofreading the manuscript. Supported by the National Research Foundation of Korea (research grants 2014R1A2A1A11054364, 2017R1A2B3007392 and 2017K1A1A2004511 to Y.C., and 2015R1D1A1A01059719 to M.C.).	Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Cai YH, 2012, CELL MOL IMMUNOL, V9, P302, DOI 10.1038/cmi.2012.15; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chang Jae-Hoon, 2014, Immune Netw, V14, P227, DOI 10.4110/in.2014.14.5.227; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Chung CP, 2007, J RHEUMATOL, V34, P1849; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Dorosz S. A., 2015, MEDIAT INFLAMM, V2015, P16; Ghazizadeh R, 2011, AM J MED SCI, V341, P394, DOI 10.1097/MAJ.0b013e3181ff8eeb; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6074; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Jin W., 2012, MEDIAT INFLAMM, V2012, P10; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kim HS, 2011, J IMMUNOL, V187, P4007, DOI 10.4049/jimmunol.1101654; Kim YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137044; Kimball AB, 2008, DERMATOLOGY, V217, P27, DOI 10.1159/000121333; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leng CH, 2010, MOL IMMUNOL, V47, P2015, DOI 10.1016/j.molimm.2010.04.012; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; McGeachy MJ, 2016, J IMMUNOL, V196; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Owaki T, 2005, J IMMUNOL, V175, P2191, DOI 10.4049/jimmunol.175.4.2191; Pan HF, 2010, EXPERT OPIN THER TAR, V14, P479, DOI 10.1517/14728221003769911; Park Hong-Jai, 2014, Immune Netw, V14, P21, DOI 10.4110/in.2014.14.1.21; Qiu HN, 2016, MOL CELL BIOCHEM, V411, P1, DOI 10.1007/s11010-015-2563-3; Reynolds CM, 2012, MOL NUTR FOOD RES, V56, P1212, DOI 10.1002/mnfr.201200058; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ryu H, 2015, CYTOKINE, V74, P219, DOI 10.1016/j.cyto.2015.03.009; Shin C, 2015, CELL REP, V11, P1929, DOI 10.1016/j.celrep.2015.05.042; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Vijayan D, 2016, J IMMUNOL, V197, P3008, DOI 10.4049/jimmunol.1600652; Wang LM, 2016, EUR J IMMUNOL, V46, P2454, DOI 10.1002/eji.201546274; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Xia LP, 2015, SCAND J RHEUMATOL, V44, P200, DOI 10.3109/03009742.2014.962080; Yoo SA, 2005, J IMMUNOL, V174, P5846, DOI 10.4049/jimmunol.174.9.5846; Yu HH, 2015, ATHEROSCLEROSIS, V243, P11, DOI 10.1016/j.atherosclerosis.2015.08.030; Yuan JS, 2016, BIOMED REP, V4, P68, DOI 10.3892/br.2015.544	52	46	50	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					583	+		10.1038/s41590-018-0102-6	http://dx.doi.org/10.1038/s41590-018-0102-6			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29713015				2022-12-18	WOS:000433041500024
J	Dutta, D; Barr, VA; Akpan, I; Mittelstadt, PR; Singha, LI; Samelson, LE; Ashwell, JD				Dutta, Debjani; Barr, Valarie A.; Akpan, Itoro; Mittelstadt, Paul R.; Singha, Laishram I.; Samelson, Lawrence E.; Ashwell, Jonathan D.			Recruitment of calcineurin to the TCR positively regulates T cell activation	NATURE IMMUNOLOGY			English	Article							IMMUNOPHILIN-LIGAND COMPLEXES; CYCLOSPORINE-A; ANTIGEN RECEPTOR; TYROSINE KINASE; SIGNALING PATHWAYS; PHOSPHORYLATION; ZAP-70; NFAT; INHIBITION; LFA-1	Calcineurin is a phosphatase whose primary targets in T cells are NFAT transcription factors, and inhibition of calcineurin activity by treatment with cyclosporin A (CsA) or FK506 is a cornerstone of immunosuppressive therapies. Here we found that calcineurin was recruited to the T cell antigen receptor (TCR) signaling complex, where it reversed inhibitory phosphorylation of the tyrosine kinase Lck on Ser59 (Lck(S59)). Loss of calcineurin activity impaired phosphorylation of Tyr493 of the tyrosine kinase ZAP-70 (ZAP-70(Y493)), as well as some downstream pathways in a manner consistent with signaling in cells expressing Lck(S59A) (Lck that cannot be phosphorylated) or Lck(S59E) (a phosphomimetic mutant). Notably, CsA inhibited integrin-LFA-1-dependent and NFAT-independent adhesion of T cells to the intercellular adhesion molecule ICAM-1, with little effect on cells expressing mutant Lck. These results provide new understanding of how widely used immunosuppressive drugs interfere with essential processes in the immune response.	[Dutta, Debjani; Mittelstadt, Paul R.; Singha, Laishram I.; Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; [Barr, Valarie A.; Akpan, Itoro; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Singha, Laishram I.] St Anthonys Coll, Dept Biotechnol, Shillong, Meghalaya, India	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov	He, Liye/C-8843-2015; Laishram, Indira Singha/AAK-3082-2020	He, Liye/0000-0002-6632-2112; Laishram, Indira Singha/0000-0002-0360-2168	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH; Indian Department of Biotechnology, Ministry of Science and Technology; NATIONAL CANCER INSTITUTE [ZICBC010978, ZIABC010774, ZIABC011715] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Indian Department of Biotechnology, Ministry of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Germain (NIAID) for the DCEK cells and Amphotropic Phoenix packaging cell lines; B. Dong for technical assistance; and S. Koyasu for suggesting that we investigate whether CsA has an effect on the activation of p38 via the alternative pathway. Supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH and the Overseas Associateship funded by the Indian Department of Biotechnology, Ministry of Science and Technology (L.I.S.).	Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; Alam MS, 2014, J EXP MED, V211, P1257, DOI 10.1084/jem.20131917; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Brennan M, 2014, ADV EXP MED BIOL, V819, P157, DOI 10.1007/978-94-017-9153-3_11; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Cho CS, 2003, INT IMMUNOL, V15, P1369, DOI 10.1093/intimm/dxg138; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; DUTZ JP, 1993, J IMMUNOL, V150, P2591; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Grybko MJ, 2007, J BIOL CHEM, V282, P18009, DOI 10.1074/jbc.M702222200; Hayden-Martinez K, 2000, J IMMUNOL, V165, P3713, DOI 10.4049/jimmunol.165.7.3713; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; Nurmi SM, 2007, J BIOL CHEM, V282, P968, DOI 10.1074/jbc.M608524200; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Paster W, 2015, EMBO J, V34, P393, DOI 10.15252/embj.201387725; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WATTS JD, 1993, J BIOL CHEM, V268, P23275; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Zeyda M, 2007, J LEUKOCYTE BIOL, V81, P319, DOI 10.1189/jlb.0606378	40	46	48	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					196	204		10.1038/ni.3640	http://dx.doi.org/10.1038/ni.3640			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27941787	Green Accepted			2022-12-18	WOS:000392360900013
J	Fang, V; Chaluvadi, VS; Ramos-Perez, WD; Mendoza, A; Baeyens, A; Rivera, R; Chun, J; Cammer, M; Schwab, SR				Fang, Victoria; Chaluvadi, V. Sai; Ramos-Perez, Willy D.; Mendoza, Alejandra; Baeyens, Audrey; Rivera, Richard; Chun, Jerold; Cammer, Michael; Schwab, Susan R.			Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-gamma response	NATURE IMMUNOLOGY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; DENDRITIC CELLS; T-CELLS; SPHINGOSINE 1-PHOSPHATE; B-CELLS; RECALL RESPONSES; SPHINGOSINE-1-PHOSPHATE; EGRESS; CXCR4; MIGRATION	The lymph node periphery is an important site for many immunological functions, from pathogen containment to the differentiation of helper T cells, yet the cues that position cells in this region are largely undefined. Here, through the use of a reporter for the signaling lipid SIP (sphingosine 1-phosphate), we found that cells sensed higher concentrations of SIP in the medullary cords than in the T cell zone and that the S1P transporter SPNS2 on lymphatic endothelial cells generated this gradient. Natural killer (NK) cells are located at the periphery of the lymph node, predominantly in the medulla, and we found that expression of SPNS2, expression of the SIP receptor S1PR5 on NK cells, and expression of the chemokine receptor CXCR4 were all required for NK cell localization during homeostasis and rapid production of interferon-gamma by NK cells after challenge. Our findings elucidate the spatial cues for NK cell organization and reveal a previously unknown role for SIP in positioning cells within the medulla.	[Fang, Victoria; Chaluvadi, V. Sai; Ramos-Perez, Willy D.; Mendoza, Alejandra; Baeyens, Audrey; Schwab, Susan R.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10012 USA; [Rivera, Richard; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Cammer, Michael] NYU, Langone Med Ctr, Microscopy Core, Off Collaborat Sci, New York, NY USA; [Ramos-Perez, Willy D.] Univ Puerto Rico, Sch Med, Microbiol & Med Zool Dept, San Juan, PR 00936 USA	New York University; Scripps Research Institute; New York University; NYU Langone Medical Center; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Schwab, SR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10012 USA.	susan.schwab@med.nyu.edu	Chun, Jerold/Y-4670-2019	Chaluvadi, Venkata/0000-0002-0055-149X; Fang, Victoria/0000-0001-9376-1279; Cammer, Michael/0000-0003-4930-1739; Schwab, Susan/0000-0002-0834-0822	US National Institutes of Health [R01 AI085166, T32 AI10085, R01 DA019674, NS084398]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853, R01AI085166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019674] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Schwab laboratory for discussions; K. Cadwell (New York University School of Medicine) for Salmonella enterica Typhimurium; M. Bigaud and V. Brinkmann (Novartis) for NIBR-0213; K. Manova, S. Fujisawa, and Y. Romin for assistance with microscopy and image analysis; and B. Breart and J. Oyster for critical reading of the manuscript. Supported by the US National Institutes of Health (R01 AI085166 to S.R.S.; T32 AI100853 to V.F. and A.M.; and R01 DA019674 and NS084398 to J.C.).	Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Coombes JL, 2012, CELL REP, V2, P124, DOI 10.1016/j.celrep.2012.06.001; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Dokun AO, 2001, J IMMUNOL, V167, P5286, DOI 10.4049/jimmunol.167.9.5286; Garcia Z, 2012, BLOOD, V120, P4744, DOI 10.1182/blood-2012-02-408179; Garrod KR, 2007, P NATL ACAD SCI USA, V104, P12081, DOI 10.1073/pnas.0702867104; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Mayol K, 2011, BLOOD, V118, P4863, DOI 10.1182/blood-2011-06-362574; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Ramos-Perez WD, 2015, NAT IMMUNOL, V16, P1245, DOI 10.1038/ni.3296; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schmidt TH, 2013, J EXP MED, V210, P1099, DOI 10.1084/jem.20122574; Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Woodruff MC, 2014, J EXP MED, V211, P1611, DOI 10.1084/jem.20132327; Zhang Y, 2016, ELIFE, V5, DOI 10.7554/eLife.18156	48	46	46	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					15	25		10.1038/ni.3619	http://dx.doi.org/10.1038/ni.3619			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27841869	Green Accepted			2022-12-18	WOS:000390080000006
J	Chandra, S; Zhao, M; Budelsky, A; Pulido, AD; Day, J; Fu, Z; Siegel, L; Smith, D; Kronenberg, M				Chandra, Shilpi; Zhao, Meng; Budelsky, Alison; Pulido, Alvaro de Mingo; Day, Jeremy; Fu, Zheng; Siegel, Lori; Smith, Dirk; Kronenberg, Mitchell			A new mouse strain for the analysis of invariant NKT cell function	NATURE IMMUNOLOGY			English	Letter							T-CELLS; MICE		[Chandra, Shilpi; Zhao, Meng; Pulido, Alvaro de Mingo; Day, Jeremy; Fu, Zheng; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Budelsky, Alison; Siegel, Lori; Smith, Dirk] Amgen Inc, Dept Inflammat Res, Seattle, WA USA	La Jolla Institute for Immunology; Amgen	Chandra, S (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	mitch@lji.org	Fu, Zheng/M-6304-2014; Kronenberg, Mitchell/AAT-6078-2021; De Mingo Pulido, Alvaro/AAK-4809-2021; de Mingo Pulido, Alvaro/AAU-7552-2021	Fu, Zheng/0000-0002-0281-3043; De Mingo Pulido, Alvaro/0000-0001-9814-1837; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI071922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR064194] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI071922, R37 AI71922] Funding Source: Medline; NIAMS NIH HHS [T32 AR064194] Funding Source: Medline; PHS HHS [R01 105215] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Meyer EH, 2008, ANNU REV MED, V59, P281, DOI 10.1146/annurev.med.59.061506.154139; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543	7	46	46	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					799	800		10.1038/ni.3203	http://dx.doi.org/10.1038/ni.3203			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26075912	Green Accepted			2022-12-18	WOS:000358299200006
J	Sheedy, FJ; Moore, KJ				Sheedy, Frederick J.; Moore, Kathryn J.			IL-1 signaling in atherosclerosis: sibling rivalry	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMASOME ACTIVATION; DEFICIENT MICE; ATHEROGENESIS	Signaling via the interleukin 1 (IL-1) family, particularly by IL-1 beta, has long been linked to the pathogenesis of atherosclerosis. Findings that atherogenic fatty acids induce IL-1 alpha to promote vascular inflammation identify a key role for this less-well-studied cytokine.	[Sheedy, Frederick J.] St James Hosp, Trinity Coll, Inst Mol Med, Dublin 8, Ireland; [Moore, Kathryn J.] NYU, Sch Med, Dept Med, Marc & Ruti Bell Vasc Biol & Dis Program,Leon H C, New York, NY USA	Trinity College Dublin; New York University	Sheedy, FJ (corresponding author), St James Hosp, Trinity Coll, Inst Mol Med, Dublin 8, Ireland.	kathryn.moore@nyumc.org	Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Sheedy, Frederick/0000-0003-2645-8493; Sheedy, Frederick/0000-0002-4722-3135	NIA NIH HHS [R01 AG020255] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kamari Y, 2011, BIOCHEM BIOPH RES CO, V405, P197, DOI 10.1016/j.bbrc.2011.01.008; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Qamar A, 2012, CURR OPIN LIPIDOL, V23, P548, DOI 10.1097/MOL.0b013e328359b0a6; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252	14	46	48	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1030	1032		10.1038/ni.2711	http://dx.doi.org/10.1038/ni.2711			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048132				2022-12-18	WOS:000324584700009
J	Mantovani, A; Garlanda, C				Mantovani, Alberto; Garlanda, Cecilia			Platelet-macrophage partnership in innate immunity and inflammation	NATURE IMMUNOLOGY			English	Editorial Material							PLATELET-FACTOR-4; CELLS	Platelets and phagocytes engage in bidirectional interaction in innate immunity and inflammation. Kupffer cell-platelet cooperation results in the rapid encasement of blood-borne bacteria and host protection.	[Mantovani, Alberto; Garlanda, Cecilia] Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Med Biotechnol & Translat Med, Rozzano, Italy	IRCCS Humanitas Research Hospital; University of Milan	Mantovani, A (corresponding author), Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Rozzano, Italy.	alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022; Garlanda, Cecilia/K-4601-2016	Mantovani, Alberto/0000-0001-5578-236X; Garlanda, Cecilia/0000-0002-1510-7703				Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; COLOTTA F, 1994, AM J PATHOL, V144, P975; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107	12	46	49	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					768	770		10.1038/ni.2666	http://dx.doi.org/10.1038/ni.2666			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23867924				2022-12-18	WOS:000322010600002
J	Andrews, DM; Sullivan, LC; Baschuk, N; Chan, CJ; Berry, R; Cotterell, CL; Lin, J; Halse, H; Watt, SV; Poursine-Laurent, J; Wang, CR; Scalzo, AA; Yokoyama, WM; Rossjohn, J; Brooks, AG; Smyth, MJ				Andrews, Daniel M.; Sullivan, Lucy C.; Baschuk, Nikola; Chan, Christopher J.; Berry, Richard; Cotterell, Claire L.; Lin, Jie; Halse, Heloise; Watt, Sally V.; Poursine-Laurent, Jennifer; Wang, Chyung-Ru; Scalzo, Anthony A.; Yokoyama, Wayne M.; Rossjohn, Jamie; Brooks, Andrew G.; Smyth, Mark J.			Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; MEDIATED REJECTION; SELF-TOLERANCE; BONE-MARROW; T-CELLS; ANTIGEN; IDENTIFICATION; DISTINCT; MICE; RESPONSIVENESS	The development and function of natural killer (NK) cells is regulated by the interaction of inhibitory receptors of the Ly49 family with distinct peptide-laden major histocompatibility complex (MHC) class I molecules, although whether the Ly49 family is able bind to other MHC class I-like molecules is unclear. Here we found that the prototypic inhibitory receptor Ly49A bound the highly conserved nonclassical MHC class I molecule H2-M3 with an affinity similar to its affinity for H-2D(d). The specific recognition of H2-M3 by Ly49A regulated the 'licensing' of NK cells and mediated 'missing-self' recognition of H2-M3-deficient bone marrow. Host peptide-H2-M3 was required for optimal NK cell activity against experimental metastases and carcinogenesis. Thus, nonclassical MHC class I molecules can act as cognate ligands for Ly49 molecules. Our results provide insight into the various mechanisms that lead to NK cell tolerance.	[Andrews, Daniel M.; Baschuk, Nikola; Chan, Christopher J.; Cotterell, Claire L.; Lin, Jie; Halse, Heloise; Smyth, Mark J.] Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, Melbourne, Australia; [Andrews, Daniel M.; Baschuk, Nikola; Cotterell, Claire L.; Halse, Heloise; Watt, Sally V.; Smyth, Mark J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Sullivan, Lucy C.; Lin, Jie; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Chan, Christopher J.; Smyth, Mark J.] Monash Univ, Dept Pathol & Immunol, Prahran, Vic, Australia; [Berry, Richard; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Poursine-Laurent, Jennifer; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Wang, Chyung-Ru] Northwestern Univ, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Scalzo, Anthony A.] Univ Western Australia, Ctr Ophthalmol & Vis Sci, Crawley, Australia; [Scalzo, Anthony A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University; Monash University; Washington University (WUSTL); Northwestern University; University of Western Australia; Lions Eye Institute; University of Western Australia; Howard Hughes Medical Institute; Washington University (WUSTL)	Andrews, DM (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, St Andrews Pl, Melbourne, Australia.	daniel.andrews@petermac.org; mark.smyth@petermac.org	Rossjohn, Jamie/F-9032-2013; Smyth, Mark J/H-8709-2014	Rossjohn, Jamie/0000-0002-2020-7522; Smyth, Mark J/0000-0001-7098-7240; Brooks, Andrew/0000-0002-4085-9683; Andrews, Dan/0000-0002-5896-7885; Sullivan, Lucy/0000-0003-2907-4989; berry, richard/0000-0001-7043-0469	National Health and Medical Research Council of Australia; Cancer Australia; Cure Cancer Australia Foundation; US National Institutes of Health [AI040310]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040310, R01AI040310] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Cure Cancer Australia Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Paget for critical analysis of the manuscript; E. Hawkins, Q. Mundrea, B. Venville, N. McLaughlin and J. Sharkey for technical assistance; and B. Murphy (UC Davis Cancer Center) for the YE1/32 antibody to Ly49A. Supported by the National Health and Medical Research Council of Australia (D.M.A., L.C.S., R.B., M.J.S., A.G.B. and J.R.), Cancer Australia, the Cure Cancer Australia Foundation, the US National Institutes of Health (AI040310 to C.-R.W.) and the Howard Hughes Medical Institute (W.M.Y.).	Andoniou CE, 2006, IMMUNOL REV, V214, P239, DOI 10.1111/j.1600-065X.2006.00465.x; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; Brodin P, 2012, J IMMUNOL, V188, P2218, DOI 10.4049/jimmunol.1102801; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Chan CJ, 2008, EUR J IMMUNOL, V38, P2964, DOI 10.1002/eji.200838764; CHAN PY, 1986, J IMMUNOL, V136, P1346; Chiu NM, 1999, J EXP MED, V190, P423, DOI 10.1084/jem.190.3.423; Colmone A, 2006, MICROBES INFECT, V8, P2277, DOI 10.1016/j.micinf.2006.03.020; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Johansson S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006046; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Michaelsson J, 2000, EUR J IMMUNOL, V30, P300; NAGASAWA R, 1987, J IMMUNOL, V138, P815; Natarajan K, 1999, IMMUNITY, V11, P591, DOI 10.1016/S1074-7613(00)80134-X; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; Ohtsuka M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-178; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Sun K, 2012, BLOOD, V119, P1590, DOI 10.1182/blood-2011-08-374314; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; WANG CR, 1991, CELL, V66, P335, DOI 10.1016/0092-8674(91)90623-7; Wang J, 2002, J BIOL CHEM, V277, P1433, DOI 10.1074/jbc.M110316200; WONG S, 1991, J IMMUNOL, V147, P1417; Xu HL, 2006, J EXP MED, V203, P449, DOI 10.1084/jem.20051866; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	50	46	46	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1171	+		10.1038/ni.2468	http://dx.doi.org/10.1038/ni.2468			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23142773	Green Accepted			2022-12-18	WOS:000311217900010
J	Fraser, IDC; Germain, RN				Fraser, Iain D. C.; Germain, Ronald N.			Navigating the network: signaling cross-talk in hematopoietic cells	NATURE IMMUNOLOGY			English	Review							PROTEIN INTERACTION NETWORK; RNA-INTERFERENCE; SYSTEMS BIOLOGY; MULTIPLEXED ANALYSIS; FLUORESCENT PROTEIN; GENE-EXPRESSION; IN-VIVO; TRANSDUCTION; TYROSINE; KINASE	Recent studies in hematopoietic cells have led to a growing appreciation of the diverse modes of molecular and functional crosstalk between canonical signaling pathways. However, these intersections represent only the tip of the iceberg. Emerging global analytical methods are providing an even richer and more complete picture of the many components that measurably interact in a network manner to produce cellular responses. Here we highlight the pieces in this Focus, emphasize the limitations of the present canonical pathway paradigm, and discuss the value of a systems biology approach using more global, quantitative experimental design and data analysis strategies. Lastly, we urge caution about overly facile interpretation of genome-and proteome-level studies.	[Fraser, Iain D. C.] NIAID, Mol & Cell Biol Grp, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIAID, Immunol Grp, Program Syst Immunol & Infect Dis Modeling, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fraser, IDC (corresponding author), NIAID, Mol & Cell Biol Grp, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Germain, Ronald/ABE-7090-2020; Fraser, Iain DC/L-4735-2017; Germain, Ronald N./Z-1945-2019	Fraser, Iain DC/0000-0003-2272-3907; 	US National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001106, ZIAAI000974] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Auld DS, 2006, METHOD ENZYMOL, V414, P566, DOI 10.1016/S0076-6879(06)14029-X; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Chao TC, 2008, J R SOC INTERFACE, V5, pS139, DOI 10.1098/rsif.2008.0233.focus; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Forrester JS, 2004, MOL PHARMACOL, V65, P813, DOI 10.1124/mol.65.4.813; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Fulton RJ, 1997, CLIN CHEM, V43, P1749; FURCHGOTT RF, 1964, ANNU REV PHARMACOL, V4, P21, DOI 10.1146/annurev.pa.04.040164.000321; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Kohn KW, 2006, MOL BIOL CELL, V17, P1, DOI 10.1091/mbc.e05-09-0824; Langley JN, 1901, J PHYSIOL-LONDON, V27, P237; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; RALL TW, 1958, J BIOL CHEM, V232, P1065; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RODBELL M, 1971, J BIOL CHEM, V246, P1877; ROSS EM, 1977, J BIOL CHEM, V252, P6966; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saveliev A, 2009, NAT IMMUNOL, V10, P361, DOI 10.1038/ni.1709; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X	57	46	47	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					327	331		10.1038/ni.1711	http://dx.doi.org/10.1038/ni.1711			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295628	Green Accepted			2022-12-18	WOS:000264425800002
J	Kohler, F; Storch, B; Kulathu, Y; Herzog, S; Kuppig, S; Reth, M; Jumaa, H				Kohler, F; Storch, B; Kulathu, Y; Herzog, S; Kuppig, S; Reth, M; Jumaa, H			A leucine zipper in the N terminus confers membrane association to SLP-65	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN RECEPTOR; ADAPTER PROTEIN SLP-65; LIPID RAFTS; NEGATIVE REGULATION; LINKER PROTEIN; B-LYMPHOCYTES; ACTIVATION; BLNK; PHOSPHORYLATION; REQUIREMENT	Membrane recruitment of adaptor proteins is crucial for coupling antigen receptors to downstream signaling events. Despite the essential function of the B cell adaptor SLP-65, the mechanism of its recruitment to the plasma membrane is not yet understood. Here we show that a highly conserved leucine zipper in the SLP-65 N terminus is responsible for membrane association. Alterations in the N terminus abolished SLP-65 membrane localization and activity, both of which were restored by replacement of the N terminus with a myristoylation signal. The N terminus is an autonomous domain that confers specific localization and function when transferred to green fluorescent protein or the adaptor protein SLP-76. Our data elucidate the mechanism of SLP-65 membrane recruitment and suggest that leucine zipper motifs are essential interaction domains of signaling proteins.	Univ Freiburg, Inst Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	University of Freiburg; Max Planck Society	Jumaa, H (corresponding author), Univ Freiburg, Inst Biol 3, D-79108 Freiburg, Germany.	reth@immunbio.mpg.de; jumaa@immunbio.mpg.de		Herzog, Sebastian/0000-0001-7167-3489; Kulathu, Yogesh/0000-0002-3274-1642				Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Cheng PC, 2001, SEMIN IMMUNOL, V13, P107, DOI 10.1006/smim.2000.0302; Cussac D, 1999, FASEB J, V13, P31, DOI 10.1096/fasebj.13.1.31; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Huber M, 2000, J IMMUNOL, V165, P124, DOI 10.4049/jimmunol.165.1.124; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Ishiai M, 2000, J EXP MED, V192, P847, DOI 10.1084/jem.192.6.847; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Jumaa H, 2003, NATURE, V423, P452, DOI 10.1038/nature01608; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Romero F, 1996, CELL SIGNAL, V8, P545, DOI 10.1016/S0898-6568(96)00118-0; ROSE MD, 1990, METHODS YEAST GENETI; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	43	46	48	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					204	210		10.1038/ni1163	http://dx.doi.org/10.1038/ni1163			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15654340				2022-12-18	WOS:000226468100024
J	Wesemann, DR; Qin, HW; Kokorina, N; Benveniste, EN				Wesemann, DR; Qin, HW; Kokorina, N; Benveniste, EN			TRADD interacts with STAT1-alpha and influences interferon-gamma signaling	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PROTEIN-TYROSINE-PHOSPHATASE; CLASS-II TRANSACTIVATOR; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; IFN-GAMMA; CD40 EXPRESSION; STAT1; APOPTOSIS; INDUCTION	Tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein (TRADD) is essential in recruiting signaling molecules to the TNFR1 receptor complex. Interferon-gamma (IFN-gamma) is a potent activator of macrophages and uses signal transducer and activator of transcription 1-alpha (STAT1-alpha) for signal transduction. Here we demonstrate that IFN-gamma induces the formation of a nuclear-localized TRADD-STAT1-alpha complex. IFN-gamma-mediated STAT1-alpha phosphorylation was prolonged in cells with reduced TRADD expression. Moreover, we noted an increase in IFN-gamma-mediated STAT1-alpha DNA-binding activity, nuclear presence and transcriptional potential in the TRADD knockdown cells. These data indicate that TRADD may be involved in IFN-gamma signaling by forming a complex with STAT1-alpha within the nucleus and regulating IFN-gamma-mediated STAT1-alpha activation.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Benveniste, EN (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.	tika@uab.edu		Wesemann, Duane/0000-0002-6690-944X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039954, R01NS036765, F30NS047051] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007051, T32 AI 07051-26] Funding Source: Medline; NINDS NIH HHS [NS 36765, F30 NS 47051, NS 39954] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039; Nguyen VT, 2000, J BIOL CHEM, V275, P23674, DOI 10.1074/jbc.M002482200; Nguyen VT, 2002, J BIOL CHEM, V277, P13796, DOI 10.1074/jbc.M111906200; O'Keefe GM, 1999, EUR J IMMUNOL, V29, P1275, DOI 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T; O'Keefe GM, 2001, J IMMUNOL, V166, P2260, DOI 10.4049/jimmunol.166.4.2260; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Screaton RA, 2003, P NATL ACAD SCI USA, V100, P5211, DOI 10.1073/pnas.0431215100; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Wesemann DR, 2002, J IMMUNOL, V169, P2354, DOI 10.4049/jimmunol.169.5.2354; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhu W, 2002, J BIOL CHEM, V277, P35787, DOI 10.1074/jbc.C200346200	27	46	47	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					199	207		10.1038/ni1025	http://dx.doi.org/10.1038/ni1025			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14730360				2022-12-18	WOS:000188512000016
J	Zhang, L; Camerini, V; Bender, TP; Ravichandran, KS				Zhang, L; Camerini, V; Bender, TP; Ravichandran, KS			A nonredundant role for the adapter protein Shc in thymic T cell development	NATURE IMMUNOLOGY			English	Article							TYROSINE KINASES; ZETA-CHAIN; THYMOCYTE DIFFERENTIATION; GAMMA-CHAIN; ACTIVATION; RECEPTOR; TCR; PATHWAY; ZAP-70; PHOSPHORYLATION	Signaling via the pre-T cell receptor (pre-TCR) regulates survival, proliferation, allelic exclusion and differentiation of thymocytes. The role played by the adapter protein Shc in T cells has remained controversial, and its role in pre-TCR signaling has not been addressed. We examined Shc function in thymic T cell development using two genetic approaches. Cre-loxP-mediated inducible expression in transgenic mice of a phosphorylation-defective mutant of Shc impaired signaling through the pre-TCR as well as subsequent proliferation and differentiation. Conditional deletion of the Shc locus in thymocytes also affected thymic maturation at the same pre-TCR developmental stage. Thus, both Shc expression and its tyrosine phosphorylation play an essential and nonredundant role in thymic T cell development.	Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.		Niklas, Victoria/N-3899-2013	Niklas, Victoria/0000-0002-5990-7235	NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055761] Funding Source: NIH RePORTER; NCI NIH HHS [CA85842, R01 CA085842] Funding Source: Medline; NIGMS NIH HHS [GM-55761] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Cantrell DA, 2002, NAT REV IMMUNOL, V2, P20, DOI 10.1038/nri703; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Galandrini R, 1997, J IMMUNOL, V159, P3767; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lai KMV, 2000, GENE DEV, V14, P1132; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Michie AM, 1999, J EXP MED, V190, P1647, DOI 10.1084/jem.190.11.1647; Northrop JP, 1996, MOL CELL BIOL, V16, P2255; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Plyte S, 2000, ONCOGENE, V19, P1529, DOI 10.1038/sj.onc.1203451; Pratt JC, 1999, J IMMUNOL, V163, P2586; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Walk SF, 1998, EUR J IMMUNOL, V28, P2265, DOI 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	38	46	48	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					749	755		10.1038/ni820	http://dx.doi.org/10.1038/ni820			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12101399				2022-12-18	WOS:000177118500014
J	Carroll, M				Carroll, M			Innate immunity in the etiopathology of autoimmunity	NATURE IMMUNOLOGY			English	Editorial Material							DISEASE		Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Carroll, M (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.							Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Ermann J, 2001, NAT IMMUNOL, V2, P759, DOI 10.1038/ni0901-759; RADIC MZ, 1995, J IMMUNOL, V155, P3213	3	46	49	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1089	1090		10.1038/ni1201-1089	http://dx.doi.org/10.1038/ni1201-1089			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725293				2022-12-18	WOS:000172473200005
J	Konopacki, C; Pritykin, Y; Rubtsov, Y; Leslie, CS; Rudensky, AY				Konopacki, Catherine; Pritykin, Yuri; Rubtsov, Yury; Leslie, Christina S.; Rudensky, Alexander Y.			Transcription factor Foxp1 regulates Foxp3 chromatin binding and coordinates regulatory T cell function	NATURE IMMUNOLOGY			English	Article							SUPPRESSIVE FUNCTION; PROJECTION NEURONS; READ ALIGNMENT; IL-2 RECEPTOR; TARGET GENES; EXPRESSION; LUNG; DIFFERENTIATION; PROLIFERATION; MECHANISMS	Regulatory T cells (T-reg cells), whose differentiation and function are controlled by transcription factor Foxp3, express the closely related family member Foxp1. Here we explored Foxp1 function in T-reg cells. We found that a large number of Foxp3-bound genomic sites in T-reg cells were occupied by Foxp1 in both T-reg cells and conventional T cells (T-conv cells). In T-reg cells, Foxp1 markedly increased Foxp3 binding to these sites. Foxp1 deficiency in T-reg cells resulted in their impaired function and competitive fitness, associated with markedly reduced CD25 expression and interleukin-2 (IL-2) responsiveness, diminished CTLA-4 expression and increased SATB1 expression. The characteristic expression patterns of CD25, Foxp3 and CTLA-4 in T-reg cells were fully or partially rescued by strong IL-2 signaling. Our studies suggest that Foxp1 serves an essential non-redundant function in T-reg cells by enforcing Foxp3-mediated regulation of gene expression and enabling efficient IL-2 signaling in these cells.	[Konopacki, Catherine; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Konopacki, Catherine; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Pritykin, Yuri; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Rubtsov, Yury] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Rubtsov, Yury] Natl Res Univ Higher Sch Econ, Fac Biol & Biotechnol, Moscow, Russia; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; HSE University (National Research University Higher School of Economics); Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.	cleslie@cbio.mskcc.org; rudenska@mskcc.org	Rubtsov, Yury P/A-8227-2014; Pritykin, Yuri/ACA-0558-2022	Rubtsov, Yury P/0000-0001-9175-3013; Pritykin, Yury/0000-0001-6589-981X	NIH [R37 AI034206, P30 CA008748, U01 HG007893]; Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research	We thank the Memorial Sloan Kettering Cancer Center (MSKCC) integrated genomics operation for sequencing RNA-seq and ChIP-seq libraries and preprocessing data. We thank A. C. Scott and D. Tran for help with tissue lymphocyte isolation and experiment optimization and all members of the A. Y. Rudensky laboratory for helpful discussions and technical assistance. This study was supported by NIH grants R37 AI034206 (A.Y.R.), P30 CA008748 (A.Y.R.) and U01 HG007893 (A.Y.R. and C.S.L.), as well as the Hilton-Ludwig Cancer Prevention Initiative funded by the Conrad N. Hilton Foundation and Ludwig Cancer Research (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Banham AH, 2005, CLIN CANCER RES, V11, P1065; Banham AH, 2001, CANCER RES, V61, P8820; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bi EG, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9741; Cesario JM, 2016, GENE EXPR PATTERNS, V20, P111, DOI 10.1016/j.gep.2016.03.001; Chen YH, 2015, NUCLEIC ACIDS RES, V43, P1268, DOI 10.1093/nar/gku1373; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Song XW, 2016, GENE, V588, P156, DOI 10.1016/j.gene.2016.05.019; Tamura S, 2004, NEUROSCIENCE, V124, P261, DOI 10.1016/j.neuroscience.2003.11.036; van der Veeken J, 2016, CELL, V166, P977, DOI 10.1016/j.cell.2016.07.006; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	55	45	50	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					232	+		10.1038/s41590-018-0291-z	http://dx.doi.org/10.1038/s41590-018-0291-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7AY	30643266	Green Accepted			2022-12-18	WOS:000458890300001
J	Safronova, A; Araujo, A; Camanzo, ET; Moon, TJ; Elliott, MR; Beiting, DP; Yarovinsky, F				Safronova, Alexandra; Araujo, Alessandra; Camanzo, Ellie T.; Moon, Taylor J.; Elliott, Michael R.; Beiting, Daniel P.; Yarovinsky, Felix			Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; RECOGNITION; RECRUITMENT; RESISTANCE; MONOCYTES; PROTEINS; PROFILIN; CELLS; ACTIVATION; RECEPTORS	Toxoplasma gondii is a common protozoan parasite that infects up to one third of the world's population. Notably, very little is known about innate immune sensing mechanisms for this obligate intracellular parasite by human cells. Here, by applying an unbiased biochemical screening approach, we show that human monocytes recognized the presence of T. gondii infection by detecting the alarmin S100A11 protein, which is released from parasite-infected cells via caspase-1-dependent mechanisms. S100A11 induced a potent chemokine response to T. gondii by engaging its receptor RAGE, and regulated monocyte recruitment in vivo by inducing expression of the chemokine CCL2. Our experiments reveal a sensing system for T. gondii by human cells that is based on the detection of infection-mediated release of S100A11 and RAGE-dependent induction of CCL2, a crucial chemokine required for host resistance to the parasite.	[Safronova, Alexandra; Araujo, Alessandra; Camanzo, Ellie T.; Moon, Taylor J.; Elliott, Michael R.; Yarovinsky, Felix] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Beiting, Daniel P.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Rochester; University of Pennsylvania	Yarovinsky, F (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	felix_yarovinsky@urmc.rochester.edu	Beiting, Daniel/AAG-6275-2019	Elliott, Michael/0000-0002-0642-482X	National Institute of Allergy and Infectious Diseases [R01AI136538, R01AI121090]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121090, R01AI136538] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grants R01AI136538 and R01AI121090 and by the Burroughs Wellcome Foundation.	Andrade WA, 2013, CELL HOST MICROBE, V13, P42, DOI 10.1016/j.chom.2012.12.003; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Burger E, 2018, CELL HOST MICROBE, V23, P177, DOI 10.1016/j.chom.2018.01.001; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Christian DA, 2014, INFECT IMMUN, V82, P4056, DOI 10.1128/IAI.01643-14; Clay GM, 2014, IMMUNOL RES, V59, P142, DOI 10.1007/s12026-014-8544-x; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Denkers EY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002794; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; Gov L, 2017, J IMMUNOL, V199, P2855, DOI 10.4049/jimmunol.1700245; Gross SR, 2014, CELL MOL LIFE SCI, V71, P1551, DOI 10.1007/s00018-013-1400-7; Hakimi MA, 2017, CLIN MICROBIOL REV, V30, P615, DOI 10.1128/CMR.00005-17; HORI M, 1993, FEBS LETT, V322, P151, DOI 10.1016/0014-5793(93)81557-G; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Koshy AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002825; Lavine MD, 2008, EUKARYOT CELL, V7, P131, DOI 10.1128/EC.00301-07; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lopez-Yglesias AH, 2018, MUCOSAL IMMUNOL, V11, P921, DOI 10.1038/mi.2017.102; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Muller UB, 2016, CURR OPIN MICROBIOL, V32, P19, DOI 10.1016/j.mib.2016.04.009; Naor A, 2018, MBIO, V9, DOI [10.1128/mBio.02401-17, 10.1128/mbio.02401-17]; Neal LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004203; Olias P, 2016, CELL HOST MICROBE, V20, P72, DOI 10.1016/j.chom.2016.06.006; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Raetz M, 2013, J IMMUNOL, V191, P4818, DOI 10.4049/jimmunol.1301301; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Tosh KW, 2016, J IMMUNOL, V196, P345, DOI 10.4049/jimmunol.1501558; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598	50	45	48	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					64	+		10.1038/s41590-018-0250-8	http://dx.doi.org/10.1038/s41590-018-0250-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30455460	Green Accepted			2022-12-18	WOS:000456273900015
J	Takatsuka, S; Yamada, H; Haniuda, K; Saruwatari, H; Ichihashi, M; Renauld, JC; Kitamura, D				Takatsuka, Shogo; Yamada, Hiroyuki; Haniuda, Kei; Saruwatari, Hiroshi; Ichihashi, Marina; Renauld, Jean-Christophe; Kitamura, Daisuke			IL-9 receptor signaling in memory B cells regulates humoral recall responses	NATURE IMMUNOLOGY			English	Article							DEPENDENT IMMUNE-RESPONSES; IN-VIVO; T-CELLS; CUTTING EDGE; EXPRESSION; IMMUNOGLOBULIN; MURINE; CHAIN; IGE; INDUCTION	Memory B cells (B-mem) are the basis of long-lasting humoral immunity. They respond to re-encountered antigens by rapidly producing specific antibodies and forming germinal centers (GCs), a recall response that has been known for decades but remains poorly understood. We found that the receptor for the cytokine IL-9 (IL-9R) was induced selectively on B-mem cells after primary immunization and that IL-9R-deficient mice exhibited a normal primary antibody response but impaired recall antibody responses, with attenuated population expansion and plasma-cell differentiation of B-mem cells. In contrast, there was augmented GC formation, possibly due to defective downregulation of the ligand for the co-stimulatory receptor ICOS on B-mem cells. A fraction of B-mem cells produced IL-9. These findings indicate that IL-9R signaling in B-mem cells regulates humoral recall responses.	[Takatsuka, Shogo; Yamada, Hiroyuki; Haniuda, Kei; Saruwatari, Hiroshi; Ichihashi, Marina; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci RIBS, Div Mol Biol, Noda, Chiba, Japan; [Renauld, Jean-Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels, Belgium; [Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, Brussels, Belgium; [Takatsuka, Shogo] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan	Tokyo University of Science; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; National Institute of Infectious Diseases (NIID)	Kitamura, D (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci RIBS, Div Mol Biol, Noda, Chiba, Japan.	kitamura@rs.noda.tus.ac.jp	; Renauld, Jean-Christophe/B-7268-2012	TAKATSUKA, SHOGO/0000-0003-3258-0129; Renauld, Jean-Christophe/0000-0003-1736-2131	Japan Society for the Promotion of Science KAKENHI [16H05206, 25111512]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Ainai and H. Hasegawa (National Institute of Infectious Diseases) for the vaccine containing whole inactivated influenza virus; S. Horiuchi, T Koike, T. Katayama, I. Shiratori and Y. Takai for reagents and technical assistance; other members of the Research Institute for Biomedical Sciences for technical advice and comments; Y. Takatsuka for figure preparation; and P. Burrows for critical reading. This work was supported by the Japan Society for the Promotion of Science KAKENHI, Grant-in-Aid for Scientific Research (B) (16H05206) and Grant-in-Aid for Scientific Research on Innovative Areas (25111512) (all to D.K.).	Ainai A, 2010, J MED VIROL, V82, P476, DOI 10.1002/jmv.21694; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bauer JH, 1998, J BIOL CHEM, V273, P9255, DOI 10.1074/jbc.273.15.9255; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; DUGAS B, 1993, EUR J IMMUNOL, V23, P1687, DOI 10.1002/eji.1830230743; Fawaz LM, 2007, J ALLERGY CLIN IMMUN, V120, P1208, DOI 10.1016/j.jaci.2007.08.022; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; Haniuda K, 2011, J IMMUNOL, V186, P5620, DOI 10.4049/jimmunol.1100213; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; McGuire HM, 2015, J IMMUNOL, V195, P5123, DOI 10.4049/jimmunol.1501463; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; PETITFRERE C, 1993, IMMUNOLOGY, V79, P146; Rankin AL, 2011, J IMMUNOL, V186, P667, DOI 10.4049/jimmunol.0903207; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Stassen M, 2000, J IMMUNOL, V164, P5549, DOI 10.4049/jimmunol.164.11.5549; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Suan D, 2017, CURR OPIN IMMUNOL, V45, P97, DOI 10.1016/j.coi.2017.03.006; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Takatsuka S, 2011, J PHARMACOL TOX MET, V63, P250, DOI 10.1016/j.vascn.2010.12.003; TAMURA SI, 1992, J IMMUNOL, V149, P981; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Vink A, 1999, J EXP MED, V189, P1413, DOI 10.1084/jem.189.9.1413; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	53	45	47	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1025	+		10.1038/s41590-018-0177-0	http://dx.doi.org/10.1038/s41590-018-0177-0			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30082831				2022-12-18	WOS:000442365100023
J	Katerndahl, CDS; Heltemes-Harris, LM; Willette, MJL; Henzler, CM; Frietze, S; Yang, RD; Schjerven, H; Silverstein, KAT; Ramsey, LB; Hubbard, G; Wells, AD; Kuiper, RP; Scheijen, B; van Leeuwen, FN; Muschen, M; Kornblau, SM; Farrar, MA				Katerndahl, Casey D. S.; Heltemes-Harris, Lynn M.; Willette, Mark J. L.; Henzler, Christine M.; Frietze, Seth; Yang, Rendong; Schjerven, Hilde; Silverstein, Kevin A. T.; Ramsey, Laura B.; Hubbard, Gregory; Wells, Andrew D.; Kuiper, Roland P.; Scheijen, Blanca; van Leeuwen, Frank N.; Muschen, Markus; Kornblau, Steven M.; Farrar, Michael A.			Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival	NATURE IMMUNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NF-KAPPA-B; SUPER-ENHANCERS; ACTIVATION; RECEPTOR; PROTEIN; IKAROS; MAINTENANCE; DISRUPTION; EXPRESSION	The transcription factor STAT5 has a critical role in B cell acute lymphoblastic leukemia (B-ALL). How STAT5 mediates this effect is unclear. Here we found that activation of STAT5 worked together with defects in signaling components of the precursor to the B cell antigen receptor (pre-BCR), including defects in BLNK, BTK, PKC beta, NF-kappa B1 and IKAROS, to initiate B-ALL. STAT5 antagonized the transcription factors NF-kappa B and IKAROS by opposing regulation of shared target genes. Super-enhancers showed enrichment for STAT5 binding and were associated with an opposing network of transcription factors, including PAX5, EBF1, PU.1, IRF4 and IKAROS. Patients with a high ratio of active STAT5 to NF-kappa B or IKAROS had more-aggressive disease. Our studies indicate that an imbalance of two opposing transcriptional programs drives B-ALL and suggest that restoring the balance of these pathways might inhibit B-ALL.	[Katerndahl, Casey D. S.; Heltemes-Harris, Lynn M.; Willette, Mark J. L.; Hubbard, Gregory; Farrar, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Henzler, Christine M.; Yang, Rendong; Silverstein, Kevin A. T.] Univ Minnesota, Supercomp Inst Adv Computat Res, Minneapolis, MN USA; [Frietze, Seth] Univ Vermont, MLRS Dept, Burlington, VT USA; [Schjerven, Hilde] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ramsey, Laura B.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Wells, Andrew D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Wells, Andrew D.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kuiper, Roland P.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Scheijen, Blanca; van Leeuwen, Frank N.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Lab Pediat Oncol, Nijmegen, Netherlands; [Scheijen, Blanca] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Pathol, Nijmegen, Netherlands; [Muschen, Markus] Beckman Res Inst, Dept Syst Biol, Pasadena, CA USA; [Muschen, Markus] City Hope Natl Med Ctr, Comprehens Canc Ctr, Pasadena, CA USA; [Kornblau, Steven M.] Univ Texas Houston, Dept Leukemia, Maryland Anderson Canc Ctr, Houston, TX 77025 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Radboud University Nijmegen; Radboud University Nijmegen; City of Hope; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Farrar, MA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Masonic Canc Ctr, Minneapolis, MN 55455 USA.; Kornblau, SM (corresponding author), Univ Texas Houston, Dept Leukemia, Maryland Anderson Canc Ctr, Houston, TX 77025 USA.	skornblau@mdanderson.org; farra005@umn.edu	Kuiper, Roland/A-9646-2014; van Leeuwen, Frank/AAQ-6799-2020; Ramsey, Laura/ABD-6113-2020; Scheijen, Blanca/E-3523-2016; Farrar, Michael A/M-7802-2013; Schjerven, Hilde/I-1437-2013	van Leeuwen, Frank/0000-0003-1107-6513; Ramsey, Laura/0000-0001-6417-3961; Scheijen, Blanca/0000-0001-8029-9230; Schjerven, Hilde/0000-0001-9287-3375; Heltemes Harris, Lynn/0000-0002-2668-8005	US National Institutes of Health [R21CA209229, CA154998, CA151845, CA185062, R01CA137060, R01CA139032, R01CA157644, R01CA169458, R01CA172558, T32-AI07313, P50 PA100632]; Cancer Research Institute; Leukemia and Lymphoma Society; Kindern Krankervrij [KIKA-55]; University of Minnesota; NATIONAL CANCER INSTITUTE [R01CA154998, R01CA157644, R21CA209229, R01CA213138, R01CA139032, R01CA172558, P50CA100632, P30CA077598, R01CA137060, R01CA151845, P30CA016672, R01CA185062, R35CA197628, R01CA169458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Kindern Krankervrij; University of Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Vegoe, R. Agneberg, J. Bednar, C. Anderson, P. Schoettler, L. Swanson, A. Kne, C. Reis, A. Mack and E. Sykes for assistance with mouse breeding; M. Mandal for advice on ChIP-Seq; P. Champoux and N. Shah for cell sorting; the University of Minnesota's Supercomputing Institute for computing resources; R. Woodland (University of Massachusetts medical School) for Xid mice on a C57BL/6 background; S. van Reijmersdal for MLPA analysis support; and L. Manlove and J. Fiege for help and discussions. Supported by the US National Institutes of Health (R21CA209229 for S.F. and H.S.; CA154998, CA151845 and CA185062 to M.A.F.; R01CA137060, R01CA139032, R01CA157644, R01CA169458 and R01CA172558 to M.M.; T32-AI07313 for C.D.S.K. and M.J.L.W.; and Leukemia Spore (P50 PA100632) to S.M.K.), the Cancer Research Institute, the Leukemia and Lymphoma Society, Kindern Krankervrij (KIKA-55 for R.P.K, B.S. and F.N.vL.) and the University of Minnesota (L.B.R.).	Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Heltemes-Harris LM, 2016, ONCOGENE, V35, P3454, DOI 10.1038/onc.2015.405; Heltemes-Harris LM, 2012, CURR OPIN IMMUNOL, V24, P146, DOI 10.1016/j.coi.2012.01.015; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nagel D, 2014, ONCOGENE, V33, P5655, DOI 10.1038/onc.2013.565; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Parker MJ, 2005, EMBO J, V24, P3895, DOI 10.1038/sj.emboj.7600850; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Pinz S, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0063-y; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	52	45	49	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					694	+		10.1038/ni.3716	http://dx.doi.org/10.1038/ni.3716			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28369050	Green Accepted			2022-12-18	WOS:000401520900014
J	Iversen, MB; Reinert, LS; Thomsen, MK; Bagdonaite, I; Nandakumar, R; Cheshenko, N; Prabakaran, T; Vakhrushev, SY; Krzyzowska, M; Kratholm, SK; Ruiz-Perez, F; Petersen, SV; Goriely, S; Bibby, BM; Eriksson, K; Rulandl, J; Thomsen, AR; Herold', BC; Wandall, HH; Frische, S; Hom, CK; Paludan, SR				Iversen, Marie B.; Reinert, Line S.; Thomsen, Martin K.; Bagdonaite, Ieva; Nandakumar, Ramya; Cheshenko, Natalia; Prabakaran, Thaneas; Vakhrushev, Sergey Y.; Krzyzowska, Malgosha; Kratholm, Sine K.; Ruiz-Perez, Fernando; Petersen, Steen V.; Goriely, Stanislas; Bibby, Bo Martin; Eriksson, Kristina; Rulandl, Jurgen; Thomsen, Allan R.; Herold', Betsy C.; Wandall, Hans H.; Frische, Sebastian; Hom, Christian K.; Paludan, Soren R.			An innate antiviral pathway acting before interferons at epithelial surfaces	NATURE IMMUNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; RECOGNITION; INFECTION; TRANSCRIPTION; ACTIVATION; PROTECTION; CHALLENGE; INDUCTION; RESPONSES; CANCER	Mucosal surfaces are exposed to environmental substances and represent a major portal of entry for microorganisms. The innate immune system is responsible for early defense against infections and it is believed that the interferons (IFNs) constitute the first line of defense against viruses. Here we identify an innate antiviral pathway that works at epithelial surfaces before the IFNs. The pathway is activated independently of known innate sensors of viral infections through a mechanism dependent on viral O-linked glycans, which induce CXCR3 chemokines and stimulate antiviral activity in a manner dependent on neutrophils. This study therefore identifies a previously unknown layer of antiviral defense that exerts its action on epithelial surfaces before the classical IFN response is operative.	[Iversen, Marie B.; Reinert, Line S.; Thomsen, Martin K.; Nandakumar, Ramya; Prabakaran, Thaneas; Kratholm, Sine K.; Petersen, Steen V.; Frische, Sebastian; Hom, Christian K.; Paludan, Soren R.] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Iversen, Marie B.; Reinert, Line S.; Thomsen, Martin K.; Nandakumar, Ramya; Prabakaran, Thaneas; Kratholm, Sine K.; Hom, Christian K.; Paludan, Soren R.] Univ Aarhus, Aarhus Res Ctr Innate Immunol, Aarhus, Denmark; [Bagdonaite, Ieva; Vakhrushev, Sergey Y.; Wandall, Hans H.] Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark; [Cheshenko, Natalia; Herold', Betsy C.] Albert Einstein Coll Med, Dept Pediat & Microbiol, New York, NY USA; [Krzyzowska, Malgosha] Mil Inst Hyg & Epidemiol, Dept Regenerat Med, Warsaw, Poland; [Ruiz-Perez, Fernando] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Goriely, Stanislas] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium; [Bibby, Bo Martin] Univ Aarhus, Dept Biostat, Aarhus, Denmark; [Eriksson, Kristina] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Rulandl, Jurgen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany; [Thomsen, Allan R.] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Yeshiva University; Military Institute of Hygiene & Epidemiology (MIHE); University of Virginia; Universite Libre de Bruxelles; Aarhus University; University of Gothenburg; Technical University of Munich; University of Copenhagen	Paludan, SR (corresponding author), Univ Aarhus, Dept Biomed, Aarhus, Denmark.	srp@biomed.au.dk	Bagdonaite, Ieva/GLT-8773-2022; Thomsen, Martin/AAU-5014-2021; Cheshenko, Natalia/ABF-5896-2021; Ruland, Jürgen/Q-6680-2018; Frische, Sebastian/B-2332-2009; Vakhrushev, Sergey Y/A-7638-2014; Prabakaran, Thaneas/K-3021-2019	Bagdonaite, Ieva/0000-0002-9383-8448; Thomsen, Martin/0000-0002-5055-7531; Ruland, Jürgen/0000-0002-8381-3597; Frische, Sebastian/0000-0002-0270-3602; Vakhrushev, Sergey Y/0000-0002-0418-5765; Holm, Christian/0000-0002-2655-3362; Reinert, Line/0000-0002-8317-0886; Vang Petersen, Steen/0000-0002-9338-911X; Krzyzowska, Malgorzata/0000-0002-8409-3974; Prabakaran, Thaneas/0000-0002-4698-7563; Thomsen, Allan Randrup/0000-0002-2392-9803; Nandakumar, Ramya/0000-0003-0074-3499; Goriely, Stanislas/0000-0002-7005-6195; Wandall, Hans H./0000-0003-0240-9232; Herold, Betsy/0000-0001-9974-0786	Danish Medical Research Council [12-124330, 1331-00133B]; Novo Nordisk Foundation; Lundbeck Foundation [R34-3855]; Aarhus University Research Foundation; EU [1333-00090A]; US National Institutes of Health [AI065309]; Faculty of Health Sciences, AU; Danish National Research Foundation [DNRF107]; Excellence Programme for Interdisciplinary Research [CDO2016]; German Research Foundation (DFG) [SFB 1054]; European Research Council [322865]; Lundbeck Foundation [R198-2015-171, R108-2012-10358] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011875, NNF15OC0017118, NNF13OC0006211] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Aarhus University Research Foundation; EU(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Health Sciences, AU; Danish National Research Foundation(Danmarks Grundforskningsfond); Excellence Programme for Interdisciplinary Research; German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank K.S. Petersen and I.M. Poulsen for technical assistance and the AU FAGS Core facility for technical help. Supported by The Danish Medical Research Council (12-124330 to S.R.P.; 1331-00133B to H.H.W.), the Novo Nordisk Foundation (S.R.P.), the Lundbeck Foundation (R34-3855 to S.R.P.), Aarhus University Research Foundation (S.R.P.), the EU FP7 Mobilex program (1333-00090A to M.K.T.), the US National Institutes of Health (AI065309 to B.C.H.), Faculty of Health Sciences, AU (M.B.I.), the Danish National Research Foundation (DNRF107 to H.H.W.), the Excellence Programme for Interdisciplinary Research (CDO2016 to H.H.W.), the German Research Foundation (DFG, SFB 1054 to J.R.) and the European Research Council (FP7, grant agreement 322865 to J.R.).	Archer NK, 2013, INFECT IMMUN, V81, P2070, DOI 10.1128/IAI.00084-13; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Cheshenko N, 2013, FASEB J, V27, P2584, DOI 10.1096/fj.12-220285; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Frazer LC, 2011, INFECT IMMUN, V79, P4029, DOI 10.1128/IAI.05535-11; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ichinohe T, 2008, EXPERT REV VACCINES, V7, P1435, DOI 10.1586/14760584.7.9.1435; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; Milligan GN, 1999, J VIROL, V73, P6380, DOI 10.1128/JVI.73.8.6380-6386.1999; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	35	45	46	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					150	158		10.1038/ni.3319	http://dx.doi.org/10.1038/ni.3319			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26595890				2022-12-18	WOS:000368571500008
J	Ramirez-Ortiz, ZG; Prasad, A; Griffith, JW; Pendergraft, WF; Cowley, GS; Root, DE; Tai, M; Luster, AD; El Khoury, J; Hacohen, N; Means, TK				Ramirez-Ortiz, Zaida G.; Prasad, Amit; Griffith, Jason W.; Pendergraft, William F., III; Cowley, Glenn S.; Root, David E.; Tai, Melissa; Luster, Andrew D.; El Khoury, Joseph; Hacohen, Nir; Means, Terry K.			The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity	NATURE IMMUNOLOGY			English	Article							AUTOANTIBODY PRODUCTION; MYELOID CELLS; DENDRITIC CELLS; CUTTING EDGE; MURINE LUPUS; TOLL; DISEASE; INFLAMMATION; GENES; MICE	The molecules and pathways that fine-tune innate inflammatory responses mediated by Toll-like receptor 7 (TLR7) remain to be fully elucidated. Using an unbiased genome-scale screen with short hairpin RNA (shRNA), we identified the receptor TREML4 as an essential positive regulator of TLR7 signaling. Macrophages from Treml4(-/-) mice were hyporesponsive to TLR7 agonists and failed to produce type I interferons due to impaired phosphorylation of the transcription factor STAT1 by the mitogen-activated protein kinase p38 and decreased recruitment of the adaptor MyD88 to TLR7. TREML4 deficiency reduced the production of inflammatory cytokines and autoantibodies in MRL/lpr mice, which are prone to systemic lupus erythematosus (SLE), and inhibited the antiviral immune response to influenza virus. Our data identify TREML4 as a positive regulator of TLR7 signaling and provide insight into the molecular mechanisms that control antiviral immunity and the development of autoimmunity.	[Ramirez-Ortiz, Zaida G.; Prasad, Amit; Griffith, Jason W.; Tai, Melissa; Luster, Andrew D.; El Khoury, Joseph; Hacohen, Nir; Means, Terry K.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Ramirez-Ortiz, Zaida G.; Prasad, Amit; Griffith, Jason W.; Tai, Melissa; Luster, Andrew D.; El Khoury, Joseph; Hacohen, Nir; Means, Terry K.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Ramirez-Ortiz, Zaida G.; Prasad, Amit; Griffith, Jason W.; Tai, Melissa; Luster, Andrew D.; El Khoury, Joseph; Hacohen, Nir; Means, Terry K.] Harvard Univ, Sch Med, Charlestown, MA USA; [Pendergraft, William F., III] Univ N Carolina, Kidney Ctr, Chapel Hill, NC USA; [Cowley, Glenn S.; Root, David E.; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA USA; [El Khoury, Joseph] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Means, TK (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA.	terry@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912; Ramirez Ortiz, Zaida/0000-0002-0253-0473	US National Institutes of Health [U01HG004085, U01HG004080]; National Institutes of Allergy and Infectious Diseases [R01-AI084884, U24 AI082660, T32-AI007061]; National Institutes of Arthritis, Musculoskeletal and Skin Diseases [K01-AR051367, K01-AR066716]; National Institute of Diabetes and Digestive and Kidney Diseases [F32-DK097891]; Lupus Research Institute; Alliance for Lupus Research; American Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116275] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084884, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR066716, K01AR051367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, F32DK097891] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lupus Research Institute; Alliance for Lupus Research; American Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Hemmi (Osaka University) and R. Steinman (The Rockefeller University) for cDNA encoding mouse TREML4; D. Golenbock (University of Massachusetts) plasmids encoding mouse TLR proteins; and B. Luo, M. Okamoto and members of the Genetic Perturbation Platform (Broad Institute) and The RNAi Consortium for shRNA lentiviral libraries and technical assistance. The vectors, embryonic stem cells and TREML4-deficient mouse strain were generated by the trans-NIH Knockout Mouse Project (KOMP) and were obtained from the KOMP Repository. The US National Institutes of Health funded the generation of 8,500 gene-targeted embryonic stem cells (by KOMP; U01HG004085 to Velocigene at Regeneron, and U01HG004080 to the CSD Consortium) and their archiving and distribution by the KOMP Repository at the University of California at Davis and Children's Hospital Oakland Research Institute (U42RR024244). Supported by the National Institutes of Allergy and Infectious Diseases (R01-AI084884 to T.K.M.; U24 AI082660 to J.E.K.; and T32-AI007061 to Z.G.R.-O.), the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (K01-AR051367 to T.K.M.; and K01-AR066716 to Z.G.R.-O.), the National Institute of Diabetes and Digestive and Kidney Diseases (F32-DK097891 to W.F.P.), the Lupus Research Institute (T.K.M. and N.H.), the Alliance for Lupus Research (T.K.M. and N.H.) and the American Society of Nephrology (W.F.P.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hemmi H, 2012, J IMMUNOL, V188, P1147, DOI 10.4049/jimmunol.1102541; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kono DH, 2013, CURR OPIN IMMUNOL, V25, P720, DOI 10.1016/j.coi.2013.10.006; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Sen SK, 2014, AM J HUM GENET, V95, P66, DOI 10.1016/j.ajhg.2014.06.003; Silbiger VN, 2013, CLIN CHIM ACTA, V421, P184, DOI 10.1016/j.cca.2013.03.011; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Wang CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03792; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175	45	45	48	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					495	U211		10.1038/ni.3143	http://dx.doi.org/10.1038/ni.3143			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25848864	Green Accepted, Green Submitted			2022-12-18	WOS:000353305200012
J	Au-Yeung, BB; Melichar, HJ; Ross, JO; Cheng, DA; Zikherman, J; Shokat, KM; Robey, EA; Weiss, A				Au-Yeung, Byron B.; Melichar, Heather J.; Ross, Jenny O.; Cheng, Debra A.; Zikherman, Julie; Shokat, Kevan M.; Robey, Ellen A.; Weiss, Arthur			Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; NEGATIVE SELECTION; TYROSINE KINASE; RECEPTOR; ZAP-70; EXPRESSION; SYK; INHIBITOR; FAMILY; LCK	The catalytic activity of Zap70 is crucial for T cell antigen receptor (TCR) signaling, but the quantitative and temporal requirements for its function in thymocyte development are not known. Using a chemical-genetic system to selectively and reversibly inhibit Zap70 catalytic activity in a model of synchronized thymic selection, we showed that CD4(+)CD8(+) thymocytes integrate multiple, transient, Zap70-dependent signals over more than 36 h to reach a cumulative threshold for positive selection, whereas 1 h of signaling was sufficient for negative selection. Titration of Zap70 activity resulted in graded reductions in positive and negative selection but did not decrease the cumulative TCR signals integrated by positively selected OT-I cells, which revealed heterogeneity, even among CD4(+)CD8(+) thymocytes expressing identical TCRs undergoing positive selection.	[Au-Yeung, Byron B.; Cheng, Debra A.; Zikherman, Julie; Shokat, Kevan M.; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Au-Yeung, Byron B.; Cheng, Debra A.; Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Res, San Francisco, CA 94143 USA; [Au-Yeung, Byron B.; Cheng, Debra A.; Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Au-Yeung, Byron B.; Cheng, Debra A.; Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Melichar, Heather J.; Ross, Jenny O.; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	erobey@berkeley.edu; aweiss@medicine.ucsf.edu		Au-Yeung, Byron/0000-0002-6446-9102; Zikherman, Julie/0000-0002-0873-192X	Arthritis Foundation postdoctoral fellowship [5476]; California Institute of Regenerative Medicine [T1-00007, TG2-01164]; Rosalind Russell Medical Research Foundation Bechtel Award; Arthritis National Research Foundation; US National Institutes of Health [K08 AR059723, AI064227, AI091580, RC2AR058947]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580, R01AI064227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058947] Funding Source: NIH RePORTER	Arthritis Foundation postdoctoral fellowship; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Rosalind Russell Medical Research Foundation Bechtel Award; Arthritis National Research Foundation(National Research Foundation of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Roque for animal husbandry and C. Zhang for synthesis of 3-MB-PP1 and HXJ42. This work was supported by the Arthritis Foundation postdoctoral fellowship 5476 (to B.B.A.-Y.), the California Institute of Regenerative Medicine postdoctoral training grant T1-00007 (to HIM.), graduate student training grant TG2-01164 (to J.O.R.), the Rosalind Russell Medical Research Foundation Bechtel Award (to J.Z.), Arthritis National Research Foundation grant (to J.Z.), and US National Institutes of Health grants K08 AR059723 (to J.Z.), AI064227 (to EAR.), AI091580 (to A.W.) and RC2AR058947 (to A.W.).	Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Clark CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018916; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dzhagalov IL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001566; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Jordan M.S., 2010, COLD SPRING HARB PER, V2; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; Levin SE, 2008, J BIOL CHEM, V283, P15419, DOI 10.1074/jbc.M709000200; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Marangoni F, 2013, IMMUNITY, V38, P237, DOI 10.1016/j.immuni.2012.09.012; Melichar HJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004400; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Palacios EH, 2007, J EXP MED, V204, P1703, DOI 10.1084/jem.20070405; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Ross J.O, P NATL ACAD SCI US; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	34	45	45	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					687	694		10.1038/ni.2918	http://dx.doi.org/10.1038/ni.2918			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24908390	Green Submitted, Green Accepted			2022-12-18	WOS:000337715600015
J	Patra, AK; Avois, A; Zahedi, RP; Schuler, T; Sickmann, A; Bommhardt, U; Serfling, E				Patra, Amiya K.; Avois, Andris; Zahedi, Rene P.; Schueler, Thomas; Sickmann, Albert; Bommhardt, Ursula; Serfling, Edgar			An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development	NATURE IMMUNOLOGY			English	Article							DEFECTIVE LYMPHOID DEVELOPMENT; RESCUES T-LYMPHOPOIESIS; MICE LACKING; CELL-DEVELOPMENT; FAMILY-MEMBERS; EXPRESSION; INTERLEUKIN-7; BCL-2; CALCINEURIN; HOMEOSTASIS	Interleukin 7 (IL-7) has a critical role in the development of early CD4(-)CD8(-) double-negative (DN) thymocytes. Although the transcription factor STAT5 is an important component of IL-7 signaling, differences in the phenotypes of mice deficient in STAT5, IL-7, IL-7 receptor alpha (IL-7r alpha) or the kinase Jak3 suggest the existence of STAT5-independent IL-7 signaling. Here we found that IL-7-Jak3 signals activated the transcription factor NFATc1 in DN thymocytes by phosphorylating Tyr371 in the regulatory region of NFATc1. This NEAT-activation pathway was critical for the survival and development of DN thymocytes, as deficiency in NFATc1 blocked thymocyte development at the DN1 stage, leading to T cell lymphopenia. In addition, our results demonstrated a cooperative function for NFATc1 and STAT5 in guiding thymocyte development in response to IL-7 signals.	[Patra, Amiya K.; Avois, Andris; Serfling, Edgar] Univ Wurzburg, Inst Pathol, Dept Mol Pathol, Wurzburg, Germany; [Zahedi, Rene P.; Sickmann, Albert] Leibniz Inst Analyt Sci, Dept Bioanalyt, Dortmund, Germany; [Schueler, Thomas; Bommhardt, Ursula] Univ Magdeburg, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany	University of Wurzburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Otto von Guericke University; Ruhr University Bochum	Patra, AK (corresponding author), Univ Wurzburg, Inst Pathol, Dept Mol Pathol, Josef Schneider Str 2, Wurzburg, Germany.	amiya.patra@uni-wuerzburg.de; serfling.e@mail.uni-wuerzburg.de	Sickmann, Albert/A-1010-2011; Zahedi, René/A-9148-2012; Zahedi, Rene/HGU-5710-2022; Serfling, Edgar/X-7212-2019	Sickmann, Albert/0000-0002-2388-5265; Zahedi, René/0000-0002-4960-5460; Patra, Amiya/0000-0002-5297-809X	Deutsche Forschungsgemeinschaft [TRR52, DFG-SFB854-TP9]; Wilhelm-Sander Foundation; Mildred Scheel Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander Foundation; Mildred Scheel Foundation(Deutsche Krebshilfe)	We thank C. Linden for cell sorting; S.Y. Na, B. Kneitz and T. Hunig (University of Wurzburg) for Rag1<SUP>-/-</SUP> and IL2<SUP>-/-</SUP> mice; A. Rao (La Jolla Institute for Allergy and Immunology) for Nfatc1<SUP>fl/fl</SUP> mice; D. Kioussis (Medical Research Council National Institute for Medical Research, London) for Vav-Cre mice; S. Chuvpilo (TheraMAB LLC, Moscow) for GST-NFATc1 constructs; R. Rost (Institute of Molecular Biology and Biochemistry, Graz, Austria) for NFATc1 expression vector; W.J. Leonard (US National Institutes of Health) for expression vectors for human IL-2R gamma and mouse IL-7R alpha; J.J. O'Shea (US National Institutes of Health) for expression vectors for human Jak3; K. Hasegawa (Kyoto Medical Center) for the BCL2 luciferase construct; J.C. Zuniga-Pflucker (University of Toronto) for OP9 and OP9-DL1 cells; J. Schneider-Schaulies (University of Wurzburg) for help in lentiviral transduction experiments; and members of the Serfling laboratory for comments on the manuscript. Supported by Deutsche Forschungsgemeinschaft (TRR52 to A.A. and E.S., and DFG-SFB854-TP9 to U.B.), the Wilhelm-Sander Foundation (E.S.) and the Mildred Scheel Foundation (E.S.).	Adachi S, 2000, J BIOL CHEM, V275, P14708, DOI 10.1074/jbc.275.19.14708; Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Aringer M, 2003, J IMMUNOL, V170, P6057, DOI 10.4049/jimmunol.170.12.6057; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bhattacharyya S, 2011, J EXP MED, V208, P823, DOI 10.1084/jem.20100945; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FOXWELL BMJ, 1995, EUR J IMMUNOL, V25, P3041, DOI 10.1002/eji.1830251109; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Goodman PA, 1998, J BIOL CHEM, V273, P17742, DOI 10.1074/jbc.273.28.17742; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kawamura T, 2004, CIRC RES, V94, P1492, DOI 10.1161/01.RES.0000129701.14494.52; Kim K, 1998, J IMMUNOL, V160, P5735; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Tibbles HE, 2001, J BIOL CHEM, V276, P17815, DOI 10.1074/jbc.M011405200; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640	49	45	46	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					127	135		10.1038/ni.2507	http://dx.doi.org/10.1038/ni.2507			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23263556				2022-12-18	WOS:000313918400007
J	Hawiger, D; Wan, YSY; Eynon, EE; Flavell, RA				Hawiger, Daniel; Wan, Yisong Y.; Eynon, Elizabeth E.; Flavell, Richard A.			The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness	NATURE IMMUNOLOGY			English	Article							LYMPHOID ORGANS; AUTOIMMUNITY; MICE; AP-1; DIFFERENTIATION; IDENTIFICATION; HOMEODOMAIN; SPECIFICITY; EXPRESSION; GENERATION	Induced regulatory T cells (iT(reg) cells) can be generated by peripheral dendritic cells (DCs) that mediate T cell unresponsiveness to rechallenge with antigen. The molecular factors required for the function of such iT(reg) cells remain unknown. We report a critical role for the transcription cofactor homeodomain-only protein (Hop; also known as Hopx) in iT(reg) cells to mediate T cell unresponsiveness in vivo. Hopx-sufficient iT(reg) cells downregulated expression of the transcription factor AP-1 complex and suppressed other T cells. In the absence of Hopx, iT(reg) cells had high expression of the AP-1 complex, proliferated and failed to mediate T cell unresponsiveness to rechallenge with antigen. Thus, Hopx is required for the function of T-reg cells induced by DCs and the promotion of DC-mediated T cell unresponsiveness in vivo.	[Hawiger, Daniel; Eynon, Elizabeth E.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Wan, Yisong Y.] Univ N Carolina, Dept Microbiol & Immunol, UNC Sch Med, Chapel Hill, NC USA; [Eynon, Elizabeth E.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Wan, Yisong/ABE-1200-2021	Wan, Yisong/0000-0003-4346-9717	American Diabetes Society; National Multiple Sclerosis Society [TA 3024A1/2]; Howard Hughes Medical Institute	American Diabetes Society; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank E. Olson (University of Texas Southwestern Medical Center) for Hopx<SUP>-/-</SUP> mice; T. Taylor for help with cell sorting; and L. Zenewicz and F. Manzo for help during preparation of the manuscript. Supported by the American Diabetes Society (D.H.), the National Multiple Sclerosis Society (TA 3024A1/2 to D.H.) and the Howard Hughes Medical Institute (R.A.F.).	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; DE LAFAILLE MAC, 2008, IMMUNITY, V29, P114; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Itoh M, 1999, J IMMUNOL, V162, P5317; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; STEINMAN RM, 1975, J EXP MED, V141, P804; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; VON BOEHMER H, 2003, IMMUNOL REV, V191, P62; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing J, 2000, J FORENSIC PSYCHIATR, V11, P7, DOI 10.1080/095851800362319; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	48	45	47	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					962	U118		10.1038/ni.1929	http://dx.doi.org/10.1038/ni.1929			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20802482	Green Accepted			2022-12-18	WOS:000281926900016
J	Leulier, F; Royet, J				Leulier, Francois; Royet, Julien			Maintaining immune homeostasis in fly gut	NATURE IMMUNOLOGY			English	Editorial Material							DUAL OXIDASE; DROSOPHILA; COMMENSAL; PATHWAY	Like every metazoan species hosting a gut flora, drosophila tolerate commensal microbiota yet remain able to mount an efficient immune response to food-borne pathogens. New findings explain how the quantity of reactive oxygen species in the gut is 'tuned' to microbial burden and how intestinal immune homeostasis is thereby maintained.	[Leulier, Francois; Royet, Julien] Univ Mediterannee Aix Marseille 2, CNRS, Unite Mixte Rech 6216, Inst Biol Dev Marseille Luminy, Marseille, France; [Leulier, Francois] CNRS, Ctr Rech Gif, Ctr Genet Mol, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Leulier, F (corresponding author), Univ Mediterannee Aix Marseille 2, CNRS, Unite Mixte Rech 6216, Inst Biol Dev Marseille Luminy, Parc Sci Luminy Case 907, Marseille, France.	royet@ibdml.univ-mrs.fr						Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006	14	45	46	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					936	938		10.1038/ni0909-936	http://dx.doi.org/10.1038/ni0909-936			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19692992				2022-12-18	WOS:000269120900005
J	Moody, DB				Moody, D. Branch			TLR gateways to CD1 function	NATURE IMMUNOLOGY			English	Review							T-CELL RECOGNITION; MHC CLASS-II; ANTIGEN PRESENTATION; CRYSTAL-STRUCTURE; LIPID ANTIGEN; DENDRITIC CELLS; NKT CELLS; EFFICIENT PRESENTATION; MOLECULAR RECOGNITION; CYTOPLASMIC TAIL	CD1-restricted T cells can be activated by diverse lipids derived from mammals, bacteria and protozoa. Certain lipids function as antigens, which bind to CD1 proteins and contact T cell antigen receptors. Other lipids activate CD1-restricted T cells by functioning as adjuvants. By stimulating Toll-like receptors on antigen-presenting cells, these adjuvants alter cytokine secretion, lipid antigen synthesis and CD1 protein translation. Delineation of the separate mechanisms by which adjuvants and antigens activate CD1-restricted T cells is leading to new hypotheses about the functions of individual CD1 proteins during the transition from innate to acquired immune responses.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Moody, DB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, R01AI071155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NIAID NIH HHS [AI049313, AI071155] Funding Source: Medline; NIAMS NIH HHS [AR48632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Askenase PW, 2005, J IMMUNOL, V175, P6390, DOI 10.4049/jimmunol.175.10.6390; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Berntman E, 2005, EUR J IMMUNOL, V35, P2100, DOI 10.1002/eji.200425846; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Cao XC, 2002, J IMMUNOL, V169, P4770, DOI 10.4049/jimmunol.169.9.4770; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; CHEN T, 2006, EMBO J ADVANCE  0622, DOI DOI 10.1028/SJ.EMBOJ.7601185; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cho S, 2005, VIROLOGY, V337, P242, DOI 10.1016/j.virol.2005.04.020; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Geng YB, 2005, J IMMUNOL, V175, P1022, DOI 10.4049/jimmunol.175.2.1022; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Grant EP, 2002, J IMMUNOL, V168, P3933, DOI 10.4049/jimmunol.168.8.3933; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 1999, IMMUNOL LETT, V65, P85, DOI 10.1016/S0165-2478(98)00129-1; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Renukaradhya GJ, 2005, J IMMUNOL, V175, P4301, DOI 10.4049/jimmunol.175.7.4301; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Sieling PA, 1999, J IMMUNOL, V162, P1851; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; SKOLD M, 2005, J IMMUNOL, V175, P3854; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Szatmari I, 2004, IMMUNITY, V21, P95, DOI 10.1016/j.immuni.2004.06.003; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	96	45	48	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					811	817		10.1038/ni1368	http://dx.doi.org/10.1038/ni1368			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855607				2022-12-18	WOS:000239147200016
J	Gerdes, T; Wabl, M				Gerdes, T; Wabl, M			Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse	NATURE IMMUNOLOGY			English	Article							NATURAL AUTOANTIBODIES; GENE REARRANGEMENT; RECEPTOR; EXCLUSION; KAPPA; EXPRESSION; LYMPHOCYTES; TOLERANCE; FREQUENCY; SELECTION	Lymphocytes typically express only one functional antigen receptor, a restriction contributed to by allelic exclusion. Here we have analyzed B lymphocyte development in offspring of a mouse generated by nuclear transfer using a single donor B lymphocyte. In this mouse, all immunoglobulin alleles were inherited as found in the donor lymphocyte. This donor cell had two rearranged immunoglobulin light chain alleles, both directing the synthesis of light chains that could form functional antigen receptors, one of which was autoreactive. Progeny mice carrying this immunoglobulin light chain allele produced mature B cells, some of which continued to express the autoreactive receptor but required another rearrangement to rescue them from negative selection. Such receptor editing failed to destroy expression of one original light chain allele, thereby recreating dual receptor expression on these surviving B cells. We suggest that autoreactive antibodies in serum of mice and humans are due in part to such 'passenger' receptors.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wabl, M (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	mutator@itsa.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041570] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI41570] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1982, MOL CELL BIOL, V2, P386, DOI 10.1128/MCB.2.4.386; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; CHAI SK, 1994, ADV EXP MED BIOL, V347, P147; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Diaw L, 1997, J IMMUNOL, V158, P968; Diaw L, 2000, MOL IMMUNOL, V37, P775, DOI 10.1016/S0161-5890(00)00100-0; Diaw L, 2001, IMMUNOL RES, V24, P303, DOI 10.1385/IR:24:3:303; DIGHIERO G, 1985, J IMMUNOL, V134, P765; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARDY RR, 1986, P NATL ACAD SCI USA, V83, P1438, DOI 10.1073/pnas.83.5.1438; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; IMAI H, 1994, J IMMUNOL, V153, P2290; Kouskoff V, 2001, LIFE SCI, V69, P1105, DOI 10.1016/S0024-3205(01)01219-X; KWAN SP, 1981, CELL, V26, P57, DOI 10.1016/0092-8674(81)90033-7; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Louzoun Y, 2002, SEMIN IMMUNOL, V14, P169, DOI 10.1016/S1044-5323(02)00041-6; LOUZOUN Y, 2002, SEMIN IMMUNOL, V14, P221; Nemazee D, 2002, SEMIN IMMUNOL, V14, P191, DOI 10.1016/S1044-5323(02)00042-8; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; RITCHIE KA, 1984, NATURE, V312, P517, DOI 10.1038/312517a0; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; SCHWARTZ RC, 1981, J IMMUNOL, V126, P2104; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VARELA FJ, 1991, IMMUNOL TODAY, V12, P159, DOI 10.1016/0167-5699(91)90081-4; WABL M, 1982, P NATL ACAD SCI-BIOL, V79, P6976, DOI 10.1073/pnas.79.22.6976; WABL MR, 1975, SCIENCE, V190, P1310, DOI 10.1126/science.1198115; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEILER E, 1965, P NATL ACAD SCI USA, V54, P1765, DOI 10.1073/pnas.54.6.1765; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7	44	45	45	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1282	1287		10.1038/ni1133	http://dx.doi.org/10.1038/ni1133			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15516926				2022-12-18	WOS:000225353500018
J	Medzhitov, R				Medzhitov, R			CpG DNA: security code for host defense	NATURE IMMUNOLOGY			English	News Item							ACTIVATION; MOTIFS		Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.							Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 2000, CURR TOP MICROBIOL, V247, P77; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Krieg AM, 1999, BBA-GENE STRUCT EXPR, V1489, P107, DOI 10.1016/S0167-4781(99)00147-5; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955	13	45	51	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					15	16		10.1038/83121	http://dx.doi.org/10.1038/83121			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135571				2022-12-18	WOS:000166261500008
J	Di Domizio, J; Belkhodja, C; Chenuet, P; Fries, A; Murray, T; Mondejar, PM; Demaria, O; Conrad, C; Homey, B; Werner, S; Speiser, DE; Ryffel, B; Gilliet, M				Di Domizio, Jeremy; Belkhodja, Cyrine; Chenuet, Pauline; Fries, Anissa; Murray, Timothy; Mondejar, Paula Marcos; Demaria, Olivier; Conrad, Curdin; Homey, Bernhard; Werner, Sabine; Speiser, Daniel E.; Ryffel, Bernhard; Gilliet, Michel			The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin	NATURE IMMUNOLOGY			English	Article							ANTIMICROBIAL PEPTIDES; SENESCENT CELLS; BACTERIAL-DNA; INTERFERONS; RESPONSIVENESS; IMMUNITY	Gilliet and colleagues demonstrate that skin wound healing occurs through the coordinated action of plasmacytoid dendritic cells, chemokines and skin microbiota. Skin wounds heal by coordinated induction of inflammation and tissue repair, but the initiating events are poorly defined. Here we uncover a fundamental role of commensal skin microbiota in this process and show that it is mediated by the recruitment and the activation of type I interferon (IFN)-producing plasmacytoid DC (pDC). Commensal bacteria colonizing skin wounds trigger activation of neutrophils to express the chemokine CXCL10, which recruits pDC and acts as an antimicrobial protein to kill exposed microbiota, leading to the formation of CXCL10-bacterial DNA complexes. These complexes and not complexes with host-derived DNA activate pDC to produce type I IFNs, which accelerate wound closure by triggering skin inflammation and early T cell-independent wound repair responses, mediated by macrophages and fibroblasts that produce major growth factors required for healing. These findings identify a key function of commensal microbiota in driving a central innate wound healing response of the skin.	[Di Domizio, Jeremy; Belkhodja, Cyrine; Fries, Anissa; Demaria, Olivier; Conrad, Curdin; Gilliet, Michel] Univ Lausanne, CHUV Univ Hosp, Dept Dermatol, Lausanne, Switzerland; [Chenuet, Pauline; Ryffel, Bernhard] Univ Orleans, Lab Expt & Mol Immunol & Neurogenet, UMR CNRS 7355, Orleans, France; [Murray, Timothy; Mondejar, Paula Marcos; Speiser, Daniel E.] Univ Lausanne, CHUV Univ Hosp, Dept Oncol, Lausanne, Switzerland; [Homey, Bernhard] Heinrich Heine Univ, Med Fac, Dept Dermatol, Dusseldorf, Germany; [Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, Div Immunol,Hlth Sci Fac, Cape Town, South Africa; [Ryffel, Bernhard] South Africa Med Res Council, Cape Town, South Africa	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Orleans; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Heinrich Heine University Dusseldorf; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cape Town	Gilliet, M (corresponding author), Univ Lausanne, CHUV Univ Hosp, Dept Dermatol, Lausanne, Switzerland.	Michel.gilliet@chuv.ch		DI DOMIZIO, Jeremy/0000-0002-6281-3918; Conrad, Curdin/0000-0002-2547-3440; Werner, Sabine/0000-0001-7397-8710	Swiss National Science Foundation [310030_163360]; Fondation Pierre Mercier; Alfred and Annemarie von Sick grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Pierre Mercier; Alfred and Annemarie von Sick grant	We thank M. Malissen from INSERM U1104 laboratory in CIML, Marseille, France for providing the Genista mice; B. Humbel and J. Daraspe from the Electron Microscopy Facility of the University of Lausanne for the electron microscopy; H. Maby-El Hajjami, L. Cagnon, S.A. Maillard and F. Stuber for recruiting healthy volunteers and for establishing and running the human skin blister study; and I. Surbeck and A. Joncic for technical assistance. This work was funded by the Swiss National Science Foundation to M.G. (grant no. 310030_163360), a grant from the Fondation Pierre Mercier to J.D.D., and an Alfred and Annemarie von Sick grant to D.E.S. and M.G.	Akbar AN, 2013, CLIN EXP IMMUNOL, V173, P163, DOI 10.1111/cei.12107; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bradley KC, 2019, CELL REP, V28, P245, DOI 10.1016/j.celrep.2019.05.105; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fischer JC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2513; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Hiebert P, 2018, DEV CELL, V46, P145, DOI 10.1016/j.devcel.2018.06.012; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2015, EUR J IMMUNOL, V45, P203, DOI 10.1002/eji.201344277; Lee EY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08868-w; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Margulieux KR, 2016, MBIO, V7, DOI 10.1128/mBio.00334-16; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin PK, 2018, NAT MICROBIOL, V3, P1131, DOI 10.1038/s41564-018-0229-0; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Ordonez-Rueda D, 2012, EUR J IMMUNOL, V42, P2395, DOI 10.1002/eji.201242589; Schmidt NW, 2015, NAT MATER, V14, P696, DOI [10.1038/NMAT4298, 10.1038/nmat4298]; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stacy A, 2019, SCIENCE, V363, P227, DOI 10.1126/science.aat4326; Stehlikova Z, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00438; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tohyama M, 2012, J INVEST DERMATOL, V132, P1933, DOI 10.1038/jid.2011.468; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; YANKEELOV JA, 1970, BIOCHEMISTRY-US, V9, P2433, DOI 10.1021/bi00814a007; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	42	44	44	13	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1034	+		10.1038/s41590-020-0721-6	http://dx.doi.org/10.1038/s41590-020-0721-6		JUL 2020	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32661363				2022-12-18	WOS:000551369600001
J	Ye, L; Schnepf, D; Becker, J; Ebert, K; Tanriver, Y; Bernasconi, V; Gad, HH; Hartmann, R; Lycke, N; Staeheli, P				Ye, Liang; Schnepf, Daniel; Becker, Jan; Ebert, Karolina; Tanriver, Yakup; Bernasconi, Valentina; Gad, Hans Henrik; Hartmann, Rune; Lycke, Nils; Staeheli, Peter			Interferon-lambda enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin	NATURE IMMUNOLOGY			English	Article							IFN-LAMBDA; EPITHELIAL-CELLS; DENDRITIC CELLS; VIRUS; INFLAMMATION; ADJUVANT; DETERMINES; PROTECTION; INDUCTION; TYPE-2	Interferon-lambda (IFN-lambda) acts on mucosal epithelial cells and thereby confers direct antiviral protection. In contrast, the role of IFN-lambda in adaptive immunity is far less clear. Here, we report that mice deficient in IFN-lambda signaling exhibited impaired CD8(+) T cell and antibody responses after infection with a live-attenuated influenza virus. Virus-induced release of IFN-lambda triggered the synthesis of thymic stromal lymphopoietin (TSLP) by M cells in the upper airways that, in turn, stimulated migratory dendritic cells and boosted antigen-dependent germinal center reactions in draining lymph nodes. The IFN-lambda-TSLP axis also boosted production of the immunoglobulins IgG1 and IgA after intranasal immunization with influenza virus subunit vaccines and improved survival of mice after challenge with virulent influenza viruses. IFN-lambda did not influence the efficacy of vaccines applied by subcutaneous or intraperitoneal routes, indicating that IFN-lambda plays a vital role in potentiating adaptive immune responses that initiate at mucosal surfaces.	[Ye, Liang; Schnepf, Daniel; Becker, Jan; Staeheli, Peter] Univ Freiburg, Inst Virol, Med Ctr, Freiburg, Germany; [Schnepf, Daniel] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Ebert, Karolina; Tanriver, Yakup] Univ Freiburg, Inst Med Microbiol, Med Ctr, Freiburg, Germany; [Tanriver, Yakup; Staeheli, Peter] Univ Freiburg, Fac Med, Freiburg, Germany; [Tanriver, Yakup] Univ Freiburg, Med Ctr, Dept Internal Med 4, Freiburg, Germany; [Bernasconi, Valentina; Lycke, Nils] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden; [Gad, Hans Henrik; Hartmann, Rune] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Gothenburg; Aarhus University	Staeheli, P (corresponding author), Univ Freiburg, Inst Virol, Med Ctr, Freiburg, Germany.; Staeheli, P (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	peter.staeheli@uniklinik-freiburg.de	Tanriver, Yakup/AAU-7064-2020; Ye, Liang/AAC-4651-2022; Ye, Liang/T-1332-2018; ye, liang/X-7553-2019	Ye, Liang/0000-0002-6735-0836; ye, liang/0000-0002-6735-0836; Hartmann, Rune/0000-0003-1159-066X; Becker, Jan/0000-0003-0438-565X; Tanriver, Yakup/0000-0002-4806-2548; Gad, Hans Henrik/0000-0001-8449-1115; Staeheli, Peter/0000-0001-7057-6177	European Union's Seventh Framework Program [607690]; Deutsche Forschungsgemeinschaft [STA 338/15-1, TA 436/4-1]; Else Kroner-Fresenius Stiftung [2017_EKES.34]; Danish Council for Independent Research, Medical Research [11-107588]	European Union's Seventh Framework Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung; Danish Council for Independent Research, Medical Research	We thank A. Ohnemus for technical support, and H. Pircher, G. Gasteiger and O. Haller for helpful discussions and comments on the manuscript. Funding for this work was provided by the European Union's Seventh Framework Program grant agreement 607690 (to P.S. and N.L.), the Deutsche Forschungsgemeinschaft grant agreement STA 338/15-1 (to P.S.) and TA 436/4-1 (to Y.T.), the Else Kroner-Fresenius Stiftung grant agreement 2017_EKES.34 (to Y.T.) and the Danish Council for Independent Research, Medical Research grant agreement 11-107588 (to R.H.).	Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; de Groen RA, 2015, J LEUKOCYTE BIOL, V98, P623, DOI 10.1189/jlb.3A0215-041RR; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Espinosa V, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5357; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Ferko B, 2004, J VIROL, V78, P13037, DOI 10.1128/JVI.78.23.13037-13045.2004; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Ganti KP, 2017, P NATL ACAD SCI USA, V114, pE951, DOI 10.1073/pnas.1620697114; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Joo S, 2017, MUCOSAL IMMUNOL, V10, P901, DOI 10.1038/mi.2016.103; Kelly A, 2016, J INTERF CYTOK RES, V36, P671, DOI 10.1089/jir.2015.0169; Kim DY, 2011, J IMMUNOL, V186, P4253, DOI 10.4049/jimmunol.0903794; Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354; Kochs G, 2009, J GEN VIROL, V90, P2990, DOI 10.1099/vir.0.015727-0; Kolpe A, 2018, ANTIVIR RES, V158, P244, DOI 10.1016/j.antiviral.2018.08.017; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takaki H, 2018, MUCOSAL IMMUNOL, V11, P82, DOI 10.1038/mi.2017.48; Van den Hoecke S, 2017, J VIROL, V91, DOI 10.1128/JVI.02500-16; Van Roey GA, 2012, EUR J IMMUNOL, V42, P353, DOI 10.1002/eji.201141787; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; West EE, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8471; Zhou Y, 2017, VIRAL IMMUNOL, V30, P601, DOI 10.1089/vim.2017.0033; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	40	44	47	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					593	+		10.1038/s41590-019-0345-x	http://dx.doi.org/10.1038/s41590-019-0345-x			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30886417				2022-12-18	WOS:000465084800016
J	Lund, H; Pieber, M; Parsa, R; Grommisch, D; Ewing, E; Kular, L; Han, JM; Zhu, KY; Nijssen, J; Hedlund, E; Needhamsen, M; Ruhrmann, S; Guerreiro-Cacais, AO; Berglund, R; Forteza, MJ; Ketelhuth, DFJ; Butovsky, O; Jagodic, M; Zhang, XM; Harris, RA				Lund, Harald; Pieber, Melanie; Parsa, Roham; Grommisch, David; Ewing, Ewoud; Kular, Lara; Han, Jinming; Zhu, Keying; Nijssen, Jik; Hedlund, Eva; Needhamsen, Maria; Ruhrmann, Sabrina; Guerreiro-Cacais, Andre Ortlieb; Berglund, Rasmus; Forteza, Maria J.; Ketelhuth, Daniel F. J.; Butovsky, Oleg; Jagodic, Maja; Zhang, Xing-Mei; Harris, Robert A.			Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-beta signaling	NATURE IMMUNOLOGY			English	Article							MICROGLIA; ABLATION; DELETION; REVEALS; NICHE; CELLS	The cytokine transforming growth factor-beta (TGF-beta) regulates the development and homeostasis of several tissueresident macrophage populations, including microglia. TGF-beta is not critical for microglia survival but is required for the maintenance of the microglia-specific homeostatic gene signature(1,2) Under defined host conditions, circulating monocytes can compete for the microglial niche and give rise to long-lived monocyte-derived macrophages residing in the central nervous system (CNS)(3-5). Whether monocytes require TGF-beta for colonization of the microglial niche and maintenance of CNS integrity is unknown. We found that abrogation of TGF-beta signaling in CX3CR1(+) monocyte-derived macrophages led to rapid onset of a progressive and fatal demyelinating motor disease characterized by myelin-laden giant macrophages throughout the spinal cord. Tgfbr2-deficient macrophages were characterized by high expression of genes encoding proteins involved in antigen presentation, inflammation and phagocytosis. TGF-beta is thus crucial for the functional integration of monocytes into the CNS microenvironment.	[Lund, Harald; Pieber, Melanie; Parsa, Roham; Grommisch, David; Han, Jinming; Zhu, Keying; Zhang, Xing-Mei; Harris, Robert A.] Karolinska Hosp Solna, Ctr Mol Med, Karolinska Inst, Dept Clin Neurosci Appl Immunol & Immunotherap, Stockholm, Sweden; [Ewing, Ewoud; Kular, Lara; Needhamsen, Maria; Ruhrmann, Sabrina; Guerreiro-Cacais, Andre Ortlieb; Berglund, Rasmus; Jagodic, Maja] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden; [Nijssen, Jik; Hedlund, Eva] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Forteza, Maria J.; Ketelhuth, Daniel F. J.] Karolinska Inst, Ctr Mol Med, Dept Med, Cardiovasc Med Unit, Stockholm, Sweden; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Dept Neurol, Boston, MA USA; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Evergrarde Ctr Immunol Dis, Boston, MA USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Harris, RA (corresponding author), Karolinska Hosp Solna, Ctr Mol Med, Karolinska Inst, Dept Clin Neurosci Appl Immunol & Immunotherap, Stockholm, Sweden.	robert.harris@ki.se	Harris, Robert A./I-6234-2019; Forteza, Maria Jose/Y-4427-2018; Zhu, Keying/X-5185-2019; Guerreiro-Cacais, Andre Ortlieb/AAE-8417-2019; Ketelhuth, Daniel/F-6580-2012; Han, Jinming/R-6607-2019; Lund, Harald/AAV-3736-2020; Parsa, Roham/AAV-4002-2021; Parsa, Roham/AHA-7145-2022; Butovsky, Oleg/ABG-9086-2020	Harris, Robert A./0000-0003-4990-509X; Zhu, Keying/0000-0001-7500-1532; Ketelhuth, Daniel/0000-0002-0087-116X; Han, Jinming/0000-0002-6084-3275; Lund, Harald/0000-0001-8046-0805; Parsa, Roham/0000-0002-0864-6098; Parsa, Roham/0000-0002-0864-6098; Butovsky, Oleg/0000-0003-0186-8867; Pieber, Melanie/0000-0002-4522-2489; Hedlund, Eva/0000-0001-6347-0075; Grommisch, David/0000-0002-2666-1419; Kular, Lara/0000-0002-2907-6071; Forteza, Maria Jose/0000-0003-4907-4783	Swedish Alzheimer Foundation (Alzheimerfonden) [AF-74004]; Swedish Research Council (Vetenskapsradet) [2014-02087, K2015-61X-20776-08-3]; Swedish Childhood Cancer Foundation (Barncancerfonden) [PR2014-0154, NCP2015-0064, NC2014-0046]; Ake Wibergs stiftelse [MI4-0263]; Foundation of Swedish MS Research (MS Forskningsfonden); Swedish Heart Lung Foundation (Hjart-Lungfonden); Novo Nordisk Foundation [NNF15CC0018346]; NIH-NINDS [1R01NS088137]; NIH-NIA [R01AG051812, R01AG054672]; National Multiple Sclerosis Society [5092A1]; Amyotrophic Lateral Sclerosis Association [ALSA2087]; Nancy Davis Foundation Faculty Award; Margaretha af Ugglas Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG051812, R01AG054672] Funding Source: NIH RePORTER	Swedish Alzheimer Foundation (Alzheimerfonden); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Childhood Cancer Foundation (Barncancerfonden); Ake Wibergs stiftelse; Foundation of Swedish MS Research (MS Forskningsfonden); Swedish Heart Lung Foundation (Hjart-Lungfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Amyotrophic Lateral Sclerosis Association; Nancy Davis Foundation Faculty Award; Margaretha af Ugglas Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Swedish Alzheimer Foundation (Alzheimerfonden, AF-74004, R.A.H.), Swedish Research Council (Vetenskapsradet, 2014-02087, R.A.H. and K2015-61X-20776-08-3, M.J.), Swedish Childhood Cancer Foundation (Barncancerfonden, PR2014-0154 and NCP2015-0064, X.-M.Z.), Ake Wibergs stiftelse (MI4-0263, X.-M.Z.), Foundation of Swedish MS Research (MS Forskningsfonden, L.K.), Swedish Heart Lung Foundation (Hjart-Lungfonden, M.J.F. and D.F.J.K.), the Novo Nordisk Foundation (NNF15CC0018346, M.J. E and D.F.J.K.), NIH-NINDS (1R01NS088137, O.B.), NIH-NIA (R01AG051812 and R01AG054672, O.B.), National Multiple Sclerosis Society (5092A1, O.B.) and Amyotrophic Lateral Sclerosis Association (ALSA2087, O.B.), and by a Nancy Davis Foundation Faculty Award (O.B.). X.-M.Z. was supported by a fellowship from the Swedish Childhood Cancer Foundation (Barncancerfonden, NC2014-0046, NBCNS). L.K. was supported by a fellowship from the Margaretha af Ugglas Foundation.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Li JY, 2013, CARCINOGENESIS, V34, P2099, DOI 10.1093/carcin/bgt172; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malipiero U, 2006, BRAIN, V129, P2404, DOI 10.1093/brain/awl192; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nagao M, 1998, J NEUROPATH EXP NEUR, V57, P329, DOI 10.1097/00005072-199804000-00004; Nijssen J, 2017, ACTA NEUROPATHOL, V133, P863, DOI 10.1007/s00401-017-1708-8; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Parsa R, 2016, GLIA, V64, P1925, DOI 10.1002/glia.23033; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Wong K, 2017, NAT IMMUNOL, V18, P633, DOI 10.1038/ni.3743; Wootz H, 2013, J COMP NEUROL, V521, P1449, DOI 10.1002/cne.23266; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007	28	44	44	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					435	+		10.1038/s41590-018-0091-5	http://dx.doi.org/10.1038/s41590-018-0091-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29662171	Green Accepted			2022-12-18	WOS:000430562400007
J	Feng, H; Lenarcic, EM; Yamane, D; Wauthier, E; Mo, J; Guo, HT; McGivern, DR; Gonzalez-Lopez, O; Misumi, I; Reid, LM; Whitmire, JK; Ting, JPY; Duncan, JA; Moorman, NJ; Lemon, SM				Feng, Hui; Lenarcic, Erik M.; Yamane, Daisuke; Wauthier, Eliane; Mo, Jinyao; Guo, Haitao; McGivern, David R.; Gonzalez-Lopez, Olga; Misumi, Ichiro; Reid, Lola M.; Whitmire, Jason K.; Ting, Jenny P-Y; Duncan, Joseph A.; Moorman, Nathaniel J.; Lemon, Stanley M.			NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR	NATURE IMMUNOLOGY			English	Article							HEPATITIS-C-VIRUS; NF-KAPPA-B; PROTEIN-KINASE R; OXYGEN SPECIES PRODUCTION; NOD-LIKE RECEPTOR; A VIRUS; TRANSCRIPTION FACTOR; I INTERFERON; INFLAMMASOME ACTIVATION; SIGNALING PATHWAYS	NLRX1 is unique among the nucleotide-binding-domain and leucine-rich-repeat (NLR) proteins in its mitochondrial localization and ability to negatively regulate antiviral innate immunity dependent on the adaptors MAVS and STING. However, some studies have suggested a positive regulatory role for NLRX1 in inducing antiviral responses. We found that NLRX1 exerted opposing regulatory effects on viral activation of the transcription factors IRF1 and IRF3, which might potentially explain such contradictory results. Whereas NLRX1 suppressed MAVS-mediated activation of IRF3, it conversely facilitated virus-induced increases in IRF1 expression and thereby enhanced control of viral infection. NLRX1 had a minimal effect on the transcription of IRF1 mediated by the transcription factor NF-kappa B and regulated the abundance of IRF1 post-transcriptionally by preventing translational shutdown mediated by the double-stranded RNA (dsRNA)-activated kinase PKR and thereby allowed virus-induced increases in the abundance of IRF1 protein.	[Feng, Hui; Lenarcic, Erik M.; Yamane, Daisuke; Wauthier, Eliane; Mo, Jinyao; Guo, Haitao; McGivern, David R.; Gonzalez-Lopez, Olga; Misumi, Ichiro; Reid, Lola M.; Whitmire, Jason K.; Ting, Jenny P-Y; Duncan, Joseph A.; Moorman, Nathaniel J.; Lemon, Stanley M.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Feng, Hui; Yamane, Daisuke; Mo, Jinyao; McGivern, David R.; Gonzalez-Lopez, Olga; Duncan, Joseph A.; Lemon, Stanley M.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA; [Lenarcic, Erik M.; Whitmire, Jason K.; Moorman, Nathaniel J.; Lemon, Stanley M.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wauthier, Eliane; Misumi, Ichiro; Whitmire, Jason K.; Ting, Jenny P-Y] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC USA; [Guo, Haitao; Reid, Lola M.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Yamane, Daisuke] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC USA; [Lenarcic, Erik M.; Yamane, Daisuke] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Tokyo Metropolitan Institute of Medical Science	Lemon, SM (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Lemon, SM (corresponding author), Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA.; Lemon, SM (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	smlemon@med.unc.edu	Misumi, Ichiro/H-8573-2019; Mcgivern, David/H-6210-2019; FENG, HUI/GSD-5926-2022	Misumi, Ichiro/0000-0003-3892-7605; Mcgivern, David/0000-0003-3497-5087; Feng, Hui/0000-0002-1451-1413; Whitmire, Jason/0000-0003-2578-6073	US National Institutes of Health [U19-AI109965, R01-AI103083, R01-AI131685, R01-AI1033, R21-AI11757511]; University of North Carolina Cancer Research Fund; Grants-in-Aid for Scientific Research [17H05070] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117575, R01AI131685, U19AI109965, R01AI103311, R01AI103083] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Glaunsinger (University of California, Berkeley) for the human IL6 3'UTR expression vector, and L. Hensley, W. Lovell, M. Deng, and M. Chua for technical support. Supported by the US National Institutes of Health (U19-AI109965 to S.M.L., J.A.D. and J.P-Y.T.; R01-AI103083 to S.M.L.; R01-AI131685 to S.M.L. and J.K.W.; R01-AI103311 to N.J.M.; and R21-AI117575 to J.K.W.) and the University of North Carolina Cancer Research Fund (S.M.L. and J.P-Y.T.).	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BROWN EA, 1994, J VIROL, V68, P1066, DOI 10.1128/JVI.68.2.1066-1074.1994; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; Dauber B, 2009, VIRUSES-BASEL, V1, P523, DOI 10.3390/v1030523; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Guo HT, 2016, CELL HOST MICROBE, V19, P515, DOI 10.1016/j.chom.2016.03.001; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hirai-Yuki A, 2016, SCIENCE, V353, P1541, DOI 10.1126/science.aaf8325; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Lanford RE, 2011, P NATL ACAD SCI USA, V108, P11223, DOI 10.1073/pnas.1101939108; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Masaki T, 2015, CELL HOST MICROBE, V17, P217, DOI 10.1016/j.chom.2014.12.014; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Mboko WP, 2014, J VIROL, V88, P6993, DOI 10.1128/JVI.00638-14; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Ousman SS, 2005, J VIROL, V79, P7514, DOI 10.1128/JVI.79.12.7514-7527.2005; Qu L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002169; Qu L, 2010, SEMIN LIVER DIS, V30, P319, DOI 10.1055/s-0030-1267534; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Saeed M, 2015, NATURE, V524, P471, DOI 10.1038/nature14899; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/nmeth.1314, 10.1038/NMETH.1314]; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Soares F, 2014, J BIOL CHEM, V289, P19317, DOI 10.1074/jbc.M114.550111; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Unger BL, 2014, J VIROL, V88, P3705, DOI 10.1128/JVI.03039-13; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Weiss G, 2012, J IMMUNOL, V189, P2860, DOI 10.4049/jimmunol.1103491; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yamane D, 2017, NUCLEIC ACIDS RES, V45, P4743, DOI 10.1093/nar/gkw1332; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yi M, 2002, J VIROL, V76, P1171, DOI 10.1128/JVI.76.3.1171-1180.2002; Ziehr B, 2016, J VIROL, V90, P3839, DOI 10.1128/JVI.02714-15	68	44	49	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1299	+		10.1038/ni.3853	http://dx.doi.org/10.1038/ni.3853			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	28967880	Green Submitted, Green Accepted			2022-12-18	WOS:000415324900008
J	Duchene, J; Novitzky-Basso, I; Thiriot, A; Casanova-Acebes, M; Bianchini, M; Etheridge, SL; Hub, E; Nitz, K; Artinger, K; Eller, K; Caamano, J; Rulicke, T; Moss, P; Megens, RTA; von Andrian, UH; Hidalgo, A; Weber, C; Rot, A				Duchene, Johan; Novitzky-Basso, Igor; Thiriot, Aude; Casanova-Acebes, Maria; Bianchini, Mariaelvy; Etheridge, S. Leah; Hub, Elin; Nitz, Katrin; Artinger, Katharina; Eller, Kathrin; Caamano, Jorge; Rulicke, Thomas; Moss, Paul; Megens, Remco T. A.; von Andrian, Ulrich H.; Hidalgo, Andres; Weber, Christian; Rot, Antal			Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis	NATURE IMMUNOLOGY			English	Article							DUFFY ANTIGEN RECEPTOR; BONE-MARROW; HOST-DEFENSE; ENDOTHELIAL-CELLS; PLASMODIUM-VIVAX; DARC; MAINTENANCE; EXPRESSION; MALARIA; SYSTEM	Healthy individuals of African ancestry have neutropenia that has been linked with the variant rs2814778(G) of the gene encoding atypical chemokine receptor 1 (ACKR1). This polymorphism selectively abolishes the expression of ACKR1 in erythroid cells, causing a Duffy-negative phenotype. Here we describe an unexpected fundamental role for ACKR1 in hematopoiesis and provide the mechanism that links its absence with neutropenia. Nucleated erythroid cells had high expression of ACKR1, which facilitated their direct contact with hematopoietic stem cells. The absence of erythroid ACKR1 altered mouse hematopoiesis including stem and progenitor cells, which ultimately gave rise to phenotypically distinct neutrophils that readily left the circulation, causing neutropenia. Individuals with a Duffy-negative phenotype developed a distinct profile of neutrophil effector molecules that closely reflected the one observed in the ACKR1-deficient mice. Thus, alternative physiological patterns of hematopoiesis and bone marrow cell outputs depend on the expression of ACKR1 in the erythroid lineage, findings with major implications for the selection advantages that have resulted in the paramount fixation of the ACKR1 rs2814778(G) polymorphism in Africa.	[Duchene, Johan; Bianchini, Mariaelvy; Nitz, Katrin; Megens, Remco T. A.; Hidalgo, Andres; Weber, Christian; Rot, Antal] Ludwig Maximilians Univ LMU, Inst Cardiovasc Prevent, Munich, Germany; [Novitzky-Basso, Igor] Queen Elizabeth Univ Hosp, Blood & Marrow Transplant Unit, Glasgow, Lanark, Scotland; [Thiriot, Aude; von Andrian, Ulrich H.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA; [Thiriot, Aude; von Andrian, Ulrich H.] Harvard Med Sch, Ctr Immune Imaging, Boston, MA USA; [Thiriot, Aude; von Andrian, Ulrich H.] Ragon Inst, Cambridge, MA USA; [Casanova-Acebes, Maria; Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Etheridge, S. Leah; Hub, Elin; Artinger, Katharina; Rot, Antal] Univ York, Dept Biol, Ctr Immunol & Infect, Heslington, England; [Nitz, Katrin] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany; [Artinger, Katharina; Eller, Kathrin] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Caamano, Jorge; Moss, Paul] Univ Birmingham, Inst Immunol & Immunotherapy, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rulicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Megens, Remco T. A.; Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Rot, Antal] Ludwig Maximilians Univ Munchen, Ctr Adv Studies, Munich, Germany; [Rot, Antal] Queen Mary Univ London, William Harvey Res Inst, London, England	University of Munich; Queen Elizabeth University Hospital (QEUH); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of York - UK; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Medical University of Graz; University of Birmingham; University of Veterinary Medicine Vienna; Maastricht University; University of Munich; University of London; Queen Mary University London	Weber, C; Rot, A (corresponding author), Ludwig Maximilians Univ LMU, Inst Cardiovasc Prevent, Munich, Germany.; Rot, A (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, Heslington, England.; Weber, C (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.; Rot, A (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Adv Studies, Munich, Germany.; Rot, A (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	chweber@med.lmu.de; a.rot@qmul.ac.uk	Weber, Christian/AAW-2153-2020; Bianchini, Mariaelvy/GZG-3300-2022; Hidalgo, Andrés/L-5643-2014; Novitzky-Basso, Igor/GLN-4839-2022; Novitzky-Basso, Igor/AAU-2356-2020; Moss, Paul/D-1728-2009; Acebes, Maria Casanova/AAH-1929-2019; Caamano, Jorge/O-7530-2019; Duchene, Johan/Q-9472-2019	Weber, Christian/0000-0003-4610-8714; Hidalgo, Andrés/0000-0001-5513-555X; Novitzky-Basso, Igor/0000-0003-3748-3117; Moss, Paul/0000-0002-6895-1967; Acebes, Maria Casanova/0000-0002-5790-1163; Caamano, Jorge/0000-0003-3530-7056; Duchene, Johan/0000-0002-3973-0022; Rot, Antal/0000-0002-9730-6166; Bianchini, Mariaelvy/0000-0002-5549-4883; megens, remco/0000-0001-9871-6696; Eller, Kathrin/0000-0002-6214-5008; Artinger, Katharina/0000-0002-5677-3171	Medical Research Council [G0802838]; Senior Visiting Fellowship of the Center for Advanced Studies LMU, Munich; Wellcome Trust [WT090962MA]; Deutsche Zentrum Fur Herz-Kreislauf-Forschung [86X2600229]; Marie Curie Actions Intra-European Fellowship ATHEROCHEMOKINE; Deutsche Forschungsgemeinschaft [SFB1123/A1, SFB1123/Z1]; INST [409/150-1 FUG]; European Research Council grant ERC [AdG o692511]; Swiss National Science Foundation [CRSII3_160719]; TransCard PhD fellowship in Translational Cardiovascular and Metabolic Medicine of the Helmholtz International Research School; ERA-EDTA short-term fellowship; Ministry of Economy, Industry and Competitiveness (MINECO) [AF2015-65607-R]; MINECO; Pro-CNIC Foundation; BBSRC [BB/K009400/1] Funding Source: UKRI; MRC [G0802838] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Senior Visiting Fellowship of the Center for Advanced Studies LMU, Munich; Wellcome Trust(Wellcome Trust); Deutsche Zentrum Fur Herz-Kreislauf-Forschung; Marie Curie Actions Intra-European Fellowship ATHEROCHEMOKINE; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); INST; European Research Council grant ERC(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TransCard PhD fellowship in Translational Cardiovascular and Metabolic Medicine of the Helmholtz International Research School; ERA-EDTA short-term fellowship; Ministry of Economy, Industry and Competitiveness (MINECO)(Spanish Government); MINECO(Spanish Government); Pro-CNIC Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.D. and I.N.-B. are joint first authors, and A.T., M.C.-A., M.B., S.L.E., E.H. and K.N. contributed equally to this work. We thank M. Ulvmar, E. Ross, G. Volpe, P. Cauchy and A. Cunningham for their advice, R. Bird and S. Kissane for their assistance with cell sorting and microarray experiments, respectively, H. Vyas and P. Kelay for help with laboratory work and D. Santovito for help with statistical analysis. We thank M. Mack (University of Regensburg) and M. Uchikawa (Japanese Red Cross) for their generous gifts of antibodies specific for mouse CCR2 and human ACKR1 antibody, respectively, and J. Allen (University of Manchester) and M. Bader (Max Delbruck Center) for critical reading of the manuscript and their suggestions. A.R. is grateful to M. Tsaloumas, A. Denniston and N. Glover for the vision. Supported by Medical Research Council grant G0802838 (A.R.), a Senior Visiting Fellowship of the Center for Advanced Studies LMU, Munich (A.R.), Wellcome Trust grant WT090962MA (I.N.-B., A.R. and P. M.), Deutsche Zentrum Fur Herz-Kreislauf-Forschung 86X2600229 (J. D. and C.W.), a Marie Curie Actions Intra-European Fellowship ATHEROCHEMOKINE (J. D.), Deutsche Forschungsgemeinschaft grants SFB1123/A1 (C.W.), SFB1123/Z1 (M.B. and R.T.A.M.) and INST 409/150-1 FUG (C.W. and R.T.A.M.), European Research Council grant ERC AdG o692511 (C.W.), Swiss National Science Foundation Sinergia grant CRSII3_160719 (E.H. and A.R.), a TransCard PhD fellowship in Translational Cardiovascular and Metabolic Medicine of the Helmholtz International Research School (K.N.), an ERA-EDTA short-term fellowship (K.A.) and Ministry of Economy, Industry and Competitiveness (MINECO) grant AF2015-65607-R (A. H.). The CNIC is supported by MINECO and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award).	Bachelerie E., 2013, PHARMACOL REV, V66, P1; Bachelerie F, 2014, NAT IMMUNOL, V15, P207, DOI 10.1038/ni.2812; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; Doss JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2156-2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fossati G., 2007, ARTHRITIS RHEUM, V46, P1351; Gao HL, 2000, EXP HEMATOL, V28, P1062, DOI 10.1016/S0301-472X(00)00513-0; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Hun J., 2016, CELL STEM CELL, V18, P508; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Lee KM, 2014, EMBO J, V33, P2564, DOI 10.15252/embj.201488887; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Minten C, 2014, BRAIN, V137, P1454, DOI 10.1093/brain/awu045; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Novitzky-Basso I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00266; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; SANGER R, 1955, BRIT J HAEMATOL, V1, P370, DOI 10.1111/j.1365-2141.1955.tb05523.x; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Thiriot A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0381-7; Thobakgale CF, 2014, CURR OPIN HEMATOL, V21, P50, DOI 10.1097/MOH.0000000000000007; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Youn BS, 2000, IMMUNOL REV, V177, P150, DOI 10.1034/j.1600-065X.2000.17701.x; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045	51	44	46	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					753	+		10.1038/ni.3763	http://dx.doi.org/10.1038/ni.3763			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28553950	Green Submitted, Green Accepted			2022-12-18	WOS:000403676300010
J	Wang, F; Alain, T; Szretter, KJ; Stephenson, K; Pol, JG; Atherton, MJ; Hoang, HD; Fonseca, BD; Zakaria, C; Chen, L; Rangwala, Z; Hesch, A; Chan, ESY; Tuinman, C; Suthar, MS; Jiang, ZZ; Ashkar, AA; Thomas, G; Kozma, SC; Gale, M; Fitzgerald, KA; Diamond, MS; Mossman, K; Sonenberg, N; Wan, YH; Lichty, BD				Wang, Fuan; Alain, Tommy; Szretter, Kristy J.; Stephenson, Kyle; Pol, Jonathan G.; Atherton, Matthew J.; Hoang, Huy-Dung; Fonseca, Bruno D.; Zakaria, Chadi; Chen, Lan; Rangwala, Zainab; Hesch, Adam; Chan, Eva Sin Yan; Tuinman, Carly; Suthar, Mehul S.; Jiang, Zhaozhao; Ashkar, Ali A.; Thomas, George; Kozma, Sara C.; Gale, Michael, Jr.; Fitzgerald, Katherine A.; Diamond, Michael S.; Mossman, Karen; Sonenberg, Nahum; Wan, Yonghong; Lichty, Brian D.			S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3	NATURE IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE-RESPONSE; I INTERFERON; MAMMALIAN TARGET; KAPPA-B; PHOSPHORYLATION; ADAPTER; SENSOR; VIRUS; MTOR	Cytosolic DNA-mediated activation of the transcription factor IRF3 is a key event in host antiviral responses. Here we found that infection with DNA viruses induced interaction of the metabolic checkpoint kinase mTOR downstream effector and kinase S6K1 and the signaling adaptor STING in a manner dependent on the DNA sensor cGAS. We further demonstrated that the kinase domain, but not the kinase function, of S6K1 was required for the S6K1-STING interaction and that the TBK1 critically promoted this process. The formation of a tripartite S6K1-STING-TBK1 complex was necessary for the activation of IRF3, and disruption of this signaling axis impaired the early-phase expression of IRF3 target genes and the induction of T cell responses and mucosal antiviral immunity. Thus, our results have uncovered a fundamental regulatory mechanism for the activation of IRF3 in the cytosolic DNA pathway.	[Wang, Fuan; Stephenson, Kyle; Pol, Jonathan G.; Atherton, Matthew J.; Chen, Lan; Rangwala, Zainab; Hesch, Adam; Chan, Eva Sin Yan; Tuinman, Carly; Ashkar, Ali A.; Mossman, Karen; Wan, Yonghong; Lichty, Brian D.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Wang, Fuan; Stephenson, Kyle; Pol, Jonathan G.; Atherton, Matthew J.; Chen, Lan; Rangwala, Zainab; Hesch, Adam; Chan, Eva Sin Yan; Tuinman, Carly; Ashkar, Ali A.; Mossman, Karen; Wan, Yonghong; Lichty, Brian D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Alain, Tommy; Hoang, Huy-Dung; Fonseca, Bruno D.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Alain, Tommy; Hoang, Huy-Dung; Fonseca, Bruno D.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Szretter, Kristy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med Mol Microbiol Pathol & Immunol, St Louis, MO USA; [Zakaria, Chadi; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Zakaria, Chadi; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Suthar, Mehul S.] Emory Univ, Dept Pediat, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Jiang, Zhaozhao; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Thomas, George; Kozma, Sara C.] Univ Cincinnati, Sch Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA; [Thomas, George; Kozma, Sara C.] IDIBELL, Bellvitge Biomed Res Inst, Lab Metab & Canc, Catalan Inst Oncol,ICO, Barcelona, Spain; [Thomas, George] Univ Barcelona, Fac Med, Dept Ciencies Fisiol 2, Barcelona 7, Spain; [Gale, Michael, Jr.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	McMaster University; McMaster University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Washington University (WUSTL); McGill University; McGill University; Emory University; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Cincinnati; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; University of Washington; University of Washington Seattle	Lichty, BD (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada.; Lichty, BD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	lichtyb@mcmaster.ca	Fitzgerald, Katherine/ABE-6317-2020; Pol, Jonathan/R-6507-2016; Diamond, Michael/AAH-1733-2019; Hoang, Huy-Dung/HDO-6126-2022	Pol, Jonathan/0000-0002-8355-7562; Diamond, Michael/0000-0002-8791-3165; Szretter, Kristy/0000-0003-0391-2307; Fitzgerald, Kate/0000-0003-3175-609X; Hoang, Huy-Dung/0000-0001-8793-1673; Ashkar, Ali/0000-0003-1139-1468; Gale, Michael/0000-0002-6332-7436	Cancer Research Society/Steven E. Drabin Research Fund; Terry Fox Foundation; Canadian Institutes of Health Research; McMaster Immunology Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI104002] Funding Source: NIH RePORTER	Cancer Research Society/Steven E. Drabin Research Fund; Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McMaster Immunology Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the other members of the McMaster Immunology Research Centre; N. Kazhdan, S. Collins, D. Cummings and C. Shao for technical help; M. Nolland and J. Govero for preparing wild-type and mutant mouse bones; K. McCoy (University of Bern) for Myd88<SUP>-/-</SUP>Trif<SUP>-/-</SUP> mice; V. Fensterl (Cleveland Clinic) and G. Sen (Cleveland Clinic) for antibody to IFIT3; X. Feng (McMaster University) for Ad-OVA and VV-OVA; M. Orr-Asman (University of Cincinnati) and C. Mercer (University of Cincinnati) for plasmids encoding S6K1; and R. Lin (McGill University) for plasmids encoding TBK1. Supported by the Cancer Research Society/Steven E. Drabin Research Fund (T.A.), Terry Fox Foundation (B.D.L.) and the Canadian Institutes of Health Research (Y.W. and the McMaster Immunology Research Centre).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Bassett JD, 2011, BLOOD, V117, P1146, DOI 10.1182/blood-2010-03-272336; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Boudreau JE, 2011, CANCER RES, V71, P2497, DOI 10.1158/0008-5472.CAN-10-3025; Boudreau JE, 2009, MOL THER, V17, P1465, DOI 10.1038/mt.2009.95; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; de Lendonck LY, 2014, CELL MOL LIFE SCI, V71, P3873, DOI 10.1007/s00018-014-1653-9; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2011, CELL MOL LIFE SCI, V68, P1157, DOI 10.1007/s00018-010-0605-2; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Nociari M, 2009, J VIROL, V83, P4081, DOI 10.1128/JVI.02591-08; Parish C.R., 2009, CURR PROTOC IMMUNOL, V84; Pol JG, 2014, MOL THER, V22, P420, DOI 10.1038/mt.2013.249; Rathinam VAK, 2011, CURR OPIN VIROL, V1, P455, DOI 10.1016/j.coviro.2011.11.004; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Senesac J, 2014, METHODS MOL BIOL, V1139, P97, DOI 10.1007/978-1-4939-0345-0_10; Soliman GA, 2005, CURR OPIN LIPIDOL, V16, P317, DOI 10.1097/01.mol.0000169352.35642.06; Stein SC, 2012, J VIROL, V86, P4527, DOI 10.1128/JVI.07071-11; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	50	44	44	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					514	+		10.1038/ni.3433	http://dx.doi.org/10.1038/ni.3433			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27043414	Green Accepted, Green Published			2022-12-18	WOS:000374323100010
J	Park, Y; Jin, HS; Lopez, J; Lee, J; Liao, L; Elly, C; Liu, YC				Park, Yoon; Jin, Hyung-Seung; Lopez, Justine; Lee, Jeeho; Liao, Lujian; Elly, Chris; Liu, Yun-Cai			SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex	NATURE IMMUNOLOGY			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; FOXP3 EXPRESSION; PROTEIN; IMMUNE; TCR; INFLAMMATION; SELECTION; ZAP-70; POLYUBIQUITIN; DYSREGULATION	SHARPIN forms a linear-ubiquitin-chain-assembly complex that promotes signaling via the transcription factor NF-kappa B. SHARPIN deficiency leads to progressive multi-organ inflammation and immune system malfunction, but how SHARPIN regulates T cell responses is unclear. Here we found that SHARPIN deficiency resulted in a substantial reduction in the number of and defective function of regulatory T cells (T-reg cells). Transfer of SHARPIN-sufficient T-reg cells into SHARPIN-deficient mice considerably alleviated their systemic inflammation. SHARPIN-deficient T cells displayed enhanced proximal signaling via the T cell antigen receptor (TCR) without an effect on the activation of NF-kappa B. SHARPIN conjugated with Lys63 (K63)-linked ubiquitin chains, which led to inhibition of the association of TCR zeta with the signaling kinase Zap70; this affected the generation of T-reg cells. Our study therefore identifies a role for SHARPIN in TCR signaling whereby it maintains immunological homeostasis and tolerance by regulating T-reg cells.	[Park, Yoon; Jin, Hyung-Seung; Lopez, Justine; Lee, Jeeho; Elly, Chris; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Liao, Lujian] E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Liu, Yun-Cai] Tsinghua Univ, Inst Immunol, Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China	La Jolla Institute for Immunology; East China Normal University; Tsinghua University	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA.	yuncail@lji.org		park, yoon/0000-0002-0871-8901; jin, hyung-seung/0000-0002-3186-3488; LIU, YUN-CAI/0000-0002-0996-7109	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [RO1AI62969, RO1A178272, PO1AI089624]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122258, R01AI062969, P01AI089624, R01AI123398, R01AI078272] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Rudensky (Memorial Sloan Kettering Cancer Center) for Foxp3<SUP>YFPCre</SUP> mice. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (RO1AI62969, RO1A178272 and PO1AI089624).	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Hwang S, 2012, J EXP MED, V209, P1781, DOI 10.1084/jem.20120058; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jin HS, 2013, P NATL ACAD SCI USA, V110, P624, DOI 10.1073/pnas.1213819110; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liang Y, 2011, J DERMATOL SCI, V63, P148, DOI 10.1016/j.jdermsci.2011.04.012; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Ohkura N, 2010, SEMIN IMMUNOPATHOL, V32, P95, DOI 10.1007/s00281-010-0200-5; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Potter CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085666; Pouwels J, 2013, CELL REP, V5, P619, DOI 10.1016/j.celrep.2013.10.011; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang Z, 2012, J CELL MOL MED, V16, P2271, DOI 10.1111/j.1582-4934.2012.01574.x; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031809	45	44	46	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					286	296		10.1038/ni.3352	http://dx.doi.org/10.1038/ni.3352			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26829767	Green Accepted			2022-12-18	WOS:000370469300013
J	Maizels, RM; Nussey, DH				Maizels, Rick M.; Nussey, Daniel H.			Into the wild: digging at immunology's evolutionary roots	NATURE IMMUNOLOGY			English	Article							IMMUNE FUNCTION; RESPONSIVENESS; POPULATION; RESISTANCE; SELECTION; SUSCEPTIBILITY; POLYMORPHISM; HELMINTHS; PARASITES; PATHOGEN		[Maizels, Rick M.; Nussey, Daniel H.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Maizels, Rick M.; Nussey, Daniel H.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Maizels, Rick M.; Nussey, Daniel H.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Maizels, RM (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	r.maizels@ed.ac.uk	Nussey, Daniel H/F-4155-2010		BBSRC [BB/H021868/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021868/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; Bonneaud C, 2012, MOL ECOL, V21, P4787, DOI 10.1111/j.1365-294X.2012.05736.x; Bonneaud C, 2011, P NATL ACAD SCI USA, V108, P7899, DOI 10.1073/pnas.1018580108; Boysen P, 2011, MOL ECOL, V20, P5103, DOI 10.1111/j.1365-294X.2011.05269.x; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Espeli M, 2012, J EXP MED, V209, P2307, DOI 10.1084/jem.20121752; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Jackson JA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-16; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Nussey DH, 2012, AGING CELL, V11, P178, DOI 10.1111/j.1474-9726.2011.00771.x; Palacios MG, 2011, ECOLOGY, V92, P952, DOI 10.1890/10-0662.1; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Quintana-Murci L, 2013, NAT REV IMMUNOL, V13, P280, DOI 10.1038/nri3421; Raberg L, 2003, EVOLUTION, V57, P1670, DOI 10.1554/02-417; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Turner AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002343; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Worley K, 2010, MOL ECOL, V19, P3064, DOI 10.1111/j.1365-294X.2010.04724.x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	44	44	1	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					879	883		10.1038/ni.2643	http://dx.doi.org/10.1038/ni.2643			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23959175				2022-12-18	WOS:000323377700001
J	Prada, JAH; Haire, RN; Allaire, M; Jakoncic, J; Stojanoff, V; Cannon, JP; Litman, GW; Ostrov, DA				Prada, Jose A. Hernandez; Haire, Robert N.; Allaire, Marc; Jakoncic, Jean; Stojanoff, Vivian; Cannon, John P.; Litman, Gary W.; Ostrov, David A.			Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxus	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN RECEPTOR; PROTEIN STRUCTURES; ELECTRON-DENSITY; DOMAIN; SUPERFAMILY; COMPLEX; RECOGNITION; RESOLUTION; SYSTEM; GENES	Although the origins of genes encoding the rearranging binding receptors remain obscure, it is predicted that their ancestral forms were nonrearranging immunoglobulin-type domains. Variable region-containing chitin-binding proteins (VCBPs) are diversified immune-type molecules found in amphioxus (Branchiostoma floridae), an invertebrate that diverged early in deuterostome phylogeny. To study the potential evolutionary relationships between VCBPs and vertebrate adaptive immune receptors, we solved the structures of both a single V-type domain (to 1.15 angstrom) and a pair of V-type domains (to 1.85 angstrom) from VCBP3. The deduced structures show integral features of the ancestral variable-region fold as well as unique features of variable-region pairing in molecules that may reflect characteristics of ancestral forms of diversified immune receptors found in modern-day vertebrates.	Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; Univ S Florida, Coll Med, Childrens Res Inst, Dept Pediat, St Petersburg, FL 33701 USA; Brookhaven Natl Lab, Natl Synchrotron Light Source Dept, Upton, NY 11973 USA; H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; All Childrens Hosp, Dept Mol Genet, St Petersburg, FL 33701 USA	State University System of Florida; University of Florida; State University System of Florida; University of South Florida; United States Department of Energy (DOE); Brookhaven National Laboratory; H Lee Moffitt Cancer Center & Research Institute	Litman, GW (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	litmang@allkids.org	stojanoff, vivian/I-7290-2012	stojanoff, vivian/0000-0002-6650-512X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL080222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023338] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL080222] Funding Source: Medline; NIAID NIH HHS [R01 AI023338, R01 AI023338-21, R01 AI023338-20, R01 AI23338] Funding Source: Medline; NIDCR NIH HHS [R01 DE013883] Funding Source: Medline; NIGMS NIH HHS [Y01 GM000080] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babu MM, 2003, NUCLEIC ACIDS RES, V31, P3345, DOI 10.1093/nar/gkg528; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Chatterji M, 2004, IMMUNOL REV, V200, P261, DOI 10.1111/j.0105-2896.2004.00167.x; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Dauter Z, 1997, CURR OPIN STRUC BIOL, V7, P681, DOI 10.1016/S0959-440X(97)80078-4; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; GARRETT TPJ, 1993, J MOL BIOL, V234, P763, DOI 10.1006/jmbi.1993.1625; Haruta C, 2006, IMMUNOGENETICS, V58, P216, DOI 10.1007/s00251-006-0098-1; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kaufman J, 2002, NAT IMMUNOL, V3, P1124, DOI 10.1038/ni1202-1124; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Laird DJ, 2000, P NATL ACAD SCI USA, V97, P6924, DOI 10.1073/pnas.97.13.6924; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prada JAH, 2004, ACTA CRYSTALLOGR D, V60, P2022, DOI 10.1107/S0907444904020827; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Suzuki T, 2005, J IMMUNOL, V174, P2885, DOI 10.4049/jimmunol.174.5.2885; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weeks CM, 2003, METHOD ENZYMOL, V374, P37, DOI 10.1016/S0076-6879(03)74003-8; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	55	44	46	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					875	882		10.1038/ni1359	http://dx.doi.org/10.1038/ni1359			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16799561	Green Accepted			2022-12-18	WOS:000239147200024
J	Holt, PG; Sly, PD; Martinez, FD; Weiss, ST; Bjorksten, B; von Mutius, E; Wahn, U				Holt, PG; Sly, PD; Martinez, FD; Weiss, ST; Bjorksten, B; von Mutius, E; Wahn, U			Drug development strategies for asthma: in search of a new paradigm	NATURE IMMUNOLOGY			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS; LUNG-FUNCTION; EARLY-LIFE; CHILDREN; CHILDHOOD; ATOPY; PREVENTION; INFECTIONS; ALLERGY; RISK	The spiraling costs of asthma treatment seem set to continue rising, given the equivocal performance of the latest generation of specific anti-inflammatory drugs in trials in adult asthmatics. We argue that the continuation of this trend is inevitable unless there is a substantial realignment of entrenched drug development policy in the pharmaceutical industry and a parallel shift in licensing policy by regulatory authorities to encourage the development of drugs capable of halting the progression from acute to chronic asthma when the disease first manifests in childhood. The theoretical framework for such an approach, including proof-of-principle data from studies in children with early-stage disease and a range of candidate drugs, already exists. What is needed is informed debate on the risks versus potential benefits of this approach.	Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; Karolinska Inst, Dept Environm Med, Stockholm, Sweden; Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; Univ Munich, Dr Von Hauner Childrens Hosp, Munich, Germany; Univ Hosp Charite Virchow, Berlin, Germany	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Arizona; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Karolinska Institutet; Karolinska Institutet; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Holt, PG (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	patrick@ichr.uwa.edu.au	Study, Raine/K-4517-2013; Sly, Peter D/F-1486-2010; Holt, Patrick/H-1548-2011	Sly, Peter D/0000-0001-6305-2201; von Mutius, Erika/0000-0002-8893-4515; Holt, Patrick/0000-0003-1193-0935				Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Custovic A, 2001, LANCET, V358, P188, DOI 10.1016/S0140-6736(01)05406-X; Ernst P, 2002, EUR RESPIR J, V20, P635, DOI 10.1183/09031936.02.00962002; Giacoia GP, 2000, J ALLERGY CLIN IMMUN, V106, pS118, DOI 10.1067/mai.2000.109417; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HIBBERT ME, 1990, PEDIATR PULM, V8, P172, DOI 10.1002/ppul.1950080308; HISLOP AA, 2002, CHILDHOOD ASTHMA OTH, P37; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; HOLT PG, 1992, CLIN EXP ALLERGY, V22, P1093, DOI 10.1111/j.1365-2222.1992.tb00135.x; Holt PG, 1997, THORAX, V52, P1, DOI 10.1136/thx.52.1.1; HOLT PG, 1994, LANCET, V344, P456, DOI 10.1016/S0140-6736(94)91776-0; Holt PG, 2002, EUR RESPIR J, V19, P538, DOI 10.1183/09031936.02.00229302; Holt PG, 2000, THORAX, V55, P700, DOI 10.1136/thorax.55.8.700; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kjellman B, 2002, RESP MED, V96, P716, DOI 10.1053/rmed.2002.1337; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Martinez FD, 2003, NEW ENGL J MED, V349, P1473, DOI 10.1056/NEJMe030041; MARTINEZ FD, 1995, AM J RESP CRIT CARE, V151, P1644, DOI 10.1164/ajrccm.151.5.7735627; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; NELSON DJ, 1994, J EXP MED, V179, P203, DOI 10.1084/jem.179.1.203; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Paramesh H., 2002, Indian Journal of Pediatrics, V69, P309, DOI 10.1007/BF02723216; Patino CM, 2001, ALLERGY, V56, P279, DOI 10.1034/j.1398-9995.2001.00135.x; Peat JK, 1996, ALLERGY, V51, P804, DOI 10.1111/j.1398-9995.1996.tb00026.x; Sherrill D, 1999, CLIN EXP ALLERGY, V29, P905; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262	31	44	46	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					695	698		10.1038/ni0704-695	http://dx.doi.org/10.1038/ni0704-695			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224096				2022-12-18	WOS:000222331200012
J	Kassahn, D; Kolb, C; Solomon, S; Bochtler, P; Illges, H				Kassahn, D; Kolb, C; Solomon, S; Bochtler, P; Illges, H			Few human autoimmune sera detect GPI	NATURE IMMUNOLOGY			English	Letter							RHEUMATOID-ARTHRITIS; DISEASE		Univ Konstanz, Fac Sci, Dept Biol, D-78457 Constance, Germany; Biotechnol Inst Thurgau, CH-8274 Tagerwilen, Switzerland	University of Konstanz	Kassahn, D (corresponding author), Univ Konstanz, Fac Sci, Dept Biol, M662, D-78457 Constance, Germany.			Ditzel, Henrik J./0000-0003-3927-5135; Schaller, Monica/0000-0002-5002-2238				Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Holmdahl R, 2000, ARTHRITIS RES, V2, P169, DOI 10.1186/ar82; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Solomon S, 2002, EUR J IMMUNOL, V32, P644, DOI 10.1002/1521-4141(200203)32:3<644::AID-IMMU644>3.0.CO;2-5	6	44	49	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					411	412		10.1038/ni0502-411b	http://dx.doi.org/10.1038/ni0502-411b			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976712				2022-12-18	WOS:000175411200003
J	Smith, N; Goncalves, P; Charbit, B; Grzelak, L; Beretta, M; Planchais, C; Bruel, T; Rouilly, V; Bondet, V; Hadjadj, J; Yatim, N; Pere, H; Merkling, SH; Ghozlane, A; Kerneis, S; Rieux-Laucat, F; Terrier, B; Schwartz, O; Mouquet, H; Duffy, D; Di Santo, JP				Smith, Nikaia; Goncalves, Pedro; Charbit, Bruno; Grzelak, Ludivine; Beretta, Maxime; Planchais, Cyril; Bruel, Timothee; Rouilly, Vincent; Bondet, Vincent; Hadjadj, Jerome; Yatim, Nader; Pere, Helene; Merkling, Sarah H.; Ghozlane, Amine; Kerneis, Solen; Rieux-Laucat, Frederic; Terrier, Benjamin; Schwartz, Olivier; Mouquet, Hugo; Duffy, Darragh; Di Santo, James P.			Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Article								Coordinated local mucosal and systemic immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection either protect against coronavirus disease 2019 (COVID-19) pathologies or fail, leading to severe clinical outcomes. To understand this process, we performed an integrated analysis of SARS-CoV-2 spike-specific antibodies, cytokines, viral load and bacterial communities in paired nasopharyngeal swabs and plasma samples from a cohort of clinically distinct patients with COVID-19 during acute infection. Plasma viral load was associated with systemic inflammatory cytokines that were elevated in severe COVID-19, and also with spike-specific neutralizing antibodies. By contrast, nasopharyngeal viral load correlated with SARS-CoV-2 humoral responses but inversely with interferon responses, the latter associating with protective microbial communities. Potential pathogenic microorganisms, often implicated in secondary respiratory infections, were associated with mucosal inflammation and elevated in severe COVID-19. Our results demonstrate distinct tissue compartmentalization of SARS-CoV-2 immune responses and highlight a role for the nasopharyngeal microbiome in regulating local and systemic immunity that determines COVID-19 clinical outcomes. Mucosal surfaces of the respiratory tract are the first sites of entry and defense against SARS-CoV-2. Di Santo and colleagues perform paired analysis of the nasopharyngeal and systemic immune responses of SARS-CoV-2-infected patients and demonstrate distinct compartmentalization of immunity and shifts in the microbiome.	[Smith, Nikaia; Bondet, Vincent; Yatim, Nader; Duffy, Darragh] Inst Pasteur, Translat Immunol Lab, Paris, France; [Goncalves, Pedro; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, INSERM U1223, Paris, France; [Charbit, Bruno] Inst Pasteur, Cytometry & Biomarkers UTechS, Paris, France; [Grzelak, Ludivine; Bruel, Timothee; Schwartz, Olivier] Inst Pasteur, Virus & Immun Unit, Paris, France; [Grzelak, Ludivine] Univ Paris, Sorbonne Paris Cite, Paris, France; [Beretta, Maxime; Planchais, Cyril; Mouquet, Hugo] Inst Pasteur, Humoral Immunol Lab, INSERM U1222, Paris, France; [Rouilly, Vincent] DATACTIX, Paris, France; [Hadjadj, Jerome; Yatim, Nader; Terrier, Benjamin] Univ Paris, Dept Internal Med, Natl Referral Ctr Rare Syst Autoimmune Dis, Assistance Publ Hop Paris Ctr APHP CUP, Paris, France; [Hadjadj, Jerome; Rieux-Laucat, Frederic] Univ Paris, Imagine Inst, Lab Immunogenet Pediat Autoimmune Dis, INSERM UMR 1163, Paris, France; [Pere, Helene] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Unite Genom Fonct Tumeurs Solides,INSERM, Paris, France; [Merkling, Sarah H.] CNRS, Insect Virus Interact Unit, UMR2000, Inst Pasteur, Paris, France; [Ghozlane, Amine] Inst Pasteur, Hub Bioinformat & Biostat, Paris, France; [Kerneis, Solen] Hop Cochin, AP HP, APHP CUP, Equipe Mobile Infectiol, Paris, France; [Kerneis, Solen] Univ Paris, IAME, INSERM, Paris, France; [Kerneis, Solen] Inst Pasteur, Epidemiol & Antimicrobial Resistance Modeling Lab, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Duffy, D (corresponding author), Inst Pasteur, Translat Immunol Lab, Paris, France.; Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, INSERM U1223, Paris, France.	darragh.duffy@pasteur.fr; james.di-santo@pasteur.fi	Schwartz, Olivier/AAZ-3765-2021; Mouquet, Hugo/M-2750-2014; Bruel, Timothée/AAI-4632-2020; Hadjadj, Jerome/AGY-3817-2022; Smith, Nikaïa/ABF-3604-2021; Di Santo, James P/M-4298-2014; Merkling, Sarah/ABF-5166-2021	Schwartz, Olivier/0000-0002-0729-1475; Mouquet, Hugo/0000-0002-4230-610X; Smith, Nikaïa/0000-0002-0202-612X; Di Santo, James P/0000-0002-7146-1862; Merkling, Sarah/0000-0002-6823-4474; Bruel, Timothee/0000-0002-3952-4261; Goncalves, Pedro/0000-0002-4127-1152; Yatim, Nader/0000-0001-5326-1624	Institut Pasteur (CoVarImm); Agence National de la Recherche (ANR-flash COVID-19); Laboratoire d'Excellence 'Milieu Interieur' [ANR-10-LABX-69-01]; Fonds IMMUNOV, for Innovation in Immunopathology; Pasteur-Roux-Cantarini Fellowship; France Genomique [ANR-10-INBS-09-09]	Institut Pasteur (CoVarImm); Agence National de la Recherche (ANR-flash COVID-19)(French National Research Agency (ANR)); Laboratoire d'Excellence 'Milieu Interieur'; Fonds IMMUNOV, for Innovation in Immunopathology; Pasteur-Roux-Cantarini Fellowship; France Genomique	This study was supported by grants from the Institut Pasteur (CoVarImm) and from the Agence National de la Recherche (ANR-flash COVID-19; to D.D. and J.P.D.), and by the Laboratoire d'Excellence 'Milieu Interieur' (grant no. ANR-10-LABX-69-01) and the Fonds IMMUNOV, for Innovation in Immunopathology. N.S. is a recipient of the Pasteur-Roux-Cantarini Fellowship. We thank the UTechS CB of the Center for Translational Research, Institut Pasteur for supporting Luminex and Simoa analysis. We thank L. Motreff and L. Ma (Biomics Platform supported by France Genomique; ANR-10-INBS-09-09), IBISA and the Illumina COVID-19 Projects' offer for microbial sequencing. We thank the Bioinformatics and Biostatistics HUB, Institut Pasteur for the assistance with the 16S rRNA-sequencing data analysis. We acknowledge all health-care workers involved in the diagnosis and treatment of patients in Cochin Hospital, especially C. Azoulay, L. Beaudeau, E. Canoui, P. Cohen, A. Contejean, B. Dunogue, D. Journois, P. Legendre, J. Marey and A. Regent.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Castelino Madhura, 2015, Lancet, V385 Suppl 1, pS27, DOI 10.1016/S0140-6736(15)60342-7; Cervia C, 2021, J ALLERGY CLIN IMMUN, V147, P545, DOI 10.1016/j.jaci.2020.10.040; Chakraborty S., 2021, DIV EARLY ANT RESP D, DOI [10.1101/2021.05.25.445649, DOI 10.1101/2021.05.25.445649, 10.1016/S0140-6736(20)30183-5]; Darnell MER, 2006, TRANSFUSION, V46, P1770, DOI 10.1111/j.1537-2995.2006.00976.x; Di Domizio J, 2020, NAT IMMUNOL, V21, P1034, DOI 10.1038/s41590-020-0721-6; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grzelak L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3103; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Lan F, 2019, J ALLERGY CLIN IMMUN, V143, P1416, DOI 10.1016/j.jaci.2018.09.041; Lee JS, 2020, NAT REV IMMUNOL, V20, P585, DOI 10.1038/s41577-020-00429-3; Lescure FX., 2020, LANCET INFECT DIS, V20, P697; Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565; Mostafa HH, 2020, MBIO, V11, DOI 10.1128/mBio.01969-20; O'Rourke MB, 2019, PROTEOMES, V7, DOI 10.3390/proteomes7030029; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Ridaura VK, 2018, J EXP MED, V215, P785, DOI 10.1084/jem.20171079; Rodero MP, 2017, J EXP MED, V214, P1547, DOI 10.1084/jem.20161451; Roltgen K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0240; Schaupp L, 2020, CELL, V181, P1080, DOI 10.1016/j.cell.2020.04.022; Schultze JL, 2021, CELL, V184, P1671, DOI 10.1016/j.cell.2021.02.029; Sierra B, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa407; Stefan KL, 2020, CELL, V183, P1312, DOI 10.1016/j.cell.2020.10.047; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Ventero MP, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.637430; Veyer D, 2021, CLIN INFECT DIS, V73, pE2890, DOI 10.1093/cid/ciaa1196; Volant S, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03666-4; Wang ZJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1555; Weitnauer M, 2016, MUCOSAL IMMUNOL, V9, P287, DOI 10.1038/mi.2015.126; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yang X, 2020, LANCET RESP MED, V8, pE26; Zhou RH, 2020, IMMUNITY, V53, P864, DOI 10.1016/j.immuni.2020.07.026; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	52	43	43	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1428	+		10.1038/s41590-021-01028-7	http://dx.doi.org/10.1038/s41590-021-01028-7		SEP 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34471264	Green Published, hybrid			2022-12-18	WOS:000691949800001
J	Abdel-Hakeem, MS; Manne, S; Beltra, JC; Stelekati, E; Chen, ZY; Nzingha, K; Ali, MA; Johnson, JL; Giles, JR; Mathew, D; Greenplate, AR; Vahedi, G; Wherry, EJ				Abdel-Hakeem, Mohamed S.; Manne, Sasikanth; Beltra, Jean-Christophe; Stelekati, Erietta; Chen, Zeyu; Nzingha, Kito; Ali, Mohammed-Alkhatim; Johnson, John L.; Giles, Josephine R.; Mathew, Divij; Greenplate, Allison R.; Vahedi, Golnaz; Wherry, E. John			Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation	NATURE IMMUNOLOGY			English	Article							CD8; PD-1; SUBSETS; PERSISTENCE; DYSFUNCTION; LANDSCAPE; PHENOTYPE; SIGNATURE; INFECTION; CHROMATIN	Exhausted CD8 T cells (T-EX) are a distinct state of T cell differentiation associated with failure to clear chronic viruses and cancer. Immunotherapies such as PD-1 blockade can reinvigorate T-EX cells, but reinvigoration is not durable. A major unanswered question is whether T-EX cells differentiate into functional durable memory T cells (T-MEM) upon antigen clearance. Here, using a mouse model, we found that upon eliminating chronic antigenic stimulation, T-EX cells partially (re)acquire phenotypic and transcriptional features of T-MEM cells. These 'recovering' T-EX cells originated from the T cell factor (TCF-1(+)) T-EX progenitor subset. Nevertheless, the recall capacity of these recovering T-EX cells remained compromised as compared to T-MEM cells. Chromatin-accessibility profiling revealed a failure to recover core memory epigenetic circuits and maintenance of a largely exhausted open chromatin landscape. Thus, despite some phenotypic and transcriptional recovery upon antigen clearance, exhaustion leaves durable epigenetic scars constraining future immune responses. These results support epigenetic remodeling interventions for T-EX cell-targeted immunotherapies. Wherry and colleagues examine whether exhausted T cells (T-EX) can differentiate into functional memory T cells (T-MEM) when chronic antigen is withdrawn. Using the chronic LCMV infection mouse model, they show that 'recovering' T-EX cells (REC-T-EX) only partially recover immunophenotypic and functional characteristics of T-MEM cells. The epigenomic status of REC-T-EX cells more closely resembles that of T-EX cells, and, upon rechallenge, the REC-T-EX cells were still compromised in their ability to respond to virus.	[Abdel-Hakeem, Mohamed S.; Manne, Sasikanth; Beltra, Jean-Christophe; Stelekati, Erietta; Chen, Zeyu; Nzingha, Kito; Ali, Mohammed-Alkhatim; Giles, Josephine R.; Mathew, Divij; Greenplate, Allison R.; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Abdel-Hakeem, Mohamed S.; Manne, Sasikanth; Beltra, Jean-Christophe; Stelekati, Erietta; Chen, Zeyu; Nzingha, Kito; Ali, Mohammed-Alkhatim; Johnson, John L.; Giles, Josephine R.; Mathew, Divij; Greenplate, Allison R.; Vahedi, Golnaz; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Abdel-Hakeem, Mohamed S.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Beltra, Jean-Christophe; Giles, Josephine R.; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Johnson, John L.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Vahedi, Golnaz] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Vahedi, Golnaz] Univ Penn, Penn Epigenet Inst, Philadelphia, PA 19104 USA; [Stelekati, Erietta] Univ Miami, Dept Microbiol & Immunol, Miami, FL USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Egyptian Knowledge Bank (EKB); Cairo University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Miami	Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu	Chen, Zeyu/HGE-0239-2022; Chen, Zeyu/HGF-2358-2022	Beltra, Jean-Christophe/0000-0002-6363-3572; Abdel Hakeem, Mohamed/0000-0003-0226-3464	CIHR [NHC-142832] Funding Source: Medline; NCI NIH HHS [P01 CA210944, T32 CA009140] Funding Source: Medline; NIAID NIH HHS [U19 AI082630, P01 AI108545, R01 AI115712, U19 AI117950, R01 AI105343, R01 AI155577] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burchill MA, 2015, J VIRAL HEPATITIS, V22, P983, DOI 10.1111/jvh.12465; Callendret B, 2014, HEPATOLOGY, V60, P1531, DOI 10.1002/hep.27278; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tonnerre P, 2021, NAT IMMUNOL, V22, P1030, DOI 10.1038/s41590-021-00982-6; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	51	43	43	4	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					1008	+		10.1038/s41590-021-00975-5	http://dx.doi.org/10.1038/s41590-021-00975-5			33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34312545	Green Accepted			2022-12-18	WOS:000677755900011
J	Yates, KB; Tonnerre, P; Martin, GE; Gerdemann, U; Al Abosy, R; Comstock, DE; Weiss, SA; Wolski, D; Tully, DC; Chung, RT; Allen, TM; Kim, AY; Fidler, S; Fox, J; Frater, J; Lauer, GM; Haining, WN; Sen, DR				Yates, Kathleen B.; Tonnerre, Pierre; Martin, Genevieve E.; Gerdemann, Ulrike; Al Abosy, Rose; Comstock, Dawn E.; Weiss, Sarah A.; Wolski, David; Tully, Damien C.; Chung, Raymond T.; Allen, Todd M.; Kim, Arthur Y.; Fidler, Sarah; Fox, Julie; Frater, John; Lauer, Georg M.; Haining, W. Nicholas; Sen, Debattama R.			Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; VIRAL PERSISTENCE; PD-1 EXPRESSION; SUPER-ENHANCERS; TRANSCRIPTION; HCV; LYMPHOCYTES; ABT-450/R-OMBITASVIR; INFLAMMATION; CLEARANCE	The degree of plasticity in the epigenetic landscape of exhausted T cells has been unclear. Sen and colleagues find that exhausted CD8(+) T cells demonstrate a stable core epigenetic exhaustion signature that persists independent of inflammation or viral antigen. T cell exhaustion is an induced state of dysfunction that arises in response to chronic infection and cancer. Exhausted CD8(+) T cells acquire a distinct epigenetic state, but it is not known whether that chromatin landscape is fixed or plastic following the resolution of a chronic infection. Here we show that the epigenetic state of exhaustion is largely irreversible, even after curative therapy. Analysis of chromatin accessibility in HCV- and HIV-specific responses identifies a core epigenetic program of exhaustion in CD8(+) T cells, which undergoes only limited remodeling before and after resolution of infection. Moreover, canonical features of exhaustion, including super-enhancers near the genes TOX and HIF1A, remain 'epigenetically scarred.' T cell exhaustion is therefore a conserved epigenetic state that becomes fixed and persists independent of chronic antigen stimulation and inflammation. Therapeutic efforts to reverse T cell exhaustion may require new approaches that increase the epigenetic plasticity of exhausted T cells.	[Yates, Kathleen B.; Gerdemann, Ulrike; Al Abosy, Rose; Comstock, Dawn E.; Weiss, Sarah A.; Haining, W. Nicholas; Sen, Debattama R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yates, Kathleen B.; Sen, Debattama R.] Harvard Med Sch, Ctr Canc Res, Massachusetts Gen Hosp, Charlestown, MA 02114 USA; [Yates, Kathleen B.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tonnerre, Pierre; Wolski, David; Chung, Raymond T.; Lauer, Georg M.] Massachusetts Gen Hosp, Liver Ctr, Div Gastroenterol, Boston, MA 02114 USA; [Tonnerre, Pierre] Inst Rech St Louis, INSERM, U976, Paris, France; [Martin, Genevieve E.; Frater, John] Univ Oxford, Nuffield Dept Med, Oxford, England; [Martin, Genevieve E.] Monash Univ, Cent Clin Sch, Dept Infect Dis, Melbourne, Vic, Australia; [Comstock, Dawn E.; Weiss, Sarah A.] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Tully, Damien C.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Tully, Damien C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Kim, Arthur Y.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Fidler, Sarah] Imperial Coll, Wright Fleming Inst, Div Med, London, England; [Fidler, Sarah] Imperial Coll, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Fox, Julie] Guys & St Thomas NHS Fdn Trust, Dept Genitourinary Med & Infect Dis, London, England; [Fox, Julie] Kings Coll London, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Frater, John] Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; [Haining, W. Nicholas] Merck Res Labs, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Monash University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Massachusetts General Hospital; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Merck & Company	Haining, WN; Sen, DR (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Sen, DR (corresponding author), Harvard Med Sch, Ctr Canc Res, Massachusetts Gen Hosp, Charlestown, MA 02114 USA.; Haining, WN (corresponding author), Merck Res Labs, Boston, MA 02115 USA.	nick.haining@merck.com; dsen@mgh.harvard.edu	Martin, Genevieve Elizabeth/AGH-1336-2022; Allen, Todd/F-5473-2011; Tonnerre, Pierre/AAA-1631-2020	Martin, Genevieve Elizabeth/0000-0001-5142-7440; Allen, Todd/0000-0002-6609-1318; Tonnerre, Pierre/0000-0002-1719-9736; Al Abosy, Rose/0000-0001-5400-1306; fox, Julie/0000-0002-0583-8019; Fidler, Sarah/0000-0003-1676-7583; Tully, Damien/0000-0002-7620-9340; /0000-0002-4155-0346	Medical Research Council [MR/L00528X/1] Funding Source: Medline; NCATS NIH HHS [UL1 TR001863] Funding Source: Medline; NCI NIH HHS [T32 CA207021] Funding Source: Medline; NIAID NIH HHS [U19 AI082630, R01 AI136715] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Baumert TF, 2019, GASTROENTEROLOGY, V156, P431, DOI 10.1053/j.gastro.2018.10.024; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chinnaswamy S, 2014, J INTERF CYTOK RES, V34, P479, DOI 10.1089/jir.2013.0113; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; El-Far M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22902; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gate RE, 2018, NAT GENET, V50, P1140, DOI 10.1038/s41588-018-0156-2; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kroy DC, 2014, GASTROENTEROLOGY, V146, P550, DOI 10.1053/j.gastro.2013.10.022; Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Monteleone K, 2014, MED MICROBIOL IMMUN, V203, P207, DOI 10.1007/s00430-014-0329-2; Nguyen S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax4077; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Rutebemberwa A, 2008, J IMMUNOL, V181, P8215, DOI 10.4049/jimmunol.181.12.8215; Rutishauser RL, 2017, AIDS RES HUM RETROV, V33, P658, DOI [10.1089/aid.2016.0324, 10.1089/AID.2016.0324]; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wolski D, 2017, IMMUNITY, V47, P648, DOI 10.1016/j.immuni.2017.09.006; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161; Zaidan SM, 2019, JAIDS-J ACQ IMM DEF, V82, P503, DOI 10.1097/QAI.0000000000002185; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	55	43	43	11	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					1020	+		10.1038/s41590-021-00979-1	http://dx.doi.org/10.1038/s41590-021-00979-1			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34312547	Green Accepted			2022-12-18	WOS:000677755900012
J	Hayward, SL; Scharer, CD; Cartwright, EK; Takamura, S; Li, ZRT; Boss, JM; Kohlmeier, JE				Hayward, Sarah L.; Scharer, Christopher D.; Cartwright, Emily K.; Takamura, Shiki; Li, Zheng-Rong Tiger; Boss, Jeremy M.; Kohlmeier, Jacob E.			Environmental cues regulate epigenetic reprogramming of airway-resident memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; TRANSCRIPTIONAL PROGRAM; VIRUS; TISSUE; EXPRESSION; INFECTION; MACROPHAGE; ANTIGEN; STRESS; MICE	Tissue-resident memory T cells (T-RM cells) are critical for cellular immunity to respiratory pathogens and reside in both the airways and the interstitium. In the present study, we found that the airway environment drove transcriptional and epigenetic changes that specifically regulated the cytolytic functions of airway T-RM cells and promoted apoptosis due to amino acid starvation and activation of the integrated stress response. Comparison of airway T-RM cells and splenic effector-memory T cells transferred into the airways indicated that the environment was necessary to activate these pathways, but did not induce T-RM cell lineage reprogramming. Importantly, activation of the integrated stress response was reversed in airway T-RM cells placed in a nutrient-rich environment. Our data defined the genetic programs of distinct lung T-RM cell populations and show that local environmental cues altered airway T-RM cells to limit cytolytic function and promote cell death, which ultimately leads to fewer T-RM cells in the lung. Kohlmeier and colleagues showed that the airway environment drove transcriptional and epigenetic changes that regulated the cytolytic functions of airway T-RM cells and promoted their apoptosis due to amino acid starvation and activation of the integrated stress response.	[Hayward, Sarah L.; Scharer, Christopher D.; Cartwright, Emily K.; Li, Zheng-Rong Tiger; Boss, Jeremy M.; Kohlmeier, Jacob E.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Takamura, Shiki] Kindai Univ, Dept Immunol, Fac Med, Osaka, Japan; [Kohlmeier, Jacob E.] Emory UGA Ctr Excellence Influenza Res & Surveill, Atlanta, GA 30322 USA	Emory University; Kindai University (Kinki University)	Kohlmeier, JE (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Kohlmeier, JE (corresponding author), Emory UGA Ctr Excellence Influenza Res & Surveill, Atlanta, GA 30322 USA.	jkohlmeier@emory.edu	Takamura, Shiki/GXV-0595-2022	Boss, Jeremy/0000-0002-2432-1840; Kohlmeier, Jacob/0000-0002-7209-6641	NIH Tetramer Core Facility [HHSN272201300006C]; NIH [F31 HL136101, R01HL122559, R01HL138508]; Centers of Excellence in Influenza Research and Surveillance [HHSN272201400004C, 1R01AI113021, P01AI125180-01]	NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers of Excellence in Influenza Research and Surveillance	We thank the New York University Genome Technology Center and University of Albama at Birmingham Helfin Genomics Core for Illumina sequencing, the Emory Integrated Genomics Core for sequencing library Bioanalyzer expertise, Children's Healthcare of Atlanta and Emory University Pediatric Flow Cytometry Core for cell sorting and the NIH Tetramer Core Facility (contract no. HHSN272201300006C). This project was supported by NIH grants (nos. R01HL122559 and R01HL138508) and Centers of Excellence in Influenza Research and Surveillance contracts (no. HHSN272201400004C (to J.E.K.), and nos. 1R01AI113021 and P01AI125180-01 (to J.M.B.)). S.L.H. was supported by an NIH grant (no. F31 HL136101).	Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Caminschi I, 2019, MUCOSAL IMMUNOL, V12, P403, DOI 10.1038/s41385-018-0124-2; de la Ballina LR, 2016, J BIOL CHEM, V291, P9700, DOI 10.1074/jbc.M115.704254; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; HOU S, 1992, J IMMUNOL, V149, P1319; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2007, J IMMUNOL, V178, P4721, DOI 10.4049/jimmunol.178.8.4721; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li TL, 2015, J BIOL CHEM, V290, P11108, DOI 10.1074/jbc.M115.645333; LIANG SH, 1994, J IMMUNOL, V152, P1653; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; McMaster SR, 2018, MUCOSAL IMMUNOL, V11, P1071, DOI 10.1038/s41385-018-0003-x; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; Mintern JD, 2007, J IMMUNOL, V179, P7220, DOI 10.4049/jimmunol.179.11.7220; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pino SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005468; Pizzolla A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6970; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scharer CD, 2017, J IMMUNOL, V198, P2238, DOI 10.4049/jimmunol.1602086; Scharer CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27030; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takamura S, 2016, J EXP MED, V213, P3057, DOI 10.1084/jem.20160938; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Van Braeckel-Budimir N, 2018, CELL REP, V24, P3374, DOI 10.1016/j.celrep.2018.08.073; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou AC, 2017, MUCOSAL IMMUNOL, V10, P1294, DOI 10.1038/mi.2016.124	51	43	43	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					309	+		10.1038/s41590-019-0584-x	http://dx.doi.org/10.1038/s41590-019-0584-x		JAN 2020	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	31953534	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000507823200001
J	Reynoso, GV; Weisberg, AS; Shannon, JP; McManus, DT; Shores, L; Americo, JL; Stan, RV; Yewdell, JW; Hickman, HD				Reynoso, Glennys V.; Weisberg, Andrea S.; Shannon, John P.; McManus, Daniel T.; Shores, Lucas; Americo, Jeffrey L.; Stan, Radu V.; Yewdell, Jonathan W.; Hickman, Heather D.			Lymph node conduits transport virions for rapid T cell activation	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; SUBCAPSULAR SINUS MACROPHAGES; CD8-ALPHA(+) DENDRITIC CELLS; IMMUNE-RESPONSE; VIRUS; INFECTION; ANTIGEN; MIGRATION; INNATE; LYMPHOCYTES	Despite intense interest in antiviral T cell priming, the routes by which virions move in lymph nodes (LNs) are imperfectly understood. Current models fail to explain how virus-infected cells rapidly appear within the LN interior after viral infection. To better understand virion trafficking in the LN, we determined the locations of virions and infected cells after administration to mice of vaccinia virus or Zika virus. Notably, many rapidly infected cells in the LN interior were adjacent to LN conduits. Through the use of confocal and electron microscopy, we clearly visualized virions within conduits. Functionally, CD8(+) T cells rapidly and preferentially associated with vaccinia virus-infected cells in the LN paracortex, which led to T cell activation in the LN interior. These results reveal that it is possible for even large virions to flow through LN conduits and infect dendritic cells within the T cell zone to prime CD8(+) T cells.	[Reynoso, Glennys V.; Shannon, John P.; McManus, Daniel T.; Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Weisberg, Andrea S.; Americo, Jeffrey L.] NIAID, Genet Engn Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Shores, Lucas; Yewdell, Jonathan W.] NIAID, Cell Biol Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Stan, Radu V.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Lebanon, NH USA; [Stan, Radu V.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Dartmouth College; Dartmouth College	Hickman, HD (corresponding author), NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Yewdell, JW (corresponding author), NIAID, Cell Biol Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jwyewdell@nih.gov; hhickman@nih.gov	Stan, Radu/AAE-7574-2021; Shannon, John/AAY-2423-2020; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Stan, Radu/0000-0003-2969-1725; Shores, Lucas/0000-0002-4601-1990; Hickman, Heather/0000-0003-4168-4894; Shannon, John/0000-0002-8722-2209	Intramural Research Program of NIAID, NIH; NIH [R21CA172983, R21CA175592, R01GM120592, AHA 16GRNT27260362]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001225, ZIAAI001211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120592] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of NIAID, NIH (H.D.H.). R.V.S. was supported by NIH grants R21CA172983, R21CA175592, R01GM120592, and AHA 16GRNT27260362. We thank K. Dowd and T. Pierson (Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID) for assistance with ZIKV infection and J. Kabat (Biological Imaging Section, NIAID) for assistance with microscopy image analysis. G. Oliver (University of Chicago) provided Prox1-CreERT2<SUP>tg/+</SUP> mice on the C57BL/6 genetic background.	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Baden LR, 2018, J INFECT DIS, V218, P633, DOI 10.1093/infdis/jiy212; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gerner MY, 2017, J EXP MED, V214, P3105, DOI 10.1084/jem.20170335; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; La Rosa C, 2017, BLOOD, V129, P114, DOI 10.1182/blood-2016-07-729756; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Moss B, 1996, Adv Exp Med Biol, V397, P7; Moss B, 2007, FIELDS VIROLOGY, P2849; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Ng CT, 2012, P NATL ACAD SCI USA, V109, P7823, DOI 10.1073/pnas.1205850109; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Steele KE, 2009, IMMUNOTHERAPY-UK, V1, P187, DOI 10.2217/1750743X.1.2.187; Steele KE, 2009, EXPERT REV ANTI-INFE, V7, P423, DOI [10.1586/eri.09.13, 10.1586/ERI.09.13]; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Thierry GR, 2018, J EXP MED, V215, P2972, DOI 10.1084/jem.20180344; Twenhafel NA, 2013, VET PATHOL, V50, P514, DOI 10.1177/0300985812469636; Woodruff MC, 2014, J EXP MED, V211, P1611, DOI 10.1084/jem.20132327; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	52	43	44	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					602	+		10.1038/s41590-019-0342-0	http://dx.doi.org/10.1038/s41590-019-0342-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30886418	Green Accepted			2022-12-18	WOS:000465084800017
J	Fritz, EL; Rosenberg, BR; Lay, K; Mihailovic, A; Tuschl, T; Papavasiliou, FN				Fritz, Eric L.; Rosenberg, Brad R.; Lay, Kenneth; Mihailovic, Aleksandra; Tuschl, Thomas; Papavasiliou, F. Nina			A comprehensive analysis of the effects of the deaminase AID on the transcriptome and methylome of activated B cells	NATURE IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; ANTIBODY DIVERSIFICATION; STEM-CELLS; IG GENES; RNA-SEQ; IN-VIVO	Beyond its well-characterized functions in antibody diversification, the cytidine deaminase AID can catalyze off-target DNA damage and has been hypothesized to edit RNA and mediate DNA demethylation. To comprehensively examine the effects of AID on the transcriptome and the pattern of DNA methylation ('methylome'), we analyzed AID-deficient (Aicda(-/-)), wildtype and AID-overexpressing activated B cells by high-throughput RNA sequencing (RNA-Seq) and reduced-representation bisulfite sequencing (RRBS). These analyses confirmed the known role of AID in immunoglobulin isotype switching and also demonstrated few other effects of AID on gene expression. Additionally, we detected no evidence of AID-dependent editing of mRNA or microRNA. Finally, the RRBS data did not support the proposed role for AID in regulating DNA methylation. Thus, despite evidence of its additional activities in other systems, antibody diversification seems to be the sole physiological function of AID in activated B cells.	[Fritz, Eric L.; Rosenberg, Brad R.; Lay, Kenneth; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Fritz, Eric L.; Lay, Kenneth] Rockefeller Univ, Rockefeller Grad Program, New York, NY 10021 USA; [Rosenberg, Brad R.] Rockefeller Univ, John C Whitehead Presidential Fellows Program, New York, NY 10021 USA; [Mihailovic, Aleksandra; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Fritz, EL (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, 1230 York Ave, New York, NY 10021 USA.	efritz@rockefeller.edu		Rosenberg, Brad/0000-0002-5885-1276	National Cancer Institute [CA098495]; Starr Cancer Consortium [I4-A447]; Howard Hughes Medical Institute; US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA098495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Consortium; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the F.N.P. laboratory for discussion; C. Hamilton and D. Schulz for comments on the manuscript; C. Mason (Weill Cornell Medical College) for ERCC spikes; G. Hovel-Miner for VSG constructs; K. Velinzon for cell sorting; S. Dewell for sequencing advice; and Y. Li for assistance with EpiTYPER assays. Supported by the National Cancer Institute (CA098495), the Starr Cancer Consortium (I4-A447), the Howard Hughes Medical Institute (T. T.) and the US National Institutes of Health (work in the T. T. laboratory).	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Bhutani N, 2013, FASEB J, V27, P1107, DOI 10.1096/fj.12-222125; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Gazumyan A, 2012, ADV CANCER RES, V113, P167, DOI 10.1016/B978-0-12-394280-7.00005-1; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kobayashi M, 2011, P NATL ACAD SCI USA, V108, P19305, DOI 10.1073/pnas.1114522108; Kobayashi M, 2009, P NATL ACAD SCI USA, V106, P22375, DOI 10.1073/pnas.0911879106; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liang GX, 2013, P NATL ACAD SCI USA, V110, P2246, DOI 10.1073/pnas.1221921110; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meyers G, 2011, P NATL ACAD SCI USA, V108, P11554, DOI 10.1073/pnas.1102600108; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nonaka T, 2009, P NATL ACAD SCI USA, V106, P2747, DOI 10.1073/pnas.0812957106; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Team R.D.C., 2012, R LANG ENV STAT COMP; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	55	43	43	3	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					749	+		10.1038/ni.2616	http://dx.doi.org/10.1038/ni.2616			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23708250	Green Accepted			2022-12-18	WOS:000320509100017
J	Wynn, TA				Wynn, Thomas A.			Basophils trump dendritic cells as APCs for T(H)2 responses	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; IN-VIVO; MESSENGER-RNA; IL-4; CD8-ALPHA(+); EOSINOPHILS; ACTIVATION; PRODUCT	Dendritic cells are best known as antigen-presenting cells that initiate adaptive immune responses. Three new papers suggest that basophils initiate allergen-and helminth-driven CD4(+) T helper type 2 responses by functioning as antigen-presenting cells in draining lymph nodes.	NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wynn, TA (corresponding author), NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021; Wynn, Thomas A/C-2797-2011	Wynn, Thomas A/0000-0002-7244-8731; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001019, ZIAAI001019, ZIAAI000829] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI001019-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BRUNNER T, 1993, J EXP MED, V177, P605, DOI 10.1084/jem.177.3.605; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; MOQBEL R, 1995, J IMMUNOL, V155, P4939; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; RANK MA, 2009, J ALLERGY CLIN IMMUN, V116, P2044; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Ying S, 1997, J IMMUNOL, V158, P3539; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	17	43	43	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					679	681		10.1038/ni0709-679	http://dx.doi.org/10.1038/ni0709-679			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19536189	Green Accepted			2022-12-18	WOS:000267142600003
J	Colgan, J; Rothman, P				Colgan, John; Rothman, Paul			All in the family: IL-27 suppression of T-H-17 cells	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; CYTOKINE; LINEAGE; INFLAMMATION; PROTEIN; MEMBERS; IL-12; BETA; TH17	Interleukin 17 (IL-17)-producing T cells are associated with inflammatory conditions. Two studies now show that IL-27, an IL-12 family member with both pro- and anti-inflammatory properties, potently suppresses the development of IL-17-producing T cells.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Colgan, J (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	paul-rothman@uiowa.edu		Colgan, John/0000-0001-9273-2644	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067489] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI067489] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002	13	43	47	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					899	901		10.1038/ni0906-899	http://dx.doi.org/10.1038/ni0906-899			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924249				2022-12-18	WOS:000239942300004
J	Kaufmann, SHE; Winau, F				Kaufmann, SHE; Winau, F			From bacteriology to immunology: the dualism of specificity	NATURE IMMUNOLOGY			English	Editorial Material							PASTEUR; BIRTH; KOCH; METCHNIKOFF; DISPUTE		Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268				[Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; Behring EV., 1890, DEUT MED WOCHENSCHR, V49, P1113; CARTER KC, 1985, MED HIST, V29, P353, DOI 10.1017/S0025727300044689; CARTER KC, 1988, B HIST MED, V62, P42; CHERNYAK L, 1988, CELL IMMUNOL, V117, P218, DOI 10.1016/0008-8749(88)90090-1; GAFFKY G, 1887, ARB KAISERLICH GESUN, V3, P1; Guttmann A., 1991, WIRKSAMKEIT KOCHSCHE, P1; HENLE J, 1910, MIASMEN KONTAGIEN MI, P12; HEYMANN B, 1932, R KOCH, V1; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; KOCH R, 1891, HIRSCHWALD, V1, P35; Koch R., 1890, DEUT MED WOCHENSCHR, V16, P1029, DOI [10.1055/s-0029-1207546, DOI 10.1055/S-0029-1207546]; Koch R., 1876, COH BEIT BIOL PFLAN, V2, P277; KOCH R, 1891, DT MED WOCHENSCHR, V38, P57; Koch R., 1884, DEUT MED WOCHENSCHR, V10, P725, DOI [10.1055/s-0028-1143334, DOI 10.1055/S-0028-1143334]; KOCH R, 1883, DEUT MED WOCHENSCHR, V9, P743, DOI DOI 10.1055/S-0029-1197083; LISTER J, 1891, VERH 10 INT MED C, V1, P1; Loeffler F., 1884, MITTHEILUNGEN KAISER, V2, P421; Mazumdar Pauline M.H., 1995, SPECIES SPECIFICITY; Mendelsohn JA, 2002, HIST PHIL LIFE SCI, V24, P3, DOI 10.1080/03919710210001714293; Ogawa M, 2000, B HIST MED, V74, P671, DOI 10.1353/bhm.2000.0193; PASTEUR L, 1860, ANN SC NATURELLES, V44, P5; Silverstein AM, 2003, NAT IMMUNOL, V4, P425, DOI 10.1038/ni0503-425; Silverstein AM, 2000, HIST PHIL LIFE SCI, V22, P29; TAUBER AI, 1989, CELL IMMUNOL, V121, P447, DOI 10.1016/0008-8749(89)90043-9; TAUBER AI, 1992, CELL IMMUNOL, V139, P505, DOI 10.1016/0008-8749(92)90089-8; VIRCHOW R, 1991, DT MED WOCHENSCHR, V17, P131; VIRCHOW R, 1871, ZELLULARPATHOLOGIE, V1, P1; WEINDLING P, 1989, LAB REVOLUTION MED, P170; Winau F, 2004, MICROBES INFECT, V6, P786, DOI 10.1016/j.micinf.2004.04.003; Winau F, 2002, MICROBES INFECT, V4, P185, DOI 10.1016/S1286-4579(01)01526-X	31	43	43	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1063	1066		10.1038/ni1105-1063	http://dx.doi.org/10.1038/ni1105-1063			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239917				2022-12-18	WOS:000232833300002
J	Parish, CR				Parish, CR			Heparan sulfate and inflammation	NATURE IMMUNOLOGY			English	Editorial Material							L-SELECTIN; P-SELECTIN; LIGANDS	Entry of leukocytes into tissues is a key feature of inflammation. New data suggest the polysaccharide heparan sulfate is required for several stages of this entry process.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Parish, CR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	christopher.parish@anu.edu.au		Parish, Christopher/0000-0001-7740-0430				Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Freeman C, 2005, J BIOL CHEM, V280, P8842, DOI 10.1074/jbc.M410769200; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; NELSON RM, 1993, BLOOD, V82, P3253; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996	12	43	44	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					861	862		10.1038/ni0905-861	http://dx.doi.org/10.1038/ni0905-861			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116461				2022-12-18	WOS:000231369800004
J	Beignon, AS; Skoberne, M; Bhardwaj, N				Beignon, AS; Skoberne, M; Bhardwaj, N			Type I interferons promote cross-priming: more functions for old cytokines	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; LYMPHOCYTES; EXPRESSION; INFECTION; CD4(+); HELP		NYU, Sch Med, New York, NY 10016 USA	New York University	Beignon, AS (corresponding author), NYU, Sch Med, 550 1st Ave,MSB507, New York, NY 10016 USA.	bhardn02@med.nyu.edu		BEIGNON, Anne-Sophie/0000-0003-0863-983X; Bhardwaj, Nina/0000-0003-1865-4187				Akira S, 2003, CURR OPIN IMMUNOL, V15, P238, DOI 10.1016/S0952-7915(03)00005-0; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317	12	43	43	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					939	941		10.1038/ni1003-939	http://dx.doi.org/10.1038/ni1003-939			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515123	Bronze			2022-12-18	WOS:000185590100006
J	Thai, TH; Purugganan, MM; Roth, DB; Kearney, JF				Thai, TH; Purugganan, MM; Roth, DB; Kearney, JF			Distinct and opposite diversifying activities of terminal transferase splice variants	NATURE IMMUNOLOGY			English	Article							DEOXYNUCLEOTIDYL TRANSFERASE; V(D)J RECOMBINATION; N-REGIONS; JUNCTIONAL SEQUENCES; DNA; MOUSE; GENES; IDENTIFICATION; EXPRESSION; SELECTION	The short splice variant of mouse terminal deoxynucleotidyl transferase (TdTS) catalyzes the addition of nontemplated nucleotides (N addition) at the coding joins of B cell and T cell antigen receptor genes. However, the activity and function of the long isoform of TdT (TdTL) have not been determined. We show here, in vitro and in vivo, that TdTL is a 3'-->5' exonuclease that catalyzes the deletion of nucleotides at coding joins. These findings suggest that the two TdT isoforms may act in concert to preserve the integrity of the variable region of antigen receptors while generating diversity.	Univ Alabama Birmingham, Dept Microbiol, Wallace Tumor Inst 378, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine	Kearney, JF (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Wallace Tumor Inst 378, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.	john.kearney@ccc.uab.edu	Kearney, John/GOV-3123-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014782, T32AI007051, R01AI036420] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 07051, R01 AI014782, T32 AI007051, AI 523133, AI36420] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Benedict CL, 2001, J EXP MED, V193, P89, DOI 10.1084/jem.193.1.89; BENTOLILA LA, 1995, EMBO J, V14, P4221, DOI 10.1002/j.1460-2075.1995.tb00096.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Boule JB, 2000, J BIOL CHEM, V275, P28984, DOI 10.1074/jbc.M005544200; Cabaniols JP, 2001, J EXP MED, V194, P1385, DOI 10.1084/jem.194.9.1385; CARLSSON L, 1992, EUR J IMMUNOL, V22, P71, DOI 10.1002/eji.1830220112; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; DOYEN N, 1993, NUCLEIC ACIDS RES, V21, P1187, DOI 10.1093/nar/21.5.1187; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; FARRAR YJK, 1991, BIOCHEMISTRY-US, V30, P3075, DOI 10.1021/bi00226a014; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; KOIWAI O, 1986, NUCLEIC ACIDS RES, V14, P5777, DOI 10.1093/nar/14.14.5777; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LEVINE M, 2000, THESIS YALE U; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Livak F, 1997, J MOL BIOL, V267, P1, DOI 10.1006/jmbi.1996.0834; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; MCVAY LD, 1991, EMBO J, V10, P83, DOI 10.1002/j.1460-2075.1991.tb07923.x; MEDINA CA, 1993, J EXP MED, V177, P1317, DOI 10.1084/jem.177.5.1317; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1; Purugganan MM, 2001, NUCLEIC ACIDS RES, V29, P1638, DOI 10.1093/nar/29.7.1638; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; REHAKRANTZ LJ, 1991, P NATL ACAD SCI USA, V88, P2417, DOI 10.1073/pnas.88.6.2417; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; ROTHENBERG E, 1983, J IMMUNOL, V130, P1627; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; SCHWAGER J, 1991, EMBO J, V10, P2461, DOI 10.1002/j.1460-2075.1991.tb07785.x; TAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P786, DOI 10.1271/bbb.58.786; VICTOR KD, 1994, J IMMUNOL, V152, P3467; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; Whitcomb EA, 1998, J IMMUNOL, V160, P4904; YANG BL, 1994, J BIOL CHEM, V269, P11859	42	43	47	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					457	462		10.1038/ni788	http://dx.doi.org/10.1038/ni788			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11938351				2022-12-18	WOS:000175411200014
J	Bagley, J; Sawada, T; Wu, Y; Iacomini, J				Bagley, J; Sawada, T; Wu, Y; Iacomini, J			A critical role for interleukin 4 in activating alloreactive CD4T cells	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; ALLOGRAFT-REJECTION; ANTIGEN; IL-4; CD28; MICE; TRANSPLANTATION; COSTIMULATION; EXPRESSION; TOLERANCE	To generate antigen-specific responses, T cells and antigen presenting cells (APCs) must physically associate with each other and elaborate soluble factors that drive the full differentiation of each cell type. Immediately after T cell activation, CD4 T cells can produce both interferon gamma (IFN-gamma) and interleukin 4 (IL-4) before polarization into distinct T helper subsets. Inhibition of IL-4 during mixed allogeneic lymphocyte culture resulted in a defect in the ability of APCs to generate sufficient costimulatory signals for activation of alloreactive T cells. In vivo, a deficiency in IL-4 production inhibited the activation of alloreactive IL-2-, IL-4- and IFN-gamma-producing CD4 T cells in mice challenged with allogeneic skin grafts, resulting in prolonged skin graft survival.-rhus, production of IL-4 by CD4 T cells helps activate alloreactive T cells by affecting APC function.	Massachusetts Gen Hosp East, Transplantat Biol Res Ctr, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital	Iacomini, J (corresponding author), Massachusetts Gen Hosp East, Transplantat Biol Res Ctr, Bldg 149,13th St, Boston, MA 02129 USA.				NIAID NIH HHS [R01 AI43619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Auchincloss H, 1996, CURR OPIN IMMUNOL, V8, P681, DOI 10.1016/S0952-7915(96)80086-0; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Davies JD, 1996, J IMMUNOL, V157, P529; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li XC, 1998, J IMMUNOL, V161, P890; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; Nakamura T, 1997, J IMMUNOL, V158, P1085; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Sawada T, 1997, TRANSPLANTATION, V64, P335, DOI 10.1097/00007890-199707270-00027; Schuler T, 1999, J EXP MED, V189, P803, DOI 10.1084/jem.189.5.803; STACK RM, 1994, J IMMUNOL, V152, P5723; Suzuki Y, 1996, J IMMUNOL, V157, P2564; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; VALLE A, 1991, INT IMMUNOL, V3, P229, DOI 10.1093/intimm/3.3.229	27	43	43	2	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					257	261		10.1038/79811	http://dx.doi.org/10.1038/79811			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973285				2022-12-18	WOS:000089815100026
J	Nakahashi-Oda, C; Udayanga, KGS; Nakamura, Y; Nakazawa, Y; Totsuka, N; Miki, H; Iino, S; Tahara-Hanaoka, S; Honda, S; Shibuya, K; Shibuya, A				Nakahashi-Oda, Chigusa; Udayanga, Kankanam Gamage Sanath; Nakamura, Yoshiyuki; Nakazawa, Yuta; Totsuka, Naoya; Miki, Haruka; Iino, Shuichi; Tahara-Hanaoka, Satoko; Honda, Shin-ichiro; Shibuya, Kazuko; Shibuya, Akira			Apoptotic epithelial cells control the abundance of T-reg cells at barrier surfaces	NATURE IMMUNOLOGY			English	Article							MAST-CELL; I INTERFERON; MAIR-I; RECEPTOR; COMMENSAL; MICROBIOTA; IMMUNITY; MICE; PHOSPHATIDYLSERINE; INFLAMMATION	Epithelial tissues continually undergo apoptosis. Commensal organisms that inhabit the epithelium influence tissue homeostasis, in which regulatory T cells (T-reg cells) have a central role. However, the physiological importance of epithelial cell apoptosis and how the number of T-reg cells is regulated are both incompletely understood. Here we found that apoptotic epithelial cells negatively regulated the commensal-stimulated proliferation of T-reg cells. Gut commensals stimulated CX3CR1(+)CD103(-)CD11b(+) dendritic cells (DCs) to produce interferon-beta (IFN-beta), which augmented the proliferation of T-reg cells in the intestine. Conversely, phosphatidylserine exposed on apoptotic epithelial cells suppressed IFN-beta production by the DCs via inhibitory signaling mediated by the cell-surface glycoprotein CD300a and thus suppressed T-reg cell proliferation. Our findings reveal a regulatory role for apoptotic epithelial cells in maintaining the number of T-reg cell and tissue homeostasis.	[Nakahashi-Oda, Chigusa; Udayanga, Kankanam Gamage Sanath; Nakamura, Yoshiyuki; Nakazawa, Yuta; Totsuka, Naoya; Miki, Haruka; Iino, Shuichi; Tahara-Hanaoka, Satoko; Honda, Shin-ichiro; Shibuya, Kazuko; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan; [Shibuya, Akira] Japan Agcy Med Res & Dev, Japan Agcy Med Res, Core Res Evolut Sci & Technol, Tokyo, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan.; Shibuya, A (corresponding author), Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan.; Shibuya, A (corresponding author), Japan Agcy Med Res & Dev, Japan Agcy Med Res, Core Res Evolut Sci & Technol, Tokyo, Japan.	ashibuya@md.tsukuba.ac.jp		Shibuya, Kazuko/0000-0002-8203-2342; Nakazawa, Yuta/0000-0003-2521-6599	Japan Society for the Promotion of Science (KAKENHI); Core Research for Evolutional Science and Technology; Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [15K15659, 25293091] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B. Malissen (UM2 Aix-Marseille Universite) for Foxp3<SUP>eGFP</SUP> mice; E. Nakayama (Okayama University) for anti-CD25; M. Tanaka (Research Center for Allergy and Immunology, Yokohama, Japan) for MFG-E8(D89E) and MFG-E8(EPT); K. Honda and G. Nunez for discussions; S. Tochihara and Y. Nomura for secretarial assistance; and F. Abe and R. Hirochika for technical assistance. Supported by Japan Society for the Promotion of Science (KAKENHI), Core Research for Evolutional Science and Technology, Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology and Uehara Memorial Foundation (A.S.).	Aldini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108112; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BAUER H, 1963, AM J PATHOL, V42, P471; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Graves CL, 2014, J IMMUNOL METHODS, V414, P20, DOI 10.1016/j.jim.2014.08.002; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kole A, 2013, J IMMUNOL, V191, P2771, DOI 10.4049/jimmunol.1301093; Lee SE, 2012, GASTROENTEROLOGY, V143, P145, DOI 10.1053/j.gastro.2012.03.042; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Monteleone G, 2011, CURR OPIN PHARMACOL, V11, P640, DOI 10.1016/j.coph.2011.09.013; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; Okoshi Y, 2005, INT IMMUNOL, V17, P65, DOI 10.1093/intimm/dxh187; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sly LM, 2009, BLOOD, V113, P2945, DOI 10.1182/blood-2008-06-166082; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; TROWBRIDGE IS, 1982, J CELL PHYSIOL, V112, P403, DOI 10.1002/jcp.1041120314; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhou Z, 2007, DEV CELL, V13, P759, DOI 10.1016/j.devcel.2007.11.009	48	42	43	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					441	+		10.1038/ni.3345	http://dx.doi.org/10.1038/ni.3345			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26855029				2022-12-18	WOS:000372508000018
J	Medzhitov, R				Medzhitov, Ruslan			Innate immunity: quo vadis?	NATURE IMMUNOLOGY			English	Article							INFECTIOUS-DISEASES; RESPONSES; RESISTANCE; TOLERANCE; DEFENSE		Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI055502] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548	16	42	46	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					551	553		10.1038/ni0710-551	http://dx.doi.org/10.1038/ni0710-551			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562835	Bronze			2022-12-18	WOS:000278926400005
J	Matthews, AGW; Oettinger, MA				Matthews, Adam G. W.; Oettinger, Marjorie A.			RAG: a recombinase diversified	NATURE IMMUNOLOGY			English	Article							HEAVY-CHAIN GENE; V(D)J RECOMBINATION; B-CELL; HISTONE ACETYLATION; IN-VITRO; IMMUNOGLOBULIN LOCI; GENOMIC INSTABILITY; PLANT HOMEODOMAIN; NUCLEOSOMAL DNA; C-TERMINUS	During B cell and T cell development, the lymphoid-specific proteins RAG-1 and RAG-2 act together to initiate the assembly of antigen receptor genes through a series of site-specific somatic DNA rearrangements that are collectively called variable-diversity-joining (V(D) J) recombination. In the past 20 years, a great deal has been learned about the enzymatic activities of the RAG-1-RAG-2 complex. Recent studies have identified several new and exciting regulatory functions of the RAG-1-RAG-2 complex. Here we discuss some of these functions and suggest that the RAG-1-RAG-2 complex nucleates a specialized subnuclear compartment that we call the 'V(D) J recombination factory'.	[Matthews, Adam G. W.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Matthews, Adam G. W.; Oettinger, Marjorie A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Matthews, AGW (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.	adamgm@mit.edu; oettinger@molbio.mgh.harvard.edu			US National Institutes of Health; Damon Runyon Cancer Research Foundation [DRG-1981-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048026] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to those whose work we were unable to cite because of space limitations. Supported by the US National Institutes of Health ( M. A. O.) and the Damon Runyon Cancer Research Foundation ( DRG-1981-08 to A. G. W. M.).	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; ALESSANDRINI A, 1991, MOL CELL BIOL, V11, P2096, DOI 10.1128/MCB.11.4.2096; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Elkin SK, 2003, EMBO J, V22, P1931, DOI 10.1093/emboj/cdg184; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Matthews AGW, 2004, EMBO J, V23, P1198, DOI 10.1038/sj.emboj.7600131; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Osipovich O, 2007, NAT IMMUNOL, V8, P809, DOI 10.1038/ni1481; Patenge N, 2004, J BIOL CHEM, V279, P35360, DOI 10.1074/jbc.M405790200; Perkins EJ, 2004, NUCLEIC ACIDS RES, V32, P1942, DOI 10.1093/nar/gkh523; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schultz HY, 2001, MOL CELL, V7, P65, DOI 10.1016/S1097-2765(01)00155-1; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; Swanson PC, 2004, J BIOL CHEM, V279, P4034, DOI 10.1074/jbc.M311100200; Tsai CL, 2003, EMBO J, V22, P1922, DOI 10.1093/emboj/cdg185; Tsai CL, 2002, GENE DEV, V16, P1934, DOI 10.1101/gad.984502	53	42	42	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					817	821		10.1038/ni.1776	http://dx.doi.org/10.1038/ni.1776			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621044	Green Accepted			2022-12-18	WOS:000268141400009
J	Okamoto, M; Van Stry, M; Chung, L; Koyanagi, M; Sun, XZ; Suzuki, Y; Ohara, O; Kitamura, H; Hijikata, A; Kubo, M; Bix, M				Okamoto, Mariko; Van Stry, Melanie; Chung, Linda; Koyanagi, Madoka; Sun, Xizhang; Suzuki, Yoshie; Ohara, Osamu; Kitamura, Hiroshi; Hijikata, Atsushi; Kubo, Masato; Bix, Mark			Mina, an Il4 repressor, controls T helper type 2 bias	NATURE IMMUNOLOGY			English	Article							MYC TARGET GENE; CELL-DIFFERENTIATION; LEISHMANIA-MAJOR; IL-4 PRODUCTION; TH2 CYTOKINES; MURINE LOCUS; EXPRESSION; INTERLEUKIN-4; MECHANISM; RESPONSES	T helper type 2 (T(H)2) bias, which is the propensity of naive CD4(+) T cells to differentiate into interleukin 4 (IL-4)-secreting T(H)2 cells, is a genetic trait that affects susceptibility to infectious, autoimmune and allergic diseases. T(H)2 bias correlates with the amount of IL-4 initially secreted by newly activated helper T cells that feeds back positively through the pathway of the IL-4 receptor and the transcription factors STAT6 and GATA-3 to drive T(H)2 development. Here we identify Mina, a member of the jumonji C (JmjC) protein family, as a genetic determinant of T(H)2 bias. Mina specifically bound to and repressed the Il4 promoter. Mina overexpression in transgenic mice impaired Il4 expression, whereas its knockdown in primary CD4(+) T cells led to Il4 derepression. Our findings collectively provide mechanistic insight into an Il4-regulatory pathway that controls helper T cell differentiation and genetic variation in T(H)2 bias.	[Van Stry, Melanie; Chung, Linda; Koyanagi, Madoka; Bix, Mark] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Okamoto, Mariko; Suzuki, Yoshie; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Sun, Xizhang] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Ohara, Osamu; Kitamura, Hiroshi; Hijikata, Atsushi] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Immunogenet Lab, Yokohama, Kanagawa, Japan	St Jude Children's Research Hospital; RIKEN; University of Washington; University of Washington Seattle; RIKEN	Bix, M (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	raysolfc@rcai.riken.jp; mark.bix@stjude.org	Okamoto, Mariko/ABA-9736-2020; Ohara, Osamu/G-5448-2015; Ohara, Osamu/A-9119-2012; Kubo, Masato/A-5918-2016; Hu, Ruogu/B-2203-2008	Okamoto, Mariko/0000-0002-8553-0232; Ohara, Osamu/0000-0002-3328-9571; Hijikata, Atsushi/0000-0003-4297-8368; Bix, Mark/0000-0003-4617-0497; Van Stry, Melanie/0000-0002-4722-2407	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048636, R01AI048636] Funding Source: NIH RePORTER; NIAID NIH HHS [AI048636, R56 AI048636, R01 AI048636, R01 AI048636-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Attar RM, 1998, MOL CELL BIOL, V18, P477, DOI 10.1128/MCB.18.1.477; Baguet A, 2004, J EXP MED, V200, P1605, DOI 10.1084/jem.20040334; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Bix M, 1998, J EXP MED, V188, P2289, DOI 10.1084/jem.188.12.2289; BRUHN KW, 1993, P NATL ACAD SCI US; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Choi P, 2005, GENES IMMUN, V6, P290, DOI 10.1038/sj.gene.6364192; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Crane IJ, 2005, CRIT REV IMMUNOL, V25, P75, DOI 10.1615/CritRevImmunol.v25.i2.10; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; FARRAR JJ, 1980, J IMMUNOL, V125, P2555; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Guler ML, 1999, J IMMUNOL, V162, P1339; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kosarova M, 1999, IMMUNOGENETICS, V49, P134, DOI 10.1007/s002510050472; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Kuroda E, 2000, J IMMUNOL, V164, P2386, DOI 10.4049/jimmunol.164.5.2386; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Liu ZG, 2004, IMMUNOL REV, V201, P57, DOI 10.1111/j.0105-2896.2004.00186.x; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rook GAW, 2007, CURR MOL MED, V7, P327; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Seki N, 2004, J IMMUNOL, V172, P6158, DOI 10.4049/jimmunol.172.10.6158; Summerton JE, 2005, ANN NY ACAD SCI, V1058, P62, DOI 10.1196/annals.1359.012; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Tokoyoda K, 2000, J BIOL CHEM, V275, P11728, DOI 10.1074/jbc.275.16.11728; Tsuneoka M, 2006, INT J ANDROL, V29, P323, DOI 10.1111/j.1365-2605.2005.00572.x; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Umetsu DT, 2006, CURR OPIN IMMUNOL, V18, P727, DOI 10.1016/j.coi.2006.09.007; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wilson KT, 1999, CURR OPIN GASTROEN, V15, P66, DOI 10.1097/00001574-199901000-00012; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yagi J, 2006, INT IMMUNOL, V18, P1681, DOI 10.1093/intimm/dxl102; Yagi R, 2002, INT IMMUNOL, V14, P1, DOI 10.1093/intimm/14.1.1; Yamashita M, 2007, CRIT REV IMMUNOL, V27, P539, DOI 10.1615/CritRevImmunol.v27.i6.40; Zhang F, 2003, J IMMUNOL, V171, P4613, DOI 10.4049/jimmunol.171.9.4613; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	57	42	47	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					872	U98		10.1038/ni.1747	http://dx.doi.org/10.1038/ni.1747			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19561615	Green Accepted			2022-12-18	WOS:000268141400016
J	Awasthi, A; Kuchroo, VK				Awasthi, Amit; Kuchroo, Vijay K.			IL-17A directly inhibits T(H)1 cells and thereby suppresses development of intestinal inflammation	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; DISEASE; MICE	T helper type 1 cells (T(H)1 cells) serve a dominant function in T cell-mediated colitis. New work reports that interleukin 17A, an effector cytokine required for the development of autoimmune tissue inflammation, directly inhibits T(H)1 development by suppressing the expression of key T(H)1-associated genes and therefore regulates T(H)1 cell-mediated colitis.	[Awasthi, Amit; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Awasthi, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu						AWASTHI A, J IMMUNOL IN PRESS; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ito H, 1997, J AUTOIMMUN, V10, P455, DOI 10.1016/S0896-8411(97)90152-9; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Weiner HL, 2001, NAT IMMUNOL, V2, P671, DOI 10.1038/90604; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	11	42	46	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					568	570		10.1038/ni0609-568	http://dx.doi.org/10.1038/ni0609-568			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448657				2022-12-18	WOS:000266384100007
J	Axtell, RC; Steinman, L				Axtell, Robert C.; Steinman, Lawrence			Gaining entry to an uninflamed brain	NATURE IMMUNOLOGY			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; INFLAMMATION; INDUCTION; CELLS	Little is known about how pathogenic T cells gain access to the uninflamed brain in multiple sclerosis and experimental autoimmune encephalomyelitis. A new study reports that interleukin 17-producing T helper cells enter the uninflamed central nervous system through the choroid plexus by a CCR6-CCL20-dependent mechanism.	[Axtell, Robert C.; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Axtell, RC (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu	Axtell, Robert/AAJ-5053-2021		Multiple Sclerosis Society [835] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; PANITCH HS, 1987, LANCET, V1, P893; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Willenborg DO, 1996, J IMMUNOL, V157, P3223; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	16	42	43	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					453	455		10.1038/ni0509-453	http://dx.doi.org/10.1038/ni0509-453			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19381137				2022-12-18	WOS:000265394400004
J	Mostoslavsky, R; Alt, FW; Bassing, CH				Mostoslavsky, R; Alt, FW; Bassing, CH			Chromatin dynamics and locus accessibility in the immune system	NATURE IMMUNOLOGY			English	Review							CLASS-SWITCH RECOMBINATION; TCR-ALPHA ENHANCER; V(D)J RECOMBINATION; MECHANISM; AID; REGION; CELLS; H2AX; BETA	Development invertebrates follows distinctive pathways of cellular differentiation. Starting from the zygote, newly formed cells continually differentiate until they reach a final mature fate. Whether differentiating into a neuron, a hepatocyte or a myofibril, every normal cell, with the exception of developing lymphocytes, carries the same genetic information enclosed within its nucleus. To acquire distinct cellular identities, cells need to control gene expression in a very regulated way. Genes encoding factors required for identity at a particular developmental stage need to be appropriately activated, whereas genes required for identity during the previous developmental stage are often silenced. Moreover, once a cell becomes terminally differentiated, 'heritable' gene expression must be maintained in all daughter cells and, thus, faithfully recapitulated after each cellular division.	Harvard Univ, Sch Med, Ctr Blood Res, Childrens Hosp,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Childrens Hosp,Howard Hughes Med Inst, Boston, MA 02115 USA.							Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chen JZ, 1996, ADV IMMUNOL, V62, P31, DOI 10.1016/S0065-2776(08)60427-7; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fugmann SD, 2003, NAT IMMUNOL, V4, P429, DOI 10.1038/ni0503-429; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Paull TT, 2001, CELL, V107, P563, DOI 10.1016/S0092-8674(01)00591-8; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; van Leeuwen F, 2003, CELL, V112, P591, DOI 10.1016/S0092-8674(03)00152-1; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	30	42	46	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					603	606		10.1038/ni0703-603	http://dx.doi.org/10.1038/ni0703-603			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830134				2022-12-18	WOS:000183952500002
J	Pereira, JP; Girard, R; Chaby, R; Cumano, A; Vieira, P				Pereira, JP; Girard, R; Chaby, R; Cumano, A; Vieira, P			Monoallelic expression of the murine gene encoding Toll-like receptor 4	NATURE IMMUNOLOGY			English	Article							X-CHROMOSOME INACTIVATION; EPIGENETIC REGULATION; C57BL/10SCCR MICE; DROSOPHILA TOLL; LPS GENE; B-CELLS; T-CELLS; ALLELES; LIPOPOLYSACCHARIDES; RESPONSES	Defects in the gene encoding Toll-like receptor 4 (Tlr4) result in impaired responses to lipopolysaccharide (LPS), rendering mice sensitive to infections by Gram-negative bacteria. C3H/HeJ mice have a codominant allele with a mutation in Tlr4, which results in an intermediate response to LPS in F-1 mice from crosses of responder and C3H/HeJ mice. Here we show that this intermediate response to LPS is due to monoallelic expression of Tlr4. Allele usage is maintained during clonal expansion, a situation that resembles allelic exclusion. In contrast, Tlr4 is deleted on the recessive C57BL/10ScCr allele and all cells from F-1 mice from crosses of responder and C57BL/10ScCr mice express TLR4, protein. Thus, Tlr4 is an autosomal gene whose expression is regulated similarly to that of genes on the X chromosome.	Inst Pasteur, CNRS, URA 1961, Unite Dev Lymphocytes, F-75015 Paris, France; Univ Paris 11, CNRS, UMR 8619, Equipe Endotoxines, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Vieira, P (corresponding author), Inst Pasteur, CNRS, URA 1961, Unite Dev Lymphocytes, 25 Rue Dr Roux, F-75015 Paris, France.		Vieira, Paulo/D-4500-2013	Vieira, Paulo/0000-0003-1307-5119; Cumano, Ana/0000-0002-4578-959X; Pereira, Joao/0000-0002-5694-4938				ANDERSSON J, 1977, CELL, V10, P27, DOI 10.1016/0092-8674(77)90136-2; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; COUTINHO A, 1977, EUR J IMMUNOL, V7, P325, DOI 10.1002/eji.1830070517; COUTINHO A, 1978, IMMUNOGENETICS, V7, P17, DOI 10.1007/BF01843983; COUTINHO A, 1975, J EXP MED, V142, P253, DOI 10.1084/jem.142.1.253; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; FREITAS AA, 1995, EUR J IMMUNOL, V25, P1729, DOI 10.1002/eji.1830250636; GALANOS C, 1993, IMMUNOBIOLOGY, V187, P346, DOI 10.1016/S0171-2985(11)80349-9; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GOVERMAN J, 1985, CELL, V40, P859, DOI 10.1016/0092-8674(85)90345-9; HANEWAY CA, 2002, ANNU REV IMMUNOL, V20, P197; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meller VH, 2000, TRENDS CELL BIOL, V10, P54, DOI 10.1016/S0962-8924(99)01693-1; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Poltorak A, 2000, J ENDOTOXIN RES, V6, P51, DOI 10.1177/09680519000060010701; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Shulman MJ, 1999, SEMIN IMMUNOL, V11, P369, DOI 10.1006/smim.1999.0193; TAHRIJOUTI MA, 1990, MOL IMMUNOL, V27, P763, DOI 10.1016/0161-5890(90)90085-E; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; WATSON J, 1974, J EXP MED, V140, P1147, DOI 10.1084/jem.140.5.1147; WEILER E, 1965, P NATL ACAD SCI USA, V54, P1765, DOI 10.1073/pnas.54.6.1765; Willard HF, 1996, CELL, V86, P5, DOI 10.1016/S0092-8674(00)80071-9	43	42	42	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					464	470		10.1038/ni917	http://dx.doi.org/10.1038/ni917			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12665857				2022-12-18	WOS:000182665400014
J	Darnell, RB; Posner, JB				Darnell, RB; Posner, JB			Observing the invisible: successful tumor immunity in humans	NATURE IMMUNOLOGY			English	Letter							PARANEOPLASTIC CEREBELLAR DEGENERATION; CELL LUNG-CANCER; ANTIBODIES		Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10012 USA; Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10012 USA	Howard Hughes Medical Institute; Rockefeller University; Memorial Sloan Kettering Cancer Center	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10012 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088				Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Albert ML, 2000, ANN NEUROL, V47, P9; Brunet M., 1957, BMJ-BRIT MED J, V1, P841, DOI DOI 10.1136/BMJ.1.5023.841; Byrne T, 1997, J NEUROL NEUROSUR PS, V62, P276, DOI 10.1136/jnnp.62.3.276; DALMAU J, 1990, ANN NEUROL, V27, P544, DOI 10.1002/ana.410270515; DARNELL RB, 1993, LANCET, V341, P21, DOI 10.1016/0140-6736(93)92485-C; DARNELL RB, IN PRESS N ENGL J ME; Dickey C, 2002, NAT MED, V8, P1337, DOI 10.1038/nm1202-1337b; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; POSNER JB, 1990, RES P ARNMD, V68, P187	12	42	43	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					201	201		10.1038/ni0303-201	http://dx.doi.org/10.1038/ni0303-201			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605223	Bronze			2022-12-18	WOS:000181201000002
J	Cerutti, A; Kim, EC; Shah, S; Schattner, EJ; Zan, H; Schaffer, A; Casali, P				Cerutti, A; Kim, EC; Shah, S; Schattner, EJ; Zan, H; Schaffer, A; Casali, P			Dysregulation of CD30(+) T cells by leukemia impairs isotype switching in normal B cells	NATURE IMMUNOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TNF RECEPTOR-2; FACTOR-BETA; ACTIVATION; LIGAND; CD40; TRAF2; IMMUNOGLOBULIN	Chronic lymphocytic leukemia (CLL) is associated with impaired immunoglobulin (Ig) class-switching from IgM to IgG and IgA, a defect that leads to recurrent infections,When activated in the presence of leukemic CLL B cells, T cells rapidly up-regulate CD30 through an OX40 ligand and interleukin 4 (IL-4)-dependent mechanism. These leukemia-induced CD30(+) T cells inhibit CD40 ligand (CD40L)-mediated S mu-->S gamma and S mu-->S alpha class-switch DNA recombination (CSR) by engaging CD30 ligand (CD30L), a molecule that interferes with the assembly of the CD40-tumor necrosis factor receptor-associated factor (TRAF) complex in nonmalignant IgD(+) B cells. In addition, engagement of T cell CD30 by CD30L on neoplastic CLL B cells down-regulates the CD3-induced expression of CD40L. These findings indicate that, in CLL, abnormal CD30-CD30L interaction impairs IgG and IgA production by interfering with the CD40-mediated differentiation of nonmalignant B cells.	Cornell Univ, Weill Med Coll, Dept Pathol, Div Mol Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Cerutti, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol, Div Mol Immunol, 1300 York Ave, New York, NY 10021 USA.		Casali, Paolo/F-6579-2010	Cerutti, Andrea/0000-0003-3026-4704	NIAID NIH HHS [T32 AI 07621, T32 AI007621, R56 AI045011, R01 AI045011, AI 45011] Funding Source: Medline; NIAMS NIH HHS [AR40908, R01 AR040908] Funding Source: Medline; NIA NIH HHS [AG 13910] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045011, R56AI045011, T32AI007621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013910] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADERKA D, 1993, BLOOD, V81, P2076; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Blair PJ, 2000, J EXP MED, V191, P651, DOI 10.1084/jem.191.4.651; BOWEN MA, 1993, J IMMUNOL, V151, P5896; Cantwell M, 1997, NAT MED, V3, P984, DOI 10.1038/nm0997-984; Cerutti A, 1998, IMMUNITY, V9, P247, DOI 10.1016/S1074-7613(00)80607-X; Cerutti A, 2000, J IMMUNOL, V165, P786, DOI 10.4049/jimmunol.165.2.786; Chaudhuri A, 1999, BIOCHEM BIOPH RES CO, V256, P620, DOI 10.1006/bbrc.1999.0385; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; CHIORAZZI N, 1979, J IMMUNOL, V122, P1087; de Totero D, 1999, BRIT J HAEMATOL, V104, P589, DOI 10.1046/j.1365-2141.1999.01219.x; DELPRETE G, 1995, IMMUNOL TODAY, V16, P76, DOI 10.1016/0167-5699(95)80092-1; DIGHIERO G, 1991, BLOOD, V78, P1901; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gattei V, 1997, BLOOD, V89, P2048, DOI 10.1182/blood.V89.6.2048; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hansen HP, 2000, J IMMUNOL, V165, P6703, DOI 10.4049/jimmunol.165.12.6703; JABBAR SAB, 1994, BRIT J HAEMATOL, V86, P496, DOI 10.1111/j.1365-2141.1994.tb04779.x; KAY NE, 1989, BLOOD, V73, P1016; KIPPS TJ, 1995, WILLIAMS HEMATOLOGY, P1017; KUREC AS, 1987, AM J HEMATOL, V25, P131, DOI 10.1002/ajh.2830250203; Kurts C, 1999, NATURE, V398, P341, DOI 10.1038/18692; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Lee HM, 1996, AI EDAM, V10, P183, DOI 10.1017/S0890060400001542; Leo E, 1999, EUR J IMMUNOL, V29, P3908, DOI 10.1002/(SICI)1521-4141(199912)29:12<3908::AID-IMMU3908>3.0.CO;2-E; Li JF, 1999, J IMMUNOL, V163, P6386; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; LOTZ M, 1994, J EXP MED, V179, P999, DOI 10.1084/jem.179.3.999; Muta H, 2000, J IMMUNOL, V165, P5105, DOI 10.4049/jimmunol.165.9.5105; Nakamura T, 1997, J IMMUNOL, V158, P2090; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Nociari MM, 1999, J IMMUNOL, V162, P3327; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; REIGNER CH, 1997, CELL, V90, P373; Renner C, 2000, CANCER IMMUNOL IMMUN, V49, P173, DOI 10.1007/s002620050617; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sampalo A, 2000, BLOOD, V96, P3168; Schaffer A, 1999, J IMMUNOL, V162, P5327; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; Tinhofer I, 1998, BLOOD, V91, P4273, DOI 10.1182/blood.V91.11.4273.411k25_4273_4281; Trentin L, 1997, CANCER RES, V57, P4940; Van den Hove LE, 1998, LEUKEMIA, V12, P1573, DOI 10.1038/sj.leu.2401146; VanKooten C, 1996, ADV IMMUNOL, V61, P1; Vendetti S, 2000, J IMMUNOL, V165, P1175, DOI 10.4049/jimmunol.165.3.1175	50	42	43	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					150	156		10.1038/84254	http://dx.doi.org/10.1038/84254			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175813	Green Accepted			2022-12-18	WOS:000166778700015
J	Deets, KA; Vance, RE				Deets, Katherine A.; Vance, Russell E.			Inflammasomes and adaptive immune responses	NATURE IMMUNOLOGY			English	Review								A fundamental concept in immunology is that the innate immune system initiates or instructs downstream adaptive immune responses. Inflammasomes are central players in innate immunity to pathogens, but how inflammasomes shape adaptive immunity is complex and relatively poorly understood. Here we highlight recent work on the interplay between inflammasomes and adaptive immunity. We address how inflammasome-dependent release of cytokines and antigen activates, shapes or even inhibits adaptive immune responses. We consider how distinct tissue or cellular contexts may alter the effects of inflammasome activation on adaptive immunity and how this contributes to beneficial or detrimental outcomes in infectious diseases, cancer and autoimmunity. We aspire to provide a framework for thinking about inflammasomes and their connection to the adaptive immune response. Deets and Vance discuss the influence of inflammasome activation on adaptive immunity.	[Deets, Katherine A.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA.	rvance@berkeley.edu		Vance, Russell/0000-0002-6686-3912	Howard Hughes Medical Institute; National Institutes of Health [AI063302, AI075039, AI155634]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research in R.E.V.'s lab is supported by an Investigator Award from the Howard Hughes Medical Institute and by National Institutes of Health grant nos. AI063302, AI075039 and AI155634. Additionally, the authors thank M. Gaidt, I. Rauch and D. Kotov for providing invaluable scientific insights and editorial feedback.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; Ahmed M, 2010, J VIROL, V84, P12093, DOI 10.1128/JVI.00406-10; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Alhallaf R, 2018, CELL REP, V23, P1085, DOI 10.1016/j.celrep.2018.03.097; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Barclay W, 2017, BRAIN PATHOL, V27, P213, DOI 10.1111/bpa.12477; Ben-Sasson SZ, 2013, COLD SH Q B, V78, P117, DOI 10.1101/sqb.2013.78.021246; Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Bibo-Verdugo B, 2020, J BIOL CHEM, V295, P11292, DOI 10.1074/jbc.RA120.014259; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Braga TT, 2019, CLIN SCI, V133, P1901, DOI 10.1042/CS20190506; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Carlos D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00164; Cerovic V, 2015, MUCOSAL IMMUNOL, V8, P38, DOI 10.1038/mi.2014.40; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Choy MC, 2017, INFLAMM BOWEL DIS, V23, P2, DOI 10.1097/MIB.0000000000000955; Christgen S, 2020, CELL RES, V30, P315, DOI 10.1038/s41422-020-0295-8; Chu LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03409-3; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cox MA, 2013, VIROLOGY, V435, P157, DOI 10.1016/j.virol.2012.09.012; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Cui BF, 2018, EXPERT REV VACCINES, V17, P335, DOI 10.1080/14760584.2018.1457443; Cummings RJ, 2016, NATURE, V539, P565, DOI 10.1038/nature20138; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707; Das S, 2020, CANCER RES, V80, P1088, DOI 10.1158/0008-5472.CAN-19-2080; Davis MA, 2019, P NATL ACAD SCI USA, V116, P5061, DOI 10.1073/pnas.1818598116; de Vasconcelos NM, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036392; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Deng J, 2019, MOL IMMUNOL, V107, P142, DOI 10.1016/j.molimm.2018.12.024; DiPeso L, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.70; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Dostert C, 2013, CURR OPIN IMMUNOL, V25, P359, DOI 10.1016/j.coi.2013.02.008; Dupaul-Chicoine J, 2015, IMMUNITY, V43, P751, DOI 10.1016/j.immuni.2015.08.013; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Engwerda CR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00498; Erlich Z, 2019, NAT IMMUNOL, V20, P397, DOI 10.1038/s41590-019-0313-5; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Evavold CL, 2018, J MOL BIOL, V430, P217, DOI 10.1016/j.jmb.2017.09.019; Feriotti C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00786; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gao YJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20190476; Garaude J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002868; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Goncalves AV, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007886; Gong ZZ, 2018, MOL IMMUNOL, V104, P11, DOI 10.1016/j.molimm.2018.09.004; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guan QD, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2018-0125; Gutierrez-Martinez E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00363; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Harapas CR, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0750-4; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Holmkvist P, 2016, EUR J IMMUNOL, V46, P1371, DOI 10.1002/eji.201545957; Hu CY, 2015, P NATL ACAD SCI USA, V112, P11318, DOI 10.1073/pnas.1513509112; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jain A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05489-7; Jain A, 2017, J IMMUNOL, V198, P3791, DOI 10.4049/jimmunol.1602000; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Johnson DC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02865-4; Jorgensen I, 2016, EUR J IMMUNOL, V46, P2761, DOI 10.1002/eji.201646647; Jorgensen I, 2016, J EXP MED, V213, P2113, DOI 10.1084/jem.20151613; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Ketelut-Carneiro N, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007990; Ketelut-Carneiro N, 2015, J IMMUNOL, V194, P4507, DOI 10.4049/jimmunol.1402321; Knudsen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065964; Ko EJ, 2019, VACCINE, V37, P3426, DOI 10.1016/j.vaccine.2019.05.018; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lebreton F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0764-x; Lee P, 2016, IMMUNOL CELL BIOL, V94, P439, DOI 10.1038/icb.2015.115; Lee PH, 2019, J EXP MED, V216, P2619, DOI 10.1084/jem.20181218; Lei-Leston AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01168; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li J, 2004, CELL IMMUNOL, V227, P103, DOI 10.1016/j.cellimm.2004.02.002; Li S, 2019, J EXP MED, V216, P2562, DOI 10.1084/jem.20190377; Li W, 2016, CELL MOL IMMUNOL, V13, P514, DOI 10.1038/cmi.2015.33; Lin KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24199; Linder A, 2020, EMBO J, V39, DOI 10.15252/embj.2020105071; Liu HW, 2017, BIOMED PHARMACOTHER, V94, P619, DOI 10.1016/j.biopha.2017.07.102; Lu AL, 2017, J IMMUNOL, V198, P1119, DOI 10.4049/jimmunol.1600659; Mak'Anyengo R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96322; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McDaniel MM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107604; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; McSorley SJ, 2014, IMMUNOL REV, V260, P168, DOI 10.1111/imr.12184; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Motta VN, 2015, J IMMUNOL, V194, P5663, DOI 10.4049/jimmunol.1400913; Muri J, 2020, CELL REP, V30, P4399, DOI 10.1016/j.celrep.2020.03.019; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Nichols RD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02266-w; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Nystrom S, 2013, VACCINES, V1, DOI 10.3390/vaccines1040415; O'Donnell H, 2014, IMMUNITY, V40, P213, DOI 10.1016/j.immuni.2013.12.013; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pang IK, 2013, NAT IMMUNOL, V14, P246, DOI 10.1038/ni.2514; Paroli AF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00913; Pedra JHF, 2007, J IMMUNOL, V179, P4783, DOI 10.4049/jimmunol.179.7.4783; Penteado LD, 2017, IMMUNOLOGY, V151, P304, DOI 10.1111/imm.12731; Pham OH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006566; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Qiu CC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02608; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Rostami A, 2017, PARASITOL RES, V116, P2361, DOI 10.1007/s00436-017-5535-6; Sanos SL, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01988; Santos JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16889-z; Santos JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798089; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018; Schulz O, 2018, CELL REP, V24, P419, DOI 10.1016/j.celrep.2018.06.038; Segovia M, 2019, CANCER CELL, V35, P767, DOI 10.1016/j.ccell.2019.04.003; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Seydoux E, 2018, J IMMUNOL, V201, P98, DOI 10.4049/jimmunol.1701604; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shin MS, 2013, J IMMUNOL, V190, P1407, DOI 10.4049/jimmunol.1201195; Silva GK, 2013, J IMMUNOL, V191, P3373, DOI 10.4049/jimmunol.1203293; Smedberg JR, 2014, J VIROL, V88, P777, DOI 10.1128/JVI.02898-13; Srinivasan A, 2007, J IMMUNOL, V178, P6342, DOI 10.4049/jimmunol.178.10.6342; Suschak JJ, 2015, J IMMUNOL, V194, P630, DOI 10.4049/jimmunol.1402530; Tartey S, 2020, J LEUKOCYTE BIOL, V107, P379, DOI 10.1002/JLB.3MIR0919-191R; Theisen E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00733-16; Theivanthiran B, 2020, J CLIN INVEST, V130, P2570, DOI 10.1172/JCI133055; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Tourlomousis P, 2020, NAT MICROBIOL, V5, P1588, DOI 10.1038/s41564-020-00801-y; Tran HQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13538-y; Trunk G, 2012, J IMMUNOL, V189, P616, DOI 10.4049/jimmunol.1200924; Tye H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06125-0; van de Veerdonk FL, 2015, IMMUNOL REV, V265, P172, DOI 10.1111/imr.12280; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang QY, 2020, NATURE, V579, P421, DOI 10.1038/s41586-020-2079-1; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wen YM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.40; Winsor N, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13079; Xi GM, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105713; Xia XJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1883-8; Xu SC, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0755-0; Yao XM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01917-2; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649; Yi YS, 2020, IMMUNOLOGY, V159, P142, DOI 10.1111/imm.13134; Zamboni DS, 2015, IMMUNOL REV, V265, P156, DOI 10.1111/imr.12291; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang HB, 2017, J IMMUNOL, V198, P4383, DOI 10.4049/jimmunol.1600714; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9; Zhao JJ, 2013, ARTHRITIS RHEUM-US, V65, P3176, DOI 10.1002/art.38174; Zhivaki D, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108381; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zhou T, 2020, NATURE, V583, P609, DOI 10.1038/s41586-020-2422-6; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	180	41	42	7	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					412	422		10.1038/s41590-021-00869-6	http://dx.doi.org/10.1038/s41590-021-00869-6		FEB 2021	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33603227				2022-12-18	WOS:000619508500001
J	Canton, J; Blees, H; Henry, CM; Buck, MD; Schulz, O; Rogers, NC; Childs, E; Zelenay, S; Rhys, H; Domart, MC; Collinson, L; Alloatti, A; Ellison, CJ; Amigorena, S; Papayannopoulos, V; Thomas, DC; Randow, F; Sousa, CRE				Canton, Johnathan; Blees, Hanna; Henry, Conor M.; Buck, Michael D.; Schulz, Oliver; Rogers, Neil C.; Childs, Eleanor; Zelenay, Santiago; Rhys, Hefin; Domart, Marie-Charlotte; Collinson, Lucy; Alloatti, Andres; Ellison, Cara J.; Amigorena, Sebastian; Papayannopoulos, Venizelos; Thomas, David C.; Randow, Felix; Reis e Sousa, Caetano			The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; DENDRITIC CELLS; EXOGENOUS ANTIGENS; SOLUBLE-ANTIGENS; T-CELLS; CROSSPRESENTATION; COMPARTMENT; RECRUITMENT; MATURATION; INFECTION	Type 1 conventional dendritic (cDC1) cells are necessary for cross-presentation of many viral and tumor antigens to CD8(+) T cells. cDC1 cells can be identified in mice and humans by high expression of DNGR-1 (also known as CLEC9A), a receptor that binds dead-cell debris and facilitates XP of corpse-associated antigens. Here, we show that DNGR-1 is a dedicated XP receptor that signals upon ligand engagement to promote phagosomal rupture. This allows escape of phagosomal contents into the cytosol, where they access the endogenous major histocompatibility complex class I antigen processing pathway. The activity of DNGR-1 maps to its signaling domain, which activates SYK and NADPH oxidase to cause phagosomal damage even when spliced into a heterologous receptor and expressed in heterologous cells. Our data reveal the existence of innate immune receptors that couple ligand binding to endocytic vesicle damage to permit MHC class I antigen presentation of exogenous antigens and to regulate adaptive immunity. The mechanism by which ingested material accesses the cytosol for cross-presentation is unclear. Caetano Reis e Sousa and colleagues demonstrate that signaling via the lectin receptor DNGR-1 ruptures the phagosome and releases its contents to the cytosol for cross-presentation.	[Canton, Johnathan; Blees, Hanna; Henry, Conor M.; Buck, Michael D.; Schulz, Oliver; Rogers, Neil C.; Childs, Eleanor; Reis e Sousa, Caetano] Francis Crick Inst, Immunobiol Lab, London, England; [Zelenay, Santiago] Univ Manchester, CRUK Manchester Inst, Canc Inflammat & Immun Grp, Alderley Park, Manchester, Lancs, England; [Rhys, Hefin] Francis Crick Inst, Flow Cytometry STP, London, England; [Domart, Marie-Charlotte; Collinson, Lucy] Francis Crick Inst, Electron Microscopy STP, London, England; [Alloatti, Andres; Amigorena, Sebastian] Inst Curie, Ctr Rech, INSERM U932, Paris, France; [Ellison, Cara J.; Randow, Felix] Francis Crick Inst, Antimicrobial Def Lab, London, England; [Ellison, Cara J.; Randow, Felix] Imperial Coll, Immun & Inflammat, 9NC, London, England; [Papayannopoulos, Venizelos] MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge, England; [Thomas, David C.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England	Francis Crick Institute; University of Manchester; Francis Crick Institute; Francis Crick Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Francis Crick Institute; Imperial College London; MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sousa, CRE (corresponding author), Francis Crick Inst, Immunobiol Lab, London, England.	caetano@crick.ac.uk	; Henry, Conor/L-8935-2017; Alloatti, Andres/P-3021-2016	Buck, Michael/0000-0002-9611-1199; Henry, Conor/0000-0001-7504-5121; Thomas, David/0000-0002-9738-2329; Alloatti, Andres/0000-0003-0555-0653; Zelenay, Santiago/0000-0002-6865-3978; Canton, Johnathan/0000-0001-8869-8404; Rogers, Neil/0000-0001-8977-7585; Childs, Eleanor/0000-0002-1167-8672; Papayannopoulos, Venizelos/0000-0002-3741-8190; Ellison, Cara/0000-0003-3483-6896	Cancer Research UK [FC001136]; UK Medical Research Council [FC001136]; Wellcome Trust [FC001136, WT104752MA]; ERC Advanced Investigator grant [AdG 268670]; Wellcome Investigator Award [WT106973MA]; FEBS Long-Term Fellowship; European Union; EMBO LTF [ALTF 1096-2018]; MRC [U105170648]; Francis Crick Institute; MRC [MC_U105170648] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC Advanced Investigator grant; Wellcome Investigator Award; FEBS Long-Term Fellowship; European Union(European Commission); EMBO LTF(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Immunobiology Laboratory for helpful discussions and suggestions. We thank the Crick BRF and Flow Cytometry STPs for their support throughout this project. We are grateful to P. Faull and B. Snijders for helpful comments. This work was supported by the Francis Crick Institute, which receives core funding from Cancer Research UK (FC001136), the UK Medical Research Council (FC001136) and the Wellcome Trust (FC001136), by an ERC Advanced Investigator grant (AdG 268670), by a Wellcome Investigator Award (WT106973MA) and by a prize from the Louis-Jeantet Foundation. C.M.H. was supported by a FEBS Long-Term Fellowship and a Marie Skodowska-Curie Individual Fellowship under Horizon 2020 from the European Union. M.D.B. was supported by an EMBO LTF (ALTF 1096-2018) and a Marie Skodowska-Curie Individual Fellowship under Horizon 2020 from the European Union. F.R. is supported by the MRC (U105170648) and the Wellcome Trust (WT104752MA).	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Alloatti A, 2017, J EXP MED, V214, P2231, DOI 10.1084/jem.20170229; Alloatti A, 2015, IMMUNITY, V43, P1087, DOI 10.1016/j.immuni.2015.11.006; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; Bottcher JP, 2015, J IMMUNOL, V195, P5066, DOI 10.4049/jimmunol.1500889; Bogovic JA, 2016, I S BIOMED IMAGING, P1123, DOI 10.1109/ISBI.2016.7493463; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Colbert JD, 2020, CURR OPIN IMMUNOL, V64, P1, DOI 10.1016/j.coi.2019.12.005; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI [10.1017/S1431927610055170, DOI 10.1017/S1431927610055170]; Dersh D, 2019, METHODS MOL BIOL, V1988, P109, DOI 10.1007/978-1-4939-9450-2_9; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dingjan I, 2017, EUR J CELL BIOL, V96, P705, DOI 10.1016/j.ejcb.2017.06.007; Dingjan I, 2016, SCI REP-UK, V6, DOI 10.1038/srep22064; Ellison CJ, 2020, CURR BIOL, V30, P2974, DOI 10.1016/j.cub.2020.05.083; Germain RN, 1996, IMMUNOL REV, V151, P5, DOI 10.1111/j.1600-065X.1996.tb00701.x; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Gros M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00041; Grotzke JE, 2017, P NATL ACAD SCI USA, V114, pE5910, DOI 10.1073/pnas.1705242114; Grotzke JE, 2015, MOL IMMUNOL, V68, P112, DOI 10.1016/j.molimm.2015.05.002; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Han, 2016, C TYPE LECTIN RECEPT, P65, DOI [10.1007/978-4-431-56015-9_5., DOI 10.1007/978-4-431-56015-9_5]; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Hanc P, 2016, EMBO J, V35, P2484, DOI 10.15252/embj.201694695; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kozik P, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107905; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Marraco SAF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00331; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Ou PJ, 2019, J EXP MED, V216, P2091, DOI 10.1084/jem.20190041; Palmowski MJ, 2006, J IMMUNOL, V177, P983, DOI 10.4049/jimmunol.177.2.983; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schulz O, 2018, CELL REP, V24, P419, DOI 10.1016/j.celrep.2018.06.038; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smed-Sorensen A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002572; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Weimershaus M, 2012, J IMMUNOL, V188, P1840, DOI 10.4049/jimmunol.1101504; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	59	41	41	2	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					140	U56		10.1038/s41590-020-00824-x	http://dx.doi.org/10.1038/s41590-020-00824-x		DEC 2020	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33349708	Green Accepted			2022-12-18	WOS:000600822500001
J	Harb, H; Stephen-Victor, E; Crestani, E; Benamar, M; Massoud, A; Cui, Y; Charbonnier, LM; Arbag, S; Baris, S; Cunnigham, A; Leyva-Castillo, JM; Geha, RS; Mousavi, AJ; Guennewig, B; Schmitz-Abe, K; Sioutas, C; Phipatanakul, W; Chatila, TA				Harb, Hani; Stephen-Victor, Emmanuel; Crestani, Elena; Benamar, Mehdi; Massoud, Amir; Cui, Ye; Charbonnier, Louis-Marie; Arbag, Sena; Baris, Safa; Cunnigham, Amparito; Leyva-Castillo, Juan Manuel; Geha, Raif S.; Mousavi, Amirhosein J.; Guennewig, Boris; Schmitz-Abe, Klaus; Sioutas, Constantinos; Phipatanakul, Wanda; Chatila, Talal A.			A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; AIRWAY INFLAMMATION; CIS-ELEMENT; PATHWAY; MICE; SUSCEPTIBILITY; HOMEOSTASIS; CONVERSION; TOLERANCE; GENES	Elucidating the mechanisms that sustain asthmatic inflammation is critical for precision therapies. We found that interleukin-6- and STAT3 transcription factor-dependent upregulation of Notch4 receptor on lung tissue regulatory T (T-reg) cells is necessary for allergens and particulate matter pollutants to promote airway inflammation. Notch4 subverted T(reg)cells into the type 2 and type 17 helper (T(H)2 and T(H)17) effector T cells by Wnt and Hippo pathway-dependent mechanisms. Wnt activation induced growth and differentiation factor 15 expression in T(reg)cells, which activated group 2 innate lymphoid cells to provide a feed-forward mechanism for aggravated inflammation. Notch4, Wnt and Hippo were upregulated in circulating T(reg)cells of individuals with asthma as a function of disease severity, in association with reduced T(reg)cell-mediated suppression. Our studies thus identify Notch4-mediated immune tolerance subversion as a fundamental mechanism that licenses tissue inflammation in asthma. Dysregulation of lung T(reg)cell function contributes to asthma development. Chatila and colleagues find that allergens upregulate Notch4-Hippo-Wnt signaling in T(reg)cells, triggering their release of GDF15 growth factor, which drives type 2 innate lymphoid cell activity and asthma.	[Harb, Hani; Stephen-Victor, Emmanuel; Crestani, Elena; Benamar, Mehdi; Massoud, Amir; Cui, Ye; Charbonnier, Louis-Marie; Arbag, Sena; Cunnigham, Amparito; Leyva-Castillo, Juan Manuel; Geha, Raif S.; Schmitz-Abe, Klaus; Phipatanakul, Wanda; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Harb, Hani; Stephen-Victor, Emmanuel; Crestani, Elena; Benamar, Mehdi; Massoud, Amir; Cui, Ye; Charbonnier, Louis-Marie; Leyva-Castillo, Juan Manuel; Geha, Raif S.; Phipatanakul, Wanda; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Baris, Safa] Marmara Univ, Fac Med, Div Pediat Allergy Immunol, Istanbul, Turkey; [Mousavi, Amirhosein J.; Sioutas, Constantinos] Univ Southern Calif, Dept Civil & Environm Engn, Los Angeles, CA USA; [Guennewig, Boris] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Brain & Mind Ctr, Sydney, NSW, Australia; [Schmitz-Abe, Klaus] Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Marmara University; University of Southern California; University of Sydney; Harvard University; Boston Children's Hospital; Harvard Medical School	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Harb, Hani/J-6517-2019; Stephen Victor, Emmanuel/HDN-0252-2022; Massoud, Amir Hossein/AAO-2940-2021; Arbag, Sena Nur/AAC-9204-2019; Harb, Hani/HGB-7333-2022	Harb, Hani/0000-0001-8218-2538; Stephen Victor, Emmanuel/0000-0001-5049-7017; Arbag, Sena Nur/0000-0002-4805-4249; Harb, Hani/0000-0001-8218-2538; Mousavi, Amirhosein/0000-0002-9437-004X; Charbonnier, Louis-Marie/0000-0002-4594-7893; Benamar, Mehdi/0000-0003-1532-8642; Guennewig, Boris/0000-0002-6357-818X; Schmitz-Abe, Klaus E./0000-0002-7242-8861; Baris, Safa/0000-0002-4730-9422; Sioutas, Constantinos/0000-0001-5146-0857	National Institutes of Health [R01 AI115699, R01 AI065617, U01AI110397, R01 HL137192]; National Health and Medical Research Council [APP1163249]; German Research Society grant [HA 8465/1-1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); German Research Society grant	This work was supported by National Institutes of Health grants (nos. R01 AI115699 and R01 AI065617 to T.A.C., U01AI110397 and R01 HL137192 to W.P.) a National Health and Medical Research Council grant (no. APP1163249 to B.G.) and a German Research Society grant (no. HA 8465/1-1 to H.H.).	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Binder AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146518; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Charbonnier LM, 2015, NAT IMMUNOL, V16, P1162, DOI 10.1038/ni.3288; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Esty B, 2019, J ALLER CL IMM-PRACT, V7, P1639, DOI 10.1016/j.jaip.2019.02.043; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Gruzieva O, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4522; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Magee CN, 2019, CIRCULATION, V140, P846, DOI 10.1161/CIRCULATIONAHA.119.040563; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Messerschmidt D, 2016, DEVELOPMENT, V143, P1993, DOI 10.1242/dev.133439; Misra JR, 2018, ANNU REV GENET, V52, P65, DOI 10.1146/annurev-genet-120417-031621; Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630; Povoleri GAM, 2018, NAT IMMUNOL, V19, P1403, DOI 10.1038/s41590-018-0230-z; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Savenije OE, 2014, J ALLERGY CLIN IMMUN, V134, P170, DOI 10.1016/j.jaci.2013.12.1080; Shi H, 2018, IMMUNITY, V49, P899, DOI 10.1016/j.immuni.2018.10.010; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Tachdjian R, 2009, J EXP MED, V206, P2191, DOI 10.1084/jem.20091480; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; van Loosdregt J, 2018, J IMMUNOL, V201, P2193, DOI 10.4049/jimmunol.1800633; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Xia MC, 2018, J ALLERGY CLIN IMMUN, V142, P1243, DOI 10.1016/j.jaci.2018.03.009; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	47	41	41	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1359	+		10.1038/s41590-020-0777-3	http://dx.doi.org/10.1038/s41590-020-0777-3		SEP 2020	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32929274	Green Accepted			2022-12-18	WOS:000569299600004
J	Gudipati, V; Rydzek, J; Doel-Perez, I; Goncalves, VD; Scharf, L; Konigsberger, S; Lobner, E; Kunert, R; Einsele, H; Stockinger, H; Hudecek, M; Huppa, JB				Gudipati, Venugopal; Rydzek, Julian; Doel-Perez, Iago; Goncalves, Vasco Dos Reis; Scharf, Lydia; Koenigsberger, Sebastian; Lobner, Elisabeth; Kunert, Renate; Einsele, Hermann; Stockinger, Hannes; Hudecek, Michael; Huppa, Johannes B.			Inefficient CAR-proximal signaling blunts antigen sensitivity	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; B-CELL; MEMBRANE MICRODOMAINS; CHIMERIC RECEPTORS; DOMAIN; AFFINITY; TCR; CYTOTOXICITY; ACTIVATION; TRACKING	Huppa and colleagues highlight signaling deficiencies in chimeric antigen receptor (CAR)-modified T cells that limit the efficacy of CAR T cell therapies to target tumors with diminished antigen expression. Rational design of chimeric antigen receptors (CARs) with optimized anticancer performance mandates detailed knowledge of how CARs engage tumor antigens and how antigen engagement triggers activation. We analyzed CAR-mediated antigen recognition via quantitative, single-molecule, live-cell imaging and found the sensitivity of CAR T cells toward antigen approximately 1,000-times reduced as compared to T cell antigen-receptor-mediated recognition of nominal peptide-major histocompatibility complexes. While CARs outperformed T cell antigen receptors with regard to antigen binding within the immunological synapse, proximal signaling was significantly attenuated due to inefficient recruitment of the tyrosine-protein kinase ZAP-70 to ligated CARs and its reduced concomitant activation and subsequent release. Our study exposes signaling deficiencies of state-of-the-art CAR designs, which presently limit the efficacy of CAR T cell therapies to target tumors with diminished antigen expression.	[Gudipati, Venugopal; Doel-Perez, Iago; Scharf, Lydia; Koenigsberger, Sebastian; Stockinger, Hannes; Huppa, Johannes B.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria; [Rydzek, Julian; Goncalves, Vasco Dos Reis; Einsele, Hermann; Hudecek, Michael] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany; [Scharf, Lydia] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Koenigsberger, Sebastian] Roche Diagnost GmbH, Penzberg, Germany; [Lobner, Elisabeth; Kunert, Renate] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria	Medical University of Vienna; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Karolinska Institutet; Karolinska University Hospital; Roche Holding; University of Natural Resources & Life Sciences, Vienna	Huppa, JB (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria.; Hudecek, M (corresponding author), Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany.	Hudecek_M@ukw.de; johannes.huppa@meduniwien.ac.at	Kunert, Renate E/B-9185-2018; Huppa, Johannes Bernhard/AAY-9471-2021; Stockinger, Hannes/E-5173-2011	Kunert, Renate E/0000-0002-3397-3621; Huppa, Johannes Bernhard/0000-0003-2634-8198; Stockinger, Hannes/0000-0001-6404-4430; Goncalves, Vasco/0000-0001-9982-3346; Doel-Perez, Iago/0000-0003-0443-9718; Gudipati, Venugopal/0000-0001-6647-0708; Laurent, Elisabeth/0000-0002-5234-5524	Austrian Science Fund [W1224, P 25775-B2]; Vienna Science and Technology Fund [LS14-031]; Platform for Advanced Cellular Therapies; Innovative Training Network EN-ACTI2NG (European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry) - European Commission; German Cancer Aid (Max Eder Program) [70110313]; German Research Foundation [324392634, TRR 221]	Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; Platform for Advanced Cellular Therapies; Innovative Training Network EN-ACTI2NG (European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry) - European Commission; German Cancer Aid (Max Eder Program); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Austrian Science Fund through project no. P 25775-B2 (V.G., S. K., L.S. and J.H.), the Vienna Science and Technology Fund (no. LS14-031 to V.G. and J.H.), the Platform for Advanced Cellular Therapies (J.H., R.K.), the Doctoral Program Biomolecular Technology of Proteins supported by the Austrian Science Fund (no. W1224 to E.L. and R.K.) and the Innovative Training Network EN-ACTI2NG (European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry) supported by the European Commission. M.H. is a member of the Young Scholar Program (Junges Kolleg) and an extraordinary member of the Bavarian Academy of Sciences. This work was supported by a grant from German Cancer Aid (Max Eder Program, grant no. 70110313 to M.H.) and the German Research Foundation (project no. 324392634, TRR 221 to M.H.). We thank V. Muhlgrabner (Medical University of Vienna) for help with fluorescence-activated cell sorting; R. Platzer (Medical University of Vienna) for help with single-molecule tracking; O. Dushek (Oxford University) for sending us the T1-CAR constructs; and U. Jager and N. Worel (Medical University of Vienna), M. Lehner (St. Anna Children's Cancer Research) and A. Rehm (Max Delbruck Center for Molecular Medicine) for constructive criticism.	AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Axmann M, 2015, JOVE-J VIS EXP, DOI 10.3791/53158; Baskar S, 2012, MABS-AUSTIN, V4, P349, DOI 10.4161/mabs.19870; Brown CE, 2005, J IMMUNOL METHODS, V297, P39, DOI 10.1016/j.jim.2004.11.021; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chmielewski M, 2004, J IMMUNOL, V173, P7647, DOI 10.4049/jimmunol.173.12.7647; Chmielewski M, 2011, GENE THER, V18, P62, DOI 10.1038/gt.2010.127; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Evans AG, 2015, BRIT J HAEMATOL, V171, P205, DOI 10.1111/bjh.13562; Finney HM, 1998, J IMMUNOL, V161, P2791; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Klesmith JR, 2019, BIOCHEMISTRY-US, V58, P4869, DOI 10.1021/acs.biochem.9b00808; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.23; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Orlando EJ, 2018, NAT MED, V24, P1504, DOI 10.1038/s41591-018-0146-z; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Pores-Fernando AT, 2009, IMMUNOL REV, V231, P160, DOI 10.1111/j.1600-065X.2009.00809.x; POTTER TA, 1987, J EXP MED, V166, P956, DOI 10.1084/jem.166.4.956; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Ruella M, 2016, COMPUT STRUCT BIOTEC, V14, P357, DOI 10.1016/j.csbj.2016.09.003; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Srivastava S, 2019, CANCER CELL, V35, P489, DOI 10.1016/j.ccell.2019.02.003; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Watanabe K, 2015, J IMMUNOL, V194, P911, DOI 10.4049/jimmunol.1402346; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	55	41	41	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					848	+		10.1038/s41590-020-0719-0	http://dx.doi.org/10.1038/s41590-020-0719-0		JUL 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32632291				2022-12-18	WOS:000547687000002
J	Jain, A; Irizarry-Caro, RA; McDaniel, MM; Chawla, AS; Carroll, KR; Overcast, GR; Philip, NH; Oberst, A; Chervonsky, AV; Katz, JD; Pasare, C				Jain, Aakanksha; Irizarry-Caro, Ricardo A.; McDaniel, Margaret M.; Chawla, Amanpreet Singh; Carroll, Kaitlin R.; Overcast, Garrett R.; Philip, Naomi H.; Oberst, Andrew; Chervonsky, Alexander V.; Katz, Jonathan D.; Pasare, Chandrashekhar			T cells instruct myeloid cells to produce inflammasome-independent IL-1 beta and cause autoimmunity	NATURE IMMUNOLOGY			English	Article							MULTIPLE-SCLEROSIS; ACTIVATION; CASPASE-8; PROTEIN; TNF; FAS; ENCEPHALOMYELITIS; LYMPHOCYTES; MECHANISMS; EXPRESSION	The cytokine interleukin (IL)-1 beta is a key mediator of antimicrobial immunity as well as autoimmune inflammation. Production of IL-1 beta requires transcription by innate immune receptor signaling and maturational cleavage by inflammasomes. Whether this mechanism applies to IL-1 beta production seen in T cell-driven autoimmune diseases remains unclear. Here, we describe an inflammasome-independent pathway of IL-1 beta production that was triggered upon cognate interactions between effector CD4(+) T cells and mononuclear phagocytes (MPs). The cytokine TNF produced by activated CD4(+) T cells engaged its receptor TNFR on MPs, leading to pro-IL-1 beta synthesis. Membrane-bound FasL, expressed by CD4(+) T cells, activated death receptor Fas signaling in MPs, resulting in caspase-8-dependent pro-IL-1 beta cleavage. The T cell-instructed IL-1 beta resulted in systemic inflammation, whereas absence of TNFR or Fas signaling protected mice from CD4(+) Tcell-driven autoimmunity. The TNFR-Fas-caspase-8-dependent pathway provides a mechanistic explanation for IL-1 beta production and its consequences in CD4(+) T cell-driven autoimmune pathology.	[Jain, Aakanksha; Irizarry-Caro, Ricardo A.; McDaniel, Margaret M.; Overcast, Garrett R.] Univ Texas Southwestern Med Ctr Dallas, Immunol Grad Program, Dallas, TX 75390 USA; [Jain, Aakanksha; Irizarry-Caro, Ricardo A.; McDaniel, Margaret M.; Chawla, Amanpreet Singh; Carroll, Kaitlin R.; Overcast, Garrett R.; Katz, Jonathan D.; Pasare, Chandrashekhar] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Jain, Aakanksha; Irizarry-Caro, Ricardo A.; McDaniel, Margaret M.; Chawla, Amanpreet Singh; Overcast, Garrett R.; Pasare, Chandrashekhar] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45229 USA; [Philip, Naomi H.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Oberst, Andrew] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Katz, Jonathan D.; Pasare, Chandrashekhar] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Jain, Aakanksha] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Yale University; University of Washington; University of Washington Seattle; University of Chicago; University System of Ohio; University of Cincinnati; Harvard University; Boston Children's Hospital	Pasare, C (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Pasare, C (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45229 USA.; Pasare, C (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	chandrashekhar.pasare@cchmc.org	Chawla, Amanpreet Singh/AAA-3261-2019	Chawla, Amanpreet Singh/0000-0001-5265-3431; Carroll, Kaitlin/0000-0003-2692-1257; Katz, Jonathan/0000-0002-9864-2268; McDaniel, Margaret/0000-0002-3986-459X	National Institutes of Health [AI113125, AI123176]; National Science Foundation [2017220107]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	We thank all the members of the Pasare laboratory and R. Bagirzadeh for helpful discussions. We thank A. Ma for sharing WT and D117A Il1b constructs. We thank M. Jordan for sharing Zbtb46-GFP reporter mice. This work was supported by grants from the National Institutes of Health (AI113125 and AI123176) to C.P. M.M.M. was supported by a National Science Foundation Graduate Research Fellowship under grant 2017220107.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; Bachmann MF, 2001, J EXP MED, V193, pF47, DOI 10.1084/jem.193.12.F47; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Conos SA, 2016, CELL DEATH DIFFER, V23, P1827, DOI 10.1038/cdd.2016.69; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Erlich Z, 2019, NAT IMMUNOL, V20, P397, DOI 10.1038/s41590-019-0313-5; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Furlan R, 1999, J IMMUNOL, V163, P2403; GEPPERT TD, 1994, MOL MED, V1, P93; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Itoh N, 1997, J EXP MED, V186, P613, DOI 10.1084/jem.186.4.613; Jain A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05489-7; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Kruglov AA, 2011, J IMMUNOL, V187, P5660, DOI 10.4049/jimmunol.1100663; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Li CR, 2014, J IMMUNOL, V192, P1425, DOI 10.4049/jimmunol.1301742; Lin CC, 2017, J IMMUNOL, V198, P4553, DOI 10.4049/jimmunol.1700263; Lopalco G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/194864; Mande P, 2018, J CLIN INVEST, V128, P2966, DOI 10.1172/JCI98219; MANNIE MD, 1987, J IMMUNOL, V138, P4229; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Philip NH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005910; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Tsoi LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15382; VanderBorght A, 2001, SEMIN ARTHRITIS RHEU, V31, P160, DOI 10.1053/sarh.2001.27736; Varanasi V, 2012, DIABETES, V61, P2862, DOI 10.2337/db11-1784; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	49	41	42	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					65	+		10.1038/s41590-019-0559-y	http://dx.doi.org/10.1038/s41590-019-0559-y			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31848486	Green Accepted			2022-12-18	WOS:000515136500014
J	Inoue, M; Okamoto, K; Terashima, A; Nitta, T; Muro, R; Negishi-Koga, T; Kitamura, T; Nakashima, T; Takayanagi, H				Inoue, Maia; Okamoto, Kazuo; Terashima, Asuka; Nitta, Takeshi; Muro, Ryunosuke; Negishi-Koga, Takako; Kitamura, Toshio; Nakashima, Tomoki; Takayanagi, Hiroshi			Arginine methylation controls the strength of gamma c-family cytokine signaling in T cell maintenance	NATURE IMMUNOLOGY			English	Article							PRE-MESSENGER-RNA; NKT CELLS; SM PROTEINS; MOUSE DEVELOPMENT; GENE-EXPRESSION; PRMT5; LINEAGE; TRANSCRIPTION; HOMEOSTASIS; ACTIVATION	The methylation of arginine residues in proteins is a post-translational modification that contributes to a wide range of biological processes. Many cytokines involved in T cell development and activation utilize the common cytokine receptor gamma-chain (gamma c) and the kinase JAK3 for signal transduction, but the regulatory mechanism that underlies the expression of these factors remains unclear. Here we found that the arginine methyltransferase PRMT5 was essential for the maintenance of invariant natural killer T cells ( iNKT cells), CD4(+) T cells and CD8(+) T cells. T cell-specific deletion of Prmt5 led to a marked reduction in signaling via gamma c-family cytokines and a substantial loss of thymic iNKT cells, as well as a decreased number of peripheral CD4(+) T cells and CD8(+) T cells. PRMT5 induced the symmetric dimethylation of Sm proteins that promoted the splicing of pre-mRNA encoding gamma c and JAK3, and this critically contributed to the expression of gamma c and JAK3. Thus, arginine methylation regulates strength of signaling via gamma c-family cytokines by facilitating the expression of signal-transducing components.	[Inoue, Maia; Nitta, Takeshi; Muro, Ryunosuke; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo, Japan; [Inoue, Maia; Okamoto, Kazuo; Terashima, Asuka; Nitta, Takeshi; Muro, Ryunosuke; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo, Japan; [Okamoto, Kazuo; Terashima, Asuka] Univ Tokyo, Grad Sch Med, Dept Osteoimmunol, Tokyo, Japan; [Negishi-Koga, Takako] Showa Univ, Sch Dent, Dept Pharmacol, Shinagawa Ku, Tokyo, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Stem Cell Signaling, Minato Ku, Tokyo, Japan; [Nakashima, Tomoki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki] JST, Precursory Res Embryon Sci & Technol PRESTO, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Showa University; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo, Japan.; Takayanagi, H (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo, Japan.	takayana@m.u-tokyo.ac.jp	Kitamura, Toshio/AAA-2071-2021		Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS) [15J05761]; JSPS Research Fellowship for Young scientists [15J05761];  [15H05703];  [16H05202];  [18H02919];  [15H05653];  [16K19102]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Research Fellowship for Young scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; ; 	We thank S. Hori (University of Tokyo) for pMSCV-Foxp3-IG; H. Kawamoto (Kyoto University) and T. Ikawa (Tokyo University of Science) for Tst4-DLL4 stromal cells; and C. Tsuda, T. Ono, K. Hamada, K. Kaneki, T. Suda, M. Tsukasaki, A. Suematsu, S. Sawa, N. Komatsu and Y. Nakayama for discussions and technical assistance. This work was supported in part by a grant for the ERATO Takayanagi Osteonetwork Project from the Japan Science and Technology Agency, and Grants-in-Aid for Specially Promoted Research (15H05703), Scientific Research (B) (16H05202 and 18H02919), Young Scientists (A) (15H05653), Young Scientists (B) (16K19102) and JSPS Research Fellow (15J05761) from the Japan Society for the Promotion of Science (JSPS). M.I. was supported by a JSPS Research Fellowship for Young scientists (15J05761).	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Blanc RS, 2016, CELL REP, V14, P1528, DOI 10.1016/j.celrep.2016.01.022; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Blanchet F, 2006, CURR OPIN IMMUNOL, V18, P321, DOI 10.1016/j.coi.2006.03.001; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Davari K, 2017, CELL REP, V19, P643, DOI 10.1016/j.celrep.2017.03.069; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Geoghegan V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7758; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; Hong CW, 2014, IMMUNITY, V40, P910, DOI 10.1016/j.immuni.2014.04.020; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim JD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500615; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Lantz O, 1997, J EXP MED, V185, P1395, DOI 10.1084/jem.185.8.1395; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Tani-ichi S, 2013, P NATL ACAD SCI USA, V110, P612, DOI 10.1073/pnas.1219242110; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Webb LM, 2017, J IMMUNOL, V198, P1439, DOI 10.4049/jimmunol.1601702; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140	49	41	43	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1265	+		10.1038/s41590-018-0222-z	http://dx.doi.org/10.1038/s41590-018-0222-z			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323341				2022-12-18	WOS:000447632200021
J	Zeng, ZT; Surewaard, BGJ; Wong, CHY; Guettler, C; Petri, B; Burkhard, R; Wyss, M; Le Moual, H; Devinney, R; Thompson, GC; Blackwood, J; Joffe, AR; McCoy, KD; Jenne, CN; Kubes, P				Zeng, Zhutian; Surewaard, Bas G. J.; Wong, Connie H. Y.; Guettler, Christopher; Petri, Bjorn; Burkhard, Regula; Wyss, Madeleine; Le Moual, Herve; Devinney, Rebekah; Thompson, Graham C.; Blackwood, Jaime; Joffe, Ari R.; McCoy, Kathy D.; Jenne, Craig N.; Kubes, Paul			Sex-hormone-driven innate antibodies protect females and infants against EPEC infection	NATURE IMMUNOLOGY			English	Article							B-CELL RESPONSES; RECEPTOR; IMMUNITY; PHAGOCYTOSIS; ANTIGENS; CRIG	Females have an overall advantage over males in resisting Gram-negative bacteremias, thus hinting at sexual dimorphism of immunity during infections. Here, through intravital microscopy, we observed a sex-biased difference in the capture of blood-borne bacteria by liver macrophages, a process that is critical for the clearance of systemic infections. Complement opsonization was indispensable for the capture of enteropathogenic Escherichia coli (EPEC) in male mice; however, a faster complement component 3-independent process involving abundant preexisting antibodies to EPEC was detected in female mice. These antibodies were elicited predominantly in female mice at puberty in response to estrogen regardless of microbiota-colonization conditions. Estrogen-driven antibodies were maternally transferrable to offspring and conferred protection during infancy. These antibodies were conserved in humans and recognized specialized oligosaccharides integrated into the bacterial lipopoly-saccharide and capsule. Thus, an estrogen-driven, innate antibody-mediated immunological strategy conferred protection to females and their offspring.	[Zeng, Zhutian; Surewaard, Bas G. J.; Wong, Connie H. Y.; Guettler, Christopher; Burkhard, Regula; Wyss, Madeleine; McCoy, Kathy D.; Jenne, Craig N.; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada; [Zeng, Zhutian; Surewaard, Bas G. J.; Wong, Connie H. Y.; Guettler, Christopher; McCoy, Kathy D.; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Calgary, AB, Canada; [Surewaard, Bas G. J.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Petri, Bjorn; Burkhard, Regula; Wyss, Madeleine; Devinney, Rebekah; McCoy, Kathy D.; Jenne, Craig N.; Kubes, Paul] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Petri, Bjorn] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Mouse Phen Resource Lab, Calgary, AB, Canada; [Le Moual, Herve] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Fac Dent, Montreal, PQ, Canada; [Thompson, Graham C.; Blackwood, Jaime] Univ Calgary, Dept Pediat & Emergency Med, Calgary, AB, Canada; [Joffe, Ari R.] Univ Alberta, Div Pediat Crit Care Med, Dept Pediat, Edmonton, AB, Canada	University of Calgary; University of Calgary; Utrecht University; Utrecht University Medical Center; University of Calgary; University of Calgary; McGill University; University of Calgary; University of Alberta	Jenne, CN; Kubes, P (corresponding author), Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.; Kubes, P (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Calgary, AB, Canada.; Jenne, CN; Kubes, P (corresponding author), Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	cnjenne@ucalgary.ca; pkubes@ucalgary.ca	McCoy, Kathy/ABD-5814-2021; Surewaard, Bas/P-9530-2017; Thompson, Graham/Y-4180-2019; Jenne, Craig/HCH-3413-2022	Surewaard, Bas/0000-0002-0519-1227; Thompson, Graham/0000-0002-6781-4186; Burkhard, Regula/0000-0002-5117-0937; Guttler, Christopher/0000-0003-2448-3986; Wong, Connie/0000-0002-9020-1847	Snyder Mouse Phenomics Resources Laboratory - Snyder Institute for Chronic Diseases at the University of Calgary; Alberta Innovates Health Solutions; Canadian Institutes of Health Research; Canada Research Chairs Program; Live Cell Imaging Facility - Snyder Institute for Chronic Diseases at the University of Calgary	Snyder Mouse Phenomics Resources Laboratory - Snyder Institute for Chronic Diseases at the University of Calgary; Alberta Innovates Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Live Cell Imaging Facility - Snyder Institute for Chronic Diseases at the University of Calgary	We thank T. Nussbaumer, W.-Y. Lee and K. Poon for technical assistance; J. Deniset, S. Fassl and C. Deppermann for critical reading and advice; J. Kearney and P. Patel for providing valuable information and help; T. Mak (University of Toronto, Toronto, Canada) for providing Fcmr<SUP>-/-</SUP> mice; R.M. Medzhitov (Yale University) for providing Lyz2-Cre x Gata6-floxed mice; B. Yipp (University of Calgary) for providing CD19<SUP>-/-</SUP> mice; Z. Tian and Q. Zhang (University of Science and Technology of China, Hefei, China) for providing Tlr2<SUP>-/-</SUP>; Tlr4<SUP>-/-</SUP>; Tlr9<SUP>-/-</SUP> serum samples; K. Poon (University of Calgary) for providing S. Typhimurium; S. Lewenza (University of Calgary) for providing P. aeruginosa; and J. Wong, the Critical Care Epidemiologic and Biologic Tissue Resource (CCEPTR tissue bank), Alberta Sepsis Network (ASN) and Snyder Biobanking Resource Laboratory for assistance in obtaining human serum. This work was supported by the Snyder Mouse Phenomics Resources Laboratory and Live Cell Imaging Facility, both of which were funded by the Snyder Institute for Chronic Diseases at the University of Calgary. This work was funded by grants from Alberta Innovates Health Solutions (Z.Z., B.G.J.S. and P.K.), the Canadian Institutes of Health Research (P.K.) and the Canada Research Chairs Program (C.N.J. and P.K.).	Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bryson S, 2016, J IMMUNOL, V196, P4723, DOI 10.4049/jimmunol.1402890; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Georgountzou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00957; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1026-2; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; Ng LG, 2006, EUR J IMMUNOL, V36, P1837, DOI 10.1002/eji.200635956; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; PERLMANN P, 1967, P SOC EXP BIOL MED, V125, P975; Quan Shu, 2013, Methods Mol Biol, V966, P359, DOI 10.1007/978-1-62703-245-2_22; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Thomassin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082475; Thomson CA, 2011, J IMMUNOL, V186, P2291, DOI 10.4049/jimmunol.0904092; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zeng ZT, 2016, CELL HOST MICROBE, V20, P99, DOI 10.1016/j.chom.2016.06.002	41	41	43	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1100	+		10.1038/s41590-018-0211-2	http://dx.doi.org/10.1038/s41590-018-0211-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30250184				2022-12-18	WOS:000445968600016
J	Santos, AM; Ponjavic, A; Fritzsche, M; Fernandes, RA; de la Serna, JB; Wilcock, MJ; Schneider, F; Urbancic, I; McColl, J; Anzilotti, C; Ganzinger, KA; Assmann, M; Depoil, D; Cornal, RJ; Dustin, ML; Klenerman, D; Davis, SJ; Eggeling, C; Lee, SF				Santos, Ana Mafalda; Ponjavic, Aleks; Fritzsche, Marco; Fernandes, Ricardo A.; de la Serna, Jorge Bernardino; Wilcock, Martin J.; Schneider, Falk; Urbancic, Iztok; McColl, James; Anzilotti, Consuelo; Ganzinger, Kristina A.; Assmann, Meike; Depoil, David; Cornal, Richard J.; Dustin, Michael L.; Klenerman, David; Davis, Simon J.; Eggeling, Christian; Lee, Steven F.			Capturing resting T cells: the perils of PLL	NATURE IMMUNOLOGY			English	Letter							RECEPTOR		[Santos, Ana Mafalda; Fritzsche, Marco; Fernandes, Ricardo A.; de la Serna, Jorge Bernardino; Wilcock, Martin J.; Schneider, Falk; Urbancic, Iztok; Anzilotti, Consuelo; Assmann, Meike; Davis, Simon J.; Eggeling, Christian] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Santos, Ana Mafalda; Fritzsche, Marco; Fernandes, Ricardo A.; de la Serna, Jorge Bernardino; Wilcock, Martin J.; Schneider, Falk; Urbancic, Iztok; Anzilotti, Consuelo; Assmann, Meike; Cornal, Richard J.; Davis, Simon J.; Eggeling, Christian] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford, England; [Ponjavic, Aleks; McColl, James; Ganzinger, Kristina A.; Klenerman, David; Lee, Steven F.] Univ Cambridge, Dept Chem, Cambridge, England; [Fritzsche, Marco; Depoil, David] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Cornal, Richard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford; University of Oxford; University of Cambridge; University of Oxford; University of Oxford	Eggeling, C (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.; Eggeling, C (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford, England.; Lee, SF (corresponding author), Univ Cambridge, Dept Chem, Cambridge, England.	christian.eggeling@rdm.ox.ac.uk; sl591@cam.ac.uk	Ganzinger, Kristina/AAD-5584-2020; de la Serna, Jorge Bernardino/O-6355-2019; Dustin, Michael/AAM-4611-2020; Fernandes, Ricardo/AAB-8165-2019; Urbančič, Iztok/AAU-3027-2020	Ganzinger, Kristina/0000-0001-9106-9406; de la Serna, Jorge Bernardino/0000-0002-1396-3338; Fernandes, Ricardo/0000-0001-5343-3334; Urbančič, Iztok/0000-0003-3603-6585; Ponjavic, Aleks/0000-0002-7561-1127; Schneider, Falk/0000-0003-0502-9139; Klenerman, David/0000-0001-7116-6954; Davis, Simon/0000-0002-2280-1170; Santos, Ana Mafalda/0000-0002-0015-5286; Fritzsche, Marco/0000-0002-8712-7471; Anzilotti, Consuelo/0000-0003-4528-0651; McColl, James/0000-0002-6692-3663; Dustin, Michael/0000-0003-4983-6389	Royal Society University [UF120277, RP150066]; EPSRC [EP/L027631/1]; Wellcome Trust [098274/Z/12/Z, WT101609MA]; PA Cephalosporin Fund; Wolfson Imaging Centre Oxford (Wolfson Foundation); Wolfson Imaging Centre Oxford (Wellcome Trust) [104924/14/Z/14]; Micron Advanced BioImaging Unit (Welcome Trust Strategic Award) [091911]; Medical Research Council [MC_UU_12010, G0902418, MC_UU_12025]; MRC/BBSRC/EPSRC award [MR/K01577X/1]; Marie Sklodowska-Curie Intra-European grant [707348]; BBSRC [BB/P026354/1] Funding Source: UKRI; MRC [MC_UU_12010/4, MR/M003051/1, MC_UU_00008/6, MC_UU_00008/4, MC_UU_12010/9, MC_UU_00008/9, MC_PC_16082, MR/K01577X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P026354/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L027631/1, 1230489] Funding Source: researchfish; Medical Research Council [MR/K01577X/1, MC_UU_00008/9, MR/M003051/1, MC_UU_00008/6, MC_UU_00008/4, MC_PC_16082, MC_UU_12010/9, MC_UU_12010/6, 2081068, MC_UU_12010/4] Funding Source: researchfish	Royal Society University(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); PA Cephalosporin Fund; Wolfson Imaging Centre Oxford (Wolfson Foundation); Wolfson Imaging Centre Oxford (Wellcome Trust); Micron Advanced BioImaging Unit (Welcome Trust Strategic Award); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/BBSRC/EPSRC award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC)Engineering & Physical Sciences Research Council (EPSRC)); Marie Sklodowska-Curie Intra-European grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Royal Society University Research Fellowship (UF120277 to S.F.L.) and Research Professorship (RP150066 to D.K.); the EPSRC (EP/L027631/1 to A.P.,); the Wellcome Trust (098274/Z/12/Z to S.J.D., and WT101609MA to R.A.F.); PA Cephalosporin Fund (C.E.); the Wolfson Imaging Centre Oxford (funded by the Wolfson Foundation and Wellcome Trust; 104924/14/Z/14); the Micron Advanced BioImaging Unit (Welcome Trust Strategic Award 091911); the Medical Research Council (MC_UU_12010/Unit Programmes G0902418 and MC_UU_12025); an MRC/BBSRC/EPSRC award (MR/K01577X/1); and a Marie Sklodowska-Curie Intra-European grant (707348 to I.U.).	Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Maity PC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005887; Pageon SV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003947; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Sood N, 2016, DRUG DELIV, V23, P758, DOI 10.3109/10717544.2014.940091	10	41	41	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					203	205		10.1038/s41590-018-0048-8	http://dx.doi.org/10.1038/s41590-018-0048-8			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29476188	Green Accepted, Green Submitted			2022-12-18	WOS:000427007500001
J	Beyaz, S; Kim, JH; Pinello, L; Xifaras, ME; Hu, Y; Huang, JL; Kerenyi, MA; Das, PP; Barnitz, RA; Herault, A; Dogum, R; Haining, WN; Yilmaz, OH; Passegue, E; Yuan, GC; Orkin, SH; Winau, F				Beyaz, Semir; Kim, Ji Hyung; Pinello, Luca; Xifaras, Michael E.; Hu, Yu; Huang, Jialiang; Kerenyi, Marc A.; Das, Partha P.; Barnitz, R. Anthony; Herault, Aurelie; Dogum, Rizkullah; Haining, W. Nicholas; Yilmaz, Omer H.; Passegue, Emmanuelle; Yuan, Guo-Cheng; Orkin, Stuart H.; Winau, Florian			The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells	NATURE IMMUNOLOGY			English	Article							LYSINE 27 DEMETHYLASES; V-ALPHA-14I NKT CELLS; INKT CELLS; SUPER-ENHANCERS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; IFN-GAMMA; CHROMATIN; JMJD3; DIFFERENTIATION	Invariant natural killer T cells (iNKT cells) are innate-like lymphocytes that protect against infection, autoimmune disease and cancer. However, little is known about the epigenetic regulation of MKT cell development. Here we found that the H3K27me3 histone demethylase UTX was an essential cell-intrinsic factor that controlled an MKT-cell lineage-specific gene-expression program and epigenetic landscape in a demethylase-activity-dependent manner. UTX-deficient iNKT cells exhibited impaired expression of iNKT cell signature genes due to a decrease in activation-associated H3K4me3 marks and an increase in repressive H3K27me3 marks within the promoters occupied by UTX. We found that JunB regulated MKT cell development and that the expression of genes that were targets of both JunB and the MKT cell master transcription factor PLZF was UTX dependent. We identified iNKT cell super-enhancers and demonstrated that UTX-mediated regulation of super-enhancer accessibility was a key mechanism for commitment to the MKT cell lineage. Our findings reveal how UTX regulates the development of iNKT cells through multiple epigenetic mechanisms.	[Beyaz, Semir; Kerenyi, Marc A.; Das, Partha P.; Barnitz, R. Anthony; Orkin, Stuart H.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Beyaz, Semir; Kerenyi, Marc A.; Das, Partha P.; Orkin, Stuart H.] Harvard Med Sch, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dept Pediat Oncol,Dana Farber Canc Inst, Boston, MA USA; [Kim, Ji Hyung; Hu, Yu; Winau, Florian] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Kim, Ji Hyung; Hu, Yu; Winau, Florian] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA; [Pinello, Luca; Huang, Jialiang; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Pinello, Luca; Huang, Jialiang; Yuan, Guo-Cheng] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Xifaras, Michael E.; Dogum, Rizkullah; Yilmaz, Omer H.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Xifaras, Michael E.; Dogum, Rizkullah; Yilmaz, Omer H.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kerenyi, Marc A.] Boehringer Ingelheim GmbH & Co KG, Dept Pharmacol & Translat Res, Vienna, Austria; [Barnitz, R. Anthony] Broad Inst MIT & Harvard, Dana Farber Canc Inst, Dept Pediat Oncol, Cambridge, MA USA; [Herault, Aurelie; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, San Francisco, CA 94143 USA; [Herault, Aurelie; Passegue, Emmanuelle] Univ Calif San Francisco, Div Hematol Oncol, Dept Med, San Francisco, CA 94143 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boehringer Ingelheim; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Orkin, SH (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA.; Orkin, SH (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dept Pediat Oncol,Dana Farber Canc Inst, Boston, MA USA.; Winau, F (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA.; Winau, F (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA.	stuart_orkin@dfci.harvard.edu; florian.winau@childrens.harvard.edu		Hu, Yu/0000-0002-9511-9383; Beyaz, Semir/0000-0003-4730-4012; Passegue, Emmanuelle/0000-0002-3516-297X; Das, Partha Pratim/0000-0003-3544-2629; Kim, JI HYUNG/0000-0001-6785-2345; Pinello, Luca/0000-0003-1109-3823	Howard Hughes Medical Institute; US National Institutes of Health [P30DK0492, RO1 AI083426]; Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology; National Research Foundation of Korea [2012R1A6A3A03040248]; National Human Genome Research Institute of the US National Institutes of Health (Career Development Award) [K99HG008399]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119099] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG008399, K99HG008399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI122291, R01AI083426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110805] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology; National Research Foundation of Korea(National Research Foundation of Korea); National Human Genome Research Institute of the US National Institutes of Health (Career Development Award); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the US National Institutes of Health Tetramer Facility for CD1d-tetramers, the Center for Cancer Computational Biology sequencing facility at the Dana-Farber Cancer Institute for Illumina HiSeq2000 sequencing, the Microarray core facility at the Dana-Farber Cancer Institute Molecular Biology Core Facilities for microarray analysis, and the Dana-Farber Cancer Institute Jimmy Fund FACS core facility for cell sorting. Supported by the Howard Hughes Medical Institute (S.H.O.), the US National Institutes of Health (P30DK0492 to S.H.O., and RO1 AI083426 to F.W.), the Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology (S.B.), the National Research Foundation of Korea (2012R1A6A3A03040248 to J.H.K.) and the National Human Genome Research Institute of the US National Institutes of Health (Career Development Award K99HG008399 to L.P.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Cook KD, 2015, IMMUNITY, V43, P703, DOI 10.1016/j.immuni.2015.09.002; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dobenecker MW, 2015, J EXP MED, V212, P297, DOI 10.1084/jem.20141499; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Engel I, 2014, CURR TOP MICROBIOL, V381, P51, DOI 10.1007/82_2014_375; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jordan-Williams KL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-16; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lawson VJ, 2009, J IMMUNOL, V183, P2575, DOI 10.4049/jimmunol.0803577; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Pinello L, 2014, P NATL ACAD SCI USA, V111, pE344, DOI 10.1073/pnas.1322570111; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Thomsen MK, 2013, J CLIN INVEST, V123, P5258, DOI 10.1172/JCI70405; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams KL, 2003, J IMMUNOL, V170, P2417, DOI 10.4049/jimmunol.170.5.2417	50	41	44	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					184	195		10.1038/ni.3644	http://dx.doi.org/10.1038/ni.3644			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27992400	Green Accepted, Green Submitted			2022-12-18	WOS:000392360900012
J	Abdul-Sater, AA; Edilova, MI; Clouthier, DL; Mbanwi, A; Kremmer, E; Watts, TH				Abdul-Sater, Ali A.; Edilova, Maria I.; Clouthier, Derek L.; Mbanwi, Achire; Kremmer, Elisabeth; Watts, Tania H.			The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR; CHAIN ASSEMBLY COMPLEX; T-CELL SURVIVAL; LINEAR UBIQUITINATION; INNATE IMMUNITY; TNF RECEPTOR-2; ARTHRITIS; ACTIVATION; LUBAC	TRAF1 is a signaling adaptor known for its role in tumor necrosis factor receptor-induced cell survival. Here we show that monocytes from healthy human subjects with a rheumatoid arthritis-associated single-nucleotide polymorphism (SNP) in the TRAF1 gene express less TRAF1 protein but greater amounts of inflammatory cytokines in response to lipopolysaccharide (LPS). The TRAF1 MATH domain binds directly to three components of the linear ubiquitination (LUBAC) complex, SHARPIN, HOIP and HOIL-1, to interfere with the recruitment and linear ubiquitination of NEMO. This results in decreased NF-KB activation and cytokine production, independently of tumor necrosis factor. Consistent with this, Traf1(-/-) mice show increased susceptibility to LPS-induced septic shock. These findings reveal an unexpected role for TRAF1 in negatively regulating Toll-like receptor signaling, providing a mechanistic explanation for the increased inflammation seen with a disease-associated TRAF1 SNP.	[Abdul-Sater, Ali A.; Edilova, Maria I.; Clouthier, Derek L.; Mbanwi, Achire; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kremmer, Elisabeth] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Mol Immunol, Munich, Germany; [Abdul-Sater, Ali A.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada	University of Toronto; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; York University - Canada	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP-74492, FDN-143250]; Sanofi Pasteur Chair in Human Immunology at the University of Toronto; CIHR; Canadian Association for HIV research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Sanofi Pasteur Chair in Human Immunology at the University of Toronto; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Association for HIV research	We thank Genentech for providing linear ubiquitin-specific antibody, B. Ghumman and J. Warzyszynska for technical assistance, L.E. Wagar for collecting and genotyping some of the PBMC samples, G Ehrhardt for providing the control-GST construct and D. Philpott, S. Girardin and M. Hayden for suggestions and comments. Supported by grants MOP-74492 and FDN-143250 from the Canadian Institutes of Health Research (CIHR) to T.H.W. T.H.W. is supported by the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. D.L.C. was supported by a doctoral award from CIHR and the Canadian Association for HIV research.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Chang M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000107; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lee SY, 2007, ADV EXP MED BIOL, V597, P25; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; McPherson AJ, 2012, J BIOL CHEM, V287, P23010, DOI 10.1074/jbc.M112.350538; Nishimoto K, 2010, ANN RHEUM DIS, V69, P368, DOI 10.1136/ard.2008.104315; Panoulas VF, 2009, ARTHRITIS RHEUM-US, V60, P39, DOI 10.1002/art.24176; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Sabbagh L, 2006, P NATL ACAD SCI USA, V103, P18703, DOI 10.1073/pnas.0602919103; Sakamoto H, 2015, ACS CHEM BIOL, V10, P675, DOI 10.1021/cb500653y; Song GG, 2014, IMMUNOL INVEST, V43, P97, DOI 10.3109/08820139.2013.837917; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	40	41	43	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					26	35		10.1038/ni.3618	http://dx.doi.org/10.1038/ni.3618			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27893701				2022-12-18	WOS:000390080000007
J	King, B; Boccalatte, F; Moran-Crusio, K; Wolf, E; Wang, JJ; Kayembe, C; Lazaris, C; Yu, XF; Aranda-Orgilles, B; Lasorella, A; Aifantis, I				King, Bryan; Boccalatte, Francesco; Moran-Crusio, Kelly; Wolf, Elmar; Wang, Jingjing; Kayembe, Clarisse; Lazaris, Charalampos; Yu, Xiaofeng; Aranda-Orgilles, Beatriz; Lasorella, Anna; Aifantis, Iannis			The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							C-MYC PROTEIN; N-MYC; PHOSPHORYLATION; DIFFERENTIATION; PROLIFERATION; ACTIVATION; EXPRESSION; GROWTH; CYCLE; ACTS	Hematopoietic stem cells (HSCs) are dormant in the bone marrow and can be activated in response to diverse stresses to replenish all blood cell types. We identified the ubiquitin ligase Huwe1 as a crucial regulator of HSC function via its post translational control of the oncoprotein N-myc (encoded by Mycn). We found Huwe1 to be essential for HSC self-renewal, quiescence and lymphoid-fate specification in mice. Through the use of a fluorescent fusion allele (Mycn(M)), we observed that N-myc expression was restricted to the most immature, multipotent stem and progenitor populations. N-myc expression was upregulated in response to stress or following loss of Huwel, which led to increased proliferation and stem-cell exhaustion. Mycn depletion reversed most of these phenotypes in vivo, which suggested that the attenuation of N-myc by Huwe1 is essential for reestablishing homeostasis following stress.	[King, Bryan; Boccalatte, Francesco; Moran-Crusio, Kelly; Wang, Jingjing; Kayembe, Clarisse; Lazaris, Charalampos; Yu, Xiaofeng; Aranda-Orgilles, Beatriz; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Boccalatte, Francesco; Moran-Crusio, Kelly; Wang, Jingjing; Kayembe, Clarisse; Lazaris, Charalampos; Yu, Xiaofeng; Aranda-Orgilles, Beatriz; Aifantis, Iannis] Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [King, Bryan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Moran-Crusio, Kelly] Quinnipiac Univ, Netter Sch Med, New Hampshire MED, Dept Med, Hamden, CT 06518 USA; [Wolf, Elmar] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Wolf, Elmar] Univ Wurzburg, Dept Biochem & Mol Biol, Bioctr, Wurzburg, Germany; [Lazaris, Charalampos] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, Dept Pathol & Cell Biol & Pediat, New York, NY USA	New York University; Memorial Sloan Kettering Cancer Center; Quinnipiac University; University of Wurzburg; University of Wurzburg; New York University; Columbia University	King, B; Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Aifantis, I (corresponding author), Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; King, B (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	kingb2@mskcc.org; iannis.aifantis@nyumc.org	Boccalatte, Francesco/AAM-6186-2020; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022; Wolf, Elmar/AAY-8493-2021; Lazaris, Charalampos/J-9230-2015; Boccalatte, Francesco/M-3511-2017	Boccalatte, Francesco/0000-0003-1732-2033; Wolf, Elmar/0000-0002-5299-6335; Lazaris, Charalampos/0000-0002-7345-8288; 	Core Center of Excellence NIDDK grant [DK56465]; US National Institutes of Health [1R01CA169784, 1R01CA133379, 1R01CA105129, 1R01CA149655, 5R01CA173636]; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society [6340-11, 6373-13]; Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; Damon Runyon Cancer Research Foundation (Berger Foundation Fellowship) [DRG-2234-15]; Deutsche Forschungsgemeinschaft (Emmy Noether Research Group) [WO 2108/1-1]; American-Italian Cancer Foundation (Alessandro and Catherine di Montezemolo endowment fund); NATIONAL CANCER INSTITUTE [R01CA173636, R01CA194923, R01CA105129, R01CA202027, R01CA149655, R01CA169784, R01CA133379, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	Core Center of Excellence NIDDK grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; Damon Runyon Cancer Research Foundation (Berger Foundation Fellowship); Deutsche Forschungsgemeinschaft (Emmy Noether Research Group)(German Research Foundation (DFG)); American-Italian Cancer Foundation (Alessandro and Catherine di Montezemolo endowment fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Aifantis laboratory for discussions; A. Heguy and members of the New York University (NYU) Genome Technology Center for assistance in RNA sequencing; the NYU Flow Cytometry facility for cell sorting; the NYU Histology Core; G. Inghirami for assistance with histopathological evaluations; S. Heimfeld (Fred Hutchinson Cancer Research Center) for human CD34<SUP>+</SUP> cells (Core Center of Excellence NIDDK grant DK56465). Supported by the US National Institutes of Health (1R01CA169784,1R01CA133379, 1R01CA105129, 1R01CA149655 and 5R01CA173636), the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society (TRP#6340-11, LLS#6373-13), The Chemotherapy Foundation, The V Foundation for Cancer Research, the Alex's Lemonade Stand Foundation for Childhood Cancer, and the St. Baldrick's Cancer Research Foundation (all for the The Aifantis laboratory); the Damon Runyon Cancer Research Foundation (Berger Foundation Fellowship DRG-2234-15 to B.K.); Deutsche Forschungsgemeinschaft (Emmy Noether Research Group WO 2108/1-1 to E.W.); and the American-Italian Cancer Foundation (Alessandro and Catherine di Montezemolo endowment fund to F.B.).	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BARRETT J, 1992, MOL CELL BIOL, V12, P3130, DOI 10.1128/MCB.12.7.3130; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Dang CV, 1999, MOL CELL BIOL, V19, P1; de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Ehninger A, 2014, BLOOD, V123, P3909, DOI 10.1182/blood-2013-10-531038; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hao ZY, 2012, J EXP MED, V209, P173, DOI 10.1084/jem.20111363; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jang ER, 2014, MOL CELL BIOL, V34, P3579, DOI 10.1128/MCB.00811-14; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Kondo M, 2010, IMMUNOL REV, V238, P37, DOI 10.1111/j.1600-065X.2010.00963.x; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Malynn BA, 2000, GENE DEV, V14, P1390; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Metzger MB, 2010, NAT CELL BIOL, V12, P1124, DOI 10.1038/ncb1210-1124; Phelan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003713; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Scognamiglio R, 2016, CELL, V164, P668, DOI 10.1016/j.cell.2015.12.033; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tesio M, 2011, CELL STEM CELL, V9, P187, DOI 10.1016/j.stem.2011.08.005; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	50	41	41	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1312	1321		10.1038/ni.3559	http://dx.doi.org/10.1038/ni.3559			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27668798	Green Accepted			2022-12-18	WOS:000386193200011
J	Kochl, R; Thelen, F; Vanes, L; Brazao, TF; Fountain, K; Xie, J; Huang, CL; Lyck, R; Stein, JV; Tybulewicz, VLJ				Kochl, Robert; Thelen, Flavian; Vanes, Lesley; Brazao, Tiago F.; Fountain, Kathryn; Xie, Jian; Huang, Chou-Long; Lyck, Ruth; Stein, Jens V.; Tybulewicz, Victor L. J.			WNK1 kinase balances T cell adhesion versus migration in vivo	NATURE IMMUNOLOGY			English	Article							INTEGRIN ACTIVATION; LEUKOCYTE MIGRATION; PROTEIN-KINASES; BLOOD-PRESSURE; ROLES; LFA-1; MICE; COTRANSPORTER; EXPRESSION; REGULATOR	Adhesion and migration of T cells are controlled by chemokines and by adhesion molecules, especially integrins, and have critical roles in the normal physiological function of T lymphocytes. Using an RNA-mediated interference screen, we identified the WNK1 kinase as a regulator of both integrin-mediated adhesion and T cell migration. We found that WNK1 is a negative regulator of integrin-mediated adhesion, whereas it acts as a positive regulator of migration via the kinases OXSR1 and STK39 and the ion co-transporter SLC12A2. WNK1-deficient T cells home less efficiently to lymphoid organs and migrate more slowly through them. Our results reveal that a pathway previously known only to regulate salt homeostasis in the kidney functions to balance T cell adhesion and migration.	[Kochl, Robert; Vanes, Lesley; Brazao, Tiago F.; Fountain, Kathryn; Tybulewicz, Victor L. J.] Francis Crick Inst, London, England; [Thelen, Flavian; Lyck, Ruth; Stein, Jens V.] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Xie, Jian; Huang, Chou-Long] Univ Texas Southwestern Med Ctr, Dallas, TX USA; [Tybulewicz, Victor L. J.] Imperial Coll, Dept Med, London, England	Francis Crick Institute; University of Bern; University of Texas System; University of Texas Southwestern Medical Center Dallas; Imperial College London	Tybulewicz, VLJ (corresponding author), Francis Crick Inst, London, England.; Tybulewicz, VLJ (corresponding author), Imperial Coll, Dept Med, London, England.	victor.t@crick.ac.uk	Brazao, Tiago/M-2315-2017	Brazao, Tiago/0000-0002-0760-4873; Xie, Jian/0000-0001-9454-1358; Stein, Jens V/0000-0002-8199-9586; Tybulewicz, Victor/0000-0003-2439-0798; Kochl, Robert/0000-0003-3370-5501; Lyck, Ruth/0000-0002-6479-4837; Fountain, Kathryn/0000-0003-2419-1713	NIH NIDDK grant, Pittsburgh Center For Kidney Research, Core B [P30 DK079307]; Francis Crick Institute, from Medical Research Council; Cancer Research UK; Medical Research Council [U117527252]; Wellcome Trust [089185]; Biotechnology and Biological Sciences Research Council [BB/L00805X/1]; US National Institute of Health [DK59530]; Swiss Multiple Sclerosis Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK059530] Funding Source: NIH RePORTER; Medical Research Council [MC_U117527252] Funding Source: researchfish; The Francis Crick Institute [10398, BB/L502297/1, 10194] Funding Source: researchfish; BBSRC [BB/L00805X/1] Funding Source: UKRI; MRC [MC_U117527252] Funding Source: UKRI	NIH NIDDK grant, Pittsburgh Center For Kidney Research, Core B; Francis Crick Institute, from Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Multiple Sclerosis Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Alessi (University of Dundee) for Oxsr1<SUP>T185A</SUP> mice, anti-pSer325-OXSR1 antibodies and discussions; R. Zamoyska (University of Edinburgh) for Jurkat cells, D. Bell (Francis Crick Institute) for help with image analysis; M. Abadier (Theodor Kocher Institute) for isolation and cultivation of primary mouse brain microvascular endothelial cells; N. Hogg (Francis Crick Institute) for Kim127 and m24 antibodies; and L. Satlin and C. Else (Mount Sinai Medical Center) for access to Slc12a2 mutant mice (supported by the NIH NIDDK grant P30 DK079307, Pittsburgh Center For Kidney Research, Core B). Supported by the Francis Crick Institute (V.T.), which receives its core funding from the Medical Research Council, Cancer Research UK and the Wellcome Trust, the Medical Research Council (U117527252 to V.T.), the Wellcome Trust (089185 to R.K. and V.T.), the Biotechnology and Biological Sciences Research Council (BB/L00805X/1 to R.K. and V.T.), the US National Institute of Health (DK59530 to C.-L.H.) and the Swiss Multiple Sclerosis Society (R.L.).	Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Faroudi M, 2010, BLOOD, V116, P5536, DOI 10.1182/blood-2010-08-299438; Feigelson SW, 2010, J IMMUNOL, V185, P7394, DOI 10.4049/jimmunol.1002246; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Steiner O, 2011, J CEREBR BLOOD F MET, V31, P315, DOI 10.1038/jcbfm.2010.96; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725	36	41	41	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1075	1083		10.1038/ni.3495	http://dx.doi.org/10.1038/ni.3495			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27400149	Green Accepted, Green Submitted			2022-12-18	WOS:000381832000011
J	Cording, S; Medvedovic, J; Aychek, T; Eberl, G				Cording, Sascha; Medvedovic, Jasna; Aychek, Tegest; Eberl, Gerard			Innate lymphoid cells in defense, immunopathology and immunotherapy	NATURE IMMUNOLOGY			English	Editorial Material							COMMENSAL BACTERIA; TYPE-2 IMMUNITY; TISSUE-DAMAGE; STEM-CELLS; T-CELLS; INFECTION; INFLAMMATION; MACROPHAGES; HOMEOSTASIS; ACTIVATION	Targeting of innate lymphoid cells, the innate counterparts of T cells, might allow early direction of the immune system into the appropriate response during preventive and therapeutic strategies aimed at pathogens and inflammatory pathologies.	[Cording, Sascha; Medvedovic, Jasna; Aychek, Tegest; Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France; [Cording, Sascha; Medvedovic, Jasna; Aychek, Tegest; Eberl, Gerard] INSERM, U1224, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Eberl, G (corresponding author), Inst Pasteur, Microenvironm & Immun Unit, Paris, France.; Eberl, G (corresponding author), INSERM, U1224, Paris, France.	gerard.eberl@pasteur.fr	Cording, Sascha/H-9470-2017; Eberl, Gerard/A-1160-2013	Cording, Sascha/0000-0003-1926-2425; Eberl, Gerard/0000-0002-1119-5638; Medvedovic, Jasna/0000-0003-0483-4128				Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	34	41	48	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					755	757		10.1038/ni.3448	http://dx.doi.org/10.1038/ni.3448			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328004				2022-12-18	WOS:000378283200006
J	Vannella, KM; Ramalingam, TR; Hart, KM; Prado, RD; Sciurba, J; Barron, L; Borthwick, LA; Smith, AD; Mentink-Kane, M; White, S; Thompson, RW; Cheever, AW; Bock, K; Moore, I; Fitz, LJ; Urban, JF; Wynn, TA				Vannella, Kevin M.; Ramalingam, Thirumalai R.; Hart, Kevin M.; Prado, Rafael de Queiroz; Sciurba, Joshua; Barron, Luke; Borthwick, Lee A.; Smith, Allen D.; Mentink-Kane, Margaret; White, Sandra; Thompson, Robert W.; Cheever, Allen W.; Bock, Kevin; Moore, Ian; Fitz, Lori J.; Urban, Joseph F., Jr.; Wynn, Thomas A.			Acidic chitinase primes the protective immune response to gastrointestinal nematodes	NATURE IMMUNOLOGY			English	Article							CD103(+) DENDRITIC CELLS; GENE-EXPRESSION PROFILES; MAMMALIAN CHITINASE; DISTINCT; TISSUE; ROLES; IL-13; CHITOTRIOSIDASE; INFLAMMATION; FAMILY	Acidic mammalian chitinase (AMCase) is known to be induced by allergens and helminths, yet its role in immunity is unclear. Using AMCase-deficient mice, we show that AMCase deficiency reduced the number of group 2 innate lymphoid cells during allergen challenge but was not required for establishment of type 2 inflammation in the lung in response to allergens or helminths. In contrast, AMCase-deficient mice showed a profound defect in type 2 immunity following infection with the chitin-containing gastrointestinal nematodes Nippostrongylus brasiliensis and Heligmosomoides polygyrus bakeri. The impaired immunity was associated with reduced mucus production and decreased intestinal expression of the signature type 2 response genes Il13, Chil3, Retnlb, and Clca1. CD103(+) dendritic cells, which regulate T cell homing, were also reduced in mesenteric lymph nodes of infected AMCase-deficient mice. Thus, AMCase functions as a critical initiator of protective type 2 responses to intestinal nematodes but is largely dispensable for allergic responses in the lung.	[Vannella, Kevin M.; Ramalingam, Thirumalai R.; Hart, Kevin M.; Prado, Rafael de Queiroz; Sciurba, Joshua; Barron, Luke; Borthwick, Lee A.; Mentink-Kane, Margaret; White, Sandra; Thompson, Robert W.; Cheever, Allen W.; Wynn, Thomas A.] NIAID, Program Tissue Immun & Repair, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Borthwick, Lee A.] Newcastle Univ, Inst Cellular Med, Tissue Fibrosis & Repair Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, Allen D.; Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Ctr, Beltsville, MD USA; [Bock, Kevin; Moore, Ian] NIAID, Infect Dis Pathogenesis Sect, NIH, Rockville, MD USA; [Fitz, Lori J.] Pfizer Worldwide R&D, Inflammat & Immun, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Newcastle University - UK; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pfizer	Wynn, TA (corresponding author), NIAID, Program Tissue Immun & Repair, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731; Urban, Joseph/0000-0002-1590-8869	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019, ZIAAI000829, ZIGAI001047] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank MedImmune for generating the anti-AMCase rabbit sera, C. Mainhart for genotyping, T. Gieseck and K. Kindrachuk for discussions, and the animal care staffs of Buildings 50 and 14BS at the US National Institutes of Health's Bethesda, Maryland campus for the conscientious care of mice.	Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; Bierbaum S, 2005, AM J RESP CRIT CARE, V172, P1505, DOI 10.1164/rccm.200506-890OC; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Fitz LJ, 2012, AM J RESP CELL MOL, V46, P71, DOI 10.1165/rcmb.2011-0095OC; Foster JM, 2005, MOL BIOCHEM PARASIT, V142, P126, DOI 10.1016/j.molbiopara.2005.03.011; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; KATONA IM, 1983, J IMMUNOL, V130, P350; Kim LK, 2015, P NATL ACAD SCI USA, V112, pE2891, DOI 10.1073/pnas.1507393112; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; NEVILLE AC, 1976, J CELL SCI, V21, P73; Ramanathan M, 2006, AM J RHINOL, V20, P330, DOI 10.2500/ajr.2006.20.2869; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Sabo-Attwood T, 2005, AM J PATHOL, V167, P1243, DOI 10.1016/S0002-9440(10)61212-6; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; Strobel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072770; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Veronico P, 2001, MOL GENET GENOMICS, V266, P28, DOI 10.1007/s004380100513; Wiesner DL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004701; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Zaph C, 2014, PARASITE IMMUNOL, V36, P439, DOI 10.1111/pim.12090; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	32	41	42	0	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					538	+		10.1038/ni.3417	http://dx.doi.org/10.1038/ni.3417			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27043413	Green Accepted			2022-12-18	WOS:000374323100013
J	Wu, N; Zhong, MC; Roncagalli, R; Perez-Quintero, LA; Guo, HJ; Zhang, ZG; Lenoir, C; Dong, ZJ; Latour, S; Veillette, A				Wu, Ning; Zhong, Ming-Chao; Roncagalli, Romain; Perez-Quintero, Luis-Alberto; Guo, Huaijian; Zhang, Zhanguang; Lenoir, Christelle; Dong, Zhongjun; Latour, Sylvain; Veillette, Andre			A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CLASS-I; INHIBITORY RECEPTORS; FAMILY RECEPTORS; SELF-TOLERANCE; ACTIVATION; RESPONSIVENESS; KINASE; DNAM-1; EAT-2	Activation of natural killer (NK) cells by hematopoietic target cells is controlled by the SLAM family of receptors and by the associated SAP family of adaptors. Here we found that SLAM receptors also enhanced NK cell activation by nonhematopoietic target cells, which lack ligands for SLAM receptors. This function was mediated by SLAMF6, a homotypic SLAM receptor found on NK cells and other hematopoietic cells, and was regulated by SAP adaptors, which uncoupled SLAM receptors from phosphatase SHP-1 and diminished the effect of SLAMF6 on NK cell responsiveness toward nonhematopoietic cells. Thus, in addition to their role in NK cell activation by hematopoietic cells, the SLAM-SAP pathways influence responsiveness toward nonhematopoietic targets by a process akin to NK cell 'education'.	[Wu, Ning; Zhong, Ming-Chao; Roncagalli, Romain; Perez-Quintero, Luis-Alberto; Guo, Huaijian; Zhang, Zhanguang; Dong, Zhongjun; Veillette, Andre] IRCM, Lab Mol Oncol, Montreal, PQ, Canada; [Roncagalli, Romain; Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Perez-Quintero, Luis-Alberto; Guo, Huaijian; Zhang, Zhanguang; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada; [Lenoir, Christelle; Latour, Sylvain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Lab Lymphocyte Activat & Susceptibil EBV, Paris, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; UDICE-French Research Universities; Universite Paris Cite	Veillette, A (corresponding author), IRCM, Lab Mol Oncol, Montreal, PQ, Canada.; Veillette, A (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.; Veillette, A (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	andre.veillette@ircm.qc.ca	Roncagalli, Romain/ABB-8786-2020; Quintero, Luis Alberto Perez/P-2013-2015; Latour, Sylvain/H-3652-2017	Quintero, Luis Alberto Perez/0000-0002-7036-8762; Zhang, Vincent/0000-0003-1134-045X; Latour, Sylvain/0000-0001-8238-4391; Roncagalli, Romain/0000-0001-7554-0552	Canadian Institutes of Health Research (CIHR); China-Canada Joint Health Research Initiative; Canadian Cancer Society Research Institute (CCSRI); Fonds de la Recherche du Quebec - Sante (FRQS); CCSRI; Institut de Recherches Cliniques de Montreal; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative; Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Fonds de la Recherche du Quebec - Sante (FRQS); CCSRI; Institut de Recherches Cliniques de Montreal; CIHR(Canadian Institutes of Health Research (CIHR))	A.V. holds the Canada Research Chair in Signaling in the Immune System. We thank the members of A.V.'s lab for discussions. We acknowledge L. Yin for the SAP-KO mouse. Supported by grants from the Canadian Institutes of Health Research (CIHR) (to A.V.), the China-Canada Joint Health Research Initiative (to A.V. and Z.D.) and the Canadian Cancer Society Research Institute (CCSRI) (to A.V.). N.W. received a fellowship from Fonds de la Recherche du Quebec - Sante (FRQS). R.R. received a studentship from CCSRI. L.-A. P.-Q. received a studentship from Institut de Recherches Cliniques de Montreal. Z.D. received a postdoctoral fellowship from CIHR.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; Gumbleton M, 2015, J IMMUNOL, V194, P2847, DOI 10.4049/jimmunol.1402930; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Perez-Quintero LA, 2014, J EXP MED, V211, P727, DOI 10.1084/jem.20132038; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Tangye SG, 2014, J CLIN IMMUNOL, V34, P772, DOI 10.1007/s10875-014-0083-7; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Veillette A, 2013, CURR OPIN ALLERGY CL, V13, P614, DOI 10.1097/ACI.0000000000000008; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Viant C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6108; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Zhang ZG, 2015, J EXP MED, V212, P2165, DOI 10.1084/jem.20150792; Zhong MC, 2013, J BIOL CHEM, V288, P31423, DOI 10.1074/jbc.M113.473736; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	48	41	43	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					387	+		10.1038/ni.3369	http://dx.doi.org/10.1038/ni.3369			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26878112				2022-12-18	WOS:000372508000012
J	Wang, XD; Gong, Y; Chen, ZL; Gong, BN; Xie, JJ; Zhong, CQ; Wang, QL; Diao, LH; Xu, AL; Han, JH; Altman, A; Li, YQ				Wang, Xu-Dong; Gong, Yu; Chen, Zhi-Long; Gong, Bei-Ni; Xie, Ji-Ji; Zhong, Chuan-Qi; Wang, Qi-Long; Diao, Liang-Hui; Xu, Anlong; Han, Jiahuai; Altman, Amnon; Li, Yingqiu			TCR-induced sumoylation of the kinase PKC-theta controls T cell synapse organization and T cell activation	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; C-THETA; IMMUNOLOGICAL SYNAPSE; PROTEIN MODIFICATION; FILAMIN-A; COSTIMULATION; UBIQUITIN; SUMO; CD28; MICROCLUSTERS	Sumoylation regulates many cellular processes, but its role in signaling via the T cell antigen receptor (TCR) remains unknown. We found that the kinase PKC-theta was sumoylated upon costimulation with antigen or via the TCR plus the coreceptor CD28, with Lys325 and Lys506 being the main sumoylation sites. We identified the SUMO E3 ligase PIASx beta as a ligase for PKC-theta. Analysis of primary mouse and human T cells revealed that sumoylation of PKC-theta was essential for T cell activation. Desumoylation did not affect the catalytic activity of PKC-theta but inhibited the association of CD28 with PKC-theta and filamin A and impaired the assembly of a mature immunological synapse and central co-accumulation of PKC-theta and CD28. Our findings demonstrate that sumoylation controls TCR-proximal signaling and that sumoylation of PKC-theta is essential for the formation of a mature immunological synapse and T cell activation.	[Wang, Xu-Dong; Gong, Yu; Chen, Zhi-Long; Gong, Bei-Ni; Xie, Ji-Ji; Wang, Qi-Long; Diao, Liang-Hui; Xu, Anlong; Li, Yingqiu] Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Ji-Ji; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Zhong, Chuan-Qi; Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen, Peoples R China	Sun Yat Sen University; La Jolla Institute for Immunology; Xiamen University	Li, YQ (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsslyq@mail.sysu.edu.cn	Diao, Lianghui/HGD-2938-2022; Han, J/G-4671-2010; Diao, Lianghui/AFO-0439-2022; Wang, Xu-Dong/Z-1721-2019; Gong, Beini/GPX-1881-2022	Diao, Lianghui/0000-0002-1159-9261; Diao, Lianghui/0000-0002-1159-9261; Wang, Xu-Dong/0000-0002-8265-1485; Xie, Jiji/0000-0002-2084-0213	Ministry of Science and Technology of China [2013CB835300, 2009CB522202]; National Natural Science Foundation of China [31170846]; State Key Laboratory of Cellular Stress Biology at Xiamen University; US National Institutes of Health [CA035299]; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cellular Stress Biology at Xiamen University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W.-L. Hu for assistance with the preparation of primary human CD4<SUP>+</SUP> T cells; A. Balancio for animal assistance; C.-y. Wu for sharing experience with experiments with peripheral blood mononuclear cells; and former and current laboratory members, K. Wang, S. Li, X. Feng, C. Zhao and D. Feng, for additional assistance. Supported by the Ministry of Science and Technology of China (2013CB835300 and 2009CB522202), the National Natural Science Foundation of China (31170846), the open research fund of State Key Laboratory of Cellular Stress Biology at Xiamen University; and the US National Institutes of Health (CA035299).	Alcover A, 2010, CURR TOP MICROBIOL, V340, P191, DOI 10.1007/978-3-642-03858-7_10; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2010, CURR TOP MICROBIOL, V340, P123, DOI 10.1007/978-3-642-03858-7_7; Cartwright NG, 2011, MOL BIOL CELL, V22, P3491, DOI 10.1091/mbc.E10-11-0916; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Dustin ML, 2008, ANNU REV CELL DEV BI, V24, P577, DOI 10.1146/annurev.cellbio.24.110707.175226; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Hayashi K, 2006, J IMMUNOL, V177, P1721, DOI 10.4049/jimmunol.177.3.1721; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kumari S, 2014, BBA-BIOMEMBRANES, V1838, P546, DOI 10.1016/j.bbamem.2013.05.004; Liang YM, 2013, NAT IMMUNOL, V14, P858, DOI 10.1038/ni.2634; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu B, 2009, MOL CELL, V35, P731, DOI 10.1016/j.molcel.2009.09.002; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Thuille N, 2005, EMBO J, V24, P3869, DOI 10.1038/sj.emboj.7600856; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhang EY, 2013, ADV PHARMACOL, V66, P267, DOI 10.1016/B978-0-12-404717-4.00006-8; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhou RW, 2014, NAT IMMUNOL, V15, P1038, DOI 10.1038/ni.3007	50	41	45	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1195	1203		10.1038/ni.3259	http://dx.doi.org/10.1038/ni.3259			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26390157				2022-12-18	WOS:000363096000013
J	Luckey, MA; Kimura, MY; Waldman, AT; Feigenbaum, L; Singer, A; Park, JH				Luckey, Megan A.; Kimura, Motoko Y.; Waldman, Adam T.; Feigenbaum, Lionel; Singer, Alfred; Park, Jung-Hyun			The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling	NATURE IMMUNOLOGY			English	Article							T-CELL LINEAGE; COMMITMENT; PROTEINS; CD8; DIFFERENTIATION; THYMOCYTES; EXPRESSION; REPRESSION; MUTANT; POK	Lineage fate in the thymus is determined by mutually exclusive expression of the transcription factors ThPOK and Runx3, with ThPOK imposing the CD4(+) lineage fate and Runx3 promoting the CD8(+) lineage fate. While it is known that cytokine signals induce thymocytes to express Runx3, it is not known how ThPOK prevents thymocytes from expressing Runx3 and adopting the CD8(+) lineage fate, nor is it understood why ThPOK itself imposes the CD4(+) lineage fate on thymocytes. We now report that genes encoding members of the SOCS (suppressor of cytokine signaling) family are critical targets of ThPOK and that their induction by ThPOK represses Runx3 expression and promotes the CD4(+) lineage fate. Thus, induction of SOCS-encoding genes is the main mechanism by which ThPOK imposes the CD4(+) lineage fate in the thymus.	[Luckey, Megan A.; Kimura, Motoko Y.; Waldman, Adam T.; Singer, Alfred; Park, Jung-Hyun] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] Leidos Biomed Res, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Park, JH (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	parkhy@mail.nih.gov	Davis, Megan/F-5339-2015; Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055; Waickman, Adam/0000-0002-4536-6714; Davis, Megan/0000-0002-9674-0753	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011215] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Singer and R. Hodes for critical review of this manuscript; R. Bosselut (National Cancer Institute) for Thpok<SUP>-/-</SUP> and ThPOK-Tg (C8) mice; J. Ihle (St. Jude Children's Research Hospital) for mice with germline deficiency in Socs1 and Ifng; D. Kappes (Fox Chase Cancer Center) for Thpok<SUP>hd/hd</SUP> mice; T. Kay (St. Vincent's Institute of Medical Research) for human CD4-Socs1 reporter mice; and M. Kubo (RIKEN) for SOCS1-Tg mice. Supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Adoro S, 2012, EMBO J, V31, P366, DOI 10.1038/emboj.2011.388; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Catlett IM, 2005, NAT IMMUNOL, V6, P715, DOI 10.1038/ni1211; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Sarafova SD, 2009, IMMUNITY, V31, P480, DOI 10.1016/j.immuni.2009.07.006; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Xiong YM, 2011, EUR J IMMUNOL, V41, P568, DOI 10.1002/eji.201041098; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836	28	41	42	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					638	645		10.1038/ni.2917	http://dx.doi.org/10.1038/ni.2917			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24880459	Green Accepted			2022-12-18	WOS:000337715600010
J	Saini, AS; Shenoy, GN; Rath, S; Bal, V; George, A				Saini, Ankur S.; Shenoy, Gautam N.; Rath, Satyajit; Bal, Vineeta; George, Anna			Inducible nitric oxide synthase is a major intermediate in signaling pathways for the survival of plasma cells	NATURE IMMUNOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; BONE-MARROW; SECRETORY APPARATUS; ANTIBODY SECRETION; CASPASE ACTIVATION; INDUCED APOPTOSIS; S-NITROSYLATION; STROMAL CELLS; DEATH	While a number of extrinsic factors are known to promote the survival of plasma cells (PCs), the signaling intermediates involved remain poorly characterized. Here we identified inducible nitric oxide synthase (iNOS) as an intermediate that supported the survival of PCs. PCs deficient in iNOS (Nos2(-/-) PCs) showed enhanced death in vitro, after transfer into congenic adoptive hosts, and in chimeras made with wild-type and Nos2(-/-) bone marrow. The iNOS-mediated protection involved activation of protein kinase G and modulation of endoplasmic reticulum stress components. Activation of caspases was also diminished. We found that iNOS was required for PCs to respond to some prosurvival mediators associated with bone marrow stromal cells and that at least one mediator, interleukin 6, fed directly into this pathway by inducing iNOS.	[Saini, Ankur S.; Shenoy, Gautam N.; Rath, Satyajit; Bal, Vineeta; George, Anna] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	George, A (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	anna@nii.re.in	Shenoy, Gautam/AAS-5848-2020; Smithers, Bernard Mark/F-2060-2010; Shenoy, Gautam N./AAD-3219-2020; Saini, Ankur/AAF-8507-2019	Smithers, Bernard Mark/0000-0002-8333-8685; Shenoy, Gautam N./0000-0001-6906-8589; Saini, Ankur/0000-0003-3963-6586	Department of Biotechnology of the Government of India [BT/PR-14592/BRB/10/858/2010, BT/PR10954/BRB/10/625/2008, BT/PR12849/MED/15/35/2009]; Department of Science and Technology of the Government of India [SR/SO/HS-0005/2011]	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology of the Government of India(Department of Science & Technology (India))	We thank R. Kumar for assistance with flow cytometry, and I. Singh for help with breeding and maintenance of mouse strains. Supported by the Department of Biotechnology of the Government of India (BT/PR-14592/BRB/10/858/2010 to S.R.; BT/PR10954/BRB/10/625/2008 and BT/PR12849/MED/15/35/2009 to A.G.; and support for the National Institute of Immunology) and the Department of Science and Technology of the Government of India (SR/SO/HS-0005/2011 to V.B.).	Auner HW, 2010, BLOOD, V116, P3445, DOI 10.1182/blood-2009-10-250423; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Gunn KE, 2006, J IMMUNOL, V177, P3791, DOI 10.4049/jimmunol.177.6.3791; Guo FJ, 2010, CELL SIGNAL, V22, P1818, DOI 10.1016/j.cellsig.2010.07.006; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Jang E, 2011, J IMMUNOL, V186, P1546, DOI 10.4049/jimmunol.1002942; Kim YM, 2000, HEPATOLOGY, V32, P770, DOI 10.1053/jhep.2000.18291; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Kolb JP, 2000, LEUKEMIA, V14, P1685, DOI 10.1038/sj.leu.2401896; Li JR, 2000, J BIOL CHEM, V275, P13026, DOI 10.1074/jbc.275.17.13026; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Loweth AC, 1997, FEBS LETT, V400, P285, DOI 10.1016/S0014-5793(96)01392-0; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; SALGO MG, 1995, BIOCHEM BIOPH RES CO, V215, P1111, DOI 10.1006/bbrc.1995.2578; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Yu XW, 2003, J BIOL CHEM, V278, P16304, DOI 10.1074/jbc.M212321200; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	44	41	41	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					275	282		10.1038/ni.2806	http://dx.doi.org/10.1038/ni.2806			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24441790				2022-12-18	WOS:000331683100013
J	Sharma, S; Rao, A				Sharma, Sonia; Rao, Anjana			RNAi screening: tips and techniques	NATURE IMMUNOLOGY			English	Editorial Material							IDENTIFIES GENES; INTERFERENCE; CELL; GENOME	By identifying gene products whose knockdown is associated with phenotypic changes, large-scale RNA-mediated interference screens have demonstrated previously unknown components of biological pathways. This commentary provides general guidelines for using such screens to answer questions of immunological interest.	[Sharma, Sonia; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Sharma, Sonia; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Sharma, S (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu			NIAID NIH HHS [R01 AI040127, R01 AI084167, R01 AI084167-05, R01 AI040127-19, R01 AI040127-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084167, R01AI040127] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZB, 2006, P NATL ACAD SCI USA, V103, P16400, DOI 10.1073/pnas.0607854103; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; McManus MT, 2002, J IMMUNOL, V169, P5754, DOI 10.4049/jimmunol.169.10.5754; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Perrimon N, 2007, GENETICS, V175, P7, DOI 10.1534/genetics.106.069963; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wein Marc N., 2008, V455, P149, DOI 10.1007/978-1-59745-104-8_11; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Yamamoto T, 2006, BLOOD, V108, P3305, DOI 10.1182/blood-2006-04-014829; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	41	41	41	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					799	804		10.1038/ni0809-799	http://dx.doi.org/10.1038/ni0809-799			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621037	Green Accepted			2022-12-18	WOS:000268141400003
J	Takizawa, H; Manz, MG				Takizawa, Hitoshi; Manz, Markus G.			Macrophage tolerance: CD47-SIRP-alpha- mediated signals matter	NATURE IMMUNOLOGY			English	Editorial Material							RED-BLOOD-CELLS; CD47; CLEARANCE; MICE	Inhibition of phagocyte activity depends on the ligation of SIRP-alpha by CD47. New findings show that Sirpa polymorphisms influence the engraftment and tolerance of xenogeneic transplants in NOD- SCID mice.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland; Osped San Giovanni Bellinzona, Oncol Inst So Switzerland, Dept Hematol, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana; Institute of Oncology Research (IOR); Regional Hospital of Bellinzona & Valleys, San Giovanni	Takizawa, H (corresponding author), Inst Biomed Res, CH-6500 Bellinzona, Switzerland.	manz@irb.unisi.ch	Takizawa, Hitoshi/G-3556-2019; Takizawa, Hitoshi/C-9895-2014; Manz, Markus G/C-7588-2011; Takizawa, Hitoshi/ABA-5165-2021	Takizawa, Hitoshi/0000-0002-5276-5430; Takizawa, Hitoshi/0000-0002-5276-5430; Takizawa, Hitoshi/0000-0002-5276-5430; Manz, Markus/0000-0002-4676-7931				Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ishikawa-Sekigami T, 2006, BIOCHEM BIOPH RES CO, V343, P1197, DOI 10.1016/j.bbrc.2006.03.094; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg PA, 2004, LEUKEMIA LYMPHOMA, V45, P1319, DOI 10.1080/1042819042000201989; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104	13	41	56	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1287	1289		10.1038/ni1207-1287	http://dx.doi.org/10.1038/ni1207-1287			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026079				2022-12-18	WOS:000251267000008
J	Litman, GW; Cooper, MD				Litman, Gary W.; Cooper, Max D.			Why study the evolution of immunity?	NATURE IMMUNOLOGY			English	Editorial Material							DIVERSIFICATION; SYSTEM	Investigations of immune recognition in nonmammalian species provide new insights into the evolution of immunity and the inner workings of the mammalian immune system. Very diverse mechanisms are used by different multicellular organisms to recognize and cope with the rapidly evolving microbial world.	Univ S Florida, Childrens Res Inst, Dept Pediat, St Petersburg, FL 33701 USA; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Litman, GW (corresponding author), Univ S Florida, Childrens Res Inst, Dept Pediat, St Petersburg, FL 33701 USA.	max.cooper@ccc.uab.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057559, R01AI023338] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI023338, R01 AI057559-04, R01 AI057559, R01 AI023338-23] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; METCHNIKOFF I, 1891, LECT COMP PATHOLOGY; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	18	41	41	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					547	548		10.1038/ni0607-547	http://dx.doi.org/10.1038/ni0607-547			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514203	Green Accepted			2022-12-18	WOS:000246703300003
J	Heyd, F; ten Dam, G; Moroy, T				Heyd, Florian; ten Dam, Gerdy; Moeroey, Tarik			Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing	NATURE IMMUNOLOGY			English	Article							PRE-MESSENGER-RNA; T-CELL-ACTIVATION; TYROSINE-PHOSPHATASE CD45; DIFFERENTIAL EXPRESSION; NEGATIVE REGULATION; REPRESSOR GFI1; POINT MUTATION; B-CELL; ISOFORMS; MICE	By alternative splicing, different isoforms of the transmembrane tyrosine phosphatase CD45 are generated that either enhance or limit T cell receptor signaling. We report here that CD45 alternative splicing is regulated by cooperative action of the splice factor U2AF26 and the transcription factor Gfi1. U2AF26 promoted formation of the less-active CD45RO by facilitating exon exclusion. Gfi1 antagonized that process by directly interacting with U2AF26, identifying a previously unknown link between a transcription factor and alternative splicing. The presence of Gfi1 led to formation of the more-active CD45RB, whereas loss of Gfi1 favored CD45RO production. We propose that the relative abundance of U2AF26 and Gfi1 determines the ratio of CD45 isoforms, thereby regulating T cell activation.	Univ Klinikum Essen, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany; Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	University of Duisburg Essen; Radboud University Nijmegen	Moroy, T (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	Tarik.Moroy@ircm.qc.ca	Moroy, Tarik/D-9923-2011					BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHUI D, 1994, EMBO J, V13, P798, DOI 10.1002/j.1460-2075.1994.tb06322.x; DEANS JP, 1992, J IMMUNOL, V148, P1898; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Graveley BR, 2002, CELL, V109, P409, DOI 10.1016/S0092-8674(02)00750-X; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kozieradzki I, 1997, J IMMUNOL, V158, P3130; Kung C, 2000, NAT MED, V6, P343; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; McNeill L, 2004, IMMUNOL LETT, V92, P125, DOI 10.1016/j.imlet.2003.10.018; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Moroy T, 2005, INT J BIOCHEM CELL B, V37, P541, DOI 10.1016/j.biocel.2004.08.011; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Shepard J, 2002, MOL CELL BIOL, V22, P221, DOI 10.1128/MCB.22.1.221-230.2002; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; ten Dam GB, 2000, J IMMUNOL, V164, P5287, DOI 10.4049/jimmunol.164.10.5287; TENDAM GB, 1999, BIOCHIM BIOPHYS ACTA, V1446, P217; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Tsujikawa K, 2000, IMMUNOBIOLOGY, V201, P506, DOI 10.1016/S0171-2985(00)80070-4; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417	38	41	52	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					859	867		10.1038/ni1361	http://dx.doi.org/10.1038/ni1361			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16819553				2022-12-18	WOS:000239147200022
J	O Besedovsky, H; Del Rey, A				O Besedovsky, Hugo; Del Rey, Adriana			Regulating inflammation by glucocorticoids	NATURE IMMUNOLOGY			English	Letter							MECHANISMS		Inst Physiol & Pathophysiol, Dept Immunophysiol, D-35037 Marburg, Germany		O Besedovsky, H (corresponding author), Inst Physiol & Pathophysiol, Dept Immunophysiol, D-35037 Marburg, Germany.	besedovs@mailer.uni-marburg.de						Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Moynagh PN, 2003, J ENDOCRINOL, V179, P139, DOI 10.1677/joe.0.1790139; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914	5	41	45	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					537	537		10.1038/ni0606-537	http://dx.doi.org/10.1038/ni0606-537			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715059	Bronze			2022-12-18	WOS:000237751200002
J	Zhang, J; Guo, J; Dzhagalov, I; He, YW				Zhang, J; Guo, J; Dzhagalov, I; He, YW			An essential function for the calcium-promoted Ras inactivator in Fc gamma receptor-mediated phagocytosis	NATURE IMMUNOLOGY			English	Article							GTPASE-ACTIVATING PROTEIN; SYK TYROSINE KINASE; SIGNAL-TRANSDUCTION; MACROPHAGES; CDC42; FAMILY; RAC1; IDENTIFICATION; RECRUITMENT; MECHANISMS	Fc receptor ( FcR) - mediated phagocytosis requires activation of the Rho GTPases Cdc42 and Rac1, but how they are recruited to the FcR is unknown. Here we show that the calcium- promoted Ras inactivator ( CAPRI), a Ras GTPase- activating protein, functions as an adaptor for Cdc42 and Rac1 during FcR- mediated phagocytosis. CAPRI- deficient macrophages had impaired Fc gamma R- mediated phagocytosis and oxidative burst, as well as defective activation of Cdc42 and Rac1. CAPRI interacted constitutively with both Cdc42 and Rac1 and translocated to phagocytic cups during Fc gamma R- mediated phagocytosis. CAPRI-deficient mice had an impaired innate immune response to bacterial infection. These results suggest that CAPRI provides a link between Fc gamma R and Cdc42 and Rac1 and is essential for innate immune responses.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	He, YW (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	he000004@mc.duke.edu		Dzhagalov, Ivan/0000-0001-9209-4582	NCI NIH HHS [R01 CA092123, CA92123] Funding Source: Medline; NIAID NIH HHS [AI54685, R01 AI054658] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054658] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen M, 1998, GENE, V218, P17, DOI 10.1016/S0378-1119(98)00394-1; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; BABA H, 1995, J NEUROSCI RES, V41, P846, DOI 10.1002/jnr.490410615; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CAMPBELL PA, 1996, CURRENT PROTOCOL IMM; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Castellano F, 2000, J CELL SCI, V113, P2955; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879, DOI 10.1128/MCB.14.10.6879; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Raeder EMB, 1999, J IMMUNOL, V163, P6785; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557	32	41	43	4	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					911	919		10.1038/ni1232	http://dx.doi.org/10.1038/ni1232			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16041389	Green Accepted			2022-12-18	WOS:000231369800021
J	Godowski, PJ				Godowski, PJ			A smooth operator for LPS responses	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTOR-4; ENDOTOXIN; MD-2; CD14		Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Godowski, PJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	ski@gene.com						Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172	11	41	43	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					544	546		10.1038/ni0605-544	http://dx.doi.org/10.1038/ni0605-544			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908933				2022-12-18	WOS:000229385900006
J	Croese, T; Castellani, I; Schwartz, M				Croese, Tommaso; Castellani, Iulia; Schwartz, Michal			Immune cell compartmentalization for brain surveillance and protection	NATURE IMMUNOLOGY			English	Review							CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS LESIONS; I INTERFERON RESPONSE; CHOROID-PLEXUS; DENDRITIC CELLS; MAST-CELLS; PERIVASCULAR MACROPHAGES; CEREBROSPINAL-FLUID; ANIMAL-MODEL	Schwartz and colleagues review the immune niches in the brain, the contribution of professional immune cells to brain functions and the relevance of immune components to brain aging and neurodegenerative disease. For decades, it was commonly accepted that the brain is secluded from peripheral immune activity and is self-sufficient for its maintenance and repair. This simplistic perception was based on the presence of resident immune cells, the microglia, and barrier systems within the brain, and the assumption that the central nervous system (CNS) lacks lymphatic drainage. This view was revised with the discoveries that higher functions of the CNS, homeostasis and repair are supported by peripheral innate and adaptive immune cells. The findings of bone marrow-derived immune cells in specialized niches, and the renewed observation that a lymphatic drainage system exists within the brain, further contributed to this revised model. In this Review, we describe the immune niches within the brain, the contribution of professional immune cells to brain functions, the bidirectional relationships between the CNS and the immune system and the relevance of immune components to brain aging and neurodegenerative diseases.	[Croese, Tommaso; Castellani, Iulia; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel	Weizmann Institute of Science	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.	michal.schwartz@weizmann.ac.il		Castellani, Giulia/0000-0002-0611-5250; Croese, Tommaso/0000-0002-3805-3429	Advanced European Research Council [7417]; Israel Science Foundation (ISF) [991/16]; ISF Legacy Heritage Bio-Medical Science Partnership research grant [1354/15]; Thompson Foundation	Advanced European Research Council(European Research Council (ERC)); Israel Science Foundation (ISF)(Israel Science Foundation); ISF Legacy Heritage Bio-Medical Science Partnership research grant; Thompson Foundation	The Schwartz research group is supported by an Advanced European Research Council grant (no. 7417), an Israel Science Foundation (ISF) research grant (no. 991/16) and an ISF Legacy Heritage Bio-Medical Science Partnership research grant (no. 1354/15). We thank the Thompson Foundation for generous support of Alzheimer's disease research, and S. Schwarzbaum for editing the manuscript.	Abe C, 2017, NAT NEUROSCI, V20, P700, DOI 10.1038/nn.4526; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Anthony IC, 2003, BRAIN, V126, P1058, DOI 10.1093/brain/awg118; Baek H, 2016, ONCOTARGET, V7, P69347, DOI 10.18632/oncotarget.12469; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Baruch K, 2013, BRAIN BEHAV IMMUN, V34, P11, DOI 10.1016/j.bbi.2013.04.002; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bereshchenko O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01332; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Butchi NB, 2011, AM J PATHOL, V179, P783, DOI 10.1016/j.ajpath.2011.04.011; CAMPBELL DJ, 1966, NATURE, V210, P756, DOI 10.1038/210756b0; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Costanza M, 2012, INT J MOL SCI, V13, P15107, DOI 10.3390/ijms131115107; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Da Mesquita S, 2015, BRAIN BEHAV IMMUN, V49, P280, DOI 10.1016/j.bbi.2015.06.008; Dani N, 2021, CELL, V184, P3056, DOI 10.1016/j.cell.2021.04.003; de Graaf MT, 2011, CYTOM PART B-CLIN CY, V80B, P43, DOI 10.1002/cyto.b.20542; de Lima KA, 2020, ANNU REV IMMUNOL, V38, P597, DOI 10.1146/annurev-immunol-102319-103410; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Ding Y, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.113003; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Edling AE, 2004, J NEUROSCI RES, V77, P709, DOI 10.1002/jnr.20176; Elyahu Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8330; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FEHR J, 1985, KLIN WOCHENSCHR, V63, P152, DOI 10.1007/BF01732168; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Fitzpatrick Z, 2020, NATURE, V587, P472, DOI 10.1038/s41586-020-2886-4; Gallizioli M, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108291; Gao X, 2021, NATURE, V589, P591, DOI 10.1038/s41586-020-03057-y; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Gelderblom M, 2018, STROKE, V49, P155, DOI 10.1161/STROKEAHA.117.019101; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Granberg T, 2020, J NEUROL, V267, P3199, DOI 10.1007/s00415-020-09971-5; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Griciuc A, 2019, NEURON, V103, P820, DOI 10.1016/j.neuron.2019.06.010; Grinker RR, 1931, ARCH NEURO PSYCHIATR, V25, P723, DOI 10.1001/archneurpsyc.1931.02230040057003; Han S, 2014, J IMMUNOL, V192, P2551, DOI 10.4049/jimmunol.1302884; Hao JW, 2011, ANN NEUROL, V69, P721, DOI 10.1002/ana.22339; Hauser Stephen L, 2008, N Engl J Med, V358, P676, DOI 10.1056/NEJMoa0706383; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Hendriksen E, 2017, NEUROSCI BIOBEHAV R, V79, P119, DOI 10.1016/j.neubiorev.2017.05.001; Hendrix S, 2006, NEUROSCI LETT, V392, P174, DOI 10.1016/j.neulet.2005.09.029; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Huang SY, 2021, CELL, V184, P441, DOI 10.1016/j.cell.2020.11.028; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Iliff Jeffrey J, 2012, Sci Transl Med, V4, p147ra111, DOI 10.1126/scitranslmed.3003748; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Ito M, 2019, INT IMMUNOL, V31, P361, DOI 10.1093/intimm/dxz031; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jiang W, 2017, P NATL ACAD SCI USA, V114, pE6202, DOI 10.1073/pnas.1705491114; Jin WN, 2021, NAT NEUROSCI, V24, P61, DOI 10.1038/s41593-020-00745-w; Kang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16191-y; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Kaunzner UW, 2012, NEUROBIOL AGING, V33, P681, DOI 10.1016/j.neurobiolaging.2010.06.007; Kertser A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4111; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kierdorf K, 2019, NAT REV NEUROSCI, V20, P547, DOI 10.1038/s41583-019-0201-x; Kierdorf K, 2017, J CLIN INVEST, V127, P3201, DOI [10.1172/JCI90602, 10.1172/jci90602]; Kim K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22479-4; Kim YR, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.613733; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; Kohm AP, 2000, IMMUNOL TODAY, V21, P539, DOI 10.1016/S0167-5699(00)01747-3; Korin B, 2018, NAT PROTOC, V13, P377, DOI 10.1038/nprot.2017.155; Krienke Christina, 2021, Science, V371, P145, DOI 10.1126/science.aay3638; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levy RL, 1917, J AMER MED ASSOC, V69, P1873; Lewitus GM, 2008, BRAIN BEHAV IMMUN, V22, P1108, DOI 10.1016/j.bbi.2008.05.002; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Linnerbauer M, 2020, NEURON, V108, P608, DOI 10.1016/j.neuron.2020.08.012; Lisak RP, 2012, J NEUROIMMUNOL, V246, P85, DOI 10.1016/j.jneuroim.2012.02.015; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Ludewig P, 2016, BBA-MOL BASIS DIS, V1862, P352, DOI 10.1016/j.bbadis.2015.11.003; Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6; Marsh SE, 2016, P NATL ACAD SCI USA, V113, pE1316, DOI 10.1073/pnas.1525466113; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Masuda T, 2020, CELL REP, V30, P1271, DOI 10.1016/j.celrep.2020.01.010; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; Medana I, 2001, AM J PATHOL, V159, P809, DOI 10.1016/S0002-9440(10)61755-5; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; Minhas PS, 2021, NATURE, V590, P122, DOI 10.1038/s41586-020-03160-0; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nevin JT, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay9368; O'Donnell MP, 2020, NATURE, V583, P415, DOI 10.1038/s41586-020-2395-5; Ortega SB, 2020, P NATL ACAD SCI USA, V117, P4983, DOI 10.1073/pnas.1913292117; Otxoa-de-Amezaga A, 2019, STROKE, V50, P1548, DOI 10.1161/STROKEAHA.118.023837; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Palin K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1289, DOI 10.1152/ajpendo.90489.2008; Pappalardo JL, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb8786; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Pellkofer HL, 2011, NEUROLOGY, V76, P1310, DOI 10.1212/WNL.0b013e3182152881; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Quintana E, 2015, GLIA, V63, P2231, DOI 10.1002/glia.22889; Rajan WD, 2020, NEUROBIOL DIS, V137, DOI 10.1016/j.nbd.2019.104722; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Rojo R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11053-8; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rosenzweig N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08352-5; Russi AE, 2016, J AUTOIMMUN, V73, P100, DOI 10.1016/j.jaut.2016.06.015; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Sabatino JJ, 2019, NAT REV NEUROSCI, V20, P728, DOI 10.1038/s41583-019-0233-2; Sas AR, 2020, NAT IMMUNOL, V21, P1496, DOI 10.1038/s41590-020-00813-0; Schetters STT, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01905; Schiller M, 2021, NAT REV IMMUNOL, V21, P20, DOI 10.1038/s41577-020-0387-1; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Sharma D, 2020, SEMIN IMMUNOPATHOL, V42, P709, DOI 10.1007/s00281-020-00829-6; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shichita T, 2017, NAT MED, V23, P723, DOI 10.1038/nm.4312; Shirai Y., 1921, JAP MED WORLD, V1, P14, DOI DOI 10.1038/NM.4041; Silva-Vargas V, 2016, CELL STEM CELL, V19, P643, DOI 10.1016/j.stem.2016.06.013; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Thanopoulou K, 2010, P NATL ACAD SCI USA, V107, P20816, DOI 10.1073/pnas.1005888107; ThyagaRajan S, 2011, J NEUROIMMUNOL, V233, P54, DOI 10.1016/j.jneuroim.2010.11.012; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Vasilache AM, 2015, BRAIN BEHAV IMMUN, V48, P31, DOI 10.1016/j.bbi.2015.02.003; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wardlaw JM, 2020, NAT REV NEUROL, V16, P137, DOI 10.1038/s41582-020-0312-z; Xue F, 2021, NEUROBIOL DIS, V152, DOI 10.1016/j.nbd.2021.105272; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747; Zhang X, 2020, NATURE, V581, P204, DOI 10.1038/s41586-020-2235-7; Zhang YY, 2020, J IMMUNOL, V205, P502, DOI 10.4049/jimmunol.2000037; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zuo ZJ, 2021, NEUROBIOL AGING, V101, P94, DOI 10.1016/j.neurobiolaging.2021.01.001	170	40	42	3	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1083	1092		10.1038/s41590-021-00994-2	http://dx.doi.org/10.1038/s41590-021-00994-2		AUG 2021	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34429552				2022-12-18	WOS:000687942300005
J	Buszko, M; Nita-Lazar, A; Park, JH; Schwartzberg, PL; Verthelyi, D; Young, HA; Rosenberg, AS				Buszko, Maja; Nita-Lazar, Aleksandra; Park, Jung-Hyun; Schwartzberg, Pamela L.; Verthelyi, Daniela; Young, Howard A.; Rosenberg, Amy S.			Lessons learned: new insights on the role of cytokines in COVID-19	NATURE IMMUNOLOGY			English	Editorial Material									[Buszko, Maja] NIAID, Cellular Immunol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nita-Lazar, Aleksandra] NIAID, Funct Cellular Networks Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Park, Jung-Hyun] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.] NIAID, Cell Signaling & Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Verthelyi, Daniela] US FDA, Lab Innate Immun, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Young, Howard A.] NCI, Lab Canc Immunometab, Ctr Canc Res, Frederick, MD 21701 USA; [Rosenberg, Amy S.] US FDA, Lab Immunol, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Buszko, M (corresponding author), NIAID, Cellular Immunol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	maja.buszko@nih.gov	; Park, Jung Hyun/B-5712-2015; Young, Howard/A-6350-2008	Buszko, Maja/0000-0002-8905-2223; Verthelyi, Daniela/0000-0002-5450-3071; Park, Jung Hyun/0000-0002-9547-9055; Young, Howard/0000-0002-3118-5111	Intramural Research Program of the NIH, NIAID; Intramural Research Program of the Center for Cancer Research, NCI, NIH; Office of Biotechnology Products, CDER, FDA	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Biotechnology Products, CDER, FDA	We thank the speakers for their valuable feedback in preparing this Meeting Report. We are also grateful to CBIIT IT operations, NCI, for hosting the virtual conference. Figures were created with the help of the Visual and Medical Arts Unit, Research Technologies Branch, NIAID, NIH, and using Biorender. This work was supported by the Intramural Research Program of the NIH, NIAID; the Intramural Research Program of the Center for Cancer Research, NCI, NIH; and the Office of Biotechnology Products, CDER, FDA. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the United States Government.	Abers MS, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144455; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bovijn J, 2020, LANCET RHEUMATOL, V2, pE658, DOI 10.1016/S2665-9913(20)30345-3; Caielli S, 2019, NAT MED, V25, P75, DOI 10.1038/s41591-018-0254-9; Canas CA, 2020, MED HYPOTHESES, V145, DOI 10.1016/j.mehy.2020.110345; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; Cheng Mary Hongying, 2020, bioRxiv, DOI 10.1101/2020.05.21.109272; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gruber Conor, 2020, medRxiv, DOI [10.1016/j.cell.2020.09.034, 10.1101/2020.07.04.20142752]; Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lingappan K, 2020, AM J PHYSIOL-LUNG C, V319, pL39, DOI 10.1152/ajplung.00183.2020; Murtas R, 2020, AUTOIMMUN HIGHLIGHTS, V11, DOI 10.1186/s13317-020-00141-1; Nehar-Belaid D, 2020, NAT IMMUNOL, V21, P1094, DOI 10.1038/s41590-020-0743-0; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Porritt RA, J CLIN INVEST; Ramaswamy A, 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.12.01.20241364, DOI 10.1101/2020.12.01.20241364]; Robinson PC, 2020, LANCET RHEUMATOL, V2, pE653, DOI 10.1016/S2665-9913(20)30309-X; Smolen JS, 2020, ANN RHEUM DIS, V79, P1, DOI 10.1136/annrheumdis-2019-216758; Stanleyraj JS, 2021, J ANTIMICROB CHEMOTH, V76, P283, DOI 10.1093/jac/dkaa442; Stebbing J, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4724; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570	36	40	42	2	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					404	411		10.1038/s41590-021-00901-9	http://dx.doi.org/10.1038/s41590-021-00901-9		MAR 2021	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33723418	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000629085700001
J	Russo, AJ; Vasudevan, SO; Mendez-Huergo, SP; Kumari, P; Menoret, A; Duduskar, S; Wang, CL; Saez, JMP; Fettis, MM; Li, C; Liu, RJ; Wanchoo, A; Chandiran, K; Ruan, JB; Vanaja, SK; Bauer, M; Sponholz, C; Hudalla, GA; Vella, AT; Zhou, BY; Deshmukh, SD; Rabinovich, GA; Rathinam, VA				Russo, Ashley J.; Vasudevan, Swathy O.; Mendez-Huergo, Santiago P.; Kumari, Puja; Menoret, Antoine; Duduskar, Shivalee; Wang, Chengliang; Perez Saez, Juan M.; Fettis, Margaret M.; Li, Chuan; Liu, Renjie; Wanchoo, Arun; Chandiran, Karthik; Ruan, Jianbin; Vanaja, Sivapriya Kailasan; Bauer, Michael; Sponholz, Christoph; Hudalla, Gregory A.; Vella, Anthony T.; Zhou, Beiyan; Deshmukh, Sachin D.; Rabinovich, Gabriel A.; Rathinam, Vijay A.			Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin	NATURE IMMUNOLOGY			English	Article							GALECTIN-1; ACTIVATION; CASPASE-11; RECEPTOR; SEPSIS; CD45; LPS; DEFINITIONS; PHOSPHATASE; MECHANISMS	Damage-associated molecular patterns (DAMPs) are released during necrotic cell death and contribute to driving inflammation. Rathinam and colleagues show that galectin-1 is a new DAMP that functions by inhibiting the receptor phosphatase CD45. Inflammatory caspase sensing of cytosolic lipopolysaccharide (LPS) triggers pyroptosis and the concurrent release of damage-associated molecular patterns (DAMPs). Collectively, DAMPs are key determinants that shape the aftermath of inflammatory cell death. However, the identity and function of the individual DAMPs released are poorly defined. Our proteomics study revealed that cytosolic LPS sensing triggered the release of galectin-1, a beta-galactoside-binding lectin. Galectin-1 release is a common feature of inflammatory cell death, including necroptosis. In vivo studies using galectin-1-deficient mice, recombinant galectin-1 and galectin-1-neutralizing antibody showed that galectin-1 promotes inflammation and plays a detrimental role in LPS-induced lethality. Mechanistically, galectin-1 inhibition of CD45 (Ptprc) underlies its unfavorable role in endotoxin shock. Finally, we found increased galectin-1 in sera from human patients with sepsis. Overall, we uncovered galectin-1 as a bona fide DAMP released as a consequence of cytosolic LPS sensing, identifying a new outcome of inflammatory cell death.	[Russo, Ashley J.; Vasudevan, Swathy O.; Kumari, Puja; Menoret, Antoine; Wang, Chengliang; Li, Chuan; Chandiran, Karthik; Ruan, Jianbin; Vanaja, Sivapriya Kailasan; Vella, Anthony T.; Zhou, Beiyan; Rathinam, Vijay A.] Univ Connecticut Hlth, Sch Med, Dept Immunol, Farmington, CT 06032 USA; [Mendez-Huergo, Santiago P.; Perez Saez, Juan M.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Lab Inmunopatol, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Menoret, Antoine] Univ Connecticut Hlth, Inst Syst Genom, Farmington, CT USA; [Duduskar, Shivalee; Bauer, Michael; Deshmukh, Sachin D.] Jena Univ Hosp, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, Jena, Germany; [Fettis, Margaret M.; Liu, Renjie; Wanchoo, Arun; Hudalla, Gregory A.] Univ Florida, Dept Biomed Engn, Gainesville, FL USA; [Bauer, Michael; Sponholz, Christoph] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Exact & Nat Sci, Buenos Aires, DF, Argentina; [Fettis, Margaret M.] AbbVie Biores Ctr, Worcester, MA USA	University of Connecticut; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Connecticut; Friedrich Schiller University of Jena; State University System of Florida; University of Florida; Friedrich Schiller University of Jena; University of Buenos Aires; AbbVie	Rathinam, VA (corresponding author), Univ Connecticut Hlth, Sch Med, Dept Immunol, Farmington, CT 06032 USA.	Rathinam@uchc.edu	Liu, Renjie Liu/GRJ-2419-2022; Duduskar, Shivalee/GRO-3285-2022	Liu, Renjie Liu/0000-0002-3885-244X; Wang, Chengliang/0000-0001-5249-4856; Vasudevan, Swathy/0000-0001-7437-8119; Zhou, Beiyan/0000-0003-0638-2428; Duduskar, Shivalee/0000-0002-5270-3432	National Institutes of Health [AI119015, AI135528]; Agencia Nacional de Promocion Cientifica y Tecnologica; Federal Ministry of Education and Research, Germany [01EO1502]; Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy [EXC 2051, 390713860]; Fundacion Sales; Fundacion Bunge y Born	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); Fundacion Sales; Fundacion Bunge y Born	We thank J. Conejo-Garcia for the Lgals1<SUP>-/-</SUP> mice and V. Dixit (Genentech) and K. Fitzgerald (University of Massachusetts Medical School) for the Casp11<SUP>-/-</SUP> and Gsdmd<SUP>-/-</SUP> mice, S. Yeung and K. Khanna for help with the multiplex analysis and G. Fong for the MS1 cell line (University of Connecticut Health). This work was supported by the National Institutes of Health (grant nos. AI119015 and AI135528 to V.A.R.); Agencia Nacional de Promocion Cientifica y Tecnologica, Fundacion Sales and Fundacion Bunge y Born to G.A.R.; the Federal Ministry of Education and Research, Germany (grant no. 01EO1502) and Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy-EXC 2051, project ID 390713860 (to M.B.).	Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Chen YH, 2019, J IMMUNOL, V203, P2712, DOI 10.4049/jimmunol.1900212; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fettis MM, 2018, BIOCONJUGATE CHEM, V29, P2489, DOI 10.1021/acs.bioconjchem.8b00425; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Galluzzi L, 2017, ANNU REV PATHOL-MECH, V12, P103, DOI 10.1146/annurev-pathol-052016-100247; Ge XN, 2016, P NATL ACAD SCI USA, V113, pE4837, DOI 10.1073/pnas.1601958113; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Huang XT, 2020, FREE RADICAL BIO MED, V146, P222, DOI 10.1016/j.freeradbiomed.2019.11.011; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kang R, 2018, CELL HOST MICROBE, V24, P97, DOI 10.1016/j.chom.2018.05.009; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee HJ, 2008, PROTEOMICS, V8, P3371, DOI 10.1002/pmic.200800111; Lei T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22135-w; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Manda P, 2018, IMMUNITY, V49, P42, DOI 10.1016/j.immuni.2018.06.011; Allo VCM, 2020, P NATL ACAD SCI USA, V117, P6630, DOI 10.1073/pnas.1922778117; Menoret A, 2009, J IMMUNOL, V183, P7489, DOI 10.4049/jimmunol.0901414; Perez CV, 2015, SCI REP-UK, V5, DOI 10.1038/srep12259; Saez JMP, 2021, ANGIOGENESIS, V24, P1, DOI 10.1007/s10456-020-09749-3; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Piercy J, 2006, IMMUNOLOGY, V118, P250, DOI 10.1111/j.1365-2567.2006.02363.x; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rathinam VAK, 2019, NAT IMMUNOL, V20, P527, DOI 10.1038/s41590-019-0368-3; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rodrigues LC, 2019, MOL IMMUNOL, V116, P80, DOI 10.1016/j.molimm.2019.10.001; Schenck EJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127143; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Song F, 2018, ANESTHESIOLOGY, V129, P311, DOI 10.1097/ALN.0000000000002196; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Sundblad V, 2017, J IMMUNOL, V199, P3721, DOI 10.4049/jimmunol.1701172; Toegel S, 2016, J IMMUNOL, V196, P1910, DOI 10.4049/jimmunol.1501165; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Walzel H, 1999, IMMUNOL LETT, V67, P193, DOI 10.1016/S0165-2478(99)00012-7; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang WX, 2018, ANESTHESIOLOGY, V129, P238, DOI 10.1097/ALN.0000000000002271	55	40	41	5	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					154	U78		10.1038/s41590-020-00844-7	http://dx.doi.org/10.1038/s41590-020-00844-7		JAN 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398185	Green Accepted			2022-12-18	WOS:000604865800001
J	Abdelsamed, HA; Zebley, CC; Nguyen, H; Rutishauser, RL; Fan, YP; Ghoneim, HE; Crawford, JC; Alfei, F; Alli, S; Ribeiro, SP; Castellaw, AH; McGargill, MA; Jin, HJ; Boi, SK; Speake, C; Serti, E; Turka, LA; Busch, ME; Stone, M; Deeks, SG; Sekaly, RP; Zehn, D; James, EA; Nepom, GT; Youngblood, B				Abdelsamed, Hossam A.; Zebley, Caitlin C.; Hai Nguyen; Rutishauser, Rachel L.; Fan, Yiping; Ghoneim, Hazem E.; Crawford, Jeremy Chase; Alfei, Francesca; Alli, Shanta; Ribeiro, Susan Pereira; Castellaw, Ashley H.; McGargill, Maureen A.; Jin, Hongjian; Boi, Shannon K.; Speake, Cate; Serti, Elisavet; Turka, Laurence A.; Busch, Michael E.; Stone, Mars; Deeks, Steven G.; Sekaly, Rafick-Pierre; Zehn, Dietmar; James, Eddie A.; Nepom, Gerald T.; Youngblood, Ben			Beta cell-specific CD8(+) T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes	NATURE IMMUNOLOGY			English	Article							EXPRESSION; ONSET; DIFFERENTIATION; PHENOTYPE; EXPANSION; RECOGNIZE	Autoreactive T cells are subject to continuous antigenic stimulation yet sustain their autoreactive functionality. Youngblood and colleagues examine type 1 diabetes systems to show that a pool of autoreactive CD8(+) T cells exhibits a stem cell-like signature that facilitates their durable activity. The pool of beta cell-specific CD8(+) T cells in type 1 diabetes (T1D) sustains an autoreactive potential despite having access to a constant source of antigen. To investigate the long-lived nature of these cells, we established a DNA methylation-based T cell 'multipotency index' and found that beta cell-specific CD8(+) T cells retained a stem-like epigenetic multipotency score. Single-cell assay for transposase-accessible chromatin using sequencing confirmed the coexistence of naive and effector-associated epigenetic programs in individual beta cell-specific CD8(+) T cells. Assessment of beta cell-specific CD8(+) T cell anatomical distribution and the establishment of stem-associated epigenetic programs revealed that self-reactive CD8(+) T cells isolated from murine lymphoid tissue retained developmentally plastic phenotypic and epigenetic profiles relative to the same cells isolated from the pancreas. Collectively, these data provide new insight into the longevity of beta cell-specific CD8(+) T cell responses and document the use of this methylation-based multipotency index for investigating human and mouse CD8(+) T cell differentiation.	[Abdelsamed, Hossam A.; Zebley, Caitlin C.; Ghoneim, Hazem E.; Crawford, Jeremy Chase; Alli, Shanta; Castellaw, Ashley H.; McGargill, Maureen A.; Boi, Shannon K.; Youngblood, Ben] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zebley, Caitlin C.; Youngblood, Ben] St Jude Childrens Res Hosp, Grad Sch Biomed Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Hai Nguyen; James, Eddie A.; Nepom, Gerald T.] Benaroya Res Inst, Translat Res Program, Seattle, WA USA; [Rutishauser, Rachel L.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Fan, Yiping; Jin, Hongjian] St Jude Childrens Res Hosp, Ctr Appl Bioinformat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Alfei, Francesca; Zehn, Dietmar] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany; [Ribeiro, Susan Pereira; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Speake, Cate] Benaroya Res Inst, Diabet Res Program, Seattle, WA USA; [Serti, Elisavet; Turka, Laurence A.; Nepom, Gerald T.] Immune Tolerance Network, Bethesda, MD USA; [Turka, Laurence A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Ctr Translat Sci, Boston, MA 02115 USA; [Busch, Michael E.; Stone, Mars] Vitalant Res Inst, San Francisco, CA USA; [Abdelsamed, Hossam A.] Univ Pittsburgh, Sch Med, Dept Surg, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; [Ghoneim, Hazem E.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Benaroya Research Institute; University of California System; University of California San Francisco; St Jude Children's Research Hospital; Technical University of Munich; Case Western Reserve University; Benaroya Research Institute; Immune Tolerance Network; Harvard University; Harvard Medical School; Massachusetts General Hospital; Vitalant; Vitalant Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University	Youngblood, B (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Youngblood, B (corresponding author), St Jude Childrens Res Hosp, Grad Sch Biomed Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	benjamin.youngblood@stjude.org	Crawford, Jeremy Chase/G-5711-2013; James, Eddie/V-4929-2019	Crawford, Jeremy Chase/0000-0003-4096-6048; Jin, Hongjian/0000-0003-3833-7170; Zehn, Dietmar/0000-0003-1393-8527; Zebley, Caitlin/0000-0002-8419-4660; Rutishauser, Rachel/0000-0003-3596-059X; James, Eddie/0000-0002-7217-5729; Deeks, Steven/0000-0001-6371-747X	NIH [1R01AI114442]; Immune Tolerance Network [UM1AI109565]; NIH Loan Repayment Program; American Lebanese Syrian Associated Charities; Assisi foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immune Tolerance Network; NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Assisi foundation	We thank P. Dogra for processing samples for methylation profiling. This work was supported by the NIH (grant no. 1R01AI114442 to B.Y.), Immune Tolerance Network (grant no. UM1AI109565 to G.T.N., E.J. and B.Y.), the NIH Loan Repayment Program to C.Z., the American Lebanese Syrian Associated Charities (to B.Y.) and Assisi foundation (to B.Y.).	Abdelsamed HA, 2017, J EXP MED, V214, P1593, DOI 10.1084/jem.20161760; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Buckner JH, 2016, J AUTOIMMUN, V71, P44, DOI 10.1016/j.jaut.2016.02.009; Burrack AL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00343; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; Daifotis AG, 2013, CLIN IMMUNOL, V149, P268, DOI 10.1016/j.clim.2013.05.001; Garyu JW, 2016, J BIOL CHEM, V291, P11230, DOI 10.1074/jbc.M115.713362; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; James EA, 2008, DIABETES, V57, P1788, DOI 10.2337/db08-0530; Knight RR, 2013, DIABETES, V62, P205, DOI 10.2337/db12-0315; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lee W, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.157; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; Liao JA, 2011, MOL CANCER RES, V9, P350, DOI 10.1158/1541-7786.MCR-10-0375; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Manzo M, 2017, EMBO J, V36, P3421, DOI 10.15252/embj.201797038; Pace L, 2018, SCIENCE, V359, P177, DOI 10.1126/science.aah6499; Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Richards DM, 2016, TRENDS IMMUNOL, V37, P114, DOI 10.1016/j.it.2015.12.005; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Skowera A, 2015, DIABETES, V64, P916, DOI 10.2337/db14-0332; Sokolov A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004790; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Vizler C, 1999, IMMUNOL REV, V169, P81; Wiedeman AE, 2020, J CLIN INVEST, V130, P480, DOI 10.1172/JCI126595; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yang J, 2014, P NATL ACAD SCI USA, V111, P14840, DOI 10.1073/pnas.1416864111; Yeo L, 2018, J CLIN INVEST, V128, P3460, DOI 10.1172/JCI120555; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161	46	40	40	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					578	+		10.1038/s41590-020-0633-5	http://dx.doi.org/10.1038/s41590-020-0633-5		MAR 2020	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32231298	Green Submitted, Green Accepted			2022-12-18	WOS:000522383000004
J	Pokatayev, V; Yang, K; Tu, XT; Dobbs, N; Wu, JJ; Kalb, RG; Yan, N				Pokatayev, Vladislav; Yang, Kun; Tu, Xintao; Dobbs, Nicole; Wu, Jianjun; Kalb, Robert G.; Yan, Nan			Homeostatic regulation of STING protein at the resting state by stabilizer TOLLIP	NATURE IMMUNOLOGY			English	Article							MOUSE MODEL; ACTIVATION; TRAFFICKING; DISEASE; TREX1; CELLS; MICE; ER	STING (stimulator of interferon genes) is an important innate immune protein, but its homeostatic regulation at the resting state is unknown. Here, we identified TOLLIP as a stabilizer of STING through direct interaction to prevent its degradation. Tollip deficiency results in reduced STING protein in nonhematopoietic cells and tissues, and renders STING protein unstable in immune cells, leading to severely dampened STING signaling capacity. The competing degradation mechanism of resting-state STING requires IRE1 alpha and lysosomes. TOLLIP mediates clearance of Huntington's disease-linked polyQ protein aggregates. Ectopically expressed polyQ proteins in vitro or endogenous polyQ proteins in Huntington's disease mouse striatum sequester TOLLIP away from STING, leading to reduced STING protein and dampened immune signaling. Tollip(-/-) also ameliorates STING-mediated autoimmune disease in Trex1(-/-) mice. Together, our findings reveal that resting-state STING protein level is strictly regulated by a constant tug-of-war between 'stabilizer' TOLLIP and 'degrader' IRE1 alpha-lysosome that together maintain tissue immune homeostasis. The protein STING has an essential function in intracellular DNA sensing, but how it is regulated under steady state is unclear. Yan and colleagues demonstrate that the protein TOLLIP stabilizes steady-state STING and facilitates its signaling.	[Pokatayev, Vladislav; Yang, Kun; Tu, Xintao; Dobbs, Nicole; Wu, Jianjun; Yan, Nan] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kalb, Robert G.] Northwestern Univ Neurol, Feinberg Sch Med, Chicago, IL USA; [Pokatayev, Vladislav] Broad Inst Harvard & MIT, Cambridge, MA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Yan, N (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu	Tu, Xintao/AGW-3112-2022; Yang, Kun/O-2172-2017	Yang, Kun/0000-0002-2011-7084; Wu, Jianjun/0000-0003-4518-8361; Tu, Xintao/0000-0001-8789-5297	National Institutes of Health [AR067135, AI134877, NS0870778, NS052325]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180288]; Burroughs Wellcome Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We thank M. Maillard (Centre hospitalier universitaire vaudois) for Tollip<SUP>-/-</SUP> mice; M. Lehrman (University of Texas Southwestern Medical Center) for Ern1<SUP>+/+</SUP>, Ern1<SUP>-/-</SUP>, Xbp1<SUP>+/+</SUP> and Xbp1<SUP>-/-</SUP> MEFs; U. Deshmukh (Oklahoma Medical Research Foundation) for the initial IHC protocol; and members of the Yan laboratory for helpful discussion. This work was supported by the National Institutes of Health (grant nos. AR067135 and AI134877 to N.Y.; grant nos. NS0870778 and NS052325 to R.G.K.), the Cancer Prevention and Research Institute of Texas (CPRIT, RP180288 to N.Y.) and the Burroughs Wellcome Fund (N.Y.).	Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fink SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7814; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Wang YM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005012; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; Xing JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00101-w; Yan N, 2017, J INTERF CYTOK RES, V37, P198, DOI 10.1089/jir.2016.0086; Yang K, 2018, J EXP MED, V215, P2600, DOI 10.1084/jem.20180783; Zhang M, 2016, CELL RES, V26, P1302, DOI 10.1038/cr.2016.125; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	27	40	41	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					158	+		10.1038/s41590-019-0569-9	http://dx.doi.org/10.1038/s41590-019-0569-9		JAN 2020	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31932809	Green Accepted			2022-12-18	WOS:000508182300003
J	Hatzi, K; Geng, HM; Doane, AS; Meydan, C; LaRiviere, R; Cardenas, M; Duy, C; Shen, H; Vidal, MNC; Baslan, T; Mohammad, HP; Kruger, RG; Shaknovich, R; Haberman, AM; Inghirami, G; Lowe, SW; Melnick, AM				Hatzi, Katerina; Geng, Huimin; Doane, Ashley S.; Meydan, Cem; LaRiviere, Reed; Cardenas, Mariano; Duy, Cihangir; Shen, Hao; Vidal, Maria Nieves Calvo; Baslan, Timour; Mohammad, Helai P.; Kruger, Ryan G.; Shaknovich, Rita; Haberman, Ann M.; Inghirami, Giorgio; Lowe, Scott W.; Melnick, Ari M.			Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis	NATURE IMMUNOLOGY			English	Article							B-CELLS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; READ ALIGNMENT; BCL6; EXPRESSION; DIFFERENTIATION; PROMOTES; COMPLEXES; DISCOVERY	Germinal center (GC) B cells feature repression of many gene enhancers to establish their characteristic transcriptome. Here we show that conditional deletion of Lsd1 in GCs significantly impaired GC formation, associated with failure to repress immune synapse genes linked to GC exit, which are also direct targets of the transcriptional repressor BCL6. We found that BCL6 directly binds LSD1 and recruits it primarily to intergenic and intronic enhancers. Conditional deletion of Lsd1 suppressed GC hyperplasia caused by constitutive expression of BCL6 and significantly delayed BCL6-driven lymphomagenesis. Administration of catalytic inhibitors of LSD1 had little effect on GC formation or GC-derived lymphoma cells. Using a CRISPR-Cas9 domain screen, we found instead that the LSD1 Tower domain was critical for dependence on LSD1 in GC-derived B cells. These results indicate an essential role for LSD1 in the humoral immune response, where it modulates enhancer function by forming repression complexes with BCL6.	[Hatzi, Katerina; Doane, Ashley S.; LaRiviere, Reed; Cardenas, Mariano; Duy, Cihangir; Shen, Hao; Vidal, Maria Nieves Calvo; Shaknovich, Rita; Melnick, Ari M.] Weill Cornell Med, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA; [Hatzi, Katerina; Baslan, Timour; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Geng, Huimin] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Doane, Ashley S.; Meydan, Cem] Weill Cornell Med, Dept Physiol & Biophys, Inst Computat Biomed, New York, NY USA; [Mohammad, Helai P.; Kruger, Ryan G.] GlaxoSmithKline, Canc Epigenet Dept, Collegeville, PA USA; [Haberman, Ann M.] Yale Univ, Sch Med, Dept Immunobiol, Dept Lab Med, New Haven, CT USA; [Inghirami, Giorgio] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Cardenas, Mariano] Rockefeller Univ, High Throughput & Spect Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Shaknovich, Rita] Canc Genet Inc, Rutherford, NJ USA	Cornell University; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Cornell University; GlaxoSmithKline; Yale University; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Rockefeller University	Melnick, AM (corresponding author), Weill Cornell Med, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA.	amm2014@med.cornell.edu	Doane, Ashley Stephen/A-6442-2015; Duy, Cihangir/AAD-7735-2022; Melnick, Ari/AAA-5763-2020	Doane, Ashley Stephen/0000-0002-1489-1786; Duy, Cihangir/0000-0001-9150-9379; Meydan, Cem/0000-0002-0663-6216	Chemotherapy Foundation; NCI [R01 CA187109, R35 CA220499]; Charles H. Revson Senior Fellowship in Biomedical Science; NIH/NCI [K99CA212276]; Follicular Lymphoma Consortium;  [LLS-TRP 6457-15];  [LLS SCOR 7012-16]; NATIONAL CANCER INSTITUTE [K99CA212276, R35CA220499] Funding Source: NIH RePORTER	Chemotherapy Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Charles H. Revson Senior Fellowship in Biomedical Science; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Follicular Lymphoma Consortium; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Melnick and Lowe laboratories for helpful discussions throughout the duration of the project. We also thank T. Hoshii and S. Armstrong for sharing CRISPR-Cas9 reagents and protocols and M. Luo, B. Laurent and Y. Shi for helpful suggestions on LSD1 demethylation assays. A.M.M. is supported by the Chemotherapy Foundation, LLS-TRP 6457-15, LLS SCOR 7012-16, NCI R01 CA187109, NCI R35 CA220499 and the Follicular Lymphoma Consortium. K.H. was supported by the Charles H. Revson Senior Fellowship in Biomedical Science and the NIH/NCI K99CA212276 award.	Beguelin W, 2016, CANCER CELL, V30, P197, DOI 10.1016/j.ccell.2016.07.006; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bond J, 2016, ONCOTARGET, V7, P65923, DOI 10.18632/oncotarget.11688; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cusan M, 2018, BLOOD, V131, P1730, DOI 10.1182/blood-2017-09-807024; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166438; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Geng HM, 2012, CANCER DISCOV, V2, P1004, DOI 10.1158/2159-8290.CD-12-0208; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kim SJ, 2008, J EXP MED, V205, P2437, DOI 10.1084/jem.20070731; Kruger RG, 2013, BLOOD, V122, P3964, DOI 10.1182/blood.V122.21.3964.3964; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku351; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Piovesan D, 2017, CELL REP, V19, P461, DOI 10.1016/j.celrep.2017.03.060; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Stamos D, 2018, J IMMUNOL, V200; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	40	40	3	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					86	+		10.1038/s41590-018-0273-1	http://dx.doi.org/10.1038/s41590-018-0273-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538335	Green Accepted			2022-12-18	WOS:000456273900017
J	Sato, R; Kato, A; Chimura, T; Saitoh, SI; Shibata, T; Murakami, Y; Fukui, R; Liu, KW; Zhang, Y; Arii, J; Sun-Wada, GH; Wada, Y; Ikenoue, T; Barber, GN; Manabe, T; Kawaguchi, Y; Miyake, K				Sato, Ryota; Kato, Akihisa; Chimura, Takahiko; Saitoh, Shin-Ichiroh; Shibata, Takuma; Murakami, Yusuke; Fukui, Ryutaro; Liu, Kaiwen; Zhang, Yun; Arii, Jun; Sun-Wada, Ge-Hong; Wada, Yoh; Ikenoue, Tsuneo; Barber, Glen N.; Manabe, Toshiya; Kawaguchi, Yasushi; Miyake, Kensuke			Combating herpesvirus encephalitis by potentiating a TLR3-mTORC2 axis	NATURE IMMUNOLOGY			English	Article							ANTIVIRAL DEFENSE; I-INTERFERON; VIRUS-INFECTION; KAPPA-B; INNATE; TLR3; IMMUNITY; ALPHA; ROLES; RECOGNITION	TLR3 is a sensor of double-stranded RNA that is indispensable for defense against infection with herpes simplex virus type 1 (HSV-1) in the brain. We found here that TLR3 was required for innate immune responses to HSV-1 in neurons and astrocytes. During infection with HSV-1, TLR3 recruited the metabolic checkpoint kinase complex mTORC2, which led to the induction of chemokines and trafficking of TLR3 to the cell periphery. Such trafficking enabled the activation of molecules (including mTORC1) required for the induction of type I interferons. Intracranial infection of mice with HSV-1 was exacerbated by impairment of TLR3 responses with an inhibitor of mTOR and was significantly 'rescued' by potentiation of TLR3 responses with an agonistic antibody to TLR3. These results suggest that the TLR3-mTORC2 axis might be a therapeutic target through which to combat herpes simplex encephalitis.	[Sato, Ryota; Saitoh, Shin-Ichiroh; Shibata, Takuma; Murakami, Yusuke; Fukui, Ryutaro; Liu, Kaiwen; Zhang, Yun; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Innate Immun, Dept Microbiol & Immunol, Tokyo, Japan; [Kato, Akihisa; Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Div Mol Virol, Dept Microbiol & Immunol, Tokyo, Japan; [Kato, Akihisa; Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan; [Chimura, Takahiko; Manabe, Toshiya] Univ Tokyo, Inst Med Sci, Div Neuronal Network, Dept Basic Med Sci, Tokyo, Japan; [Sun-Wada, Ge-Hong] Doshisha Womens Coll, Fac Pharmaceut Sci, Dept Biochem, Kyoto, Japan; [Wada, Yoh] Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Osaka, Japan; [Ikenoue, Tsuneo] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan; [Barber, Glen N.] Univ Miami, Miller Sch Med, UM Sylvester Canc Ctr, Miami, FL 33136 USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; University of Tokyo; University of Miami	Miyake, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Innate Immun, Dept Microbiol & Immunol, Tokyo, Japan.; Kawaguchi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Virol, Dept Microbiol & Immunol, Tokyo, Japan.; Kawaguchi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan.	ykawagu@ims.u-tokyo.ac.jp; kmiyake@ims.u-tokyo.ac.jp	Shibata, Takuma/M-8196-2019; liu, kaiwen/GVS-5259-2022	Murakami, Yusuke/0000-0001-6820-709X; Kawaguchi, Yasushi/0000-0001-8232-6925	Grant for Joint Research Project of the Institute of Medical Science; US National Institutes of Health (NIAID) [AI079336]; University of Tokyo; Japan Initiative for Global Research Network on Infectious Diseases [JP18fm0108006];  [16H06388];  [17H04080];  [16K08827];  [17K09369];  [17K08851];  [18K07169];  [17H05069];  [18K15133];  [17K19548];  [17K19549];  [16H06433];  [16H06429];  [16K21723];  [18H04666];  [18H04968];  [18H04856]	Grant for Joint Research Project of the Institute of Medical Science; US National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Tokyo; Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	We thank P.W. Kincade for critical reading of the manuscript; K. Kontani (Meiji Pharmaceutical University) for rabbit polyclonal antibody to mouse Arl8; T. Kitamura (The University of Tokyo) for retroviral pMXpuro vectors; S. Akira (Osaka University) for C57BL/6 Tlr3<SUP>-/-</SUP> mice; and N. Tanimura, C. Sato and Y. Motoi for advice on the experiments. Supported by Grant-in-Aid for Scientific Research (S) (16H06388 to K. M.); Grant-in-Aid for Scientific Research (B) (17H04080 to Y.K.); Grant-in-Aid for Scientific Research (C) (16K08827 and 17K09369 to T.I.; 17K08851 to J.A.; and 18K07169 to R.F.); Grant for Joint Research Project of the Institute of Medical Science; the US National Institutes of Health (NIAID/AI079336 to G.N.B.); the University of Tokyo; a Grant-in-Aid for Young Scientists (A) (17H05069 to A.K.; and 18K15133 to Y.M.); Grant-in-Aid for Challenging Exploratory Research (17K19548 to K.M.; and 17K19549 to A.K.); Grant-in-Aid for Scientific Research on Innovative Areas (16H06433, 16H06429 and 16K21723 to Y.K.; 18H04666 to K.M.; 18H04968 to A.K.; and 18H04856 to S.-I.S.); and a contract research fund from the Japan Initiative for Global Research Network on Infectious Diseases (JP18fm0108006 to Y.K.).	Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bodur C, 2018, EMBO J, V37, P19, DOI 10.15252/embj.201696164; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Caron A, 2015, ANNU REV NUTR, V35, P321, DOI 10.1146/annurev-nutr-071714-034355; Chen CY, 2017, EMBO REP, V18, P169, DOI 10.15252/embr.201642586; Dalpke AH, 2002, J IMMUNOL, V168, P4854, DOI 10.4049/jimmunol.168.10.4854; Ebner M, 2017, J CELL BIOL, V216, P343, DOI 10.1083/jcb.201610060; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; Fukui R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01491; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Johnson J, 2007, J BIOL CHEM, V282, P15022, DOI 10.1074/jbc.M700421200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawamura N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2069; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Menasria R, 2013, J VIROL, V87, P7301, DOI 10.1128/JVI.00591-13; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; Murakami Y, 2014, J IMMUNOL, V193, P5208, DOI 10.4049/jimmunol.1400386; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; Saitoh SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01687-x; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Schmitz F., EUR J IMMUNOL, V38; Temizoz B, 2015, EUR J IMMUNOL, V45, P1159, DOI 10.1002/eji.201445132; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; Wisner TW, 2011, J VIROL, V85, P5919, DOI 10.1128/JVI.00116-11; Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x; Zhang SY, 2015, J EXP MED, V212, P1342, DOI 10.1084/jem.2129insight4	48	40	44	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1071	+		10.1038/s41590-018-0203-2	http://dx.doi.org/10.1038/s41590-018-0203-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30201994				2022-12-18	WOS:000445968600013
J	Bezbradica, JS; Rosenstein, RK; DeMarco, RA; Brodsky, I; Medzhitov, R				Bezbradica, Jelena S.; Rosenstein, Rachel K.; DeMarco, Richard A.; Brodsky, Igor; Medzhitov, Ruslan			A role for the ITAM signaling module in specifying cytokine-receptor functions	NATURE IMMUNOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; FC-GAMMA RECEPTORS; INTERFERON-GAMMA; IFN-GAMMA; IMMUNE-COMPLEXES; MACROPHAGES; ACTIVATION; PATHWAY; STAT1; PHOSPHORYLATION	Diverse cellular responses to external cues are controlled by a small number of signal-transduction pathways, but how the specificity of functional outcomes is achieved remains unclear. Here we describe a mechanism for signal integration based on the functional coupling of two distinct signaling pathways widely used in leukocytes: the ITAM pathway and the Jak-STAT pathway. Through the use of the receptor for interferon-gamma (IFN-gamma R) and the ITAM adaptor Fc gamma as an example, we found that IFN-gamma modified responses of the phagocytic antibody receptor Fc gamma RI (CD64) to specify cell-autonomous antimicrobial functions. Unexpectedly, we also found that in peritoneal macrophages, IFN-gamma R itself required tonic signaling from Fc gamma through the kinase PI(3) K for the induction of a subset of IFN-gamma-specific antimicrobial functions. Our findings may be generalizable to other ITAM and Jak-STAT signaling pathways and may help explain signal integration by those pathways.	[Bezbradica, Jelena S.; Rosenstein, Rachel K.; Brodsky, Igor; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Bezbradica, Jelena S.; Rosenstein, Rachel K.; Brodsky, Igor; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [DeMarco, Richard A.] Amnis EMD Millipore, Seattle, WA USA	Howard Hughes Medical Institute; Yale University; Yale University; Merck KGaA; MilliporeSigma	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu		Bezbradica, Jelena/0000-0003-1441-1727	Howard Hughes Medical Institute; US National Institutes of Health [1R56AI087725-01 AI046688, AI055502, AI089771, DK071754]; Damon Runyon Cancer Research Foundation [DRG-1968-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089771, R37AI046688, R56AI087725, R01AI046688, R01AI055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Stetson (University of Washington, Seattle) for modified retroviral vector pMSCV.hCD2 and vectors MIGR2 and pMSCV.IRES-GFP; members of the Medzhitov laboratory and S. Joyce for discussions and reading of the manuscript; and C. Annicelli and S. Cronin for assistance with animal work. Supported by the Howard Hughes Medical Institute (R.M. and J.S.B.), the US National Institutes of Health (1R56AI087725-01 AI046688, AI055502, AI089771 and DK071754 to R.M.) and the Damon Runyon Cancer Research Foundation (DRG-1968-08 to J.S.B.).	AGARWAL A, 1993, J BIOL CHEM, V268, P15900; Beekman JA, 2008, IMMUNOL LETT, V116, P149, DOI 10.1016/j.imlet.2007.12.003; Bezbradica JS, 2012, CURR OPIN IMMUNOL, V24, P58, DOI 10.1016/j.coi.2011.12.010; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; ESPARZA I, 1983, J IMMUNOL, V131, P2117; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; Gamero AM, 2000, J BIOL CHEM, V275, P16574, DOI 10.1074/jbc.M910149199; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; VIRGIN HW, 1985, J IMMUNOL, V135, P3735; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023	50	40	43	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					333	+		10.1038/ni.2845	http://dx.doi.org/10.1038/ni.2845			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24608040	Green Accepted, Green Published			2022-12-18	WOS:000333252000008
J	Sidibe, A; Imhof, BA				Sidibe, Adama; Imhof, Beat A.			VE-cadherin phosphorylation decides: vascular permeability or diapedesis	NATURE IMMUNOLOGY			English	Editorial Material							TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CADHERIN; BETA-CATENIN; MAINTAINS; BARRIER		[Sidibe, Adama; Imhof, Beat A.] Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, Geneva, Switzerland	University of Geneva	Sidibe, A (corresponding author), Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, Geneva, Switzerland.	beat.imhof@unige.ch	SIDIBE, Adama/AAA-5679-2021	SIDIBE, Adama/0000-0003-2808-3744				Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Turowski P, 2008, J CELL SCI, V121, P29, DOI 10.1242/jcs.022681; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824	12	40	40	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					215	217		10.1038/ni.2825	http://dx.doi.org/10.1038/ni.2825			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24549064				2022-12-18	WOS:000331683100004
J	Beal, AM; Ramos-Hernandez, N; Riling, CR; Nowelsky, EA; Oliver, PM				Beal, Allison M.; Ramos-Hernandez, Natalia; Riling, Chris R.; Nowelsky, Erin A.; Oliver, Paula M.			TGF-beta induces the expression of the adaptor Ndfip1 to silence IL-4 production during iT(reg) cell differentiation	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; FACTOR FAMILY-MEMBER; UBIQUITIN LIGASE; FOXP3 EXPRESSION; DOWN-REGULATION; CUTTING EDGE; INDUCTION; PROTEIN; ITCH	Mice deficient in the adaptor Ndfip1 develop inflammation at sites of environmental antigen exposure. We show here that such mice had fewer inducible regulatory T cells (iT(reg) cells). In vitro, Ndfip1-deficient T cells expressed normal amounts of the transcription factor Foxp3 during the first 48 h of iT(reg) cell differentiation; however, this expression was not sustained. Abortive Foxp3 expression was caused by production of interleukin 4 (IL-4) by Ndfip1(-/-) cells. We found that Ndfip1 expression was transiently upregulated during iT(reg) cell differentiation in a manner dependent on transforming growth factor-beta (TGF-beta). Once expressed, Ndfip1 promoted degradation of the transcription factor JunB mediated by the E3 ubiquitin ligase Itch, thus preventing IL-4 production. On the basis of our data, we propose that TGF-beta signaling induces Ndfip1 expression to silence IL-4 production, thus permitting iT(reg) cell differentiation.	[Beal, Allison M.; Nowelsky, Erin A.; Oliver, Paula M.] Childrens Hosp Philadelphia, Cell Pathol Div, Philadelphia, PA 19104 USA; [Ramos-Hernandez, Natalia; Riling, Chris R.; Oliver, Paula M.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Oliver, Paula M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Oliver, PM (corresponding author), Childrens Hosp Philadelphia, Cell Pathol Div, Philadelphia, PA 19104 USA.	paulao@mail.med.upenn.edu			U.S. National Institutes of Health [RO3 AR057144, 1F32AI085837, R01AI093566]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI085837, R01AI093566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057144] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Ramon for discussions and for help with setting up iT<INF>reg</INF> cell culture conditions; A. Bhandoola for critical reading of the manuscript; J.K. Burkhardt for discussions; A. Laroche for technical assistance; and the staff of the flow cytometry core at the University of Pennsylvania. Supported by the U.S. National Institutes of Health (RO3 AR057144, 1F32AI085837 and R01AI093566).	Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Li-Weber M, 1998, J BIOL CHEM, V273, P32460, DOI 10.1074/jbc.273.49.32460; Liang QL, 2010, J IMMUNOL, V185, P5704, DOI 10.4049/jimmunol.1000690; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Park J, 2006, BIOCHEM PHARMACOL, V71, P1229, DOI 10.1016/j.bcp.2005.12.036; Ramon HE, 2011, MUCOSAL IMMUNOL, V4, P314, DOI 10.1038/mi.2010.69; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thornton AM, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090106; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Xu L, 2010, MUCOSAL IMMUNOL, V3, P230, DOI 10.1038/mi.2010.7; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	50	40	43	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					77	U104		10.1038/ni.2154	http://dx.doi.org/10.1038/ni.2154			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22080920	Green Accepted			2022-12-18	WOS:000298412800014
J	Curry, JD; Geier, JK; Schlissel, MS				Curry, JD; Geier, JK; Schlissel, MS			Single-strand recombination signal sequence nicks in vivo: Evidence for a capture model of synapsis	NATURE IMMUNOLOGY			English	Article							BROKEN DNA-MOLECULES; DEVELOPING B-CELLS; V(D)J RECOMBINATION; GENE REARRANGEMENT; MOUSE THYMOCYTES; RAG2 PROTEINS; CHAIN GENE; BREAKS; LOCUS; TRANSCRIPTION	Variable ( diversity) joining (V(D)J) recombination is initiated by the introduction of single-strand DNA breaks ( nicks) at recombination signal sequences (RSSs). The importance and fate of these RSS nicks for the regulation of the V( D) J rearrangement and their potential contribution to genomic instability are poorly understood. Using two new methodologies, we were able to detect and quantify specific RSS nicks introduced into genomic DNA by incubation with recombination-activating gene proteins in vitro. In vivo, however, we found that nicks mediated by recombination-activating gene ( RAG) proteins were detectable only in gene segments associated with RSSs containing 12-base pair spacers but not in those containing 23-base pair spacers. These data support a model of capture rather than synapsis for pairwise RSS cleavage during V( D) J recombination.	Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schlissel, MS (corresponding author), Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mss@berkeley.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040227, R01AI040227] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48702] Funding Source: Medline; NIAID NIH HHS [AI40227] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Curry JD, 2005, J IMMUNOL METHODS, V296, P19, DOI 10.1016/j.jim.2004.10.003; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Greenbaum S, 2004, J BIOL CHEM, V279, P45028, DOI 10.1074/jbc.M400061200; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; LEWIS S, 1985, SCIENCE, V228, P677, DOI 10.1126/science.3158075; LEWIS S, 1989, CELL, V59, P585, DOI 10.1016/0092-8674(89)90002-0; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Neiditch MB, 2002, MOL CELL, V9, P871, DOI 10.1016/S1097-2765(02)00494-X; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TONEGAWA S, 1978, COLD SPRING HARB SYM, V42, P921; VanGent DC, 1996, CURR TOP MICROBIOL, V217, P1; Zhong XP, 1999, J IMMUNOL, V163, P295	32	40	41	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1272	1279		10.1038/ni1270	http://dx.doi.org/10.1038/ni1270			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16286921				2022-12-18	WOS:000233371900016
J	Levite, M				Levite, M			Autoimmune epilepsy	NATURE IMMUNOLOGY			English	Letter									Tel Aviv Univ, Sackler Fac Med, Rehovot, Israel; Weizmann Inst Sci, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Levite, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Rehovot, Israel.								0	40	50	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					500	500		10.1038/ni0602-500	http://dx.doi.org/10.1038/ni0602-500			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032558	Bronze			2022-12-18	WOS:000175874700003
J	Tuzlak, S; Dejean, AS; Iannacone, M; Quintana, FJ; Waisman, A; Ginhoux, F; Korn, T; Becher, B				Tuzlak, Selma; Dejean, Anne S.; Iannacone, Matteo; Quintana, Francisco J.; Waisman, Ari; Ginhoux, Florent; Korn, Thomas; Becher, Burkhard			Repositioning T-H cell polarization from single cytokines to complex help	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR GATA-3; COLONY-STIMULATING FACTOR; CXC CHEMOKINE RECEPTOR-5; GM-CSF; GROWTH-FACTOR; IFN-GAMMA; INTERFERON-GAMMA; TGF-BETA; INFLAMMATORY CYTOKINE	When helper T (T-H) cell polarization was initially described three decades ago, the T-H cell universe grew dramatically. New subsets were described based on their expression of few specific cytokines. Beyond T(H)1 and T(H)2 cells, this led to the coining of various T(H)17 and regulatory (T-reg) cell subsets as well as T(H)22, T(H)25, follicular helper (T-FH), T(H)3, T(H)5 and T(H)9 cells. High-dimensional single-cell analysis revealed that a categorization of T-H cells into a single-cytokine-based nomenclature fails to capture the complexity and diversity of T-H cells. Similar to the simple nomenclature used to describe innate lymphoid cells (ILCs), we propose that T-H cell polarization should be categorized in terms of the help they provide to phagocytes (type 1), to B cells, eosinophils and mast cells (type 2) and to non-immune tissue cells, including the stroma and epithelium (type 3). Studying T-H cells based on their helper function and the cells they help, rather than phenotypic features such as individual analyzed cytokines or transcription factors, better captures T-H cell plasticity and conversion as well as the breadth of immune responses in vivo. The T helper subset paradigm has been instrumental in informing our understanding of T cell diversity; however, modern single-cell analyses have revealed the limits of the concept. In their Perspective, Becher and colleagues propose an alternative framework in which to understand T helper diversity, based not on transcription factors and cytokines but rather physiological functionality.	[Tuzlak, Selma; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Dejean, Anne S.] Univ Toulouse III, Inst Toulousain Malad Infect & Inflammatoires INF, INSERM UMR1291, CNRS,UMR5051, Toulouse, France; [Iannacone, Matteo] IRCCS, Div Immunol Transplantat & Infect Dis, San Raffaele Sci Inst, Milan, Italy; [Iannacone, Matteo] Univ Vita Salute San Raffaele, Milan, Italy; [Quintana, Francisco J.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Quintana, Francisco J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Univ Med Ctr, Mainz, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy, Univ Med Ctr, Mainz, Germany; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China; [Korn, Thomas] Tech Univ Munich, Inst Expt Neuroimmunol, Klinikum Rechts Isar, Munich, Germany; [Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Korn, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University; Technical University of Munich; Technical University of Munich; University of Munich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.; Korn, T (corresponding author), Tech Univ Munich, Inst Expt Neuroimmunol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	thomas.korn@tum.de; becher@immunology.uzh.ch	Iannacone, Matteo/I-8507-2018; Becher, Burkhard/ABE-4225-2020; Waisman, Ari/C-7383-2015	Iannacone, Matteo/0000-0002-9370-2671; Becher, Burkhard/0000-0002-1541-7867; Korn, Thomas/0000-0002-3633-0955; Ginhoux, Florent/0000-0002-2857-7755; Waisman, Ari/0000-0003-4304-8234; Dejean, Anne S./0000-0002-8846-1113	Agence Nationale de la Recherche (ANR FoxoTic); ARSEP foundation [ARSEP R19191BB]; FRM [R20097BB]; European Research Council (ERC) Consolidator Grant [725038]; ERC [957502, CoG647215, AdG 882424]; Italian Association for Cancer Research [19891, 22737]; Italian Ministry of Health [RF-2018-12365801, COVID-2020-12371617]; Lombardy Foundation for Biomedical Research [2015-0010]; European Molecular Biology Organization Young Investigator Program; Gilead Sciences; Takis Biotech; Toscana Life Sciences and Asher Bio; NIH [NS102807, ES02530, ES029136, AI126880]; National Multiple Sclerosis Society [RG4111A1]; International Progressive MS Alliance [PA-1604-08459]; EMBO YIP; BMRC Central Research Fund (UIBR) award; Singapore NRF Senior Investigatorship [NRFI2017-02]; Deutsche Forschungsgemeinschaft [SFB1054, TRR128, TRR274, EXC 2145, 390857198, TRR156, CRC1292]; Swiss National Science Foundation [733 310030_170320, 1030 310030_188450, CRSII5_183478]; H2020 Projects [826121, 847782]	Agence Nationale de la Recherche (ANR FoxoTic)(French National Research Agency (ANR)); ARSEP foundation; FRM(Fondation pour la Recherche Medicale); European Research Council (ERC) Consolidator Grant(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Lombardy Foundation for Biomedical Research; European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Gilead Sciences(Gilead Sciences); Takis Biotech; Toscana Life Sciences and Asher Bio; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); International Progressive MS Alliance; EMBO YIP(European Molecular Biology Organization (EMBO)); BMRC Central Research Fund (UIBR) award; Singapore NRF Senior Investigatorship(National Research Foundation, Singapore); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); H2020 Projects	We thank F. Sallusto and S. Sakaguchi for helpful comments on the manuscript. A.S.D. is supported by the Agence Nationale de la Recherche (ANR FoxoTic), the ARSEP foundation (ARSEP R19191BB) and the FRM (R20097BB); M.I. is supported by the European Research Council (ERC) Consolidator Grant 725038, the ERC Proof of Concept Grant 957502, the Italian Association for Cancer Research grants 19891 and 22737, the Italian Ministry of Health grants RF-2018-12365801 and COVID-2020-12371617, the Lombardy Foundation for Biomedical Research grant 2015-0010, the European Molecular Biology Organization Young Investigator Program and funded research agreements from Gilead Sciences, Takis Biotech, Toscana Life Sciences and Asher Bio. F.J.Q. is supported by NS102807, ES02530, ES029136 and AI126880 from the NIH; RG4111A1 from the National Multiple Sclerosis Society; and PA-1604-08459 from the International Progressive MS Alliance. F.G. is supported by the EMBO YIP, a BMRC Central Research Fund (UIBR) award and a Singapore NRF Senior Investigatorship (NRFI2017-02); TK is supported by the Deutsche Forschungsgemeinschaft (SFB1054, TRR128, TRR274, EXC 2145 (ID 390857198)) and the ERC (CoG647215); A.W. is supported by the Deutsche Forschungsgemeinschaft (TRR128, TRR156, CRC1292 and a Reinhard Koselleck prize); B.B. is supported by the Swiss National Science Foundation (733 310030_170320, 1030 310030_188450 and CRSII5_183478 to B.B.), H2020 Projects (826121, 847782) and the ERC (AdG 882424).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Ahn HJ, 1997, J IMMUNOL, V159, P2125; ANDO DG, 1989, CELL IMMUNOL, V124, P132, DOI 10.1016/0008-8749(89)90117-2; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borghi M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00506; BOTTOMLY K, 1978, J EXP MED, V148, P1216, DOI 10.1084/jem.148.5.1216; Bradley LM, 1996, J IMMUNOL, V157, P1350; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Croxford AL, 2014, J INVEST DERMATOL, V134, P728, DOI 10.1038/jid.2013.404; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Darrieutort-Laffite C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/241840; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eberl G, 2018, TRENDS IMMUNOL, V39, P261, DOI 10.1016/j.it.2017.11.004; Eberl G, 2016, NAT REV IMMUNOL, V16, P524, DOI 10.1038/nri.2016.75; Eisenbarth SC, 2021, TRENDS IMMUNOL, V42, P658, DOI 10.1016/j.it.2021.06.003; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Ferber IA, 1996, J IMMUNOL, V156, P5; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Galli E, 2019, EUR J IMMUNOL, V49, P212, DOI 10.1002/eji.201847758; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Herndler-Brandstetter D, 2014, CELL RES, V24, P1379, DOI 10.1038/cr.2014.155; Hertzog P, 2011, J INTERF CYTOK RES, V31, P5, DOI 10.1089/jir.2010.0126; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; KAPPLER JW, 1977, J EXP MED, V146, P1748, DOI 10.1084/jem.146.6.1748; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kubick N, 2021, GENES-BASEL, V12, DOI 10.3390/genes12060813; Kunkl M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020482; KURTJONES EA, 1987, J EXP MED, V166, P1774, DOI 10.1084/jem.166.6.1774; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liu YW, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6519465; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Mehta P, 2020, LANCET RESP MED, V8, P822, DOI 10.1016/S2213-2600(20)30267-8; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Olatunde AC, 2021, TRENDS IMMUNOL, V42, P536, DOI 10.1016/j.it.2021.04.006; PARISH CR, 1972, J EXP MED, V135, P298, DOI 10.1084/jem.135.2.298; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Plank MW, 2017, J IMMUNOL, V198, P2182, DOI 10.4049/jimmunol.1601480; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Pradeu T, 2013, NAT REV IMMUNOL, V13, P764, DOI 10.1038/nri3521; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Regen T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.aaz6563; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; RENAULD JC, 1993, CANCER INVEST, V11, P635, DOI 10.3109/07357909309011682; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sanmarco LM, 2021, NATURE, V590, P473, DOI 10.1038/s41586-020-03116-4; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sheng W., 2015, IMMUNOME RES, V11, DOI [10.4172/1745-7580.1000098, DOI 10.4172/1745-7580.1000098]; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sparber F, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020054; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Sun L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01922; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TADA T, 1978, J EXP MED, V147, P446, DOI 10.1084/jem.147.2.446; Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x; Tortola L, 2020, IMMUNITY, V53, P597, DOI 10.1016/j.immuni.2020.07.001; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; van Hamburg JP, 2018, J AUTOIMMUN, V87, P69, DOI 10.1016/j.jaut.2017.12.006; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; VOSKUHL RR, 1993, AUTOIMMUNITY, V15, P137, DOI 10.3109/08916939309043888; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wu L, 2015, J IMMUNOL, V194, P4528, DOI 10.4049/jimmunol.1402760; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zwicky P, 2020, J EXP MED, V217, DOI 10.1084/jem.20191123	138	39	39	2	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1210	1217		10.1038/s41590-021-01009-w	http://dx.doi.org/10.1038/s41590-021-01009-w		SEP 2021	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34545250	Bronze			2022-12-18	WOS:000698024500001
J	Hartl, FA; Beck-Garcia, E; Woessner, NM; Flachsmann, LJ; Cardenas, RMHV; Brandl, SM; Taromi, S; Fiala, GJ; Morath, A; Mishra, P; Yousefi, OS; Zimmermann, J; Hoefflin, N; Kohn, M; Wohrl, BM; Zeiser, R; Schweimer, K; Gunther, S; Schamel, WW; Minguet, S				Hartl, Frederike A.; Beck-Garcia, Esmeralda; Woessner, Nadine M.; Flachsmann, Lea J.; Cardenas, Rubi M-H Velasco; Brandl, Simon M.; Taromi, Sanaz; Fiala, Gina J.; Morath, Anna; Mishra, Pankaj; Yousefi, O. Sascha; Zimmermann, Julia; Hoefflin, Nico; Koehn, Maja; Woehrl, Birgitta M.; Zeiser, Robert; Schweimer, Kristian; Guenther, Stefan; Schamel, Wolfgang W.; Minguet, Susana			Noncanonical binding of Lck to CD3 epsilon promotes TCR signaling and CAR function	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; CHIMERIC ANTIGEN RECEPTOR; SRC-FAMILY KINASES; SH3 DOMAIN; PROTEIN; RECRUITMENT; ACTIVATION; CD4; NCK; DIFFERENTIATION	How Lck is recruited to the TCR to initiate signaling is not well known. Here Minguet and colleagues report a previously unknown binding motif in the CD3 epsilon cytoplasmic tail that interacts in a noncanonical mode with the Lck SH3 domain that may help to improve TCR activation and the antitumor activity of a clinically approved CAR. Initiation of T cell antigen receptor (TCR) signaling involves phosphorylation of CD3 cytoplasmic tails by the tyrosine kinase Lck. How Lck is recruited to the TCR to initiate signaling is not well known. We report a previously unknown binding motif in the CD3 epsilon cytoplasmic tail that interacts in a noncanonical mode with the Lck SH3 domain: the receptor kinase (RK) motif. The RK motif is accessible only upon TCR ligation, demonstrating how ligand binding leads to Lck recruitment. Binding of the Lck SH3 domain to the exposed RK motif resulted in local augmentation of Lck activity, CD3 phosphorylation, T cell activation and thymocyte development. Introducing the RK motif into a well-characterized 41BB-based chimeric antigen receptor enhanced its antitumor function in vitro and in vivo. Our findings underscore how a better understanding of the functioning of the TCR might promote rational improvement of chimeric antigen receptor design for the treatment of cancer.	[Hartl, Frederike A.; Beck-Garcia, Esmeralda; Woessner, Nadine M.; Flachsmann, Lea J.; Cardenas, Rubi M-H Velasco; Brandl, Simon M.; Fiala, Gina J.; Morath, Anna; Yousefi, O. Sascha; Zimmermann, Julia; Hoefflin, Nico; Koehn, Maja; Schamel, Wolfgang W.; Minguet, Susana] Albert Ludwigs Univ Freiburg, Fac Biol, Freiburg, Germany; [Hartl, Frederike A.; Woessner, Nadine M.; Cardenas, Rubi M-H Velasco; Brandl, Simon M.; Fiala, Gina J.; Morath, Anna; Yousefi, O. Sascha; Hoefflin, Nico; Koehn, Maja; Zeiser, Robert; Schamel, Wolfgang W.; Minguet, Susana] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Hartl, Frederike A.; Woessner, Nadine M.; Cardenas, Rubi M-H Velasco; Brandl, Simon M.; Fiala, Gina J.; Morath, Anna; Yousefi, O. Sascha; Hoefflin, Nico; Koehn, Maja; Zeiser, Robert; Schamel, Wolfgang W.; Minguet, Susana] Univ Freiburg, CIBSS, Freiburg, Germany; [Hartl, Frederike A.; Schamel, Wolfgang W.; Minguet, Susana] Univ Clin & Med Fac, Ctr Chron Immunodeficiency CCI, Freiburg, Germany; [Woessner, Nadine M.; Brandl, Simon M.; Morath, Anna; Yousefi, O. Sascha] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Taromi, Sanaz; Zeiser, Robert] Univ Freiburg, Dept Med 1, Fac Med, Med Ctr, Freiburg, Germany; [Taromi, Sanaz] Furtwangen Univ, Fac Med & Life Sci, Campus VS Schwenningen, Furtwangen, Germany; [Mishra, Pankaj; Guenther, Stefan] Albert Ludwigs Univ Freiburg, Pharmaceut Bioinformat, Freiburg, Germany; [Woehrl, Birgitta M.; Schweimer, Kristian] Univ Bayreuth, Biopolymers, Bayreuth, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Bayreuth	Minguet, S (corresponding author), Albert Ludwigs Univ Freiburg, Fac Biol, Freiburg, Germany.; Minguet, S (corresponding author), Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany.; Minguet, S (corresponding author), Univ Freiburg, CIBSS, Freiburg, Germany.; Minguet, S (corresponding author), Univ Clin & Med Fac, Ctr Chron Immunodeficiency CCI, Freiburg, Germany.	susana.minguet@biologie.uni-freiburg.de	Köhn, Maja/G-5131-2012; Günther, Stefan/AAY-8944-2020	Köhn, Maja/0000-0001-8142-3504; Brandl, Simon/0000-0002-1632-0127; Zeiser, Robert/0000-0001-6565-3393; Yousefi, Omid Sascha/0000-0001-5304-729X; Schweimer, Kristian/0000-0002-3837-8442; Minguet, Susana/0000-0001-8211-5538	German Research Foundation (DFG) [BIOSS -EXC294, CIBSS - EXC 2189, SFB1160, SFB850, SFB854, SFB1381]; DFG [GU1225/3-1]; DFG through GSC-4 (Spemann Graduate School); Baden Wurttemberg Stiftung; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [721358]	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG through GSC-4 (Spemann Graduate School); Baden Wurttemberg Stiftung; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa)	We thank K. Fehrenbach, A. Buschky, L. Herr, S. Pathan-Chhatbar and R. Heissmann for technical assistance and K. Astrahantseff, K. Schachtrup, Y. Kulathu and H. van Santen for critical reading of the manuscript. We also thank B. Alarcon for providing reagents and S. Andrade for scientific discussion. This study was supported by the German Research Foundation (DFG) through BIOSS -EXC294 and CIBSS - EXC 2189 to W.W.S., M.K. and S.M.; SFB1160 (P5 to S.M.); SFB850 (C10 to S.M.); SFB854 (B19 to W.W.S.); and SFB1381 (A9 to W.W.S.). The work of P.M. is financially supported by DFG through GU1225/3-1. O.S.Y., N.M.W., A.M. and S.M.B. were supported by DFG through GSC-4 (Spemann Graduate School). F.A.H. was partially supported by the Baden Wurttemberg Stiftung (Eliteprogramm to S.M.). R.M.V.C. was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 721358.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Ballek O, 2015, IMMUNOL CELL BIOL, V93, P384, DOI 10.1038/icb.2014.100; Blanco R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005650; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Borroto A, 2013, J IMMUNOL, V190, P1103, DOI 10.4049/jimmunol.1202055; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Casas J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6624; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dopfer EP, 2010, IMMUNOL LETT, V130, P43, DOI 10.1016/j.imlet.2009.12.011; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Feucht J, 2019, NAT MED, V25, P82, DOI 10.1038/s41591-018-0290-5; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gkourtsa A, 2016, MICROBIOL RES, V190, P27, DOI 10.1016/j.micres.2016.04.018; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; GRANJA CB, 1994, IMMUNOLOGY, V83, P414; Hem CD, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0109-7; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Li LY, 2017, P NATL ACAD SCI USA, V114, pE5891, DOI 10.1073/pnas.1701990114; Lund TC, 1999, J VIROL, V73, P1689, DOI 10.1128/JVI.73.2.1689-1694.1999; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Paensuwan P, 2016, J IMMUNOL, V196, P448, DOI 10.4049/jimmunol.1500958; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PERI KG, 1993, ONCOGENE, V8, P2765; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Roh KH, 2015, P NATL ACAD SCI USA, V112, pE1604, DOI 10.1073/pnas.1503532112; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Rudd ML, 2006, MOL CELL BIOL, V26, P7892, DOI 10.1128/MCB.00968-06; Schamel WW, 2019, IMMUNOL REV, V291, P8, DOI 10.1111/imr.12788; Schonle A, 2016, BLOOD, V127, P1930, DOI 10.1182/blood-2015-09-672428; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shah NH, 2018, ELIFE, V7, DOI 10.7554/eLife.35190; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Sun C, 2020, CANCER CELL, V37, P216, DOI 10.1016/j.ccell.2019.12.014; Swamy M, 2016, IMMUNITY, V44, P1091, DOI 10.1016/j.immuni.2016.04.011; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; VEILLETTE A, 1992, ONCOGENE, V7, P971; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	54	39	41	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					902	+		10.1038/s41590-020-0732-3	http://dx.doi.org/10.1038/s41590-020-0732-3		JUL 2020	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32690949				2022-12-18	WOS:000550625000004
J	Liu, L; Gong, T; Tao, WY; Lin, BL; Li, C; Zheng, XS; Zhu, S; Jiang, W; Zhou, RB				Liu, Lei; Gong, Tao; Tao, Wanyin; Lin, Bolong; Li, Cong; Zheng, Xuesen; Zhu, Shu; Jiang, Wei; Zhou, Rongbin			Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling	NATURE IMMUNOLOGY			English	Article							T-CELLS; RECOGNITION; INFLAMMATION; EXPRESSION; MICROBIOTA; PROTEIN; VIROME; IRF-1; BETA; NOD2	Much attention has focused on commensal bacteria in health and disease, but the role of commensal viruses is understudied. Although metagenomic analysis shows that the intestine of healthy humans and animals harbors various commensal viruses and the dysbiosis of these viruses can be associated with inflammatory diseases, there is still a lack of causal data and underlying mechanisms to understand the physiological role of commensal viruses in intestinal homeostasis. In the present study, we show that commensal viruses are essential for the homeostasis of intestinal intraepithelial lymphocytes (IELs). Mechanistically, the cytosolic viral RNA-sensing receptor RIG-I in antigen-presenting cells can recognize commensal viruses and maintain IELs via a type I interferon-independent, but MAVS-IRF1-IL-15 axis-dependent, manner. The recovery of IELs by interleukin-15 administration reverses the susceptibility of commensal virus-depleted mice to dextran sulfate sodium-induced colitis. Collectively, our results indicate that commensal viruses maintain the IELs and consequently sustain intestinal homeostasis via noncanonical RIG-I signaling.	[Liu, Lei; Gong, Tao; Tao, Wanyin; Lin, Bolong; Li, Cong; Zheng, Xuesen; Zhu, Shu; Jiang, Wei; Zhou, Rongbin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis, Div Life Sci & Med,Sch Basic Med Sci, Hefei, Anhui, Peoples R China; [Zhou, Rongbin] Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhu, S; Jiang, W; Zhou, RB (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis, Div Life Sci & Med,Sch Basic Med Sci, Hefei, Anhui, Peoples R China.; Zhou, RB (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Hefei, Anhui, Peoples R China.	zhushu@ustc.edu.cn; ustcjw@ustc.edu.cn; zrb1980@ustc.edu.cn	Zhou, Rongbin/B-1430-2013; Tao, Wanyin/AAR-9230-2020; Zhu, Shu/P-6163-2018	Gong, Tao/0000-0002-9414-6902; Zhu, Shu/0000-0002-8163-0869	National Key R&D program of China [2018YFA0507403]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29030102]; National Natural Science Foundation of China [31770991, 91742202, 81525013, 81722022, 81821001, 81788101]; Young Talent Support Program; Fundamental Research Funds for the Central Universities	National Key R&D program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Support Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank S. Akria, J. Tschopp, M. Colonna, Z. Yi and Z. Jiang for providing mice lines. We thank T. Xue for providing AAV plasmids. This work was supported by the National Key R&D program of China (grant no. 2018YFA0507403 to R.Z.), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDB29030102 to R.Z. and S.Z.), the National Natural Science Foundation of China (grant nos. 31770991 to W.J., 91742202 to R.Z., 81525013 to R.Z., 81722022 to W.J., 81821001 to R.Z., W.J. and S.Z., 81788101 to R.Z.) and the Young Talent Support Program and the Fundamental Research Funds for the Central Universities.	Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Cheroutre H, 2004, NAT REV IMMUNOL, V4, P290, DOI 10.1038/nri1333; Cheroutre H, 2008, CURR OPIN IMMUNOL, V20, P185, DOI 10.1016/j.coi.2008.03.009; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fischer JC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2513; Fujihashi K, 1997, EUR J IMMUNOL, V27, P2133, DOI 10.1002/eji.1830270903; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; Lopetuso LR, 2016, INFLAMM BOWEL DIS, V22, P1708, DOI 10.1097/MIB.0000000000000807; Luda KM, 2016, IMMUNITY, V44, P860, DOI 10.1016/j.immuni.2016.02.008; Ma HD, 2019, CELL MOL IMMUNOL, V16, P216, DOI 10.1038/s41423-019-0208-2; Manso CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02239-5; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Qiu Y, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4281865; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Shi Y, 2017, CELL MOL IMMUNOL, V14, P339, DOI 10.1038/cmi.2016.64; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Sweere JM, 2019, SCIENCE, V363, P1416, DOI 10.1126/science.aat9691; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; van Konijnenburg DPH, 2017, CELL, V171, P783, DOI 10.1016/j.cell.2017.08.046; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009; Yu QS, 2006, J IMMUNOL, V176, P6180, DOI 10.4049/jimmunol.176.10.6180; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhu HB, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0471-3	59	39	40	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1681	+		10.1038/s41590-019-0513-z	http://dx.doi.org/10.1038/s41590-019-0513-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31636462				2022-12-18	WOS:000497949800022
J	Niehrs, A; Garcia-Beltran, WF; Norman, PJ; Watson, GM; Holzemer, A; Chapel, A; Richert, L; Pommerening-Roser, A; Korner, C; Ozawa, M; Martrus, G; Rossjohn, J; Lee, JH; Berry, R; Carrington, M; Altfeld, M				Niehrs, Annika; Garcia-Beltran, Wilfredo F.; Norman, Paul J.; Watson, Gabrielle M.; Hoelzemer, Angelique; Chapel, Anais; Richert, Laura; Pommerening-Roeser, Andreas; Koerner, Christian; Ozawa, Mikki; Martrus, Gloria; Rossjohn, Jamie; Lee, Jar-How; Berry, Richard; Carrington, Mary; Altfeld, Marcus			A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; KILLER-CELLS; TUMOR-CELLS; HEPATITIS-B; RECOGNITION; ANTIGEN; EXPRESSION; NK; IDENTIFICATION; ACTIVATION	Natural killer (NK) cells can recognize virus-infected and stressed cells(1) using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity(2,3), the NK cell receptors that specifically recognize HLA class II molecules have never been identified. We investigated whether two major families of NK cell receptors, killer-cell immunoglobulin-like receptors (KIRs) and natural cytotoxicity receptors (NCRs), contained receptors that bound to HLA class II, and identified a direct interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including HLA-DP401, one of the most frequent class II allotypes in white populations(4). Using NKp444 zeta(+) reporter cells and primary human NKp44(+) NK cells, we demonstrated that interactions between NKp44 and HLA-DP401 trigger functional NK cell responses. This interaction between a subset of HLA-DP molecules and NKp44 implicates HLA class II as a component of the innate immune response, much like HLA class I. It also provides a potential mechanism for the described associations between HLA-DP subtypes and several disease outcomes, including hepatitis B virus infection(5-7), graft-versus-host diseases and inflammatory bowel disease(9,10).	[Niehrs, Annika; Garcia-Beltran, Wilfredo F.; Hoelzemer, Angelique; Chapel, Anais; Richert, Laura; Koerner, Christian; Martrus, Gloria; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Res Dept Virus Immunol, Hamburg, Germany; [Niehrs, Annika; Hoelzemer, Angelique; Altfeld, Marcus] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany; [Garcia-Beltran, Wilfredo F.; Carrington, Mary] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Norman, Paul J.] Univ Colorado, Sch Med, Div Biomed Informat & Personalized Med, Aurora, CO USA; [Norman, Paul J.] Univ Colorado, Sch Med, Dept Microbiol & Immunol, Aurora, CO USA; [Watson, Gabrielle M.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Watson, Gabrielle M.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Watson, Gabrielle M.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Hoelzemer, Angelique] Univ Med Ctr Eppendorf, Dept Internal Med 1, Hamburg, Germany; [Richert, Laura] Univ Bordeaux, INSERM, INRIA, SISTM Bordeaux Populat Hlth Res Ctr,UMR 1219, Bordeaux, France; [Pommerening-Roeser, Andreas] Univ Hamburg, Dept Microbiol & Biotechnol, Hamburg, Germany; [Ozawa, Mikki; Lee, Jar-How] One Lambda Inc, Canoga Pk, CA USA; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales; [Carrington, Mary] Frederick Natl Lab Canc Res, HLA Immunogenet Sect, Basic Sci Program, Frederick, MD USA; [Chapel, Anais] Inst Pasteur, Unite HIV Inflammat & Persistance, Paris, France	Heinrich Pette Institute; German Center for Infection Research; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Monash University; Monash University; Monash University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Inria; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Hamburg; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Res Dept Virus Immunol, Hamburg, Germany.; Altfeld, M (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany.	marcus.altfeld@leibniz-hpi.de	Altfeld, Marcus/AAE-7306-2019; Körner, Christian/ABB-8335-2020; Rossjohn, Jamie/F-9032-2013	Altfeld, Marcus/0000-0001-5972-2997; Körner, Christian/0000-0002-3431-7319; Rossjohn, Jamie/0000-0002-2020-7522; Watson, Gabrielle/0000-0003-0056-7528; Richert, Laura/0000-0002-7682-2225; Norman, Paul/0000-0001-8370-7703; Niehrs, Annika/0000-0002-2190-4346; Martrus, Gloria/0000-0003-2879-3201	Pathogenesis Program of the Heinrich Pette Institute; Viral Latency Program of the Heinrich Pette Institute; Leibniz Institute for Experimental Virology; German Center for Infection Research (DZIF) [TTU 04.810, TI 07.002]; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the National Institutes of Health, Frederick National Laboratory, Center for Cancer Research; National Institute of General Medical Sciences [T32GM007752]; NIH [P01-AI104715, F31AI116366, U19 NS095774]; Australian Research Council Laureate Fellowship [FL160100049]; National Health and Medical Research Council of Australia [APP1109901]; German Center for Infection Research (DZIF) via the Clinician Scientist Program of the Faculty of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI090905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U19NS095774] Funding Source: NIH RePORTER	Pathogenesis Program of the Heinrich Pette Institute; Viral Latency Program of the Heinrich Pette Institute; Leibniz Institute for Experimental Virology; German Center for Infection Research (DZIF); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health, Frederick National Laboratory, Center for Cancer Research; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Laureate Fellowship(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Center for Infection Research (DZIF) via the Clinician Scientist Program of the Faculty of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been funded in part by the Pathogenesis and the Viral Latency Programs of the Heinrich Pette Institute, Leibniz Institute for Experimental Virology and the German Center for Infection Research (DZIF) through TTU 04.810. This project has been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the National Institutes of Health, Frederick National Laboratory, Center for Cancer Research. W.F.G.-B. was supported by National Institute of General Medical Sciences (T32GM007752) and the NIH (P01-AI104715 and F31AI116366). P.J.N. was supported by NIH U19 NS095774. A.H. was supported by the German Center for Infection Research (DZIF) through an MD/PhD Stipend (TI 07.002) and via the Clinician Scientist Program of the Faculty of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. J.R was supported by an Australian Research Council Laureate Fellowship (FL160100049) and R.B was supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (APP1109901). We would like to thank H. Reid and K. Loh for their kind gift of HLA-DQ2 viral stocks. We would like to thank the NIH Tetramer Core Facility for all provided HLA class II monomers.	ALDACCAK R, 1991, HUM IMMUNOL, V31, P277, DOI 10.1016/0198-8859(91)90100-N; Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Barrow AD, 2018, CELL, V172, P534, DOI 10.1016/j.cell.2017.11.037; Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Campbell KS, 2004, J IMMUNOL, V172, P899, DOI 10.4049/jimmunol.172.2.899; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Chapel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02449-x; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; De Maria A, 2009, INT IMMUNOL, V21, P245, DOI 10.1093/intimm/dxn144; Deuss FA, 2019, STRUCTURE, V27, P219, DOI 10.1016/j.str.2018.10.023; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hadley D, 2015, AM J GASTROENTEROL, V110, P915, DOI 10.1038/ajg.2015.150; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Ho JW, 2008, J VIROL, V82, P2028, DOI 10.1128/JVI.02065-07; Holling TM, 2004, BLOOD, V103, P1438, DOI 10.1182/blood-2003-05-1491; Holzemer A., SCI IMMUNOL; Jiang YZ, 1996, IMMUNOLOGY, V87, P481, DOI 10.1046/j.1365-2567.1996.483556.x; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Lobo PI, 1996, IMMUNOLOGY, V88, P625, DOI 10.1046/j.1365-2567.1996.d01-679.x; NIZETIC D, 1987, P NATL ACAD SCI USA, V84, P5828, DOI 10.1073/pnas.84.16.5828; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; O'Connor GM, 2014, J IMMUNOL, V192, P2875, DOI 10.4049/jimmunol.1303142; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Siewiera J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10183; SLIERENDREGT BL, 1995, IMMUNOGENETICS, V41, P29, DOI 10.1007/BF00188429; Stevanovic S, 2013, BLOOD, V122, P1963, DOI 10.1182/blood-2012-12-470872; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Thompson JA, 2006, CANCER RES, V66, P1147, DOI 10.1158/0008-5472.CAN-05-2289; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008; Xu WL, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001853	50	39	39	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1129	+		10.1038/s41590-019-0448-4	http://dx.doi.org/10.1038/s41590-019-0448-4			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31358998	Green Accepted			2022-12-18	WOS:000482212600013
J	Richard, AC; Lun, ATL; Lau, WWY; Gottgens, B; Marioni, JC; Griffiths, GM				Richard, Arianne C.; Lun, Aaron T. L.; Lau, Winnie W. Y.; Gottgens, Berthold; Marioni, John C.; Griffiths, Gillian M.			T cell cytolytic capacity is independent of initial stimulation strength	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RECEPTOR SIGNAL STRENGTH; RNA-SEQ EXPERIMENTS; EFFECTOR DIFFERENTIATION; ANTIGEN AFFINITY; TCR; EXPANSION; CD8; ACTIVATION; THRESHOLD	How cells respond to myriad stimuli with finite signaling machinery is central to immunology. In naive T cells, the inherent effect of ligand strength on activation pathways and endpoints has remained controversial, confounded by environmental fluctuations and intercellular variability within populations. Here we studied how ligand potency affected the activation of CD8(+) T cells in vitro, through the use of genome-wide RNA, multi-dimensional protein and functional measurements in single cells. Our data revealed that strong ligands drove more efficient and uniform activation than did weak ligands, but all activated cells were fully cytolytic. Notably, activation followed the same transcriptional pathways regardless of ligand potency. Thus, stimulation strength did not intrinsically dictate the T cell-activation route or phenotype; instead, it controlled how rapidly and simultaneously the cells initiated activation, allowing limited machinery to elicit wide-ranging responses.	[Richard, Arianne C.; Lau, Winnie W. Y.; Gottgens, Berthold; Griffiths, Gillian M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Richard, Arianne C.; Lun, Aaron T. L.; Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Lau, Winnie W. Y.; Gottgens, Berthold] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Med Res Council, Dept Haematol, Cambridge, England; [Marioni, John C.] EBI, EMBL, Cambridge, England; [Marioni, John C.] Wellcome Sanger Inst, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Griffiths, GM (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.; Marioni, JC (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.; Marioni, JC (corresponding author), EBI, EMBL, Cambridge, England.; Marioni, JC (corresponding author), Wellcome Sanger Inst, Cambridge, England.	john.marioni@cruk.cam.ac.uk; gg305@cam.ac.uk	Lun, Aaron T. L./J-3807-2019	Lun, Aaron T. L./0000-0002-3564-4813; Gottgens, Berthold/0000-0001-6302-5705; Richard, Arianne/0000-0002-8708-9997; Marioni, John/0000-0001-9092-0852; Lau, Winnie WY/0000-0003-1209-1854; Griffiths, Gillian/0000-0003-0434-5842	MRC Skills Development Fellowship [MR/P014178/1]; Wellcome Trust [103930, 100140]; Cancer Research UK [A17197, C1163/A12765, C1163/A21762]; EMBL; University of Cambridge; Hutchison Whampoa Limited; MRC Clinical Research Infrastructure fund [MR/M008975/1]; Bloodwise [12029]; CIMR Flow Cytometry Core Facility; MRC [MR/M008975/1, MR/P014178/1] Funding Source: UKRI	MRC Skills Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); EMBL; University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; MRC Clinical Research Infrastructure fund; Bloodwise; CIMR Flow Cytometry Core Facility; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by an MRC Skills Development Fellowship (MR/P014178/1 to A.C.R.); the Wellcome Trust (grants [103930] and [100140] to G.M.G.); Cancer Research UK (core funding (A17197) to J.C.M.); EMBL (core funding to J.C.M.); the University of Cambridge; and Hutchison Whampoa Limited. Single-cell collection and analysis were supported through MRC Clinical Research Infrastructure funds for the Cambridge Single Cell Facility (MR/M008975/1). W.W.Y.L. and B.G. were supported by Bloodwise (12029) and Cancer Research UK (C1163/A12765 and C1163/A21762). This research was supported by the CIMR Flow Cytometry Core Facility. We thank R. Schulte and C. Cossetti for their advice and support in cell sorting; the CRUK-CI Flow Cytometry core, particularly M. Strzelecki and R. Grenfell, and Genomics core for their resources and assistance; the Wellcome Trust Sanger Institute Mouse Genetics Project (Sanger MGP) and its funders for the wildtype C57BL/6 mouse line (funding information, https://www.sanger.ac.uk/science/collaboration/mouse-resource-portal); and C. Gawden-Bone, J. Warland, A. Denton and G. Frazer for critical reading of the manuscript.	Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Allison KA, 2016, ELIFE, V5, DOI 10.7554/eLife.10134; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ashouri JF, 2017, J IMMUNOL, V198, P657, DOI 10.4049/jimmunol.1601301; Au-Yeung BB, 2017, J IMMUNOL, V198, P2445, DOI 10.4049/jimmunol.1601453; Au-Yeung BB, 2014, P NATL ACAD SCI USA, V111, pE3679, DOI 10.1073/pnas.1413726111; Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Balyan R, 2017, J IMMUNOL, V198, P1823, DOI 10.4049/jimmunol.1600083; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Cantrell D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018788; Chen JL, 2010, J IMMUNOL, V184, P1829, DOI 10.4049/jimmunol.0902103; Conley JM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00076; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Le Borgne M, 2016, J IMMUNOL, V196, P1471, DOI 10.4049/jimmunol.1502414; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lun ATL, 2017, GENOME RES, V27, P1795, DOI 10.1101/gr.222877.117; Lun ATL, 2017, NAT METHODS, V14, P707, DOI 10.1038/nmeth.4295; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Marchingo JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13540; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Mayya V, 2016, TRENDS IMMUNOL, V37, P513, DOI 10.1016/j.it.2016.06.005; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Navarro MN, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005477; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Ozga AJ, 2016, J EXP MED, V213, P2811, DOI 10.1084/jem.20160206; Palmer E, 2016, EUR J IMMUNOL, V46, P1887, DOI 10.1002/eji.201545909; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Schmeier S, 2017, NUCLEIC ACIDS RES, V45, pD145, DOI 10.1093/nar/gkw1007; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Tan TCJ, 2017, P NATL ACAD SCI USA, V114, pE6117, DOI 10.1073/pnas.1700939114; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Voisinne G, 2015, CELL REP, V11, P1208, DOI 10.1016/j.celrep.2015.04.051; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zahm CD, 2017, CANCER IMMUNOL RES, V5, P630, DOI 10.1158/2326-6066.CIR-16-0374; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zikherman J, 2015, CURR OPIN IMMUNOL, V33, P43, DOI 10.1016/j.coi.2015.01.012	63	39	39	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					849	+		10.1038/s41590-018-0160-9	http://dx.doi.org/10.1038/s41590-018-0160-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30013148	Green Submitted, Green Accepted			2022-12-18	WOS:000439470900021
J	Ben Baruch-Morgenstern, N; Shik, D; Moshkovits, I; Itan, M; Karo-Atar, D; Bouffi, C; Fulkerson, PC; Rashkovan, D; Jung, S; Rothenberg, ME; Munitz, A				Ben Baruch-Morgenstern, Netali; Shik, Dana; Moshkovits, Itay; Itan, Michal; Karo-Atar, Danielle; Bouffi, Carine; Fulkerson, Patricia C.; Rashkovan, Diana; Jung, Steffen; Rothenberg, Marc E.; Munitz, Ariel			Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development	NATURE IMMUNOLOGY			English	Article							PIR-B; INHIBITORY RECEPTOR; DENDRITIC CELLS; BONE-MARROW; INTERLEUKIN-5; ANTIBODY; VIVO; PROGENITORS; ACTIVATION; RESPONSES	Eosinophilia is a hallmark characteristic of T helper type 2 (T(H)2) cell-associated diseases and is critically regulated by the central eosinophil growth factor interleukin 5 (IL-5). Here we demonstrate that IL-5 activity in eosinophils was regulated by paired immunoglobulin-like receptors PIR-A and PIR-B. Upon self-recognition of beta(2)-microglobulin (beta M-2) molecules, PIR-B served as a permissive checkpoint for IL-5-induced development of eosinophils by suppressing the proapoptotic activities of PIR-A, which were mediated by the Grb2-Erk-Bim pathway. PIR-B-deficient bone marrow eosinophils underwent compartmentalized apoptosis, resulting in decreased blood eosinophilia in naive mice and in mice challenged with IL-5. Subsequently, Pirb(-/-) mice displayed impaired aeroallergen-induced lung eosinophilia and induction of lung T(H)2 cell responses. Collectively, these data uncover an intrinsic, self-limiting pathway regulating IL-5-induced expansion of eosinophils, which has broad implications for eosinophil-associated diseases.	[Ben Baruch-Morgenstern, Netali; Shik, Dana; Moshkovits, Itay; Itan, Michal; Karo-Atar, Danielle; Munitz, Ariel] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Ramat Aviv, Israel; [Bouffi, Carine; Fulkerson, Patricia C.; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Rashkovan, Diana; Jung, Steffen] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Weizmann Institute of Science	Munitz, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Ramat Aviv, Israel.	arielm@post.tau.ac.il	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; Ben-Baruch Morgenstern, Netali/0000-0001-6530-0387	Marie-Curie Reintegration [256311]; Israel Science Foundation [955/11, 1708/11]; Israel Cancer Research Foundation Research Career Development Award; Fritz Thyssen Foundation; US-Israel Bi-national Science Foundation [2009222]; US National Institutes of Health NIAID [R01AI083450, R37AI045898]; Campaign Urging Research for Eisonophilic Disease (CURED) Foundation; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083450, R37AI045898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	Marie-Curie Reintegration(European Commission); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Foundation Research Career Development Award; Fritz Thyssen Foundation; US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); US National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Campaign Urging Research for Eisonophilic Disease (CURED) Foundation; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Kubagawa (University of Alabama) for providing Pirb<SUP>-/-</SUP> mice, and S.P. Hogan, O. Mandelboim, I. Bachelet, N. Osherov and A. Ben-Baruch for critically reviewing this manuscript and helpful discussions. This work was performed in partial fulfillment of the requirements for the PhD degree of N.B.B.-M., and D.S. at Tel Aviv University. Supported by the FP7 Marie-Curie Reintegration grant (256311), the Israel Science Foundation (955/11 and 1708/11) the Israel Cancer Research Foundation Research Career Development Award and the Fritz Thyssen Foundation (to A.M.); the US-Israel Bi-national Science Foundation (2009222 to A.M. and M.E.R.); US National Institutes of Health NIAID (R01AI083450 and R37AI045898), Campaign Urging Research for Eisonophilic Disease (CURED) Foundation and Buckeye Foundation (to M.E.R.).	Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bochner BS, 2004, J ALLERGY CLIN IMMUN, V113, P3, DOI 10.1016/j.jaci.2003.09.046; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Chu J, 1998, BLOOD, V92, P1697, DOI 10.1182/blood.V92.5.1697.417a06_1697_1706; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Kanamaru Y, 2007, BLOOD, V109, P203, DOI 10.1182/blood-2006-06-025882; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Karo-Atar D, 2013, AM J RESP CELL MOL, V48, P456, DOI 10.1165/rcmb.2012-0329OC; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; Mitsuhashi Y, 2012, BLOOD, V120, P3256, DOI 10.1182/blood-2012-03-419093; Moshkovits I, 2014, MUCOSAL IMMUNOL, V7, P292, DOI 10.1038/mi.2013.47; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Munitz A, 2008, BLOOD, V111, P5694, DOI 10.1182/blood-2007-12-126748; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; RENNICK DM, 1990, BLOOD, V76, P312; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; ROTHENBERG ME, 1989, J IMMUNOL, V143, P2311; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Tomaki M, 2000, J IMMUNOL, V165, P4040, DOI 10.4049/jimmunol.165.7.4040; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; van den Berg TK, 2008, TRENDS IMMUNOL, V29, P203, DOI 10.1016/j.it.2008.02.004; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Varol Chen, 2009, V531, P71, DOI 10.1007/978-1-59745-396-7_6; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wheadon H, 2002, CELL SIGNAL, V14, P219, DOI 10.1016/S0898-6568(01)00241-8; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027	45	39	40	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					36	44		10.1038/ni.2757	http://dx.doi.org/10.1038/ni.2757			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24212998	Green Accepted			2022-12-18	WOS:000328800500010
J	Vuong, BQ; Herrick-Reynolds, K; Vaidyanathan, B; Pucella, JN; Ucher, AJ; Donghia, NM; Gu, XW; Nicolas, L; Nowak, U; Rahman, N; Strout, MP; Mills, KD; Stavnezer, J; Chaudhuri, J				Vuong, Bao Q.; Herrick-Reynolds, Kayleigh; Vaidyanathan, Bharat; Pucella, Joseph N.; Ucher, Anna J.; Donghia, Nina M.; Gu, Xiwen; Nicolas, Laura; Nowak, Urszula; Rahman, Numa; Strout, Matthew P.; Mills, Kevin D.; Stavnezer, Janet; Chaudhuri, Jayanta			A DNA break- and phosphorylation-dependent positive feedback loop promotes immunoglobulin class-switch recombination	NATURE IMMUNOLOGY			English	Article							CYTIDINE DEAMINASE AID; REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; BINDING PROTEIN; S-REGIONS; KINASE-A; ACTIVATION; ATM; PHASE	The ability of activation-induced cytidine deaminase (AID) to efficiently mediate class-switch recombination (CSR) is dependent on its phosphorylation at Ser38; however, the trigger that induces AID phosphorylation and the mechanism by which phosphorylated AID drives CSR have not been elucidated. Here we found that phosphorylation of AID at Ser38 was induced by DNA breaks. Conversely, in the absence of AID phosphorylation, DNA breaks were not efficiently generated at switch (S) regions in the immunoglobulin heavy-chain locus (Igh), consistent with a failure of AID to interact with the endonuclease APE1. Additionally, deficiency in the DNA-damage sensor ATM impaired the phosphorylation of AID at Ser38 and the interaction of AID with APE1. Our results identify a positive feedback loop for the amplification of DNA breaks at S regions through the phosphorylation- and ATM-dependent interaction of AID with APE1.	[Vuong, Bao Q.; Herrick-Reynolds, Kayleigh; Vaidyanathan, Bharat; Pucella, Joseph N.; Nicolas, Laura; Nowak, Urszula; Rahman, Numa; Chaudhuri, Jayanta] Gerstner Sloan Kettering Grad Sch, Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Vaidyanathan, Bharat; Nowak, Urszula; Chaudhuri, Jayanta] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Ucher, Anna J.; Stavnezer, Janet] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Donghia, Nina M.; Mills, Kevin D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Gu, Xiwen; Strout, Matthew P.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; Yale University	Chaudhuri, J (corresponding author), Gerstner Sloan Kettering Grad Sch, Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA.	janet.stavnezer@umassmed.edu; chaudhuj@mskcc.org	Gu, Xiwen/P-9761-2015	Gu, Xiwen/0000-0001-9767-4105; Herrick-Reynolds, Kayleigh/0000-0002-9603-8737; Pucella, Joseph/0000-0003-0875-8046; Vuong, Bao/0000-0001-5416-9635; Gu, Xiwen/0000-0002-9575-5654	US National Institutes of Health [RO1AI23283, R21 AI099908, 5 R01 CA138646-04, 1RO1AI072194]; Starr Cancer Consortium [I4-A447]; NATIONAL CANCER INSTITUTE [K08CA140718, R01CA138646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194, R01AI023283, R21AI099988] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Hurwitz (Memorial Sloan-Kettering Cancer Center) for recombinant human RPA; members of the Chaudhuri laboratory, D. Sant' Angelo and L. Denzin for critically reviewing the manuscript and for discussions and suggestions; V. Bermudez and J. Hurwitz for help in purifying recombinant human RPA; J. Lange and S. Keeney (Memorial Sloan-Kettering Cancer Center) for Atm<SUP>-/-</SUP> mice; and D. M. Wilson III (US National Institutes of Health) for the plasmid for expression of human APE1. Supported by the US National Institutes of Health (RO1AI23283 and R21 AI099908 to J. S., 5 R01 CA138646-04 to K. D. M. and 1RO1AI072194 to J. C.) and the Starr Cancer Consortium (I4-A447 to J.C.).	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Guikema JEJ, 2010, J IMMUNOL, V184, P6177, DOI 10.4049/jimmunol.0904085; Hasham MG, 2012, J IMMUNOL, V189, P2374, DOI 10.4049/jimmunol.1200414; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ishiai M, 1996, J BIOL CHEM, V271, P20868, DOI 10.1074/jbc.271.34.20868; IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Vuong BQ, 2012, SEMIN IMMUNOL, V24, P264, DOI 10.1016/j.smim.2012.05.006; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	46	39	40	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1183	U107		10.1038/ni.2732	http://dx.doi.org/10.1038/ni.2732			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24097111	Green Accepted			2022-12-18	WOS:000326023400015
J	Huang, YJ; Park, Y; Wang-Zhu, Y; Larange, A; Arens, R; Bernardo, I; Olivares-Villagomez, D; Herndler-Brandstetter, D; Abraham, N; Grubeck-Loebenstein, B; Schoenberger, SP; Van Kaer, L; Kronenberg, M; Teitell, MA; Cheroutre, H				Huang, Yujun; Park, Yunji; Wang-Zhu, Yiran; Larange, Alexandre; Arens, Ramon; Bernardo, Ivan; Olivares-Villagomez, Danyvid; Herndler-Brandstetter, Dietmar; Abraham, Ninan; Grubeck-Loebenstein, Beatrix; Schoenberger, Stephen P.; Van Kaer, Luc; Kronenberg, Mitchell; Teitell, Michael A.; Cheroutre, Hilde			Mucosal memory CD8(+) T cells are selected in the periphery by an MHC class I molecule	NATURE IMMUNOLOGY			English	Article							THYMUS LEUKEMIA ANTIGEN; CUTTING EDGE; CORECEPTOR FUNCTION; HLA-G; EXPRESSION; CD8-ALPHA-ALPHA; APOPTOSIS; RESPONSES; LYMPHOCYTES; SUBSETS	The presence of immune memory at pathogen-entry sites is a prerequisite for protection. Nevertheless, the mechanisms that warrant immunity at peripheral interfaces are not understood. Here we show that the nonclassical major histocompatibility complex (MHC) class I molecule thymus leukemia antigen (TL), induced on dendritic cells interacting with CD8 alpha alpha on activated CD8 alpha beta(+) T cells, mediated affinity-based selection of memory precursor cells. Furthermore, constitutive expression of TL on epithelial cells led to continued selection of mature CD8 alpha beta(+) memory T cells. The memory process driven by TL and CD8 alpha alpha was essential for the generation of CD8 alpha beta(+) memory T cells in the intestine and the accumulation of highly antigen-sensitive CD8 alpha beta(+) memory T cells that form the first line of defense at the largest entry port for pathogens.	[Huang, Yujun; Park, Yunji; Wang-Zhu, Yiran; Larange, Alexandre; Arens, Ramon; Bernardo, Ivan; Schoenberger, Stephen P.; Kronenberg, Mitchell; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA; [Olivares-Villagomez, Danyvid; Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Herndler-Brandstetter, Dietmar; Grubeck-Loebenstein, Beatrix] Austrian Acad Sci, Div Immunol, Inst Biomed Aging Res, Innsbruck, Austria; [Abraham, Ninan] Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	La Jolla Institute for Immunology; Vanderbilt University; Austrian Academy of Sciences; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA.	hilde@liai.org	Arens, Ramon/V-4010-2018; Van Kaer, Luc/H-1033-2015; Kronenberg, Mitchell/AAT-6078-2021; Abraham, Ninan/K-5572-2012	Arens, Ramon/0000-0001-5058-4110; Van Kaer, Luc/0000-0001-5275-2309; Abraham, Ninan/0000-0002-2747-1246; Bernardo, Ivan/0000-0002-9452-0079; Park, Yunji/0000-0003-0042-202X	US National Institutes of Health [R01 AI064584, R01 AI050265, R01 AG10152, CA009385]; Vanderbilt University Digestive Disease Research Center; Vanderbilt-Meharry Center for AIDS Research; Austrian Science Fund [S9308-B05]; Austrian Federal Ministry of Science and Research; NATIONAL CANCER INSTITUTE [R01CA156674, R01CA090571, T32CA009385] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064584, R01AI050265, R56AI050265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010152] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center; Vanderbilt-Meharry Center for AIDS Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M.J. Bevan (University of Washington) for LM-N4 and LM-Q4; E. Stockert and L. Old (Memorial Sloan-Kettering) for anti-TL (HD168); M. Cheroutre for contributions; L. Qiao, X.Z. Wang and members of the Cheroutre and Kronenberg laboratories for discussions and technical assistance; and D. Littman (New York University School of Medicine) for Delta E8<INF>I</INF> mice. Supported by the US National Institutes of Health (R01 AI064584 and R01 AI050265 to H.C.; R01 AG10152 to M.K. and H.C.; and CA009385 to D.O.-V.), the Vanderbilt University Digestive Disease Research Center and the Vanderbilt-Meharry Center for AIDS Research (L.V.K.), the Austrian Science Fund (Project S9308-B05 to B.G.-L.) and the Austrian Federal Ministry of Science and Research (Future Leaders of Ageing Research in Europe; D.H.-B.). This is manuscript 1063 from the La Jolla Institute for Allergy & Immunology.	Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Attinger A, 2005, J IMMUNOL, V174, P3501, DOI 10.4049/jimmunol.174.6.3501; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Belyakov IM, 2006, BLOOD, V107, P3258, DOI 10.1182/blood-2005-11-4374; Boulassel MR, 2007, CLIN IMMUNOL, V124, P149, DOI 10.1016/j.clim.2007.05.005; Chandele A, 2005, J IMMUNOL, V175, P5619, DOI 10.4049/jimmunol.175.9.5619; Cheroutre H, 2005, CELL MOL LIFE SCI, V62, P2853, DOI 10.1007/s00018-005-5232-y; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Contini P, 2005, J IMMUNOL, V175, P7244, DOI 10.4049/jimmunol.175.11.7244; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; EGHTESADY P, 1992, IMMUNOGENETICS, V36, P377, DOI 10.1007/BF00218045; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Le Bouteiller P, 2001, MICROBES INFECT, V3, P323, DOI 10.1016/S1286-4579(01)01386-7; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Puppo F, 2000, INT IMMUNOL, V12, P195, DOI 10.1093/intimm/12.2.195; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sargent IL, 2005, MOL HUM REPROD, V11, P695, DOI 10.1093/molehr/gah196; Starks H, 2004, J IMMUNOL, V173, P420, DOI 10.4049/jimmunol.173.1.420; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2005, J IMMUNOL, V175, P2066, DOI 10.4049/jimmunol.175.4.2066; WU M, 1991, J EXP MED, V174, P213, DOI 10.1084/jem.174.1.213; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhong WM, 2005, EUR J IMMUNOL, V35, P3103, DOI 10.1002/eji.200535162	44	39	41	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1086	U95		10.1038/ni.2106	http://dx.doi.org/10.1038/ni.2106			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21964609	Green Accepted			2022-12-18	WOS:000296500100014
J	Colonna, M				Colonna, Marco			All roads lead to CARD9	NATURE IMMUNOLOGY			English	Editorial Material							ADAPTER PROTEIN CARD9; DECTIN-1; RECEPTORS; ACTIVATION; INDUCTION; RESPONSES; ZYMOSAN; PATHWAY; YEAST; CELLS	Multiple receptors alert cells to microbial invasion by initiating intracellular signals that modify gene expression. New work provides a more complex view of microbe-induced signaling through the adaptor CARD9.	Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wuslt.edu		Colonna, Marco/0000-0001-5222-4987				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816	16	39	45	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					554	555		10.1038/ni0607-554	http://dx.doi.org/10.1038/ni0607-554			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514206				2022-12-18	WOS:000246703300006
J	Geissmann, F				Geissmann, Frederic			The origin of dendritic cells	NATURE IMMUNOLOGY			English	Editorial Material							PERIPHERAL LYMPHOID ORGANS; IDENTIFICATION; MONOCYTES; SUBSETS; MICE	Dendritic cells are specialized in antigen presentation to lymphocytes. New research clarifies the origin and kinetics of differentiation of a subset of dendritic cells in the spleen and lymph nodes.	Univ Paris 05, Fac Med, Hop Necker Enfants Malad, INSERM,U838, F-75105 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Geissmann, F (corresponding author), Univ Paris 05, Fac Med, Hop Necker Enfants Malad, INSERM,U838, F-75105 Paris, France.	geissmann@necker.fr		geissmann, frederic/0000-0001-5029-2468	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Manz MG, 2001, ANN NY ACAD SCI, V938, P167; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	13	39	42	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					558	560		10.1038/ni0607-558	http://dx.doi.org/10.1038/ni0607-558			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514208				2022-12-18	WOS:000246703300008
J	Bailey, ST; Ghosh, S				Bailey, ST; Ghosh, S			'PPAR'ting ways with inflammation	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B; MACROPHAGE ACTIVATION; GENE	Although it often acts as a transcriptional activator, the nuclear hormone receptor PPAR-gamma also `transrepresses' inflammatory responses mediated by the transcription factor NF-kappa B. New data demonstrate that sumoylation of PPAR-gamma leads to the retention of repressor complexes on promoters of inflammatory genes.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06519 USA	Yale University; Yale University	Bailey, ST (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06519 USA.	sankar.ghosh@yale.edu	Bailey, Shannon/B-8045-2014	Ghosh, Sankar/0000-0002-3227-0588				Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; PASCUAL G, 2005, NATURE          0828, DOI DOI 10.1038/NATURE0398; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Tan JA, 2000, MOL ENDOCRINOL, V14, P14, DOI 10.1210/me.14.1.14; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x	12	39	42	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					966	967		10.1038/ni1005-966	http://dx.doi.org/10.1038/ni1005-966			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16177802				2022-12-18	WOS:000232027200006
J	Wucherpfennig, KW; Eisenbarth, GS				Wucherpfennig, KW; Eisenbarth, GS			Type I diabetes	NATURE IMMUNOLOGY			English	News Item							MOLECULES	Type I diabetes is preventable in animal models and predictable in humans. The increase in our knowledge of basic immunology has allowed the initiation of large-scale clinical efforts to prevent diabetes.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	Kai_Wucherpfennig@dfci.harvard.edu; george.eisenbarth@uchsc.edu						Kagi D, 1999, J IMMUNOL, V162, P4598; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; Patel DD, 2001, J CLIN INVEST, V107, P155, DOI 10.1172/JCI11966; Perheentupa J, 1999, MED INTELL UNIT, P19; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Wen L, 2000, J EXP MED, V191, P97, DOI 10.1084/jem.191.1.97; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J	11	39	41	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					767	768		10.1038/ni0901-767	http://dx.doi.org/10.1038/ni0901-767			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526380				2022-12-18	WOS:000170781200006
J	Schon, MP; Ruzicka, T				Schon, MP; Ruzicka, T			Psoriasis: the plot thickens ...	NATURE IMMUNOLOGY			English	Letter							CHEMOKINE		Otto Von Guericke Univ, Dept Dermatol, D-39120 Magdeburg, Germany; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany	Otto von Guericke University; Heinrich Heine University Dusseldorf	Schon, MP (corresponding author), Otto Von Guericke Univ, Dept Dermatol, Leipzigerstr 44, D-39120 Magdeburg, Germany.							Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Christophers E, 1996, INT ARCH ALLERGY IMM, V110, P199, DOI 10.1159/000237288; Goebeler M, 1998, J PATHOL, V184, P89, DOI 10.1002/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Mazanet MM, 2000, J IMMUNOL, V164, P5383, DOI 10.4049/jimmunol.164.10.5383; Raychaudhuri SP, 1999, ACTA DERM-VENEREOL, V79, P9; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	10	39	41	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					91	91		10.1038/84293	http://dx.doi.org/10.1038/84293			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175798	Bronze			2022-12-18	WOS:000166778700002
J	Ng, SS; Rivera, FD; Yan, JM; Corvino, D; Das, I; Zhang, P; Kuns, R; Chauhan, SB; Hou, JJ; Li, XY; Frame, TCM; McEnroe, BA; Moore, E; Na, JR; Engel, JA; Soon, MSF; Singh, B; Kueh, AJ; Herold, MJ; de Oca, MM; Singh, SS; Bunn, PT; Aguilera, AR; Casey, M; Braun, M; Ghazanfari, N; Wani, S; Wang, YL; Amante, FH; Edwards, CL; Haque, A; Dougall, WC; Singh, OP; Baxter, AG; Teng, MWL; Loukas, A; Daly, NL; Cloonan, N; Degli-Esposti, MA; Uzonna, J; Heath, WR; Bald, T; Tey, SK; Nakamura, K; Hill, GR; Kumar, R; Sundar, S; Smyth, MJ; Engwerda, CR				Ng, Susanna S.; Rivera, Fabian De Labastida; Yan, Juming; Corvino, Dillon; Das, Indrajit; Zhang, Ping; Kuns, Rachel; Chauhan, Shashi Bhushan; Hou, Jiajie; Li, Xian-Yang; Frame, Teija C. M.; McEnroe, Benjamin A.; Moore, Eilish; Na, Jinrui; Engel, Jessica A.; Soon, Megan S. F.; Singh, Bhawana; Kueh, Andrew J.; Herold, Marco J.; de Oca, Marcela Montes; Singh, Siddharth Sankar; Bunn, Patrick T.; Aguilera, Amy Roman; Casey, Mika; Braun, Matthias; Ghazanfari, Nazanin; Wani, Shivangi; Wang, Yulin; Amante, Fiona H.; Edwards, Chelsea L.; Haque, Ashraful; Dougall, William C.; Singh, Om Prakash; Baxter, Alan G.; Teng, Michele W. L.; Loukas, Alex; Daly, Norelle L.; Cloonan, Nicole; Degli-Esposti, Mariapia A.; Uzonna, Jude; Heath, William R.; Bald, Tobias; Tey, Siok-Keen; Nakamura, Kyohei; Hill, Geoffrey R.; Kumar, Rajiv; Sundar, Shyam; Smyth, Mark J.; Engwerda, Christian R.			The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; IMMUNE CHECKPOINT BLOCKADE; CD8(+) T-CELLS; TUMOR REJECTION; RESPONSES; EXPRESSION; DIFFERENTIATION; SEQUESTRATION; PATHOLOGY; REPORTER	Immune-modulating therapies have revolutionized the treatment of chronic diseases, particularly cancer. However, their success is restricted and there is a need to identify new therapeutic targets. Here, we show that natural killer cell granule protein 7 (NKG7) is a regulator of lymphocyte granule exocytosis and downstream inflammation in a broad range of diseases. NKG7 expressed by CD4(+)and CD8(+)T cells played key roles in promoting inflammation during visceral leishmaniasis and malaria-two important parasitic diseases. Additionally, NKG7 expressed by natural killer cells was critical for controlling cancer initiation, growth and metastasis. NKG7 function in natural killer and CD8(+)T cells was linked with their ability to regulate the translocation of CD107a to the cell surface and kill cellular targets, while NKG7 also had a major impact on CD4(+)T cell activation following infection. Thus, we report a novel therapeutic target expressed on a range of immune cells with functions in different immune responses. NKG7 is a molecule well associated with NK cells but of unknown function. Engwerda and colleagues demonstrate that NKG7 is also associated with T(H)1 cells and is essential for type I and cytotoxic responses.	[Ng, Susanna S.; Rivera, Fabian De Labastida; Yan, Juming; Corvino, Dillon; Das, Indrajit; Zhang, Ping; Kuns, Rachel; Hou, Jiajie; Li, Xian-Yang; Frame, Teija C. M.; McEnroe, Benjamin A.; Moore, Eilish; Na, Jinrui; Engel, Jessica A.; Soon, Megan S. F.; de Oca, Marcela Montes; Bunn, Patrick T.; Aguilera, Amy Roman; Casey, Mika; Braun, Matthias; Wani, Shivangi; Wang, Yulin; Amante, Fiona H.; Edwards, Chelsea L.; Haque, Ashraful; Dougall, William C.; Teng, Michele W. L.; Cloonan, Nicole; Bald, Tobias; Tey, Siok-Keen; Nakamura, Kyohei; Smyth, Mark J.; Engwerda, Christian R.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ng, Susanna S.; Wang, Yulin] Griffith Univ, Sch Environm & Sci, Nathan, Qld, Australia; [Yan, Juming; Corvino, Dillon; Frame, Teija C. M.; Moore, Eilish; Na, Jinrui; Soon, Megan S. F.; Edwards, Chelsea L.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Chauhan, Shashi Bhushan; Singh, Bhawana; Singh, Siddharth Sankar; Kumar, Rajiv; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India; [Kueh, Andrew J.; Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Div Blood Cells & Blood Canc, Melbourne, Vic, Australia; [Kueh, Andrew J.; Herold, Marco J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Bunn, Patrick T.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Ghazanfari, Nazanin; Heath, William R.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Wani, Shivangi] Univ Queensland, Inst Mol Biol, Brisbane, Qld, Australia; [Singh, Om Prakash] Banaras Hindu Univ, Inst Sci, Dept Biochem, Varanasi, Uttar Pradesh, India; [Baxter, Alan G.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Loukas, Alex; Daly, Norelle L.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Cloonan, Nicole] Univ Auckland, Fac Sci, Auckland, New Zealand; [Degli-Esposti, Mariapia A.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [Degli-Esposti, Mariapia A.] Monash Univ, Biomed Discovery Inst, Dept Microbiol, Melbourne, Vic, Australia; [Degli-Esposti, Mariapia A.] Lions Eye Inst, Ctr Expt Immunol, Perth, WA, Australia; [Uzonna, Jude] Univ Manitoba, Max Rady Coll Med, Dept Immunol, Winnipeg, MB, Canada; [Hill, Geoffrey R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Kumar, Rajiv] Banaras Hindu Univ, Ctr Expt Med & Surg, Inst Med Sci, Varanasi, Uttar Pradesh, India; [Ng, Susanna S.; Corvino, Dillon] Univ Bonn, Univ Hosp Bonn, Med Fac, Inst Expt Oncol, Bonn, Germany	QIMR Berghofer Medical Research Institute; Griffith University; University of Queensland; Banaras Hindu University (BHU); University of Melbourne; Griffith University; University of Melbourne; University of Queensland; Banaras Hindu University (BHU); James Cook University; James Cook University; University of Auckland; Monash University; Monash University; Lions Eye Institute; University of Western Australia; University of Manitoba; Fred Hutchinson Cancer Center; Banaras Hindu University (BHU); University of Bonn	Engwerda, CR (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	chrisE@qimr.edu.au	Teng, Michele WL/S-5055-2016; Kumar, Rajiv/GSE-5530-2022; Herold, Marco J/C-8039-2013; Ng, Susanna S/L-9906-2014; Hou, Jiajie/CAF-2235-2022; Tey, Siok-Keen/I-6380-2015; Loukas, Alex/B-7355-2014	Teng, Michele WL/0000-0003-1886-9145; Herold, Marco J/0000-0001-7539-7581; Ng, Susanna S/0000-0002-8494-7722; Hou, Jiajie/0000-0002-9011-6837; Engel, Jessica/0000-0001-6175-1797; Heath, William/0000-0001-9670-259X; Casey, Mika/0000-0001-9013-750X; zhang, ping/0000-0002-0311-6725; Dougall, William/0000-0001-9487-251X; Wang, Yulin/0000-0002-9976-5315; Tey, Siok-Keen/0000-0001-9567-382X; Na, Jinrui/0000-0002-0134-5970; Corvino, Dillon/0000-0003-0683-1369; Kumar, Rajiv/0000-0003-2338-1494; Degli-Esposti, Mariapia/0000-0002-7808-5935; Engwerda, Christian/0000-0003-2813-4804; Das, Indrajit/0000-0001-8407-9796; Chauhan, Shashi Bhushan/0000-0002-3268-852X; Loukas, Alex/0000-0002-0896-8441; Singh, Om Prakash/0000-0003-2146-8107	Australian Phenomics Network (APN); Australian government through the National Collaborative Research Infrastructure Strategy program; National Health and Medical Research Council of Australia (NHMRC) [1037304, 1058685, 1078671, 1132519, 1132975, 1154265]; National Institutes of Health Tropical Medicine Research Centre (TMRC) grant [U19 AI074321]; Australian post-graduate awards through Griffith University's Institute of Glycomics; School of Natural Sciences; Dr. Mildred Scheel Stiftung fur Krebsforschung scholarship from Deutsche Krebshilfe; INSPIRE Faculty grant by the Indian government Department of Science and Technology (DST), Banaras Hindu University [LSBM-109/IF-14]; University Grants Commission [M-14-70]; Indian Council of Medical Research; Queensland State Government	Australian Phenomics Network (APN); Australian government through the National Collaborative Research Infrastructure Strategy program(Australian GovernmentDepartment of Industry, Innovation and Science); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health Tropical Medicine Research Centre (TMRC) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian post-graduate awards through Griffith University's Institute of Glycomics; School of Natural Sciences; Dr. Mildred Scheel Stiftung fur Krebsforschung scholarship from Deutsche Krebshilfe; INSPIRE Faculty grant by the Indian government Department of Science and Technology (DST), Banaras Hindu University; University Grants Commission(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Queensland State Government	We thank the staff at the Kala-Azar Medical Research Centre (KAMRC), Muzaffarpur, India for help with the collection of blood samples, as well as patients and volunteers for allowing the use of blood samples. We thank staff at the QIMR Berghofer flow cytometry laboratory for assistance, and staff at the QIMR Berghofer animal facility for animal husbandry. We acknowledge the facilities, and the scientific and technical assistance of the MAGEC, Walter and Eliza Hall Institute of Medical Research. The MAGEC is supported by the Australian Phenomics Network (APN) and the APN is supported by the Australian government through the National Collaborative Research Infrastructure Strategy program. We thank the NIH tetramer facility (Atlanta, GA, United States) for production of the I-Ab-PEPCK335-351 tetramer used to detect L. donovani PEPCK-specific CD4+ T cells in these studies. This work was made possible through Queensland State Government funding and grants and fellowships from the National Health and Medical Research Council of Australia (NHMRC; grant numbers 1037304, 1058685, 1078671, 1132519, 1132975 and 1154265). Funding was also provided through a National Institutes of Health Tropical Medicine Research Centre (TMRC) grant (U19 AI074321), as well as Australian post-graduate awards through Griffith University's Institute of Glycomics and School of Natural Sciences to P.T.B. and S.S.N., respectively; a Dr. Mildred Scheel Stiftung fur Krebsforschung scholarship from Deutsche Krebshilfe to M.B.; and an INSPIRE Faculty grant (LSBM-109/IF-14) provided by the Indian government Department of Science and Technology (DST), Banaras Hindu University and University Grants Commission (M-14-70) to R.K. B.S. was supported by a Junior Research Fellowship from the Indian Council of Medical Research.	Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Antignano F, 2014, J CLIN INVEST, V124, P1945, DOI 10.1172/JCI69592; Aschenbrenner D, 2018, NAT IMMUNOL, V19, P1126, DOI 10.1038/s41590-018-0200-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P119; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Cursons J, 2019, CANCER IMMUNOL RES, V7, P1162, DOI 10.1158/2326-6066.CIR-18-0500; de Andrade LF, 2014, CANCER RES, V74, P7298, DOI 10.1158/0008-5472.CAN-14-1339; de Oca MM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005398; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Engwerda CR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00498; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Eppig JT, 2015, MAMM GENOME, V26, P448, DOI 10.1007/s00335-015-9600-0; Fairfax BP, 2020, NAT MED, V26, P193, DOI 10.1038/s41591-019-0734-6; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Hochheiser K, 2018, EUR J IMMUNOL, V48, P576, DOI 10.1002/eji.201747131; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Krzewski K, 2013, BLOOD, V121, P4672, DOI 10.1182/blood-2012-08-453738; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Markey KA, 2015, J IMMUNOL METHODS, V423, P40, DOI 10.1016/j.jim.2015.04.029; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moreira-Teixeira L, 2020, NAT IMMUNOL, V21, P464, DOI 10.1038/s41590-020-0610-z; Mou ZR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5477; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; Putz EM, 2017, J CLIN INVEST, V127, P2777, DOI 10.1172/JCI92958; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schett G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05800-6; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Smyth MJ, 1998, J EXP MED, V188, P1611, DOI 10.1084/jem.188.9.1611; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; STERN JJ, 1988, J IMMUNOL, V140, P3971; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Tubo NJ, 2014, CLIN MICROBIOL REV, V27, P200, DOI 10.1128/CMR.00097-13; TURMAN MA, 1993, HUM IMMUNOL, V36, P34, DOI 10.1016/0198-8859(93)90006-M; Valencia-Hernandez AM, 2020, CELL HOST MICROBE, V27, P950, DOI 10.1016/j.chom.2020.04.010; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Young A, 2016, CANCER CELL, V30, P391, DOI 10.1016/j.ccell.2016.06.025	70	38	38	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1205	+		10.1038/s41590-020-0758-6	http://dx.doi.org/10.1038/s41590-020-0758-6		AUG 2020	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32839608	Green Accepted			2022-12-18	WOS:000562393000006
J	Edner, NM; Heuts, F; Thomas, N; Wang, CJ; Petersone, L; Kenefeck, R; Kogimtzis, A; Ovcinnikovs, V; Ross, EM; Ntavli, E; Elfaki, Y; Eichmann, M; Baptista, R; Ambery, P; Jermutus, L; Peakman, M; Rosenthal, M; Walker, LSK				Edner, Natalie M.; Heuts, Frank; Thomas, Niclas; Wang, Chun Jing; Petersone, Lina; Kenefeck, Rupert; Kogimtzis, Alexandros; Ovcinnikovs, Vitalijs; Ross, Ellen M.; Ntavli, Elisavet; Elfaki, Yassin; Eichmann, Martin; Baptista, Roman; Ambery, Philip; Jermutus, Lutz; Peakman, Mark; Rosenthal, Miranda; Walker, Lucy S. K.			Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes	NATURE IMMUNOLOGY			English	Article							B-CELLS; ABATACEPT; ONSET; ICOS; DIFFERENTIATION; MODULATION; PHENOTYPE; SUBSET; BCL6	Follicular helper T (T-FH) cells are implicated in type 1 diabetes (T1D), and their development has been linked to CD28 costimulation. We tested whether T(FH)cells were decreased by costimulation blockade using the CTLA-4-immunoglobulin (Ig) fusion protein (abatacept) in a mouse model of diabetes and in individuals with new-onset T1D. Unbiased bioinformatics analysis identified that inducible costimulatory molecule (ICOS)(+)T(FH)cells and other ICOS(+)populations, including peripheral helper T cells, were highly sensitive to costimulation blockade. We used pretreatment T(FH)profiles to derive a model that could predict clinical response to abatacept in individuals with T1D. Using two independent approaches, we demonstrated that higher frequencies of ICOS(+)T(FH)cells at baseline were associated with a poor clinical response following abatacept administration. Therefore, T(FH)analysis may represent a new stratification tool, permitting the identification of individuals most likely to benefit from costimulation blockade. The CTLA-4-Ig fusion protein (abatacept) can have beneficial effects in autoimmune disease. Walker and colleagues show in mouse and human type 1 diabetes that abatacept targets pathogenic follicular helper T cells, and the frequencies of these cells at baseline can be used to stratify treatment responses in patients.	[Edner, Natalie M.; Heuts, Frank; Thomas, Niclas; Wang, Chun Jing; Petersone, Lina; Kenefeck, Rupert; Kogimtzis, Alexandros; Ovcinnikovs, Vitalijs; Ross, Ellen M.; Ntavli, Elisavet; Elfaki, Yassin; Rosenthal, Miranda; Walker, Lucy S. K.] UCL, Div Infect & Immun, Inst Immun & Transplantat, Royal Free Campus, London, England; [Eichmann, Martin; Baptista, Roman; Peakman, Mark] Kings Coll London, Dept Immunobiol, London, England; [Ambery, Philip] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden; [Jermutus, Lutz] AstraZeneca, BioPharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Cambridge, England	University of London; University College London; University of London; King's College London; AstraZeneca; AstraZeneca	Walker, LSK (corresponding author), UCL, Div Infect & Immun, Inst Immun & Transplantat, Royal Free Campus, London, England.	lucy.walker@ucl.ac.uk	Eichmann, Martin/AAV-4823-2020	Eichmann, Martin/0000-0002-8675-2822; Petersone, Lina/0000-0001-8571-9185; Peakman, Mark/0000-0003-3328-3513; Elfaki, Yassin/0000-0001-6628-3080; Edner, Natalie Mona/0000-0003-2799-2890; Walker, Lucy/0000-0001-5986-5015	Diabetes UK; AstraZeneca; Medical Research Council; Rosetrees Trust; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [675395]; Type One Mission; Type 1 Diabetes TrialNet study group; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509]; Juvenile Diabetes Research Foundation (JDRF); MRC [MR/S009140/1, MR/N001435/1] Funding Source: UKRI	Diabetes UK(Diabetes UK); AstraZeneca(AstraZeneca); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; Type One Mission; Type 1 Diabetes TrialNet study group; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Diabetes UK, MedImmune (now AstraZeneca), the Medical Research Council and the Rosetrees Trust. The authors received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant no. 675395. Diabetes research in the Walker laboratory is supported by Type One Mission. We acknowledge the support of the Type 1 Diabetes TrialNet study group, which identified study participants and provided samples and follow-up data for this study. The Type 1 Diabetes TrialNet study group is a clinical trial network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development through the cooperative agreement nos. U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509 and the Juvenile Diabetes Research Foundation (JDRF). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or JDRF. We thank A. Pesenacker for helpful comments on the manuscript.	Arvaniti E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14825; Bell EB, 2001, EUR J IMMUNOL, V31, P1685, DOI 10.1002/1521-4141(200106)31:6<1685::AID-IMMU1685>3.0.CO;2-V; Blair HA, 2017, DRUGS, V77, P1221, DOI 10.1007/s40265-017-0775-4; Bocharnikov AV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130062; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Breiman L, 1997, 486 U CAL; Brunner HI, 2018, ARTHRITIS RHEUMATOL, V70, P1144, DOI 10.1002/art.40466; Cabrera SM, 2018, DIABETOLOGIA, V61, P2356, DOI 10.1007/s00125-018-4708-x; Clough LE, 2008, J IMMUNOL, V180, P5393, DOI 10.4049/jimmunol.180.8.5393; Ekman I, 2019, DIABETOLOGIA, V62, P1681, DOI 10.1007/s00125-019-4936-8; Ferreira RC, 2015, DIABETOLOGIA, V58, P781, DOI 10.1007/s00125-015-3509-8; Fortea-Gordo P, 2019, RHEUMATOLOGY, V58, P1662, DOI 10.1093/rheumatology/kez169; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Glatigny S, 2019, J IMMUNOL, V202, P1373, DOI 10.4049/jimmunol.1801425; Glinos D. A., 2018, GENOMIC PROFILING T, DOI [10.1101/421099v1, DOI 10.1101/421099V1]; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Heit A, 2017, J EXP MED, V214, P2139, DOI 10.1084/jem.20161794; Hill DL, 2019, J EXP MED, V216, P1857, DOI 10.1084/jem.20190301; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kenefeck R, 2015, J CLIN INVEST, V125, P292, DOI 10.1172/JCI76238; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Linsley PS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126136; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; Mease PJ, 2017, ANN RHEUM DIS, V76, P1550, DOI 10.1136/annrheumdis-2016-210724; Merica R, 2000, J IMMUNOL, V164, P4551, DOI 10.4049/jimmunol.164.9.4551; Monaco G, 2016, BIOINFORMATICS, V32, P2473, DOI 10.1093/bioinformatics/btw191; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Orban T, 2014, DIABETES, V63, P3449, DOI 10.2337/db14-0047; Orban T, 2014, DIABETES CARE, V37, P1069, DOI 10.2337/dc13-0604; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Piantoni S, 2018, CLIN EXP RHEUMATOL, V36, P685; Pieper J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-34; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Serr I, 2016, P NATL ACAD SCI USA, V113, pE6659, DOI 10.1073/pnas.1606646113; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Verstappen GM, 2017, ARTHRITIS RHEUMATOL, V69, P1850, DOI 10.1002/art.40165; Viisanen T, 2017, DIABETES, V66, P437, DOI 10.2337/db16-0714; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079858; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	50	38	39	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1244	+		10.1038/s41590-020-0744-z	http://dx.doi.org/10.1038/s41590-020-0744-z		AUG 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32747817	Green Submitted, Green Accepted			2022-12-18	WOS:000555415800002
J	Urban, SL; Jensen, IJ; Shan, Q; Pewe, LL; Xue, HH; Badovinac, VP; Harty, JT				Urban, Stina L.; Jensen, Isaac J.; Shan, Qiang; Pewe, Lecia L.; Xue, Hai-Hui; Badovinac, Vladimir P.; Harty, John T.			Peripherally induced brain tissue-resident memory CD8(+)T cells mediate protection against CNS infection	NATURE IMMUNOLOGY			English	Article							CD8 T-CELLS; CENTRAL-NERVOUS-SYSTEM; IMMUNE; RESPONSES; EFFECTOR; VIRUS; FLUID	The central nervous system (CNS) is classically viewed as immune-privileged; however, recent advances highlight interactions between the peripheral immune system and CNS in controlling infections and tissue homeostasis. Tissue-resident memory (T-RM) CD8(+)T cells in the CNS are generated after brain infections, but it is unknown whether CNS infection is required to generate brain T(RM)cells. We show that peripheral infections generate antigen-specific CD8(+)memory T cells in the brain that adopt a unique T(RM)signature. Upon depletion of circulating and perivascular memory T cells, this brain signature was enriched and the surveilling properties of brain T(RM)cells was revealed by intravital imaging. Notably, peripherally induced brain T(RM)cells showed evidence of rapid activation and enhanced cytokine production and mediated protection after brain infections. These data reveal that peripheral immunizations can generate brain T(RM)cells and will guide potential use of T cells as therapeutic strategies against CNS infections and neurological diseases. Harty and colleagues show that peripheral infections can establish and maintain functional antigen-specific tissue-resident memory CD8(+) T cells in the central nervous system.	[Urban, Stina L.; Jensen, Isaac J.; Pewe, Lecia L.; Badovinac, Vladimir P.; Harty, John T.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Jensen, Isaac J.; Badovinac, Vladimir P.; Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA; [Shan, Qiang; Xue, Hai-Hui] Hackensack Univ, Ctr Discovery & Innovat, Med Ctr, Hackensack, NJ USA; [Xue, Hai-Hui] VA New Jersey Hlth Care Syst, E Orange, NJ USA; [Badovinac, Vladimir P.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA	University of Iowa; University of Iowa; Hackensack University Medical Center; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.; Harty, JT (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		Shan, Qiang/0000-0002-7089-0278; Badovinac, Vladimir/0000-0003-3180-2439; Xue, Hai-Hui/0000-0002-9163-7669; Jensen, Isaac/0000-0002-3107-3961	National Institutes of Health [AI42767, AI114543, GM134880, AI121080, AI139874, T32 AI007343, T32 AI007511]; Veteran Affairs BLR&D Merit Review Program [BX002903]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs BLR&D Merit Review Program	We thank S. Perlman for critical review and comments on the manuscript and S. Anthony for helpful discussion. We thank J. Fishbaugh, H. Vignes and M. Shey (University of Iowa Flow Cytometry Core Facility) for cell sorting, I. Antoshechkin (California Institute of Technology) and Admera health for RNA-seq. Data herein were obtained from the Flow Cytometry Facility, which is a Carver College of Medicine Core Research Facilities/Holden Comprehensive Cancer Center Core Laboratory at the University of Iowa. This work was supported by grants from the National Institutes of Health (AI42767 to J.T.H., AI114543 to J.T.H. and V.P.B., GM134880 to V.P.B., AI121080 and AI139874 to H.-H.X., T32 AI007343 to S.L.U. and T32 AI007511 to I.J.J.) and the Veteran Affairs BLR&D Merit Review Program (BX002903) to H.-H.X.	Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; BAENZIGER J, 1986, EUR J IMMUNOL, V16, P387, DOI 10.1002/eji.1830160413; Behr FM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01770; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Dulken B, 2019, NATURE, V571, P205, DOI 10.1038/s41586-019-1362-5; Frost EL, 2015, J IMMUNOL, V195, P3520, DOI 10.4049/jimmunol.1501521; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Griffin DE, 2011, CURR OPIN VIROL, V1, P216, DOI 10.1016/j.coviro.2011.05.021; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hickman Heather D, 2015, Intravital, V4, pe1055425, DOI 10.1080/21659087.2015.1055425; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Landrith TA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00335; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Ludwig A, 2008, J NEUROIMMUNOL, V198, P92, DOI 10.1016/j.jneuroim.2008.04.024; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Manglani M, 2018, CURR PROTOC IMMUNOL, V120, P2421; Manglani Monica, 2018, Curr Protoc Immunol, V121, pe44, DOI 10.1002/cpim.44; Manglani M, 2018, CURR OPIN VIROL, V28, P116, DOI 10.1016/j.coviro.2017.12.003; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; Martin MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005219; Maru S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006318; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Milner JJ, 2018, CURR OPIN IMMUNOL, V51, P162, DOI 10.1016/j.coi.2018.03.017; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mockus TE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007365; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Mueller SN, 2010, J IMMUNOL, V185, P2182, DOI 10.4049/jimmunol.1001142; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Petito CK, 2005, J NEUROIMMUNOL, V162, P19, DOI 10.1016/j.jneuroim.2004.12.020; Prasad S, 2019, VIRAL IMMUNOL, V32, P48, DOI 10.1089/vim.2018.0084; Prasad S, 2018, IMMUN INFLAMM DIS, V6, P332, DOI 10.1002/iid3.221; Prasad S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0860-3; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Steinbach K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02827; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Topham DJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00515; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Welten SPM, 2018, IMMUNOL REV, V283, P161, DOI 10.1111/imr.12649; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	56	38	38	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					938	+		10.1038/s41590-020-0711-8	http://dx.doi.org/10.1038/s41590-020-0711-8		JUN 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32572242	Green Accepted			2022-12-18	WOS:000542142500001
J	Slon-Campos, JL; Dejnirattisai, W; Jagger, BW; Lopez-Camacho, C; Wongwiwat, W; Durnell, LA; Winkler, ES; Chen, RE; Reyes-Sandoval, A; Rey, FA; Diamond, MS; Mongkolsapaya, J; Screaton, GR				Slon-Campos, Jose Luis; Dejnirattisai, Wanwisa; Jagger, Brett W.; Lopez-Camacho, Cesar; Wongwiwat, Wiyada; Durnell, Lorellin A.; Winkler, Emma S.; Chen, Rita E.; Reyes-Sandoval, Arturo; Rey, Felix A.; Diamond, Michael S.; Mongkolsapaya, Juthathip; Screaton, Gavin R.			A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection	NATURE IMMUNOLOGY			English	Article							NEUTRALIZING HUMAN-ANTIBODIES; CROSS-REACTIVITY; STRUCTURAL BASIS; MOUSE MODEL; EPITOPE; POTENT	Infections with dengue virus (DENV) and Zika virus (ZIKV) can induce cross-reactive antibody responses. Two immunodominant epitopes-one to precursor membrane protein and one to the fusion loop epitope on envelope (E) protein-are recognized by cross-reactive antibodies 1-3 that are not only poorly neutralizing, but can also promote increased viral replication and disease severity via Fcy receptor-mediated infection of myeloid cells-a process termed antibody-dependent enhancement (ADE)(1,4,5). ADE is a significant concern for both ZIKV and DENV vaccines as the induction of poorly neutralizing cross-reactive antibodies may prime an individual for ADE on natural infection. In this report, we describe the design and production of covalently stabilized ZIKV E dimers, which lack precursor membrane protein and do not expose the immunodominant fusion loop epitope. Immunization of mice with ZIKV E dimers induces dimer-specific antibodies, which protect against ZIKV challenge during pregnancy. Importantly, the ZIKV E-dimer-induced response does not cross-react with DENV or induce ADE of DENV infection.	[Slon-Campos, Jose Luis; Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip] Univ Oxford, Nuffield Dept Med, Wellcome Ctr Human Genet, Oxford, England; [Jagger, Brett W.; Durnell, Lorellin A.; Winkler, Emma S.; Chen, Rita E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Lopez-Camacho, Cesar; Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, Paris, France; [Rey, Felix A.] CNRS, Unite Mixte Rech 3569, Paris, France; [Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA; [Mongkolsapaya, Juthathip] Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok, Thailand; [Screaton, Gavin R.] Univ Oxford, Div Med Sci, Oxford, England; [Jagger, Brett W.] Western Michigan Univ, Dept Med, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA	University of Oxford; Wellcome Centre for Human Genetics; Washington University (WUSTL); University of Oxford; Jenner Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Mahidol University; University of Oxford; Western Michigan University	Mongkolsapaya, J (corresponding author), Univ Oxford, Nuffield Dept Med, Wellcome Ctr Human Genet, Oxford, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok, Thailand.; Screaton, GR (corresponding author), Univ Oxford, Div Med Sci, Oxford, England.	jmongkol@well.ox.ac.uk; gavin.screaton@medsci.ox.ac.uk	Diamond, Michael/AAH-1733-2019; Lopez-Camacho, Cesar/AID-3761-2022; Wongwiwat, Wiyada/AAJ-8936-2021	Diamond, Michael/0000-0002-8791-3165; Lopez-Camacho, Cesar/0000-0001-7932-2341; Slon Campos, Jose Luis/0000-0002-0012-5247; Rey, Felix/0000-0002-9953-7988; Wongwiwat, Wiyada/0000-0002-5889-0929; Reyes-Sandoval, Arturo/0000-0002-2648-1696; Screaton, Gavin/0000-0002-3549-4309	Wellcome Trust [203224/Z/16/Z, 095541/A/11/Z]; National Institute for Health Research Biomedical Research Centre Funding Scheme; Medical Research Council Newton fund (UK-Thailand joint initiative of infectious diseases grant) [MR/R020957/1]; National Institutes of Health [R01 AI073755, R01 AI127828, R01 HD091218, T32 AI007172]; UK Department of Health and Social Care [972216, 971557]; French Government's Programme d'Investissements d'Avenir (Labex Integrative Biology of Emerging Infectious Diseases grant) [ANR-10-LABX-62IBEID 4E AAP]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, R01AI127828, R01AI073755] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre Funding Scheme(National Institute for Health Research (NIHR)); Medical Research Council Newton fund (UK-Thailand joint initiative of infectious diseases grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Department of Health and Social Care; French Government's Programme d'Investissements d'Avenir (Labex Integrative Biology of Emerging Infectious Diseases grant)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Wellcome Trust (collaborative grant 203224/Z/16/Z to G.R.S. and J.M.), National Institute for Health Research Biomedical Research Centre Funding Scheme (to G.R.S.), Medical Research Council Newton fund (UK-Thailand joint initiative of infectious diseases grant MR/R020957/1 to J.M.), National Institutes of Health (grants R01 AI073755, R01 AI127828 and R01 HD091218 to M.S.D., and grant T32 AI007172 to B.W.J.), UK Department of Health and Social Care (projects 972216 and 971557 to A. R.-S.) and French Government's Programme d'Investissements d'Avenir (Labex Integrative Biology of Emerging Infectious Diseases grant ANR-10-LABX-62IBEID 4E AAP to F.A.R.). G.R.S. is supported as a Wellcome Trust Senior Investigator (grant 095541/A/11/Z). We thank Y.C.Kim and B.D. Jimenez for technical assistance.	Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0; Bailey MJ, 2019, J VIROL, V93, DOI 10.1128/JVI.00405-19; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001; Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127; Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749; Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77; George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1; Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726; Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003; Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17; Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116; Lopez-Camacho C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040322; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674; Petris G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096700; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	53	38	40	4	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1291	+		10.1038/s41590-019-0477-z	http://dx.doi.org/10.1038/s41590-019-0477-z			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31477918	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000486615900013
J	Hojen, JF; Kristensen, MLV; McKee, AS; Wade, MT; Azam, T; Lunding, LP; de Graaf, DM; Swartzwelter, BJ; Wegmann, M; Tolstrup, M; Beckman, K; Fujita, M; Fischer, S; Dinarello, CA				Hojen, Jesper Falkesgaard; Kristensen, Marie Louise Vindvad; McKee, Amy S.; Wade, Megan Taylor; Azam, Tania; Lunding, Lars P.; de Graaf, Dennis M.; Swartzwelter, Benjamin J.; Wegmann, Michael; Tolstrup, Martin; Beckman, Karsten; Fujita, Mayumi; Fischer, Stephan; Dinarello, Charles A.			IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease	NATURE IMMUNOLOGY			English	Article							RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN-36-RECEPTOR ANTAGONIST DEFICIENCY; SKIN INFLAMMATION; MAST-CELL; ACTIVATION; INTERLEUKIN-1-BETA; PSORIASIS; MICE; EXPRESSION; ANTIBODY	Interleukin (IL)-1R3 is the co-receptor in three signaling pathways that involve six cytokines of the IL-1 family (IL-1 alpha, IL-1 beta, IL-33, IL-36 alpha, IL-36 beta and IL-36 gamma). In many diseases, multiple cytokines contribute to disease pathogenesis. For example, in asthma, both IL-33 and IL-1 are of major importance, as are IL-36 and IL-1 in psoriasis. We developed a blocking monoclonal antibody (mAb) to human IL-1R3 (MAB-hR3) and demonstrate here that this antibody specifically inhibits signaling via IL-1, IL-33 and IL-36 in vitro. Also, in three distinct in vivo models of disease (crystal-induced peritonitis, allergic airway inflammation and psoriasis), we found that targeting IL-1R3 with a single mAb to mouse IL-1R3 (MAB-mR3) significantly attenuated heterogeneous cytokine-driven inflammation and disease severity. We conclude that in diseases driven by multiple cytokines, a single antagonistic agent such as a mAb to IL-1R3 is a therapeutic option with considerable translational benefit.	[Hojen, Jesper Falkesgaard; Tolstrup, Martin] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Hojen, Jesper Falkesgaard; Tolstrup, Martin] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Hojen, Jesper Falkesgaard; Kristensen, Marie Louise Vindvad; McKee, Amy S.; Wade, Megan Taylor; Azam, Tania; de Graaf, Dennis M.; Swartzwelter, Benjamin J.; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [McKee, Amy S.; Fujita, Mayumi] Univ Colorado Denver, Dept Microbiol & Immunol, Aurora, CO USA; [Lunding, Lars P.; Wegmann, Michael] German Ctr Lung Res DZL, Div Asthma Exacerbat & Regulat Prior Area Asthma, Leibniz Lung Ctr Borstel, ARCN, Borstel, Germany; [de Graaf, Dennis M.; Dinarello, Charles A.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Beckman, Karsten; Fischer, Stephan] MAB Discovery GmbH, Neuried, Germany; [Fujita, Mayumi] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA	Aarhus University; Aarhus University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Radboud University Nijmegen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.; Dinarello, CA (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands.	cdinare333@aol.com		Hojen, Jesper Falkesgaard/0000-0002-2629-5391; Tolstrup, Martin/0000-0001-7020-5173; Wegmann, Michael/0000-0002-1658-1554; Swartzwelter, Benjamin/0000-0002-6283-5199	University of Colorado Cancer Center NIH at the University of Colorado Anschutz Medical Campus [P30CA046934]; Oticon Foundation; Lundbeck Foundation; Knud Hojgaard Foundation; Interleukin Foundation; NIH [HL126736, ES025534, HL135872-01, AI-15614]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614] Funding Source: NIH RePORTER	University of Colorado Cancer Center NIH at the University of Colorado Anschutz Medical Campus; Oticon Foundation; Lundbeck Foundation(Lundbeckfonden); Knud Hojgaard Foundation; Interleukin Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Domenico and M. Wade for their technical assistance, and S. H. Kim (Laboratory of Cytokine Immunology, Konkuk Univ., Republic of Korea) and M. Fujita for providing cell lines. We thank the OLAR Vivarium, the ClinImmune Flow Core Facility and the Histology Shared Resource Center funded by the University of Colorado Cancer Center NIH grant (no. P30CA046934) at the University of Colorado Anschutz Medical Campus. We also thank the University of Colorado School of Medicine Biological Mass Spectrometry Facility for analyzing IP samples. J.F.H. was supported by the Oticon Foundation, Lundbeck Foundation, Knud Hojgaard Foundation and the Interleukin Foundation. M.L.V.K and B.J.S. was supported by the Interleukin Foundation. A.S.M. was funded by NIH grants no. HL126736, ES025534 and HL135872-01. C.A.D. was funded by NIH grant no. AI-15614.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Alvarez P., 2016, MEDIAT INFLAMM, P1; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cullinan EB, 1998, J IMMUNOL, V161, P5614; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Enoksson M, 2013, BLOOD, V121, P530, DOI 10.1182/blood-2012-05-434209; Fehrenbach H, 1998, VIRCHOWS ARCH, V432, P229, DOI 10.1007/s004280050160; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hawkes JE, 2017, J ALLERGY CLIN IMMUN, V140, P645, DOI 10.1016/j.jaci.2017.07.004; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Jaras M, 2010, P NATL ACAD SCI USA, V107, P16280, DOI 10.1073/pnas.1004408107; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; KAKIMOTO K, 1995, CELL IMMUNOL, V165, P26, DOI 10.1006/cimm.1995.1183; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lee HY, 2014, EXP LUNG RES, V40, P66, DOI 10.3109/01902148.2013.870261; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lunding LP, 2015, J IMMUNOL, V194, P5615, DOI 10.4049/jimmunol.1402529; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mashiko S, 2015, J ALLERGY CLIN IMMUN, V136, P351, DOI 10.1016/j.jaci.2015.01.033; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; Mckee AS, 2015, MUCOSAL IMMUNOL, V8, P1237, DOI 10.1038/mi.2015.14; Moore HB, 2015, SHOCK, V43, P39, DOI 10.1097/SHK.0000000000000245; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Possa SS, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00046; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rabeony H, 2015, EUR J IMMUNOL, V45, P2847, DOI 10.1002/eji.201445215; Ramanan VK, 2015, BRAIN, V138, P3076, DOI 10.1093/brain/awv231; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rossi-Semerano L, 2013, PEDIATRICS, V132, pE1043, DOI 10.1542/peds.2012-3935; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Sticherling M, 1999, ACTA DERM-VENEREOL, V79, P4; Tanabe T, 2014, CLIN EXP ALLERGY, V44, P540, DOI 10.1111/cea.12283; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009; van de Veerdonk FL, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00762; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727	55	38	40	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1138	+		10.1038/s41590-019-0467-1	http://dx.doi.org/10.1038/s41590-019-0467-1			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31427775	Green Accepted, Green Submitted			2022-12-18	WOS:000482212600014
J	Legoux, F; Gilet, J; Procopio, E; Echasserieau, K; Bernardeau, K; Lantz, O				Legoux, Francois; Gilet, Jules; Procopio, Emanuele; Echasserieau, Klara; Bernardeau, Karine; Lantz, Olivier			Molecular mechanisms of lineage decisions in metabolite-specific T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; SELECTION; ALPHA; FATE; PLZF; BIAS; MR1	Mucosal-associated invariant T cells (MAIT cells) recognize the microbial metabolite 5-(2-oxopropylideneamino)-6-D-ribity-laminouracil (5-OP-RU) presented by the MHC class lb molecule, MR1. MAIT cells acquire effector functions during thymic development, but the mechanisms involved are unclear. Here we used single-cell RNA-sequencing to characterize the developmental path of 5-OP-RU-specific thymocytes. In addition to the known MAIT1 and MAIT17 effector subsets selected on bone-marrow-derived hematopoietic cells, we identified 5-OP-RU-specific thymocytes that were selected on thymic epithelial cells and differentiated into CD44(-) naive Tcells. MAIT cell positive selection required signaling through the adapter, SAP, that controlled the expression of the transcription factor, ZBTB16. Pseudotemporal ordering of single cells revealed transcriptional trajectories of 5-OP-RU-specific thymocytes selected on either thymic epithelial cells or hematopoietic cells. The resulting model illustrates T cell lineage decisions.	[Legoux, Francois; Gilet, Jules; Procopio, Emanuele; Lantz, Olivier] PSL Univ, Inst Curie, INSERM U932, Paris, France; [Echasserieau, Klara; Bernardeau, Karine] Ctr Rech Cancerol & Immunol Nantes Angers, Prod Prot Recombinantes, INSERM 1232, Nantes, France; [Lantz, Olivier] Inst Curie, Lab Immunol Clin, Paris, France; [Lantz, Olivier] Gustave Roussy Inst Curie, Ctr Invest Clin Biotherapie, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Legoux, F; Lantz, O (corresponding author), PSL Univ, Inst Curie, INSERM U932, Paris, France.; Lantz, O (corresponding author), Inst Curie, Lab Immunol Clin, Paris, France.; Lantz, O (corresponding author), Gustave Roussy Inst Curie, Ctr Invest Clin Biotherapie, Paris, France.	francois.legoux@curie.fr; olivier.lantz@curie.fr		GILET, Jules/0000-0002-1132-9608; Lantz, olivier/0000-0003-3161-7719	Agence Nationale de la Recherche ('Investissements d'Avenir' program) [ANR10EQPX03, ANR10INBS0908]; Canceropole Ile-de-France; Marie-Sklodowska Curie individual fellowship from the European Commission [706353]; Institut National de la Sante et de la Recherche Medicale; Institut Curie; Agence Nationale de la Recherche (Blanc (MAIT)); Agence Nationale de la Recherche (Blanc (NEOMAIT)); Agence Nationale de la Recherche (Blanc (DIABMAIT)); Agence Nationale de la Recherche (Labex DCBIOL); Equipe labellisee de la Ligue Contre le Cancer	Agence Nationale de la Recherche ('Investissements d'Avenir' program)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Marie-Sklodowska Curie individual fellowship from the European Commission; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Agence Nationale de la Recherche (Blanc (MAIT))(French National Research Agency (ANR)); Agence Nationale de la Recherche (Blanc (NEOMAIT))(French National Research Agency (ANR)); Agence Nationale de la Recherche (Blanc (DIABMAIT))(French National Research Agency (ANR)); Agence Nationale de la Recherche (Labex DCBIOL)(French National Research Agency (ANR)); Equipe labellisee de la Ligue Contre le Cancer	We thank the ICGex NGS platform of the Institut Curie (S. Lameiras, S. Baulande, M. Bohec) for technical help with single-cell RNA-seq experiments. ICGex is supported by the grants ANR10EQPX03 (Equipex) and ANR10INBS0908 (France Genomique Consortium) from the Agence Nationale de la Recherche ('Investissements d'Avenir' program), by the Canceropole Ile-de-France and by the SiRICCurie program. For the affymetrix data, we thank A. Vieillefon, A. Rapinat and D. Gentien from the Genomics Platform of the Translational Research Department at Institut Curie. We thank V. Dangles-Marie, M. Garcia, C. Pauchard, the mouse facility technicians and the flow cytometry core at Institut Curie. We thank N. Manel for reviewing the manuscript. F.L. was supported by a Marie-Sklodowska Curie individual fellowship (706353) from the European Commission. This work was supported by the Institut National de la Sante et de la Recherche Medicale, Institut Curie, Agence Nationale de la Recherche (Blanc (MAIT, NEOMAIT and DIABMAIT) and Labex DCBIOL). O.L.'s group was supported by the 'Equipe labellisee de la Ligue Contre le Cancer'.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Boudinot P, 2016, P NATL ACAD SCI USA, V113, pE2983, DOI 10.1073/pnas.1600674113; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; Dutta M, 2013, J IMMUNOL, V190, P2121, DOI 10.4049/jimmunol.1202145; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Legoux F. P., 2012, JOVE-J VIS EXP, V22, P4420; Legoux F, 2017, ANNU REV CELL DEV BI, V33, P511, DOI 10.1146/annurev-cellbio-100616-060725; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; Lu Y, 2019, NAT IMMUNOL, V20, P447, DOI 10.1038/s41590-019-0334-0; Mao AP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00882-0; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salou M, 2019, J EXP MED, V216, P133, DOI 10.1084/jem.20181483; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seach N, 2013, J IMMUNOL, V191, P6002, DOI 10.4049/jimmunol.1301212; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/NMETH.4612, 10.1038/nmeth.4612]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tuttle KD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05026-6; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wang HG, 2018, ELIFE, V7, DOI 10.7554/eLife.34793; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	43	38	38	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1244	+		10.1038/s41590-019-0465-3	http://dx.doi.org/10.1038/s41590-019-0465-3			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31431722				2022-12-18	WOS:000482212600023
J	Dijkgraaf, FE; Matos, TR; Hoogenboezem, M; Toebes, M; Vredevoogd, DW; Mertz, M; van den Broek, B; Song, JY; Teunissen, MBM; Luiten, RM; Beltman, JB; Schumacher, TN				Dijkgraaf, Feline E.; Matos, Tiago R.; Hoogenboezem, Mark; Toebes, Mireille; Vredevoogd, David W.; Mertz, Marjolijn; van den Broek, Bram; Song, Ji-Ying; Teunissen, Marcel B. M.; Luiten, Rosalie M.; Beltman, Joost B.; Schumacher, Ton N.			Tissue patrol by resident memory CD8(+) T cells in human skin	NATURE IMMUNOLOGY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; MIGRATION; RESPONSES; SURVIVAL; IMMUNITY; TRIGGER	Emerging data show that tissue-resident memory T (T-RM) cells play an important protective role at murine and human barrier sites. T-RM cells in the epidermis of mouse skin patrol their surroundings and rapidly respond when antigens are encountered. However, whether a similar migratory behavior is performed by human T-RM cells is unclear, as technology to longitudinally follow them in situ has been lacking. To address this issue, we developed an ex vivo culture system to label and track T cells in fresh skin samples. We validated this system by comparing in vivo and ex vivo properties of murine T-RM cells. Using nanobody labeling, we subsequently demonstrated in human ex vivo skin that CD8(+) T-RM cells migrated through the papillary dermis and the epidermis, below sessile Langerhans cells. Collectively, this work allows the dynamic study of resident immune cells in human skin and provides evidence of tissue patrol by human CD8(+) T-RM cells.	[Dijkgraaf, Feline E.; Toebes, Mireille; Vredevoogd, David W.; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Matos, Tiago R.; Teunissen, Marcel B. M.; Luiten, Rosalie M.] Univ Amsterdam, Dept Dermatol, Amsterdam, Netherlands; [Matos, Tiago R.; Teunissen, Marcel B. M.; Luiten, Rosalie M.] Univ Amsterdam, Netherlands Inst Pigment Disorders, Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Hoogenboezem, Mark] Sanquin Amsterdam, Res Facil, Amsterdam, Netherlands; [Mertz, Marjolijn; van den Broek, Bram] Netherlands Canc Inst, BioImaging Facil, Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Anim Pathol, Amsterdam, Netherlands; [Beltman, Joost B.] Leiden Univ, Div Drug Discovery & Safety, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Netherlands Cancer Institute; University of Amsterdam; University of Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University - Excl LUMC	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.	t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Matos, Tiago R./0000-0003-2864-8207; Vredevoogd, David/0000-0001-6718-1422; Mertz, Marjolijn/0000-0002-9188-3579; Beltman, Joost/0000-0001-9215-3087	DV Research Fellowship; ERC AdG Life-His-T	DV Research Fellowship; ERC AdG Life-His-T	Plasmid sequences for anti-mouse and anti-human CD8 nanobodies were kindly provided by 121Bio with support of M. Gostissa and G. Grotenbreg (Agenus subsequently acquired substantially all the assets of 121Bio). We thank H. Ploegh (Harvard University) for providing the sortase expression vector and D. Elatmioui and H. Ovaa (LUMC) for the GGGC peptide. We would like to acknowledge P.G.L. Koolen (Rode Kruis Ziekenhuis), T. Venema (Slotervaart Ziekenhuis) and W.G. van Selms (Onze Lieve Vrouwe Gasthuis West) and staff of the plastic surgery departments for providing human skin tissue. We thank M. Hoekstra for illustrations, M. Willemsen, L. Brocks, L. Oomen, T. Rademakers, the NKI flow cytometry and animal facility for technical support, and S. Ariotti and members of the Schumacher and Haanen laboratories for discussions. This work was supported by an..DV Research Fellowship (to T.R.M.) and ERC AdG Life-His-T (to T.N.S.).	Antos J. M., 2017, CURR PROTOC PROTEIN, V89; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Bins AD, 2005, NAT MED, V11, P899, DOI 10.1038/nm1264; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Cheuk S, 2014, J IMMUNOL, V192, P3111, DOI 10.4049/jimmunol.1302313; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Edwards J, 2018, CLIN CANCER RES, V24, P3036, DOI 10.1158/1078-0432.CCR-17-2257; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masters BR, 2004, J BIOMED OPT, V9, P1265, DOI 10.1117/1.1806135; Matos TR, 2017, J CLIN INVEST, V127, P4031, DOI 10.1172/JCI93396; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Mort RL, 2010, PIGM CELL MELANOMA R, V23, P299, DOI 10.1111/j.1755-148X.2010.00669.x; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Oakford ME, 2011, J INVEST DERMATOL, V131, P1950, DOI 10.1038/jid.2011.146; Omelyanenko NP, 2013, CONNECTIVE TISSUE HI; Oosterhuis K, 2012, HUM GENE THER, V23, P1301, DOI 10.1089/hum.2012.101; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shirshin EA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01238-w; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Thome JJC, 2015, TRENDS IMMUNOL, V36, P428, DOI 10.1016/j.it.2015.05.003; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Webb JR, 2014, CLIN CANCER RES, V20, P434, DOI 10.1158/1078-0432.CCR-13-1877; Wu HJ, 2018, AUTOIMMUN REV, V17, P906, DOI 10.1016/j.autrev.2018.03.014; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; 2020, Z PHYS, V2, P244	45	38	37	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					756	+		10.1038/s41590-019-0404-3	http://dx.doi.org/10.1038/s41590-019-0404-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31110315	Green Submitted			2022-12-18	WOS:000468505100018
J	Piliponsky, AM; Shubin, NJ; Lahiri, AK; Truong, P; Clauson, M; Niino, K; Tsuha, AL; Nedospasov, SA; Karasuyama, H; Reber, LL; Tsai, M; Mukai, K; Galli, SJ				Piliponsky, Adrian M.; Shubin, Nicholas J.; Lahiri, Asha K.; Phuong Truong; Clauson, Morgan; Niino, Kerri; Tsuha, Avery L.; Nedospasov, Sergei A.; Karasuyama, Hajime; Reber, Laurent L.; Tsai, Mindy; Mukai, Kaori; Galli, Stephen J.			Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice	NATURE IMMUNOLOGY			English	Article							T-CELLS; EFFECTOR FUNCTION; SEPTIC SHOCK; IGE ANTIBODY; FACTOR-ALPHA; IN-VIVO; TNF; INTERLEUKIN-6; INFLAMMATION; IMMUNITY	Basophils are evolutionarily conserved in vertebrates, despite their small numbers and short life span, suggesting that they have beneficial roles in maintaining health. However, these roles are not fully defined. Here we demonstrate that basophil-deficient mice exhibit reduced bacterial clearance and increased morbidity and mortality in the cecal ligation and puncture (CLP) model of sepsis. Among the several proinflammatory mediators that we measured, tumor necrosis factor (TNF) was the only cytokine that was significantly reduced in basophil-deficient mice after CLP. In accordance with that observation, we found that mice with genetic ablation of Tnf in basophils exhibited reduced systemic concentrations of TNF during endotoxemia. Moreover, after CLP, mice whose basophils could not produce TNF, exhibited reduced neutrophil and macrophage TNF production and effector functions, reduced bacterial clearance, and increased mortality. Taken together, our results show that basophils can enhance the innate immune response to bacterial infection and help prevent sepsis.	[Piliponsky, Adrian M.; Shubin, Nicholas J.; Lahiri, Asha K.; Phuong Truong; Clauson, Morgan; Niino, Kerri; Tsuha, Avery L.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Piliponsky, Adrian M.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Piliponsky, Adrian M.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Nedospasov, Sergei A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Reber, Laurent L.; Tsai, Mindy; Mukai, Kaori; Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Tsai, Mindy; Mukai, Kaori; Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Tokyo Medical & Dental University (TMDU); Stanford University; Stanford University; Stanford University	Piliponsky, AM (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA.; Piliponsky, AM (corresponding author), Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.; Piliponsky, AM (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.; Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	adrian.piliponsky@seattlechildrens.org; sgalli@stanford.edu	Reber, Laurent L/K-4148-2014; Karasuyama, Hajime/A-7966-2011	Reber, Laurent L/0000-0003-3384-6769; Karasuyama, Hajime/0000-0003-0689-0836; Shubin, Nicholas/0000-0001-7709-4496; Tsai, Mindy/0000-0002-8421-4721; Lahiri, Asha/0000-0001-7673-9205; Piliponsky, Adrian/0000-0003-4945-1809	National Institutes of Health (NIH) [R01 HL113351, R01 HL141094]; American Heart Association [12GRNT9680021]; NIH [R01 CA72074, R37 AI23990, R01 AI070813, R01 AR067145]; Department of Pathology, Stanford University; Russian Science Foundation [14-50-00060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067145] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Stanford University(Stanford University); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank R.M. Locksley for providing the Basoph8 mice and members of the Piliponsky and Galli laboratories for helpful discussions. Research in the Piliponsky laboratory was supported by National Institutes of Health (NIH) grant nos. R01 HL113351 and R01 HL141094, and an American Heart Association grant no. 12GRNT9680021. Research in the Galli laboratory was supported by NIH grant nos. R01 CA72074, R37 AI23990, R01 AI070813, and R01 AR067145, and by the Department of Pathology, Stanford University. Research in the Nedospasov laboratory was supported by a grant from the Russian Science Foundation (grant no. 14-50-00060).	BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; Barton BE, 1996, INFECT IMMUN, V64, P714, DOI 10.1128/IAI.64.3.714-718.1996; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Canfield PJ, 1998, AUST VET J, V76, P793, DOI 10.1111/j.1751-0813.1998.tb12328.x; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Eberle JU, 2016, SEMIN IMMUNOPATHOL, V38, P605, DOI 10.1007/s00281-016-0563-3; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; Echtenacher B, 2001, INFECT IMMUN, V69, P3550, DOI 10.1128/IAI.69.6.3550-3555.2001; Ehrlich P, 1879, ARCH ANAT PHYSL, V3, P571; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Karasuyama H, 2014, CURR OPIN IMMUNOL, V31, P1, DOI 10.1016/j.coi.2014.07.004; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Korosec P, 2017, J ALLERGY CLIN IMMUN, V140, P750, DOI 10.1016/j.jaci.2016.12.989; LEUNG DYM, 1993, J CLIN INVEST, V92, P1374, DOI 10.1172/JCI116711; LIU FT, 1980, J IMMUNOL, V124, P2728; Mannel DN, 2000, CHEM IMMUNOL, V74, P141; Marone G, 2014, CHEM IMMUNOL ALLERGY, V100, P172, DOI 10.1159/000358734; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Mukai K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00053-17; MULLEN PG, 1995, J SURG RES, V58, P124, DOI 10.1006/jsre.1995.1020; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reitz M, 2017, MUCOSAL IMMUNOL, V10, P481, DOI 10.1038/mi.2016.56; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sato E, 2003, J ALLERGY CLIN IMMUN, V111, P143, DOI 10.1067/mai.2003.9; SINGH RK, 1991, IMMUNOL LETT, V28, P127, DOI 10.1016/0165-2478(91)90110-V; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; TITE JP, 1991, J IMMUNOL, V147, P3161; Torrero MN, 2009, CLIN EXP ALLERGY, V39, P361, DOI 10.1111/j.1365-2222.2008.03154.x; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Weighardt H, 2006, J IMMUNOL, V177, P5623, DOI 10.4049/jimmunol.177.8.5623; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yousefi S, 2015, ALLERGY, V70, P1184, DOI 10.1111/all.12662	54	38	39	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					129	+		10.1038/s41590-018-0288-7	http://dx.doi.org/10.1038/s41590-018-0288-7			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30664762	Green Accepted			2022-12-18	WOS:000456279100011
J	Kim, JH; Podstawka, J; Lou, YF; Li, L; Lee, EKS; Divangahi, M; Petri, B; Jirik, FR; Kelly, MM; Yipp, BG				Kim, Jung Hwan; Podstawka, John; Lou, Yuefei; Li, Lu; Lee, Esther K. S.; Divangahi, Maziar; Petri, Bjorn; Jirik, Frank R.; Kelly, Margaret M.; Yipp, Bryan G.			Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells	NATURE IMMUNOLOGY			English	Article							CONNECTIVE-TISSUE DISEASE; BONE-MARROW; NEUTROPHIL APOPTOSIS; MARGINATED POOL; IN-VIVO; JAM-C; MECHANISMS; FIBROSIS; CXCR4; INFLAMMATION	Pulmonary immunity requires tight regulation, as interstitial inflammation can compromise gas exchange and lead to respiratory failure. Here we found a greater number of aged CD11b(hi)L-selectin(lo)CXCR4(+) polymorphonuclear leukocytes (PMNs) in lung vasculature than in the peripheral circulation. Using pulmonary intravital microscopy, we observed lung PMNs physically interacting with B cells via beta(2) integrins; this initiated neutrophil apoptosis, which led to macrophage-mediated clearance. Genetic deletion of B cells led to the accumulation of aged PMNs in the lungs without systemic inflammation, which caused pathological fibrotic interstitial lung disease that was attenuated by the adoptive transfer of B cells or depletion of PMNs. Thus, the lungs are an intermediary niche in the PMN lifecycle wherein aged PMNs are regulated by B cells, which restrains their potential to cause pulmonary pathology.	[Kim, Jung Hwan; Podstawka, John; Lou, Yuefei; Li, Lu; Lee, Esther K. S.; Kelly, Margaret M.; Yipp, Bryan G.] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada; [Kim, Jung Hwan; Podstawka, John; Lou, Yuefei; Li, Lu; Lee, Esther K. S.; Yipp, Bryan G.] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada; [Divangahi, Maziar] McGill Univ, Meakins Christie Labs, McGill Int TB Ctr, Dept Med,Dept Microbiol & Immunol,Dept Pathol, Montreal, PQ, Canada; [Petri, Bjorn] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Mouse Phen Resource Lab, Calgary, AB, Canada; [Petri, Bjorn] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Jirik, Frank R.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Kelly, Margaret M.] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada	University of Calgary; University of Calgary; McGill University; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Yipp, BG (corresponding author), Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.; Yipp, BG (corresponding author), Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada.	bgyipp@ucalgary.ca	Kelly, Margaret M/G-4128-2012	Kelly, Margaret M/0000-0002-1629-3210; Yipp, Bryan/0000-0002-5887-9551; Lee, Esther Kyung Su/0000-0002-4778-5891	Snyder Institute; Canadian Foundation for Innovation-John R. Evans Leaders fund; Alberta Enterprise and Advanced Education Research Capacity Program; Canadian Institutes of Health Research [RS-342013]; Department of Critical Care Medicine of the University of Calgary; University of Calgary Medical Group; Cumming School of Medicine Research Enhancement Program; Canada Research Chair in Pulmonary Immunology, Inflammation and Host Defense	Snyder Institute; Canadian Foundation for Innovation-John R. Evans Leaders fund; Alberta Enterprise and Advanced Education Research Capacity Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Critical Care Medicine of the University of Calgary; University of Calgary Medical Group; Cumming School of Medicine Research Enhancement Program; Canada Research Chair in Pulmonary Immunology, Inflammation and Host Defense	We thank P. Kubes for mentorship and lab members; L. Zbytnuik, T. Nussbaumer and M. Willson for assisting with reagents and animals; and E. De Heuvel for assistance in processing the histology; and acknowledge the use of the Snyder Mouse Phenomics Resources Laboratory and Live Cell imaging facility (funded by the Snyder Institute) and the flow cytometry core facility. Supported by the Canadian Foundation for Innovation-John R. Evans Leaders fund with matching support from the Alberta Enterprise and Advanced Education Research Capacity Program (infrastructure funding), the Canadian Institutes of Health Research (operating grant RS-342013), the Department of Critical Care Medicine of the University of Calgary (startup funds), the University of Calgary Medical Group (bridge funding), the Cumming School of Medicine Research Enhancement Program and a tier II Canada Research Chair in Pulmonary Immunology, Inflammation and Host Defense (B.G.Y.).	Aschner Y, 2016, AM J RESP CELL MOL, V54, P647, DOI 10.1165/rcmb.2015-0391TR; Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214; BOSMA GC, 1988, J EXP MED, V167, P1016, DOI 10.1084/jem.167.3.1016; Brain JD, 1999, AM J PHYSIOL-LUNG C, V276, pL146, DOI 10.1152/ajplung.1999.276.1.L146; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Cerutti A, 2013, J LEUKOCYTE BIOL, V94, P677, DOI 10.1189/jlb.1112596; Colom B, 2015, IMMUNITY, V42, P1075, DOI 10.1016/j.immuni.2015.05.010; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Demircik F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060643; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Enomoto K, 2003, RESPIROLOGY, V8, P149, DOI 10.1046/j.1440-1843.2003.00445.x; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hasan SA, 2013, J ALLERGY CLIN IMMUN, V131, P1663, DOI 10.1016/j.jaci.2013.01.015; Kamenyeva O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004827; Kuebler WM, 2002, EUR SURG RES, V34, P92, DOI 10.1159/000048894; Liote H, 2010, EUR RESPIR J, V35, P681, DOI 10.1183/09031936.00080209; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Maarschalk-Ellerbroek LJ, 2014, J CLIN IMMUNOL, V34, P642, DOI 10.1007/s10875-014-0068-6; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martinod K, 2017, J EXP MED, V214, P439, DOI 10.1084/jem.20160530; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Roubille C, 2014, SEMIN ARTHRITIS RHEU, V43, P613, DOI 10.1016/j.semarthrit.2013.09.005; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Shum AK, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000284; Smith ML, 2016, ARCH PATHOL LAB MED, V140, P221, DOI 10.5858/arpa.2015-0288-SA; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Thomas BJ, 2016, AM J RESP CELL MOL, V55, P759, DOI 10.1165/rcmb.2016-0248PS; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Uhl B, 2016, BLOOD, V128, P2327, DOI 10.1182/blood-2016-05-718999; Verma N, 2015, LANCET RESP MED, V3, P651, DOI 10.1016/S2213-2600(15)00202-7; Wallace B, 2016, CURR OPIN RHEUMATOL, V28, P236, DOI 10.1097/BOR.0000000000000270; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Weinmann P, 2003, BLOOD, V101, P739, DOI 10.1182/blood-2002-01-0239; Wells AU, 2014, NAT REV RHEUMATOL, V10, P728, DOI 10.1038/nrrheum.2014.149; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Wu DQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20545; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	50	38	38	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					192	+		10.1038/s41590-017-0030-x	http://dx.doi.org/10.1038/s41590-017-0030-x			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29335647				2022-12-18	WOS:000423435200019
J	Liu, S; Jiang, MH; Wang, WD; Liu, W; Song, XQ; Ma, ZF; Zhang, SK; Liu, L; Liu, Y; Cao, XT				Liu, Shuo; Jiang, Minghong; Wang, Wendie; Liu, Wei; Song, Xiaoqi; Ma, Zhongfei; Zhang, Shikun; Liu, Lun; Liu, Yin; Cao, Xuetao			Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA	NATURE IMMUNOLOGY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; TRANSCRIPTION FACTOR STAT1; PERSISTENT LCMV INFECTION; UBIQUITIN E3 LIGASE; GENE-EXPRESSION; RING1B; DEGRADATION; CHROMATIN; BINDING; POLYUBIQUITINATION	Prolonged activation of interferon-STAT1 signaling is closely related to inflammatory autoimmune disorders, and therefore the identification of negative regulators of these pathways is important. Through high-content screening of 115 mouse RING-domain E3 ligases, we identified the E3 ubiquitin ligase RNF2 as a potent inhibitor of interferon-dependent antiviral responses. RNF2 deficiency substantially enhanced interferon-stimulated gene (ISG) expression and antiviral responses. Mechanistically, nuclear RNF2 directly bound toSTAT1 after interferon stimulation and increased K33-linked polyubiquitination of the DNA-binding domain of STAT1 at position K379, in addition to promoting the disassociation of STAT1/STAT2 from DNA and consequently suppressing ISG transcription. Our study provides insight into the regulation of interferon-dependent responses via a previously unrecognized post-translational modification of STAT1 in the nucleus.	[Liu, Shuo; Jiang, Minghong; Wang, Wendie; Liu, Wei; Song, Xiaoqi; Ma, Zhongfei; Zhang, Shikun; Liu, Lun; Liu, Yin; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Dept Immunol, Beijing, Peoples R China; [Liu, Shuo; Jiang, Minghong; Wang, Wendie; Liu, Wei; Song, Xiaoqi; Ma, Zhongfei; Zhang, Shikun; Liu, Lun; Liu, Yin; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Ctr Immunotherapy, Beijing, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Dept Immunol, Beijing, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Ctr Immunotherapy, Beijing, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.	caoxt@immunol.org			National Natural Science Foundation of China [81788104, 31390431]; National Key Basic Research Program of China [2013CB530503, 2013CB944903]; National 135 Mega Program of China [2017ZX10102032-001]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National 135 Mega Program of China; CAMS Innovation Fund for Medical Sciences	This work is supported by the National Natural Science Foundation of China (grants 81788104 and 31390431 to X.C.), the National Key Basic Research Program of China (grant 2013CB530503 to X.C.; grant 2013CB944903 to M.J.), the National 135 Mega Program of China (grant 2017ZX10102032-001 to X.C.) and the CAMS Innovation Fund for Medical Sciences (grant 2016-12M-1-003 to X.C.).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Grinde B, 2006, INT IMMUNOPHARMACOL, V6, P1311, DOI 10.1016/j.intimp.2006.04.005; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lawrence DW, 2016, CELL SIGNAL, V28, P1833, DOI 10.1016/j.cellsig.2016.08.014; Luesch H, 2006, NAT CHEM BIOL, V2, P158, DOI 10.1038/nchembio769; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meng J, 2016, J AUTOIMMUN, V73, P42, DOI 10.1016/j.jaut.2016.05.012; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Mizoguchi Y, 2014, J LEUKOCYTE BIOL, V95, P667, DOI 10.1189/jlb.0513250; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Rai K, 2015, CANCER DISCOV, V5, P1314, DOI 10.1158/2159-8290.CD-15-0493; Rosas-Murrieta NH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-263; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang WD, 2016, P NATL ACAD SCI USA, V113, P9581, DOI 10.1073/pnas.1604277113; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Yuan WC, 2014, MOL CELL, V54, P586, DOI 10.1016/j.molcel.2014.03.035; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	40	38	39	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					41	+		10.1038/s41590-017-0003-0	http://dx.doi.org/10.1038/s41590-017-0003-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242538				2022-12-18	WOS:000419765300012
J	Placek, K; Hu, GQ; Cui, KR; Zhang, DF; Ding, Y; Lee, JE; Jang, Y; Wang, CC; Konkel, JE; Song, JZ; Liu, CY; Ge, K; Chen, WJ; Zhao, KJ				Placek, Katarzyna; Hu, Gangqing; Cui, Kairong; Zhang, Dunfang; Ding, Yi; Lee, Ji-Eun; Jang, Younghoon; Wang, Chaochen; Konkel, Joanne Elizabeth; Song, Jiuzhou; Liu, Chengyu; Ge, Kai; Chen, Wanjun; Zhao, Keji			MLL4 prepares the enhancer landscape for Foxp3 induction via chromatin looping	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; SUPER-ENHANCERS; GENE-EXPRESSION; HUMAN GENOME; CIS-ELEMENT; IDENTITY; DISEASE; METHYLATION; PLASTICITY; MUTATIONS	MLL4 is an essential subunit of the histone H3 Lys4 (H3K4)-methylation complexes. We found that MLL4 deficiency compromised the development of regulatory T cells (T-reg cells) and resulted in a substantial decrease in monomethylated H3K4 (H3K4me1) and chromatin interaction at putative gene enhancers, a considerable portion of which were not direct targets of MLL4 but were enhancers that interacted with MLL4-bound sites. The decrease in H3K4me1 and chromatin interaction at the enhancers not bound by MLL4 correlated with MLL4 binding at distant interacting regions. Deletion of an upstream MLL4-binding site diminished the abundance of H3K4me1 at the regulatory elements of the gene encoding the transcription factor Foxp3 that were looped to the MLL4-binding site and compromised both the thymic differentiation and the inducible differentiation of T-reg cells. We found that MLL4 catalyzed methylation of H3K4 at distant unbound enhancers via chromatin looping, which identifies a previously unknown mechanism for regulating the T cell enhancer landscape and affecting T-reg cell differentiation.	[Placek, Katarzyna; Hu, Gangqing; Cui, Kairong; Ding, Yi; Wang, Chaochen; Zhao, Keji] NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zhang, Dunfang; Konkel, Joanne Elizabeth; Chen, Wanjun] NIDCR, Mucosal Immunol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Ding, Yi; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Lee, Ji-Eun; Jang, Younghoon; Wang, Chaochen; Ge, Kai] NIDDK, Adipocyte Biol & Gene Regulat Sect, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA.; Chen, WJ (corresponding author), NIDCR, Mucosal Immunol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	wchen@dir.nidcr.nih.gov; zhaok@nhlbi.nih.gov	Ding, Yi/U-3314-2019; Wang, Chaochen/AAE-6657-2022; Lee, Ji-Eun/F-7891-2011; Hu, Gangqing/ABA-3507-2020; Ge, Kai/H-2810-2019; Wang, Chaochen/AAO-2998-2021; Placek, Katarzyna/AAK-2475-2021; Song, Jiuzhou/AAD-6440-2020; Hu, Gangqing/K-5849-2012	Wang, Chaochen/0000-0003-2346-2884; Lee, Ji-Eun/0000-0002-3768-7016; Ge, Kai/0000-0002-7442-5138; Zhang, Dunfang/0000-0001-7545-9930; Hu, Gangqing/0000-0001-5453-6888; Placek, Katarzyna/0000-0002-4944-6375; Jang, Younghoon/0000-0002-5705-4945	Division of Intramural Research of NHLBI; NIDCR; NIDDK of the US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020] Funding Source: NIH RePORTER	Division of Intramural Research of NHLBI; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK of the US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the NHLBI DNA Sequencing Core facility for sequencing the libraries; the NHLBI Systems Biology Core and the NIH Biowulf High Performance Computing Systems for computing services; the NHLBI Flow Cytometry Core facility for cell sorting; the NHLBI and NIAID Animal Facilities for animal care; and X. Wang and S Gao (NHLBI Systems Biology Core) and X. Zheng (Carnegie Institution for Science) for discussions on Hi-C data analysis. Supported by the Division of Intramural Research of NHLBI (K.Z.), NIDCR (W.C.) and NIDDK (K.G.) of the US National Institutes of Health.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hollander M, 1973, NONPARAMETRIC STAT M; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Klein L, 2011, SEMIN IMMUNOL, V23, P401, DOI 10.1016/j.smim.2011.06.003; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roychoudhuri R, 2015, CURR OPIN IMMUNOL, V33, P101, DOI 10.1016/j.coi.2015.02.003; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suvas S, 2006, CURR OPIN IMMUNOL, V18, P344, DOI 10.1016/j.coi.2006.03.005; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zhang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071590; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	53	38	41	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					1035	+		10.1038/ni.3812	http://dx.doi.org/10.1038/ni.3812			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28759003	Green Accepted			2022-12-18	WOS:000408137700013
J	Wong, K; Noubade, R; Manzanillo, P; Ota, N; Foreman, O; Hackney, JA; Friedman, BA; Pappu, R; Scearce-Levie, K; Ouyang, WJ				Wong, Kit; Noubade, Rajkumar; Manzanillo, Paolo; Ota, Naruhisa; Foreman, Oded; Hackney, Jason A.; Friedman, Brad A.; Pappu, Rajita; Scearce-Levie, Kimberly; Ouyang, Wenjun			Mice deficient in NRROS show abnormal microglial development and neurological disorders	NATURE IMMUNOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MYELOID CELLS; LANGERHANS CELLS; MACROPHAGES; ORIGIN; EXPRESSION; TISSUE; MAINTENANCE; PROGENITOR; RECEPTOR	Microglia and other tissue-resident macrophages within the central nervous system (CNS) have essential roles in neural development, inflammation and homeostasis. However, the molecular pathways underlying their development and function remain poorly understood. Here we report that mice deficient in NRROS, a myeloid-expressed transmembrane protein in the endoplasmic reticulum, develop spontaneous neurological disorders. NRROS-deficient (Nrros(-/-)) mice show defects in motor functions and die before 6 months of age. Nrros(-/-) mice display astrogliosis and lack normal CD11b(hi)CD45(lo) microglia, but they show no detectable demyelination or neuronal loss. Instead, perivascular macrophage-like myeloid cells populate the Nrros(-/-) CNS. Cx3cr1-driven deletion of Nrros shows its crucial role in microglial establishment during early embryonic stages. NRROS is required for normal expression of Sall1 and other microglial genes that are important for microglial development and function. Our study reveals a NRROS-mediated pathway that controls CNS-resident macrophage development and affects neurological function.	[Wong, Kit; Noubade, Rajkumar; Manzanillo, Paolo; Ota, Naruhisa; Pappu, Rajita; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Foreman, Oded] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Hackney, Jason A.; Friedman, Brad A.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Scearce-Levie, Kimberly] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Noubade, Rajkumar; Manzanillo, Paolo; Ouyang, Wenjun] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA; [Scearce-Levie, Kimberly] Denali Therapeut, Dept Preclin Translat Biol, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Amgen	Wong, K; Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.; Ouyang, WJ (corresponding author), Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA.	kitw@gene.com; wouyang@amgen.com	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864; Friedman, Brad/0000-0002-5864-5253; Hackney, Jason/0000-0002-5922-563X				Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Altuntas CZ, 2008, J NEUROIMMUNOL, V203, P58, DOI 10.1016/j.jneuroim.2008.06.038; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; FORD AL, 1995, J IMMUNOL, V154, P4309; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanson JE, 2014, J NEUROSCI, V34, P8277, DOI 10.1523/JNEUROSCI.5106-13.2014; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Morgan K, 2008, JOVE-J VIS EXP, V16, pe789; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noubade R, 2014, NATURE, V509, P235, DOI 10.1038/nature13152; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Sachs HH, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551955; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	60	38	39	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					633	+		10.1038/ni.3743	http://dx.doi.org/10.1038/ni.3743			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28459434				2022-12-18	WOS:000401520900008
J	Wu, C; Chen, ZJ; Dardalhon, V; Xiao, S; Thalhamer, T; Liao, MY; Madi, A; Franca, RF; Han, T; Oukka, M; Kuchroo, V				Wu, Chuan; Chen, Zuojia; Dardalhon, Valerie; Xiao, Sheng; Thalhamer, Theresa; Liao, Mengyang; Madi, Asaf; Franca, Rafael F.; Han, Timothy; Oukka, Mohammed; Kuchroo, Vijay			The transcription factor musculin promotes the unidirectional development of peripheral T-reg cells by suppressing the T(H)2 transcriptional program	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; FOXP3 GENE; EXPRESSION; BINDING; DIFFERENTIATION; PLASTICITY; INDUCTION; INFECTION; PROTEINS	Although master transcription factors (TFs) are key to the development of specific T cell subsets, whether additional transcriptional regulators are induced by the same stimuli that dominantly repress the development of other, non-specific T cell lineages has not been fully elucidated. Through the use of regulatory T cells (T-reg cells) induced by transforming growth factor-beta (TGF-(3), we identified the TF musculin (MSC) as being critical for the development of induced Treg cells (iT(reg) cells) by repression of the T helper type 2 (T(H)2) transcriptional program. Loss of MSC reduced expression of the Treg cell master TF Foxp3 and induced TH2 differentiation even under iT(reg)-cell-differentiation conditions. MSC interrupted binding of the TF GATA-3 to the locus encoding T(H)2-cell-related cytokines and diminished intrachromosomal interactions within that locus. MSC-deficient (Msc(-/-)) iTreg cells were unable to suppress T(H)2 responses, and Msc(-/-) mice spontaneously developed gut and lung inflammation with age. MSC therefore enforced Foxp3 expression and promoted the unidirectional induction of iT(reg) cells by repressing the T(H)2 developmental program.	[Wu, Chuan; Chen, Zuojia; Dardalhon, Valerie; Xiao, Sheng; Thalhamer, Theresa; Madi, Asaf; Franca, Rafael F.; Han, Timothy; Kuchroo, Vijay] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Wu, Chuan; Chen, Zuojia; Dardalhon, Valerie; Xiao, Sheng; Thalhamer, Theresa; Madi, Asaf; Franca, Rafael F.; Han, Timothy; Kuchroo, Vijay] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Liao, Mengyang] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Oukka, Mohammed] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Wu, Chuan] NCI, Expt Immunol Branch, US NIH, Bldg 10, Bethesda, MD 20892 USA; [Dardalhon, Valerie] CNRS, UMR5535, GMM, Montpellier, France; [Franca, Rafael F.] Univ Sao Paulo, Dept Pharmacol, Ribeirao Preto, SP, Brazil	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universidade de Sao Paulo	Wu, C; Kuchroo, V (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Wu, C; Kuchroo, V (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Wu, C (corresponding author), NCI, Expt Immunol Branch, US NIH, Bldg 10, Bethesda, MD 20892 USA.	cwu11@rics.bwh.harvard.edu; vkuchroo@evergrande.hms.harvard.edu	Chen, Zuojia/AAM-9465-2020; Freitas de Oliveira Franca, Rafael/ABB-2376-2021; Wu, Chuan/H-6379-2013	Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Han, Timothy/0000-0001-5365-0259; Wu, Chuan/0000-0003-2288-353X; Madi, Asaf/0000-0003-3441-3228	National Multiple Sclerosis Society [TA 3059-A-2]; US National Institutes of Health [KAI110649A, K01DK09105, P01AI073748, P01AI056299, P01AI039671, R01NS045937, R01 NS030843]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124735, P01AI073748, P01AI056299, R00AI110649, P01AI039671, K99AI110649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937, R01NS030843] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz for cell sorting; T. Chatila for advice; M. Collins for advice and editing the manuscript; E.N. Olson (University of Texas Southwestern Medical Center at Dallas) for Msc<SUP>-/-</SUP> mice; L. Maggio-Price (University of Washington) for Smad3<SUP>-/-</SUP> mice; and A. Yoshimura (Keio University School of Medicine) for the plasmid pCMV5-Smad3. Supported by the National Multiple Sclerosis Society (Career Transition Award TA 3059-A-2 to C.W.) and the US National Institutes of Health (K99 NIH Pathway to Independence Award KAI110649A to C.W.; K01DK09105 to S.X.; and P01AI073748, P01AI056299, P01AI039671, R01NS045937 and R01 NS030843 to V.K.).	Beal AM, 2012, NAT IMMUNOL, V13, P77, DOI 10.1038/ni.2154; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Debuisson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084415; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Pillemer BBL, 2009, J IMMUNOL, V183, P155, DOI 10.4049/jimmunol.0803733; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; RUEGEMER JJ, 1990, J IMMUNOL, V144, P1767; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tao Xiaojuan, 2008, Int J Biomed Sci, V4, P52; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; WAHL SM, 1988, J IMMUNOL, V140, P3026; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040314; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	48	38	41	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					344	353		10.1038/ni.3667	http://dx.doi.org/10.1038/ni.3667			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28114290	Green Accepted			2022-12-18	WOS:000394413400014
J	Yi, ZA; Lin, WW; Stunz, LL; Bishop, GA				Yi, Zuoan; Lin, Wai Wai; Stunz, Laura L.; Bishop, Gail A.			The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FACTOR-3 TRAF3; ACTIVATION; KINASES; ROLES; RECRUITMENT; SPECIFICITY; TOLERANCE; REG	The number of Foxp(3+) regulatory T cells (T-reg cells) must be tightly controlled for efficient suppression of autoimmunity with no impairment of normal immune responses. Here we found that the adaptor TRAF3 was intrinsically required for restraining the lineage determination of thymic T-reg cells. T cell-specific deficiency in TRAF3 resulted in a two- to threefold greater frequency Of T-reg cells, due to the more efficient transition of precursors of T-reg cells into Foxp(3+) T-reg cells. TRAF3 dampened interleukin 2 (IL-2) signaling by facilitating recruitment of the tyrosine phosphatase TCPTP to the IL-2 receptor complex, which resulted in dephosphorylation of the signaling molecules Jak1 and Jak3 and negative regulation of signaling via Jak and the transcription factor STAT5. Our results identify a role for TRAF3 as an important negative regulator of signaling via the IL-2 receptor that affects the development of T-reg cells.	[Yi, Zuoan; Lin, Wai Wai; Stunz, Laura L.; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Lin, Wai Wai] Univ Iowa, Grad Immunol Program, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Cancer Institute of the US National Institutes of Health [P30CA086862]; US National Institutes of Health [AI28847, 5T32AI007260-27]; US Department of Veterans Affairs; Office of Research and Development of the Veterans Health Administration of the US Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260, R01AI028847, R29AI028847, R56AI028847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001702] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Office of Research and Development of the Veterans Health Administration of the US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	We thank F. Sutterwala (University of Iowa) for Rag1<SUP>-/-</SUP> mice; A. Rudensky (Memorial Sloan-Kettering Cancer Center) and T.J. Waldschmidt (University of Iowa) for Foxp3-GFP mice; A. Schlueter (University of Iowa) for OT-II mice; R. Schreiber (University of Washington at St. Louis) and D. Parker (Oregon Health Science University) for Nik<SUP>-/-</SUP> mice; N. Tonks (Cold Spring Harbor Laboratory) for plasmids encoding the 45-10a and 48-kDa forms of TCPTP and the substrate-trapping mutant of each; and J. Colgan for advice in making retrogenic BM chimeras. Supported by the National Cancer Institute of the US National Institutes of Health (P30CA086862), the US National Institutes of Health (AI28847 to G.A.B., and 5T32AI007260-27 for support for Z.Y.) and the US Department of Veterans Affairs (G.A.B.). This work was based on work supported by the Office of Research and Development of the Veterans Health Administration of the US Department of Veterans Affairs.	Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Bishop GA, 2013, J IMMUNOL, V191, P3483, DOI 10.4049/jimmunol.1390048; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; BURNS LA, 1993, J BIOL CHEM, V268, P17659; Chang JH, 2014, J EXP MED, V211, P137, DOI 10.1084/jem.20131019; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Johnston JA, 1996, J LEUKOCYTE BIOL, V60, P441, DOI 10.1002/jlb.60.4.441; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lin WW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00477; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; MINAMI Y, 1995, CURR OPIN CELL BIOL, V7, P156, DOI 10.1016/0955-0674(95)80023-9; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Motegi H, 2011, GENES CELLS, V16, P179, DOI 10.1111/j.1365-2443.2010.01474.x; Murray SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076216; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yi ZA, 2014, CYTOKINE GROWTH F R, V25, P147, DOI 10.1016/j.cytogfr.2013.12.002; Yi ZA, 2013, J EXP MED, V210, P1079, DOI 10.1084/jem.20122135; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou YJ, 2000, MOL CELL BIOL, V20, P4371, DOI 10.1128/MCB.20.12.4371-4380.2000	45	38	40	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					866	874		10.1038/ni.2944	http://dx.doi.org/10.1038/ni.2944			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25029551	Green Accepted			2022-12-18	WOS:000340739400014
J	Galli, SJ; Nakae, S				Galli, SJ; Nakae, S			Mast cells to the defense	NATURE IMMUNOLOGY			English	Editorial Material							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; TNF-ALPHA; MICE; RECRUITMENT; MODEL; MOUSE		Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, L-235,300 Pasteur Dr, Stanford, CA 94305 USA.							Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Schoenberger SP, 2003, NAT IMMUNOL, V4, P937, DOI 10.1038/ni1003-937; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455	12	38	40	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1160	1162		10.1038/ni1203-1160	http://dx.doi.org/10.1038/ni1203-1160			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639463				2022-12-18	WOS:000186769500006
J	Cooke, A; Phillips, JM; Parish, NM				Cooke, A; Phillips, JM; Parish, NM			Tolerogenic strategies to halt or prevent type I diabetes	NATURE IMMUNOLOGY			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INCOMPLETE FREUNDS-ADJUVANT; PANCREATIC BETA-CELLS; MYELIN BASIC-PROTEIN; HEAT-SHOCK-PROTEIN; CD8(+) T-CELLS; NOD MICE; MONOCLONAL-ANTIBODY; NONDEPLETING ANTI-CD4; SELF-TOLERANCE	A variety of therapeutic strategies have been developed to tolerize autoreactive T cells and prevent autoimmune pathology. In terms of type I diabetes, prevention strategies can inhibit the priming and expansion of autoreactive T cells; however, a cure for diabetes would require tolerance to be established in the presence of primed effector cells together with replacement of the destroyed cell mass. Replacement of beta cells could be accomplished by transplantation of islets or stem cells or through islet regeneration. We will focus here on tolerogenic strategies that have been used to pre. vent onset of type I diabetes and discuss the potential for a cure.	Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Cooke, A (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.		Cooke, Anne/E-8709-2012; Cooke, Anne/S-4763-2019	Cooke, Anne/0000-0003-3327-6081				ALSABBAGH A, 1994, EUR J IMMUNOL, V24, P2104, DOI 10.1002/eji.1830240926; Arreaza GA, 1997, J CLIN INVEST, V100, P2243, DOI 10.1172/JCI119762; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; BANTING FG, 1922, J LAB CLIN MED, V7, P465; BITAR DM, 1988, CELL IMMUNOL, V112, P364, DOI 10.1016/0008-8749(88)90305-X; BOITARD C, 1985, P NATL ACAD SCI USA, V82, P6627, DOI 10.1073/pnas.82.19.6627; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Burrows GG, 2000, J IMMUNOL, V164, P6366, DOI 10.4049/jimmunol.164.12.6366; CAMPBELL IL, 1985, DIABETES, V34, P1205, DOI 10.2337/diabetes.34.11.1205; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1990, TRANSPLANTATION, V49, P697, DOI 10.1097/00007890-199004000-00009; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; CORBETT JA, 1993, FASEB J, V7, P369, DOI 10.1096/fasebj.7.2.8440413; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Friend PJ, 1999, TRANSPLANTATION, V68, P1632, DOI 10.1097/00007890-199912150-00005; GU DL, 1993, DEVELOPMENT, V118, P33; Guo ZG, 2001, TRANSPLANTATION, V71, P1656, DOI 10.1097/00007890-200106150-00027; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; HARADA M, 1990, DIABETES RES CLIN PR, V8, P85, DOI 10.1016/0168-8227(90)90017-N; Heeger PS, 2000, J IMMUNOL, V164, P5771, DOI 10.4049/jimmunol.164.11.5771; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; HUTCHINGS P, 1992, EUR J IMMUNOL, V22, P1913, DOI 10.1002/eji.1830220735; Hutchings P, 1998, J AUTOIMMUN, V11, P127, DOI 10.1006/jaut.1997.0184; Hutchings P, 1993, Autoimmunity, V15 Suppl, P21, DOI 10.3109/08916939309008856; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Kuttler B, 1999, J MOL MED-JMM, V77, P226, DOI 10.1007/s001090050342; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; MANDRUPPOULSEN T, 1987, DIABETES, V36, P641, DOI 10.2337/diabetes.36.5.641; Martins TC, 1999, CLIN EXP IMMUNOL, V115, P248, DOI 10.1046/j.1365-2249.1999.00781.x; METZLER B, 1993, INT IMMUNOL, V5, P1159, DOI 10.1093/intimm/5.9.1159; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; Molano RD, 2001, DIABETES, V50, P270, DOI 10.2337/diabetes.50.2.270; NAKHOODA AF, 1978, DIABETOLOGIA, V14, P199, DOI 10.1007/BF00429781; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; OREILLY LA, 1991, EUR J IMMUNOL, V21, P1171, DOI 10.1002/eji.1830210512; OReilly LA, 1997, DIABETES, V46, P599, DOI 10.2337/diabetes.46.4.599; PARISH NM, 1988, IMMUNOLOGY, V63, P199; Parish NM, 1998, EUR J IMMUNOL, V28, P4362, DOI 10.1002/(SICI)1521-4141(199812)28:12<4362::AID-IMMU4362>3.3.CO;2-U; Phillips JM, 2000, J IMMUNOL, V165, P1949, DOI 10.4049/jimmunol.165.4.1949; Pictet R., 1972, HDB PHYSL, P25; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Quintana FJ, 2000, J IMMUNOL, V165, P6148, DOI 10.4049/jimmunol.165.11.6148; Ramiya VK, 2000, NAT MED, V6, P278; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; SEMPE P, 1991, EUR J IMMUNOL, V21, P1163, DOI 10.1002/eji.1830210511; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SIBLEY RK, 1985, LAB INVEST, V53, P132; Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636; TAKI T, 1991, DIABETES, V40, P1203, DOI 10.2337/diabetes.40.9.1203; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tisch R, 1999, J IMMUNOL, V163, P1178; Todd JA, 1997, PATHOL BIOL, V45, P219; VABULAS RM, 2001, J BIOL CHEM; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WEIR GC, 1990, J CLIN INVEST, V85, P983, DOI 10.1172/JCI114574; Woodle ES, 1999, TRANSPLANTATION, V68, P608, DOI 10.1097/00007890-199909150-00003; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	65	38	41	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					810	815		10.1038/ni0901-810	http://dx.doi.org/10.1038/ni0901-810			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526391				2022-12-18	WOS:000170781200016
J	Cyster, JG				Cyster, JG			B cells on the front line	NATURE IMMUNOLOGY			English	News Item							MARGINAL-ZONE; SPLEEN	Marginal zone B cells may steal the limelight as the roles of Pyk-2 and BLyS begin to be elucidated. Pyk-2 deficiency leads to their loss whereas signaling via the BLyS receptor may augment their function.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.							Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Tierens A, 1999, BLOOD, V93, P226, DOI 10.1182/blood.V93.1.226.401a30_226_234; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889	10	38	45	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					9	10		10.1038/76859	http://dx.doi.org/10.1038/76859			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881164				2022-12-18	WOS:000089814800004
J	Collier, JL; Weiss, SA; Pauken, KE; Sen, DR; Sharpe, AH				Collier, Jenna L.; Weiss, Sarah A.; Pauken, Kristen E.; Sen, Debattama R.; Sharpe, Arlene H.			Not-so-opposite ends of the spectrum: CD8(+) T cell dysfunction across chronic infection, cancer and autoimmunity	NATURE IMMUNOLOGY			English	Review							NONOBESE DIABETIC MICE; MULTIPLE-SCLEROSIS; VIRUS-INFECTION; EPIGENETIC LANDSCAPE; METASTATIC MELANOMA; AVIDITY MATURATION; ADVERSE EVENTS; CO-STIMULATION; HIGH-FREQUENCY; PD-1	Sharpe and colleagues review salient aspects of CD8(+) T cell dysfunction in cancer, chronic viral infections and autoimmunity, with a view of developing new ways to alleviate T cell exhaustion and enhance CD8(+) T cell functions in cancer and chronic viral infection, as well as strategies to induce or augment exhaustion-like features to treat autoimmunity. CD8(+) T cells are critical mediators of cytotoxic effector function in infection, cancer and autoimmunity. In cancer and chronic viral infection, CD8(+) T cells undergo a progressive loss of cytokine production and cytotoxicity, a state termed T cell exhaustion. In autoimmunity, autoreactive CD8(+) T cells retain the capacity to effectively mediate the destruction of host tissues. Although the clinical outcome differs in each context, CD8(+) T cells are chronically exposed to antigen in all three. These chronically stimulated CD8(+) T cells share some common phenotypic features, as well as transcriptional and epigenetic programming, across disease contexts. A better understanding of these CD8(+) T cell states may reveal novel strategies to augment clearance of chronic viral infection and cancer and to mitigate self-reactivity leading to tissue damage in autoimmunity.	[Collier, Jenna L.; Weiss, Sarah A.; Pauken, Kristen E.; Sen, Debattama R.; Sharpe, Arlene H.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA; [Collier, Jenna L.; Weiss, Sarah A.; Pauken, Kristen E.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Collier, Jenna L.; Weiss, Sarah A.; Pauken, Kristen E.; Sharpe, Arlene H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Weiss, Sarah A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Weiss, Sarah A.; Sharpe, Arlene H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sen, Debattama R.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Sharpe, AH (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	Arlene_Sharpe@hms.harvard.edu		Collier, Jenna/0000-0002-4071-4986; /0000-0002-4155-0346; Sharpe, Arlene/0000-0002-9736-2109	National Institutes of Health [T32GM007753]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.H.S. received funding from the National Institutes of Health, grants P01 AI56299, P01AI039671 and P01 AI108545. S.A.W. received funding from the National Institutes of Health, award T32GM007753.	Abdelsamed HA, 2020, NAT IMMUNOL, V21, P578, DOI 10.1038/s41590-020-0633-5; Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Becker JC, 1999, J INVEST DERMATOL, V113, P1033, DOI 10.1046/j.1523-1747.1999.00805.x; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bender C, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5586; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bobbala D, 2012, DIABETOLOGIA, V55, P3010, DOI 10.1007/s00125-012-2675-1; Boniface K, 2018, J INVEST DERMATOL, V138, P355, DOI 10.1016/j.jid.2017.08.038; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Byrne KT, 2011, ONCOTARGET, V2, P684; Byrne KT, 2011, J CLIN INVEST, V121, P1797, DOI 10.1172/JCI44849; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Chen PM, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1620; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Christoffersson G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aam6533; Coutzac C, 2017, J CROHNS COLITIS, V11, P1238, DOI 10.1093/ecco-jcc/jjx081; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Culina S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4013; DALMAU J, 1992, AM J PATHOL, V141, P881; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; de Jersey J, 2007, P NATL ACAD SCI USA, V104, P1295, DOI 10.1073/pnas.0610057104; Dick J, 2016, IMMUNOTHERAPY-UK, V8, P1033, DOI 10.2217/imt-2016-0083; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Ding HL, 2006, CLIN IMMUNOL, V118, P258, DOI 10.1016/j.clim.2005.10.017; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Dougan SK, 2013, CANCER IMMUNOL RES, V1, P99, DOI 10.1158/2326-6066.CIR-13-0047; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garyu JW, 2016, J BIOL CHEM, V291, P11230, DOI 10.1074/jbc.M115.713362; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gebauer C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1260212; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Hirata S, 2005, J IMMUNOL, V174, P1888, DOI 10.4049/jimmunol.174.4.1888; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Hosokawa K, 2016, J IMMUNOL, V196, P1568, DOI 10.4049/jimmunol.1501739; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Hwang S, 2016, J EXP MED, V213, P1799, DOI 10.1084/jem.20151995; Ifergan I, 2011, BRAIN, V134, P3557, DOI 10.1093/brain/awr268; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jaber SH, 2006, ARCH DERMATOL, V142, P166, DOI 10.1001/archderm.142.2.166; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Jilek S, 2007, CLIN IMMUNOL, V123, P105, DOI 10.1016/j.clim.2006.11.004; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; John S, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0258-x; Johnnidis JB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3702; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Kanev K, 2019, P NATL ACAD SCI USA, V116, P20070, DOI 10.1073/pnas.1902701116; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Khattri R, 1999, J IMMUNOL, V162, P5784; Kim JH, 2016, J ALLERGY CLIN IMMUN, V137, P1466, DOI 10.1016/j.jaci.2015.11.021; Kivisakk P, 1998, CLIN EXP IMMUNOL, V111, P193; Krishna S, 2020, SCIENCE, V370, P1328, DOI 10.1126/science.abb9847; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Kusnadi A, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe4782; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Le Gal FA, 2001, J INVEST DERMATOL, V117, P1464, DOI 10.1046/j.0022-202x.2001.01605.x; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Lo JA, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd8636; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Luoma AM, 2020, CELL, V182, P655, DOI 10.1016/j.cell.2020.06.001; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Malmestrom C, 2008, J NEUROIMMUNOL, V196, P159, DOI 10.1016/j.jneuroim.2008.03.001; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller AM, 2019, CANCER IMMUNOL RES, V7, P40, DOI 10.1158/2326-6066.CIR-18-0371; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Nish SA, 2017, J EXP MED, V214, P39, DOI 10.1084/jem.20161046; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Page N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21109-3; Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Palermo B, 2005, EUR J IMMUNOL, V35, P3153, DOI 10.1002/eji.200535110; Pauken KE, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107827; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pauken KE, 2013, DIABETES, V62, P2859, DOI 10.2337/db12-1475; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Philip M, 2019, CURR OPIN IMMUNOL, V58, P98, DOI 10.1016/j.coi.2019.04.014; Pittet CL, 2011, GLIA, V59, P841, DOI 10.1002/glia.21158; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Raptopoulou AP, 2010, ARTHRITIS RHEUM-US, V62, P1870, DOI 10.1002/art.27500; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Richmond JM, 2019, J INVEST DERMATOL, V139, P769, DOI 10.1016/j.jid.2018.10.032; Richmond JM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7710; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Rosenfeld MR, 2001, ANN NEUROL, V50, P339, DOI 10.1002/ana.1288; Rutishauser RL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136648; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Shin BY, 2018, J EXP MED, V215, P1803, DOI 10.1084/jem.20172335; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Sinha S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00619; Skowera A, 2015, DIABETES, V64, P916, DOI 10.2337/db14-0332; Song MY, 2015, GUT, V64, P260, DOI 10.1136/gutjnl-2014-307311; Tan CL, 2021, J EXP MED, V218, DOI 10.1084/jem.20182232; Trabattoni D, 2009, J IMMUNOL, V183, P4984, DOI 10.4049/jimmunol.0901038; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; Vignali D, 2018, DIABETES, V67, P936, DOI 10.2337/db17-1390; Wagner CA, 2020, J CLIN INVEST, V130, P203, DOI 10.1172/JCI132531; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang JA, 2010, INT IMMUNOL, V22, P443, DOI 10.1093/intimm/dxq026; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; Wei SC, 2021, CANCER DISCOV, V11, P614, DOI 10.1158/2159-8290.CD-20-0856; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wiedeman AE, 2020, J CLIN INVEST, V130, P480, DOI 10.1172/JCI126595; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xing PY, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0779-6; Yamauchi T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133920; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yoshida T, 2008, P NATL ACAD SCI USA, V105, P3533, DOI 10.1073/pnas.0710951105; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zakharov PN, 2020, J EXP MED, V217, DOI 10.1084/jem.20192362; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	182	37	37	3	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					809	819		10.1038/s41590-021-00949-7	http://dx.doi.org/10.1038/s41590-021-00949-7		JUN 2021	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34140679	Bronze, Green Accepted			2022-12-18	WOS:000662827000002
J	Choi, JY; Diao, HT; Faliti, CE; Truong, J; Rossi, M; Belanger, S; Yu, BF; Goldrath, AW; Pipkin, ME; Crotty, S				Choi, Jinyong; Diao, Huitian; Faliti, Caterina E.; Truong, Jacquelyn; Rossi, Meghan; Belanger, Simon; Yu, Bingfei; Goldrath, Ananda W.; Pipkin, Matthew E.; Crotty, Shane			Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits	NATURE IMMUNOLOGY			English	Article							NEGATIVE REGULATOR; B-CELLS; DIFFERENTIATION; BLIMP-1; GENE; EXPRESSION; DOMAIN; COREPRESSOR; INHIBITION; LANDSCAPES	T follicular helper (T-FH) cells are a distinct type of CD4(+)T cells that are essential for most antibody and B lymphocyte responses. T(FH)cell regulation and dysregulation is involved in a range of diseases. Bcl-6 is the lineage-defining transcription factor of T(FH)cells and its activity is essential for T(FH)cell differentiation and function. However, how Bcl-6 controls T(FH)biology has largely remained unclear, at least in part due to the intrinsic challenges of connecting repressors to gene upregulation in complex cell types with multiple possible differentiation fates. Multiple competing models were tested here by a series of experimental approaches to determine that Bcl-6 exhibits negative autoregulation and controls pleiotropic attributes of T(FH)differentiation and function, including migration, costimulation, inhibitory receptors and cytokines, via multiple repressor-of-repressor gene circuits. Bcl-6 is the signature transcription factor for T(FH)cells. Crotty and colleagues provide a comprehensive transcriptional map depicting the regulatory circuitry controlled by Bcl-6 in determining T(FH)cell fate and function.	[Choi, Jinyong; Faliti, Caterina E.; Truong, Jacquelyn; Rossi, Meghan; Belanger, Simon; Crotty, Shane] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA; [Diao, Huitian; Pipkin, Matthew E.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL USA; [Yu, Bingfei; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA.	shane@lji.org	Choi, Jinyong/H-4110-2018	Choi, Jinyong/0000-0003-2474-2837; Rossi, Meghan/0000-0002-2151-3230; Faliti, Katia/0000-0003-0487-1914	US National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI109976]; NIAID [R01 AI072543]; NIH [S10 RR027366]; internal LJI institutional funds	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); internal LJI institutional funds	We thank C. Kim, L. Boggeman, D. Hinz and C. Dillingham of the La Jolla Insitute for Immunology (LJI) Flow Cytometry Core Facility for cell sorting; J. Greenbaum and A. Sethi of the LJI Bioinformatics core for bioinformatics analysis; G. Seumois and J. Day of the LJI Sequencing core; and K. Jepsen of the University of California San Diego IGM sequencing core for consultation. We thank MaxCyte for generously providing the MaxCyte ATX electroporator and reagents. This work was funded by grants from the US National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases (NIAID) U19 AI109976 and NIAID R01 AI072543, NIH S10 RR027366 (LJI) and internal LJI institutional funds to S.C.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bartfeld D, 2002, STRUCTURE, V10, P1395, DOI 10.1016/S0969-2126(02)00853-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Geng JL, 2019, J IMMUNOL, V202, P2991, DOI 10.4049/jimmunol.1801626; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Iwata S, 2017, IMMUNITY, V46, P983, DOI 10.1016/j.immuni.2017.05.005; Jain R, 2016, IMMUNITY, V44, P131, DOI 10.1016/j.immuni.2015.11.009; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kim CJ, 2018, IMMUNITY, V49, P1034, DOI 10.1016/j.immuni.2018.10.012; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Kwon H-K, 2017, NAT IMMUNOL, V486, P549; Lahmann A, 2019, J IMMUNOL, V202, P2229, DOI 10.4049/jimmunol.1801400; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Li FY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07853-z; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nance JP, 2015, P NATL ACAD SCI USA, V112, P13324, DOI 10.1073/pnas.1507312112; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pasqualucci L, 2018, BLOOD, V131, P2307, DOI 10.1182/blood-2017-11-764332; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raykov YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162259; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sahoo A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8997; Seumois G, 2016, J IMMUNOL, V197, P655, DOI 10.4049/jimmunol.1600397; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Stormo Gary D, 2013, Quant Biol, V1, P115; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Wingender E, 2018, NUCLEIC ACIDS RES, V46, pD343, DOI 10.1093/nar/gkx987; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xie MM, 2017, EUR J IMMUNOL, V47, P1136, DOI 10.1002/eji.201747034; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	62	37	41	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					777	+		10.1038/s41590-020-0706-5	http://dx.doi.org/10.1038/s41590-020-0706-5		JUN 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32572238	Green Accepted			2022-12-18	WOS:000542142500004
J	Vijay, R; Guthmiller, JJ; Sturtz, AJ; Surette, FA; Rogers, KJ; Sompallae, RR; Li, FY; Pope, RL; Chan, JA; Rivera, FD; Andrew, D; Webb, L; Maury, WJ; Xue, HH; Engwerda, CR; McCarthy, JS; Boyle, MJ; Butler, NS				Vijay, Rahul; Guthmiller, Jenna J.; Sturtz, Alexandria J.; Surette, Fionna A.; Rogers, Kai J.; Sompallae, Ramakrishna R.; Li, Fengyin; Pope, Rosemary L.; Chan, Jo-Anne; Rivera, Fabian de Labastida; Andrew, Dean; Webb, Lachlan; Maury, Wendy J.; Xue, Hai-Hui; Engwerda, Christian R.; McCarthy, James S.; Boyle, Michelle J.; Butler, Noah S.			Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; BLOOD-STAGE MALARIA; CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM; PROTECTIVE IMMUNITY; ACQUIRED-IMMUNITY; GAMMA-INTERFERON; RESPONSES; DIFFERENTIATION; GENERATION	Plasmodium parasite-specific antibodies are critical for protection against malaria, yet the development of long-lived and effective humoral immunity against Plasmodium takes many years and multiple rounds of infection and cure. Here, we report that the rapid development of short-lived plasmablasts during experimental malaria unexpectedly hindered parasite control by impeding germinal center responses. Metabolic hyperactivity of plasmablasts resulted in nutrient deprivation of the germinal center reaction, limiting the generation of memory B cell and long-lived plasma cell responses. Therapeutic administration of a single amino acid to experimentally infected mice was sufficient to overcome the metabolic constraints imposed by plasmablasts and enhanced parasite clearance and the formation of protective humoral immune memory responses. Thus, our studies not only challenge the current model describing the role and function of blood-stage Plasmodium-induced plasmablasts but they also reveal new targets and strategies to improve anti-Plasmodium humoral immunity. Early humoral responses to malaria fail to induce durable protective antibodies. Butler and colleagues report that low-affinity, short-lived plasmablasts become nutrient sinks for glutamine and starve germinal center B and T cells, thereby reducing the generation of high-affinity B cells and long-lived plasma cells and memory B cells.	[Vijay, Rahul; Sturtz, Alexandria J.; Surette, Fionna A.; Rogers, Kai J.; Maury, Wendy J.; Xue, Hai-Hui; Butler, Noah S.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Guthmiller, Jenna J.; Pope, Rosemary L.; Butler, Noah S.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Surette, Fionna A.; Maury, Wendy J.; Xue, Hai-Hui; Butler, Noah S.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Sompallae, Ramakrishna R.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Chan, Jo-Anne; Boyle, Michelle J.] Burnet Inst, Melbourne, Vic, Australia; [Rivera, Fabian de Labastida; Andrew, Dean; Webb, Lachlan; Engwerda, Christian R.; McCarthy, James S.; Boyle, Michelle J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Xue, Hai-Hui] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Guthmiller, Jenna J.] Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Li, Fengyin] Univ Sci & Technol China, Div Life Sci & Med, Hefei, Peoples R China	University of Iowa; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Iowa; University of Iowa; Burnet Institute; QIMR Berghofer Medical Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Chicago; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Butler, NS (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; Butler, NS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.; Butler, NS (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	noah-butler@uiowa.edu	Webb, Lachlan/AAY-3321-2021	Butler, Noah/0000-0002-1429-0796; Engwerda, Christian/0000-0003-2813-4804; McCarthy, James/0000-0001-6596-9718; Chan, Jo-Anne/0000-0003-0708-8263; Boyle, Michelle/0000-0002-0268-232X; Webb, Lachlan/0000-0002-5209-0314	NCI [P30CA086862]; National Center for Research Resources of the NIH [S10OD016199]; American Heart Association [16PRE27660002]; NIH [AI125446, AI127481, AI139902, T32 AI007485, T32 GM067795, AI134733, AI121080, AI139874]; Veteran Affairs BLR&D Merit Review Program [BX002903]; NHMRC Senior Research Fellowship [1154265]; NHMRC Program grant [1132975]; NHMRC Practitioner Fellowship [1135955]; NHMRC Career Development Fellowship [1141632]; NHMRC Project Grant [1141278]; Medicine for Malaria Venture	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs BLR&D Merit Review Program; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Medicine for Malaria Venture	We thank members of the University of Iowa Butler laboratory for assistance and helpful discussions, F. Lund (University of Alabama, Birmingham) for the mu S<SUP>-/-</SUP> mice, T. Honjo (Kyoto University) for the Aicda<SUP>-/-</SUP> mice, T. Waldschmidt (University of Iowa) for the clone MR-1 antibody, J. Harty and S. Perlman (University of Iowa) for critical reading of the manuscript and helpful discussions, A. Pewa, E. Taylor and A. Rauckhorst (University of Iowa) for assistance with the metabolic measurements, G. Beuttener and B. Wagner (University of Iowa) for the metabolic flux assays, and members of the University of Iowa Flow Cytometry Facility for cell sorting. The research reported in this publication was supported by the NCI (grant number P30CA086862) and the National Center for Research Resources of the NIH (grant number S10OD016199). J.J.G. was supported by a Predoctoral Fellowship from the American Heart Association (grant number 16PRE27660002). F.A.S. was supported by the NIH (grant number T32 AI007485). K.J.R. was supported by the NIH (T32 GM067795). W.J.M. was supported by the NIH (grant numbers AI134733 and AI139902). H.-H.X. was supported by the NIH (grant numbers AI121080 and AI139874) and the Veteran Affairs BLR&D Merit Review Program (BX002903). C.R.E. was supported by an NHMRC Senior Research Fellowship (grant number 1154265) and an NHMRC Program grant (grant number 1132975). J.S.M. was supported by an NHMRC Program grant (grant number 1132975) and an NHMRC Practitioner Fellowship (grant number 1135955). M.J.B. was supported by an NHMRC Career Development Fellowship (grant number 1141632) and an NHMRC Project Grant (grant number 1141278). N.S.B. was supported by the NIH (grant numbers AI125446, AI127481 and AI139902). We thank the participants involved in the malaria VISs, Q-Pharm staff and the Medicine for Malaria Venture for funding the clinical trials.	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cantor J, 2009, NAT IMMUNOL, V10, P412, DOI 10.1038/ni.1712; Changrob S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26677-x; Chapuis N, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00405; Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins KA, 2018, J CLIN INVEST, V128, P1551, DOI 10.1172/JCI98012; Cordy RJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125156; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; de Oca MM, 2016, CELL REP, V17, P399, DOI 10.1016/j.celrep.2016.09.015; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Guthmiller JJ, 2017, J IMMUNOL, V198, P617, DOI 10.4049/jimmunol.1601762; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Inoue T, 2018, IMMUNOL REV, V283, P138, DOI 10.1111/imr.12640; Keitany GJ, 2016, CELL REP, V17, P3193, DOI 10.1016/j.celrep.2016.11.060; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kurup SP, 2017, NAT MED, V23, P1220, DOI 10.1038/nm.4395; Labak CM, 2016, AM J CANCER RES, V6, P1599; Lam WY, 2018, CELL REP, V24, P2479, DOI 10.1016/j.celrep.2018.07.084; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Longley RJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005888; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021914, 10.1371/journal.pone.0024413]; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Miyakoda M, 2008, J IMMUNOL, V181, P1420, DOI 10.4049/jimmunol.181.2.1420; Ndungu FM, 2013, EUR J IMMUNOL, V43, P2919, DOI 10.1002/eji.201343630; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Obeng-Adjei N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006576; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rockett RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-48; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Sullivan RT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004894; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; WHO, 2018, WORLD MAL REP 2018; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; Zhu X, 2012, PARASITE IMMUNOL, V34, P412, DOI 10.1111/j.1365-3024.2012.01374.x	56	37	38	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					790	+		10.1038/s41590-020-0678-5	http://dx.doi.org/10.1038/s41590-020-0678-5		MAY 2020	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32424361	Green Accepted			2022-12-18	WOS:000533852800002
J	De Giovanni, M; Cutillo, V; Giladi, A; Sala, E; Maganuco, CG; Medaglia, C; Di Lucia, P; Bono, E; Cristofani, C; Consolo, E; Giustini, L; Fiore, A; Eickhoff, S; Kastenmuller, W; Amit, I; Kuka, M; Iannacone, M				De Giovanni, Marco; Cutillo, Valeria; Giladi, Amir; Sala, Eleonora; Maganuco, Carmela G.; Medaglia, Chiara; Di Lucia, Pietro; Bono, Elisa; Cristofani, Claudia; Consolo, Eleonora; Giustini, Leonardo; Fiore, Alessandra; Eickhoff, Sarah; Kastenmueller, Wolfgang; Amit, Ido; Kuka, Mirela; Iannacone, Matteo			Spatiotemporal regulation of type I interferon expression determines the antiviral polarization of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							FOLLICULAR-HELPER-CELLS; DENDRITIC CELLS; CHEMOKINE RECEPTOR; B-CELL; CHORIOMENINGITIS VIRUS; CYTOKINE RESPONSES; IMMUNE-RESPONSES; TRANSGENIC MICE; TH1; MACROPHAGES	Iannacone and colleagues show that the spatiotemporal regulation of type I interferon expression shapes the differentiation of antiviral CD4(+) T cells into T-FH or T(H)1 cells. Differentiation of CD4(+) T cells into either follicular helper T (T-FH) or type 1 helper T (T(H)1) cells influences the balance between humoral and cellular adaptive immunity, but the mechanisms whereby pathogens elicit distinct effector cells are incompletely understood. Here we analyzed the spatiotemporal dynamics of CD4(+) T cells during infection with recombinant vesicular stomatitis virus (VSV), which induces early, potent neutralizing antibodies, or recombinant lymphocytic choriomeningitis virus (LCMV), which induces a vigorous cellular response but inefficient neutralizing antibodies, expressing the same T cell epitope. Early exposure of dendritic cells to type I interferon (IFN), which occurred during infection with VSV, induced production of the cytokine IL-6 and drove T-FH cell polarization, whereas late exposure to type I IFN, which occurred during infection with LCMV, did not induce IL-6 and allowed differentiation into T(H)1 cells. Thus, tight spatiotemporal regulation of type I IFN shapes antiviral CD4(+) T cell differentiation and might instruct vaccine design strategies.	[De Giovanni, Marco; Cutillo, Valeria; Sala, Eleonora; Maganuco, Carmela G.; Di Lucia, Pietro; Bono, Elisa; Cristofani, Claudia; Consolo, Eleonora; Giustini, Leonardo; Kuka, Mirela; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy; [De Giovanni, Marco; Cutillo, Valeria; Sala, Eleonora; Consolo, Eleonora; Fiore, Alessandra; Kuka, Mirela; Iannacone, Matteo] Univ Vita Salute San Raffaele, Milan, Italy; [Giladi, Amir; Medaglia, Chiara; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Eickhoff, Sarah; Kastenmueller, Wolfgang] Inst Syst Immunol, Wurzburg, Germany; [Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Weizmann Institute of Science; University of Wurzburg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kuka, M; Iannacone, M (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy.; Kuka, M; Iannacone, M (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Iannacone, M (corresponding author), IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy.	kuka.mirela@hsr.it; iannacone.matteo@hsr.it	Iannacone, Matteo/I-8507-2018; KUKA, MIRELA/G-6410-2018; Bono, Elisa/AAN-3108-2020; Sala, Eleonora/AAN-4305-2020	Iannacone, Matteo/0000-0002-9370-2671; KUKA, MIRELA/0000-0001-9418-1559; Bono, Elisa/0000-0002-5212-3446; Sala, Eleonora/0000-0001-5109-6362; De Giovanni, Marco/0000-0001-7521-3092; , Leonardo/0000-0003-3462-7891	European Research Council (ERC) [725038]; Italian Association for Cancer Research (AIRC) [19891, 22737]; Italian Ministry of Health (MoH) [GR-2011-02347925]; Lombardy Foundation for Biomedical Research (FRRB) [2015-0010]; European Molecular Biology Organization Young Investigator Program; Giovanni Armenise-Harvard Foundation; Italian Ministry of Education [SIR-RBSI14BAO5, PRIN-2017ZXT5WR]	European Research Council (ERC)(European Research Council (ERC)European Commission); Italian Association for Cancer Research (AIRC); Italian Ministry of Health (MoH); Lombardy Foundation for Biomedical Research (FRRB); European Molecular Biology Organization Young Investigator Program; Giovanni Armenise-Harvard Foundation; Italian Ministry of Education	We thank M. Mainetti and M. Freschi for technical support; M. Silva for secretarial assistance; J.C. de la Torre (The Scripps Research Institute) for providing rLCMV; D. Pinschewer (University of Basel) for providing rVSV; M. Linterman (Babraham Institute) for providing Cd11c-Cre; Ifnar1fl/fl bone marrow; R. Pardi and A. Mondino for critical reading of the manuscript; and the members of the Iannacone laboratory for helpful discussions. Confocal immunofluorescence histology was carried out at Alembic, San Raffaele Scientific Institute, and the Vita-Salute San Raffaele University. Flow cytometry was carried out at FRACTAL, San Raffaele Scientific Institute. We would like to acknowledge the PhD program in Basic and Applied Immunology and Oncology at Vita-Salute San Raffaele University, as V.C. and E.S. conducted this study as partial fulfillment of their PhD in Molecular Medicine within this program. M.I. is supported by European Research Council (ERC) Consolidator grant 725038, Italian Association for Cancer Research (AIRC) grants 19891 and 22737, Italian Ministry of Health (MoH) grant GR-2011-02347925, Lombardy Foundation for Biomedical Research (FRRB) grant 2015-0010, the European Molecular Biology Organization Young Investigator Program and a Career Development award from the Giovanni Armenise-Harvard Foundation. M.K. is supported by Italian Ministry of Education grants SIR-RBSI14BAO5 and PRIN-2017ZXT5WR.	Arnaout RA, 2000, J THEOR BIOL, V204, P431, DOI 10.1006/jtbi.2000.2027; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Bradley LM, 1996, J IMMUNOL, V157, P1350; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chakarov S, 2014, EMBO MOL MED, V6, P590, DOI 10.1002/emmm.201403841; Cook KD, 2015, J LEUKOCYTE BIOL, V98, P153, DOI 10.1189/jlb.4HI1214-594R; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Eschli B, 2007, J VIROL, V81, P11650, DOI 10.1128/JVI.00955-07; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fallet B, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6817; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gerner MY, 2017, J EXP MED, V214, P3105, DOI 10.1084/jem.20170335; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KAWANO Y, 1995, IMMUNOLOGY, V84, P278; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kuka M, 2019, IMMUNOL LETT, V215, P19, DOI 10.1016/j.imlet.2019.01.013; Kuka M, 2018, NAT REV IMMUNOL, V18, P255, DOI 10.1038/nri.2017.133; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maloy KJ, 1999, J IMMUNOL, V162, P2867; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Osokine I, 2014, P NATL ACAD SCI USA, V111, P7409, DOI 10.1073/pnas.1401662111; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Oxenius A, 1999, J IMMUNOL, V162, P965; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prigge JR, 2015, J IMMUNOL, V195, P5347, DOI 10.4049/jimmunol.1501553; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sammicheli S, 2018, METHODS MOL BIOL, V1763, P63, DOI 10.1007/978-1-4939-7762-8_7; Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Schijns VECJ, 1998, J IMMUNOL, V160, P3958; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tan YR, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0139-y; Tonti E, 2013, CELL REP, V5, P323, DOI 10.1016/j.celrep.2013.09.004; Trinchieri G, 2012, CELL HOST MICROBE, V11, P553, DOI 10.1016/j.chom.2012.05.007; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wu TQ, 2015, J IMMUNOL, V195, P2515, DOI 10.4049/jimmunol.1500317; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798	62	37	37	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					321	+		10.1038/s41590-020-0596-6	http://dx.doi.org/10.1038/s41590-020-0596-6		FEB 2020	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066949	Green Accepted			2022-12-18	WOS:000514067400006
J	Rua, R; Lee, JV; Silva, AB; Swafford, IS; Maric, D; Johnson, KR; McGavern, DB				Rua, Rejane; Lee, Jane, V; Silva, Alexander B.; Swafford, Isabella S.; Maric, Dragan; Johnson, Kory R.; McGavern, Dorian B.			Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; TISSUE-RESIDENT MACROPHAGES; MANNOSE RECEPTOR; PERIVASCULAR MACROPHAGES; CANDIDA-ALBICANS; VAGUS NERVE; CELLS; SIGNR1; MICROGLIA; EXPRESSION	Tissue macrophages have an embryonic origin and can be replenished in some tissues under steady-state conditions by blood monocytes. However, little is known about the residency and properties of infiltrating monocytes after an inflammatory challenge. The meninges of the central nervous system (CNS) are populated by a dense network of macrophages that act as resident immune sentinels. Here we show that, following lymphocytic choriomeningitis virus infection, resident meningeal macrophages (MMs) acquired viral antigen and interacted directly with infiltrating cytotoxic T lymphocytes, which led to macrophage depletion. Concurrently, the meninges were infiltrated by inflammatory monocytes that engrafted the meningeal niche and remained in situ for months after viral clearance. This engraftment led to interferon-gamma-dependent functional changes in the pool of MMs, including loss of bacterial and immunoregulatory sensors. Collectively, these data indicate that peripheral monocytes can engraft the meninges after an inflammatory challenge, imprinting the compartment with long-term defects in immune function.	[Rua, Rejane; Lee, Jane, V; Silva, Alexander B.; Swafford, Isabella S.; Maric, Dragan; Johnson, Kory R.; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Rua, Rejane/GLQ-7139-2022; McGavern, Dorian/HCH-3601-2022	Rua, Rejane/0000-0002-4289-3498; McGavern, Dorian/0000-0001-9568-545X; Swafford, Isabella/0000-0001-8638-2772; Silva, Alexander/0000-0003-0838-4136	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003111] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH).	Butler SJ, 2015, DEV BIOL, V398, P135, DOI 10.1016/j.ydbio.2014.09.033; Coles JA, 2017, PROG NEUROBIOL, V156, P107, DOI 10.1016/j.pneurobio.2017.05.002; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Derecki NC, 2011, BRAIN BEHAV IMMUN, V25, P379, DOI 10.1016/j.bbi.2010.11.009; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; Faraco G, 2017, J MOL MED, V95, P1143, DOI 10.1007/s00109-017-1573-x; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gossa S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06664; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Haddad-Tovolli R, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00224; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047; Italiani P, 2017, RESULTS PROBL CELL D, V62, P23, DOI 10.1007/978-3-319-54090-0_2; Kang SS, 2008, FRONT BIOSCI-LANDMRK, V13, P4529, DOI 10.2741/3021; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; Kato C, 2010, GLYCOCONJUGATE J, V27, P525, DOI 10.1007/s10719-010-9298-x; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Laurent Paoline, 2017, Front Immunol, V8, P454, DOI 10.3389/fimmu.2017.00454; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Manglani M, 2018, CURR PROTOC IMMUNOL, V120, P2421; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mowat AM, 2017, NAT MED, V23, P1258, DOI 10.1038/nm.4430; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rua R, 2018, TRENDS MOL MED, V24, P542, DOI 10.1016/j.molmed.2018.04.003; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Song I, 2018, BRAIN RES BULL, V136, P101, DOI 10.1016/j.brainresbull.2017.03.003; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Takahara K, 2012, INFECT IMMUN, V80, P1699, DOI 10.1128/IAI.06308-11; Takahara K, 2012, INT IMMUNOL, V24, P89, DOI 10.1093/intimm/dxr103; Takahara K, 2011, EUR J IMMUNOL, V41, P1435, DOI 10.1002/eji.200940188; Tebruegge M, 2008, CLIN MICROBIOL REV, V21, P519, DOI 10.1128/CMR.00009-08; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017	56	37	37	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					407	+		10.1038/s41590-019-0344-y	http://dx.doi.org/10.1038/s41590-019-0344-y			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30886419	Green Accepted			2022-12-18	WOS:000461904200012
J	Emmanuel, AO; Arnovitz, S; Haghi, L; Mathur, PS; Mondal, S; Quandt, J; Okoreeh, MK; Maienschein-Cline, M; Khazaie, K; Dose, M; Gounari, F				Emmanuel, Akinola Olumide; Arnovitz, Stephen; Haghi, Leila; Mathur, Priya S.; Mondal, Soumi; Quandt, Jasmin; Okoreeh, Michael K.; Maienschein-Cline, Mark; Khazaie, Khashayarsha; Dose, Marei; Gounari, Fotini			TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4(+)CD8(+) thymocytes	NATURE IMMUNOLOGY			English	Article							T-CELL DIFFERENTIATION; GENE-EXPRESSION; LEF-1; TCR; SPECIFICATION; CHROMATIN; SELECTION; RECEPTOR; BCL11B; CD4	Thymocyte development requires a complex orchestration of multiple transcription factors. Ablating either TCF-1 or HEB in CD4(+)CD8(+) thymocytes elicits similar developmental outcomes including increased proliferation, decreased survival, and fewer late Tcra rearrangements. Here, we provide a mechanistic explanation for these similarities by showing that TCF-1 and HEB share similar to 7,000 DNA-binding sites genome wide and promote chromatin accessibility. The binding of both TCF-1 and HEB was required at these shared sites for epigenetic and transcriptional gene regulation. Binding of TCF-1 and HEB to their conserved motifs in the enhancer regions of genes associated with T cell differentiation promoted their expression. Binding to sites lacking conserved motifs in the promoter regions of cell-cycle-associated genes limited proliferation. TCF-1 displaced nucleosomes, allowing for chromatin accessibility. Importantly, TCF-1 inhibited Notch signaling and consequently protected HEB from Notch-mediated proteasomal degradation. Thus, TCF-1 shifts nucleosomes and safeguards HEB, thereby enabling their cooperation in establishing the epigenetic and transcription profiles of CD4(+)CD8(+) thymocytes.	[Emmanuel, Akinola Olumide; Arnovitz, Stephen; Haghi, Leila; Mathur, Priya S.; Mondal, Soumi; Quandt, Jasmin; Okoreeh, Michael K.; Dose, Marei; Gounari, Fotini] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Maienschein-Cline, Mark] Univ Illinois, Core Res Informat, Chicago, IL USA; [Khazaie, Khashayarsha] Mayo Clin, Dept Surg, Dept Immunol, Rochester, MN USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Mayo Clinic	Dose, M; Gounari, F (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mareidose0@gmail.com; fgounari@uchicago.edu		Okoreeh, Michael/0000-0001-7680-9488; Dose, Marei/0000-0001-5394-9779	National Institutes of Health [R21AI076720, R01AI108682, U54CA193419]; ASH bridge grant; Chicago Biomedical Consortium; NIH; NRSA [T32 HL07605]; AAI Careers in Immunology Fellowship;  [T32HD007009];  [R01CA160436];  [UL1TR002003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA160436] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASH bridge grant; Chicago Biomedical Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAI Careers in Immunology Fellowship; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Kawamoto (RIKEN Research Center for Allergy and Immunology) for reagents; M. Mandal for help with ATAC-seq; B. Kee, M. Clark, A. Khan, and A. Bendelac for advice; and M. Krishnan for helpful suggestions. This work was supported by National Institutes of Health grants R21AI076720, R01AI108682, and U54CA193419, and an ASH bridge grant (to F.G.), and R01CA160436 (to K.K). Further support came from the Chicago Biomedical Consortium (to F.G.) and UL1TR002003 (to M.M.-C.). A.O.E. was supported by an NIH minority supplement; P.S.M. was supported by Institutional NRSA T32 HL07605 and is currently supported as an LLS Fellow; J.Q. was supported by an AAI Careers in Immunology Fellowship; and M.K.O. is a T32HD007009 recipient.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Barndt R, 1999, J IMMUNOL, V163, P3331; Ben Baruch-Morgenstern N, 2014, NAT IMMUNOL, V15, P36, DOI 10.1038/ni.2757; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Huang H, 2009, MOL CELL BIOL, V29, P4103, DOI 10.1128/MCB.00090-09; Huang ZF, 2006, J IMMUNOL, V176, P4880, DOI 10.4049/jimmunol.176.8.4880; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Kumata K, 2015, ACS CHEM NEUROSCI, V6, P339, DOI 10.1021/cn500269g; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schilham MW, 1998, J IMMUNOL, V161, P3984; Scripture-Adams DD, 2014, J IMMUNOL, V193, P3470, DOI 10.4049/jimmunol.1301663; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080936; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Tinsley KW, 2013, BLOOD, V122, P2358, DOI 10.1182/blood-2012-12-472076; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang DC, 2006, J IMMUNOL, V177, P109, DOI 10.4049/jimmunol.177.1.109; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Whyte W. A., 2012, CELL, V153, P207; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	37	37	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1366	+		10.1038/s41590-018-0254-4	http://dx.doi.org/10.1038/s41590-018-0254-4			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30420627	Green Accepted			2022-12-18	WOS:000452873000017
J	De Rosa, V; La Cava, A; Matarese, G				De Rosa, Veronica; La Cava, Antonio; Matarese, Giuseppe			Metabolic pressure and the breach of immunological self-tolerance	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NOD MICE; INSULIN-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; RHEUMATOID-ARTHRITIS; BACTERIAL AGENTS; SPLICE VARIANTS; DENDRITIC CELLS; PROTECTS MICE	The prevalence of autoimmune disorders in affluent countries has reached epidemic proportions. Over the past 50 years, a reverse trend between the frequency of infectious diseases and the incidence of autoimmune and allergic diseases led to the so-called 'hygiene hypothesis'. Given the epidemiological evidence and recent experimental data, we propose that this concept should also include metabolic pressure secondary to exposure to excessive daily caloric intake and overnutrition. We discuss how metabolic workload can modulate immunological tolerance and review the molecular mechanisms and the state of the art of the field. We also critically evaluate possibilities for restoring immunological homeostasis under conditions of metabolic pressure.	[De Rosa, Veronica; Matarese, Giuseppe] CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [La Cava, Antonio] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Matarese, Giuseppe] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Treg Cell Lab, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of California System; University of California Los Angeles; University of Naples Federico II	De Rosa, V; Matarese, G (corresponding author), CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy.; Matarese, G (corresponding author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Treg Cell Lab, Naples, Italy.	veronica.derosa@cnr.it; giuseppe.matarese@unina.it	/AAG-9576-2020; Matarese, Giuseppe/AAO-4077-2021	/0000-0002-8839-0933; Matarese, Giuseppe/0000-0001-9429-0616	European Research Council [310496]; Fondazione Italiana Sclerosi Multipla [2016/R/18, 2014/R/21]; Telethon [GGP17086]; Associazione Italiana per la Ricerca sul Cancro-Cariplo TRansforming IDEas in Oncological Research [17447]; US National Institutes of Health [AI109677]	European Research Council(European Research Council (ERC)European Commission); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro-Cariplo TRansforming IDEas in Oncological Research(Fondazione AIRC per la ricerca sul cancro); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Bruzzaniti for manuscript editing. This work is dedicated to the memory of Eugenia Papa and Serafino Zappacosta. Supported by the European Research Council ("menTORingTregs" grant 310496 to G.M.), the Fondazione Italiana Sclerosi Multipla (2016/R/18 to G.M. and 2014/R/21 to V.D.R.), Telethon (GGP17086 to G.M.), Associazione Italiana per la Ricerca sul Cancro-Cariplo TRansforming IDEas in Oncological Research (17447 to V.D.R.) and the US National Institutes of Health (AI109677 to A.L.C.).	Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BENNUN A, 1995, J IMMUNOL, V154, P2939; BENNUN A, 1993, EUR J IMMUNOL, V23, P689, DOI 10.1002/eji.1830230318; Bhargava A, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5407; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Brown K, 2016, ISME J, V10, P321, DOI 10.1038/ismej.2015.114; Candon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125448; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Daley SR, 2013, ELIFE, V2, DOI 10.7554/eLife.01020; DARMAWAN J, 1993, BRIT J RHEUMATOL, V32, P537; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Di Rosa F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00051; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; Endo Y, 2015, CELL REP, V12, P1042, DOI 10.1016/j.celrep.2015.07.014; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Ferrara CT, 2017, DIABETES CARE, V40, P698, DOI 10.2337/dc16-2331; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fourlanos S, 2008, DIABETES CARE, V31, P1546, DOI 10.2337/dc08-0239; Fourlanos S, 2008, CURR OPIN ENDOCRINOL, V15, P321, DOI 10.1097/MED.0b013e3283073a5a; Friedman JM, 1997, NATURE, V385, P119, DOI 10.1038/385119a0; Galgani M, 2010, J LEUKOCYTE BIOL, V87, P17, DOI 10.1189/jlb.0809530; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Harpsoe MC, 2014, INT J EPIDEMIOL, V43, P843, DOI 10.1093/ije/dyu045; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; He XH, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43003; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Kaur G, 2010, MOL IMMUNOL, V48, P321, DOI 10.1016/j.molimm.2010.07.008; Kim JG, 2014, NAT NEUROSCI, V17, P908, DOI 10.1038/nn.3725; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kono D. H., 2017, KELLEY FIRESTEINS TX, V2, P301; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kuchroo VK, 2003, NATURE, V422, P27, DOI 10.1038/422027a; Kurien BT, 2006, FREE RADICAL BIO MED, V41, P549, DOI 10.1016/j.freeradbiomed.2006.05.020; LEHMANN D, 1992, J AUTOIMMUN, V5, P675, DOI 10.1016/0896-8411(92)90185-S; Lerner A, 2015, INT J CELIAC DIS, V3, P151, DOI [10.12691/ijcd-3-4-8, DOI 10.12691/IJCD-3-4-8]; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Manzel A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0404-6; Matarese G, 2004, TRENDS IMMUNOL, V25, P193, DOI 10.1016/j.it.2004.02.009; Matarese G, 2013, P NATL ACAD SCI USA, V110, P6193, DOI 10.1073/pnas.1210644110; MCFARLANE H, 1971, LANCET, V2, P1146; Melis D, 2017, J IMMUNOL, V198, P3803, DOI 10.4049/jimmunol.1601946; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Mokry LE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002053; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Odegaard JI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007724; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; Perry RJ, 2016, DIABETOLOGIA, V59, P933, DOI 10.1007/s00125-016-3909-4; Prentice AM, 1999, BRIT J NUTR, V81, P345, DOI 10.1017/S0007114599000628; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Procaccini C, 2012, TRENDS IMMUNOL, V33, P1, DOI 10.1016/j.it.2011.09.002; Procaccini C, 2011, EXPERT REV CLIN IMMU, V7, P287, DOI [10.1586/ECI.11.18, 10.1586/eci.11.18]; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Pross H F, 1974, Adv Immunol, V18, P133, DOI 10.1016/S0065-2776(08)60309-0; Qin HY, 1997, J AUTOIMMUN, V10, P271, DOI 10.1006/jaut.1997.0136; Reis BS, 2015, J IMMUNOL, V194, P5253, DOI 10.4049/jimmunol.1402996; Sabbatini M, 2015, CLIN EXP IMMUNOL, V182, P230, DOI 10.1111/cei.12669; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Scudellari M, 2017, P NATL ACAD SCI USA, V114, P1433, DOI 10.1073/pnas.1700688114; Selmi C, 2010, AUTOIMMUN REV, V9, pA247, DOI 10.1016/j.autrev.2010.02.004; SERREZE DV, 1994, CURR OPIN IMMUNOL, V6, P900, DOI 10.1016/0952-7915(94)90011-6; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Stelzner K, 2016, EUR J IMMUNOL, V46, P2043, DOI 10.1002/eji.201546263; Sterry W, 2007, BRIT J DERMATOL, V157, P649, DOI 10.1111/j.1365-2133.2007.08068.x; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; Turner MS, 2014, DIABETOLOGIA, V57, P1428, DOI 10.1007/s00125-014-3233-9; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Vatanen T, 2016, CELL, V165, P1551, DOI 10.1016/j.cell.2016.05.056; Versini M, 2014, AUTOIMMUN REV, V13, P981, DOI 10.1016/j.autrev.2014.07.001; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhu JF, 2014, NAT IMMUNOL, V15, P1002, DOI 10.1038/ni.3014	99	37	37	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1190	1196		10.1038/ni.3851	http://dx.doi.org/10.1038/ni.3851			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044230				2022-12-18	WOS:000413457300005
J	Lee, EY; Lee, HC; Kim, HK; Jang, SY; Park, SJ; Kim, YH; Kim, JH; Hwang, J; Kim, JH; Kim, TH; Abul Arif; Kim, SY; Choi, YK; Lee, C; Lee, CH; Jung, JU; Fox, PL; Kim, S; Lee, JS; Kim, MH				Lee, Eun-Young; Lee, Hyun-Cheol; Kim, Hyun-Kwan; Jang, Song Yee; Park, Seong-Jun; Kim, Yong-Hoon; Kim, Jong Hwan; Hwang, Jungwon; Kim, Jae-Hoon; Kim, Tae-Hwan; Abul Arif; Kim, Seon-Young; Choi, Young-Ki; Lee, Cheolju; Lee, Chul-Ho; Jung, Jae U.; Fox, Paul L.; Kim, Sunghoon; Lee, Jong-Soo; Kim, Myung Hee			Infection-specific phosphorylation of glutamyl-prolyl tRNA synthetase induces antiviral immunity	NATURE IMMUNOLOGY			English	Article							RIG-I; TRANSLATIONAL CONTROL; INNATE IMMUNITY; NONCANONICAL FUNCTION; INTERFERON-GAMMA; MAVS DEGRADATION; UBIQUITIN LIGASE; RESPONSES; COMPLEX; BINDING	The mammalian cytoplasmic multi-tRNA synthetase complex (MSC) is a depot system that regulates non-translational cellular functions. Here we found that the MSC component glutamyl-prolyl-tRNA synthetase (EPRS) switched its function following viral infection and exhibited potent antiviral activity. Infection-specific phosphorylation of EPRS at Ser990 induced its dissociation from the MSC, after which it was guided to the antiviral signaling pathway, where it interacted with PCBP2, a negative regulator of mitochondrial antiviral signaling protein (MAVS) that is critical for antiviral immunity. This interaction blocked PCBP2-mediated ubiquitination of MAVS and ultimately suppressed viral replication. EPRS-haploid (Eprs(+/-)) mice showed enhanced viremia and inflammation and delayed viral clearance. This stimulus-inducible activation of MAVS by EPRS suggests an unexpected role for the MSC as a regulator of immune responses to viral infection.	[Lee, Eun-Young; Kim, Hyun-Kwan; Jang, Song Yee; Hwang, Jungwon; Kim, Myung Hee] KRIBB, Microbi & Immun Res Ctr, Infect & Immun Res Lab, Daejeon, South Korea; [Lee, Hyun-Cheol; Kim, Hyun-Kwan; Kim, Jae-Hoon; Kim, Tae-Hwan; Lee, Jong-Soo] Chungnam Natl Univ, Coll Vet Med, Daejeon, South Korea; [Park, Seong-Jun; Lee, Cheolju] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul, South Korea; [Kim, Yong-Hoon; Lee, Chul-Ho] UST, KRIBB, Lab Anim Resource Ctr, Daejeon, South Korea; [Kim, Yong-Hoon; Kim, Seon-Young] KRIBB, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Abul Arif; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Choi, Young-Ki] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Choi, Young-Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea; [Lee, Cheolju] UST, Dept Biol Chem, Daejeon, South Korea; [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Med Bioconvergence Res Ctr, Seoul, South Korea; [Kim, Myung Hee] UST, Biosyst & Bioengn Program, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Korea Institute of Science & Technology (KIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Cleveland Clinic Foundation; Chungbuk National University; Chungbuk National University; University of Science & Technology (UST); University of Southern California; Seoul National University (SNU); University of Science & Technology (UST)	Kim, MH (corresponding author), KRIBB, Microbi & Immun Res Ctr, Infect & Immun Res Lab, Daejeon, South Korea.; Lee, JS (corresponding author), Chungnam Natl Univ, Coll Vet Med, Daejeon, South Korea.; Kim, MH (corresponding author), UST, Biosyst & Bioengn Program, Daejeon, South Korea.	jongsool@cnu.ac.kr; mhk8@kribb.re.kr	Kim, Sunghoon/AAE-8314-2020	kim, sunghoon/0000-0002-1570-3230; Lee, Jong-Soo/0000-0001-5119-0711	KRIBB Initiative Program [KGM4541622]; National Research Foundation of Korea; Ministry of Science, ICT & Future Planning of Korea [NRF-2010-0029767, 2014R1A2A1A01005971, NRF-M3A6A4-2010-0029785, 2015020957]; Korea Institute of Oriental Medicine [K12050]; Ministry for Food, Agriculture, Forestry and Fisheries [315044031SB010]; Korea Health Industry Development Institute [H114C3484]; NATIONAL CANCER INSTITUTE [R01CA082057] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116585] Funding Source: NIH RePORTER	KRIBB Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning of Korea; Korea Institute of Oriental Medicine; Ministry for Food, Agriculture, Forestry and Fisheries; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the KRIBB Initiative Program (KGM4541622 to M.H.K.), the National Research Foundation of Korea, funded by the Ministry of Science, ICT & Future Planning of Korea (NRF-2010-0029767 and 2014R1A2A1A01005971 to M.H.K.; NRF-M3A6A4-2010-0029785 to S.K.; and 2015020957 to J.-S.L.), the Korea Institute of Oriental Medicine (K12050 to J.-S.L.), the Ministry for Food, Agriculture, Forestry and Fisheries (315044031SB010 to J.-S.L.) and the Korea Health Industry Development Institute (H114C3484 to C.L.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/NCHEMBIO.1158, 10.1038/nchembio.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Jacobs JL, 2014, J BIOL CHEM, V289, P1604, DOI 10.1074/jbc.M113.520254; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P570, DOI 10.1038/nri3050; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Son J, 2013, ACTA CRYSTALLOGR D, V69, P2136, DOI 10.1107/S0907444913020556; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tandle AT, 2009, EXP CELL RES, V315, P1850, DOI 10.1016/j.yexcr.2009.03.021; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wang YT, 2012, J IMMUNOL, V189, P5304, DOI 10.4049/jimmunol.1201445; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200; Xia PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9132; Yang XL, 2013, CHEM BIOL, V20, P1093, DOI 10.1016/j.chembiol.2013.07.013; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	39	37	40	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1252	1262		10.1038/ni.3542	http://dx.doi.org/10.1038/ni.3542			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27595231	Green Accepted			2022-12-18	WOS:000386193200005
J	Ramos-Perez, WD; Fang, V; Escalante-Alcalde, D; Cammer, M; Schwab, SR				Ramos-Perez, Willy D.; Fang, Victoria; Escalante-Alcalde, Diana; Cammer, Michael; Schwab, Susan R.			A map of the distribution of sphingosine 1-phosphate in the spleen	NATURE IMMUNOLOGY			English	Article							SPLENIC MARGINAL ZONE; B-CELL LOCALIZATION; LYMPHOCYTE EGRESS; DENDRITIC CELLS; SPHINGOSINE-1-PHOSPHATE; MICE; LIGAND; TRAFFICKING; PROMOTES; PHOSPHORYLATION	Despite the importance of signaling lipids, many questions remain about their function because few tools are available for charting lipid gradients in vivo. Here we generated a sphingosine 1-phosphate (S1P) reporter mouse and used this mouse to define the distribution of S1P in the spleen. Unexpectedly, the presence of blood did not serve as a predictor of the concentration of signaling-available S1P. Large areas of the red pulp had low concentrations of S1P, while SIP was sensed by cells inside the white pulp near the marginal sinus. The lipid phosphate phosphatase LPP3 maintained low SIP concentrations in the spleen and enabled efficient shuttling of marginal zone B cells. The exquisitely tight regulation of S1P availability might explain how a single lipid can simultaneously orchestrate the movements of many cells of the immune system.	[Ramos-Perez, Willy D.; Fang, Victoria; Schwab, Susan R.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10010 USA; [Escalante-Alcalde, Diana] Univ Nacl Autonoma Mexico, Div Neurociencias, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Cammer, Michael] NYU, Microscopy Core, Off Collaborat Sci, Langone Med Ctr, New York, NY USA	New York University; Universidad Nacional Autonoma de Mexico; New York University; NYU Langone Medical Center	Schwab, SR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10010 USA.	susan.schwab@med.nyu.edu		Escalante-Alcalde, Diana/0000-0003-0325-6602; Fang, Victoria/0000-0001-9376-1279; Schwab, Susan/0000-0002-0834-0822; Cammer, Michael/0000-0003-4930-1739	US National Institutes of Health [AI085166]; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085166, T32AI100853] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Schwab laboratory, J. Cyster, T. Schmidt, J. Green, D. Littman, M. Dustin, S. Koralov, and T. Lu for discussions, and J. Cyster and L. Pitt for critical reading of the manuscript. Supported by the US National Institutes of Health (AI085166 to S.R.S.) and the Pew Charitable Trusts (S.R.S.).	Arnon TI, 2014, CURR TOP MICROBIOL, V378, P107, DOI 10.1007/978-3-319-05879-5_5; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Cahalan SM, 2011, NAT CHEM BIOL, V7, P254, DOI 10.1038/nchembio.547; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Czeloth N, 2007, J IMMUNOL, V179, P5855, DOI 10.4049/jimmunol.179.9.5855; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Escalante-Alcalde D, 2007, GENESIS, V45, P465, DOI 10.1002/dvg.20314; Gatto D, 2013, TRENDS IMMUNOL, V34, P336, DOI 10.1016/j.it.2013.01.007; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Groom AC., 2002, COMPLETE SPLEEN STRU, P23, DOI 10.1007/978-1-59259-124-4_3; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; HAHN WC, 1993, J EXP MED, V178, P1831, DOI 10.1084/jem.178.5.1831; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lopez-Juarez A, 2011, GLIA, V59, P577, DOI 10.1002/glia.21126; MACDONALD IC, 1991, MICROVASC RES, V42, P60, DOI 10.1016/0026-2862(91)90075-M; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Muinonen-Martin AJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001966; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; SCHMIDT EE, 1985, J MORPHOL, V186, P17, DOI 10.1002/jmor.1051860103; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200	47	37	40	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1245	1252		10.1038/ni.3296	http://dx.doi.org/10.1038/ni.3296			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26502404	Green Accepted			2022-12-18	WOS:000365062100008
J	Siednienko, J; Jackson, R; Mellett, M; Delagic, N; Yang, S; Wang, BW; Tang, LS; Callanan, JJ; Mahon, BP; Moynagh, PN				Siednienko, Jakub; Jackson, Ruaidhri; Mellett, Mark; Delagic, Nezira; Yang, Shuo; Wang, Bingwei; Tang, Lisa S.; Callanan, John J.; Mahon, Bernard P.; Moynagh, Paul N.			Pellino3 targets the IRF7 pathway and facilitates autoregulation of TLR3-and viral-induced expression of type I interferons	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; UBIQUITIN LIGASE PELLINO; CUTTING EDGE; REGULATORY FACTOR-3; PROTEIN-KINASES; ACTIVATION; TRAF6; FAMILY; INTERLEUKIN-1	Toll-like receptors (TLRs) sense pathogen-associated molecules and respond by inducing cytokines and type I interferon. Here we show that genetic ablation of the E3 ubiquitin ligase Pellino3 augmented the expression of type I interferon but not of proinflammatory cytokines in response to TLR3 activation. Pellino3-deficient mice had greater resistance against the pathogenic and lethal effects of encephalomyocarditis virus (EMCV). TLR3 signaling induced Pellino3, which in turn interacted with and ubiquitinated TRAF6. This modification suppressed the ability of TRAF6 to interact with and activate IRF7, resulting in downregulation of type I interferon expression. Our findings highlight a new physiological role for Pellino3 and define a new autoregulatory network for controlling type I interferon expression.	[Siednienko, Jakub; Jackson, Ruaidhri; Mellett, Mark; Delagic, Nezira; Yang, Shuo; Wang, Bingwei; Tang, Lisa S.; Mahon, Bernard P.; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland; [Callanan, John J.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Callanan, John J.] UCD, Conway Inst Biomol & Biomed Res, Dublin, Ireland	Maynooth University; University College Dublin; University College Dublin	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland.	paul.moynagh@nuim.ie	Mahon, Bernard/AAP-2504-2020	Mahon, Bernard/0000-0003-1538-7490; Callanan, John/0000-0003-4356-1783; Mellett, Mark/0000-0002-6315-167X; wang, Bingwei/0000-0002-9306-4323; Moynagh, Paul/0000-0002-4139-3061; Siednienko, Jakub/0000-0003-2358-5876	Science Foundation Ireland [07/IN.1/B972]; Health Research Board of Ireland [PhD/2007/09]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland	This work was funded by Science Foundation Ireland (07/IN.1/B972) and the Health Research Board of Ireland (under grant PhD/2007/09). We thank B. Cloak and S.Worrell for technical assistance with photomicroscopy, and M. Healy for assistance with flow cytometry.	Buettner N, 2010, J GEN VIROL, V91, P220, DOI 10.1099/vir.0.015172-0; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Butler MP, 2005, J BIOL CHEM, V280, P27759, DOI 10.1074/jbc.M500756200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choubey D, 2011, J INTERF CYTOK RES, V31, P857, DOI 10.1089/jir.2011.0101; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Jensen LE, 2003, FEBS LETT, V545, P199, DOI 10.1016/S0014-5793(03)00533-7; Jensen LE, 2003, J IMMUNOL, V171, P1500, DOI 10.4049/jimmunol.171.3.1500; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim JH, 2011, MOL CELLS, V31, P85, DOI 10.1007/s10059-011-0006-x; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Moynagh PN, 2011, NAT IMMUNOL, V12, P927, DOI 10.1038/ni.2108; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Sasai M, 2010, MOL IMMUNOL, V47, P1283, DOI 10.1016/j.molimm.2009.12.002; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Strelow A, 2003, FEBS LETT, V547, P157, DOI 10.1016/S0014-5793(03)00697-5; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075	47	37	38	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1055	1062		10.1038/ni.2429	http://dx.doi.org/10.1038/ni.2429			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23042151	Green Accepted			2022-12-18	WOS:000310091700008
J	Phee, H; Dzhagalov, I; Mollenauer, M; Wang, Y; Irvine, DJ; Robey, E; Weiss, A				Phee, Hyewon; Dzhagalov, Ivan; Mollenauer, Marianne; Wang, Yana; Irvine, Darrell J.; Robey, Ellen; Weiss, Arthur			Regulation of thymocyte positive selection and motility by GIT2	NATURE IMMUNOLOGY			English	Article							GTPASE-ACTIVATING PROTEINS; T-CELL DEVELOPMENT; CUTTING EDGE; TCR SIGNALS; RECEPTOR; FAMILY; MIGRATION; EXPRESSION; COMPLEX; PIX	Thymocytes are highly motile cells that migrate under the influence of chemokines in distinct thymic compartments as they mature. The motility of thymocytes is tightly regulated; however, the molecular mechanisms that control thymocyte motility are not well understood. Here we report that G protein-coupled receptor kinase-interactor 2 (GIT2) was required for efficient positive selection. Notably, Git2(-/-) double-positive thymocytes showed greater activation of the small GTPase Rac, actin polymerization and migration toward the chemokines CXCL12 (SDF-1) and CCL25 in vitro. By two-photon laser-scanning microscopy, we found that the scanning activity of Git2(-/-) thymocytes was compromised in the thymic cortex, which suggests GIT2 has a key role in regulating the chemokine-mediated motility of double-positive thymocytes.	[Phee, Hyewon; Mollenauer, Marianne; Weiss, Arthur] Univ Calif San Francisco, Div Rheumatol, Dept Med, Rosalind Russell Med Res Ctr Arthritis, San Francisco, CA 94143 USA; [Dzhagalov, Ivan; Robey, Ellen] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Mollenauer, Marianne; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Wang, Yana] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Weiss, A (corresponding author), Univ Calif San Francisco, Div Rheumatol, Dept Med, Rosalind Russell Med Res Ctr Arthritis, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu		Phee, Hyewon/0000-0002-1942-0414; Dzhagalov, Ivan/0000-0001-9209-4582	Leukemia and Lymphoma Society; National Institutes of Health [R01AI064227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR059754] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the Transgenic/Targeted Mutagenesis Core Facility of the University of California San Francisco Comprehensive Cancer Center for creating Git2<SUP>-/-</SUP> mice; the Biological Imaging Development Center of the University of California San Francisco for Imaris software support; and E. Manser (Institute of Molecular and Cell Biology, Singapore) for monoclonal and polyclonal antibodies that recognize the alpha- and beta-isoforms of PIX. Supported by the Leukemia and Lymphoma Society (H. P.) and the National Institutes of Health (R01AI064227 to E. R.).	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Ladi E, 2008, J IMMUNOL, V181, P7014, DOI 10.4049/jimmunol.181.10.7014; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Radhakrishna H, 1999, J CELL SCI, V112, P855; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schmalzigaug R, 2007, J HISTOCHEM CYTOCHEM, V55, P1039, DOI 10.1369/jhc.7A7207.2007; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Suzuki G, 1999, J IMMUNOL, V162, P5981; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 2000, J CELL SCI, V113, P4139; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Zaitseva MB, 1998, J IMMUNOL, V161, P3103; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	41	37	40	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					503	U70		10.1038/ni.1868	http://dx.doi.org/10.1038/ni.1868			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20431621	Green Accepted, Green Submitted			2022-12-18	WOS:000277821300011
J	Fraenkel, S; Mostoslavsky, R; Novobrantseva, TI; Pelanda, R; Chaudhuri, J; Esposito, G; Jung, S; Alt, FW; Rajewsky, K; Cedar, H; Bergman, Y				Fraenkel, Shira; Mostoslavsky, Raul; Novobrantseva, Tatiana I.; Pelanda, Roberta; Chaudhuri, Jayanta; Esposito, Gloria; Jung, Steffen; Alt, Frederick W.; Rajewsky, Klaus; Cedar, Howard; Bergman, Yehudit			Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin kappa-chain locus	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; ANTIBODY DIVERSIFICATION; DNA DEAMINATION; GENE-EXPRESSION; MOUSE STRAIN; HEAVY-CHAIN; GERM-LINE; V-GENE; EXCLUSION; TRANSCRIPTION	Monoallelic demethylation and rearrangement control allelic exclusion of the immunoglobulin kappa-chain locus (Igk locus) in B cells. Here, through the introduction of pre-rearranged Igk genes into their physiological position, the critical rearrangement step was bypassed, thereby generating mice producing B cells simultaneously expressing two different immunoglobulin-kappa light chains. Such 'double- expressing' B cells still underwent monoallelic demethylation at the Igk locus, and the demethylated allele was the 'preferred' substrate for somatic hypermutation in each cell. However, methylation itself did not directly inhibit the activation-induced cytidine-deaminase reaction in vitro. Thus, it seems that the epigenetic mechanisms that initially bring about monoallelic variable-(diversity)-joining rearrangement continue to be involved in the control of antibody diversity at later stages of B cell development.	Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Albylam Pharmaceut, Cambridge, MA 02142 USA; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Artemis Pharmaceut, D-51063 Cologne, Germany; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Hebrew University of Jerusalem; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Cologne; National Jewish Health; Memorial Sloan Kettering Cancer Center; Weizmann Institute of Science; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Bergman, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel.	yberg@md2.huji.ac.il	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; Rajewsky, Klaus/0000-0002-6633-6370				BACCALA R, 1989, P NATL ACAD SCI USA, V86, P4624, DOI 10.1073/pnas.86.12.4624; Bergman Y, 2003, CURR OPIN IMMUNOL, V15, P176, DOI 10.1016/S0952-7915(03)00016-5; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gerdes T, 2004, NAT IMMUNOL, V5, P1282, DOI 10.1038/ni1133; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; GORSKI J, 1983, SCIENCE, V220, P1179, DOI 10.1126/science.6857243; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Novobrantseva T, 2005, INT IMMUNOL, V17, P343, DOI 10.1093/intimm/dxh214; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; PECH M, 1981, NATURE, V291, P668, DOI 10.1038/291668a0; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634; ROES J, 1989, J IMMUNOL, V142, P1022; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Torres RM, 1997, LAB PROTOCOLS CONDIT; WEBER JS, 1991, J IMMUNOL, V146, P3218; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yang SY, 2006, J EXP MED, V203, P2919, DOI 10.1084/jem.20061835; ZOU YR, 1993, SCIENCE, V262, P1271, DOI 10.1126/science.8235658	49	37	47	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					715	722		10.1038/ni1476	http://dx.doi.org/10.1038/ni1476			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17546032				2022-12-18	WOS:000247718100012
J	Tang, QZ; Bluestone, JA				Tang, Qizhi; Bluestone, Jeffrey A.			Plasmacytoid DCs and T-reg cells: casual acquaintance or monogamous relationship?	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; INDUCE; GENERATION; MICE	Dendritic cells initiate immune responses but also influence regulatory T cell activity and homeostasis. Functional outcomes of dendritic cell-T cell interactions depend on the immunological context of their encounter.	Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tang, QZ (corresponding author), Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu		Tang, Qizhi/0000-0001-7313-3574				Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cong YZ, 2005, J IMMUNOL, V174, P2787, DOI 10.4049/jimmunol.174.5.2787; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422	15	37	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					551	553		10.1038/ni0606-551	http://dx.doi.org/10.1038/ni0606-551			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715063				2022-12-18	WOS:000237751200006
J	Godfrey, DI; McCluskey, J; Rossjohn, J				Godfrey, DI; McCluskey, J; Rossjohn, J			CD1d antigen presentation: treats for NKT cells	NATURE IMMUNOLOGY			English	Editorial Material							RECOGNITION; GLYCOLIPIDS	Structural studies of CD1d presentation of alpha-galactosylceramide have shown that the lipid component fits snugly in the cleft, whereas the galactosyl head group protrudes upward, with key contact points between CD1d and the antigen conserved between mouse and human structures.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia	University of Melbourne; Monash University	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@med.edu.au	Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Godfrey, Dale/0000-0002-3009-5472				Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	12	37	37	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					754	756		10.1038/ni0805-754	http://dx.doi.org/10.1038/ni0805-754			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034430				2022-12-18	WOS:000230646200007
J	Kappes, DJ; He, X; He, X				Kappes, DJ; He, X; He, X			CD4-CD8 lineage commitment: an inside view	NATURE IMMUNOLOGY			English	Review							T-CELL DEVELOPMENT; CHROMATIN REMODELING COMPLEXES; RUNX3 TRANSCRIPTION FACTOR; P56(LCK) TYROSINE KINASE; SINGLE-POSITIVE LINEAGE; GENE-EXPRESSION; CD8 LINEAGE; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; IMMATURE THYMOCYTES	The mechanism of CD4-CD8 lineage commitment, which ensures the correlation between T cell receptor specificity and adoption of the T killer or T helper phenotype, has long been the subject of intense debate. Various approaches are slowly elucidating the underlying molecular pathways. Analysis of the function of T cell receptor signaling ( the 'top-down' approach) supports the view that differences in signal strength and/or duration 'instruct' alternative commitment. Analysis of the transcriptional regulation of the genes encoding CD4 and CD8 (the 'bottom- up' approach) has identified critical cis-acting elements and their interacting factors. Finally, identification of the transcription factor Th-POK as a central component of the CD4 lineage-determining pathway has provided a new starting point from which to unravel this intriguing process 'from the inside out'.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Kappes, DJ (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dj_kappes@fccc.edu	He, Xi/GXH-3286-2022	He, Xi/0000-0002-4383-0157; He, Xiao/0000-0002-9286-9859				Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; BARON A, 1994, EUR J IMMUNOL, V24, P1933, DOI 10.1002/eji.1830240834; Bhandoola A, 2000, INT IMMUNOL, V12, P1035, DOI 10.1093/intimm/12.7.1035; Bommhardt U, 1999, J IMMUNOL, V163, P715; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chan S, 1998, J EXP MED, V188, P2321, DOI 10.1084/jem.188.12.2321; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Delaire S, 2004, J EXP MED, V200, P1427, DOI 10.1084/jem.20041041; Ehlers M, 2003, J IMMUNOL, V171, P3594, DOI 10.4049/jimmunol.171.7.3594; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; KYDD R, 1995, J IMMUNOL, V155, P3806; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Merkenschlager M, 2004, J EXP MED, V200, P1437, DOI 10.1084/jem.20041127; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Robey EA, 2004, CURR OPIN IMMUNOL, V16, P360, DOI 10.1016/j.coi.2004.03.009; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Widom RL, 1997, GENE, V198, P407, DOI 10.1016/S0378-1119(97)00360-0; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	77	37	38	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					761	767		10.1038/ni1230	http://dx.doi.org/10.1038/ni1230			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034433				2022-12-18	WOS:000230646200016
J	Hayakawa, Y; Berzins, SP; Crowe, NY; Godfrey, DI; Smyth, MJ				Hayakawa, Y; Berzins, SP; Crowe, NY; Godfrey, DI; Smyth, MJ			RETRACTED: Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors (Retracted article. See vol 7, pg 890, 2006)	NATURE IMMUNOLOGY			English	Article; Retracted Publication							NK T-CELLS; ALPHA-GALACTOSYLCERAMIDE; SELECTIVE REDUCTION; CYTOKINE PRODUCTION; NEGATIVE SELECTION; BONE-MARROW; MICE; LYMPHOCYTES; CYTOTOXICITY; RECOGNITION	CD1d-restricted invariant natural killer T cell (iNKT cells) have a limited T cell receptor (TCR) repertoire and share characteristics common to T cells and natural killer cells. While intrathymic selection facilitates the production of T cells carrying self major histocompatibility complex-restricted TCRs, natural killer cells carry an appropriate repertoire of self major histocompatibility complex-recognizing receptors to avoid self-reactivity. Here we show that chronic exposure to specific glycolipid antigen resulted in iNKT cell disappearance and thymus-dependent repopulation of iNKT cells with increased expression of inhibitory Ly-49 molecules that resulted in impaired responsiveness. Thymic selection of peripheral Ly-49-expressing iNKT cell repertoire inhibited cytokine production and other functions in vivo. These observations emphasize the acquisition of self-recognizing inhibitory receptors on NKT cells as a previously unknown mechanism of thymic tolerance after chronic antigen exposure.	Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Peter Maccallum Cancer Center; University of Melbourne	Hayakawa, Y (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, St Andrews Pl, Melbourne, Vic 3002, Australia.	yoshihiro.hayakawa@petermac.org	Smyth, Mark/H-8709-2014	Smyth, Mark/0000-0001-7098-7240; Godfrey, Dale/0000-0002-3009-5472				Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Huard B, 2000, EUR J IMMUNOL, V30, P1665, DOI 10.1002/1521-4141(200006)30:6<1665::AID-IMMU1665>3.0.CO;2-2; Huard B, 2000, NATURE, V403, P325, DOI 10.1038/35002105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kojo S, 2001, ARTHRITIS RHEUM-US, V44, P1127, DOI 10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W; Korner H, 2000, J EXP MED, V191, P89, DOI 10.1084/jem.191.1.89; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; MacDonald HR, 1998, J EXP MED, V187, P2109, DOI 10.1084/jem.187.12.2109; MacDonald HR, 2002, SCIENCE, V296, P481, DOI 10.1126/science.1071492; Mieza MA, 1996, J IMMUNOL, V156, P4035; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Ortaldo JR, 1998, J IMMUNOL, V160, P1158; Pellicci DG, 2003, EUR J IMMUNOL, V33, P1816, DOI 10.1002/eji.200323894; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Singh N, 1999, J IMMUNOL, V163, P2373; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2002, CURR OPIN IMMUNOL, V14, P165, DOI 10.1016/S0952-7915(02)00316-3; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; TAKEDA K, 1993, J EXP MED, V177, P155, DOI 10.1084/jem.177.1.155; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Voyle RB, 2003, J EXP MED, V197, P919, DOI 10.1084/jem.20021615; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Yanagisawa K, 2002, J IMMUNOL, V168, P6494, DOI 10.4049/jimmunol.168.12.6494; Yang JQ, 2003, J IMMUNOL, V171, P4439, DOI 10.4049/jimmunol.171.8.4439; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; [No title captured]	49	37	39	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					590	596		10.1038/ni1069	http://dx.doi.org/10.1038/ni1069			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15122252				2022-12-18	WOS:000221664000017
J	Ma, YJ; Hendershot, LM				Ma, YJ; Hendershot, LM			The stressful road to antibody secretion	NATURE IMMUNOLOGY			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR XBP-1; PLASMA-CELL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; B-CELLS; ATF6; IRE1	Terminal B cell differentiation requires a massive increase in the biosynthetic capacity to synthesize antibodies in response to infection. New data shows the ER stress response activates and commits B cells to this robust metabolic state.	St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Ma, YJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Linda.Hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274				Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	12	37	42	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					310	311		10.1038/ni0403-310	http://dx.doi.org/10.1038/ni0403-310			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660729				2022-12-18	WOS:000181987700008
J	Bordignon, C; Roncarolo, MG				Bordignon, C; Roncarolo, MG			Therapeutic applications for hematopoietic stem cell gene transfer	NATURE IMMUNOLOGY			English	Editorial Material							BONE-MARROW; VECTORS; TRANSPLANTATION; LYMPHOCYTES; ENGRAFTMENT; DELIVERY; BETA		Univ Vita Salute San Raffaele, Ist Sci HS Raffaele, Canc Immunotherapy & Gene Therapy Program, HSR TIGET Genet Dis, I-20132 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bordignon, C (corresponding author), Univ Vita Salute San Raffaele, Ist Sci HS Raffaele, Canc Immunotherapy & Gene Therapy Program, HSR TIGET Genet Dis, Via Olgettina 58, I-20132 Milan, Italy.	claudio.bordignon@hsr.it		RONCAROLO, Maria Grazia/0000-0002-2193-9186	Telethon [TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Ardouin L, 1998, J EXP MED, V187, P105, DOI 10.1084/jem.187.1.105; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bordignon C, 1998, NAT MED, V4, P19, DOI 10.1038/nm0198-019; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; BRENNER MK, 1993, LANCET, V341, P85, DOI 10.1016/0140-6736(93)92560-G; Buchschacher GL, 2001, HUM GENE THER, V12, P1013, DOI 10.1089/104303401750214249; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Dallal RM, 2000, CURR OPIN IMMUNOL, V12, P583, DOI 10.1016/S0952-7915(00)00146-1; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HOEKZEMA R, 1985, J IMMUNOL, V135, P265; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; KOHN DB, 1995, NAT MED, V1, P1017, DOI 10.1038/nm1095-1017; Kohn DB, 1998, NAT MED, V4, P775, DOI 10.1038/nm0798-775; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Malech HL, 1997, P NATL ACAD SCI USA, V94, P12133, DOI 10.1073/pnas.94.22.12133; Mautino MR, 2001, J VIROL, V75, P3590, DOI 10.1128/JVI.75.8.3590-3599.2001; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Miller N, 1997, HUM GENE THER, V8, P803, DOI 10.1089/hum.1997.8.7-803; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pardoll DM, 2000, CLIN IMMUNOL, V95, pS44, DOI 10.1006/clim.1999.4819; RIZZARDI GP, 2002, HIV HUMAN VIRUS GUID, P300; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Takatoku M, 2001, J CLIN INVEST, V108, P447, DOI 10.1172/JCI12593; Tarner IH, 2001, CURR OPIN IMMUNOL, V13, P676, DOI 10.1016/S0952-7915(01)00278-3; TOMITA Y, 1994, J IMMUNOL, V153, P1087; Vandenbark AA, 1996, NAT MED, V2, P1109, DOI 10.1038/nm1096-1109; Yao QP, 2000, J GENE MED, V2, P210, DOI 10.1002/(SICI)1521-2254(200005/06)2:3<210::AID-JGM101>3.0.CO;2-P; ZHANG JW, 1995, J IMMUNOL, V155, P5868	30	37	39	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					318	321		10.1038/ni0402-318	http://dx.doi.org/10.1038/ni0402-318			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919567				2022-12-18	WOS:000174623600004
J	Berger, T; Kretzler, M				Berger, T; Kretzler, M			Interaction of DAP3 and FADD only after cellular disruption	NATURE IMMUNOLOGY			English	Letter									Univ Munich, Klin BIochem, D-80336 Munich, Germany	University of Munich	Kretzler, M (corresponding author), Univ Munich, Klin BIochem, Schillerstr 42, D-80336 Munich, Germany.		Berger, Thorsten/J-7632-2012					Berger T, 2000, J CELL SCI, V113, P3603; Hengen PN, 1997, TRENDS BIOCHEM SCI, V22, P33, DOI 10.1016/S0968-0004(96)30047-9; Hulkko SM, 2000, BIOCHEM J, V349, P885, DOI 10.1042/bj3490885; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Morgan CJ, 2001, BIOCHEM BIOPH RES CO, V280, P177, DOI 10.1006/bbrc.2000.4119; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200	9	37	37	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					3	4		10.1038/ni0102-3b	http://dx.doi.org/10.1038/ni0102-3b			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753396				2022-12-18	WOS:000173148700002
J	Chauss, D; Freiwald, T; McGregor, R; Yan, BY; Wang, LP; Nova-Lamperti, E; Kumar, D; Zhang, ZH; Teague, H; West, EE; Vannella, KM; Ramos-Benitez, MJ; Bibby, J; Kelly, A; Malik, A; Freeman, AF; Schwartz, DM; Portilla, D; Chertow, DS; John, S; Lavender, P; Kemper, C; Lombardi, G; Mehta, NN; Cooper, N; Lionakis, MS; Laurence, A; Kazemian, M; Afzali, B				Chauss, Daniel; Freiwald, Tilo; McGregor, Reuben; Yan, Bingyu; Wang, Luopin; Nova-Lamperti, Estefania; Kumar, Dhaneshwar; Zhang, Zonghao; Teague, Heather; West, Erin E.; Vannella, Kevin M.; Ramos-Benitez, Marcos J.; Bibby, Jack; Kelly, Audrey; Malik, Amna; Freeman, Alexandra F.; Schwartz, Daniella M.; Portilla, Didier; Chertow, Daniel S.; John, Susan; Lavender, Paul; Kemper, Claudia; Lombardi, Giovanna; Mehta, Nehal N.; Cooper, Nichola; Lionakis, Michail S.; Laurence, Arian; Kazemian, Majid; Afzali, Behdad			Autocrine vitamin D signaling switches off pro-inflammatory programs of T(H)1 cells	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; 1,25-DIHYDROXYVITAMIN D-3; COMPLEMENT ACTIVATION; SUPER-ENHANCERS; GENERATION; EXPRESSION; INTERLEUKIN-6; PSORIASIS; CYTOKINES; IMMUNITY	The molecular mechanisms governing orderly shutdown and retraction of CD4(+) type 1 helper T (T(H)1) cell responses remain poorly understood. Here we show that complement triggers contraction of T(H)1 responses by inducing intrinsic expression of the vitamin D (VitD) receptor and the VitD-activating enzyme CYP27B1, permitting T cells to both activate and respond to VitD. VitD then initiated the transition from pro-inflammatory interferon-gamma(+) T(H)1 cells to suppressive interleukin-10(+) cells. This process was primed by dynamic changes in the epigenetic landscape of CD4(+) T cells, generating super-enhancers and recruiting several transcription factors, notably c-JUN, STAT3 and BACH2, which together with VitD receptor shaped the transcriptional response to VitD. Accordingly, VitD did not induce interleukin-10 expression in cells with dysfunctional BACH2 or STAT3. Bronchoalveolar lavage fluid CD4(+) T cells of patients with COVID-19 were T(H)1-skewed and showed de-repression of genes downregulated by VitD, from either lack of substrate (VitD deficiency) and/or abnormal regulation of this system. During homeostasis T(H)1 cells activate a cell-intrinsic inflammatory shutdown program and shift to IL-10 production. Chauss et al. find that this T(H)1 homeostatic program is dependent on vitamin D signaling and is disrupted in severe COVID-19.	[Chauss, Daniel; Freiwald, Tilo; McGregor, Reuben; Kumar, Dhaneshwar; Portilla, Didier; Afzali, Behdad] NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Freiwald, Tilo] Goethe Univ, Univ Hosp Frankfurt, Dept Nephrol, Med Clin 3, Frankfurt, Germany; [McGregor, Reuben] Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland, New Zealand; [Yan, Bingyu; Kazemian, Majid] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Wang, Luopin; Kumar, Dhaneshwar; Kazemian, Majid] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Nova-Lamperti, Estefania] Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Mol & Translat Immunol Lab, Concepcion, Chile; [Zhang, Zonghao] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Teague, Heather; Mehta, Nehal N.] NHLBI, Lab Inflammat & Cardiometab Dis, NIH, Bldg 10, Bethesda, MD 20892 USA; [West, Erin E.; Bibby, Jack; Kemper, Claudia] NHLBI, Complement & Inflammat Res Sect, NIH, Bldg 10, Bethesda, MD 20892 USA; [Vannella, Kevin M.; Ramos-Benitez, Marcos J.; Chertow, Daniel S.] NIAID, Lab Immunoregulat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Vannella, Kevin M.; Ramos-Benitez, Marcos J.; Chertow, Daniel S.] NIH, Emerging Pathogens Sect, Crit Care Med Dept, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Kelly, Audrey; John, Susan; Lavender, Paul; Lombardi, Giovanna] Kings Coll London, Fac Life Sci & Med, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Malik, Amna; Cooper, Nichola] Imperial Coll London, Dept Med, London, England; [Freeman, Alexandra F.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Schwartz, Daniella M.] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Portilla, Didier] Univ Virginia, Div Nephrol, Charlottesville, VA USA; [Portilla, Didier] Univ Virginia, Ctr Immun Inflammat & Regenerat Med, Charlottesville, VA USA; [Kemper, Claudia] Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany; [Lionakis, Michail S.] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Laurence, Arian] Univ Oxford, Nuffield Dept Med, Oxford, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Auckland; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidad de Concepcion; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of London; King's College London; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Virginia; University of Virginia; University of Lubeck; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford	Afzali, B (corresponding author), NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA.; Kazemian, M (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Kazemian, M (corresponding author), Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA.	kazemian@purdue.edu; behdad.afzali@nih.gov	Lionakis, Michail/J-8840-2017; Afzali, Behdad/H-8565-2013	Lionakis, Michail/0000-0003-4994-9500; McGregor, Reuben/0000-0003-0684-7635; Chauss, Daniel/0000-0002-8343-0860; Freiwald, Tilo/0000-0002-4759-717X; Yan, Bingyu/0000-0003-4429-8200; Ramos-Benitez, Marcos J./0000-0001-9445-3294; Wang, Luopin/0000-0001-5758-4092; Afzali, Behdad/0000-0003-2968-1156	Wellcome Trust [097261/Z/11/Z]; Crohn's and Colitis Foundation of America [3765]; British Heart Foundation [RG/13/12/30395]; National Institute of General Medical Sciences [R35GM138283]; Showalter Trust; German Research Foundation (DFG scholarship) [FR 3851/2-1]; NIDDK [DK12262401A1]; National Agency of Research and Development of Chile [PAI79170073]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Intramural Research Programs of the NIDDK [ZIA/DK075149]; National Heart, Lung and Blood Institute [ZIA/Hl006223, ZIA/HL006193]; NIAID of the NIH [ZIA/AI001175]; NIH Office of Dietary Supplements research scholar award	Wellcome Trust(Wellcome Trust); Crohn's and Colitis Foundation of America; British Heart Foundation(British Heart Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Showalter Trust; German Research Foundation (DFG scholarship)(German Research Foundation (DFG)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Agency of Research and Development of Chile; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London(General Electric); Intramural Research Programs of the NIDDK; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of Dietary Supplements research scholar award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank patients who contributed samples for this study. We acknowledge G. Denisov and the NIH HPC (Biowulf) for their efforts in maintaining essential bioinformatic programs. We thank Q. Zhu, N. Liu, D. Janssens and S. Henikoff for critical discussions related to CUT&RUN experimentation and data analysis. This work was supported by the Wellcome Trust (grant 097261/Z/11/Z to B.A.), the Crohn's and Colitis Foundation of America (grant CCFA no. 3765 - CCFA genetics initiative to A.L.), British Heart Foundation (grant RG/13/12/30395 to G.L.), the National Institute of General Medical Sciences (R35GM138283 to M.K.), the Showalter Trust (research award to M.K.), German Research Foundation (DFG scholarship to T.F.; FR 3851/2-1), the NIDDK (DK12262401A1 to D.P.) and the National Agency of Research and Development of Chile (grant PAI79170073 to E.N.L.). Research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. This research was supported (in part) by the Intramural Research Programs of the NIDDK (project no. ZIA/DK075149 to B.A), the National Heart, Lung and Blood Institute (project nos. ZIA/Hl006223 to C.K. and ZIA/HL006193 to N.M.), the NIAID (project no. ZIA/AI001175 to M.S.L.) of the NIH. D.C. is supported by an NIH Office of Dietary Supplements research scholar award.	Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Akbar MR, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.660420; Alcala-Diaz JF, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061760; Armstrong AW, 2020, JAMA-J AM MED ASSOC, V323, P1945, DOI 10.1001/jama.2020.4006; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Break TJ, 2021, SCIENCE, V373, DOI 10.1126/science.abi8835; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6; Chen DJ, 2017, ONCOTARGET, V8, P62099, DOI 10.18632/oncotarget.19062; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Jin JO, 2013, J AUTOIMMUN, V40, P28, DOI 10.1016/j.jaut.2012.07.009; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kolev M, 2020, IMMUNITY, V52, P513, DOI 10.1016/j.immuni.2020.02.006; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Nogues X., 2021, J CLIN ENDOCR METAB, V106, pDGAB405; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Ohta R, 2011, MICROBIOL IMMUNOL, V55, P191, DOI 10.1111/j.1348-0421.2011.00309.x; Playford MP, 2019, ATHEROSCLEROSIS, V289, P44, DOI 10.1016/j.atherosclerosis.2019.08.006; Povoleri GAM, 2018, NAT IMMUNOL, V19, P1403, DOI 10.1038/s41590-018-0230-z; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramlall Vijendra, 2020, medRxiv, DOI 10.1101/2020.05.05.20092452; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; ROBBINS RA, 1987, AM REV RESPIR DIS, V135, P651; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rockx B, 2009, J VIROL, V83, P7062, DOI 10.1128/JVI.00127-09; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Schedel M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10213; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sinkovits G, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.663187; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Song JP, 2018, CARDIOVASC RES, V114, P870, DOI 10.1093/cvr/cvy034; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stubbington MJT, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0045-x; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; TURKSEN K, 1992, P NATL ACAD SCI USA, V89, P5068, DOI 10.1073/pnas.89.11.5068; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Wendling D, 2012, J RHEUMATOL, V39, P657, DOI 10.3899/jrheum.111166; West EE, 2018, ANNU REV IMMUNOL, V36, P309, DOI 10.1146/annurev-immunol-042617-053245; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Yan BY, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg0833; Yegorov S, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00166; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zhu Q, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1802-4	74	36	36	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					62	+		10.1038/s41590-021-01080-3	http://dx.doi.org/10.1038/s41590-021-01080-3		NOV 2021	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34764490	Bronze, Green Accepted			2022-12-18	WOS:000717408600001
J	Seo, H; Gonzalez-Avalos, E; Zhang, WD; Ramchandani, P; Yang, C; Lio, CWJ; Rao, A; Hogan, PG				Seo, Hyungseok; Gonzalez-Avalos, Edahi; Zhang, Wade; Ramchandani, Payal; Yang, Chao; Lio, Chan-Wang J.; Rao, Anjana; Hogan, Patrick G.			BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR IRF4; EFFECTOR; ACTIVATION; CALCIUM; CHECKPOINT; CHROMATIN; JUN	Chronic antigen stimulation leads to CD8(+) T cell exhaustion, which is mediated by persistent activation of the transcription factor NFAT in the absence of AP-1. Seo, Gonzalez-Avalos and colleagues show that overexpressed BATF cooperates with IRF4 to counteract NFAT-induced exhaustion and promote better tumor control by CAR T cells in mouse models. The transcription factors nuclear factor of activated T cells (NFAT) and activator protein 1 (AP-1; Fos-Jun) cooperate to promote the effector functions of T cells, but NFAT in the absence of AP-1 imposes a negative feedback program of T cell hyporesponsiveness (exhaustion). Here, we show that basic leucine zipper ATF-like transcription factor (BATF) and interferon regulatory factor 4 (IRF4) cooperate to counter T cell exhaustion in mouse tumor models. Overexpression of BATF in CD8(+) T cells expressing a chimeric antigen receptor (CAR) promoted the survival and expansion of tumor-infiltrating CAR T cells, increased the production of effector cytokines, decreased the expression of inhibitory receptors and the exhaustion-associated transcription factor TOX and supported the generation of long-lived memory T cells that controlled tumor recurrence. These responses were dependent on BATF-IRF interaction, since cells expressing a BATF variant unable to interact with IRF4 did not survive in tumors and did not effectively delay tumor growth. BATF may improve the antitumor responses of CAR T cells by skewing their phenotypes and transcriptional profiles away from exhaustion and towards increased effector function.	[Seo, Hyungseok; Gonzalez-Avalos, Edahi; Zhang, Wade; Ramchandani, Payal; Yang, Chao; Lio, Chan-Wang J.; Rao, Anjana; Hogan, Patrick G.] La Jolla Inst Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Gonzalez-Avalos, Edahi] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Zhang, Wade] Univ Calif San Diego, Bioengn Grad Program, Bioengn Dept, La Jolla, CA 92093 USA; [Ramchandani, Payal] Univ Calif San Diego, Contiguous BS MS Program, Biol Dept, La Jolla, CA 92093 USA; [Rao, Anjana] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Rao, Anjana; Hogan, Patrick G.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Rao, Anjana; Hogan, Patrick G.] La Jolla Inst Immunol, Ctr Canc Immunotherapy, La Jolla, CA 92037 USA; [Seo, Hyungseok; Ramchandani, Payal] Novartis Inst BioMed Res, Cambridge, MA USA; [Lio, Chan-Wang J.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; La Jolla Institute for Immunology; Novartis; University System of Ohio; Ohio State University	Rao, A; Hogan, PG (corresponding author), La Jolla Inst Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA.; Rao, A (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Rao, A (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.; Rao, A; Hogan, PG (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.; Rao, A; Hogan, PG (corresponding author), La Jolla Inst Immunol, Ctr Canc Immunotherapy, La Jolla, CA 92037 USA.	arao@lji.org; phogan@lji.org		Lio, Jerry/0000-0003-3876-6741; Rao, Anjana/0000-0002-1870-1775				Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; *BIIOC COR TEAM, 2015, MUS MUSC ANN PACK MU; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; *BRAOD I, 2018, PIC TOOLK; Chang YMK, 2018, BMC MOL BIOL, V19, DOI 10.1186/s12867-018-0106-7; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Pham D, 2019, CELL REP, V29, P1203, DOI 10.1016/j.celrep.2019.09.064; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Grenningloh R, 2011, J IMMUNOL, V186, P969, DOI 10.4049/jimmunol.1002099; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hogan PG, 2017, CELL CALCIUM, V63, P66, DOI 10.1016/j.ceca.2017.01.014; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hooijberg E, 2000, BLOOD, V96, P459; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Krueger F., 2015, TRIM GALORE WRAPPER; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JJ, 2018, FRONT NEUROL, V9, P1, DOI 10.3389/fneur.2018.00623; Li P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02738; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; *MATHWORKS, 2010, MATLAB V7 10 0; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Pereira RM, 2017, J LEUKOCYTE BIOL, V102, P601, DOI 10.1189/jlb.2RI0317-097R; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Su S, 2017, BIOINFORMATICS, V33, P2050, DOI 10.1093/bioinformatics/btx094; Team R.C, 2015, R LANG ENV STAT COMP; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wickham H., 2016, GGPLOT2 USE R, V1st, P147, DOI [10.1007/978-3-319-24277-4_7, DOI 10.1007/978-3-319-24277-4_7]; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	80	36	36	6	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					983	+		10.1038/s41590-021-00964-8	http://dx.doi.org/10.1038/s41590-021-00964-8		JUL 2021	40	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34282330	Bronze, Green Accepted			2022-12-18	WOS:000674567000005
J	Nitta, T; Tsutsumi, M; Nitta, S; Muro, R; Suzuki, EC; Nakano, K; Tomofuji, Y; Sawa, S; Okamura, T; Penninger, JM; Takayanagi, H				Nitta, Takeshi; Tsutsumi, Masanori; Nitta, Sachiko; Muro, Ryunosuke; Suzuki, Emma C.; Nakano, Kenta; Tomofuji, Yoshihiko; Sawa, Shinichiro; Okamura, Tadashi; Penninger, Josef M.; Takayanagi, Hiroshi			Fibroblasts as a source of self-antigens for central immune tolerance	NATURE IMMUNOLOGY			English	Article							PROMISCUOUS GENE-EXPRESSION; THYMIC EPITHELIAL-CELLS; MESENCHYMAL CELLS; RETICULAR CELLS; AIRE; MICE; DIFFERENTIATION; GENERATION; PROTEIN; RANK	Fibroblasts are one of the most common but also neglected types of stromal cells, the heterogeneity of which underlies the specific function of tissue microenvironments in development and regeneration. In the thymus, autoreactive T cells are thought to be negatively selected by reference to the self-antigens expressed in medullary epithelial cells, but the contribution of other stromal cells to tolerance induction has been poorly examined. In the present study, we report a PDGFR(+)gp38(+)DPP4(-)thymic fibroblast subset that is required for T cell tolerance induction. The deletion of the lymphotoxin beta-receptor in thymic fibroblasts caused an autoimmune phenotype with decreased expression of tissue-restricted and fibroblast-specific antigens, offering insight into the long-sought target of lymphotoxin signaling in the context of the regulation of autoimmunity. Thus, thymic medullary fibroblasts play an essential role in the establishment of central tolerance by producing a diverse array of self-antigens. Takayanagi and colleagues show that thymic medullary fibroblasts can contribute to central tolerance mechanisms by expressing cell-type-specific antigens distinct from those expressed by medullary thymic epithelial cells.	[Nitta, Takeshi; Tsutsumi, Masanori; Nitta, Sachiko; Muro, Ryunosuke; Suzuki, Emma C.; Tomofuji, Yoshihiko; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Nitta, Takeshi; Tsutsumi, Masanori; Nitta, Sachiko; Muro, Ryunosuke; Suzuki, Emma C.; Tomofuji, Yoshihiko; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo, Japan; [Nakano, Kenta; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo, Japan; [Sawa, Shinichiro] Kyushu Univ, Res Ctr Syst Immunol, Med Inst Bioregulat, Div Mucosal Immunol, Fukuoka, Japan; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, Vienna, Austria; [Penninger, Josef M.] Univ British Columbia, Life Sci Inst, Vancouver, BC, Canada	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan; Kyushu University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of British Columbia	Nitta, T; Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan.; Nitta, T; Takayanagi, H (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	nit-im@m.u-tokyo.ac.jp; takayana@m.u-tokyo.ac.jp	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sawa, Shinichiro/0000-0002-8850-446X	Japan Society for Promotion of Science [KAKENHI 15H05703, 16H05202, 17H05788, 19H03485, 19H04802]; CREST program of the Japan Agency for Medical Research and Development [20gm1210008]; Tokyo Society of Medical Science; National Center for Global Health and Medicine [26-105, 29-1001]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST program of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Tokyo Society of Medical Science; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	We thank K. Kubo, Y. Nakayama, R. Yanobu-Takanashi, K. Kaneki, Y. Yoshitomi, R. Sakuma, S. Igaue, K. Ikeda, T. Iguchi, N. C-N. Huynh, M. Tsukasaki and A. Ota for technical assistance and all laboratory members for insightful discussions. Special thanks to N. Akiyama and T. Akiyama for technical support in thymus transplant experiments. This work was supported by the Japan Society for Promotion of Science (grant nos. KAKENHI 15H05703 to H.T. and 16H05202, 17H05788, 19H03485 and 19H04802 to T.N.), the CREST program of the Japan Agency for Medical Research and Development (grant no. 20gm1210008 to H.T.), the Tokyo Society of Medical Science (to T.N.) and the National Center for Global Health and Medicine (grant nos. 26-105 and 29-1001 to T.O.).	Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; Chen YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12446-5; Chin RK, 2006, J IMMUNOL, V177, P290, DOI 10.4049/jimmunol.177.1.290; Cosway EJ, 2017, J EXP MED, V214, P3183, DOI 10.1084/jem.20171000; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Fuertbauer E, 2013, IMMUNOL LETT, V154, P31, DOI 10.1016/j.imlet.2013.07.007; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Itoi M, 2007, INT IMMUNOL, V19, P953, DOI 10.1093/intimm/dxm060; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kedl RM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02247-z; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Lynch MD, 2018, J CLIN INVEST, V128, P26, DOI 10.1172/JCI93555; Martins VC, 2008, J IMMUNOL, V181, P400, DOI 10.4049/jimmunol.181.1.400; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mouri Y, 2011, J IMMUNOL, V186, P5047, DOI 10.4049/jimmunol.1003533; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Nitta T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5165; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; Nitta Takeshi, 2013, Methods Mol Biol, V946, P85, DOI 10.1007/978-1-62703-128-8_6; Odaka C, 2009, J HISTOCHEM CYTOCHEM, V57, P373, DOI 10.1369/jhc.2008.952895; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Seach N, 2008, J IMMUNOL, V180, P5384, DOI 10.4049/jimmunol.180.8.5384; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; St-Pierre C, 2015, J IMMUNOL, V195, P498, DOI 10.4049/jimmunol.1500558; Sun LN, 2015, SCI REP-UK, V5, DOI 10.1038/srep14871; Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051; Takahama Y, 2017, NAT REV IMMUNOL, V17, P295, DOI 10.1038/nri.2017.12; Tomofuji Y, 2020, NAT IMMUNOL, V21, P892, DOI 10.1038/s41590-020-0717-2; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VANVLIET E, 1984, EUR J IMMUNOL, V14, P524, DOI 10.1002/eji.1830140608; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; Wohlfahrt T, 2019, NATURE, V566, P344, DOI 10.1038/s41586-019-0896-x; Wu WW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44481	56	36	37	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1172	+		10.1038/s41590-020-0756-8	http://dx.doi.org/10.1038/s41590-020-0756-8		AUG 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32839611				2022-12-18	WOS:000562393000002
J	Zhang, BC; Nandakumar, R; Reinert, LS; Huang, JR; Laustsen, A; Gao, ZL; Sun, CL; Jensen, SB; Troldborg, A; Assil, S; Berthelsen, MF; Scavenius, C; Zhang, Y; Windross, SJ; Olagnier, D; Prabakaran, T; Bodda, C; Narita, R; Cai, YJ; Zhang, CG; Stenmark, H; Doucet, CM; Noda, T; Guo, Z; Goldbach-Mansky, R; Hartmann, R; Chen, ZJJ; Enghild, JJ; Bak, RO; Thomsen, MK; Paludan, SR				Zhang, Bao-cun; Nandakumar, Ramya; Reinert, Line S.; Huang, Jinrong; Laustsen, Anders; Gao, Zong-liang; Sun, Cheng-long; Jensen, Soren Beck; Troldborg, Anne; Assil, Sonia; Berthelsen, Martin F.; Scavenius, Carsten; Zhang, Yan; Windross, Samuel J.; Olagnier, David; Prabakaran, Thaneas; Bodda, Chiranjeevi; Narita, Ryo; Cai, Yujia; Zhang, Cong-gang; Stenmark, Harald; Doucet, Christine M.; Noda, Takeshi; Guo, Zheng; Goldbach-Mansky, Raphaela; Hartmann, Rune; Chen, Zhijian J.; Enghild, Jan J.; Bak, Rasmus O.; Thomsen, Martin K.; Paludan, Soren R.			STEEP mediates STING ER exit and activation of signaling	NATURE IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; INNATE IMMUNITY; DNA VIRUSES; ADAPTER; TRANSLOCATION; PHOSPHORYLATION; 2ND-MESSENGER; AUTOPHAGY; SYNTHASE	STING ER exit is the rate-limiting step in STING signaling, but the mechanism that drives this process is not understood. Paludan and colleagues identify CxORF56, called STEEP here, as a positive regulator of STING signaling. STING is essential for control of infections and for tumor immunosurveillance, but it can also drive pathological inflammation. STING resides on the endoplasmic reticulum (ER) and traffics following stimulation to the ERGIC/Golgi, where signaling occurs. Although STING ER exit is the rate-limiting step in STING signaling, the mechanism that drives this process is not understood. Here we identify STEEP as a positive regulator of STING signaling. STEEP was associated with STING and promoted trafficking from the ER. This was mediated through stimulation of phosphatidylinositol-3-phosphate (PtdIns(3)P) production and ER membrane curvature formation, thus inducing COPII-mediated ER-to-Golgi trafficking of STING. Depletion of STEEP impaired STING-driven gene expression in response to virus infection in brain tissue and in cells from patients with STING-associated diseases. Interestingly, STING gain-of-function mutants from patients interacted strongly with STEEP, leading to increased ER PtdIns(3)P levels and membrane curvature. Thus, STEEP enables STING signaling by promoting ER exit.	[Zhang, Bao-cun; Nandakumar, Ramya; Reinert, Line S.; Huang, Jinrong; Laustsen, Anders; Gao, Zong-liang; Sun, Cheng-long; Jensen, Soren Beck; Troldborg, Anne; Assil, Sonia; Berthelsen, Martin F.; Windross, Samuel J.; Olagnier, David; Prabakaran, Thaneas; Bodda, Chiranjeevi; Narita, Ryo; Cai, Yujia; Bak, Rasmus O.; Thomsen, Martin K.; Paludan, Soren R.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Huang, Jinrong] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Troldborg, Anne; Berthelsen, Martin F.; Thomsen, Martin K.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Troldborg, Anne] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark; [Scavenius, Carsten; Narita, Ryo; Hartmann, Rune; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Zhang, Yan; Guo, Zheng] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Zhang, Cong-gang; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Ctr Inflammat Res, Dallas, TX 75390 USA; [Zhang, Cong-gang; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA; [Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Doucet, Christine M.] Univ Montpellier, Ctr Biochim Struct CBS, CNRS, INSERM, Montpellier, France; [Noda, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Goldbach-Mansky, Raphaela] NIAID, Translat Autoinflammatory Dis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bak, Rasmus O.] Aarhus Univ, Aarhus Inst Adv Studies AIAS, Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oslo; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Aarhus University	Paludan, SR (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	srp@biomed.au.dk	Thomsen, Martin/AAU-5014-2021; Huang, Jinrong/AAV-1225-2021; Bak, Rasmu/GLT-3180-2022; Bak, Rasmus O./AAH-9748-2021; Stenmark, Harald/B-8868-2008; Noda, Takeshi/B-7240-2008; Scavenius, Carsten/Q-5941-2017	Thomsen, Martin/0000-0002-5055-7531; Huang, Jinrong/0000-0001-8085-9939; Bak, Rasmu/0000-0002-8257-8986; Bak, Rasmus O./0000-0002-7383-0297; Noda, Takeshi/0000-0003-3581-7961; Scavenius, Carsten/0000-0002-4304-0681; Doucet, Christine/0000-0002-1611-8279; Olagnier, David/0000-0001-6912-0674; Prabakaran, Thaneas/0000-0002-4698-7563; Assil, Sonia/0000-0001-7765-2953; Zhang, Bao-cun/0000-0001-6104-0848; Troldborg, Anne/0000-0002-9501-1268; Reinert, Line/0000-0002-8317-0886; Hartmann, Rune/0000-0003-1159-066X	European Research Council (ERC-AdG ENVISION) [786602]; Novo Nordisk Foundation [NNF18OC0030274]; Lundbeck Foundation [R198-2015-171, R268-2016-3927, R264-2017-3344]; Danish Council for Independent Research, Medical Sciences [5053-00083B]; European Union under the Horizon 2020 Research and Innovation Program; European Union under Marie Sklodowska-Curie Actions (MSCA) -international fellowship [PathAutoBio 796840]; MSCA-Innovative Training Networks Programme MSCA-ITN (EDGE) [675278]	European Research Council (ERC-AdG ENVISION); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); European Union under the Horizon 2020 Research and Innovation Program; European Union under Marie Sklodowska-Curie Actions (MSCA) -international fellowship; MSCA-Innovative Training Networks Programme MSCA-ITN (EDGE)	The technical assistance of K. S. Petersen, the AU FACS Core Facility and the AU Health Bioimaging Core Facility is greatly appreciated. We acknowledge T. Melia, Yale University, for critical reading of the manuscript. This work was funded by the European Research Council (ERC-AdG ENVISION; 786602), the Novo Nordisk Foundation (NNF18OC0030274) and the Lundbeck Foundation (R198-2015-171; R268-2016-3927); B.-c.Z. is funded by a postdoctoral grant from the Danish Council for Independent Research, Medical Sciences (5053-00083B); the postdoctoral salary to S.A. was funded by the European Union under the Horizon 2020 Research and Innovation Program and Marie Sklodowska-Curie Actions (MSCA) -international fellowship (PathAutoBio 796840); the PhD scholarship to S.J.W. was funded by the European Union under the Horizon 2020 Research and Innovation Program and the MSCA-Innovative Training Networks Programme MSCA-ITN (EDGE, 675278); the postdoctoral grant to A.T. was funded by the Lundbeck Foundation (R264-2017-3344).	An J, 2017, ARTHRITIS RHEUMATOL, V69, P800, DOI 10.1002/art.40002; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Ge L, 2014, ELIFE, V3, DOI 10.7554/eLife.04135; Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hanna MG, 2016, J BIOL CHEM, V291, P1014, DOI 10.1074/jbc.M115.672287; Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915; He SS, 2013, NAT CELL BIOL, V15, P1206, DOI 10.1038/ncb2848; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hirama T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01554-9; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jongsma MLM, 2016, CELL, V166, P152, DOI 10.1016/j.cell.2016.05.078; Kawasaki T, 2013, CELL HOST MICROBE, V14, P148, DOI 10.1016/j.chom.2013.07.011; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Ni GX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7119; Ogawa E, 2018, BIOCHEM BIOPH RES CO, V503, P138, DOI 10.1016/j.bbrc.2018.05.199; Paludan SR, 2019, NAT REV IMMUNOL, V19, P141, DOI 10.1038/s41577-018-0117-0; Paludan SR, 2015, MICROBIOL MOL BIOL R, V79, P225, DOI 10.1128/MMBR.00061-14; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun MS, 2018, CELL REP, V25, P3086, DOI 10.1016/j.celrep.2018.11.048; Szappanos D, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007397; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wei J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007336; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04759-8	54	36	37	5	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					868	+		10.1038/s41590-020-0730-5	http://dx.doi.org/10.1038/s41590-020-0730-5		JUL 2020	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32690950	Green Submitted, Green Accepted			2022-12-18	WOS:000550625000002
J	Wan, XX; Vomund, AN; Peterson, OJ; Chervonsky, AV; Lichti, CF; Unanue, ER				Wan, Xiaoxiao; Vomund, Anthony N.; Peterson, Orion J.; Chervonsky, Alexander V.; Lichti, Cheryl F.; Unanue, Emil R.			The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides	NATURE IMMUNOLOGY			English	Article							CD4 T-CELLS; A BETA-CHAIN; NONENZYMATIC DEAMIDATION; LYMPH-NODES; INSULIN; ANTIGEN; SPECIFICITY; EPITOPE; MOUSE; MICE	The nature of autoantigens that trigger autoimmune diseases has been much discussed, but direct biochemical identification is lacking for most. Addressing this question demands unbiased examination of the self-peptides displayed by a defined autoimmune major histocompatibility complex class II (MHC-II) molecule. Here, we examined the immunopeptidome of the pancreatic islets in non-obese diabetic mice, which spontaneously develop autoimmune diabetes based on the I-A(g7) variant of MHC-II. The relevant peptides that induced pathogenic CD4(+) T cells at the initiation of diabetes derived from proinsulin. These peptides were also found in the MHC-II peptidome of the pancreatic lymph nodes and spleen. The proinsulin-derived peptides followed a trajectory from their generation and exocytosis in beta cells to uptake and presentation in islets and peripheral sites. Such a pathway generated conventional epitopes but also resulted in the presentation of post-translationally modified peptides, including deamidated sequences. These analyses reveal the key features of a restricted component in the self-MHC-II peptidome that caused autoreactivity. Unanue and colleagues examine the immunopeptidome of pancreatic islets in non-obese diabetic (NOD) mice, which spontaneously develop autoimmune diabetes, to reveal the key features of a restricted component in the self-MHC-II peptidome that causes autoreactivity.	[Wan, Xiaoxiao; Vomund, Anthony N.; Peterson, Orion J.; Lichti, Cheryl F.; Unanue, Emil R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Wan, Xiaoxiao; Vomund, Anthony N.; Peterson, Orion J.; Lichti, Cheryl F.; Unanue, Emil R.] Washington Univ, Sch Med, Bursky Ctr Human Immunol & Immunotherapy, St Louis, MO 63130 USA; [Chervonsky, Alexander V.] Univ Chicago, Sch Med, Dept Pathol, Chicago, IL 60637 USA	Washington University (WUSTL); Washington University (WUSTL); University of Chicago	Lichti, CF; Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Lichti, CF; Unanue, ER (corresponding author), Washington Univ, Sch Med, Bursky Ctr Human Immunol & Immunotherapy, St Louis, MO 63130 USA.	clichti@wustl.edu; unanue@wustl.edu	Wan, Xiaoxiao/AAO-9209-2020	Lichti, Cheryl/0000-0003-4099-4954	National Institutes of Health [DK120340, DK058177, AI114551]; Juvenile Diabetes Research Foundation; Kilo Diabetes and Vascular Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Kilo Diabetes and Vascular Research Foundation	Members of the Unanue laboratory provided advice on many aspects of this project. We thank K. Frederick for maintaining the animal colony, P. Zakharov for assistance in prediction of the MHC-II epitopes and M. Gross for advice on mass spectrometry. This study is supported by grants from the National Institutes of Health (DK120340, DK058177 and AI114551), Juvenile Diabetes Research Foundation and Kilo Diabetes and Vascular Research Foundation.	ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Andreatta M, 2017, NUCLEIC ACIDS RES, V45, pW458, DOI 10.1093/nar/gkx248; Babad J, 2010, IMMUNOLOGY, V131, P459, DOI 10.1111/j.1365-2567.2010.03362.x; Babon JAB, 2016, NAT MED, V22, P1482, DOI 10.1038/nm.4203; Berkers CR, 2009, INT J BIOCHEM CELL B, V41, P66, DOI 10.1016/j.biocel.2008.08.036; Chang KY, 2009, INT IMMUNOL, V21, P705, DOI 10.1093/intimm/dxp039; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Ebstein F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24032; Faridi P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700464; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gioia L, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw6329; Halbout P, 2002, J IMMUNOL, V169, P2436, DOI 10.4049/jimmunol.169.5.2436; Han X, 2011, J PROTEOME RES, V10, P2930, DOI 10.1021/pr200153k; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Kelemen K, 2001, DIABETES, V50, P1729, DOI 10.2337/diabetes.50.8.1729; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Levisetti MG, 2008, DIABETES, V57, P1852, DOI 10.2337/db08-0068; Levisetti MG, 2004, DIABETES, V53, P3115, DOI 10.2337/diabetes.53.12.3115; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; Marre ML, 2018, DIABETES, V67, P1356, DOI 10.2337/db17-1166; Michels AW, 2017, DIABETES, V66, P722, DOI 10.2337/db16-1025; Mishto M, 2017, TRENDS IMMUNOL, V38, P904, DOI 10.1016/j.it.2017.07.011; MIYAZAKI T, 1990, NATURE, V345, P722, DOI 10.1038/345722a0; Mohan JF, 2013, J EXP MED, V210, P2403, DOI 10.1084/jem.20130582; Mohan JF, 2012, NAT REV IMMUNOL, V12, P721, DOI 10.1038/nri3294; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Singer SM, 1998, DIABETES, V47, P1570, DOI 10.2337/diabetes.47.10.1570; So M, 2018, P NATL ACAD SCI USA, V115, P10732, DOI 10.1073/pnas.1809208115; Sofron A, 2016, EUR J IMMUNOL, V46, P319, DOI 10.1002/eji.201545930; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; Tai NW, 2016, J EXP MED, V213, P2129, DOI 10.1084/jem.20160526; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Unanue ER, 2016, IMMUNOL REV, V272, P183, DOI 10.1111/imr.12430; Unanue ER, 2014, ANNU REV IMMUNOL, V32, P579, DOI 10.1146/annurev-immunol-032712-095941; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Wan X, 2018, NATURE, V560, P107, DOI 10.1038/s41586-018-0341-6; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wiles TA, 2019, J PROTEOME RES, V18, P814, DOI 10.1021/acs.jproteome.8b00875; Wiles TA, 2017, J AUTOIMMUN, V78, P11, DOI 10.1016/j.jaut.2016.10.007; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	51	36	36	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					455	+		10.1038/s41590-020-0623-7	http://dx.doi.org/10.1038/s41590-020-0623-7		MAR 2020	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32152506	Green Accepted			2022-12-18	WOS:000518737000003
J	Wang, YT; Lifshitz, L; Gellatly, K; Vinton, CL; Busman-Sahay, K; McCauley, S; Vangala, P; Kim, K; Derr, A; Jaiswal, S; Kucukural, A; McDonel, P; Hunt, PW; Greenough, T; Houghton, J; Somsouk, M; Estes, JD; Brenchley, JM; Garber, M; Deeks, SG; Luban, J				Wang, Yetao; Lifshitz, Lawrence; Gellatly, Kyle; Vinton, Carol L.; Busman-Sahay, Kathleen; McCauley, Sean; Vangala, Pranitha; Kim, Kyusik; Derr, Alan; Jaiswal, Smita; Kucukural, Alper; McDonel, Patrick; Hunt, Peter W.; Greenough, Thomas; Houghton, JeanMarie; Somsouk, Ma; Estes, Jacob D.; Brenchley, Jason M.; Garber, Manuel; Deeks, Steven G.; Luban, Jeremy			HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells	NATURE IMMUNOLOGY			English	Article							INTERFERON-GAMMA; GENE-EXPRESSION; SELF-RENEWAL; ACTIVATION; DIFFERENTIATION; INFLAMMATION; PROGENITORS; INFECTION; SUBSET; TCF-1	HIV-1 infection is associated with persistent inflammation that can contribute to a variety of comorbidities. Luban and colleagues demonstrate that HIV-1 infection results in permanent depletion of innate lymphoid cells, leading to breakdown of gut barrier function and a feed-forward inflammation loop, which includes skewing of NK cells toward an inflammatory/memory phenotype. Human immunodeficiency virus 1 (HIV-1) infection is associated with heightened inflammation and excess risk of cardiovascular disease, cancer and other complications. These pathologies persist despite antiretroviral therapy. In two independent cohorts, we found that innate lymphoid cells (ILCs) were depleted in the blood and gut of people with HIV-1, even with effective antiretroviral therapy. ILC depletion was associated with neutrophil infiltration of the gut lamina propria, type 1 interferon activation, increased microbial translocation and natural killer (NK) cell skewing towards an inflammatory state, with chromatin structure and phenotype typical of WNT transcription factor TCF7-dependent memory T cells. Cytokines that are elevated during acute HIV-1 infection reproduced the ILC and NK cell abnormalities ex vivo. These results show that inflammatory cytokines associated with HIV-1 infection irreversibly disrupt ILCs. This results in loss of gut epithelial integrity, microbial translocation and memory NK cells with heightened inflammatory potential, and explains the chronic inflammation in people with HIV-1.	[Wang, Yetao; Lifshitz, Lawrence; McCauley, Sean; Kim, Kyusik; Jaiswal, Smita; Greenough, Thomas; Garber, Manuel; Luban, Jeremy] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Gellatly, Kyle; Vangala, Pranitha; Derr, Alan; Kucukural, Alper; McDonel, Patrick; Garber, Manuel] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Vinton, Carol L.; Brenchley, Jason M.] NIAID, Barrier Immun Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Busman-Sahay, Kathleen; Estes, Jacob D.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Busman-Sahay, Kathleen; Estes, Jacob D.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Hunt, Peter W.; Somsouk, Ma; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Houghton, JeanMarie] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Luban, Jeremy] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luban, J (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.; Luban, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	jeremy.luban@umassmed.edu	Hunt, Peter W./P-2976-2017; Kucukural, Alper/T-3563-2018	Hunt, Peter W./0000-0002-4571-4870; Kucukural, Alper/0000-0001-9983-394X; Brenchley, Jason/0000-0001-8357-2984; Kim, Kyusik/0000-0001-9217-673X; McDonel, Patrick/0000-0002-5254-3635; Deeks, Steven/0000-0001-6371-747X; Gellatly, Kyle/0000-0003-3500-2025; Busman-Sahay, Kathleen/0000-0002-8549-0023; Wang, Yetao/0000-0001-8101-5455; Luban, Jeremy/0000-0001-5650-4054	NIH [U01HG007910, R37AI147868, R01AI111809, DP1DA034990, R21AI119885, R01DK105837, P51OD01192]; Translational Medicine Core of the University of Massachusetts Center for AIDS Research [P30 AI042845]; UCSF/Gladstone Institute of Virology and Immunology CFAR [P30 AI027763]; CFAR Network of Integrated Systems [R24 AI067039]; Delaney AIDS Research Enterprise [AI096109, AI127966]; Division of Intramural Research/NIAID/NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Medicine Core of the University of Massachusetts Center for AIDS Research; UCSF/Gladstone Institute of Virology and Immunology CFAR; CFAR Network of Integrated Systems; Delaney AIDS Research Enterprise; Division of Intramural Research/NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the study participants who provided blood and colon biopsy samples, as well as their caretakers, J. Daly, S. Cheeseman and M. Wessolossky of the UMMS. C. Mannarino, A. Foley, M. McManus (UMMS) and M. Krone (UCSF) provided Institutional Review Board regulatory assistance, sample preparation and record keeping. K. Luzuriaga (UMMS) supported the patient sample database and repository. A. Ratner, S. Boswell and A. Klein (Harvard Medical School) contributed technical assistance and barcoded hydrogel beads. T. Fazzio and T. Wu provided technical support and protein A-MNase for CUT&RUN. D. Artis, L. Berg, M. Colonna, J. Huh, J. Kang, R. Rutishauser and S. Swain offered invaluable advice. This research was supported by NIH grants U01HG007910 (to M.G. and J.L.), R37AI147868 (to J.L.), R01AI111809 (to J.L.), DP1DA034990 (to J.L.), R21AI119885 (to M.G.), R01DK105837 (to M.G.) and P51OD01192 (to J.D.E. at the Oregon National Primate Research Center), and the Translational Medicine Core of the University of Massachusetts Center for AIDS Research (P30 AI042845). The UCSF-based SCOPE cohort was supported by the UCSF/Gladstone Institute of Virology and Immunology CFAR (P30 AI027763) and the CFAR Network of Integrated Systems (R24 AI067039). Additional support was provided by the Delaney AIDS Research Enterprise (AI096109 and AI127966). Funding for this study was provided in part by the Division of Intramural Research/NIAID/NIH (to J.M.B.). The content of this publication does not necessarily reflect the views or policies of DHHS, nor does the mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Aksoy I, 2007, STEM CELLS, V25, P2996, DOI 10.1634/stemcells.2007-0066; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Bruel T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10844; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Davis ZB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005421; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Derr A, 2016, GENOME RES, V26, P1397, DOI 10.1101/gr.207902.116; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; Fregni G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-33; Gazit R, 2004, BLOOD, V103, P1965, DOI 10.1182/blood-2003-11-3796; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Hainer SJ, 2019, CELL, V177, P1319, DOI 10.1016/j.cell.2019.03.014; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hechenbichler K., 2004, DISCUSSION PAPER 399, V386; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Liu LL, 2016, CELL REP, V15, P1088, DOI 10.1016/j.celrep.2016.04.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Mudd JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05528-3; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sconocchia G, 1997, BLOOD, V90, P716, DOI 10.1182/blood.V90.2.716.716_716_725; Shin HM, 2013, IMMUNITY, V39, P661, DOI 10.1016/j.immuni.2013.08.032; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Thomas R, 2012, AIDS RES HUM RETROV, V28, P844, DOI [10.1089/aid.2011.0253, 10.1089/AID.2011.0253]; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Walker W, 1999, J IMMUNOL, V162, P5894; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	70	36	36	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					274	+		10.1038/s41590-020-0593-9	http://dx.doi.org/10.1038/s41590-020-0593-9		FEB 2020	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066947	Green Submitted, Green Accepted			2022-12-18	WOS:000514067400008
J	Chen, ELY; Thompson, PK; Zuniga-Pflucker, JC				Chen, Edward L. Y.; Thompson, Patrycja K.; Zuniga-Pflucker, Juan Carlos			RBPJ-dependent Notch signaling initiates the T cell program in a subset of thymus-seeding progenitors	NATURE IMMUNOLOGY			English	Article							BETA-SELECTION CHECKPOINT; HEMATOPOIETIC PROGENITORS; LINEAGE COMMITMENT; B-CELL; EMBRYONIC LETHALITY; C/EBP-ALPHA; TRANSCRIPTION; DIFFERENTIATION; EXPRESSION; MOUSE	T cell specification and commitment require Notch signaling. Although the requirement for Notch signaling during intrathymic T cell development is known, it is still unclear whether the onset of T cell priming can occur in a prethymic niche and whether RBPJ-dependent Notch signaling has a role during this event. Here, we established an Rbpj-inducible system that allowed temporal and tissue-specific control of the responsiveness to Notch in all hematopoietic cells. Using this system, we found that Notch signaling was required before the early T cell progenitor stage in the thymus. Lymphoid-primed multipotent progenitors in the bone marrow underwent Notch signaling with Rbpj induction, which inhibited development towards the myeloid lineage in thymus-seeding progenitors. Thus, our results indicated that the onset of T cell differentiation occurred in a prethymic setting, and that Notch played an important role during this event.	[Chen, Edward L. Y.; Thompson, Patrycja K.; Zuniga-Pflucker, Juan Carlos] Sunnybrook Res Inst, Toronto, ON, Canada; [Chen, Edward L. Y.; Thompson, Patrycja K.; Zuniga-Pflucker, Juan Carlos] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Zuniga-Pflucker, JC (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.; Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	jczp@sri.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178	Canadian Institutes of Health Research [MOP-119538, FND-154332]; National Institutes of Health [NIH-1P01AI102853-01]; Krembil Foundation; Ontario Graduate Scholarship; Banting and Best Doctoral Research Award; Canada Research Chair in Developmental Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102853] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krembil Foundation; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting and Best Doctoral Research Award; Canada Research Chair in Developmental Immunology(Canada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to G. Awong and C. McIntosh for expertise and assistance in flow cytometry and cell sorting, and to C. Lee and L. Wells for assistance with animal care. We are thankful to R. Dickson and T. McGaha for assistance with the single-cell RNA-Seq analysis, and M. K. Anderson for helpful discussions and critical review of the manuscript. This work was supported by grants from the Canadian Institutes of Health Research (MOP-119538 and FND-154332), National Institutes of Health (NIH-1P01AI102853-01) and Krembil Foundation. E.L.Y.C. was supported by an Ontario Graduate Scholarship. P.K.T. was supported by a Banting and Best Doctoral Research Award. J.C.Z.-P. is supported by a Canada Research Chair in Developmental Immunology.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen YL, 2013, J EXP MED, V210, P2515, DOI 10.1084/jem.20130536; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; De Bellard ME, 2002, DEV BIOL, V249, P121, DOI 10.1006/dbio.2002.0756; De Obaldia ME, 2013, NAT IMMUNOL, V14, P1277, DOI 10.1038/ni.2760; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hamazaki Y, 2015, EUR J IMMUNOL, V45, P2985, DOI 10.1002/eji.201545844; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hosokawa H, 2018, IMMUNITY, V49, P782, DOI 10.1016/j.immuni.2018.09.019; Hozumi K, 2008, EUR J IMMUNOL, V38, P977, DOI 10.1002/eji.200737688; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; KAWAICHI M, 1991, J BIOL CHEM, V266, P18387; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; OKA C, 1995, DEVELOPMENT, V121, P3291; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schnell FJ, 2006, J IMMUNOL, V176, P4740, DOI 10.4049/jimmunol.176.8.4740; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Sultana DA, 2012, J IMMUNOL, V188, P4385, DOI 10.4049/jimmunol.1101116; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Tanaka M, 1999, J NEUROBIOL, V41, P524, DOI 10.1002/(SICI)1097-4695(199912)41:4<524::AID-NEU8>3.3.CO;2-9; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wen XM, 2011, CELL RES, V21, P1701, DOI 10.1038/cr.2011.183; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Zhu YFPP, 2018, CELL REP, V24, P2329, DOI 10.1016/j.celrep.2018.07.097; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	60	36	36	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1456	+		10.1038/s41590-019-0518-7	http://dx.doi.org/10.1038/s41590-019-0518-7			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31636466	Green Accepted			2022-12-18	WOS:000492309600016
J	Chen, L; Carico, Z; Shih, HY; Krangel, MS				Chen, Liang; Carico, Zachary; Shih, Han-Yu; Krangel, Michael S.			A discrete chromatin loop in the mouse Tcra-Tcrd locus shapes the TCR delta and TCR alpha repertoires	NATURE IMMUNOLOGY			English	Article							CHROMOSOME CONFORMATION; V(D)J RECOMBINATION; IGH LOCUS; NONCODING TRANSCRIPTION; GENE RECOMBINATION; 3D STRUCTURE; CTCF; GENOME; REGION; ENHANCER	The locus encoding the T cell antigen receptor (TCR) alpha-chain and delta-chain (Tcra-Tcrd) undergoes recombination of its variable-diversity-joining (V(D)J) segments in CD4(-)CD8(-) double-negative thymocytes and CD4(+)CD8(+) double-positive thymocytes to generate diverse TCR delta repertoires and TCR alpha repertoires, respectively. Here we identified a chromatin-interaction network in the Tcra-Tcrd locus in double-negative thymocytes that was formed by interactions between binding elements for the transcription factor CTCF. Disruption of a discrete chromatin loop encompassing the D, J and constant (C) segments of Tcrd allowed a single V segment to frequently contact and rearrange to D and J segments and dominate the adult TCR delta repertoire. Disruption of this loop also narrowed the TCR alpha repertoire, which, we believe, followed as a consequence of the restricted TCR delta repertoire. Hence, a single CTCF-mediated chromatin loop directly regulated TCR delta diversity and indirectly regulated TCR alpha diversity.	[Chen, Liang; Carico, Zachary; Shih, Han-Yu; Krangel, Michael S.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA	Duke University	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.	krang001@mc.duke.edu		Shih, Han-Yu/0000-0002-7525-5433	US National Institutes of Health [R37 GM41052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Bock for the production of mice with gene targeting; Y.-W. He (Duke University) for the targeting vector pGKneoF2L2DTA; O. Fedrigo for sequencing of 4C samples; D. Corcoran for advice on the processing of 4C sequencing data, L. Martinek, N. Martin and M. Cook for help with cell sorting and analysis; J. Liang for technical advice; Z. Huang for technical support; and E. Oltz and Y. Zhuang for comments on the manuscript. Supported by the US National Institutes of Health (R37 GM41052 to M.S.K.).	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; Bassing CH, 2003, P NATL ACAD SCI USA, V100, P2598, DOI 10.1073/pnas.0437943100; Bosc N, 2003, DEV COMP IMMUNOL, V27, P465, DOI 10.1016/S0145-305X(03)00027-2; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Genolet R, 2012, EMBO J, V31, P4247, DOI 10.1038/emboj.2012.277; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hao BT, 2011, J IMMUNOL, V187, P2484, DOI 10.4049/jimmunol.1100468; Hawwari A, 2007, P NATL ACAD SCI USA, V104, P903, DOI 10.1073/pnas.0608248104; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Ji YH, 2010, J EXP MED, V207, P2809, DOI 10.1084/jem.20101136; Jouvin-Marche E, 2009, ADV EXP MED BIOL, V650, P82; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Livak F, 1996, MOL CELL BIOL, V16, P609; Majumder K, 2015, J EXP MED, V212, P107, DOI 10.1084/jem.20141479; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Monroe RJ, 1999, IMMUNITY, V10, P503, DOI 10.1016/S1074-7613(00)80050-3; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pasqual N, 2002, J EXP MED, V196, P1163, DOI 10.1084/jem.20021074; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shih HY, 2012, P NATL ACAD SCI USA, V109, pE3493, DOI 10.1073/pnas.1214131109; Shih HY, 2010, J EXP MED, V207, P1835, DOI 10.1084/jem.20100772; Shrimali S, 2012, NUCLEIC ACIDS RES, V40, P7753, DOI 10.1093/nar/gks556; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Verma-Gaur J, 2012, P NATL ACAD SCI USA, V109, P17004, DOI 10.1073/pnas.1208398109; Weber-Arden J, 2000, J IMMUNOL, V164, P1002, DOI 10.4049/jimmunol.164.2.1002; Xiang YG, 2014, J IMMUNOL, V193, P3746, DOI 10.4049/jimmunol.1401574; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	45	36	37	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1085	+		10.1038/ni.3232	http://dx.doi.org/10.1038/ni.3232			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26258942	Green Submitted, Green Accepted			2022-12-18	WOS:000361686500014
J	Berry, R; Ng, N; Saunders, PM; Vivian, JP; Lin, J; Deuss, FA; Corbett, AJ; Forbes, CA; Widjaja, JM; Sullivan, LC; McAlister, AD; Perugini, MA; Call, MJ; Scalzo, AA; Degli-Esposti, MA; Coudert, JD; Beddoe, T; Brooks, AG; Rossjohn, J				Berry, Richard; Ng, Natasha; Saunders, Philippa M.; Vivian, Julian P.; Lin, Jie; Deuss, Felix A.; Corbett, Alexandra J.; Forbes, Catherine A.; Widjaja, Jacqueline M.; Sullivan, Lucy C.; McAlister, Adrian D.; Perugini, Matthew A.; Call, Melissa J.; Scalzo, Anthony A.; Degli-Esposti, Mariapia A.; Coudert, Jerome D.; Beddoe, Travis; Brooks, Andrew G.; Rossjohn, Jamie			Targeting of a natural killer cell receptor family by a viral immunoevasin	NATURE IMMUNOLOGY			English	Article							CLASS-I LIGAND; MURINE CYTOMEGALOVIRUS M157; MOUSE CYTOMEGALOVIRUS; ACTIVATION RECEPTOR; CRYSTAL-STRUCTURE; CRITICAL RESIDUES; BINDING-SITE; RECOGNITION; COMPLEX; INFECTION	Activating and inhibitory receptors on natural killer (NK) cells have a crucial role in innate immunity, although the basis of the engagement of activating NK cell receptors is unclear. The activating receptor Ly49H confers resistance to infection with murine cytomegalovirus by binding to the 'immunoevasin' m157. We found that m157 bound to the helical stalk of Ly49H, whereby two m157 monomers engaged the Ly49H dimer. The helical stalks of Ly49H lay centrally across the m157 platform, whereas its lectin domain was not required for recognition. Instead, m157 targeted an 'aromatic peg motif' present in stalks of both activating and inhibitory receptors of the Ly49 family, and substitution of this motif abrogated binding. Furthermore, ligation of m157 to Ly49H or Ly49C resulted in intracellular signaling. Accordingly, m157 has evolved to 'tackle the legs' of a family of NK cell receptors.	[Berry, Richard; Ng, Natasha; Vivian, Julian P.; Deuss, Felix A.; McAlister, Adrian D.; Beddoe, Travis; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Saunders, Philippa M.; Lin, Jie; Corbett, Alexandra J.; Widjaja, Jacqueline M.; Sullivan, Lucy C.; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Forbes, Catherine A.; Scalzo, Anthony A.; Degli-Esposti, Mariapia A.; Coudert, Jerome D.] Univ Western Australia, Immunol & Virol Program, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia; [Forbes, Catherine A.; Scalzo, Anthony A.; Degli-Esposti, Mariapia A.; Coudert, Jerome D.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia; [Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Call, Melissa J.] Univ Melbourne, Struct Biol Div, Walter & Eliza Hall Inst, Parkville, Vic 3052, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Monash University; University of Melbourne; University of Western Australia; Lions Eye Institute; University of Western Australia; La Trobe University; University of Melbourne; Walter & Eliza Hall Institute; Cardiff University	Beddoe, T (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	travis.beddoe@monash.edu; agbrooks@unimelb.edu.au; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013; Coudert, Jerome D/B-2628-2008; Corbett, Alexandra/A-1225-2019; Degli-Esposti, Mariapia/H-9073-2014; Beddoe, Travis/F-3415-2014	Rossjohn, Jamie/0000-0002-2020-7522; Coudert, Jerome D/0000-0001-6081-8494; Corbett, Alexandra/0000-0003-1618-4337; Beddoe, Travis/0000-0003-4550-2277; berry, richard/0000-0001-7043-0469; Widjaja, Jacqueline/0000-0002-4946-5584; Deuss, Felix/0000-0002-0386-4336; Vivian, Julian/0000-0002-9400-4437; Sullivan, Lucy/0000-0003-2907-4989; Degli-Esposti, Mariapia/0000-0002-7808-5935; Brooks, Andrew/0000-0002-4085-9683	National Health and Medical Research Council of Australia; Australian Research Council; Pfizer Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Pfizer Australia(PfizerPfizer Australia)	We thank the staff of the crystallization facility of Monash University for assistance; A. Shahine, R. Koh, M. Peverelli and I. Larma for technical assistance; S. Lemieux (Institut Armand-Frappier) for the 4LO3311 hybridoma; and W. Yokoyama (Washington University) for BWZ HD12 and BWZ DAP12 cells and the 3D10 hybridoma. This research was undertaken on the MX2 beamline at the Australian Synchrotron, Victoria, Australia. Supported by the National Health and Medical Research Council of Australia (M.J.C., R. B., L. C. S., J.D.C. and J.R.), Australian Research Council (M. A. P., M.J.C. and J.P.V.) and Pfizer Australia (T.B.).	Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Anderson SK, 2001, IMMUNOL REV, V181, P79, DOI 10.1034/j.1600-065X.2001.1810106.x; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Back J, 2007, P NATL ACAD SCI USA, V104, P3978, DOI 10.1073/pnas.0607418104; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Choi TW, 2011, J IMMUNOL, V186, P3911, DOI 10.4049/jimmunol.1004168; Clements CS, 2006, ACTA CRYSTALLOGR F, V62, P70, DOI 10.1107/S1744309105041473; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Davis AH, 2008, J IMMUNOL, V181, P265, DOI 10.4049/jimmunol.181.1.265; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Evans EJ, 2003, IMMUNITY, V19, P213, DOI 10.1016/S1074-7613(03)00198-5; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kielczewska A, 2007, J IMMUNOL, V178, P369, DOI 10.4049/jimmunol.178.1.369; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; McWhorter AR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003111; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith KM, 1998, J IMMUNOL, V161, P7; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Wang J, 2002, J BIOL CHEM, V277, P1433, DOI 10.1074/jbc.M110316200; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yoder JA, 2011, IMMUNOGENETICS, V63, P123, DOI 10.1007/s00251-010-0506-4; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	45	36	37	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					699	+		10.1038/ni.2605	http://dx.doi.org/10.1038/ni.2605			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23666294				2022-12-18	WOS:000320509100011
J	Zohren, F; Souroullas, GP; Luo, M; Gerdemann, U; Imperato, MR; Wilson, NK; Gottgens, B; Lukov, GL; Goodell, MA				Zohren, Fabian; Souroullas, George P.; Luo, Min; Gerdemann, Ulrike; Imperato, Maria R.; Wilson, Nicola K.; Goettgens, Berthold; Lukov, Georgi L.; Goodell, Margaret A.			The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors	NATURE IMMUNOLOGY			English	Article							ADULT HEMATOPOIETIC STEM; CELL DEVELOPMENT; B-CELL; MULTIPOTENT PROGENITORS; EXPRESSION; PROTEINS; THYMUS; GENE; SCL; DIFFERENTIATION	Thymopoiesis depends on the recruitment and expansion of bone marrow-derived progenitor populations; tight regulation of these processes is required for maintenance of the homeostasis of the T lineage. Lyl-1, a transcription factor that regulates hematopoietic progenitors, is expressed in thymocyte progenitors until T cell commitment. Here we demonstrate a requirement for Lyl-1 in lymphoid specification and the maintenance of early T lineage progenitors (ETPs). Lyl-1 deficiency resulted in profound defects in the generation of lymphoid-primed multipotent progenitors (LMPPs), common lymphoid progenitors (CLPs) and ETPs. Lyl-1-deficient ETPs and thymocyte progenitors at the CD4(-)CD8(-)double-negative 2 (DN2) stage showed more apoptosis, blocked differentiation and impaired population expansion. We identified Gfi1 as a critical transcriptional target of Lyl-1-mediated lymphopoiesis of T cells. Thus, Lyl-1 is a pivotal component of a transcriptional program that controls the lymphoid specification and maintenance of ETPs.	[Zohren, Fabian; Souroullas, George P.; Luo, Min; Gerdemann, Ulrike; Imperato, Maria R.; Lukov, Georgi L.; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Zohren, Fabian; Souroullas, George P.; Luo, Min; Gerdemann, Ulrike; Imperato, Maria R.; Lukov, Georgi L.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zohren, Fabian] Univ Dusseldorf, Dept Haematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; [Imperato, Maria R.] Univ Naples Federico II, Ctr Ingn Genet Biotecnol Avanzate, Naples, Italy; [Imperato, Maria R.] Univ Naples Federico II, European Sch Mol Med, Naples, Italy; [Wilson, Nicola K.; Goettgens, Berthold] Univ Cambridge, Dept Hematol, Cambridge Inst Med Res, Cambridge, England; [Lukov, Georgi L.] Brigham Young Univ Hawaii, Dept Biochem, Laie, HI USA	Baylor College of Medicine; Baylor College of Medicine; Heinrich Heine University Dusseldorf; University of Naples Federico II; University of Naples Federico II; University of Cambridge; Brigham Young University; Brigham Young University - Hawaii	Goodell, MA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	goodell@bcm.edu	Lukov, Georgi/AAI-8544-2021	Goodell, Margaret A./0000-0003-1111-2932; Souroullas, George P./0000-0003-2196-8662; luo, min/0000-0003-4883-4189; Gerdemann, Ulrike/0000-0002-3600-0366; Gottgens, Berthold/0000-0001-6302-5705	US National Institutes of Health [DK58192, DK092883, CA126752, P30 CA125123, AI007495]; Dan L. Duncan Cancer Center; UK Medical Research Council; Leukaemia and Lymphoma Research; Dr. Mildred Scheel Foundation for Cancer Research fellowship; Cancer Prevention and Research Institute of Texas [RP101499]; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0900951, G0800784] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784B, G0900951, G0800784] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA126752, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192, R56DK092883, R01DK092883] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; Dr. Mildred Scheel Foundation for Cancer Research fellowship; Cancer Prevention and Research Institute of Texas; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M.K. Brenner for comments on the manuscript; and J.C. Zuniga-Pflucker (University of Toronto) for OP9 cell lines. Supported by US National Institutes of Health (DK58192, DK092883, CA126752, P30 CA125123 and AI007495), the Dan L. Duncan Cancer Center, the UK Medical Research Council, Leukaemia and Lymphoma Research, the Dr. Mildred Scheel Foundation for Cancer Research fellowship (F.Z.) and the Cancer Prevention and Research Institute of Texas (RP101499 to F.Z.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Grimes HL, 1996, P NATL ACAD SCI USA, V93, P14569, DOI 10.1073/pnas.93.25.14569; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2001, CURR OPIN IMMUNOL, V13, P180, DOI 10.1016/S0952-7915(00)00202-8; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023; Lukov GL, 2011, LEUKEMIA RES, V35, P405, DOI 10.1016/j.leukres.2010.07.023; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Murre C, 2000, NAT IMMUNOL, V1, P97, DOI 10.1038/77881; NAKAHATA T, 1982, J CELL PHYSIOL, V111, P239, DOI 10.1002/jcp.1041110304; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Souroullas GP, 2011, GENESIS, V49, P441, DOI 10.1002/dvg.20743; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; VISVADER J, 1991, ONCOGENE, V6, P187; Wang SF, 2008, BLOOD, V111, P2878, DOI 10.1182/blood-2007-07-103119; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wilson NK, 2010, MOL CELL BIOL, V30, P3853, DOI 10.1128/MCB.00032-10; Xu W, 2007, BLOOD, V109, P4406, DOI 10.1182/blood-2006-08-043331; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	48	36	37	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					761	+		10.1038/ni.2365	http://dx.doi.org/10.1038/ni.2365			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22772404	Green Accepted			2022-12-18	WOS:000306569600012
J	Rothenberg, EV				Rothenberg, Ellen V.			Cell lineage regulators in B and T cell development	NATURE IMMUNOLOGY			English	Review							TRANSCRIPTIONAL REPRESSOR BLIMP-1; GENE-EXPRESSION; TARGET GENES; ALPHA-BETA; NOTCH; GATA-3; PAX5; DELTA; GAMMA; DIFFERENTIATION	This special issue highlights a pivotal set of regulatory molecules that have emerged as central controllers of cell-type identity in the immune system. Each in its own way has been considered as a kind of 'master' regulator of a particular cell fate choice, but the actual modes of action of these factors vary widely. The comparison among them sheds light on the different ways that an essential regulatory input can affect cellular identity.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X				Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Davidson E.H., 2006, REGULATORY GENOME GE; Davis MM, 2007, NAT IMMUNOL, V8, P445, DOI 10.1038/ni0507-445; De Smedt M, 2005, BLOOD, V106, P3498, DOI 10.1182/blood-2005-02-0496; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Hasegawa SL, 2007, DEV BIOL, V301, P568, DOI 10.1016/j.ydbio.2006.09.030; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Jenkinson EJ, 2006, NAT REV IMMUNOL, V6, P551, DOI 10.1038/nri1883; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Liberg D, 2002, MOL CELL BIOL, V22, P8389, DOI 10.1128/MCB.22.24.8389-8397.2002; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Smith EMK, 2005, BLOOD, V106, P1995, DOI 10.1182/blood-2004-12-4744; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yin ZN, 2002, J IMMUNOL, V168, P1566, DOI 10.4049/jimmunol.168.4.1566; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461	70	36	38	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					441	444		10.1038/ni1461	http://dx.doi.org/10.1038/ni1461			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440447				2022-12-18	WOS:000245831600002
J	Taneja, V; David, CS				Taneja, V; David, CS			Lessons from animal models for human autoimmune diseases	NATURE IMMUNOLOGY			English	Editorial Material							SPONTANEOUS INFLAMMATORY DISEASE; TRANSGENIC MICE; MULTIPLE-SCLEROSIS; T-CELL; ARTHRITIS; HLA-B27; MOLECULES; HLA-DRB1	A variety of different animal models are used to study autoimmune disease. What have we learned?	Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Taneja, V (corresponding author), Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA.			Taneja, Veena/0000-0003-2401-694X				Allen RL, 1999, J IMMUNOL, V162, P5045; Dobbs CM, 2001, J IMMUNOL, V166, P2495, DOI 10.4049/jimmunol.166.4.2495; DRAKE CG, 1995, IMMUNOL REV, V144, P51, DOI 10.1111/j.1600-065X.1995.tb00065.x; Drescher KM, 1998, J CLIN INVEST, V101, P1765, DOI 10.1172/JCI167; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Khare SD, 1998, J IMMUNOL, V160, P101; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leiter EH, 1999, EXPERIMENTAL MODELS OF DIABETES, P257; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Suri A, 1999, IMMUNOL REV, V169, P55, DOI 10.1111/j.1600-065X.1999.tb01306.x; Taneja V, 1999, IMMUNOL REV, V169, P67, DOI 10.1111/j.1600-065X.1999.tb01307.x; Taneja V, 1998, INT IMMUNOL, V10, P1449, DOI 10.1093/intimm/10.10.1449; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; Wen L, 2000, J EXP MED, V191, P97, DOI 10.1084/jem.191.1.97; Wen L, 2001, J CLIN INVEST, V107, P871, DOI 10.1172/JCI11708; ZANELLI E, 1995, IMMUNOL TODAY, V16, P274, DOI 10.1016/0167-5699(95)80181-2	18	36	49	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					781	784		10.1038/ni0901-781	http://dx.doi.org/10.1038/ni0901-781			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526385				2022-12-18	WOS:000170781200010
J	Ataide, MA; Komander, K; Knopper, K; Peters, AE; Wu, H; Eickhoff, S; Gogishvili, T; Weber, J; Grafen, A; Kallies, A; Garbi, N; Einsele, H; Hudecek, M; Gasteiger, G; Holzel, M; Vaeth, M; Kastenmuller, W				Ataide, Marco A.; Komander, Karl; Knoepper, Konrad; Peters, Annika E.; Wu, Hao; Eickhoff, Sarah; Gogishvili, Tea; Weber, Justus; Grafen, Anika; Kallies, Axel; Garbi, Natalio; Einsele, Hermann; Hudecek, Michael; Gasteiger, Georg; Hoelzel, Michael; Vaeth, Martin; Kastenmueller, Wolfgang			BATF3 programs CD8(+)T cell memory	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; T-CELLS; DENDRITIC CELLS; CHEMOKINE RECEPTOR; EFFECTOR; AP-1; SUBSETS; ROLES; DIFFERENTIATION; IDENTIFICATION	BATF3 is a member of the AP-1 transcription factor family. Kastenmuller and colleagues show that BATF3 is needed to promote memory CD8(+)T cell responses. Activated CD8(+)T cells transiently upregulate BATF3, which in turn suppresses expression of proapoptotic BIM to promote cell survival. Antiviral CD8(+)T cell responses are characterized by an initial activation/priming of T lymphocytes followed by a massive proliferation, subset differentiation, population contraction and the development of a stable memory pool. The transcription factor BATF3 has been shown to play a central role in the development of conventional dendritic cells, which in turn are critical for optimal priming of CD8(+)T cells. Here we show that BATF3 was expressed transiently within the first days after T cell priming and had long-lasting T cell-intrinsic effects. T cells that lackedBatf3showed normal expansion and differentiation, yet succumbed to an aggravated contraction and had a diminished memory response. Vice versa, BATF3 overexpression in CD8(+)T cells promoted their survival and transition to memory. Mechanistically, BATF3 regulated T cell apoptosis and longevity via the proapoptotic factor BIM. By programing CD8(+)T cell survival and memory, BATF3 is a promising molecule to optimize adoptive T cell therapy in patients.	[Ataide, Marco A.; Komander, Karl; Knoepper, Konrad; Peters, Annika E.; Wu, Hao; Eickhoff, Sarah; Gogishvili, Tea; Grafen, Anika; Gasteiger, Georg; Vaeth, Martin; Kastenmueller, Wolfgang] Univ Wurzburg, Wurzburg Inst Syst Immunol, Max Planck Res Grp, Wurzburg, Germany; [Weber, Justus; Einsele, Hermann; Hudecek, Michael] Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany; [Kallies, Axel] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Garbi, Natalio] Univ Bonn, Inst Expt Immunol, Med Fac, Bonn, Germany; [Hoelzel, Michael] Univ Bonn, Inst Expt Oncol, Med Fac, Bonn, Germany	Max Planck Society; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Melbourne; University of Bonn; University of Bonn	Ataide, MA; Kastenmuller, W (corresponding author), Univ Wurzburg, Wurzburg Inst Syst Immunol, Max Planck Res Grp, Wurzburg, Germany.	marco.ataide@uni-wuerzburg.de; wolfgang.kastenmueller@uni-wuerzburg.de		wu, hao/0000-0002-6713-7752; Ataide, Marco/0000-0003-4014-0326; Vaeth, Martin/0000-0001-8974-7052; Weber, Justus/0000-0002-4919-952X; Kallies, Axel/0000-0002-6312-6968; Knopper, Konrad/0000-0003-2076-2160; Gasteiger, Georg/0000-0001-6986-127X	Core Unit SysMed of the IZKF Wurzburg; German Research Foundation [SFB TR 221]; German Research Foundation Emmy Noether programme [GA2129/2-1]; European Research Council [819329, 759176]; Max Planck Society (Max Planck Research Groups); Germany's Excellence Strategy [EXC2151, 390873048]	Core Unit SysMed of the IZKF Wurzburg; German Research Foundation(German Research Foundation (DFG)); German Research Foundation Emmy Noether programme(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Max Planck Society (Max Planck Research Groups)(Max Planck Society); Germany's Excellence Strategy	We thank the Core Unit for FACS and the Core Unit SysMed of the IZKF Wurzburg for supporting this study, H.C. Probst (Institute for Immunology, Mainz University) and T. Kaisho (Immunology Frontier Research Center, Osaka University) for providing the P14 and XCR1-DTR-Venus mice31, respectively. The B8R tetramer was obtained through the National Institutes of Health Tetramer Core Facility. This work was supported by grants through the German Research Foundation, SFB TR 221 (project A03 to M. Hudecek and H.E.), Germany's Excellence Strategy -EXC2151 -(390873048 to M. Holzel) and German Research Foundation Emmy Noether programme (GA2129/2-1 to G.G.) and by grants of the European Research Council to W.K. (819329-STEP2) and G.G. (759176-TissueLymphoContexts). W.K., G.G. and M.V. are supported by the by the Max Planck Society (Max Planck Research Groups).	Alexandre YO, 2016, J EXP MED, V213, P75, DOI 10.1084/jem.20142350; Bedoui S, 2016, IMMUNOL REV, V272, P52, DOI 10.1111/imr.12426; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Hajji N, 2010, ESSAYS BIOCHEM, V48, P121, DOI [10.1042/bse0480121, 10.1042/BSE0480121]; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Huang RL, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00445; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Kitano M, 2016, P NATL ACAD SCI USA, V113, P1044, DOI 10.1073/pnas.1513607113; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Logan MR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.49; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Mattiuz R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02805; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Punkenburg E, 2016, GUT, V65, P1139, DOI 10.1136/gutjnl-2014-308227; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Weiser Christian, 2018, Oncotarget, V9, P15942, DOI 10.18632/oncotarget.24639; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798	52	35	35	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1397	+		10.1038/s41590-020-0786-2	http://dx.doi.org/10.1038/s41590-020-0786-2		SEP 2020	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32989328				2022-12-18	WOS:000573447100005
J	Smole, U; Gour, N; Phelan, J; Hofer, G; Kohler, C; Kratzer, B; Tauber, PA; Xiao, X; Yao, N; Dvorak, J; Caraballo, L; Puerta, L; Rosskopf, S; Chakir, J; Malle, E; Lane, AP; Pickl, WF; Lajoie, S; Wills-Karp, M				Smole, Ursula; Gour, Naina; Phelan, Jordan; Hofer, Gerhard; Koehler, Cordula; Kratzer, Bernhard; Tauber, Peter A.; Xiao, Xiao; Yao, Nu; Dvorak, Jan; Caraballo, Luis; Puerta, Leonardo; Rosskopf, Sandra; Chakir, Jamila; Malle, Ernst; Lane, Andrew P.; Pickl, Winfried F.; Lajoie, Stephane; Wills-Karp, Marsha			Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; RECOMBINANT ALLERGEN; BLOMIA-TROPICALIS; PROTEIN; EXPRESSION; BINDING; ASTHMA; MITE; SAA; A1	The molecular basis for the propensity of a small number of environmental proteins to provoke allergic responses is largely unknown. Herein, we report that mite group 13 allergens of the fatty acid-binding protein (FABP) family are sensed by an evolutionarily conserved acute-phase protein, serum amyloid A1 (SAA1), that promotes pulmonary type 2 immunity. Mechanistically, SAA1 interacted directly with allergenic mite FABPs (Der p 13 and Blo t 13). The interaction between mite FABPs and SAA1 activated the SAA1-binding receptor, formyl peptide receptor 2 (FPR2), which drove the epithelial release of the type-2-promoting cytokine interleukin (IL)-33 in a SAA1-dependent manner. Importantly, the SAA1-FPR2-IL-33 axis was upregulated in nasal epithelial cells from patients with chronic rhinosinusitis. These findings identify an unrecognized role for SAA1 as a soluble pattern recognition receptor for conserved FABPs found in common mite allergens that initiate type 2 immunity at mucosal surfaces.	[Smole, Ursula; Gour, Naina; Phelan, Jordan; Xiao, Xiao; Yao, Nu; Lajoie, Stephane; Wills-Karp, Marsha] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA; [Smole, Ursula; Koehler, Cordula; Kratzer, Bernhard; Tauber, Peter A.; Rosskopf, Sandra; Pickl, Winfried F.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Hofer, Gerhard] Karl Franzens Univ Graz, Inst Mol Biosci, BioTechMed Graz, Graz, Austria; [Dvorak, Jan] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Dvorak, Jan] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Dvorak, Jan] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Caraballo, Luis; Puerta, Leonardo] Univ Cartagena, Inst Immunol Res, Cartagena, Colombia; [Chakir, Jamila] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Malle, Ernst] Med Univ Graz, Gottfried Schatz Res Ctr, Div Mol Biol & Biochem, Graz, Austria; [Lane, Andrew P.; Lajoie, Stephane] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Div Rhinol & Sinus Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical University of Vienna; University of Graz; Czech University of Life Sciences Prague; Medical University of Vienna; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universidad de Cartagena; Laval University; Medical University of Graz; Johns Hopkins University; Johns Hopkins Medicine	Smole, U; Wills-Karp, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA.; Smole, U (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria.	ursula.smole@irc.vib-ugent.be; mwkarp@jhu.edu		Pickl, Winfried F./0000-0003-0430-4952; Smole, Ursula/0000-0001-5124-2024; Dvorak, Jan/0000-0002-6824-9000; Lajoie, Stephane/0000-0002-0514-1801; Kratzer, Bernhard/0000-0003-1091-4327; Hofer, Gerhard/0000-0002-9248-6989; Tauber, Peter/0000-0002-1784-1602	National Institute of Allergy and Infectious Diseases [U19AI070235, R01 AI083315]; NIH [R56AI118791, R01AI127644, R01AI132590]; Austrian Science Fund [DK W1248, SFB F4609]; Erwin Schrodinger Fellowship of the Austrian Science Fund [J3332-B21]; American Thoracic Society; NIEHS [5T32ES007141]; Austrian National Bank [17600]; Operational Programme Research, Development and Education, the Call International Mobility of Researchers -MSCA - IF [CZ.02.2.69/0.0/0.0/17_050/0008014]; Canadian Institutes of Health Research [DC0190GP]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Erwin Schrodinger Fellowship of the Austrian Science Fund(Austrian Science Fund (FWF)); American Thoracic Society; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Austrian National Bank; Operational Programme Research, Development and Education, the Call International Mobility of Researchers -MSCA - IF; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank M. C. de Beer (University of Kentucky Medical Center, KY, US) for providing the Saa<SUP>-/-</SUP> mice; E. Schmidt and R. Zeiner for animal care; and Z. Lijie, D. Trapin and S. Kickmaier for expert technical assistance. We also thank M. Marlovics (dsgn & cde; hq@dsgncde.com) for the graphic designs in Figs. 5 and 8 and C. Zwicker for critically reading the manuscript and for helpful discussion and suggestions. This work was funded by the National Institute of Allergy and Infectious Diseases (grants U19AI070235 and R01 AI083315 to M.W.-K.) and the NIH (grants R56AI118791 and R01AI127644 to S.L. and R01AI132590 to A.P.L.) as well as the Austrian Science Fund (DK W1248 and SFB F4609 to W.F.P.). U.S. was supported by an Erwin Schrodinger Fellowship (J3332-B21) of the Austrian Science Fund, a research grant of the American Thoracic Society and DK W1248. N.G. was supported by an NIEHS 5T32ES007141 grant. E.M. was supported by the Austrian National Bank (17600). J.D. was supported by Operational Programme Research, Development and Education, the Call International Mobility of Researchers -MSCA - IF (CZ.02.2.69/0.0/0.0/17_050/0008014). J.C. was supported by the Canadian Institutes of Health Research (DC0190GP).	Ather JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34901-x; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; Buyukozturk S, 2004, TOHOKU J EXP MED, V204, P209, DOI 10.1620/tjem.204.209; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Caraballo L, 1997, INT ARCH ALLERGY IMM, V112, P341, DOI 10.1159/000237478; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chen MJ, 2014, IMMUNOBIOLOGY, V219, P916, DOI 10.1016/j.imbio.2014.08.002; Cheng N, 2018, EMBO REP, V19, DOI 10.15252/embr.201745517; Christenson K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00092; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Darveau ME, 2008, J ALLERGY CLIN IMMUN, V121, P692, DOI 10.1016/j.jaci.2007.11.023; de Beer MC, 2010, J LIPID RES, V51, P3117, DOI 10.1194/jlr.M005413; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Frame NM, 2017, J STRUCT BIOL, V200, P293, DOI 10.1016/j.jsb.2017.06.007; Franchini GR, 2015, PROSTAG LEUKOTR ESS, V93, P31, DOI 10.1016/j.plefa.2014.08.003; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Goulet F, 1996, AM J RESP CELL MOL, V15, P312, DOI 10.1165/ajrcmb.15.3.8810634; Gour N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aam9841; Green BJ, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-15; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hinrichs BH, 2018, AM J PATHOL, V188, P937, DOI 10.1016/j.ajpath.2017.12.013; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jayaraman S, 2017, P NATL ACAD SCI USA, V114, pE6507, DOI 10.1073/pnas.1707120114; Jousilahti P, 2002, ANN ALLERG ASTHMA IM, V89, P381, DOI 10.1016/S1081-1206(10)62039-X; Kim MH, 2013, CYTOKINE, V61, P506, DOI 10.1016/j.cyto.2012.10.019; Kratzer B, 2019, ALLERGY, V74, P246, DOI 10.1111/all.13573; Labrada M, 2002, INT ARCH ALLERGY IMM, V129, P212, DOI 10.1159/000066775; Lajoie S, 2014, CLIN EXP ALLERGY, V44, P976, DOI 10.1111/cea.12341; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Leontovyc A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006446; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; Malle E, 1998, SCAND J IMMUNOL, V48, P557; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Miljkovic D, 2014, ALLERGY, V69, P1154, DOI 10.1111/all.12440; Niemi MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13841; Ozseker F, 2006, INT IMMUNOPHARMACOL, V6, P1569, DOI 10.1016/j.intimp.2006.05.006; Paris G, 2014, INT FORUM ALLERGY RH, V4, P15, DOI 10.1002/alr.21237; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Puerta L, 1999, INT ARCH ALLERGY IMM, V119, P181, DOI 10.1159/000024193; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Ricklefs I, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93534; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Scott IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21589-2; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Smole U, 2020, EUR J IMMUNOL, V50, P624, DOI 10.1002/eji.201847811; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Sun L, 2016, GENE, V583, P48, DOI 10.1016/j.gene.2016.02.044; Suojalehto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127003; Thaumaturgo N, 2001, MEM I OSWALDO CRUZ, V96, P79, DOI 10.1590/S0074-02762001000900011; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Wang Y, 2011, BIOCHEM BIOPH RES CO, V407, P725, DOI 10.1016/j.bbrc.2011.03.090; Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138; Zhou HB, 2017, J IMMUNOL, V199, P1105, DOI 10.4049/jimmunol.1700470; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	62	35	36	2	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					756	+		10.1038/s41590-020-0698-1	http://dx.doi.org/10.1038/s41590-020-0698-1		JUN 2020	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32572240	Green Accepted			2022-12-18	WOS:000542142500002
J	Tanaka, S; Ise, W; Inoue, T; Ito, A; Ono, C; Shima, Y; Sakakibara, S; Nakayama, M; Fujii, K; Miura, I; Sharif, J; Koseki, H; Koni, PA; Raman, I; Li, QZ; Kubo, M; Fujiki, K; Nakato, R; Shirahige, K; Araki, H; Miura, F; Ito, T; Kawakami, E; Baba, Y; Kurosaki, T				Tanaka, Shinya; Ise, Wataru; Inoue, Takeshi; Ito, Ayako; Ono, Chisato; Shima, Yoshihito; Sakakibara, Shuhei; Nakayama, Manabu; Fujii, Kentaro; Miura, Ikuo; Sharif, Jafar; Koseki, Haruhiko; Koni, Pandelakis A.; Raman, Indu; Li, Quan-Zhen; Kubo, Masato; Fujiki, Katsunori; Nakato, Ryuichiro; Shirahige, Katsuhiko; Araki, Hiromitsu; Miura, Fumihito; Ito, Takashi; Kawakami, Eiryo; Baba, Yoshihiro; Kurosaki, Tomohiro			Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DNA METHYLATION; MECHANISMS; TOLERANCE; MOUSE; COSTIMULATION; LYMPHOCYTES; EXPRESSION; CLONING; ANERGY	A contribution of epigenetic modifications to B cell tolerance has been proposed but not directly tested. Here we report that deficiency of ten-eleven translocation (Tet) DNA demethylase family members Tet2 and Tet3 in B cells led to hyperactivation of B and T cells, autoantibody production and lupus-like disease in mice. Mechanistically, in the absence of Tet2 and Tet3, downregulation of CD86, which normally occurs following chronic exposure of self-reactive B cells to self-antigen, did not take place. The importance of dysregulated CD86 expression in Tet2- and Tet3-deficient B cells was further demonstrated by the restriction, albeit not complete, on aberrant T and B cell activation following anti-CD86 blockade. Tet2- and Tet3-deficient B cells had decreased accumulation of histone deacetylase 1 (HDAC1) and HDAC2 at theCd86locus. Thus, our findings suggest that Tet2- and Tet3-mediated chromatin modification participates in repression of CD86 on chronically stimulated self-reactive B cells, which contributes, at least in part, to preventing autoimmunity. Ten-eleven translocation (Tet) enzymes oxidize 5-methylcytosine, facilitating DNA demethylation. Kurosaki and colleagues show that B cell-specific loss of Tet2 and Tet3 leads to lupus-like autoimmunity in mice, in part through increased B cell expression of CD86 and enhanced activation of CD4(+)T cells.	[Tanaka, Shinya; Ise, Wataru; Inoue, Takeshi; Ito, Ayako; Fujii, Kentaro; Baba, Yoshihiro; Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka, Japan; [Tanaka, Shinya; Ono, Chisato; Baba, Yoshihiro] Kyushu Univ, Med Inst Bioregulat, Div Immunol & Genome Biol, Fukuoka, Japan; [Tanaka, Shinya; Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba, Japan; [Shima, Yoshihito] Osaka Univ, Lab Thermotherapeut Vasc Dysfunct, Suita, Osaka, Japan; [Sakakibara, Shuhei] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Lab Med Omics Res, Kisarazu, Japan; [Miura, Ikuo] RIKEN BioResource Res Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan; [Sharif, Jafar; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Koseki, Haruhiko] Chiba Univ, Grad Sch Med, Adv Res Dept, Chiba, Japan; [Koni, Pandelakis A.] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA; [Raman, Indu; Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Microarray Core Facil, Dallas, TX 75390 USA; [Kubo, Masato] RIKEN Ctr Integrat Med Sci, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan; [Fujiki, Katsunori; Nakato, Ryuichiro; Shirahige, Katsuhiko] Univ Tokyo, Inst Quantitat Biosci, Tokyo, Japan; [Araki, Hiromitsu; Miura, Fumihito; Ito, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka, Japan; [Kawakami, Eiryo] RIKEN, Med Sci Innovat Hub Program, Yokohama, Kanagawa, Japan; [Kawakami, Eiryo] Chiba Univ, Grad Sch Med, Dept Artificial Intelligence Med, Chiba, Japan; [Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Yokohama, Kanagawa, Japan	Osaka University; Kyushu University; Tokyo University of Science; Osaka University; Osaka University; Kazusa DNA Research Institute; RIKEN; RIKEN; Chiba University; University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas; RIKEN; University of Tokyo; Kyushu University; RIKEN; Chiba University; RIKEN	Baba, Y; Kurosaki, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka, Japan.; Baba, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Immunol & Genome Biol, Fukuoka, Japan.; Kurosaki, T (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Yokohama, Kanagawa, Japan.	babay@bioreg.kyushu-u.ac.jp; kurosaki@ifrec.osaka-u.ac.jp	Miura, Fumihito/AAZ-5474-2021; Tanaka, Shinya/AAO-8771-2021	Miura, Fumihito/0000-0003-2656-486X; Tanaka, Shinya/0000-0001-6470-3301; Nakato, Ryuichiro/0000-0003-3019-5817; Sakakibara, Shuhei/0000-0003-3157-5870; Shima, Yoshihito/0000-0002-2523-2938; Ito, Takashi/0000-0001-6097-2803	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [JP19am0101103, JP19am0101105]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); AMED [19gm6110004h0003]	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED	We thank A.C. Chan (Genentech) for providing the anti-CD20 monoclonal antibody, K. Rajewsky (Max Delbruck Center for Molecular Medicine) for the Cd19-Cre and mu MT mice, C.C. Goodnow (Garvan Institute of Medical Research) for MD4 and ML5 mice, A. O'Garra (Francis Crick Institute) for TCR7 TCR-transgenic mice, T. Shimaoka (Tokyo University of Science) for anti-CD4 monoclonal antibody, H. Fukuyama for assistance with the RNA-seq experiment, A. Baba for plasmid DNA construction, C. Kawai for assistance with experiments, K. Tanaka for assistance with the computational analysis, and N. Yakushiji-Kaminatsui and H. Sugishita for assistance with the ChIP-seq experiment and data processing. We appreciate the technical assistance from the Research Support Center at the Kyushu University Graduate School of Medical Sciences. This research was partially supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under grant no. JP19am0101103 and JP19am0101105. This work is supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and AMED (Grant-in-Aid for Scientific Research (S) for T.K., AMED under grant no. 19gm6110004h0003 and Grant-in-Aid for Scientific Research (B) for Y.B. and Grant-in-Aid for Scientific Research (C) for S.T.).	Alberghini F, 2015, IMMUNOL CELL BIOL, V93, P253, DOI 10.1038/icb.2014.116; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Audzevich T, 2017, P NATL ACAD SCI USA, V114, pE3954, DOI 10.1073/pnas.1616417114; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Choukrallah MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00156; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Demirci FY, 2016, ARTHRITIS RHEUMATOL, V68, P174, DOI 10.1002/art.39403; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Li W, 2017, CURR OPIN RHEUMATOL, V29, P434, DOI 10.1097/BOR.0000000000000412; Lio CW, 2016, ELIFE, V5, DOI 10.7554/eLife.18290; Lio CWJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7523; Lio CWJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00210; Liu ZY, 2015, DEVELOPMENT, V142, P2452, DOI 10.1242/dev.125492; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Martin-Orozco N, 2007, SEMIN CANCER BIOL, V17, P288, DOI 10.1016/j.semcancer.2007.06.003; Mazzone R, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0632-2; Miura F, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz435; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Neighbors M, 2006, EUR J IMMUNOL, V36, P2315, DOI 10.1002/eji.200636432; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Orlanski S, 2016, P NATL ACAD SCI USA, V113, P5018, DOI 10.1073/pnas.1604365113; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pelanda R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007146; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Prak ETL, 2011, ANN NY ACAD SCI, V1217, P96, DOI 10.1111/j.1749-6632.2010.05877.x; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rohatgi S, 2008, J IMMUNOL METHODS, V339, P205, DOI 10.1016/j.jim.2008.09.017; Sakakibara S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16681-y; Schoeler K, 2019, FEBS J, V286, P3566, DOI 10.1111/febs.14934; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Tanaka S, 2018, J EXP MED, V215, P1853, DOI 10.1084/jem.20170779; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Tsagaratou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00220; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wu HJ, 2018, CELL MOL IMMUNOL, V15, P676, DOI 10.1038/cmi.2017.133; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xue SJ, 2016, CELL REP, V16, P1096, DOI 10.1016/j.celrep.2016.06.068; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	58	35	35	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					950	+		10.1038/s41590-020-0700-y	http://dx.doi.org/10.1038/s41590-020-0700-y		JUN 2020	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32572241				2022-12-18	WOS:000542142500005
J	Kennedy, DE; Okoreeh, MK; Maienschein-Cline, M; Ai, JT; Veselits, M; McLean, KC; Dhungana, Y; Wang, H; Peng, JM; Chi, HB; Mandal, M; Clark, MR				Kennedy, Domenick E.; Okoreeh, Michael K.; Maienschein-Cline, Mark; Ai, Junting; Veselits, Margaret; McLean, Kaitlin C.; Dhungana, Yogesh; Wang, Hong; Peng, Junmin; Chi, Hongbo; Mandal, Malay; Clark, Marcus R.			Novel specialized cell state and spatial compartments within the germinal center	NATURE IMMUNOLOGY			English	Article							CYTIDINE DEAMINASE ACTIVITY; CENTER B; TRANSCRIPTIONAL REGULATION; CENTER SELECTION; CENTER DARK; CYCLE; EXPRESSION; ZONE; AID; MUTATIONS	Germinal centers are typically divided into dark and light zones. Clark and colleagues identify 'gray zone' cyclin B1(+) B cell clusters as sites of ongoing cell proliferation, and these cells are distinct from dark zone B cells that undergo AID-dependent somatic hypermutation. This separation of function safeguards B cells undergoing DNA replication against potential mutagenic events that could result in neoplastic transformation. Within germinal centers (GCs), complex and highly orchestrated molecular programs must balance proliferation, somatic hypermutation and selection to both provide effective humoral immunity and to protect against genomic instability and neoplastic transformation. In contrast to this complexity, GC B cells are canonically divided into two principal populations, dark zone (DZ) and light zone (LZ) cells. We now demonstrate that, following selection in the LZ, B cells migrated to specialized sites within the canonical DZ that contained tingible body macrophages and were sites of ongoing cell division. Proliferating DZ (DZp) cells then transited into the larger DZ to become differentiating DZ (DZd) cells before re-entering the LZ. Multidimensional analysis revealed distinct molecular programs in each population commensurate with observed compartmentalization of noncompatible functions. These data provide a new three-cell population model that both orders critical GC functions and reveals essential molecular programs of humoral adaptive immunity.	[Kennedy, Domenick E.; Okoreeh, Michael K.; Ai, Junting; Veselits, Margaret; McLean, Kaitlin C.; Mandal, Malay; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kennedy, Domenick E.; Okoreeh, Michael K.; Ai, Junting; Veselits, Margaret; McLean, Kaitlin C.; Mandal, Malay; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Maienschein-Cline, Mark] Univ Illinois, Core Res Informat, Chicago, IL USA; [Dhungana, Yogesh; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Hong; Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Hong; Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Clark, MR (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA.	mclark@uchicago.edu	Peng, Junmin/N-2614-2018; Chi, Hongbo/M-9397-2018	Peng, Junmin/0000-0003-0472-7648; Chi, Hongbo/0000-0002-9997-2496; Dhungana, Yogesh/0000-0002-4021-0075; Wang, Hong/0000-0002-6215-6348; Okoreeh, Michael/0000-0001-7680-9488; Kennedy, Domenick/0000-0002-5329-3711; McLean, Kaitlin/0000-0003-4566-5105	US National Institutes of Health [R01AI143778, R21AI128785, T32 HL007605, F32AI143120, T32HD007009, R01AG047928]; Cancer Center Support grant [P30CA014599]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant	We thank D. Leclerc and the UChicago flow cytometry core for providing the latest flow cytometry technologies. We also thank Y. Wang for assistance in proteomics experiments. This work is supported by the US National Institutes of Health grant nos. R01AI143778 and R21AI128785 (to M.R.C.), T32 HL007605 and F32AI143120 (to D.E.K.), T32HD007009 (to M.K.O.), R01AG047928 (to J.P.) and the Cancer Center Support grant (no. P30CA014599) for the UChicago flow cytometry core.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Brink R, 2018, ANNU REV IMMUNOL, V36, P339, DOI 10.1146/annurev-immunol-051116-052510; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Endl E, 2000, J CELL PHYSIOL, V182, P371, DOI 10.1002/(SICI)1097-4652(200003)182:3<371::AID-JCP8>3.0.CO;2-J; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Finkin S, 2019, IMMUNITY, V51, P324, DOI 10.1016/j.immuni.2019.06.013; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hodson DJ, 2016, P NATL ACAD SCI USA, V113, pE2039, DOI 10.1073/pnas.1600557113; Khair L, 2014, J IMMUNOL, V192, P4887, DOI 10.4049/jimmunol.1303481; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H., 2013, ARXIV13033997 Q BIO, P1303, DOI DOI 10.6084/M9.FIGSHARE.963153.V1; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mandal M, 2019, NAT IMMUNOL, V20, P1393, DOI 10.1038/s41590-019-0468-0; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Milpied P, 2018, NAT IMMUNOL, V19, P1013, DOI 10.1038/s41590-018-0181-4; Niu MM, 2017, ANAL CHEM, V89, P2956, DOI 10.1021/acs.analchem.6b04415; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Perez-Garcia A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16067; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Recaldin T, 2016, CLIN EXP IMMUNOL, V183, P65, DOI 10.1111/cei.12702; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohlich K., 1930, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V20, P287; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Sharbeen G, 2012, J EXP MED, V209, P965, DOI 10.1084/jem.20112379; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Song S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02026; Stewart E, 2018, CANCER CELL, V34, P411, DOI 10.1016/j.ccell.2018.07.012; Stewart I, 2018, IMMUNITY, V49, P477, DOI 10.1016/j.immuni.2018.08.025; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Tan HY, 2015, PROTEOMICS, V15, P500, DOI 10.1002/pmic.201400171; Trabucco SE, 2016, J IMMUNOL, V197, P1699, DOI 10.4049/jimmunol.1600721; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Veselits M, 2017, J EXP MED, V214, P3775, DOI 10.1084/jem.20161868; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang H, 2015, J PROTEOME RES, V14, P829, DOI 10.1021/pr500882h; Wang Q, 2017, J EXP MED, V214, P49, DOI 10.1084/jem.20161649; Weber TS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01313; Yao S, 2018, SEMIN CANCER BIOL, V50, P77, DOI 10.1016/j.semcancer.2017.11.018; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zan H, 2013, AUTOIMMUNITY, V46, P83, DOI 10.3109/08916934.2012.749244; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	70	35	36	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					660	+		10.1038/s41590-020-0660-2	http://dx.doi.org/10.1038/s41590-020-0660-2		APR 2020	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32341509	Green Accepted			2022-12-18	WOS:000529079200001
J	Miller, CH; Klawon, DEJ; Zeng, SR; Lee, V; Socci, ND; Savage, PA				Miller, Christine H.; Klawon, David E. J.; Zeng, Sharon; Lee, Victoria; Socci, Nicholas D.; Savage, Peter A.			Eomes identifies thymic precursors of self-specific memory-phenotype CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							CORD BLOOD; ANTIGEN; RECEPTOR; MAINTENANCE; HOMEOSTASIS; EXPRESSION; PEPTIDE; CANCER; LIVER; BET	Savage and colleagues show virtual memory CD8 T cells arise in the thymus of replete mice, where their differentiation is a robust TCR-directed process. Clonal analyses show their TCR repertoire is reproducible and distinct from conventional cells and that progeny cells harboring such TCRs infiltrate tumors and express PD-1. Unprimed mice harbor a substantial population of 'memory-phenotype' CD8(+) T cells (CD8-MP cells) that exhibit hallmarks of activation and innate-like functional properties. Due to the lack of faithful markers to distinguish CD8-MP cells from bona fide CD8(+) memory T cells, the developmental origins and antigen specificities of CD8-MP cells remain incompletely defined. Using deep T cell antigen receptor (TCR) sequencing, we found that the TCRs expressed by CD8-MP cells are highly recurrent and distinct from the TCRs expressed by naive-phenotype CD8(+) T cells. CD8-MP clones exhibited reactivity to widely expressed self-ligands. T cell precursors expressing CD8-MP TCRs showed upregulation of the transcription factor Eomes during maturation in the thymus, prior to induction of the full memory phenotype, which is suggestive of a unique program triggered by recognition of self-ligands. Moreover, CD8-MP cells infiltrate oncogene-driven prostate tumors and express high densities of PD-1, which suggests potential roles in antitumor immunity and the response to immunotherapy.	[Miller, Christine H.; Klawon, David E. J.; Zeng, Sharon; Lee, Victoria; Savage, Peter A.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA	University of Chicago; Memorial Sloan Kettering Cancer Center	Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	psavage@bsd.uchicago.edu		Savage, Peter/0000-0002-2506-7717; Zeng, Sharon/0000-0001-7150-1345; Miller, Christine/0000-0003-2176-9516	National Institutes of Health/National Cancer Institute F30 predoctoral fellowship [F30-CA236061, F30-CA217109]; Univeristy of Chicago Medical Scientist Training Program [T32-GM007281];  [R01-AI110507];  [T32-AI007090]	National Institutes of Health/National Cancer Institute F30 predoctoral fellowship; Univeristy of Chicago Medical Scientist Training Program; ; 	We thank A. Bendelac for critical reading of the manuscript. We thank S. Kasal, A. Bendelac, V. Leone, E. Chang, Z. Earley, B. Jabri, E. Hegermiller and B. Kee for sharing reagents and resources. We thank M. Nussenzweig at Rockefeller University for Rag2GFP mice. We thank T. Walzer at Inserm for Eomes-GFP mice. Flow cytometry and FACS were performed at the University of Chicago Cytometry and Antibody Technology Facility. This work was funded by R01-AI110507 (to P.A.S.). C.H.M. was supported by a National Institutes of Health/National Cancer Institute F30 predoctoral fellowship (F30-CA236061). V.L. was supported by a National Institutes of Health/National Cancer Institute F30 predoctoral fellowship (F30-CA217109). C.H.M and V.L. were supported by the Univeristy of Chicago Medical Scientist Training Program (T32-GM007281). D.K. was supported by T32-AI007090.	Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Drobek A, 2018, EMBO J, V37, DOI 10.15252/embj.201798518; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hogquist KA, 2000, METH MOL B, V156, P219; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jacomet F, 2015, EUR J IMMUNOL, V45, P1926, DOI 10.1002/eji.201545539; Jameson SC, 2015, ADV IMMUNOL, V126, P173, DOI 10.1016/bs.ai.2014.12.001; Lee JY, 2013, P NATL ACAD SCI USA, V110, P13498, DOI 10.1073/pnas.1307572110; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Leventhal DS, 2016, IMMUNITY, V44, P847, DOI 10.1016/j.immuni.2016.01.025; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Magurran A.E, 1988, ECOLOGICAL DIVERSITY; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Turner VM, 2010, J IMMUNOL METHODS, V360, P162, DOI 10.1016/j.jim.2010.06.007; Warren HS, 2006, J LEUKOCYTE BIOL, V79, P1252, DOI 10.1189/jlb.0905536; White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34; White JT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11291; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	43	35	35	1	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					567	+		10.1038/s41590-020-0653-1	http://dx.doi.org/10.1038/s41590-020-0653-1		APR 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32284593	Green Accepted			2022-12-18	WOS:000526627600003
J	Baazim, H; Schweiger, M; Moschinger, M; Xu, HF; Scherer, T; Popa, A; Gallage, S; Ali, A; Khamina, K; Kosack, L; Vilagos, B; Smyth, M; Lercher, A; Friske, J; Merkler, D; Aderem, A; Helbich, TH; Heikenwalder, M; Lang, PA; Zechner, R; Bergthaler, A				Baazim, Hatoon; Schweiger, Martina; Moschinger, Michael; Xu, Haifeng; Scherer, Thomas; Popa, Alexandra; Gallage, Suchira; Ali, Adnan; Khamina, Kseniya; Kosack, Lindsay; Vilagos, Bojan; Smyth, Mark; Lercher, Alexander; Friske, Joachim; Merkler, Doron; Aderem, Alan; Helbich, Thomas H.; Heikenwaelder, Mathias; Lang, Philipp A.; Zechner, Rudolf; Bergthaler, Andreas			CD8(+) T cells induce cachexia during chronic viral infection	NATURE IMMUNOLOGY			English	Article							ADIPOSE-TISSUE; MOLECULAR-MECHANISMS; CLONAL EXPANSION; WASTING DISEASE; DEFICIENT MICE; IMMUNE; METABOLISM; GLUCOCORTICOIDS; EXPRESSION; INFLAMMATION	Cachexia represents a leading cause of morbidity and mortality in various cancers, chronic inflammation and infections. Understanding of the mechanisms that drive cachexia has remained limited, especially for infection-associated cachexia (IAC). In the present paper we describe a model of reversible cachexia in mice with chronic viral infection and identify an essential role for CD8(+) T cells in IAC. Cytokines linked to cancer-associated cachexia did not contribute to IAC. Instead, virus-specific CD8(+) T cells caused morphologic and molecular changes in the adipose tissue, which led to depletion of lipid stores. These changes occurred at a time point that preceded the peak of the CD8(+) T cell response and required Tcell-intrinsic type I interferon signaling and antigen-specific priming. Our results link systemic antiviral immune responses to adipose-tissue remodeling and reveal an underappreciated role of CD8(+) T cells in IAC.	[Baazim, Hatoon; Moschinger, Michael; Popa, Alexandra; Ali, Adnan; Khamina, Kseniya; Kosack, Lindsay; Vilagos, Bojan; Smyth, Mark; Lercher, Alexander; Bergthaler, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Schweiger, Martina; Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Xu, Haifeng; Lang, Philipp A.] Heinrich Heine Univ, Dept Mol Med 2, Dusseldorf, Germany; [Scherer, Thomas] Med Univ Vienna, Dept Med 3, Div Endocrinol & Metab, Vienna, Austria; [Gallage, Suchira; Heikenwaelder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Friske, Joachim; Helbich, Thomas H.] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Gender & Mol Imaging, Preclin Imaging Lab, Vienna, Austria; [Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Aderem, Alan] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Graz; Heinrich Heine University Dusseldorf; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Vienna; University of Geneva; Seattle Children's Hospital	Bergthaler, A (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.	abergthaler@cemm.oeaw.ac.at	Bergthaler, Andreas/ABG-5047-2020; Heikenwalder, Mathias/AAA-2269-2020; Merkler, Doron/N-9157-2016	Bergthaler, Andreas/0000-0003-0597-1976; Lercher, Alexander/0000-0003-3478-5304; Gallage, Suchira/0000-0002-1956-3597; /0000-0003-4243-4950; Scherer, Thomas/0000-0003-4980-706X; Merkler, Doron/0000-0002-0247-2007	European Research Council under the European Union's Seventh Framework Programme; Horizon 2020 research and innovation program from the German Research Council [677006, 340896, SFB974, KFO217, LA-2558/5-1]; Austrian Science Fund [FWF P26766]; US National Institutes of Health [R01AI032972, U19AI100627]; DOC fellowships of the Austrian Academy of Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI032972] Funding Source: NIH RePORTER	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Horizon 2020 research and innovation program from the German Research Council; Austrian Science Fund(Austrian Science Fund (FWF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOC fellowships of the Austrian Academy of Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Niggemeyer, S. Jungwirth and J. Riede for animal husbandry. The authors would like to thank L. Bakiri, V. Baracos, Y. Belkaid, R. Medzhitov, G. Superti-Furga, E. Wagner and R. M. Zinkernagel for valuable feedback and discussions. This project has received funding from the European Research Council under the European Union's Seventh Framework Programme and Horizon 2020 research and innovation program (grant agreement no. 677006, 'CMIL' to A. B., no. 340896 and 'LipoCheX' to R. Z.) from the German Research Council (grant nos. SFB974, KFO217, LA-2558/5-1 and Jurgen Manchot Graduate School MOI III to P.A.L.), from the Austrian Science Fund (grant no. FWF P26766 to T.S.) and from the US National Institutes of Health (grant nos. R01AI032972, U19AI100627 to A. Aderem). A.L. and M. Smyth are supported by DOC fellowships of the Austrian Academy of Sciences.	Baatar D, 2011, MOL CELL ENDOCRINOL, V340, P44, DOI 10.1016/j.mce.2011.04.019; Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Danai LV, 2018, NATURE, V558, P600, DOI 10.1038/s41586-018-0235-7; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DOHERTY PC, 1993, J NEUROIMMUNOL, V46, P11, DOI 10.1016/0165-5728(93)90228-Q; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Flint TR, 2017, TRENDS MOL MED, V23, P451, DOI 10.1016/j.molmed.2017.03.001; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Hildeman D, 2000, VIRAL IMMUNOL, V13, P273, DOI 10.1089/08828240050144617; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kamperschroer C, 2002, J IMMUNOL, V169, P340, DOI 10.4049/jimmunol.169.1.340; Kandarian SC, 2018, J CACHEXIA SARCOPENI, V9, P1109, DOI 10.1002/jcsm.12346; Kir S, 2016, CELL METAB, V23, P315, DOI 10.1016/j.cmet.2015.11.003; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KOMURO K, 1975, IMMUNOGENETICS, V1, P452; Kotler D, 2004, JAIDS-J ACQ IMM DEF, V37, pS280, DOI 10.1097/01.qai.0000144383.55091.c1; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Miller AH, 1997, PSYCHONEUROENDOCRINO, V22, P455, DOI 10.1016/S0306-4530(97)00028-0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nencioni A, 2018, NAT REV CANCER, V18, P707, DOI 10.1038/s41568-018-0061-0; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Patel HJ, 2017, LIFE SCI, V170, P56, DOI 10.1016/j.lfs.2016.11.033; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Peschon JJ, 1998, J IMMUNOL, V160, P943; Petruzzelli M, 2016, GENE DEV, V30, P489, DOI 10.1101/gad.276733.115; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Prigge JR, 2015, J IMMUNOL, V195, P5347, DOI 10.4049/jimmunol.1501553; Quatrini L, 2018, NAT IMMUNOL, V19, P954, DOI 10.1038/s41590-018-0185-0; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Ruud J, 2015, NATURE, V527, P43, DOI 10.1038/527043a; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sitnick MT, 2013, DIABETES, V62, P3350, DOI 10.2337/db13-0500; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stamm A, 2012, VIROLOGY, V425, P122, DOI 10.1016/j.virol.2012.01.005; Sullivan BM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004588; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; Vaitkus JA, 2017, EXP BIOL MED, V242, P473, DOI 10.1177/1535370216683282; Vegiopoulos A, 2017, EMBO J, V36, P1999, DOI 10.15252/embj.201696206; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Von Haehling S., 2014, INT J CARDIOL, V184, P726; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	63	35	35	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					701	+		10.1038/s41590-019-0397-y	http://dx.doi.org/10.1038/s41590-019-0397-y			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31110314	Green Accepted			2022-12-18	WOS:000468505100013
J	Ji, YW; Sun, SY; Shrestha, N; Darragh, LB; Shirakawa, J; Xing, Y; He, Y; Carboneau, BA; Kim, H; An, D; Ma, ML; Oberholzer, J; Soleimanpour, SA; Gannon, M; Liu, CY; Naji, A; Kulkarni, RN; Wang, Y; Kersten, S; Qi, L				Ji, Yewei; Sun, Shengyi; Shrestha, Neha; Darragh, Laurel B.; Shirakawa, Jun; Xing, Yuan; He, Yi; Carboneau, Bethany A.; Kim, Hana; An, Duo; Ma, Minglin; Oberholzer, Jose; Soleimanpour, Scott A.; Gannon, Maureen; Liu, Chengyang; Naji, Ali; Kulkarni, Rohit N.; Wang, Yong; Kersten, Sander; Qi, Ling			Toll-like receptors TLR2 and TLR4 block the replication of pancreatic beta cells in diet-induced obesity	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; PRIMARY MECHANISM; CYCLIN D2; MICE; PROLIFERATION; ACTIVATION; EXPRESSION	Consumption of a high-energy Western diet triggers mild adaptive beta cell proliferation to compensate for peripheral insulin resistance; however, the underlying molecular mechanism remains unclear. In the present study we show that the toll-like receptors TLR2 and TLR4 inhibited the diet-induced replication of beta cells in mice and humans. The combined, but not the individual, loss of TLR2 and TLR4 increased the replication of beta cells, but not that of alpha cells, leading to enlarged beta cell area and hyperinsulinemia in diet-induced obesity. Loss of TLR2 and TLR4 increased the nuclear abundance of the cell cycle regulators cyclin D2 and Cdk4 in a manner dependent on the signaling mediator Erk. These data reveal a regulatory mechanism controlling the proliferation of beta cells in diet-induced obesity and suggest that selective targeting of the TLR2/TLR4 pathways may reverse beta cell failure in patients with diabetes.	[Ji, Yewei; Shrestha, Neha; Qi, Ling] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ji, Yewei; Sun, Shengyi; Darragh, Laurel B.; Kim, Hana; Kersten, Sander; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Shirakawa, Jun; Kulkarni, Rohit N.] Harvard Med Sch, Sect Islet Cell & Regenerat Biol, Joslin Diabet Ctr, Dept Med,Brigham & Womens Hosp,Harvard Stem Cell, Boston, MA 02115 USA; [Xing, Yuan; He, Yi; Oberholzer, Jose; Wang, Yong] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Carboneau, Bethany A.; Gannon, Maureen] Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Nashville, TN USA; [An, Duo; Ma, Minglin] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Soleimanpour, Scott A.; Qi, Ling] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Liu, Chengyang; Naji, Ali] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Sun, Shengyi] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Ctr Mol Med & Genet, Detroit, MI USA; [Darragh, Laurel B.] Univ Colorado, Dept Radiat Oncol, Sch Med, Aurora, CO USA; [Kim, Hana] XBiotech USA Inc, Austin, TX USA	University of Michigan System; University of Michigan; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Virginia; Vanderbilt University; Cornell University; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Wageningen University & Research; Wayne State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Qi, L (corresponding author), Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Qi, L (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.; Qi, L (corresponding author), Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA.	lingq@med.umich.edu	Shrestha, Neha/AAA-3671-2022	Shrestha, Neha/0000-0003-2069-1825; Sun, Shengyi/0000-0002-1734-3902; Soleimanpour, Scott/0000-0001-6777-4498; Shirakawa, Jun/0000-0002-0822-8750; Darragh, Laurel/0000-0002-6445-7988; Ji, Yewei/0000-0003-4960-9928	National Cancer Institute of the NIH [P30CA046592]; NIH [R01DK108921, R03 DK106304, R01DK091526, U01 DK070430, R01DK67536, R01DK103215, R01DK11174, R01DK117639]; Juvenile Diabetes Research Foundation (JDRF) [CDA-2016-189]; VA Merit award 1 [I01 BX003744-01]; JDRF Microfluidic-Based Functional Facility at the University of Illinois at Chicago; Chicago Diabetes Project; NIDDK/City of Hope Integrated Islet Distribution Program; JDRF [47-2012-767, 1-SRA-2014-251-Q-R]; American Heart Association Scientist Development [17SDG33670192]; Michigan Nutrition Obesity Research Center Pilot/Feasibility grant [P30DK089503]; Junior Faculty and Career Development Awards from the American Diabetes Association; Howard Hughes Medical Institute [59107338]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111174, P30DK089503, R01DK117639, R01DK108921, P30DK058404, R01DK103215, P30DK020572, R01DK067536, P30DK036836] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003744] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); VA Merit award 1(US Department of Veterans Affairs); JDRF Microfluidic-Based Functional Facility at the University of Illinois at Chicago; Chicago Diabetes Project; NIDDK/City of Hope Integrated Islet Distribution Program; JDRF(Juvenile Diabetes Research Foundation); American Heart Association Scientist Development(American Heart Association); Michigan Nutrition Obesity Research Center Pilot/Feasibility grant; Junior Faculty and Career Development Awards from the American Diabetes Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank L. Hajjar and D. Russell for sharing reagents, Histology and Vision Research Core Facilities at the University of Michigan Medical School and the TEM core facility at the Weill Cornell Medical College for their assistance, and P. Arvan and R.B. Reinert, G. H. Kim and X. Shu, as well as other members of the Qi/Arvan labs and islet club at University of Michigan Diabetes Center, for comments and technical assistance. The Histology Core at the University of Michigan Medical School was supported by the National Cancer Institute of the NIH (award no. P30CA046592). This work was supported by NIH (grant nos. R01DK108921, R03 DK106304), and Juvenile Diabetes Research Foundation (JDRF; grant no. CDA-2016-189; to S.A.S.), VA Merit award 1 (no. I01 BX003744-01 to M.G.), NIH (grant no. R01DK091526), JDRF Microfluidic-Based Functional Facility at the University of Illinois at Chicago, and the Chicago Diabetes Project (to J.O. and Y.W.), NIH (grant no. U01 DK070430) and NIDDK/City of Hope Integrated Islet Distribution Program (to A.N.), NIH (grant nos. R01DK67536, R01DK117639 and R01DK103215 to R.N.K.), and JDRF (grant nos. 47-2012-767 and 1-SRA-2014-251-Q-R), NIH (grant nos. R01DK11174 and R01DK117639; to L.Q.). Y.J. is supported by American Heart Association Scientist Development (grant no. 17SDG33670192) and Michigan Nutrition Obesity Research Center Pilot/Feasibility grant (no. P30DK089503). S.S. was an international student research fellow of the Howard Hughes Medical Institute (no. 59107338) and a Helen Hay Whitney Postdoctoral Fellow. L. Q. is the recipient of the Junior Faculty and Career Development Awards from the American Diabetes Association.	Adewola AF, 2010, BIOMED MICRODEVICES, V12, P409, DOI 10.1007/s10544-010-9398-1; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Brissova M, 2014, CELL METAB, V19, P498, DOI 10.1016/j.cmet.2014.02.001; Carofano A, 2000, FASEB J, V14, P2611, DOI 10.1096/fj.00-0015com; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Cox AR, 2016, DIABETOLOGIA, V59, P1231, DOI 10.1007/s00125-016-3922-7; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Golson ML, 2010, OPEN ENDOCRINOL, V4, P66, DOI [10.2174/1874216501004010066, DOI 10.2174/1874216501004010066]; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Ji YW, 2014, CELL REP, V8, P137, DOI 10.1016/j.celrep.2014.05.040; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li Q, 2017, ENDOCRINOLOGY, V158, P1634, DOI 10.1210/en.2016-1551; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Razolli DS, 2015, ENDOCRINOLOGY, V156, P103, DOI 10.1210/en.2014-1552; Ricordi C, 2016, DIABETES, V65, P3418, DOI 10.2337/db16-0234; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Sha HB, 2014, CELL METAB, V20, P458, DOI 10.1016/j.cmet.2014.06.015; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stamateris RE, 2013, AM J PHYSIOL-ENDOC M, V305, pE149, DOI 10.1152/ajpendo.00040.2013; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Szot Gregory L, 2007, J Vis Exp, P404, DOI 10.3791/404; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Wang P, 2015, NAT REV ENDOCRINOL, V11, P201, DOI 10.1038/nrendo.2015.9; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xing Y, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0109-4; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096; 2017, MOL METAB, V6, P548, DOI DOI 10.1016/J.MOLMET.2017.04.002	55	35	39	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					677	+		10.1038/s41590-019-0396-z	http://dx.doi.org/10.1038/s41590-019-0396-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31110312	Green Accepted			2022-12-18	WOS:000468505100011
J	Lu, Y; Zhong, MC; Qian, J; Calderon, V; Tleugabulova, MC; Mallevaey, T; Veillette, A				Lu, Yan; Zhong, Ming-Chao; Qian, Jin; Calderon, Virginie; Tleugabulova, Mayra Cruz; Mallevaey, Thierry; Veillette, Andre			SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; FAMILY RECEPTORS; SAP ADAPTERS; LY108; ACTIVATION; MICE; EXPRESSION; INDUCTION; DELETION; IMMUNITY	Invariant natural killer T cells (iNKT cells) develop through an incompletely understood process that requires positive selection by CD4(+) CD8(+) double-positive thymocytes and SLAM family receptors (SFRs). Here we found that SFRs promoted the development of iNKT cells by reducing the strength of the T cell antigen receptor (TCR) signal after positive selection. This effect improved the survival of iNKT cells and their responses to antigen. Loss of SFRs upregulated the expression of inhibitory receptors, including PD-1, on iNKT cells to mitigate the deleterious effect of SFR deficiency. The role of SFRs could be mimicked by expression of SLAMF6 alone in SFR-deficient mice, and this involved the adaptor SAP-kinase Fyn complex and the phosphatase SHP-1. Thus, SFRs foster iNKT cell development by attenuating TCR signal strength after positive selection.	[Lu, Yan; Zhong, Ming-Chao; Qian, Jin; Veillette, Andre] Inst Rech Clin Montreal, Lab Mol Oncol, Montreal, PQ, Canada; [Calderon, Virginie] Inst Rech Clin Montreal, Bioinformat Core Facil, Montreal, PQ, Canada; [Tleugabulova, Mayra Cruz; Mallevaey, Thierry] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Mallevaey, Thierry] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Toronto; University of Toronto; Universite de Montreal; McGill University	Veillette, A (corresponding author), Inst Rech Clin Montreal, Lab Mol Oncol, Montreal, PQ, Canada.; Veillette, A (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.; Veillette, A (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	andre.veillette@ircm.qc.ca	Lu, Yan/AAX-7831-2020; Mallevaey, Thierry/AAH-4499-2020	Lu, Yan/0000-0002-5893-6114; 	International Development Research Centre [108403]; Canadian Institutes of Health Research [MOP-114911, MT-14429, MOP-82906, FDN-143338]; Bristol Myers-Squibb	International Development Research Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bristol Myers-Squibb(Bristol-Myers Squibb)	We thank members of the Veillette laboratory for useful discussions. We also acknowledge T. Honjo (Kyoto), B. Neel (New York) and T. Moroy (Montreal) for providing mice. This work was supported by grants from the International Development Research Centre (Project #108403 to A. V.) and the Canadian Institutes of Health Research (MOP-114911 to T.M.; MT-14429, MOP-82906, FDN-143338 to A. V.). A. V. also receives a contract from Bristol Myers-Squibb to study the mechanism of action of anti-SLAMF7 monoclonal antibody elotuzumab in multiple myeloma. T.M. holds the Canada Research Chair in NKT cell Immunobiology, while A. V. holds the Canada Research Chair on Signaling in the Immune System.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bedel R, 2014, P NATL ACAD SCI USA, V111, pE119, DOI 10.1073/pnas.1320777110; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chen J, 2017, NATURE, V544, P493, DOI 10.1038/nature22076; Chen SS, 2017, J EXP MED, V214, P475, DOI 10.1084/jem.20161312; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crosby CM, 2018, NAT REV IMMUNOL, V18, P559, DOI 10.1038/s41577-018-0034-2; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; De Calisto J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00186; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dutta M, 2013, J IMMUNOL, V190, P2121, DOI 10.4049/jimmunol.1202145; Dutta M, 2012, J IMMUNOL, V188, P3031, DOI 10.4049/jimmunol.1103226; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Guo HJ, 2016, J EXP MED, V213, P2187, DOI 10.1084/jem.20160552; Hu JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156074; Huang BN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156072; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Krovi SH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01393; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Siegemund S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124661; Tuttle KD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05026-6; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang HG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01450; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu N, 2016, NAT IMMUNOL, V17, P387, DOI 10.1038/ni.3369; Wu N, 2016, CURR OPIN IMMUNOL, V38, P45, DOI 10.1016/j.coi.2015.11.003; Zhong MC, 2013, J BIOL CHEM, V288, P31423, DOI 10.1074/jbc.M113.473736; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	45	35	35	4	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					447	+		10.1038/s41590-019-0334-0	http://dx.doi.org/10.1038/s41590-019-0334-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30833791				2022-12-18	WOS:000461904200015
J	Newton, RH; Shrestha, S; Sullivan, JM; Yates, KB; Compeer, EB; Ron-Harell, N; Blazar, BR; Bensinger, SJ; Haining, WN; Dustin, ML; Campbell, DJ; Chi, HB; Turka, LA				Newton, Ryan H.; Shrestha, Sharad; Sullivan, Jenna M.; Yates, Kathleen B.; Compeer, Ewoud B.; Ron-Harell, Noga; Blazar, Bruce R.; Bensinger, Steven J.; Haining, W. Nicholas; Dustin, Michael L.; Campbell, Daniel J.; Chi, Hongbo; Turka, Laurence A.			Maintenance of CD4 T cell fitness through regulation of Foxo1	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; RAG GTPASES; MTORC1; DIFFERENTIATION; ACTIVATION; EXPRESSION; COUPLES; KINASE; INTERLEUKIN-2; QUIESCENCE	Foxo transcription factors play an essential role in regulating specialized lymphocyte functions and in maintaining T cell quiescence. Here, we used a system in which Foxo1 transcription-factor activity, which is normally terminated upon cell activation, cannot be silenced, and we show that enforcing Foxo1 activity disrupts homeostasis of CD4 conventional and regulatory T cells. Despite limiting cell metabolism, continued Foxo1 activity is associated with increased activation of the kinase Akt and a cellintrinsic proliferative advantage; however, survival and cell division are decreased in a competitive setting or growth-factorlimiting conditions. Via control of expression of the transcription factor Myc and the IL-2 receptor P-chain, termination of Foxo1 signaling couples the increase in cellular cholesterol to biomass accumulation after activation, thereby facilitating immunological synapse formation and mTORC1 activity. These data reveal that Foxo1 regulates the integration of metabolic and mitogenic signals essential for T cell competitive fitness and the coordination of cell growth with cell division.	[Newton, Ryan H.; Turka, Laurence A.] Massachusetts Gen Hosp, Ctr Transplantat Sci, Dept Surg, Boston, MA 02114 USA; [Newton, Ryan H.; Turka, Laurence A.] Harvard Med Sch, Boston, MA 02115 USA; [Shrestha, Sharad; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Sullivan, Jenna M.; Campbell, Daniel J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Sullivan, Jenna M.; Campbell, Daniel J.] Benaroya Res Inst, Immunol Program, Seattle, WA USA; [Yates, Kathleen B.; Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA 02115 USA; [Yates, Kathleen B.; Haining, W. Nicholas; Dustin, Michael L.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Compeer, Ewoud B.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford, England; [Ron-Harell, Noga] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Newton, Ryan H.] Celsius Therapeut, Cambridge, MA USA; [Turka, Laurence A.] Rheos Med, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; Benaroya Research Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles	Turka, LA (corresponding author), Massachusetts Gen Hosp, Ctr Transplantat Sci, Dept Surg, Boston, MA 02114 USA.; Turka, LA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Turka, LA (corresponding author), Rheos Med, Cambridge, MA 02139 USA.	Iturka@rheosrx.com	Compeer, Ewoud Bernardus/E-8553-2015; Dustin, Michael/AAM-4611-2020; Chi, Hongbo/M-9397-2018	Compeer, Ewoud Bernardus/0000-0002-3050-7633; Chi, Hongbo/0000-0002-9997-2496; Dustin, Michael/0000-0003-4983-6389	US National Institutes of Health [P01HL018646, R21AI126143, R01A1124693, R01HL011879, P01AI056299, AI101407, CA176624]; Wellcome Trust [PRF I00262]; European Research Council [ERC-2014-AdG_670930]; NATIONAL CANCER INSTITUTE [R01CA176624, P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067, P01HL018646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, T32AI106677, R01AI124693, R21AI126143, U19AI051731, R01AI101407] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Li (Memorial Sloan Kettering Cancer Center) for Foxol<SUP>AAA</SUP> mice; F. Gounari (University of Chicago) for CD4<SUP>Cre-ERT2</SUP> mice; M. Farrar (University of Minnesota) for a constitutively active STAT5b retroviral construct; Z. Herbert and K. Bi for assistance with transcriptome analysis; the MGH-CNY FACS core facility for cell sorting; and members of the laboratory of L.A.T. for discussions. This work was supported by the US National Institutes of Health (P01HL018646 to L.A.T.; R21AI126143 to L.A.T. and R.H.N.; R01A1124693 to D.J.C.; R01HL011879 and P01AI056299 to B.R.B.; AI101407 and CA176624 to H.C.), the Wellcome Trust (PRF I00262 to M.L.D.) and the European Research Council (ERC-2014-AdG_670930 to M.L.D. and E.B.C.).	Aghajani K, 2012, GENESIS, V50, P908, DOI 10.1002/dvg.22052; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Castellano BM, 2017, SCIENCE, V355, P1306, DOI 10.1126/science.aag1417; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Hecht VC, 2016, J CELL BIOL, V212, P439, DOI 10.1083/jcb.201506118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lord JD, 1998, J IMMUNOL, V161, P4627; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	46	35	36	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					838	+		10.1038/s41590-018-0157-4	http://dx.doi.org/10.1038/s41590-018-0157-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	29988091	Green Accepted, Green Submitted			2022-12-18	WOS:000439470900020
J	Xu, X; Xu, JF; Zheng, GX; Lu, HW; Duan, JL; Rui, W; Guan, JH; Cheng, LQ; Yang, DD; Wang, MC; Lv, QZ; Li, JX; Zhao, XQ; Chen, CX; Shi, P; Jia, XM; Lin, X				Xu, Xia; Xu, Jin-Fu; Zheng, Guoxing; Lu, Hai-Wen; Duan, Jie-Lin; Rui, Wei; Guan, Jian-Hong; Cheng, Li-Qing; Yang, Dan-Dan; Wang, Ming-Chao; Lv, Quan-Zhen; Li, Jian-Xiong; Zhao, Xueqiang; Chen, Chun-Xia; Shi, Peng; Jia, Xin-Ming; Lin, Xin			CARD9(S12N) facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses	NATURE IMMUNOLOGY			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; COLITIS SUSCEPTIBILITY LOCI; NF-KAPPA-B; CYSTIC-FIBROSIS; AIRWAY HYPERRESPONSIVENESS; EOSINOPHILIC ASTHMA; ANTIFUNGAL IMMUNITY; CARD9 DEFICIENCY; FUNGAL-INFECTION; BONE-MARROW	The adaptor CARD9 functions downstream of C-type lectin receptors (CLRs) for the sensing of microbial infection, which leads to responses by the T(H)1 and T(H)17 subsets of helper T cells. The single-nucleotide polymorphism rs4077515 at CARD9 in the human genome, which results in the substitution(S12N) (CARD9(S12N)), is associated with several autoimmune diseases. However, the function of CARD9(S12N) has remained unknown. Here we generated CARD9(S12N) knock-in mice and found that CARD9(S12N) facilitated the induction of type 2 immune responses after engagement of CLRs. Mechanistically, CARD9(S12N) mediated CLR-induced activation of the non-canonical transcription factor NF-kappa B subunit RelB, which initiated production of the cytokine IL-5 in alveolar macrophages for the recruitment of eosinophils to drive T(H)2 cell-mediated allergic responses. We identified the homozygous CARD9 mutation encoding S12N in patients with allergic bronchopulmonary aspergillosis and revealed activation of RelB and production of IL-5 in peripheral blood mononuclear cells from these patients. Our study provides genetic and functional evidence demonstrating that CARD9(S12N) can turn alveolar macrophages into IL-5-producing cells and facilitates TH2 cell-mediated pathologic responses.	[Xu, Xia; Duan, Jie-Lin; Guan, Jian-Hong; Lv, Quan-Zhen; Chen, Chun-Xia; Jia, Xin-Ming] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Clin Translat Res Ctr, Shanghai, Peoples R China; [Xu, Xia; Zheng, Guoxing; Rui, Wei; Cheng, Li-Qing; Yang, Dan-Dan; Wang, Ming-Chao; Zhao, Xueqiang; Lin, Xin] Tsinghua Univ, Peking Univ Joint Ctr Life Sci, Inst Immunol, Sch Med, Beijing, Peoples R China; [Xu, Jin-Fu; Lu, Hai-Wen; Li, Jian-Xiong] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai, Peoples R China; [Shi, Peng] Fudan Univ, Childrens Hosp, Med Stat Dept, Shanghai, Peoples R China	Tongji University; Tsinghua University; Tongji University; Fudan University	Jia, XM (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Med, Clin Translat Res Ctr, Shanghai, Peoples R China.	jiaxm@tongji.edu.cn; linxin307@tsinghua.edu.cn	Xu, Jin-fu/AAC-6980-2020	Xu, Jin-fu/0000-0002-8039-8973	National Natural Science Foundation of China [31622023, 81571611, 81630058, 91542107]; Outstanding academic leader program of Shanghai health and Family Planning Commission [2017BR024]; Shanghai laboratory animal research fund [16140902600]; Shuguang Program of Shanghai Education Development Foundation [17SG24]; Shuguang Program of Shanghai Municipal Education Commission [17SG24]; Tsinghua University-Peking University Joint Center for Life Sciences (Tsinghua University); Shanghai Leading Talent Program [2016036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding academic leader program of Shanghai health and Family Planning Commission; Shanghai laboratory animal research fund; Shuguang Program of Shanghai Education Development Foundation; Shuguang Program of Shanghai Municipal Education Commission; Tsinghua University-Peking University Joint Center for Life Sciences (Tsinghua University); Shanghai Leading Talent Program	This work was supported by the National Natural Science Foundation of China (31622023 and 81571611 to X.M.J, 81630058 and 91542107 to X.L.), Outstanding academic leader program of Shanghai health and Family Planning Commission (2017BR024 to X.M.J.), Shanghai laboratory animal research fund (16140902600 to X.M.J), Shuguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission (17SG24 to X.M.J.), a start-up fund from the Tsinghua University-Peking University Joint Center for Life Sciences (with grants from Tsinghua University to X.L.) and Shanghai Leading Talent Program (2016036 to J.F.X).	Ader F, 2005, CLIN MICROBIOL INFEC, V11, P427, DOI 10.1111/j.1469-0691.2005.01143.x; Bailey E, 2013, P NATL ACAD SCI USA, V110, P21113, DOI 10.1073/pnas.1310559110; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brouard J, 2005, J INFECT DIS, V191, P1988, DOI 10.1086/429964; Burghardt KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085915; Chauhan B, 1997, J IMMUNOL, V159, P4072; Chauhan B, 1996, J CLIN INVEST, V97, P2324, DOI 10.1172/JCI118675; DUBUCQUOI S, 1994, J EXP MED, V179, P703, DOI 10.1084/jem.179.2.703; Faccioli LH, 1996, MEDIAT INFLAMM, V5, P24, DOI 10.1155/S096293519600004X; Fei MJ, 2011, P NATL ACAD SCI USA, V108, P5360, DOI 10.1073/pnas.1015476108; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gavino C, 2014, CLIN INFECT DIS, V59, P81, DOI 10.1093/cid/ciu215; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Ghazi A, 2012, EXPERT OPIN BIOL TH, V12, P113, DOI 10.1517/14712598.2012.642359; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hamelmann E, 1997, AM J RESP CELL MOL, V16, P674, DOI 10.1165/ajrcmb.16.6.9191469; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Hogan MB, 2000, J ALLERGY CLIN IMMUN, V106, P329, DOI 10.1067/mai.2000.108309; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Janse M, 2011, HEPATOLOGY, V53, P1977, DOI 10.1002/hep.24307; Jhingran A, 2012, CELL REP, V2, P1762, DOI 10.1016/j.celrep.2012.10.026; Jia XM, 2014, J EXP MED, V211, P2307, DOI 10.1084/jem.20132349; Karta MR, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0581-6; Kauffman HF, 2003, FRONT BIOSCI-LANDMRK, V8, pE190, DOI 10.2741/990; Knutsen AP, 2004, ALLERGY, V59, P81, DOI 10.1046/j.1398-9995.2003.00129.x; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Loures FV, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004643; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miller PW, 1996, AM J HUM GENET, V59, P45; Mori A, 1999, J IMMUNOL, V163, P4763; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rivera A, 2006, IMMUNITY, V25, P665, DOI 10.1016/j.immuni.2006.08.016; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Robinson DS, 2013, EXPERT REV RESP MED, V7, P13, DOI [10.1586/ers.12.84, 10.1586/ERS.12.84]; Rosentul DC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00483; Rosentul DC, 2011, J INFECT DIS, V204, P1138, DOI 10.1093/infdis/jir458; Sauer KA, 2006, NAT PROTOC, V1, P2870, DOI 10.1038/nprot.2006.435; Saxena S, 2003, J ALLERGY CLIN IMMUN, V111, P1001, DOI 10.1067/mai.2003.1395; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stranick KS, 1997, J BIOL CHEM, V272, P16453, DOI 10.1074/jbc.272.26.16453; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Walsh GM, 2013, BIOL-TARGETS THER, V7, P7, DOI 10.2147/BTT.S30133; Wilson SJ, 2000, CLIN EXP ALLERGY, V30, P493; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhao XQ, 2014, J BIOL CHEM, V289, P30052, DOI 10.1074/jbc.M114.588574; Zhao XQ, 2017, NAT MED, V23, P337, DOI 10.1038/nm.4260	58	35	39	4	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					547	+		10.1038/s41590-018-0112-4	http://dx.doi.org/10.1038/s41590-018-0112-4			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777223				2022-12-18	WOS:000433041500021
J	[Anonymous]				[Anonymous]			A current view on inflammation	NATURE IMMUNOLOGY			English	Editorial Material																			0	35	37	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					825	825		10.1038/ni.3798	http://dx.doi.org/10.1038/ni.3798			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722714	Bronze			2022-12-18	WOS:000405821100001
J	Dashtsoodol, N; Shigeura, T; Aihara, M; Ozawa, R; Kojo, S; Harada, M; Endo, TA; Watanabe, T; Ohara, O; Taniguchi, M				Dashtsoodol, Nyambayar; Shigeura, Tomokuni; Aihara, Minako; Ozawa, Ritsuko; Kojo, Satoshi; Harada, Michishige; Endo, Takaho A.; Watanabe, Takashi; Ohara, Osamu; Taniguchi, Masaru			Alternative pathway for the development of V(alpha)14(+) NKT cells directly from CD4(-)CD8(-) thymocytes that bypasses the CD4(+)CD8(+) stage	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; ROR-GAMMA-T; ALPHA-BETA; RECEPTOR; RECOGNITION; REPERTOIRE; EXPRESSION; LINEAGE; GENE; MIGRATION	Although invariant V(alpha)14(+)-natural killer T cells (NKT cells) are thought to be generated from CD4(+)CD8(+) double-positive (DP) thymocytes, the developmental origin of CD4(-)CD8(-) double-negative (DN) NKT cells still remains unresolved. Here we provide definitive genetic evidence obtained, through studies of mice with DP-stage-specific ablation of expression of the gene encoding the recombinase component RAG-2 (Rag2) and by a fate-mapping approach, that supports the proposal of the existence of an alternative developmental pathway through which a fraction of DN NKT cells with strong T-helper-type-1 (T(H)1)-biased and cytotoxic characteristics develop from late DN-stage thymocytes, bypassing the DP stage. These findings provide new insight into understanding of the development of NKT cells and propose a role for timing of expression of the invariant T cell antigen receptor. in determining the functional properties of NKT cells.	[Dashtsoodol, Nyambayar; Shigeura, Tomokuni; Aihara, Minako; Ozawa, Ritsuko; Kojo, Satoshi; Harada, Michishige; Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci, Lab Immune Regulat, Yokohama, Kanagawa, Japan; [Dashtsoodol, Nyambayar] Mongolian Natl Univ Med Sci, Core Res Lab, Ulaanbaatar, Mongolia; [Endo, Takaho A.; Watanabe, Takashi; Ohara, Osamu] RIKEN, Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa, Japan	RIKEN; Mongolian National University of Medical Sciences; RIKEN	Dashtsoodol, N; Taniguchi, M (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Immune Regulat, Yokohama, Kanagawa, Japan.; Dashtsoodol, N (corresponding author), Mongolian Natl Univ Med Sci, Core Res Lab, Ulaanbaatar, Mongolia.	nyambayar.dashtsoodol@riken.jp; masaru.taniguchi@riken.jp	Ohara, Osamu/G-5448-2015; Kojo, Satoshi/N-7135-2018	Ohara, Osamu/0000-0002-3328-9571; Kojo, Satoshi/0000-0002-9263-8831; Dashtsoodol, Nyambayar/0000-0003-4890-9267	Japan Society for the Promotion of Science (KAKENHI) [24790490, 23229005]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Singer (US National Institutes of Health) for E8<INF>III</INF>-Cre mice; F. Constantini (Columbia University) for Rosa26-YFP mice; D. Littman (New York University) for Rorc<SUP>-/-</SUP> mice; P. Burrows for critical reading of this manuscript; T. Hasegawa for support with animal facility services; and N. Takeuchi for secretarial assistance. Supported by the Japan Society for the Promotion of Science (KAKENHI grants 24790490 to N.D. and 23229005 to AT.).	Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Crispe IN, 2012, J HEPATOL, V57, P218, DOI 10.1016/j.jhep.2011.12.035; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dashtsoodol N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003688; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Genolet R, 2012, EMBO J, V31, P1666, DOI 10.1038/emboj.2012.48; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Hendricks DW, 2009, J IMMUNOL, V182, P4267, DOI 10.4049/jimmunol.0804180; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kanno Rieko, 1994, P193; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Laky K, 2007, J EXP MED, V204, P2115, DOI 10.1084/jem.20070550; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Levanon D, 2007, NAT IMMUNOL, V8, P145; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Shimizu K, 2013, J IMMUNOL, V190, P5609, DOI 10.4049/jimmunol.1300033; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	38	35	35	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					274	282		10.1038/ni.3668	http://dx.doi.org/10.1038/ni.3668			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28135253				2022-12-18	WOS:000394413400007
J	Dufner, A; Kisser, A; Niendorf, S; Basters, A; Reissig, S; Schonle, A; Aichem, A; Kurz, T; Schlosser, A; Yablonski, D; Groettrup, M; Buch, T; Waisman, A; Schamel, WW; Prinz, M; Knobeloch, KP				Dufner, Almut; Kisser, Agnes; Niendorf, Sandra; Basters, Anja; Reissig, Sonja; Schoenle, Anne; Aichem, Annette; Kurz, Thorsten; Schlosser, Andreas; Yablonski, Deborah; Groettrup, Marcus; Buch, Thorsten; Waisman, Ari; Schamel, Wolfgang W.; Prinz, Marco; Knobeloch, Klaus-Peter			The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells	NATURE IMMUNOLOGY			English	Article							STRUCTURAL BASIS; RECEPTOR; BINDING; SLP-76; NAIVE; DIFFERENTIATION; SURVIVAL; DOMAIN; FOXO1; UBPY	The modification of proteins by ubiquitin has a major role in cells of the immune system and is counteracted by various deubiquitinating enzymes (DUBs) with poorly defined functions. Here we identified the ubiquitin-specific protease USP8 as a regulatory component of the T cell antigen receptor (TCR) signalosome that interacted with the adaptor Gads and the regulatory molecule 14-3-3 beta 3. Caspase-dependent processing of USP8 occurred after stimulation of the TCR. T cell-specific deletion of USP8 in mice revealed that USP8 was essential for thymocyte maturation and upregulation of the gene encoding the cytokine receptor IL-7R alpha mediated by the transcription factor Foxo1. Mice with T cell-specific USP8 deficiency developed colitis that was promoted by disturbed T cell homeostasis, a predominance of CD8(+) gamma delta T cells in the intestine and impaired regulatory T cell function. Collectively, our data reveal an unexpected role for USP8 as an immunomodulatory DUB in T cells.	[Dufner, Almut; Basters, Anja; Schoenle, Anne; Prinz, Marco; Knobeloch, Klaus-Peter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Kisser, Agnes; Niendorf, Sandra; Knobeloch, Klaus-Peter] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Reissig, Sonja; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Aichem, Annette; Groettrup, Marcus] Univ Konstanz, Biotechnol Inst Thurgau, Kreuzlingen, Switzerland; [Kurz, Thorsten; Schlosser, Andreas] Univ Freiburg, Ctr Biol Syst Anal, D-79106 Freiburg, Germany; [Yablonski, Deborah] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Groettrup, Marcus] Univ Konstanz, Dept Biol, Div Immunol, Constance, Germany; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Buch, Thorsten] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Schamel, Wolfgang W.] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79106 Freiburg, Germany; [Schamel, Wolfgang W.] Univ Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg, Germany; [Schamel, Wolfgang W.; Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Johannes Gutenberg University of Mainz; University of Freiburg; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Konstanz; Technical University of Munich; University of Zurich; University of Freiburg; University of Freiburg; University of Freiburg	Knobeloch, KP (corresponding author), Ludwig Boltzmann Inst Hlth Technol Assessment, Vienna, Austria.	almut.dufner@uniklinik-freiburg.de; klaus-peterknobeloch@uniklinik-freiburg.de	Waisman, Ari/C-7383-2015; Groettrup, Marcus/AAT-2623-2020; Buch, Thorsten/P-1659-2019	Waisman, Ari/0000-0003-4304-8234; Buch, Thorsten/0000-0002-2236-9074; Yablonski, Deborah/0000-0003-2979-0440	Deutsche Forschungsgemeinschaft [KN590/4-1, EXC294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Oberle, C. Fix, T. el Gaz, A. Nikolaev and T. Bass for technical assistance; J. Wersing for cell sorting; S. Hemmers for support with generation of the Cd4-CreER<SUP>T2</SUP> mice; A. Izcue for protocols; S. Feller (University of Halle) and E. Martegani (University of Milano-Bicocca) for anti-USP8 antiserum; and R. Beyaert (University of Ghent) for tagged ubiquitin-expression vectors. Supported by Deutsche Forschungsgemeinschaft (KN590/4-1 to K.-P.K.; support via EXC294 (the Center for Biological Signaling Studies) to W.W.S.).	Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Heissmeyer V, 2013, IMMUNOL REV, V253, P273, DOI 10.1111/imr.12056; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Ketscher L, 2015, P NATL ACAD SCI USA, V112, P1577, DOI 10.1073/pnas.1412881112; Lasserre R, 2011, J CELL BIOL, V195, P839, DOI 10.1083/jcb.201103105; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Naik E, 2014, J EXP MED, V211, P1947, DOI 10.1084/jem.20140860; Nanno M, 2008, GASTROENTEROLOGY, V134, P481, DOI 10.1053/j.gastro.2007.11.056; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang XH, 2012, J BIOL CHEM, V287, P34091, DOI 10.1074/jbc.M112.371062; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	39	35	36	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					950	960		10.1038/ni.3230	http://dx.doi.org/10.1038/ni.3230			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26214742	Green Submitted, Green Accepted			2022-12-18	WOS:000359876900013
J	Zhou, RW; Mkhikian, H; Grigorian, A; Hong, A; Chen, D; Arakelyan, A; Demetriou, M				Zhou, Raymond W.; Mkhikian, Haik; Grigorian, Ani; Hong, Amanda; Chen, David; Arakelyan, Araz; Demetriou, Michael			N-glycosylation bidirectionally extends the boundaries of thymocyte positive selection by decoupling Lck from Ca2+ signaling	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; ASPARAGINE-LINKED OLIGOSACCHARIDES; NEGATIVE SELECTION; MULTIPLE-SCLEROSIS; THYMIC SELECTION; MEDIATED AUTOIMMUNITY; RECEPTOR; CD4; ACTIVATION; COMPLEX	Positive selection of diverse yet self-tolerant thymocytes is vital to immunity and requires a limited degree of T cell antigen receptor (TCR) signaling in response to self peptide-major histocompatibility complexes (self peptide-MHCs). Affinity of newly generated TCR for peptide-MHC primarily sets the boundaries for positive selection. We report that N-glycan branching of TCR and the CD4 and CD8 coreceptors separately altered the upper and lower affinity boundaries from which interactions between peptide-MHC and TCR positively select T cells. During thymocyte development, N-glycan branching varied approximately 15-fold. N-glycan branching was required for positive selection and decoupled Lck signaling from TCR-driven Ca2+ flux to simultaneously promote low-affinity peptide-MHC responses while inhibiting high-affinity ones. Therefore, N-glycan branching imposes a sliding scale on interactions between peptide-MHC and TCR that bidirectionally expands the affinity range for positive selection.	[Zhou, Raymond W.; Grigorian, Ani; Hong, Amanda; Chen, David; Arakelyan, Araz; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Zhou, Raymond W.; Mkhikian, Haik; Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Zhou, Raymond W.; Mkhikian, Haik; Grigorian, Ani; Demetriou, Michael] Univ Calif Irvine, Inst Immunol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	mdemetri@uci.edu		Demetriou, Michael/0000-0002-2224-7798	US National Institutes of Health through the National Institute of Allergy and Infectious Disease [R01AI053331]; National Heart, Lung, and Blood Institute [F30HL108451]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL108451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053331] Funding Source: NIH RePORTER	US National Institutes of Health through the National Institute of Allergy and Infectious Disease; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Andersen for K14-Cre mice and K.H. Khachikyan for helping with experiments. We thank the members of M.D's lab for proofreading the manuscript. Supported by the US National Institutes of Health through the National Institute of Allergy and Infectious Disease (R01AI053331 to M.D.) and the National Heart, Lung, and Blood Institute (F30HL108451 to H.M.).	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Cainan B. J., 1995, IMMUNITY, V3, P273, DOI DOI 10.1016/1074-7613(95)90113-2; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2012, SEMIN IMMUNOPATHOL, V34, P415, DOI 10.1007/s00281-012-0307-y; Grigorian A, 2012, ANN NY ACAD SCI, V1253, P49, DOI 10.1111/j.1749-6632.2011.06391.x; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Li CF, 2013, J NEUROIMMUNOL, V256, P71, DOI 10.1016/j.jneuroim.2012.12.008; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; TaylorFishwick DA, 1995, EUR J IMMUNOL, V25, P3215, DOI 10.1002/eji.1830251203; Trobridge PA, 2001, J IMMUNOL, V166, P809, DOI 10.4049/jimmunol.166.2.809; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Vidal K, 1999, J IMMUNOL, V163, P4811; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; Wang D, 2012, NAT IMMUNOL, V13, P560, DOI 10.1038/ni.2301; Yu Z, 2014, GENES IMMUN, V15, P218, DOI 10.1038/gene.2014.7	47	35	35	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1038	1045		10.1038/ni.3007	http://dx.doi.org/10.1038/ni.3007			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25263124				2022-12-18	WOS:000343640700009
J	Xie, JM; Huppa, JB; Newell, EW; Huang, J; Ebert, PJR; Li, QJ; Davis, MM				Xie, Jianming; Huppa, Johannes B.; Newell, Evan W.; Huang, Jun; Ebert, Peter J. R.; Li, Qi-Jing; Davis, Mark M.			Photocrosslinkable pMHC monomers stain T cells specifically and cause ligand-bound TCRs to be 'preferentially' transported to the cSMAC	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; RECEPTOR MICROCLUSTERS; ACTIN CYTOSKELETON; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; ANTIGEN RECEPTOR; ACTIVATION; COMPLEX; LYMPHOCYTES; AFFINITY	The binding of T cell antigen receptors (TCRs) to specific complexes of peptide and major histocompatibility complex (pMHC) is typically of very low affinity, which necessitates the use of multimeric pMHC complexes to label T lymphocytes stably. We report here the development of pMHC complexes able to be crosslinked by ultraviolet irradiation; even as monomers, these efficiently and specifically stained cognate T cells. We also used this reagent to probe T cell activation and found that a covalently bound pMHC was more stimulatory than an agonist pMHC on lipid bilayers. This finding suggested that serial engagement of TCRs is dispensable for activation when a substantial fraction of TCRs are stably engaged. Finally, pMHC-bound TCRs were 'preferentially' transported into the central supramolecular activation cluster after activation, which suggested that ligand engagement enabled linkage of the TCR and its associated CD3 signaling molecules to the cytoskeleton.	[Xie, Jianming; Huppa, Johannes B.; Newell, Evan W.; Huang, Jun; Ebert, Peter J. R.; Li, Qi-Jing; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Newell, Evan W/F-9711-2012; Xie, Jianming/AAC-6359-2019; Xie, Jianming/G-6567-2012; Huppa, Johannes Bernhard/AAY-9471-2021	Newell, Evan W/0000-0002-2889-243X; Xie, Jianming/0000-0003-4112-650X; Huppa, Johannes Bernhard/0000-0003-2634-8198; Davis, Mark/0000-0001-6868-657X	Cancer Research Institute; Howard Hughes Medical Institute; US National Institutes of Health [R01 AI022511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091878, R01AI022511, T32AI007290] Funding Source: NIH RePORTER	Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Valitutti and Y. Wong for critical reading of the manuscript; A. Ting (Massachusetts Institute of Technology) for constructs for the expression of monovalent streptavidin; A. Shaw and M. Kelly (Washington University St. Louis) for AND mouse spleen cells; and Y.-H. Chien, J. Campbell, F. Wang, J. Zhou, P. Nelida, N. Sigal and A. Girvin for discussions and/or experimental assistance. Supported by the Cancer Research Institute (J. X.), the Howard Hughes Medical Institute (M. M. D.) and the US National Institutes of Health (R01 AI022511 to M.M.D.).	ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hudrisier D, 1998, J IMMUNOL, V161, P553; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; LEYVA E, 1986, J AM CHEM SOC, V108, P3783, DOI 10.1021/ja00273a037; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; LUESCHER IF, 1994, J BIOL CHEM, V269, P5574; Ma ZY, 2010, TRENDS IMMUNOL, V31, P1, DOI 10.1016/j.it.2009.09.008; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rock E.P., 1993, THESIS STANFORD U, P60; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Thomas S, 2011, BLOOD, V118, P319, DOI 10.1182/blood-2010-12-326736; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weber K.S., P NATL ACAD IN PRESS; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	52	35	35	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					674	+		10.1038/ni.2344	http://dx.doi.org/10.1038/ni.2344			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22660579	Green Accepted			2022-12-18	WOS:000305483800013
J	Barber, GN				Barber, Glen N.			STING-dependent signaling	NATURE IMMUNOLOGY			English	Editorial Material							INTRACELLULAR DNA; INNATE IMMUNITY; SENSOR	The sensing of pathogen-associated DNA in the cytoplasm is an important trigger of host-defense responses that include the production of type I interferon. A new study suggests that the DExDc helicase DDX41 may function in dendritic cells as a DNA sensor to activate STING-dependent innate immune responses.	Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33152 USA	University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33152 USA.	gbarber@med.miami.edu						Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2011, CELL MOL LIFE SCI, V68, P1157, DOI 10.1007/s00018-010-0605-2; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Onomoto K, 2010, J INTERF CYTOK RES, V30, P875, DOI 10.1089/jir.2010.0117; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	12	35	43	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					929	930		10.1038/ni.2118	http://dx.doi.org/10.1038/ni.2118			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21934672				2022-12-18	WOS:000295084500007
J	Clark, MR				Clark, Marcus R.			Flippin' lipids	NATURE IMMUNOLOGY			English	Editorial Material							PHOSPHATIDYLSERINE; RECOMBINATION; ATP11C	B cell generation is disturbed in four newly identified mouse mutants bearing X-linked mutations in the gene encoding the ATPase ATP11C. These findings suggest that the distribution of membrane phospholipids confers a yet-to-be delineated developmental signal.	[Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mclark@medicine.bsd.uchicago.edu						Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Singh H, 2007, ADV EXP MED BIOL, V596, P57; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011	12	35	37	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					373	375		10.1038/ni.2024	http://dx.doi.org/10.1038/ni.2024			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21502987				2022-12-18	WOS:000289666600004
J	Li, ZH; Zhang, YA; Liu, ZD; Wu, XD; Zheng, YH; Tao, ZY; Mao, KR; Wang, J; Lin, GM; Tian, L; Ji, YY; Qin, ML; Sun, SH; Zhu, XL; Sun, B				Li, Zhenhu; Zhang, Yuan; Liu, Zhiduo; Wu, Xiaodong; Zheng, Yuhan; Tao, Zhiyun; Mao, Kairui; Wang, Jie; Lin, Guomei; Tian, Lin; Ji, Yongyong; Qin, Meiling; Sun, Shuhui; Zhu, Xueliang; Sun, Bing			ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1)	NATURE IMMUNOLOGY			English	Article							MATRIX PROTEIN-1 ECM1; T-CELLS; SPHINGOSINE-1-PHOSPHATE; TRAFFICKING; RECEPTOR; MOUSE; DIFFERENTIATION; EXPRESSION; INDUCTION; MIGRATION	Type 2 helper T cells (T(H)2) are critically involved in allergies and asthma. Here we demonstrate that extracellular matrix protein-1 (ECM1) is highly and selectively expressed in T(H)2 cells. ECM1 deficiency caused impaired T(H)2 responses and reduced allergic airway inflammation in vivo. Functional analysis demonstrated that although the T(H)2 polarization of ECM1-deficient cells was unimpaired, these cells had a defect in migration and were retained in peripheral lymphoid organs. This was associated with reduced expression of KLF2 and S1P(1). We also found that ECM1 could directly bind the interleukin-2 (IL-2) receptor to inhibit IL-2 signaling and activate S1P(1) expression. Our data identify a previously unknown function of ECM1 in regulating T(H)2 cell migration through control of KLF2 and S1P(1) expression.	[Li, Zhenhu; Zhang, Yuan; Liu, Zhiduo; Wu, Xiaodong; Zheng, Yuhan; Tao, Zhiyun; Mao, Kairui; Wang, Jie; Lin, Guomei; Tian, Lin; Ji, Yongyong; Qin, Meiling; Zhu, Xueliang; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; [Sun, Shuhui] Fudan Univ, Sch Med, Shanghai 200433, Peoples R China; [Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Mol Virus Unit, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Sun, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China.	bsun@sibs.ac.cn	Zheng, Yuhan/X-3266-2018; Zhang, Yuan/C-7777-2018	Zhang, Yuan/0000-0001-9932-917X; Wang, Jie/0000-0003-4495-8862	National Natural Science Foundation of China [30623003, 31030029, 30721065, 30801011, 90713044, 30870126, 30950002]; Chinese Academy of Sciences [KSCX2-YW-R-161, KSCX2-YW-R-169]; Technology Commission of Shanghai Municipality [08DZ2291703, 088014199, 08431903004]; National 973 key project [2007CB512404]; National 863 project [2006AA02A247]; EU [SP5B-CT-2006-044161]; China National Science and Technology [2008ZX10002-014, 2008ZX10004-002, 2009ZX10004-105, 2009ZX10004-016]; China National Ministry of Science and Technology [20072714]; Shanghai Pasteur Health Research Foundation [SPHRF2008001, SPHRF2009001]; E-institutes of the Shanghai Universities Immunology Division; Li Kha Shing Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National 973 key project(National Basic Research Program of China); National 863 project(National High Technology Research and Development Program of China); EU(European Commission); China National Science and Technology; China National Ministry of Science and Technology(Ministry of Science and Technology, China); Shanghai Pasteur Health Research Foundation; E-institutes of the Shanghai Universities Immunology Division; Li Kha Shing Foundation	We thank R. Caspi, Y. He, Y. Zhuang, H. Gu, W. Zhang, Y. Liu and D. Li for helpful comments about this paper, S. Skinner for reviewing the manuscript, and X. Zhu for help with the experiments. This work was supported by grants from the National Natural Science Foundation of China (30623003, 31030029, 30721065, 30801011, 90713044, 30870126, 30950002), a Chinese Academy of Sciences project (KSCX2-YW-R-161, KSCX2-YW-R-169), the Technology Commission of Shanghai Municipality (08DZ2291703, 088014199, 08431903004), the National 973 key project (2007CB512404), the National 863 project (2006AA02A247), an EU project (SP5B-CT-2006-044161), a China National Science and Technology Major Project (2008ZX10002-014, 2008ZX10004-002, 2009ZX10004-105, 2009ZX10004-016), the China National Ministry of Science and Technology (20072714), the Shanghai Pasteur Health Research Foundation (SPHRF2008001, SPHRF2009001), the E-institutes of the Shanghai Universities Immunology Division and the Li Kha Shing Foundation.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; BHALERAO J, 1995, J BIOL CHEM, V270, P16385, DOI 10.1074/jbc.270.27.16385; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dang XT, 2009, BBA-GENE REGUL MECH, V1789, P146, DOI 10.1016/j.bbagrm.2008.10.004; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; Grahler MH, 2005, J IMMUNOL, V174, P1997; Hamada T, 2002, CLIN EXP DERMATOL, V27, P624, DOI 10.1046/j.1365-2230.2002.01143.x; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kuznetsova SA, 2004, INT J BIOCHEM CELL B, V36, P1126, DOI 10.1016/j.biocel.2003.12.006; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu ZD, 2009, J IMMUNOL, V183, P6320, DOI 10.4049/jimmunol.0900975; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Miller JD, 2008, IMMUNOL CELL BIOL, V86, P192, DOI 10.1038/sj.icb.7100128; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Wang LP, 2003, CANCER LETT, V200, P57, DOI 10.1016/S0304-3835(03)00350-1; Wang Y, 2009, CELL RES, V19, P962, DOI 10.1038/cr.2009.77; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wu XD, 2006, J IMMUNOL, V177, P934, DOI 10.4049/jimmunol.177.2.934; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	36	35	41	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					178	U95		10.1038/ni.1983	http://dx.doi.org/10.1038/ni.1983			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21217760				2022-12-18	WOS:000286378400012
J	Porcelli, SA; Jacobs, WR				Porcelli, Steven A.; Jacobs, William R., Jr.			Tuberculosis: unsealing the apoptotic envelope	NATURE IMMUNOLOGY			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; MACROPHAGES; BURDEN		[Porcelli, Steven A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Porcelli, SA (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	jacobs@aecom.yu.edu		Jacobs, William/0000-0003-3321-3080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026170] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; KNIGHT CRL, 1991, BIOCHIM BIOPHYS ACTA, V1096, P312, DOI 10.1016/0925-4439(91)90067-J; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Ma ASP, 1996, ARCH DERMATOL RES, V288, P596, DOI 10.1007/s004030050109; Menaker RJ, 2003, MICROBES INFECT, V5, P1149, DOI 10.1016/J.MICINF.2003.08.001; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	12	35	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1101	1102		10.1038/ni1008-1101	http://dx.doi.org/10.1038/ni1008-1101			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18800161				2022-12-18	WOS:000259315600007
J	Yokoyama, WM				Yokoyama, Wayne M.			Mistaken notions about natural killer cells	NATURE IMMUNOLOGY			English	Article							C-TYPE LECTINS; INHIBITORY RECEPTOR; NK CELLS; HLA-E; MHC; CD94; RECOGNITION; CLONING; COMPLEX; FAMILY	As natural killer (NK) cells were first described more than 30 years ago-a lifetime in recent immunological history-this is a good time to reflect on their transition from outcasts of mainstream immunology to prominent players in innate immunity. Whereas much of our existing knowledge about NK cells is taken as longstanding fact, it may be surprising to immunologists of a younger vintage, particularly those working on NK cells today, that some of this knowledge was, at least initially, unexpected. In this Perspective, I take an unconventional approach to discussing our progress in understanding NK cells.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA.	yokoyama@im.wustl.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANEGON I, 1988, J EXP MED, V167, P452, DOI 10.1084/jem.167.2.452; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; [Anonymous], 2007, REPORT COMMISSIONER; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; BROOKS CG, 1983, NATURE, V305, P155, DOI 10.1038/305155a0; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Conan Doyle Arthur, 1901, ADVENTURES SHERLOCK, P1; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; LANIER LL, 1986, J IMMUNOL, V137, P2735; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; Matsumoto N, 1998, IMMUNITY, V8, P245, DOI 10.1016/S1074-7613(00)80476-8; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Rojo S, 1997, J IMMUNOL, V158, P9; SHELLAM GR, 1981, P NATL ACAD SCI-BIOL, V78, P5104, DOI 10.1073/pnas.78.8.5104; SMITH HRC, 1994, J IMMUNOL, V153, P1068; STONEMAN ER, 1995, J EXP MED, V182, P305, DOI 10.1084/jem.182.2.305; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wang J, 2002, J BIOL CHEM, V277, P1433, DOI 10.1074/jbc.M110316200; Wang LL, 1997, J IMMUNOL, V158, P13; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Westgaard IH, 1998, EUR J IMMUNOL, V28, P1839, DOI 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379; Yokoyama WM, 1998, P NATL ACAD SCI USA, V95, P4791, DOI 10.1073/pnas.95.9.4791; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	55	35	36	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					481	485		10.1038/ni1583	http://dx.doi.org/10.1038/ni1583			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425104				2022-12-18	WOS:000255153500009
J	Beutler, B; Du, X; Xia, Y				Beutler, Bruce; Du, Xin; Xia, Yu			Precis on forward genetics in mice	NATURE IMMUNOLOGY			English	Editorial Material							CODING MUTATIONS; MOUSE; TRANSPOSITION; MUTAGENESIS; DISRUPTION; DISORDER; DISEASE; NUMBER; DRIVEN	Mutations have been the driving force behind some of the most important discoveries in immunology, and the growing speed with which they can be found has impelled the use of random mutagenesis to create new immunological phenotypes in mice. Here we describe how phenotypes are created, detected and ascribed to genetic change.	Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA.	bruce@scripps.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI070167] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Keays DA, 2007, MAMM GENOME, V18, P123, DOI 10.1007/s00335-006-0065-z; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Lehoczky JA, 2006, MAMM GENOME, V17, P903, DOI 10.1007/s00335-006-0041-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rinchik EM, 1999, GENETICS, V152, P373; Robin NH, 2001, AM J MED GENET, V101, P334, DOI 10.1002/1096-8628(20010715)101:4<334::AID-AJMG1233>3.3.CO;2-Z; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	28	35	36	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					659	664		10.1038/ni0707-659	http://dx.doi.org/10.1038/ni0707-659			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579639				2022-12-18	WOS:000247718100002
J	Palm, NW; Medzhitov, R				Palm, Noah W.; Medzhitov, Ruslan			Antifungal defense turns 17	NATURE IMMUNOLOGY			English	Editorial Material							TGF-BETA; RECOGNITION; INDUCTION; IMMUNITY; RECEPTOR; DECTIN-1; PATHWAY; T(H)17; CELLS	Fungal recognition occurs partially through the C-type lectin dectin-1. New studies show that dectin- mediated immune recognition of Candida albicans induces the differentiation of interleukin 17-producing T helper cells that express chemokine receptors characteristic of mucosal homing.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06405 USA	Howard Hughes Medical Institute; Yale University; Yale University	Palm, NW (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA.	ruslan.medzhitov@yale.edu		Palm, Noah/0000-0001-7262-9455				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cua DJ, 2006, NAT IMMUNOL, V7, P557, DOI 10.1038/ni0606-557; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	13	35	36	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					549	551		10.1038/ni0607-549	http://dx.doi.org/10.1038/ni0607-549			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514204				2022-12-18	WOS:000246703300004
J	Fairweather, D; Rose, NR				Fairweather, D; Rose, NR			Type 1 diabetes: virus infection or autoimmune disease?	NATURE IMMUNOLOGY			English	Editorial Material							INDUCTION		Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Fairweather, D (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	nrrose@jhsph.edu						Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Fairweather D, 2001, J AUTOIMMUN, V16, P175, DOI 10.1006/jaut.2000.0492; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Horwitz MS, 2000, NAT MED, V6, P693, DOI 10.1038/76277; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Rose NR, 2000, CELL MOL LIFE SCI, V57, P542, DOI 10.1007/PL00000716; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Stauffer Y, 2001, IMMUNITY, V15, P591, DOI 10.1016/S1074-7613(01)00212-6; SZOPA TM, 1993, DIABETOLOGIA, V36, P687, DOI 10.1007/BF00401138; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Wucherpfennig KW, 2001, NAT IMMUNOL, V2, P767, DOI 10.1038/ni0901-767; Yoon JW, 1990, CURR TOP MICROBIOL I, V164, P95	14	35	37	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					338	340		10.1038/ni0402-338	http://dx.doi.org/10.1038/ni0402-338			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919574				2022-12-18	WOS:000174623600011
J	DeFranco, AL				DeFranco, AL			Vav and the B cell signalosome	NATURE IMMUNOLOGY			English	News Item							FAMILY	Genetic ablation experiments have shown that Vav is critical for TCR signaling. Evidence is now emerging that the Vav family of signaling molecules play a critical role in antigen receptor signaling in B cells as well as in T cells.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, George Williams Hooper Fdn, HSW 1501, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.							Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gulbranson-Judge A, 1999, EUR J IMMUNOL, V29, P477, DOI 10.1002/(SICI)1521-4141(199902)29:02&lt;477::AID-IMMU477&gt;3.0.CO;2-V; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2	9	35	35	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					482	484		10.1038/88669	http://dx.doi.org/10.1038/88669			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376331				2022-12-18	WOS:000169078000008
J	Lopes, N; McIntyre, C; Martin, S; Raverdeau, M; Sumaria, N; Kohlgruber, AC; Fiala, GJ; Agudelo, LZ; Dyck, L; Kane, H; Douglas, A; Cunningham, S; Prendeville, H; Loftus, R; Carmody, C; Pierre, P; Kellis, M; Brenner, M; Arguello, RJ; Silva-Santos, B; Pennington, DJ; Lynch, L				Lopes, Noella; McIntyre, Claire; Martin, Stefania; Raverdeau, Mathilde; Sumaria, Nital; Kohlgruber, Ayano C.; Fiala, Gina J.; Agudelo, Leandro Z.; Dyck, Lydia; Kane, Harry; Douglas, Aaron; Cunningham, Stephen; Prendeville, Hannah; Loftus, Roisin; Carmody, Colleen; Pierre, Philippe; Kellis, Manolis; Brenner, Michael; Arguello, Rafael J.; Silva-Santos, Bruno; Pennington, Daniel J.; Lynch, Lydia			Distinct metabolic programs established in the thymus control effector functions of gamma delta T cell subsets in tumor microenvironments	NATURE IMMUNOLOGY			English	Article							AEROBIC GLYCOLYSIS; LACTIC-ACID; EXPRESSION; DIFFERENTIATION; ACTIVATION; SIGNATURES; RECEPTOR; GENES; FATE	Metabolic programming controls immune cell lineages and functions, but little is known about gamma delta T cell metabolism. Here, we found that gamma delta T cell subsets making either interferon-gamma (IFN-gamma) or interleukin (IL)-17 have intrinsically distinct metabolic requirements. Whereas IFN-gamma(+) gamma delta T cells were almost exclusively dependent on glycolysis, IL-17(+) gamma delta T cells strongly engaged oxidative metabolism, with increased mitochondrial mass and activity. These distinct metabolic signatures were surprisingly imprinted early during thymic development and were stably maintained in the periphery and within tumors. Moreover, pro-tumoral IL-17(+) gamma delta T cells selectively showed high lipid uptake and intracellular lipid storage and were expanded in obesity and in tumors of obese mice. Conversely, glucose supplementation enhanced the antitumor functions of IFN-gamma(+) gamma delta T cells and reduced tumor growth upon adoptive transfer. These findings have important implications for the differentiation of effector gamma delta T cells and their manipulation in cancer immunotherapy.	[Lopes, Noella; Fiala, Gina J.; Silva-Santos, Bruno] Univ Lisbon, Inst Med Mol Joao Lobo Antunes, Fac Med, Lisbon, Portugal; [McIntyre, Claire; Kohlgruber, Ayano C.; Kane, Harry; Carmody, Colleen; Brenner, Michael; Lynch, Lydia] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Martin, Stefania; Sumaria, Nital; Pennington, Daniel J.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med, London, England; [Raverdeau, Mathilde; Dyck, Lydia; Kane, Harry; Douglas, Aaron; Cunningham, Stephen; Prendeville, Hannah; Loftus, Roisin; Lynch, Lydia] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland; [Agudelo, Leandro Z.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Pierre, Philippe; Arguello, Rafael J.] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Pierre, Philippe] Univ Aveiro, Inst Res Biomed iBiMED, Aveiro, Portugal; [Pierre, Philippe] Univ Aveiro, Ilidio Pinho Fdn, Dept Med Sci, Aveiro, Portugal	Universidade de Lisboa; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; Queen Mary University London; Trinity College Dublin; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universidade de Aveiro; Universidade de Aveiro	Pennington, DJ (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med, London, England.	d.pennington@qmul.ac.uk	Lynch, Lydia/ABD-5598-2021	McIntyre, Claire/0000-0003-2489-7724; Arguello, Rafael J/0000-0001-9785-3883; Fiala, Gina/0000-0002-8226-5584; Noella, LOPES/0000-0002-6296-8426; Kohlgruber, Ayano/0000-0001-6758-3966; Raverdeau, Mathilde/0000-0002-6088-6902; pierre, philippe/0000-0003-0863-8255; Pennington, Daniel/0000-0001-7889-9923	Wellcome Trust [092973/Z/10/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) UK [BB/R017808/1]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [646701, StG_679173]; Science Foundation Ireland (SFI) [16/FRL/3865]; NIH [NS115064, HG008155, AG062377, R01 AI134861, S10 OD020100]; Fundacao Astrazeneca (Premio FAZ Ciencia 2019); FEDER (POR Lisboa 2020 (Programa Operacional Regional de Lisboa, do Portugal 2020)) [PAC-PRECISE LISBOA-01-0145-FEDER-016394]; EMBO [ALTF 752-2018]; Medical Research Council (MRC) UK; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [752932]; Irish Research Council fellowships; Fundacao para a Ciencia e a Tecnologia (Portugal); BBSRC [BB/R017808/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Science Foundation Ireland (SFI)(Science Foundation Ireland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Astrazeneca (Premio FAZ Ciencia 2019); FEDER (POR Lisboa 2020 (Programa Operacional Regional de Lisboa, do Portugal 2020)); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); Irish Research Council fellowships(Irish Research Council for Science, Engineering and Technology); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful for the valuable assistance of the staff of the flow cytometry, bioimaging and animal facilities at our institutions. We thank J.-W. Taanman, A. Magalhaes, J. Ribot, K. Serre and N. Sousa for technical suggestions and administrative help. This work was supported by the Wellcome Trust (092973/Z/10/Z to D.J.P.), Biotechnology and Biological Sciences Research Council (BBSRC) UK (BB/R017808/1 to D.J.P.), European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 646701 to B.S.-S.; StG_679173 to L.L.), Science Foundation Ireland (SFI) (16/FRL/3865 to L.L.), NIH (NS115064, HG008155, AG062377 to M.K.), NIH (R01 AI134861 and metabolic core grant S10 OD020100 to L.L.), Fundacao Astrazeneca (Premio FAZ Ciencia 2019 to B.S.-S. and N.L.) and PAC-PRECISE LISBOA-01-0145-FEDER-016394, co-funded by FEDER (POR Lisboa 2020 (Programa Operacional Regional de Lisboa, do Portugal 2020)) and Fundacao para a Ciencia e a Tecnologia (Portugal). N.L. is supported by a postdoctoral fellowship from EMBO (ALTF 752-2018); S.M. was supported by a studentship from the Medical Research Council (MRC) UK; G.F. is supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 752932; and A.D., S.C., L.D. and H.P. are supported by Irish Research Council fellowships.	Almeida AR, 2016, CLIN CANCER RES, V22, P5795, DOI 10.1158/1078-0432.CCR-16-0597; Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Arguello RJ, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.007; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Coffey F, 2014, J EXP MED, V211, P329, DOI 10.1084/jem.20131540; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Di Luccia B, 2019, J EXP MED, V216, P2231, DOI 10.1084/jem.20180549; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Goldberg EL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav2026; Guo QM, 2000, CANCER RES, V60, P5922; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hayday AC, 2019, J IMMUNOL, V203, P311, DOI 10.4049/jimmunol.1800934; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; In TSH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02225-5; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Le Goffe C, 1999, BIOCHEM J, V344, P643, DOI 10.1042/0264-6021:3440643; Legut M, 2015, CELL MOL IMMUNOL, V12, P656, DOI 10.1038/cmi.2015.28; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linderman G.C., 2018, ZERO PRESERVING IMPU, DOI [DOI 10.1101/397588, 10.1101/397588.]; Lu Y, 2015, J IMMUNOL, V195, P4273, DOI 10.4049/jimmunol.1500939; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; McCully ML, 2015, J IMMUNOL, V195, P96, DOI 10.4049/jimmunol.1402961; McKenzie DR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15632; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Munoz-Ruiz M, 2017, TRENDS IMMUNOL, V38, P336, DOI 10.1016/j.it.2017.01.007; Munoz-Ruiz M, 2016, NAT IMMUNOL, V17, P721, DOI 10.1038/ni.3424; Nakamizo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14292-1; O'Sullivan D, 2019, NAT REV IMMUNOL, V19, P324, DOI 10.1038/s41577-019-0140-9; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Schmolka N, 2015, SEMIN IMMUNOL, V27, P19, DOI 10.1016/j.smim.2015.01.001; Schmolka N, 2013, NAT IMMUNOL, V14, P1093, DOI 10.1038/ni.2702; Sebestyen Z, 2020, NAT REV DRUG DISCOV, V19, P169, DOI 10.1038/s41573-019-0038-z; Shin BY, 2020, CELL REP, V30, P1898, DOI 10.1016/j.celrep.2020.01.022; Silva-Santos B, 2019, NAT REV CANCER, V19, P392, DOI 10.1038/s41568-019-0153-5; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumaria N, 2017, CELL REP, V19, P2469, DOI 10.1016/j.celrep.2017.05.071; Tan LK, 2019, CELL REP, V27, P3657, DOI 10.1016/j.celrep.2019.05.064; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vu JP, 2017, J NUTR, V147, P2243, DOI 10.3945/jn.117.257873; Wang ZX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00202	59	34	34	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					179	U136		10.1038/s41590-020-00848-3	http://dx.doi.org/10.1038/s41590-020-00848-3		JAN 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33462452	Green Submitted, Green Accepted			2022-12-18	WOS:000608675100001
J	Swadling, L; Maini, MK				Swadling, Leo; Maini, Mala K.			T cells in COVID-19-united in diversity	NATURE IMMUNOLOGY			English	Editorial Material								Comprehensive mapping reveals that functional CD4(+)and CD8(+)T cells targeting multiple regions of SARS-CoV-2 are maintained in the resolution phase of both mild and severe COVID-19, and their magnitude correlates with the antibody response.	[Swadling, Leo; Maini, Mala K.] UCL, Div Infect & Immun, London, England; [Swadling, Leo; Maini, Mala K.] UCL, Inst Immun & Transplantat, London, England	University of London; University College London; University of London; University College London	Maini, MK (corresponding author), UCL, Div Infect & Immun, London, England.; Maini, MK (corresponding author), UCL, Inst Immun & Transplantat, London, England.	m.maini@ucl.ac.uk		Maini, Mala/0000-0001-6384-1462; Swadling, Leo/0000-0002-0537-6715				Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Sariol A, 2020, IMMUNITY, V53, P248, DOI 10.1016/j.immuni.2020.07.005; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006	11	34	35	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1307	1308		10.1038/s41590-020-0798-y	http://dx.doi.org/10.1038/s41590-020-0798-y		SEP 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32895541	Green Submitted, Bronze			2022-12-18	WOS:000566874900001
J	Ferreira, C; Barros, L; Baptista, M; Blankenhaus, B; Barros, A; Figueiredo-Campos, P; Konjar, S; Laine, A; Kamenjarin, N; Stojanovic, A; Cerwenka, A; Probst, HC; Marie, JC; Veldhoen, M				Ferreira, Cristina; Barros, Leandro; Baptista, Marta; Blankenhaus, Birte; Barros, Andre; Figueiredo-Campos, Patricia; Konjar, Spela; Laine, Alexandra; Kamenjarin, Nadine; Stojanovic, Ana; Cerwenka, Adelheid; Probst, Hans C.; Marie, Julien C.; Veldhoen, Marc			Type 1 T-reg cells promote the generation of CD8(+) tissue-resident memory T cells	NATURE IMMUNOLOGY			English	Article							NONLYMPHOID TISSUE; LOCAL ANTIGEN; TGF-BETA; DIFFERENTIATION; INFECTION; EFFECTOR; ACTIVATION; EXPRESSION; MIGRATION; REQUIREMENT	Tissue-resident memory T (T-RM) cells provide rapid front-line protection against infection. Veldhoen and colleagues demonstrate that the type 1 regulatory T cell subset supports generation of T-RM cells. Tissue-resident memory T (T-RM) cells, functionally distinct from circulating memory T cells, have a critical role in protective immunity in tissues, are more efficacious when elicited after vaccination and yield more effective antitumor immunity, yet the signals that direct development of T-RM cells are incompletely understood. Here we show that type 1 regulatory T (T-reg) cells, which express the transcription factor T-bet, promote the generation of CD8(+) T-RM cells. The absence of T-bet-expressing type 1 T-reg cells reduces the presence of T-RM cells in multiple tissues and increases pathogen burden upon infectious challenge. Using infection models, we show that type 1 T-reg cells are specifically recruited to local inflammatory sites via the chemokine receptor CXCR3. Close proximity with effector CD8(+) T cells and T-reg cell expression of integrin-beta 8 endows the bioavailability of transforming growth factor-beta in the microenvironment, thereby promoting the generation of CD8(+) T-RM cells.	[Ferreira, Cristina; Barros, Leandro; Baptista, Marta; Blankenhaus, Birte; Figueiredo-Campos, Patricia; Konjar, Spela; Veldhoen, Marc] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Barros, Andre] Inst Gulbenkian Ciencias, Innate Immun & Inflammat, Oeiras, Portugal; [Laine, Alexandra; Marie, Julien C.] Canc Res Ctr Lyon, Tumor Escape Resistance Immun Dept, UMR INSERM1052, Lyon, France; [Laine, Alexandra; Marie, Julien C.] Univ Lyon 1, Lyon, France; [Laine, Alexandra; Marie, Julien C.] Ctr Leon Berard, Lyon, France; [Laine, Alexandra; Marie, Julien C.] Labex DEVweCAN, F-69008 Lyon, France; [Laine, Alexandra; Marie, Julien C.] Equipe Labelisee Ligue Natl Canc, Lyon, France; [Kamenjarin, Nadine; Probst, Hans C.] Univ Med Ctr Mainz, Inst Immunol, Mainz, Germany; [Kamenjarin, Nadine; Probst, Hans C.] Univ Med Ctr Mainz, Res Ctr Immunotherapy, Mainz, Germany; [Stojanovic, Ana; Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, Dept Immunobiochem, Mannheim Inst Innate & Mmunosci MI3, Mannheim, Germany; [Stojanovic, Ana; Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Ferreira, C; Veldhoen, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal.	cristina.ferreira@medicina.ulisboa.pt; marc.veldhoen@medicina.ulsboa.pt	Veldhoen, Marc/AAM-5357-2021; Konjar, Špela/AAU-6390-2020	Stojanovic, Ana/0000-0001-9503-2256; Cerwenka, Adelheid/0000-0001-6977-3536; Barros, Leandro/0000-0002-7339-9994; Laine, Alexandra/0000-0002-8367-6115; Figueiredo-Campos, Patricia/0000-0002-9808-6230; Marie, Julien/0000-0001-6713-7923; Veldhoen, Marc/0000-0002-1478-9562	European Union [667824]; Fundo iMM-Laco [100010434, LCF/PR/HR19/52160005]; 'la caixa' Foundation [100010434, LCF/PR/HR19/52160005]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/131605/2017, PD/BD/138847/2018, SFRH/BD/138900/2018]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB1366, 394046768-SFB 1366, SPP 1937, CE 140/2-1, SFB1292]; Ligue Nationale Contre le Cancer; Foncer Contre le Cancer; EL-2016 LNCC Labelisation Ligue Nationale Contre Cancer	European Union(European Commission); Fundo iMM-Laco; 'la caixa' Foundation(La Caixa Foundation); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Foncer Contre le Cancer; EL-2016 LNCC Labelisation Ligue Nationale Contre Cancer	We acknowledge the excellent contributions from the iMM flow cytometry, rodent, histology and microscopy facilities. The project leading to these results has received funding from the European Union H2020 ERA project (no. 667824, EXCELLtoINNOV), Fundo iMM-Laco and 'la caixa' Foundation (ID 100010434) under agreement LCF/PR/HR19/52160005 for work in the Veldhoen laboratory, with additional funding from the Fundacao para a Ciencia e a Tecnologia to P.F.-C. (SFRH/BD/131605/2017), to L.B. (PD/BD/138847/2018) and to A.B. (SFRH/BD/138900/2018). In addition, the work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) SFB1366 (project no. 394046768-SFB 1366; C02) and by SPP 1937 (CE 140/2-1) to A.C and SFB1292 (TP13) and TR156 (TPB02) to H.C.P. A.L. was supported by Ligue Nationale Contre le Cancer. Other grants supporting this study: Foncer Contre le Cancer (JCM) and EL-2016 LNCC Labelisation Ligue Nationale Contre Cancer. TL-tetramer was obtained through the National Institutes of Health Tetramer Core Facility.	Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bergsbaken T, 2017, CELL REP, V19, P114, DOI 10.1016/j.celrep.2017.03.031; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cossarizza A, 2019, EUR J IMMUNOL, V49, P1457, DOI 10.1002/eji.201970107; de Herve MGD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1992; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Figueiredo-Campos P, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3122; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kalia V, 2015, IMMUNITY, V42, P1116, DOI 10.1016/j.immuni.2015.05.023; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Konjar S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan2543; Konjar S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01281; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Paust HJ, 2016, J AM SOC NEPHROL, V27, P1933, DOI 10.1681/ASN.2015020203; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROSE ME, 1989, INFECT IMMUN, V57, P1599, DOI 10.1128/IAI.57.5.1599-1603.1989; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Tan TG, 2016, P NATL ACAD SCI USA, V113, P14103, DOI 10.1073/pnas.1616710113; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Xiong YB, 2016, J IMMUNOL, V196, P2526, DOI 10.4049/jimmunol.1502537; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	66	34	34	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					766	+		10.1038/s41590-020-0674-9	http://dx.doi.org/10.1038/s41590-020-0674-9		MAY 2020	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32424367				2022-12-18	WOS:000533852800005
J	Razani, B; Whang, MI; Kim, FS; Nakamura, MC; Sun, XF; Advincula, R; Turnbaugh, JA; Pendse, M; Tanbun, P; Achacoso, P; Turnbaugh, PJ; Malynn, BA; Ma, AV				Razani, Bahram; Whang, Michael I.; Kim, Francis S.; Nakamura, Mary C.; Sun, Xiaofei; Advincula, Rommel; Turnbaugh, Jessie A.; Pendse, Mihir; Tanbun, Priscilia; Achacoso, Philip; Turnbaugh, Peter J.; Malynn, Barbara A.; Ma, Averil			Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; MODIFYING ENZYME A20; RESTRICTS UBIQUITINATION; LINEAR POLYUBIQUITIN; NLRP3 INFLAMMASOME; CELL-DEATH; ACTIVATION; RECOGNITION; INHIBITION; PATHOGENESIS	The deubiquitinase A20 is a potent inhibitor of NF-kappa B signaling pathways. Ma and colleagues identify distinct roles for A20 ubiquitin-binding ZF4 and ZF7 domains, which exhibit different phenotypes upon mutation, but play synergistic roles in regulating inflammatory responses. A20 is an anti-inflammatory protein that is strongly linked to human disease. Here, we find that mice expressing three distinct targeted mutations of A20's zinc finger 7 (ZF7) ubiquitin-binding motif uniformly developed digit arthritis with features common to psoriatic arthritis, while mice expressing point mutations in A20's OTU or ZF4 motifs did not exhibit this phenotype. Arthritis in A20(ZF7) mice required T cells and MyD88, was exquisitely sensitive to tumor necrosis factor and interleukin-17A, and persisted in germ-free conditions. A20(ZF7) cells exhibited prolonged I kappa B kinase activity that drove exaggerated transcription of late-phase nuclear factor-kappa B response genes in vitro and in prediseased mouse paws in vivo. In addition, mice expressing double-mutant A20 proteins in A20's ZF4 and ZF7 motifs died perinatally with multi-organ inflammation. Therefore, A20's ZF4 and ZF7 motifs synergistically prevent inflammatory disease in a non-catalytic manner.	[Razani, Bahram; Whang, Michael I.; Kim, Francis S.; Nakamura, Mary C.; Sun, Xiaofei; Advincula, Rommel; Pendse, Mihir; Tanbun, Priscilia; Achacoso, Philip; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Razani, Bahram] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Kim, Francis S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Turnbaugh, Jessie A.; Turnbaugh, Peter J.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malynn, BA; Ma, AV (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Barbara.malynn@ucsf.edu; averil.ma@ucsf.edu	Sun, Xiaofei/S-9786-2018; Nakamura, Mary/ABI-2887-2020	Sun, Xiaofei/0000-0002-4835-9309; Nakamura, Mary/0000-0001-8127-9426; Razani, Bahram/0000-0003-4069-8178; Turnbaugh, Peter/0000-0002-0888-2875	NIH [R01 AI135198, R01 AI117908, AR070155]; Dermatology Foundation Fellowship; Russell/Engleman Arthritis Center at UCSF; Department of Veterans Affairs Health Care System; National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR066262]; UCSF Liver Center grant from the National Institute of Diabetes and Digestive and Kidney Diseases [P30DK026743]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation Fellowship; Russell/Engleman Arthritis Center at UCSF; Department of Veterans Affairs Health Care System(US Department of Veterans Affairs); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UCSF Liver Center grant from the National Institute of Diabetes and Digestive and Kidney Diseases	supported by NIH R01 AI135198 and R01 AI117908 (to A.M.), AR070155 (to M.C.N.) and a Dermatology Foundation Fellowship (to B.R.). M.C.N. is also supported by the Russell/Engleman Arthritis Center at UCSF and the Department of Veterans Affairs Health Care System. B.R. is also supported by the Department of Veterans Affairs Health Care System. Micro-CT analyses were performed by the UCSF Core Center for Musculoskeletal Biology and Medicine, supported by P30AR066262 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The FACS analyses were supported by UCSF Liver Center grant P30DK026743 from the National Institute of Diabetes and Digestive and Kidney Diseases. We thank J. Ashouri Sinha, J. Zikherman, H.-E. Liang and J. Zhang for helpful discussions and advice and N. Szeto for the micro-CT reconstructions. This work was1	Aeschlimann FA, 2018, ANN RHEUM DIS, V77, P728, DOI 10.1136/annrheumdis-2017-212403; Aki A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180481; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Berteau F, 2018, AUTOIMMUN REV, V17, P809, DOI 10.1016/j.autrev.2018.02.012; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643; Kadowaki T, 2018, J ALLERGY CLIN IMMUN, V141, P1485, DOI 10.1016/j.jaci.2017.10.039; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Malynn BA, 2019, CELL IMMUNOL, V340, DOI 10.1016/j.cellimm.2019.04.002; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557; Robert M, 2019, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00364; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Veale DJ, 2018, LANCET, V391, P2273, DOI 10.1016/S0140-6736(18)30830-4; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zilberman-Rudenko J, 2016, P NATL ACAD SCI USA, V113, P1612, DOI 10.1073/pnas.1518163113	49	34	35	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					422	+		10.1038/s41590-020-0634-4	http://dx.doi.org/10.1038/s41590-020-0634-4		MAR 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205880	Green Accepted, Green Submitted			2022-12-18	WOS:000519843600001
J	Brown, FD; Sen, DR; LaFleur, MW; Godec, J; Lukacs-Kornek, V; Schildberg, FA; Kim, HJ; Yates, KB; Ricoult, SJH; Bi, K; Trombley, JD; Kapoor, VN; Stanley, IA; Cremasco, V; Danial, NN; Manning, BD; Sharpe, AH; Haining, WN; Turley, SJ				Brown, Flavian D.; Sen, Debattama R.; LaFleur, Martin W.; Godec, Jernej; Lukacs-Kornek, Veronika; Schildberg, Frank A.; Kim, Hye-Jung; Yates, Kathleen B.; Ricoult, Stephane J. H.; Bi, Kevin; Trombley, Justin D.; Kapoor, Varun N.; Stanley, Illana A.; Cremasco, Viviana; Danial, Nika N.; Manning, Brendan D.; Sharpe, Arlene H.; Haining, W. Nicholas; Turley, Shannon J.			Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling	NATURE IMMUNOLOGY			English	Article							LYMPH-NODE; NITRIC-OXIDE; DENDRITIC CELLS; STROMAL CELLS; CHROMATIN; IMMUNE; DIFFERENTIATION; HOMEOSTASIS; MIGRATION; GENE	Lymph node fibroblastic reticular cells (FRCs) respond to signals from activated T cells by releasing nitric oxide, which inhibits T cell proliferation and restricts the size of the expanding T cell pool. Whether interactions with FRCs also support the function or differentiation of activated CD8(+) T cells is not known. Here we report that encounters with FRCs enhanced cytokine production and remodeled chromatin accessibility in newly activated CD8(+) T cells via interleukin-6. These epigenetic changes facilitated metabolic reprogramming and amplified the activity of pro-survival pathways through differential transcription factor activity. Accordingly, FRC conditioning significantly enhanced the persistence of virus-specific CD8(+) T cells in vivo and augmented their differentiation into tissue-resident memory T cells. Our study demonstrates that FRCs play a role beyond restricting T cell expansion-they can also shape the fate and function of CD8(+) T cells.	[Brown, Flavian D.; Sen, Debattama R.; LaFleur, Martin W.; Godec, Jernej] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Brown, Flavian D.; Sen, Debattama R.; LaFleur, Martin W.; Godec, Jernej; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA; [Brown, Flavian D.; LaFleur, Martin W.; Godec, Jernej; Schildberg, Frank A.; Kim, Hye-Jung; Trombley, Justin D.; Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Brown, Flavian D.; LaFleur, Martin W.; Godec, Jernej; Schildberg, Frank A.; Trombley, Justin D.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Brown, Flavian D.; LaFleur, Martin W.; Godec, Jernej; Schildberg, Frank A.; Trombley, Justin D.; Sharpe, Arlene H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Brown, Flavian D.; Lukacs-Kornek, Veronika; Schildberg, Frank A.; Kim, Hye-Jung; Cremasco, Viviana; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA USA; [Yates, Kathleen B.; Bi, Kevin; Sharpe, Arlene H.; Haining, W. Nicholas] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Ricoult, Stephane J. H.; Manning, Brendan D.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Kapoor, Varun N.; Turley, Shannon J.] Dept Canc Immunol Genentech, South San Francisco, CA USA; [Stanley, Illana A.; Danial, Nika N.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA; [Stanley, Illana A.; Danial, Nika N.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Brown, Flavian D.] Neon Therapeut Inc, Cambridge, MA USA; [Lukacs-Kornek, Veronika] Rhein Friedrich Wilhelms Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Schildberg, Frank A.] Univ Hosp Bonn, Clin Orthoped & Trauma Surg, Bonn, Germany; [Cremasco, Viviana] Novartis Inst BioMed Res, Immunooncol, Cambridge, MA USA; [Haining, W. Nicholas] Merck Res Labs, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; University of Bonn; University of Bonn; Novartis; Merck & Company	Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA.; Sharpe, AH (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Turley, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA USA.; Sharpe, AH; Haining, WN (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.; Turley, SJ (corresponding author), Dept Canc Immunol Genentech, South San Francisco, CA USA.; Sharpe, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Haining, WN (corresponding author), Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu; nick.haining@merck.com; turley.shannon@gene.com	Sen, Debattama/AAC-5679-2020; Manning, Brendan/ABD-6528-2021	Sen, Debattama/0000-0002-0947-8284; Manning, Brendan/0000-0003-3895-5956; Schildberg, Frank Alexander/0000-0003-0797-1945	US National Institutes of Health [RO1 5R01DK074500, P01AI108545, T32 CA207021]; Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study; NATIONAL CANCER INSTITUTE [T32CA207021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health (grant no. RO1 5R01DK074500 to S.J.T. and W.N.H.; no. P01AI108545 to A.H.S; no. T32 CA207021 to M.W.L) and by a Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study (to F.D.B). We thank members of the Turley, Haining and Sharpe laboratories for scientific insights and discussions. We also thank A. E. Mayfield for critical reading of the manuscript.	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Alexandre YO, 2018, IMMUNOL REV, V283, P77, DOI 10.1111/imr.12641; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Brown FD, 2015, J IMMUNOL, V194, P1389, DOI 10.4049/jimmunol.1402520; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Khan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026138; Knoblich K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005046; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Li QS, 2010, J LEUKOCYTE BIOL, V87, P257, DOI 10.1189/jlb.0409221; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2011, IMMUNOL LETT, V138, P9, DOI 10.1016/j.imlet.2011.02.006; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Mueller SN, 2010, J IMMUNOL, V185, P2182, DOI 10.4049/jimmunol.1001142; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pasztoi M, 2017, EUR J IMMUNOL, V47, P2142, DOI 10.1002/eji.201746960; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Scharer CD, 2017, J IMMUNOL, V198, P2238, DOI 10.4049/jimmunol.1602086; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Yu M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03459-5; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832	64	34	34	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1668	+		10.1038/s41590-019-0515-x	http://dx.doi.org/10.1038/s41590-019-0515-x			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31636464	Green Accepted			2022-12-18	WOS:000497949800021
J	Kanayama, M; Xu, SJ; Danzaki, K; Gibson, JR; Inoue, M; Gregory, SG; Shinohara, ML				Kanayama, Masashi; Xu, Shengjie; Danzaki, Keiko; Gibson, Jason R.; Inoue, Makoto; Gregory, Simon G.; Shinohara, Mari L.			Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; HEMATOPOIETIC STEM; T-CELLS; EMERGENCY GRANULOPOIESIS; INTESTINAL INFLAMMATION; CUTTING EDGE; BONE-MARROW; G-CSF; EXPRESSION	The balance of myeloid populations and lymphoid populations must be well controlled. Here we found that osteopontin (OPN) skewed this balance during pathogenic conditions such as infection and autoimmunity. Notably, two isoforms of OPN exerted distinct effects in shifting this balance through cell-type-specific regulation of apoptosis. Intracellular OPN (iOPN) diminished the population size of myeloid progenitor cells and myeloid cells, and secreted OPN (sOPN) increase the population size of lymphoid cells. The total effect of OPN on skewing the leukocyte population balance was observed as host sensitivity to early systemic infection with Candida albicans and T cell-mediated colitis. Our study suggests previously unknown detrimental roles for two OPN isoforms in causing the imbalance of leukocyte populations.	[Kanayama, Masashi; Xu, Shengjie; Danzaki, Keiko; Inoue, Makoto; Shinohara, Mari L.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Gibson, Jason R.; Gregory, Simon G.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Gregory, Simon G.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Shinohara, Mari L.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA; [Kanayama, Masashi] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo, Japan; [Inoue, Makoto] Univ Illinois, Dept Comparat Biosci, Urbana, IL USA	Duke University; Duke University; Duke University; Duke University; Tokyo Medical & Dental University (TMDU); University of Illinois System; University of Illinois Urbana-Champaign	Shinohara, ML (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC USA.; Shinohara, ML (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA.	mari.shinohara@duke.edu		Shinohara, Mari/0000-0002-6808-9844; Gregory, Simon/0000-0002-7805-1743; Xu, Shengjie/0000-0003-2716-6230; Kanayama, Masashi/0000-0001-8366-5275	US National Institutes of Health [R01AI088100, R21AI103584]; US Department of Defense [PC100266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103584, R01AI088100] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Ciofani and M. Zuberbuehler for help in an experiment with fetal liver; M. Kondo for analysis of ex vivo progenitor-differentiation assays; G. Kucera for generating the LSL-iOPN bacterial artificial chromosome construct; the staff at the David H Murdock Research Institute for generating the sequence data; K. Abramson and E. Grass for generating the 10x single-cell libraries; and T. Kadota for help with in vitro experiments with BMMs in this study. Supported by the US National Institutes of Health (R01AI088100 and R21AI103584 to M.L.S.) and the US Department of Defense (PC100266 to M.L.S.).	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Basu S, 2000, BLOOD, V95, P3725; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004; Bugl S, 2013, BLOOD, V121, P723, DOI 10.1182/blood-2012-05-429589; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Inoue M, 2014, P NATL ACAD SCI USA, V111, P5295, DOI 10.1073/pnas.1321427111; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Inoue M, 2011, J IMMUNOL, V186, P19, DOI 10.4049/jimmunol.1002735; Kanayama M, 2015, J IMMUNOL, V194, P5465, DOI 10.4049/jimmunol.1403249; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Leavenworth JW, 2015, P NATL ACAD SCI USA, V112, P494, DOI 10.1073/pnas.1423011112; Leavenworth JW, 2015, NAT IMMUNOL, V16, P96, DOI 10.1038/ni.3050; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Oz HS, 2012, DIGEST DIS SCI, V57, P1554, DOI 10.1007/s10620-011-2009-z; PATCHEN ML, 1991, BLOOD, V77, P472; Qin FN, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-31; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Robinson BS, 2011, CURR BIOL, V21, pR890, DOI 10.1016/j.cub.2011.09.019; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Shevde LA, 2014, MATRIX BIOL, V37, P131, DOI 10.1016/j.matbio.2014.03.001; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Toyonaga T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135552; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Yang B, 2004, NEPHRON EXP NEPHROL, V96, pE39, DOI 10.1159/000076403; Zhan Y, 2000, IMMUNOL CELL BIOL, V78, P118, DOI 10.1046/j.1440-1711.2000.00891.x; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	46	34	36	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					973	+		10.1038/ni.3791	http://dx.doi.org/10.1038/ni.3791			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28671690	Green Accepted			2022-12-18	WOS:000408137700007
J	Neyen, C; Runchel, C; Schupfer, F; Meier, P; Lemaitre, B				Neyen, Claudine; Runchel, Christopher; Schupfer, Fanny; Meier, Pascal; Lemaitre, Bruno			The regulatory isoform rPGRP-LC induces immune resolution via endosomal degradation of receptors	NATURE IMMUNOLOGY			English	Article							PEPTIDOGLYCAN-RECOGNITION PROTEIN; DROSOPHILA-IMD-PATHWAY; PGRP-LC; BACTERIAL-INFECTION; PATTERN-RECOGNITION; SYSTEM; ACTIVATION; RESPONSES; LE; TOLERANCE	The innate immune system needs to distinguish between harmful and innocuous stimuli to adapt its activation to the level of threat. How Drosophila mounts differential immune responses to dead and live Gram-negative bacteria using the single peptidoglycan receptor PGRP-LC is unknown. Here we describe rPGRP-LC, an alternative splice variant of PGRP-LC that selectively dampens immune response activation in response to dead bacteria. rPGRP-LC-deficient flies cannot resolve immune activation after Gram-negative infection and die prematurely. The alternative exon in the encoding gene, here called rPGRP-LC, encodes an adaptor module that targets rPGRP-LC to membrane microdomains and interacts with the negative regulator Pirk and the ubiquitin ligase DIAP2. We find that rPGRP-LC-mediated resolution of an efficient immune response requires degradation of activating and regulatory receptors via endosomal ESCRT sorting. We propose that rPGRP-LC selectively responds to peptidoglycans from dead bacteria to tailor the immune response to the level of threat.	[Neyen, Claudine; Schupfer, Fanny; Lemaitre, Bruno] Swiss Fed Inst Technol, Global Hlth Inst, Lausanne, Switzerland; [Runchel, Christopher; Meier, Pascal] Inst Canc Res, Breakthrough Toby Robins Breast Canc Res Ctr, London, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Neyen, C; Lemaitre, B (corresponding author), Swiss Fed Inst Technol, Global Hlth Inst, Lausanne, Switzerland.	claudine.neyen@exeter.oxon.org; bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667; Meier, Pascal/0000-0003-2760-6523; Neyen, Claudine/0000-0002-9870-5548	National Research Fund Luxembourg [AFR08/037]; UK National Health Service; BBSRC [BB/L021684/1] Funding Source: UKRI; MRC [MR/M019217/1, G1000089] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L021684/1] Funding Source: researchfish; Medical Research Council [MR/M019217/1, G1000089] Funding Source: researchfish	National Research Fund Luxembourg(Luxembourg National Research Fund); UK National Health Service; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the National Research Fund Luxembourg (AFR08/037) (C.N.) and UK National Health Service funding to the National Institute for Health Research Biomedical Research Centre (P.M.). We thank members of B.L.'s lab for discussions, D. Mengin-Lecreulx (Centre National de la Recherche Scientifique, Universite de Paris-Sud) for PGN and TCT, S. Boy, J. Rybniker (Ecole Polytechnique Federale de Lausanne) and A. Kleino (University of Massachusetts) for sharing advice and plasmids, C. Day, M. Miaczynska and N. Silverman for insightful comments, K. Hofmann and A. Kajava for help with RHIM analysis, M. Gonzalez-Gaitan (University of Geneva), H. Kramer (University of Texas Southwestern Medical Center), A. H. Tang (Eastern Virginia Medical School), and the Bloomington Drosophila Stock Center (BDSC), the Transgenic RNAi Project (TRiP) and the Vienna Drosophila Resource Centre (VDRC) for fly stocks.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Compagnon J, 2009, J CELL SCI, V122, P25, DOI 10.1242/jcs.033027; Costechareyre D, 2016, J INNATE IMMUN, V8, P67, DOI 10.1159/000437368; DiNitto Jonathan P, 2003, Sci STKE, V2003, pre16, DOI 10.1126/stke.2132003re16; Dworkin J, 2014, ANNU REV MICROBIOL, V68, P137, DOI 10.1146/annurev-micro-091213-112844; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Guruharsha KG, 2012, FLY, V6, P246, DOI 10.4161/fly.22108; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Maminska A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0848; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Neyen C, 2014, METHODS, V68, P116, DOI 10.1016/j.ymeth.2014.02.023; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Perrin J, 2015, J INNATE IMMUN, V7, P37, DOI 10.1159/000365112; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	54	34	36	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1150	+		10.1038/ni.3536	http://dx.doi.org/10.1038/ni.3536			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27548432	Green Accepted			2022-12-18	WOS:000384302900006
J	Kincaid, EZ; Murata, S; Tanaka, K; Rock, KL				Kincaid, Eleanor Z.; Murata, Shigeo; Tanaka, Keiji; Rock, Kenneth L.			Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; NEGATIVE SELECTION; MEDULLA MIGRATION; EPITHELIAL-CELLS; CLONAL DELETION; ANTIGEN; THYMOCYTES; EXPRESSION; RECEPTOR; LIGANDS	The cells that stimulate positive selection express specialized proteasome beta-subunits different from those expressed by all other cells, including those involved in negative selection. Mice that lack all four specialized proteasome beta-subunits, and therefore express only constitutive proteasomes in all cells, had a profound defect in the generation of CD8(+) T cells. While a defect in positive selection would reflect an inability to generate the appropriate positively selecting peptides, a block at negative selection would point to the potential need to switch peptides between positive selection and negative selection to avoid the two processes' often cancelling each other out. We found that the block in T cell development occurred around the checkpoints of positive selection and, unexpectedly, negative selection as well.	[Kincaid, Eleanor Z.; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Tokyo, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Tokyo Metropolitan Institute of Medical Science	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	kenneth.rock@umassmed.edu	Kincaid, Eleanor/AAV-3326-2021; Murata, Shigeo/A-1426-2010	Murata, Shigeo/0000-0002-3177-3503	Diabetes Endocrinology Research Center [DK32520]; US National Institutes of Health [AI20248, AI110374, T32CA130807-02]; University of Massachusetts Diabetes and Endocrine Research Center [DK32520]; Japan Society for the Promotion of Science KAKENHI [21000012, 25221102]; NATIONAL CANCER INSTITUTE [T32CA130807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020248, R01AI110374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Diabetes Endocrinology Research Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Diabetes and Endocrine Research Center; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Littman (New York University School of Medicine) for Runx3d<SUP>YFP/YFP</SUP> mice, and A. Singer and E. Huseby for discussions. Core resources of the University of Massachusetts were used (supported by the Diabetes Endocrinology Research Center (DK32520)). Supported by the US National Institutes of Health (AI20248 and AI110374 to K.L.R., and T32CA130807-02 to E.Z.K.), the University of Massachusetts Diabetes and Endocrine Research Center (DK32520 for K.R.) and Japan Society for the Promotion of Science KAKENHI (21000012 to K.T., and 25221102 to S.M.).	Adoro S, 2012, EMBO J, V31, P366, DOI 10.1038/emboj.2011.388; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; JENKINSON EJ, 1994, DEV IMMUNOL, V3, P265, DOI 10.1155/1994/75434; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; LEHMANNGRUBE F, 1994, J IMMUNOL, V153, P595; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; Merkenschlager M, 2004, J EXP MED, V200, P1437, DOI 10.1084/jem.20041127; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Ohta Y, 2002, J IMMUNOL, V168, P771, DOI 10.4049/jimmunol.168.2.771; Ramsdell F., 2001, CURRENT PROTOCOLS IM; REISER H, 1994, IMMUNOLOGY, V81, P532; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sasaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8484; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sprent J, 2009, IMMUNOL CELL BIOL, V87, P46, DOI 10.1038/icb.2008.88; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Suen AYW, 2012, P NATL ACAD SCI USA, V109, P893, DOI 10.1073/pnas.1114834109; Takada K, 2015, NAT IMMUNOL, V16, P1069, DOI 10.1038/ni.3237; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; TAKEUCHI Y, 1989, IMMUNOLOGY, V66, P362; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	50	34	34	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					938	+		10.1038/ni.3480	http://dx.doi.org/10.1038/ni.3480			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27294792	Green Accepted			2022-12-18	WOS:000380647000011
J	Meylan, E; Tschopp, J				Meylan, Etienne; Tschopp, Juerg			IRAK2 takes its place in TLR signaling	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR-ASSOCIATED KINASE; INTERLEUKIN-1 RECEPTOR; MICE LACKING; KAPPA-B; ACTIVATION; PATHWAYS	Toll-like receptors trigger an innate immune response by activating signaling pathways that are dependent on IRAK kinases. According to Kawagoe et al., the least understood IRAK member, IRAK2, is required for the perpetuation of these signals.	[Meylan, Etienne] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Massachusetts Institute of Technology (MIT); University of Lausanne	Meylan, E (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jurg.tschopp@unil.ch		Meylan, Etienne/0000-0002-0899-2230				Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; MARTIN M, 1994, EUR J IMMUNOL, V24, P1566, DOI 10.1002/eji.1830240717; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Thomas JA, 1999, J IMMUNOL, V163, P978; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	13	34	35	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					581	582		10.1038/ni0608-581	http://dx.doi.org/10.1038/ni0608-581			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490904	Green Published			2022-12-18	WOS:000256067900004
J	Catlett, IM; Hedrick, SM				Catlett, IM; Hedrick, SM			Suppressor of cytokine signaling 1 is required for the differentiation of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							RECEPTOR-DEFICIENT MICE; DOUBLE-POSITIVE THYMOCYTES; IN-VITRO; TYROSINE PHOSPHATASE; DOWN-REGULATION; IFN-GAMMA; ACTIVATION; SELECTION; SOCS1; VIVO	Suppressor of cytokine signaling 1 (Socs1) is critical for the regulation of interferon-c responses and T cell homeostasis. Although the presentation of the inflammatory disease of Socs1-deficient mice is complex, we have tested here the hypothesis that it originates from inappropriate T cell development and the appearance of autoreactive T cells. Socs1-deficient T cell receptor-transgenic mice showed severely impaired positive selection and a substantial alteration in CD4-CD8 T cell fate specification. These defects were dependent on interferon-gamma. Moreover, negative selection was also impaired, suggesting that autoimmunity contributes to the disease observed in Socs1(-/-) mice. We conclude that the constitutive expression of Socs1 in the thymus protects the process of thymic development and selection from the effects of systemic inflammation.	Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	Hedrick, Stephen M/E-9171-2010	Catlett, Ian/0000-0001-6220-2626; Hedrick, Stephen/0000-0002-6345-8751	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021372, R01AI021372, R01AI037988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37988-09, AI21372-20] Funding Source: Medline; NIDDK NIH HHS [5T32DK07233] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Carter JD, 1999, INT IMMUNOL, V11, P1999, DOI 10.1093/intimm/11.12.1999; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; Cope AP, 2003, RHEUMATOLOGY, V42, P716, DOI 10.1093/rheumatology/keg262; Cornish AL, 2003, J IMMUNOL, V170, P878, DOI 10.4049/jimmunol.170.2.878; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; KAYE J, 1992, J IMMUNOL, V148, P3342; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Lindeman GJ, 2001, GENE DEV, V15, P1631, DOI 10.1101/gad.880801; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsuda T, 2000, FEBS LETT, V472, P235, DOI 10.1016/S0014-5793(00)01444-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; SCOLLAY R, 1983, THYMUS, V5, P245; Sharp LL, 1999, J IMMUNOL, V163, P6598; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zhang JY, 1999, J IMMUNOL, V163, P3012; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	41	34	36	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					715	721		10.1038/ni1211	http://dx.doi.org/10.1038/ni1211			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15924143				2022-12-18	WOS:000229975500015
J	Long, EO				Long, EO			Versatile signaling through NKG2D	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; DAP12	Receptors in the immune system usually specialize in transmitting specific types of signals. However, by associating with two different signaling subunits, the receptor NKG2D can transmit distinct signals for either costimulation or full-fledged activation.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Long, EO (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.		Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000842] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chang CW, 1999, J IMMUNOL, V163, P4651; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Namekawa T, 2000, J IMMUNOL, V165, P1138, DOI 10.4049/jimmunol.165.2.1138; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	12	34	42	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1119	1120		10.1038/ni1202-1119	http://dx.doi.org/10.1038/ni1202-1119			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12447364				2022-12-18	WOS:000179467800004
J	Aurrand-Lions, M; Johnson-Leger, C; Imhof, BA				Aurrand-Lions, M; Johnson-Leger, C; Imhof, BA			The last molecular fortress in leukocyte trans-endothelial migration	NATURE IMMUNOLOGY			English	Editorial Material							JUNCTIONAL ADHESION MOLECULE; CELLS	Leukocyte arrest on inflamed endothelium constitutes only the first phase of their recruitment into the tissues. New data points to the roles played by JAM-1 and CD99 in leukocyte passage through the barrier posed by the vascular endothelium during inflammatory responses.	Ctr Med Univ Geneva, Dept Pathol, CH-1204 Geneva, Switzerland	University of Geneva	Aurrand-Lions, M (corresponding author), Ctr Med Univ Geneva, Dept Pathol, CH-1204 Geneva, Switzerland.		Aurrand-Lions, Michel/O-9953-2016	Aurrand-Lions, Michel/0000-0002-8361-3034				ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Hahn JH, 1997, J IMMUNOL, V159, P2250; IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9; Johnson-Leger C, 2000, J CELL SCI, V113, P921; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Ozaki H, 1999, J IMMUNOL, V163, P553; Poggi A, 1996, EUR J IMMUNOL, V26, P817, DOI 10.1002/eji.1830260414; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; SIMIONESCU M, 1975, J CELL BIOL, V67, P863, DOI 10.1083/jcb.67.3.863; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	16	34	35	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					116	118		10.1038/ni0202-116	http://dx.doi.org/10.1038/ni0202-116			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812986				2022-12-18	WOS:000173562400010
J	Mosmann, T				Mosmann, T			Complexity or coherence? Cytokine secretion by B cells	NATURE IMMUNOLOGY			English	News Item							T-CELL; DIFFERENTIATION; PERSISTENCE; EXPRESSION; TH1		Univ Rochester, Med Ctr, Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Rochester, NY 14642 USA	University of Rochester	Mosmann, T (corresponding author), Univ Rochester, Med Ctr, Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Rochester, NY 14642 USA.							ACTOR JK, 1994, EUR J IMMUNOL, V24, P3050, DOI 10.1002/eji.1830241220; Akai PS, 1999, MICROBES INFECT, V1, P51, DOI 10.1016/S1286-4579(99)80014-8; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kelso A, 1999, SPRINGER SEMIN IMMUN, V21, P231, DOI 10.1007/s002810050065; KOJIMA S, 1975, CELL IMMUNOL, V17, P383, DOI 10.1016/S0008-8749(75)80042-6; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SEDER RA, 1999, FUNDAMENTAL IMMUNOLO; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2	16	34	36	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					465	466		10.1038/82707	http://dx.doi.org/10.1038/82707			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101865				2022-12-18	WOS:000165724600008
J	Roose, J; Weiss, A				Roose, J; Weiss, A			T cells: getting a GRP on Ras	NATURE IMMUNOLOGY			English	News Item									Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Roose, J (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.			Roose, Jeroen/0000-0003-4746-2811				Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200	11	34	35	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					275	276		10.1038/79713	http://dx.doi.org/10.1038/79713			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017094				2022-12-18	WOS:000089869700006
J	Peng, YC; Felce, SL; Dong, DN; Penkava, F; Mentzer, AJ; Yao, X; Liu, GH; Yin, ZX; Chen, JL; Lu, YX; Wellington, D; Wing, PAC; Dominey-Foy, DCC; Jin, C; Wang, WB; Abd Hamid, M; Fernandes, RA; Wang, BB; Fries, A; Zhuang, XD; Ashley, N; Rostron, T; Waugh, C; Sopp, P; Hublitz, P; Beveridge, R; Tan, TK; Dold, C; Kwok, AJ; Rich-Griffin, C; Dejnirattisa, W; Liu, C; Kurupati, P; Nassiri, I; Watson, RA; Tong, O; Taylor, CA; Sharma, PK; Sun, B; Curion, F; Revale, S; Garner, LC; Jansen, K; Ferreira, RC; Attar, M; Fry, JW; Russell, RA; Stauss, HJ; James, W; Townsend, A; Ho, LP; Klenerman, P; Mongkolsapaya, J; Screaton, GR; Dendrou, C; Sansom, SN; Bashford-Rogers, R; Chain, B; Smith, GL; McKeating, JA; Fairfax, BP; Bowness, P; McMichael, AJ; Ogg, G; Knight, JC; Dong, T				Peng, Yanchun; Felce, Suet Ling; Dong, Danning; Penkava, Frank; Mentzer, Alexander J.; Yao, Xuan; Liu, Guihai; Yin, Zixi; Chen, Ji-Li; Lu, Yongxu; Wellington, Dannielle; Wing, Peter A. C.; Dominey-Foy, Delaney C. C.; Jin, Chen; Wang, Wenbo; Abd Hamid, Megat; Fernandes, Ricardo A.; Wang, Beibei; Fries, Anastasia; Zhuang, Xiaodong; Ashley, Neil; Rostron, Timothy; Waugh, Craig; Sopp, Paul; Hublitz, Philip; Beveridge, Ryan; Tan, Tiong Kit; Dold, Christina; Kwok, Andrew J.; Rich-Griffin, Charlotte; Dejnirattisa, Wanwisa; Liu, Chang; Kurupati, Prathiba; Nassiri, Isar; Watson, Robert A.; Tong, Orion; Taylor, Chelsea A.; Sharma, Piyush Kumar; Sun, Bo; Curion, Fabiola; Revale, Santiago; Garner, Lucy C.; Jansen, Kathrin; Ferreira, Ricardo C.; Attar, Moustafa; Fry, Jeremy W.; Russell, Rebecca A.; Stauss, Hans J.; James, William; Townsend, Alain; Ho, Ling-Pei; Klenerman, Paul; Mongkolsapaya, Juthathip; Screaton, Gavin R.; Dendrou, Calliope; Sansom, Stephen N.; Bashford-Rogers, Rachael; Chain, Benny; Smith, Geoffrey L.; McKeating, Jane A.; Fairfax, Benjamin P.; Bowness, Paul; McMichael, Andrew J.; Ogg, Graham; Knight, Julian C.; Dong, Tao		COMBAT Consortium	An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease	NATURE IMMUNOLOGY			English	Article							RNA-SEQ; SARS-COV-2; RECOMBINANT; GENE	NP105-113-B*07:02-specific CD8(+) T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong association of this response with mild disease. Analysis of NP105-113-B*07:02-specific T cell clones and single-cell sequencing were performed concurrently, with functional avidity and antiviral efficacy assessed using an in vitro SARS-CoV-2 infection system, and were correlated with T cell receptor usage, transcriptome signature and disease severity (acute n = 77, convalescent n = 52). We demonstrated a beneficial association of NP105-113-B*07:02-specific T cells in COVID-19 disease progression, linked with expansion of T cell precursors, high functional avidity and antiviral effector function. Broad immune memory pools were narrowed postinfection but NP105-113-B*07:02-specific T cells were maintained 6 months after infection with preserved antiviral efficacy to the SARS-CoV-2 Victoria strain, as well as Alpha, Beta, Gamma and Delta variants. Our data show that NP105-113-B*07:02-specific T cell responses associate with mild disease and high antiviral efficacy, pointing to inclusion for future vaccine design. Peng et al. find that immunodominant cytotoxic T lymphocytes (CTLs) specific for NP105-113-B*07:02 are associated with reduced COVID-19 severity. Mechanistically, NP105-113-B*07:02-specific CTLs show potent antiviral functionality and may represent rational T cell vaccine targets.	[Peng, Yanchun; Dong, Danning; Yin, Zixi; Chen, Ji-Li; Wellington, Dannielle; Tan, Tiong Kit; Kurupati, Prathiba; Nassiri, Isar; Townsend, Alain; Ho, Ling-Pei; Ogg, Graham; Dong, Tao] Univ Oxford, Radcliffe Dept Med, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Peng, Yanchun; Felce, Suet Ling; Dong, Danning; Yao, Xuan; Liu, Guihai; Yin, Zixi; Chen, Ji-Li; Wellington, Dannielle; Wing, Peter A. C.; Dominey-Foy, Delaney C. C.; Jin, Chen; Wang, Wenbo; Abd Hamid, Megat; Fernandes, Ricardo A.; Wang, Beibei; Liu, Chang; Townsend, Alain; Mongkolsapaya, Juthathip; Screaton, Gavin R.; McKeating, Jane A.; McMichael, Andrew J.; Ogg, Graham; Knight, Julian C.; Dong, Tao] Univ Oxford, Chinese Acad Med Sci Oxford Inst, Oxford, England; [Felce, Suet Ling; Mentzer, Alexander J.; Fries, Anastasia; Kwok, Andrew J.; Rich-Griffin, Charlotte; Dejnirattisa, Wanwisa; Liu, Chang; Nassiri, Isar; Sun, Bo; Curion, Fabiola; Revale, Santiago; Ferreira, Ricardo C.; Mongkolsapaya, Juthathip; Screaton, Gavin R.; Dendrou, Calliope; Bashford-Rogers, Rachael; Knight, Julian C.] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Felce, Suet Ling; Mentzer, Alexander J.; Yao, Xuan; Liu, Guihai; Yin, Zixi; Wing, Peter A. C.; Dominey-Foy, Delaney C. C.; Jin, Chen; Wang, Wenbo; Abd Hamid, Megat; Fernandes, Ricardo A.; Wang, Beibei; Fries, Anastasia; Zhuang, Xiaodong; Kwok, Andrew J.; Dejnirattisa, Wanwisa; Liu, Chang; Mongkolsapaya, Juthathip; Screaton, Gavin R.; McKeating, Jane A.; McMichael, Andrew J.; Knight, Julian C.; Dong, Tao] Univ Oxford, Nuffield Dept Med, Oxford, England; [Dong, Danning; Nassiri, Isar] Xinjiang Med Univ, Xinjiang Tumor Hosp, CAMS Key Lab Tumor Immunol & Radiat Therapy, Urumqi, Peoples R China; [Penkava, Frank; Bowness, Paul] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Liu, Guihai] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Lu, Yongxu; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge, England; [Ashley, Neil] Univ Oxford, MRC Weatherall Inst Mol Med, Single Cell Facil, Oxford, England; [Rostron, Timothy] Univ Oxford, MRC Weatherall Inst Mol Med, Sequencing Facil, Oxford, England; [Waugh, Craig; Sopp, Paul] Univ Oxford, MRC Weatherall Inst Mol Med, Flow Cytometry Facil, Oxford, England; [Hublitz, Philip] Univ Oxford, MRC Weatherall Inst Mol Med, Genome Engn Facil, Oxford, England; [Beveridge, Ryan] Univ Oxford, MRC Weatherall Inst Mol Med, Virus Screening Facil, Oxford, England; [Dold, Christina] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Dold, Christina] Univ Oxford, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford, England; [Watson, Robert A.; Tong, Orion; Taylor, Chelsea A.; Sharma, Piyush Kumar; Fairfax, Benjamin P.] Univ Oxford, Dept Oncol, Oxford, England; [Nassiri, Isar; Watson, Robert A.; Tong, Orion; Taylor, Chelsea A.; Sharma, Piyush Kumar; Garner, Lucy C.; Fairfax, Benjamin P.] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England; [Curion, Fabiola] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Computat Biol, Neuherberg, Germany; [Garner, Lucy C.; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England; [Jansen, Kathrin; Attar, Moustafa; Sansom, Stephen N.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Fry, Jeremy W.] Prolmmune Ltd, Oxford, England; [Russell, Rebecca A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Stauss, Hans J.] UCL, Inst Immun & Transplantat, London, England; [James, William] Univ Oxford, Sir William Dunn Sch Pathol, James & Lillian Martin Ctr, Oxford, England; [Klenerman, Paul] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Siriaj Hosp, Dengue Hemorrhag Fever Res Unit,Off Res & Dev, Bangkok, Thailand; [Chain, Benny] UCL, Div Infect & Immun, London, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Xinjiang Medical University; University of Oxford; Capital Medical University; University of Cambridge; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of Oxford; University of Oxford; Mahidol University; University of London; University College London	Dong, T (corresponding author), Univ Oxford, Radcliffe Dept Med, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.; Knight, JC; Dong, T (corresponding author), Univ Oxford, Chinese Acad Med Sci Oxford Inst, Oxford, England.; Knight, JC (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford, England.; Knight, JC; Dong, T (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	julian.knight@well.ox.ac.uk; tao.dong@imm.ox.ac.uk	Abd Hamid, Megat Hafizzuddin Bin/AAA-9052-2022; Garner, Lucy/GXV-6561-2022; Wang, Dapeng/AAK-5651-2020; james, william/H-4289-2013; Knight, Julian/W-2399-2019	Abd Hamid, Megat Hafizzuddin Bin/0000-0002-9072-1367; Wang, Dapeng/0000-0002-9925-4574; james, william/0000-0002-2506-1198; Hublitz, Philip/0000-0001-8810-3247; Dominey-Foy, Delaney Charles Conleth/0000-0001-9209-323X; Yin, Zixi/0000-0002-2044-5838; Ge, Mingxv/0000-0003-4730-0804; Prathiba, Kurupati/0000-0003-0633-889X; Taylor, Chelsea/0000-0002-1635-4167; Zhuang, Alan Xiaodong/0000-0002-6870-9003; Knight, Julian/0000-0002-0377-5536; Sun, Bo/0000-0002-5507-6657; Dong, Tao/0000-0003-3545-3758; Garner, Lucy/0000-0002-6461-252X; Rich-Griffin, Charlotte/0000-0001-8212-9542; Mentzer, Alexander/0000-0002-4502-2209; Yongxu, Lu/0000-0003-4701-5560; Peng, Yanchun/0000-0003-2340-0499; Tong, Orion/0000-0002-0659-5944; Screaton, Gavin/0000-0002-3549-4309; Tan, Tiong Kit/0000-0001-8746-8308; Felce, Ling/0000-0001-8534-1629	UK RI; UK Medical Research Council (MRC); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), China [2018-I2M-2-002]; National Institutes of Health, National Key R&D Program of China [2020YFE0202400]; China Scholarship Council; NIHR Oxford Biomedical Research Centre; Schmidt Futures; National Institute for Health Research (NIHR) (UKRIDHSC COVID-19 Rapid Response Rolling Call) [COV19-RECPLAS, WT109965MA]; Huo Family Foundation; UK-CIC; DHSC (PITCH); Wellcome Investigator award [204969/Z/16/Z, 200838/Z/16/Z]; UK MRC [MR/R022011/1]; Oxford Biomedical Research Centre; Cancer Research UK	UK RI(UK Research & Innovation (UKRI)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), China; National Institutes of Health, National Key R&D Program of China(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Schmidt Futures; National Institute for Health Research (NIHR) (UKRIDHSC COVID-19 Rapid Response Rolling Call); Huo Family Foundation; UK-CIC; DHSC (PITCH); Wellcome Investigator award; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Biomedical Research Centre; Cancer Research UK(Cancer Research UK)	We thank all the participants for donating their samples and data for these analyses, and the research teams involved in the consenting, recruitment and sampling of these participants. We thank K. Clark and S.-A. Clark from WIMM flow cytometry facility for their help with cell sorting. The B.1.617.2 (Delta) variant was provided by W. Barclay and T. De Silva from the UK RI-funded Genotype to Phenotype Consortium (G2P-UK). This work is supported by the UK Medical Research Council (MRC, to T.D., G.O., Y.P. and J.C.); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), China (grant no. 2018-I2M-2-002 to T.D., Y.P., S.L.F., X.Y., G.L., D.D., J.C.K., G.O., G.S., J.M., A.M, J.A.M. and A.T.); National Institutes of Health, National Key R&D Program of China (no. 2020YFE0202400 to T.D.); China Scholarship Council (to Z.Y., G.L., C.J. and C.L.). The present study is also funded by the NIHR Oxford Biomedical Research Centre (L.P.H., G.O., J.C.K., P.B. and A.J.M.), Senior Investigator Award (to G.O.) and Clinical Research Network (to G.O.); Schmidt Futures (G.R.S); the National Institute for Health Research (NIHR) (UKRIDHSC COVID-19 Rapid Response Rolling Call, grant no. COV19-RECPLAS), WT109965MA, Huo Family Foundation, UK-CIC and DHSC (PITCH; to P.K.). J.C.K. is supported by a Wellcome Investigator award (no. 204969/Z/16/Z). The McKeating laboratory is funded by a Wellcome Investigator Award (to J.A.M., no. 200838/Z/16/Z) and UK MRC project grant (no. MR/R022011/1). Initial funding for the VSF was provided by the Oxford Biomedical Research Centre and Cancer Research UK. We thank the donors to the University of Oxford's COVID-19 Research Response Fund for the philanthropic support of the COMBAT study. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the UK Department of Health. This work uses data provided by patients and collected by the NHS as part of their care and support #DataSavesLives.	Abd Hamid M, 2020, CANCER IMMUNOL RES, V8, P203, DOI 10.1158/2326-6066.CIR-19-0554; Abd Hamid M, 2019, CANCER IMMUNOL RES, V7, P1293, DOI 10.1158/2326-6066.CIR-18-0885; Ahern D. J., BLOOD ATLAS COVID 19, DOI 10.1101/2021.05.11.21256877(2021; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Akthar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9423; Amezquita RA, 2020, NAT METHODS, V17, P137, DOI 10.1038/s41592-019-0654-x; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brunson, 2020, J OPEN SOURCE SOFTWA, DOI 10.21105/joss.02017; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Danileviciute E., 2019, PARK7 DJ 1 PROMOTES, DOI 10.1101/2019.12.20.884809v1; de Silva TI, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103353; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Huang H, 2020, NAT BIOTECHNOL, V38, P1194, DOI 10.1038/s41587-020-0505-4; HUANG X, BIOINFORMATICS; Huang YH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1865-2; JOHANSSON C, MUCOSAL IMMUNOL; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lineburg KE, 2021, IMMUNITY, V54, P1055, DOI 10.1016/j.immuni.2021.04.006; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Nguyen THO, 2021, IMMUNITY, V54, P1066, DOI 10.1016/j.immuni.2021.04.009; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Peng YC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00287; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rajapaksa US, 2012, P NATL ACAD SCI USA, V109, P13353, DOI 10.1073/pnas.1204199109; Ranasinghe SRF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001341; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Singh Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17723; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; Smith LK, 2018, IMMUNITY, V48, P299, DOI 10.1016/j.immuni.2018.01.006; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; van der Loo MPJ, 2014, R J, V6, P111; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wing PAC, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109020; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579; Zhang J, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00372-8; ZHENG GX, 2017, NATURE, V0008; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	48	33	33	4	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					50	+		10.1038/s41590-021-01084-z	http://dx.doi.org/10.1038/s41590-021-01084-z		DEC 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34853448	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000724647800001
J	Abbas, A; Manh, TPV; Valente, M; Collinet, N; Attaf, N; Dong, C; Naciri, K; Chelbi, R; Brelurut, G; Cervera-Marzal, I; Rauwel, B; Davignon, JL; Bessou, G; Thomas-Chollier, M; Thieffry, D; Villani, AC; Milpied, P; Dalod, M; Tomasello, E				Abbas, Abdenour; Thien-Phong Vu Manh; Valente, Michael; Collinet, Nils; Attaf, Noudjoud; Dong, Chuang; Naciri, Karima; Chelbi, Rabie; Brelurut, Geoffray; Cervera-Marzal, Inaki; Rauwel, Benjamin; Davignon, Jean-Luc; Bessou, Gilles; Thomas-Chollier, Morgane; Thieffry, Denis; Villani, Alexandra-Chloe; Milpied, Pierre; Dalod, Marc; Tomasello, Elena			The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; INTERFERON-ALPHA/BETA; IFN-ALPHA; T-CELLS; RNA-SEQ; EXPRESSION; RESPONSES; SPECIALIZATION; REGULATOR; CYTOKINES	Plasmacytoid dendritic cells (pDCs) are a major source of type I interferon (IFN-I). Dalod and colleagues show that IFN-I production and T cell activation were performed by the same pDC, but these occurred sequentially and in different micro-anatomical locations during virus infection. Plasmacytoid dendritic cells (pDCs) are a major source of type I interferon (IFN-I). What other functions pDCs exert in vivo during viral infections is controversial, and more studies are needed to understand their orchestration. In the present study, we characterize in depth and link pDC activation states in animals infected by mouse cytomegalovirus by combiningIfnb1reporter mice with flow cytometry, single-cell RNA sequencing, confocal microscopy and a cognate CD4 T cell activation assay. We show that IFN-I production and T cell activation were performed by the same pDC, but these occurred sequentially in time and in different micro-anatomical locations. In addition, we show that pDC commitment to IFN-I production was marked early on by their downregulation of leukemia inhibitory factor receptor and was promoted by cell-intrinsic tumor necrosis factor signaling. We propose a new model for how individual pDCs are endowed to exert different functions in vivo during a viral infection, in a manner tightly orchestrated in time and space.	[Abbas, Abdenour; Thien-Phong Vu Manh; Valente, Michael; Collinet, Nils; Attaf, Noudjoud; Dong, Chuang; Naciri, Karima; Chelbi, Rabie; Cervera-Marzal, Inaki; Bessou, Gilles; Milpied, Pierre; Dalod, Marc; Tomasello, Elena] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Turing Ctr Living Syst, CIML,CNRS,INSERM, Marseille, France; [Brelurut, Geoffray; Thomas-Chollier, Morgane; Thieffry, Denis] Univ PSL, Inst Biol ENS, Dept Biol, Ecole Normale Super,CNRS,INSERM, Paris, France; [Rauwel, Benjamin; Davignon, Jean-Luc] Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Villani, Alexandra-Chloe] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Villani, Alexandra-Chloe] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Abbas, Abdenour] PSL Res Univ, Inst Curie, Paris, France; [Cervera-Marzal, Inaki] Eura Nova, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Dalod, M; Tomasello, E (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, Turing Ctr Living Syst, CIML,CNRS,INSERM, Marseille, France.	dalod@ciml.univ-mrs.fr; tomasell@ciml.univ-mrs.fr	Dalod, Marc/AAK-6163-2020; Milpied, Pierre J/Q-1380-2015	Dalod, Marc/0000-0002-6436-7966; Milpied, Pierre J/0000-0003-1873-5358; ABBAS, Abdenour/0000-0003-2372-4530; Cervera-Marzal, Inaki/0000-0002-9341-2252; Thieffry, Denis/0000-0003-0271-1757; Vu Manh, Thien-Phong/0000-0002-0294-342X; Tomasello, Elena/0000-0002-6839-5219; valente, michael/0000-0002-0844-9799; Thomas-Chollier, Morgane/0000-0003-2608-476X; ATTAF, Noudjoud/0000-0001-7254-7679	GenomEast platform (Strasbourg, France), a member of the France Genomique consortium [ANR-10-INBS-0009]; European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) [281225]; Agence Nationale de la Recherche (ANR) (SCAPIN) [ANR-15-CE15-0006-01]; Fondation pour la Recherche Medicale [DEQ20180339172]; DCBIOL Labex by the French government's Investissements d'Avenir program [ANR-11-LABEX-0043, ANR-10-IDEX-0001-02 PSL*]; A*MIDEX project by the French government's Investissements d'Avenir program [ANR11-IDEX-0001-02]; French National Research Agency through the Investments for the Future program (France-BioImaging) [ANR-10-INBS-04]; DCBIOL Labex; INSERM	GenomEast platform (Strasbourg, France), a member of the France Genomique consortium; European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013); Agence Nationale de la Recherche (ANR) (SCAPIN)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); DCBIOL Labex by the French government's Investissements d'Avenir program(French National Research Agency (ANR)); A*MIDEX project by the French government's Investissements d'Avenir program(French National Research Agency (ANR)); French National Research Agency through the Investments for the Future program (France-BioImaging)(French National Research Agency (ANR)); DCBIOL Labex; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank all the staff of the CIML and CIPHE mouse houses for their assistance, as well as the staff of the CIML flow cytometry and imaging (ImagImm) core facilities. We thank L. Spinelli for fruitful discussions on single-cell data analysis and the CIML genomics and bioinformatics platform for their technical and methodological help. Microarray experiments and sequencing for the SS2 datasets were performed by V. Alunni or B. Jost in the GenomEast platform (Strasbourg, France), a member of the France Genomique consortium (ANR-10-INBS-0009), managed by C. Thibault-Carpentier. FB5P-seq library sequencing was performed by HalioDx testing laboratory, Marseille, France. We thank S. Henri (CIML) for the generous gift of OT-II mice and H. Luche for advice on cell and tissue fixation to preserve the YFP signal. This research was funded by grants from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013, grant no. 281225, SystemsDendritic, to M.D.), the Agence Nationale de la Recherche (ANR) (SCAPIN, grant no. ANR-15-CE15-0006-01, to M.D.), and the Fondation pour la Recherche Medicale (grant no. DEQ20180339172, Equipe Labellisee, to M.D.). We also thank the DCBIOL Labex (ANR-11-LABEX-0043, grant no. ANR-10-IDEX-0001-02 PSL*), the A*MIDEX project (grant no. ANR11-IDEX-0001-02) funded by the French government's Investissements d'Avenir program managed by the ANR, and institutional support from CNRS, INSERM, Aix-Marseille Universite and Marseille Immunopole. This work was supported by the French National Research Agency through the Investments for the Future program (France-BioImaging, ANR-10-INBS-04). A.A. and R.C. were supported by the DCBIOL Labex. G. Brelurut's apprenticeship was supported by INSERM.	Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Alculumbre SG, 2018, NAT IMMUNOL, V19, P63, DOI 10.1038/s41590-017-0012-z; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson DA, 2019, ADV IMMUNOL, V143, P99, DOI 10.1016/bs.ai.2019.09.001; Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Assil S, 2019, CELL HOST MICROBE, V25, P730, DOI 10.1016/j.chom.2019.03.005; Attaf N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00216; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Baranek T, 2012, CELL HOST MICROBE, V12, P571, DOI 10.1016/j.chom.2012.09.002; Bauer J, 2016, J IMMUNOL, V196, P4447, DOI 10.4049/jimmunol.1500383; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Frenz T, 2014, J IMMUNOL, V193, P2496, DOI 10.4049/jimmunol.1400215; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hentschel E, 2013, MICROB BIOTECHNOL, V6, P196, DOI 10.1111/j.1751-7915.2012.00360.x; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Jaehn PS, 2008, EUR J IMMUNOL, V38, P1822, DOI 10.1002/eji.200737552; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lau CM, 2016, J EXP MED, V213, P415, DOI 10.1084/jem.20150642; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Leylek R, 2019, CELL REP, V29, P3736, DOI 10.1016/j.celrep.2019.11.042; Leylek R, 2019, INT REV CEL MOL BIO, V349, P177, DOI 10.1016/bs.ircmb.2019.10.002; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; O'Keeffe M, 2012, J IMMUNOL, V188, P3774, DOI 10.4049/jimmunol.1101365; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Segura E, 2009, J IMMUNOL, V183, P1514, DOI 10.4049/jimmunol.0901524; Sesti-Costa R, 2020, J IMMUNOL, V204, P2257, DOI 10.4049/jimmunol.1900604; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Tomasello E, 2018, EMBO J, V37, DOI 10.15252/embj.201798836; Tomasello E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00526; Tombolini R, 1997, FEMS MICROBIOL ECOL, V22, P17, DOI 10.1016/S0168-6496(96)00068-2; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Villani AC, 2017, METHODS MOL BIOL, V1514, P203, DOI 10.1007/978-1-4939-6548-9_16; Wimmers F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05784-3; Zhang JS, 2013, J BIOL CHEM, V288, P4310, DOI 10.1074/jbc.M112.351197; Zucchini N, 2008, INT IMMUNOL, V20, P45, DOI 10.1093/intimm/dxm119	59	33	35	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					983	+		10.1038/s41590-020-0731-4	http://dx.doi.org/10.1038/s41590-020-0731-4		JUL 2020	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32690951	Green Accepted			2022-12-18	WOS:000550625000001
J	Mukherjee, S; Kumar, R; Lenou, ET; Basrur, V; Kontoyiannis, DL; Ioakeimidis, F; Mosialos, G; Theiss, AL; Flavell, RA; Venuprasad, K				Mukherjee, Sandip; Kumar, Ritesh; Lenou, Elviche Tsakem; Basrur, Venkatesha; Kontoyiannis, Dimitris L.; Ioakeimidis, Fotis; Mosialos, George; Theiss, Arianne L.; Flavell, Richard A.; Venuprasad, K.			Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation	NATURE IMMUNOLOGY			English	Article							BOWEL-DISEASE; HOST-DEFENSE; IL-18; EXPRESSION; COLITIS; INTERLEUKIN-18; UBIQUITIN; IMMUNITY; REVEALS; SYSTEM	NLRP6 is highly expressed in the gut; however, persistent NLRP6 activation can lead to excessive IL-18 production and intestinal bowel disease. Venuprasad and colleagues identify the K63-linked ubiquitin deubiquitinase Cyld as a negative regulator of NLRP6. The inflammasome NLRP6 plays a crucial role in regulating inflammation and host defense against microorganisms in the intestine. However, the molecular mechanisms by which NLRP6 function is inhibited to prevent excessive inflammation remain unclear. Here, we demonstrate that the deubiquitinase Cyld prevents excessive interleukin 18 (IL-18) production in the colonic mucosa by deubiquitinating NLRP6. We show that deubiquitination inhibited the NLRP6-ASC inflammasome complex and regulated the maturation of IL-18. Cyld deficiency in mice resulted in elevated levels of active IL-18 and severe colonic inflammation following Citrobacter rodentium infection. Further, in patients with ulcerative colitis, the concentration of active IL-18 was inversely correlated with CYLD expression. Thus, we have identified a novel regulatory mechanism that inhibits the NLRP6-IL-18 pathway in intestinal inflammation.	[Mukherjee, Sandip; Kumar, Ritesh; Lenou, Elviche Tsakem; Venuprasad, K.] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Mukherjee, Sandip; Kumar, Ritesh; Lenou, Elviche Tsakem; Venuprasad, K.] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA; [Basrur, Venkatesha] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kontoyiannis, Dimitris L.; Mosialos, George] Aristotle Univ Thessaloniki, Sch Biol, Thessaloniki, Greece; [Kontoyiannis, Dimitris L.; Ioakeimidis, Fotis] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece; [Theiss, Arianne L.] Univ Colorado, Div Gastroenterol & Hepatol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; Aristotle University of Thessaloniki; Alexander Fleming Biomedical Sciences Research Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; Yale University	Venuprasad, K (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.; Venuprasad, K (corresponding author), UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA.	venuprasad.poojary@utsouthwestern.edu	Mukherjee, Sandip/ABI-6554-2020; Kumar, Ritesh/AFC-1479-2022	Mukherjee, Sandip/0000-0002-8445-0994; Kumar, Ritesh/0000-0002-0150-8880; Theiss, Arianne/0000-0003-2862-0933; Kontoyiannis, Dimitris/0000-0003-4682-9490; Flavell, Richard/0000-0003-4461-0778; poojary, venuprasd/0000-0001-8986-9092; Mosialos, George/0000-0002-5342-4873	National Institutes of Health [R01-DK115668-01]; Cancer Prevention Research Institute of Texas [RP160577, RP190527]; Baylor Charles A. Sammons Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Baylor Charles A. Sammons Cancer Center	We thank E. Burstein for helpful discussions and W. Lancaster for critical reading of the manuscript. This work was supported by the National Institutes of Health (grant R01-DK115668-01), the Cancer Prevention Research Institute of Texas (grants RP160577 and RP190527) and the Baylor Charles A. Sammons Cancer Center and BSWRI-TGEN collaborative grants to K.V.	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Cleynen I, 2014, GUT, V63, P1265, DOI 10.1136/gutjnl-2012-303205; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Han S, 2015, J BIOL CHEM, V290, P18124, DOI 10.1074/jbc.M115.645549; Hara H, 2018, CELL, V175, P1651, DOI 10.1016/j.cell.2018.09.047; Hrdinka M, 2016, CELL REP, V14, P2846, DOI 10.1016/j.celrep.2016.02.062; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Iggo R, 2015, METHODS MOL BIOL, V1293, P137, DOI 10.1007/978-1-4939-2519-3_8; Kanai T, 2001, GASTROENTEROLOGY, V121, P875, DOI 10.1053/gast.2001.28021; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Karatzas DN, 2016, CELL ONCOL, V39, P287, DOI 10.1007/s13402-016-0279-3; Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Leach ST, 2008, INFLAMM BOWEL DIS, V14, P68, DOI 10.1002/ibd.20272; Leon AJ, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/580450; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Lochner M, 2002, PATHOBIOLOGY, V70, P164, DOI 10.1159/000068149; Man SM, 2018, NAT REV GASTRO HEPAT, V15, P721, DOI 10.1038/s41575-018-0054-1; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Monteleone G, 1999, J IMMUNOL, V163, P143; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Ohta Y, 2001, ARCH DERMATOL RES, V293, P334, DOI 10.1007/s004030100240; Peng DJ, 2011, J IMMUNOL, V186, P5638, DOI 10.4049/jimmunol.1003801; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Shen C, 2019, P NATL ACAD SCI USA, V116, P2052, DOI 10.1073/pnas.1817221116; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Singh AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06924-5; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Tucker TA, 2003, AM J PHYSIOL-CELL PH, V284, pC791, DOI 10.1152/ajpcell.00435.2002; Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047	46	33	35	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					626	+		10.1038/s41590-020-0681-x	http://dx.doi.org/10.1038/s41590-020-0681-x		MAY 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424362	Green Accepted			2022-12-18	WOS:000533852800008
J	Lu, D; Liu, L; Sun, YZ; Song, J; Yin, Q; Zhang, GZ; Qi, F; Hu, ZX; Yang, ZL; Zhou, Z; Hu, Y; Zhang, LH; Ji, JF; Zhao, XY; Jin, Y; McNutt, MA; Yin, YX				Lu, Dan; Liu, Liang; Sun, Yizhe; Song, Jia; Yin, Qi; Zhang, Guangze; Qi, Fang; Hu, Zixi; Yang, Zeliang; Zhou, Zhe; Hu, Ying; Zhang, Lianhai; Ji, Jiafu; Zhao, Xuyang; Jin, Yan; McNutt, Michael A.; Yin, Yuxin			The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CANCER; IMMUNOTHERAPY; TRANSCRIPTION; INSIGHTS; GENES; MODEL	Cancer cells subvert immune surveillance through inhibition of T cell effector function. Elucidation of the mechanism of T cell dysfunction is therefore central to cancer immunotherapy. Here, we report that dual specificity phosphatase 2 (DUSP2; also known as phosphatase of activated cells 1, PAC1) acts as an immune checkpoint in T cell antitumor immunity. PAC1 is selectively upregulated in exhausted tumor-infiltrating lymphocytes and is associated with poor prognosis of patients with cancer. PAC1(hi) effector T cells lose their proliferative and effector capacities and convert into exhausted T cells. Deletion of PAC1 enhances immune responses and reduces cancer susceptibility in mice. Through activation of EGR1, excessive reactive oxygen species in the tumor microenvironment induce expression of PAC1, which recruits the Mi-2 beta nucleosome-remodeling and histone-deacetylase complex, eventually leading to chromatin remodeling of effector T cells. Our study demonstrates that PAC1 is an epigenetic immune regulator and highlights the importance of targeting PAC1 in cancer immunotherapy. Yin and colleagues show that the phosphatase PAC1 (DUSP2) acts as a checkpoint in cytotoxic T cells to restrain their antitumor function.	[Lu, Dan; Liu, Liang; Sun, Yizhe; Song, Jia; Yin, Qi; Zhang, Guangze; Qi, Fang; Hu, Zixi; Yang, Zeliang; Zhou, Zhe; Zhao, Xuyang; Jin, Yan; McNutt, Michael A.; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing, Peoples R China; [Sun, Yizhe; Song, Jia; Zhang, Guangze; Qi, Fang; Yang, Zeliang; Zhou, Zhe; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China; [Yin, Qi; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Hu, Ying; Zhang, Lianhai; Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Tumor Syst Biol, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Yin, YX (corresponding author), Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing, Peoples R China.; Yin, YX (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China.; Yin, YX (corresponding author), Peking Univ, Hlth Sci Ctr, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Yin, YX (corresponding author), Peking Univ, Hlth Sci Ctr, Beijing Key Lab Tumor Syst Biol, Beijing, Peoples R China.	yinyuxin@hsc.pku.edu.cn	Hu, Ying/GQZ-8100-2022	Sun, Yizhe/0000-0002-5986-3826; Liu, Liang/0000-0002-2279-1638; Lu, Dan/0000-0002-3000-5094; Zhang, Guangze/0000-0001-8151-6751; Qi, Fang/0000-0001-9856-926X; Song, Jia/0000-0003-1418-3656	National Key Research and Development Program of China [2016YFA0500302]; National Natural Science Foundation of China [81430056, 31420103905, 81874235, 81501360, 31800749]; Beijing Natural Science Foundation [7161007]; Lam Chung Nin Foundation for Systems Biomedicine; Fund for Fostering Young Scholars of Peking University Health Science Center [BMU2018YJ003]; China Postdoctoral Science Foundation [2018M630045]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Lam Chung Nin Foundation for Systems Biomedicine; Fund for Fostering Young Scholars of Peking University Health Science Center; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank H. Tang (Institute Pasteur of Shanghai Chinese Academy of Sciences) for providing OT-I mice; J. Zhang (Peking University Health Science Center) for providing LCMV virus; Z. Zhu for help with mouse experiments; M. Chen, J. Gong and Z. Hou for help with tumor models; and X. Li. and Y. Zhu for help with bioinformatics analysis. This work was supported by grants from the National Key Research and Development Program of China (grant no. 2016YFA0500302 to Y.Y.), the National Natural Science Foundation of China (key grant nos 81430056, 31420103905 and 81874235 to Y.Y.; grant no. 81501360 to D.L.; and grant no. 31800749 to L.L.), the Beijing Natural Science Foundation (key grant no. 7161007 to Y.Y.), the Lam Chung Nin Foundation for Systems Biomedicine, the Fund for Fostering Young Scholars of Peking University Health Science Center (grant no. BMU2018YJ003 to D.L.) and the China Postdoctoral Science Foundation (grant no. 2018M630045 to L.L.).	BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bornelov S, 2018, MOL CELL, V71, P56, DOI 10.1016/j.molcel.2018.06.003; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Durgeau A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00014; Dyson HJ, 2012, MOL BIOSYST, V8, P97, DOI 10.1039/c1mb05258f; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Kalinowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058764; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Lin MV, 2015, ANNU REV PATHOL-MECH, V10, P345, DOI 10.1146/annurev-pathol-012414-040323; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lu D, 2015, NAT IMMUNOL, V16, P1263, DOI 10.1038/ni.3278; Maglione JE, 2001, CANCER RES, V61, P8298; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Ott PA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0218-5; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shen E, 2018, P NATL ACAD SCI USA, V115, P6780, DOI 10.1073/pnas.1805239115; Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028; Stecher C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00572; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wang GX, 2015, CELL RES, V25, P1189, DOI 10.1038/cr.2015.115; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wei Z, 2018, BIOINFORMATICS, V34, P2664, DOI 10.1093/bioinformatics/bty141; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112	50	33	33	5	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					287	+		10.1038/s41590-019-0577-9	http://dx.doi.org/10.1038/s41590-019-0577-9		JAN 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	31932812				2022-12-18	WOS:000508182300002
J	Cheng, WC; Tsui, YC; Ragusa, S; Koelzer, VH; Mina, M; Franco, F; Laubli, H; Tschumi, B; Speiser, D; Romero, P; Zippelius, A; Petrova, TV; Mertz, K; Ciriello, G; Ho, PC				Cheng, Wan-Chen; Tsui, Yao-Chen; Ragusa, Simone; Koelzer, Viktor H.; Mina, Marco; Franco, Fabien; Laubli, Heinz; Tschumi, Benjamin; Speiser, Daniel; Romero, Pedro; Zippelius, Alfred; Petrova, Tatiana V.; Mertz, Kirsten; Ciriello, Giovanni; Ho, Ping-Chih			Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; UCP2; EXPRESSION; MELANOMA; GENE; PROLIFERATION; CHECKPOINT; NIVOLUMAB; BLOCKADE; IRF5	Immune checkpoint blockade therapy has shifted the paradigm for cancer treatment. However, the majority of patients lack effective responses due to insufficient T cell infiltration in tumors. Here we show that expression of mitochondrial uncoupling protein 2 (UCP2) in tumor cells determines the immunostimulatory feature of the tumor microenvironment (TME) and is positively associated with prolonged survival. UCP2 reprograms the immune state of the TME by altering its cytokine milieu in an interferon regulatory factor 5-dependent manner. Consequently, UCP2 boosts the conventional type 1 dendritic cell- and CD8(+) T cell-dependent anti-tumor immune cycle and normalizes the tumor vasculature. Finally we show, using either a genetic or pharmacological approach, that induction of UCP2 sensitizes melanomas to programmed cell death protein-1 blockade treatment and elicits effective anti-tumor responses. Together, this study demonstrates that targeting the UCP2 pathway is a potent strategy for alleviating the immunosuppressive TME and overcoming the primary resistance of programmed cell death protein-1 blockade.	[Cheng, Wan-Chen; Tsui, Yao-Chen; Ragusa, Simone; Franco, Fabien; Tschumi, Benjamin; Speiser, Daniel; Romero, Pedro; Petrova, Tatiana V.; Ho, Ping-Chih] Univ Lausanne, Dept Fundamental Oncol, Lausanne, Switzerland; [Cheng, Wan-Chen; Tsui, Yao-Chen; Ragusa, Simone; Franco, Fabien; Tschumi, Benjamin; Speiser, Daniel; Romero, Pedro; Petrova, Tatiana V.; Ho, Ping-Chih] Univ Lausanne, Ludwig Canc Res, Epalinges, Switzerland; [Ragusa, Simone; Petrova, Tatiana V.] CHU Vaudois, Div Expt Pathol, Lausanne, Switzerland; [Koelzer, Viktor H.; Mertz, Kirsten] Cantonal Hosp Baselland, Inst Pathol, Liestal, Switzerland; [Mina, Marco; Ciriello, Giovanni] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Mina, Marco; Ciriello, Giovanni] Swiss Inst Bioinformat, Lausanne, Switzerland; [Laubli, Heinz; Zippelius, Alfred] Univ Hosp Basel, Dept Biomed, Basel, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Baselland; University of Lausanne; Swiss Institute of Bioinformatics; University of Basel	Ho, PC (corresponding author), Univ Lausanne, Dept Fundamental Oncol, Lausanne, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Ludwig Canc Res, Epalinges, Switzerland.	ping-chih.ho@unil.ch	Speiser, Daniel E./F-2173-2013; Mertz, Kirsten/AAY-1660-2020	Mertz, Kirsten/0000-0002-3074-6925; Koelzer, Viktor/0000-0001-9206-4885; Ciriello, Giovanni/0000-0003-2021-8683; Ho, Ping-Chih/0000-0003-3078-3774	Swiss Institute for Experimental Cancer Research [ISREC 26075483]; Swiss Cancer Foundation [KFS-3949-08-2016]; SNSF project [31003A_163204]; Cancer Research Institute; Harry J. Lloyd Charitable Trust Career Development Grant; Roch-pRED grant; SITC-MRA Young Investigator Award; SNSF [320030_162575, CRSII3_160708, 31003A_156469]; MEDIC Foundation; Swiss Cancer League [KLS 3406-02-2016]; Giorgi-Cavaglieri Foundation	Swiss Institute for Experimental Cancer Research; Swiss Cancer Foundation; SNSF project; Cancer Research Institute; Harry J. Lloyd Charitable Trust Career Development Grant; Roch-pRED grant; SITC-MRA Young Investigator Award; SNSF(Swiss National Science Foundation (SNSF)); MEDIC Foundation; Swiss Cancer League; Giorgi-Cavaglieri Foundation	This study was supported in part by the Swiss Institute for Experimental Cancer Research (no. ISREC 26075483), the Swiss Cancer Foundation (no. KFS-3949-08-2016), a SNSF project grant (no. 31003A_163204), a Clinic and Laboratory Integration Program award from the Cancer Research Institute, a Harry J. Lloyd Charitable Trust Career Development Grant, a Roch-pRED grant and a SITC-MRA Young Investigator Award to P.-C.H. A.Z. and P.R. are supported by SNSF project grants (no. 320030_162575 to A.Z., nos. CRSII3_160708 and 31003A_156469 to P.R.). T.P. is supported by the MEDIC Foundation and Swiss Cancer League (no. KLS 3406-02-2016) and G.C. is supported by the Giorgi-Cavaglieri Foundation. We also thank Camilla Jandus for providing human melanoma cell lines.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Algood HMS, 2004, J IMMUNOL, V173, P3287; Andrilenas KK, 2018, NUCLEIC ACIDS RES, V46, P2509, DOI 10.1093/nar/gky002; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dalla Pozza E, 2012, BBA-MOL CELL RES, V1823, P1856, DOI 10.1016/j.bbamcr.2012.06.007; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Pons DG, 2015, FREE RADICAL BIO MED, V86, P67, DOI 10.1016/j.freeradbiomed.2015.04.032; Gajewski TF, 2015, SEMIN ONCOL, V42, P663, DOI 10.1053/j.seminoncol.2015.05.011; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Giannakis M, 2016, CELL REP, V17, P1206, DOI 10.1016/j.celrep.2016.10.009; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hass DT, 2016, NEURAL REGEN RES, V11, P1197, DOI 10.4103/1673-5374.189159; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Ho PC, 2014, CANCER RES, V74, P3205, DOI 10.1158/0008-5472.CAN-13-3461; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Huang YH, 2018, NAT REV IMMUNOL, V18, P195, DOI 10.1038/nri.2017.145; Imai K, 2017, ONCOL LETT, V14, P951, DOI 10.3892/ol.2017.6212; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kageyama Y, 2004, FASEB J, V18, P1028, DOI 10.1096/fj.03-1233fje; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Parikh JR, 2010, NUCLEIC ACIDS RES, V38, pW109, DOI 10.1093/nar/gkq424; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Schelker M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02289-3; Schmittnaegel M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9670; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Spranger S., 2017, CANCER CELL, V1; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Sun S, 2018, THORAC CANCER, V9, P218, DOI 10.1111/1759-7714.12579; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tsapogas P, 2014, HAEMATOLOGICA, V99, P638, DOI 10.3324/haematol.2013.089482; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Uccellini L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-170; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	54	33	34	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					206	+		10.1038/s41590-018-0290-0	http://dx.doi.org/10.1038/s41590-018-0290-0			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30664764				2022-12-18	WOS:000456279100018
J	Perkins, DJ; Richard, K; Hansen, AM; Lai, W; Nallar, S; Koller, B; Vogel, SN				Perkins, Darren J.; Richard, Katharina; Hansen, Anne-Marie; Lai, Wendy; Nallar, Shreeram; Koller, Beverly; Vogel, Stefanie N.			Autocrine-paracrine prostaglandin E-2 signaling restricts TLR4 internalization and TRIF signaling	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL RESPONSES; MURINE MACROPHAGES; PGE(2) PRODUCTION; ADAPTER TRIF; RECEPTOR; LIPOPOLYSACCHARIDE; ACTIVATION; INDUCTION; INFECTION	The unique cell biology of Toll-like receptor 4 (TLR4) allows it to initiate two signal-transduction cascades: a signal dependent on the adaptors TIRAP (Mal) and MyD88 that begins at the cell surface and regulates proinflammatory cytokines, and a signal dependent on the adaptors TRAM and TRIF that begins in the endosomes and drives the production of type I interferons. Negative feedback circuits to limit TLR4 signals from both locations are necessary to balance the inflammatory response. We describe a negative feedback loop driven by autocrine-paracrine prostaglandin E-2 (PGE(2)) and the PGE(2) receptor EP4 that restricted TRIF-dependent signals and the induction of interferon-beta through the regulation of TLR4 trafficking. Inhibition of PGE(2) production or antagonism of EP4 increased the rate at which TLR4 translocated to endosomes and amplified TRIF-dependent activation of the transcription factor IRF3 and caspase-8. This PGE(2)-driven mechanism restricted TLR4-TRIF signaling in vitro after infection of macrophages by the Gram-negative pathogens Escherichia coli or Citrobacter rodentium and protected mice against mortality induced by Salmonella enteritidis serovar Typhimurium. Thus, PGE(2) restricted TLR4-TRIF signaling specifically in response to lipopolysaccharide.	[Perkins, Darren J.; Richard, Katharina; Hansen, Anne-Marie; Lai, Wendy; Nallar, Shreeram; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Koller, Beverly] UNC, Dept Genet, Sch Med, Chapel Hill, NC USA	University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Perkins, DJ; Vogel, SN (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	dperkins@som.umaryland.edu; svogel@som.umaryland.edu		, darren/0000-0003-1368-6366; Richard, Katharina/0000-0003-0939-2103; Vogel, Stefanie/0000-0001-8244-2555	US National Institutes of Health [AI123371, AI125215, AR061491]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125215, R01AI123371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Hewlett (University of Virginia) for purified AC from B. pertussis; L. Wahl (National Institute of Dental and Craniofacial Research, US National Institutes of Health) for blood from healthy human volunteers at the Department of Transfusion Medicine of the US National Institutes of Health; R. Ernst (University of Maryland, Baltimore) for Salmonella Typhimurium strain SL1344; J.B. Kaper (University of Maryland, Baltimore) for enterohemorrhagic and enteropathogenic E. coli and C. rodentium; R. Rajaiah for technical assistance with the TLR4-internalization assay; and J.C. Blanco and D. Prantner for critique of this manuscript. Flow cytometry and microarray analyses were performed at the Center for Innovative Biomedical Resources at the University of Maryland, School of Medicine. Supported by the US National Institutes of Health (AI123371 and AI125215 to S.N.V.; and AR061491 to B.K.).	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; BARTHOLD SW, 1976, LAB ANIM SCI, V26, P889; BOTHWELL W, 1982, J PHARMACOL EXP THER, V220, P229; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; Bowman CC, 2004, J IMMUNOL, V172, P2469, DOI 10.4049/jimmunol.172.4.2469; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Bryant CE, 2015, MOL IMMUNOL, V63, P162, DOI 10.1016/j.molimm.2014.06.033; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Castiglia V, 2016, CELL HOST MICROBE, V19, P375, DOI 10.1016/j.chom.2016.02.003; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Facemire CS, 2011, AM J PHYSIOL-RENAL, V301, pF1035, DOI 10.1152/ajprenal.00054.2011; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Guichard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006603; Guichard A, 2014, NAT REV MICROBIOL, V12, P624, DOI 10.1038/nrmicro3325; Guichard A, 2013, CELL HOST MICROBE, V14, P294, DOI 10.1016/j.chom.2013.08.001; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Hessle CC, 2003, INFLAMMATION, V27, P329, DOI 10.1023/B:IFLA.0000006700.41614.21; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; LEVINE MM, 1978, LANCET, V1, P1119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOORE RN, 1979, INFECT IMMUN, V26, P408, DOI 10.1128/IAI.26.2.408-414.1979; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Mortimer L, 2016, NAT IMMUNOL, V17, P1176, DOI 10.1038/ni.3538; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Perkins DJ, 2007, MOL MICROBIOL, V66, P1003, DOI 10.1111/j.1365-2958.2007.05972.x; Perkins DJ, 2015, J IMMUNOL, V195, P2461, DOI 10.4049/jimmunol.1500105; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Richard K, 2016, INNATE IMMUN-LONDON, V22, P363, DOI 10.1177/1753425916650027; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Stefan KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188600; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Van Acker T, 2014, J BIOL CHEM, V289, P1364, DOI 10.1074/jbc.M113.499194; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Xu XJ, 2008, J IMMUNOL, V180, P2125, DOI 10.4049/jimmunol.180.4.2125; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zaslona Z, 2017, J IMMUNOL, V198, P3558, DOI 10.4049/jimmunol.1602072	69	33	33	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1309	+		10.1038/s41590-018-0243-7	http://dx.doi.org/10.1038/s41590-018-0243-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30397349	Green Accepted			2022-12-18	WOS:000452873000012
J	Jelencic, V; Sestan, M; Kavazovic, I; Lenartic, M; Marinovic, S; Holmes, TD; Prchal-Murphy, M; Lisnic, B; Sexl, V; Bryceson, YT; Wensveen, FM; Polic, B				Jelencic, Vedrana; Sestan, Marko; Kavazovic, Inga; Lenartic, Maja; Marinovic, Sonja; Holmes, Tim D.; Prchal-Murphy, Michaela; Lisnic, Berislav; Sexl, Veronika; Bryceson, Yenan T.; Wensveen, Felix M.; Polic, Bojan			NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTORS; HEMATOPOIETIC STEM; ADAPTER PROTEIN; INFECTION; DAP12; MICE; RECOGNITION; RESISTANCE; RESPONSES	The activation of natural killer (NK) cells depends on a change in the balance of signals from inhibitory and activating receptors. The activation threshold values of NK cells are thought to be set by engagement of inhibitory receptors during development. Here, we found that the activating receptor NKG2D specifically set the activation threshold for the activating receptor NCR1 through a process that required the adaptor DAP12. As a result, NKGD2-deficient (Klrk1(-/-)) mice controlled tumors and cytomegalovirus infection better than wild-type controls through the NCR1-induced production of the cytokine IFN-gamma. Expression of NKG2D before the immature NK cell stage increased expression of the adaptor CD3 zeta. Reduced expression of CD3. in Klrk1(-/-) mice was associated with enhanced signal transduction through NCR1, and CD3. deficiency resulted in hyper-responsiveness to stimulation via NCR1. Thus, an activating receptor developmentally set the activity of another activating receptor on NK cells and determined NK cell reactivity to cellular threats.	[Jelencic, Vedrana; Sestan, Marko; Kavazovic, Inga; Lenartic, Maja; Marinovic, Sonja; Lisnic, Berislav; Wensveen, Felix M.; Polic, Bojan] Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka, Croatia; [Holmes, Tim D.; Bryceson, Yenan T.] Karolinska Inst, Dept Med Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Prchal-Murphy, Michaela; Sexl, Veronika] Univ Vet Med Vienna, Inst Pharmacol & Toxicol, Dept Biomed Sci, Vienna, Austria; [Bryceson, Yenan T.] Univ Bergen, Dept Clin Sci, Broegelmann Lab, Bergen, Norway	University of Rijeka; Karolinska Institutet; University of Veterinary Medicine Vienna; University of Bergen	Polic, B (corresponding author), Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka, Croatia.	bojan.polic@medri.uniri.hr	Marinović, Sonja/S-2859-2018; Wensveen, Felix/O-3122-2018; Šestan, Marko/S-4142-2018; Polic, Bojan/B-8622-2014; Jelenčić, Vedrana/S-4624-2018; Kavazovic, Inga/S-1098-2018; Bryceson, Yenan/D-2121-2018; Sexl, Veronika/B-8657-2016	Marinović, Sonja/0000-0002-4054-338X; Wensveen, Felix/0000-0002-1333-8882; Šestan, Marko/0000-0002-1473-6647; Polic, Bojan/0000-0003-3930-9630; Jelenčić, Vedrana/0000-0001-8606-9313; Kavazovic, Inga/0000-0003-4704-6199; Bryceson, Yenan/0000-0002-7783-9934; Sexl, Veronika/0000-0001-9363-0412	EFIS-IL Short-term Fellowship; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [311335]; Swedish Research Council; Norwegian Research Council; Swedish Foundation for Strategic Research; Wallenberg Foundation; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation; Stockholm County Council; Karolinska Institutet Center for Innovative Medicine; Netherlands Organization for Scientific Research [91614029]; European Commission [PCIG14-GA-2013-630827]; University of Rijeka [865.10.2101, 803.10.1103]; European Social Fund [HR.3.2.01-0263]; Croatian Science Foundation [IP-2016-06-9306, KK.01.1.1.01.0006, IP-2016-06-8027]; European Regional Development Fund	EFIS-IL Short-term Fellowship; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wallenberg Foundation(European Commission); Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet Center for Innovative Medicine; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Rijeka; European Social Fund(European Social Fund (ESF)); Croatian Science Foundation; European Regional Development Fund(European Commission)	We thank S. Slavic Stupac, M. Samsa, E. Marinovic, A. Mise and K. Mikic for technical assistance. We thank S. Jonjic for discussions and overall support to this work. We thank O. Mandelboim (Hebrew University Hadassah Medical School), M. Colonna (Washington University School of Medicine in St. Louis, St. Louis, MO, USA), M. Busslinger (Research Institute of Molecular Pathology, Vienna, Austria), A. Waisman (Institute of Molecular Biology, Mainz, Germany), D.R. Littman (NYU School of Medicine, New York, NY, USA), J. McGlade (University of Toronto, Toronto, Canada) and K. Rajewsky (MDC Center for Molecular Medicine, Berlin, Germany) for providing mouse lines. This work was supported by an EFIS-IL Short-term Fellowship grant to V. J., European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 311335, Swedish Research Council, Norwegian Research Council, Swedish Foundation for Strategic Research, Wallenberg Foundation, Swedish Cancer Foundation, Swedish Childhood Cancer Foundation, as well as the Stockholm County Council and Karolinska Institutet Center for Innovative Medicine to Y.T.B., Netherlands Organization for Scientific Research (91614029), the European Commission (PCIG14-GA-2013-630827), a University of Rijeka Support grant (865.10.2101) and a Croatian Science Foundation Grant (IP-2016-06-8027) to F.M.W., a European Social Fund grant (HR.3.2.01-0263), University of Rijeka Support grant (803.10.1103) and Croatian Science Foundation grant (IP-2016-06-9306) to B.P. and the grant KK.01.1.1.01.0006, awarded to the Scientific Centre of Excellence for Virus Immunology and Vaccines and co-financed by the European Regional Development Fund.	Arase H, 2001, J IMMUNOL, V166, P21, DOI 10.4049/jimmunol.166.1.21; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Davis AH, 2008, J IMMUNOL, V181, P265, DOI 10.4049/jimmunol.181.1.265; Della Chiesa M, 2008, EUR J IMMUNOL, V38, P2284, DOI 10.1002/eji.200838434; Deng GM, 2013, J IMMUNOL, V191, P3563, DOI 10.4049/jimmunol.1300634; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Goh W, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00130; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman Jessica A, 2006, Sci STKE, V2006, pre1, DOI 10.1126/stke.3202006re1; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Jelencic V, 2017, IMMUNOL LETT, V189, P48, DOI 10.1016/j.imlet.2017.04.006; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lenartic M, 2017, J IMMUNOL, V198, P1531, DOI 10.4049/jimmunol.1600461; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Mulrooney TJ, 2013, J LEUKOCYTE BIOL, V94, P301, DOI 10.1189/jlb.0213093; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Overwijk W. W., 2001, CURRENT PROTOCOLS IM, V39; Schuster IS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00235; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Sjolin-Goodfellow H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005596; Sjolin H, 2006, J IMMUNOL, V177, P2908, DOI 10.4049/jimmunol.177.5.2908; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Takaki R, 2006, IMMUNOL REV, V214, P118, DOI 10.1111/j.1600-065X.2006.00466.x; Takeda K, 2011, J LEUKOCYTE BIOL, V90, P777, DOI 10.1189/jlb.0411208; Utsuyama M, 2003, EXP MOL PATHOL, V74, P319, DOI 10.1016/S0014-4800(03)00026-1; Viant C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6108; Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wu N, 2016, NAT IMMUNOL, V17, P387, DOI 10.1038/ni.3369; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zafirova B, 2011, CELL MOL LIFE SCI, V68, P3519, DOI 10.1007/s00018-011-0797-0; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	49	33	34	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1083	+		10.1038/s41590-018-0209-9	http://dx.doi.org/10.1038/s41590-018-0209-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30224819	Green Accepted			2022-12-18	WOS:000445968600014
J	Inshaw, JRJ; Cutler, AJ; Burren, OS; Stefana, MI; Todd, JA				Inshaw, Jamie R. J.; Cutler, Antony J.; Burren, Oliver S.; Stefana, M. Irina; Todd, John A.			Approaches and advances in the genetic causes of autoimmune disease and their implications	NATURE IMMUNOLOGY			English	Review							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; MENDELIAN RANDOMIZATION; SUSCEPTIBILITY LOCI; NONSENSE MUTATION; PANCREATIC-ISLETS; SUPER-ENHANCERS; BAYESIAN METHOD; GUT MICROBIOTA; JOINT ANALYSIS	Genome-wide association studies are transformative in revealing the polygenetic basis of common diseases, with autoimmune diseases leading the charge. Although the field is just over 10 years old, advances in understanding the underlying mechanistic pathways of these conditions, which result from a dense multifactorial blend of genetic, developmental and environmental factors, have already been informative, including insights into therapeutic possibilities. Nevertheless, the challenge of identifying the actual causal genes and pathways and their biological effects on altering disease risk remains for many identified susceptibility regions. It is this fundamental knowledge that will underpin the revolution in patient stratification, the discovery of therapeutic targets and clinical trial design in the next 20 years. Here we outline recent advances in analytical and phenotyping approaches and the emergence of large cohorts with standardized gene-expression data and other phenotypic data that are fueling a bounty of discovery and improved understanding of human physiology.	[Inshaw, Jamie R. J.; Cutler, Antony J.; Stefana, M. Irina; Todd, John A.] Univ Oxford, NIHR Oxford Biomed Res Ctr, JDRF Wellcome Diabet & Inflammat Lab, Wellcome Ctr Human Genet,Nuffield Dept Med, Oxford, England; [Burren, Oliver S.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England	University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Todd, JA (corresponding author), Univ Oxford, NIHR Oxford Biomed Res Ctr, JDRF Wellcome Diabet & Inflammat Lab, Wellcome Ctr Human Genet,Nuffield Dept Med, Oxford, England.	jatodd@well.ox.ac.uk	; Todd, John/A-3542-2010	Stefana, Irina/0000-0002-4796-5884; Burren, Oliver/0000-0002-3388-5760; Inshaw, Jamie/0000-0002-7003-8966; Cutler, Antony/0000-0002-9617-9994; Todd, John/0000-0003-2740-8148	JDRF [9-2011-253, 5-SRA-2015-130-A-N]; Wellcome [091157, 107212, WT107881]	JDRF(Juvenile Diabetes Research Foundation); Wellcome	We thank the JDRF (grant codes 9-2011-253 and 5-SRA-2015-130-A-N) and Wellcome (grant codes 091157 and 107212). O.S.B. is funded by Wellcome (grant code WT107881).	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Al- Mossawi H., 2018, BIORXIV, DOI [10.1101/262410, DOI 10.1101/262410]; Alasoo K, 2018, NAT GENET, V50, P424, DOI 10.1038/s41588-018-0046-7; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bekpen C, 2012, GENOME RES, V22, P1050, DOI 10.1101/gr.134098.111; Benner C, 2017, AM J HUM GENET, V101, P539, DOI 10.1016/j.ajhg.2017.08.012; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Beyerlein A, 2016, JAMA-J AM MED ASSOC, V315, P1899, DOI 10.1001/jama.2016.2181; Blaabjerg L, 2014, J MOL ENDOCRINOL, V53, P417, DOI 10.1530/JME-14-0056; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Brorsson CA, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9570424; Burgess S, 2015, INT J EPIDEMIOL, V44, P379, DOI 10.1093/ije/dyv108; Burren OS, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1285-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/166298, DOI 10.1136/heartjnl-2013-303950]; Calderari S, 2018, GENOMICS, V110, P98, DOI 10.1016/j.ygeno.2017.09.001; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; Cooper N. J, 2017, BIORXIV, DOI [10.1101/120022, DOI 10.1101/120022]; Corbin LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03109-y; Cortes A, 2017, NAT GENET, V49, P1311, DOI 10.1038/ng.3926; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; Davies JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158327; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; De Jager PL, 2015, SEMIN IMMUNOL, V27, P51, DOI 10.1016/j.smim.2015.03.003; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Dooley J, 2016, NAT GENET, V48, P519, DOI 10.1038/ng.3531; Dunne JL, 2014, CLIN EXP IMMUNOL, V177, P30, DOI 10.1111/cei.12321; Eberhard D, 2013, BIOESSAYS, V35, P584, DOI 10.1002/bies.201300035; Elkon R, 2017, NAT BIOTECHNOL, V35, P732, DOI 10.1038/nbt.3863; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Graham Kate L, 2012, Rev Diabet Stud, V9, P148, DOI 10.1900/RDS.2012.9.148; Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63; Hartwig FP, 2016, INT J EPIDEMIOL, V45, P1717, DOI 10.1093/ije/dyx028; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; Hemani G, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007081; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huang Q. Q., 2017, BIORXIV, DOI [10.1101/209171, DOI 10.1101/209171]; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Inoshita M, 2018, SCI REP-UK, V8, DOI 10.1038/srep46947; Inshaw JRJ, 2018, DIABETOLOGIA, V61, P147, DOI 10.1007/s00125-017-4440-y; Ivison S, 2017, CURR OPIN IMMUNOL, V49, P56, DOI 10.1016/j.coi.2017.09.006; Jacobs JP, 2014, FEBS LETT, V588, P4102, DOI 10.1016/j.febslet.2014.02.052; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kasela S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006643; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Keshishian H, 2015, MOL CELL PROTEOMICS, V14, P2375, DOI 10.1074/mcp.M114.046813; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kindt ASD, 2018, J AUTOIMMUN, V89, P63, DOI 10.1016/j.jaut.2017.11.008; Kohling HL, 2017, CLIN IMMUNOL, V183, P63, DOI 10.1016/j.clim.2017.07.001; Koellinger PD, 2018, SCIENCE, V359, P386, DOI 10.1126/science.aar6429; Koreth J., 2017, NEW ENGL J MED, V365, P2055; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kumasaka N., 2017, BIORXIV, DOI [10.1101/227389, DOI 10.1101/227389]; Lai MC, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0224-6; Lappalainen T, 2017, NAT REV GENET, V18, P441, DOI 10.1038/nrg.2017.32; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Liu SL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00098; Lotta LA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002179; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Mahajan, 2018, BIORXIV, P245506, DOI [10.1101/245506, DOI 10.1101/245506]; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Marroqui L, 2017, DIABETOLOGIA, V60, P656, DOI 10.1007/s00125-016-4201-3; Marroqui L, 2015, DIABETES, V64, P3808, DOI 10.2337/db15-0362; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; Matzaraki V, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1207-1; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Mullaney JA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0417-4; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Needell JC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0781-z; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Newcombe PJ, 2016, GENET EPIDEMIOL, V40, P188, DOI 10.1002/gepi.21953; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Ongen H, 2017, NAT GENET, V49, P1676, DOI 10.1038/ng.3981; Pappalardo JL, 2016, CELL, V167, P894, DOI 10.1016/j.cell.2016.10.040; Paun A, 2017, J IMMUNOL, V198, P590, DOI 10.4049/jimmunol.1601519; Pekalski ML, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93739; Perri ER, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00080; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rainbow DB., 2017, BIORXIV, P1, DOI [10.1101/108126, DOI 10.1101/108126]; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Reinius B, 2016, NAT GENET, V48, P1430, DOI 10.1038/ng.3678; Rhead B, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000097; Rodriguez-Calvo T, 2016, AUTOIMMUN REV, V15, P964, DOI 10.1016/j.autrev.2016.07.019; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Saadoun D., 2017, NEW ENGL J MED, V365, P2067; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Santin I, 2016, METHODS MOL BIOL, V1433, P21, DOI 10.1007/7651_2015_291; Schmid J, 2011, P NATL ACAD SCI USA, V108, P13722, DOI 10.1073/pnas.1110965108; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun B. B., NATURE; Thomas NJ, 2018, LANCET DIABETES ENDO, V6, P122, DOI 10.1016/S2213-8587(17)30362-5; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Tibshirani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-106; Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2018, EUR J HUM GENET, V26, P925, DOI 10.1038/s41431-018-0142-2; Todd JA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002139; Tong M, 2014, ISME J, V8, P2193, DOI 10.1038/ismej.2014.64; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Turpin W, 2018, GUT MICROBES, V9, P357, DOI 10.1080/19490976.2018.1445956; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; van der Wijst M. G. P., 2017, BIORXIV, DOI [10.1101/177568, DOI 10.1101/177568]; Varshney A, 2017, P NATL ACAD SCI USA, V114, P2301, DOI 10.1073/pnas.1621192114; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Vodovotz Y, 2017, TRENDS IMMUNOL, V38, P116, DOI 10.1016/j.it.2016.11.006; Wacklin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094863; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wallace C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005272; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Wijesekara N, 2017, FASEB J, V31, P5409, DOI 10.1096/fj.201700431R; Wijmenga C, 2018, NAT GENET, V50, P322, DOI 10.1038/s41588-018-0066-3; Yang JJ, 2017, AM J HUM GENET, V101, P404, DOI 10.1016/j.ajhg.2017.08.002; Yurkovetskiy LA, 2015, CELL HOST MICROBE, V17, P548, DOI 10.1016/j.chom.2015.04.010; Zhang CC, 2017, ONCOTARGET, V8, P44994, DOI 10.18632/oncotarget.16690; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Ziegler AG, 2016, MOL METAB, V5, P255, DOI 10.1016/j.molmet.2016.02.003; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	161	33	33	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					674	684		10.1038/s41590-018-0129-8	http://dx.doi.org/10.1038/s41590-018-0129-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925982	Green Submitted			2022-12-18	WOS:000436341300013
J	Wun, KS; Reijneveld, JF; Cheng, TY; Ladell, K; Uldrich, AP; Le Nours, J; Miners, KL; McLaren, JE; Grant, EJ; Haigh, OL; Watkins, TS; Suliman, S; Iwany, S; Jimenez, J; Calderon, R; Tamara, KL; Leon, SR; Murray, MB; Mayfield, JA; Altman, JD; Purcell, AW; Miles, JJ; Godfrey, DI; Gras, S; Price, DA; Van Rhijn, I; Moody, DB; Rossjohn, J				Wun, Kwok S.; Reijneveld, Josephine F.; Cheng, Tan-Yun; Ladell, Kristin; Uldrich, Adam P.; Le Nours, Jerome; Miners, Kelly L.; McLaren, James E.; Grant, Emma J.; Haigh, Oscar L.; Watkins, Thomas S.; Suliman, Sara; Iwany, Sarah; Jimenez, Judith; Calderon, Roger; Tamara, Kattya L.; Leon, Segundo R.; Murray, Megan B.; Mayfield, Jacob A.; Altman, John D.; Purcell, Anthony W.; Miles, John J.; Godfrey, Dale I.; Gras, Stephanie; Price, David A.; Van Rhijn, Ildiko; Moody, D. Branch; Rossjohn, Jamie			T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids	NATURE IMMUNOLOGY			English	Article							ANTIGEN RECEPTOR RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX; BIOSYNTHESIS; DISCOVERY; SELECTION; ANGSTROM; REVEALS; BEE	The hallmark function of alpha beta T cell antigen receptors (TCRs) involves the highly specific co-recognition of a major histocompatibility complex molecule and its carried peptide. However, the molecular basis of the interactions of TCRs with the lipid antigen-presenting molecule CD1c is unknown. We identified frequent staining of human T cells with CD1c tetramers across numerous subjects. Whereas TCRs typically show high specificity for antigen, both tetramer binding and autoreactivity occurred with CD1c in complex with numerous, chemically diverse self lipids. Such extreme polyspecificity was attributable to binding of the TCR over the closed surface of CD1c, with the TCR covering the portal where lipids normally protrude. The TCR essentially failed to contact lipids because they were fully seated within CD1c. These data demonstrate the sequestration of lipids within CD1c as a mechanism of autoreactivity and point to small lipid size as a determinant of autoreactive T cell responses.	[Wun, Kwok S.; Le Nours, Jerome; Purcell, Anthony W.; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Wun, Kwok S.; Le Nours, Jerome; Purcell, Anthony W.; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Wun, Kwok S.; Le Nours, Jerome; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Reijneveld, Josephine F.] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Reijneveld, Josephine F.; Cheng, Tan-Yun; Suliman, Sara; Iwany, Sarah; Mayfield, Jacob A.; Van Rhijn, Ildiko; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Reijneveld, Josephine F.; Cheng, Tan-Yun; Suliman, Sara; Iwany, Sarah; Mayfield, Jacob A.; Van Rhijn, Ildiko; Moody, D. Branch] Harvard Med Sch, Boston, MA 02115 USA; [Ladell, Kristin; Miners, Kelly L.; McLaren, James E.; Grant, Emma J.; Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff, S Glam, Wales; [Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic, Australia; [Haigh, Oscar L.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Watkins, Thomas S.; Miles, John J.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Australian Inst Trop Hlth & Med, Cairn, Australia; [Watkins, Thomas S.; Miles, John J.] James Cook Univ, Ctr Biosecur & Trop Infect Dis, Australian Inst Trop Hlth & Med, Cairn, Australia; [Jimenez, Judith; Calderon, Roger; Tamara, Kattya L.; Leon, Segundo R.] Soc Salud Sucursal Peru, Lima, Peru; [Murray, Megan B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Global Hlth & Social Med, Boston, MA USA; [Murray, Megan B.] Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA USA; [Altman, John D.] Emory Univ, Sch Med, Atlanta, GA USA	Monash University; Monash University; Monash University; Utrecht University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cardiff University; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; James Cook University; James Cook University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Emory University	Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia.; Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Moody, DB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff, S Glam, Wales.	bmoody@bwh.harvard.edu; jamie.rossjohn@monash.edu	Ladell, Kristin/C-8301-2013; Leon, Segundo Ramos/J-3058-2019; Miles, John J/ABC-1105-2020; Haigh, Oscar/AAD-4324-2022; Price, David A/C-7876-2013; Purcell, Anthony/AAH-1942-2019; Uldrich, Adam/AAX-3785-2020; Haigh, Oscar L/G-1905-2010; Rossjohn, Jamie/F-9032-2013; Miners, Kelly/AAC-6903-2020; Grant, Emma/AAR-3766-2021	Ladell, Kristin/0000-0002-9856-2938; Leon, Segundo Ramos/0000-0002-5630-5714; Miles, John J/0000-0001-5506-6304; Haigh, Oscar/0000-0001-5022-4692; Price, David A/0000-0001-9416-2737; Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; Godfrey, Dale/0000-0002-3009-5472; Wun, Kwok/0000-0002-1908-4596; Le Nours, Jerome/0000-0002-2221-7636; Calderon, Roger I./0000-0001-8932-0489; Van Rhijn, Ildiko/0000-0002-1446-5701; Grant, Emma/0000-0001-7193-9427; gras, stephanie/0000-0001-7416-038X; ULDRICH, ADAM/0000-0002-6350-5976; McLaren, James/0000-0002-7021-5934; Mayfield, Jacob/0000-0002-5762-6755	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish; NIAID NIH HHS [U19 AI111224, R01 AI049313] Funding Source: Medline; NIAMS NIH HHS [R01 AR048632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bagchi S, 2017, J CLIN INVEST, V127, P2339, DOI 10.1172/JCI92217; Birkinshaw RW, 2015, NAT IMMUNOL, V16, P258, DOI 10.1038/ni.3098; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourgeois EA, 2015, J EXP MED, V212, P149, DOI 10.1084/jem.20141505; Bricogne G., 2011, AUTOBUSTER VERSION 1; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gras S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13257; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Guo TX, 2018, J IMMUNOL, V200, P500, DOI 10.4049/jimmunol.1700677; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Lepore M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/21624011.2014.970463; Lepore M, 2014, J EXP MED, V211, P1360, DOI 10.1084/jem.20140410; Ly D, 2013, J EXP MED, V210, P729, DOI 10.1084/jem.20120624; Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mansour S, 2016, P NATL ACAD SCI USA, V113, pE1266, DOI 10.1073/pnas.1519246113; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Melenhorst JJ, 2008, J IMMUNOL, V180, P6484, DOI 10.4049/jimmunol.180.10.6484; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Roura-Mir C, 2005, J IMMUNOL, V174, P3773, DOI 10.4049/jimmunol.174.6.3773; Roy S, 2016, J IMMUNOL, V196, P1933, DOI 10.4049/jimmunol.1502202; Roy S, 2014, P NATL ACAD SCI USA, V111, pE4648, DOI 10.1073/pnas.1408549111; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Shahine A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1384; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Subramaniam S, 2016, EUR J IMMUNOL, V46, P242, DOI 10.1002/eji.201545869; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Van Rhijn I, 2016, P NATL ACAD SCI USA, V113, P380, DOI 10.1073/pnas.1520947112; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yakimchuk K, 2011, EUR J IMMUNOL, V41, P694, DOI 10.1002/eji.201040808; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002; Young DC, 2015, CHEM BIOL, V22, P516, DOI 10.1016/j.chembiol.2015.03.015; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948	56	33	33	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					397	+		10.1038/s41590-018-0065-7	http://dx.doi.org/10.1038/s41590-018-0065-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29531339	Green Accepted			2022-12-18	WOS:000428151000019
J	Akkaya, M; Akkaya, B; Kim, AS; Miozzo, P; Sohn, H; Pena, M; Roesler, AS; Theall, BP; Henke, T; Kabat, J; Lu, JH; Dorward, DW; Dahlstrom, E; Skinner, J; Millers, LH; Pierce, SK				Akkaya, Munir; Akkaya, Billur; Kim, Ann S.; Miozzo, Pietro; Sohn, Haewon; Pena, Mirna; Roesler, Alexander S.; Theall, Brandon P.; Henke, Travis; Kabat, Juraj; Lu, Jinghua; Dorward, David W.; Dahlstrom, Eric; Skinner, Jeff; Millers, Louis H.; Pierce, Susan K.			Toll-like receptor 9 antagonizes antibody affinity maturation	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; GERMINAL CENTER; RESPONSES; DIFFERENTIATION; PROLIFERATION; LYMPHOCYTES; MEMBRANE; ENERGY	Key events in T cell-dependent antibody responses, including affinity maturation, are dependent on the B cell's presentation of antigen to helper T cells at critical checkpoints in germinal-center formation in secondary lymphoid organs. Here we found that signaling via Toll-like receptor 9 (TLR9) blocked the ability of antigen-specific B cells to capture, process and present antigen and to activate antigen-specific helper T cells in vitro. In a mouse model in vivo and in a human clinical trial, the TLR9 agonist CpG enhanced the magnitude of the antibody response to a protein vaccine but failed to promote affinity maturation. Thus, TLR9 signaling might enhance antibody titers at the expense of the ability of B cells to engage in germinal-center events that are highly dependent on B cells' capture and presentation of antigen.	[Akkaya, Munir; Kim, Ann S.; Miozzo, Pietro; Sohn, Haewon; Pena, Mirna; Roesler, Alexander S.; Theall, Brandon P.; Henke, Travis; Lu, Jinghua; Skinner, Jeff; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Akkaya, Billur] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Kabat, Juraj] NIAID, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dorward, David W.; Dahlstrom, Eric] NIAID, Res Technol Branch, NIH, Hamilton, MT USA; [Millers, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@nih.gov	Akkaya, Munir/J-3975-2019; AKKAYA, BILLUR/AAC-6499-2021	Akkaya, Munir/0000-0002-9949-9424; AKKAYA, BILLUR/0000-0002-6808-3776; Skinner, Jeff/0000-0001-5697-0442; Theall, Brandon/0000-0003-3852-5139; Kim, Ann/0000-0001-6709-4089; Benson, Travis/0000-0001-9172-0254; Miozzo, Pietro/0000-0003-3486-4061; Roesler, Alexander/0000-0001-5768-1589	Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000899, ZIAAI000898, ZIAAI000241, ZICAI001052, ZICAI001051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118964, TL4GM118965, RL5GM118963] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Akira (Osaka University) for TLR9-deficient mice; I. Gery (US National Institutes of Health) for 3A9 mice; N. Barclay (University of Oxford) for mouse mAb OX68; P. Roche (US National Institutes of Health) for the hybridoma secreting mouse mAb AW3.18; L. Lantz (US National Institutes of Health) for producing purified mouse mAb AW3.18; J. Charles-Guery and D. Hudrisier (University of Toulouse) for mouse mAb F10.6; O. Voss (US National Institutes of Health) for the NIH3T3 mouse fibroblast cell line; P. Tolar (The Francis Crick Institute) for Matlab code; and J. Brzostowski and S. Bolland for suggestions. Supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Akkaya B, 2017, J IMMUNOL METHODS, V441, P67, DOI 10.1016/j.jim.2016.11.013; Akkaya B, 2016, J IMMUNOL, V197, P2027, DOI 10.4049/jimmunol.1600727; Akkaya M, 2017, EUR J IMMUNOL, V47, P1890, DOI 10.1002/eji.201747113; Akkaya M, 2017, J IMMUNOL, V199, P931, DOI 10.4049/jimmunol.1700348; Akkaya M, 2016, VIROLOGY, V488, P1, DOI 10.1016/j.virol.2015.10.026; Akkaya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063325; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Davey AM, 2012, J IMMUNOL, V188, P3332, DOI 10.4049/jimmunol.1102322; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Francica JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7565; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Hoogeboom R, 2016, CURR TOP MICROBIOL, V393, P45, DOI 10.1007/82_2015_476; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; LANZAVECCHIA A, 1986, CURR TOP MICROBIOL, V130, P65; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Sohn HW, 2010, METHODS MOL BIOL, V591, P159, DOI 10.1007/978-1-60761-404-3_10; Tolar P, 2009, IMMUNOL REV, V232, P34, DOI 10.1111/j.1600-065X.2009.00833.x; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; Traba J, 2016, JOVE-J VIS EXP, DOI 10.3791/54918; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005392; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619	45	33	35	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					255	+		10.1038/s41590-018-0052-z	http://dx.doi.org/10.1038/s41590-018-0052-z			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29476183	Green Accepted			2022-12-18	WOS:000427007500015
J	Monzon-Casanova, E; Screen, M; Diaz-Munoz, MD; Coulson, RMR; Bell, SE; Lamers, G; Solimena, M; Smith, CWJ; Turner, M				Monzon-Casanova, Elisa; Screen, Michael; Diaz-Munoz, Manuel D.; Coulson, Richard M. R.; Bell, Sarah E.; Lamers, Greta; Solimena, Michele; Smith, Christopher W. J.; Turner, Martin			The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers	NATURE IMMUNOLOGY			English	Article							C-MYC; AFFINITY MATURATION; DYNAMIC REGULATION; CENTER LIGHT; EXPRESSION; REGULATOR; KINASE; GENE; PROLIFERATION; TRANSLATION	Antibody affinity maturation occurs in germinal centers (GCs), where B cells cycle between the light zone (LZ) and the dark zone. In the LZ, GC B cells bearing immunoglobulins with the highest affinity for antigen receive positive selection signals from helper T cells, which promotes their rapid proliferation. Here we found that the RNA-binding protein PTBP1 was needed for the progression of GC B cells through late S phase of the cell cycle and for affinity maturation. PTBP1 was required for proper expression of the c-MYC-dependent gene program induced in GC B cells receiving T cell help and directly regulated the alternative splicing and abundance of transcripts that are increased during positive selection to promote proliferation.	[Monzon-Casanova, Elisa; Screen, Michael; Diaz-Munoz, Manuel D.; Coulson, Richard M. R.; Bell, Sarah E.; Lamers, Greta; Turner, Martin] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England; [Monzon-Casanova, Elisa; Smith, Christopher W. J.] Univ Cambridge, Dept Biochem, Cambridge, England; [Solimena, Michele] Tech Univ Dresden, Univ Hosp, Mol Diabetol, Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Fac Med, Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Hosp, Dresden, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Solimena, Michele] German Ctr Diabet Res DZD eV, Neuherberg, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England.	martin.turner@babraham.ac.uk	Solimena, Michele/E-1275-2011; Diaz-Munoz, Manuel D/H-2080-2018; Diaz-Munoz, Manuel D./AAB-6518-2020; Solimena, Michele/GVS-5990-2022; Turner, Martin/N-9976-2014	Diaz-Munoz, Manuel D/0000-0002-9227-7474; Diaz-Munoz, Manuel D./0000-0002-9227-7474; Monzon-Casanova, Elisa/0000-0001-6617-6138; Bell, Sarah/0000-0002-3249-707X; Turner, Martin/0000-0002-3801-9896; Smith, Chris/0000-0002-2753-3398	Biotechnology and Biological Sciences Research Council [BB/J004472/1, BB/J00152X/1]; Wellcome Trust [200823/Z/16/Z]; Bloodwise [14022]; Biotechnology and Biological Sciences Research Council [BB/P01898X/1, BB/J001457/1, BBS/E/B/000C0428, BBS/E/B/000C0407, BBS/E/B/000C0427, BBS/E/B/000C0409] Funding Source: researchfish; BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0428, BBS/E/B/000C0407, BB/P01898X/1, BBS/E/B/000C0427, BB/J001457/1, BB/J00152X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Bloodwise; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. L. Black (Brain Research Institute, University of California) for Ptbp2f l " mice; M. Reth (Max Planck Institute of Immunobiology and Epigenetics) for Cd79a<SUP>Cre</SUP> mice; M. Busslinger (Research Institute of Molecular Pathology) for AicdaTg-Cre mice; B. P. Sleckman (Weill Cornell Medicine Pathology & Laboratory Medicine) for Myc<SUP>GFP/GFP</SUP> mice; F. W Alt (Department of Genetics, Harvard Medical School) for Rag2<SUP>-/-</SUP> mice; J. Ule, N. Haberman and T. Cork for help with ICLIP data; G. Butcher for assistance in generating monoclonal antibodies to PTBP3; K. Bates, D. Sanger, A. Davis, the Biological Support Unit, Flow Cytometry and Bioinformatics Facilities for technical assistance; and M. Spivakov and members of the Turner and Smith laboratories for helpful discussions. Supported by The Biotechnology and Biological Sciences Research Council (BB/J004472/1 and BB/J00152X/1 to M.T.), the Wellcome Trust (200823/Z/16/Z to M.T.) and Bloodwise (14022 to M.T).	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Baralle FE, 2017, NAT REV MOL CELL BIO, V18, P437, DOI 10.1038/nrm.2017.27; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chan LN, 2017, NATURE, V542, P479, DOI 10.1038/nature21076; Chang X, 2015, P NATL ACAD SCI USA, V112, pE1888, DOI 10.1073/pnas.1422490112; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Diaz-Munoz MD, 2015, NAT IMMUNOL, V16, P415, DOI 10.1038/ni.3115; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gooding C, 2003, J BIOL CHEM, V278, P15201, DOI 10.1074/jbc.M210131200; Hann SR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014399; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hogenbirk MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069815; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Ke YB, 1996, MOL CELL BIOL, V16, P376; Keppetipola N, 2012, CRIT REV BIOCHEM MOL, V47, P360, DOI 10.3109/10409238.2012.691456; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knoch KP, 2014, MOL METAB, V3, P518, DOI 10.1016/j.molmet.2014.05.002; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; La Porta J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158708; Li Q, 2014, ELIFE, V3, DOI 10.7554/eLife.01201; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Pioli PD, 2014, J IMMUNOL, V193, P2546, DOI 10.4049/jimmunol.1401275; Porter JF, 2008, J IMMUNOL, V181, P3336, DOI 10.4049/jimmunol.181.5.3336; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schaub A, 2017, INT IMMUNOL, V29, P173, DOI 10.1093/intimm/dxx026; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Suckale J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016992; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tan LY, 2015, NUCLEIC ACIDS RES, V43, P5586, DOI 10.1093/nar/gkv429; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vavassori S, 2009, EUR J IMMUNOL, V39, P2224, DOI 10.1002/eji.200839163; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Vuong JK, 2016, CELL REP, V17, P2766, DOI 10.1016/j.celrep.2016.11.034; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	65	33	36	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					267	+		10.1038/s41590-017-0035-5	http://dx.doi.org/10.1038/s41590-017-0035-5			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29358707	Green Submitted, Green Accepted			2022-12-18	WOS:000427007500016
J	He, ZH; Ma, J; Wang, RQ; Zhang, J; Huang, ZF; Wang, F; Sen, S; Rothenberg, EV; Sun, ZM				He, Zhiheng; Ma, Jian; Wang, Ruiqing; Zhang, Jing; Huang, Zhaofeng; Wang, Fei; Sen, Subha; Rothenberg, Ellen V.; Sun, Zuoming			A two-amino-acid substitution in the transcription factor ROR gamma(g)t disrupts its function in T(H)17 differentiation but not in thymocyte development	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TH17 DIFFERENTIATION; CELL; SURVIVAL; ACTIVATION; DRIVES	The transcription factor ROR gamma t regulates differentiation of the T(H)17 subset of helper T cells, thymic T cell development and lymph-node genesis. Although elimination of ROR gamma t prevents T(H)17 cell-mediated experimental autoimmune encephalomyelitis (EAE), it also disrupts thymocyte development, which could lead to lethal thymic lymphoma. Here we identified a two-aminoacid substitution in ROR gamma t (ROR gamma t(M)) that 'preferentially' disrupted T(H)17 differentiation but not thymocyte development. Mice expressing ROR gamma t(M) were resistant to EAE associated with defective T(H)17 differentiation but maintained normal thymocyte development and normal lymph-node genesis, except for Peyer's patches. ROR gamma t(M) showed less ubiquitination at Lys69 that was selectively required for T(H)17 differentiation but not T cell development. This study will inform the development of treatments that selectively target T(H)17 cell-mediated autoimmunity but do not affect thymocyte development or induce lymphoma.	[He, Zhiheng; Ma, Jian; Wang, Ruiqing; Zhang, Jing; Wang, Fei; Sen, Subha; Sun, Zuoming] Beckman Res Inst City Hope, Div Mol Immunol, Duarte, CA 91016 USA; [Wang, Ruiqing; Zhang, Jing] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Sun Yat Sen University; California Institute of Technology	Sun, ZM (corresponding author), Beckman Res Inst City Hope, Div Mol Immunol, Duarte, CA 91016 USA.	zsun@coh.org	SEN, SUBHA/AAY-5860-2021	Rothenberg, Ellen/0000-0002-3901-347X; HE, ZHIHENG/0000-0002-0088-178X	US National Institutes of Health [R01-AI053147, R01-AI109644]; National Cancer Institute of the National Institutes of Health [P30CA33572]; Science and Technology Department of Guangdong Province [2016A050503023]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109644, R01AI053147] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Science and Technology Department of Guangdong Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.C. Zuniga-Pflucker (University of Toronto) for the DP9-DL4 stroma cell line; W.S. Pear (University of Pennsylvania) for the retroviral vector MIGR; T. Dawson (Johns Hopkins) for RK5-HA-ubiquitin constructs; and Biocytogen for assisting with design and generation of the Ror gamma t<SUP>M/M</SUP> mice. Supported by the US National Institutes of Health (R01-AI053147 and R01-AI109644), institutional pilot funding, the National Cancer Institute of the National Institutes of Health (P30CA33572, which includes work performed in the Animal Resource Center, Integrative Genomics, Analytical Cytometry, and Mass Spectrometry and Proteomics Cores) and the Science and Technology Department of Guangdong Province (2016A050503023 to Z. Huang). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Debard N, 1999, SEMIN IMMUNOL, V11, P183, DOI 10.1006/smim.1999.0174; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Han L, 2014, J BIOL CHEM, V289, P25546, DOI 10.1074/jbc.M114.565291; He Z, 2016, J IMMUNOL, V197, P1148, DOI 10.4049/jimmunol.1600548; Holmes R., 2009, COLD SPRING HARB PRO; Huang ZF, 2007, EXPERT OPIN THER TAR, V11, P737, DOI 10.1517/14728222.11.6.737; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jain R, 2016, IMMUNITY, V44, P131, DOI 10.1016/j.immuni.2015.11.009; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Ma J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024768; Miller MJ, 2010, P NATL ACAD SCI USA, V107, P16512, DOI 10.1073/pnas.1004181107; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Sheridan C, 2013, NAT BIOTECHNOL, V31, P370, DOI 10.1038/nbt0513-370; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Ueda E, 2002, CANCER RES, V62, P901; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Wang XW, 2015, J BIOL CHEM, V290, P29086, DOI 10.1074/jbc.M115.664573; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Xie HM, 2006, CRIT REV IMMUNOL, V26, P475, DOI 10.1615/CritRevImmunol.v26.i6.10; Yang J, 2015, J IMMUNOL, V194, P4094, DOI 10.4049/jimmunol.1401451; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702	35	33	34	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1128	+		10.1038/ni.3832	http://dx.doi.org/10.1038/ni.3832			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28846085	Green Accepted			2022-12-18	WOS:000411134000017
J	Newman, R; Ahlfors, H; Saveliev, A; Galloway, A; Hodson, DJ; Williams, R; Besra, GS; Cook, CN; Cunningham, AF; Bell, SE; Turner, M				Newman, Rebecca; Ahlfors, Helena; Saveliev, Alexander; Galloway, Alison; Hodson, Daniel J.; Williams, Robert; Besra, Gurdyal S.; Cook, Charlotte N.; Cunningham, Adam F.; Bell, Sarah E.; Turner, Martin			Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1	NATURE IMMUNOLOGY			English	Article							LYMPHOPOIESIS; EXPRESSION; VISUALIZATION; HOMEOSTASIS; ALIGNMENT; PREVENT; FATE; MICE; BIM	RNA-binding proteins of the ZFP36 family are best known for inhibiting the expression of cytokines through binding to AU-rich elements in the 3' untranslated region and promoting mRNA decay. Here we identified an indispensable role for ZFP36L1 as the regulator of a post-transcriptional hub that determined the identity of marginal-zone B cells by promoting their proper localization and survival. ZFP36L1 controlled a gene-expression program related to signaling, cell adhesion and locomotion; it achieved this in part by limiting expression of the transcription factors KLF2 and IRF8, which are known to enforce the follicular B cell phenotype. These mechanisms emphasize the importance of integrating transcriptional and post-transcriptional processes by RNA-binding proteins for maintaining cellular identity among closely related cell types.	[Newman, Rebecca; Ahlfors, Helena; Saveliev, Alexander; Galloway, Alison; Williams, Robert; Bell, Sarah E.; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Newman, Rebecca] Francis Crick Inst, Immune Receptor Activat Lab, London, England; [Hodson, Daniel J.] Univ Cambridge, Dept Haematol, Clifford Allbutt Bldg,Cambridge Biomed Campus, Cambridge, England; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Cook, Charlotte N.; Cunningham, Adam F.] Univ Birmingham, Sch Immun & Infect, MRC Ctr Immune Regulat, Birmingham, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Francis Crick Institute; University of Cambridge; University of Birmingham; University of Birmingham	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	martin.turner@babraham.ac.uk	Hodson, Daniel J/K-6817-2016; Turner, Martin/N-9976-2014	Hodson, Daniel J/0000-0001-6225-2033; Besra, Gurdyal/0000-0002-5605-0395; Saveliev, Alexander/0000-0003-0840-4774; Turner, Martin/0000-0002-3801-9896; Ahlfors, Helena/0000-0002-8183-0895; Galloway, Alison/0000-0001-8780-0382; Cunningham, Adam/0000-0003-0248-964X; Bell, Sarah/0000-0002-3249-707X	GlaxoSmithKline-CASE studentship; Biotechnology and Biological Sciences Research Council; Medical Research Council; Bloodwise; BBSRC [BBS/E/B/0000M740, BBS/E/B/000C0409, BBS/E/B/000C0428, BBS/E/B/0000M206, BB/L009986/1, BBS/E/B/000C0407, BB/J00152X/1, BBS/E/B/0000H322] Funding Source: UKRI; MRC [G0601618, MR/M008584/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0428, BBS/E/B/0000H322, BBS/E/B/000C0407, BB/L009986/1, BB/J00152X/1, BB/C506121/1, BBS/E/B/0000M740, BBS/E/B/000C0409, BBS/E/B/0000M206] Funding Source: researchfish; Medical Research Council [G0601618, MR/M008584/1, MC_PC_12009] Funding Source: researchfish	GlaxoSmithKline-CASE studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloodwise; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Busslinger (Research Institute of Molecular Pathology) for the mice expressing CD23-Cre; M. Reth (Max Planck Institute for Immunobiology and Epigenetics) for the mice expressing Mb1-Cre; T. Ludwig (Columbia University) for the mice expressing R26<SUP>ERT2-Cre</SUP>; and D. Kioussis (National Institute for Medical Research) for the mice expressing CD2-iCre; K. Bates, R. Walker, A. Davies and L. Waugh and members of the Biological Services Unit for technical support; D. Bell and P. Tolar for help with immunofluorescence analysis; and members of the Turner laboratory, L. Webb, M. Linterman and T. Arnon for advice. Supported by a GlaxoSmithKline-CASE studentship, the Biotechnology and Biological Sciences Research Council, The Medical Research Council and Bloodwise.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aranda JF, 2011, MOL BIOL CELL, V22, P1252, DOI 10.1091/mbc.E10-11-0910; Aranda JF, 2013, MOL BIOL CELL, V24, P483, DOI 10.1091/mbc.E11-11-0914; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Clipson A, 2015, LEUKEMIA, V29, P1177, DOI 10.1038/leu.2014.330; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Devis L, 2017, J PATHOL, V241, P475, DOI 10.1002/path.4851; Farley BM, 2012, MOL BIOL CELL, V23, P4473, DOI 10.1091/mbc.E12-03-0216; Fasnacht N, 2014, J EXP MED, V211, P2265, DOI 10.1084/jem.20132528; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Galloway A, 2016, SCIENCE, V352, P453, DOI 10.1126/science.aad5978; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hart G.T., 2010, P NATL ACAD SCI USA, V2, P1; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hoek KL, 2010, IMMUNITY, V33, P254, DOI 10.1016/j.immuni.2010.07.016; Hsiao SP, 2010, BIOCHEM J, V428, P223, DOI 10.1042/BJ20100250; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026866; Kaymak E, 2013, J BIOL CHEM, V288, P30463, DOI 10.1074/jbc.M113.496547; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleiman E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00030; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Nalvarte I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150236; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Santio NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130340; Simonetti G, 2013, J EXP MED, V210, P2887, DOI 10.1084/jem.20131026; Song J, 2013, P NATL ACAD SCI USA, V110, pE2915, DOI 10.1073/pnas.1218131110; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tamburino AM, 2013, G3-GENES GENOM GENET, V3, P297, DOI 10.1534/g3.112.004390; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Vogel KU, 2016, J IMMUNOL, V197, P2673, DOI 10.4049/jimmunol.1600854; Winkelmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097953; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510	64	33	34	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					683	+		10.1038/ni.3724	http://dx.doi.org/10.1038/ni.3724			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28394372	Green Submitted, Green Published, Green Accepted			2022-12-18	WOS:000401520900013
J	Zitvogel, L; Kroemer, G				Zitvogel, Laurence; Kroemer, Guido			Subversion of anticancer immunosurveillance by radiotherapy	NATURE IMMUNOLOGY			English	Editorial Material							IRRADIATION; IMMUNITY	Paradoxically, radiotherapy can reinforce immunosuppressive pathways that undermine anticancer immunosurveillance and treatment efficacy. Irradiation induces Langerhans cells to migrate from the skin to lymph nodes, where they stimulate regulatory T cells.	[Zitvogel, Laurence] Gustave Roussy, Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Zitvogel, Laurence] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc 507, Villejuif, France; [Kroemer, Guido] INSERM, U1138, Ctr Rech Cordeliers, Ligue Natl Canc,Equipe 11, Paris, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; Univ Paris 06, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy	Zitvogel, L (corresponding author), Gustave Roussy, Canc Campus, Villejuif, France.	laurence.zitvogel@orange.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998				Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Filatenkov A, 2015, CLIN CANCER RES, V21, P3727, DOI 10.1158/1078-0432.CCR-14-2824; Ko A, 2014, CELL DEATH DIFFER, V21, P92, DOI 10.1038/cdd.2013.124; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; Surace L, 2015, IMMUNITY, V42, P767, DOI 10.1016/j.immuni.2015.03.009; Vatner RE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00325; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Zitvogel L, 2015, SCIENCE, V349, P476, DOI 10.1126/science.aac8475; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	12	33	34	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1005	1007		10.1038/ni.3236	http://dx.doi.org/10.1038/ni.3236			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26343538				2022-12-18	WOS:000361686500002
J	Fauci, AS; Folkers, GK; Dieffenbach, CW				Fauci, Anthony S.; Folkers, Gregory K.; Dieffenbach, Carl W.			HIV-AIDS: much accomplished, much to do	NATURE IMMUNOLOGY			English	Article							RISK BEHAVIORS; PREVENTION; INFECTION	As a result of decades of research-driven breakthroughs in basic and clinical science and recent advances in the broad-scale implementation of interventions for the prevention and treatment of infection with HIV, a turning point has been reached in the global HIV-AIDS pandemic. To end the pandemic and achieve the goal of an AIDS-free generation, researchers and clinicians must follow the dual pathway of optimizing the implementation of existing prevention and treatment interventions and discovering with basic and clinical research new and effective tools in both of these arenas.	[Fauci, Anthony S.; Folkers, Gregory K.; Dieffenbach, Carl W.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						[Anonymous], 2013, UNAIDS REP GLOB AIDS; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Centers for Disease Control and Prevention, 2012, HIV SURV SUPPL REP; Centers for Disease Control and Prevention, 2013, TOD HIV AIDS EP; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Cohen J, 2013, SCIENCE, V339, P1134, DOI 10.1126/science.339.6124.1134; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Johnston MI, 2011, NEW ENGL J MED, V365, P873, DOI 10.1056/NEJMp1107621; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saez-Cirion A., 2013, PLOS PATHOG, V9; Smith Michael, 2012, HIV DROP FOLLOWS INC; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971; WHO, 2013, GLOB UPD HIV TREATM	25	33	34	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1104	1107						4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145780				2022-12-18	WOS:000326023400003
J	Trautmann, L; Sekaly, RP				Trautmann, Lydie; Sekaly, Rafick-Pierre			Solving vaccine mysteries: a systems biology perspective	NATURE IMMUNOLOGY			English	Editorial Material							YELLOW-FEVER VACCINE; IMMUNE	Systems biology has emerged as a promising research strategy that can be applied to vaccine development. This approach can lead to the identification of new mechanisms and predictors of inactivated vaccine immunogenicity.	[Trautmann, Lydie; Sekaly, Rafick-Pierre] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA	Vaccine & Gene Therapy Institute of Florida	Trautmann, L (corresponding author), Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA.	rpsekaly@vgtifl.org		Trautmann, Lydie/0000-0002-3012-0009				Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	12	33	33	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					729	731		10.1038/ni.2078	http://dx.doi.org/10.1038/ni.2078			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772284	Bronze			2022-12-18	WOS:000292870700010
J	Bevan, MJ				Bevan, Michael J.			Understand memory, design better vaccines	NATURE IMMUNOLOGY			English	Review							T-CELLS	Naive lymphocytes have a finite lifespan and are continually replaced by input from generative organs. In contrast, memory cells or their progeny can last a lifetime. The expanded populations of memory cells and their more widespread distribution provide protection against recurrent infection.	[Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Bevan, Michael J.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@uw.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335-19, R01 AI019335] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	12	33	34	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					463	465		10.1038/ni.2041	http://dx.doi.org/10.1038/ni.2041			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21587308	Green Accepted, Bronze			2022-12-18	WOS:000290707100002
J	Clemens, J; Holmgren, J; Kaufmann, SHE; Mantovani, A				Clemens, John; Holmgren, Jan; Kaufmann, Stefan H. E.; Mantovani, Alberto			Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress	NATURE IMMUNOLOGY			English	Article								Diseases preventable by underused vaccines cause the death of approximately 3 million children per year. The Global Alliance for Vaccines and Immunization (GAVI) was launched 10 years ago to tackle this appalling situation.	[Clemens, John] Int Vaccine Inst, Seoul, South Korea; [Holmgren, Jan] Univ Gothenburg, Gothenburg, Sweden; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Mantovani, Alberto] Univ Milan, Ist Clin Humanitas, Inst Ricovero & Cura Carattere Sci, Milan, Italy	International Vaccine Institute; University of Gothenburg; Max Planck Society; IRCCS Humanitas Research Hospital; University of Milan	Clemens, J (corresponding author), Int Vaccine Inst, Seoul, South Korea.	alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022; Kaufmann, Stefan HE/I-5454-2014	Mantovani, Alberto/0000-0001-5578-236X; Kaufmann, Stefan HE/0000-0001-9866-8268; Holmgren, Jan/0000-0003-1784-5918				Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Kaufmann SHE, 2007, NAT MED, V13, P299, DOI 10.1038/nm0307-299; Levine R, 2005, MAKING MARKETS VACCI; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Nossal GJV, 2000, NAT IMMUNOL, V1, P5, DOI 10.1038/76852; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Usher AD, 2010, LANCET, V375, P791, DOI 10.1016/S0140-6736(10)60328-5	11	33	33	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1069	1072		10.1038/ni1210-1069	http://dx.doi.org/10.1038/ni1210-1069			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21079627	Bronze			2022-12-18	WOS:000284262200002
J	Nomura, T; Sakaguchi, S				Nomura, Takashi; Sakaguchi, Shimon			Foxp3 and Aire in thymus-generated T-reg cells: a link in self-tolerance	NATURE IMMUNOLOGY			English	Editorial Material								The transcriptional regulators Foxp3 and Aire have key functions in self-tolerance. New studies emphasize potential links between Aire-expressing thymic stromal cells and the development of Foxp3-expressing regulatory T cells.	Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan	Kyoto University	Nomura, T (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Su MA, 2004, CURR OPIN IMMUNOL, V16, P746, DOI 10.1016/j.coi.2004.09.009; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886	10	33	35	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					333	334		10.1038/ni0407-333	http://dx.doi.org/10.1038/ni0407-333			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375092				2022-12-18	WOS:000245075900005
J	Greene, W				Greene, W			The brightening future of HIV therapeutics	NATURE IMMUNOLOGY			English	Editorial Material							ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; VIRAL ENTRY; INFECTION; SCIENCE	The natural history of human immunodeficiency virus (HIV) infection has been altered through the development of drugs targeting two key viral enzymes, reverse transcriptase and protease. Continued advances from basic science have unearthed many other points of attack in the HIV life cycle that could lead to new classes of HIV therapeutics.	Univ Calif San Francisco, Dept Med, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Greene, W (corresponding author), Univ Calif San Francisco, Dept Med, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	wgreene@gladstone.ucsf.edu						Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Billich Andreas, 2003, Curr Opin Investig Drugs, V4, P206; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; HANNA G, 2004, 11 C RETR OPP INF SA; Jacobson JM, 2004, ANTIMICROB AGENTS CH, V48, P423, DOI 10.1128/AAC.48.2.423-429.2004; Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stoddart CA, 2003, J VIROL, V77, P2124, DOI 10.1128/JVI.77.3.2124-2133.2003; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	20	33	38	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					867	871		10.1038/ni0904-867	http://dx.doi.org/10.1038/ni0904-867			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334078				2022-12-18	WOS:000223612500004
J	Scadden, DT				Scadden, DT			Cancer stem cells refined	NATURE IMMUNOLOGY			English	Editorial Material							SCID MICE; LEUKEMIA; IDENTIFICATION	A hierarchy of stem cells has been identified within leukemias, providing a more complex view of how these self-renewing populations parallel the normal stem cell compartment. As the resemblance between normal and malignant stem cells deepens, new opportunities for understanding and treating malignancy emerge.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, 149 13th St,Room 5212, Boston, MA 02129 USA.	scadden.david@mgh.harvard.edu						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], J MEC THEOR APPL; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Singh SK, 2003, CANCER RES, V63, P5821	10	33	38	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					701	703		10.1038/ni0704-701	http://dx.doi.org/10.1038/ni0704-701			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224098				2022-12-18	WOS:000222331200014
J	Canelles, M; Park, ML; Schwartz, OM; Fowlkes, BJ				Canelles, M; Park, ML; Schwartz, OM; Fowlkes, BJ			The influence of the thymic environment on the CD4-versus-CD8 T lineage decision	NATURE IMMUNOLOGY			English	Article							RECEPTOR TRANSGENIC MICE; ACTIVATED PROTEIN-KINASE; CELL-RECEPTOR; POSITIVE SELECTION; CD8 LINEAGE; IMMATURE THYMOCYTES; ANTIGEN RECEPTOR; CYTOPLASMIC DOMAIN; NEGATIVE SELECTION; COMMITMENT	T cell receptor signaling is an essential factor regulating thymocyte selection, but the function of the thymic environment in this process is not clear. In mice transgenic for major histocompatibility complex class II-restricted T cell receptors, every thymocyte is potentially selectable for maturation in the CD4 lineage. To address whether selection frequency affects positive selection, we created hematopoietic chimeras with mixtures of selectable and nonselectable precursors. With increased proportions of nonselectable thymocytes, positive selection of MHC class II-specific precursors was enhanced, generating not only CD4 but also CD8 thymocytes. These results indicate that the CD4 versus CD8 fate of selectable precursors can be influenced by the selection potential of its neighbors.	NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Res Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fowlkes, BJ (corresponding author), NIAID, Cellular & Mol Immunol Lab, NIH, Bldg 4,Room 111, Bethesda, MD 20892 USA.		Canelles, Matilde/AAB-1011-2019	Canelles, Matilde/0000-0003-2973-609X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000486, ZIAAI000486] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Basson MA, 1998, J EXP MED, V187, P1249; Bommhardt U, 1997, EUR J IMMUNOL, V27, P1152, DOI 10.1002/eji.1830270516; Bommhardt U, 1999, J IMMUNOL, V163, P715; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Brabb T, 1997, EUR J IMMUNOL, V27, P136, DOI 10.1002/eji.1830270121; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; BRUCE J, 1981, J IMMUNOL, V127, P2496; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; EZINE S, 1984, NATURE, V309, P629, DOI 10.1038/309629a0; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goverman J, 1997, IMMUNOL TODAY, V18, P204; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Irie HY, 1998, J IMMUNOL, V161, P183; Itano A, 2000, IMMUNITY, V12, P383, DOI 10.1016/S1074-7613(00)80190-9; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MARK C, 1982, IMMUNOGENETICS, V16, P95, DOI 10.1007/BF00364447; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Peterson DA, 1999, J IMMUNOL, V162, P3117; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Robey E A, 1990, Semin Immunol, V2, P25; Salmon P, 1999, J IMMUNOL, V163, P5312; SCHEID MP, 1979, IMMUNOGENETICS, V9, P423, DOI 10.1007/BF01570435; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	53	33	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					756	764		10.1038/ni953	http://dx.doi.org/10.1038/ni953			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12858172				2022-12-18	WOS:000184441500012
J	Erman, B; Feigenbaum, L; Coligan, JE; Singer, A				Erman, B; Feigenbaum, L; Coligan, JE; Singer, A			Early TCR alpha expression generates TCR complexes that signal the DN-to-DP transition and impair development	NATURE IMMUNOLOGY			English	Article							DELTA-GENE REARRANGEMENT; CELL RECEPTOR-ALPHA; GAMMA-DELTA; TRANSGENIC MICE; THYMOCYTE DEVELOPMENT; MONOCLONAL-ANTIBODY; BETA EXPRESSION; CHAIN; SELECTION; DIFFERENTIATION	Clonotypic T cell receptor (TCR) genes undergo ordered rearrangement and expression in the thymus with the result that TCRalpha and TCRgamma proteins are not expressed in the same cell at the same time. Such "TCRalpha/gamma exclusion" is a feature of normal thymocyte differentiation, but it is abrogated in TCR-transgenic mice, which prematurely express transgenic TCRalpha proteins in early double-negative (DN) thymocytes. We report here that early expression of TCRalpha proteins results in the formation of TCRalpha/gamma complexes that efficiently signal the differentiation of DN into double-positive thymocytes independently of pre-TCR and TCRbeta expression. Thus, abrogation of TCRalpha/gamma exclusion by early TCRalpha expression results in the formation of isotypically mixed TCRalphagamma complexes whose in vivo signals circumvent TCRbeta selection and redirect thymocyte development along an aberrant developmental pathway.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; NIAID, Lab Allerg Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		erman, batu/AAE-1963-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000352] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKER MLB, 1989, CELL, V58, P911, DOI 10.1016/0092-8674(89)90943-4; Brabb T, 1997, EUR J IMMUNOL, V27, P3039, DOI 10.1002/eji.1830271142; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Fritsch M, 1998, EUR J IMMUNOL, V28, P828, DOI 10.1002/(SICI)1521-4141(199803)28:03&lt;828::AID-IMMU828&gt;3.0.CO;2-X; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HOCHSTENBACH F, 1989, NATURE, V340, P562, DOI 10.1038/340562a0; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JAMESON SC, 1991, J IMMUNOL, V147, P3185; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; KEARSE KP, 1995, IMMUNITY, V2, P391; KUBO RT, 1989, J IMMUNOL, V142, P2736; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEW AM, 1986, SCIENCE, V234, P1401, DOI 10.1126/science.3787252; LOVE PE, 1994, J EXP MED, V179, P1485, DOI 10.1084/jem.179.5.1485; Malissen M, 1997, J EXP MED, V186, P1277, DOI 10.1084/jem.186.8.1277; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Pardoll D M, 1987, Adv Exp Med Biol, V225, P241; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; SAMELSON LE, 1984, IMMUNOL REV, V81, P131, DOI 10.1111/j.1600-065X.1984.tb01107.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4	42	33	33	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					564	569		10.1038/ni800	http://dx.doi.org/10.1038/ni800			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021779				2022-12-18	WOS:000175874700016
J	Golenbock, DT; Fenton, MJ				Golenbock, DT; Fenton, MJ			Extolling the diversity of bacterial endotoxins	NATURE IMMUNOLOGY			English	News Item							TOLL-LIKE RECEPTOR-4; CUTTING EDGE; LIPOPOLYSACCHARIDE; MICE; TLR4; RESPONSIVENESS; MUTATIONS; GENE		Boston Univ, Sch Med, Evans Biomed Res Ctr, Boston, MA 02118 USA	Boston University	Golenbock, DT (corresponding author), Boston Univ, Sch Med, Evans Biomed Res Ctr, 650 Albany St, Boston, MA 02118 USA.							Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RAETZ CRH, COMMUNICATION; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	16	33	33	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					286	288		10.1038/86289	http://dx.doi.org/10.1038/86289			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276196				2022-12-18	WOS:000167982900007
J	Yao, C; Lou, GH; Sun, HW; Zhu, ZA; Sun, Y; Chen, ZY; Chauss, D; Moseman, EA; Cheng, J; D'Antonio, MA; Shi, WK; Shi, JW; Kometani, K; Kurosaki, T; Wherry, EJ; Afzali, B; Gattinoni, L; Zhu, YW; McGavern, DB; O'Shea, JJ; Schwartzberg, PL; Wu, TQ				Yao, Chen; Lou, Guohua; Sun, Hong-Wei; Zhu, Ziang; Sun, Yi; Chen, Zeyu; Chauss, Daniel; Moseman, E. Ashley; Cheng, Jun; D'Antonio, Marc A.; Shi, Wangke; Shi, Junwei; Kometani, Kohei; Kurosaki, Tomohiro; Wherry, E. John; Afzali, Behdad; Gattinoni, Luca; Zhu, Yuwen; McGavern, Dorian B.; O'Shea, John J.; Schwartzberg, Pamela L.; Wu, Tuoqi			BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8(+) T cells	NATURE IMMUNOLOGY			English	Article								During chronic infection and cancer, a self-renewing CD8(+) T cell subset maintains long-term immunity and is critical to the effectiveness of immunotherapy. These stem-like CD8(+) T cells diverge from other CD8(+) subsets early after chronic viral infection. However, pathways guarding stem-like CD8(+) T cells against terminal exhaustion remain unclear. Here, we show that the gene encoding transcriptional repressor BACH2 is transcriptionally and epigenetically active in stem-like CD8(+) T cells but not terminally exhausted cells early after infection. BACH2 overexpression enforced stem-like cell fate, whereas BACH2 deficiency impaired stem-like CD8(+) T cell differentiation. Single-cell transcriptomic and epigenomic approaches revealed that BACH2 established the transcriptional and epigenetic programs of stem-like CD8(+) T cells. In addition, BACH2 suppressed the molecular program driving terminal exhaustion through transcriptional repression and epigenetic silencing. Thus, our study reveals a new pathway that enforces commitment to stem-like CD8(+) lineage and prevents an alternative terminally exhausted cell fate. Tuoqi Wu and colleagues show that the transcriptional repressor BACH2 is required early after chronic viral infection to enforce a stem-like fate in activated CD8(+) T cells. BACH2 acts to suppress genes that lead to the exhausted cell state.	[Yao, Chen; Sun, Hong-Wei; Schwartzberg, Pamela L.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Lou, Guohua; Zhu, Ziang; D'Antonio, Marc A.; Shi, Wangke; Wu, Tuoqi] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA; [Sun, Yi; Zhu, Yuwen; O'Shea, John J.] Univ Colorado, Dept Surg, Div Surg Oncol, Anschutz Med Campus, Aurora, CO 80045 USA; [Chen, Zeyu; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Chauss, Daniel; Afzali, Behdad] NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Moseman, E. Ashley] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Cheng, Jun; Wu, Tuoqi] NHGRI, NIH, Bethesda, MD 20892 USA; [Shi, Junwei] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Kometani, Kohei; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Yokohama, Kanagawa, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka, Japan; [Gattinoni, Luca] Univ Regensburg, Regensburg Ctr Intervent Immunol, Regensburg, Germany; [McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.; Wu, Tuoqi] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; RIKEN; Osaka University; University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yao, C (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.; Wu, TQ (corresponding author), Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA.; Wu, TQ (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.; Wu, TQ (corresponding author), NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	chen.yao2@nih.gov; tuoqi.wu@cuanschutz.edu	McGavern, Dorian/HCH-3601-2022; Chen, Zeyu/HGE-0239-2022; Gattinoni, Luca/A-2281-2008; Afzali, Behdad/H-8565-2013	McGavern, Dorian/0000-0001-9568-545X; Gattinoni, Luca/0000-0003-2239-3282; D'Antonio, Marc/0000-0002-4243-7230; Chauss, Daniel/0000-0002-8343-0860; Yao, Chen/0000-0001-6852-5661; Sun, Hong-Wei/0000-0001-9765-6505; Afzali, Behdad/0000-0003-2968-1156; Kometani, Kohei/0000-0003-4281-4371	NIH [AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, CA210944, AG056524, CA234842]; NIAMS; NIAID; NHGRI; NINDS; National Cancer Institute; NIDDK; NIH Office of Dietary Supplements Research Scholar scholarship; Stand Up To Cancer; Parker Institute for Cancer Immunotherapy	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Office of Dietary Supplements Research Scholar scholarship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer; Parker Institute for Cancer Immunotherapy	We thank T. Kupfer (CU), G. Hedlund (CU), K. Helm (CU), Y. Zhang (CU), M. Kirby (NHGRI), S. Anderson (NHGRI), J. Reilley (NIAID), R. Handon (NHGRI), L. Garrett (NHGRI), I. Ginty (NHGRI), G. Gutierrez-Cruz (NIAMS) and S. Dell'Orso (NIAMS) for their excellent technical support. This research was supported in part by an NIH grant (AG056524) to T.W.; the intramural programs of the NIAMS (to J.J.O.), NIAID (to P.L.S.), NHGRI (to P.L.S.), NINDS (to D.B.M.), National Cancer Institute (to L.G.) and NIDDK (to B.A.); an NIH Office of Dietary Supplements Research Scholar scholarship to D.C.; grants from the NIH (AI105343, AI117950, AI082630, AI112521, AI115712, AI108545 and CA210944) and Stand Up To Cancer to E.J.W.; and NIH grant (CA234842) to Z.C. E.J.W. is also supported by the Parker Institute for Cancer Immunotherapy, which supports the Cancer Immunology program at Penn Institute for Immunology.	Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Chu HH, 2016, IMMUNITY, V45, P159, DOI 10.1016/j.immuni.2016.06.013; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Huang Z, 2019, J EXP MED, V216, P1791, DOI 10.1084/jem.20190173; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Igarashi K, 2017, NAT REV IMMUNOL, V17, P437, DOI 10.1038/nri.2017.26; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Ji Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09882-8; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Richer MJ, 2016, J IMMUNOL, V197, P1009, DOI 10.4049/jimmunol.1600847; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	32	32	3	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					370	+		10.1038/s41590-021-00868-7	http://dx.doi.org/10.1038/s41590-021-00868-7		FEB 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33574619	Green Accepted			2022-12-18	WOS:000617117400005
J	Demetriou, P; Abu-Shah, E; Valvo, S; McCuaig, S; Mayya, V; Kvalvaag, A; Starkey, T; Korobchevskaya, K; Lee, LYW; Friedrich, M; Mann, E; Kutuzov, MA; Morotti, M; Wietek, N; Rada, H; Yusuf, S; Afrose, J; Siokis, A; Meyer-Hermann, M; Ahmed, AA; Depoil, D; Dustin, ML				Demetriou, Philippos; Abu-Shah, Enas; Valvo, Salvatore; McCuaig, Sarah; Mayya, Viveka; Kvalvaag, Audun; Starkey, Thomas; Korobchevskaya, Kseniya; Lee, Lennard Y. W.; Friedrich, Matthias; Mann, Elizabeth; Kutuzov, Mikhail A.; Morotti, Matteo; Wietek, Nina; Rada, Heather; Yusuf, Shamsideen; Afrose, Jehan; Siokis, Anastasios; Meyer-Hermann, Michael; Ahmed, Ahmed Ashour; Depoil, David; Dustin, Michael L.		Oxford IBD Cohort Investigators	A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; PLASMA-MEMBRANE MICRODOMAINS; CUTTING EDGE; CD2; ACTIVATION; ADHESION; SEGREGATION; LYMPHOCYTES; ENGAGEMENT; EXPRESSION	The CD2-CD58 recognition system promotes adhesion and signaling and counters exhaustion in human T cells. We found that CD2 localized to the outer edge of the mature immunological synapse, with cellular or artificial APC, in a pattern we refer to as a 'CD2 corolla'. The corolla captured engaged CD28, ICOS, CD226 and SLAM-F1 co-stimulators. The corolla amplified active phosphorylated Src-family kinases (pSFK), LAT and PLC-gamma over T cell receptor (TCR) alone. CD2-CD58 interactions in the corolla boosted signaling by 77% as compared with central CD2-CD58 interactions. Engaged PD-1 invaded the CD2 corolla and buffered CD2-mediated amplification of TCR signaling. CD2 numbers and motifs in its cytoplasmic tail controlled corolla formation. CD8(+)tumor-infiltrating lymphocytes displayed low expression of CD2 in the majority of people with colorectal, endometrial or ovarian cancer. CD2 downregulation may attenuate antitumor T cell responses, with implications for checkpoint immunotherapies. The adhesion receptor CD2 plays an important role in the full activation of T cells. Dustin and colleagues show that CD2 occupies a region in the periphery of the immunological synapse where it amplifies cognate antigen signals, whereas the presence of PD-1 disrupts this effect.	[Demetriou, Philippos; Abu-Shah, Enas; Valvo, Salvatore; McCuaig, Sarah; Mayya, Viveka; Kvalvaag, Audun; Korobchevskaya, Kseniya; Friedrich, Matthias; Mann, Elizabeth; Rada, Heather; Yusuf, Shamsideen; Afrose, Jehan; Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Abu-Shah, Enas; Kutuzov, Mikhail A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Mayya, Viveka; Afrose, Jehan; Depoil, David; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10003 USA; [Starkey, Thomas; Lee, Lennard Y. W.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Morotti, Matteo; Wietek, Nina; Ahmed, Ahmed Ashour] Univ Oxford, MRC Weatherall Inst Mol Med, Ovarian Canc Cell Lab, Oxford, England; [Siokis, Anastasios; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, Braunschweig, Germany; [Siokis, Anastasios; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany; [Meyer-Hermann, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Braunschweig, Germany; [Afrose, Jehan] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA; [Depoil, David] Immunocore Ltd, Abingdon, Oxon, England	University of Oxford; University of Oxford; New York University; University of Birmingham; University of Oxford; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; City University of New York (CUNY) System; Hunter College (CUNY)	Dustin, ML (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.; Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10003 USA.	michael.dustin@kennedy.ox.ac.uk		Barnes, Eleanor/0000-0002-0860-0831; Starkey, Thomas/0000-0002-6692-9563; Kvalvaag, Audun/0000-0002-6437-2247; Culver, Emma/0000-0001-9644-8392; Dustin, Michael/0000-0003-4983-6389; Abu-Shah, Enas/0000-0001-5033-8171; Braden, Barbara/0000-0002-8534-6873; Yusuf, Salim/0000-0003-4776-5601; Allan, Philip/0000-0003-2682-772X; klenerman, paul/0000-0003-4307-9161; Lee, Lennard/0000-0002-8993-8438	Kennedy Trust for Rheumatology (KTRR) Prize Studentship; UCB-Oxford Post-doctoral Fellowship; Research Council of Norway; Marie Sklodowska-Curie Actions [275466]; Wellcome Trust Principal Research Fellowship [100262Z/12/Z]; KTRR; Kennedy Institute Microscopy Facility; Weatherall Institute Microscopy Facility; Human Frontiers Science Program; German Research Foundation (DFG); Collaborative Research Center 'Molecular Organization of Cellular Communication within the Immune System' [SFB 854]; Philippe Foundation; Wellcome Trust Senior Research Fellowship [207537/Z/17/Z]; Oxford Gastro-Intestinal Biobank; Oxford Inflammatory Bowel Disease Cohort; NIHR Oxford Biomedical Research Centre; MRC [MC_UU_00008/7, MC_UU_12010/7, MR/S036377/1, MC_PC_MR/S025952/1] Funding Source: UKRI	Kennedy Trust for Rheumatology (KTRR) Prize Studentship; UCB-Oxford Post-doctoral Fellowship; Research Council of Norway(Research Council of Norway); Marie Sklodowska-Curie Actions; Wellcome Trust Principal Research Fellowship(Wellcome Trust); KTRR; Kennedy Institute Microscopy Facility; Weatherall Institute Microscopy Facility; Human Frontiers Science Program(Human Frontier Science Program); German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Center 'Molecular Organization of Cellular Communication within the Immune System'; Philippe Foundation; Wellcome Trust Senior Research Fellowship(Wellcome Trust); Oxford Gastro-Intestinal Biobank; Oxford Inflammatory Bowel Disease Cohort; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Davis, P.A. Van Der Merwe, O. Dushek and R. Owens (University of Oxford) for kindly providing plasmids and HLA-A2 pMHC monomers. We also thank M. Dumoux (The Rosalind Franklin Institute) for kindly providing plasmids. We thank M. H. Brown and S. Sivakumar for helpful discussion and feedback on experiments and writing of the manuscript, and all the Dustin lab members for their kind support. We thank S. Balint for his help on some experiments and for maintaining the TIRF microscope, C. Laggerholm for access to and assistance with the Airyscan confocal microscope and P. Cespedes for his contribution in methods development for quantification of surface molecules on T cells. The results published here are in part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.A Kennedy Trust for Rheumatology (KTRR) Prize Studentship supported P.D. An UCB-Oxford Post-doctoral Fellowship supported E.A.S. A grant from The Research Council of Norway in conjunction with Marie Sklodowska-Curie Actions (275466) supported A.K. Wellcome Trust Principal Research Fellowship 100262Z/12/Z, and a grant from KTRR supported M.L.D. KTRR supports the Kennedy Institute Microscopy Facility and the Wolfson Foundation supports the Weatherall Institute Microscopy Facility. A collaborative grant from the Human Frontiers Science Program supported E.A.-S., A.S. and M.M.-H. A.S. was supported by the German Research Foundation (DFG) and Collaborative Research Center (SFB 854) `Molecular Organization of Cellular Communication within the Immune System'. A fellowship from Philippe Foundation partially supported D.D. A Wellcome Trust Senior Research Fellowship 207537/Z/17/Z supported E.A.-S. and M.A.K. NIHR Biomedical Research Centre, Oxford, supports the Oxford Gastro-Intestinal Biobank and the Oxford Inflammatory Bowel Disease Cohort study. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. We acknowledge the contribution to this study made by the Oxford Centre for Histopathology Research and the Oxford Radcliffe Biobank, which are supported by the NIHR Oxford Biomedical Research Centre.	Abu-Shah E, 2019, ELIFE, V8, DOI 10.7554/eLife.48221; Aversa G, 1997, J IMMUNOL, V158, P4036; Cai E, 2017, SCIENCE, V356, DOI 10.1126/science.aal3118; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; Chirica M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1016698; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Clarkson NG, 2009, J BIOL CHEM, V284, P24725, DOI 10.1074/jbc.M109.028209; Colin-York H, 2020, J CELL SCI, V133, DOI 10.1242/jcs.232322; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dustin ML, 2007, CURR PROTOC IMMUNOL, V76, P18131; Espagnolle N, 2007, INT IMMUNOL, V19, P239, DOI 10.1093/intimm/dxl141; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Huyghe N, 2020, GASTROENTEROL REP, V8, P11, DOI 10.1093/gastro/goz061; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Leitner J, 2015, J IMMUNOL, V195, P477, DOI 10.4049/jimmunol.1401917; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Razak FRA, 2016, GENES IMMUN, V17, P363, DOI 10.1038/gene.2016.30; Saliba DG, 2019, ELIFE, V8, DOI 10.7554/eLife.47528; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SANDERS ME, 1988, J IMMUNOL, V140, P1401; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Siokis A, 2020, SILICO CHARACTERIZAT, DOI [10.1101/2020.01.16.908723, DOI 10.1101/2020.01.16.908723]; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Vendrame E, 2020, AIDS, V34, P801, DOI 10.1097/QAD.0000000000002488; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Yao X, 2016, J IMMUNOTHER, V39, P191, DOI 10.1097/CJI.0000000000000123; Zar J. H, 1984, BIOSTAT ANAL; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	49	32	32	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1232	+		10.1038/s41590-020-0770-x	http://dx.doi.org/10.1038/s41590-020-0770-x		SEP 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32929275	Green Submitted, Green Accepted			2022-12-18	WOS:000569299600002
J	Martens, A; Priem, D; Hoste, E; Vetters, J; Rennen, S; Catrysse, L; Voet, S; Deelen, L; Sze, M; Vikkula, H; Slowicka, K; Hochepied, T; Iliaki, K; Wullaert, A; Janssens, S; Lamkanfi, M; Beyaert, R; Armaka, M; Bertrand, MJM; van Loo, G				Martens, Arne; Priem, Dario; Hoste, Esther; Vetters, Jessica; Rennen, Sofie; Catrysse, Leen; Voet, Sofie; Deelen, Laura; Sze, Mozes; Vikkula, Hanna; Slowicka, Karolina; Hochepied, Tino; Iliaki, Kalliopi; Wullaert, Andy; Janssens, Sophie; Lamkanfi, Mohamed; Beyaert, Rudi; Armaka, Marietta; Bertrand, Mathieu J. M.; van Loo, Geert			Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; LINEAR POLYUBIQUITIN; TNFAIP3; GENE; INFLAMMATION; DEFICIENCY; ACTIVATION; MUTATIONS; DOMAINS; DEATH	Protein ubiquitination regulates protein stability and modulates the composition of signaling complexes. A20 is a negative regulator of inflammatory signaling, but the molecular mechanisms involved are ill understood. Here, we generated Tnfaip3 gene-targeted A20 mutant mice bearing inactivating mutations in the zinc finger 7 (ZnF7) and ZnF4 ubiquitin-binding domains, revealing that binding to polyubiquitin is essential for A20 to suppress inflammatory disease. We demonstrate that a functional ZnF7 domain was required for recruiting A20 to the tumor necrosis factor receptor 1 (TNFR1) signaling complex and to suppress inflammatory signaling and cell death. The combined inactivation of ZnF4 and ZnF7 phenocopied the postnatal lethality and severe multiorgan inflammation of A20-deficient mice. Conditional tissue-specific expression of mutant A20 further revealed the key role of ubiquitin-binding in myeloid and intestinal epithelial cells. Collectively, these results demonstrate that the anti-inflammatory and cytoprotective functions of A20 are largely dependent on its ubiquitin-binding properties. van Loo and colleagues provide insights into the action of the anti-inflammatory protein A20. The ZnF7 and ZnF4 ubiquitin-binding domains of A20 are both required to suppress inflammatory signaling and cell death; however, these zinc fingers operate via distinct mechanisms.	[Martens, Arne; Priem, Dario; Hoste, Esther; Vetters, Jessica; Rennen, Sofie; Catrysse, Leen; Voet, Sofie; Deelen, Laura; Sze, Mozes; Vikkula, Hanna; Slowicka, Karolina; Hochepied, Tino; Wullaert, Andy; Janssens, Sophie; Lamkanfi, Mohamed; Beyaert, Rudi; Bertrand, Mathieu J. M.; van Loo, Geert] VIB Ctr Inflammat Res, Ghent, Belgium; [Martens, Arne; Priem, Dario; Hoste, Esther; Catrysse, Leen; Voet, Sofie; Deelen, Laura; Sze, Mozes; Vikkula, Hanna; Slowicka, Karolina; Hochepied, Tino; Wullaert, Andy; Beyaert, Rudi; Bertrand, Mathieu J. M.; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Vetters, Jessica; Rennen, Sofie; Wullaert, Andy; Janssens, Sophie; Lamkanfi, Mohamed] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Iliaki, Kalliopi; Armaka, Marietta] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Lamkanfi, Mohamed] Pharmaceut Co Johnson Johnson, Janssen Immunosci, World Dis Accelerator, Beerse, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Alexander Fleming Biomedical Sciences Research Center; Johnson & Johnson	van Loo, G (corresponding author), VIB Ctr Inflammat Res, Ghent, Belgium.; van Loo, G (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	geert.vanloo@irc.vib-ugent.be	Armaka, Marietta/Q-6139-2017; Bertrand, Mathieu JM/AAD-2653-2019; Janssens, Sophie/HHN-1756-2022; Hoste, Esther/M-9926-2014	Armaka, Marietta/0000-0003-0985-9076; Bertrand, Mathieu JM/0000-0001-9000-0626; Wullaert, Andy/0000-0001-5012-654X; Vetters, Jessica/0000-0001-5817-0086; Priem, Dario/0000-0002-2527-1101; Martens, Arne/0000-0002-9816-2512; Hoste, Esther/0000-0002-3181-431X	'Concerted Research Actions' (GOA) of the Ghent University; Research Foundation-Flanders (FWO); 'Geneeskundige Stichting Koningin Elisabeth' (GSKE); CBC Banque Prize; Charcot Foundation; Belgian Foundation against Cancer; Kom op tegen Kanker; GOA of Ghent University; Stavros Niarchos Foundation	'Concerted Research Actions' (GOA) of the Ghent University(Ghent University); Research Foundation-Flanders (FWO)(FWO); 'Geneeskundige Stichting Koningin Elisabeth' (GSKE); CBC Banque Prize; Charcot Foundation; Belgian Foundation against Cancer; Kom op tegen Kanker; GOA of Ghent University; Stavros Niarchos Foundation	We thank D. Huyghebaert, L. Bellen and D. Vanhede for animal care and A. Fossoul and M. Gennadi for excellent technical assistance. We also thank the InfrafrontierGR infrastructure (ERDF and NSRF 2007-2013 and 2014-2020) for providing histology and mCT facilities. A.M. is supported by a grant from the `Concerted Research Actions' (GOA) of the Ghent University. Research in the G.v.L. laboratory is supported by research grants from The Research Foundation-Flanders (FWO), the `Geneeskundige Stichting Koningin Elisabeth' (GSKE), the CBC Banque Prize, the Charcot Foundation, the `Belgian Foundation against Cancer', `Kom op tegen Kanker' and the GOA of Ghent University. The M.A. laboratory is supported by a start-up grant from the Stavros Niarchos Foundation to BSRC `Alexander Fleming'.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Armaka M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02935-4; Baird D., 2017, INTRO GENSTAT WINDOW, V19; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Priem D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1937-y; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sokhi UK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03081-7; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	30	32	33	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					381	+		10.1038/s41590-020-0621-9	http://dx.doi.org/10.1038/s41590-020-0621-9		MAR 2020	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205881	Green Published			2022-12-18	WOS:000519843600003
J	Zammit, NW; Siggs, OM; Gray, PE; Horikawa, K; Langley, DB; Walters, SN; Daley, SR; Loetsch, C; Warren, J; Yap, JY; Cultrone, D; Russell, A; Malle, EK; Villanueva, JE; Cowley, MJ; Gayevskiy, V; Dinger, ME; Brink, R; Zahra, D; Chaudhri, G; Karupiah, G; Whittle, B; Roots, C; Bertram, E; Yamada, M; Jeelall, Y; Enders, A; Clifton, BE; Mabbitt, PD; Jackson, CJ; Watson, SR; Jenne, CN; Lanier, LL; Wiltshire, T; Spitzer, MH; Nolan, GP; Schmitz, F; Aderem, A; Porebski, BT; Buckle, AM; Abbott, DW; Ziegler, JB; Craig, ME; Benitez-Aguirre, P; Teo, J; Tangye, SG; King, C; Wong, M; Cox, MP; Phung, W; Tang, J; Sandoval, W; Wertz, IE; Christ, D; Goodnow, CC; Grey, ST				Zammit, Nathan W.; Siggs, Owen M.; Gray, Paul E.; Horikawa, Keisuke; Langley, David B.; Walters, Stacey N.; Daley, Stephen R.; Loetsch, Claudia; Warren, Joanna; Yap, Jin Yan; Cultrone, Daniele; Russell, Amanda; Malle, Elisabeth K.; Villanueva, Jeanette E.; Cowley, Mark J.; Gayevskiy, Velimir; Dinger, Marcel E.; Brink, Robert; Zahra, David; Chaudhri, Geeta; Karupiah, Gunasegaran; Whittle, Belinda; Roots, Carla; Bertram, Edward; Yamada, Michiko; Jeelall, Yogesh; Enders, Anselm; Clifton, Benjamin E.; Mabbitt, Peter D.; Jackson, Colin J.; Watson, Susan R.; Jenne, Craig N.; Lanier, Lewis L.; Wiltshire, Tim; Spitzer, Matthew H.; Nolan, Garry P.; Schmitz, Frank; Aderem, Alan; Porebski, Benjamin T.; Buckle, Ashley M.; Abbott, Derek W.; Ziegler, John B.; Craig, Maria E.; Benitez-Aguirre, Paul; Teo, Juliana; Tangye, Stuart G.; King, Cecile; Wong, Melanie; Cox, Murray P.; Phung, Wilson; Tang, Jia; Sandoval, Wendy; Wertz, Ingrid E.; Christ, Daniel; Goodnow, Christopher C.; Grey, Shane T.			Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; GENOME SEQUENCE; CELL-DEATH; T-CELLS; TOLERANCE; ADMIXTURE; VIRUS; INFLAMMATION; NEANDERTHAL; ACTIVATION	Resisting and tolerating microbes are alternative strategies to survive infection, but little is known about the evolutionary mechanisms controlling this balance. Here genomic analyses of anatomically modern humans, extinct Denisovan hominins and mice revealed a TNFAIP3 allelic series with alterations in the encoded immune response inhibitor A20. Each TNFAIP3 allele encoded substitutions at non-catalytic residues of the ubiquitin protease OTU domain that diminished I kappa B kinase-dependent phosphorylation and activation of A20. Two TNFAIP3 alleles encoding A20 proteins with partial phosphorylation deficits seemed to be beneficial by increasing immunity without causing spontaneous inflammatory disease: A20 T108A;1207L, originating in Denisovans and introgressed in modern humans throughout Oceania, and A20 I325N, from an N-ethyl-N-nitrosourea (ENU)-mutagenized mouse strain. By contrast, a rare human TNFAIP3 allele encoding an A20 protein with 95% loss of phosphorylation, C243Y, caused spontaneous inflammatory disease in humans and mice. Analysis of the partial-phosphorylation A20 I325N allele in mice revealed diminished tolerance of bacterial lipopolysaccharide and poxvirus inoculation as tradeoffs for enhanced immunity.	[Zammit, Nathan W.; Siggs, Owen M.; Langley, David B.; Walters, Stacey N.; Loetsch, Claudia; Warren, Joanna; Yap, Jin Yan; Cultrone, Daniele; Russell, Amanda; Malle, Elisabeth K.; Villanueva, Jeanette E.; Cowley, Mark J.; Gayevskiy, Velimir; Dinger, Marcel E.; Brink, Robert; Zahra, David; Tangye, Stuart G.; King, Cecile; Christ, Daniel; Goodnow, Christopher C.; Grey, Shane T.] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Zammit, Nathan W.; Langley, David B.; Walters, Stacey N.; Warren, Joanna; Cultrone, Daniele; Cowley, Mark J.; Brink, Robert; Zahra, David; Tangye, Stuart G.; King, Cecile; Christ, Daniel; Goodnow, Christopher C.; Grey, Shane T.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Siggs, Owen M.] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA, Australia; [Gray, Paul E.; Ziegler, John B.] Sydney Childrens Hosp, Dept Immunol & Infect Dis, Randwick, NSW, Australia; [Gray, Paul E.; Ziegler, John B.; Craig, Maria E.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Horikawa, Keisuke; Daley, Stephen R.; Chaudhri, Geeta; Karupiah, Gunasegaran; Whittle, Belinda; Roots, Carla; Bertram, Edward; Yamada, Michiko; Jeelall, Yogesh; Enders, Anselm] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Dinger, Marcel E.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Clifton, Benjamin E.; Mabbitt, Peter D.; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Watson, Susan R.; Jenne, Craig N.; Lanier, Lewis L.; Spitzer, Matthew H.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Watson, Susan R.; Jenne, Craig N.; Lanier, Lewis L.; Spitzer, Matthew H.] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA; [Wiltshire, Tim] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Spitzer, Matthew H.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Schmitz, Frank; Aderem, Alan] Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA; [Porebski, Benjamin T.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Craig, Maria E.; Benitez-Aguirre, Paul; Teo, Juliana; Wong, Melanie] Childrens Hosp Westmead, Dept Haematol, Westmead, NSW, Australia; [Cox, Murray P.] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand; [Phung, Wilson; Tang, Jia; Sandoval, Wendy; Wertz, Ingrid E.] Genentech Inc, San Francisco, CA 94080 USA; [Daley, Stephen R.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Chaudhri, Geeta] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Karupiah, Gunasegaran] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Jenne, Craig N.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Spitzer, Matthew H.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Schmitz, Frank] Celgene, Seattle, WA USA	Garvan Institute of Medical Research; University of New South Wales Sydney; Flinders University South Australia; University of New South Wales Sydney; Australian National University; John Curtin School of Medical Research; University of New South Wales Sydney; Australian National University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; Center for Infectious Disease Research; Monash University; Case Western Reserve University; University of Sydney; Massey University; Roche Holding; Genentech; Monash University; Australian National University; University of Tasmania; University of Calgary; University of California System; University of California San Francisco; Bristol-Myers Squibb; Celgene Corporation	Goodnow, CC; Grey, ST (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW, Australia.; Goodnow, CC; Grey, ST (corresponding author), Univ New South Wales, Fac Med, Sydney, NSW, Australia.	c.goodnow@garvan.org.au; s.grey@garvan.org.au	Nolan, Garry/AAE-7903-2019; Zammit, Nathan/AAV-2071-2020; Lanier, Lewis L/E-2139-2014; Goodnow, Christopher C/V-8108-2018; Enders, Anselm/B-1165-2011; King, Cecile/Q-9794-2019; Tang, Jia/AAJ-7790-2020; Mabbitt, Peter/AAI-9669-2020; Grey, Shane T/B-3020-2008; Jenne, Craig/HCH-3413-2022; Christ, Daniel/C-1861-2018	Lanier, Lewis L/0000-0003-1308-3952; Goodnow, Christopher C/0000-0001-5296-6155; Enders, Anselm/0000-0001-5933-6463; King, Cecile/0000-0003-2193-2563; Mabbitt, Peter/0000-0001-7202-400X; Grey, Shane T/0000-0003-2160-1625; Villanueva, Jeanette/0000-0002-6856-6778; Gray, Paul/0000-0003-2057-3968; Horikawa, Keisuke/0000-0002-7381-9450; Daley, Stephen/0000-0002-5870-644X; Siggs, Owen/0000-0003-2840-4851; Jeelall, Yogesh/0000-0002-8557-6433; Karupiah, Gunasegaran/0000-0001-6306-4405; Brink, Robert/0000-0002-9586-3655; Clifton, Ben/0000-0002-7469-7424; Christ, Daniel/0000-0002-7313-3977; Buckle, Ashley/0000-0003-2943-9044; Chaudhri, Geeta/0000-0003-3388-2102; Zammit, Nathan/0000-0002-3694-2951; Jackson, Colin/0000-0001-6150-3822; Nolan, Garry/0000-0002-8862-9043; Cowley, Mark/0000-0002-9519-5714; Craig, Maria E/0000-0001-6004-576X	National Health and Medical Research Council of Australia (NHMRC) [634301]; Australian postgraduate award; International Pancreas and Islet Transplant Association Derek Gray Scholarship; Bill and Patricia Ritchie Chair; NHMRC Senior Principal Research Fellowship; NHMRC Senior Research Fellowship; NIH [AI52127, AI054523, AI100627, DK076169]; NHMRC [1016953, 585490, 1081858, 1130222, 1140691]; Jeffrey Modell Foundation; John Cook Brown Foundation; Sydney Children's Hospital Network	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); International Pancreas and Islet Transplant Association Derek Gray Scholarship; Bill and Patricia Ritchie Chair; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Jeffrey Modell Foundation; John Cook Brown Foundation; Sydney Children's Hospital Network	This manuscript is dedicated to the memory of Susan Watson, who led the isolation of the I325N mouse. We thank the National Computational Infrastructure, Xenon systems, Nvidia and the Multi-modal Australian ScienceS Imaging and Visualization Environment (MASSIVE; http://www.massive.org.au/) for computing resources. We thank O. Venn, I. Mathieson, B. Llamas, Y. Souilmi, R. Tobler and A. Cooper for stimulating discussions. C. N. J. thanks J. Cyster for mentorship. We thank K. Newton and V. Dixit for reagents (Genentech). We thank M. Flodstrom-Tullberg (Karolinska Institutet) for kindly providing coxsackievirus B4 strain E2. This study makes use of data generated by the Telethon Kids Institute. A full list of the investigators who contributed to the generation of the data is available from http://bioinformatics.childhealthresearch.org.au/AGHS.We thank CIRCA for collecting and coordinating human samples (http://www.garvan.org.au/research/collaborative-programs/circa/about-circa).Funding for the project was provided by the National Health and Medical Research Council of Australia (NHMRC) under award 634301. N. W. Z. was supported by an Australian postgraduate award and is supported by the International Pancreas and Islet Transplant Association Derek Gray Scholarship. A. M. B. was an NHMRC Senior Research Fellow (1022688). S. G. T. was a Principal Research Fellow (1042925) of the NHMRC.C.C.G. was supported by the Bill and Patricia Ritchie Chair and by an NHMRC Senior Principal Research Fellowship. S. T. G. was supported by an NHMRC Senior Research Fellowship. The research was supported by grants to C.C.G. from the NIH (AI52127, AI054523, AI100627) and NHMRC (1016953, 585490, 1081858) and to S. T. G. from the NIH (DK076169) and NHMRC (1130222, 1140691). CIRCA was supported by the Jeffrey Modell Foundation, the John Cook Brown Foundation and the Sydney Children's Hospital Network.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Boughton CR, 2002, INTERN MED J, V32, P59; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; CALDWELL RM, 1958, SCIENCE, V128, P714, DOI 10.1126/science.128.3326.714; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; FENNER F, 1983, PROC R SOC SER B-BIO, V218, P259, DOI 10.1098/rspb.1983.0039; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Grey ST, 2003, J IMMUNOL, V170, P6250, DOI 10.4049/jimmunol.170.12.6250; Grey ST, 2001, TRANSPLANT P, V33, P577, DOI 10.1016/S0041-1345(00)02149-7; HARTIG PC, 1983, J INFECTION, V6, P43, DOI 10.1016/S0163-4453(83)95566-4; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hudjashov G, 2017, MOL BIOL EVOL, V34, P2439, DOI 10.1093/molbev/msx196; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Jacobs GS, 2019, AM J PHYS ANTHROPOL, V168, P112; Jeelall YS, 2012, J EXP MED, V209, P1907, DOI 10.1084/jem.20112744; KIBRICK S, 1958, PEDIATRICS, V22, P857; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Langley DB, 2018, BMC STRUCT BIOL, V18, DOI 10.1186/s12900-018-0090-7; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Malle EK, 2015, J EXP MED, V212, P1239, DOI 10.1084/jem.20150218; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Shigemura T, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000223; Siggs OM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01544; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Tahiliani V, 2013, J VIROL, V87, P3852, DOI 10.1128/JVI.03038-12; Tan BM, 2013, DIABETOLOGIA, V56, P520, DOI 10.1007/s00125-012-2784-x; Tang D, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.23; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Wallace A.R., 1863, J R GEOGR SOC, V33, P217, DOI DOI 10.2307/1798448; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Xu SH, 2012, P NATL ACAD SCI USA, V109, P4574, DOI 10.1073/pnas.1118892109; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zoldak G, 2004, J BIOL CHEM, V279, P47601, DOI 10.1074/jbc.M406883200	70	32	33	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1299	+		10.1038/s41590-019-0492-0	http://dx.doi.org/10.1038/s41590-019-0492-0			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31534238	Green Submitted			2022-12-18	WOS:000486615900014
J	Mann, TH; Kaech, SM				Mann, Thomas H.; Kaech, Susan M.			CD8(+) T CELLS Tick-TOX, it's time for T cell exhaustion	NATURE IMMUNOLOGY			English	Editorial Material							PROMOTES		[Mann, Thomas H.; Kaech, Susan M.] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Kaech, SM (corresponding author), Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	skaech@salk.edu						Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	16	32	33	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1092	1094		10.1038/s41590-019-0478-y	http://dx.doi.org/10.1038/s41590-019-0478-y			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31427776				2022-12-18	WOS:000482212600008
J	Jarjour, NN; Schwarzkopf, EA; Bradstreet, TR; Shchukina, I; Lin, CC; Huang, SCC; Lai, CW; Cook, ME; Taneja, R; Stappenbeck, TS; Randolph, GJ; Artyomov, MN; Urban, JF; Edelson, BT				Jarjour, Nicholas N.; Schwarzkopf, Elizabeth A.; Bradstreet, Tara R.; Shchukina, Irina; Lin, Chih-Chung; Huang, Stanley Ching-Cheng; Lai, Chin-Wen; Cook, Melissa E.; Taneja, Reshma; Stappenbeck, Thaddeus S.; Randolph, Gwendalyn J.; Artyomov, Maxim N.; Urban, Joseph F., Jr.; Edelson, Brian T.			Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity	NATURE IMMUNOLOGY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; RESIDENT MACROPHAGES; SELF-RENEWAL; TRANSCRIPTION; EXPRESSION; PERITONEAL; REGULATOR; SIGNALS; STRA13; CELLS	Most tissue-resident macrophage populations develop during embryogenesis, self-renew in the steady state and expand during type 2 immunity. Whether shared mechanisms regulate the proliferation of macrophages in homeostasis and disease is unclear. Here we found that the transcription factor Bhlhe40 was required in a cell-intrinsic manner for the self-renewal and maintenance of large peritoneal macrophages (LPMs), but not that of other tissue-resident macrophages. Bhlhe40 was necessary for the proliferation, but not the polarization, of LPMs in response to the cytokine IL-4. During infection with the helminth Heligmosomoides polygyrus bakeri, Bhlhe40 was required for cell cycling of LPMs. Bhlhe40 repressed the expression of genes encoding the transcription factors c-Maf and Mafb and directly promoted expression of transcripts encoding cell cycle-related proteins to enable the proliferation of LPMs. In LPMs, Bhlhe40 bound to genomic sites co-bound by the macrophage lineage-determining factor PU.1 and to unique sites, including Maf and loci encoding cell-cycle-related proteins. Our findings demonstrate a tissue-specific control mechanism that regulates the proliferation of resident macrophages in homeostasis and type 2 immunity.	[Jarjour, Nicholas N.; Schwarzkopf, Elizabeth A.; Bradstreet, Tara R.; Shchukina, Irina; Lin, Chih-Chung; Huang, Stanley Ching-Cheng; Lai, Chin-Wen; Cook, Melissa E.; Stappenbeck, Thaddeus S.; Randolph, Gwendalyn J.; Artyomov, Maxim N.; Edelson, Brian T.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Taneja, Reshma] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Lin, Chih-Chung] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Lin, Chih-Chung] Harvard Med Sch, Boston, MA 02115 USA; [Huang, Stanley Ching-Cheng] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Washington University (WUSTL); National University of Singapore; United States Department of Agriculture (USDA); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Case Western Reserve University	Edelson, BT (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	bedelson@path.wustl.edu	Taneja, Reshma/F-9658-2014; Huang, Stanley Ching-Cheng/AAE-7866-2019	Taneja, Reshma/0000-0002-2151-2094; Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Urban, Joseph/0000-0002-1590-8869; Edelson, Brian/0000-0003-2856-7650; Jarjour, Nicholas/0000-0001-9400-4448; Cook, Melissa/0000-0002-2336-956X; Reshma, Taneja/0000-0001-6214-6177	National Institute of Allergy and Infectious Disease (NIAID) [AI113118, AI132653]; Burroughs Wellcome Fund Career Award for Medical Scientists; NIAID [5T32AI007163]; McDonnell International Scholars Academy at Washington University; Case Comprehensive Cancer Center American Cancer Society IRG Award [IRG-16-186-21]; National Science Foundation Graduate Research Fellowship program [DGE-1745038]; Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR002345]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, R01AI113118, R01AI132653] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); McDonnell International Scholars Academy at Washington University; Case Comprehensive Cancer Center American Cancer Society IRG Award; National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease (NIAID) (AI113118 and AI132653) (B.T.E.) and a Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.). N.N.J. was supported by grant 5T32AI007163 from the NIAID. C.-C.L. was supported by the McDonnell International Scholars Academy at Washington University. S.C.-C.H. was supported by the Case Comprehensive Cancer Center American Cancer Society IRG Award (IRG-16-186-21). M.E.C. was supported by the National Science Foundation Graduate Research Fellowship program (DGE-1745038). Research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. We thank E. Lantelme, A. Cullen and D. Brinja for help with fluorescence-activated cell sorting. We thank W. Beatty and L. Mwaghore for electron microscopy. We thank S. Van Dyken and C. Farnsworth for critical reading of the manuscript. We thank the members of the G. Randolph laboratory for helpful discussions about this project. We thank J. Bando, M. Robinette and T. Ai for help with flow cytometry of the gut.	Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bando JK, 2018, IMMUNITY, V48, P1208, DOI 10.1016/j.immuni.2018.04.012; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Camponeschi A, 2018, IMMUNOL LETT, V198, P7, DOI 10.1016/j.imlet.2018.03.014; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Franklin RA, 2016, TRENDS CANCER, V2, P20, DOI 10.1016/j.trecan.2015.11.004; Gabrysova L, 2018, J EXP MED, V215, P1767, DOI 10.1084/jem.20180824; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Imperatore F, 2017, EMBO J, V36, P2353, DOI 10.15252/embj.201695737; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kim KW, 2016, J EXP MED, V213, P1951, DOI 10.1084/jem.20160486; Kreslavsky T, 2017, NAT IMMUNOL, V18, P442, DOI 10.1038/ni.3694; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Qian YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086328; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Ruckerl D, 2014, IMMUNOL REV, V262, P113, DOI 10.1111/imr.12221; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seimiya M, 2004, EUR J IMMUNOL, V34, P1322, DOI 10.1002/eji.200324700; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014; 2018, J EXP MED, V215, P2536, DOI DOI 10.1084/JEM.20180534; 2014, CURR TOP DEV BIOL, V110, P339, DOI DOI 10.1016/B978-0-12-405943-6.00010-5	58	32	33	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					687	+		10.1038/s41590-019-0382-5	http://dx.doi.org/10.1038/s41590-019-0382-5			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31061528	Green Accepted			2022-12-18	WOS:000468505100012
J	Biram, A; Stromberg, A; Winter, E; Stoler-Barak, L; Salomon, R; Addadi, Y; Dahan, R; Yaari, G; Bemark, M; Shulman, Z				Biram, Adi; Stromberg, Anneli; Winter, Eitan; Stoler-Barak, Liat; Salomon, Ran; Addadi, Yoseph; Dahan, Rony; Yaari, Gur; Bemark, Mats; Shulman, Ziv			BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patches	NATURE IMMUNOLOGY			English	Article							B-CELL-INTERACTIONS; MONOCLONAL-ANTIBODIES; CLONAL SELECTION; DYNAMICS; RESPONSES; MATURATION; MICROSCOPY; REVEALS; CCR6; SAP	Gut-derived antigens trigger immunoglobulin A (IgA) immune responses that are initiated by cognate B cells in Peyer's patches (PPs). These cells colonize the subepithelial domes (SEDs) of the PPs and subsequently infiltrate pre-existing germinal centers (GCs). Here we defined the pre-GC events and the micro-anatomical site at which affinity-based B cell selection occurred in PPs. Using whole-organ imaging, we showed that the affinity of the B cell antigen receptor (BCR) regulated the infiltration of antigen-specific B cells into GCs but not clonal competition in the SED. Follicular helper-like T cells resided in the SED and promoted its B cell colonization, independently of the magnitude of BCR affinity. Imaging and immunoglobulin sequencing indicated that selective clonal expansion ensued during infiltration into GCs. Thus, in contrast to the events in draining lymph nodes and spleen, in PPs, T cells promoted mainly the population expansion of B cells without clonal selection during pre-GC events. These findings have major implications for the design of oral vaccines.	[Biram, Adi; Stoler-Barak, Liat; Salomon, Ran; Dahan, Rony; Shulman, Ziv] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Stromberg, Anneli; Bemark, Mats] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Winter, Eitan; Yaari, Gur] Bar Ilan Univ, Fac Engn, Ramat Gan, Israel; [Addadi, Yoseph] Weizmann Inst Sci, Dept Life Sci Core Facil, Rehovot, Israel	Weizmann Institute of Science; University of Gothenburg; Bar Ilan University; Weizmann Institute of Science	Shulman, Z (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ziv.shulman@weamann.ac.il	Bemark, Mats/B-2578-2019; Yaari, Gur/ABD-5122-2021; Shulman, Ziv/AAE-2654-2020	Bemark, Mats/0000-0001-7416-9819; Yaari, Gur/0000-0001-9311-9884; Shulman, Ziv/0000-0002-9604-212X; Addadi, Sefi/0000-0001-9827-0436; Dahan, Rony/0000-0002-8420-7601	European Research Council [677713]; Human Frontiers of Science Program [CDA-00023/2016]; Israel Science Foundation [1090/18]; Azrieli Foundation; Rising Tide Foundation; Morris Kahn Institute for Human Immunology; Benoziyo Endowment Fund for the Advancement of Science; Sir Charles Clore Research Prize; Comisaroff Family Trust; Irma & Jacques Ber-Lehmsdorf Foundation; Gerald O. Mann Charitable Foundation; David M. Polen Charitable Trust	European Research Council(European Research Council (ERC)European Commission); Human Frontiers of Science Program(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Azrieli Foundation; Rising Tide Foundation; Morris Kahn Institute for Human Immunology; Benoziyo Endowment Fund for the Advancement of Science; Sir Charles Clore Research Prize; Comisaroff Family Trust; Irma & Jacques Ber-Lehmsdorf Foundation; Gerald O. Mann Charitable Foundation; David M. Polen Charitable Trust	Z.S. is supported by the European Research Council (grant No. 677713), Human Frontiers of Science Program (grant No. CDA-00023/2016), Israel Science Foundation (grant No. 1090/18), Azrieli Foundation, Rising Tide Foundation and the Morris Kahn Institute for Human Immunology. Z.S. is a member in the European Molecular Biology Organization Young Investigator Program and is supported by grants from The Benoziyo Endowment Fund for the Advancement of Science, The Sir Charles Clore Research Prize, Comisaroff Family Trust, Irma & Jacques Ber-Lehmsdorf Foundation, Gerald O. Mann Charitable Foundation and David M. Polen Charitable Trust. Imaging was made possible thanks to The de Picciotto-Lesser Cell Observatory in memory of Wolf and Ruth Lesser.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cong YZ, 1996, EUR J IMMUNOL, V26, P2587, DOI 10.1002/eji.1830261108; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dahan R, 2016, CANCER CELL, V29, P820, DOI 10.1016/j.ccell.2016.05.001; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; GOIDL EA, 1968, J IMMUNOL, V100, P371; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Gupta J, 2014, BIOPROTOCOL, V4, pe1289, DOI DOI 10.21769/BI0PR0T0C.1289; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Kurosaki T, 2011, MOL IMMUNOL, V48, P1287, DOI 10.1016/j.molimm.2010.12.007; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; LIN YL, 2017, FRONT IMMUNOL, V8, P1, DOI DOI 10.3389/FMICB.2017.00932; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lycke NY, 2017, MUCOSAL IMMUNOL, V10, P1361, DOI 10.1038/mi.2017.62; Macpherson AJ, 2012, IMMUNOL REV, V245, P132, DOI 10.1111/j.1600-065X.2011.01072.x; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Reimer D, 2017, IMMUNOL CELL BIOL, V95, P33, DOI 10.1038/icb.2016.68; Rommel PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069208; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wagner C, 2018, CELL IMMUNOL, V330, P159, DOI 10.1016/j.cellimm.2018.01.012; Wiede F, 2013, IMMUNOL CELL BIOL, V91, P335, DOI 10.1038/icb.2013.14; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129	53	32	32	4	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					482	+		10.1038/s41590-019-0325-1	http://dx.doi.org/10.1038/s41590-019-0325-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30833793				2022-12-18	WOS:000461904200018
J	Herzig, Y; Nevo, S; Bornstein, C; Brezis, MR; Ben-Hur, S; Shkedy, A; Eisenberg-Bord, M; Levi, B; Delacher, M; Goldfarb, Y; David, E; Weinberger, L; Viukov, S; Ben-Dor, S; Giraud, M; Hanna, JH; Breiling, A; Lyko, F; Amit, I; Feuerer, M; Abramson, J				Herzig, Yonatan; Nevo, Shir; Bornstein, Chamutal; Brezis, Miriam R.; Ben-Hur, Sharon; Shkedy, Aya; Eisenberg-Bord, Michal; Levi, Ben; Delacher, Michael; Goldfarb, Yael; David, Eyal; Weinberger, Leehee; Viukov, Sergey; Ben-Dor, Shifra; Giraud, Matthieu; Hanna, Jacob H.; Breiling, Achim; Lyko, Frank; Amit, Ido; Feuerer, Markus; Abramson, Jakub			Transcriptional programs that control expression of the autoimmune regulator gene Aire	NATURE IMMUNOLOGY			English	Article							THYMIC EPITHELIAL-CELLS; DNA METHYLATION; MECHANISMS; SELECTION; SITES; CTCF	Aire is a transcriptional regulator that induces promiscuous expression of thousands of genes encoding tissue-restricted antigens (TRAs) in medullary thymic epithelial cells (mTECs). While the target genes of Aire are well characterized, the transcriptional programs that regulate its own expression have remained elusive. Here we comprehensively analyzed both cis-acting and trans-acting regulatory mechanisms and found that the Aire locus was insulated by the global chromatin organizer CTCF and was hypermethylated in cells and tissues that did not express Aire. In mTECs, however, Aire expression was facilitated by concurrent eviction of CTCF, specific demethylation of exon 2 and the proximal promoter, and the coordinated action of several transcription activators, including Irf4, Irf8, Tbx21, Tcf7 and Ctcfl, which acted on mTEC-specific accessible regions in the Aire locus.	[Herzig, Yonatan; Nevo, Shir; Bornstein, Chamutal; Brezis, Miriam R.; Ben-Hur, Sharon; Shkedy, Aya; Eisenberg-Bord, Michal; Levi, Ben; Goldfarb, Yael; David, Eyal; Amit, Ido; Abramson, Jakub] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Delacher, Michael; Feuerer, Markus] German Canc Res Ctr, Res Grp Immune Tolerance, Tumor Immunol Program, Heidelberg, Germany; [Weinberger, Leehee; Viukov, Sergey; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Ben-Dor, Shifra] Weizmann Inst Sci, Biol Serv Dept, Bioinformat Unit, Rehovot, Israel; [Giraud, Matthieu] Cochin Inst, Dept Infect Immun & Inflammat, Paris, France; [Breiling, Achim; Lyko, Frank] German Canc Res Ctr, Div Epigenet, DKFZ ZMBH Alliance, Heidelberg, Germany	Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ); Weizmann Institute of Science; Weizmann Institute of Science; UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; German Cancer Research Center (DKFZ)	Abramson, J (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	jakub.abramson@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019; Delacher, Michael/AAA-5224-2019; Giraud, Matthieu/E-4972-2017; Delacher, Michael/AAM-9710-2021; Hanna, Jacob/K-1339-2012	BEN-DOR, SHIFRA/0000-0001-9604-1939; Giraud, Matthieu/0000-0002-1208-9677; Hanna, Jacob/0000-0003-2042-9974; Breiling, Achim/0000-0002-7928-299X; Nevo, Shir/0000-0001-6913-1867	Israel Science Foundation [1825/10, 1376/13]; Sy Syms Foundation; Dr. Celia Zwillenberg-Fridman and Dr. Lutz Fridman Career Development Chair; Weizmann-German Cancer Research Center PhD fellowship program; German Cancer Research Center-Israeli Ministry of Science and Technology foundation for German-Israeli [2431]; Agence Nationale de Recherche [2011-CHEX-001-R12004KK]; European Federation of Immunological Societies fellowship program	Israel Science Foundation(Israel Science Foundation); Sy Syms Foundation; Dr. Celia Zwillenberg-Fridman and Dr. Lutz Fridman Career Development Chair; Weizmann-German Cancer Research Center PhD fellowship program; German Cancer Research Center-Israeli Ministry of Science and Technology foundation for German-Israeli; Agence Nationale de Recherche(French National Research Agency (ANR)); European Federation of Immunological Societies fellowship program	We thank M. Anderson (University of California at San Francisco) for Aire-Igrp-GFP mice; D. Graf (University of Zurich) for B6.Foxn1-Cre mice (obtained with the consent of N. Manley (University of Georgia)); H. Clevers (Hubrecht Institute) for Tcf7<SUP>-/-</SUP> mice; and Y. Peleg, G. Yona and V. Krupalnik for experimental expertise and help. Supported by the Israel Science Foundation (1825/10 and 1376/13), the Sy Syms Foundation, the Dr. Celia Zwillenberg-Fridman and Dr. Lutz Fridman Career Development Chair (J.A.), the Weizmann-German Cancer Research Center PhD fellowship program (Y.H., M.D., J.A., M.F.), the German Cancer Research Center-Israeli Ministry of Science and Technology foundation for German-Israeli co-operation (2431 to J.A. and M.F.), the Agence Nationale de Recherche (2011-CHEX-001-R12004KK to M.Gi.) and the European Federation of Immunological Societies fellowship program (M.R.B.).	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kont V, 2011, MOL IMMUNOL, V49, P518, DOI 10.1016/j.molimm.2011.09.022; LaFlam TN, 2015, J EXP MED, V212, P1993, DOI 10.1084/jem.20151069; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Sansom S. N., 2014, POPULATION SINGLE CE, P1918; Singh H, 2013, COLD SH Q B, V78, P101, DOI 10.1101/sqb.2013.78.020305; Sleutels F, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-8; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	29	32	33	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					161	172		10.1038/ni.3638	http://dx.doi.org/10.1038/ni.3638			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27941786				2022-12-18	WOS:000392360900010
J	Flossdorf, M; Rossler, J; Buchholz, VR; Busch, DH; Hofer, T				Flossdorf, Michael; Roessler, Jens; Buchholz, Veit R.; Busch, Dirk H.; Hoefer, Thomas			CD8(+) T cell diversification by asymmetric cell division	NATURE IMMUNOLOGY			English	Letter							EFFECTOR; FATES; EXPRESSION; IMMUNITY		[Flossdorf, Michael; Roessler, Jens; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, Heidelberg, Germany; [Flossdorf, Michael; Roessler, Jens; Hoefer, Thomas] Heidelberg Univ, Bioquant Ctr, Heidelberg, Germany; [Buchholz, Veit R.; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Busch, Dirk H.] Tech Univ Munich, Focus Grp Clin Cell Proc & Purificat, Inst Adv Study, D-80290 Munich, Germany; [Busch, Dirk H.] Helmholtz Ctr Munich, Clin Cooperat Grp Antigenspecif Immunotherapy & I, Munich, Germany; [Busch, Dirk H.] German Ctr Infect Res DZIF, Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Center for Infection Research	Flossdorf, M (corresponding author), German Canc Res Ctr, Div Theoret Syst Biol, Heidelberg, Germany.	dirk.busch@tum.de; thoefer@dkfz.de	Höfer, Thomas/G-5665-2013; Buchholz, Veit R./AAF-6966-2021	Höfer, Thomas/0000-0003-3560-8780; Buchholz, Veit R./0000-0003-0441-3913				Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Buchholz V.R., FRONT IMMUNOL; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859	13	32	32	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					891	893		10.1038/ni.3235	http://dx.doi.org/10.1038/ni.3235			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287584				2022-12-18	WOS:000359876900001
J	Hamilton, SE; Porter, BB; Messingham, KAN; Badovinac, VP; Harty, JT				Hamilton, SE; Porter, BB; Messingham, KAN; Badovinac, VP; Harty, JT			MHC class Ia-restricted memory T cells inhibit expansion of a nonprotective MHC class Ib (H2-M3)-restricted memory response	NATURE IMMUNOLOGY			English	Article							N-FORMYLATED PEPTIDES; LISTERIA-MONOCYTOGENES; PROTECTIVE IMMUNITY; ANTILISTERIAL IMMUNITY; SPECIALIZED FUNCTIONS; ANTIGEN PRESENTATION; POSITIVE SELECTION; CUTTING EDGE; MICE LACKING; PERFORIN	Listeria monocytogenes infection generates major histocompatibility complex (MHC) class Ia-restricted and MHC class Ib-(H2- M3)-restricted effector and memory CD8(+) T cells. However, only MHC class Ia-restricted memory cells expand after rechallenge, and it is unknown if MHC class Ib-restricted memory CD8(+) T cells generated by vaccination are protective. We show here that H2- M3-restricted memory CD8(+) T cells were capable of secondary expansion but, in contrast to primary H2-M3-restricted effector cells, failed to provide protective immunity. In LM-immune mice, MHC class Ia- restricted memory CD8(+) T cells prevented the expansion of H2-M3-restricted memory T cell populations by limiting dendritic cell antigen presentation. Thus, protective immunity by H2-M3-resricted T cells is limited to primary infection, indicating that memory MHC class Ia- restricted T cells prevent nonessential immune responses during secondary infection.	Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu	Messingham, Kelly/AAD-8388-2020; badovinac, Vladimir/O-7760-2015	Messingham, Kelly/0000-0003-4630-0722; Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042767, R01AI042767, T32AI007485, R01AI046653, R01AI050073, T32AI007511, T32AI007260, R37AI042767] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI 07260, AI 50073, T32 AI 07485, AI 46653, T32 AI 07511, AI 42767] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bouwer HGA, 1997, J IMMUNOL, V159, P2795; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Chiu NM, 1999, J EXP MED, V190, P1869, DOI 10.1084/jem.190.12.1869; Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; D'Orazio SEF, 2003, J IMMUNOL, V171, P291, DOI 10.4049/jimmunol.171.1.291; Hamilton SE, 2002, J IMMUNOL, V169, P4936, DOI 10.4049/jimmunol.169.9.4936; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Jensen ER, 1998, INFECT IMMUN, V66, P4143; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; KAUFMANN SHE, 1988, J IMMUNOL, V140, P3173; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Kerksiek KM, 2003, J IMMUNOL, V170, P1862, DOI 10.4049/jimmunol.170.4.1862; Kerksiek KM, 2001, J IMMUNOL, V166, P1132, DOI 10.4049/jimmunol.166.2.1132; Lenz LL, 1997, IMMUNOL REV, V158, P115, DOI 10.1111/j.1600-065X.1997.tb00997.x; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851; LUKACS K, 1989, J IMMUNOL, V143, P3731; Messingham KAN, 2003, J IMMUNOL, V171, P4254, DOI 10.4049/jimmunol.171.8.4254; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Rolph MS, 2000, J IMMUNOL, V165, P4575, DOI 10.4049/jimmunol.165.8.4575; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; San Mateo LR, 2002, J IMMUNOL, V169, P5202, DOI 10.4049/jimmunol.169.9.5202; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; Seaman MS, 1999, J IMMUNOL, V162, P5429; SHAWAR SM, 1991, J EXP MED, V174, P941, DOI 10.1084/jem.174.4.941; SHAWAR SM, 1990, J EXP MED, V171, P897, DOI 10.1084/jem.171.3.897; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Tawab A, 2002, INT IMMUNOL, V14, P225, DOI 10.1093/intimm/14.2.225; Urdahl KB, 2003, J IMMUNOL, V170, P1987, DOI 10.4049/jimmunol.170.4.1987; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; WANG CR, 1991, CELL, V66, P335, DOI 10.1016/0092-8674(91)90623-7; White DW, 1998, J IMMUNOL, V160, P898; White DW, 1999, J IMMUNOL, V162, P980; Wong P, 2003, IMMUNITY, V18, P499, DOI 10.1016/S1074-7613(03)00081-5	49	32	33	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					159	168		10.1038/ni1026	http://dx.doi.org/10.1038/ni1026			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14745446				2022-12-18	WOS:000188512000011
J	Margulies, DH				Margulies, DH			TCR avidity: it's not how strong you make it, it's how you make it strong	NATURE IMMUNOLOGY			English	News Item							IMMUNOLOGICAL SYNAPSE; ACTIVATION; SELECTION; CELLS	Unlike the BCR, the TCR cannot undergo affinity maturation. However T cells respond with greater sensitivity to antigen during an immune response. New evidence suggests T cells undergo avidity maturation to enhance T cell responsiveness in the absence of changes in intrinsic affinity.	NIAID, Mol Biol Sect, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Immunol Lab, 10 Ctr Dr, Bethesda, MD 20892 USA.	dhm@nih.gov		Margulies, David/0000-0001-8530-7375	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000622, Z01AI000394] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Derby MA, 2001, INT IMMUNOL, V13, P817, DOI 10.1093/intimm/13.6.817; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Yee C, 1999, J IMMUNOL, V162, P2227	14	32	33	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					669	670		10.1038/90601	http://dx.doi.org/10.1038/90601			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477399				2022-12-18	WOS:000170230100006
J	Bikah, G; Pogue-Caley, RR; McHeyzer-Williams, LJ; McHeyzer-Williams, MG				Bikah, G; Pogue-Caley, RR; McHeyzer-Williams, LJ; McHeyzer-Williams, MG			Regulating T helper cell immunity through antigen responsiveness and calcium entry	NATURE IMMUNOLOGY			English	Article							IN-VIVO; DRIVEN SELECTION; CA2+ ENTRY; RECEPTOR; ACTIVATION; LYMPHOCYTE; CHANNELS; MEMORY; ASSOCIATION; DEFICIENT	We evaluated changes in the signaling potentials and proliferative capacity of single antigen-specific T helper (T-H) cells during a primary immune response to a protein antigen. At the peak of cellular expansion in vivo all antigen-specific T-H cells exhibited a profound block in CD3- and CD4-mediated mobilization of intracellular calcium together with a more global block in T cell receptor-independent capacitative calcium entry (CCE). The proliferative resp on se of these antigen-specific T-H cells to anti-CD3, anti-CD28 and IL-2 was also severely blunted. Cross-linking CD69 on a substantial fraction of CD69(+) antigen-specific T-H cells relieved this block in CCE and restored proliferative capacity in vitro. The CCE rescue operated through a CD69-coupled G protein and required calcium-bound calmodulin and calcineurin. These data reveal critical changes in the responsiveness of antigen-specific T-H cells and provide evidence of new mechanisms for the regulation of antigen-specific T-H cell development in vivo.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	McHeyzer-Williams, MG (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.				NIAID NIH HHS [AI40215] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040215] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DAVIS MM, 1998, ANNU REV IMMUNOL, V16, P201; DRIVER DJ, 2000, UNPUB J IMMUNOL; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Estacion M, 1999, BIOCHEM J, V341, P41, DOI 10.1042/0264-6021:3410041; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GulbransonJudge A, 1996, EUR J IMMUNOL, V26, P1830, DOI 10.1002/eji.1830260825; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Haverstick DM, 1998, CELL CALCIUM, V23, P361, DOI 10.1016/S0143-4160(98)90092-6; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MARASKOVSKY E, 1991, INT IMMUNOL, V3, P255, DOI 10.1093/intimm/3.3.255; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Mikszta JA, 1999, J IMMUNOL, V163, P5978; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; PANUS JF, 2000, IN PRESS J EXP MED; PHILOSOPHE B, 1989, EUR J IMMUNOL, V19, P695, DOI 10.1002/eji.1830190419; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; RAMSDELL F, 1992, SCIENCE, V257, P1130, DOI 10.1126/science.257.5073.1130; RISSO A, 1991, J IMMUNOL, V146, P4105; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; SERAFINI AT, 1995, IMMUNITY, V3, P239, DOI 10.1016/1074-7613(95)90093-4; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng B, 1996, NATURE, V384, P263, DOI 10.1038/384263a0; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	56	32	35	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					402	412		10.1038/80841	http://dx.doi.org/10.1038/80841			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062500				2022-12-18	WOS:000165076100013
J	Nossal, GJV				Nossal, GJV			The global alliance for vaccines and immunization - a millennial challenge	NATURE IMMUNOLOGY			English	Editorial Material								Global immunization of children is an elusive goal of public health officials world-wide. Extraordinary recent funding and organizational initiatives as described by Gustav Nossal have ignited renewed optimism that the stage is finally set to bring this achievement within our grasp.	Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	University of Melbourne	Nossal, GJV (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.							FENNER F, 1988, SMALLPAX ITS ERADICA; Nossal GJV, 1999, SCIENCE, V284, P587; NOSSAL GJV, 1999, FUNDAMENTAL IMMUNOLO, P1387	3	32	33	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					5	8		10.1038/76852	http://dx.doi.org/10.1038/76852			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881163				2022-12-18	WOS:000089814800003
J	Stravalaci, M; Pagani, I; Paraboschi, EM; Pedotti, M; Doni, A; Scavello, F; Mapelli, SN; Sironi, M; Perucchini, C; Varani, L; Matkovic, M; Cavalli, A; Cesana, D; Gallina, P; Pedemonte, N; Capurro, V; Clementi, N; Mancini, N; Invernizzi, P; Bayarri-Olmos, R; Garred, P; Rappuoli, R; Duga, S; Bottazzi, B; Uguccioni, M; Asselta, R; Vicenzi, E; Mantovani, A; Garlanda, C				Stravalaci, Matteo; Pagani, Isabel; Paraboschi, Elvezia Maria; Pedotti, Mattia; Doni, Andrea; Scavello, Francesco; Mapelli, Sarah N.; Sironi, Marina; Perucchini, Chiara; Varani, Luca; Matkovic, Milos; Cavalli, Andrea; Cesana, Daniela; Gallina, Pierangela; Pedemonte, Nicoletta; Capurro, Valeria; Clementi, Nicola; Mancini, Nicasio; Invernizzi, Pietro; Bayarri-Olmos, Rafael; Garred, Peter; Rappuoli, Rino; Duga, Stefano; Bottazzi, Barbara; Uguccioni, Mariagrazia; Asselta, Rosanna; Vicenzi, Elisa; Mantovani, Alberto; Garlanda, Cecilia			Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules	NATURE IMMUNOLOGY			English	Article							MANNOSE-BINDING LECTIN; LONG PENTRAXIN PTX3; WHOLE-GENOME ASSOCIATION; LENTIVIRAL VECTORS; PROTEIN; POLYMORPHISMS; MBL; AFRICAN; DOMAIN; CELLS	The humoral arm of innate immunity includes diverse molecules with antibody-like functions, some of which serve as disease severity biomarkers in coronavirus disease 2019 (COVID-19). The present study was designed to conduct a systematic investigation of the interaction of human humoral fluid-phase pattern recognition molecules (PRMs) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Of 12 PRMs tested, the long pentraxin 3 (PTX3) and mannose-binding lectin (MBL) bound the viral nucleocapsid and spike proteins, respectively. MBL bound trimeric spike protein, including that of variants of concern (VoC), in a glycan-dependent manner and inhibited SARS-CoV-2 in three in vitro models. Moreover, after binding to spike protein, MBL activated the lectin pathway of complement activation. Based on retention of glycosylation sites and modeling, MBL was predicted to recognize the Omicron VoC. Genetic polymorphisms at the MBL2 locus were associated with disease severity. These results suggest that selected humoral fluid-phase PRMs can play an important role in resistance to, and pathogenesis of, COVID-19, a finding with translational implications. Stravalaci et al. examined recognition of SARS-CoV-2 by human soluble innate pattern recognition receptor. They report that pentraxin 3 and mannose-binding protein recognize viral nucleoprotein and spike, respectively. Mannose-binding lectin has antiviral activity, and human genetic polymorphisms of MBL2 are associated with more severe COVID-19.	[Stravalaci, Matteo; Paraboschi, Elvezia Maria; Doni, Andrea; Scavello, Francesco; Mapelli, Sarah N.; Sironi, Marina; Perucchini, Chiara; Duga, Stefano; Bottazzi, Barbara; Asselta, Rosanna; Mantovani, Alberto; Garlanda, Cecilia] IRCCS Humanitas Res Hosp, Milan, Italy; [Stravalaci, Matteo; Paraboschi, Elvezia Maria; Duga, Stefano; Uguccioni, Mariagrazia; Asselta, Rosanna; Mantovani, Alberto; Garlanda, Cecilia] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Pagani, Isabel; Vicenzi, Elisa] IRCCS San Raffaele Sci Inst, Viral Pathogenesis & Biosafety Unit, Milan, Italy; [Pedotti, Mattia; Varani, Luca; Matkovic, Milos; Cavalli, Andrea; Uguccioni, Mariagrazia] Univ Svizzera italiana USI, Inst Res Biomed, Bellinzona, Switzerland; [Cavalli, Andrea] Swiss Inst Bioinformat, Lausanne, Switzerland; [Cesana, Daniela; Gallina, Pierangela] IRCCS, San Raffaele Telethon Inst Gene Therapy SR Tiget, San Raffaele Sci Inst, Milan, Italy; [Pedemonte, Nicoletta; Capurro, Valeria] IRCCS Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Clementi, Nicola; Mancini, Nicasio] IRCCS Sci Inst, Lab Microbiol & Virol, Milan, Italy; [Clementi, Nicola; Mancini, Nicasio] Univ Vita Salute San Raffaele, Milan, Italy; [Invernizzi, Pietro] Univ Milano Bicocca, Div Gastroenterol, Dept Med & Surg, Ctr Autoimmune Liver Dis, Monza, Italy; [Invernizzi, Pietro] San Gerardo Hosp, European Reference Network Hepatol Dis ERN RARE L, Monza, Italy; [Bayarri-Olmos, Rafael; Garred, Peter] Copenhagen Univ Hosp, Lab Mol Med, Dept Clin Immunol, Rigshosp,Sect 7631, Copenhagen, Denmark; [Rappuoli, Rino] Fdn Toscana Life Sci, Monoclonal Antibody Discovery Lab, Siena, Italy; [Rappuoli, Rino] Imperial Coll London, Fac Med, London, England; [Mantovani, Alberto; Garlanda, Cecilia] Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London, England	Humanitas University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita della Svizzera Italiana; Swiss Institute of Bioinformatics; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Genoa; IRCCS Istituto Giannina Gaslini; Vita-Salute San Raffaele University; University of Milano-Bicocca; San Gerardo Hospital; Rigshospitalet; University of Copenhagen; Imperial College London; University of London; Queen Mary University London	Mantovani, A; Garlanda, C (corresponding author), IRCCS Humanitas Res Hosp, Milan, Italy.; Mantovani, A; Garlanda, C (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.; Vicenzi, E (corresponding author), IRCCS San Raffaele Sci Inst, Viral Pathogenesis & Biosafety Unit, Milan, Italy.; Mantovani, A; Garlanda, C (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London, England.	vicenzi.elisa@hsr.it; alberto.mantovani@humanitasresearch.it; cecilia.garlanda@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022; Scavello, Francesco/AHE-5653-2022; sironi, marina/AAB-5757-2020; Clementi, Nicola/G-8545-2014; Asselta, Rosanna/AAC-2367-2019; mapelli, sarah natalia/AAC-6093-2022; Garlanda, Cecilia/K-4601-2016; Stravalaci, Matteo/AAB-8963-2019; Paraboschi, Elvezia Maria/K-6799-2016	Mantovani, Alberto/0000-0001-5578-236X; Scavello, Francesco/0000-0002-0297-0946; sironi, marina/0000-0002-3342-1149; Clementi, Nicola/0000-0002-1822-9861; Asselta, Rosanna/0000-0001-5351-0619; mapelli, sarah natalia/0000-0002-0129-2055; Garlanda, Cecilia/0000-0002-1510-7703; Stravalaci, Matteo/0000-0002-5636-4204; Perucchini, Chiara/0000-0003-3010-8576; Pagani, Isabel/0000-0001-5396-0740; Varani, Luca/0000-0002-0963-0987; Uguccioni, Mariagrazia/0000-0002-9570-7011; Cavalli, Andrea/0000-0003-4063-4502; Paraboschi, Elvezia Maria/0000-0002-7935-798X	Italian Ministry of Health [COVID-2020-12371640]; Italian Ministry of University and Research; Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic); Banca Intesa San Paolo; European Union [101003650]; SNF (Swiss National Science Foundation) [31003A_182270]; AMAF Monza ONLUS; AIRCS	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic); Banca Intesa San Paolo; European Union(European Commission); SNF (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); AMAF Monza ONLUS; AIRCS	This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to A.M., C.G. and E.V.), by the Italian Ministry of Health for COVID-19 (COVID-202012371640 to A.M. and C.G.), by the Italian Ministry of University and Research (to P.I.) and by the Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic, to P.I.). We also thank the generous contribution of Banca Intesa San Paolo and AMAF Monza ONLUS and AIRCS for the unrestricted research funding. L.V. has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 101003650 and from SNF (Swiss National Science Foundation) grant 31003A_182270. This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force (the members are listed in the Supplementary Note). This paper is dedicated to S. Duga, who passed on 10 November 2021 and gave a key contribution to the genetic section of this report.	Ali YM, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.714511; Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Asselta R, 2020, AGING-US, V12, P10087, DOI 10.18632/aging.103415; Bayarri-Olmos R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02238; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Brunetta E, 2021, NAT IMMUNOL, V22, P19, DOI 10.1038/s41590-020-00832-x; Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chiodo F., 2020, BIORXIV, DOI 10.1101/2020.05.13.092478; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Clementi N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01704; De Gasparo R, 2021, NATURE, V593, P424, DOI 10.1038/s41586-021-03461-y; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Fu B, 2014, J COMPUT CHEM, V35, P1101, DOI 10.1002/jcc.23588; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Garlanda C, 2018, PHYSIOL REV, V98, P623, DOI 10.1152/physrev.00016.2017; Garred P, 2002, PEDIATR PULM, V33, P201, DOI 10.1002/ppul.10064; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Han B, 2012, LAB INVEST, V92, P1285, DOI 10.1038/labinvest.2012.92; Hartenian E, 2020, J BIOL CHEM, V295, P12910, DOI 10.1074/jbc.REV120.013930; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hsieh MH, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.641360; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Karwaciak I, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010054; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; King C, 2021, TRENDS IMMUNOL, V42, P312, DOI 10.1016/j.it.2021.02.003; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kosmicki J A, 2021, medRxiv, DOI 10.1101/2020.10.28.20221804; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Lu Q, 2021, IMMUNITY, V54, P1304, DOI 10.1016/j.immuni.2021.05.006; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; MANTEL N, 1959, J NATL CANCER I, V22, P719; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; Medetalibeyoglu A, 2021, INFECT GENET EVOL, V89, DOI 10.1016/j.meegid.2021.104717; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Mycroft-West CJ, 2020, THROMB HAEMOSTASIS, V120, P1700, DOI 10.1055/s-0040-1721319; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7; Schirinzi A, 2021, J INFECTION, V82, P121, DOI 10.1016/j.jinf.2020.10.027; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Stravalaci M, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.591908; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Yuan FF, 2005, TISSUE ANTIGENS, V66, P291, DOI 10.1111/j.1399-0039.2005.00476.x; Zeng WH, 2020, BIOCHEM BIOPH RES CO, V527, P618, DOI 10.1016/j.bbrc.2020.04.136; Zhang HX, 2005, J INFECT DIS, V192, P1355, DOI 10.1086/491479; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhou YC, 2010, J VIROL, V84, P8753, DOI 10.1128/JVI.00554-10; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	71	31	31	13	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					275	+		10.1038/s41590-021-01114-w	http://dx.doi.org/10.1038/s41590-021-01114-w		JAN 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35102342	Green Submitted, Bronze			2022-12-18	WOS:000750323300002
J	Moreira-Teixeira, L; Tabone, O; Graham, CM; Singhania, A; Stavropoulos, E; Redford, PS; Chakravarty, P; Priestnall, SL; Suarez-Bonnet, A; Herbert, E; Mayer-Barber, KD; Sher, A; Fonseca, KL; Sousa, J; Ca, B; Verma, R; Haldar, P; Saraiva, M; O'Garra, A				Moreira-Teixeira, Lucia; Tabone, Olivier; Graham, Christine M.; Singhania, Akul; Stavropoulos, Evangelos; Redford, Paul S.; Chakravarty, Probir; Priestnall, Simon L.; Suarez-Bonnet, Alejandro; Herbert, Eleanor; Mayer-Barber, Katrin D.; Sher, Alan; Fonseca, Kaori L.; Sousa, Jeremy; Ca, Baltazar; Verma, Raman; Haldar, Pranabashis; Saraiva, Margarida; O'Garra, Anne			Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis	NATURE IMMUNOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; HOST-RESISTANCE; LUNG GRANULOMAS; INFECTION; IMMUNITY; DISEASE; MICE; INFLAMMATION; NEUTROPHILS	Although mouse infection models have been extensively used to study the host response to Mycobacterium tuberculosis, their validity in revealing determinants of human tuberculosis (TB) resistance and disease progression has been heavily debated. Here, we show that the modular transcriptional signature in the blood of susceptible mice infected with a clinical isolate of M. tuberculosis resembles that of active human TB disease, with dominance of a type I interferon response and neutrophil activation and recruitment, together with a loss in B lymphocyte, natural killer and T cell effector responses. In addition, resistant but not susceptible strains of mice show increased lung B cell, natural killer and T cell effector responses in the lung upon infection. Notably, the blood signature of active disease shared by mice and humans is also evident in latent TB progressors before diagnosis, suggesting that these responses both predict and contribute to the pathogenesis of progressive M. tuberculosis infection. The pathobiological validity of mouse models of mycobacteria infection is sometimes questioned. O'Garra and colleagues demonstrate that mice share transcriptomic modules with active human tuberculosis and a characteristic type I IFN signature.	[Moreira-Teixeira, Lucia; Tabone, Olivier; Graham, Christine M.; Singhania, Akul; Stavropoulos, Evangelos; Redford, Paul S.; O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, London, England; [Chakravarty, Probir] Francis Crick Inst, Bioinformat Core, London, England; [Priestnall, Simon L.; Suarez-Bonnet, Alejandro; Herbert, Eleanor] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England; [Priestnall, Simon L.; Suarez-Bonnet, Alejandro; Herbert, Eleanor] Francis Crick Inst, Expt Histopathol Team, London, England; [Mayer-Barber, Katrin D.] NIAID, Inflammat & Innate Immun Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Fonseca, Kaori L.; Sousa, Jeremy; Ca, Baltazar; Saraiva, Margarida] Univ Porto, I3S, Porto, Portugal; [Fonseca, Kaori L.; Sousa, Jeremy; Ca, Baltazar; Saraiva, Margarida] Univ Porto, IBMC, Porto, Portugal; [Fonseca, Kaori L.; Sousa, Jeremy; Ca, Baltazar] Univ Porto, ICBAS, Porto, Portugal; [Fonseca, Kaori L.; Ca, Baltazar] IGC, Programa Posgrad Ciencia Desenvolvimento PGCD, Oeiras, Portugal; [Verma, Raman; Haldar, Pranabashis] Univ Leicester, Dept Resp Sci, Natl Inst Hlth Res Resp Biomed Res Ctr, Leicester, Leics, England; [O'Garra, Anne] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Redford, Paul S.] GlaxoSmithKline Res & Dev Ltd, Med Res Ctr, Stevenage, Herts, England	Francis Crick Institute; Francis Crick Institute; University of London; University of London Royal Veterinary College; Francis Crick Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; University of Leicester; Imperial College London; GlaxoSmithKline	O'Garra, A (corresponding author), Francis Crick Inst, Lab Immunoregulat & Infect, London, England.; O'Garra, A (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	Anne.OGarra@crick.ac.uk	Singhania, Akul/I-4633-2019; Saraiva, Margarida/E-8781-2011	Singhania, Akul/0000-0002-6941-3618; Moreira-Teixeira, Lucia/0000-0002-4817-8196; Saraiva, Margarida/0000-0002-8180-1293; Ca, Baltazar/0000-0002-0376-7755; O'Garra, Anne/0000-0001-9845-6134; chakravarty, probir/0000-0003-1146-8824; Sousa, Jeremy/0000-0002-1310-1201; Priestnall, Simon/0000-0002-6027-1879; Tabone, Olivier/0000-0001-6021-8640; Haldar, Pranabashis/0000-0002-1572-5421; Herbert, Eleanor/0000-0002-2216-7771	Francis Crick Institute from Cancer Research UK [FC001126]; UK MRC [FC001126, U117565642]; Wellcome Trust [FC001126]; European Research Council [294682-TBPATH]; Royal Veterinary College; Francis Crick Institute; Intramural Research Program of the National Institutes of Allergy and Infectious Disease; FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020; Fundacao para a Ciencia e a Tecnologia (FCT) [POCI-01-0145-FEDER-007274]; FCT through Estimulo Individual ao Emprego Cientifico; FCT [SFRH/BD/114405/2016, SFRH/BD/114403/2016]; NIHR Leicester Biomedical Research Centre; University of Leicester; MRC [MC_U117565642] Funding Source: UKRI	Francis Crick Institute from Cancer Research UK; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Royal Veterinary College; Francis Crick Institute; Intramural Research Program of the National Institutes of Allergy and Infectious Disease; FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT through Estimulo Individual ao Emprego Cientifico(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NIHR Leicester Biomedical Research Centre; University of Leicester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank S. Hadebe (Francis Crick Institute UK, now UCT, South Africa) and J. Pitt (Medical Research Council (MRC), National Institute for Medical Research (NIMR), UK) for some of the early mouse M. tuberculosis infections and samples and sample processing leading up to the current study and K. Potempa (MRC, NIMR, UK) for early analysis of some of the microarray data leading up to the current study. The authors also thank L. Gabrysova (Francis Crick Institute UK, now Novartis, Basel, Switzerland) for her intellectual contribution to discussion of the project. The authors thank X. Wu for her help in organization of mice for TB experiments. The authors thank the Francis Crick Institute Science Technology Platforms: Biological Services for breeding and maintenance of the mice used for the early mouse M. tuberculosis infections and samples leading up to the current study; Advanced Sequencing Facility, Bioinformatics and Biostatistics Science Technology Platforms for their contribution to our sequencing processing and R. Goldstone for excellent project management of sequencing and D. Jackson for support of sequencing; and Experimental Histopathology for their excellent work in preparing lung sections for histological analyses. This study was funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001126), the UK MRC (FC001126) and the Wellcome Trust (FC001126); before that by the UK MRC (U117565642); and by the European Research Council (294682-TBPATH). A.O'G., L.M-T., O.T., C.M.G., A. Singhania and E.S. were supported by the Francis Crick Institute, which receives its core funding as described above; L.M.-T., and A. Singhania, were additionally funded by the European Research Council (294682-TBPATH). S.L.P., A.S.-B. and E.H. were funded by the Royal Veterinary College and the Francis Crick Institute. K.D.M.-B. and A. Sher were funded by the Intramural Research Program of the National Institutes of Allergy and Infectious Disease. M.S. was funded by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020 and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia (FCT) in the framework of the project `Institute for Research and Innovation in Health Sciences' (POCI-01-0145-FEDER-007274) and by FCT through Estimulo Individual ao Emprego Cientifico. K.L.F. and B.C. are funded by FCT PhD scholarships SFRH/BD/114405/2016 and SFRH/BD/114403/2016, respectively. P.H. and R.V. were supported by NIHR Leicester Biomedical Research Centre and the University of Leicester.	Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blankley S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162220; Blankley S, 2016, EUR RESPIR J, V47, P1873, DOI 10.1183/13993003.02121-2015; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carmona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067277; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chen ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40508; Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Domaszewska T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11812-x; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Esmail H, 2018, P NATL ACAD SCI USA, V115, pE964, DOI 10.1073/pnas.1711853115; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; Hadley Wickham, 2016, GGPLOT2 ELEGANT GRAP; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Irwin SM, 2015, DIS MODEL MECH, V8, P591, DOI 10.1242/dmm.019570; Ji DX, 2019, NAT MICROBIOL, V4, P2128, DOI 10.1038/s41564-019-0578-3; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kramnik I, 2016, SEMIN IMMUNOPATHOL, V38, P221, DOI 10.1007/s00281-015-0538-9; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; Moreira-Teixeira L, 2018, J EXP MED, V215, P1273, DOI 10.1084/jem.20180325; Moreira-Teixeira L, 2017, J IMMUNOL, V199, P613, DOI 10.4049/jimmunol.1601340; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pichugin AV, 2009, AM J PATHOL, V174, P2190, DOI 10.2353/ajpath.2009.081075; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Scriba TJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006687; Singhania A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10601-6; Singhania A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04579-w; Verma R, 2019, CLIN INFECT DIS, V70, P933; World Health Organization, 2017, GLOB TUB REP 2017; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	65	31	33	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					464	+		10.1038/s41590-020-0610-z	http://dx.doi.org/10.1038/s41590-020-0610-z		MAR 2020	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205882	Green Accepted			2022-12-18	WOS:000519843600004
J	Schwickert, TA; Tagoh, H; Schindler, K; Fischer, M; Jaritz, M; Busslinger, M				Schwickert, Tanja A.; Tagoh, Hiromi; Schindler, Karina; Fischer, Maria; Jaritz, Markus; Busslinger, Meinrad			Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells	NATURE IMMUNOLOGY			English	Article							EXPRESSION; IKZF1; MICE; IGD; ASSOCIATION; LYMPHOCYTES; TOLERANCE; CHROMATIN; PROTEINS; ZFP318	The establishment of a diverse B cell antigen receptor (BCR) repertoire by V(D)J recombination also generates autoreactive B cells. Anergy is one tolerance mechanism; it renders autoreactive B cells insensitive to stimulation by self-antigen, whereas Toll-like receptor (TLR) signaling can reactivate anergic B cells. Here, we describe a critical role of the transcription factor Ikaros in controlling BCR anergy and TLR signaling. Mice with specific deletion of Ikaros in mature B cells developed systemic autoimmunity. Ikaros regulated many anergy-associated genes, including Zfp318, which is implicated in the attenuation of BCR responsiveness by promoting immunoglobulin D expression in anergic B cells. TLR signaling was hyperactive in Ikaros-deficient B cells, which failed to upregulate feedback inhibitors of the MyD88-nuclear factor kappa B signaling pathway. Systemic inflammation was lost on expression of a non-self-reactive BCR or loss of MyD88 in Ikaros-deficient B cells. Thus, Ikaros acts as a guardian preventing autoimmunity by promoting BCR anergy and restraining TLR signaling.	[Schwickert, Tanja A.; Tagoh, Hiromi; Schindler, Karina; Fischer, Maria; Jaritz, Markus; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Tagoh, Hiromi] Univ Oxford, Ludwig Inst Canc Res, Oxford, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Ludwig Institute for Cancer Research; University of Oxford	Schwickert, TA; Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria.	tanja.schwickert@imp.ac.at; meinrad.busslinger@imp.ac.at	Busslinger, Meinrad/J-1249-2016; Tagoh, Hiromi/B-2954-2009	Busslinger, Meinrad/0000-0002-9111-9351; Tagoh, Hiromi/0000-0001-9905-6992; Jaritz, Markus/0000-0002-9326-2047	Boehringer Ingelheim; European Research Council under the European Union [740349]; Austrian Industrial Research Promotion Agency [FFG-852936]; Austrian Science Fund [T838-B26]	Boehringer Ingelheim(Boehringer Ingelheim); European Research Council under the European Union(European Research Council (ERC)); Austrian Industrial Research Promotion Agency; Austrian Science Fund(Austrian Science Fund (FWF))	We thank R. Medzhitov, A. Tarakhovsky and S. L. Nutt for providing the Myd88<SUP>fl/fl</SUP>, Prdm1<SUP>fl/fl</SUP> and Prdm1<SUP>Gfp/+</SUP> mice, respectively; J. Cyster for providing the HyHEL9 antibody; G. Schmauss and M. Weninger for fluorescence-activated cell sorting; A. Sommer's team at the Vienna BioCenter Core Facilities for Illumina sequencing; and A. Kavirayani's team at the Vienna BioCenter Core Facilities for histology support and pathology review. This research was supported by Boehringer Ingelheim, the European Research Council (under the European Union's Horizon 2020 research and innovation program (grant agreement number 740349-PlasmaCellControl)), the Austrian Industrial Research Promotion Agency (Headquarter Grant FFG-852936) and the Austrian Science Fund (T838-B26 to T.A.S.).	Abdul-Sater AA, 2017, NAT IMMUNOL, V18, P26, DOI 10.1038/ni.3618; Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bogaert DJ, 2018, J ALLERGY CLIN IMMUN, V141, P432, DOI 10.1016/j.jaci.2017.08.019; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Degn SE, 2017, CELL, V170, P913, DOI 10.1016/j.cell.2017.07.026; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Enders A, 2014, P NATL ACAD SCI USA, V111, P4513, DOI 10.1073/pnas.1402739111; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Georgopoulos K, 2017, GENE DEV, V31, P439, DOI 10.1101/gad.297002.117; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Hoshino A, 2017, J ALLERGY CLIN IMMUN, V140, P223, DOI 10.1016/j.jaci.2016.09.029; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019; Kuehn HS, 2016, NEW ENGL J MED, V374, P1032, DOI 10.1056/NEJMoa1512234; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lech M, 2011, ANN RHEUM DIS, V70, P2207, DOI 10.1136/ard.2011.155515; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maity PC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005887; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Nickerson KM, 2013, J IMMUNOL, V190, P1447, DOI 10.4049/jimmunol.1202115; Noviski M, 2018, CURR OPIN IMMUNOL, V55, P67, DOI 10.1016/j.coi.2018.09.015; Noviski M, 2018, ELIFE, V7, DOI 10.7554/eLife.35074; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pioli PD, 2014, J IMMUNOL, V193, P2546, DOI 10.4049/jimmunol.1401275; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Sabouri Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13381; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Sharma S, 2015, J IMMUNOL, V195, P3507, DOI 10.4049/jimmunol.1500964; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Sindhava VJ, 2017, J CLIN INVEST, V127, P1651, DOI 10.1172/JCI89931; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; Van Nieuwenhove E, 2018, J ALLERGY CLIN IMMUN, V142, P699, DOI 10.1016/j.jaci.2018.04.008; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wohner M, 2016, J EXP MED, V213, P1201, DOI 10.1084/jem.20152002; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang YM, 2017, SCAND J RHEUMATOL, V46, P210, DOI 10.1080/03009742.2016.1194458; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	72	31	31	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1517	+		10.1038/s41590-019-0490-2	http://dx.doi.org/10.1038/s41590-019-0490-2			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591571	Green Accepted, Green Submitted			2022-12-18	WOS:000492309600021
J	Dolezal, E; Infantino, S; Drepper, F; Borsig, T; Singh, A; Wossning, T; Fiala, GJ; Minguet, S; Warscheid, B; Tarlinton, DM; Jumaa, H; Medgyesi, D; Reth, M				Dolezal, Elmar; Infantino, Simona; Drepper, Friedel; Borsig, Theresa; Singh, Aparajita; Wossning, Thomas; Fiala, Gina J.; Minguet, Susana; Warscheid, Bettina; Tarlinton, David M.; Jumaa, Hassan; Medgyesi, David; Reth, Michael			The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex	NATURE IMMUNOLOGY			English	Article							ARGININE METHYLATION; V(D)J RECOMBINATION; RAG-2 ACCUMULATION; PROTEIN; BTG2; GENE; PRMT1; EXPRESSION; LINKS; METHYLTRANSFERASE	Developing pre-B cells in the bone marrow alternate between proliferation and differentiation phases. We found that protein arginine methyl transferase 1 (PRMT1) and B cell translocation gene 2 (BTG2) are critical components of the pre-B cell differentiation program. The BTG2-PRMT1 module induced a cell-cycle arrest of pre-B cells that was accompanied by re-expression of Rag1 and Rag2 and the onset of immunoglobulin light chain gene rearrangements. We found that PRMT1 methylated cyclin-dependent kinase 4 (CDK4), thereby preventing the formation of a CDK4-Cyclin-D3 complex and cell cycle progression. Moreover, BTG2 in concert with PRMT1 efficiently blocked the proliferation of BCR-ABL1-transformed pre-B cells in vitro and in vivo. Our results identify a key molecular mechanism by which the BTG2-PRMT1 module regulates pre-B cell differentiation and inhibits pre-B cell leukemogenesis.	[Dolezal, Elmar; Borsig, Theresa; Singh, Aparajita; Fiala, Gina J.; Minguet, Susana; Jumaa, Hassan; Medgyesi, David; Reth, Michael] Albert Ludwigs Univ Freiburg, Dept Mol Immunol, Fac Biol, Freiburg, Germany; [Dolezal, Elmar; Singh, Aparajita; Wossning, Thomas; Medgyesi, David; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Dolezal, Elmar] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Infantino, Simona; Tarlinton, David M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Infantino, Simona; Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Infantino, Simona; Tarlinton, David M.] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia; [Drepper, Friedel; Fiala, Gina J.; Minguet, Susana; Warscheid, Bettina; Jumaa, Hassan; Medgyesi, David; Reth, Michael] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Dept Biochem & Funct Prote, Fac Biol, Freiburg, Germany; [Fiala, Gina J.; Minguet, Susana] Univ Clin & Med Fac, CCI, Freiburg, Germany; [Jumaa, Hassan] Univ Hosp Ulm, Inst Immunol, Ulm, Germany; [Dolezal, Elmar] Roche Pharma AG, Grenzach, Germany; [Wossning, Thomas] ProQinase GmbH, Freiburg, Germany	University of Freiburg; Max Planck Society; University of Freiburg; Walter & Eliza Hall Institute; University of Melbourne; Monash University; University of Freiburg; University of Freiburg; Ulm University; ProQinase	Medgyesi, D; Reth, M (corresponding author), Albert Ludwigs Univ Freiburg, Dept Mol Immunol, Fac Biol, Freiburg, Germany.; Medgyesi, D; Reth, M (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.; Medgyesi, D; Reth, M (corresponding author), Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	medgyesi@ie-freiburg.mpg.de; michael.reth@bioss.uni-freiburg.de		Tarlinton, David/0000-0001-9928-686X; Fiala, Gina/0000-0002-8226-5584; Warscheid, Bettina/0000-0001-5096-1975; Minguet, Susana/0000-0001-8211-5538; Drepper, Friedel/0000-0002-2043-5795	Deutsche Forschungsgemeinschaft (DFG) [TRR130]; Excellence Initiative of the German Federal & State Governments (Grant EXC 294 BIOSS Centre for Biological Signalling Studies); ERC [32297]; German Cancer Foundation [111026]; Deutsche Forschungsgemeinschaft [SFB746, MI1942/2-1]; National Health and Medical Research Council (NHMRC) Australia program [1054925]; DRFG Fellowship; NHMRC Research Fellowship	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Initiative of the German Federal & State Governments (Grant EXC 294 BIOSS Centre for Biological Signalling Studies); ERC(European Research Council (ERC)European Commission); German Cancer Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council (NHMRC) Australia program(National Health and Medical Research Council (NHMRC) of Australia); DRFG Fellowship; NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful to S. Richard (McGill University) and to K. Rajewsky (Max Delbr~ck Center) for providing the Prmt1<SUP>f/f</SUP> and CD19-cre mouse lines, respectively. The authors thank C. Sainz-Rueda, B. Knapp, S. Welz and Y. Kori for their technical assistance, and S. Herzog (Biocenter Innsbruck) and M. Jung, (Institute of Pharmaceutical Sciences) for providing reagents. Furthermore, we thank P.J. Nielsen, L. Leclercq and E. Molnar for critically reading the manuscript. Work in the laboratory of M.R and B.W. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; TRR130) and the Excellence Initiative of the German Federal & State Governments (Grant EXC 294 BIOSS Centre for Biological Signalling Studies). The work in the laboratory of M.R. was also supported by ERC-grant 32297, the German Cancer Foundation grant 111026 and by the Deutsche Forschungsgemeinschaft through SFB746. G.J.F. is financially supported by the DFG through MI1942/2-1 to S.M. D.M.T. is supported by a National Health and Medical Research Council (NHMRC) Australia program grant (1054925), S. I. by a DRFG Fellowship and D.M.T. by an NHMRC Research Fellowship.	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Colucci F, 1999, J IMMUNOL, V162, P2761; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cristodero M, 2013, MOL MICROBIOL, V90, P744, DOI 10.1111/mmi.12397; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Good-Jacobson KL, 2015, J EXP MED, V212, P1001, DOI 10.1084/jem.20150191; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hata K, 2007, EXP CELL RES, V313, P2356, DOI 10.1016/j.yexcr.2007.03.021; Hata K, 2016, FEBS LETT, V590, P1200, DOI 10.1002/1873-3468.12161; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Infantino S, 2010, J EXP MED, V207, P711, DOI 10.1084/jem.20091303; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Knackmuss U, 2016, CELL DEATH DIFFER, V23, P242, DOI 10.1038/cdd.2015.87; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Mao BJ, 2015, MOL MED REP, V12, P4917, DOI 10.3892/mmr.2015.4051; Mao BJ, 2015, INT J ONCOL, V46, P459, DOI 10.3892/ijo.2014.2765; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Parker MJ, 2005, EMBO J, V24, P3895, DOI 10.1038/sj.emboj.7600850; Reth M, 2014, ADV IMMUNOL, V122, P129, DOI 10.1016/B978-0-12-800267-4.00004-3; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Scorilas A, 2000, BIOCHEM BIOPH RES CO, V278, P349, DOI 10.1006/bbrc.2000.3807; Shojaee S, 2015, CANCER CELL, V28, P114, DOI 10.1016/j.ccell.2015.05.008; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tijchon E, 2016, HAEMATOLOGICA, V101, P272, DOI 10.3324/haematol.2015.139675; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003	52	31	31	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					911	+		10.1038/ni.3774	http://dx.doi.org/10.1038/ni.3774			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28628091				2022-12-18	WOS:000405821100014
J	Kashiwagi, M; Hosoi, J; Lai, JF; Brissette, J; Ziegler, SF; Morgan, BA; Georgopoulos, K				Kashiwagi, Mariko; Hosoi, Junichi; Lai, Jen-Feng; Brissette, Janice; Ziegler, Steven F.; Morgan, Bruce A.; Georgopoulos, Katia			Direct control of regulatory I cells by keratinocytes	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CHROMATIN REMODELER MI-2-BETA; T-CELLS; ATOPIC-DERMATITIS; STRESS SURVEILLANCE; MOUSE KERATINOCYTES; SKIN INFLAMMATION; EPITHELIAL-CELLS; TREG CELLS; DIFFERENTIATION	Environmental challenges to epithelial cells trigger gene expression changes that elicit context-appropriate immune responses. We found that the chromatin remodeler Mi-2 beta controls epidermal homeostasis by regulating the genes involved in keratinocyte and immune-cell activation to maintain an inactive state. Mi-2 beta depletion resulted in rapid deployment of both a pro inflammatory and an immunosuppressive response in the skin. A key target of Mi-2 beta in keratinocytes is the pro-inflammatory cytokine thymic stromal lymphopoietin (TSLP). Loss of TSLP receptor (TSLPR) signaling specifically in regulatory T (T-reg) cells prevented their activation and permitted rapid progression from a skin pro-inflammatory response to a lethal systemic condition. Thus, in addition to their well-characterized role in pro-inflammatory responses, keratinocytes also directly support immune suppressive responses that are critical for re-establishing organismal homeostasis.	[Kashiwagi, Mariko; Hosoi, Junichi; Morgan, Bruce A.; Georgopoulos, Katia] Harvard Med Sch, Massachusetts Gen Hosp, Cuteneous Biol Res Ctr, Charlestown, MA 02115 USA; [Lai, Jen-Feng; Ziegler, Steven F.] Benaroya Res Inst Virginia Mason, Program Immunol, Seattle, WA USA; [Brissette, Janice] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Harvard University; Massachusetts General Hospital; Benaroya Research Institute; Virginia Mason Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Kashiwagi, M; Georgopoulos, K (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Cuteneous Biol Res Ctr, Charlestown, MA 02115 USA.	mariko.kashiwagi@cbrc2.mgh.harvard.edu; katia.georgopoulos@cbrc2.mgh.harvard.edu			NIH [R21 AR055813, RO1 AR064390, R01AR069132, RO1 AI068731, PO1 HL098067, R01 AR055256]; Shiseido grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068731, R01AI124220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069625, R01AR064390, R01AR069132, R01AR055256, R21AR055813, R01AR055218, R01AR045284] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shiseido grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Chambon (Institute of Genetics and Cellular and Molecular Biology) and V.K. Kuchroo (Brigham and Women's Hospital) for the Krt14-Cre-ERT2 mice and Foxp3-IRES-EGFP mice, respectively. We thank M.E. Bigby for consultation on lymphocyte isolation from the skin and L.M. Francisco and A.H. Sharpe for consultation on Tree cell and DC analysis. We thank E. Wu and B. Czyzewski for mouse husbandry, A. Cho, M. Ahl, J.E. King and J. Brandollni for bone marrow transplantation, and T. Minegishi for R platform support. We also thank J.M. Park, H. Cantor, H.J. Kim, F. Gounari and K. Khashayarsha for critical comments on the manuscript. This research was supported by NIH R21 AR055813, RO1 AR064390 and R01AR069132 to K.G., NIH RO1 AI068731 and PO1 HL098067 to S.F.Z., and NIH R01 AR055256 to B.A.M. K.G. is an MGH scholar supported by J. de Gunzburg. J.H. was supported by a Shiseido grant. High-throughput RNA sequencing was performed at the Bauer Center for Genomic research Harvard University, Cambridge.	Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Deane JA, 2012, J IMMUNOL, V188, P2179, DOI 10.4049/jimmunol.1102752; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gomez-del Arco P, 2016, CELL METAB, V23, P881, DOI 10.1016/j.cmet.2016.04.008; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kashiwagi M, 2007, DEVELOPMENT, V134, P1571, DOI 10.1242/dev.001750; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Li JG, 2016, J ALLERGY CLIN IMMUN, V138, P150, DOI 10.1016/j.jaci.2016.01.013; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Mohammed J, 2013, J INVEST DERMATOL, V133, P135, DOI 10.1038/jid.2012.241; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rangwala S, 2011, BRIT J DERMATOL, V165, P953, DOI 10.1111/j.1365-2133.2011.10507.x; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Volpe E, 2014, J ALLERGY CLIN IMMUN, V134, P373, DOI 10.1016/j.jaci.2014.04.022; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	50	31	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					334	343		10.1038/ni.3661	http://dx.doi.org/10.1038/ni.3661			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28092372	Green Accepted			2022-12-18	WOS:000394413400013
J	Kabashima, K; Otsuka, A; Nomura, T				Kabashima, Kenji; Otsuka, Atsushi; Nomura, Takashi			Linking air pollution to atopic dermatitis	NATURE IMMUNOLOGY			English	Editorial Material							SENSORY NEURONS; ARTEMIN; EXPRESSION; FILAGGRIN; PRURITUS; BARRIER; TRPA1	The relationship between atopic dermatitis and air pollution has been long debated but has now been connected via the aryl hydrocarbon receptor and its control of skin innervation and the consequent triggering of an itch-scratch response.	[Kabashima, Kenji; Otsuka, Atsushi; Nomura, Takashi] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan	Kyoto University	Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	kaba@kuhp.kyoto-u.ac.jp	Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554; Otsuka, Atsushi/0000-0001-7365-947X	Grants-in-Aid for Scientific Research [15H05790] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Furue M, 2015, J DERMATOL SCI, V80, P83, DOI 10.1016/j.jdermsci.2015.07.011; Haas K., 2016, J INVEST DERMATOL; Hidaka T., 2017, NAT IMMUNOL, V18, P64; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Murota H, 2012, J ALLERGY CLIN IMMUN, V130, P671, DOI 10.1016/j.jaci.2012.05.027; Otsuka A, 2014, J ALLERGY CLIN IMMUN, V133, P139, DOI 10.1016/j.jaci.2013.07.027; Schafer M, 2014, EMBO MOL MED, V6, P442, DOI 10.1002/emmm.201303281; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Yoshida N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-41	12	31	32	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					5	6		10.1038/ni.3615	http://dx.doi.org/10.1038/ni.3615			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27984566				2022-12-18	WOS:000390080000001
J	Luis, TC; Luc, S; Mizukami, T; Boukarabila, H; Thongjuea, S; Woll, PS; Azzoni, E; Giustacchini, A; Lutteropp, M; Bouriez-Jones, T; Vaidya, H; Mead, AJ; Atkinson, D; Boiers, C; Carrelha, J; Macaulay, IC; Patient, R; Geissmann, F; Nerlov, C; Sandberg, R; de Bruijn, MFTR; Blackburn, CC; Godin, I; Jacobsen, SEW				Luis, Tiago C.; Luc, Sidinh; Mizukami, Takuo; Boukarabila, Hanane; Thongjuea, Supat; Woll, Petter S.; Azzoni, Emanuele; Giustacchini, Alice; Lutteropp, Michael; Bouriez-Jones, Tiphaine; Vaidya, Harsh; Mead, Adam J.; Atkinson, Deborah; Boiers, Charlotta; Carrelha, Joana; Macaulay, Iain C.; Patient, Roger; Geissmann, Frederic; Nerlov, Claus; Sandberg, Rickard; de Bruijn, Marella F. T. R.; Blackburn, C. Clare; Godin, Isabelle; Jacobsen, Sten Eirik W.			Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors	NATURE IMMUNOLOGY			English	Article							CELL-LINEAGE; STEM-CELLS; PRECURSORS	The final stages of restriction to the T cell lineage occur in the thymus after the entry of thymus-seeding progenitors (TSPs). The identity and lineage potential of TSPs remains unclear. Because the first embryonic TSPs enter a non-vascularized thymic rudiment, we were able to directly image and establish the functional and molecular properties of embryonic thymopoiesis-initiating progenitors (T-IPs) before their entry into the thymus and activation of Notch signaling. T-IPs did not include multipotent stem cells or molecular evidence of T cell restricted progenitors. Instead, single-cell molecular and functional analysis demonstrated that most fetal T-IPs expressed genes of and had the potential to develop into lymphoid as well as myeloid components of the immune system. Moreover, studies of embryos deficient in the transcriptional regulator RBPJ demonstrated that canonical Notch signaling was not involved in pre-thymic restriction to the T cell lineage or the migration of T-IPs.	[Luis, Tiago C.; Luc, Sidinh; Mizukami, Takuo; Boukarabila, Hanane; Thongjuea, Supat; Woll, Petter S.; Giustacchini, Alice; Lutteropp, Michael; Bouriez-Jones, Tiphaine; Mead, Adam J.; Atkinson, Deborah; Carrelha, Joana; Macaulay, Iain C.; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Haematopoiet Stem Cell Lab, Oxford, England; [Luc, Sidinh] Lund Univ, Lund Stem Cell Ctr, Hematopoiet Stem Cell Lab, Lund, Sweden; [Luc, Sidinh; Thongjuea, Supat; Azzoni, Emanuele; Lutteropp, Michael; Patient, Roger; Nerlov, Claus; de Bruijn, Marella F. T. R.; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England; [Vaidya, Harsh; Blackburn, C. Clare] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland; [Boiers, Charlotta] Lund Univ, Div Mol Med & Gene Therapy, Lund Stem Cell Ctr, Lund, Sweden; [Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London, England; [Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Sandberg, Rickard] Ludwig Inst Canc Res, Stockholm, Sweden; [Godin, Isabelle] INSERM, Villejuif, France; [Godin, Isabelle] Univ Paris Saclay, Univ Paris Sud, Villejuif, France; [Godin, Isabelle] Gustave Roussy, Villejuif, France; [Jacobsen, Sten Eirik W.] Karolinska Inst, Wallenberg Inst Regenerat Med, Dept Cell & Mol Biol, Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Inst, Dept Med Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Univ Hosp, Stockholm, Sweden; [Luc, Sidinh] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Luc, Sidinh] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA	University of Oxford; Lund University; University of Oxford; University of Edinburgh; Lund University; University of London; King's College London; Memorial Sloan Kettering Cancer Center; Karolinska Institutet; Ludwig Institute for Cancer Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Jacobsen, SEW (corresponding author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Haematopoiet Stem Cell Lab, Oxford, England.; Jacobsen, SEW (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England.; Jacobsen, SEW (corresponding author), Karolinska Inst, Wallenberg Inst Regenerat Med, Dept Cell & Mol Biol, Stockholm, Sweden.; Jacobsen, SEW (corresponding author), Karolinska Inst, Dept Med Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden.; Jacobsen, SEW (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	sten.eirik.jacobsen@ki.se	Blackburn, Clare/B-2847-2009; Mead, Adam/A-8796-2012; Blackburn, Clare/AAM-7954-2020; Jacobsen, Sten Eirik W/D-3974-2018; Vaidya, Harsh/L-4903-2019; Giustacchini, Alice/D-4074-2018; Mizukami, Takuo/F-9248-2016; Azzoni, Emanuele/AAE-8064-2022; GODIN, Isabelle/K-5769-2013	Blackburn, Clare/0000-0002-6326-640X; Mead, Adam/0000-0001-8522-1002; Blackburn, Clare/0000-0002-6326-640X; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Giustacchini, Alice/0000-0002-8733-8594; Mizukami, Takuo/0000-0001-6105-6049; Azzoni, Emanuele/0000-0002-4572-5692; Carrelha, Joana/0000-0002-0324-2617; Macaulay, Iain/0000-0002-6761-757X; GODIN, Isabelle/0000-0001-8577-8388; Luc, Sidinh/0000-0001-7006-6169; Boiers, Charlotta/0000-0002-4876-1218; Thongjuea, Supat/0000-0002-9129-4694; Woll, Petter S./0000-0002-2340-2526; Cunha Luis, Tiago/0000-0002-6305-1257	MRC HIU; MRC MHU [MC_UU_12009]; NIHR Oxford BRC; John Fell Fund [131/030, 101/517]; EPA fund [CF182, CF170]; WIMM Strategic Alliance awards [G0902418, MC_UU_12025]; MRC via the WIMM Strategic Alliance [G0902418]; MHU [MC_UU_12009]; HIU [MC_UU_12010]; Wolfson Foundation [18272]; MRC/BBSRC/EPSRC [MR/K015777X/1]; MIC-Nanoscopy Oxford (NanO): Novel Super-resolution Imaging Applied to Biomedical Sciences, Micron [107457/Z/15Z]; WIMM Strategic Alliance [G0902418, MC_UU_12025]; Medical Research Council UK [G0801073, MC_UU_12009/5]; Swedish Research Council; Knut och Alice Wallenberg Foundation (WIRM); Tobias Foundation; StratRegen, KI; EU-FP7 EuroSyStem Integrated projects; Swedish Research Council Linnaeus (Hemato-Linne grant); MRC (Molecular Haematology Unit core award); EMBO-LTF; Kay Kendall Leukaemia Fund; Leukaemia and Lymphoma Research; MRC [MC_U137981013, G0900892, G0801073, MR/L006340/1, MR/M00919X/1, G0501838, MC_UU_12009/16, MC_UU_12009/2, G0701761, MC_UU_12009/5, MC_UU_12009/8, MC_UU_12009/7] Funding Source: UKRI; Medical Research Council [G1000801a, MC_UU_12009/8, G0501838, MC_UU_12009/2, MC_UU_12009/16, MR/L006340/1, MR/M00919X/1, G0701761, MC_UU_12009/5, MC_UU_12009/7, G0900892, MC_U137981013, G0801073] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130345] Funding Source: NIH RePORTER	MRC HIU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC MHU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford BRC; John Fell Fund; EPA fund; WIMM Strategic Alliance awards; MRC via the WIMM Strategic Alliance(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MHU; HIU; Wolfson Foundation; MRC/BBSRC/EPSRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); MIC-Nanoscopy Oxford (NanO): Novel Super-resolution Imaging Applied to Biomedical Sciences, Micron; WIMM Strategic Alliance; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenberg Foundation (WIRM); Tobias Foundation; StratRegen, KI; EU-FP7 EuroSyStem Integrated projects; Swedish Research Council Linnaeus (Hemato-Linne grant); MRC (Molecular Haematology Unit core award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO-LTF(European Molecular Biology Organization (EMBO)); Kay Kendall Leukaemia Fund; Leukaemia and Lymphoma Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Sakaguchi (Kumamoto University) for the Rag1-GFP mouse line; M. Reth (Max Planck Institute of Immunobiology) for Cd79a<SUP>tm1(cre)Reth</SUP> mice; S. Srinivas (University of Oxford) for R26-stop-eYFP mice; T. Rabbitts (University of Oxford) for Rag1-Cre mice; S. Cory (The Walter & Eliza Hall Institute of Medical Research) for vavP-Mcl1 trangenic mice; N. Iscove (Ontario Cancer Institute, University Health Network) for W<SUP>41</SUP> mice; A. Cumano (Institut Pasteur) for OP9 and OP9-DL1 stromal cells; Biomedical Services at Oxford University for animal support; B. Wu for technical assistance; P. Sopp and S-A. Clark (WIMM FACS facility, supported by the MRC HIU; MRC MHU (MC_UU_12009); NIHR Oxford BRC and the John Fell Fund (131/030 and 101/517), the EPA fund (CF182 and CF170) and by WIMM Strategic Alliance awards G0902418 and MC_UU_12025); C. Lagerholm and D. Waithe (Wolfson Imaging Centre Oxford, supported by the MRC via the WIMM Strategic Alliance (G0902418), the MHU (MC_UU_12009), the HIU (MC_UU_12010), the Wolfson Foundation (18272), MRC/BBSRC/EPSRC (MR/K015777X/1), and MIC-Nanoscopy Oxford (NanO): Novel Super-resolution Imaging Applied to Biomedical Sciences, Micron (107457/Z/15Z)) and the WIMM Strategic Alliance (G0902418 and MC_UU_12025)). Supported by the Medical Research Council UK (G0801073 and MC_UU_12009/5 to S.E.W.J.), the Swedish Research Council (S.E.W.J.), the Knut och Alice Wallenberg Foundation (WIRM; S.E.W.J.), the Tobias Foundation (S.E.W.J.), StratRegen, KI (S.E.W.J.), EU-FP7 EuroSyStem Integrated projects (S.E.W.J., C.C.B.), the Swedish Research Council Linnaeus (Hemato-Linne grant to S.E.W.J.), the MRC (Molecular Haematology Unit core award to M.F.T.R.d.B.), EMBO-LTF (T.C.L.), Kay Kendall Leukaemia Fund (T.C.L.) and Leukaemia and Lymphoma Research (C.C.B. and A.J.M.).	Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; De Obaldia ME, 2013, BLOOD, V121, P64, DOI 10.1182/blood-2012-08-451773; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Desanti GE, 2011, J IMMUNOL, V186, P5227, DOI 10.4049/jimmunol.1002686; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Ferrero I, 2013, EUR J IMMUNOL, V43, P2845, DOI 10.1002/eji.201343527; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Jenkinson EJ, 2006, NAT REV IMMUNOL, V6, P551, DOI 10.1038/nri1883; Jenkinson WE, 2007, EUR J IMMUNOL, V37, P2090, DOI 10.1002/eji.200737212; Kawamoto H, 1998, J IMMUNOL, V161, P3799; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431; Pear WS, 2003, SEMIN IMMUNOL, V15, P69, DOI 10.1016/S1044-5323(03)00003-4; PEAULT B, 1994, EUR J IMMUNOL, V24, P781, DOI 10.1002/eji.1830240345; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tacke R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10055; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	44	31	31	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1424	1435		10.1038/ni.3576	http://dx.doi.org/10.1038/ni.3576			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27695000	Green Accepted, Green Submitted			2022-12-18	WOS:000388056400013
J	Belanger, S; Crotty, S				Belanger, Simon; Crotty, Shane			Dances with cytokines, featuring T-FH cells, IL-21, IL-4 and B cells	NATURE IMMUNOLOGY			English	Editorial Material							FOLLICULAR-HELPER-CELLS; INTERLEUKIN-21	Follicular helper T cells (T-FH cells) sequentially acquire the potential to secrete interleukin 21 (IL-21) and IL-4. The shift from secretion of IL-21 to that of IL-4 modifies the nature of the 'help' signals delivered by T-FH cells to germinal center (GC) B cells.	[Belanger, Simon; Crotty, Shane] La Jolla Inst, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	shane@lji.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 				Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; Havenar-Daughton C, 2016, J IMMUNOL, V197, P994, DOI 10.4049/jimmunol.1600320; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Tangye SG, 2015, CURR OPIN IMMUNOL, V34, P107, DOI 10.1016/j.coi.2015.02.010; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554	13	31	31	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1135	1136		10.1038/ni.3561	http://dx.doi.org/10.1038/ni.3561			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648538				2022-12-18	WOS:000384302900002
J	Miller, MS; Rialdi, A; Ho, JSY; Tilove, M; Martinez-Gil, L; Moshkina, NP; Peralta, Z; Noel, J; Melegari, C; Maestre, AM; Mitsopoulos, P; Madrenas, J; Heinz, S; Benner, C; Young, JAT; Feagins, AR; Basler, CF; Fernandez-Sesma, A; Becherel, OJ; Lavin, MF; van Bakel, H; Marazzi, I				Miller, Matthew S.; Rialdi, Alexander; Ho, Jessica Sook Yuin; Tilove, Micah; Martinez-Gil, Luis; Moshkina, Natasha P.; Peralta, Zuleyma; Noel, Justine; Melegari, Camilla; Maestre, Ana M.; Mitsopoulos, Panagiotis; Madrenas, Joaquin; Heinz, Sven; Benner, Chris; Young, John A. T.; Feagins, Alicia R.; Basler, Christopher F.; Fernandez-Sesma, Ana; Becherel, Olivier J.; Lavin, Martin F.; van Bakel, Harm; Marazzi, Ivan			Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis	NATURE IMMUNOLOGY			English	Article							RNA-POLYMERASE-II; DIFFERENTIAL EXPRESSION ANALYSIS; AICARDI-GOUTIERES-SYNDROME; DNA-DAMAGE; TERMINATION; HELICASE; YEAST; ACTIVATION; MECHANISMS; INITIATION	The human helicase senataxin (SETX) has been linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS4) and ataxia with oculomotor apraxia (AOA2). Here we identified a role for SETX in controlling the antiviral response. Cells that had undergone depletion of SETX and SETX-deficient cells derived from patients with AOA2 had higher expression of antiviral mediators in response to infection than did wild-type cells. Mechanistically, we propose a model whereby SETX attenuates the activity of RNA polymerase II (RNAPII) at genes stimulated after a virus is sensed and thus controls the magnitude of the host response to pathogens and the biogenesis of various RNA viruses (e.g., influenza A virus and West Nile virus). Our data indicate a potentially causal link among inborn errors in SETX, susceptibility to infection and the development of neurologic disorders.	[Miller, Matthew S.; Rialdi, Alexander; Tilove, Micah; Martinez-Gil, Luis; Moshkina, Natasha P.; Noel, Justine; Melegari, Camilla; Maestre, Ana M.; Feagins, Alicia R.; Basler, Christopher F.; Fernandez-Sesma, Ana; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Miller, Matthew S.] McMaster Univ, Dept Biochem & Biomed Sci, Inst Infect Dis Res, McMaster Immunol Res Ctr, Hamilton, ON L8N 3Z5, Canada; [Ho, Jessica Sook Yuin] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Methyltransferases Dev & Dis, Singapore 117548, Singapore; [Peralta, Zuleyma; van Bakel, Harm] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Mitsopoulos, Panagiotis; Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Heinz, Sven; Benner, Chris] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Young, John A. T.] F Hoffmann La Roche, Basel, Switzerland; [Becherel, Olivier J.; Lavin, Martin F.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia; [van Bakel, Harm] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; McMaster University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Icahn School of Medicine at Mount Sinai; McGill University; Salk Institute; Roche Holding; University of Queensland; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	van Bakel, H (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.	harm.vanbakel@mssm.edu; ivan.marazzi@mssm.edu	Lavin, Martin F/F-5961-2014; Madrenas, Quim/P-5008-2019; Basler, Christopher/AAG-8346-2019; van Bakel, Harm/N-9561-2017; Merens, Ana Maestre/I-2445-2019; Martinez-Gil, Luis/M-7422-2014	Lavin, Martin F/0000-0002-5940-4769; Basler, Christopher/0000-0003-4195-425X; van Bakel, Harm/0000-0002-1376-6916; Merens, Ana Maestre/0000-0002-2494-0879; Martinez-Gil, Luis/0000-0002-9076-7760; Fernandez-Sesma, Ana/0000-0002-3405-6702; Young, John/0000-0003-1824-2561; Heinz, Sven/0000-0002-4665-1007; Benner, Christopher/0000-0002-4618-0719; Noel, Justine/0000-0002-0692-1412; Miller, Matthew/0000-0003-3426-5069; marazzi, ivan/0000-0003-3376-0922; Ho, Jessica Sook Yuin/0000-0003-2234-2602; Rialdi, Alexander/0000-0001-5393-9247	Canadian Institutes of Health Research; US National Institutes of Health [U19AI106754]; National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance [HHSN272201400008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, U19AI106754, R01AI073450, R01AI113186] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lim (Icahn School of Medicine at Mount Sinai) for Kunjin virus; M. Evans (Icahn School of Medicine at Mount Sinai) for Gag-Pol; P. Palese (Icahn School of Medicine at Mount Sinai) for comments, anti-PB2 and unpublished observations; A. Telenti for comments; A. Garcia-Sastre (Icahn School of Medicine at Mount Sinai) for comments, RIG-I deficient A549 cells and unpublished observations; R. Roeder (Rockefeller University) for TAF4 reagents; M.F. Lavin (The University of Queensland) for anti-SETX; and the Genomic facility at Icahn and the Proteomics facilities at Rockefeller University. Supported by the computational resources and staff of the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai; the Canadian Institutes of Health Research (M.S.M.); the US National Institutes of Health (U19AI106754 to I.M.); and the National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance (HHSN272201400008C to I.M. and H.v.B.).	Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Becherel OJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003435; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chen WY, 2013, GENE DEV, V27, P1596, DOI 10.1101/gad.216192.113; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Chopra VS, 2011, MOL CELL, V42, P837, DOI 10.1016/j.molcel.2011.05.009; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Downes C.P., 2014, CELLULAR RESPONSES S; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; Henriques T, 2013, MOL CELL, V52, P517, DOI 10.1016/j.molcel.2013.10.001; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258; Wright KJ, 2009, P NATL ACAD SCI USA, V106, P55, DOI 10.1073/pnas.0811914106; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12	50	31	32	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					485	U198		10.1038/ni.3132	http://dx.doi.org/10.1038/ni.3132			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25822250	Green Accepted, Green Submitted			2022-12-18	WOS:000353305200011
J	Koff, WC; Gust, ID; Plotkin, SA				Koff, Wayne C.; Gust, Ian D.; Plotkin, Stanley A.			Toward a Human Vaccines Project	NATURE IMMUNOLOGY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HIV-1; DESIGN	Technological advances in antigen discovery, genomics and immunological monitoring offer tremendous potential for revolutionizing vaccine development. On 5-6 February 2014, 35 leading vaccine scientists met to consider how best to harness these advances and spur innovation.	[Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Gust, Ian D.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Plotkin, Stanley A.] Univ Penn, Philadelphia, PA 19104 USA; [Plotkin, Stanley A.] Vaxconsult, Doylestown, PA USA	International AIDS Vaccine Initiative; University of Melbourne; University of Pennsylvania	Koff, WC (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.	wkoff@iavi.org						Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P621; Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lang PO, 2013, CURR TOP MED CHEM, V13, P2541, DOI 10.2174/15680266113136660181; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Marinova D, 2013, EXPERT REV VACCINES, V12, P1431, DOI 10.1586/14760584.2013.856765; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Parks CL, 2013, CURR OPIN HIV AIDS, V8, P402, DOI 10.1097/COH.0b013e328363d389; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Reinhold B, 2010, ANAL CHEM, V82, P9090, DOI 10.1021/ac102387t; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; US Food & Drug Administration, VACC BLOOD BIOL; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wenxue M., 2014, CURR MED CHEM; Wood N, 2011, CURR OPIN INFECT DIS, V24, P190, DOI 10.1097/QCO.0b013e328345d563; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	29	31	33	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					589	592		10.1038/ni.2871	http://dx.doi.org/10.1038/ni.2871			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24940943	Bronze			2022-12-18	WOS:000337715600001
J	Cohen, P				Cohen, Philip			Immune diseases caused by mutations in kinases and components of the ubiquitin system	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; X-LINKED AGAMMAGLOBULINEMIA; DEUBIQUITINATING ENZYME CYLD; HERPES-SIMPLEX ENCEPHALITIS; LINEAR POLYUBIQUITIN CHAINS; INFLAMMATORY-BOWEL-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; GENOME-WIDE ASSOCIATION; CHINESE HAN POPULATION; OPEN-ANGLE GLAUCOMA	The signaling networks that control the immune system are coordinated by a myriad of interconnecting phosphorylation and ubiquitylation events. This review provides an overview of mutations in human genes encoding these proteins that give rise to immune diseases. Analysis of the biological effects of these mutations has revealed the true physiological roles of particular signaling networks and promises to revolutionize the treatment of these diseases.	Univ Dundee, MRC, Coll Life Sci, Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, MRC, Coll Life Sci, Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland.	p.cohen@dundee.ac.uk			Wellcome Trust Senior Investigator award [WT100294]; UK Medical Research Council [MRC-MR/K000985/1]; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Janssen Pharmaceuticals; Merck-Serono; Pfizer; MRC [MC_U127084348, MC_EX_G0800765, MC_EX_UU_G0800765, MR/K000985/1, MC_UU_12016/11] Funding Source: UKRI; Medical Research Council [MC_U127084348, MR/K000985/1, MC_EX_UU_G0800765, MC_EX_G0800765, MC_UU_12016/11] Funding Source: researchfish	Wellcome Trust Senior Investigator award(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck-Serono(Merck & Company); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	I thank S. Nanda, C. Emmerich and K. Clark for suggestions and A. Nicoll for assistance in preparing the manuscript. Supported by a Wellcome Trust Senior Investigator award (WT100294), the UK Medical Research Council (MRC_MR/K000985/1), AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen Pharmaceuticals, Merck-Serono and Pfizer.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bleich A, 2010, INFLAMM BOWEL DIS, V16, P765, DOI 10.1002/ibd.21146; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Boulard O, 2012, J EXP MED, V209, P1309, DOI 10.1084/jem.20120239; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Caster DJ, 2013, J AM SOC NEPHROL, V24, P1743, DOI 10.1681/ASN.2013020148; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Conley ME, 1998, AM J HUM GENET, V62, P1034, DOI 10.1086/301828; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Fischer A, 2010, SEMIN IMMUNOPATHOL, V32, P107, DOI 10.1007/s00281-010-0196-x; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Gregersen PK, 2012, ANN NEUROL, V72, P927, DOI 10.1002/ana.23691; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hasan Z, 2006, SCAND J IMMUNOL, V63, P241, DOI 10.1111/j.1365-3083.2006.01733.x; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Heine M, 2005, J BIOL CHEM, V280, P25637, DOI 10.1074/jbc.M502265200; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Holinski-Feder E, 1998, PEDIATRICS, V101, P276, DOI 10.1542/peds.101.2.276; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Jacob CO, 2007, ARTHRITIS RHEUM-US, V56, P4164, DOI 10.1002/art.23060; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Laurence Arian, 2012, Open Rheumatol J, V6, P232, DOI 10.2174/1874312901206010232; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Luo C, 2008, CELL MOL IMMUNOL, V5, P1, DOI 10.1038/cmi.2008.1; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, ARCH DERMATOL, V145, P462, DOI 10.1001/archdermatol.2009.73; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nocturne G, 2013, BLOOD, V122, P4068, DOI 10.1182/blood-2013-05-503383; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shah JA, 2012, J IMMUNOL, V189, P1737, DOI 10.4049/jimmunol.1103541; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wang SJ, 2011, J MOL MED, V89, P1241, DOI 10.1007/s00109-011-0796-5; Watford WT, 2006, IMMUNITY, V25, P695, DOI 10.1016/j.immuni.2006.10.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang Q, 2013, BRIT J DERMATOL, V168, P1060, DOI 10.1111/bjd.12142; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	128	31	32	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					521	529		10.1038/ni.2892	http://dx.doi.org/10.1038/ni.2892			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840983	Green Accepted			2022-12-18	WOS:000336419300006
J	Goubau, D; Rehwinkel, J; Sousa, CRE				Goubau, Delphine; Rehwinkel, Jan; Reis e Sousa, Caetano			PYHIN proteins: center stage in DNA sensing	NATURE IMMUNOLOGY			English	Editorial Material							CYTOSOLIC DNA; IMMUNE-RESPONSES; DAI DLM-1/ZBP1; INNATE; INFLAMMASOME; RECOGNITION; INTERFERON; PATHWAY; SENSOR		[Goubau, Delphine; Rehwinkel, Jan; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Immunobiol Lab, London, England	Cancer Research UK	Goubau, D (corresponding author), Canc Res UK London Res Inst, Immunobiol Lab, London, England.	caetano@cancer.org.uk	Rehwinkel, Jan/CAG-1436-2022; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Rehwinkel, Jan/0000-0003-3841-835X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119				Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Lippmann J, 2008, CELL MICROBIOL, V10, P2579, DOI 10.1111/j.1462-5822.2008.01232.x; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876	14	31	34	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					984	986		10.1038/ni1110-984	http://dx.doi.org/10.1038/ni1110-984			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959802				2022-12-18	WOS:000283127800007
J	Barnes, MJ; Powrie, F				Barnes, Michael J.; Powrie, Fiona			Hybrid T-reg cells: steel frames and plastic exteriors	NATURE IMMUNOLOGY			English	Editorial Material							T-H-17 CELLS; FOXP3(+); DIFFERENTIATION; RESPONSES; DISEASE	Regulatory T cells have the remarkable ability to suppress immune responses driven by different types of effector T cells. Two recent studies, documenting important functions for T-bet and IRF4 in regulatory T cells, demonstrate that this ability requires the expression of transcription factors typically associated with effector T cell function.	[Barnes, Michael J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Barnes, MJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	fiona.powrie@path.ox.ac.uk		Barnes, Michael/0000-0003-0846-3352				Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	18	31	32	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					563	564		10.1038/ni0609-563	http://dx.doi.org/10.1038/ni0609-563			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448654				2022-12-18	WOS:000266384100004
J	Peng, SL; Li, J; Lin, L; Gerth, A				Peng, SL; Li, J; Lin, L; Gerth, A			The role of T-bet in B cells	NATURE IMMUNOLOGY			English	Letter									Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Peng, SL (corresponding author), Washington Univ, Sch Med, Campus Box 8045,CSRB 6617,660 S Euclid Ave, St Louis, MO 63110 USA.		Peng, Stanford/S-6723-2019					Harris MB, 1999, MOL CELL BIOL, V19, P7264; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Rifkin IR, 2003, NAT IMMUNOL, V4, P650, DOI 10.1038/ni0703-650; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874	6	31	31	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1041	1041		10.1038/ni1103-1041a	http://dx.doi.org/10.1038/ni1103-1041a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586416	Bronze			2022-12-18	WOS:000186241100002
J	O'Neill, LAJ				O'Neill, LAJ			SIGIRR puts the brakes on Toll-like receptors	NATURE IMMUNOLOGY			English	Editorial Material							NEGATIVE REGULATOR; IDENTIFICATION; MEMBERS	Members of the Toll-like receptor-interleukin 1 receptor superfamily signal inflammatory responses. However, a member of this family is now shown to modulate these responses by acting as a negative regulator.	Univ Dublin Trinity Coll, Dept Biochem, Cytokine Res Grp, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Cytokine Res Grp, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; DUNNE A, 2003, SCI STKE, V171, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	12	31	33	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					823	824		10.1038/ni0903-823	http://dx.doi.org/10.1038/ni0903-823			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942080				2022-12-18	WOS:000185002200006
J	Perussia, B				Perussia, B			Signaling for cytotoxicity	NATURE IMMUNOLOGY			English	News Item							CELL		Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Perussia, B (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Kimmel Canc Ctr, BLSB 750,233 S 10th St, Philadelphia, PA 19107 USA.							Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; BONNEMA JD, 1994, ANN NY ACAD SCI, V766, P209; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; Chang CW, 1999, J IMMUNOL, V163, P4651; Galandrini R, 1999, J IMMUNOL, V162, P3148; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Gismondi A, 2000, J IMMUNOL, V164, P2272, DOI 10.4049/jimmunol.164.5.2272; Huang JY, 2000, P NATL ACAD SCI USA, V97, P10923, DOI 10.1073/pnas.97.20.10923; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Perussia B, 1998, CURR TOP MICROBIOL, V230, P63; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	12	31	32	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					372	374		10.1038/80808	http://dx.doi.org/10.1038/80808			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062493				2022-12-18	WOS:000165076100007
J	Patterson, S				Patterson, S			Flexibility and cooperation among dendritic cells	NATURE IMMUNOLOGY			English	News Item							T-CELLS; INTERFERON; ALPHA		Chelsea & Westminster Hosp, Imperial Coll, Sch Med, Dept Immunol, London SW10 9NH, England	Imperial College London	Patterson, S (corresponding author), Chelsea & Westminster Hosp, Imperial Coll, Sch Med, Dept Immunol, 369 Fulham Rd, London SW10 9NH, England.	s.patterson@ic.ac.uk						Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Parronchi P, 1996, EUR J IMMUNOL, V26, P697, DOI 10.1002/eji.1830260328; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109	11	31	34	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					273	274		10.1038/83644	http://dx.doi.org/10.1038/83644			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017093				2022-12-18	WOS:000089869700005
J	Duckworth, BC; Lafouresse, F; Wimmer, VC; Broomfield, BJ; Dalit, L; Alexandre, YO; Sheikh, AA; Qin, RZ; Alvarado, C; Mielke, LA; Pellegrini, M; Mueller, SN; Boudier, T; Rogers, KL; Groom, JR				Duckworth, Brigette C.; Lafouresse, Fanny; Wimmer, Verena C.; Broomfield, Benjamin J.; Dalit, Lennard; Alexandre, Yannick O.; Sheikh, Amania A.; Qin, Raymond Z.; Alvarado, Carolina; Mielke, Lisa A.; Pellegrini, Marc; Mueller, Scott N.; Boudier, Thomas; Rogers, Kelly L.; Groom, Joanna R.			Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands	NATURE IMMUNOLOGY			English	Article								T cells dynamically interact with multiple, distinct cellular subsets to determine effector and memory differentiation. Here, we developed a platform to quantify cell location in three dimensions to determine the spatial requirements that direct T cell fate. After viral infection, we demonstrated that CD8(+) effector T cell differentiation is associated with positioning at the lymph node periphery. This was instructed by CXCR3 signaling since, in its absence, T cells are confined to the lymph node center and alternatively differentiate into stem-like memory cell precursors. By mapping the cellular sources of CXCR3 ligands, we demonstrated that CXCL9 and CXCL10 are expressed by spatially distinct dendritic and stromal cell subsets. Unlike effector cells, retention of stem-like memory precursors in the paracortex is associated with CCR7 expression. Finally, we demonstrated that T cell location can be tuned, through deficiency in CXCL10 or type I interferon signaling, to promote effector or stem-like memory fates. T cells are highly dynamic and their spatial and cellular interactions can influence their differentiation program. Groom and colleagues use three-dimensional spatial imaging to show that effector and stem-like memory cell fates are imposed within distinct lymph node regions.	[Duckworth, Brigette C.; Lafouresse, Fanny; Broomfield, Benjamin J.; Dalit, Lennard; Sheikh, Amania A.; Qin, Raymond Z.; Alvarado, Carolina; Groom, Joanna R.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Duckworth, Brigette C.; Lafouresse, Fanny; Wimmer, Verena C.; Dalit, Lennard; Sheikh, Amania A.; Qin, Raymond Z.; Pellegrini, Marc; Boudier, Thomas; Rogers, Kelly L.; Groom, Joanna R.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Wimmer, Verena C.; Boudier, Thomas; Rogers, Kelly L.] Walter & Eliza Hall Inst Med Res, Ctr Dynam Imaging, Parkville, Vic, Australia; [Alexandre, Yannick O.; Mueller, Scott N.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Mielke, Lisa A.] La Trobe Univ Sch Canc Med, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Pellegrini, Marc] Walter & Eliza Hall Inst Med Res Parkville Victor, Div Infect & Immun, Parkville, Vic, Australia; [Mueller, Scott N.] Univ Melbourne, Ctr Excellence Adv Mol Imaging, Australian Res Council, Melbourne, Vic, Australia; [Lafouresse, Fanny] Univ Toulouse III Paul Sabatier, Equipe Labellisee Ligue Natl Canc, INSERM U1037, Ctr Rech Cancerol Toulouse, Toulouse, France; [Boudier, Thomas] Sorbonne Univ, Paris, France	Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; Olivia Newton-John Cancer Research Institute; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite	Duckworth, BC (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia.; Duckworth, BC; Groom, JR (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	duckworth.b@wehi.edu.au; groom@wehi.edu.au	Sheikh, Amania Anwar/AHE-3533-2022; Lafouresse, Fanny/AAH-2069-2021	Sheikh, Amania Anwar/0000-0003-0769-2081; Lafouresse, Fanny/0000-0001-6572-8631; Qin, Raymond/0000-0002-8787-0011; Duckworth, Brigette/0000-0002-2134-3542; Broomfield, Benjamin/0000-0002-0474-3915; Rogers, Kelly L./0000-0002-6755-0221; Alexandre, Yannick/0000-0002-6634-4098; Groom, Joanna/0000-0001-5251-7835; Boudier, Thomas/0000-0002-0148-7733; Mielke, Lisa/0000-0002-9522-9320	National Health and Medical Research Council (NHMRC) [GNT1182649, GNT1137989, GNT1006592, GNT1045549, GNT1065626, GNT1185513]; WEHI Academic Excellence scholarship; Melbourne research scholarships; Australian Research Council Future Fellowship [FT130100708]; Walter and Eliza Hall Centenary Fellowship - CSL Behring; NHMRC [GNT1175011]; Sylvia & Charles Viertel Senior Medical Research Fellowships; Victorian Cancer Agency mid-career fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); WEHI Academic Excellence scholarship; Melbourne research scholarships; Australian Research Council Future Fellowship(Australian Research Council); Walter and Eliza Hall Centenary Fellowship - CSL Behring; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia & Charles Viertel Senior Medical Research Fellowships; Victorian Cancer Agency mid-career fellowship	We thank S. L. Nutt, K. L. Good-Jacobson and K. D. Shortman for helpful discussions and/or critical reading of the manuscript. This work was supported by National Health and Medical Research Council (NHMRC) Ideas (no. GNT1182649) and Project (no. GNT1137989) grants to J.R.G.; grant nos. GNT1006592, GNT1045549 and GNT1065626 to M.P.; and grant no. GNT1185513 to L.A.M. B.C.D. is supported by a WEHI Academic Excellence scholarship. A.A.S. and L.D. are supported by Melbourne research scholarships. J.R.G. was supported by an Australian Research Council Future Fellowship (no. FT130100708) and is supported by a Walter and Eliza Hall Centenary Fellowship sponsored by CSL Behring. M.P. is supported by an NHMRC Investigator (no. GNT1175011) and Sylvia & Charles Viertel Senior Medical Research Fellowships. L.A.M. is supported by a Victorian Cancer Agency mid-career fellowship. The experimental scheme figures were generated with BioRender. This work was made possible through the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme.	Alexandre YO, 2018, IMMUNOL REV, V283, P77, DOI 10.1111/imr.12641; Ballester M, 2008, J CELL BIOCHEM, V105, P262, DOI 10.1002/jcb.21823; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Brown FD, 2019, NAT IMMUNOL, V20, P1668, DOI 10.1038/s41590-019-0515-x; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; De Simone G, 2019, J IMMUNOL, V203, P3179, DOI 10.4049/jimmunol.1901072; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Duckworth BC, 2021, IMMUNOL REV, V300, P203, DOI 10.1111/imr.12945; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Dyer DP, 2020, IMMUNOLOGY, V160, P336, DOI 10.1111/imm.13200; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gregory JL, 2017, CELL REP, V18, P406, DOI 10.1016/j.celrep.2016.12.038; Groom JR, 2019, IMMUNOL REV, V289, P101, DOI 10.1111/imr.12742; Groom JR, 2015, IMMUNOL CELL BIOL, V93, P330, DOI 10.1038/icb.2015.29; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Huang Z, 2019, J EXP MED, V216, P1791, DOI 10.1084/jem.20190173; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; Marsman C, 2018, IMMUNOL CELL BIOL, V96, P1083, DOI 10.1111/imcb.12173; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Mielke LA, 2019, J EXP MED, V216, P1682, DOI 10.1084/jem.20181778; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Ozga AJ, 2016, J EXP MED, V213, P2811, DOI 10.1084/jem.20160206; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Preibisch S, 2014, NAT METHODS, V11, P645, DOI [10.1038/NMETH.2929, 10.1038/nmeth.2929]; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Raghu D, 2019, TRENDS IMMUNOL, V40, P1149, DOI 10.1016/j.it.2019.10.006; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Sheikh AA, 2019, CELL REP, V28, P1758, DOI 10.1016/j.celrep.2019.07.034; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	58	30	30	1	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					434	+		10.1038/s41590-021-00878-5	http://dx.doi.org/10.1038/s41590-021-00878-5		MAR 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33649580				2022-12-18	WOS:000623928600001
J	Zhou, QD; Chi, X; Lee, MS; Hsieh, WY; Mkrtchyan, JJ; Feng, AC; He, CW; York, AG; Bui, VL; Kronenberger, EB; Ferrari, A; Xiao, X; Daly, AE; Tarling, EJ; Damoiseaux, R; Scumpia, PO; Smale, ST; Williams, KJ; Tontonoz, P; Bensinger, SJ				Zhou, Quan D.; Chi, Xun; Lee, Min Sub; Hsieh, Wei Yuan; Mkrtchyan, Jonathan J.; Feng, An-Chieh; He, Cuiwen; York, Autumn G.; Bui, Viet L.; Kronenberger, Eliza B.; Ferrari, Alessandra; Xiao, Xu; Daly, Allison E.; Tarling, Elizabeth J.; Damoiseaux, Robert; Scumpia, Philip O.; Smale, Stephen T.; Williams, Kevin J.; Tontonoz, Peter; Bensinger, Steven J.			Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins	NATURE IMMUNOLOGY			English	Article							DEPENDENT CYTOLYSINS; I INTERFERONS; CELLS; 25-HYDROXYCHOLESTEROL; ENTRY; INACTIVATION; INFLAMMATION; TRAFFICKING; MACROPHAGES; RESOLUTION	Plasma membranes of animal cells are enriched for cholesterol. Cholesterol-dependent cytolysins (CDCs) are pore-forming toxins secreted by bacteria that target membrane cholesterol for their effector function. Phagocytes are essential for clearance of CDC-producing bacteria; however, the mechanisms by which these cells evade the deleterious effects of CDCs are largely unknown. Here, we report that interferon (IFN) signals convey resistance to CDC-induced pores on macrophages and neutrophils. We traced IFN-mediated resistance to CDCs to the rapid modulation of a specific pool of cholesterol in the plasma membrane of macrophages without changes to total cholesterol levels. Resistance to CDC-induced pore formation requires the production of the oxysterol 25-hydroxycholesterol (25HC), inhibition of cholesterol synthesis and redistribution of cholesterol to an esterified cholesterol pool. Accordingly, blocking the ability of IFN to reprogram cholesterol metabolism abrogates cellular protection and renders mice more susceptible to CDC-induced tissue damage. These studies illuminate targeted regulation of membrane cholesterol content as a host defense strategy. Bensinger and colleagues show that interferons promote host cell resistance to bacterial cytolysins by decreasing cholesterol synthesis and promoting the esterification of cholesterol, which alters the availability of this pool of 'free' cholesterol needed for pore formation.	[Zhou, Quan D.; Lee, Min Sub; York, Autumn G.; Damoiseaux, Robert; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Zhou, Quan D.] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Surg Oncol, Hangzhou, Peoples R China; [Chi, Xun; Hsieh, Wei Yuan; Mkrtchyan, Jonathan J.; Feng, An-Chieh; Bui, Viet L.; Kronenberger, Eliza B.; Daly, Allison E.; Scumpia, Philip O.; Smale, Stephen T.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [He, Cuiwen; Tarling, Elizabeth J.; Scumpia, Philip O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [York, Autumn G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [York, Autumn G.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Ferrari, Alessandra; Xiao, Xu; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Williams, Kevin J.; Tontonoz, Peter] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Zhejiang University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; Howard Hughes Medical Institute; Yale University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bensinger, SJ (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Bensinger, SJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	sbensinger@mednet.ucla.edu	Damoiseaux, Robert/F-1086-2011	Damoiseaux, Robert/0000-0002-7611-7534; Mkrtchyan, Jonathan/0000-0002-1512-9646; Xiao, Xu/0000-0002-5033-7627; Zhou, Quan/0000-0002-0184-4884; Chi, Xun (Allison)/0000-0001-5519-6037	NIH [AI093768, HL146358, AR073940, HL136543]; Ruth L. Kirschstein National Research Service Award [AI007323]; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI grant [UL1TR001881]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by NIH grants AI093768 (to S.J.B.), HL146358 (to S.J.B. and P.T.), AR073940 (to P.O.S), and HL136543 (to E.J.T.). M.S.L. is supported by Ruth L. Kirschstein National Research Service Award AI007323. The research described was also supported by an NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI grant (UL1TR001881). We thank S. Young, T. Weston and R.S. Jung for help with protein purification. We thank T. Weston for NanoSIMS sample preparation and SEM imaging. We thank A. Divakaruni for guidance with PFO permeabilization assays. We thank A. Radhakrishnan for ALO-D4 and full-length ALO plasmids. We thank S. Young, A. Hoffmann, Y. Du, R. Sun, T.-T. Wu, J. F. Miller and M. Li for thoughtful discussions.	Araldi E, 2017, CELL REP, V19, P2743, DOI 10.1016/j.celrep.2017.05.093; Argus JP, 2018, CELL REP, V25, P2919, DOI 10.1016/j.celrep.2018.11.041; Arif N, 2016, EPIDEMIOL INFECT, V144, P1338, DOI 10.1017/S0950268815002745; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bhattacharjee P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24955-2; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chakrabarti RS, 2017, ELIFE, V6, DOI 10.7554/eLife.23355; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Das DK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-348; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Endapally S, 2019, METHODS MOL BIOL, V1949, P153, DOI 10.1007/978-1-4939-9136-5_12; Endapally S, 2019, CELL, V176, P1040, DOI 10.1016/j.cell.2018.12.042; Gay A, 2015, BIOPHYS J, V108, P1459, DOI 10.1016/j.bpj.2015.02.008; Gilbert RJC, 2005, STRUCTURE, V13, P1097, DOI 10.1016/j.str.2005.04.019; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; He CW, 2018, P NATL ACAD SCI USA, V115, pE8499, DOI 10.1073/pnas.1810724115; He CW, 2017, J INVEST MED, V65, P669, DOI 10.1136/jim-2016-000239; He C, 2017, P NATL ACAD SCI USA, V114, P2000, DOI 10.1073/pnas.1621432114; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Infante RE, 2017, ELIFE, V6, DOI 10.7554/eLife.25466; KANDUTSCH AA, 1975, J CELL PHYSIOL, V85, P415, DOI 10.1002/jcp.1040850408; Keyel PA, 2012, J IMMUNOL, V189, P4621, DOI 10.4049/jimmunol.1200828; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; Mazzon M, 2014, CELL MICROBIOL, V16, P1493, DOI 10.1111/cmi.12340; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Panousis CG, 2000, J LIPID RES, V41, P75; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Rawat SS, 2003, MOL MEMBR BIOL, V20, P243, DOI 10.1080/0968768031000104944; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Romero M, 2017, CELL DEATH DIFFER, V24, P798, DOI 10.1038/cdd.2017.11; Sag D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7354; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Tweten RK, 2015, ANNU REV MICROBIOL, V69, P323, DOI 10.1146/annurev-micro-091014-104233; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045	56	30	32	2	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					746	+		10.1038/s41590-020-0695-4	http://dx.doi.org/10.1038/s41590-020-0695-4		JUN 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32514064	Green Submitted, Green Accepted			2022-12-18	WOS:000539349000002
J	Luo, W; Hawse, W; Conter, L; Trivedi, N; Weisel, F; Wikenheiser, D; Cattley, RT; Shlomchik, MJ				Luo, Wei; Hawse, William; Conter, Laura; Trivedi, Nikita; Weisel, Florian; Wikenheiser, Daniel; Cattley, Richard T.; Shlomchik, Mark J.			The AKT kinase signaling network is rewired by PTEN to control proximal BCR signaling in germinal center B cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; CUTTING EDGE; MEMORY B; CENTER SELECTION; HIGH-AFFINITY; C-MYC; RECEPTOR; PHOSPHORYLATION; PHOSPHATASE; ANTIGEN	B cell antigen receptor (BCR) and CD40 signaling are rewired in germinal center (GC) B cells (GCBCs) to optimize selection for high-affinity B cells. In GCBC, BCR signals are constrained, but the mechanisms are not well understood. Here we describe a GC-specific, AKT-kinase-driven negative feedback loop that attenuates BCR signaling. Mass spectrometry revealed that AKT target activity was altered in GCBCs compared with naive B cells. Retargeting was linked to differential AKT T308 and S473 phosphorylation, in turn controlled by GC-specific upregulation of phosphoinositide-dependent protein kinase PDK1 and the phosphatase PTEN. In GCBCs, AKT preferentially targeted CSK, SHP-1 and HPK1, which are negative regulators of BCR signaling. We found that phosphorylation enhances enzymatic activity of these proteins, creating a negative feedback loop that dampens upstream BCR signaling. AKT inhibition relieved this negative feedback and enhanced activation of BCR-proximal kinase LYN, as well as downstream BCR signaling molecules in GCBCs.	[Luo, Wei; Hawse, William; Conter, Laura; Trivedi, Nikita; Weisel, Florian; Wikenheiser, Daniel; Cattley, Richard T.; Shlomchik, Mark J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.	mshlomch@pitt.edu	Luo, Wei/ABD-3082-2021; Shlomchik, Mark J./AAN-6189-2020	Luo, Wei/0000-0003-2826-1723; Shlomchik, Mark J./0000-0002-2152-0959	National Institutes of Health [R01 AI105018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603, R01AI105018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Garrett-Sinha, L. Kane, G. Delgoffe and B. Su for critical reading of the manuscript. We thank R. Elsner for useful discussions. We thank S. Joachim for supporting experimental procedures. This work was supported by National Institutes of Health grant no. R01 AI105018 to M.J.S.	Akerlund J, 2015, J AUTOIMMUN, V62, P45, DOI 10.1016/j.jaut.2015.06.007; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Franks SE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00665; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Getahun A, 2016, J EXP MED, V213, P751, DOI 10.1084/jem.20150537; Good-Jacobson KL, 2014, P NATL ACAD SCI USA, V111, P9585, DOI 10.1073/pnas.1402485111; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Karnell FG, 2005, J BIOL CHEM, V280, P25621, DOI 10.1074/jbc.M503162200; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; King LB, 1999, J IMMUNOL, V162, P2655; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Palomba ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079987; Polikowsky HG, 2015, J IMMUNOL, V195, P1364, DOI 10.4049/jimmunol.1500904; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu CG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan0787; Yan H, 2017, CELL REP, V19, P995, DOI 10.1016/j.celrep.2017.04.022; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200; 2013, BIOCHEM J, V453, P413, DOI DOI 10.1042/BJ20121528; 2015, CANCER DISCOV, V5, P1194, DOI DOI 10.1158/2159-8290.CD-15-0460	62	30	30	4	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					736	+		10.1038/s41590-019-0376-3	http://dx.doi.org/10.1038/s41590-019-0376-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31011187	Green Accepted			2022-12-18	WOS:000468505100016
J	Yang, J; Hu, SM; Zhao, LM; Kaplan, DH; Perdew, GH; Xiong, N				Yang, Jie; Hu, Shaomin; Zhao, Luming; Kaplan, Daniel H.; Perdew, Gary H.; Xiong, Na			Selective programming of CCR10(+) innate lymphoid cells in skin-draining lymph nodes for cutaneous homeostatic regulation	NATURE IMMUNOLOGY			English	Article							DELTA-T-CELLS; ATOPIC-DERMATITIS; INTESTINAL INFLAMMATION; LANGERHANS CELLS; DENDRITIC CELLS; EXPRESSION; CCL27; MAINTENANCE; CHEMOKINES; VITAMIN-D3	Innate lymphoid cells (ILCs) 'preferentially' localize into barrier tissues, where they function in tissue protection but can also contribute to inflammatory diseases. The mechanisms that regulate the establishment of ILCs in barrier tissues are poorly understood. Here we found that under steady-state conditions, ILCs in skin-draining lymph nodes (sLNs) were continuously activated to acquire regulatory properties and high expression of the chemokine receptor CCR10 for localization into the skin. CCR10(+) ILCs promoted the homeostasis of skin-resident T cells and, reciprocally, their establishment in the skin required T cell-regulated homeostatic environments. CD207(+) dendritic cells expressing the transcription factor Foxn1 were required for the proper generation of CCR10(+) ILCs. These observations reveal mechanisms that underlie the specific programming and priming of skin-homing CCR10(+) ILCs in the sLNs.	[Yang, Jie; Hu, Shaomin; Zhao, Luming; Xiong, Na] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Kaplan, Daniel H.] Univ Minnesota, Ctr Immunol, Dept Dermatol, Minneapolis, MN USA; [Perdew, Gary H.] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Xiong, N (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.	nux1@psu.edu	Zhao, Luming/C-7902-2015		National Institute of Allergy and Infectious Diseases; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the US National Institutes of Health [R01AI071043, R01AR064831, ES019964]; National Institute of Environmental Health Sciences of the US National Institutes of Health [R01AI071043, R01AR064831, ES019964]; Pennsylvania State University from the National Institutes of Health [T32 AI074551]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071043, T32AI074551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019964] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis, Musculoskeletal and Skin Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Environmental Health Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Pennsylvania State University from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Bradfield (University of Wisconsin) for Ahr<SUP>-/-</SUP> mice; and X. Zang (Albert Einstein College of Medicine) for antibodies to mouse PDL-2, mouse B7x, mouse B7h and mouse B7H3. Supported by the National Institute of Allergy and Infectious Diseases and the National Institute of Arthritis, Musculoskeletal and Skin Diseases and National Institute of Environmental Health Sciences of the US National Institutes of Health (R01AI071043 and R01AR064831 to N.X., and ES019964 to G.H.P.) and matching institutional funds from Pennsylvania State University for T32 AI074551 from the National Institutes of Health (for J.Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jin Y, 2010, J IMMUNOL, V185, P5723, DOI 10.4049/jimmunol.1001612; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; McCully ML, 2012, BLOOD, V120, P4591, DOI 10.1182/blood-2012-05-433037; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moed H, 2004, J PATHOL, V204, P39, DOI 10.1002/path.1619; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Riis JL, 2011, EXP DERMATOL, V20, P789, DOI 10.1111/j.1600-0625.2011.01323.x; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xia MC, 2014, J ALLERGY CLIN IMMUN, V134, P634, DOI 10.1016/j.jaci.2014.03.010	44	30	31	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					48	+		10.1038/ni.3312	http://dx.doi.org/10.1038/ni.3312			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26523865	Green Accepted			2022-12-18	WOS:000366675800010
J	Nagashima, H; Okuyama, Y; Asao, A; Kawabe, T; Yamaki, S; Nakano, H; Croft, M; Ishii, N; So, T				Nagashima, Hiroyuki; Okuyama, Yuko; Asao, Atsuko; Kawabe, Takeshi; Yamaki, Satoshi; Nakano, Hiroyasu; Croft, Michael; Ishii, Naoto; So, Takanori			The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; NEGATIVE REGULATOR; STRUCTURAL BASIS; TH17 CELLS; PATHWAYS; OX40; INTERLEUKIN-6; RECOGNITION; RESPONSES; MEMBERS	The physiological functions of members of the tumor-necrosis factor (TNF) receptor (TNFR)-associated factor (TRAF) family in T cell immunity are not well understood. We found that in the presence of interleukin 6 ( IL-6), naive TRAF5- deficient CD4(+) T cells showed an enhanced ability to differentiate into the T(H)17 subset of helper T cells. Accordingly, TH17 cell-associated experimental autoimmune encephalomyelitis (EAE) was greatly exaggerated in Traf5(-/-) mice. Although it is normally linked with TNFR signaling pathways, TRAF5 constitutively associated with a cytoplasmic region in the signal- transducing receptor gp130 that overlaps with the binding site for the transcription activator STAT3 and suppressed the recruitment and activation of STAT3 in response to IL- 6. Our results identify TRAF5 as a negative regulator of the IL-6 receptor signaling pathway that limits the induction of proinflammatory CD4(+) T cells that require IL-6 for their development.	[Nagashima, Hiroyuki; Okuyama, Yuko; Asao, Atsuko; Kawabe, Takeshi; Yamaki, Satoshi; Ishii, Naoto; So, Takanori] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan; [Nakano, Hiroyasu] Juntendo Univ, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Nakano, Hiroyasu] Toho Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Croft, Michael] La Jolla Inst, Div Immune Regulat, La Jolla, CA USA	Tohoku University; Juntendo University; Toho University	So, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan.	tso@med.tohoku.ac.jp	Asao, Atsuko/AAC-4576-2019; So, Takanori/R-6175-2019; Nagashima, Hiroyuki/AAL-3128-2021	Asao, Atsuko/0000-0003-3578-4127; So, Takanori/0000-0003-3004-8526; Ishii, Naoto/0000-0002-0549-8245; Nakano, Hiroyasu/0000-0003-4843-1427	Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research [24590571]; Ichiro Kanehara Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; US National Institutes of Health [AI049453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049453] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [14J06157] Funding Source: KAKEN	Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ichiro Kanehara Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank W. Heath (University of Melbourne) for OT-II mice; S. Nagata (Kyoto University) and S. Akira (Osaka University) for the Flag-pEF-STAT3 vector. Supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (C) (24590571 to T. S.), the Ichiro Kanehara Foundation (T. S.), the Takeda Science Foundation (T. S.), the Suzuken Memorial Foundation (T. S.) and the US National Institutes of Health (AI049453 to M. C.).	Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Buchta CM, 2014, J IMMUNOL, V192, P145, DOI 10.4049/jimmunol.1301901; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Esparza EM, 2006, J BIOL CHEM, V281, P8559, DOI 10.1074/jbc.M512915200; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech A, 2000, MOL IMMUNOL, V37, P721, DOI 10.1016/S0161-5890(00)00098-5; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; So T, 2004, J IMMUNOL, V172, P4292, DOI 10.4049/jimmunol.172.7.4292; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	48	30	31	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					449	+		10.1038/ni.2863	http://dx.doi.org/10.1038/ni.2863			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24681564	Green Accepted			2022-12-18	WOS:000334667900010
J	Subrahmanyam, R; Du, HS; Ivanova, I; Chakraborty, T; Ji, YH; Zhang, Y; Alt, FW; Schatz, DG; Sen, RJ				Subrahmanyam, Ramesh; Du, Hansen; Ivanova, Irina; Chakraborty, Tirtha; Ji, Yanhong; Zhang, Yu; Alt, Frederick W.; Schatz, David G.; Sen, Ranjan			Localized epigenetic changes induced by D-H recombination restricts recombinase to DJ(H) junctions	NATURE IMMUNOLOGY			English	Article							V-H; V(D)J RECOMBINATION; PLANT HOMEODOMAIN; GENE; LYSINE-4; REARRANGEMENTS; INHIBITION; ACTIVATION; DELETION; ELEMENTS	Genes encoding immunoglobulin heavy chains (Igh) are assembled by rearrangement of variable (V-H), diversity (D-H) and joining (J(H)) gene segments. Three critical constraints govern V-H recombination. These include timing (V-H recombination follows D-H recombination), precision (V-H gene segments recombine only to DJ(H) junctions) and allele specificity (V-H recombination is restricted to DJ(H)-recombined alleles). Here we provide a model for these universal features of V-H recombination. Analyses of DJ(H)-recombined alleles showed that DJ(H) junctions were selectively epigenetically marked, became nuclease sensitive and bound RAG recombinase proteins, which thereby permitted D-H-associated recombination signal sequences to initiate the second step of Igh gene assembly. We propose that V-H recombination is precise, because these changes did not extend to germline D-H segments located 5' of the DJ(H) junction.	[Subrahmanyam, Ramesh; Du, Hansen; Ivanova, Irina; Chakraborty, Tirtha; Sen, Ranjan] NIA, US NIH, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Ji, Yanhong; Schatz, David G.] Yale Med Sch, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT USA; [Zhang, Yu; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Zhang, Yu; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst,Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Howard Hughes Medical Institute; Yale University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute	Sen, RJ (corresponding author), NIA, US NIH, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA.	senranja@grc.nia.nih.gov	Schatz, David/A-6748-2013; Subrahmanyam, Ramesh/K-5503-2012	Schatz, David/0000-0002-5669-1176; 	Intramural Research Program of the National Institute on Aging (US National Institutes of Health) [AI20047, AI32524]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032524, R01AI020047, R37AI032524, R37AI020047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000383, ZIAAG000372] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging (US National Institutes of Health); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Intramural Research Program of the National Institute on Aging (US National Institutes of Health; AI20047 to F.W.A., and AI32524 to D.G.S.) and the Howard Hughes Medical Institute (F.W.A. and D.G.S.).	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Bates JG, 2007, J EXP MED, V204, P3247, DOI 10.1084/jem.20071787; Bergman Y, 2010, SEMIN IMMUNOL, V22, P323, DOI 10.1016/j.smim.2010.07.003; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Ciubotaru M, 2003, J BIOL CHEM, V278, P5584, DOI 10.1074/jbc.M209758200; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Degner-Leisso SC, 2010, SEMIN IMMUNOL, V22, P346, DOI 10.1016/j.smim.2010.08.002; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hewitt SL, 2010, IMMUNOL REV, V237, P43, DOI 10.1111/j.1600-065X.2010.00931.x; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Koralov SB, 2005, J EXP MED, V201, P341, DOI 10.1084/jem.20041577; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Osipovich O, 2010, SEMIN IMMUNOL, V22, P313, DOI 10.1016/j.smim.2010.07.001; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Spicuglia S, 2010, SEMIN IMMUNOL, V22, P330, DOI 10.1016/j.smim.2010.07.002; Stanton ML, 2005, J IMMUNOL, V174, P3164, DOI 10.4049/jimmunol.174.6.3164; Subrahmanyam R, 2012, CURR TOP MICROBIOL, V356, P39, DOI 10.1007/82_2011_153; Subrahmanyam R, 2010, SEMIN IMMUNOL, V22, P337, DOI 10.1016/j.smim.2010.08.003; Thomas LR, 2009, ADV EXP MED BIOL, V650, P103; Xu CR, 2008, P NATL ACAD SCI USA, V105, P8685, DOI 10.1073/pnas.0711758105; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	39	30	30	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1205	+		10.1038/ni.2447	http://dx.doi.org/10.1038/ni.2447			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23104096	Green Submitted, Green Accepted			2022-12-18	WOS:000311217900014
J	Puneet, P; McGrath, MA; Tay, HK; Al-Riyami, L; Rzepecka, J; Moochhala, SM; Pervaiz, S; Harnett, MM; Harnett, W; Melendez, AJ				Puneet, Padmam; McGrath, Mairi A.; Tay, Hwee Kee; Al-Riyami, Lamyaa; Rzepecka, Justyna; Moochhala, Shabbir M.; Pervaiz, Shazib; Harnett, Margaret M.; Harnett, William; Melendez, Alirio J.			RETRACTED: The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88 (Retracted article. See vol. 12, pg. 804, 2011)	NATURE IMMUNOLOGY			English	Article; Retracted Publication							INTENSIVE-CARE UNITS; SEVERE SEPSIS; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; SECRETED PRODUCT; ENDOTOXIN; EPIDEMIOLOGY; RESPONSES; DEFINITIONS; NEUTROPHILS	Sepsis is one of the most challenging health problems worldwide. Here we found that phagocytes from patients with sepsis had considerable upregulation of Toll-like receptor 4 (TLR4) and TLR2; however, shock-inducing inflammatory responses mediated by these TLRs were inhibited by ES-62, an immunomodulator secreted by the filarial nematode Acanthocheilonema viteae. ES-62 subverted TLR4 signaling to block TLR2- and TLR4-driven inflammatory responses via autophagosome-mediated downregulation of the TLR adaptor-transducer MyD88. In vivo, ES-62 protected mice against endotoxic and polymicrobial septic shock by TLR4-mediated induction of autophagy and was protective even when administered after the induction of sepsis. Given that the treatments for septic shock at present are inadequate, the autophagy-dependent mechanism of action by ES-62 might form the basis for urgently needed therapeutic intervention against this life-threatening condition.	[Puneet, Padmam; Pervaiz, Shazib; Melendez, Alirio J.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Puneet, Padmam; Melendez, Alirio J.] Univ Liverpool, Ctr Drug Safety Studies, MRC, Inst Translat Med,Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [McGrath, Mairi A.; Tay, Hwee Kee; Harnett, Margaret M.] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Al-Riyami, Lamyaa; Rzepecka, Justyna; Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Moochhala, Shabbir M.] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Pervaiz, Shazib] Natl Univ Singapore, Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Pervaiz, Shazib] Singapore MIT Alliance, Singapore, Singapore	National University of Singapore; University of Liverpool; University of Glasgow; University of Strathclyde; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Melendez, AJ (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.	a.melendez-romero@liv.ac.uk		MOOCHHALA, SHABBIR/0000-0003-4521-3192; Harnett, William/0000-0001-9545-9401	Medical Research Council UK [G0700794]; Biomedical Research Council of Singapore; Wellcome Trust; Biotechnology and Biological Sciences Research Council UK; American Asthma Foundation; Medical Research Council [G0700794] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); American Asthma Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Medical Research Council UK (G0700794), the Biomedical Research Council of Singapore, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council UK and the American Asthma Foundation.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1177/09680519010070030101; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Balk RA, 2000, CRIT CARE CLIN, V16, P179, DOI 10.1016/S0749-0704(05)70106-8; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BUSTIN M, 2002, SCI STKE, V151, pPE39; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; EXLEY AR, 1992, GUT, V33, P1126, DOI 10.1136/gut.33.8.1126; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morton AM, 2007, J IMMUNOL, V179, P8026, DOI 10.4049/jimmunol.179.12.8026; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; PHILLIP DR, 2004, CRIT CARE MED, V32, P282; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Sethu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010506; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; Weighardt H, 2007, IMMUNOBIOLOGY, V212, P715, DOI 10.1016/j.imbio.2007.09.010	47	30	37	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					344	U100		10.1038/ni.2004	http://dx.doi.org/10.1038/ni.2004			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21358639				2022-12-18	WOS:000288593400013
J	O'Neill, LAJ				O'Neill, Luke A. J.			'Fine tuning' TLR signaling	NATURE IMMUNOLOGY			English	Editorial Material							NEGATIVE REGULATION; PHOSPHATASE; INTERFERON; RECEPTORS	Toll-like receptor signaling induces the production of proinflammatory cytokines and type I interferons. Inhibition of the kinase IRAK1 by the phosphatase SHP-1 provides reciprocal regulation of these pathways by dampening the former while enhancing the latter.	Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	8	30	30	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					459	461		10.1038/ni0508-459	http://dx.doi.org/10.1038/ni0508-459			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425098				2022-12-18	WOS:000255153500004
J	Austen, KF				Austen, K. Frank			The cysteinyl leukotrienes: Where do they come from? What are they? Where are they going?	NATURE IMMUNOLOGY			English	Editorial Material							SLOW-REACTING SUBSTANCE; GUINEA-PIG LUNG; GENE DISRUPTION REVEALS; ANAPHYLAXIS SRS-A; C-4 SYNTHASE; VASCULAR-PERMEABILITY; RECEPTOR; MICE; EXPRESSION; HISTAMINE	Cysteinyl leukotrienes are established mediators of bronchial asthma and have agonist roles analogous to those of histamine in allergic rhinitis. We now know that the substance originally termed slow-reacting substance of anaphylaxis was composed of three cysteinyl leukotrienes that act in the inflammatory response via receptors on smooth muscle and on bone marrow-derived inflammatory cells. K. Frank Austen describes the work culminating in the identification, biosynthesis and functional characterization of these moieties.	[Austen, K. Frank] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Austen, K. Frank] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Austen, KF (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	fausten@rics.bwh.harvard.edu						Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; AUSTEN KF, 1961, J EXP MED, V113, P541, DOI 10.1084/jem.113.3.541; AUSTEN KF, 1961, J EXP MED, V114, P29, DOI 10.1084/jem.114.1.29; AUSTEN KF, 1961, J EXP MED, V113, P521, DOI 10.1084/jem.113.3.521; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Hsieh FH, 2001, J EXP MED, V193, P123, DOI 10.1084/jem.193.1.123; ISHIZAKA T, 1970, J IMMUNOL, V104, P854; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P4922, DOI 10.1073/pnas.81.15.4922; LEWIS RA, 1980, BIOCHEM BIOPH RES CO, V96, P271, DOI 10.1016/0006-291X(80)91210-3; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2002, J BIOL CHEM, V277, P20820, DOI 10.1074/jbc.M203163200; MARFAT A, 1985, ADV PROSTAG THROMB L, V14, P155; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; ORANGE RP, 1973, J IMMUNOL, V110, P760; Penrose JF, 1996, J BIOL CHEM, V271, P11356, DOI 10.1074/jbc.271.19.11356; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; STECHSCHULTE DJ, 1967, J EXP MED, V125, P127, DOI 10.1084/jem.125.1.127; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	24	30	31	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					113	115		10.1038/ni0208-113	http://dx.doi.org/10.1038/ni0208-113			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204420				2022-12-18	WOS:000252503000003
J	Hodgkin, PD; Heath, WR; Baxter, AG				Hodgkin, Philip D.; Heath, William R.; Baxter, Alan G.			The clonal selection theory: 50 years since the revolution	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGY	October 2007 marks the 50th anniversary of the publication of Frank Macfarlane Burnet's clonal selection theory in the Australian Journal of Science. This short article, republished at the end of this commentary, revolutionized the field of immunology.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; James Cook Univ N Queensland, Comparat Genom Ctr, Townsville, Qld 4811, Australia	Walter & Eliza Hall Institute; James Cook University	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	heath@wehi.edu.au	Baxter, Alan G/A-1412-2010	Baxter, Alan G/0000-0002-6960-9821; Heath, William/0000-0001-9670-259X; Hodgkin, Philip/0000-0002-8604-1940				BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BREINL F, 1930, PHYSIOL CHEM PHYS M, V192, P45; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet F. Macfarlane, 1941, PRODUCTION ANTIBODIE; Burnet F. Macfarlane, 1956, ENZYME ANTIGEN VIRUS; BURNET FM, 1967, COLD SPRING HARB SYM, V32, P1; BURNET FM, 1948, HEREDITY, V2, P289, DOI 10.1038/hdy.1948.19; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Burnet FM, 1949, PRODUCTION ANTIBODIE; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CRUSE JM, 1994, J IMMUNOL, V153, P919; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; FORSDYKE DR, 1995, FASEB J, V9, P164, DOI 10.1096/fasebj.9.2.7781918; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Kuhn T. S., 1962, STRUCTURE SCI REVOLU; Landsteiner K, 1941, J EXP MED, V73, P431, DOI 10.1084/jem.73.3.431; MACKAY IR, 1958, MA ARCH INT MED, V101, P30; SIMONSEN MORTEN, 1957, ACTA PATHOL ET MICROBLOL SCAND, V40, P480; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323	19	30	31	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1019	1023		10.1038/ni1007-1019	http://dx.doi.org/10.1038/ni1007-1019			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878907				2022-12-18	WOS:000249691400005
J	Mosmann, TR; Livingstone, AM				Mosmann, TR; Livingstone, AM			Dendritic cells: the immune information management experts	NATURE IMMUNOLOGY			English	Editorial Material							GENERATION; RESPONSES; CD4(+); TH1	Dendritic cells sense and respond to multiple signals that are then conveyed to lymphocytes to direct appropriate immune responses. This flow of information is bidirectional, as antigen-experienced T cells also influence dendritic cell function.	Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Mosmann, TR (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Rochester, NY 14642 USA.	tim_mosmann@urmc.rochester.edu						Alpan O, 2004, NAT IMMUNOL, V5, P615, DOI 10.1038/ni1077; Creusot RJ, 2003, EUR J IMMUNOL, V33, P1686, DOI 10.1002/eji.200323811; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Lebre MC, 2003, J INVEST DERMATOL, V120, P990, DOI 10.1046/j.1523-1747.2003.12245.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Schipf A, 2003, EUR J IMMUNOL, V33, P1697, DOI 10.1002/eji.200323809; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3	12	30	35	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					564	566		10.1038/ni0604-564	http://dx.doi.org/10.1038/ni0604-564			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164014				2022-12-18	WOS:000221664000006
J	Rock, KL				Rock, KL			The ins and outs of cross-presentation	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; IMMUNITY; PEPTIDES; PROTEINS; ANTIGEN; CELLS		Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.							Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GUERMONPREZ P, 2003, NATURE          0924; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOUDE M, 2003, NATURE          0924; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X	10	30	31	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					941	943		10.1038/ni1003-941	http://dx.doi.org/10.1038/ni1003-941			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515124				2022-12-18	WOS:000185590100007
J	Katzmarski, N; Dominguez-Andres, J; Cirovic, B; Renieris, G; Ciarlo, E; Le Roy, D; Lepikhov, K; Kattler, K; Gasparoni, G; Handler, K; Theis, H; Beyer, M; van der Meer, JWM; Joosten, LAB; Walter, J; Schultze, JL; Roger, T; Giamarellos-Bourboulis, EJ; Schlitzer, A; Netea, MG				Katzmarski, Natalie; Dominguez-Andres, Jorge; Cirovic, Branko; Renieris, Georgios; Ciarlo, Eleonora; Le Roy, Didier; Lepikhov, Konstantin; Kattler, Kathrin; Gasparoni, Gilles; Handler, Kristian; Theis, Heidi; Beyer, Marc; van der Meer, Jos W. M.; Joosten, Leo A. B.; Walter, Jorn; Schultze, Joachim L.; Roger, Thierry; Giamarellos-Bourboulis, Evangelos J.; Schlitzer, Andreas; Netea, Mihai G.			Transmission of trained immunity and heterologous resistance to infections across generations	NATURE IMMUNOLOGY			English	Article							TRANSGENERATIONAL TRANSMISSION; RECEPTOR; CELL; ACTIVATION; EXPRESSION; RESPONSES; DNA	Intergenerational inheritance of immune traits linked to epigenetic modifications has been demonstrated in plants and invertebrates. Here we provide evidence for transmission of trained immunity across generations to murine progeny that survived a sublethal systemic infection with Candida albicans or a zymosan challenge. The progeny of trained mice exhibited cellular, developmental, transcriptional and epigenetic changes associated with the bone marrow-resident myeloid effector and progenitor cell compartment. Moreover, the progeny of trained mice showed enhanced responsiveness to endotoxin challenge, alongside improved protection against systemic heterologous Escherichia coli and Listeria monocytogenes infections. Sperm DNA of parental male mice intravenously infected with the fungus C. albicans showed DNA methylation differences linked to immune gene loci. These results provide evidence for inheritance of trained immunity in mammals, enhancing protection against infections. Transgenerational transmission of acquired immunological traits has been demonstrated in invertebrates and plants but not mammals. Katzmarski et al. demonstrate that trained immunity that protects against heterologous infections can be transmitted to F2 offspring.	[Katzmarski, Natalie; Cirovic, Branko; Schlitzer, Andreas] Univ Bonn, Life & Med Sci Inst, Quantitat Syst Biol, Bonn, Germany; [Dominguez-Andres, Jorge; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Dominguez-Andres, Jorge; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Dominguez-Andres, Jorge; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Renieris, Georgios; Giamarellos-Bourboulis, Evangelos J.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece; [Ciarlo, Eleonora; Le Roy, Didier; Roger, Thierry] Lausanne Univ Hosp, Dept Med, Infect Dis Serv, Epalinges, Switzerland; [Ciarlo, Eleonora; Le Roy, Didier; Roger, Thierry] Univ Lausanne, Epalinges, Switzerland; [Lepikhov, Konstantin; Kattler, Kathrin; Gasparoni, Gilles; Walter, Jorn] Saarland Univ, Dept Genet Epigenet, Saarbrucken, Germany; [Handler, Kristian; Theis, Heidi; Beyer, Marc] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, Bonn, Germany; [Handler, Kristian; Theis, Heidi; Beyer, Marc] Univ Bonn, Bonn, Germany; [Beyer, Marc; Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Mol Immunol Neurodegenerat, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci Inst, Bonn, Germany; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst, Dept Immunol & Metab, Bonn, Germany	University of Bonn; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; National & Kapodistrian University of Athens; University of Lausanne; Saarland University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Dominguez-Andres, J; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Dominguez-Andres, J; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.; Dominguez-Andres, J; Netea, MG (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.; Netea, MG (corresponding author), Univ Bonn, Life & Med Sci Inst, Dept Immunol & Metab, Bonn, Germany.	Jorge.DominguezAndres@radboudumc.nl; Mihai.Netea@radboudumc.nl	Walter, Jörn/AFN-6428-2022; Schultze, Joachim L./ABA-8176-2020; Roger, Thierry/G-2007-2012; Dominguez-Andres, Jorge/S-6211-2017	Walter, Jörn/0000-0003-0563-7417; Schultze, Joachim L./0000-0003-2812-9853; Roger, Thierry/0000-0002-9358-0109; Renieris, Georgios/0000-0002-2985-0901; Ciarlo, Eleonora/0000-0003-4614-0191; Cirovic, Branko/0000-0002-0754-0099; Kattler, Kathrin/0000-0001-5488-6650; Handler, Kristian/0000-0001-5273-5277; Dominguez-Andres, Jorge/0000-0002-9091-1961	European Research Council [833247]; Spinoza grant of the Netherlands Organization for Scientific Research; Hellenic Institute for the Study of Sepsis; Swiss National Science Foundation [310030_173123]; Fondation Carigest/Promex Stiftung fur die Forschung; Fondation de Recherche en Biochimie; Netherlands Organization for Scientific Research [09150161910024]; Horizon 2020 Marie Sklodowska-Curie Action-European Sepsis Academy-Innovative Training Network [676129]; Deutsche Forschungsgemeinschaft (DFG) [SCHL2116/1-1]; DFG under Germany's Excellence Strategy [EXC2151 390873048]; DFG [SFB 1309]	European Research Council(European Research Council (ERC)European Commission); Spinoza grant of the Netherlands Organization for Scientific Research; Hellenic Institute for the Study of Sepsis; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Carigest/Promex Stiftung fur die Forschung; Fondation de Recherche en Biochimie; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Horizon 2020 Marie Sklodowska-Curie Action-European Sepsis Academy-Innovative Training Network; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	M.G.N. was supported by a European Research Council advanced grant (no. 833247) and a Spinoza grant of the Netherlands Organization for Scientific Research. E.J.G.-B. is funded by the Hellenic Institute for the Study of Sepsis. T.R. was supported by the Swiss National Science Foundation (no. 310030_173123) and grants from Fondation Carigest/Promex Stiftung fur die Forschung and Fondation de Recherche en Biochimie. J.D.-A. is supported by the Netherlands Organization for Scientific Research (VENI grant no. 09150161910024). G.R. is funded by the Horizon 2020 Marie Sklodowska-Curie Action-European Sepsis Academy-Innovative Training Network (no. 676129). A.S. holds an Emmy Noether fellowship of the Deutsche Forschungsgemeinschaft (DFG) (no. SCHL2116/1-1). M.G.N., A.S. and J.L.S. are funded by the DFG under Germany's Excellence Strategy EXC2151 390873048. J.W. and K.L. are funded by the DFG within the SFB 1309 (Chemical Biology of Epigenetic Modifications). M.B. is a member of the excellence cluster ImmunoSensation2. We thank K. Nordstrom for bioinformatics support.	Beccaloni GW, 2008, NATURE, V451, P1050, DOI 10.1038/4511050d; Belicard T, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0571-y; Ciarlo E, 2020, J INFECT DIS, V222, P1869, DOI 10.1093/infdis/jiz692; Cramer SD, 1999, HUM MOL GENET, V8, P2063, DOI 10.1093/hmg/8.11.2063; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Das A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00022; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dominguez-Andres J, 2017, IMMUNITY, V46, P1059, DOI 10.1016/j.immuni.2017.05.009; Eggert H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2089; Emin M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0634; Ferguson-Smith AC, 2011, CELL METAB, V13, P115, DOI 10.1016/j.cmet.2011.01.011; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Hedl M, 2014, J IMMUNOL, V192, P5924, DOI 10.4049/jimmunol.1302727; Hong JY, 2016, YONSEI MED J, V57, P1412, DOI 10.3349/ymj.2016.57.6.1412; Hrasovec S, 2013, DIS MARKERS, V34, P93, DOI [10.1155/2013/427890, 10.3233/DMA-120948]; Kaludercic N, 2014, ANTIOXID REDOX SIGN, V20, P267, DOI 10.1089/ars.2012.4616; Kazachenka A, 2018, CELL, V175, P1259, DOI 10.1016/j.cell.2018.09.043; Klaver EJ, 2015, GENES IMMUN, V16, P378, DOI 10.1038/gene.2015.18; Klengel T, 2016, NEUROPSYCHOPHARMACOL, V41, P219, DOI 10.1038/npp.2015.249; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Lee SH, 2009, BIOCHEM BIOPH RES CO, V381, P214, DOI 10.1016/j.bbrc.2009.02.026; Lopez JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0454; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Maekawa T, 2018, NUCLEIC ACIDS RES, V46, P4487, DOI 10.1093/nar/gky155; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Morris VA, 2016, MOL CELL BIOL, V36, P559, DOI 10.1128/MCB.00712-15; Nankabirwa V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1497-8; Nohra R, 2010, GENES IMMUN, V11, P279, DOI 10.1038/gene.2009.111; Norouzitallab P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21166; Oey H, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0047-z; Pundhir S, 2018, CELL REP, V23, P2744, DOI 10.1016/j.celrep.2018.05.012; Qin QS, 2014, VIROLOGY, V448, P125, DOI 10.1016/j.virol.2013.10.011; Ramanan D, 2020, CELL, V181, P1276, DOI 10.1016/j.cell.2020.04.030; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Rowe AH, 2008, TOXICON, V52, P597, DOI 10.1016/j.toxicon.2008.07.004; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Siklenka K, 2015, SCIENCE, V350, DOI 10.1126/science.aab2006; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Sun WF, 2018, NAT MED, V24, P1372, DOI 10.1038/s41591-018-0102-y; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Volkova Olga, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P209, DOI 10.1089/mab.2014.0010; Weber-Stadlbauer U, 2017, MOL PSYCHIATR, V22, P102, DOI 10.1038/mp.2016.41; Yu HB, 2015, NUCLEIC ACIDS RES, V43, P836, DOI 10.1093/nar/gku1369; Yue F, 2013, DEV COMP IMMUNOL, V41, P569, DOI 10.1016/j.dci.2013.07.001; Zhu FG, 2001, IMMUNOLOGY, V103, P226, DOI 10.1046/j.1365-2567.2001.01222.x	49	29	29	10	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1382	+		10.1038/s41590-021-01052-7	http://dx.doi.org/10.1038/s41590-021-01052-7		OCT 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34663978	Green Submitted			2022-12-18	WOS:000708376800002
J	de Jong, MME; Kellermayer, Z; Papazian, N; Tahri, S; Bruinink, DHO; Hoogenboezem, R; Sanders, MA; van de Woestijne, PC; Bos, PK; Khandanpour, C; Vermeulen, J; Moreau, P; van Duin, M; Broijl, A; Sonneveld, P; Cupedo, T				de Jong, Madelon M. E.; Kellermayer, Zoltan; Papazian, Natalie; Tahri, Sabrin; Hofste Op Bruinink, Davine; Hoogenboezem, Remco; Sanders, Mathijs A.; van de Woestijne, Pieter C.; Bos, P. Koen; Khandanpour, Cyrus; Vermeulen, Jessica; Moreau, Philippe; van Duin, Mark; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom			The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape	NATURE IMMUNOLOGY			English	Article							CANCER-ASSOCIATED FIBROBLASTS; SUPPRESSOR-CELLS; INTERLEUKIN-6; TARGET; GROWTH	Multiple myeloma disease progression and therapy response are influenced by the bone marrow niche in which the tumor cells reside. To characterize this supportive niche, Cupedo and colleagues use single-cell transcriptomic analysis of bone marrow stromal cell populations from individuals with multiple myeloma. They identify a myeloma-specific inflammatory mesenchymal stromal cell (iMSC) population that spatially colocalizes with tumor cells. Anti-myeloma induction therapy does not influence iMSC presence, suggesting a role for bone marrow inflammation in myeloma persistence or relapse. Progression and persistence of malignancies are influenced by the local tumor microenvironment, and future eradication of currently incurable tumors will, in part, hinge on our understanding of malignant cell biology in the context of their nourishing surroundings. Here, we generated paired single-cell transcriptomic datasets of tumor cells and the bone marrow immune and stromal microenvironment in multiple myeloma. These analyses identified myeloma-specific inflammatory mesenchymal stromal cells, which spatially colocalized with tumor cells and immune cells and transcribed genes involved in tumor survival and immune modulation. Inflammatory stromal cell signatures were driven by stimulation with proinflammatory cytokines, and analyses of immune cell subsets suggested interferon-responsive effector T cell and CD8(+) stem cell memory T cell populations as potential sources of stromal cell-activating cytokines. Tracking stromal inflammation in individuals over time revealed that successful antitumor induction therapy is unable to revert bone marrow inflammation, predicting a role for mesenchymal stromal cells in disease persistence.	[de Jong, Madelon M. E.; Kellermayer, Zoltan; Papazian, Natalie; Tahri, Sabrin; Hofste Op Bruinink, Davine; Hoogenboezem, Remco; Sanders, Mathijs A.; van Duin, Mark; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom] Erasmus MC, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands; [van de Woestijne, Pieter C.] Erasmus MC, Dept Cardiothorac Surg, Rotterdam, Netherlands; [Bos, P. Koen] Erasmus MC, Dept Orthped Surg, Rotterdam, Netherlands; [Khandanpour, Cyrus] Univ Hosp Munster, Med Dept A, Munster, Germany; [Vermeulen, Jessica] Janssen Res & Dev LLC, Leiden, Netherlands; [Moreau, Philippe] Nantes Univ Hosp Hotel Dieu, Nantes, France	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Munster	Sonneveld, P; Cupedo, T (corresponding author), Erasmus MC, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands.	p.sonneveld@erasmusmc.nl; t.cupedo@erasmusmc.nl	Cupedo, Tom/GQQ-0614-2022	Hofste op Bruinink, Davine/0000-0002-1296-120X; moreau, philippe/0000-0003-1780-8746; de Jong, Madelon/0000-0002-6145-6154; Khandanpour, Cyrus/0000-0003-4655-6269	European Myeloma Network (EMN) [HO95-EMN02-FB01102018]; ZonMw [95103008]; Jose Carreras Leukaemia Foundation [DJCLS 17R/2018]; Deutsche Krebshilfe [70112392]; Deutsche Forschungsgemeinschaft [KH331/2-3]; faculty of Medicine at University Hospital of Muenster [Kha2/002/20]; European Union [707404]	European Myeloma Network (EMN); ZonMw(Netherlands Organization for Health Research and Development); Jose Carreras Leukaemia Foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); faculty of Medicine at University Hospital of Muenster; European Union(European Commission)	We thank members of Myeloma Research Rotterdam and the Department of Hematology for critical discussions and reading of the manuscript, and the participants, families and nurses for their contributions to this study. We thank N. Leimkuhler (Department of Hematology, Erasmus MC, the Netherlands) for help with the collection of healthy bone marrow biopsies and E. Bindels (Department of Hematology, Erasmus MC, the Netherlands) for help with sequencing. This work was supported by grants from the European Myeloma Network (EMN, grant HO95-EMN02-FB01102018 to P.S.) and ZonMw (grant 95103008 to P.S.). C.K. is supported by the Jose Carreras Leukaemia Foundation (grant DJCLS 17R/2018), the Deutsche Krebshilfe (grant 70112392), Deutsche Forschungsgemeinschaft (grant KH331/2-3) and the intramural funding of the faculty of Medicine at University Hospital of Muenster (grant Kha2/002/20). This project received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 707404 (to Z.K.). The opinions expressed in this document reflect only the authors' views. The European Commission is not responsible for any use that may be made of the information it contains.	Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Bailur JK, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127807; Barrionuevo N, 2019, PROTEIN J, V38, P667, DOI 10.1007/s10930-019-09865-0; BARUT BA, 1992, LEUKEMIA RES, V16, P951, DOI 10.1016/0145-2126(92)90073-G; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chen X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163715; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Das R, 2016, NAT MED, V22, P1351, DOI 10.1038/nm.4202; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Favaloro J, 2014, LEUKEMIA LYMPHOMA, V55, P2893, DOI 10.3109/10428194.2014.904511; Filippi I, 2018, CELL PHYSIOL BIOCHEM, V46, P203, DOI 10.1159/000488423; Gars M. L., 2019, CD38 CONTRIBUTES HUM, DOI 10.1101/349084; Ghobrial IM, 2018, NAT REV CLIN ONCOL, V15, P219, DOI 10.1038/nrclinonc.2017.197; Gorgun GT, 2013, BLOOD, V121, P2975, DOI 10.1182/blood-2012-08-448548; Helbling PM, 2019, CELL REP, V29, P3313, DOI 10.1016/j.celrep.2019.11.004; Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623; Hope C, 2016, BLOOD, V128, P680, DOI 10.1182/blood-2016-03-705780; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Li A, 2018, ONCOGENE, V37, P5952, DOI 10.1038/s41388-018-0379-9; Liu TY, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0770-1; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lomas OC, 2020, CURR OPIN ONCOL, V32, P170, DOI 10.1097/CCO.0000000000000615; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miyai Y, 2020, CANCER SCI, V111, P1047, DOI 10.1111/cas.14346; Molejon MI, 2015, ONCOTARGET, V6, P7408, DOI 10.18632/oncotarget.3510; Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703; Monteran L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01835; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreau P, 2019, LANCET, V394, P29, DOI 10.1016/S0140-6736(19)31240-1; Morris EV, 2020, J BONE MINER RES, V35, P942, DOI 10.1002/jbmr.3951; NISHIMOTO N, 1994, J EXP MED, V179, P1343, DOI 10.1084/jem.179.4.1343; Nooka AK, 2019, CANCER-AM CANCER SOC, V125, P2364, DOI 10.1002/cncr.32065; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Ping Z, 2019, LEUKEMIA, V33, P536, DOI 10.1038/s41375-018-0267-x; Rajkumar SV, 2009, CURR PROB CANCER, V33, P7, DOI 10.1016/j.currproblcancer.2009.01.001; RUBARTELLI A, 1993, CYTOKINE, V5, P117, DOI 10.1016/1043-4666(93)90050-F; Santi A, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700167; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schaeuble K, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000072; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Shi HF, 2018, CANCER SCI, V109, P3826, DOI 10.1111/cas.13809; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tobin RP, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01223; Tong DL, 2018, CANCER METAST REV, V37, P355, DOI 10.1007/s10555-018-9752-y; Vulpis E, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1279372; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Yang CX, 2019, ONCOGENE, V38, P7113, DOI 10.1038/s41388-019-0899-y; Zavidij O, 2020, NAT CANCER, V1, DOI 10.1038/s43018-020-0053-3; Zhang H, 2017, ONCOGENE, V36, P2095, DOI 10.1038/onc.2016.367	61	29	29	6	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					769	+		10.1038/s41590-021-00931-3	http://dx.doi.org/10.1038/s41590-021-00931-3		MAY 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34017122				2022-12-18	WOS:000652579200007
J	Junqueira, C; Polidoro, RB; Castro, G; Absalon, S; Liang, ZT; Sen Santara, S; Crespo, A; Pereira, DB; Gazzinelli, RT; Dvorin, JD; Lieberman, J				Junqueira, Caroline; Polidoro, Rafael B.; Castro, Guilherme; Absalon, Sabrina; Liang, Zhitao; Sen Santara, Sumit; Crespo, Angela; Pereira, Dhelio B.; Gazzinelli, Ricardo T.; Dvorin, Jeffrey D.; Lieberman, Judy			gamma delta T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis	NATURE IMMUNOLOGY			English	Article							PROFESSIONAL ANTIGEN-PRESENTATION; IN-VITRO GROWTH; MALARIA; GRANULYSIN; IMMUNITY; LYMPHOCYTES; ACTIVATION; PROTECTION; MECHANISM; INHIBIT	Activated V gamma 9V delta 2 (gamma delta 2) T lymphocytes that sense parasite-produced phosphoantigens are expanded in Plasmodium falciparum-infected patients. Although previous studies suggested that gamma delta 2 T cells help control erythrocytic malaria, whether gamma delta 2 T cells recognize infected red blood cells (iRBCs) was uncertain. Here we show that iRBCs stained for the phosphoantigen sensor butyrophilin 3A1 (BTN3A1). gamma delta 2 T cells formed immune synapses and lysed iRBCs in a contact, phosphoantigen, BTN3A1 and degranulation-dependent manner, killing intracellular parasites. Granulysin released into the synapse lysed iRBCs and delivered death-inducing granzymes to the parasite. All intra-erythrocytic parasites were susceptible, but schizonts were most sensitive. A second protective gamma delta 2 T cell mechanism was identified. In the presence of patient serum, gamma delta 2 T cells phagocytosed and degraded opsonized iRBCs in a CD16-dependent manner, decreasing parasite multiplication. Thus, gamma delta 2 T cells have two ways to control blood-stage malaria-gamma delta T cell antigen receptor (TCR)-mediated degranulation and phagocytosis of antibody-coated iRBCs.	[Junqueira, Caroline; Polidoro, Rafael B.; Liang, Zhitao; Sen Santara, Sumit; Crespo, Angela; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Junqueira, Caroline; Polidoro, Rafael B.; Absalon, Sabrina; Liang, Zhitao; Sen Santara, Sumit; Crespo, Angela; Dvorin, Jeffrey D.; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Junqueira, Caroline; Castro, Guilherme; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Castro, Guilherme; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Absalon, Sabrina; Dvorin, Jeffrey D.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Pereira, Dhelio B.] Ctr Pesquisa Med Trop Rondonia, Porto Velho, RO, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Plataforma Med Translac, Ribeirao Preto, SP, Brazil; [Absalon, Sabrina] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Fundacao Oswaldo Cruz; Indiana University System; Indiana University Bloomington	Junqueira, C; Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Junqueira, C; Lieberman, J (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Junqueira, C (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Belo Horizonte, MG, Brazil.	caroline.junqueira@fiocruz.br; judy.lieberman@childrens.harvard.edu	Pereira, Dhelio Batista/F-9312-2017; Polidoro, Rafael Barbosa/A-6385-2016; Junqueira, Caroline/GVR-8109-2022	Pereira, Dhelio Batista/0000-0002-7761-5498; Polidoro, Rafael Barbosa/0000-0003-2982-0072; Dvorin, Jeffrey/0000-0002-5883-7271; Castro, Guilherme/0000-0002-7182-1813; Junqueira, Caroline/0000-0003-0545-0986; LIANG, ZHITAO/0000-0001-5320-6107	NIH [AI116577, AI131632, AI145941]; Amazonian Center of Excellence in Malaria Research [NIH U19 AI089681]; Harvard University Lemann Brazil Fund; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG [APQ-00653-16]; FundacAo de Amparo a Pesquisa do Estado de SAo Paulo-FAPESP [2016/23618-8]; Brazilian National Institute of Science and Technology for Vaccines (CNPq/FAPMIG); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq) fellowships	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amazonian Center of Excellence in Malaria Research; Harvard University Lemann Brazil Fund; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FundacAo de Amparo a Pesquisa do Estado de SAo Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Institute of Science and Technology for Vaccines (CNPq/FAPMIG); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq) fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This research was supported by NIH AI116577 and AI131632 (J.L. and R.T.G.), NIH U19 AI089681 Amazonian Center of Excellence in Malaria Research (C.J. and R.T.G.), NIH AI145941 (J.D.D.), Harvard University Lemann Brazil Fund (J.L. and C.J.) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG APQ-00653-16 (C.J.), FundacAo de Amparo a Pesquisa do Estado de SAo Paulo-FAPESP, 2016/23618-8 (C.J. and R.T.G.), Brazilian National Institute of Science and Technology for Vaccines (CNPq/FAPMIG) (C.J. and R.T.G.). C.J., R.B.P., G.C. and R.T.G. are recipients of Conselho Nacional de Desenvolvimento Cienti'fico e Tecnolo'gico (CNPq) fellowships. C.J. and G.C. are fellows of Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES).	Arora G, 2018, ELIFE, V7, DOI 10.7554/eLife.36806; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Barisa M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02886-8; Barry A, 2016, PARASITOLOGY, V143, P125, DOI 10.1017/S0031182015001778; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Costa G, 2011, BLOOD, V118, P6952, DOI 10.1182/blood-2011-08-376111; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; Das S, 2015, CELL IMMUNOL, V296, P87, DOI 10.1016/j.cellimm.2015.04.007; Dotiwala F, 2016, NAT MED, V22, P210, DOI 10.1038/nm.4023; Dotiwalal F, 2019, CURR OPIN IMMUNOL, V60, P19, DOI 10.1016/j.coi.2019.04.013; Farouk SE, 2004, EUR J IMMUNOL, V34, P2248, DOI 10.1002/eji.200424861; Farrington LA, 2016, J INFECT DIS, V213, P1483, DOI 10.1093/infdis/jiv600; Goodier MR, 2020, IMMUNOL REV, V293, P25, DOI 10.1111/imr.12798; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Guenot M, 2015, INFECT IMMUN, V83, P3816, DOI 10.1128/IAI.00446-15; Hart GT, 2019, J EXP MED, V216, P1280, DOI 10.1084/jem.20181681; Hernandez-Castaneda MA, 2020, J IMMUNOL, V204, P1798, DOI 10.4049/jimmunol.1900725; Himoudi N, 2012, J IMMUNOL, V188, P1708, DOI 10.4049/jimmunol.1102654; Howard J, 2017, J INFECT DIS, V215, P1569, DOI 10.1093/infdis/jix149; Hsiao CHC, 2014, CHEM BIOL, V21, P945, DOI 10.1016/j.chembiol.2014.06.006; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jagannathan P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10624-3; Jagannathan P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009793; Junqueira C, 2018, NAT MED, V24, P1330, DOI 10.1038/s41591-018-0117-4; Karunakaran MM, 2020, IMMUNITY, V52, P487, DOI 10.1016/j.immuni.2020.02.014; Kurup SP, 2019, NAT REV IMMUNOL, V19, P457, DOI 10.1038/s41577-019-0158-z; Liu CX, 2018, CELL IMMUNOL, V334, P11, DOI 10.1016/j.cellimm.2018.08.012; Meuter S, 2010, P NATL ACAD SCI USA, V107, P8730, DOI 10.1073/pnas.1002769107; Moebius J, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00711-19; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Muto M, 2015, CANCER IMMUNOL IMMUN, V64, P941, DOI 10.1007/s00262-015-1700-x; Pichyangkul S, 1997, J INFECT DIS, V176, P233, DOI 10.1086/514029; Ramsey JM, 2002, J PARASITOL, V88, P59, DOI 10.1645/0022-3395(2002)088[0059:PFAPVG]2.0.CO;2; Rayenhill BJ, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0596-y; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rigau M, 2020, SCIENCE, V367, P642, DOI 10.1126/science.aay5516; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; SILVESTR.D, 1970, NATURE, V228, P67, DOI 10.1038/228067a0; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Thiery J, 2010, CURR PROTOC CELL BIO, V47, P3371, DOI 10.1002/0471143030.cb0337s47; Troye-Blomberg M, 1999, SCAND J IMMUNOL, V50, P642, DOI 10.1046/j.1365-3083.1999.00647.x; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wang H, 2013, J IMMUNOL, V191, P1029, DOI 10.4049/jimmunol.1300658; Worku S, 1997, CLIN EXP IMMUNOL, V108, P34, DOI 10.1046/j.1365-2249.1997.d01-981.x; Wu Y, 2009, J IMMUNOL, V183, P5622, DOI 10.4049/jimmunol.0901772; Yang YY, 2019, IMMUNITY, V50, P1043, DOI 10.1016/j.immuni.2019.02.016; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zaidi I, 2017, J IMMUNOL, V199, P3781, DOI 10.4049/jimmunol.1700314	53	29	29	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					347	+		10.1038/s41590-020-00847-4	http://dx.doi.org/10.1038/s41590-020-00847-4		JAN 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33432229	Green Accepted			2022-12-18	WOS:000607030200003
J	Inclan-Rico, JM; Ponessa, JJ; Valero-Pacheco, N; Hernandez, CM; Sy, CB; Lemenze, AD; Beaulieu, AM; Siracusa, MC				Inclan-Rico, Juan M.; Ponessa, John J.; Valero-Pacheco, Nuriban; Hernandez, Christina M.; Sy, Chandler B.; Lemenze, Alexander D.; Beaulieu, Aimee M.; Siracusa, Mark C.			Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition	NATURE IMMUNOLOGY			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; TYPE-2 IMMUNITY; NEURONAL REGULATION; MAST-CELLS; RESPONSES; NEUROMEDIN; INDUCTION; INFECTION; INSIGHTS	Siracusa and colleagues reveal a regulatory role for basophils in the context of anti-helminth immunity and identify the neuropeptide neuromedin B as a potent inhibitor of type 2 inflammation. Type 2 cytokine responses promote parasitic immunity and initiate tissue repair; however, they can also result in immunopathologies when not properly restricted. Although basophilia is recognized as a common feature of type 2 inflammation, the roles basophils play in regulating these responses are unknown. Here, we demonstrate that helminth-induced group 2 innate lymphoid cell (ILC2) responses are exaggerated in the absence of basophils, resulting in increased inflammation and diminished lung function. Additionally, we show that ILC2s from basophil-depleted mice express reduced amounts of the receptor for the neuropeptide neuromedin B (NMB). Critically, NMB stimulation inhibited ILC2 responses from control but not basophil-depleted mice, and basophils were sufficient to directly enhance NMB receptor expression on ILC2s. These studies suggest that basophils prime ILC2s to respond to neuron-derived signals necessary to maintain tissue integrity. Further, these data provide mechanistic insight into the functions of basophils and identify NMB as a potent inhibitor of type 2 inflammation.	[Inclan-Rico, Juan M.; Ponessa, John J.; Valero-Pacheco, Nuriban; Hernandez, Christina M.; Sy, Chandler B.; Beaulieu, Aimee M.; Siracusa, Mark C.] Rutgers State Univ, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 08854 USA; [Inclan-Rico, Juan M.; Ponessa, John J.; Hernandez, Christina M.; Sy, Chandler B.; Siracusa, Mark C.] Rutgers State Univ, New Jersey Med Sch, Dept Med, Newark, NJ 08854 USA; [Valero-Pacheco, Nuriban; Beaulieu, Aimee M.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Lemenze, Alexander D.] Rutgers State Univ, New Jersey Med Sch, Dept Pathol Immunol & Lab Med, Newark, NJ USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Siracusa, MC (corresponding author), Rutgers State Univ, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 08854 USA.; Siracusa, MC (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Med, Newark, NJ 08854 USA.	mark.siracusa@rutgers.edu	Valero-Pacheco, Nuriban/GPS-5781-2022	Valero-Pacheco, Nuriban/0000-0001-6091-6043; Inclan-Rico, Juan/0000-0003-1134-9139; Sy, Chandler/0000-0002-8739-561X; Siracusa, Mark/0000-0003-3499-5408; Ponessa, John/0000-0002-0245-7667; Hernandez, Christina/0000-0001-5788-6138	National Institutes of Health [RO1 AI123224, RO1 AI131634, T32AI125185, 3R01AI131634-02W1]; Mexican Council of Science Technology [CVU 536876]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mexican Council of Science Technology	We thank members of the Center for Immunity and Inflammation for discussions and critical reading, the New Jersey Medical School (NJMS) Flow Cytometry and Immunology Core Laboratory for technical assistance and the NJMS Histology Core and the NJMS Genomics Research Lab for bioinformatics assistance. We thank D. Voehringer for kindly providing the Mcpt8Cre mice and D. Sant'Angelo for providing the OP9-DL1 cell line. This work was supported by the National Institutes of Health (grant nos. RO1 AI123224 and RO1 AI131634 to M.C.S., T32AI125185 to C.B.S. and 3R01AI131634-02W1 to C.M.H.). J.M.I.R. is supported by the Mexican Council of Science & Technology (CVU 536876).	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; [Anonymous], 2016, WKLY EPIDEMIOL REC, V91, P585; Bouchery T, 2017, Curr Protoc Mouse Biol, V7, P236, DOI 10.1002/cpmo.34; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Flamar AL, 2020, IMMUNITY, V52, P606, DOI 10.1016/j.immuni.2020.02.009; Gajjar S, 2017, PHARMACOL REP, V69, P438, DOI 10.1016/j.pharep.2017.01.009; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Giacomin PR, 2012, J IMMUNOL, V189, P4371, DOI 10.4049/jimmunol.1200691; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Han H, 2018, MUCOSAL IMMUNOL, V11, P394, DOI 10.1038/mi.2017.61; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inclan-Rico JM, 2018, TRENDS PARASITOL, V34, P861, DOI 10.1016/j.pt.2018.08.007; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Joseph C, 2013, CELL STEM CELL, V13, P520, DOI 10.1016/j.stem.2013.10.010; Jourdan PM, 2018, LANCET, V391, P252, DOI 10.1016/S0140-6736(17)31930-X; Jungblut Melanie, 2009, J Vis Exp, DOI 10.3791/1266; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Klose CSN, 2019, CURR OPIN IMMUNOL, V56, P94, DOI 10.1016/j.coi.2018.11.002; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marsland BJ, 2008, EUR J IMMUNOL, V38, P479, DOI 10.1002/eji.200737827; Minutti CM, 2019, IMMUNITY, V50, P645, DOI 10.1016/j.immuni.2019.01.008; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; OGILVIE BM, 1978, EXP PARASITOL, V46, P20, DOI 10.1016/0014-4894(78)90153-4; Ohki-Hamazaki H, 2000, PROG NEUROBIOL, V62, P297, DOI 10.1016/S0301-0082(00)00004-6; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; ROTH RL, 1980, EXP PARASITOL, V50, P331, DOI 10.1016/0014-4894(80)90036-3; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Santoro R, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10144687; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Ugajin T, 2011, AM J PATHOL, V179, P775, DOI 10.1016/j.ajpath.2011.04.023; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Webb LM, 2019, J EXP MED, V216, P1268, DOI 10.1084/jem.20180131; Zhan B, 2014, EXPERT REV VACCINES, V13, P321, DOI 10.1586/14760584.2014.872035; Zhou Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00501	62	29	29	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1181	+		10.1038/s41590-020-0753-y	http://dx.doi.org/10.1038/s41590-020-0753-y		AUG 2020	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32807943	Green Accepted			2022-12-18	WOS:000561014100003
J	Sajti, E; Link, VM; Ouyang, ZY; Spann, NJ; Westin, E; Romanoski, CE; Fonseca, GJ; Prince, LS; Glass, CK				Sajti, Eniko; Link, Verena M.; Ouyang, Zhengyu; Spann, Nathanael J.; Westin, Emma; Romanoski, Casey E.; Fonseca, Gregory J.; Prince, Lawrence S.; Glass, Christopher K.			Transcriptomic and epigenetic mechanisms underlying myeloid diversity in the lung	NATURE IMMUNOLOGY			English	Article							FETAL MONOCYTES; MACROPHAGES; DIFFERENTIATION; RESOLUTION; INDUCTION; RESPONSES; SELECTION; RECEPTOR; INJURY	The lung harbors multiple macrophage subsets that play distinct roles. Sajti and colleagues perform genome-wide epigenetic profiling on sorted populations of lung myeloid cell subsets to determine the effects of genetic background and inflammatory insults on gene expression patterns. The lung is inhabited by resident alveolar and interstitial macrophages as well as monocytic cells that survey lung tissues. Each cell type plays distinct functional roles under homeostatic and inflammatory conditions, but mechanisms establishing their molecular identities and functional potential remain poorly understood. In the present study, systematic evaluation of transcriptomes and open chromatin of alveolar macrophages (AMs), interstitial macrophages (IMs) and lung monocytes from two mouse strains enabled inference of common and cell-specific transcriptional regulators. We provide evidence that these factors drive selection of regulatory landscapes that specify distinct phenotypes of AMs and IMs and entrain qualitatively different responses to toll-like receptor 4 signaling in vivo. These studies reveal a striking divergence in a fundamental innate immune response pathway in AMs and establish a framework for further understanding macrophage diversity in the lung.	[Sajti, Eniko; Prince, Lawrence S.] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, La Jolla, CA 92093 USA; [Link, Verena M.; Ouyang, Zhengyu; Spann, Nathanael J.; Westin, Emma; Romanoski, Casey E.; Fonseca, Gregory J.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Link, Verena M.] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Romanoski, Casey E.] Univ Arizona, Coll Med, Dept Cellular & Mol Med, Biosci Res Labs, Tucson, AZ USA; [Fonseca, Gregory J.] McGill Univ, Dept Med, Div Quantitat Life Sci, Meakins Christie Labs,Hlth Ctr, Montreal, PQ, Canada; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Arizona; McGill University; University of California System; University of California San Diego	Sajti, E (corresponding author), Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, La Jolla, CA 92093 USA.	esajti@health.ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Sajti, Eniko/0000-0002-0531-7715; Westin, Emma/0000-0002-9236-2548; Prince, Lawrence/0000-0002-7010-4548; Link, Verena/0000-0002-3207-312X; Romanoski, Casey/0000-0002-0149-225X	National Institutes of Health (NIH) [DK091183, DK063491]; NIH [K08HL140198, R00HL123485, R01HL147187, HL086324, HL126703, HL143256]; Gerber Foundation [1823-3830]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerber Foundation	These studies were supported by National Institutes of Health (NIH) grants (nos. DK091183 and DK063491). E.S. was supported by a NIH grant (no. K08HL140198). C.E.R. was supported by NIH grants (nos. R00HL123485 and R01HL147187). L.S.P. was supported by NIH grants (nos. HL086324, HL126703 and HL143256) and the Gerber Foundation (grant no. 1823-3830). We thank T. Rombaldo for assistance with FACS, J. Collier for technical assistance and L. van Ael for help with preparation of the manuscript. Sequencing of RNA-seq and ATAC-seq libraries was conducted at the IGM Genomics Center, University of California San Diego, La Jolla, CA.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Ardini-Poleske ME, 2017, AM J PHYSIOL-LUNG C, V313, pL733, DOI 10.1152/ajplung.00139.2017; Baker AD, 2010, BIOCHEM BIOPH RES CO, V393, P682, DOI 10.1016/j.bbrc.2010.02.056; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jardine L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09913-4; Kannan MB, 2012, BBA-MOL CELL RES, V1823, P1841, DOI 10.1016/j.bbamcr.2012.06.012; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Link VM, 2018, NUCLEIC ACIDS RES, V46, P7006, DOI 10.1093/nar/gky491; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; Russell CD, 2014, IMMUNOLOGY, V141, P166, DOI 10.1111/imm.12206; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; Tatham KC, 2018, THORAX, V73, P350, DOI 10.1136/thoraxjnl-2016-208977; Thomas GD, 2016, IMMUNITY, V45, P975, DOI 10.1016/j.immuni.2016.10.011; Whitehead GS, 2006, IMMUNOGENETICS, V58, P793, DOI 10.1007/s00251-006-0147-9; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Zhang DX, 2013, J MOL ENDOCRINOL, V51, pT37, DOI 10.1530/JME-13-0216; Zhen A, 2014, J VIROL, V88, P9934, DOI 10.1128/JVI.00616-14	52	29	30	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					221	+		10.1038/s41590-019-0582-z	http://dx.doi.org/10.1038/s41590-019-0582-z		JAN 2020	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31959980	Green Submitted, Green Accepted			2022-12-18	WOS:000508964100001
J	Lo, WL; Shah, NH; Rubin, SA; Zhang, WG; Horkova, V; Fallahee, IR; Stepanek, O; Zon, LI; Kuriyan, J; Weiss, A				Lo, Wan-Lin; Shah, Neel H.; Rubin, Sara A.; Zhang, Weiguo; Horkova, Veronika; Fallahee, Ian R.; Stepanek, Ondrej; Zon, Leonard I.; Kuriyan, John; Weiss, Arthur			Slow phosphorylation of a tyrosine residue in LAT optimizes T cell ligand discrimination	NATURE IMMUNOLOGY			English	Article							HOMOLOGY 2 DOMAIN; LYMPHOPROLIFERATIVE DISEASE; PHOSPHOLIPASE C-GAMMA-1; SIGNALING COMPLEXES; SELF-PEPTIDES; ACTIVATION; RECEPTOR; TCR; LINKER; BINDING	Self-non-self discrimination is central to T cell-mediated immunity. The kinetic proofreading model can explain T cell antigen receptor (TCR) ligand discrimination; however, the rate-limiting steps have not been identified. Here, we show that tyrosine phosphorylation of the T cell adapter protein LAT at position Y132 is a critical kinetic bottleneck for ligand discrimination. LAT phosphorylation at Y132, mediated by the kinase ZAP-70, leads to the recruitment and activation of phospholipase C-gamma 1 (PLC-gamma 1), an important effector molecule for T cell activation. The slow phosphorylation of Y132, relative to other phosphosites on LAT, is governed by a preceding glycine residue (G131) but can be accelerated by substituting this glycine with aspartate or glutamate. Acceleration of Y132 phosphorylation increases the speed and magnitude of PLC-gamma 1 activation and enhances T cell sensitivity to weaker stimuli, including weak agonists and self-peptides. These observations suggest that the slow phosphorylation of Y132 acts as a proofreading step to facilitate T cell ligand discrimination.	[Lo, Wan-Lin; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Rosalind Russell & Ephraim P Engleman Arthrit Res, Div Rheumatol, San Francisco, CA 94143 USA; [Shah, Neel H.; Fallahee, Ian R.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Rubin, Sara A.; Zon, Leonard I.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rubin, Sara A.; Zon, Leonard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Rubin, Sara A.; Zon, Leonard I.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Rubin, Sara A.; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Rubin, Sara A.; Zon, Leonard I.] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA; [Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Horkova, Veronika; Stepanek, Ondrej] Czech Acad Sci, Inst Mol Genet, Prague, Czech Republic; [Zon, Leonard I.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA; [Zon, Leonard I.] Harvard Univ, Boston, MA 02115 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Shah, Neel H.] Columbia Univ, Dept Chem, New York, NY 10027 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Duke University; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Columbia University	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Rosalind Russell & Ephraim P Engleman Arthrit Res, Div Rheumatol, San Francisco, CA 94143 USA.; Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	art.weiss@ucsf.edu	Shah, Neel H/AAD-9217-2022; Stepanek, Ondrej/AAG-3180-2020	Shah, Neel H/0000-0002-1186-0626; Stepanek, Ondrej/0000-0002-2735-3311; Weiss, Arthur/0000-0002-2414-9024; Horkova, Veronika/0000-0002-3679-2236	Jane Coffin Childs Fund [61-1560]; Damon Runyon Cancer Research Foundation [DRG 2198-14, DFS 31-18]; Czech Science Foundation [19-03435Y]; Howard Hughes Medical Institute; NIH, NIAID [P01 AI091580-06, 1R37AI114575]; DRC Center [P30 DK063720]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI114575, P01AI091580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Jane Coffin Childs Fund; Damon Runyon Cancer Research Foundation; Czech Science Foundation(Grant Agency of the Czech Republic); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DRC Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Roque (University of California, San Francisco) for animal husbandry, S. Muratcioglu (University of California, Berkeley) for providing the GFP-labeled PLC-gamma 1 tandem N-SH2 protein, the NIH Tetramer Core Facility for providing the OVA and APL peptide-loaded H-2K<SUP>b</SUP> monomers or OVA-loaded H-2A<SUP>b</SUP> tetramers, the UCSF Parnassus Flow Cytometry Core for maintaining the BD FACSAria II, R. Mathieu (Boston Children's Hospital) and the BCH Department of Hematology/Oncology Flow Cytometry Research Facility for technical assistance, B. Au-Yeung (Emory University), P. Allen and D. Donermeyer (Washington University in St. Louis), and G. Morris and L.-F. Lu (University of California, San Diego) for critical feedback on the manuscript. The work was supported by the Jane Coffin Childs Fund 61-1560 (to W.-L.L.), the Damon Runyon Cancer Research Foundation DRG 2198-14 and DFS 31-18 (to N.H.S.), the Czech Science Foundation 19-03435Y (to O. S.), the Howard Hughes Medical Institute (to A.W. and J.K.) and NIH, NIAID P01 AI091580-06 (to A.W. and J.K.), 1R37AI114575 (to A. W.), and DRC Center Grant P30 DK063720 (UCSF Parnassus Flow Cytometry Core). All data to understand and access the conclusions of this study are available in the main text, the supplementary materials, and the indicated repositories.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Bartelt RR, 2013, WIRES SYST BIOL MED, V5, P101, DOI 10.1002/wsbm.1194; Brameshuber M, 2018, NAT IMMUNOL, V19, P487, DOI 10.1038/s41590-018-0092-4; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Conrad ML, 2007, CYTOM PART A, V71A, P925, DOI 10.1002/cyto.a.20435; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Covacu R, 2016, CELL REP, V14, P2733, DOI 10.1016/j.celrep.2016.02.056; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui WP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202331; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Feinerman O, 2008, MOL IMMUNOL, V45, P619, DOI 10.1016/j.molimm.2007.03.028; Flajnik MF, 2018, NAT REV IMMUNOL, V18, P438, DOI 10.1038/s41577-018-0003-9; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Germain RN, 2010, FEBS LETT, V584, P4814, DOI 10.1016/j.febslet.2010.10.027; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Lo WL, 2018, NAT IMMUNOL, V19, P733, DOI 10.1038/s41590-018-0131-1; Lo WL, 2014, ELIFE, V3, DOI 10.7554/eLife.01457; Lo WL, 2014, CURR TOP MICROBIOL, V373, P49, DOI 10.1007/82_2013_319; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Miyaji M, 2009, P NATL ACAD SCI USA, V106, P14502, DOI 10.1073/pnas.0903894106; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Saavedra HG, 2018, NATURE, V558, P324, DOI 10.1038/s41586-018-0183-2; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Shah NH, 2018, ELIFE, V7, DOI 10.7554/eLife.35190; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Siller-Farfan JA, 2018, IMMUNOL REV, V285, P194, DOI 10.1111/imr.12690; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Stoica B, 1998, J IMMUNOL, V160, P1059; Sun SQ, 1998, J EXP MED, V188, P2335, DOI 10.1084/jem.188.12.2335; Tang MAK, 2014, PROTEIN J, V33, P313, DOI 10.1007/s10930-014-9562-1; Thill PA, 2016, MOL CELL BIOL, V36, P2396, DOI 10.1128/MCB.00165-16; Tischer DK, 2019, ELIFE, V8, DOI 10.7554/eLife.42498; WEISS A, 1987, J IMMUNOL, V138, P2169; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; Yousefi OS, 2019, ELIFE, V8, DOI 10.7554/eLife.42475; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	58	29	29	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1481	+		10.1038/s41590-019-0502-2	http://dx.doi.org/10.1038/s41590-019-0502-2			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31611699	Green Accepted, Green Submitted			2022-12-18	WOS:000492309600018
J	Fischer, J; Walter, C; Tonges, A; Aleth, H; Jordao, MJC; Leddin, M; Groning, V; Erdmann, T; Lenz, G; Roth, J; Vogl, T; Prinz, M; Dugas, M; Jacobsen, ID; Rosenbauer, F				Fischer, Josephine; Walter, Carolin; Toenges, Alexander; Aleth, Hanna; Jordao, Marta Joana Costa; Leddin, Mathias; Groening, Verena; Erdmann, Tabea; Lenz, Georg; Roth, Johannes; Vogl, Thomas; Prinz, Marco; Dugas, Martin; Jacobsen, Ilse D.; Rosenbauer, Frank			Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophils	NATURE IMMUNOLOGY			English	Article							THROUGHPUT CHROMATIN IMMUNOPRECIPITATION; CANDIDA-ALBICANS; ACTIVATION STATE; INNATE IMMUNITY; MACROPHAGE; INFECTION; BINDING; PROTEIN; DEFICIENCY; CHEMOKINES	Neutrophils are essential first-line defense cells against invading pathogens, yet when inappropriately activated, their strong immune response can cause collateral tissue damage and contributes to immunological diseases. However, whether neutrophils can intrinsically titrate their immune response remains unknown. Here we conditionally deleted the Spi1 gene, which encodes the myeloid transcription factor PU.1, from neutrophils of mice undergoing fungal infection and then performed comprehensive epigenomic profiling. We found that as well as providing the transcriptional prerequisite for eradicating pathogens, the predominant function of PU.1 was to restrain the neutrophil defense by broadly inhibiting the accessibility of enhancers via the recruitment of histone deacetylase 1. Such epigenetic modifications impeded the immunostimulatory AP-1 transcription factor JUNB from entering chromatin and activating its targets. Thus, neutrophils rely on a PU.1-installed inhibitor program to safeguard their epigenome from undergoing uncontrolled activation, protecting the host against an exorbitant innate immune response.	[Fischer, Josephine; Toenges, Alexander; Aleth, Hanna; Groening, Verena; Rosenbauer, Frank] Univ Munster, Inst Mol Tumor Biol, Munster, Germany; [Walter, Carolin; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany; [Jordao, Marta Joana Costa; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany; [Jordao, Marta Joana Costa] Univ Freiburg, Fac Biol, Freiburg, Germany; [Leddin, Mathias] Max Delbruck Ctr Mol Med, Berlin, Germany; [Erdmann, Tabea; Lenz, Georg] Univ Hosp Muenster, Dept Med A, Munster, Germany; [Roth, Johannes; Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Ctr NeuroModulat, Fac Med, Freiburg, Germany; [Jacobsen, Ilse D.] Hans Knoell Inst, Res Grp Microbial Immunol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Jacobsen, Ilse D.] Friedrich Schiller Univ, Inst Microbiol, Jena, Germany; [Leddin, Mathias] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev Informat, Basel, Switzerland	University of Munster; University of Munster; University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munster; University of Munster; University of Freiburg; University of Freiburg; University of Freiburg; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Roche Holding	Rosenbauer, F (corresponding author), Univ Munster, Inst Mol Tumor Biol, Munster, Germany.	frank.rosenbauer@ukmuenster.de		Fischer, Josephine/0000-0003-3773-9311	Deutsche Forschungsgemeinschaft (DFG) [RO2295/6-1]; University of Muenster Medical Faculty [Ros2/007/15]; DFG [SFB992, SFB1160, SFB/TRR167]; DFG (Reinhart-Koselleck-Grant)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Muenster Medical Faculty; DFG(German Research Foundation (DFG)); DFG (Reinhart-Koselleck-Grant)(German Research Foundation (DFG))	We thank J. Rettkowski and J. Kamping for assistance with experiments, T. Konig for FACS sorting, J. Brands for help with figure preparations and C. Brennecka for linguistic support. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; RO2295/6-1) and the University of Muenster Medical Faculty (Ros2/007/15) to F.R. M.P. is supported by the DFG (SFB992, SFB1160, SFB/TRR167, Reinhart-Koselleck-Grant).	Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai YC, 2005, J IMMUNOL, V175, P5160, DOI 10.4049/jimmunol.175.8.5160; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; CHAM BP, 1994, AM J PATHOL, V144, P1369; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DETMERS PA, 1990, J EXP MED, V171, P1155, DOI 10.1084/jem.171.4.1155; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Egesten A, 2007, INT J COLORECTAL DIS, V22, P1421, DOI 10.1007/s00384-007-0370-3; Elmore SA, 2016, TOXICOL PATHOL, V44, P173, DOI 10.1177/0192623315625859; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fontana MF, 2015, J IMMUNOL, V194, P177, DOI 10.4049/jimmunol.1401595; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Fradin C, 2007, INFECT IMMUN, V75, P1493, DOI 10.1128/IAI.01651-06; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier L., 2004, AFFY ANAL AFFYMETRIX; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jacobsen ID, 2014, J ANTIMICROB CHEMOTH, V69, P2785, DOI 10.1093/jac/dku198; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kihara-Negishi F, 2001, ONCOGENE, V20, P6039, DOI 10.1038/sj.onc.1204756; Kolodziej KE, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-6; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McDonald B, 2012, TOXICOL PATHOL, V40, P157, DOI 10.1177/0192623311427570; MCQUITTY LL, 1966, EDUC PSYCHOL MEAS, V26, P825, DOI 10.1177/001316446602600402; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Ostuni R, 2016, SEMIN IMMUNOL, V28, P83, DOI 10.1016/j.smim.2016.04.002; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Persy VP, 2003, KIDNEY INT, V63, P543, DOI 10.1046/j.1523-1755.2003.00767.x; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sahoo M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004327; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tak T, 2015, CLIN EXP IMMUNOL, V182, P204, DOI 10.1111/cei.12676; Taslim C, 2009, BIOINFORMATICS, V25, P2334, DOI 10.1093/bioinformatics/btp384; Tecchio C, 2016, SEMIN IMMUNOL, V28, P119, DOI 10.1016/j.smim.2016.04.003; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tuite A, 2004, GENES IMMUN, V5, P576, DOI 10.1038/sj.gene.6364130; van Riel B, 2014, BIOL CHEM, V395, P1265, DOI 10.1515/hsz-2014-0195; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wenzel SS, 2013, LEUKEMIA, V27, P1381, DOI 10.1038/leu.2012.367; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Yamamoto H, 1999, ONCOGENE, V18, P1495, DOI 10.1038/sj.onc.1202427; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	71	29	32	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					546	+		10.1038/s41590-019-0343-z	http://dx.doi.org/10.1038/s41590-019-0343-z			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30911105				2022-12-18	WOS:000465084800012
J	Koh, AS; Miller, EL; Buenrostro, JD; Moskowitz, DM; Wang, J; Greenleaf, WJ; Chang, HY; Crabtree, GR				Koh, Andrew S.; Miller, Erik L.; Buenrostro, Jason D.; Moskowitz, David M.; Wang, Jing; Greenleaf, William J.; Chang, Howard Y.; Crabtree, Gerald R.			Rapid chromatin repression by Aire provides precise control of immune tolerance	NATURE IMMUNOLOGY			English	Article							PROMISCUOUS GENE-EXPRESSION; EPITHELIAL-CELLS; THYMIC EPITHELIUM; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; PHD FINGER; ANTIGEN; COMPLEXES; PATTERNS; REVEALS	Aire mediates the expression of tissue-specific antigens in thymic epithelial cells to promote tolerance against self-reactive T lymphocytes. However, the mechanism that allows expression of tissue-specific genes at levels that prevent harm is unknown. Here we show that Brg1 generates accessibility at tissue-specific loci to impose central tolerance. We found that Aire has an intrinsic repressive function that restricts chromatin accessibility and opposes Brg1 across the genome. Aire exerted this repressive influence within minutes after recruitment to chromatin and restrained the amplitude of active transcription. Disease-causing mutations that impair Aire-induced activation also impair the protein's repressive function, which indicates dual roles for Aire. Together, Brg1 and Aire fine-tune the expression of tissue-specific genes at levels that prevent toxicity yet promote immune tolerance.	[Koh, Andrew S.; Miller, Erik L.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Koh, Andrew S.; Moskowitz, David M.; Greenleaf, William J.; Chang, Howard Y.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Koh, Andrew S.; Miller, Erik L.; Crabtree, Gerald R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Miller, Erik L.; Moskowitz, David M.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Buenrostro, Jason D.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Buenrostro, Jason D.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Wang, Jing; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Greenleaf, William J.] Chan Zuckerburg Biohub, San Francisco, CA USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Stanford University	Koh, AS; Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Koh, AS; Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Koh, AS; Crabtree, GR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	ashkoh@stanford.edu; crabtree@stanford.edu		Crabtree, Robert/0000-0002-6639-8707; Moskowitz, David/0000-0003-4878-0053	Howard Hughes Medical Institute; NIH [CA163915, NS046789, P50-HG007735, T32HG000044, T32 GM007790]; Lymphoma and Leukemia Society; National Library of Medicine [LM-07033]; NATIONAL CANCER INSTITUTE [R01CA163915] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R01NS046789] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to N. Manley (University of Georgia, Athens, GA, USA) for Foxn1ex9Cre mice; N. Hathaway (University of North Carolina, Chapel Hill, NC, USA), C. Kadoch (Harvard Medical School, Boston, MA, USA), S. Braun (Stanford University, Stanford, CA, USA) and E. Chory (Stanford University, Stanford, CA, USA) for CiA constructs; M. Toribio (Universidad Autonoma de Madrid, Madrid, Spain) and D. Mathis (Harvard Medical School, Boston, MA, USA) for the 4D6 cTEC line; D. Mathis, M. Anderson and S. Denny for insightful comments; Y. Chien, C. Weber, J. Kirkland, L. Wagar and J. Ronan for critical reading of the manuscript; and J. Gardner, P. Chu and R. Li for technical assistance. We thank the Stanford Shared FACS facility and S. Kim for flow cytometry and cell sorting. The Stanford BioX3 cluster was used for computational analyses (NIH S10 grant 1S10RR02664701). This work was supported by the Howard Hughes Medical Institute (to G.R.C.), the NIH (grants CA163915 and NS046789 to G. R. C., P50-HG007735 to H.Y.C. and W.J.G., T32HG000044 to J.D.B., and T32 GM007790 to E.L.M.), the Lymphoma and Leukemia Society (A.S.K.) and the National Library of Medicine (Stanford Biomedical Informatics Training Grant LM-07033 to D.M.M.).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Bruserud O, 2016, CURR OPIN IMMUNOL, V43, P8, DOI 10.1016/j.coi.2016.07.003; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Falanga A, 2015, SEMIN THROMB HEMOST, V41, P756, DOI 10.1055/s-0035-1564040; FERNANDEZ E, 1994, BLOOD, V83, P3245; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iglesias P, 2014, EUR J ENDOCRINOL, V170, pR147, DOI 10.1530/EJE-13-1012; Jain R, 2014, CURR PROTOC IMMUNOL, V107; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; John S, 2013, CURR PROTOC MOL BIOL, P1; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lin JQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10562; Lomada D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005777; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Manley NR, 2010, PROG MOL BIOL TRANSL, V92, P103, DOI 10.1016/S1877-1173(10)92005-X; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Miller EL, 2017, NAT STRUCT MOL BIOL, V24, P344, DOI 10.1038/nsmb.3384; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Satoh R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005776; Schneider R, 2010, EXP CLIN ENDOCR DIAB, V118, P520, DOI 10.1055/s-0029-1231083; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Takahama Y, 2017, NAT REV IMMUNOL, V17, P295, DOI 10.1038/nri.2017.12; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trotter KW, 2015, MOL CELL BIOL, V35, P2799, DOI 10.1128/MCB.00230-15; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	69	29	30	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					162	+		10.1038/s41590-017-0032-8	http://dx.doi.org/10.1038/s41590-017-0032-8			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29335648	Green Accepted			2022-12-18	WOS:000423435200016
J	Roufaiel, M; Gracey, E; Siu, A; Zhu, SN; Lau, A; Ibrahim, H; Althagafi, M; Tai, K; Hyduk, SJ; Cybulsky, KO; Ensan, S; Li, A; Besla, R; Becker, HM; Xiao, HY; Luther, SA; Inman, RD; Robbins, CS; Jongstra-Bilen, J; Cybulsky, MI				Roufaiel, Mark; Gracey, Eric; Siu, Allan; Zhu, Su-Ning; Lau, Andrew; Ibrahim, Hisham; Althagafi, Marwan; Tai, Kelly; Hyduk, Sharon J.; Cybulsky, Kateryna O.; Ensan, Sherine; Li, Angela; Besla, Rickvinder; Becker, Henry M.; Xiao, Haiyan; Luther, Sanjiv A.; Inman, Robert D.; Robbins, Clinton S.; Jongstra-Bilen, Jenny; Cybulsky, Myron I.			CCL19-CCR7 dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; OXIDIZED LDL; BONE-MARROW; JAM-C; PNEUMONIAE; MACROPHAGES; EMIGRATION; INFECTION; MOUSE; ATHEROSCLEROSIS	Regions of the normal arterial intima predisposed to atherosclerosis are sites of ongoing monocyte trafficking and also contain resident myeloid cells with features of dendritic cells. However, the pathophysiological roles of these cells are poorly understood. Here we found that intimal myeloid cells underwent reverse transendothelial migration (RTM) into the arterial circulation after systemic stimulation of pattern-recognition receptors (PRRs). This process was dependent on expression of the chemokine receptor CCR7 and its ligand CCL19 by intimal myeloid cells. In mice infected with the intracellular pathogen Chlamydia muridarum, blood monocytes disseminated infection to the intima. Subsequent CCL19-CCR7 dependent RTM was critical for the clearance of intimal C. muridarum. This process was inhibited by hypercholesterolemia. Thus, RTM protects the normal arterial intima, and compromised RTM during atherogenesis might contribute to the intracellular retention of pathogens in atherosclerotic lesions.	[Roufaiel, Mark; Siu, Allan; Zhu, Su-Ning; Lau, Andrew; Ibrahim, Hisham; Althagafi, Marwan; Tai, Kelly; Hyduk, Sharon J.; Cybulsky, Kateryna O.; Ensan, Sherine; Li, Angela; Besla, Rickvinder; Becker, Henry M.; Xiao, Haiyan; Robbins, Clinton S.; Jongstra-Bilen, Jenny; Cybulsky, Myron I.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Roufaiel, Mark; Siu, Allan; Ibrahim, Hisham; Althagafi, Marwan; Besla, Rickvinder; Becker, Henry M.; Robbins, Clinton S.; Jongstra-Bilen, Jenny; Cybulsky, Myron I.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gracey, Eric; Inman, Robert D.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Gracey, Eric; Tai, Kelly; Ensan, Sherine; Li, Angela; Becker, Henry M.; Inman, Robert D.; Robbins, Clinton S.; Jongstra-Bilen, Jenny; Cybulsky, Myron I.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, Ctr Immun & Infect Lausanne, CH-1015 Lausanne, Switzerland; [Inman, Robert D.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Lausanne; University of Toronto	Cybulsky, MI (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.; Cybulsky, MI (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Cybulsky, MI (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	myron.cybulsky@utoronto.ca	Luther, Sanjiv/AAP-6525-2020; Cybulsky, Myron I./AAD-6539-2019; Luther, Sanjiv A/B-4380-2016; Gracey, Eric/AAD-7560-2020	Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; Cybulsky, Myron/0000-0002-1696-2867; Inman, Robert/0000-0002-4750-1422; Gracey, Eric/0000-0003-0984-435X; Hyduk, Sharon J./0000-0003-2862-0300; Robbins, Clinton/0000-0001-9848-1495	Canadian Institutes of Health Research [MOP-84446, MOP-106522, MOP-89740]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank P. Lesnik (University of Pierre and Marie Curie) for CD1lc-hBcl-2mice; M.C. Nussenzweig (The Rockefeller University) for CD11c-eYFP mice;	Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cybulsky MI, 2016, CIRC RES, V118, P637, DOI 10.1161/CIRCRESAHA.115.306542; deBruijn MFTR, 1996, EUR J IMMUNOL, V26, P2850, DOI 10.1002/eji.1830261208; Evani SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19058; Filardo S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/378658; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fujimura N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11664; Gautier EL, 2008, J IMMUNOL, V180, P6941, DOI 10.4049/jimmunol.180.10.6941; Gieffers J, 2001, CIRCULATION, V103, P351; Gracey E, 2015, EUR J IMMUNOL, V45, P3417, DOI 10.1002/eji.201545874; Grayston JT, 1999, CLIN INFECT DIS, V28, P993, DOI 10.1086/514764; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; Huttenlocher A, 2008, TRENDS CELL BIOL, V18, P298, DOI 10.1016/j.tcb.2008.04.001; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Keiper T, 2005, FASEB J, V19, P2078, DOI 10.1096/fj.05-4196fje; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; Kuo CC, 2000, J INFECT DIS, V181, pS432, DOI 10.1086/315615; Lee JY, 2009, J LEUKOCYTE BIOL, V86, P1285, DOI 10.1189/jlb.0309214; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Millonig G, 2001, ARTERIOSCL THROM VAS, V21, P503, DOI 10.1161/01.ATV.21.4.503; Moazed TC, 1998, J INFECT DIS, V177, P1322, DOI 10.1086/515280; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Rajaram K, 2015, INFECT IMMUN, V83, P3164, DOI 10.1128/IAI.00382-15; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Soloff AC, 2010, CELL RES, V20, P872, DOI 10.1038/cr.2010.94; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Xu X, 2014, COMPUT STRUCT BIOTEC, V9, DOI 10.5936/csbj.201403003; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866; Zimmer S, 2015, CIRC RES, V116, P323, DOI 10.1161/CIRCRESAHA.116.301135	47	29	29	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1263	1272		10.1038/ni.3564	http://dx.doi.org/10.1038/ni.3564			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27668800				2022-12-18	WOS:000386193200006
J	O'Neill, LAJ				O'Neill, Luke A. J.			Glycolytic reprogramming by TLRs in dendritic cells	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMATION; METABOLISM	The activation of dendritic cells by Toll-like receptors leads to a rapid enhancement in glycolysis. Glucose is metabolized to pyruvate and from there to citrate in the mitochondria, which leads ultimately to membrane biosynthesis in the endoplasmic reticulum and Golgi to support the activation of dendritic cells.	Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	7	29	29	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					314	315		10.1038/ni.2852	http://dx.doi.org/10.1038/ni.2852			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24646590				2022-12-18	WOS:000333252000004
J	Chiang, HS; Zhao, Y; Song, JH; Liu, S; Wang, NH; Terhorst, C; Sharpe, AH; Basavappa, M; Jeffrey, KL; Reinecker, HC				Chiang, Hao-Sen; Zhao, Yun; Song, Joo-Hye; Liu, Song; Wang, Ninghai; Terhorst, Cox; Sharpe, Arlene H.; Basavappa, Megha; Jeffrey, Kate L.; Reinecker, Hans-Christian			GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; RIG-I; VIRUS-INFECTION; INNATE IMMUNITY; ACTIN CYTOSKELETON; SIGNALING PATHWAY; DENDRITIC CELLS; EXCHANGE FACTOR	Detailed understanding of the signaling intermediates that confer the sensing of intracellular viral nucleic acids for induction of type I interferons is critical for strategies to curtail viral mechanisms that impede innate immune defenses. Here we show that the activation of the microtubule-associated guanine nucleotide exchange factor GEE-H1, encoded by Arhgef2, is essential for sensing of foreign RNA by RIG-I-like receptors. Activation of GEE-H1 controls RIG-I-dependent and Mda5-dependent phosphorylation of IRF3 and induction of IFN-beta expression in macrophages. Generation of Arhgef2(-/-) mice revealed a pronounced signaling defect that prevented antiviral host responses to encephalomyocarditis virus and influenza A virus. Microtubule networks sequester GEF-H1 that upon activation is released to enable antiviral signaling by intracellular nucleic acid detection pathways.	[Chiang, Hao-Sen; Zhao, Yun; Song, Joo-Hye; Liu, Song; Basavappa, Megha; Jeffrey, Kate L.; Reinecker, Hans-Christian] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Chiang, Hao-Sen; Zhao, Yun; Song, Joo-Hye; Liu, Song; Basavappa, Megha; Jeffrey, Kate L.; Reinecker, Hans-Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA USA; [Wang, Ninghai; Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Immunol, Boston, MA 02215 USA; [Wang, Ninghai; Terhorst, Cox] Harvard Univ, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reinecker, HC (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA.	hans-christian_reinecker@hms.harvard.edu	Chiang, Hao-Sen/K-7658-2019	Chiang, Hao-Sen/0000-0001-5041-9705; Jeffrey, Kate/0000-0001-5746-0153; Chiang, Hao-Sen/0000-0002-6762-0293	US National Institutes of Health [AI-093588, DK-068181, DK-033506, DK-043351, DK-52510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK068181, R01DK052510, P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI-093588 (H.-C.R.), DK-068181 (H.-C.R.), DK-033506 (H.-C.R.), DK-043351 (H.-C.R. and C.T.) and DK-52510 (C.T.) from the US National Institutes of Health.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aksoy E, 2005, EUR J IMMUNOL, V35, P2200, DOI 10.1002/eji.200425801; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Garcia A, 2000, MICROBES INFECT, V2, P401, DOI 10.1016/S1286-4579(00)00327-0; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Matsuzawa T, 2004, EMBO J, V23, P3570, DOI 10.1038/sj.emboj.7600359; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Ohman T, 2009, J IMMUNOL, V182, P5682, DOI 10.4049/jimmunol.0803093; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhao Y, 2012, INFLAMM BOWEL DIS, V18, P603, DOI 10.1002/ibd.21851	50	29	29	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					63	71		10.1038/ni.2766	http://dx.doi.org/10.1038/ni.2766			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24270516	Green Accepted, Green Submitted			2022-12-18	WOS:000328800500013
J	Chan, AC; Behrens, TW				Chan, Andrew C.; Behrens, Timothy W.			Personalizing medicine for autoimmune and inflammatory diseases	NATURE IMMUNOLOGY			English	Article							MONOCLONAL-ANTIBODY; INTERFERON; ALPHA	Therapies that target molecular pathways do not provide uniform benefits for all patients at present. New transformative therapies for autoimmune and inflammatory diseases require greater molecular understanding of patient subsets and the ability to personalize targeted therapies for each subset.	[Chan, Andrew C.; Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Chan, AC (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	acc@gene.com; behrens.tim@gene.coml						Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	19	29	30	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					106	109		10.1038/ni.2473	http://dx.doi.org/10.1038/ni.2473			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23334822				2022-12-18	WOS:000313918400001
J	Ben-Neriah, Y; Schmidt-Supprian, M				Ben-Neriah, Yinon; Schmidt-Supprian, Marc			Epithelial NF-kappa B maintains host gut microflora homeostasis	NATURE IMMUNOLOGY			English	Editorial Material							INHIBITION; DISEASE; INFLAMMATION; ACTIVATION; IKK	Epithelial NF-kappa B preserves the integrity of the gut epithelial barrier and coordinates the antimicrobial actions of the innate and adaptive immune systems. Deficiency in or hyperactivation of this transcription factor results in chronic inflammatory bowel disease.	Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91220 Jerusalem, Israel; CBR Inst Biomed Res, Boston, MA 02115 USA	Hebrew University of Jerusalem; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91220 Jerusalem, Israel.	yinon@cc.huji.ac.il	Ben-Neriah, Yinon/L-6285-2019; Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166				Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Orange JS, 2005, IMMUNOL REV, V203, P21, DOI 10.1111/j.0105-2896.2005.00221.x; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Reddy A, 2007, PARASITOL RES, V100, P921, DOI 10.1007/s00436-006-0416-4; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	14	29	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					479	481		10.1038/ni0507-479	http://dx.doi.org/10.1038/ni0507-479			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440457				2022-12-18	WOS:000245831600011
J	Hill, JA; Benoist, C; Mathis, D				Hill, Jonathan A.; Benoist, Christophe; Mathis, Diane			T-reg cells: guardians for life	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTOR FOXP3; CUTTING EDGE; DEPLETION; IMPINGE	Regulatory T cells expressing the transcription factor Foxp3 are known to control autoreactivity during and subsequent to the development of the peripheral immune system. New evidence emphasizes the fact that those cells are constant and powerful guardians against the state of 'horror autotoxicus'.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hill, JA (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu						Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151	11	29	35	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					124	125		10.1038/ni0207-124	http://dx.doi.org/10.1038/ni0207-124			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242683				2022-12-18	WOS:000243597600007
J	Chaturvedi, A; Siddiqui, Z; Bayiroglu, F; Rao, KVS				Chaturvedi, A; Siddiqui, Z; Bayiroglu, F; Rao, KVS			A GPI-linked isoform of the IgD receptor regulates resting B cell activation	NATURE IMMUNOLOGY			English	Article							ANTIGEN RECEPTOR; LIPID RAFTS; COSTIMULATORY MOLECULES; GERMINAL-CENTERS; UP-REGULATION; CUTTING EDGE; EXPRESSION; IMMUNOGLOBULIN; PHOSPHORYLATION; DIFFERENTIATION	The induction of a humoral response depends upon efficient cross-linking by antigen of surface immunoglobulin on primary B lymphocytes. We demonstrate here the presence of a glycosylphosphatidylinositol-linked isoform of membrane IgD (mIgD) receptors on murine resting B cells. This subset was constitutively localized to cell membrane raft microdomains. Its stimulation resulted in the activation of cAMP-dependent signaling pathways, which integrated with signals derived from the transmembrane mIgD receptors. This, in turn, provided a mechanism by which the activation status of the target cells could be variably regulated. Thus, by partitioning receptor activity, preimmune B cells can moderate the extent to which they are activated, depending upon the strength of the antigenic stimulus.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Bayiroglu, Fahri/B-2249-2018					Agarwal A, 1998, J IMMUNOL, V161, P5832; Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; BRINK R, 1995, EUR J IMMUNOL, V25, P1980, DOI 10.1002/eji.1830250727; CAMBIER JC, 1997, ANNU REV IMMUNOL, V5, P175; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Cheng PC, 2001, J IMMUNOL, V166, P3693, DOI 10.4049/jimmunol.166.6.3693; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Chung JB, 2001, J IMMUNOL, V166, P736, DOI 10.4049/jimmunol.166.2.736; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Galibert L, 1996, J EXP MED, V183, P77, DOI 10.1084/jem.183.1.77; George J, 1992, Semin Immunol, V4, P11; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; Harlow E LD, 1988, ANTIBODIES LAB MANUA; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Kimoto H, 1997, EUR J IMMUNOL, V27, P268, DOI 10.1002/eji.1830270140; Koni PA, 1999, J EXP MED, V189, P855, DOI 10.1084/jem.189.5.855; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lahvis GP, 1997, J IMMUNOL, V159, P1783; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; Manivel V, 2002, J IMMUNOL, V169, P888, DOI 10.4049/jimmunol.169.2.888; Manser T, 1998, IMMUNOL REV, V162, P183, DOI 10.1111/j.1600-065X.1998.tb01441.x; MOND JJ, 1981, J IMMUNOL, V127, P881; MOROKATA T, 1995, EUR J IMMUNOL, V25, P1992, DOI 10.1002/eji.1830250729; Natarajan K, 2001, J IMMUNOL, V167, P114, DOI 10.4049/jimmunol.167.1.114; NOSSAL GJV, 1994, IMMUNOL REV, V137, P173, DOI 10.1111/j.1600-065X.1994.tb00664.x; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; PURE E, 1992, P NATL ACAD SCI USA, V89, P114, DOI 10.1073/pnas.89.1.114; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sproul TW, 2000, J IMMUNOL, V165, P6020, DOI 10.4049/jimmunol.165.11.6020; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; WIENANDS J, 1992, NATURE, V356, P246, DOI 10.1038/356246a0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YUANTSENG P, 1992, J BIOL CHEM, V267, P21250	48	29	30	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					951	957		10.1038/ni839	http://dx.doi.org/10.1038/ni839			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244313				2022-12-18	WOS:000178242100016
J	Rai, P; Janardhan, KS; Meacham, J; Madenspacher, JH; Lin, WC; Karmaus, PWF; Martinez, J; Li, QZ; Yan, M; Zeng, JL; Grinstaff, MW; Shirihai, OS; Taylor, GA; Fessler, MB				Rai, Prashant; Janardhan, Kyathanahalli S.; Meacham, Julie; Madenspacher, Jennifer H.; Lin, Wan-Chi; Karmaus, Peer W. F.; Martinez, Jennifer; Li, Quan-Zhen; Yan, Mei; Zeng, Jialiu; Grinstaff, Mark W.; Shirihai, Orian S.; Taylor, Gregory A.; Fessler, Michael B.			IRGM1 links mitochondrial quality control to autoimmunity	NATURE IMMUNOLOGY			English	Article							IMMUNITY-RELATED GTPASE; AUTOPHAGY; DNA; LRG-47; ACIDIFICATION; LOCALIZATION; INFLAMMATION; MATURATION; RESISTANCE; BACTERIAL	Mitochondrial abnormalities have been noted in lupus, but the causes and consequences remain obscure. Autophagy-related genes ATG5, ATG7 and IRGM have been previously implicated in autoimmune disease. We reasoned that failure to clear defective mitochondria via mitophagy might be a foundational driver in autoimmunity by licensing mitochondrial DNA-dependent induction of type I interferon. Here, we show that mice lacking the GTPase IRGM1 (IRGM homolog) exhibited a type I interferonopathy with autoimmune features. Irgm1 deletion impaired the execution of mitophagy with cell-specific consequences. In fibroblasts, mitochondrial DNA soiling of the cytosol induced cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING)-dependent type I interferon, whereas in macrophages, lysosomal Toll-like receptor 7 was activated. In vivo, Irgm1(-/-) tissues exhibited mosaic dependency upon nucleic acid receptors. Whereas salivary and lacrimal gland autoimmune pathology was abolished and lung pathology was attenuated by cGAS and STING deletion, pancreatic pathology remained unchanged. These findings reveal fundamental connections between mitochondrial quality control and tissue-selective autoimmune disease. Fessler and colleagues report that loss of the IFN-gamma-induced GTPase IRGM1 results in autoinflammatory disease. Deficient IRGM1 activity led to defective lysosomal maturation and impaired mitophagy, prompting the release of cytosolic mtDNA and thereby activating the cGAS-STING pathway.	[Rai, Prashant; Meacham, Julie; Madenspacher, Jennifer H.; Lin, Wan-Chi; Karmaus, Peer W. F.; Martinez, Jennifer; Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.] NIEHS, Cellular & Mol Pathol Branch, Natl Toxicol Program, Res Triangle Pk, NC USA; [Janardhan, Kyathanahalli S.] Integrated Lab Syst Inc, Res Triangle Pk, NC USA; [Yan, Mei; Zeng, Jialiu] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Quan-Zhen; Yan, Mei] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA; [Zeng, Jialiu; Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA USA; [Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol, Los Angeles, CA 90095 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Div Geriatr,Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Taylor, Gregory A.] VA Med Ctr, 2Geriatr Res Educ & Clin Ctr, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Boston University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Duke University; Duke University; Duke University	Rai, P; Fessler, MB (corresponding author), NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	prashant.rai@nih.gov; fesslerm@niehs.nih.gov	Zeng, Jialiu/AAB-3039-2019	Zeng, Jialiu/0000-0001-7802-1432; Rai, Prashant/0000-0003-0258-4567	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01 ES102005, ZIA ES103286];  [AI135398];  [AI145929];  [AI148243];  [R21AG063373];  [R21AG060456]	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; ; ; 	We thank P. West, D. Sliter, F. Zhao, and J. Santos for helpful discussions; N. Yan (UTSW) and R. Youle (NINDS/NIH) for reagents; G. Barber (University of Miami) for Tmem173-/-mice; C. Bosio (NIAID/NIH) for Tlr9-/-mice; L. Perrow for assistance with breeding; D. King for blood cell count analysis; the NIEHS Histology Core laboratory for assistance with processing, sectioning, and staining of tissues; K. Gerrish, B. Elgart and N. Clausen of the NIEHS Molecular Genomics Core; N. Martin and D. Chen of the NIEHS Viral Vector Core; C.J. Tucker, A.K. Janoshazi, and E. Scappini of the NIEHS Fluorescence Microscopy and Imaging Center; and C. Bortner and M. Sifre of the NIEHS Flow Cytometry Core Facility. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (grant no. Z01 ES102005 (M.B.F.) and grant no. ZIA ES103286 (J. Martinez)); and by grant nos. AI135398, AI145929, and AI148243 (G.A.T.); grant no. R21AG063373 (M.W.G.); and grant no. R21AG060456 (O.S.S.).	Ajayi TA, 2019, AM J PHYSIOL-GASTR L, V316, pG95, DOI 10.1152/ajpgi.00196.2018; Azzam KM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91914; Borralho PM, 2015, ADV EXP MED BIOL, V887, P31, DOI 10.1007/978-3-319-22380-3_3; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Caza TN, 2014, ANN RHEUM DIS, V73, P1888, DOI 10.1136/annrheumdis-2013-203794; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Di Malta C, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00114; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Gkirtzimanaki K, 2018, CELL REP, V25, P921, DOI 10.1016/j.celrep.2018.09.001; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; He L, 2016, J LEUKOCYTE BIOL, V100, P1113, DOI 10.1189/jlb.3A1015-463R; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861; Kumar S, 2018, J CELL BIOL, V217, P997, DOI 10.1083/jcb.201708039; Lama L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08620-4; Ma F, 2015, J IMMUNOL, V194, P1545, DOI 10.4049/jimmunol.1402066; Maric-Biresev J, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0255-4; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; McWilliams TG, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180108; Monteith AJ, 2016, P NATL ACAD SCI USA, V113, pE2142, DOI 10.1073/pnas.1513943113; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nocturne G, 2013, NAT REV RHEUMATOL, V9, P544, DOI 10.1038/nrrheum.2013.110; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Perl A, 2004, INT REV IMMUNOL, V23, P293, DOI 10.1080/08830180490452576; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Rodriguez-Nuevo A, 2018, EMBO J, V37, DOI 10.15252/embj.201796553; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Sharma S, 2015, P NATL ACAD SCI USA, V112, pE710, DOI 10.1073/pnas.1420217112; Shi B, 2017, AUTOPHAGY, V13, P285, DOI 10.1080/15548627.2016.1261238; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Thorlacius GE, 2018, CURR OPIN RHEUMATOL, V30, P471, DOI 10.1097/BOR.0000000000000524; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Trudeau KM, 2016, J CELL BIOL, V214, P25, DOI 10.1083/jcb.201511042; Vitner EB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0570-2; West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Xia Q, 2017, GENES IMMUN, V18, P42, DOI 10.1038/gene.2016.48; Yao QM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7959707; Zhao YO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008648; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	53	28	28	4	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					312	+		10.1038/s41590-020-00859-0	http://dx.doi.org/10.1038/s41590-020-00859-0		JAN 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33510463	Green Accepted			2022-12-18	WOS:000612589300001
J	Aguilar, SV; Aguilar, O; Allan, R; Amir, ED; Angeli, V; Artyomov, MN; Asinovski, N; Astarita, J; Austen, KF; Bajpai, G; Barrett, N; Baysoy, A; Benoist, C; Bellemare-Pelletier, A; Berg, B; Best, A; Bezman, N; Blair, D; Blander, JM; Bogunovic, M; Brennan, P; Brenner, M; Brown, B; Buechler, M; Buenrostro, J; Casanova, MA; Choi, K; Chow, A; Chudnovskiy, A; Cipoletta, D; Cohen, N; Collins, JJ; Colonna, M; Cook, A; Costello, J; Cremasco, V; Crowl, T; Crozat, K; Cruse, R; D'Angelo, J; Dalod, M; Davis, S; Demiralp, C; Deng, TD; Desai, JV; Desland, F; Dhainaut, M; Ding, JR; Doedens, A; Dominguez, C; Doran, G; Dress, R; Dustin, M; Dwyer, D; Dzhagalov, I; Elpek, K; Ergun, A; Ericson, J; Esomonu, E; Fairfax, K; Fletcher, A; Frascoli, M; Fuchs, A; Gainullina, A; Gal-Oz, S; Gallagher, M; Gautier, E; Gazit, R; Gibbings, S; Giraud, M; Ginhoux, F; Goldrath, A; Gotthardt, D; Gray, D; Greter, M; Grieshaber-Bouyer, R; Guilliams, M; Haidermota, S; Hardy, R; Hashimoto, D; Helft, J; Hendricks, D; Heng, T; Hill, J; Hyatt, G; Idoyaga, J; Jakubzick, C; Jarjoura, J; Jepson, D; Jia, BS; Jianu, R; Johanson, T; Jordan, S; Jojic, V; Jordan, S; Kamimura, Y; Kana, V; Kang, JS; Kapoor, V; Kenigsberg, E; Kent, A; Kim, C; Kim, E; Kim, F; Kim, J; Kim, K; Kiner, E; Knell, J; Koller, D; Kozinn, L; Krchma, K; Kreslavsky, T; Kronenberg, M; Kwan, WH; Laidlaw, D; Lam, V; Lanier, L; Laplace, C; Lareau, C; Lavin, Y; Lavine, KJ; Leader, A; Leboeuf, M; Lee, JC; Lee, JS; Li, B; Li, H; Li, YS; Lionakis, MS; Luche, H; Lynch, L; Magen, A; Maier, B; Malhotra, D; Malhotra, N; Malissen, M; Maslova, A; Mathis, D; McFarland, A; Merad, M; Meunier, E; Miller, J; Milner, J; Mingueneau, M; Min-Oo, G; Monach, P; Moodley, D; Mortha, A; Morvan, M; Mostafavi, S; Muller, S; Muus, C; Nabekura, T; Rao, TN; Narang, V; Narayan, K; Ner-Gaon, H; Nguyen, Q; Nigrovic, PA; Novakovsky, G; Nutt, S; Omilusik, K; Ortiz-Lopez, A; Paidassi, H; Paik, H; Painter, M; Paynich, M; Peng, VC; Potempa, M; Pradhan, R; Price, J; Qi, YL; Qi, YQ; Quon, S; Ramirez, R; Ramanan, D; Randolph, G; Regev, A; Rhoads, A; Robinette, M; Rose, S; Rossi, D; Rothamel, K; Sachidanandam, R; Sathe, P; Scott, C; Seddu, K; See, P; Sergushichev, A; Shaw, L; Shay, T; Shemesh, A; Shinton, S; Shyer, J; Sieweke, M; Smillie, C; Spel, L; Spidale, N; Stifano, G; Subramanian, A; Sun, JS; Sylvia, K; Tellier, J; This, S; Tomasello, E; Todorov, H; Turley, S; Vijaykumar, B; Wagers, A; Wakamatsu, E; Wang, CD; Wang, PTL; Wroblewska, A; Wu, J; Yang, ED; Yang, L; Yim, A; Yng, LS; Yoshida, H; Yu, BF; Zhou, Y; Zhu, YN; Ziemkiewicz, C				Aguilar, Stephanie Vargas; Aguilar, Oscar; Allan, Rhys; Amir, El Ad David; Angeli, Veronique; Artyomov, Maxim N.; Asinovski, Natasha; Astarita, Jilian; Austen, K. Frank; Bajpai, Geetika; Barrett, Nora; Baysoy, Alev; Benoist, Christophe; Bellemare-Pelletier, Angelique; Berg, Brad; Best, Adam; Bezman, Natalie; Blair, David; Blander, Julie M.; Bogunovic, Milena; Brennan, Patrick; Brenner, Michael; Brown, Brian; Buechler, Matthew; Buenrostro, Jason; Casanova, Maria Acebes; Choi, Kyunghee; Chow, Andrew; Chudnovskiy, Aleksey; Cipoletta, Daniela; Cohen, Nadia; Collins, James J.; Colonna, Marco; Cook, Alison; Costello, James; Cremasco, Viviana; Crowl, Ty; Crozat, Karine; Cruse, Richard; D'Angelo, June; Dalod, Marc; Davis, Scott; Demiralp, Cagatay; Deng, Tianda; Desai, Jigar, V; Desland, Fiona; Dhainaut, Maxime; Ding, Jiarui; Doedens, Andrew; Dominguez, Claudia; Doran, Graeme; Dress, Regine; Dustin, Michael; Dwyer, Daniel; Dzhagalov, Ivan; Elpek, Kutlu; Ergun, Ayla; Ericson, Jeff; Esomonu, Eunice; Fairfax, Keke; Fletcher, Anne; Frascoli, Michela; Fuchs, Anja; Gainullina, Anastasiia; Gal-Oz, Shani; Gallagher, Michael; Gautier, Emmanuel; Gazit, Roi; Gibbings, Sophie; Giraud, Matthieu; Ginhoux, Florent; Goldrath, Ananda; Gotthardt, Dagmar; Gray, Daniel; Greter, Melanie; Grieshaber-Bouyer, Ricardo; Guilliams, Martin; Haidermota, Sara; Hardy, Randy; Hashimoto, Daigo; Helft, Julie; Hendricks, Deborah; Heng, Tracy; Hill, Jonathan; Hyatt, Gordon; Idoyaga, Juliana; Jakubzick, Claudia; Jarjoura, Jessica; Jepson, Daniel; Jia, Baosen; Jianu, Radu; Johanson, Tim; Jordan, Stefan; Jojic, Vladimir; Jordan, Stefan; Kamimura, Yosuke; Kana, Veronica; Kang, Joonsoo; Kapoor, Varun; Kenigsberg, Ephriam; Kent, Andrew; Kim, Charles; Kim, Edy; Kim, Francis; Kim, Joel; Kim, Kiwook; Kiner, Evgeny; Knell, Jamie; Koller, Daphne; Kozinn, Larry; Krchma, Karen; Kreslavsky, Taras; Kronenberg, Mitchell; Kwan, Wing-Hong; Laidlaw, David; Lam, Viola; Lanier, Lewis; Laplace, Catherine; Lareau, Caleb; Lavin, Yonit; Lavine, Kory J.; Leader, Andrew; Leboeuf, Marylene; Lee, Jacob; Lee, Jisu; Li, Bo; Li, Hu; Li, Yuesheng; Lionakis, Michail S.; Luche, Herve; Lynch, Lydia; Magen, Assaf; Maier, Barbara; Malhotra, Deepali; Malhotra, Nidhi; Malissen, Marie; Maslova, Alexandra; Mathis, Diane; McFarland, Adelle; Merad, Miriam; Meunier, Etienne; Miller, Jennifer; Milner, Justin; Mingueneau, Michael; Min-Oo, Gundula; Monach, Paul; Moodley, Devapregasan; Mortha, Arthur; Morvan, Maelig; Mostafavi, Sara; Muller, Soren; Muus, Christoph; Nabekura, Tsukasa; Rao, Tata Nageswara; Narang, Vipin; Narayan, Kavitha; Ner-Gaon, Hadas; Nguyen, Quyhn; Nigrovic, Peter A.; Novakovsky, German; Nutt, Stephan; Omilusik, Kayla; Ortiz-Lopez, Adriana; Paidassi, Helena; Paik, Henry; Painter, Michio; Paynich, Mallory; Peng, Vincent; Potempa, Marc; Pradhan, Rachana; Price, Jeremy; Qi, Yilin; Qi, Yiqing; Quon, Sara; Ramirez, Ricardo; Ramanan, Deepshika; Randolph, Gwendalyn; Regev, Aviv; Rhoads, Andrew; Robinette, Michelle; Rose, Samuel; Rossi, Derrick; Rothamel, Katie; Sachidanandam, Ravi; Sathe, Priyanka; Scott, Charlotte; Seddu, Kumba; See, Peter; Sergushichev, Alexey; Shaw, Laura; Shay, Tal; Shemesh, Avishai; Shinton, Susan; Shyer, Justin; Sieweke, Michael; Smillie, Chris; Spel, Lotte; Spidale, Nick; Stifano, Giuseppina; Subramanian, Ayshwarya; Sun, Joseph; Sylvia, Katelyn; Tellier, Julie; This, Sebastien; Tomasello, Elena; Todorov, Helena; Turley, Shannon; Vijaykumar, Brinda; Wagers, Amy; Wakamatsu, Ei; Wang, Chendi; Wang, Peter L.; Wroblewska, Aleksandra; Wu, Jun; Yang, Edward; Yang, Liang; Yim, Aldrin; Yng, Lim Sheau; Yoshida, Hideyuki; Yu, Bingfei; Zhou, Yan; Zhu, Yanan; Ziemkiewicz, Caroline		Immunological Genome Project	ImmGen at 15	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTIONAL PROGRAMS; GENE-EXPRESSION; REGULATORS; UNDERLIE; IDENTITY; NETWORK	Nature Immunology's20(th)anniversary is a good opportunity to reminisce about the ImmGen collective endeavor - its goals, successes and horror stories - and the group's exploration of various modes of scientific publishing.	[Aguilar, Stephanie Vargas; Crozat, Karine; Dalod, Marc; Sieweke, Michael; Tomasello, Elena] French Natl Ctr Sci Res, Ctr Immunol Marseille Luminy, Marseille, France; [Aguilar, Oscar; Bezman, Natalie; Gotthardt, Dagmar; Hendricks, Deborah; Jarjoura, Jessica; Johanson, Tim; Kamimura, Yosuke; Kim, Charles; Krchma, Karen; Kreslavsky, Taras; Min-Oo, Gundula; Morvan, Maelig; Nabekura, Tsukasa; Potempa, Marc; Shemesh, Avishai; Sun, Joseph; Zhu, Yanan] Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Allan, Rhys; Kapoor, Varun; Nutt, Stephan; Tellier, Julie] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Amir, El Ad David; Blander, Julie M.; Bogunovic, Milena; Casanova, Maria Acebes; Chow, Andrew; Chudnovskiy, Aleksey; Desland, Fiona; Greter, Melanie; Hashimoto, Daigo; Helft, Julie; Idoyaga, Juliana; Jia, Baosen; Jordan, Stefan] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Amir, El Ad David; Blander, Julie M.; Bogunovic, Milena; Casanova, Maria Acebes; Chow, Andrew; Chudnovskiy, Aleksey; Desland, Fiona; Greter, Melanie; Hashimoto, Daigo; Helft, Julie; Idoyaga, Juliana; Jia, Baosen; Jordan, Stefan] Icahn Sch Med Mt Sinai, Tisch Canc Inst, 1, New York, NY 10029 USA; [Angeli, Veronique; Yng, Lim Sheau] Natl Univ Singapore, Ctr Life Sci, Singapore, Singapore; [Artyomov, Maxim N.; Choi, Kyunghee; Colonna, Marco; D'Angelo, June; Fairfax, Keke; Fuchs, Anja; Gainullina, Anastasiia; Kim, Kiwook; Lareau, Caleb; Lee, Jacob; McFarland, Adelle; Peng, Vincent; Randolph, Gwendalyn; Robinette, Michelle; Sergushichev, Alexey; Wang, Peter L.; Wu, Jun; Yim, Aldrin] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA; [Artyomov, Maxim N.; Asinovski, Natasha; Baysoy, Alev; Benoist, Christophe; Choi, Kyunghee; Cipoletta, Daniela; Colonna, Marco; Cook, Alison; Cruse, Richard; D'Angelo, June; Davis, Scott; Doran, Graeme; Ergun, Ayla; Ericson, Jeff; Esomonu, Eunice; Giraud, Matthieu; Gray, Daniel; Haidermota, Sara; Heng, Tracy; Hill, Jonathan; Hyatt, Gordon; Jepson, Daniel; Kiner, Evgeny; Kronenberg, Mitchell; Mathis, Diane; Mingueneau, Michael; Moodley, Devapregasan; Ortiz-Lopez, Adriana; Paik, Henry; Painter, Michio; Qi, Yiqing; Ramirez, Ricardo; Ramanan, Deepshika; Rhoads, Andrew; Rothamel, Katie; Seddu, Kumba; Spel, Lotte; Vijaykumar, Brinda; Wakamatsu, Ei; Yang, Liang; Yoshida, Hideyuki] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Astarita, Jilian; Bellemare-Pelletier, Angelique; Buechler, Matthew; Cremasco, Viviana; Dominguez, Claudia; Elpek, Kutlu; Fletcher, Anne; Malhotra, Deepali; Muller, Soren; Pradhan, Rachana; Shyer, Justin; Turley, Shannon] Genentech Inc, Dept Canc Immunol, South San Francisco, CA USA; [Austen, K. Frank; Barrett, Nora] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Bajpai, Geetika; Lam, Viola] Washington Univ, Div Cardiol, Dept Med, Ctr Cardiovasc Res,Sch Med, St Louis, MO USA; [Berg, Brad; Demiralp, Cagatay; Jianu, Radu; Kozinn, Larry; Ziemkiewicz, Caroline] Brown Univ, Brown Comp Sci, Providence, RI 02912 USA; [Best, Adam; Crowl, Ty; Deng, Tianda; Doedens, Andrew; Goldrath, Ananda; Milner, Justin; Nguyen, Quyhn; Omilusik, Kayla; Quon, Sara; Shaw, Laura; Yang, Edward; Yu, Bingfei] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Blair, David; Dustin, Michael] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Brennan, Patrick; Brenner, Michael; Kim, Edy; Lynch, Lydia] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA; [Brennan, Patrick; Brenner, Michael; Kim, Edy; Lynch, Lydia] Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA; [Brown, Brian; Dhainaut, Maxime; Rose, Samuel; Wroblewska, Aleksandra] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Buenrostro, Jason; Kim, Francis; Kwan, Wing-Hong; Rao, Tata Nageswara; Wagers, Amy] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cohen, Nadia; Collins, James J.; Costello, James; Li, Hu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cohen, Nadia; Collins, James J.; Costello, James; Li, Hu] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Desai, Jigar, V; Lionakis, Michail S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ding, Jiarui; Lavine, Kory J.; Li, Bo; Muus, Christoph; Regev, Aviv; Smillie, Chris; Subramanian, Ayshwarya] Broad Inst MIT & Harvard, Cambridge, MA USA; [Dress, Regine; Ginhoux, Florent; Narang, Vipin; See, Peter; Shinton, Susan] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Dzhagalov, Ivan] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Frascoli, Michela; Gallagher, Michael; Kang, Joonsoo; Lavin, Yonit; Lee, Jisu; Malhotra, Nidhi; Narayan, Kavitha; Qi, Yilin; Spidale, Nick; Sylvia, Katelyn] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Gal-Oz, Shani; Ner-Gaon, Hadas; Shay, Tal] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; [Gautier, Emmanuel] Natl Inst Hlth & Med Res, Fac Med, Paris, France; [Gazit, Roi; Rossi, Derrick] Childrens Hosp Boston, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA USA; [Gibbings, Sophie; Jakubzick, Claudia] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Grieshaber-Bouyer, Ricardo; Monach, Paul; Nigrovic, Peter A.; Stifano, Giuseppina] Boston Univ, Dept Med, Boston, MA 02215 USA; [Guilliams, Martin; Scott, Charlotte; Todorov, Helena] Univ Ghent VIB, Inflammat Res Ctr, Lab Immunoregulat, Ghent, Belgium; [Hardy, Randy; Li, Yuesheng; Zhou, Yan] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Jojic, Vladimir] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Knell, Jamie; Paynich, Mallory] La Jolla Inst Immunol, La Jolla, CA USA; [Luche, Herve; Malissen, Marie] CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France; [Maslova, Alexandra; Meunier, Etienne; Mostafavi, Sara; Novakovsky, German; Wang, Chendi] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Paidassi, Helena; This, Sebastien] Univ Lyon, Int Ctr Res Infect Dis, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Francisco; Walter & Eliza Hall Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National University of Singapore; Washington University (WUSTL); Harvard University; Harvard Medical School; Roche Holding; Genentech; Harvard University; Brigham & Women's Hospital; Washington University (WUSTL); Brown University; University of California System; University of California San Diego; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Harvard University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National Yang Ming Chiao Tung University; University of Massachusetts System; University of Massachusetts Worcester; Ben Gurion University; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); National Jewish Health; Boston University; Flanders Institute for Biotechnology (VIB); Ghent University; Fox Chase Cancer Center; Stanford University; La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of British Columbia	Benoist, C (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu	Hashimoto, Daigo/O-1013-2013; Muller, Soren/AAG-4846-2022; Guilliams, Martin/N-7803-2013; Lionakis, Michail/J-8840-2017; Giraud, Matthieu/E-4972-2017; Dalod, Marc/AAK-6163-2020; Jordan, Stefan/AAI-1073-2021; Ner-gaon, Hadas/O-8396-2019; Gal-Oz, Shani Talia/AAE-9478-2019; Helft, Julie/ABE-6179-2020; Kronenberg, Mitchell/AAT-6078-2021; Lynch, Lydia/ABD-5598-2021; Gainullina, Anastasiia/O-4727-2019; Crozat, Karine/L-7297-2019; Sergushichev, Alexey A/J-8756-2015; LUCHE, Herve/GLT-1401-2022; Morvan, Maelig/ABE-6566-2020; Heng, Tracy/B-9847-2015; Mortha, Arthur/ABE-6250-2020; Gautier, Emmanuel L./E-2259-2017; bajpai, geetika/ABH-1952-2020; Heng, Tracy/AAR-5712-2021; LI, Yue/GRS-8071-2022; Kim, Edy/ABF-7592-2021; Shay, Tal/J-4028-2016; Jordan, Stefan/AAH-8261-2021; Spel, Lotte/AAC-2125-2022; Muller, Soren/AFK-6577-2022; Lareau, Caleb/ABF-9490-2020; Nutt, Stephen/C-9256-2013; Grieshaber-Bouyer, Dr. Ricardo/R-7512-2016	Hashimoto, Daigo/0000-0001-9489-9704; Guilliams, Martin/0000-0003-3525-7570; Lionakis, Michail/0000-0003-4994-9500; Giraud, Matthieu/0000-0002-1208-9677; Dalod, Marc/0000-0002-6436-7966; Jordan, Stefan/0000-0001-9330-1715; Ner-gaon, Hadas/0000-0002-6288-5065; Gal-Oz, Shani Talia/0000-0001-7775-2006; Helft, Julie/0000-0002-2733-1972; Gainullina, Anastasiia/0000-0003-3796-2337; Crozat, Karine/0000-0003-4761-3675; Sergushichev, Alexey A/0000-0003-1159-7220; Morvan, Maelig/0000-0001-5978-6894; Heng, Tracy/0000-0003-4147-8986; Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Kim, Edy/0000-0002-9095-3109; Shay, Tal/0000-0003-0755-1350; Jordan, Stefan/0000-0001-9330-1715; Lareau, Caleb/0000-0003-4179-4807; Smillie, Chris/0000-0002-7606-3433; Sieweke, Michael/0000-0002-3228-9537; Malissen, Marie/0000-0003-2331-1445; Gotthardt, Dagmar/0000-0002-8416-1236; Nutt, Stephen/0000-0002-0020-6637; Gazit, Roi/0000-0002-0548-2147; Maier, Barbara/0000-0002-7359-6576; Kana, Veronika/0000-0002-9362-3156; Costello, James/0000-0003-3158-9682; Omilusik, Kyla/0000-0003-3675-048X; Grieshaber-Bouyer, Dr. Ricardo/0000-0002-2873-5135; Buechler, Matthew/0000-0003-1902-622X; Mortha, Arthur/0000-0003-2673-0485; Dress, Regine J./0000-0001-8785-5471; Tellier, Julie/0000-0003-2787-8174; Narang, Vipin/0000-0001-8669-9964; Paidassi, Helena/0000-0001-9915-4365; Allan, Rhys/0000-0003-0906-2980; This, Sebastien/0000-0003-2931-9050; Vargas Aguilar, Stephanie/0000-0002-6584-0209; See, Peter/0000-0003-4428-7763	NIH NIAID [R24-AI072073]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ImmGen was made possible by its sponsors and supporters, foremost the NIH NIAID, whose grant (R24-AI072073) unflinchingly supported the enterprise, but also by companies in the immunogenomics arena (eBioscience, BioLegend and Qiagen) who understood the goals and helped with collaborative participation in experimental design and discounted reagents. We thank the profiling facilities (Expression Analysis, Broad BTL and Genomics Platforms) for their professionalism and dedication in data generation.	Benoist C, 2016, NAT IMMUNOL, V17, P741, DOI 10.1038/ni.3478; Benoist C, 2012, NAT REV IMMUNOL, V12, P734, DOI 10.1038/nri3300; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Ericson J. A., 2013, IMMGEN MOBILE PHONE; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Gal-Oz ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12348-6; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Maslova A, 2019, PREPRINT AT BIORXIV, DOI [10.1101/2019.12.21.885814, DOI 10.1101/2019.12.21.885814]; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mostafavi S, 2014, J IMMUNOL, V193, P4485, DOI 10.4049/jimmunol.1401280; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Regev Aviv, 2017, Elife, V6, DOI 10.7554/eLife.27041; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036	23	28	28	2	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					700	703		10.1038/s41590-020-0687-4	http://dx.doi.org/10.1038/s41590-020-0687-4			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577013	Green Published, Bronze			2022-12-18	WOS:000542863800003
J	Tomofuji, Y; Takaba, H; Suzuki, HI; Benlaribi, R; Martinez, CDP; Abe, Y; Morishita, Y; Okamura, T; Taguchi, A; Kodama, T; Takayanagi, H				Tomofuji, Yoshihiko; Takaba, Hiroyuki; Suzuki, Hiroshi, I; Benlaribi, Rayene; Martinez, Cristian David Pena; Abe, Yoshihiro; Morishita, Yasuyuki; Okamura, Tadashi; Taguchi, Akashi; Kodama, Tatsuhiko; Takayanagi, Hiroshi			Chd4 choreographs self-antigen expression for central immune tolerance	NATURE IMMUNOLOGY			English	Article							T-CELL; GENE-EXPRESSION; NEGATIVE SELECTION; AUTOIMMUNE-DISEASE; AIRE; TRANSCRIPTION; IDENTITY; FEZF2; AUTOANTIBODIES; REPERTOIRE	Takayanagi and colleagues show that the chromatin remodeler Chd4 works with both Fezf2 and Aire to promote promiscuous tissue-restricted antigen expression in medullary thymic epithelial cells, mediating central tolerance in the thymus. Autoreactive T cells are eliminated in the thymus to prevent autoimmunity by promiscuous expression of tissue-restricted self-antigens in medullary thymic epithelial cells. This expression is dependent on the transcription factor Fezf2, as well as the transcriptional regulator Aire, but the entire picture of the transcriptional program has been obscure. Here, we found that the chromatin remodeler Chd4, also called Mi-2 beta, plays a key role in the self-antigen expression in medullary thymic epithelial cells. To maximize the diversity of self-antigen expression, Fezf2 and Aire utilized completely distinct transcriptional mechanisms, both of which were under the control of Chd4. Chd4 organized the promoter regions of Fezf2-dependent genes, while contributing to the Aire-mediated induction of self-antigens via super-enhancers. Mice deficient in Chd4 specifically in thymic epithelial cells exhibited autoimmune phenotypes, including T cell infiltration. Thus, Chd4 plays a critical role in integrating Fezf2- and Aire-mediated gene induction to establish central immune tolerance.	[Tomofuji, Yoshihiko; Takaba, Hiroyuki; Benlaribi, Rayene; Martinez, Cristian David Pena; Abe, Yoshihiro; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Tomofuji, Yoshihiko; Takaba, Hiroyuki; Benlaribi, Rayene; Martinez, Cristian David Pena; Abe, Yoshihiro; Morishita, Yasuyuki; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo, Japan; [Suzuki, Hiroshi, I] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Suzuki, Hiroshi, I] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Oncol, Nagoya, Aichi, Japan; [Morishita, Yasuyuki] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Sect Anim Models, Tokyo, Japan; [Taguchi, Akashi; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo; University of Tokyo; Massachusetts Institute of Technology (MIT); Nagoya University; University of Tokyo; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; University of Tokyo	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan.; Takayanagi, H (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	takayana@m.u-tokyo.ac.jp		Suzuki, Hiroshi/0000-0003-4682-5086; Benlaribi, Rayene/0000-0002-9397-3199; Pena Martinez, Cristian/0000-0003-1048-6158	Takeda Visionary Research Grant from the Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT/JSPS of Japan [26670231, 17K19545, 16H06228, 15H05703]; AMED-CREST [20gm1210008]; United States Public Health Service from the NIH [R01-GM034277, R01-CA133404, P01-CA042063]; National Cancer Institute [P30-CA14051]; Whitehead Institute for Biomedical Research; Novo Nordisk	Takeda Visionary Research Grant from the Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT/JSPS of Japan; AMED-CREST; United States Public Health Service from the NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Whitehead Institute for Biomedical Research; Novo Nordisk(Novo Nordisk)	We thank P. A. Sharp, Y. Kurikawa and L. Danks for insightful and valuable comments, D. Mathis and H. Yoshida for providing information on super-enhancers and the microarray data on Brd4, B. Hendrich for providing Chd4 floxed mice, B. Malissen for providing Foxp3-ires-GFP mice, T. Tsubokawa for technical assistance, and other laboratory members for helpful discussions. This work was supported by a Takeda Visionary Research Grant to H. Takaba from the Takeda Science Foundation, a grant to H. Takaba from the Astellas Foundation for Research on Metabolic Disorders, a grant for Challenging Exploratory Research (26670231), a Challenging Research (Exploratory) Grant (17K19545), a Young Scientists A Grant (16H06228) to H. Takaba, and a Specially Promoted Research Grant (15H05703) to H. Takayanagi from MEXT/JSPS of Japan. This work was also supported by AMED-CREST (20gm1210008) to H. Takayanagi. Studies conducted by H.I.S. at the Massachusetts Institute of Technology were supported by United States Public Health Service grants R01-GM034277 and R01-CA133404 to P. A. Sharp and P01-CA042063 to T. Jacks from the NIH, as well as a Koch Institute Support (core) grant (P30-CA14051) from the National Cancer Institute, and supported in part by an agreement between the Whitehead Institute for Biomedical Research and Novo Nordisk.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Akaike H., 1973, 2 INT S INFORM THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Cheng M, 2018, NAT IMMUNOL, V19, P659, DOI 10.1038/s41590-018-0128-9; Clement CC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85633; Colobran R, 2011, HUM MOL GENET, V20, P3415, DOI 10.1093/hmg/ddr247; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Gimenez-Barcons M, 2014, J IMMUNOL, V193, P3872, DOI 10.4049/jimmunol.1400223; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffmeister H, 2017, NUCLEIC ACIDS RES, V45, P10534, DOI 10.1093/nar/gkx711; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Kasai M, 1996, EUR J IMMUNOL, V26, P2101, DOI 10.1002/eji.1830260921; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2018, NAT IMMUNOL, V19, P162, DOI 10.1038/s41590-017-0032-8; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2019, BIOINFORMATICS, V35, P421, DOI 10.1093/bioinformatics/bty648; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lenda DM, 2004, J IMMUNOL, V173, P4744, DOI 10.4049/jimmunol.173.7.4744; Lewis MJ, 2018, J AUTOIMMUN, V91, P1, DOI 10.1016/j.jaut.2018.02.009; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lodato S, 2014, NAT NEUROSCI, V17, P1046, DOI 10.1038/nn.3757; Lomada D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005777; Low JKK, 2016, J BIOL CHEM, V291, P15853, DOI 10.1074/jbc.M115.707018; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Michaelidou K, 2013, INT J ONCOL, V42, P1770, DOI 10.3892/ijo.2013.1860; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; O'Shaughnessy-Kirwan A, 2015, DEVELOPMENT, V142, P2586, DOI 10.1242/dev.125450; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Rattay K, 2016, J AUTOIMMUN, V67, P65, DOI 10.1016/j.jaut.2015.10.001; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; SEELIG HP, 1995, ARTHRITIS RHEUM-US, V38, P1389, DOI 10.1002/art.1780381006; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sjowall C, 2002, J AUTOIMMUN, V19, P155, DOI 10.1006/jaut.2002.0608; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Torrado M, 2017, FEBS J, V284, P4216, DOI 10.1111/febs.14301; Tzartos JS, 2017, RHEUMATOLOGY, V56, P2114, DOI 10.1093/rheumatology/kex328; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Yoshida T, 2019, GENE DEV, V33, P763, DOI 10.1101/gad.321901.118; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	70	28	28	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					892	+		10.1038/s41590-020-0717-2	http://dx.doi.org/10.1038/s41590-020-0717-2		JUN 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32601470				2022-12-18	WOS:000544172900001
J	Emming, S; Bianchi, N; Polletti, S; Balestrieri, C; Leoni, C; Montagner, S; Chirichella, M; Delaleu, N; Natoli, G; Monticelli, S				Emming, Stefan; Bianchi, Niccolo; Polletti, Sara; Balestrieri, Chiara; Leoni, Cristina; Montagner, Sara; Chirichella, Michele; Delaleu, Nicolas; Natoli, Gioacchino; Monticelli, Silvia			A molecular network regulating the proinflammatory phenotype of human memory T lymphocytes	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; BINDING SITE MOTIFS; HELPER-CELLS; GM-CSF; RHEUMATOID-ARTHRITIS; E-BOX; TRANSCRIPTION; EXPRESSION; MACROPHAGE; DIFFERENTIATION	Understanding the mechanisms that modulate helper T lymphocyte functions is crucial to decipher normal and pathogenic immune responses in humans. To identify molecular determinants influencing the pathogenicity of T cells, we separated ex vivo-isolated primary human memory T lymphocytes on the basis of their ability to produce high levels of inflammatory cytokines. We found that the inflammatory, cytokine-producing phenotype of memory T lymphocytes was defined by a specific core gene signature and was mechanistically regulated by the constitutive activation of the NF-kappa B pathway and by the expression of the transcriptional repressor BHLHE40. BHLHE40 attenuated the expression of anti-inflammatory factors, including miR-146a, a negative regulator of NF-kappa B activation and ZC3H12D, an RNase of the Regnase-1 family able to degrade inflammatory transcripts. Our data reveal a molecular network regulating the proinflammatory phenotype of human memory T lymphocytes, with the potential to contribute to disease. Monticelli and colleagues analyze primary human CD4(+) T cells to interrogate gene expression regulatory pathways that distinguish GM-CSF+ pathogenic programs from noninflammatory programs. They identify the transcriptional repressor BHLHE40 as an enforcer of proinflammatory gene expression by suppressing the NF-kappa B inhibitor miR-146a and the RNase ZC3H12D.	[Emming, Stefan; Bianchi, Niccolo; Leoni, Cristina; Montagner, Sara; Chirichella, Michele; Monticelli, Silvia] USI, Inst Res Biomed, Bellinzona, Switzerland; [Emming, Stefan; Bianchi, Niccolo] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Polletti, Sara; Balestrieri, Chiara; Natoli, Gioacchino] European Inst Oncol IRCCS IEO, Dept Expt Oncol, Milan, Italy; [Delaleu, Nicolas] USI, Oncol Inst Southern Switzerland, Oncol Res Inst, Bellinzona, Switzerland; [Delaleu, Nicolas] 2C SysBioMed, Contra, Switzerland; [Delaleu, Nicolas] Univ Bergen, Dept Clin Med, Bergen, Norway; [Natoli, Gioacchino] Humanitas Univ, Dept Biomed Sci, Milan, Italy	Universita della Svizzera Italiana; University of Bern; Institute of Oncology Research (IOR); Universita della Svizzera Italiana; University of Bergen; Humanitas University	Monticelli, S (corresponding author), USI, Inst Res Biomed, Bellinzona, Switzerland.	silvia.monticelli@irb.usi.ch	Natoli, gioacchino/J-2100-2018; Polletti, Sara/AAA-9543-2021; Natoli, gioacchino/ABB-8679-2020; Monticelli, Silvia/ABE-7054-2020	Polletti, Sara/0000-0002-5433-0502; Emming, Stefan/0000-0002-3851-335X; Natoli, Gioacchino/0000-0003-0711-2411; Monticelli, Silvia/0000-0002-5909-8802; Balestrieri, Chiara/0000-0001-7362-3530	Swiss National Science Foundation [156875, 175569]; NCCR `RNA Disease'; Swiss MS Society; Ceresio Foundation; Vontobel Stiftung; Kurt und Senta Herrmann Stiftung; Marie Heim-Vogtlin postdoctoral fellowship [164489]; Italian Ministry of Health	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR `RNA Disease'; Swiss MS Society; Ceresio Foundation; Vontobel Stiftung; Kurt und Senta Herrmann Stiftung; Marie Heim-Vogtlin postdoctoral fellowship; Italian Ministry of Health(Ministry of Health, Italy)	The authors thank D. Jarossay, S. Notarbartolo and F. Mele for invaluable technical support and input; M. Perez for help with Fig. 1; L. Vincenzetti for pilot CRISPR-Cas9 experiments and E. Dzafo for help with experiments involving Regnase-4. This work was supported by the Swiss National Science Foundation (grant number 156875 and 175569), the NCCR `RNA & Disease', the Swiss MS Society, the Ceresio Foundation, the Vontobel Stiftung and the Kurt und Senta Herrmann Stiftung (all to S. Monticelli). S. Montagner was supported by a Marie Heim-Vogtlin postdoctoral fellowship (number 164489). This work was also partially supported by the Italian Ministry of Health with Ricerca Corrente and 5x1000 funds (to G.N.).	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Balestrieri C, 2018, CELL, V173, P1150, DOI 10.1016/j.cell.2018.03.081; Behrens F, 2015, ANN RHEUM DIS, V74, P1058, DOI 10.1136/annrheumdis-2013-204816; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Campbell IK, 1998, J IMMUNOL, V161, P3639; Cao YH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8038; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Curina A, 2017, GENE DEV, V31, P399, DOI 10.1101/gad.293134.116; Delaleu N, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4362; DEVRIES EGE, 1991, LANCET, V338, P517, DOI 10.1016/0140-6736(91)90594-F; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Ferber IA, 1996, J IMMUNOL, V156, P5; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Hartmann FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6056; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helmstetter C, 2015, IMMUNITY, V42, P108, DOI 10.1016/j.immuni.2014.12.018; Hirota K, 2018, IMMUNITY, V48, P1220, DOI 10.1016/j.immuni.2018.04.009; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Housley WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9223; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kongsbak M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00148; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lindner SE, 2017, EMBO REP, V18, P1604, DOI 10.15252/embr.201643735; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Mele F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7431; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Minagawa K, 2014, J IMMUNOL, V192, P1512, DOI 10.4049/jimmunol.1301619; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; Monticelli S, 2017, METHODS MOL BIOL, V1514, P153, DOI 10.1007/978-1-4939-6548-9_13; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Oestreich KJ, 2012, TRENDS IMMUNOL, V33, P78, DOI 10.1016/j.it.2011.10.005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Su Gang, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0813s47; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wawro M, 2017, J CELL BIOCHEM, V118, P487, DOI 10.1002/jcb.25665; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	28	29	3	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					388	+		10.1038/s41590-020-0622-8	http://dx.doi.org/10.1038/s41590-020-0622-8		MAR 2020	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205878	Green Accepted			2022-12-18	WOS:000519843600002
J	Awad, W; Ler, GJM; Xu, WJ; Keller, AN; Mak, JYW; Lim, XY; Liu, LG; Eckle, SBG; Le Nours, JM; McCluskey, J; Corbett, AJ; Fairlie, DP; Rossjohn, J				Awad, Wael; Ler, Geraldine J. M.; Xu, Weijun; Keller, Andrew N.; Mak, Jeffrey Y. W.; Lim, Xin Yi; Liu, Ligong; Eckle, Sidonia B. G.; Le Nours, Jerome; McCluskey, James; Corbett, Alexandra J.; Fairlie, David P.; Rossjohn, Jamie			The molecular basis underpinning the potency and specificity of MAIT cell antigens	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; INVARIANT T-CELLS; RECEPTOR HETEROGENEITY; RECOGNITION; ACTIVATION; TCR	Mucosal-associated invariant T (MAIT) cells are activated by microbial riboflavin-based metabolite antigens when presented by MR1. How modifications to the potent antigen 5-OP-RU affect presentation by MR1 and MAIT cell activation remains unclear. Here we design 20 derivatives, termed altered metabolite ligands (AMLs), to dissect the impact of different antigen components on the human MAIT-MR1 axis. Analysis of 11 crystal structures of MAIT T cell antigen receptor (TCR)-MR1-AML ternary complexes, along with biochemical and functional assays, shows that MR1 cell-surface upregulation is influenced by ribityl and non-ribityl components of the ligand and the hydrophobicity of the MR1-AML interface. The polar ribityl chain of the AML strongly influences MAIT cell activation potency through dynamic compensatory interactions within a MAIT TCR-MR1-AML interaction triad. We define the basis by which the MAIT TCR can differentially recognize AMLs, thereby providing insight into MAIT cell antigen specificity and potency. Mucosal-associated invariant T (MAIT) cells recognize vitamin B metabolites presented by the molecule MR1. Rossjohn and colleagues generate multiple altered metabolite ligands and determine their structures in the context of MR1 and the TCR to develop a generalized framework for MAIT cell antigen recognition.	[Awad, Wael; Keller, Andrew N.; Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia; [Awad, Wael; Keller, Andrew N.; Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Awad, Wael; Keller, Andrew N.; Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Ler, Geraldine J. M.; Xu, Weijun; Mak, Jeffrey Y. W.; Liu, Ligong; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ler, Geraldine J. M.; Xu, Weijun; Mak, Jeffrey Y. W.; Liu, Ligong; Fairlie, David P.] Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Brisbane, Qld, Australia; [Lim, Xin Yi; Eckle, Sidonia B. G.; McCluskey, James; Corbett, Alexandra J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, S Glam, Wales	Monash University; Monash University; Monash University; University of Queensland; University of Queensland; University of Melbourne; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia.; Fairlie, DP (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.; Fairlie, DP (corresponding author), Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Brisbane, Qld, Australia.; Corbett, AJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, S Glam, Wales.	corbetta@unimelb.edu.au; d.fairlie@imb.uq.edu.au; jamie.rossjohn@monash.edu	liu, ligong/B-1690-2010; McCluskey, James/A-1291-2007; Mak, Jeffrey YW/E-8764-2011; xu, wei/HHD-2891-2022; Eckle, Sidonia/O-8146-2014; Corbett, Alexandra/A-1225-2019; Rossjohn, Jamie/F-9032-2013	liu, ligong/0000-0002-2693-1896; McCluskey, James/0000-0002-8597-815X; Mak, Jeffrey YW/0000-0002-8011-4539; Eckle, Sidonia/0000-0003-0766-171X; Corbett, Alexandra/0000-0003-1618-4337; Rossjohn, Jamie/0000-0002-2020-7522; Awad, Wael/0000-0002-7597-2133; Le Nours, Jerome/0000-0002-2221-7636	Australian National Health and Medical Research Council (NHMRC) [1125493, 1113293]; Australian Research Council (ARC) Centre of Excellence in Advanced Molecular Imaging [CE140100011]; The University of Queensland [UQECR1834385]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Advanced Molecular Imaging(Australian Research Council); The University of Queensland(University of Queensland)	We thank the staff at the National Synchrotron for assistance with data collection and the staff at the Monash Macromolecular Crystallization Facility and the Doherty Flow Cytometry Facility. This research was undertaken in part by using the MX2 beamline at the Australian Synchrotron, part of ANSTO, and made use of the Australian Cancer Research Foundation (ACRF) detector. This work was supported by the Australian National Health and Medical Research Council (NHMRC; 1125493 and 1113293), the Australian Research Council (ARC) Centre of Excellence in Advanced Molecular Imaging (CE140100011) and The University of Queensland (UQECR1834385). D.P.F. was an NHMRC Senior Principal Research Fellow (1027369 and 1117017), S.E. is an ARC DECRA Fellow (DE170100407), A.J.C. (FT160100083) and J.L.N. (FT160100074) are ARC Future Fellows and J.R. is an Australian ARC Laureate Fellow (FL160100049).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Awad W, 2018, IMMUNOL CELL BIOL, V96, P588, DOI 10.1111/imcb.12017; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Crowther MD, 2020, NAT IMMUNOL, V21, P178, DOI 10.1038/s41590-019-0578-8; De Libero G, 2015, FRONT IMMUNOL, V5, P679; Eckle SBG, 2015, J BIOL CHEM, V290, P30204, DOI 10.1074/jbc.R115.685990; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Harriff MJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao2556; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; HWANG DR, 1985, J ORG CHEM, V50, P1264, DOI 10.1021/jo00208a022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller AN, 2017, CURR OPIN IMMUNOL, V46, P66, DOI 10.1016/j.coi.2017.04.002; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; La Gruta NL, 2018, NAT REV IMMUNOL, V18, P467, DOI 10.1038/s41577-018-0007-5; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Nours J, 2019, SCIENCE, V366, P1522, DOI 10.1126/science.aav3900; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Ler GJM, 2019, CHEM-EUR J, V25, P15594, DOI 10.1002/chem.201903732; Mak JYW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14599; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McWilliam HEG, 2016, NAT IMMUNOL, V17, P531, DOI 10.1038/ni.3416; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Toubal A, 2019, NAT REV IMMUNOL, V19, P643, DOI 10.1038/s41577-019-0191-y; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Wang HM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0402; Wang HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05202-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001	42	28	28	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					400	+		10.1038/s41590-020-0616-6	http://dx.doi.org/10.1038/s41590-020-0616-6		MAR 2020	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32123373				2022-12-18	WOS:000517740900002
J	Fayngerts, SA; Wang, ZJ; Zamani, A; Sun, HH; Boggs, AE; Porturas, TP; Xie, WD; Lin, M; Cathopoulis, T; Goldsmith, JR; Vourekas, A; Chen, YHH				Fayngerts, Svetlana A.; Wang, Zhaojun; Zamani, Ali; Sun, Honghong; Boggs, Amanda E.; Porturas, Thomas P.; Xie, Weidong; Lin, Mei; Cathopoulis, Terry; Goldsmith, Jason R.; Vourekas, Anastassios; Chen, Youhai H.			Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein TIPE2	NATURE IMMUNOLOGY			English	Article							NEGATIVE REGULATOR; EXCITABLE NETWORKS; CELLS; COFILIN; INFLAMMATION; CHEMOTAXIS; 3-KINASE; TNFAIP8; INNATE; METASTASIS	The polarization of leukocytes toward chemoattractants is essential for the directed migration (chemotaxis) of leukocytes. How leukocytes acquire polarity after encountering chemical gradients is not well understood. We found here that leukocyte polarity was generated by TIPE2 (TNFAIP8L2), a transfer protein for phosphoinositide second messengers. TIPE2 functioned as a local enhancer of phosphoinositide-dependent signaling and cytoskeleton remodeling, which promoted leading-edge formation. Conversely, TIPE2 acted as an inhibitor of the GTPase Rac, which promoted trailing-edge polarization. Consequently, TIPE2-deficient leukocytes were defective in polarization and chemotaxis, and TIPE2-deficient mice were resistant to leukocyte-mediated neural inflammation. Thus, the leukocyte polarizer is a dual-role phosphoinositide-transfer protein and represents a potential therapeutic target for the treatment of inflammatory diseases.	[Fayngerts, Svetlana A.; Wang, Zhaojun; Zamani, Ali; Sun, Honghong; Boggs, Amanda E.; Porturas, Thomas P.; Xie, Weidong; Lin, Mei; Cathopoulis, Terry; Goldsmith, Jason R.; Vourekas, Anastassios; Chen, Youhai H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Zhaojun] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University	Chen, YHH (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yhc@pennmedicine.upenn.edu	Vourekas, Anastasios/AAI-8278-2020; Porturas, Thomas/AGF-1557-2022; Wang, Zhaojun/GKS-9141-2022; Chen, Youhai/AAJ-4031-2021; Goldsmith, Jason/V-7527-2019	Wang, Zhaojun/0000-0003-2853-1850; Goldsmith, Jason/0000-0003-2874-8013; Chen, Youhai/0000-0002-9695-6757; Vourekas, Anastassios/0000-0002-1850-5635	US National Institutes of Health [AI121166, AI099216, AI50059, T32CA009140]; National Multiple Sclerosis Society [1501-02782]; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099216, R56AI050059, R01AI050059, R01AI121166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Pear (University of Pennsylvania) for NGFR vector; M. Lemmon (University of Pennsylvania) for the peGFP-GRP1-PH vector and for discussions; G. Luo, N. Li, D. Johnson, A. Stout, J. Zhao, G. Ruthel, the CDB Microscopy Core, and the PennVet Imaging Core for discussions and/or technical assistance. Supported by the US National Institutes of Health (AI121166, AI099216, and AI50059 to Y.H.C.; and T32CA009140 to A.E.B.) and the National Multiple Sclerosis Society (1501-02782 to Y.H.C.).	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Boulven I, 2006, J IMMUNOL, V176, P7621, DOI 10.4049/jimmunol.176.12.7621; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; Deng Q, 2012, J CELL SCI, V125, P3949, DOI 10.1242/jcs.093633; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Hirayama A, 2007, J LEUKOCYTE BIOL, V81, P720, DOI 10.1189/jlb.0506314; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; JoVE Science Education Database, 2017, CELL BIOL; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Leithner A, 2016, NAT CELL BIOL, V18, P1253, DOI 10.1038/ncb3426; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Ma Y, 2013, SCAND J IMMUNOL, V78, P523, DOI 10.1111/sji.12110; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Miao YC, 2017, NAT CELL BIOL, V19, P329, DOI 10.1038/ncb3495; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Steinbach K, 2013, J IMMUNOL, V191, P4531, DOI 10.4049/jimmunol.1202613; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun HH, 2012, J IMMUNOL, V189, P2768, DOI 10.4049/jimmunol.1103477; Sun J, 2005, J IMMUNOL, V175, P4783, DOI 10.4049/jimmunol.175.7.4783; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tang M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6175; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Vargas P, 2016, NAT CELL BIOL, V18, P43, DOI 10.1038/ncb3284; Wang LC, 2014, TUMOR BIOL, V35, P2319, DOI 10.1007/s13277-013-1307-9; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896; Wrighton KH, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm2985; Xi WJ, 2011, MOL IMMUNOL, V48, P1203, DOI 10.1016/j.molimm.2011.03.002; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x; Yang M, 2014, HISTOPATHOLOGY, V65, P517, DOI 10.1111/his.12413; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020; Zhang CB, 2013, INT J CANCER, V133, P31, DOI 10.1002/ijc.27996; Zhang X, 2009, NAT STRUCT MOL BIOL, V16, P89, DOI 10.1038/nsmb.1522; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	48	28	32	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1353	+		10.1038/ni.3866	http://dx.doi.org/10.1038/ni.3866			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29058702	Green Accepted			2022-12-18	WOS:000415324900013
J	Harrison, SC				Harrison, Stephen C.			Immunogenic cross-talk between dengue and Zika viruses	NATURE IMMUNOLOGY			English	Editorial Material							ANTIBODY-DEPENDENT ENHANCEMENT; INFECTION	At least five recent papers have shown an unexpected antigenic relationship between Zika and dengue viruses, with potential implications for vaccines and therapeutics.	[Harrison, Stephen C.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.; Harrison, SC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	harrison@crystal.harvard.edu						Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	14	28	33	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1010	1012		10.1038/ni.3539	http://dx.doi.org/10.1038/ni.3539			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27540984	Bronze			2022-12-18	WOS:000381832000003
J	Kim, MS; Yan, JQ; Wu, WH; Zhang, G; Zhang, YL; Cai, DS				Kim, Min Soo; Yan, Jingqi; Wu, Wenhe; Zhang, Guo; Zhang, Yalin; Cai, Dongsheng			Rapid linkage of innate immunological signals to adaptive immunity by the brain-fat axis	NATURE IMMUNOLOGY			English	Article							WHITE ADIPOSE-TISSUE; BETA/NF-KAPPA-B; INSULIN-RESISTANCE; IKK-BETA; INFLAMMATION; OBESITY; RECEPTORS; LEPTIN; CELLS; ACCUMULATION	Innate immunological signals induced by pathogen- and/or damage-associated molecular patterns are essential for adaptive immune responses, but it is unclear if the brain has a role in this process. Here we found that while the abundance of tumor-necrosis factor (TNF) quickly increased in the brain of mice following bacterial infection, intra-brain delivery of TNF mimicked bacterial infection to rapidly increase the number of peripheral lymphocytes, especially in the spleen and fat. Studies of various mouse models revealed that hypothalamic responses to TNF were accountable for this increase in peripheral lymphocytes in response to bacterial infection. Finally, we found that hypothalamic induction of lipolysis mediated the brain's action in promoting this increase in the peripheral adaptive immune response. Thus, the brain-fat axis is important for rapid linkage of innate immunity to adaptive immunity.	[Kim, Min Soo; Yan, Jingqi; Wu, Wenhe; Zhang, Guo; Zhang, Yalin; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Kim, Min Soo; Yan, Jingqi; Wu, Wenhe; Zhang, Guo; Zhang, Yalin; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Kim, Min Soo; Yan, Jingqi; Wu, Wenhe; Zhang, Guo; Zhang, Yalin; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	dongsheng.cai@einstein.yu.edu	Zhang, Guo/Q-8513-2016	Zhang, Guo/0000-0003-0841-4710; yan, Jingqi/0000-0002-7024-6423; Zhang, Guo/0000-0002-3880-6996	US National Institutes of Health [R01 DK078750, R01 AG031774, R01 HL113180, R01 DK 099136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the laboratory of D.C. for technical assistance. Supported by the US National Institutes of Health (R01 DK078750, R01 AG031774, R01 HL113180 and R01 DK 099136 to D.C.).	Banyer J L, 2000, Rev Immunogenet, V2, P359; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Chen CP, 1999, AM J PATHOL, V155, P2145, DOI 10.1016/S0002-9440(10)65532-0; COUSIN B, 1993, ENDOCRINOLOGY, V133, P2255, DOI 10.1210/en.133.5.2255; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; GROSS PM, 1992, PROG BRAIN RES, V91, P219; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P1, DOI 10.1016/j.coi.2006.11.018; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Matarese G, 2013, P NATL ACAD SCI USA, V110, P6193, DOI 10.1073/pnas.1210644110; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peschon JJ, 1998, J IMMUNOL, V160, P943; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stentz FB, 2006, BIOCHEM BIOPH RES CO, V346, P721, DOI 10.1016/j.bbrc.2006.05.159; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Trotter-Mayo RN, 2008, ENDOCRINOLOGY, V149, P5209, DOI 10.1210/en.2008-0476; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yang G, 2013, P NATL ACAD SCI USA, V110, P10306, DOI 10.1073/pnas.1222895110; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	49	28	29	1	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					525	U245		10.1038/ni.3133	http://dx.doi.org/10.1038/ni.3133			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25848866	Green Accepted			2022-12-18	WOS:000353305200015
J	Lin, AE; Ebert, G; Ow, Y; Preston, SP; Toe, JG; Cooney, JP; Scott, HW; Sasaki, M; Saibil, SD; Dissanayake, D; Kim, RH; Wakeham, A; You-Ten, A; Shahinian, A; Duncan, G; Silvester, J; Ohashi, PS; Mak, TW; Pellegrini, M				Lin, Amy E.; Ebert, Gregor; Ow, Yongkai; Preston, Simon P.; Toe, Jesse G.; Cooney, James P.; Scott, Hamish W.; Sasaki, Masato; Saibil, Samuel D.; Dissanayake, Dilan; Kim, Raymond H.; Wakeham, Andrew; You-Ten, Annick; Shahinian, Arda; Duncan, Gordon; Silvester, Jennifer; Ohashi, Pamela S.; Mak, Tak W.; Pellegrini, Marc			ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; VIRUS-INFECTION; GENE; BETA; UBIQUITINATION; TRANSCRIPTION; DEGRADATION; FAMILY; P65	The E3 ligase ARIH2 has an unusual structure and mechanism of elongating ubiquitin chains. To understand its physiological role, we generated gene-targeted mice deficient in ARIH2. ARIH2 deficiency resulted in the embryonic death of C57BL/6 mice. On a mixed genetic background, the lethality was attenuated, with some mice surviving beyond weaning and then succumbing to an aggressive multiorgan inflammatory response. We found that in dendritic cells (DCs), ARIH2 caused degradation of the inhibitor I kappa B beta in the nucleus, which abrogated its ability to sequester, protect and transcriptionally coactivate the transcription factor subunit p65 in the nucleus. Loss of ARIH2 caused dysregulated activation of the transcription factor NF-kappa B in DCs, which led to lethal activation of the immune system in ARIH2-sufficent mice reconstituted with ARIH2-deficient hematopoietic stem cells. Our data have therapeutic implications for targeting ARIH2 function.	[Ebert, Gregor; Preston, Simon P.; Toe, Jesse G.; Cooney, James P.; Scott, Hamish W.; Pellegrini, Marc] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Lin, Amy E.; Kim, Raymond H.; Ohashi, Pamela S.; Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Lin, Amy E.; Ow, Yongkai; Sasaki, Masato; Saibil, Samuel D.; Dissanayake, Dilan; Kim, Raymond H.; Wakeham, Andrew; You-Ten, Annick; Shahinian, Arda; Duncan, Gordon; Silvester, Jennifer; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Lin, Amy E.; Saibil, Samuel D.; Kim, Raymond H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Preston, Simon P.; Toe, Jesse G.; Saibil, Samuel D.; Dissanayake, Dilan; Pellegrini, Marc] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Ohashi, Pamela S.; Mak, Tak W.] Univ Melbourne, Dept Immunol, Melbourne, Vic, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Melbourne; University of Melbourne	Pellegrini, M (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	tmak@uhnresearch.ca; pellegrini@wehi.edu.au	Pellegrini, Marc/F-7670-2014; Duncan, Gordon/AIE-7011-2022; Lin, Amy Erica/ABG-4745-2020	Lin, Amy Erica/0000-0002-0554-2832; Dissanayake, Dilan/0000-0003-4270-7015; Cooney, James/0000-0003-3680-4644; Kim, Raymond/0000-0002-2147-8674; Pellegrini, Marc/0000-0003-3627-3126; Ohashi, Pamela S./0000-0003-2915-9317; Ebert, Gregor/0000-0002-5318-3037; Preston, Simon/0000-0001-8969-8297; Silvester, Jennifer/0000-0001-6087-4066	Terry Fox Cancer Foundation; National Cancer Institute of Canada; Canada Research Chairs; Cancer Research Institute; National Health and Medical Research Council Australia [637350]; Victorian State Government Operational Infrastructure Support; Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council; Canadian Institutes of Health Research	Terry Fox Cancer Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chairs(Canada Research ChairsCGIAR); Cancer Research Institute; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank J. Haight for animal care; A. Elia, L. Zhou and K. So and M. Macasaet for assistance with histopathology; R. Nayyar and F. Tong for flow cytometry support; M. Herold for assistance with the transduction of retroviruses, lentiviruses and short hairpin RNA; and T. Calzascia, C. Deluca, Y.J. Yang, A. Cheung, J. Woodgett, V. Stambolic and M. Minden for discussions. Supported by the Terry Fox Cancer Foundation (T.W.M. and P.S.O.), the National Cancer Institute of Canada (T.W.M. and P.S.O.), Canada Research Chairs (P.S.O.), the Cancer Research Institute (M.P.), National Health and Medical Research Council Australia (Career Development Award 637350 to M.P.), Victorian State Government Operational Infrastructure Support (M.P.), the Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council (M.P.) and the Canadian Institutes of Health Research (A.E.L.).	Aguilera M, 2000, GENETICS, V155, P1231; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Chiffoleau E, 2003, J IMMUNOL, V171, P5751, DOI 10.4049/jimmunol.171.11.5751; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Donate PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054803; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin ACC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023940; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marteijn JA, 2009, LEUKEMIA, V23, P1480, DOI 10.1038/leu.2009.57; McKinsey TA, 1997, J BIOL CHEM, V272, P22377, DOI 10.1074/jbc.272.36.22377; Metcalf D, 2000, P NATL ACAD SCI USA, V97, P9174, DOI 10.1073/pnas.160255197; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Pietschmann K, 2012, INT J BIOCHEM CELL B, V44, P132, DOI 10.1016/j.biocel.2011.10.008; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tan NGS, 2000, CYTOGENET CELL GENET, V90, P242, DOI 10.1159/000056780; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Wang H, 2011, J BIOL CHEM, V286, P16832, DOI 10.1074/jbc.M110.213975; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	42	28	29	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					27	33		10.1038/ni.2478	http://dx.doi.org/10.1038/ni.2478			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23179078				2022-12-18	WOS:000312433800007
J	Mandrup-Poulsen, T				Mandrup-Poulsen, Thomas			IAPP boosts islet macrophage IL-1 in type 2 diabetes	NATURE IMMUNOLOGY			English	Editorial Material							OXIDATIVE STRESS; INTERLEUKIN-1; ACTIVATION; MELLITUS; PROTEIN	IAPP, a hormone secreted together with insulin and deposited in pancreatic islets in type 2 diabetes, can induce macrophage processing of interleukin 1 linked to beta-cell destruction in type 2 diabetes.	[Mandrup-Poulsen, Thomas] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Hagedorn Res Inst, Gentofte, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Med & Surg, Stockholm, Sweden	University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Karolinska Institutet	Mandrup-Poulsen, T (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	tmpo@sund.ku.dk		Mandrup-Poulsen, Thomas/0000-0002-3215-9273				DINARELLO CA, CURR OPIN E IN PRESS; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	12	28	30	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					881	883		10.1038/ni1010-881	http://dx.doi.org/10.1038/ni1010-881			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20856216				2022-12-18	WOS:000281926900004
J	Anderson, P				Anderson, Paul			Intrinsic mRNA stability helps compose the inflammatory symphony	NATURE IMMUNOLOGY			English	Editorial Material							TRISTETRAPROLIN; ALPHA	The intrinsic stability of mRNA is important in the regulation of gene expression. New data show that the intrinsic stability of tumor necrosis factor-induced mRNA transcripts strongly influences the coordinated expression of genes that promote distinct phases of the inflammatory response.	[Anderson, Paul] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Anderson, Paul] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Anderson, P (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu						Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; BEG AA, 1996, SCIENCE, V274, P784; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944; FELDMANN M, ANN REV IMM IN PRESS; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; HAO S, 2007, NAT IMMUNOL, V10, P281; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2	15	28	30	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					233	234		10.1038/ni0309-233	http://dx.doi.org/10.1038/ni0309-233			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19221551				2022-12-18	WOS:000263456500004
J	Costa-Mattioli, M; Sonenberg, N				Costa-Mattioli, Mauro; Sonenberg, Nahum			RAPping production of type I interferon in pDCs through mTOR	NATURE IMMUNOLOGY			English	Editorial Material							MESSENGER-RNA TRANSLATION; PATTERN-RECOGNITION RECEPTORS; PLASMACYTOID DENDRITIC CELLS; VIRAL-INFECTION; ACTIVATION; IRF-7		[Costa-Mattioli, Mauro; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Costa-Mattioli, Mauro; Sonenberg, Nahum] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.	nahum.sonenberg@mcgill.ca						Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kaur S, 2008, CELL CYCLE, V7, P2112, DOI 10.4161/cc.7.14.6258; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946	14	28	33	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1097	1099		10.1038/ni1008-1097	http://dx.doi.org/10.1038/ni1008-1097			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18800159	Green Published			2022-12-18	WOS:000259315600005
J	Flajnik, MF				Flajnik, MF			The last flag unfurled? A new immunoglobulin isotype in fish expressed in early development	NATURE IMMUNOLOGY			English	Editorial Material							HEAVY-CHAIN	Gene reassortment confers immunoglobulin diversity. Functional diversity occurs by use of distinct heavy chains. Identification of a previously unknown immunoglobulin gene in zebrafish suggests such functional specialization also occurs in this species and probably in all bony fish.	Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Flajnik, MF (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	mflajnik@som.umaryland.edu		Flajnik, Martin Francis/0000-0002-2792-5084				Bromage ES, 2004, J IMMUNOL, V173, P7317, DOI 10.4049/jimmunol.173.12.7317; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Dunon D, 1997, J EXP MED, V186, P977, DOI 10.1084/jem.186.7.977; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; LEWIS SM, 2004, MOL BIOL B CELLS, P773; LITMAN GW, 2004, MOL BIOL B CELLS, P417; MARCHALO.J, 1965, J EXP MED, V122, P601, DOI 10.1084/jem.122.3.601; Ota T, 2003, P NATL ACAD SCI USA, V100, P2501, DOI 10.1073/pnas.0538029100; Traver D, 2003, ADV IMMUNOL, V81, P253; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; Zapata A, 2000, CURR TOP MICROBIOL, V248, P67	12	28	29	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					229	230		10.1038/ni0305-229	http://dx.doi.org/10.1038/ni0305-229			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716968				2022-12-18	WOS:000227117400004
J	Huang, AC; Zappasodi, R				Huang, Alexander C.; Zappasodi, Roberta			A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; STAGE-III MELANOMA; METASTATIC MELANOMA; LYMPHOID STRUCTURES; B-CELLS; NEOADJUVANT IMMUNOTHERAPY; PATHOLOGICAL RESPONSE; ADOPTIVE TRANSFER; LANGERHANS CELLS	Enormous progress has been made in the ten years since immune checkpoint blockade (ICB) was first approved for treating melanoma. Zappasodi and Huang review the current state of the art of ICB for melanoma and prospects for the future. Ten years since the immune checkpoint inhibitor ipilimumab was approved for advanced melanoma, it is time to reflect on the lessons learned regarding modulation of the immune system to treat cancer and on novel approaches to further extend the efficacy of current and emerging immunotherapies. Here, we review the studies that led to our current understanding of the melanoma immune microenvironment in humans and the mechanistic work supporting these observations. We discuss how this information is guiding more precise analyses of the mechanisms of action of immune checkpoint blockade and novel immunotherapeutic approaches. Lastly, we review emerging evidence supporting the negative impact of melanoma metabolic adaptation on anti-tumor immunity and discuss how to counteract such mechanisms for more successful use of immunotherapy.	[Huang, Alexander C.] Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Huang, Alexander C.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Huang, Alexander C.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Huang, Alexander C.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Huang, Alexander C.; Zappasodi, Roberta] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Zappasodi, Roberta] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA; [Zappasodi, Roberta] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Zappasodi, Roberta] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Huang, AC (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.; Huang, AC (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.; Huang, AC (corresponding author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; Huang, AC (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Huang, AC; Zappasodi, R (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Zappasodi, R (corresponding author), Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA.; Zappasodi, R (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.; Zappasodi, R (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	alexander.huang@pennmedicine.upenn.edu; roz4002@med.cornell.edu			NIH [K08 CA230157]; Doris Duke CSDA; Damon Runyon CIA; Tara Miller Melanoma Foundation; Parker Institute for Cancer Immunotherapy Bridge Fellows Award; NCI SPORE [P50-CA192937]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke CSDA; Damon Runyon CIA; Tara Miller Melanoma Foundation; Parker Institute for Cancer Immunotherapy Bridge Fellows Award; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank G. Linette, B. Carreno, R. Amaravadi, T. Mitchell, and J. D. Wolchok for their insightful feedback on this manuscript. A. C. H. is funded by grant K08 CA230157 from the NIH, the Doris Duke CSDA, Damon Runyon CIA, and funding from the Tara Miller Melanoma Foundation. R. Z. was supported by the Parker Institute for Cancer Immunotherapy Bridge Fellows Award. R. Z . acknowledges funding from the NCI SPORE (P50-CA192937).	Afzal MZ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0375-1; Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amaria RN, 2019, LANCET ONCOL, V20, pE378, DOI 10.1016/S1470-2045(19)30332-8; Amaria RN, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.9502; Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Andrews LP, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc2728; Ascierto PA, 2019, JAMA ONCOL, V5, P187, DOI 10.1001/jamaoncol.2018.4514; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blank CU, 2020, J CLIN ONCOL, V38; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brahmer JR, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002435; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Cipponi A, 2012, CANCER RES, V72, P3997, DOI 10.1158/0008-5472.CAN-12-1377; CLARK WH, 1969, CANCER RES, V29, P705; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Cohen BE, 2020, AM J CLIN DERMATOL, V21, P669, DOI 10.1007/s40257-020-00524-0; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Curti BD, 2021, NEW ENGL J MED, V384, P2229, DOI 10.1056/NEJMra2034861; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2021, LANCET ONCOL, V22, P643, DOI 10.1016/S1470-2045(21)00065-6; Eggermont AMM, 2019, EUR J CANCER, V119, P1, DOI 10.1016/j.ejca.2019.07.001; Enninga EAL, 2016, MELANOMA RES, V26, P429, DOI 10.1097/CMR.0000000000000281; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Eschweiler S, 2021, NAT IMMUNOL, V22, P1052, DOI 10.1038/s41590-021-00958-6; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Fischer GM, 2019, CANCER DISCOV, V9, P628, DOI 10.1158/2159-8290.CD-18-1489; Garg K, 2016, HUM PATHOL, V54, P157, DOI 10.1016/j.humpath.2016.03.022; Gilbert AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019330; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Itzhaki O, 2011, J IMMUNOTHER, V34, P212, DOI 10.1097/CJI.0b013e318209c94c; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jaiswal AR, 2020, CANCER IMMUNOL RES, V8, P1365, DOI 10.1158/2326-6066.CIR-19-0005; Jakob John A, 2012, Cancer, V118, P4014, DOI 10.1002/cncr.26724; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kavanagh B, 2008, BLOOD, V112, P1175, DOI 10.1182/blood-2007-11-125435; Khalil DN, 2019, J CLIN INVEST, V129, P3435, DOI 10.1172/JCI128562; Kim SH, 2017, J INVEST DERMATOL, V137, P1740, DOI 10.1016/j.jid.2017.03.033; Klarquist JS, 2012, ONCOIMMUNOLOGY, V1, P1584, DOI 10.4161/onci.22660; Korman AJ, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-SY09-01; Krishna S, 2020, SCIENCE, V370, P1328, DOI 10.1126/science.abb9847; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Ladanyi A, 2011, CANCER IMMUNOL IMMUN, V60, P1729, DOI 10.1007/s00262-011-1071-x; Lauerova L, 2002, NEOPLASMA, V49, P159; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Leko V, 2020, CANCER CELL, V38, P454, DOI 10.1016/j.ccell.2020.07.013; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Liu WT, 2013, PEERJ, V1, DOI 10.7717/peerj.49; LIVINGSTON PO, 1994, J CLIN ONCOL, V12, P1036, DOI 10.1200/JCO.1994.12.5.1036; Long GV, 2021, CLIN CANCER RES, V27, P5280, DOI 10.1158/1078-0432.CCR-21-0793; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Luke J, 2021, ANN ONCOL, V32, pS1314, DOI 10.1016/j.annonc.2021.08.2116; Martinez-Rodriguez M, 2014, HISTOPATHOLOGY, V65, P726, DOI 10.1111/his.12437; Maruhashi T, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001014; Marzagalli M, 2019, SEMIN CANCER BIOL, V59, P236, DOI 10.1016/j.semcancer.2019.08.002; Menzies AM, 2021, NAT MED, V27, P301, DOI 10.1038/s41591-020-01188-3; Miniotis MF, 2013, CANCER RES, V73, P4039, DOI 10.1158/0008-5472.CAN-12-1969; Mortarini R, 2005, CANCER RES, V65, P3428, DOI 10.1158/0008-5472.CAN-04-3239; Moschos SJ, 2006, J CLIN ONCOL, V24, P3164, DOI 10.1200/JCO.2005.05.2498; MUKHERJI B, 1989, J EXP MED, V169, P1961, DOI 10.1084/jem.169.6.1961; Najjar YG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124989; Nevala WK, 2009, CLIN CANCER RES, V15, P1931, DOI 10.1158/1078-0432.CCR-08-1980; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Oliveira, 2021, J IMMUNOTHER CANCER, V9; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pauken KE, 2021, SEMIN IMMUNOL, V52, DOI 10.1016/j.smim.2021.101480; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pfreundschuh Michael, 2012, Cancer Immun, V12, P7; Pieniazek M, 2018, ONCOL LETT, V15, P5399, DOI 10.3892/ol.2018.8021; Prickett TD, 2016, CANCER IMMUNOL RES, V4, P669, DOI 10.1158/2326-6066.CIR-15-0215; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Rawson RV, 2021, ANN ONCOL, V32, P766, DOI 10.1016/j.annonc.2021.03.006; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rozeman EA, 2021, NAT MED, V27, P256, DOI 10.1038/s41591-020-01211-7; RUSCETTI FW, 1977, J IMMUNOL, V119, P131; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharma A, 2019, CLIN CANCER RES, V25, P1233, DOI 10.1158/1078-0432.CCR-18-0762; Shen RL, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf5107; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Strome SE, 2003, CANCER RES, V63, P6501; Sun XY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00951; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; Tarhini AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087705; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tawbi HA, 2022, NEW ENGL J MED, V386, P24, DOI 10.1056/NEJMoa2109970; Thomas NE, 2013, J CLIN ONCOL, V31, P4252, DOI 10.1200/JCO.2013.51.3002; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tucci M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01148; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Valpione S, 2020, NAT CANCER, V1, P210, DOI 10.1038/s43018-019-0022-x; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wang LC, 2009, J IMMUNOL, V183, P5548, DOI 10.4049/jimmunol.0900235; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; Watson MJ, 2021, NATURE, V591, P645, DOI 10.1038/s41586-020-03045-2; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wolchok JD, 2022, J CLIN ONCOL, V40, P127, DOI 10.1200/JCO.21.02229; Zappasodi R, 2021, NATURE, V591, P652, DOI 10.1038/s41586-021-03326-4; Zappasodi R, 2018, CURR HEMATOL MALIG R, V13, P383, DOI 10.1007/s11899-018-0471-9; Zappasodi R, 2018, CANCER CELL, V33, P1017, DOI 10.1016/j.ccell.2018.05.009; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	150	27	26	10	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					660	670		10.1038/s41590-022-01141-1	http://dx.doi.org/10.1038/s41590-022-01141-1		MAR 2022	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35241833	Green Accepted, Bronze			2022-12-18	WOS:000763899900002
J	Gee, S; Chandiramani, M; Seow, J; Modestini, C; Das, A; Doores, KJ; Tribe, RM; Pollock, E; Tree, T; Gibbons, DL				Gee, Sarah; Chandiramani, Manju; Seow, Jeffrey; Modestini, Carlotta; Das, Abhishek; Doores, Katie J.; Tribe, Rachel M.; Pollock, Emily; Tree, Timothy; Gibbons, Deena L.			The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSE; EXPOSURE; COVID-19; METHYLATION; EXPRESSION; PREGNANCY; PATTERNS; OUTCOMES; GAMMA	Many babies have now been born to mothers who were exposed to SARS-CoV-2 during their pregnancy. Here the authors look at the effect of this exposure on the immunology of human neonates, showing immune changes and increased neonatal cytokine responses despite limited evidence of vertical transmission. Despite extensive studies into severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the effect of maternal infection on the neonate is unclear. To investigate this, we characterized the immunology of neonates born to mothers with confirmed SARS-CoV-2 infection during pregnancy. Here we show that maternal SARS-CoV-2 infection affects the neonatal immune system. Despite similar proportions of B cells, CD4(+) T cells and CD8(+) T cells, increased percentages of natural killer cells, V delta 2(+) gamma delta T cells and regulatory T cells were detected in neonates born to mothers with recent or ongoing infection compared with those born to recovered or uninfected mothers. Increased plasma cytokine levels were also evident in neonates and mothers within the recent or ongoing infection group. Cytokine functionality was enhanced in neonates born to SARS-CoV-2-exposed mothers, compared to those born to uninfected mothers. In most neonates, this immune imprinting was nonspecific, suggesting vertical transmission of SARS-CoV-2 is limited, a finding supported by a lack of SARS-CoV-2-specific IgM in neonates despite maternal IgG transfer.	[Gee, Sarah; Das, Abhishek; Pollock, Emily; Tree, Timothy; Gibbons, Deena L.] Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Chandiramani, Manju; Modestini, Carlotta] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Dept Womens Hlth, London, England; [Seow, Jeffrey; Doores, Katie J.] Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Tribe, Rachel M.] Kings Coll London, St Thomas Hosp, Fac Life Sci & Med, Sch Life Course Sci,Dept Women & Childrens Hlth, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Gibbons, DL (corresponding author), Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England.	deena.gibbons@kcl.ac.uk		Pollock, Emily/0000-0002-7297-4205; Tribe, Rachel/0000-0003-3675-9978; Gee, Sarah/0000-0002-2997-6563; Das, Abhishek/0000-0002-8798-035X; Gibbons, Deena/0000-0002-7953-3576; Seow, Jeffrey/0000-0003-0722-8561	MRC-KCL Doctoral Training Partnership in Biomedical Sciences [MR/N013700/1]; Action Medical Research [GN2790]; National Institute for Health Research (NIHR) [BRC COVID-19, 1060508, 1167073]; Kings Together Rapid COVID-19 call award; Huo Family Foundation; T1DUK Immunotherapy Consortium - Diabetes UK [15/0005232]; NIHR Biomedical Research Centre based at GSTT; King's College London; NIHR Clinical Research Facility	MRC-KCL Doctoral Training Partnership in Biomedical Sciences(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Kings Together Rapid COVID-19 call award; Huo Family Foundation; T1DUK Immunotherapy Consortium - Diabetes UK; NIHR Biomedical Research Centre based at GSTT; King's College London(General Electric); NIHR Clinical Research Facility	We thank the mothers and their neonates for blood collection and all the midwives (GSTT) for sample collection. We also thank S. Kamdar and other staff involved with COVID-IP (King's College London)20 for some sample processing and T. Lechmere (King's College London) for assistance with ELISA assays. We thank I. Zlatareva (King's College London) for assistance with the cytokine multiplex analysis. We also acknowledge Evolve Biosystems for funding (to R.T. and D.G.) toward the NSE neonatal cord blood sample collection and the staff involved: N. Kelly, L. McMillan, S. Kheirallah and J. Mi; GSTT and King's College London). We thank Y. Wu (King's College London) for critical reading of the manuscript. S.G. is supported by an MRC-KCL Doctoral Training Partnership in Biomedical Sciences (MR/N013700/1); D.L.G. is supported by Action Medical Research (GN2790); M.C. is supported by the National Institute for Health Research (NIHR) BRC COVID-19 call; R.M.T. is supported by Tommy's (charity no. 1060508) and Borne (1167073); J.S. and K.J.D. are supported by a Kings Together Rapid COVID-19 call award and a Huo Family Foundation award; and E.P. and T.T. are supported by the T1DUK Immunotherapy Consortium funded by Diabetes UK (15/0005232). The research was also supported by the NIHR Biomedical Research Centre based at GSTT and King's College London (part of the King's Health Partners Academic Sciences Centre) and/or the NIHR Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Acquah JK, 2017, AM J PUBLIC HEALTH, V107, P1477, DOI 10.2105/AJPH.2017.303887; Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Apostol AC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00123; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Atyeo C, 2021, CELL, V184, P628, DOI 10.1016/j.cell.2020.12.027; Babik JM, 2011, J INFECT DIS, V203, P196, DOI 10.1093/infdis/jiq044; Beharier O, 2021, J CLIN INVEST, V131, DOI [10.1172/JCI150319, 10.1172/JCI154834]; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bordt Evan A, 2021, bioRxiv, DOI 10.1101/2021.03.29.437516; Chen G, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.675476; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621; Edlow AG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30455; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Fenizia C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18933-4; Flannery DD, 2021, JAMA PEDIATR, V175, P594, DOI 10.1001/jamapediatrics.2021.0038; Gabriel B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48434-4; Gale C, 2021, LANCET CHILD ADOLESC, V5, P113, DOI 10.1016/S2352-4642(20)30342-4; Garcia-Flores Valeria, 2021, Res Sq, DOI 10.21203/rs.3.rs-362886/v1; Garcia-Knight MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143043; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Gleditsch DD, 2014, PEDIATR RES, V76, P33, DOI 10.1038/pr.2014.57; Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Kadiwar S, 2021, LANCET, V397, P1539, DOI 10.1016/S0140-6736(21)00716-9; Kamdar S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14923-8; Kappanayil M, 2021, LANCET CHILD ADOLESC, V5, P304, DOI 10.1016/S2352-4642(21)00055-9; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Liu P, 2020, J ALLERGY CLIN IMMUN, V146, P101, DOI 10.1016/j.jaci.2020.04.038; Lohman-Payne B, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0206-5; Lu WJ, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02561-y; Lu-Culligan A, 2021, MED-CAMBRIDGE, V2, P591, DOI 10.1016/j.medj.2021.04.016; Martinez DR, 2019, CELL, V178, P190, DOI 10.1016/j.cell.2019.05.046; Martinez-Perez O, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03742-4; Mishra A, 2021, CELL, V184, P3394, DOI 10.1016/j.cell.2021.04.039; Monin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8; Pickering S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008817; Reuschel E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010332; Salvatore CM, 2020, LANCET CHILD ADOLESC, V4, P721, DOI 10.1016/S2352-4642(20)30235-2; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Sherer ML, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.03.028; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-33; Torow N, 2017, J IMMUNOL, V198, P557, DOI 10.4049/jimmunol.1601253; van Esch BCAM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02141; Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820	50	27	27	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1490	+		10.1038/s41590-021-01049-2	http://dx.doi.org/10.1038/s41590-021-01049-2		OCT 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34616036	Green Submitted, Bronze			2022-12-18	WOS:000705730700001
J	Mandal, M; Okoreeh, MK; Kennedy, DE; Maienschein-Cline, M; Ai, JT; McLean, KC; Kaverina, N; Veselits, M; Aifantis, I; Gounari, F; Clark, MR				Mandal, Malay; Okoreeh, Michael K.; Kennedy, Domenick E.; Maienschein-Cline, Mark; Ai, Junting; McLean, Kaitlin C.; Kaverina, Natalya; Veselits, Margaret; Aifantis, Iannis; Gounari, Fotini; Clark, Marcus R.			CXCR4 signaling directs Igk recombination and the molecular mechanisms of late B lymphopoiesis	NATURE IMMUNOLOGY			English	Article							LIGHT-CHAIN RECOMBINATION; GENE RECOMBINATION; CELL PROLIFERATION; TRANSCRIPTION; IKAROS; DIFFERENTIATION; EXPRESSION; RECEPTOR; NETWORK; TARGETS	In B lymphopoiesis, activation of the pre-B cell antigen receptor (pre-BCR) is associated with both cell cycle exit and Igk recombination. Yet how the pre-BCR mediates these functions remains unclear. Here, we demonstrate that the pre-BCR initiates a feed-forward amplification loop mediated by the transcription factor interferon regulatory factor 4 and the chemokine receptor C-X-C motif chemokine receptor 4 (CXCR4). CXCR4 ligation by C-X-C motif chemokine ligand 12 activates the mitogenactivated protein kinase extracellular-signal-regulated kinase, which then directs the development of small pre- and immature B cells, including orchestrating cell cycle exit, pre-BCR repression, Igk recombination and BCR expression. In contrast, preBCR expression and escape from interleukin-7 have only modest effects on B cell developmental transcriptional and epigenetic programs. These data show a direct and central role for CXCR4 in orchestrating late B cell lymphopoiesis. Furthermore, in the context of previous findings, our data provide a three-receptor system sufficient to recapitulate the essential features of B lymphopoiesis in vitro.	[Mandal, Malay; Okoreeh, Michael K.; Kennedy, Domenick E.; Ai, Junting; McLean, Kaitlin C.; Veselits, Margaret; Gounari, Fotini; Clark, Marcus R.] Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Mandal, Malay; Okoreeh, Michael K.; Kennedy, Domenick E.; Ai, Junting; McLean, Kaitlin C.; Veselits, Margaret; Gounari, Fotini; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Maienschein-Cline, Mark] Univ Illinois, Core Res Informat, Chicago, IL USA; [Kaverina, Natalya] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Aifantis, Iannis] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; New York University; New York University	Mandal, M; Clark, MR (corresponding author), Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Mandal, M; Clark, MR (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA.	mmandal@medicine.bsd.uchicago.edu; mclark@uchicago.edu		Okoreeh, Michael/0000-0001-7680-9488; McLean, Kaitlin/0000-0003-4566-5105; Gounari, Fotini/0000-0003-2936-066X; Mandal, Malay/0000-0002-0451-3896; Kennedy, Domenick/0000-0002-5329-3711	US National Institutes of Health [AI120715, AI128785, AI143778, AI120715-02, AI128785-01A1, F32AI143120, T32GM007281, UL1TR002003, T32HD007009]; NCATS [UL1TR002003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120715, R01AI143778] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Olson, R. Ladd and D. Leclerc for cell-sorting services, and the ImmGen Consortium for data assembly. We thank H. Singh (University of Pittsburgh) for providing the PAX5 and FOXO1 ChIP-Seq data, and M. Schlissel (University of Michigan) for providing the C kappa-YFP reporter mice. This work is supported by US National Institutes of Health grants AI120715, AI128785 and AI143778 (to M.R.C.), AI120715-02 and AI128785-01A1 (to M. M.), F32AI143120 (to D.E.K.), T32GM007281 (to K.C.M.), UL1TR002003 (to M.M.-C.) and T32HD007009 (to M.K.O.). Part of the bioinformatics analysis was performed by the UIC Research Informatics Core, supported in part by NCATS through grant UL1TR002003.	Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Amin RH, 2009, P NATL ACAD SCI USA, V106, P522, DOI 10.1073/pnas.0808895106; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Clark MR, 2005, CURR TOP MICROBIOL, V290, P87; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Derudder E, 2009, NAT IMMUNOL, V10, P647, DOI 10.1038/ni.1732; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fistonich C, 2018, J EXP MED, V215, P2586, DOI 10.1084/jem.20180778; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Lagergren A, 2007, J BIOL CHEM, V282, P14454, DOI 10.1074/jbc.M610263200; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06165-6; Mandal M, 2015, NAT IMMUNOL, V16, P1094, DOI 10.1038/ni.3249; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Montresor Alessio, 2018, Oncotarget, V9, P35123, DOI 10.18632/oncotarget.26212; Nodland SE, 2011, BLOOD, V118, P2116, DOI 10.1182/blood-2010-08-302513; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Sakamoto S, 2012, J IMMUNOL, V188, P5547, DOI 10.4049/jimmunol.1002346; Song ZY, 2019, ONCOGENE, V38, P1560, DOI 10.1038/s41388-018-0519-2; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tian YY, 2018, MOL MED REP, V18, P4374, DOI 10.3892/mmr.2018.9444; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Vikstrom IB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.237; Zheng N, 2019, MOL CARCINOGEN, V58, P144, DOI 10.1002/mc.22916	40	27	27	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1393	+		10.1038/s41590-019-0468-0	http://dx.doi.org/10.1038/s41590-019-0468-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31477919	Green Accepted			2022-12-18	WOS:000486615900022
J	Guillamot, M; Ouazia, D; Dolgalev, I; Yeung, ST; Kourtis, N; Dai, YL; Corrigan, K; Zea-Redondo, L; Saraf, A; Florens, L; Washburn, MP; Tikhonova, AN; Malumbres, M; Gong, YX; Tsirigos, A; Park, C; Barbieri, C; Khanna, KM; Busino, L; Aifantis, I				Guillamot, Maria; Ouazia, Dahmane; Dolgalev, Igor; Yeung, Stephen T.; Kourtis, Nikos; Dai, Yuling; Corrigan, Kate; Zea-Redondo, Luna; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Tikhonova, Anastasia N.; Malumbres, Marina; Gong, Yixiao; Tsirigos, Aristotelis; Park, Christopher; Barbieri, Christopher; Khanna, Kamal M.; Busino, Luca; Aifantis, Iannis			The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; MYELOID DIFFERENTIATION; PROTEOMIC ANALYSIS; PROTEIN; EXPRESSION; INNATE; IDENTIFICATION; DRIVEN; UBIQUITYLATION; COMMITMENT	The response to systemic infection and injury requires the rapid adaptation of hematopoietic stem cells (HSCs), which proliferate and divert their differentiation toward the myeloid lineage. Significant interest has emerged in understanding the signals that trigger the emergency hematopoietic program. However, the mechanisms that halt this response of HSCs, which is critical to restore homeostasis, remain unknown. Here we reveal that the E3 ubiquitin ligase Speckle-type BTB-POZ protein (SPOP) restrains the inflammatory activation of HSCs. In the absence of Spop, systemic inflammation proceeded in an unresolved manner, and the sustained response in the HSCs resulted in a lethal phenotype reminiscent of hyper-inflammatory syndrome or sepsis. Our proteomic studies decipher that SPOP restricted inflammation by ubiquitinating the innate signal transducer myeloid differentiation primary response protein 88 (MYD88). These findings unearth an HSC-intrinsic post-translational mechanism that is essential for reestablishing homeostasis after emergency hematopoiesis.	[Guillamot, Maria; Dolgalev, Igor; Kourtis, Nikos; Dai, Yuling; Corrigan, Kate; Zea-Redondo, Luna; Tikhonova, Anastasia N.; Malumbres, Marina; Gong, Yixiao; Tsirigos, Aristotelis; Park, Christopher; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Guillamot, Maria; Dolgalev, Igor; Kourtis, Nikos; Dai, Yuling; Corrigan, Kate; Zea-Redondo, Luna; Tikhonova, Anastasia N.; Malumbres, Marina; Gong, Yixiao; Tsirigos, Aristotelis; Park, Christopher; Aifantis, Iannis] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10003 USA; [Ouazia, Dahmane; Busino, Luca] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Dolgalev, Igor; Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, Off Sci & Res, New York, NY USA; [Yeung, Stephen T.; Khanna, Kamal M.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Barbieri, Christopher] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Barbieri, Christopher] Weill Cornell Med, Dept Urol, New York, NY USA	New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; New York University; New York University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Cornell University; Cornell University	Guillamot, M; Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.; Guillamot, M; Aifantis, I (corresponding author), NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10003 USA.; Busino, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.	maria.guillamot-ruano@nyumc.org; businol@upenn.edu; iannis.aifantis@nyumc.org	Dolgalev, Igor/AAY-6406-2020	Dolgalev, Igor/0000-0003-4451-126X; Guillamot Ruano, Maria/0000-0001-6970-5250; Tsirigos, Aristotelis/0000-0002-7512-8477; Malumbres, Marina/0000-0003-3823-2512; Florens, Laurence/0000-0002-9310-6650	National Institutes of Health, National Cancer Institute [P30CA016087-30]; National Institutes of Health [R01CA133379, 5R01CA173636, RO1CA216421, RO1CA133379]; Leukemia and Lymphoma Society (TRP Program); NYSTEM program of the New York State Health Department [NYSTEM-N11G-255]; National Cancer Institute [R00-CA166181-04, R01-CA207513-01]; Gilead Sciences Research Scholars Program in Hematology/Oncology; NYU Histology Core [5P30CA16087-31]; NATIONAL CANCER INSTITUTE [R01CA133379, R01CA228135] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society (TRP Program)(Leukemia and Lymphoma Society); NYSTEM program of the New York State Health Department; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gilead Sciences Research Scholars Program in Hematology/Oncology; NYU Histology Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank all members of the Aifantis laboratory for discussions throughout the duration of this project, specifically E. Wang and B. Aranda for expert advice in CRISPR/Cas9 technology and K. Hockemeyer for expert advice in preparing the manuscript; A. Heguy and the NYU Genome Technology Center (supported in part by National Institutes of Health, National Cancer Institute grant P30CA016087-30) for expertise with sequencing experiments; the NYU Histology Core (5P30CA16087-31) for assistance; C. Loomis and L. Chiriboga for immunohistochemistry experiments; and S. Naik for her intellectual input. This work used computing resources at the High-Performance Computing Facility at the NYU Medical Center. I.A. is supported by the National Institutes of Health (grant nos. R01CA133379, 5R01CA173636, RO1CA216421, RO1CA133379), the Leukemia and Lymphoma Society (TRP Program) and the NYSTEM program of the New York State Health Department (NYSTEM-N11G-255). L.B. is supported in part by grants (nos. R00-CA166181-04 and R01-CA207513-01) from the National Cancer Institute and Gilead Sciences Research Scholars Program in Hematology/Oncology. I.A. dedicates this work to the memory of his mentor H. von Boehmer.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barreyro L, 2018, BLOOD, V132, P1553, DOI 10.1182/blood-2018-03-784116; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004; Bowman RL, 2018, CELL STEM CELL, V22, P157, DOI 10.1016/j.stem.2018.01.011; Buenrostro JD, 2015, CURR PROTOC MOL BIOL, V109, P2921; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai HC, 2016, P NATL ACAD SCI USA, V113, P14751, DOI 10.1073/pnas.1612520114; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; De Luca K, 2009, LEUKEMIA, V23, P2063, DOI 10.1038/leu.2009.155; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Florens Laurence, 2006, V328, P159; Gao J, 2015, ELIFE, V4, DOI 10.7554/eLife.07539; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Heger K, 2018, NATURE, V559, P120, DOI 10.1038/s41586-018-0256-2; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; King B, 2016, NAT IMMUNOL, V17, P1312, DOI 10.1038/ni.3559; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LORD KA, 1990, ONCOGENE, V5, P1095; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Medvar B, 2016, PHYSIOL GENOMICS, V48, P502, DOI 10.1152/physiolgenomics.00031.2016; Medyouf H, 2017, BLOOD, V129, P1617, DOI 10.1182/blood-2016-11-696070; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pietras EM, 2014, J EXP MED, V211, P245, DOI 10.1084/jem.20131043; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Schuettpelz LG, 2014, LEUKEMIA, V28, P1851, DOI 10.1038/leu.2014.68; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Strikoudis A, 2014, EMBO REP, V15, P365, DOI 10.1002/embr.201338373; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Wang ZL, 2009, CURR TOP MED CHEM, V9, P724, DOI 10.2174/156802609789044407; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	68	27	31	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1196	+		10.1038/s41590-019-0454-6	http://dx.doi.org/10.1038/s41590-019-0454-6			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31406379	Green Accepted			2022-12-18	WOS:000482212600019
J	Zhang, MY; Dong, Y; Hu, FX; Yang, D; Zhao, QH; Lv, C; Wang, Y; Xia, CX; Weng, QT; Liu, XF; Li, C; Zhou, PQ; Wang, TJ; Guan, YX; Guo, RQ; Liu, LJ; Geng, Y; Wu, HL; Du, J; Hu, Z; Xu, S; Chen, JK; He, AB; Liu, B; Wang, DM; Yang, YG; Wang, JY				Zhang, Mengyun; Dong, Yong; Hu, Fangxiao; Yang, Dan; Zhao, Qianhao; Lv, Cui; Wang, Ying; Xia, Chengxiang; Weng, Qitong; Liu, Xiaofei; Li, Chen; Zhou, Peiqing; Wang, Tongjie; Guan, Yuxian; Guo, Rongqun; Liu, Lijuan; Geng, Yang; Wu, Hongling; Du, Juan; Hu, Zheng; Xu, Sheng; Chen, Jiekai; He, Aibin; Liu, Bing; Wang, Demin; Yang, Yong-Guang; Wang, Jinyong			Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; GENE; EXPRESSION; FETAL; PAX5; DIFFERENTIATION; CHROMATIN; RECONSTITUTION; REARRANGEMENT; IDENTITY	Deletion of master regulators of the B cell lineage reprograms B cells into T cells. Here we found that the transcription factor Hoxb5, which is expressed in uncommitted hematopoietic progenitor cells but is not present in cells committed to the B cell or T cell lineage, was able to reprogram pro-pre-B cells into functional early T cell lineage progenitors. This reprogramming started in the bone marrow and was completed in the thymus and gave rise to T lymphocytes with transcriptomes, hierarchical differentiation, tissue distribution and immunological functions that closely resembled those of their natural counterparts. Hoxb5 repressed B cell 'master genes', activated regulators of T cells and regulated crucial chromatin modifiers in pro-pre-B cells and ultimately drove the B cell fate-to-T cell fate conversion. Our results provide a de novo paradigm for the generation of functional T cells through reprogramming in vivo.	[Zhang, Mengyun; Dong, Yong; Hu, Fangxiao; Yang, Dan; Zhao, Qianhao; Lv, Cui; Wang, Ying; Xia, Chengxiang; Weng, Qitong; Liu, Xiaofei; Zhou, Peiqing; Wang, Tongjie; Guan, Yuxian; Guo, Rongqun; Liu, Lijuan; Geng, Yang; Wu, Hongling; Du, Juan; Chen, Jiekai; Wang, Jinyong] Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Zhang, Mengyun; Dong, Yong; Hu, Fangxiao; Yang, Dan; Zhao, Qianhao; Lv, Cui; Wang, Ying; Xia, Chengxiang; Weng, Qitong; Liu, Xiaofei; Zhou, Peiqing; Wang, Tongjie; Guan, Yuxian; Guo, Rongqun; Liu, Lijuan; Geng, Yang; Wu, Hongling; Du, Juan; Chen, Jiekai; Wang, Jinyong] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Mengyun; Dong, Yong; Wang, Ying; Xia, Chengxiang; Weng, Qitong; Zhou, Peiqing; Guo, Rongqun; Chen, Jiekai; Wang, Jinyong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Chen; He, Aibin] Peking Univ, Beijing Key Lab Cardiometab Mol Med, Inst Mol Med, Beijing, Peoples R China; [Hu, Zheng; Yang, Yong-Guang] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China; [Hu, Zheng; Yang, Yong-Guang] Jilin Univ, Inst Immunol, Changchun, Jilin, Peoples R China; [Xu, Sheng] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Xu, Sheng] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Liu, Bing] Acad Mil Med Sci, Affiliated Hosp, Translat Med Ctr Ivy 307, State Key Lab Prote,Translat Med Ctr Stem Cells,L, Beijing, Peoples R China; [Wang, Demin] Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fuzhou, Fujian, Peoples R China; [Wang, Demin] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Yang, Yong-Guang] Columbia Univ Coll Phys & Surg, Columbia Ctr Translat Immunol, 630 W 168th St, New York, NY 10032 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Jilin University; Jilin University; Naval Medical University; Naval Medical University; Academy of Military Medical Sciences - China; Fujian Normal University; Versiti Blood Center of Wisconsin; Columbia University	Wang, JY (corresponding author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.; Wang, JY (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.; Wang, JY (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	wang_jinyong@gibh.ac.cn	Zhao, Sponge/GQQ-8273-2022; Xia, Chengxiang/AAB-5099-2022; Wang, Demin/AAX-4449-2020; He, Aibin/AAI-1639-2019	Wang, Demin/0000-0001-5549-3795; He, Aibin/0000-0002-3489-2305; Guo, Rongqun/0000-0002-1238-4772; Yang, Yong-Guang/0000-0003-4985-1247; Dong, Yong/0000-0003-4058-3610; Zhao, Qianhao/0000-0001-5514-5862; Wang, Jinyong/0000-0002-7218-0659; xu, sheng/0000-0002-9547-8052	Major National Research Project of China [2015CB964401, 2015CB964404, 2015CB964902, 2015CB964901]; CAS Key Research Program of Frontier Sciences [QYZDB-SSW-SMC057]; Major Scientific and Technological Project of Guangdong Province [2014B020225005]; Strategic Priority Research Program of the Chinese Academic of Sciences [XDA01020311]; Guangdong Natural Science Foundation [2014A030312012]; National Natural Science Foundation of China [31471117, 81470281, 31600948, 91642208, 81770222]; National Key Research and Development Program of China [2017YFA0103401, 2017YFA0103402]; US National Institutes of Health [AI079087, HL130724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087] Funding Source: NIH RePORTER	Major National Research Project of China; CAS Key Research Program of Frontier Sciences; Major Scientific and Technological Project of Guangdong Province; Strategic Priority Research Program of the Chinese Academic of Sciences; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Cheng, D. Pei and E. H. Bresnick for comments on the manuscript; Z. Liu (Institute of Biophysics, CAS, China) for Rag1<SUP>-/ -</SUP> mice; and the animal center and instrument center of Guangzhou Institutes of Biomedicine and Health for the animal care, cell sorting and skin imaging. Supported by the Major National Research Project of China (2015CB964401 to J.W.; 2015CB964404 to Y.-G.Y. and Z.H.; 2015CB964902 to J.D.; and 2015CB964901 to H.W., CAS Key Research Program of Frontier Sciences (QYZDB-SSW-SMC057), the Major Scientific and Technological Project of Guangdong Province (2014B020225005), the Strategic Priority Research Program of the Chinese Academic of Sciences (XDA01020311), the co-operation program of the Guangdong Natural Science Foundation (2014A030312012), the National Natural Science Foundation of China (31471117 and 81470281 to J.W.; 31600948 to D.Y.; 91642208 to Y.-G.Y.; and 81770222 to D.W.), the National Key Research and Development Program of China (2017YFA0103401 to B.L.; and 2017YFA0103402 to A.H.) and the US National Institutes of Health (AI079087 and HL130724 to D.W).	Ai SS, 2017, ELIFE, V6, DOI 10.7554/eLife.24570; Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Braunstein M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/678705; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; He AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5907; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kokavec J, 2017, STEM CELLS, V35, P1614, DOI 10.1002/stem.2604; Krivega I, 2014, GENE DEV, V28, P1278, DOI 10.1101/gad.239749.114; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Limon A, 1997, BLOOD, V90, P3316, DOI 10.1182/blood.V90.9.3316; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; RAMASAMY I, 1992, J CLIN PATHOL, V45, P770, DOI 10.1136/jcp.45.9.770; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Ungerbick J., 2015, EXP MED, V212, P1109; Vaillant F, 2002, J IMMUNOL, V169, P2866, DOI 10.4049/jimmunol.169.6.2866; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang H, 2016, CELL STEM CELL, V18, P481, DOI 10.1016/j.stem.2016.02.004; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	54	27	27	3	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					279	+		10.1038/s41590-018-0046-x	http://dx.doi.org/10.1038/s41590-018-0046-x			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29434353	Green Accepted			2022-12-18	WOS:000427007500017
J	Bernhardt, G				Bernhardt, Guenter			TACTILE becomes tangible: CD96 discloses its inhibitory peculiarities	NATURE IMMUNOLOGY			English	Editorial Material							NK-CELL CYTOTOXICITY; ADHESION RECEPTOR; CD155; DNAM-1; TIGIT; PVR		Hannover Med Sch, Inst Immunol, Hannover, Germany	Hannover Medical School	Bernhardt, G (corresponding author), Hannover Med Sch, Inst Immunol, Hannover, Germany.	bernhardt.guenter@mh-hannover.de	Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853				Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gramatzki M, 1998, EXP HEMATOL, V26, P1209; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Oda T, 2004, BIOCHEM BIOPH RES CO, V319, P1253, DOI 10.1016/j.bbrc.2004.05.111; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; WANG PL, 1992, J IMMUNOL, V148, P2600; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	16	27	30	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					406	408		10.1038/ni.2855	http://dx.doi.org/10.1038/ni.2855			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24747702				2022-12-18	WOS:000334667900002
J	Fleige, H; Haas, JD; Stahl, FR; Willenzon, S; Prinz, I; Forster, R				Fleige, Henrike; Haas, Jan D.; Stahl, Felix R.; Willenzon, Stefanie; Prinz, Immo; Foerster, Reinhold			Induction of BALT in the absence of IL-17	NATURE IMMUNOLOGY			English	Letter							VIRUS; LUNGS		[Fleige, Henrike; Haas, Jan D.; Stahl, Felix R.; Willenzon, Stefanie; Prinz, Immo; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany	Hannover Medical School	Fleige, H (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	foerster.reinhold@mh-hannover.de	Förster, Reinhold/D-6770-2011; Stahl, Felix/O-8715-2019; Prinz, Immo/A-3026-2010	Stahl, Felix/0000-0002-7443-8967; Prinz, Immo/0000-0002-8789-9578; Forster, Reinhold/0000-0001-6190-7923				GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Kocks JR, 2009, J IMMUNOL, V182, P6861, DOI 10.4049/jimmunol.0801826; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Reading PC, 2003, J GEN VIROL, V84, P1973, DOI 10.1099/vir.0.19285-0	7	27	28	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					1	1		10.1038/ni.2167	http://dx.doi.org/10.1038/ni.2167			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22179267	Bronze			2022-12-18	WOS:000298412800001
J	Davis, BK; Ting, JPY				Davis, Beckley K.; Ting, Jenny Pan-Yun			NLRP3 has a sweet tooth	NATURE IMMUNOLOGY			English	Editorial Material							NALP3 INFLAMMASOME; CELL-DEATH; ACTIVATION; CASPASE-1; SILICA; ASC	The signaling intermediates that activate inflammasomes are elusive. New data now show that reactive oxygen species causes TXNIP to associate with NLRP3 and activate the inflammasome.	[Davis, Beckley K.; Ting, Jenny Pan-Yun] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Immunol Microbiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Davis, BK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Immunol Microbiol, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu						Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	14	27	28	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					105	106		10.1038/ni0210-105	http://dx.doi.org/10.1038/ni0210-105			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20084064				2022-12-18	WOS:000273730200003
J	Brown, GD				Brown, Gordon D.			Sensing necrosis with Mincle	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTORS; CELLS; DECTIN-1; ANTIGEN; KINASE; LECTIN		Univ Cape Town, Inst Infect Dis & Mol Med, Clin Sci Lab, Div Immunol, ZA-7925 Cape Town, South Africa	University of Cape Town	Brown, GD (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Sci Lab, Div Immunol, ZA-7925 Cape Town, South Africa.	gordon.brown@mweb.co.za	brown, gordon/B-4249-2012	brown, gordon/0000-0002-0287-5383				Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Masumoto M, 1999, J IMMUNOL, V163, P5039; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	11	27	29	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1099	1100		10.1038/ni1008-1099	http://dx.doi.org/10.1038/ni1008-1099			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18800160				2022-12-18	WOS:000259315600006
J	Virgin, HW				Virgin, Herbert W. 'Skip'			In vivo veritas: pathogenesis of infection as it actually happens	NATURE IMMUNOLOGY			English	Review							MURINE GAMMAHERPESVIRUS 68; GENOME-WIDE ASSOCIATION; GAMMA-INTERFERON; VACCINIA VIRUS; CROHN-DISEASE; REACTIVATION; LATENCY; MODEL; MICE; IDENTIFICATION	Host-microbe interactions define the life histories of all organisms. We live and die surrounded by harmless and harmful organisms that affect us in a multitude of ways and are themselves affected by our responses. Generations of such reciprocal interactions have produced homeostasis between us and some microbes (commensals), but not between us and others (pathogens), whereas still other microbes (opportunists) change status depending on the host. The study of pathogenesis seeks to define in molecular and genetic terms the difference between these outcomes with the hope of finding ways to prevent disease without losing the symbiotic benefits of microbial colonization.	Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu		Virgin, Herbert/0000-0001-8580-7628				Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Alcami A, 1996, P NATL ACAD SCI USA, V93, P11029, DOI 10.1073/pnas.93.20.11029; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Dal Canto AJ, 2001, J CLIN INVEST, V107, pR15, DOI 10.1172/JCI11540; Gangappa S, 2002, J EXP MED, V195, P931, DOI 10.1084/jem.20011825; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McMichael AJ, 2007, NAT IMMUNOL, V8, P1149, DOI 10.1038/ni1107-1149; Moretta L, 2003, TRENDS IMMUNOL, V24, P136, DOI 10.1016/S1471-4906(03)00031-0; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sarawar SR, 1997, J VIROL, V71, P3916, DOI 10.1128/JVI.71.5.3916-3921.1997; Steed AL, 2006, J VIROL, V80, P192, DOI 10.1128/JVI.80.1.192-200.2006; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Velazquez P, 2007, NAT IMMUNOL, V8, P1153, DOI 10.1038/ni1520; VIRGIN HW, 2007, FIELDS VIROLOGY, P327; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Weck KE, 1997, NAT MED, V3, P1346, DOI 10.1038/nm1297-1346; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519	40	27	28	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1143	1147		10.1038/ni1529	http://dx.doi.org/10.1038/ni1529			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952037				2022-12-18	WOS:000250338900002
J	Trowbridge, JJ; Moon, RT; Bhatia, M				Trowbridge, Jennifer J.; Moon, Randall T.; Bhatia, Mickie			Hematopoietic stem cell biology: too much of a Wnt thing	NATURE IMMUNOLOGY			English	Editorial Material							BETA-CATENIN; IN-VIVO; LYMPHOPOIESIS	Wnt signaling has been shown to be involved in stem cell regulation and may represent a key pathway in controlling hematopoiesis. But is it possible for hematopoietic stem cells to get too much of a good thing?.	McMaster Stem Cell & Canc Res Inst, Hamilton, ON L9G 4L6, Canada; McMaster Univ, Dept Biochem, Hamilton, ON, Canada; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	McMaster University; McMaster University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Trowbridge, JJ (corresponding author), McMaster Stem Cell & Canc Res Inst, Hamilton, ON L9G 4L6, Canada.	mbhatia@mcmaster.ca	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408				Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	16	27	29	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1021	1023		10.1038/ni1006-1021	http://dx.doi.org/10.1038/ni1006-1021			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985497				2022-12-18	WOS:000241437100006
J	Nadler, MJS; Kinet, JP				Nadler, MJS; Kinet, JP			Uncovering new complexities in mast cell signaling	NATURE IMMUNOLOGY			English	Editorial Material							AFFINITY IGE RECEPTOR; TYROSINE KINASES; RBL-2H3 CELLS; DEGRANULATION; ACTIVATION; SYK; LYN		Harvard Univ, Sch Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Nadler, MJS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.							Costello PS, 1996, ONCOGENE, V13, P2595; EISEMAN E, 1992, NATURE, V355, P78; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Nadler M J, 2000, Adv Immunol, V76, P325; Nishizumi H, 1997, J IMMUNOL, V158, P2350; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	11	27	27	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					707	708		10.1038/ni0802-707	http://dx.doi.org/10.1038/ni0802-707			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145654				2022-12-18	WOS:000177118500006
J	Hirano, T				Hirano, T			Revival of the autoantibody model in rheumatoid arthritis	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL; DISEASE		Osaka Univ, Grad Sch Med, Dept Mol Oncol, RIKEN Res Ctr Allergy & Immunol,Lab Cytokine Sign, Suita, Osaka 5650871, Japan	Osaka University; RIKEN	Hirano, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Oncol, RIKEN Res Ctr Allergy & Immunol,Lab Cytokine Sign, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hirano@molonc.med.osaka-u.ac.jp	Hirano, Toshio/C-8194-2009					Ermann J, 2001, NAT IMMUNOL, V2, P759, DOI 10.1038/ni0901-759; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Hirano T, 1998, Int Rev Immunol, V16, P249; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Zvaifler N J, 1973, Adv Immunol, V16, P265, DOI 10.1016/S0065-2776(08)60299-0; 2002, IMMUNITY, V16, P157	13	27	31	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					342	344		10.1038/ni0402-342	http://dx.doi.org/10.1038/ni0402-342			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919576				2022-12-18	WOS:000174623600013
J	Boothby, M				Boothby, M			Specificity of SN50 for NF-kappa B?	NATURE IMMUNOLOGY			English	Letter							TOXOPLASMA-GONDII; T-LYMPHOCYTES; APOPTOSIS; IMMUNITY; FAMILY; MEMBER; T1/ST2; CELLS		Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Boothby, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.							Aronica MA, 1999, J IMMUNOL, V163, P5116; Caamano J, 1999, J IMMUNOL, V163, P4453; Caamano J, 2000, J IMMUNOL, V165, P5720, DOI 10.4049/jimmunol.165.10.5720; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Glimcher LH, 2000, GENE DEV, V14, P1693; Hilliard B, 1999, J IMMUNOL, V163, P2937; Kolenko V, 1999, J IMMUNOL, V163, P590; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	13	27	27	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					471	471		10.1038/88652	http://dx.doi.org/10.1038/88652			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376325	Bronze			2022-12-18	WOS:000169078000002
J	Zon, LI				Zon, LI			Self-renewal versus differentiation, a job for the mighty morphogens	NATURE IMMUNOLOGY			English	News Item							XENOPUS; PROTEINS; MESODERM; SIGNALS; BMP-4	The proliferation and differentiation of hematopoietic stem cells is regulated by BMP-4 and Shh. These factors collaborate with cytokines in the bone marrow to create an environment that maintains stem cell homeostasis	Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Zon, LI (corresponding author), Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA.							Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Farrington SM, 1997, MECH DEVELOP, V62, P197, DOI 10.1016/S0925-4773(97)00664-3; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Schmid B, 2000, DEVELOPMENT, V127, P957; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	11	27	27	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					142	143		10.1038/84239	http://dx.doi.org/10.1038/84239			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175810				2022-12-18	WOS:000166778700013
J	Silverstein, AM				Silverstein, AM			Clemens Freiherr von Pirquet: Explaining immune complex disease in 1906	NATURE IMMUNOLOGY			English	Editorial Material									Johns Hopkins Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Silverstein, AM (corresponding author), Johns Hopkins Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.	arts@jhmi.edu						Cochrane C G, 1973, Adv Immunol, V16, P185, DOI 10.1016/S0065-2776(08)60298-9; DIXON FJ, 1954, J IMMUNOL, V72, P179; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P979, DOI [10.1055/s-0029-1206682, DOI 10.1055/S-0029-1206682]; EHRLICH P, 1903, MED WOCHENSCHR, V50, P1193; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; Kraus R, 1897, WIEN KLIN WOCHENSCHR, V10, P736; MARKOWITZ LE, 1988, J INFECT DIS, V158, P481, DOI 10.1093/infdis/158.2.480; MITUS A, 1959, NEW ENGL J MED, V261, P882, DOI 10.1056/NEJM195910292611802; Silverstein AM, 2000, SEMIN IMMUNOL, V12, P173, DOI 10.1006/smim.2000.0228; Silverstein AM, 2000, NAT IMMUNOL, V1, P93, DOI 10.1038/77874; THEOFILOPOULOS AN, 1979, ADV IMMUNOL, V28, P1; Unanue E R, 1967, Adv Immunol, V6, P1, DOI 10.1016/S0065-2776(08)60521-0; von Pirquet CE, 1911, ARCH INTERN MED, V7, P259; VONPIRQUET C, 1910, ERG INN MED KINDERHK, V5, P459; VONPIRQUET C, 1907, BERL KLIN WCHNSCHR, V44, P699; VONPIRQUET C, 1929, WIEN KLIN WOCHENSCHR, V42, P65; VONPIRQUET C, 1951, SERUM SICKNESS, P103; VONPIRQUET C, 1951, SERUMKEANKHEIT, V103; VONPIRQUET C, 1903, WIEN KLIN WSCHR, V16, P758; VONPIRQUET C, 1905, SERUMKEANKHEIT; VONPIRQUET C, 1930, ALLERGIE LEBENSALTER; WAGNER R, 1968, HIS LIFE WORK; WAGNER R, 1968, HIS LIFE WORK, P52	23	27	27	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					453	455		10.1038/82691	http://dx.doi.org/10.1038/82691			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101860				2022-12-18	WOS:000165724600003
J	Chou, J; Thomas, PG; Randolph, AG				Chou, Janet; Thomas, Paul G.; Randolph, Adrienne G.			Immunology of SARS-CoV-2 infection in children	NATURE IMMUNOLOGY			English	Review							MULTISYSTEM INFLAMMATORY SYNDROME; PLASMACYTOID DENDRITIC CELLS; KAWASAKI-LIKE DISEASE; IMMUNE DYSREGULATION; SEVERE COVID-19; I INTERFERON; MIS-C; INFLUENZA	Children are generally resistant to severe disease resulting from SARS-CoV-2 infection, but cases of pediatric COVID-19 and a new syndrome called MIS-C can occur. In this Review, the authors summarize what is known about the immunology of COVID-19 and MIS-C and how the pediatric response to SARS-CoV-2 is different from the immune response in adults. Children and adolescents exhibit a broad range of clinical outcomes from SARS-CoV-2 infection, with the majority having minimal to mild symptoms. Additionally, some succumb to a severe hyperinflammatory post-infectious complication called multisystem inflammatory syndrome in children (MIS-C), predominantly affecting previously healthy individuals. Studies characterizing the immunological differences associated with these clinical outcomes have identified pathways important for host immunity to SARS-CoV-2 and innate modulators of disease severity. In this Review, we delineate the immunological mechanisms underlying the spectrum of pediatric immune response to SARS-CoV-2 infection in comparison with that of adults.	[Chou, Janet] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Thomas, Paul G.] St Jude Grad Sch Biomed Sci, Memphis, TN USA; [Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; St Jude Children's Research Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Randolph, AG (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.; Randolph, AG (corresponding author), Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA.; Randolph, AG (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	Adrienne.Randolph@childrens.harvard.edu	; Thomas, Paul G./H-1063-2018	Randolph, Adrienne/0000-0002-3084-3071; Thomas, Paul G./0000-0001-7955-0256	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK130465]; National Institute of Allergy and Infectious Diseases [U01AI144616, R01AI154470, R01AI139633-04S1]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK130465 to J. C.) and the National Institute of Allergy and Infectious Diseases (U01AI144616 to P. T., R01AI154470 to A. G. R., and R01AI139633-04S1 to J. C.).	Abrams JY, 2021, LANCET CHILD ADOLESC, V5, P323, DOI 10.1016/S2352-4642(21)00050-X; Anaeigoudari A, 2021, INFLAMMATION, V44, P2151, DOI 10.1007/s10753-021-01519-7; Anderson EM, 2021, J PEDIAT INF DIS SOC, V10, P669, DOI 10.1093/jpids/piaa161; [Anonymous], WEEKL UPD SEL DEM GE; Arevalo CP, 2020, P NATL ACAD SCI USA, V117, P17221, DOI 10.1073/pnas.1920321117; Argyropoulos KV, 2020, AM J PATHOL, V190, P1881, DOI 10.1016/j.ajpath.2020.07.001; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Aydillo T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23977-1; Aydiner EK, 2022, ALLERGY, V77, P282, DOI 10.1111/all.15025; Aykac K, 2021, J MED VIROL, V93, P3077, DOI 10.1002/jmv.26853; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bartsch YC, 2021, NAT MED, V27, P454, DOI 10.1038/s41591-021-01263-3; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Berbudi A, 2020, CURR DIABETES REV, V16, P442, DOI 10.2174/1573399815666191024085838; Bourgeois FT, 2021, PEDIATR RES, V90, P250, DOI 10.1038/s41390-020-01259-8; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; Centers for Disease Control and Prevention, 2021, EM PREP RESP MULT IN; Chang JC, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.121.021428; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Cheng MH, 2020, P NATL ACAD SCI USA, V117, P25254, DOI 10.1073/pnas.2010722117; Chou JE, 2021, J ALLERGY CLIN IMMUN, V148, P732, DOI 10.1016/j.jaci.2021.06.024; Chung E, 2021, JAMA PEDIATR, V175, DOI 10.1001/jamapediatrics.2021.2025; Cohen CA, 2021, NAT COMMUN, V12, DOI [10.1101/2021.02.02.21250988, 10.1038/s41467-021-24938-4]; Combes Alexis J, 2021, Nature, V591, P124, DOI [10.1038/s41586-021-03234-7, 10.1101/2020.10.28.359935]; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; de Cevins C, 2021, MED-CAMBRIDGE, V2, P1072, DOI 10.1016/j.medj.2021.08.002; de Marcken M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw1347; Delahoy MJ, 2021, MMWR-MORBID MORTAL W, V70, P1255, DOI 10.15585/mmwr.mm7036e2; Delavari S, 2021, J CLIN IMMUNOL, V41, P345, DOI 10.1007/s10875-020-00928-x; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Elyahu Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8330; Esenboga S, 2021, J CLIN IMMUNOL, V41, P1515, DOI 10.1007/s10875-021-01065-9; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Feldstein LR, 2021, JAMA-J AM MED ASSOC, V325, P1074, DOI 10.1001/jama.2021.2091; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Garrido C, 2021, JCI INSIGHT, V6, DOI [10.1172/jci.insight.150909, 10.1101/2021.04.17.21255663]; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2; Goodwin E, 2018, IMMUNITY, V48, P339, DOI 10.1016/j.immuni.2018.01.005; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Heald-Sargent T, 2020, JAMA PEDIATR, V174, P902, DOI 10.1001/jamapediatrics.2020.3651; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holt PG, 2019, J ALLERGY CLIN IMMUN, V143, P1176, DOI 10.1016/j.jaci.2018.08.035; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; Jia R, 2020, VIROL SIN, V35, P734, DOI 10.1007/s12250-020-00265-8; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Josyabhatla R, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.748368; Kenmoe S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242302; Khan T, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144499; Kim C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250358; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Kwak JH., 2020, CLIN EXP PEDIAT, V64, P68; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Lapp SA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256482; Laxminarayan Ramanan, 2020, Science, V370, P691, DOI 10.1126/science.abd7672; Le Page A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-2; Lee PY, 2020, J ALLERGY CLIN IMMUN, V146, P1194, DOI 10.1016/j.jaci.2020.07.033; Lemarquis A, 2021, J ALLERGY CLIN IMMUN, V148, P96, DOI 10.1016/j.jaci.2021.03.034; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li GJ, 2015, J IMMUNOL, V195, P865, DOI 10.4049/jimmunol.1402389; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Macal M, 2018, IMMUNITY, V48, P730, DOI 10.1016/j.immuni.2018.03.020; Madera S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81934-w; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Meade P, 2020, MBIO, V11, DOI 10.1128/mBio.03243-19; Mendez-Echevarria A, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10060700; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Molony RD, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan2392; Moreews M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh1516; Mudd PA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe3024; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Nguyen NT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254066; Nielsen SCA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2004; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Notarbartolo S, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg5021; Noz MP, 2018, STROKE, V49, P2910, DOI 10.1161/STROKEAHA.118.023192; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Oygar PD, 2021, PEDIATR INFECT DIS J, V40, pE294, DOI 10.1097/INF.0000000000003199; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Pierce CA, 2021, JCI INSIGHT, V6, DOI [10.1101/2021.02.12.21251310, 10.1172/jci.insight.148694]; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Porritt RA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI151520; Porritt RA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146614; Preston LE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5298; Ramaswamy A, 2021, IMMUNITY, V54, P1083, DOI 10.1016/j.immuni.2021.04.003; Ranjeva S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09652-6; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Rivas MN, 2021, J ALLERGY CLIN IMMUN, V147, P57, DOI 10.1016/j.jaci.2020.10.008; Saatci D, 2021, JAMA PEDIATR, V175, P928, DOI 10.1001/jamapediatrics.2021.1685; Sancho-Shimizu V, 2021, J EXP MED, V218, DOI 10.1084/jem.20210446; Sandoval M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255544; Sasson JM, 2021, MBIO, V12, DOI 10.1128/mBio.01229-21; Schuler BA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140766; Sermet-Gaudelus I, 2021, EUROSURVEILLANCE, V26, P9, DOI 10.2807/1560-7917.ES.2021.26.13.2001782; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shaunak M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044899; Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; Solanich X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.719115; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Tsankov BK, 2021, INT J INFECT DIS, V103, P246, DOI 10.1016/j.ijid.2020.11.163; Tu WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02111; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; van der Wijst MGP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh2624; Velasquez SR, 2021, INT J INFECT DIS, V110, P457, DOI 10.1016/j.ijid.2021.07.060; Vella LA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7570; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; Viner RM, 2020, LANCET, V395, P1741, DOI 10.1016/S0140-6736(20)31129-6; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang A, 2020, ELIFE, V9, DOI 10.7554/eLife.62522; Wang X, 2020, LANCET GLOB HEALTH, V8, pE497, DOI 10.1016/S2214-109X(19)30545-5; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Wendel BS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00645-x; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Xia HJ, 2020, J INTERF CYTOK RES, V40, P543, DOI 10.1089/jir.2020.0214; Yang HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4302; Yang Q, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2104547118, 10.1101/2021.03.01.21252250]; Yonker LM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149633; Zhao YC, 2021, CELL RES, V31, P818, DOI 10.1038/s41422-021-00495-9; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	149	26	26	12	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					177	185		10.1038/s41590-021-01123-9	http://dx.doi.org/10.1038/s41590-021-01123-9		FEB 2022	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35105983	Green Accepted, Bronze			2022-12-18	WOS:000749438100001
J	Christo, SN; Evrard, M; Park, SL; Gandolfo, LC; Burn, TN; Fonseca, R; Newman, DM; Alexandre, YO; Collins, N; Zamudio, NM; Souza-Fonseca-Guimaraes, F; Pellicci, DG; Chisanga, D; Shi, W; Bartholin, L; Belz, GT; Huntington, ND; Lucas, A; Lucas, M; Mueller, SN; Heath, WR; Ginhoux, F; Speed, TP; Carbone, FR; Kallies, A; Mackay, LK				Christo, Susan N.; Evrard, Maximilien; Park, Simone L.; Gandolfo, Luke C.; Burn, Thomas N.; Fonseca, Raissa; Newman, Dane M.; Alexandre, Yannick O.; Collins, Nicholas; Zamudio, Natasha M.; Souza-Fonseca-Guimaraes, Fernando; Pellicci, Daniel G.; Chisanga, David; Shi, Wei; Bartholin, Laurent; Belz, Gabrielle T.; Huntington, Nicholas D.; Lucas, Andrew; Lucas, Michaela; Mueller, Scott N.; Heath, William R.; Ginhoux, Florent; Speed, Terence P.; Carbone, Francis R.; Kallies, Axel; Mackay, Laura K.			Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity	NATURE IMMUNOLOGY			English	Article							NONLYMPHOID TISSUES; RM CELLS; INFECTION; MAINTENANCE; BETA; DIFFERENTIATION; EFFECTOR; ACTIVATION; GENERATION; SIGNATURE	Tissue-resident memory T (T-RM) cells are distributed throughout the body as relatively sessile populations. Mackay and colleagues find that the tissue in which T-RM cells are generated dictates their properties and is in turn defined according to T-RM-cell-intrinsic sensitivity to signaling via the cytokine TGF beta. Tissue-resident memory T (T-RM) cells are non-recirculating cells that exist throughout the body. Although T-RM cells in various organs rely on common transcriptional networks to establish tissue residency, location-specific factors adapt these cells to their tissue of lodgment. Here we analyze T-RM cell heterogeneity between organs and find that the different environments in which these cells differentiate dictate T-RM cell function, durability and malleability. We find that unequal responsiveness to TGF beta is a major driver of this diversity. Notably, dampened TGF beta signaling results in CD103(-) T-RM cells with increased proliferative potential, enhanced function and reduced longevity compared with their TGF beta-responsive CD103(+) T-RM counterparts. Furthermore, whereas CD103(-) T-RM cells readily modified their phenotype upon relocation, CD103(+) T-RM cells were comparatively resistant to transdifferentiation. Thus, despite common requirements for T-RM cell development, tissue adaptation of these cells confers discrete functional properties such that T-RM cells exist along a spectrum of differentiation potential that is governed by their local tissue microenvironment.	[Christo, Susan N.; Evrard, Maximilien; Park, Simone L.; Gandolfo, Luke C.; Burn, Thomas N.; Fonseca, Raissa; Newman, Dane M.; Alexandre, Yannick O.; Collins, Nicholas; Zamudio, Natasha M.; Pellicci, Daniel G.; Mueller, Scott N.; Heath, William R.; Carbone, Francis R.; Kallies, Axel; Mackay, Laura K.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Gandolfo, Luke C.; Speed, Terence P.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia; [Gandolfo, Luke C.; Chisanga, David; Shi, Wei; Belz, Gabrielle T.; Speed, Terence P.; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Souza-Fonseca-Guimaraes, Fernando; Belz, Gabrielle T.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Pellicci, Daniel G.] Murdoch Childrens Res Inst, Cellular Immunol Grp, Melbourne, Vic, Australia; [Bartholin, Laurent] Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon CRCL, INSERM 1052,CNRS 5286,Ctr Leon Berard, Lyon, France; [Huntington, Nicholas D.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Lucas, Andrew; Lucas, Michaela] Univ Western Australia, Med Sch, Perth, WA, Australia; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; University of Queensland; Murdoch Children's Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Monash University; University of Western Australia; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Mackay, LK (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	lkmackay@unimelb.edu.au	Chisanga, David/AAB-1751-2019; Belz, Gabrielle T/C-9350-2013; Mackay, Laura K/HGC-6580-2022; Mueller, Scott/B-1918-2012	Chisanga, David/0000-0002-0421-3957; Belz, Gabrielle T/0000-0002-9660-9587; Mackay, Laura K/0000-0002-8496-6632; Mueller, Scott/0000-0002-3838-3989; Lucas, Michaela/0000-0001-8881-9990; Kallies, Axel/0000-0002-6312-6968; Alexandre, Yannick/0000-0002-6634-4098; Fonseca, Raissa/0000-0001-8202-4871; Heath, William/0000-0001-9670-259X; Lucas, Andrew Douglas/0000-0003-2899-1806; Evrard, Maximilien/0000-0002-2105-1160	Howard Hughes Medical Institute; Bill & Melinda Gates International Research Scholarship [OPP1175796]; National Health and Medical Research Council (NHMRC) [APP1129711]; Cancer Council Victoria Postdoctoral Fellowship; NHMRC Emerging Leadership Investigator Grant; Priority driven Collaborative Cancer Research Scheme [1158085]; Cure Cancer Australia; Cancer Australia; Sylvia and Charles Viertel Charitable Foundation; NHMRC [1140406]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill & Melinda Gates International Research Scholarship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC Emerging Leadership Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); Priority driven Collaborative Cancer Research Scheme; Cure Cancer Australia; Cancer Australia; Sylvia and Charles Viertel Charitable Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank the Flow Cytometry Unit and Bioresources Facility at Peter Doherty Institute (University of Melbourne) for technical assistance. This work was supported by a Howard Hughes Medical Institute and Bill & Melinda Gates International Research Scholarship OPP1175796 to L.K.M. and National Health and Medical Research Council (NHMRC) APP1129711 to L.K.M. S.L.P. was supported by a Cancer Council Victoria Postdoctoral Fellowship and an NHMRC Emerging Leadership Investigator Grant. F.S.-F.-G. was supported by a project grant from the NHMRC (no. 1140406), and a grant (no. 1158085) awarded through the Priority driven Collaborative Cancer Research Scheme and funded by Cure Cancer Australia with the assistance of Cancer Australia. L.K.M. is a Senior Medical Research Fellow supported by the Sylvia and Charles Viertel Charitable Foundation.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425; Behr FM, 2020, NAT IMMUNOL, V21, P1070, DOI 10.1038/s41590-020-0723-4; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Bommireddy R, 2003, J IMMUNOL, V170, P4612, DOI 10.4049/jimmunol.170.9.4612; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Frizzell H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay9283; Hu YH, 2015, J IMMUNOL, V194, P2407, DOI 10.4049/jimmunol.1402369; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Klose CSN, 2014, IMMUNITY, V41, P230, DOI 10.1016/j.immuni.2014.06.018; Kok L, 2020, J EXP MED, V217, DOI 10.1084/jem.20191711; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Milner JJ, 2020, IMMUNITY, V52, P808, DOI 10.1016/j.immuni.2020.04.007; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Omilusik KD, 2019, CURR OPIN IMMUNOL, V58, P89, DOI 10.1016/j.coi.2019.04.009; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park SL, 2019, NATURE, V565, P366, DOI 10.1038/s41586-018-0812-9; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sasson SC, 2020, CELL MOL IMMUNOL, V17, P113, DOI 10.1038/s41423-019-0359-1; Schenkel JM, 2016, J IMMUNOL, V196, P3920, DOI 10.4049/jimmunol.1502337; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Thom JT, 2015, CELL REP, V13, P1125, DOI 10.1016/j.celrep.2015.09.082; Verma NK, 2012, J BIOL CHEM, V287, P27204, DOI 10.1074/jbc.M112.376616; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Walsh DA, 2019, J IMMUNOL, V203, P946, DOI 10.4049/jimmunol.1900052; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	49	26	26	3	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1140	+		10.1038/s41590-021-01004-1	http://dx.doi.org/10.1038/s41590-021-01004-1		AUG 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34426691				2022-12-18	WOS:000687501700002
J	Park, JH; Kim, HJ; Kim, CW; Kim, HC; Jung, YJ; Lee, HS; Lee, Y; Ju, YS; Oh, JE; Park, SH; Lee, JH; Lee, SK; Lee, HK				Park, Jang Hyun; Kim, Hyun-Jin; Kim, Chae Won; Kim, Hyeon Cheol; Jung, Yujin; Lee, Hyun-Soo; Lee, Yunah; Ju, Young Seok; Oh, Ji Eun; Park, Sung-Hong; Lee, Jeong Ho; Lee, Sung Ki; Lee, Heung Kyu			Tumor hypoxia represses gamma delta T cell-mediated antitumor immunity against brain tumors	NATURE IMMUNOLOGY			English	Article								Glioblastoma is one of the most intractable tumors and presents a hypoxic and immunologically cold microenvironment. Lee and colleagues demonstrate that normalizing oxygen tension unleashes gamma delta T cell anti-glioblastoma function. The anatomic location and immunologic characteristics of brain tumors result in strong lymphocyte suppression. Consequently, conventional immunotherapies targeting CD8 T cells are ineffective against brain tumors. Tumor cells escape immunosurveillance by various mechanisms and tumor cell metabolism can affect the metabolic states and functions of tumor-infiltrating lymphocytes. Here, we discovered that brain tumor cells had a particularly high demand for oxygen, which affected gamma delta T cell-mediated antitumor immune responses but not those of conventional T cells. Specifically, tumor hypoxia activated the gamma delta T cell protein kinase A pathway at a transcriptional level, resulting in repression of the activatory receptor NKG2D. Alleviating tumor hypoxia reinvigorated NKG2D expression and the antitumor function of gamma delta T cells. These results reveal a hypoxia-mediated mechanism through which brain tumors and gamma delta T cells interact and emphasize the importance of gamma delta T cells for antitumor immunity against brain tumors.	[Park, Jang Hyun; Kim, Hyun-Jin; Kim, Chae Won; Kim, Hyeon Cheol; Lee, Yunah; Ju, Young Seok; Oh, Ji Eun; Lee, Jeong Ho; Lee, Heung Kyu] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Jung, Yujin; Lee, Hyun-Soo; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Ju, Young Seok; Oh, Ji Eun; Lee, Jeong Ho; Lee, Heung Kyu] Korea Adv Inst Sci & Technol, BioMed Res Ctr, Daejeon, South Korea; [Lee, Sung Ki] Konyang Univ, Coll Med, Myunggok Med Res Ctr, Dept Obstet & Gynecol, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Konyang University; Konyang University Hospital	Lee, HK (corresponding author), Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea.; Lee, HK (corresponding author), Korea Adv Inst Sci & Technol, BioMed Res Ctr, Daejeon, South Korea.	heungkyu.lee@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668; Kim, Chae Won/0000-0002-4875-4501; Lee, Hyun-soo/0000-0002-0197-8460; Kim, Hyeon Cheol/0000-0003-3370-8438	National Research Foundation of Korea [NRF-2018M3A9H3024611]; Samsung Science and Technology Foundation, Republic of Korea [SSTF-BA1902-05]	National Research Foundation of Korea(National Research Foundation of Korea); Samsung Science and Technology Foundation, Republic of Korea(Samsung)	The authors thank the members of the Hyehwa forum for helpful discussions and J. Y. Kim at the BioMedical Research Center for technical service. This work was supported by the National Research Foundation of Korea (NRF-2018M3A9H3024611). This study was also supported by the Samsung Science and Technology Foundation (SSTF-BA1902-05), Republic of Korea.	Arvanitis CD, 2020, NAT REV CANCER, V20, P26, DOI 10.1038/s41568-019-0205-x; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Barnes TA, 2017, BRIT J CANCER, V117, P451, DOI 10.1038/bjc.2017.220; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Beck BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122387; Belcaid Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101764; Brill-Karniely Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2861; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Chauvin C, 2019, CLIN CANCER RES, V25, P7218, DOI 10.1158/1078-0432.CCR-19-0375; Dowling RJO, 2016, CELL METAB, V23, P567, DOI 10.1016/j.cmet.2016.03.006; Duan W, 2019, AM J TRANSL RES, V11, P2393; Eikawa S, 2015, P NATL ACAD SCI USA, V112, P1809, DOI 10.1073/pnas.1417636112; Goldman M, 2019, UCSC XENA PLATFORM P, DOI DOI 10.1101/326470; Han JS, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00390-18; Henze AT, 2016, J CLIN INVEST, V126, P3672, DOI 10.1172/JCI84427; Jayaprakash P, 2018, J CLIN INVEST, V128, P5137, DOI 10.1172/JCI96268; Jensen RL, 2014, NEURO-ONCOLOGY, V16, P280, DOI 10.1093/neuonc/not148; Kim IK, 2018, J EXP MED, V215, P963, DOI 10.1084/jem.20170123; Kuen DS, 2020, IMMUNE NETW, V20, DOI 10.4110/in.2020.20.e6; Lee JH, 2018, NATURE, V560, P243, DOI 10.1038/s41586-018-0389-3; Lee M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00555; Li LF, 2018, CANCER RES, V78, P1779, DOI 10.1158/0008-5472.CAN-17-2460; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Najjar YG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124989; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oh DS, 2021, AUTOPHAGY, V17, P2111, DOI 10.1080/15548627.2020.1812218; Oh DS, 2017, ONCOTARGET, V8, P47440, DOI 10.18632/oncotarget.17663; Pang DJ, 2012, IMMUNOLOGY, V136, P283, DOI 10.1111/j.1365-2567.2012.03582.x; Parajuli Prahlad, 2013, J Spine Neurosurg, VSuppl 1; Park JH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02145; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rivadeneira DB, 2018, CLIN CANCER RES, V24, P2473, DOI 10.1158/1078-0432.CCR-17-0894; Salmon H, 2019, NAT REV CANCER, V19, P215, DOI 10.1038/s41568-019-0125-9; Scharping NE, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040046; Scharping NE, 2017, CANCER IMMUNOL RES, V5, P9, DOI 10.1158/2326-6066.CIR-16-0103; Sesen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123721; Simko V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09549-8; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sumaria N, 2017, CELL REP, V19, P2469, DOI 10.1016/j.celrep.2017.05.071; Suzuki T, 2010, ANTICANCER RES, V30, P4509; Taggart D, 2018, P NATL ACAD SCI USA, V115, pE1540, DOI 10.1073/pnas.1714089115; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Varn FS, 2017, CANCER RES, V77, P1271, DOI 10.1158/0008-5472.CAN-16-2490; Zhai LJ, 2018, CELL MOL IMMUNOL, V15, P447, DOI 10.1038/cmi.2017.143; Zhao Z, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.24; Zheng XH, 2019, NAT IMMUNOL, V20, P1656, DOI 10.1038/s41590-019-0511-1	51	26	26	11	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					336	+		10.1038/s41590-020-00860-7	http://dx.doi.org/10.1038/s41590-020-00860-7		FEB 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33574616				2022-12-18	WOS:000617117400002
J	Graham, AL				Graham, Andrea L.			Naturalizing mouse models for immunology	NATURE IMMUNOLOGY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; OPTIMAL HOUSING TEMPERATURES; THERMAL ENVIRONMENT; IMMUNE-SYSTEM; MICE; INFECTION; INDIVIDUALITY; FITNESS; MEN	Laboratory mice have provided invaluable insight into mammalian immune systems. Yet the immune phenotypes of mice bred and maintained in conventional laboratory conditions often differ from the immune phenotypes of wild mammals. Recent work to naturalize the environmental experience of inbred laboratory mice-to take them where the wild things are (to borrow a phrase from Maurice Sendak), via approaches such as construction of exposure histories, provision of fecal transplants or surrogate mothering by wild mice, and rewilding-is poised to expand understanding, complementing genetic and phylogenetic research on how natural selection has shaped mammalian immune systems while improving the translational potential of mouse research. Animal models provide invaluable insights into the functioning of the immune system; however, they have their limitations. In a Perspective, Andrea Graham argues that using a more naturalized biotic and abiotic setting can help capture a more accurate picture of the immune system.	[Graham, Andrea L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Graham, AL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	algraham@princeton.edu	Graham, Andrea/GON-8450-2022; Graham, Andrea L./A-8808-2010	Graham, Andrea L./0000-0002-6580-2755				Abolins S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003538; Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811; Bar J, 2020, FEMS MICROBIOL ECOL, V96, DOI 10.1093/femsec/fiaa167; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Blazquez-Prieto J, 2018, AM J RESP CELL MOL, V59, P289, DOI 10.1165/rcmb.2018-0101PS; Blomqvist A, 2018, NEUROSCIENTIST, V24, P381, DOI 10.1177/1073858418760481; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Budischak SA, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01914; Cope EC, 2019, HIPPOCAMPUS, V29, P366, DOI 10.1002/hipo.23033; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Davenport MP, 2020, NAT REV IMMUNOL, V20, P499, DOI 10.1038/s41577-020-0332-3; Garcia MD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092569; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Ezenwa VO, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015080118; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Flies AS, 2020, SCIENCE, V369, P37, DOI 10.1126/science.abb8664; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Frodermann V, 2019, NAT MED, V25, P1761, DOI 10.1038/s41591-019-0633-x; Froy H, 2019, SCIENCE, V365, P1296, DOI 10.1126/science.aaw5822; Ganeshan K, 2017, NAT REV ENDOCRINOL, V13, P458, DOI 10.1038/nrendo.2017.48; Gaukler SM, 2016, EVOL APPL, V9, P685, DOI 10.1111/eva.12365; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Glover M, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007926; Goh Jorming, 2015, Curr Protoc Mouse Biol, V5, P283, DOI 10.1002/9780470942390.mo140295; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Hamilton SE, 2020, J IMMUNOL, V205, P3, DOI 10.4049/jimmunol.2000171; Hogberg H, 2006, OBESITY, V14, P673, DOI 10.1038/oby.2006.76; Hopwood TW, 2018, SCI REP, V8, P1; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988; Keijer J, 2019, MOL METAB, V25, P168, DOI 10.1016/j.molmet.2019.04.001; Knackstedt SL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0336; Knudsen NH, 2020, SCIENCE, V368, P488, DOI 10.1126/science.aat3987; Lamb TJ, 2008, IMMUNITY, V28, P288, DOI 10.1016/j.immuni.2008.02.003; Leung JM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004108; Lin JD, 2020, CELL HOST MICROBE, V27, P830, DOI 10.1016/j.chom.2020.03.001; Littman DR, 2015, CELL, V162, P1186, DOI 10.1016/j.cell.2015.08.038; Lopes PC, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00010; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maizels RM, 2013, NAT IMMUNOL, V14, P879, DOI 10.1038/ni.2643; Makowska IJ, 2019, ILAR J, V60, P373, DOI 10.1093/ilar/ilaa001; Maltez VI, 2016, J IMMUNOL, V196, P956, DOI 10.4049/jimmunol.1502060; Maltez VI, 2015, IMMUNITY, V43, P987, DOI 10.1016/j.immuni.2015.10.010; Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nobis CC, 2019, P NATL ACAD SCI USA, V116, P20077, DOI 10.1073/pnas.1905080116; Onishi KG, 2020, BRAIN BEHAV IMMUN, V83, P33, DOI 10.1016/j.bbi.2019.07.024; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143; Touzel MP, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007873; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Qing H, 2020, CELL, V182, P372, DOI 10.1016/j.cell.2020.05.054; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Ruff JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3245; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; SCOTT ME, 1991, PARASITOLOGY, V103, P429, DOI 10.1017/S0031182000059953; Scott ME, 2006, PARASITOLOGY, V132, P669, DOI 10.1017/S0031182005009583; Soroush F, 2020, FASEB J, V34, P2691, DOI 10.1096/fj.201900048R; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; Spoelstra K, 2016, P NATL ACAD SCI USA, V113, P686, DOI 10.1073/pnas.1516442113; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Tao LL, 2017, TRENDS IMMUNOL, V38, P181, DOI 10.1016/j.it.2016.12.007; Taylor CH, 2019, FUNCT ECOL, V33, P1425, DOI 10.1111/1365-2435.13354; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Viney M, 2019, LAB ANIM-UK, V53, P252, DOI 10.1177/0023677218787538; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yeung F, 2020, CELL HOST MICROBE, V27, P809, DOI 10.1016/j.chom.2020.02.015; Zhang X, 2020, NATURE, V581, P204, DOI 10.1038/s41586-020-2235-7	81	26	26	4	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					111	117		10.1038/s41590-020-00857-2	http://dx.doi.org/10.1038/s41590-020-00857-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33495644	Bronze			2022-12-18	WOS:000611636400008
J	Roels, J; Kuchmiy, A; De Decker, M; Strubbe, S; Lavaert, M; Liang, KL; Leclercq, G; Vandekerckhove, B; Van Nieuwerburgh, F; Van Vlierberghe, P; Taghon, T				Roels, Juliette; Kuchmiy, Anna; De Decker, Matthias; Strubbe, Steven; Lavaert, Marieke; Liang, Kai Ling; Leclercq, Georges; Vandekerckhove, Bart; Van Nieuwerburgh, Filip; Van Vlierberghe, Pieter; Taghon, Tom			Distinct and temporary-restricted epigenetic mechanisms regulate human alpha beta and gamma delta T cell development	NATURE IMMUNOLOGY			English	Article							HELIX PROTEIN ID3; LINEAGE COMMITMENT; CHIP-SEQ; GENE-EXPRESSION; B-CELL; PROGENITORS; PRECURSORS; NETWORKS; MOUSE	The epigenetic landscape of human alpha beta and gamma delta T cell development has remained unexplored thus far. Taghon and colleagues provide a resource of RNA-seq and ATAC-seq profiles examining human thymocyte development. The development of TCR alpha beta and TCR gamma delta T cells comprises a step-wise process in which regulatory events control differentiation and lineage outcome. To clarify these mechanisms, we employed RNA-sequencing, ATAC-sequencing and ChIPmentation on well-defined thymocyte subsets that represent the continuum of human T cell development. The chromatin accessibility dynamics show clear stage specificity and reveal that human T cell-lineage commitment is marked byGATA3- andBCL11B-dependent closing of PU.1 sites. A temporary increase in H3K27me3 without open chromatin modifications is unique for beta-selection, whereas emerging gamma delta T cells, which originate from common precursors of beta-selected cells, show large chromatin accessibility changes due to strong T cell receptor (TCR) signaling. Furthermore, we unravel distinct chromatin landscapes between CD4(+)and CD8(+)alpha beta-lineage cells that support their effector functions and reveal gene-specific mechanisms that define mature T cells. This resource provides a framework for studying gene regulatory mechanisms that drive normal and malignant human T cell development.	[Roels, Juliette; Van Vlierberghe, Pieter] Univ Ghent, Dept Biomol Med, Ghent, Belgium; [Roels, Juliette; Kuchmiy, Anna; De Decker, Matthias; Strubbe, Steven; Lavaert, Marieke; Liang, Kai Ling; Leclercq, Georges; Vandekerckhove, Bart; Taghon, Tom] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium; [Roels, Juliette; Kuchmiy, Anna; Liang, Kai Ling; Leclercq, Georges; Vandekerckhove, Bart; Van Nieuwerburgh, Filip; Van Vlierberghe, Pieter; Taghon, Tom] Canc Res Inst Ghent, Ghent, Belgium; [Van Nieuwerburgh, Filip] Univ Ghent, Lab Pharmaceut Biotechnol, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Taghon, T (corresponding author), Univ Ghent, Dept Diagnost Sci, Ghent, Belgium.; Taghon, T (corresponding author), Canc Res Inst Ghent, Ghent, Belgium.	tom.taghon@ugent.be	Roels, juliette/AAJ-6841-2021; Leclercq, Georges/H-9659-2017; Van Nieuwerburgh, Filip/H-9697-2015; Liang, Kai Ling/K-2125-2019; Van Vlierberghe, Pieter/G-8894-2013	Roels, juliette/0000-0001-7230-3690; Leclercq, Georges/0000-0002-1691-5294; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Liang, Kai Ling/0000-0002-8534-2362; Van Vlierberghe, Pieter/0000-0001-9063-7205; Strubbe, Steven/0000-0003-0361-2523; Taghon, Tom/0000-0002-5781-0288	Fund for Scientific Research Flanders (FWO) [G037514N, G053816N, G053916N]; Ghent University Research Fund (GOA) [BOF18-GOA-024]; European Research Council (ERC) [StG 639784]; Foundation against Cancer (Stichting Tegen Kanker) [FAF-F/2016/824]; Cancer Research Institute Ghent (CRIG); Research Foundation-Flanders (FWO); Flemish Government, Department EWI	Fund for Scientific Research Flanders (FWO)(FWO); Ghent University Research Fund (GOA); European Research Council (ERC)(European Research Council (ERC)); Foundation against Cancer (Stichting Tegen Kanker); Cancer Research Institute Ghent (CRIG); Research Foundation-Flanders (FWO)(FWO); Flemish Government, Department EWI	We thank C. de Bock for help on the ATAC-seq protocol; S. Vermaut and K. Reynvoet for flow cytometry help; K. Weening for assistance in molecular cloning; K. Francois and G. Van Nooten (Department of Cardiac Surgery, Ghent University Hospital) for thymus tissue; the Red Cross Flanders for CB; and the Ghent University Hospital Hematopoietic Biobank. This work was supported by the Fund for Scientific Research Flanders (FWO, grant nos. G037514N, G053816N and G053916N to T.T., fellowship grant to S.S.); the Concerted Research Action from the Ghent University Research Fund (GOA, grant no. BOF18-GOA-024 to T.T. and P.V.V.); the European Research Council (ERC, grant no. StG 639784 to P.V.V.); the Foundation against Cancer (Stichting Tegen Kanker, grant no. FAF-F/2016/824 to T.T.); and the Cancer Research Institute Ghent (CRIG, YIPOC to A.K.). The computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Research Foundation-Flanders (FWO) and the Flemish Government, Department EWI.	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Barski A, 2017, J IMMUNOL, V198; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Blom B, 1999, EMBO J, V18, P2793, DOI 10.1093/emboj/18.10.2793; Boehm T, 2006, TRENDS IMMUNOL, V27, P477, DOI 10.1016/j.it.2006.08.004; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cante-Barrett K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00032; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Coffey F, 2014, J EXP MED, V211, P329, DOI 10.1084/jem.20131540; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ha VL, 2017, LEUKEMIA, V31, P2503, DOI 10.1038/leu.2017.70; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Hayday AC, 2019, J IMMUNOL, V203, P311, DOI 10.4049/jimmunol.1800934; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Joachims ML, 2006, J IMMUNOL, V176, P1543, DOI 10.4049/jimmunol.176.3.1543; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lavaert M, 2020, IMMUNITY, V52, P1088, DOI 10.1016/j.immuni.2020.03.019; Lee SY, 2010, SEMIN IMMUNOL, V22, P237, DOI 10.1016/j.smim.2010.04.008; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Rothenberg EV, 2016, ADV IMMUNOL, V129, P109, DOI 10.1016/bs.ai.2015.09.002; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/NMETH.3542, 10.1038/nmeth.3542]; Silva-Santos B, 2019, NAT REV CANCER, V19, P392, DOI 10.1038/s41568-019-0153-5; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon T, 2002, BLOOD, V99, P1197, DOI 10.1182/blood.V99.4.1197; Taghon T, 2008, SEMIN IMMUNOPATHOL, V30, P383, DOI 10.1007/s00281-008-0134-3; Taniuchi I, 2018, ANNU REV IMMUNOL, V36, P579, DOI 10.1146/annurev-immunol-042617-053411; Tuttle KD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05026-6; Van de Walle I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11171; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412; Willcox BE, 2019, NAT IMMUNOL, V20, P121, DOI 10.1038/s41590-018-0304-y; Wu Y, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax9364; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Yukawa M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182009; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhu LJ, 2013, METHODS MOL BIOL, V1067, P105, DOI 10.1007/978-1-62703-607-8_8	54	26	26	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1280	+		10.1038/s41590-020-0747-9	http://dx.doi.org/10.1038/s41590-020-0747-9		JUL 2020	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32719521				2022-12-18	WOS:000553242700004
J	Minguet, S; Klasener, K; Schaffer, AM; Fiala, GJ; Osteso-Ibanez, T; Raute, K; Navarro-Lerida, I; Hartl, FA; Seidl, M; Reth, M; Del Pozo, MA				Minguet, Susana; Klaesener, Kathrin; Schaffer, Anna-Maria; Fiala, Gina J.; Osteso-Ibanez, Teresa; Raute, Katrin; Navarro-Lerida, Inmaculada; Hartl, Frederike A.; Seidl, Maximilian; Reth, Michael; Del Pozo, Miguel A.			Caveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance	NATURE IMMUNOLOGY			English	Article							BRUTONS TYROSINE KINASE; ANTIGEN RECEPTOR; LIPID RAFTS; NULL-MICE; PROTEIN; ACTIN; CAVEOLAE; PHOSPHORYLATION; RECRUITMENT; SPECIFICITY	Caveolin-1 (Cav1) regulates the nanoscale organization and compartmentalization of the plasma membrane. Here we found that Cav1 controlled the distribution of nanoclusters of isotype-specific B cell antigen receptors (BCRs) on the surface of B cells. In mature B cells stimulated with antigen, the immunoglobulin M BCR (IgM-BCR) gained access to lipid domains enriched for GM1 glycolipids, by a process that was dependent on the phosphorylation of Cav1 by the Src family of kinases. Antigen-induced reorganization of nanoclusters of IgM-BCRs and IgD-BCRs regulated BCR signaling in vivo. In immature Cav1-deficient B cells, altered nanoscale organization of IgM-BCRs resulted in a failure of receptor editing and a skewed repertoire of B cells expressing immunoglobulin-m heavy chains with hallmarks of poly-and auto-reactivity, which ultimately led to autoimmunity in mice. Thus, Cav1 emerges as a cell-intrinsic regulator that prevents B cell-induced autoimmunity by means of its role in plasma-membrane organization.	[Minguet, Susana; Klaesener, Kathrin; Schaffer, Anna-Maria; Fiala, Gina J.; Raute, Katrin; Hartl, Frederike A.; Reth, Michael] Univ Freiburg, Fac Biol, Inst Biol 3, Dept Immunol, Freiburg, Germany; [Minguet, Susana; Klaesener, Kathrin; Fiala, Gina J.; Raute, Katrin; Hartl, Frederike A.; Reth, Michael] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany; [Minguet, Susana; Schaffer, Anna-Maria; Seidl, Maximilian] Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, CCI, Freiburg, Germany; [Minguet, Susana; Osteso-Ibanez, Teresa; Navarro-Lerida, Inmaculada; Del Pozo, Miguel A.] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Mechanoadaptat & Caveolae Biol Lab, Cell Biol & Physiol Program, Cell & Dev Biol Area, Madrid, Spain; [Klaesener, Kathrin; Reth, Michael] Max Planck Inst Immunbiol & Epigenet, Freiburg, Germany; [Raute, Katrin] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Seidl, Maximilian] Univ Freiburg, Univ Med Ctr Freiburg, Inst Surg Pathol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Max Planck Society; University of Freiburg; University of Freiburg	Minguet, S (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 3, Dept Immunol, Freiburg, Germany.; Minguet, S (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany.; Minguet, S (corresponding author), Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, CCI, Freiburg, Germany.; Minguet, S (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Mechanoadaptat & Caveolae Biol Lab, Cell Biol & Physiol Program, Cell & Dev Biol Area, Madrid, Spain.	susana.minguet@biologie.uni-freiburg.de	del Pozo, Miguel Angel/L-2861-2014; Seidl, Maxmilian/ABF-3322-2021; Osteso, Teresa/AAD-6364-2021	del Pozo, Miguel Angel/0000-0001-9077-391X; Seidl, Maxmilian/0000-0002-5559-4980; Minguet, Susana/0000-0001-8211-5538; Klasener, Kathrin/0000-0002-5969-2553; Osteso-Ibanez, Teresa/0000-0003-4247-8734; Navarro-Lerida, Inmaculada/0000-0001-9994-8069; Fiala, Gina/0000-0002-8226-5584; Schaffer, Anna-Maria/0000-0002-2561-0820	German Research Foundation (DFG) [SFB1160 IMPATH P5, MI1942/2-1]; Spemann Graduate School (Excellence Initiative) [GSC-4]; BIOSS Centre for Biological Signalling Studies [EXC294, TRR130-P02, SFB746-P07]; European Research Council [32297]; Spanish Ministry of Economy and Competitiveness [SAF2008-02100, SAF2011-25047, CSD2009-00016, SAF2014-51876-R]; Worldwide Cancer Research Foundation [15-0404]; MINECO; Asociacion Espanola Contra el Cancer; Pro-CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]	German Research Foundation (DFG)(German Research Foundation (DFG)); Spemann Graduate School (Excellence Initiative); BIOSS Centre for Biological Signalling Studies; European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Worldwide Cancer Research Foundation; MINECO(Spanish Government); Asociacion Espanola Contra el Cancer; Pro-CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government)	We thank the BIOSS toolbox for reagents; M.C. Guadamillas and A. Cerezo for the generation of the B6.Cav1<SUP>Y14F/Y14F</SUP> mice; E. Hobeika (Max Planck Institute of Immunology and Epigenetics) for Cd79a<SUP>-/-</SUP> mice; H. Jumaa (Max Planck Institute of Immunology and Epigenetics) for 3-83Igi mice; C. Johner, U. Stauffer, N. Joswig, and K. Fehrenbach for experimental help; Y. Kulathu, M. Swamy M. Rizzi, K. Schachtrup and Y.R. Carrasco for critical reading of the manuscript; and W. Schamel for intellectual input and scientific discussions. Supported by the German Research Foundation (DFG) (SFB1160 IMPATH P5 to S.M., supporting F.A.H. and A.-M.S.; MI1942/2-1 to S.M., supporting G.J.F.; the Spemann Graduate School (Excellence Initiative GSC-4 to K.R.); the BIOSS Centre for Biological Signalling Studies (EXC294 to S.M. and M.R.); TRR130-P02 to M.R.; and SFB746-P07 to M.R), the European Research Council (32297 to M.R.), the Spanish Ministry of Economy and Competitiveness (SAF2008-02100 (support for S.M. in 2008); SAF2011-25047, CSD2009-00016 and SAF2014-51876-R to M.A.D.P.; and support for CNIC), the Worldwide Cancer Research Foundation (15-0404 to M.A.D.P.), the Ramon y Cajal Program from the MINECO (2009-2011 to S.M.), Asociacion Espanola Contra el Cancer (I.N.-L.), the Pro-CNIC Foundation (support for CNIC) and Severo Ochoa Center of Excellence (SEV-2015-0505 for CNIC).	Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fiala GJ, 2015, J EXP MED, V212, P1693, DOI 10.1084/jem.20141271; FRA AM, 1994, J BIOL CHEM, V269, P30745; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Grimaldi C, 2005, J IMMUNOL, V174, P1775, DOI 10.4049/jimmunol.174.4.1775; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hoffmann C, 2010, J CELL SCI, V123, P4280, DOI 10.1242/jcs.064006; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hucka S, 2001, AUTOIMMUNITY, V33, P213, DOI 10.3109/08916930109008048; Jo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091582; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; KIM KJ, 1979, J IMMUNOL, V122, P549; Klasener K, 2014, ELIFE, V3, DOI 10.7554/eLife.02069; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lee WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079148; Maity PC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005887; Maity PC, 2015, BBA-MOL CELL RES, V1853, P830, DOI 10.1016/j.bbamcr.2014.11.010; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Medina FA, 2006, CELL CYCLE, V5, P1865, DOI 10.4161/cc.5.16.3132; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Park DS, 2003, BIOCHEMISTRY-US, V42, P15124, DOI 10.1021/bi0356348; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Razani B, 2001, J BIOL CHEM, V276, P38121; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Schonle A, 2016, BLOOD, V127, P1930, DOI 10.1182/blood-2015-09-672428; SEPPALA IJT, 1984, IMMUNOLOGY, V53, P827; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Sproul TW, 2000, J IMMUNOL, V165, P6020, DOI 10.4049/jimmunol.165.11.6020; Tomassian T, 2011, J IMMUNOL, V187, P2993, DOI 10.4049/jimmunol.1101447; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Treanor B, 2011, J EXP MED, V208, P1055, DOI 10.1084/jem.20101125; Vargas L, 2002, J BIOL CHEM, V277, P9351, DOI 10.1074/jbc.M108537200; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	54	26	26	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1150	+		10.1038/ni.3813	http://dx.doi.org/10.1038/ni.3813			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28805811	Green Accepted			2022-12-18	WOS:000411134000019
J	Wen, L; Wong, FS				Wen, Li; Wong, F. Susan			Dietary short-chain fatty acids protect against type 1 diabetes	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; ANTIGEN	The short-chain fatty acids (SCFAs) acetate and butyrate, which are released from specialized diets by gut microbes, protect non-obese diabetic (NOD) mice against insulitis and slow the progression of diabetes.	[Wen, Li] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol, New Haven, CT 06510 USA; [Wong, F. Susan] Cardiff Univ, Div Infect & Immun, Sch Med, Cardiff, S Glam, Wales	Yale University; Cardiff University	Wen, L (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol, New Haven, CT 06510 USA.	li.wen@yale.edu		Wong, F. Susan/0000-0002-2812-8845; Wen, Li/0000-0002-8805-2934	NIH [DK092882, DK100500, P30DK045735]; JDRF [1-INO-2015-136]; ADA [1-14-BS-222]; UK Medical Research Council [MR/ K021141/1]; Diabetes UK; European Foundation for the Study of Diabetes; British Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100500, P30DK045735, R01DK092882] Funding Source: NIH RePORTER; MRC [MR/K021141/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); ADA(American Diabetes Association); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); European Foundation for the Study of Diabetes; British Council(The British Council in India); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the NIH (DK092882, DK100500 and P30DK045735 to L.W.), JDRF (F.S.W.; 1-INO-2015-136 to L.W.), ADA (1-14-BS-222 to L.W.), the UK Medical Research Council (MR/ K021141/1 to F.S.W.), Diabetes UK (to F.S.W.), the European Foundation for the Study of Diabetes (F.S.W.) and the British Council (F.S.W.).	Atkinson MA, 2015, DIABETES CARE, V38, P979, DOI 10.2337/dc15-0144; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Lakhter AJ, 2016, J BIOL CHEM, V291, P21869, DOI 10.1074/jbc.M115.712166; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mizuno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173032; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Tai NW, 2016, J EXP MED, V213, P2129, DOI 10.1084/jem.20160526; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Ziegler AG, 2016, MOL METAB, V5, P255, DOI 10.1016/j.molmet.2016.02.003	15	26	29	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					484	486		10.1038/ni.3730	http://dx.doi.org/10.1038/ni.3730			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28418384	Green Accepted			2022-12-18	WOS:000399378700005
J	Johanson, TM; Keown, AA; Cmero, M; Yeo, JHC; Kumar, A; Lew, AM; Zhan, YF; Chong, MMW				Johanson, Timothy M.; Keown, Ashleigh A.; Cmero, Marek; Yeo, Janet H. C.; Kumar, Amit; Lew, Andrew M.; Zhan, Yifan; Chong, Mark M. W.			Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis	NATURE IMMUNOLOGY			English	Article							MICRORNA BIOGENESIS; INDUCIBLE DELETION; EXPRESSION; DICER; PROGENITORS; INTERFERENCE; IDENTIFICATION; TRANSCRIPTION	To investigate if the microRNA (miRNA) pathway is required for dendritic cell (DC) development, we assessed the effect of ablating Drosha and Dicer, the two enzymes central to miRNA biogenesis. We found that while Dicer deficiency had some effect, Drosha deficiency completely halted DC development and halted myelopoiesis more generally. This indicated that while the miRNA pathway did have a role, it was a non-miRNA function of Drosha that was particularly critical. Drosha repressed the expression of two mRNAs encoding inhibitors of myelopoiesis in early hematopoietic progenitors. We found that Drosha directly cleaved stem-loop structure within these mRNAs and that this mRNA degradation was necessary for myelopoiesis. We have therefore identified a mechanism that regulates the development of DCs and other myeloid cells.	[Johanson, Timothy M.; Yeo, Janet H. C.; Lew, Andrew M.; Zhan, Yifan] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Johanson, Timothy M.; Yeo, Janet H. C.; Lew, Andrew M.; Zhan, Yifan] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Johanson, Timothy M.; Keown, Ashleigh A.; Cmero, Marek; Yeo, Janet H. C.; Kumar, Amit; Chong, Mark M. W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Lew, Andrew M.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Chong, Mark M. W.] Univ Melbourne, Dept Med St Vincents, Fitzroy, Vic 3065, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne	Chong, MMW (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	mchong@svi.edu.au	Chong, Mark/H-6684-2016; Lew, Andrew/C-7248-2013	Chong, Mark/0000-0002-3701-7397; Kumar, Amit/0000-0003-4771-0627; Zhan, Yifan/0000-0001-6974-0486; Lew, Andrew/0000-0002-2198-8164; Cmero, Marek/0000-0001-7783-5530	National Health and Medical Research Council, Australia [637338, 1004541, 1042211, 1079586, 1037321, 1043414, 1080321]; Juvenile Diabetes Research Foundation [5-2011-100]; Diabetes Australia Research Trust [Y13G-CHOM]; Australian Research Council; Victorian State Government Operational Infrastructure Support; Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Australia Research Trust; Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support; Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia)	We thank C. Yates for animal husbandry. Supported by the National Health and Medical Research Council, Australia (637338, 1004541, 1042211 and 1079586 to M.M.W.C.; 1037321, 1043414 and 1080321 to A.M.L.), the Juvenile Diabetes Research Foundation (5-2011-100 to M.M.W.C.), the Diabetes Australia Research Trust (Y13G-CHOM to M.M.W.C.), the Australian Research Council (M.M.W.C.) and the Victorian State Government Operational Infrastructure Support and Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Basu S, 2000, BLOOD, V95, P3725; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Johanson TM, 2015, IMMUNOL CELL BIOL, V93, P480, DOI 10.1038/icb.2014.109; Johanson TM, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130144; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuipers H, 2010, MOL IMMUNOL, V48, P333, DOI 10.1016/j.molimm.2010.07.007; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li HYS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052341; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Teta M, 2012, DEVELOPMENT, V139, P1405, DOI 10.1242/dev.070920; Zhdanova O, 2011, KIDNEY INT, V80, P719, DOI 10.1038/ki.2011.122; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	26	26	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1134	1141		10.1038/ni.3293	http://dx.doi.org/10.1038/ni.3293			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26437240				2022-12-18	WOS:000363096000007
J	Mandal, M; Hamel, KM; Maienschein-Cline, M; Tanaka, A; Teng, G; Tuteja, JH; Bunker, JJ; Bahroos, N; Eppig, JJ; Schatz, DG; Clark, MR				Mandal, Malay; Hamel, Keith M.; Maienschein-Cline, Mark; Tanaka, Azusa; Teng, Grace; Tuteja, Jigyasa H.; Bunker, Jeffrey J.; Bahroos, Neil; Eppig, John J.; Schatz, David G.; Clark, Marcus R.			Histone reader BRWD1 targets and restricts recombination to the Igk locus	NATURE IMMUNOLOGY			English	Article							LIGHT-CHAIN RECOMBINATION; V(D)J RECOMBINATION; CHROMATIN-STRUCTURE; CELL-CYCLE; GENE; DNA; CLEAVAGE; SEQUENCE; PHOSPHORYLATION; BINDING	B lymphopoiesis requires that immunoglobulin genes be accessible to RAG1-RAG2 recombinase. However, the RAG proteins bind widely to open chromatin, which suggests that additional mechanisms must restrict RAG-mediated DNA cleavage. Here we show that developmental downregulation of interleukin 7 (IL-7)-receptor signaling in small pre-B cells induced expression of the bromodomain-family member BRWD1, which was recruited to a specific epigenetic landscape at Igk dictated by pre-B cell receptor (pre-BCR)-dependent Erk activation. BRWD1 enhanced RAG recruitment, increased gene accessibility and positioned nucleosomes 5' to each J(kappa) recombination signal sequence. BRWD1 thus targets recombination to Igk and places recombination within the context of signaling cascades that control B cell development. Our findings represent a paradigm in which, at any particular antigen-receptor locus, specialized mechanisms enforce lineage-and stage-specific recombination.	[Mandal, Malay; Hamel, Keith M.; Tanaka, Azusa; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Mandal, Malay; Hamel, Keith M.; Tanaka, Azusa; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Maienschein-Cline, Mark; Bahroos, Neil] Univ Illinois, Ctr Res Informat, Chicago, IL USA; [Teng, Grace; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Teng, Grace; Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Tuteja, Jigyasa H.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Bunker, Jeffrey J.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Eppig, John J.] Jackson Lab, Reprod Biol, Bar Harbor, ME 04609 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University; Howard Hughes Medical Institute; Yale University; University of Chicago; University of Chicago; Jackson Laboratory	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mmandal@medicine.bsd.uchicago.edu; mclark@uchicago.edu		Bunker, Jeffrey/0000-0002-9351-7003	US National Institutes of Health [GM088847, GM101090, AI120715, U19 AI082724]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524, U19AI082724, R01AI120715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847, R01GM101090] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Olson and D. Leclerc for cell-sorting services and the ImmGen Consortium for data assembly. We thank W.J. Greenleaf (Stanford University) for ATAC-Seq methodology. We also thank O. Kalinina (University of Chicago, Chicago, Illinois, USA) for Igk<SUP>del</SUP> mice. Supported by the US National Institutes of Health (GM088847, GM101090, AI120715 and U19 AI082724 to M.R.C.). D.G.S. is an investigator of the Howard Hughes Medical Institute.	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Du HS, 2008, MOL CELL, V31, P641, DOI 10.1016/j.molcel.2008.08.012; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Huang H, 2003, DEV DYNAM, V227, P608, DOI 10.1002/dvdy.10344; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Osipovich O, 2007, NAT IMMUNOL, V8, P809, DOI 10.1038/ni1481; Patenge N, 2004, J BIOL CHEM, V279, P35360, DOI 10.1074/jbc.M405790200; Philipps DL, 2008, DEV BIOL, V317, P72, DOI 10.1016/j.ydbio.2008.02.018; Rahman NS, 2006, J BIOL CHEM, V281, P12370, DOI 10.1074/jbc.M507906200; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; Stadhouders R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001791; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003; Zhang M, 2008, J BIOL CHEM, V283, P6717, DOI 10.1074/jbc.M710301200; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	54	26	26	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1094	+		10.1038/ni.3249	http://dx.doi.org/10.1038/ni.3249			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26301565	Green Accepted			2022-12-18	WOS:000361686500015
J	Siegemund, S; Sauer, K				Siegemund, Sabine; Sauer, Karsten			Balancing pro- and anti-inflammatory TLR4 signaling	NATURE IMMUNOLOGY			English	Editorial Material							INNATE IMMUNITY	Limiting immune responses is critical for protecting the host from harm. The p110 delta isoform of the kinase PI(3)K acts as a balance between pro- and anti-inflammatory TLR4 signaling in dendritic cells.	[Siegemund, Sabine; Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Siegemund, S (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ksauer@scripps.edu			NIGMS NIH HHS [R01 GM100785] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fruman DA, 2011, CANCER DISCOV, V1, P562, DOI 10.1158/2159-8290.CD-11-0249; Gunzl P, 2010, J LEUKOCYTE BIOL, V88, P1259, DOI 10.1189/jlb.0110001; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Uno JK, 2010, GASTROENTEROLOGY, V139, P1642, DOI 10.1053/j.gastro.2010.07.008; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	13	26	28	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1031	1033		10.1038/ni.2452	http://dx.doi.org/10.1038/ni.2452			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23080196				2022-12-18	WOS:000310091700004
J	Wills-Karp, M; Finkelman, FD				Wills-Karp, Marsha; Finkelman, Fred D.			Innate lymphoid cells wield a double-edged sword	NATURE IMMUNOLOGY			English	Editorial Material							EPIDERMAL-GROWTH-FACTOR; TYPE-2 IMMUNITY; CYTOKINES; RECEPTOR; ASTHMA; AIRWAY; IL-33; IL-13	Type 2 cytokine-producing innate lymphoid cells are present in human and mouse lungs, where they contribute to both type 2 immune responses and tissue repair.	[Wills-Karp, Marsha; Finkelman, Fred D.] Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Med, Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Wills-Karp, M (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH USA.	wildc7@cchmc.org						Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	14	26	28	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1025	1027		10.1038/ni.2142	http://dx.doi.org/10.1038/ni.2142			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	22012433				2022-12-18	WOS:000296500100004
J	Flajnik, MF				Flajnik, Martin F.			All GOD's creatures got dedicated mucosal immunity	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOGLOBULIN; ISOTYPE; CHAIN; IGM; IDENTIFICATION; VERTEBRATES; AMPHIBIANS; FISH	Mucosal IgA regulates the composition of gut microbiota. IgT in bony fish is now shown to have-via convergent evolution-the same properties as IgA, demonstrating strong evolutionary pressure to preserve both systemic and mucosal immunity.	Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Flajnik, MF (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	mflajnik@som.umaryland.edu		Flajnik, Martin Francis/0000-0002-2792-5084	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006603] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR006603] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Braathen R, 2007, J IMMUNOL, V178, P1589, DOI 10.4049/jimmunol.178.3.1589; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Flajnik MF, 2005, NAT IMMUNOL, V6, P229, DOI 10.1038/ni0305-229; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Mussmann R, 1996, EUR J IMMUNOL, V26, P409, DOI 10.1002/eji.1830260221; Mussmann R, 1996, EUR J IMMUNOL, V26, P2823, DOI 10.1002/eji.1830261205; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; PORTIS JL, 1975, NATURE, V258, P547, DOI 10.1038/258547a0; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Ye JM, 2010, J IMMUNOL, V184, P844, DOI 10.4049/jimmunol.0902364; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103	15	26	28	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					777	779		10.1038/ni0910-777	http://dx.doi.org/10.1038/ni0910-777			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20720582				2022-12-18	WOS:000281115500003
J	Bogdan, C				Bogdan, Christian			Oxidative burst without phagocytes: the role of respiratory proteins	NATURE IMMUNOLOGY			English	Editorial Material							SUPEROXIDE ANION; IN-VITRO; GENERATION; HEMOCYTES	Respiratory proteins of vertebrates (hemoglobin) and invertebrates (hemocyanin) can generate highly reactive oxygen intermediates. New work shows that microbial compounds directly activate this release of reactive oxygen intermediates that kills the microbes.	Univ Clin Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Bogdan, C (corresponding author), Univ Clin Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany.	christian.bogdan@uk-erlangen.de		Bogdan, Christian/0000-0002-2300-0631				ARK JW, 2007, P NATL ACAD SCI USA, V104, P6602; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Immesberger A, 2004, J COMP PHYSIOL B, V174, P169, DOI 10.1007/s00360-003-0402-4; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Johansson MW, 1999, J CELL SCI, V112, P917; KLEBANOFF SJ, 1999, INFLAMMATION BASIC P, V1, P721; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Reed I., 1954, IEEE T INFORM THEORY, V3, P6; Renwick J, 2007, DEV COMP IMMUNOL, V31, P347, DOI 10.1016/j.dci.2006.06.007; Vidya N, 2007, J EXP ZOOL PART A, V307A, P383, DOI 10.1002/jez.393; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	12	26	26	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1029	1031		10.1038/ni1007-1029	http://dx.doi.org/10.1038/ni1007-1029			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878909				2022-12-18	WOS:000249691400008
J	Hunter, CA				Hunter, Christopher A.			Act1-ivating IL-17 inflammation	NATURE IMMUNOLOGY			English	Editorial Material							SIGNAL-TRANSDUCTION; ACT1; PROTEIN; IL-23; IMMUNITY; RECEPTOR	The signaling adaptor Act1 is now shown in vivo to be essential for interleukin 17-mediated inflammation in the brain during experimental autoimmune encephalomyelitis and in gut epithelial cells during induced colitis.	Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Hunter, Christopher/H-1970-2011					Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Xia YF, 2002, BIOCHEM BIOPH RES CO, V296, P406, DOI 10.1016/S0006-291X(02)00887-2	12	26	27	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					232	234		10.1038/ni0307-232	http://dx.doi.org/10.1038/ni0307-232			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304231				2022-12-18	WOS:000244275100007
J	Cahalan, MD; Gutman, GA				Cahalan, MD; Gutman, GA			The sense of place in the immune system	NATURE IMMUNOLOGY			English	Review							T-CELLS; DENDRITIC CELLS; LYMPH-NODES; B-CELLS; SPHINGOSINE 1-PHOSPHATE; IN-VIVO; LYMPHOCYTES; MIGRATION; MOTILITY; TISSUE	This series of reviews examines the effect of differing tissue environments on the activity and functional capacity of cells in the immune system. From their origins as hematopoietic stem cells, throughout their development and as mature cells, cells of the immune system find themselves in distinct and highly specialized niches, and contact with antigen or inflammatory signals changes their phenotype, activity and trafficking. Two-photon microscopy has provided the first direct observations of living cells and their activation choreography in the tissue environment and will no doubt continue to provide greater understanding of cellular dynamics and immune function.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu			NIGMS NIH HHS [R01 GM041514, R01 GM041514-21, GM41514] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GOWANS JL, 1959, J PHYSIOL-LONDON, V146, P54, DOI 10.1113/jphysiol.1959.sp006177; GUTMAN GA, 1972, IMMUNOLOGY, V23, P465; HOWARD JC, 1972, J EXP MED, V135, P200, DOI 10.1084/jem.135.2.200; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; SCOLLAY R, 1978, NATURE, V276, P79, DOI 10.1038/276079a0; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; WEISSMAN IL, 1967, J EXP MED, V126, P291, DOI 10.1084/jem.126.2.291; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160	29	26	26	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					329	332		10.1038/ni0406-329	http://dx.doi.org/10.1038/ni0406-329			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550194	Green Accepted			2022-12-18	WOS:000236171000002
J	Shimizu, Y				Shimizu, Y			LFA-1: more than just T cell velcro	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; CYTOHESIN-1; DEPENDENCE; EXPRESSION	The LFA-1 integrin is known to mediate adhesion between T cells and antigen-presenting cells. New evidence, however, is provided for its role in transmitting signals that promote T cell activation and differentiation.	Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol & Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shimizu, Y (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol & Canc Ctr, MMC 334-31,Church St SE, Minneapolis, MN 55455 USA.			Shimizu, Yoji/0000-0001-9760-0288				Abraham C, 1999, J IMMUNOL, V162, P4399; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Dierks H, 2001, J BIOL CHEM, V276, P37472, DOI 10.1074/jbc.M101502200; Geginat J, 1999, J IMMUNOL, V162, P5085; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; VAN SG, 1990, J IMMUNOL, V144, P4579	15	26	27	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1052	1054		10.1038/ni1103-1052	http://dx.doi.org/10.1038/ni1103-1052			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586422				2022-12-18	WOS:000186241100008
J	Vilcek, J				Vilcek, J			Boosting p53 with interferon and viruses	NATURE IMMUNOLOGY			English	Editorial Material							DEFENSE	Interferon-alpha/beta proteins are vital for innate immune responses to viruses. The tumor suppressor p53 mediates cell cycle arrest and apoptosis. A recent study in Nature reports that interferon-alpha/beta stimulates p53 synthesis, demonstrating a hitherto unrecognized link.	NYU, Sch Med, New York, NY 10010 USA	New York University	Vilcek, J (corresponding author), NYU, Sch Med, New York, NY 10010 USA.							Biron C.A., 2001, FIELDS VIROLOGY, P321; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	9	26	27	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					825	826		10.1038/ni0903-825	http://dx.doi.org/10.1038/ni0903-825			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942081				2022-12-18	WOS:000185002200007
J	Shaw, AS; Allen, PM				Shaw, AS; Allen, PM			Kissing cousins: immunological and neurological synapses	NATURE IMMUNOLOGY			English	News Item							LYMPHOCYTE		Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid, St Louis, MO 63110 USA.							Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; KHAN AA, 2001, SCIENCE, V10, P565; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680	10	26	26	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					575	576		10.1038/89712	http://dx.doi.org/10.1038/89712			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429536				2022-12-18	WOS:000169682100006
J	Rogers, NJ; Mirenda, V; Jackson, I; Dorling, A; Lechler, RI				Rogers, NJ; Mirenda, V; Jackson, I; Dorling, A; Lechler, RI			Costimulatory blockade by the induction of an endogenous xenospecific antibody response	NATURE IMMUNOLOGY			English	Article							LONG-TERM ACCEPTANCE; T-CELL ACTIVATION; TRANSPLANT REJECTION; CARDIAC ALLOGRAFTS; ISLET; CTLA4IG; XENOTRANSPLANTATION; PREVENTION; REPERTOIRE; SURVIVAL	Xenogeneic tissues induce vigorous T cell immunity, reflecting the ability of costimulatory molecules to function across species barriers. We describe a strategy to inhibit costimulation that exploits species differences using the model of porcine pancreatic islet transplantation into mice. Mice were immunized with chimeric peptides that contained a known T cell epitope and selected sequences of the porcine costimulatory molecule CD86. This resulted in anti-peptide antibody responses that recognized intact porcine CD86, blocked costimulation by porcine CD86 but not murine CD86 in vitro, and prolonged the survival of porcine islet grafts in vivo. This strategy of inducing endogenous donor-specific costimulatory blockade has potential clinical applicability.	Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London W12 0NN, England	Imperial College London	Lechler, RI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.			Dorling, Anthony/0000-0003-3102-2600				BALIGA P, 1994, TRANSPLANTATION, V58, P1082, DOI 10.1097/00007890-199411270-00005; BALL JM, 1994, J IMMUNOL METHODS, V171, P37, DOI 10.1016/0022-1759(94)90226-7; Dorling A, 1996, XENOTRANSPLANTATION, V3, P112, DOI 10.1111/j.1399-3089.1996.tb00127.x; Dorling A, 1996, EUR J IMMUNOL, V26, P1378, DOI 10.1002/eji.1830260630; DORLING A, 1996, PASSENGER LEUCOCYTE; FAUSTMAN DL, 1984, P NATL ACAD SCI-BIOL, V81, P3864, DOI 10.1073/pnas.81.12.3864; GALVIN F, 1992, J IMMUNOL, V149, P3802; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hornick PI, 1998, CIRCULATION, V97, P1257, DOI 10.1161/01.CIR.97.13.1257; KIRK AD, 1992, TRANSPLANT P, V24, P602; KIRK AD, 1993, TRANSPLANTATION, V55, P924, DOI 10.1097/00007890-199304000-00043; KumagaiBraesch M, 1997, XENOTRANSPLANTATION, V4, P85, DOI 10.1111/j.1399-3089.1997.tb00170.x; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Lu LN, 1997, TRANSPLANTATION, V64, P1808, DOI 10.1097/00007890-199712270-00031; Maher SE, 1996, J IMMUNOL, V157, P3838; Mason PD, 1996, KIDNEY INT, V50, P1019, DOI 10.1038/ki.1996.404; Mirenda V, 1998, TRANSPLANTATION, V66, P1485, DOI 10.1097/00007890-199812150-00012; RICORDI C, 1990, SURGERY, V107, P688; SAD S, 1991, J REPROD IMMUNOL, V19, P197, DOI 10.1016/0165-0378(91)90017-K; Satake M, 1996, XENOTRANSPLANTATION, V3, P198, DOI 10.1111/j.1399-3089.1996.tb00138.x; Schmoeckel M, 1998, TRANSPLANTATION, V65, P1570, DOI 10.1097/00007890-199806270-00006; SIMEONOVIC CJ, 1980, TRANSPLANTATION, V30, P175; Sun H, 1997, TRANSPLANTATION, V64, P1838, DOI 10.1097/00007890-199712270-00035; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; Waterworth PD, 1998, J HEART LUNG TRANSPL, V17, P1201; YAMADA K, 1995, J IMMUNOL, V155, P5249; Zaidi A, 1998, TRANSPLANTATION, V65, P1584, DOI 10.1097/00007890-199806270-00008	30	26	26	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					163	168		10.1038/77853	http://dx.doi.org/10.1038/77853			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248810				2022-12-18	WOS:000089814900018
J	McCaffrey, EF; Donato, M; Keren, L; Chen, ZH; Delmastro, A; Fitzpatrick, MB; Gupta, S; Greenwald, NF; Baranski, A; Graf, W; Kumar, R; Bosse, M; Fullaway, CC; Ramdial, PK; Forgo, E; Jojic, V; Van Valen, D; Mehra, S; Khader, SA; Bendall, SC; van de Rijn, M; Kalman, D; Kaushal, D; Hunter, RL; Banaei, N; Steyn, AJC; Khatri, P; Angelo, M				McCaffrey, Erin F.; Donato, Michele; Keren, Leeat; Chen, Zhenghao; Delmastro, Alea; Fitzpatrick, Megan B.; Gupta, Sanjana; Greenwald, Noah F.; Baranski, Alex; Graf, William; Kumar, Rashmi; Bosse, Marc; Fullaway, Christine Camacho; Ramdial, Pratista K.; Forgo, Erna; Jojic, Vladimir; Van Valen, David; Mehra, Smriti; Khader, Shabaana A.; Bendall, Sean C.; van de Rijn, Matt; Kalman, Daniel; Kaushal, Deepak; Hunter, Robert L.; Banaei, Niaz; Steyn, Adrie J. C.; Khatri, Purvesh; Angelo, Michael			The immunoregulatory landscape of human tuberculosis granulomas	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; BLOOD; EXPANSION; TUMOR; MICROENVIRONMENT; DISSEMINATION; INFLAMMATION; SARCOIDOSIS; MECHANISMS; IMPAIRS	MIBI-TOF is a mass spectrometry-based multiplexed imaging platform that has been used to map tumors. In this Resource article, MIBI-TOF is used to provide a spatial atlas of immune responses within human tuberculosis granulomas. Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in infected tissues, the architecture and composition of which are thought to affect disease outcome. However, our understanding of the spatial relationships that control human granulomas is limited. Here, we used multiplexed ion beam imaging by time of flight (MIBI-TOF) to image 37 proteins in tissues from patients with active TB. We constructed a comprehensive atlas that maps 19 cell subsets across 8 spatial microenvironments. This atlas shows an IFN-gamma-depleted microenvironment enriched for TGF-beta, regulatory T cells and IDO1(+) PD-L1(+) myeloid cells. In a further transcriptomic meta-analysis of peripheral blood from patients with TB, immunoregulatory trends mirror those identified by granuloma imaging. Notably, PD-L1 expression is associated with progression to active TB and treatment response. These data indicate that in TB granulomas, there are local spatially coordinated immunoregulatory programs with systemic manifestations that define active TB.	[McCaffrey, Erin F.; Delmastro, Alea; Greenwald, Noah F.; Baranski, Alex; Kumar, Rashmi; Bosse, Marc; Fullaway, Christine Camacho; Forgo, Erna; Bendall, Sean C.; van de Rijn, Matt; Banaei, Niaz; Angelo, Michael] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Donato, Michele; Gupta, Sanjana; Khatri, Purvesh] Stanford Univ, Sch Med, Dept Med, Div Biomed Informat Res, Stanford, CA 94305 USA; [Donato, Michele; Gupta, Sanjana; Khatri, Purvesh] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Keren, Leeat] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Chen, Zhenghao; Jojic, Vladimir] Cal Life Sci LLC, San Francisco, CA USA; [Fitzpatrick, Megan B.] Univ Wisconsin, Dept Pathol, Madison, WI 53706 USA; [Graf, William; Van Valen, David] CALTECH, Div Biol & Bioengn, Pasadena, CA 91125 USA; [Ramdial, Pratista K.; Steyn, Adrie J. C.] Univ KwaZulu Natal, Afr Hlth Res Inst, Durban, South Africa; [Mehra, Smriti] Texas Biomed Res Inst, San Antonio, TX USA; [Khader, Shabaana A.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Kalman, Daniel] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kaushal, Deepak] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Hunter, Robert L.] Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Banaei, Niaz] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Steyn, Adrie J. C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Stanford University; Stanford University; Stanford University; Weizmann Institute of Science; University of Wisconsin System; University of Wisconsin Madison; California Institute of Technology; University of Kwazulu Natal; Texas Biomedical Research Institute; Washington University (WUSTL); Emory University; Texas Biomedical Research Institute; University of Texas System; University of Texas Health Science Center Houston; Stanford University; University of Alabama System; University of Alabama Birmingham	Angelo, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mangelo0@stanford.edu	Bendall, Sean/AGG-0126-2022; Greenwald, Noah/GNH-3982-2022	Banaei, Niaz/0000-0001-8501-3000; Khatri, Purvesh/0000-0002-4143-4708; Angelo, Michael/0000-0003-1531-5067; van de Rijn, Matt/0000-0002-1909-9739; Steyn, Adrie JC/0000-0001-9177-8827; McCaffrey, Erin/0000-0001-7241-1798; A Khader, Shabaana/0000-0002-9545-4982; Bendall, Sean/0000-0003-1341-2453; Kumar, Rashmi/0000-0001-8994-5091; Delmastro, Alea/0000-0002-7959-3165; Donato, Michele/0000-0002-9968-6027; Greenwald, Noah/0000-0002-7836-4379; Fitzpatrick, Megan/0000-0001-7040-8018	National Science Foundation [2017242837, 5T32AI007290]; Damon Runyon Cancer Research Foundation [DRG-2292-17]; EMBO [ALTF 1128-2016]; National Cancer Institute [CA246880-01]; Stanford University; National Institutes of Health [5U54CA20997105, 5DP5OD01982205, 1R01CA24063801A1, 5R01AG06827902, 5UH3CA24663303, 5R01CA22952904, 1U24CA22430901, 5R01AG05791504, 5R01AG05628705, R61/33AI138280, R01AI134810]; CRDF Global; South African Medical Research Council; National Research Foundation BRICS multilateral grant; Bill and Melinda Gates Foundation [OPP1113682]; National Institute of Allergy and Infectious Diseases [1U19AI109662, U19AI057229, 5R01AI125197]; Department of Defense [W81XWH2110143, W81XWH-18-1-0253, W81XWH1910235]; Ralph & Marian Falk Medical Research Trust; Wellcome Trust; Cancer Research Institute; Parker Center for Cancer Immunotherapy; Breast Cancer Research Foundation; Bill and Melinda Gates Foundation	National Science Foundation(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stanford University(Stanford University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRDF Global; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation BRICS multilateral grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Ralph & Marian Falk Medical Research Trust; Wellcome Trust(Wellcome Trust); Cancer Research Institute; Parker Center for Cancer Immunotherapy; Breast Cancer Research Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank T. Risom, D. Glass, M. Carter, J. Mattila, J. Flynn and A. Kasmar for discussions and comments. We thank P. Chu and the Stanford Human Histology Core for providing technical assistance. E.F.M. was supported by the National Science Foundation (graduate research fellowship grant 2017242837) and training grant 5T32AI007290. L.K. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2292-17) and a nonstipendiary awardee of the EMBO long-term fellowship (ALTF 1128-2016). N.F.G. was supported by the National Cancer Institute (grant CA246880-01) and Stanford University (graduate fellowship). A.J.C.S. was supported by the National Institutes of Health (grants R61/33AI138280 and R01AI134810), CRDF Global, the South African Medical Research Council and a National Research Foundation BRICS multilateral grant. P.K. was funded in part by the Bill and Melinda Gates Foundation (OPP1113682), the National Institute of Allergy and Infectious Diseases (grants 1U19AI109662, U19AI057229 and 5R01AI125197), the Department of Defense (contracts W81XWH-18-1-0253 and W81XWH1910235) and the Ralph & Marian Falk Medical Research Trust. M.A. was supported by the National Institutes of Health (grants 5U54CA20997105, 5DP5OD01982205, 1R01CA24063801A1, 5R01AG06827902, 5UH3CA24663303, 5R01CA22952904, 1U24CA22430901, 5R01AG05791504 and 5R01AG05628705), the Department of Defense (contracts W81XWH2110143), the Wellcome Trust and other funding from the Bill and Melinda Gates Foundation, Cancer Research Institute, the Parker Center for Cancer Immunotherapy and the Breast Cancer Research Foundation.	Anand K, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000866; Anastasopoulou A, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0717-7; Bagaitkar J, 2014, BLOOD, V124, P1701, DOI 10.1182/blood-2014-07-589341; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bannon D, 2021, NAT METHODS, V18, P43, DOI 10.1038/s41592-020-01023-0; Barber DL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2702; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Cadena AM, 2017, NAT REV IMMUNOL, V17, P691, DOI 10.1038/nri.2017.69; Carow B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09816-4; Chen ZH, 2020, J COMPUT BIOL, V27, P1204, DOI 10.1089/cmb.2019.0340; Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Collins JM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137131; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; DiFazio RM, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0043-3; Elkington PT, 2018, AM J RESP CRIT CARE, V198, P1451, DOI 10.1164/rccm.201807-1250LE; Ernst JD, 2018, J INFECT DIS, V218, P1653, DOI 10.1093/infdis/jiy142; Facco M, 2011, THORAX, V66, P144, DOI 10.1136/thx.2010.140319; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Gautam US, 2018, P NATL ACAD SCI USA, V115, pE62, DOI 10.1073/pnas.1711373114; Gern BH, 2021, CELL HOST MICROBE, V29, P594, DOI 10.1016/j.chom.2021.02.005; Gideon, 2020, SINGLE CELL PROFILIN, DOI 10.24.352492; Gideon HP, 2019, MUCOSAL IMMUNOL, V12, P1370, DOI 10.1038/s41385-019-0195-8; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hartmann F.J., 2020, MULTIPLEXED SINGLE C, DOI [10.1101/2020.01.17.909796, DOI 10.1101/2020.01.17.909796]; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Haynes WA, 2017, BIOCOMPUTING, P144, DOI 10.1142/9789813207813_0015; Hu ZC, 2018, CELL REP, V24, P1377, DOI 10.1016/j.celrep.2018.07.003; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Kauffman KD, 2018, MUCOSAL IMMUNOL, V11, P462, DOI 10.1038/mi.2017.60; Keren L, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5851; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177; Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073; Martin CJ, 2017, MBIO, V8, DOI 10.1128/mBio.00312-17; McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421; Mehra S, 2013, J INFECT DIS, V207, P1115, DOI 10.1093/infdis/jis778; Mulder K, 2021, IMMUNITY, V54, P1883, DOI 10.1016/j.immuni.2021.07.007; Munn DH, 2016, TRENDS IMMUNOL, V37, P193, DOI 10.1016/j.it.2016.01.002; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Polena H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33162; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; ROSSI GA, 1986, AM REV RESPIR DIS, V133, P1086; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Scriba TJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006687; Shen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38362; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Subbian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132249; Sweeney TE, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw797; Tezera LB, 2020, ELIFE, V9, DOI 10.7554/eLife.52668; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Warsinske H, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002786; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; WHO, 2021, TUBERCULOSIS; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Wong EA, 2020, J IMMUNOL, V204, P644, DOI 10.4049/jimmunol.1901211; Wong EA, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00426-18; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	78	25	25	11	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					318	+		10.1038/s41590-021-01121-x	http://dx.doi.org/10.1038/s41590-021-01121-x		JAN 2022	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35058616	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000744891300001
J	Gu, MD; Zhou, XF; Sohn, JH; Zhu, LL; Jie, ZL; Yang, JY; Zheng, XF; Xie, XP; Yang, J; Shi, YY; Brightbill, HD; Kim, JB; Wang, J; Cheng, XH; Sun, SC				Gu, Meidi; Zhou, Xiaofei; Sohn, Jee Hyung; Zhu, Lele; Jie, Zuliang; Yang, Jin-Young; Zheng, Xiaofeng; Xie, Xiaoping; Yang, Jie; Shi, Yaoyao; Brightbill, Hans D.; Kim, Jae Bum; Wang, Jing; Cheng, Xuhong; Sun, Shao-Cong			NF-kappa B-inducing kinase maintains T cell metabolic fitness in antitumor immunity	NATURE IMMUNOLOGY			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; OXIDATIVE STRESS; AUTOPHAGY; PATHWAY; AUTOIMMUNITY; ACTIVATION; SURVIVAL; DAMAGE; PD-1; NIK	Metabolic reprograming toward aerobic glycolysis is a pivotal mechanism shaping immune responses. Here we show that deficiency in NF-kappa B-inducing kinase (NIK) impairs glycolysis induction, rendering CD8(+) effector T cells hypofunctional in the tumor microenvironment. Conversely, ectopic expression of NIK promotes CD8(+) T cell metabolism and effector function, thereby profoundly enhancing antitumor immunity and improving the efficacy of T cell adoptive therapy. NIK regulates T cell metabolism via a NF-kappa B-independent mechanism that involves stabilization of hexokinase 2 (HK2), a rate-limiting enzyme of the glycolytic pathway. NIK prevents autophagic degradation of HK2 through controlling cellular reactive oxygen species levels, which in turn involves modulation of glucose-6-phosphate dehydrogenase (G6PD), an enzyme that mediates production of the antioxidant NADPH. We show that the G6PD-NADPH redox system is important for HK2 stability and metabolism in activated T cells. These findings establish NIK as a pivotal regulator of T cell metabolism and highlight a post-translational mechanism of metabolic regulation. Metabolic rewiring of cytotoxic T lymphocytes (CTLs) can impair their antitumor functions. Sun and colleagues demonstrate that CTL-intrinsic activity of the kinase NIK is essential for CTL metabolic fitness in the tumor microenvironment.	[Gu, Meidi; Zhou, Xiaofei; Zhu, Lele; Jie, Zuliang; Yang, Jin-Young; Xie, Xiaoping; Yang, Jie; Shi, Yaoyao; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sohn, Jee Hyung; Kim, Jae Bum] Seoul Natl Univ, Natl Creat Res Initiatives Ctr Adipose Tissue Rem, Inst Mol Biol & Genet, Dept Biol Sci, Seoul, South Korea; [Yang, Jin-Young] Busan Natl Univ, Dept Biol Sci, Busan, South Korea; [Zheng, Xiaofeng; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Brightbill, Hans D.] Genentech Inc, Dept Immunol, San Francisco, CA USA; [Sun, Shao-Cong] MD Anderson Canc Ctr UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Yang, Jie] Precis Med, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Seoul National University (SNU); Pusan National University; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; Genentech	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sun, SC (corresponding author), MD Anderson Canc Ctr UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA.	ssun@mdanderson.org	ZHU, LELE/AAP-9075-2020	ZHU, LELE/0000-0002-1732-8753; Sohn, Jee Hyung/0000-0003-2739-134X; zhou, xiaofei/0000-0002-9289-2215; KIM, Jae Bum/0000-0003-2337-6935	National Institutes of Health (NIH) [GM84459]; National Research Foundation - South Korean government [MISP 2011-0018312]; NIH/National Cancer Institute Cancer Center Support Grant [P30CA016672]; NIH [IS10OD012304]; Cancer Prevention and Research Institute of Texas [RP130397]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation - South Korean government; NIH/National Cancer Institute Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas	We thank Genentech for providing the Map3k14 flox mice. This study was supported by a grant from the National Institutes of Health (NIH) (no. GM84459 to S.-C.S.) and partially supported by a grant from the National Research Foundation funded by the South Korean government (no. MISP 2011-0018312 to J.B.K.). We thank the flow cytometry, sequencing and microarray, proteomics and animal facility of the shared resources at the MD Anderson Cancer Center, supported by the NIH/National Cancer Institute Cancer Center Support Grant no. P30CA016672. The Proteomics Facility is also supported by NIH grant no. IS10OD012304 and the Cancer Prevention and Research Institute of Texas grant no. RP130397.	Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Brightbill HD, 2015, J IMMUNOL, V195, P953, DOI 10.4049/jimmunol.1401514; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Choi HJ, 2015, MOL CELLS, V38, P918, DOI 10.14348/molcells.2015.0168; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Durgeau A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00014; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Gershon TR, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-2; Gnanaprakasam JNR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01075; Ham M, 2016, DIABETES, V65, P2624, DOI 10.2337/db16-0060; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Ho HY, 2007, REDOX REP, V12, P109, DOI 10.1179/135100007X200209; Kamat JP, 1999, REDOX REP, V4, P179, DOI 10.1179/135100099101534882; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Li Y, 2016, TRANSL PSYCHIAT, V6, pe715, DOI [10.1038/tp.2015.202, DOI 10.1038/srep22115]; Lim AR, 2020, ELIFE, V9, DOI 10.7554/eLife.55185; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mehta MM, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0184-5; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Ouyang C, 2014, J BIOL CHEM, V289, P24226, DOI 10.1074/jbc.M114.559963; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; Rivadeneira DB, 2018, CLIN CANCER RES, V24, P2473, DOI 10.1158/1078-0432.CCR-17-0894; Ronquist G, 2007, SCAND J CLIN LAB INV, V67, P105, DOI 10.1080/00365510601047910; Saravia J, 2020, CELL RES, V30, P328, DOI 10.1038/s41422-020-0301-1; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Shyer JA, 2020, CELL RES, V30, P649, DOI 10.1038/s41422-020-0379-5; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Varanasi SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191533; Wang JL, 1998, J IMMUNOL, V161, P5516; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang HC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091055; Yang K, 2012, SEMIN IMMUNOL, V24, P421, DOI 10.1016/j.smim.2012.12.004; Yu JY, 2014, J IMMUNOL, V193, P422, DOI 10.4049/jimmunol.1303237; Zhou XF, 2019, NAT IMMUNOL, V20, P879, DOI 10.1038/s41590-019-0405-2	49	25	25	6	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					193	U163		10.1038/s41590-020-00829-6	http://dx.doi.org/10.1038/s41590-020-00829-6		JAN 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398181	Green Accepted			2022-12-18	WOS:000604865800005
J	Yoo, SA; Kim, M; Kang, MC; Kong, JS; Kim, KM; Lee, S; Hong, BK; Jeong, GH; Lee, J; Shin, MG; Kim, YG; Apicella, I; Cicatiello, V; De Falco, S; Yoon, CH; Cho, CS; Ryoo, ZY; Lee, SH; Kim, WU				Yoo, Seung-Ah; Kim, Mingyo; Kang, Min-Cheol; Kong, Jin-Sun; Kim, Ki-Myo; Lee, Saseong; Hong, Bong-Ki; Jeong, Gi Heon; Lee, Jinhee; Shin, Min-Gyeong; Kim, Yeon-Gu; Apicella, Ivana; Cicatiello, Valeria; De Falco, Sandro; Yoon, Chong-Hyeon; Cho, Chul-Soo; Ryoo, Zae Young; Lee, Seung-Hyo; Kim, Wan-Uk			Placental growth factor regulates the generation of T(H)17 cells to link angiogenesis with autoimmunity	NATURE IMMUNOLOGY			English	Article							T-CELLS; TUMOR-GROWTH; FACTOR-I; ACTIVATION; INFLAMMATION; LYMPHOCYTES; HEPARIN; BINDING; FLT-1	Helper T cells actively communicate with adjacent cells by secreting soluble mediators, yet crosstalk between helper T cells and endothelial cells remains poorly understood. Here we found that placental growth factor (PIGF), a homolog of the vascular endothelial growth factor that enhances an angiogenic switch in disease, was selectively secreted by the T(H)17 subset of helper T cells and promoted angiogenesis. Interestingly, the 'angio-lymphokine' PIGF, in turn, specifically induced the differentiation of pathogenic T(H)17 cells by activating the transcription factor STAT3 via binding to its receptors and replaced the activity of interleukin-6 in the production of interleukin-17, whereas it suppressed the generation of regulatory T cells. Moreover, T cell-derived PIGF was required for the progression of autoimmune diseases associated with T(H)17 differentiation, including experimental autoimmune encephalomyelitis and collagen-induced arthritis, in mice. Collectively, our findings provide insights into the PIGF-dictated links among angiogenesis, T(H)17 cell development and autoimmunity.	[Yoo, Seung-Ah; Kong, Jin-Sun; Kim, Ki-Myo; Lee, Saseong; Hong, Bong-Ki; Jeong, Gi Heon; Yoon, Chong-Hyeon; Cho, Chul-Soo; Kim, Wan-Uk] Catholic Univ Korea, Ctr Integrat Rheumatoid Transcript & Dynam, Seoul, South Korea; [Yoo, Seung-Ah; Kong, Jin-Sun; Kim, Ki-Myo; Lee, Saseong; Hong, Bong-Ki; Jeong, Gi Heon; Kim, Wan-Uk] Catholic Univ Korea, Dept Biomed & Hlth Sci, Seoul, South Korea; [Kim, Mingyo; Lee, Seung-Hyo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Biomed Res Ctr, KAIST Inst BioCentury, Daejeon, South Korea; [Kim, Mingyo] Gyeongsang Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Jinju, South Korea; [Kang, Min-Cheol; Lee, Jinhee; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea; [Shin, Min-Gyeong; Kim, Yeon-Gu] Korea Res Inst Biosci & Biotechnol, Biotherapeut Translat Res Ctr, Daejeon, South Korea; [Apicella, Ivana; Cicatiello, Valeria; De Falco, Sandro] CNR, Ist Genet & Biofis Adriano Buzzati Traverso, Naples, Italy; [Yoon, Chong-Hyeon; Cho, Chul-Soo; Kim, Wan-Uk] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST); Gyeongsang National University; Gyeongsang National University Hospital; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Catholic University of Korea	Kim, WU (corresponding author), Catholic Univ Korea, Ctr Integrat Rheumatoid Transcript & Dynam, Seoul, South Korea.; Kim, WU (corresponding author), Catholic Univ Korea, Dept Biomed & Hlth Sci, Seoul, South Korea.; Lee, SH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Biomed Res Ctr, KAIST Inst BioCentury, Daejeon, South Korea.; Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea.; Kim, WU (corresponding author), Catholic Univ Korea, Dept Internal Med, Seoul, South Korea.	jaewoong64@hanmail.net; sl131345@kaist.ac.kr; wan725@catholic.ac.kr	yoo, seung ah/AAR-9869-2020; /AAO-8374-2020; Kim, Wan-Uk/AAO-8502-2020; Lee, Seung-Hyo/B-9922-2015; RYOO, ZAEYOUNG/AAQ-1573-2020	Lee, Seung-Hyo/0000-0003-0010-4072; De Falco, Sandro/0000-0002-6501-1697; Kim, Mingyo/0000-0003-3744-8522; Hong, Bong-Ki/0000-0001-7758-3943	National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2015R1A3A2032927, 2014R1A6A3A04054066, 2019R1A2C2010897]; Project SATIN-POR Campania FESR 2014/2020	National Research Foundation of Korea (NRF) - Ministry of Science and ICT; Project SATIN-POR Campania FESR 2014/2020	We thank the members of the Center for Integrative Rheumatoid Transcriptomics and Dynamics at the Catholic University of Korea for their assistance. This work was supported by grants the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (grant no. 2015R1A3A2032927) to W.U.K. and (grant nos. 2014R1A6A3A04054066 and 2019R1A2C2010897) to S.A.Y., respectively, and by Project SATIN-POR Campania FESR 2014/2020 to S.D.F.	Allen Irving C, 2013, Methods Mol Biol, V1031, P101, DOI 10.1007/978-1-62703-481-4_13; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Basu A, 2010, J IMMUNOL, V184, P545, DOI 10.4049/jimmunol.0900397; Bellik L, 2005, BRIT J PHARMACOL, V146, P568, DOI 10.1038/sj.bjp.0706347; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Dewerchin M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011056; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dong C, 2014, CELL RES, V24, P901, DOI 10.1038/cr.2014.92; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; FREEMAN MR, 1995, CANCER RES, V55, P4140; Fujino M, 2013, JAK STAT, V2; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Hwang SH, 2015, P NATL ACAD SCI USA, V112, pE6535, DOI 10.1073/pnas.1514152112; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Kang MC, 2014, ARTERIOSCL THROM VAS, V34, P2276, DOI 10.1161/ATVBAHA.114.303693; Kim KJ, 2012, EXP MOL MED, V44, P10, DOI 10.3858/emm.2012.44.1.023; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Muramatsu M, 2010, CANCER RES, V70, P8211, DOI 10.1158/0008-5472.CAN-10-0202; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Tarallo V, 2011, AM J CANCER RES, V1, P265; Tran Chinh N, 2005, Pathophysiology, V12, P183, DOI 10.1016/j.pathophys.2005.07.005; Volin M. V., 2011, RHEUMATOLOGY SUNNYVA, V1; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yoo SA, 2015, J IMMUNOL, V194, P2513, DOI 10.4049/jimmunol.1402900; Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783; Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	42	25	25	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1348	+		10.1038/s41590-019-0456-4	http://dx.doi.org/10.1038/s41590-019-0456-4			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31406382				2022-12-18	WOS:000486615900018
J	Choi, AMK; Nakahira, K				Choi, Augustine M. K.; Nakahira, Kiichi			Dampening insulin signaling by an NLRP3 'meta-flammasome'	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMASOME; ACTIVATION	The inflammasome has been linked to metabolic disorders such as obesity and type 2 diabetes. Data now suggest that the crosstalk between the inflammasome and autophagy critically mediates cytoplasmic receptor NLRP3-dependent activation of the inflammasome by the saturated fatty acids contained in a high-fat diet.	[Choi, Augustine M. K.; Nakahira, Kiichi] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Choi, AMK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	amchoi@rics.bwh.harvard.edu			NHLBI NIH HHS [R01 HL055330] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055330] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	12	25	26	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					379	380		10.1038/ni.2028	http://dx.doi.org/10.1038/ni.2028			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21502990	Green Accepted			2022-12-18	WOS:000289666600007
J	Tanchot, C; Rocha, B				Tanchot, C; Rocha, B			CD8 and B cell memory: same strategy, same signals	NATURE IMMUNOLOGY			English	Editorial Material							HELP	Generation of B cell memory requires CD4(+) T cell help and involves triggering of CD40 in target B cells. Several recent studies indicate that similar signals are involved in the generation of memory CD8(+)T lymphocytes.	Inst Necker, INSERM, U591, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tanchot, C (corresponding author), Inst Necker, INSERM, U591, Paris, France.			Tanchot, Corinne/0000-0002-2913-1755				Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Gray D, 1994, Semin Immunol, V6, P303, DOI 10.1006/smim.1994.1039; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4	10	25	26	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					431	432		10.1038/ni0503-431	http://dx.doi.org/10.1038/ni0503-431			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719734				2022-12-18	WOS:000182665400008
J	Hall, VG; Ferreira, VH; Wood, H; Ierullo, M; Majchrzak-Kita, B; Manguiat, K; Robinson, A; Kulasingam, V; Humar, A; Kumar, D				Hall, Victoria G.; Ferreira, Victor H.; Wood, Heidi; Ierullo, Matthew; Majchrzak-Kita, Beata; Manguiat, Kathy; Robinson, Alyssia; Kulasingam, Vathany; Humar, Atul; Kumar, Deepali			Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses	NATURE IMMUNOLOGY			English	Article							IMMUNOGENICITY	Delayed dosing intervals are a strategy to immunize a greater proportion of the population. In an observational study, we compared humoral and cellular responses in health care workers receiving two doses of BNT162b2 (Pfizer-BioNTech) vaccine at standard (3- to 6-week) and delayed (8- to 16-week) intervals. In the delayed-interval group, anti-receptor-binding domain antibody titers were significantly enhanced compared to the standard-interval group. The 50% plaque reduction neutralization test (PRNT50) and PRNT90 titers against wild-type (ancestral) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Alpha, Beta and Delta variants were higher in the delayed-interval group. Spike-specific polyfunctional CD4(+) and CD8(+) T cells expressing interferon-gamma and interleukin-2 were comparable between the two groups. Here, we show that the strategy of delaying second doses of mRNA vaccination may lead to enhanced humoral immune responses, including improved virus neutralization against wild-type and variant SARS-CoV-2 viruses. This finding has potentially important implications as vaccine implementation continues across a greater proportion of the global population. Delaying a second COVID-19 vaccine dose is a common strategy to maximize vaccine coverage, but the immunological effects are unclear. Hall et al. demonstrate that a delayed second dose significantly enhances neutralizing humoral immunity.	[Hall, Victoria G.; Ferreira, Victor H.; Ierullo, Matthew; Majchrzak-Kita, Beata; Humar, Atul; Kumar, Deepali] Univ Hlth Network, Transplant Infect Dis & Ajmera Transplant Ctr, Toronto, ON, Canada; [Wood, Heidi; Manguiat, Kathy; Robinson, Alyssia] Natl Microbiol Lab, Winnipeg, MB, Canada; [Wood, Heidi; Manguiat, Kathy; Robinson, Alyssia] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Kulasingam, Vathany] Univ Hlth Network, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Public Health Agency of Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hall, VG; Kumar, D (corresponding author), Univ Hlth Network, Transplant Infect Dis & Ajmera Transplant Ctr, Toronto, ON, Canada.	Victoria.hall@uhn.ca; Deepali.kumar@uhn.ca	Ferreira, Victor H/AAY-8861-2021	Ferreira, Victor H/0000-0002-1472-9711; Ierullo, Matthew/0000-0001-9638-873X	Public Health Agency of Canada through the COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group; Avant Mutual; Canadian Society of Transplantation; Ajmera Transplant Centre at University Health Network	Public Health Agency of Canada through the COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group; Avant Mutual; Canadian Society of Transplantation; Ajmera Transplant Centre at University Health Network	We thank N. Pinzon for expert study coordination and T. Ku for laboratory assistance. This work was supported by the Public Health Agency of Canada through the COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group (D.K., A.H., V.G.H. and V.H.F.). V.G.H. has received research support funding from Avant Mutual, the Canadian Society of Transplantation and Ajmera Transplant Centre at University Health Network.	[Anonymous], 2007, GUID IND TOX GRAD SC; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Demonbreun AR, 2021, J INFECT DIS, V224, P793, DOI 10.1093/infdis/jiab314; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Hall VG, 2021, AM J TRANSPLANT, V21, P3980, DOI 10.1111/ajt.16766; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Macallan DC, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5010005; Mendoza Emelissa J, 2020, Curr Protoc Microbiol, V57, pecpmc105, DOI 10.1002/cpmc.105; Payne RP, 2021, CELL, V184, P5699, DOI 10.1016/j.cell.2021.10.011; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Robertson JFR, 2021, LANCET, V397, P879, DOI 10.1016/S0140-6736(21)00455-4; Skowronski D.M., 2 DOSE SARS COV 2 VA, DOI 10.26.21265397 (2021; Valcourt EJ, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00886-21; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3	14	24	23	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					380	+		10.1038/s41590-021-01126-6	http://dx.doi.org/10.1038/s41590-021-01126-6		FEB 2022	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35115679	Green Submitted, Bronze			2022-12-18	WOS:000750712800001
J	Chen, Y; Zander, RA; Wu, XP; Schauder, DM; Kasmani, MY; Shen, J; Zheng, SK; Burns, R; Taparowsky, EJ; Cui, WG				Chen, Yao; Zander, Ryan A.; Wu, Xiaopeng; Schauder, David M.; Kasmani, Moujtaba Y.; Shen, Jian; Zheng, Shikan; Burns, Robert; Taparowsky, Elizabeth J.; Cui, Weiguo			BATF regulates progenitor to cytolytic effector CD8(+) T cell transition during chronic viral infection	NATURE IMMUNOLOGY			English	Article							INHIBITORY RECEPTOR PD-1; TERMINAL DIFFERENTIATION; READ ALIGNMENT; TRANSCRIPTION; MEMORY; BET; EXPRESSION; SUBSETS; SPECIFICITY; CHECKPOINT	During chronic viral infection, CD8(+) T cells develop into three major phenotypically and functionally distinct subsets: Ly108(+)TCF-1(+) progenitors, Ly108(-)CX(3)CR1(-) terminally exhausted cells and the recently identified CX(3)CR1(+) cytotoxic effector cells. Nevertheless, how CX(3)CR1(+) effector cell differentiation is transcriptionally and epigenetically regulated remains elusive. Here, we identify distinct gene regulatory networks and epigenetic landscapes underpinning the formation of these subsets. Notably, our data demonstrate that CX(3)CR1(+) effector cells bear a striking similarity to short-lived effector cells during acute infection. Genetic deletion of Tbx21 significantly diminished formation of the CX(3)CR1(+) subset. Importantly, we further identify a previously unappreciated role for the transcription factor BATF in maintaining a permissive chromatin structure that allows the transition from TCF-1(+) progenitors to CX(3)CR1(+) effector cells. BATF directly bound to regulatory regions near Tbx21 and Klf2, modulating their enhancer accessibility to facilitate the transition. These mechanistic insights can potentially be harnessed to overcome T cell exhaustion during chronic infection and cancer. Distinct subsets of effector CD8(+) T cells can arise in chronically infected mice. Cui and colleagues examine the epigenetic trajectory of TCF-1(+)Ly108(+) 'stem-like' progenitor cells differentiating into CX(3)CR1(+) cytolytic effector CD8(+) T cells in LCMV-infected mice. Single-cell transcriptomic and ATAC-seq analyses reveal that this progression requires the transcription factors T-bet and BATF.	[Chen, Yao; Zander, Ryan A.; Wu, Xiaopeng; Schauder, David M.; Kasmani, Moujtaba Y.; Shen, Jian; Zheng, Shikan; Burns, Robert; Cui, Weiguo] Versiti, Blood Res Inst, Milwaukee, WI 53226 USA; [Chen, Yao; Schauder, David M.; Kasmani, Moujtaba Y.; Shen, Jian; Cui, Weiguo] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA; [Taparowsky, Elizabeth J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Taparowsky, Elizabeth J.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cui, WG (corresponding author), Versiti, Blood Res Inst, Milwaukee, WI 53226 USA.; Cui, WG (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.	weiguo.cui@bcw.edu		Shen, Jian/0000-0001-8398-2318; Zander, Ryan/0000-0002-7431-8535; Kasmani, Moujtaba/0000-0002-5753-5335; Cui, Weiguo/0000-0003-1562-9218				Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Bancos S, 2009, CELL IMMUNOL, V257, P44, DOI 10.1016/j.cellimm.2009.02.006; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meers MP, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0287-4; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Schauder DM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013452118; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Utzschneider DT, 2018, CELL REP, V22, P3454, DOI 10.1016/j.celrep.2018.03.020; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Ye T, 2014, METHODS MOL BIOL, V1150, P141, DOI 10.1007/978-1-4939-0512-6_8; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150	65	24	24	5	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					996	+		10.1038/s41590-021-00965-7	http://dx.doi.org/10.1038/s41590-021-00965-7		JUL 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34282329	Green Accepted			2022-12-18	WOS:000674567000002
J	Ferreira, ACF; Szeto, ACH; Heycock, MWD; Clark, PA; Walker, JA; Crisp, A; Barlow, JL; Kitching, S; Lim, A; Gogoi, M; Berks, R; Daly, M; Jolin, HE; McKenzie, ANJ				Ferreira, Ana C. F.; Szeto, Aydan C. H.; Heycock, Morgan W. D.; Clark, Paula A.; Walker, Jennifer A.; Crisp, Alastair; Barlow, Jillian L.; Kitching, Sophie; Lim, Alfred; Gogoi, Mayuri; Berks, Richard; Daly, Maria; Jolin, Helen E.; McKenzie, Andrew N. J.			ROR alpha is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; RNA-SEQ; LINEAGE; EXPRESSION; BCL11B; PROGENITORS; DIFFERENTIATION; GATA3; IL-4; NK	Type 2 innate lymphoid cells (ILC2) contribute to immune homeostasis, protective immunity and tissue repair. Here we demonstrate that functional ILC2 cells can arise in the embryonic thymus from shared T cell precursors, preceding the emergence of CD4(+)CD8(+) (double-positive) T cells. Thymic ILC2 cells migrated to mucosal tissues, with colonization of the intestinal lamina propria. Expression of the transcription factor ROR alpha repressed T cell development while promoting ILC2 development in the thymus. From RNA-seq, assay for transposase-accessible chromatin sequencing (ATAC-seq) and chromatin immunoprecipitation followed by sequencing (ChIP-seq) data, we propose a revised transcriptional circuit to explain the co-development of T cells and ILC2 cells from common progenitors in the thymus. When Notch signaling is present, BCL11B dampens Nfil3 and Id2 expression, permitting E protein-directed T cell commitment. However, concomitant expression of ROR alpha overrides the repression of Nfil3 and Id2 repression, allowing ID2 to repress E proteins and promote ILC2 differentiation. Thus, we demonstrate that ROR alpha expression represents a critical checkpoint at the bifurcation of the T cell and ILC2 lineages in the embryonic thymus.	[Ferreira, Ana C. F.; Szeto, Aydan C. H.; Heycock, Morgan W. D.; Clark, Paula A.; Walker, Jennifer A.; Crisp, Alastair; Barlow, Jillian L.; Kitching, Sophie; Lim, Alfred; Gogoi, Mayuri; Berks, Richard; Daly, Maria; Jolin, Helen E.; McKenzie, Andrew N. J.] MRC Lab Mol Biol, Cambridge, England; [Walker, Jennifer A.] AstraZeneca, Aaron Klug Bldg, Cambridge, England; [Barlow, Jillian L.] Univ York, Dept Biol, York, N Yorkshire, England; [Lim, Alfred] Theolytics Ltd, Oxford, England	MRC Laboratory Molecular Biology; AstraZeneca; University of York - UK	Ferreira, ACF; McKenzie, ANJ (corresponding author), MRC Lab Mol Biol, Cambridge, England.	ferreira@mrc-lmb.cam.ac.uk; anm@mrc-lmb.cam.ac.uk		Crisp, Alastair/0000-0001-8069-2294; Barlow, Jillian Lynne/0000-0002-8680-3589; Storrar, Sophie/0000-0002-1963-1449	UK Medical Research Council [U105178805]; Wellcome Trust [100963/Z/13/Z]; Croucher Cambridge International Scholarship; MRC [MC_U105178805, MC_EX_MR/S300001/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Croucher Cambridge International Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the Ares staff, genotyping facility and flow cytometry core for their technical assistance. This study was supported by grants from the UK Medical Research Council (U105178805 to J.L.B., M.W.D.H., M.G., H.E.J., M.D., R.B., A.C.) and the Wellcome Trust (100963/Z/13/Z to A.C.F.F., J.A.W., P.A.C., S.K., A.L.). A.C.H.S. was supported by a Croucher Cambridge International Scholarship.	Anderson G., 2007, CSH PROTOC, V2007, pt4808; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; CHANG HC, 1989, J EXP MED, V169, P2073, DOI 10.1084/jem.169.6.2073; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fiorini E, 2008, J IMMUNOL, V181, P8199, DOI 10.4049/jimmunol.181.12.8199; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hosokawa H, 2020, J EXP MED, V217, DOI 10.1084/jem.20190972; Hosokawa H, 2018, NAT IMMUNOL, V19, P1427, DOI 10.1038/s41590-018-0238-4; Hosokawa H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028621; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Jones R, 2018, EUR J IMMUNOL, V48, P1481, DOI 10.1002/eji.201847511; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; Lun Aaron T L, 2016, F1000Res, V5, P2122; Masuda K, 2009, MOL IMMUNOL, V46, P1756, DOI 10.1016/j.molimm.2009.01.015; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Miyazaki M, 2017, IMMUNITY, V46, P818, DOI 10.1016/j.immuni.2017.04.022; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Sagar, 2020, EMBO J, V39, DOI 10.15252/embj.2019104159; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/NMETH.3542, 10.1038/nmeth.3542]; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Spidale NA, 2018, IMMUNITY, V49, P857, DOI 10.1016/j.immuni.2018.09.010; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Sultana T, 2019, MOL CELL, V74, P555, DOI 10.1016/j.molcel.2019.02.036; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Tang YJ, 2012, BLOOD, V120, P63, DOI 10.1182/blood-2011-02-337980; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Walker JA, 2013, CURR OPIN IMMUNOL, V25, P148, DOI 10.1016/j.coi.2013.02.010; White AJ, 2017, J EXP MED, V214, P2205, DOI 10.1084/jem.20170271; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2013, BLOOD, V121, P1534, DOI 10.1182/blood-2012-08-449447; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010	65	24	24	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					166	U106		10.1038/s41590-020-00833-w	http://dx.doi.org/10.1038/s41590-020-00833-w		JAN 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33432227	Green Accepted			2022-12-18	WOS:000607030200004
J	Burrows, N; Bashford-Rogers, RJM; Bhute, VJ; Penalver, A; Ferdinand, JR; Stewart, BJ; Smith, JEG; Deobagkar-Lele, M; Giudice, G; Connor, TM; Inaba, A; Bergamaschi, L; Smith, S; Tran, MGB; Petsalaki, E; Lyons, PA; Espeli, M; Huntly, BJP; Smith, KGC; Cornall, RJ; Clatworthy, MR; Maxwell, PH				Burrows, Natalie; Bashford-Rogers, Rachael J. M.; Bhute, Vijesh J.; Penalver, Ana; Ferdinand, John R.; Stewart, Benjamin J.; Smith, Joscelin E. G.; Deobagkar-Lele, Mukta; Giudice, Girolamo; Connor, Thomas M.; Inaba, Akimichi; Bergamaschi, Laura; Smith, Sam; Tran, Maxine G. B.; Petsalaki, Evangelia; Lyons, Paul A.; Espeli, Marion; Huntly, Brian J. P.; Smith, Kenneth G. C.; Cornall, Richard J.; Clatworthy, Menna R.; Maxwell, Patrick H.			Dynamic regulation of hypoxia-inducible factor-1 alpha activity is essential for normal B cell development	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER HYPOXIA; EXPRESSION; MOUSE; LYMPHOCYTES; TOLERANCE; ALIGNER; NETWORK; QUALITY; REVEAL; CD19	B lymphocyte development and selection are central to adaptive immunity and self-tolerance. These processes require B cell receptor (BCR) signaling and occur in bone marrow, an environment with variable hypoxia, but whether hypoxia-inducible factor (HIF) is involved is unknown. We show that HIF activity is high in human and murine bone marrow pro-B and pre-B cells and decreases at the immature B cell stage. This stage-specific HIF suppression is required for normal B cell development because genetic activation of HIF-1 alpha in murine B cells led to reduced repertoire diversity, decreased BCR editing and developmental arrest of immature B cells, resulting in reduced peripheral B cell numbers. HIF-1 alpha activation lowered surface BCR, CD19 and B cell-activating factor receptor and increased expression of proapoptotic BIM. BIM deletion rescued the developmental block. Administration of a HIF activator in clinical use markedly reduced bone marrow and transitional B cells, which has therapeutic implications. Together, our work demonstrates that dynamic regulation of HIF-1 alpha is essential for normal B cell development. B cell development and selection occur in the often hypoxic environment of the bone marrow. Burrows and colleagues demonstrate that dynamic regulation of B cell-intrinsic hypoxia-inducible factor-1 alpha is essential for normal B cell development and function.	[Burrows, Natalie; Bhute, Vijesh J.; Penalver, Ana; Smith, Joscelin E. G.; Smith, Sam; Maxwell, Patrick H.] Univ Cambridge, Cambridge Inst Med Res, Keith Peters Bldg,Cambridge Biomed Campus, Cambridge, England; [Burrows, Natalie; Bashford-Rogers, Rachael J. M.; Bhute, Vijesh J.; Penalver, Ana; Smith, Joscelin E. G.; Bergamaschi, Laura; Smith, Sam; Lyons, Paul A.; Smith, Kenneth G. C.; Maxwell, Patrick H.] Univ Cambridge, Dept Med, Sch Clin Med, Cambridge Biomed Campus, Cambridge, England; [Bashford-Rogers, Rachael J. M.; Cornall, Richard J.] Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Ferdinand, John R.; Stewart, Benjamin J.; Inaba, Akimichi; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, MRC Lab Mol Biol, Cambridge, England; [Stewart, Benjamin J.; Clatworthy, Menna R.] Wellcome Sanger Inst, Cellular Genet, Hinxton, England; [Deobagkar-Lele, Mukta; Cornall, Richard J.] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Giudice, Girolamo; Petsalaki, Evangelia] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Connor, Thomas M.] Oxford Univ Hosp NHS Fdn Trust, Oxford Kidney Unit, Churchill Hosp, Oxford, England; [Bergamaschi, Laura; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis, Jeffrey Cheah Biomed Ctr, Cambridge, England; [Tran, Maxine G. B.] Royal Free Hosp, UCL Div Surg & Intervent Sci, London, England; [Tran, Maxine G. B.] Royal Free Hosp, Specialist Ctr Kidney Canc, London, England; [Espeli, Marion] Univ Paris, Inst Rech St Louis, EMiLy, Inserm,U1160, Paris, France; [Huntly, Brian J. P.] Univ Cambridge, Wellcome Trust MRC Cambridge Stem Cell Inst, Dept Haematol, Jeffrey Cheah Biomed Ctr, Cambridge, England	University of Cambridge; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; European Molecular Biology Laboratory (EMBL); Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge	Burrows, N (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Keith Peters Bldg,Cambridge Biomed Campus, Cambridge, England.; Burrows, N (corresponding author), Univ Cambridge, Dept Med, Sch Clin Med, Cambridge Biomed Campus, Cambridge, England.	nb470@cam.ac.uk	Espeli, Marion/AAH-4483-2021; Petsalaki, Evangelia/ABC-3561-2020; Maxwell, Patrick H/C-5557-2008; Bergamaschi, Laura/ABE-1175-2020; Tran, Maxine/ABF-4197-2021	Espeli, Marion/0000-0001-5005-1664; Petsalaki, Evangelia/0000-0002-8294-2995; Maxwell, Patrick H/0000-0002-0338-2679; Stewart, Benjamin J/0000-0003-4522-0085; Bashford-Rogers, Rachael/0000-0002-6838-0711; Clatworthy, Menna/0000-0002-3340-9828; Inaba, Akimichi/0000-0002-9726-9860; Tran, Maxine Gia Binh/0000-0002-6034-4433; Giudice, Girolamo/0000-0002-5359-8208; Burrows, Natalie/0000-0001-6591-5971; Deobagkar, Mukta/0000-0002-8543-6801; Smith, Joscelin/0000-0001-9271-1157	Wellcome Trust [100140, 19710, WT106068AIA]; Cambridge National Institute for Health Research (NIHR) [NF-SI-0514-10122]; Rosetrees Trust [G102721]; Wellcome Clinical PhD fellowship [216366/Z/19/Z]; MRC Clinic Research Training Fellowship [G0802266, 89800]; Lister Institute of Preventive Medicine; NIHR [CL-2006-14-006]; Versus Arthritis Cure Challenge Research Grant [21777]; NIHR Research Professorship [RP-2017-08-ST2-002]; Wellcome Trust/MRC [097922/Z/11/Z]; Chan-Zuckerberg Initiative Human Cell Atlas technology development grant; MRC [MC_PC_17230, MC_UU_00008/6, G0802266] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge National Institute for Health Research (NIHR); Rosetrees Trust(Rosetrees Trust); Wellcome Clinical PhD fellowship; MRC Clinic Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute of Preventive Medicine; NIHR(National Institute for Health Research (NIHR)); Versus Arthritis Cure Challenge Research Grant; NIHR Research Professorship; Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Chan-Zuckerberg Initiative Human Cell Atlas technology development grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust (no. 19710), a Cambridge National Institute for Health Research (NIHR) senior investigator award (no. NF-SI-0514-10122) and the Rosetrees Trust (no. G102721) to P.H.M., supporting N.B., V.J.B., A.P. and J.E.G.S. R.J.M.B.-R. was supported by the Wellcome Trust (no. WT106068AIA). B.J.S. was supported by a Wellcome Clinical PhD fellowship (216366/Z/19/Z). T.M.C. was supported by a MRC Clinic Research Training Fellowship (G0802266, ID 89800). S.S. was supported by a summer studentship award from the Lister Institute of Preventive Medicine. M.G.B.T. was supported by a NIHR grant (no. CL-2006-14-006). M.R.C. was supported by a Chan-Zuckerberg Initiative Human Cell Atlas technology development grant, a Versus Arthritis Cure Challenge Research Grant (no. 21777) and an NIHR Research Professorship (no. RP-2017-08-ST2-002). The CIMR core facilities were supported by a Wellcome Trust/MRC grant (no. 097922/Z/11/Z) and a Wellcome Trust strategic award (no. 100140). We thank R. Schulte, C. Cossetti, M. Maj and G. Grondys-Kotarba (CIMR Flow Cytometry Core Facility), and M. Gratian and M. Bowen (CIMR microscopy core facility) for their help and support; Y. Umrania for bioinformatics support; M. Reth (University of Freiburg, Germany) and M. Turner (Babraham Institute, Cambridge) for providing the Mb1-cre mice; and R. Johnson (Karolinska Institutet, Sweden) for providing Hif1a<SUP>-/-</SUP> mice. We thank J. Sale and M. Ashcroft for useful discussions and T. Wilson, K. Scott and D. Gale for experimental and technical support.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bashford-Rogers RJM, 2016, LEUKEMIA, V30, P2312, DOI 10.1038/leu.2016.142; Bashford-Rogers RJM, 2013, GENOME RES, V23, P1874, DOI 10.1101/gr.154815.113; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Christodoulou C, 2020, NATURE, V578, P278, DOI 10.1038/s41586-020-1971-z; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Gaspar HB, 2000, CLIN EXP IMMUNOL, V119, P383, DOI 10.1046/j.1365-2249.2000.01192.x; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Gruneboom A, 2019, NAT METAB, V1, P236, DOI 10.1038/s42255-018-0016-5; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kojima H, 2002, P NATL ACAD SCI USA, V99, P2170, DOI 10.1073/pnas.052706699; Kojima H, 2010, J IMMUNOL, V184, P154, DOI 10.4049/jimmunol.0800167; Kouskoff V, 2000, P NATL ACAD SCI USA, V97, P7435, DOI 10.1073/pnas.130182597; Kreuzaler M, 2012, J IMMUNOL, V188, P497, DOI 10.4049/jimmunol.1102321; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P633, DOI 10.1101/pdb.ip85; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meng XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02683-x; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Ryan HE, 2000, CANCER RES, V60, P4010; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun A, 2015, P NATL ACAD SCI USA, V112, pE458, DOI 10.1073/pnas.1418001112; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tussiwand R, 2012, EUR J IMMUNOL, V42, P206, DOI 10.1002/eji.201141957; Vela JL, 2008, IMMUNITY, V28, P161, DOI 10.1016/j.immuni.2007.12.011; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699	53	24	25	4	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1408	+		10.1038/s41590-020-0772-8	http://dx.doi.org/10.1038/s41590-020-0772-8		AUG 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32868930	Green Accepted, Green Submitted			2022-12-18	WOS:000565239800003
J	Zhou, BS; Magana, L; Hong, ZG; Huang, LS; Chakraborty, S; Tsukasaki, Y; Huang, C; Wang, L; Di, AK; Ganesh, B; Gao, XP; Rehman, J; Malik, AB				Zhou, Bisheng; Magana, Lissette; Hong, Zhigang; Huang, Long Shuang; Chakraborty, Sreeparna; Tsukasaki, Yoshikazu; Huang, Cary; Wang, Li; Di, Anke; Ganesh, Balaji; Gao, Xiaopei; Rehman, Jalees; Malik, Asrar B.			The angiocrine Rspondin3 instructs interstitial macrophage transition via metabolic-epigenetic reprogramming and resolves inflammatory injury	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; TET2; POLARIZATION; REGENERATION; ACTIVATION; CELLS; RECOGNITION; METHYLATION; PLASTICITY; IDENTITY	The angiocrine Rspondin3 is produced by endothelial cells (ECs) and controls growth and development. Malik and colleagues show that lung ECs produce Rspondin3 following injury and specifically direct interstitial macrophages into an anti-inflammatory and wound-healing program. Macrophages demonstrate remarkable plasticity that is essential for host defense and tissue repair. The tissue niche imprints macrophage identity, phenotype and function. The role of vascular endothelial signals in tailoring the phenotype and function of tissue macrophages remains unknown. The lung is a highly vascularized organ and replete with a large population of resident macrophages. We found that, in response to inflammatory injury, lung endothelial cells release the Wnt signaling modulator Rspondin3, which activates beta-catenin signaling in lung interstitial macrophages and increases mitochondrial respiration by glutaminolysis. The generated tricarboxylic acid cycle intermediate alpha-ketoglutarate, in turn, serves as the cofactor for the epigenetic regulator TET2 to catalyze DNA hydroxymethylation. Notably, endothelial-specific deletion of Rspondin3 prevented the formation of anti-inflammatory interstitial macrophages in endotoxemic mice and induced unchecked severe inflammatory injury. Thus, the angiocrine-metabolic-epigenetic signaling axis specified by the endothelium is essential for reprogramming interstitial macrophages and dampening inflammatory injury.	[Zhou, Bisheng; Magana, Lissette; Hong, Zhigang; Huang, Long Shuang; Chakraborty, Sreeparna; Tsukasaki, Yoshikazu; Huang, Cary; Wang, Li; Di, Anke; Gao, Xiaopei; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol & Regenerat Med, Chicago, IL 60612 USA; [Zhou, Bisheng; Magana, Lissette; Hong, Zhigang; Huang, Long Shuang; Chakraborty, Sreeparna; Tsukasaki, Yoshikazu; Huang, Cary; Wang, Li; Di, Anke; Gao, Xiaopei; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; [Ganesh, Balaji] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Rehman, Jalees] Univ Illinois, Coll Med, Dept Med, Div Cardiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rehman, J; Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol & Regenerat Med, Chicago, IL 60612 USA.; Rehman, J; Malik, AB (corresponding author), Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA.; Rehman, J (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Cardiol, Chicago, IL 60612 USA.	jalees@uic.edu; abmalik@uic.edu	Zhou, Bisheng/K-2160-2019; Chakraborty, Sreeparna/GVU-8013-2022; Rehman, Jalees/GVU-1981-2022	Rehman, Jalees/0000-0002-2787-9292; Zhou, Bisheng/0000-0003-1551-0612; Huang, Cary/0000-0003-1238-4550; Malik, Asrar/0000-0002-8205-7128; Magana, Lissette/0000-0001-7546-5935	National Institutes of Health [R01-HL45638, P01-HL60678, T32-HL007829, R01-HL118068, R01-HL90152]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The studies were supported by National Institutes of Health grants R01-HL45638 (to A.B.M.), P01-HL60678 (to A.B.M. and J.R.), T32-HL007829 (to A.B.M.), R01-HL118068 (to J.R. and A.B.M.) and R01-HL90152 (to J.R. and A.B.M.). The VE-Cadherin-CreERT2 mice were kindly provided by R. Adams at the Max Planck Institute.	Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Di AK, 2018, IMMUNITY, V49, P56, DOI 10.1016/j.immuni.2018.04.032; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Goiffon RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7271; Hume PS, 2020, AM J RESP CRIT CARE, V201, P1209, DOI 10.1164/rccm.201911-2105OC; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kang SJ, 2018, NAT IMMUNOL, V19, P561, DOI 10.1038/s41590-018-0108-0; Keiran N, 2019, NAT IMMUNOL, V20, P581, DOI 10.1038/s41590-019-0372-7; Lambrecht BN, 2017, IMMUNITY, V47, P807, DOI 10.1016/j.immuni.2017.11.005; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu ML, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10134-y; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Luo YL, 2018, ACS NANO, V12, P994, DOI 10.1021/acsnano.7b07874; Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nelson VL, 2018, GENE DEV, V32, P1035, DOI 10.1101/gad.312355.118; Nepal S, 2019, P NATL ACAD SCI USA, V116, P16513, DOI 10.1073/pnas.1821601116; Pan W, 2017, IMMUNITY, V47, P284, DOI 10.1016/j.immuni.2017.07.020; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Salome Berengere, 2020, Nat Rev Immunol, V20, P277, DOI 10.1038/s41577-020-0303-8; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Scholz B, 2016, DEV CELL, V36, P79, DOI 10.1016/j.devcel.2015.12.015; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Svedberg FR, 2019, NAT IMMUNOL, V20, P571, DOI 10.1038/s41590-019-0352-y; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Tan BH, 2018, CANCER RES, V78, P4929, DOI 10.1158/0008-5472.CAN-18-0152; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wang QY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03390-x; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	54	24	26	6	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1430	+		10.1038/s41590-020-0764-8	http://dx.doi.org/10.1038/s41590-020-0764-8		AUG 2020	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32839607	Green Accepted, Bronze			2022-12-18	WOS:000562393000004
J	Chaudhri, VK; Dienger-Stambaugh, K; Wu, ZG; Shrestha, M; Singh, H				Chaudhri, Virendra K.; Dienger-Stambaugh, Krista; Wu, Zhiguo; Shrestha, Mahesh; Singh, Harinder			Charting the cis-regulome of activated B cells by coupling structural and functional genomics	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTIONAL REGULATION; GENE; CHROMATIN; MAP; PRINCIPLES; ENHANCERS; NETWORKS; ELEMENTS; ASSAYS	Cis-regulomes underlying immune-cell-specific genomic states have been extensively analyzed by structure-based chromatin profiling. By coupling such approaches with a high-throughput enhancer screen (self-transcribing active regulatory region sequencing (STARR-seq)), we assembled a functional cis-regulome for lipopolysaccharide-activated B cells. Functional enhancers, in contrast with accessible chromatin regions that lack enhancer activity, were enriched for enhancer RNAs (eRNAs) and preferentially interacted in vivo with B cell lineage-determining transcription factors. Interestingly, preferential combinatorial binding by these transcription factors was not associated with differential enrichment of their sites. Instead, active enhancers were resolved by principal component analysis (PCA) from all accessible regions by co-varying transcription factor motif scores involving a distinct set of signaling-induced transcription factors. High-resolution chromosome conformation capture (Hi-C) analysis revealed multiplex, activated enhancer-promoter configurations encompassing numerous multi-enhancer genes and multi-genic enhancers engaged in the control of divergent molecular pathways. Motif analysis of pathway-specific enhancers provides a catalog of diverse transcription factor codes for biological processes encompassing B cell activation, cycling and differentiation. Singh and colleagues leverage genome-wide assays to identify functionally active enhancers that are present in naive and lipopolysaccharide-activated B cells by FAIRE-seq, STARR-seq and Hi-C structural interactome analyses and identify additional transcription factors that regulate gene expression modules.	[Chaudhri, Virendra K.; Dienger-Stambaugh, Krista; Wu, Zhiguo; Shrestha, Mahesh; Singh, Harinder] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA; [Chaudhri, Virendra K.; Dienger-Stambaugh, Krista; Wu, Zhiguo; Shrestha, Mahesh; Singh, Harinder] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Chaudhri, Virendra K.; Singh, Harinder] Univ Pittsburgh, Ctr Syst Immunol, Pittsburgh, PA 15260 USA; [Chaudhri, Virendra K.; Singh, Harinder] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA.; Singh, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Ctr Syst Immunol, Cincinnati, OH 45229 USA.; Singh, H (corresponding author), Univ Pittsburgh, Ctr Syst Immunol, Pittsburgh, PA 15260 USA.; Singh, H (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	Harinder@pitt.edu	Chaudhri, Virendra/S-9767-2019	Chaudhri, Virendra/0000-0003-3528-4667; Singh, Harinder/0000-0002-6330-8526	Cincinnati Children's Research Foundation (CCRF)	Cincinnati Children's Research Foundation (CCRF)	This study was supported by funds from the Cincinnati Children's Research Foundation (CCRF) to H.S. We thank the core facilities of the Cincinnati Children's Hospital Medical Center for assistance with mouse colony management, flow cytometry and highthroughput DNA sequencing. We thank M. Haas (CCHMC) for advice with FAIRE-seq and D. Fletcher (CCHMC) for technical support in sequencing of STARR-seq and eRNA libraries. The genomic analyses were made possible through use of the CCHMC BMI computing cluster and the Center for Research Computing at the University of Pittsburgh (PA, USA). We are particularly grateful to the following colleagues at CCHMC: L. Grimes, M.Weirauch, E. Miraldi and S. Pasare for useful scientific discussions and critical input on the manuscript.	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Babbitt CC, 2015, GENOMICS, V106, P137, DOI 10.1016/j.ygeno.2015.06.002; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dailey L, 2015, GENOMICS, V106, P151, DOI 10.1016/j.ygeno.2015.06.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grosschedl R, 2013, COLD SH Q B, V78, P23, DOI 10.1101/sqb.2013.78.020057; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Johanson TM, 2018, NAT IMMUNOL, V19, P1257, DOI 10.1038/s41590-018-0234-8; Kieffer-Kwon KR, 2017, MOL CELL, V67, P566, DOI 10.1016/j.molcel.2017.07.013; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langdon WB, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-014-0034-0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02738; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Maricque BB, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw942; Muerdter F, 2018, NAT METHODS, V15, P141, DOI 10.1038/nmeth.4534; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Palozola KC, 2017, SCIENCE, V358, P119, DOI 10.1126/science.aal4671; Phanstiel DH, 2014, BIOINFORMATICS, V30, P2808, DOI 10.1093/bioinformatics/btu379; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ren G, 2017, MOL CELL, V67, P1049, DOI 10.1016/j.molcel.2017.08.026; Rochman Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8858; Roy AL, 2011, TRENDS IMMUNOL, V32, P532, DOI 10.1016/j.it.2011.06.012; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sen R, 2010, GENE DEV, V24, P973, DOI 10.1101/gad.1930610; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team R.C, 2015, R LANG ENV STAT COMP; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vaidyanathan B, 2017, J EXP MED, V214, P197, DOI 10.1084/jem.20160789; Vanhille L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7905; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	54	24	24	2	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					210	+		10.1038/s41590-019-0565-0	http://dx.doi.org/10.1038/s41590-019-0565-0		DEC 2019	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31873292				2022-12-18	WOS:000507726700001
J	Stadinski, BD; Blevins, SJ; Spidale, NA; Duke, BR; Huseby, PG; Stern, LJ; Huseby, ES				Stadinski, Brian D.; Blevins, Sydney J.; Spidale, Nicholas A.; Duke, Brian R.; Huseby, Priya G.; Stern, Lawrence J.; Huseby, Eric S.			A temporal thymic selection switch and ligand binding kinetics constrain neonatal Foxp3(+) T-reg cell development	NATURE IMMUNOLOGY			English	Article							SELF-ANTIGEN; DENDRITIC CELLS; MASS-SPECTROMETRY; II MOLECULES; TOLERANCE; EXPRESSION; PEPTIDES; AIRE; AUTOIMMUNITY; RECOGNITION	The neonatal thymus generates Foxp3(+) regulatory T (tT(reg)) cells that are critical in controlling immune homeostasis and preventing multiorgan autoimmunity. The role of antigen specificity on neonatal tT(reg) cell selection is unresolved. Here we identify 17 self-peptides recognized by neonatal tT(reg) cells, and reveal ligand specificity patterns that include self-antigens presented in an age- and inflammation-dependent manner. Fate-mapping studies of neonatal peptidyl arginine deiminase type IV (Padi4)specific thymocytes reveal disparate fate choices. Neonatal thymocytes expressing T cell receptors that engage IA(b)-Padi4 with moderate dwell times within a conventional docking orientation are exported as tT(reg) cells. In contrast, Padi4-specific T cell receptors with short dwell times are expressed on CD4(+) T cells, while long dwell times induce negative selection. Temporally, Padi4-specific thymocytes are subject to a developmental stage-specific change in negative selection, which precludes tT(reg) cell development. Thus, a temporal switch in negative selection and ligand binding kinetics constrains the neonatal tT(reg) selection window.	[Stadinski, Brian D.; Blevins, Sydney J.; Spidale, Nicholas A.; Duke, Brian R.; Huseby, Priya G.; Stern, Lawrence J.; Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Huseby, ES (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	Eric.Huseby@umassmed.edu		Huseby, Eric/0000-0001-5423-2542; Stern, Lawrence/0000-0001-9870-8557	US National Institutes of Health [DK095077, AR071269, AI109858]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071269] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the US National Institutes of Health (DK095077, AR071269 and AI109858 to E.S.H.). X-ray diffraction data were collected at the LRL-CAT (31-ID) beamline at APS at the Argonne National Laboratory for PDB IDs 6MKD and 6MKR, and the FMX (17-ID-2) beamline at NSLS II at the Brookhaven National Laboratory for PDB IDs 6MNM, 6MNO, 6MNN and 6MNG.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Bogunovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010599; Bozzacco L, 2011, J PROTEOME RES, V10, P5016, DOI 10.1021/pr200503g; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Dong MQ, 2017, J IMMUNOL, V199, P965, DOI 10.4049/jimmunol.1602137; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fugmann T, 2017, J IMMUNOL, V198, P1357, DOI 10.4049/jimmunol.1601157; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Gratz IK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00333; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huseby ES, 2001, IMMUNITY, V14, P471, DOI 10.1016/S1074-7613(01)00127-3; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalekar LA, 2016, NAT IMMUNOL, V17, P304, DOI 10.1038/ni.3331; Kieback E, 2016, IMMUNITY, V44, P1114, DOI 10.1016/j.immuni.2016.04.018; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Klein L, 2019, NAT REV IMMUNOL, V19, P7, DOI 10.1038/s41577-018-0083-6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; Leonard JD, 2017, IMMUNITY, V47, P107, DOI 10.1016/j.immuni.2017.06.015; Leventhal DS, 2016, IMMUNITY, V44, P847, DOI 10.1016/j.immuni.2016.01.025; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Liu X, 2009, IMMUNITY, V31, P909, DOI 10.1016/j.immuni.2009.09.023; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nanaware PP, 2019, MOL CELL PROTEOMICS, V18, P490, DOI 10.1074/mcp.RA118.000956; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schubert DA, 2012, J EXP MED, V209, P335, DOI 10.1084/jem.20111485; Sofron A, 2016, EUR J IMMUNOL, V46, P319, DOI 10.1002/eji.201545930; Spence A, 2018, P NATL ACAD SCI USA, V115, P5265, DOI 10.1073/pnas.1715590115; Stadinski BD, 2016, NAT IMMUNOL, V17, P946, DOI 10.1038/ni.3491; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Thiault N, 2015, NAT IMMUNOL, V16, P628, DOI 10.1038/ni.3150; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177; Weist BM, 2015, NAT IMMUNOL, V16, P635, DOI 10.1038/ni.3171; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yang X, 2015, J IMMUNOL, V194, P446, DOI 10.4049/jimmunol.1400711	70	24	24	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1046	+		10.1038/s41590-019-0414-1	http://dx.doi.org/10.1038/s41590-019-0414-1			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31209405	Green Accepted			2022-12-18	WOS:000476621200019
J	Castro, W; Chelbi, ST; Niogret, C; Ramon-Barros, C; Welten, SPM; Osterheld, K; Wang, HP; Rota, G; Morgado, L; Vivier, E; Raeber, ME; Boyman, O; Delorenzi, M; Barras, D; Ho, PC; Oxenius, A; Guarda, G				Castro, Wilson; Chelbi, Sonia T.; Niogret, Charlene; Ramon-Barros, Cristina; Welten, Suzanne P. M.; Osterheld, Kevin; Wang, Haiping; Rota, Giorgia; Morgado, Leonor; Vivier, Eric; Raeber, Miro E.; Boyman, Onur; Delorenzi, Mauro; Barras, David; Ho, Ping-Chih; Oxenius, Annette; Guarda, Greta			The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity	NATURE IMMUNOLOGY			English	Article							DEFICIENCY; QUIESCENCE; EXPRESSION; MICE; IDENTIFICATION; ASSOCIATION; ADIPOSE; RAPTOR; LOCI; RISK	Regulatory factor X 7 (Rfx7) is an uncharacterized transcription factor belonging to a family involved in ciliogenesis and immunity. Here, we found that deletion of Rfx7 leads to a decrease in natural killer (NK) cell maintenance and immunity in vivo. Genomic approaches showed that Rfx7 coordinated a transcriptional network controlling cell metabolism. Rfx7(-/-) NK lymphocytes presented increased size, granularity, proliferation, and energetic state, whereas genetic reduction of mTOR activity mitigated those defects. Notably, Rfx7-deficient NK lymphocytes were rescued by interleukin 15 through engagement of the Janus kinase (Jak) pathway, thus revealing the importance of this signaling for maintenance of such spontaneously activated NK cells. Rfx7 therefore emerges as a novel transcriptional regulator of NK cell homeostasis and metabolic quiescence.	[Castro, Wilson; Chelbi, Sonia T.; Niogret, Charlene; Ramon-Barros, Cristina; Osterheld, Kevin; Rota, Giorgia; Morgado, Leonor; Guarda, Greta] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Chelbi, Sonia T.; Guarda, Greta] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Welten, Suzanne P. M.; Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Wang, Haiping; Delorenzi, Mauro; Ho, Ping-Chih] Univ Lausanne, Ludwig Ctr Canc Res, Epalinges, Switzerland; [Wang, Haiping; Delorenzi, Mauro; Ho, Ping-Chih] Univ Lausanne, Dept Fundamental Oncol, Epalinges, Switzerland; [Vivier, Eric] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, Inserm, Marseille, France; [Vivier, Eric] Hop La Timone, AP HP, Serv Immunol, Marseille, France; [Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Raeber, Miro E.; Boyman, Onur] Univ Zurich, Univ Hosp Zurich, Dept Immunol, Zurich, Switzerland; [Delorenzi, Mauro; Barras, David] Swiss Inst Bioinformat SIB, Lausanne, Switzerland	University of Lausanne; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Zurich; University Zurich Hospital; Swiss Institute of Bioinformatics	Guarda, G (corresponding author), Univ Lausanne, Dept Biochem, Epalinges, Switzerland.; Guarda, G (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland.	greta.guarda@irb.usi.ch	Vivier, Eric/F-8939-2010; chelbi, sonia/Q-5150-2019; Raeber, Miro E/J-7626-2012	Vivier, Eric/0000-0001-7022-8287; chelbi, sonia/0000-0003-3465-6537; Raeber, Miro E/0000-0003-2609-0246; Boyman, Onur/0000-0001-8279-5545; Welten, Suzanne/0000-0002-8224-7984; Guarda, Greta/0000-0001-9243-6116; Ramon, Cristina/0000-0002-0930-8226; Castro, Wilson/0000-0002-9649-9883	European Research Council [ERC-2012-StG310890]; Swiss National Science Foundation [PPOOP3_139094, PPOOP3_165833, 310030-172978, 31003A_163204]; ETH post-doctoral fellowship program [FEL29 15-2]; Horten Foundation; ERC under the European Unions Horizon 2020 research and innovation programme [694502]; Agence Nationale de la Recherche, Innate Pharma, MSDAvenir, Ligue Nationale contre le Cancer (Equipe labelisee 'La Ligue'); Marseille-Immunopole; Swiss Cancer Research [KFS-4136-02-2017]; Fondation Medic, Lausanne; Swiss Cancer League [KFS-3949-08-2016]; Melanoma Research Alliance Young Investigator award;  [KFS-MDPhD-3557-06-2015]	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH post-doctoral fellowship program; Horten Foundation; ERC under the European Unions Horizon 2020 research and innovation programme; Agence Nationale de la Recherche, Innate Pharma, MSDAvenir, Ligue Nationale contre le Cancer (Equipe labelisee 'La Ligue'); Marseille-Immunopole; Swiss Cancer Research; Fondation Medic, Lausanne; Swiss Cancer League; Melanoma Research Alliance Young Investigator award; 	We thank M. Thome-Miazza and P. Schneider (UNIL, Lausanne); W Reith (UNIGE Medical School, Geneva); M. Riiegg and M. Hall (Biozentrum, Basel); and M. Mazzone (VIB, Leuven) for sharing reagents important for this study. We thank N. Fonta, W Held, R. Bedel, S. Siegert, S. Calderon, K. Harshman, and R. Hertzano for technical help. Studies in the group of G.G. were funded by the European Research Council (ERC-2012-StG310890) and the Swiss National Science Foundation (PPOOP3_139094 and PPOOP3_165833). S.P.M.W. is supported by the ETH post-doctoral fellowship program (FEL29 15-2) and the Horten Foundation. The laboratory of E.V is supported by the ERC under the European Unions Horizon 2020 research and innovation programme (grant agreement 694502), Agence Nationale de la Recherche, Innate Pharma, MSDAvenir, Ligue Nationale contre le Cancer (Equipe labelisee 'La Ligue') and Marseille-Immunopole. O.B. was supported by the Swiss National Science Foundation 310030-172978 and Swiss Cancer Research KFS-4136-02-2017. M.E.R. was supported by KFS-MDPhD-3557-06-2015. M.D. was supported by the Fondation Medic, Lausanne. P-C.H. was supported by the Swiss National Science Foundation (31003A_163204), the Swiss Cancer League (KFS-3949-08-2016), and a Melanoma Research Alliance Young Investigator award.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Baas D, 2006, EUR J NEUROSCI, V24, P1020, DOI 10.1111/j.1460-9568.2006.05002.x; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Boros K, 2011, EXP HEMATOL, V39, P1090, DOI 10.1016/j.exphem.2011.07.007; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brune W, 2001, CUR PROTOC IMMUNOL, V43; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; Clausen BE, 1998, IMMUNITY, V8, P143, DOI 10.1016/S1074-7613(00)80467-7; Colpitts SL, 2013, J IMMUNOL, V191, P3017, DOI 10.4049/jimmunol.1301389; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Dai QG, 2017, CELL DEATH DIFFER, V24, P1886, DOI 10.1038/cdd.2017.110; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DORN A, 1987, P NATL ACAD SCI USA, V84, P6249, DOI 10.1073/pnas.84.17.6249; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Emery P, 1996, MOL CELL BIOL, V16, P4486; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Held W, 2000, METH MOL B, V121, P5; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; Keramati AR, 2014, NEW ENGL J MED, V370, P1909, DOI 10.1056/NEJMoa1301824; Kistler WS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005368; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Ludigs K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10554; Ludigs K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005088; Manojlovic Z, 2014, MECH DEVELOP, V132, P28, DOI 10.1016/j.mod.2014.02.001; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Piccand J, 2014, CELL REP, V9, P2219, DOI 10.1016/j.celrep.2014.11.033; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers LM, 2013, J IMMUNOL, V190, P4393, DOI 10.4049/jimmunol.1203227; Rota G, 2016, J IMMUNOL, V196, P2939, DOI 10.4049/jimmunol.1502084; Rusiniak ME, 2012, ONCOGENE, V31, P4034, DOI 10.1038/onc.2011.566; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Slager SL, 2012, BLOOD, V120, P843, DOI 10.1182/blood-2012-03-413591; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Wang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11023; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wei HR, 2016, J IMMUNOL, V196, P3537, DOI 10.4049/jimmunol.1501896; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12730; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096; Zurbach KA, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-71	64	24	25	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					809	+		10.1038/s41590-018-0144-9	http://dx.doi.org/10.1038/s41590-018-0144-9			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	29967452	Green Accepted			2022-12-18	WOS:000439470900018
J	Borlido, J; Sakuma, S; Raices, M; Carrette, F; Tinoco, R; Bradley, LM; D'Angelo, MA				Borlido, Joana; Sakuma, Stephen; Raices, Marcela; Carrette, Florent; Tinoco, Roberto; Bradley, Linda M.; D'Angelo, Maximiliano A.			Nuclear pore complex-mediated modulation of TCR signaling is required for naive CD4(+) T cell homeostasis	NATURE IMMUNOLOGY			English	Article							L-SELECTIN; RECEPTOR; EXPRESSION; PROTEINS; TRANSCRIPTION; SURVIVAL; MOUSE; DIFFERENTIATION; SPECIFICITY; RECOGNITION	Nuclear pore complexes (NPCs) are channels connecting the nucleus with the cytoplasm. We report that loss of the tissue-specific NPC component Nup210 causes a severe deficit of naive CD4(+) T cells. Nup210-deficient CD4(+) T lymphocytes develop normally but fail to survive in the periphery. The decreased survival results from both an impaired ability to transmit tonic T cell receptor (TCR) signals and increased levels of Fas, which sensitize Nup210(-/-) naive CD4(+) T cells to Fas-mediated cell death. Mechanistically, Nup210 regulates these processes by modulating the expression of Cav2 (encoding Caveolin-2) and Jun at the nuclear periphery. Whereas the TCR-dependent and CD4(+) T cell-specific upregulation of Cav2 is critical for proximal TCR signaling, cJun expression is required for STAT3-dependent repression of Fas. Our results uncover an unexpected role for Nup210 as a cell-intrinsic regulator of TCR signaling and T cell homeostasis and expose NPCs as key players in the adaptive immune system.	[Borlido, Joana; Sakuma, Stephen; Raices, Marcela; D'Angelo, Maximiliano A.] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA; [Borlido, Joana; Sakuma, Stephen; Raices, Marcela; Carrette, Florent; Tinoco, Roberto; Bradley, Linda M.; D'Angelo, Maximiliano A.] NCI Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Carrette, Florent; Tinoco, Roberto; Bradley, Linda M.; D'Angelo, Maximiliano A.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	D'Angelo, MA (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.; D'Angelo, MA (corresponding author), NCI Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.; D'Angelo, MA (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	mdangelo@sbpdiscovery.org	Sakuma, Stephen/AAH-1880-2020	Sakuma, Stephen/0000-0002-0779-5139; Sarabando Borlido, Joana/0000-0003-2622-0901; D'Angelo, Maximiliano/0000-0001-7025-0142; Tinoco, Roberto/0000-0001-5420-9692; Bradley, Linda/0000-0002-8697-8565	American Heart Association Award [15POST22600000]; SBP Fishman Fund Fellowship; Pew Biomedical Science Scholar Award from the American Cancer Society [RSG-17-148-01-CCG]; American Cancer Society [RSG-17-148-01-CCG]; National Institutes of Health [RO1AR065083, RO1AR065083-S1]; NCI Cancer Center [P30 CA030199]; Waitt Advanced Biophotonics Core Facility of the Salk Institute; NIH-NCI [CCSG: P30 014195]; NINDS Neuroscience Core Grant; Waitt Foundation; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065083] Funding Source: NIH RePORTER	American Heart Association Award(American Heart Association); SBP Fishman Fund Fellowship; Pew Biomedical Science Scholar Award from the American Cancer Society; American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Waitt Advanced Biophotonics Core Facility of the Salk Institute; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS Neuroscience Core Grant; Waitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. E. Samelson (National Institutes of Health) for kindly providing the SLP-76-EYFP cell line and M. Hetzer (Salk Institute) for kindly providing the anti-Nup107 antibody. J.B. was supported by American Heart Association Award 15POST22600000 and an SBP Fishman Fund Fellowship. M.A.D. was supported by a Pew Biomedical Science Scholar Award and Research Scholar Grant RSG-17-148-01-CCG from the American Cancer Society. This work was also supported by the National Institutes of Health (awards RO1AR065083 and RO1AR065083-S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was additionally supported by the NCI Cancer Center grant P30 CA030199, which supports the animal, flow cytometry, genomics, and bioinformatics cores at the SBP La Jolla campus. The electron microscopy work was supported by the Waitt Advanced Biophotonics Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 014195, an NINDS Neuroscience Core Grant and the Waitt Foundation.	Aghajani K, 2012, GENESIS, V50, P908, DOI 10.1002/dvg.22052; Au-Yeung BB, 2014, P NATL ACAD SCI USA, V111, pE3679, DOI 10.1073/pnas.1413726111; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Cho JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13373; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; D'Urso A, 2017, CURR GENET, V63, P435, DOI 10.1007/s00294-016-0661-8; Faria AMC, 2006, IMMUNITY, V24, P295, DOI 10.1016/j.immuni.2006.01.014; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gabriel CH, 2016, J BIOL CHEM, V291, P24172, DOI 10.1074/jbc.M116.739326; GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x; Gu YN, 2016, CELL, V166, P1526, DOI 10.1016/j.cell.2016.07.042; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lapetina DL, 2017, J CELL BIOL, V216, P3145, DOI 10.1083/jcb.201609049; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Liu HB, 2015, MOL CELL, V59, P840, DOI 10.1016/j.molcel.2015.07.015; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Moreira TG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17655; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; Olsson M, 2004, EXP CELL RES, V292, P359, DOI 10.1016/j.yexcr.2003.09.014; Pascual-Garcia P, 2017, MOL CELL, V66, P63, DOI 10.1016/j.molcel.2017.02.020; Raices M, 2017, DEV CELL, V41, P540, DOI 10.1016/j.devcel.2017.05.007; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Sandberg Y, 2007, LEUKEMIA, V21, P230, DOI 10.1038/sj.leu.2404486; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Schonle A, 2016, BLOOD, V127, P1930, DOI 10.1182/blood-2015-09-672428; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tomassian T, 2011, J IMMUNOL, V187, P2993, DOI 10.4049/jimmunol.1101447; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yewdell WT, 2011, MOL BIOL CELL, V22, P1375, DOI 10.1091/mbc.E10-06-0554; Yu JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7074	56	24	25	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					594	+		10.1038/s41590-018-0103-5	http://dx.doi.org/10.1038/s41590-018-0103-5			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29736031	Green Accepted, Green Submitted			2022-12-18	WOS:000433041500025
J	Xia, PY; Wang, S; Xiong, Z; Zhu, XX; Ye, BQ; Du, Y; Meng, S; Qu, Y; Liu, J; Gao, GX; Tian, Y; Fan, ZS				Xia, Pengyan; Wang, Shuo; Xiong, Zhen; Zhu, Xiaoxiao; Ye, Buqing; Du, Ying; Meng, Shu; Qu, Yuan; Liu, Jing; Gao, Guangxia; Tian, Yong; Fan, Zusen			The ER membrane adaptor ERAdP senses the bacterial second messenger c-di-AMP and initiates anti-bacterial immunity	NATURE IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; LISTERIA-MONOCYTOGENES INFECTION; ENDOPLASMIC-RETICULUM ADAPTER; I IFN PRODUCTION; INNATE IMMUNITY; DNA SENSOR; CYTOSOLIC DNA; ANTIVIRAL IMMUNITY; ACTIVATION; PATHWAY	Cyclic diadenylate monophosphate (c-di-AMP) is secreted by bacteria as a secondary messenger. How immune cells detect c-di-AMP and initiate anti-bacterial immunity remains unknown. We found that the endoplasmic reticulum (ER) membrane adaptor ERAdP acts as a direct sensor for c-di-AMP. ERAdP-deficient mice were highly susceptible to Listeria monocytogenes infection and exhibited reduced pro-inflammatory cytokines. Mechanistically, c-di-AMP bound to the C-terminal domain of ERAdP, which in turn led to dimerization of ERAdP, resulting in association with and activation of the kinase TAK1. TAK1 activation consequently initiated activation of the transcription factor NF-kappa B to induce the production of pro-inflammatory cytokines in innate immune cells. Moreover, double-knockout of ERAdP and TAK1 resulted in heightened susceptibility to L. monocytogenes infection. Thus, ERAdP-mediated production of pro-inflammatory cytokines is critical for controlling bacterial infection.	[Xia, Pengyan; Wang, Shuo; Xiong, Zhen; Ye, Buqing; Du, Ying; Qu, Yuan; Liu, Jing; Gao, Guangxia; Fan, Zusen] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab Infect & Immun CAS, Beijing, Peoples R China; [Xiong, Zhen; Qu, Yuan; Liu, Jing; Gao, Guangxia; Tian, Yong; Fan, Zusen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xiaoxiao; Meng, Shu; Tian, Yong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol CAS, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab Infect & Immun CAS, Beijing, Peoples R China.; Tian, Y; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Tian, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol CAS, Beijing, Peoples R China.	ytian@ibp.ac.cn; fanz@moon.ibp.ac	TIAN, YONG/ABF-4406-2021; Zhu, Xiaoxiao/AAD-1561-2019; TIAN, YONG/L-2414-2019	TIAN, YONG/0000-0002-8790-1148	National Natural Science Foundation of China [91640203, 31530093, 31429001, 81601361, 31770939, 31570872, 81722023, 31671531, 31471386, 8157243, 81772646, 31601189]; Chinese Academy of Sciences [XDB19030203]; Youth Innovation Promotion Association of CAS; China Postdoctoral Science Foundation [2015M571141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of CAS; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank J. Jia and Y. Teng for technical support; D. Zhou (Xiamen University) for Vav-Cre mice; J. Bennink (National Institute of Allergy and Infectious Diseases) for VSV and VACV viral strains; H. Peng (Institute of Biophysics, Chinese Academy of Sciences) for Vero cells and herpes simplex virus strain HSV-1f; and D. Fan for mouse model preparation. Supported by the National Natural Science Foundation of China (91640203, 31530093 and 31429001 to Z.F.; 81601361, 31770939 and 31570872 to P.X.; 81722023, 31671531 and 31471386 to S.W.; 8157243 and 81772646 to Y.T.; and 31601189 to X.Z.), the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDB19030203 to Z.F.). Youth Innovation Promotion Association of CAS (to S.W.) and the China Postdoctoral Science Foundation (2015M571141 to P.X.).	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chen J, 2015, J IMMUNOL, V194, P1292, DOI 10.4049/jimmunol.1402593; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Dancz CE, 2002, J BACTERIOL, V184, P5935, DOI 10.1128/JB.184.21.5935-5945.2002; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; McFarland AP, 2017, IMMUNITY, V46, P433, DOI 10.1016/j.immuni.2017.02.014; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Orzalli MH, 2014, ANNU REV MICROBIOL, V68, P477, DOI 10.1146/annurev-micro-091313-103409; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Surpris G, 2016, J IMMUNOL, V196, P547, DOI 10.4049/jimmunol.1501415; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Whiteley AT, 2015, CELL HOST MICROBE, V17, P788, DOI 10.1016/j.chom.2015.05.006; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia PY, 2016, PROTEIN CELL, V7, P777, DOI 10.1007/s13238-016-0320-3; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xia PY, 2015, J EXP MED, V212, P2305, DOI 10.1084/jem.20150618; Xia PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9132; Xia PY, 2015, NAT IMMUNOL, V16, P366, DOI 10.1038/ni.3117; Xia PY, 2014, J EXP MED, V211, P2119, DOI 10.1084/jem.20140169; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	50	24	30	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					141	+		10.1038/s41590-017-0014-x	http://dx.doi.org/10.1038/s41590-017-0014-x			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29292386				2022-12-18	WOS:000423435200014
J	Culshaw, A; Ladell, K; Gras, S; McLaren, JE; Miners, KL; Farenc, C; van den Heuvel, H; Gostick, E; Dejnirattisai, W; Wangteeraprasert, A; Duangchinda, T; Chotiyarnwong, P; Limpitikul, W; Vasanawathana, S; Malasit, P; Dong, T; Rossjohn, J; Mongkolsapaya, J; Price, DA; Screaton, GR				Culshaw, Abigail; Ladell, Kristin; Gras, Stephanie; McLaren, James E.; Miners, Kelly L.; Farenc, Carine; van den Heuvel, Heleen; Gostick, Emma; Dejnirattisai, Wanwisa; Wangteeraprasert, Apirath; Duangchinda, Thaneeya; Chotiyarnwong, Pojchong; Limpitikul, Wannee; Vasanawathana, Sirijitt; Malasit, Prida; Dong, Tao; Rossjohn, Jamie; Mongkolsapaya, Juthathip; Price, David A.; Screaton, Gavin R.			Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8(+) T cell response	NATURE IMMUNOLOGY			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; HEMORRHAGIC-FEVER; DISEASE SEVERITY; SHOCK SYNDROME; ETHNIC THAIS; HLA-B; RECEPTOR; INFECTIONS; RECOGNITION	Adaptive immune responses protect against infection with dengue virus (DENV), yet cross-reactivity with distinct serotypes can precipitate life-threatening clinical disease. We found that clonotypes expressing the T cell antigen receptor (TCR) beta-chain variable region 11 (TRBV11-2) were 'preferentially' activated and mobilized within immunodominant human-leukocyteantigen (HLA) A* 11: 01-restricted CD8(+) T cell populations specific for variants of the nonstructural protein epitope NS3(133) that characterize the serotypes DENV1, DENV3 and DENV4. In contrast, the NS3(133)-DENV2-specific repertoire was largely devoid of such TCRs. Structural analysis of a representative TRBV11-2(+) TCR demonstrated that cross-serotype reactivity was governed by unique interplay between the variable antigenic determinant and germline-encoded residues in the second beta-chain complementarity-determining region (CDR2 beta). Extensive mutagenesis studies of three distinct TRBV11-2+ TCRs further confirmed that antigen recognition was dependent on key contacts between the serotype-defined peptide and discrete residues in the CDR2 beta loop. Collectively, these data reveal an innate-like mode of epitope recognition with potential implications for the outcome of sequential exposure to heterologous DENVs.	[Culshaw, Abigail; Dejnirattisai, Wanwisa; Wangteeraprasert, Apirath; Chotiyarnwong, Pojchong; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, London, England; [Ladell, Kristin; McLaren, James E.; Miners, Kelly L.; Gostick, Emma; Rossjohn, Jamie; Price, David A.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales; [Gras, Stephanie; Farenc, Carine; van den Heuvel, Heleen; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Clayton, Vic, Australia; [Gras, Stephanie; Farenc, Carine; van den Heuvel, Heleen; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Gras, Stephanie; Farenc, Carine; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Duangchinda, Thaneeya] Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Limpitikul, Wannee] Songkhla Hosp, Minist Publ Hlth, Pediat Dept, Songkhla, Thailand; [Vasanawathana, Sirijitt] Khon Kaen Hosp, Minist Publ Hlth, Pediat Dept, Khon Kaen, Thailand; [Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dengue Hemorrhag Fever Res Unit,Off Res & Dev, Bangkok, Thailand; [Dong, Tao] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford, England; [Price, David A.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Wangteeraprasert, Apirath; Chotiyarnwong, Pojchong] Naresuan Univ, Phitsanulok, Thailand; [Chotiyarnwong, Pojchong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Orthopaed Surg, Bangkok, Thailand	Imperial College London; Cardiff University; Monash University; Monash University; Monash University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naresuan University; Mahidol University	Mongkolsapaya, J; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, London, England.; Rossjohn, J; Price, DA (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales.; Rossjohn, J (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dengue Hemorrhag Fever Res Unit,Off Res & Dev, Bangkok, Thailand.; Price, DA (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD USA.	jamie.rossjohn@monash.edu; j.mongkolsapaya@imperial.ac.uk; priced6@cardiff.ac.uk; g.screaton@imperial.ac.uk	Miners, Kelly/AAC-6903-2020; Rossjohn, Jamie/F-9032-2013; Price, David A/C-7876-2013; chotiyarnwong, pojchong/GPX-3849-2022; chotiyarnwong, pojchong/AAC-8700-2021; Ladell, Kristin/C-8301-2013	Rossjohn, Jamie/0000-0002-2020-7522; Price, David A/0000-0001-9416-2737; Ladell, Kristin/0000-0002-9856-2938; McLaren, James/0000-0002-7021-5934; Screaton, Gavin/0000-0002-3549-4309; gras, stephanie/0000-0001-7416-038X; Dong, Tao/0000-0003-3545-3758; Farenc, Carine/0000-0001-6383-3032	Australian Research Council; National Health and Medical Research Council; National Institute for Health Research; Thailand National Centre for Genetic Engineering and Biotechnology; Thailand Tropical Disease Research Program T2; Wellcome Trust; MRC [G1001046, G0600520, MR/L018942/1, G0801508, G0600000] Funding Source: UKRI; Medical Research Council [G0801508, MR/L018942/1, G1001046, G0600520, G0600000] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR)); Thailand National Centre for Genetic Engineering and Biotechnology; Thailand Tropical Disease Research Program T2; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank N. Tangthawornchaikul for management of the clinical database; K. Campbell, H. Halim, A. Nguyen and staff at the Monash Macromolecular Crystallization Facility for technical support; and staff at the Australian Synchrotron for assistance with data collection. Supported by the Australian Research Council (S.G. and J.R.), the National Health and Medical Research Council, the National Institute for Health Research, the Thailand National Centre for Genetic Engineering and Biotechnology, the Thailand Tropical Disease Research Program T2 and the Wellcome Trust (D.A.P. and G.R.S.).	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Alvarez M, 2006, AM J TROP MED HYG, V75, P1113, DOI 10.4269/ajtmh.2006.75.1113; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Chandanayingyong D, 1997, HUM IMMUNOL, V53, P174, DOI 10.1016/S0198-8859(96)00284-4; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61; Gras S, 2016, IMMUNITY, V45, P749, DOI 10.1016/j.immuni.2016.09.007; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Jirakanjanakit N, 1997, T ROY SOC TROP MED H, V91, P614, DOI 10.1016/S0035-9203(97)90050-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581; MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; MORENS DM, 1987, J MED VIROL, V22, P163, DOI 10.1002/jmv.1890220207; Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Quigley Maire F, 2011, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1033s94; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reid SW, 1996, FEBS LETT, V383, P119, DOI 10.1016/0014-5793(96)00226-8; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Vejbaesya S, 2015, J INFECT DIS, V212, P939, DOI 10.1093/infdis/jiv127; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; World Health Organization, 1997, DENG HAEM FEV DIAGN; Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228; Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	56	24	24	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1228	+		10.1038/ni.3850	http://dx.doi.org/10.1038/ni.3850			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28945243	Green Accepted, Green Submitted			2022-12-18	WOS:000413457300009
J	Hunter, CA; Jones, SA				Hunter, Christopher A.; Jones, Simon A.			IL-6 as a keystone cytokine in health and disease (vol 16, pg 448, 2015)	NATURE IMMUNOLOGY			English	Correction																		Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153	1	24	24	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1271	1271		10.1038/ni1117-1271b	http://dx.doi.org/10.1038/ni1117-1271b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044237	Bronze			2022-12-18	WOS:000413457300018
J	Babdor, J; Descamps, D; Adiko, AC; Tohme, M; Maschalidi, S; Evnouchidou, I; Vasconcellos, LR; De Luca, M; Mauvais, FX; Garfa-Traore, M; Brinkmann, MM; Chignard, M; Manoury, B; Saveanu, L				Babdor, Joel; Descamps, Delphyne; Adiko, Aime Cezaire; Tohme, Mira; Maschalidi, Sophia; Evnouchidou, Irini; Vasconcellos, Luiz Ricardo; De Luca, Mariacristina; Mauvais, Francois-Xavier; Garfa-Traore, Meriem; Brinkmann, Melanie M.; Chignard, Michel; Manoury, Benedicte; Saveanu, Loredana			IRAP(+) endosomes restrict TLR9 activation and signaling	NATURE IMMUNOLOGY			English	Article							RECEPTOR 9; CROSS-PRESENTATION; DENDRITIC CELLS; TRAFFICKING; PROTEIN; COMPARTMENT; CLEAVAGE; FORMINS; ALPHA; DNA	The retention of intracellular Toll-like receptors (TLRs) in the endoplasmic reticulum prevents their activation under basal conditions. TLR9 is activated by sensing ligands in specific endosomal-lysosomal compartments. Here we identified IRAP(+) endosomes as major cellular compartments for the early steps of TLR9 activation in dendritic cells (DCs). Both TLR9 and its ligand, the dinucleotide CpG, were present as cargo in IRAP(+) endosomes. In the absence of the aminopeptidase IRAP, the trafficking of CpG and TLR9 to lysosomes and signaling via TLR9 were enhanced in DCs and in mice following bacterial infection. IRAP stabilized CpG-containing endosomes by interacting with the actin-nucleation factor FHOD4, which slowed the trafficking of TLR9 toward lysosomes. Thus, endosomal retention of TLR9 via the interaction of IRAP with the actin cytoskeleton is a mechanism that prevents hyper-activation of TLR9 in DCs.	[Babdor, Joel; Descamps, Delphyne; Tohme, Mira; Maschalidi, Sophia; Vasconcellos, Luiz Ricardo; Mauvais, Francois-Xavier; Garfa-Traore, Meriem; Manoury, Benedicte] INSERM, Unite 1151, Paris, France; [Babdor, Joel; Descamps, Delphyne; Tohme, Mira; Maschalidi, Sophia; Vasconcellos, Luiz Ricardo; Mauvais, Francois-Xavier; Garfa-Traore, Meriem; Manoury, Benedicte] CNRS, Unite 8253, Paris, France; [Babdor, Joel; Descamps, Delphyne; Tohme, Mira; Maschalidi, Sophia; Vasconcellos, Luiz Ricardo; Mauvais, Francois-Xavier; Garfa-Traore, Meriem; Manoury, Benedicte] Univ Paris 05, Sorbonne Paris Cite, Fac Med Paris Descartes, Paris, France; [Descamps, Delphyne] Univ Paris Saclay, INRA, VIM, Jouy En Josas, France; [Adiko, Aime Cezaire; Evnouchidou, Irini; De Luca, Mariacristina; Saveanu, Loredana] Ctr Rech Inflammat, Unite UMR 1149, INSERM, Paris, France; [Adiko, Aime Cezaire; Evnouchidou, Irini; De Luca, Mariacristina; Saveanu, Loredana] Univ Paris Diderot, Fac Med Xavier Bichat, Paris, France; [Tohme, Mira] Harvard Med Sch, Dept Pediat, Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Maschalidi, Sophia] INSERM, UMR1163, Lab Normal & Pathol Homeostasis Immune Syst, Paris, France; [Vasconcellos, Luiz Ricardo] Univ Fed Rio de Janeiro, Inst Microbiologia Paulo de Goes, Lab Inflamacao & Imunidade, Rio De Janeiro, Brazil; [Brinkmann, Melanie M.] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Chignard, Michel] CDR St Antoine, UMR S 938, INSERM, Paris, France; [Chignard, Michel] UPMC Univ Paris 06, CDR St Antoine, UMR S 938, Sorbonne Univ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal do Rio de Janeiro; Helmholtz Association; Helmholtz-Center for Infection Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Manoury, B (corresponding author), INSERM, Unite 1151, Paris, France.; Manoury, B (corresponding author), CNRS, Unite 8253, Paris, France.; Manoury, B (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med Paris Descartes, Paris, France.; Saveanu, L (corresponding author), Ctr Rech Inflammat, Unite UMR 1149, INSERM, Paris, France.; Saveanu, L (corresponding author), Univ Paris Diderot, Fac Med Xavier Bichat, Paris, France.	benedicte.manoury@inserm.fr; loredana.saveanu@inserm.fr	Evnouchidou, Irini/Z-3072-2019; SAVEANU, Loredana/Q-1241-2019; Saveanu, Loredana/K-6821-2017; Mauvais, François-Xavier/AAA-4989-2019	SAVEANU, Loredana/0000-0003-3138-7968; Mauvais, François-Xavier/0000-0002-5240-4280; /0000-0002-3877-7013; Manoury, Benedicte/0000-0001-7784-3389; GARFA TRAORE, Meriem/0000-0001-8597-6472; Adiko, Aime Cezaire/0000-0001-8618-926X	'Agence Nationale de Recherche' (ANR IRAPDC) [ANR-15-CE15-0005, ANR 2010 MIDI 008 01]; Fondation pour la Recherche Medicale; Institut Curie; Initiative and Networking Fund of the Helmholtz Association [VH-NG-637]; 'ARC pour la Recherche sur le cancer'	'Agence Nationale de Recherche' (ANR IRAPDC)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut Curie; Initiative and Networking Fund of the Helmholtz Association; 'ARC pour la Recherche sur le cancer'	We thank S. Lory (Harvard Medical School) for P. aeruginosa strain PAK; S. Keller (University of Virginia) for IRAP-deficient mice and rabbit anti-IRAP; D. Billadeau (Mayo Clinic College of Medicine) for rabbit polyclonal anti-FHOD4 and anti-FHOD1; F. Benvenutti (International Centre for Genetic Engineering and Biotechnology, Trieste) for the VAMP3-GFP plasmid; F. Perez (Curie Institut, Paris) for the pmCherry plasmid; S. Blystone (SUNY Upstate Medical University) for the FHOD4-GFP plasmid; N. Goudin and S. Benadda for advice on analysis and quantification of confocal microscopy images; and 'ARC pour la Recherche sur le cancer' for acquisition of the Leica SP8 confocal microscope. Supported by the 'Agence Nationale de Recherche' (ANR IRAPDC; ANR-15-CE15-0005 to L.S.; ANR 2010 MIDI 008 01 to B.M.; and post-doctoral support for D. D.), Fondation pour la Recherche Medicale (A.C.A.), Institut Curie (M.T.), the Initiative and Networking Fund of the Helmholtz Association (VH-NG-637 to M.M.B.) and 'ARC pour la Recherche sur le cancer' (J.B. and S.M.).	Acharya M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10917; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; BenMohamed F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090466; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Cheng H, 2014, J INVEST DERMATOL, V134, P359, DOI 10.1038/jid.2013.317; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hayashi K, 2015, INT IMMUNOL, V27, P435, DOI 10.1093/intimm/dxv021; Hazeki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073894; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hipp MM, 2013, IMMUNITY, V39, P711, DOI 10.1016/j.immuni.2013.09.004; Hirata Y, 2011, BIOCHEM BIOPH RES CO, V405, P96, DOI 10.1016/j.bbrc.2010.12.134; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee BL, 2014, TRENDS CELL BIOL, V24, P360, DOI 10.1016/j.tcb.2013.12.002; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Leuchowius K. J., 2011, CURRENT PROTOCOLS CY; Maschalidi S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002841; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Prete F, 2013, J EXP MED, V210, P355, DOI 10.1084/jem.20120363; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Saveanu L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00057; Saveanu L, 2009, SCIENCE, V325, P213, DOI 10.1126/science.1172845; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Tojo H, 2003, MOL ENDOCRINOL, V17, P1216, DOI 10.1210/me.2003-0056; Weimershaus M, 2012, J IMMUNOL, V188, P1840, DOI 10.4049/jimmunol.1101504; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324	42	24	26	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					509	518		10.1038/ni.3711	http://dx.doi.org/10.1038/ni.3711			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28319098	Green Submitted			2022-12-18	WOS:000399378700008
J	Vieth, JA; Das, J; Ranaivoson, FM; Comoletti, D; Denzin, LK; Sant'Angelo, DB				Vieth, Joshua A.; Das, Joy; Ranaivoson, Fanomezana M.; Comoletti, Davide; Denzin, Lisa K.; Sant'Angelo, Derek B.			TCR alpha-TCR beta pairing controls recognition of CD1d and directs the development of adipose NKT cells	NATURE IMMUNOLOGY			English	Article							RECEPTOR; CERAMIDE; ANTIGENS; BIOLOGY	The interaction between the T cell antigen receptor (TCR) expressed by natural killer T cells (NKT cells) and the antigen-presenting molecule CD1d is distinct from interactions between the TCR and major histocompatibility complex (MHC). Our molecular modeling suggested that a hydrophobic patch created after TCR alpha-TCR beta pairing has a role in maintaining the conformation of the NKT cell TCR. Disruption of this patch ablated recognition of CD1d by the NKT cell TCR but not interactions of the TCR with MHC. Partial disruption of the patch, while permissive to the recognition of CD1d, significantly altered NKT cell development, which resulted in the selective accumulation of adipose-tissue-resident NKT cells. These results indicate that a key component of the TCR is essential for the development of a distinct population of NKT cells.	[Vieth, Joshua A.; Ranaivoson, Fanomezana M.; Comoletti, Davide; Denzin, Lisa K.; Sant'Angelo, Derek B.] Rutgers State Univ, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Vieth, Joshua A.; Ranaivoson, Fanomezana M.; Comoletti, Davide; Denzin, Lisa K.; Sant'Angelo, Derek B.] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA; [Das, Joy] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Comoletti, Davide] Rutgers State Univ, Dept Neurosci & Cell Biol, New Brunswick, NJ USA; [Denzin, Lisa K.; Sant'Angelo, Derek B.] Rutgers State Univ, Rutgers Grad Sch Biomed Sci, New Brunswick, NJ 08901 USA; [Denzin, Lisa K.; Sant'Angelo, Derek B.] Rutgers State Univ, Dept Pediat, New Brunswick, NJ 08901 USA; [Denzin, Lisa K.; Sant'Angelo, Derek B.] Rutgers State Univ, Dept Pharmacol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sant'Angelo, DB (corresponding author), Rutgers State Univ, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA.; Sant'Angelo, DB (corresponding author), Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.; Sant'Angelo, DB (corresponding author), Rutgers State Univ, Rutgers Grad Sch Biomed Sci, New Brunswick, NJ 08901 USA.; Sant'Angelo, DB (corresponding author), Rutgers State Univ, Dept Pediat, New Brunswick, NJ 08901 USA.; Sant'Angelo, DB (corresponding author), Rutgers State Univ, Dept Pharmacol, New Brunswick, NJ 08901 USA.	santandb@rwjms.rutgers.edu		Vieth, Joshua/0000-0001-8756-2759; Ranaivoson, Fanomezana Moutse/0000-0001-5599-2682	NIAID of the US National Institutes of Health [R01 AI083988, AI059739]; NIMH of the US National Institutes of Health [MH092906, NSF BRAIN EAGER MCB-1450895]; New Jersey Commission on Cancer Research Fellowship; Robert Wood Johnson Foundation [67038]; Century for the Cure (Fellowship in Translational Immunology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059739, R01AI083988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092906] Funding Source: NIH RePORTER	NIAID of the US National Institutes of Health; NIMH of the US National Institutes of Health; New Jersey Commission on Cancer Research Fellowship; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Century for the Cure (Fellowship in Translational Immunology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Osorio for technical assistance; R. Worth and V. Shapiro for review of the manuscript; A. Roberts for cell sorting; A. Laouar (Rutgers University) for the Rag1<SUP>-/-</SUP> mice; the late C. Janeway (Yale University School of Medicine) for the 4G4 cell line; T. Novak (Yale University) for the pMCFR vector; and the US National Institutes of Health Tetramer Core for the CD1d-PBS57 and CD1d-OCH tetramer reagents. Supported by the NIAID of the US National Institutes of Health (R01 AI083988 and AI059739 to D.B.S.), the NIMH of the US National Institutes of Health (MH092906 and NSF BRAIN EAGER MCB-1450895 to D.C.), the New Jersey Commission on Cancer Research Fellowship and Century for the Cure (Fellowship in Translational Immunology to J.A.V.) and by the Robert Wood Johnson Foundation (67038 to the Child Health Institute of New Jersey).	BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Dao T, 2004, EUR J IMMUNOL, V34, P3542, DOI 10.1002/eji.200425546; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Martin-Murphy BV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0080949, 10.1371/journal.pone.0103352, 10.1371/journal.pone.0109166]; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Rakhshandehroo M, 2014, J BIOL CHEM, V289, P22128, DOI 10.1074/jbc.M114.551242; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yang WH, 2011, INVEST OPHTH VIS SCI, V52, P3094, DOI 10.1167/iovs.10-7067; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005	30	24	25	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					36	44		10.1038/ni.3622	http://dx.doi.org/10.1038/ni.3622			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27869818				2022-12-18	WOS:000390080000008
J	Hagglof, T; Sedimbi, SK; Yates, JL; Parsa, R; Salas, BH; Harris, RA; Leadbetter, EA; Karlsson, MCI				Hagglof, Thomas; Sedimbi, Saikiran K.; Yates, Jennifer L.; Parsa, Roham; Salas, Briana Hauff; Harris, Robert A.; Leadbetter, Elizabeth A.; Karlsson, Mikael C. I.			Neutrophils license iNKT cells to regulate self reactive mouse B cell responses	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NKT CELLS; ACTIVATION; IMMUNITY; IL-18; IDENTIFICATION; INNATE	The innate responsiveness of the immune system is important not only for quick responses to pathogens but also for the initiation and shaping of the subsequent adaptive immune response. Activation via the cytokine IL-18, a product of inflammasomes, gives rise to a rapid response that includes the production of self-reactive antibodies. As increased concentrations of this cytokine are found in inflammatory diseases, we investigated the origin of the B cell response and its regulation. We identified an accumulation of B cell helper neutrophils in the spleen that interacted with innate-type invariant natural killer T cells (iNKT cells) to regulate B cell responses. We found that neutrophil-dependent expression of the death-receptor ligand FasL by iNKT cells was needed to restrict autoantibody production. Neutrophils can thus license MKT cells to regulate potentially harmful autoreactive B cell responses during inflammasome-driven inflammation.	[Hagglof, Thomas; Sedimbi, Saikiran K.; Karlsson, Mikael C. I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Yates, Jennifer L.; Leadbetter, Elizabeth A.] Trudeau Inst, Saranac Lake, NY USA; [Parsa, Roham; Harris, Robert A.] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, Solna, Sweden; [Salas, Briana Hauff; Leadbetter, Elizabeth A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA	Karolinska Institutet; Trudeau Institute; Karolinska Institutet; Karolinska University Hospital; University of Texas System; University of Texas Health San Antonio	Karlsson, MCI (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden.	mikael.karlsson@ki.se	Harris, Robert A./I-6234-2019; Parsa, Roham/AHA-7145-2022; Parsa, Roham/AAV-4002-2021	Harris, Robert A./0000-0003-4990-509X; Parsa, Roham/0000-0002-0864-6098; Parsa, Roham/0000-0002-0864-6098; Sedimbi, Saikiran/0000-0001-5243-8395; Yates, Jennifer/0000-0001-8841-9401; Hagglof, Thomas/0000-0002-7751-0928; Karlsson, Mikael/0000-0001-5582-614X	Swedish Research Council; Center for Allergy Research Karolinska Institutet; Swedish Medical Society; King Gustaf V's 80-year Foundation; Magnus Bergvall Foundation; Karolinska Institutet; Erik and Edith Fernstrom foundation; Swedish Society for Medical Research; Centre for Allergy Research; Ellen, Walter and Lennart Hesselman foundation; O.E. and Edla Johansson's Foundation; Tore Nilsson's foundation; Karolinska Institutet's foundations; US National Institutes of Health [AI104788-01A1]; Trudeau Institute; University of Texas Health Science Center at San Antonio	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Allergy Research Karolinska Institutet(Karolinska Institutet); Swedish Medical Society; King Gustaf V's 80-year Foundation; Magnus Bergvall Foundation; Karolinska Institutet(Karolinska Institutet); Erik and Edith Fernstrom foundation; Swedish Society for Medical Research; Centre for Allergy Research; Ellen, Walter and Lennart Hesselman foundation; O.E. and Edla Johansson's Foundation; Tore Nilsson's foundation; Karolinska Institutet's foundations(Karolinska Institutet); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trudeau Institute; University of Texas Health Science Center at San Antonio	We thank M. Tighe, A. Dublin, E. Lind and P. Lanthier for technical assistance; M. Winerdal for illustrations; the US National Institutes of Health tetramer core facility for CD1d tetramers; M. Johansson and P. Hoglund (Karolinska Institutet) for iNKT cell-deficient C57BL/6 Cd1d1<SUP>-/-</SUP> mice and C57BL/6 Traj18<SUP>-/-</SUP> mice backcrossed for more than ten generations; and S. Smiley (Trudeau Institute) for Pad4<SUP>-/-</SUP> mice on a BALB/c background. Supported by the Swedish Research Council, The Center for Allergy Research Karolinska Institutet, The Swedish Medical Society, King Gustaf V's 80-year Foundation, the Magnus Bergvall Foundation, the Karolinska Institutet (M.C.I.K.), the Erik and Edith Fernstrom foundation, the Swedish Society for Medical Research, the Centre for Allergy Research, the Ellen, Walter and Lennart Hesselman foundation (T.H.), O.E. and Edla Johansson's Foundation, Tore Nilsson's foundation, Karolinska Institutet's foundations (S.K.S.), the US National Institutes of Health (AI104788-01A1 to E.A.L.), the Trudeau Institute and the University of Texas Health Science Center at San Antonio (E.A.L.).	Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Birkholz AM, 2015, J BIOL CHEM, V290, P20746, DOI 10.1074/jbc.A115.647057; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Bosch X, 2011, NEW ENGL J MED, V365, P758, DOI 10.1056/NEJMcibr1107085; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Coquery CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102284; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Donadieu J, 2013, HEMATOL ONCOL CLIN N, V27, P1, DOI 10.1016/j.hoc.2012.11.003; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Enoksson SL, 2011, P NATL ACAD SCI USA, V108, pE1399, DOI 10.1073/pnas.1107830108; Figgett WA, 2013, IMMUNITY, V39, P573, DOI 10.1016/j.immuni.2013.05.019; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Green MRJ, 2007, ARTHRITIS RHEUM-US, V56, P303, DOI 10.1002/art.22326; Hostetter SJ, 2012, VET CLIN N AM-SMALL, V42, P157, DOI 10.1016/j.cvsm.2011.09.010; Jonsson F, 2013, J LEUKOCYTE BIOL, V94, P643, DOI 10.1189/jlb.1212623; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; King IL, 2013, J IMMUNOL, V191, P572, DOI 10.4049/jimmunol.1300299; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Parsa R, 2016, J EXP MED, V213, P1537, DOI 10.1084/jem.20150577; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Sedimbi SK, 2013, CELL MOL LIFE SCI, V70, P4795, DOI 10.1007/s00018-013-1425-y; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tanaka T, 2001, INT ARCH ALLERGY IMM, V125, P236, DOI 10.1159/000053821; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wermeling F, 2010, J EXP MED, V207, P943, DOI 10.1084/jem.20091314; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wingender G, 2012, J IMMUNOL, V188, P3000, DOI 10.4049/jimmunol.1101273; Wu L, 2009, CURR MOL MED, V9, P4, DOI 10.2174/156652409787314534	43	24	24	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1407	1414		10.1038/ni.3583	http://dx.doi.org/10.1038/ni.3583			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27798616				2022-12-18	WOS:000388056400011
J	Zhang, Y; Su, HC; Lenardo, MJ				Zhang, Yu; Su, Helen C.; Lenardo, Michael J.			Genomics is rapidly advancing precision medicine for immunological disorders	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; IMMUNE DYSREGULATION; INBORN-ERRORS; GERMLINE MUTATIONS; IMMUNODEFICIENCY; GLYCOSYLATION; DEFICIENCY; GUIDELINES; INFECTION; APOPTOSIS	Advances in human genomics, when validated functionally, can lead to new insights into how the immune system works. Notably, previously unknown mechanisms revealed by genomics can lead to the development of precision medicine unanticipated on the basis of phenotype alone.	[Zhang, Yu; Su, Helen C.] NIAID, Human Immunol Dis Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Zhang, Yu; Su, Helen C.; Lenardo, Michael J.] NIAID, Clin Genom Program, NIH, Bethesda, MD 20892 USA; [Zhang, Yu; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhang, Y (corresponding author), NIAID, Human Immunol Dis Unit, Lab Host Def, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lenardo@nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI001059] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Boisson B, 2015, CURR OPIN IMMUNOL, V32, P90, DOI 10.1016/j.coi.2015.01.005; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Chaigne-Delalande B, 2013, SCIENCE, V341, P186, DOI 10.1126/science.1240094; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Haapaniemi EM, 2015, BLOOD, V125, P639, DOI 10.1182/blood-2014-04-570101; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Jing H, 2014, J ALLERGY CLIN IMMUN, V133, P1667, DOI 10.1016/j.jaci.2014.03.025; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Lo B, 2013, J CLIN IMMUNOL, V33, P479, DOI 10.1007/s10875-012-9811-z; Lu W, 2014, CELL, V159, P1578, DOI 10.1016/j.cell.2014.12.001; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021; Oliveira JB, 2007, P NATL ACAD SCI USA, V104, P8953, DOI 10.1073/pnas.0702975104; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Price S, 2014, BLOOD, V123, P1989, DOI 10.1182/blood-2013-10-535393; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	39	24	24	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1001	1004		10.1038/ni.3275	http://dx.doi.org/10.1038/ni.3275			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26382860				2022-12-18	WOS:000361686500001
J	Irish, JM				Irish, Jonathan Michael			Beyond the age of cellular discovery	NATURE IMMUNOLOGY			English	Editorial Material							CYTOMETRY; EXPRESSION; CONTINUUM		[Irish, Jonathan Michael] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Irish, Jonathan Michael] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Irish, JM (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	jonathan.irish@vanderbilt.edu	Irish, Jonathan M/E-1180-2013	Irish, Jonathan M/0000-0001-9428-8866	NCI NIH HHS [R00 CA143231] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R00CA143231] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Van Epps HL, 2006, J EXP MED, V203, P1389, DOI 10.1084/jem.2036fta	11	24	25	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1095	1097		10.1038/ni.3034	http://dx.doi.org/10.1038/ni.3034			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25396342				2022-12-18	WOS:000344841900003
J	Morel, PA; Ross, G				Morel, Penelope A.; Ross, Gillian			The physician scientist: balancing clinical and research duties	NATURE IMMUNOLOGY			English	Article									[Morel, Penelope A.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Ross, Gillian] Univ London, Royal Marsden Hosp, London, England; [Ross, Gillian] Univ London, Inst Canc Res, London, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Marsden NHS Foundation Trust; University of London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Morel, PA (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	morel@pitt.edu	Morel, Penelope Anne/AAI-6239-2020	Morel, Penelope Anne/0000-0002-1743-3676				Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Garrison HH, 2014, FASEB J, V28, P1049, DOI 10.1096/fj.13-241687; Rubio DM, 2011, ACAD MED, V86, P1571, DOI 10.1097/ACM.0b013e31823592fd	3	24	24	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1092	1094		10.1038/ni.3010	http://dx.doi.org/10.1038/ni.3010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25396341				2022-12-18	WOS:000344841900002
J	Ivanov, S; Roy, CR				Ivanov, Stanimir; Roy, Craig R.			NDP52: the missing link between ubiquitinated bacteria and autophagy	NATURE IMMUNOLOGY			English	Editorial Material							SALMONELLA-CONTAINING VACUOLE; INFECTION; CELLS	Mammalian cells ubiquitinate bacteria that erroneously enter the cytosol and target these intruding microbes for destruction by autophagy. New work shows that the protein NDP52 directly binds to ubiquitinated bacteria and facilitates the assembly of an autophagic membrane that surrounds these invaders.	[Ivanov, Stanimir; Roy, Craig R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06520 USA	Yale University	Ivanov, S (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06520 USA.	craig.roy@yale.edu	Ivanov, Stanimir/J-4289-2019	Ivanov, Stanimir/0000-0002-3294-7595; Roy, Craig/0000-0003-4490-440X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048770, R01AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084485] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041699, R01 AI048770, R01 AI048770-09] Funding Source: Medline; NIGMS NIH HHS [F32 GM084485-02, F32 GM084485] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; NODA T, 2009, INT IMMUNOL     0907; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Radtke AL, 2008, CELL MICROBIOL, V10, P2197, DOI 10.1111/j.1462-5822.2008.01199.x; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800	10	24	25	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1137	1139		10.1038/ni1109-1137	http://dx.doi.org/10.1038/ni1109-1137			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19841643	Green Accepted			2022-12-18	WOS:000270955900002
J	Unutmaz, D; Pulendran, B				Unutmaz, Derya; Pulendran, Bali			The gut feeling of T-reg cells: IL-10 is the silver lining during colitis	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE	Regulatory T cells that express the transcription factor Foxp3 are pivotal in suppressing autoimmune responses. A report in this issue describes a key role for interleukin 10 produced by lamina propria macrophages in maintaining Foxp3 expression during inflammatory responses in the intestine.	[Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, Dept Pathol, New York, NY 10016 USA; [Pulendran, Bali] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	New York University; Emory University	Unutmaz, D (corresponding author), NYU, Sch Med, Dept Microbiol, Dept Pathol, New York, NY 10016 USA.	derya@mac.com; bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021					Braat H, 2003, EXPERT OPIN BIOL TH, V3, P725, DOI 10.1517/eobt.3.5.725.21237; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Gasche C, 2000, J CLIN IMMUNOL, V20, P362, DOI 10.1023/A:1006672114184; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	11	24	26	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1141	1143		10.1038/ni1109-1141	http://dx.doi.org/10.1038/ni1109-1141			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19841645				2022-12-18	WOS:000270955900004
J	Rudnicka, D; Schwartz, O				Rudnicka, Dominika; Schwartz, Olivier			Intrusive HIV-1-infected cells	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; B-CELLS; TRANSMISSION; MECHANISM	Macrophages infected with human immunodeficiency virus type 1 emit long intercellular conduits that shuttle the viral protein Nef to bystander B cells, where it impairs cellular function and immunoglobulin class switching.	[Rudnicka, Dominika; Schwartz, Olivier] CNRS, URA3015, Inst Pasteur, Unite Virus & Immunite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Rudnicka, D (corresponding author), CNRS, URA3015, Inst Pasteur, Unite Virus & Immunite, Paris, France.	schwartz@pasteur.fr	Schwartz, Olivier/AAZ-3765-2021	Schwartz, Olivier/0000-0002-0729-1475				Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753	12	24	24	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					933	934		10.1038/ni0909-933	http://dx.doi.org/10.1038/ni0909-933			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19692990				2022-12-18	WOS:000269120900003
J	Philpott, DJ; Girardin, SE				Philpott, Dana J.; Girardin, Stephen E.			Crohn's disease-associated Nod2 mutants reduce IL10 transcription	NATURE IMMUNOLOGY			English	Editorial Material							FRAMESHIFT MUTATION; PEPTIDOGLYCAN; RECOGNITION	The 3020insC mutation in Nod2 is associated with Crohn's disease, but how it influences disease pathogenesis is unknown. A new study shows that the 3020insC mutant protein fails to activate a key transcription factor that drives interleukin 10 expression, resulting in reduced production of this anti-inflammatory cytokine.	[Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	dana.philpott@utoronto.ca						Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	14	24	24	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					455	457		10.1038/ni0509-455	http://dx.doi.org/10.1038/ni0509-455			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19381138				2022-12-18	WOS:000265394400005
J	Stromnes, IM; Goverman, JM				Stromnes, Ingunn M.; Goverman, Joan M.			Osteopontin-induced survival of T cells	NATURE IMMUNOLOGY			English	Editorial Material							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPRESSION	Relapses and exacerbation of clinical symptoms are hallmarks of debilitating autoimmune diseases like multiple sclerosis. Osteopontin-induced survival of autoreactive T cells may be one mechanism underlying the clinical progression of autoimmune disease.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Stromnes, IM (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	goverman@u.washington.edu		Goverman, Joan/0000-0002-7361-9424				Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Berger T, 1997, LAB INVEST, V76, P355; Blom T, 2003, SCIENCE, V299; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394	11	24	26	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					19	20		10.1038/ni0107-19	http://dx.doi.org/10.1038/ni0107-19			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179966				2022-12-18	WOS:000242934400008
J	Han, JH				Han, JH			MyD88 beyond Toll	NATURE IMMUNOLOGY			English	Editorial Material							INTERFERON-GAMMA; INVOLVEMENT; KINASE		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	jhan@scripps.edu	Han, J/G-4671-2010					Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396	11	24	26	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					370	371		10.1038/ni0406-370	http://dx.doi.org/10.1038/ni0406-370			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550203				2022-12-18	WOS:000236171000010
J	Lanzavecchia, A; Sallusto, F				Lanzavecchia, A; Sallusto, F			Lead and follow: the dance of the dendritic cell and T cell	NATURE IMMUNOLOGY			English	Editorial Material							LYMPH-NODES; PRODUCTS; ANTIGEN	The interaction between dendritic cells and T cells is critical for induction of appropriate immune responses. Visualization of their interaction in intact lymph nodes provides insight into the process of generating immunity or tolerance.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch						Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065	10	24	24	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1201	1202		10.1038/ni1204-1201	http://dx.doi.org/10.1038/ni1204-1201			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549117				2022-12-18	WOS:000225353500005
J	Silverstein, AM				Silverstein, AM			The Clonal Selection Theory: what it really is and why modern challenges are misplaced	NATURE IMMUNOLOGY			English	Editorial Material							TOLERANCE; SELF; INDUCTION; RESPONSES; NONSELF; DANGER		Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.	arts@jhmi.edu						[Anonymous], 1984, ANTIBODY ENIGMA; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Breinl F, 1930, H-S Z PHYSIOL CHEM, V192, P45, DOI 10.1515/bchm2.1930.192.1-3.45; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BURNER FM, 1949, PRODUCTION ANTIBODIE; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; BURNET F. M., 1963, P7; Burnet F. M., 1968, CHANGING PATTERNS AT, P206; Burnet F.M., 1959, CLONAL SELECTION THE, P59; Burnet F. Macfarlane, 1941, PRODUCTION ANTIBODIE; BURNET FM, 1967, COLD SPRING HARB SYM, V32, P1; BURNET FM, 1961, SCIENCE, V133, P307, DOI 10.1126/science.133.3449.307; BURNET FM, 1962, INTEGRITY BODY; BURNET FM, 1969, SELF NOT SELF; Burnet FM, 1949, PRODUCTION ANTIBODIE; BURNET FM, 1969, SELF NOT SELF, P30; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; COHEN IR, 1992, IMMUNOL TODAY, V13, P441, DOI 10.1016/0167-5699(92)90071-E; COHEN IR, 2000, COHENS TENDING ADAMS; COHN M, 1994, ANNU REV IMMUNOL, V12, P1; COHN M, 1974, PROGR IMMUNOLOGY 2, V2, P261; Cohn M., 1980, PROGR IMMUNOLOGY, V4, P153; COUTINHO A, 1984, IMMUNOL REV, V79, P151, DOI 10.1111/j.1600-065X.1984.tb00492.x; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; CUNNINGHAM AJ, 1976, GENERATION ANTIBODY; Dreifus C., 1998, NY TIMES        0616, pF4; DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864; Erlich P, 1897, KLIN JB JENA, V6, P299; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; HOOD L, 1970, SCIENCE, V168, P325, DOI 10.1126/science.168.3929.325; Janeway CA, 1996, CURR BIOL, V6, P519, DOI 10.1016/S0960-9822(02)00531-6; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Johnson G., 1996, NY TIMES, p[C, C]; Klein J., 1982, IMMUNOLOGY SCI SELF; Langman RE, 1996, SCAND J IMMUNOL, V44, P544, DOI 10.1046/j.1365-3083.1996.d01-359.x; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medawar PB, 1944, J ANAT, V78, P176; MEDAWAR PB, 1946, BRIT J EXP PATHOL, V27, P9; MEDAWAR PB, 1946, BRIT J EXP PATHOL, V27, P15; MEDAWAR PB, 1945, J ANAT, V79, P157; NOSSAL GJV, 1962, ANNU REV MICROBIOL, V16, P53, DOI 10.1146/annurev.mi.16.100162.000413; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Pennisi E, 1996, SCIENCE, V271, P1665, DOI 10.1126/science.271.5256.1665; Podolsky S.H., 1997, GENERATION DIVERSITY, P369; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; SCHAFFNER KF, 1992, THEOR MED, V13, P175, DOI 10.1007/BF02163627; Silverstein AM, 2000, SEMIN IMMUNOL, V12, P173, DOI 10.1006/smim.2000.0228; Silverstein AM, 1997, IMMUNOL REV, V159, P197, DOI 10.1111/j.1600-065X.1997.tb01016.x; SILVERSTEIN AM, 1991, CELL IMMUNOL, V132, P515, DOI 10.1016/0008-8749(91)90047-F; Silverstein AM, 2002, P EHRLICHS RECEPTOR; Stockinger B, 1996, IMMUNOL TODAY, V17, P249, DOI 10.1016/0167-5699(96)80534-2; SZENBERG A, 1962, BRIT J EXP PATHOL, V43, P129; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; Tauber A.I., 1994, IMMUNE SELF THEORY M, P93; TRENTIN JOHN J., 1963, P66; Wilson David, 1971, SCI SELF REPORT NEW; ZINKERNAGEL RM, 1979, ADV IMMUNOL, V27, P1; 1941, PRODUCTION ANTIBODIE; [No title captured]	66	24	25	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					793	796		10.1038/ni0902-793	http://dx.doi.org/10.1038/ni0902-793			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12205463				2022-12-18	WOS:000177694900002
J	Pasqualini, R; McDonald, DM; Arap, W				Pasqualini, R; McDonald, DM; Arap, W			Vascular targeting and antigen presentation	NATURE IMMUNOLOGY			English	Letter							ENDOTHELIAL-CELLS; T-CELLS; DENDRITIC CELLS; LIVER; DIFFERENTIATION		Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco	Pasqualini, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.							Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; BURGER DR, 1981, HUM IMMUNOL, V3, P209, DOI 10.1016/0198-8859(81)90019-7; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; HIRSCHBERG H, 1981, HUM IMMUNOL, V2, P235, DOI 10.1016/0198-8859(81)90015-X; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; MCLEAN JW, 1997, AM J PHYSIOL, V273, P387; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; PASQUALINI R, 2000, PHAGE DISPLAY LAB MA, P1; Pober JS, 1999, IMMUNOL RES, V19, P225, DOI 10.1007/BF02786490; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Thurston G, 1998, J CLIN INVEST, V101, P1401, DOI 10.1172/JCI965; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; WAGNER CR, 1984, IMMUNOBIOLOGY, V168, P453, DOI 10.1016/S0171-2985(84)80130-8	17	24	24	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					567	568		10.1038/89704	http://dx.doi.org/10.1038/89704			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429533				2022-12-18	WOS:000169682100003
J	Silverstein, AM				Silverstein, AM			The lymphocyte in immunology: from James B. Murphy to James L. Gowans	NATURE IMMUNOLOGY			English	Editorial Material									Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.	arts@jhmi.edu						Amos Bernard, 1963, CELL BOUND ANTIBODIE; [Anonymous], 1935, GENESIS DEV SCI FACT; BILLINGHAM RE, 1957, TRANSPLAN B, V4, P58; BRENT L, 1997, HIST TRANSPLANTATION, P60; BRENT LA, 1997, HIST TRANSPLANTATION, P66; CANGULLHEM, 1974, ETUDES HIST PHILOS S, P11; CHASE MW, 1945, P SOC EXP BIOL MED, V59, P134, DOI 10.3181/00379727-59-15006P; CORNER A, 1964, HIST ROCKEFELLER I 1; DAVIS AB, 1974, DSB, V9, P586; Dienes L, 1932, AM J PATHOL, V8, P689; Dulbecco R, 1976, Biogr Mem Natl Acad Sci, V48, P275; Hektoen L, 1920, J INFECT DIS, V27, P23, DOI 10.1093/infdis/27.1.23; HENDERSON JS, 1971, AM PHILOS SOC YB, P168; KABAT EA, 1949, J EXP MED, V89, P395, DOI 10.1084/jem.89.4.395; KABAT EA, 1947, J EXP MED, V85, P117, DOI 10.1084/jem.85.1.117; Landsteiner K, 1942, P SOC EXP BIOL MED, V49, P688, DOI 10.3181/00379727-49-13670; LITTLE CC, 1964, BIOGRAPHICAL MEMOIRS, V34, P183; LOWY, 1990, HIST STUD PHYS BIOL, V21, P1; LOWY I, 1989, B HIST MED, V63, P356; MEDAWAR PB, 1945, J ANAT, V79, P157; MURPHY, SCI REPORTS CORP BOA; MURPHY, 1957, HARVEY LECT, V52, P144; Murphy JB, 1918, J EXP MED, V28, P1, DOI 10.1084/jem.28.1.1; Murphy JB, 1919, J EXP MED, V29, P1; Murphy JB, 1915, J EXP MED, V22, P204, DOI 10.1084/jem.22.2.204; Murphy JB, 1919, J EXP MED, V29, P31; Murphy JB, 1919, J EXP MED, V29, P25; Murphy JB, 1914, J EXP MED, V20, P397, DOI 10.1084/jem.20.4.397; Murphy JB, 1914, J EXP MED, V19, P181, DOI 10.1084/jem.19.2.181; Murphy JB, 1923, J EXP MED, V38, P183, DOI 10.1084/jem.38.2.183; Murphy JB, 1925, J EXP MED, V41, P245, DOI 10.1084/jem.41.2.245; Murphy JB, 1916, J EXP MED, V24, P1, DOI 10.1084/jem.24.1.1; Murphy JB, 1914, J EXP MED, V19, P513, DOI 10.1084/jem.19.5.513; MURPHY JB, 1926, MONOGRAPHS ROCKEFELL, V21; Nakahara W, 1921, J EXP MED, V33, P433, DOI 10.1084/jem.33.4.433; Nakahara W, 1921, J EXP MED, V33, P429, DOI 10.1084/jem.33.4.429; Rich A., 1951, PATHOGENESIS TUBERCU, V2nd; Rous P, 1911, J AMER MED ASSOC, V56, P198; Sandler I, 1979, Hist Sci, V17, P170; Schone G, 1912, HETEROPLASTISCHE HOM; Shirai Y., 1921, JAP MED WORLD, V1, P14, DOI DOI 10.1038/NM.4041; SILVERSTEIN AM, 1986, CELL IMMUNOL, V97, P173, DOI 10.1016/0008-8749(86)90387-4; SILVERSTEIN AM, 1991, CELL IMMUNOL, V132, P515, DOI 10.1016/0008-8749(91)90047-F; Silverstein AM, 1989, HIST IMMUNOLOGY, P275; SIMONSEN M, 1985, IMMUNOL REV, V88, P5, DOI 10.1111/j.1600-065X.1985.tb01151.x; SIMONSEN MORTEN, 1957, ACTA PATHOL ET MICROBLOL SCAND, V40, P480; Taylor HD, 1919, J EXP MED, V29, P53; TYZZER EE, 1916, J CANCER RES, V1, P125; WOGLOM WILLIAM H., 1929, CANCER REV, V4, P129; YOFFEY JM, 1961, BIOLOGICAL ACTIVITY, P45	50	24	24	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					569	571		10.1038/89706	http://dx.doi.org/10.1038/89706			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429534				2022-12-18	WOS:000169682100004
J	Dustin, ML; Dustin, LB				Dustin, ML; Dustin, LB			The immunological relay race: B cells take antigen by synapse	NATURE IMMUNOLOGY			English	News Item							DENDRITIC CELLS; ACTIVATION; AFFINITY	T cells, move over. B cells are now reported, in a recent paper in Nature,to have their own immunological synapses with APCs. Only this time the antigen is whole and B cells don't keep it to themselves.	NYU, Sch Med, Skirball Inst Mol Med, Dept Pathol, New York, NY 10016 USA; Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA	New York University; Rockefeller University	Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst Mol Med, Dept Pathol, New York, NY 10016 USA.		Dustin, Michael/AAM-4611-2020; Dustin, Lynn/G-5690-2011	Dustin, Lynn/0000-0002-2619-1867; Dustin, Michael/0000-0003-4983-6389				Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BATISTA FD, 2001, IN PRESS NATURE, P411; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; BRAUN J, 1978, J CELL BIOL, V79, P409, DOI 10.1083/jcb.79.2.409; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Ludenbach G, 1999, MATERIALWISS WERKST, V30, P185, DOI 10.1002/(SICI)1521-4052(199904)30:4<185::AID-MAWE185>3.0.CO;2-4; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; Wykes M, 1998, J IMMUNOL, V161, P1313	12	24	25	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					480	482		10.1038/88666	http://dx.doi.org/10.1038/88666			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376330	Bronze			2022-12-18	WOS:000169078000007
J	Nakanishi, K				Nakanishi, K			Innate and acquired activation pathways in T cells	NATURE IMMUNOLOGY			English	News Item							INTERFERON-GAMMA PRODUCTION; IL-18; TH1; CYTOKINE; EXPRESSION; INDUCTION; CLONING	Secretion of IFN-gamma by T cells is usually the result of antigen stimulation. However, a newly identified GADD45 beta pathway can implement IFN-gamma production after exposure to cytokines IL-18 and IL-12 without need of antigen.	Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan	Hyogo College of Medicine	Nakanishi, K (corresponding author), Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan.	nakaken@hyo-med.ac.jp						Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	20	24	24	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					140	142		10.1038/84236	http://dx.doi.org/10.1038/84236			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175809				2022-12-18	WOS:000166778700012
J	Lemischka, IR; Jordan, CT				Lemischka, IR; Jordan, CT			The return of clonal marking sheds new light on human hematopoietic stem cells	NATURE IMMUNOLOGY			English	News Item							IMMUNE-DEFICIENT MICE; MOUSE; POPULATION		Princeton Univ, Dept Mol Biol, Lewis Thomas Lab 210, Princeton, NJ 08544 USA; Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA	Princeton University; University of Kentucky	Lemischka, IR (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab 210, Washington Rd, Princeton, NJ 08544 USA.		jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465				Barquinero J, 2000, BLOOD, V95, P3085, DOI 10.1182/blood.V95.10.3085.010k01_3085_3093; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Guenechea G, 2000, MOL THER, V1, P566, DOI 10.1006/mthe.2000.0077; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hao QL, 1996, BLOOD, V88, P3306, DOI 10.1182/blood.V88.9.3306.bloodjournal8893306; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kim HJ, 2000, BLOOD, V96, P1; LEMISCHKA IR, 1992, CURR TOP MICROBIOL, V177, P59; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; VERFAILLIE CM, 1995, BLOOD, V86, P2137, DOI 10.1182/blood.V86.6.2137.bloodjournal8662137; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; Zanjani ED, 1996, INT J HEMATOL, V63, P179	17	24	26	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					11	12		10.1038/83115	http://dx.doi.org/10.1038/83115			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135569				2022-12-18	WOS:000166261500006
J	Roukens, AHE; Pothast, CR; Konig, M; Huisman, W; Dalebout, T; Tak, T; Azimi, S; Kruize, Y; Hagedoorn, RS; Zlei, M; Staal, FJT; de Bie, FJ; van Dongen, JJM; Arbous, SM; Zhang, JLH; Verheij, M; Prins, C; van der Does, AM; Hiemstra, PS; de Vries, JJC; Janse, JJ; Roestenberg, M; Myeni, SK; Kikkert, M; Yazdanbakhsh, M; Heemskerk, MHM; Smits, HH; Jochems, SP				Roukens, Anna H. E.; Pothast, Cilia R.; Koenig, Marion; Huisman, Wesley; Dalebout, Tim; Tak, Tamar; Azimi, Shohreh; Kruize, Yvonne; Hagedoorn, Renate S.; Zlei, Mihaela; Staal, Frank J. T.; de Bie, Fenna J.; van Dongen, Jacques J. M.; Arbous, Sesmu M.; Zhang, Jaimie L. H.; Verheij, Maaike; Prins, Corine; van der Does, Anne M.; Hiemstra, Pieter S.; de Vries, Jutte J. C.; Janse, Jacqueline J.; Roestenberg, Meta; Myeni, Sebenzile K.; Kikkert, Marjolein; Yazdanbakhsh, Maria; Heemskerk, Mirjam H. M.; Smits, Hermelijn H.; Jochems, Simon P.		Collaboration BEAT-COVID Grp; Collaboration COVID-19 LUMC Grp	Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8(+) T cell responses following COVID-19	NATURE IMMUNOLOGY			English	Article							INFLAMMATION; INFECTION	Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are extensively documented, but these are less well studied in the (upper) respiratory tract, where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicates(1-6). Here, we characterized nasal and systemic immune cells in individuals with COVID-19 who were hospitalized or convalescent and compared the immune cells to those seen in healthy donors. We observed increased nasal granulocytes, monocytes, CD11c(+) natural killer (NK) cells and CD4(+) T effector cells during acute COVID-19. The mucosal proinflammatory populations positively associated with peripheral blood human leukocyte antigen (HLA)-DRlow monocytes, CD38(+)PD1(+)CD4(+) T effector (T-eff) cells and plasmablasts. However, there was no general lymphopenia in nasal mucosa, unlike in peripheral blood. Moreover, nasal neutrophils negatively associated with oxygen saturation levels in blood. Following convalescence, nasal immune cells mostly normalized, except for CD127(+) granulocytes and CD38(+)CD8(+) tissue-resident memory T cells (T-RM). SARS-CoV-2-specific CD8(+) T cells persisted at least 2 months after viral clearance in the nasal mucosa, indicating that COVID-19 has both transient and long-term effects on upper respiratory tract immune responses.	[Roukens, Anna H. E.; Zhang, Jaimie L. H.; Verheij, Maaike; Prins, Corine; Roestenberg, Meta] Leiden Univ Med Ctr, Leiden Univ, Dept Infect Dis, Ctr Infect Dis, Leiden, Netherlands; [Pothast, Cilia R.; Hagedoorn, Renate S.; Heemskerk, Mirjam H. M.] Leiden Univ Med Ctr, Dept Hematol, Leiden, Netherlands; [Koenig, Marion; Huisman, Wesley; Tak, Tamar; Azimi, Shohreh; Kruize, Yvonne; Janse, Jacqueline J.; Roestenberg, Meta; Yazdanbakhsh, Maria; Smits, Hermelijn H.; Jochems, Simon P.] Leiden Univ Med Ctr, Leiden Univ, Dept Parasitol, Ctr Infect Dis, Leiden, Netherlands; [Dalebout, Tim; de Vries, Jutte J. C.; Myeni, Sebenzile K.; Kikkert, Marjolein] Leiden Univ Med Ctr, Leiden Univ, Dept Med Microbiol, Ctr Infect Dis, Leiden, Netherlands; [Zlei, Mihaela; Staal, Frank J. T.; de Bie, Fenna J.; van Dongen, Jacques J. M.] Leiden Univ Med Ctr, Dept Immunol, Leiden, Netherlands; [Arbous, Sesmu M.] Leiden Univ Med Ctr, Dept Intens Care, Leiden, Netherlands; [van der Does, Anne M.; Hiemstra, Pieter S.] Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Jochems, SP (corresponding author), Leiden Univ Med Ctr, Leiden Univ, Dept Parasitol, Ctr Infect Dis, Leiden, Netherlands.	s.p.jochems@lumc.nl	van der Does, Anne M./AAA-2247-2022; Kikkert, Marjolein/AAK-5514-2020; Jochems, Simon/AAT-9156-2021; Heemskerk, Mirjam H.M./ABI-2336-2020; Jochems, Simon/FFT-0345-2022; Arbous, Sesmu/ABI-1083-2020; Snijder, Eric/E-6073-2018	van der Does, Anne M./0000-0002-1613-106X; Jochems, Simon/0000-0002-4835-1032; Heemskerk, Mirjam H.M./0000-0001-6320-9133; Arbous, Sesmu/0000-0001-5242-3257; Pothast, Cilia R/0000-0002-9761-3123; Roukens, Anna/0000-0002-1397-0992; Joosten, Simone A/0000-0002-9878-0863; Pike-Overzet, Karin/0000-0002-8827-246X; Huisman, Wesley/0000-0002-5699-7087; Tak, Tamar/0000-0002-5959-7927; de Vries, Jutte J.C./0000-0003-2530-6260; Snijder, Eric/0000-0003-3297-2309; van den Berg, Bernard/0000-0002-5726-5777; Konig, Marion/0000-0002-9892-218X	ZonMW [114025007]; Proefdiervrij; Wake Up To Corona crowdfunding by Leids Universitair Fonds; LUMC Gisela Thier Fellowship; Netherlands Lung Foundation [AWWA-12017001]; LSH-TKI project DC4Balance [LSHM18056-SGF]	ZonMW(Netherlands Organization for Health Research and Development); Proefdiervrij; Wake Up To Corona crowdfunding by Leids Universitair Fonds; LUMC Gisela Thier Fellowship; Netherlands Lung Foundation; LSH-TKI project DC4Balance	We thank all participants and healthy volunteers for taking part in this study. This work was supported by a MKMD-COVID-19 grant (114025007) from ZonMW and Proefdiervrij (P.S.H.). This work was also supported by Wake Up To Corona crowdfunding by Leids Universitair Fonds (A.H.E.R.). Further funding came from LUMC Gisela Thier Fellowship (S.P.J.), a Consortium grant (AWWA-12017001) from the Netherlands Lung Foundation (H.H.S.) and LSH-TKI project DC4Balance LSHM18056-SGF (T.T. and M.K.). Fig. 1 was partly created with BioRender.com. The authors gratefully acknowledge the FCF at LUMC, Leiden, the Netherlands (https://www.lumc.nl/research/facilities/fcf), coordinated by K. Schepers and M. Hameetman, run by the FCF Operators E.F.E de Haas, J.P. Jansen, D.M. Lowie, S. van de Pas and G.IJ. Reyneveld (Directors: F.J.T. Staal and J.J.M. van Dongen) for technical support in the mass and flow cytometry studies. MHC class I peptides were a gift from P. Kvistborg.	Argelaguet R, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178124; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Burt BM, 2008, J LEUKOCYTE BIOL, V84, P1039, DOI 10.1189/jlb.0408256; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; De Filippo K, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12949; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Gangaev A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22811-y; Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hartmann FJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28791-2; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Jochems SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169805; Kelly EAB, 2009, J IMMUNOL, V182, P1404, DOI 10.4049/jimmunol.182.3.1404; Kvedaraite E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018587118; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Marini O, 2017, BLOOD, V129, P1343, DOI 10.1182/blood-2016-04-713206; Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832; Peng Y., 2020, NAT IMMUNOL, V21, P1336, DOI DOI 10.1038/s41590-020-0782-6; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pizzolla A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6970; Rahman AH, 2016, CYTOM PART A, V89A, P601, DOI 10.1002/cyto.a.22826; Rodriguez L, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100078; Schuyler RP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02367; Smith N, 2021, NAT IMMUNOL, V22, P1428, DOI 10.1038/s41590-021-01028-7; Szabo PA, 2021, IMMUNITY, V54, P797, DOI 10.1016/j.immuni.2021.03.005; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Trump S, 2021, NAT BIOTECHNOL, V39, P705, DOI 10.1038/s41587-020-00796-1; van Bergen CAM, 2017, J CLIN INVEST, V127, P517, DOI 10.1172/JCI86175; van der Burg M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00246; van der Velden VHJ, 2019, J IMMUNOL METHODS, V475, DOI 10.1016/j.jim.2017.03.011; Wauters E, 2021, CELL RES, V31, P272, DOI 10.1038/s41422-020-00455-9; Zhou RH, 2020, IMMUNITY, V53, P864, DOI 10.1016/j.immuni.2020.07.026; Ziegler CGK, 2021, CELL, V184, P4713, DOI 10.1016/j.cell.2021.07.023; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	40	23	23	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					23	+		10.1038/s41590-021-01095-w	http://dx.doi.org/10.1038/s41590-021-01095-w		DEC 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937933	Green Submitted, Bronze			2022-12-18	WOS:000733875700010
J	Guo, HT; Wang, Q; Ghneim, K; Wang, L; Rampanelli, E; Holley-Guthrie, E; Cheng, L; Garrido, C; Margolis, DM; Eller, LA; Robb, ML; Sekaly, RP; Chen, X; Su, LS; Ting, JPY				Guo, Haitao; Wang, Qi; Ghneim, Khader; Wang, Li; Rampanelli, Elena; Holley-Guthrie, Elizabeth; Cheng, Liang; Garrido, Carolina; Margolis, David M.; Eller, Leigh A.; Robb, Merlin L.; Sekaly, Rafick-Pierre; Chen, Xian; Su, Lishan; Ting, Jenny P. -Y.			Multi-omics analyses reveal that HIV-1 alters CD4(+) T cell immunometabolism to fuel virus replication	NATURE IMMUNOLOGY			English	Article								Individuals infected with human immunodeficiency virus type-1 (HIV-1) show metabolic alterations of CD4(+) T cells through unclear mechanisms with undefined consequences. We analyzed the transcriptome of CD4(+) T cells from patients with HIV-1 and revealed that the elevated oxidative phosphorylation (OXPHOS) pathway is associated with poor outcomes. Inhibition of OXPHOS by the US Food and Drug Administration-approved drug metformin, which targets mitochondrial respiratory chain complex-I, suppresses HIV-1 replication in human CD4(+) T cells and humanized mice. In patients, HIV-1 peak viremia positively correlates with the expression of NLRX1, a mitochondrial innate immune receptor. Quantitative proteomics and metabolic analyses reveal that NLRX1 enhances OXPHOS and glycolysis during HIV-1-infection of CD4(+) T cells to promote viral replication. At the mechanistic level, HIV infection induces the association of NLRX1 with the mitochondrial protein FASTKD5 to promote expression of mitochondrial respiratory complex components. This study uncovers the OXPHOS pathway in CD4(+) T cells as a target for HIV-1 therapy. Ting and colleagues use multi-omics to examine the alterations undergone by CD4(+) T cells following HIV-1 infection. They describe mechanistic changes that lead to elevated oxidative phosphorylation, which, if inhibited, leads to suppression of HIV-1 infection.	[Guo, Haitao; Wang, Qi; Rampanelli, Elena; Holley-Guthrie, Elizabeth; Cheng, Liang; Chen, Xian; Su, Lishan; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Guo, Haitao; Holley-Guthrie, Elizabeth; Ting, Jenny P. -Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Ghneim, Khader; Sekaly, Rafick-Pierre] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Wang, Li; Chen, Xian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Garrido, Carolina; Margolis, David M.] Univ N Carolina, HIV Cure Ctr, Chapel Hill, NC 27515 USA; [Garrido, Carolina; Margolis, David M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Eller, Leigh A.; Robb, Merlin L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Eller, Leigh A.; Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Su, Lishan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Su, Lishan; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill	Su, LS; Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Ting, JPY (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.; Su, LS (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Su, LS; Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	lsu@ihv.umaryland.edu; jenny_ting@med.unc.edu	Garrido, Carolina/GWM-5557-2022; , UNC Flow Cytometry Core/AGU-9839-2022	Margolis, David/0000-0001-5714-0002; Rampanelli, Elena/0000-0002-7742-0092	Cancer Center Core Support Grant [P30 CA016086]; NIH [R01-AI029564, U19AI109965, AI127346, DK119937]; UNC CFAR Award [P30 AI50410]; Henry M. Jackson Foundation for the Advancement of Military Medicine [P30 AI50410]; US Department of Defense [W81XWH-18-2-0040]	Cancer Center Core Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC CFAR Award; Henry M. Jackson Foundation for the Advancement of Military Medicine; US Department of Defense(United States Department of Defense)	We thank the UNC Flow Cytometry Core Facility, supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center, for assistance with flow cytometry. We thank S. K. Chanda at Sanford Burnham Prebys Medical Discovery Institute for providing the pNL4-3.EGFP.E-construct. This work was supported by NIH grants R01-AI029564 (J.P.-Y.T.), U19AI109965 (J.P.-Y.T.), AI127346 (L.S.) and DK119937 (L.S.); and UNC CFAR Award P30 AI50410 (H.G.). The RV217 study was supported by a cooperative agreement (W81XWH-18-2-0040) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the US Department of Defense.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021; Carr A, 2003, NAT REV DRUG DISCOV, V2, P624, DOI 10.1038/nrd1151; Chan EY, 2009, J VIROL, V83, P9283, DOI 10.1128/JVI.00814-09; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Dagenais-Lussier X, 2015, CYTOKINE GROWTH F R, V26, P603, DOI 10.1016/j.cytogfr.2015.09.001; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Guo HT, 2016, CELL HOST MICROBE, V19, P515, DOI 10.1016/j.chom.2016.03.001; Guo HT, 2014, J BIOL CHEM, V289, P21716, DOI 10.1074/jbc.M114.566620; Hegedus A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0098-4; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Koblansky AA, 2016, CELL REP, V14, P2562, DOI 10.1016/j.celrep.2016.02.064; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Korencak M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126675; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lei Y, 2016, ONCOGENE, V35, P4698, DOI 10.1038/onc.2016.11; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Moyo D, 2014, DIABETES RES CLIN PR, V103, pE34, DOI 10.1016/j.diabres.2013.12.042; National Research Council, 2011, GUIDE CARE USE LAB A, DOI 10.17226/12910; Palmer Clovis S, 2018, F1000Res, V7, P125, DOI 10.12688/f1000research.11881.1; Palmer CS, 2014, J IMMUNOL, V193, P5595, DOI 10.4049/jimmunol.1303092; Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952; Routy JP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028444; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley TL, 2012, J INFECT DIS, V205, pS383, DOI 10.1093/infdis/jis205; Stokman G, 2017, J EXP MED, V214, P2405, DOI 10.1084/jem.20161031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarancon-Diez L, 2019, EBIOMEDICINE, V42, P86, DOI 10.1016/j.ebiom.2019.03.004; Uchimura T, 2018, IMMUNITY, V49, P1049, DOI 10.1016/j.immuni.2018.10.008; Valle-Casuso JC, 2019, CELL METAB, V29, P611, DOI 10.1016/j.cmet.2018.11.015; Vermeire J, 2016, CELL REP, V17, P413, DOI 10.1016/j.celrep.2016.09.023; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Ye CB, 2017, J VIROL, V91, DOI 10.1128/JVI.01389-16; Zecha J, 2019, MOL CELL PROTEOMICS, V18, P1468, DOI 10.1074/mcp.TIR119.001385; Zuniga JA, 2018, INT J STD AIDS, V29, P63, DOI 10.1177/0956462417717650	50	23	24	6	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					423	+		10.1038/s41590-021-00898-1	http://dx.doi.org/10.1038/s41590-021-00898-1		MAR 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33767427	Green Accepted, Green Submitted			2022-12-18	WOS:000632800300004
J	Faustino, LD; Griffith, JW; Rahimi, RA; Nepal, K; Hamilos, DL; Cho, JL; Medoff, BD; Moon, JJ; Vignali, DAA; Luster, AD				Faustino, Lucas D.; Griffith, Jason W.; Rahimi, Rod A.; Nepal, Keshav; Hamilos, Daniel L.; Cho, Josalyn L.; Medoff, Benjamin D.; Moon, James J.; Vignali, Dario A. A.; Luster, Andrew D.			Interleukin-33 activates regulatory T cells to suppress innate gamma delta T cell responses in the lung	NATURE IMMUNOLOGY			English	Article							AIRWAY HYPERREACTIVITY; INFLAMMATION; HOMEOSTASIS; EXPRESSION; MUSCLE; MICE; SPECIALIZATION; POPULATION; INDUCE; ASTHMA	Foxp3(+)regulatory T (T-reg) cells expressing the interleukin (IL)-33 receptor ST2 mediate tissue repair in response to IL-33. Whether T(reg)cells also respond to the alarmin IL-33 to regulate specific aspects of the immune response is not known. Here we describe an unexpected function of ST2(+)T(reg)cells in suppressing the innate immune response in the lung to environmental allergens without altering the adaptive immune response. Following allergen exposure, ST2(+)T(reg)cells were activated by IL-33 to suppress IL-17-producing gamma delta T cells. ST2 signaling in T(reg)cells induced Ebi3, a component of the heterodimeric cytokine IL-35 that was required for T(reg)cell-mediated suppression of gamma delta T cells. This response resulted in fewer eosinophil-attracting chemokines and reduced eosinophil recruitment into the lung, which was beneficial to the host in reducing allergen-induced inflammation. Thus, we define a fundamental role for ST2(+)T(reg)cells in the lung as a negative regulator of the early innate gamma delta T cell response to mucosal injury. Luster and colleagues show that T(reg)cells that reside in lung mucosa can respond to IL-33 upon allergen exposure and suppress innate cell responses. IL-33-activated ST2(+)T(reg)cells secrete IL-35, which suppresses IL-17 production by gamma delta T cells and lessens eosinophil recruitment into the lung.	[Faustino, Lucas D.; Griffith, Jason W.; Rahimi, Rod A.; Nepal, Keshav; Hamilos, Daniel L.; Cho, Josalyn L.; Medoff, Benjamin D.; Moon, James J.; Luster, Andrew D.] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Griffith, Jason W.; Rahimi, Rod A.; Cho, Josalyn L.; Medoff, Benjamin D.; Moon, James J.] Harvard Med Sch, Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luster, AD (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020; Cho, Josalyn/ABF-8931-2021; Faustino, Lucas/G-7642-2014; moon, james/F-1031-2014	Luster, Andrew/0000-0001-9679-7912; Cho, Josalyn/0000-0002-0367-4495; Moon, James/0000-0001-8246-931X; Faustino, Lucas/0000-0002-9535-3735; Vignali, Dario/0000-0002-2771-5992; moon, james/0000-0001-8071-1491	National Institutes of Health [R01AI040618, U19AI095261, T32HL116275, K08AI125816, K08 HL140173, R01CA203689]; National Council of Scientific Development and Technology [237062/2012-7]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council of Scientific Development and Technology	We thank R. Lee for providing Il1rl1<SUP>fl/fl</SUP> mice and L. Wu for providing Il33<SUP>-/-</SUP>mice. This work was supported by grants from the National Institutes of Health to A.D.L. (R01AI040618, U19AI095261 and T32HL116275), J.W.G. (K08AI125816), R.A.R. (K08 HL140173) and D.A.A.V. (R01CA203689) and from the National Council of Scientific Development and Technology to L.D.F. (CNPq; 237062/2012-7).	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Chenuet P, 2017, CLIN SCI, V131, P2533, DOI 10.1042/CS20171034; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Cho JL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1370; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Faustino L, 2013, J IMMUNOL, V190, P2614, DOI 10.4049/jimmunol.1202354; Fulkerson PC, 2006, P NATL ACAD SCI USA, V103, P16418, DOI 10.1073/pnas.0607863103; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Guo XZJ, 2018, IMMUNITY, V49, P531, DOI 10.1016/j.immuni.2018.07.011; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Legoux FP, 2012, JOVE-J VIS EXP, DOI 10.3791/4420; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Raredon MSB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw3851; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Severa M, 2014, J IMMUNOL, V192, P2291, DOI 10.4049/jimmunol.1301799; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Valladao AC, 2016, J IMMUNOL, V197, P4541, DOI 10.4049/jimmunol.1600007; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	62	23	23	2	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1371	+		10.1038/s41590-020-0785-3	http://dx.doi.org/10.1038/s41590-020-0785-3		SEP 2020	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32989331	Green Accepted			2022-12-18	WOS:000573447100002
J	Schumann, K; Raju, SS; Lauber, M; Kolb, S; Shifrut, E; Cortez, JT; Skartsis, N; Nguyen, VQ; Woo, JM; Roth, TL; Yu, R; Nguyen, MLT; Simeonov, DR; Nguyen, DN; Targ, S; Gate, RE; Tang, QZ; Bluestone, JA; Spitzer, MH; Ye, CJ; Marson, A				Schumann, Kathrin; Raju, Siddharth S.; Lauber, Michael; Kolb, Saskia; Shifrut, Eric; Cortez, Jessica T.; Skartsis, Nikolaos; Nguyen, Vinh Q.; Woo, Jonathan M.; Roth, Theodore L.; Yu, Ruby; Nguyen, Michelle L. T.; Simeonov, Dimitre R.; Nguyen, David N.; Targ, Sasha; Gate, Rachel E.; Tang, Qizhi; Bluestone, Jeffrey A.; Spitzer, Matthew H.; Ye, Chun Jimmie; Marson, Alexander			Functional CRISPR dissection of gene networks controlling human regulatory T cell identity	NATURE IMMUNOLOGY			English	Article							IMMUNE DYSREGULATION; FOXP3; SCHNURRI-2; POLYENDOCRINOPATHY; DIFFERENTIATION; ENTEROPATHY; MODULATION; REPRESSION; STABILITY; PROGRAM	Human regulatory T (T-reg) cells are essential for immune homeostasis. The transcription factor FOXP3 maintains T-reg cell identity, yet the complete set of key transcription factors that control T-reg cell gene expression remains unknown. Here, we used pooled and arrayed Cas9 ribonucleoprotein screens to identify transcription factors that regulate critical proteins in primary human T-reg cells under basal and proinflammatory conditions. We then generated 54,424 single-cell transcriptomes from T-reg cells subjected to genetic perturbations and cytokine stimulation, which revealed distinct gene networks individually regulated by FOXP3 and PRDM1, in addition to a network coregulated by FOXO1 and IRF4. We also discovered that HIVEP2, to our knowledge not previously implicated in T(reg)cell function, coregulates another gene network with SATB1 and is important for T-reg cell-mediated immunosuppression. By integrating CRISPR screens and single-cell RNA-sequencing profiling, we have uncovered transcriptional regulators and downstream gene networks in human T-reg cells that could be targeted for immunotherapies.	[Schumann, Kathrin; Lauber, Michael; Kolb, Saskia] Tech Univ Munchen TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schumann, Kathrin; Lauber, Michael; Kolb, Saskia; Ye, Chun Jimmie] TUM, Inst Adv Study, Munich, Germany; [Raju, Siddharth S.; Targ, Sasha; Gate, Rachel E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Raju, Siddharth S.; Targ, Sasha; Gate, Rachel E.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Raju, Siddharth S.; Shifrut, Eric; Cortez, Jessica T.; Woo, Jonathan M.; Roth, Theodore L.; Yu, Ruby; Nguyen, Michelle L. T.; Simeonov, Dimitre R.; Nguyen, David N.; Bluestone, Jeffrey A.; Spitzer, Matthew H.; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Raju, Siddharth S.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Shifrut, Eric; Cortez, Jessica T.; Woo, Jonathan M.; Roth, Theodore L.; Yu, Ruby; Nguyen, Michelle L. T.; Simeonov, Dimitre R.; Nguyen, David N.; Tang, Qizhi; Bluestone, Jeffrey A.; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Shifrut, Eric; Cortez, Jessica T.; Woo, Jonathan M.; Roth, Theodore L.; Yu, Ruby; Nguyen, Michelle L. T.; Simeonov, Dimitre R.; Nguyen, David N.; Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Skartsis, Nikolaos; Ye, Chun Jimmie; Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nguyen, Vinh Q.; Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Bluestone, Jeffrey A.; Spitzer, Matthew H.; Ye, Chun Jimmie; Marson, Alexander] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Spitzer, Matthew H.; Ye, Chun Jimmie; Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA 94129 USA; [Spitzer, Matthew H.; Marson, Alexander] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Marson, Alexander] Gladstone Inst, San Francisco, CA 94158 USA; [Raju, Siddharth S.] Broad Inst, Cambridge, MA USA	Technical University of Munich; Technical University of Munich; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Schumann, K (corresponding author), Tech Univ Munchen TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Schumann, K (corresponding author), TUM, Inst Adv Study, Munich, Germany.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Marson, A (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94129 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	kathrin.schumann@tum.de; alexander.marson@ucsf.edu	Shifrut, Eric/AAK-9263-2021; Ye, Chun/AAK-4868-2021	Shifrut, Eric/0000-0001-6827-0128; Ye, Chun/0000-0001-6560-3783; Roth, Theodore/0000-0002-3970-9573; Schumann, Kathrin/0000-0002-0993-3910; Raju, Siddharth/0000-0002-3916-0293	Diabetes Research Center (NIH) [P30 DK063720]; Juno Therapeutics; NIH [DP3DK111914-01, P50GM082250, DP5OD023056]; Keck Foundation; National Multiple Sclerosis Society [CA 1074-A-21]; Career Award for Medical Scientists from the Burroughs Wellcome Fund; Lloyd Old STAR career award from the Cancer Research Institute; Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy; German Research Foundation (DFG); Hanns-Seidel-Stiftung	Diabetes Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juno Therapeutics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Lloyd Old STAR career award from the Cancer Research Institute; Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy; German Research Foundation (DFG)(German Research Foundation (DFG)); Hanns-Seidel-Stiftung	We thank members of the Marson, Ye, Spitzer and Bluestone laboratories for helpful suggestions and technical assistance; S. Sakaguchi for sharing Treg and Teff DNA methylation data; A. Levine for suggestions on the manuscript; and E. Wan for technical assistance with single-cell RNA-seq. The UCSF Flow Cytometry Core was supported by the Diabetes Research Center (NIH grant no. P30 DK063720). We also thank the CyTUM-MIH Flow Cytometry core for assistance. We thank V. Tobin for assistance in coordinating blood donations at UCSF and the German Heart Center Munich for the provision of buffy coats. This research was supported by Juno Therapeutics; NIH grant nos. DP3DK111914-01 (A.M.), P50GM082250 (A.M.) and DP5OD023056 (M.H.S.); grants from the Keck Foundation (A.M.); the National Multiple Sclerosis Society (A.M.; grant no. CA 1074-A-21); and gifts from J. Aronov, G. Hoskin, K. Jordan and B. Bakar. A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and received the Lloyd Old STAR career award from the Cancer Research Institute. The Marson laboratory has received funding from the Innovative Genomics Institute and the Parker Institute for Cancer Immunotherapy. A.M. and M.H.S. are Chan Zuckerberg Biohub investigators. K.S. was supported by the German Research Foundation (DFG). M.L. was supported by the Hanns-Seidel-Stiftung.	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bhela S, 2017, J IMMUNOL, V199, P1342, DOI 10.4049/jimmunol.1700520; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chandran S, 2017, AM J TRANSPLANT, V17, P2945, DOI 10.1111/ajt.14415; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ferreira LMR, 2019, NAT REV DRUG DISCOV, V18, P749, DOI 10.1038/s41573-019-0041-4; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Goswami S, 2018, J CLIN INVEST, V128, P3813, DOI 10.1172/JCI99760; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Hannon M, 2014, TRANSFUSION, V54, P353, DOI 10.1111/trf.12279; Iwashita Y, 2012, J BIOL CHEM, V287, P9887, DOI 10.1074/jbc.M111.298521; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kimura MY, 2007, J IMMUNOL, V178, P4926, DOI 10.4049/jimmunol.178.8.4926; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Konopacki C, 2019, NAT IMMUNOL, V20, P232, DOI 10.1038/s41590-018-0291-z; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Miska J, 2019, CELL REP, V27, P226, DOI 10.1016/j.celrep.2019.03.029; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Ohkura N, 2020, IMMUNITY, V52, P1119, DOI 10.1016/j.immuni.2020.04.006; Otsubo K, 2011, CLIN IMMUNOL, V141, P111, DOI 10.1016/j.clim.2011.06.006; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Srivastava S, 2016, EUR J HUM GENET, V24, P556, DOI 10.1038/ejhg.2015.151; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Steinfeld H, 2016, NEUROGENETICS, V17, P158, DOI 10.1007/s10048-016-0479-z; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Ting PY, 2018, NAT METHODS, V15, P941, DOI 10.1038/s41592-018-0149-1; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang D, 2018, CELL REP, V23, P3262, DOI 10.1016/j.celrep.2018.05.050; Yue XJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09541-y; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	53	23	23	6	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1456	+		10.1038/s41590-020-0784-4	http://dx.doi.org/10.1038/s41590-020-0784-4		SEP 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32989329	Green Accepted			2022-12-18	WOS:000573447100003
J	Roskin, KM; Jackson, KJL; Lee, JY; Hoh, RA; Joshi, SA; Hwang, KK; Bonsignori, M; Pedroza-Pacheco, I; Liao, HX; Moody, MA; Fire, AZ; Borrow, P; Haynes, BF; Boyd, SD				Roskin, Krishna M.; Jackson, Katherine J. L.; Lee, Ji-Yeun; Hoh, Ramona A.; Joshi, Shilpa A.; Hwang, Kwan-Ki; Bonsignori, Mattia; Pedroza-Pacheco, Isabela; Liao, Hua-Xin; Moody, M. Anthony; Fire, Andrew Z.; Borrow, Persephone; Haynes, Barton F.; Boyd, Scott D.			Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth	NATURE IMMUNOLOGY			English	Article							COLD AGGLUTININS; AUTOREACTIVITY; IMMUNOGLOBULIN; MATURATION; INFECTION; RESPONSES; GERMLINE; VIRUS	A subset of HIV-infected individuals can develop broadly neutralizing antibodies. Boyd and colleagues studied such HIV-infected individuals and found significant perturbations in their antibody repertoires, including increased frequencies of B cells expressing antibodies with features associated with autoreactivity. A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clones. We sequenced antibody heavy-chain repertoires in a large cohort of HIV-infected individuals with bNAb responses or no neutralization breadth and uninfected controls, identifying consistent features of bNAb repertoires, encompassing thousands of B cell clones per individual, with correlated T cell phenotypes. These repertoire features were not observed during chronic cytomegalovirus infection in an independent cohort. Our data indicate that the development of numerous B cell lineages with antibody features associated with autoreactivity may be a key aspect in the development of HIV neutralizing antibody breadth.	[Roskin, Krishna M.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Roskin, Krishna M.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Roskin, Krishna M.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Jackson, Katherine J. L.] Garvan Inst Med Res, Dept Immunol, Darlinghurst, NSW, Australia; [Lee, Ji-Yeun; Hoh, Ramona A.; Joshi, Shilpa A.; Fire, Andrew Z.; Boyd, Scott D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Hwang, Kwan-Ki; Bonsignori, Mattia; Liao, Hua-Xin; Moody, M. Anthony; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Pedroza-Pacheco, Isabela; Borrow, Persephone] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Fire, Andrew Z.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA; [Haynes, Barton F.] Duke Univ, Duke Global Hlth Inst, Sch Med, Durham, NC 27708 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Garvan Institute of Medical Research; Stanford University; Duke University; University of Oxford; Stanford University; Duke University; Duke University; Duke University	Boyd, SD (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA.; Haynes, BF (corresponding author), Duke Univ, Duke Global Hlth Inst, Sch Med, Durham, NC 27708 USA.	barton.haynes@duke.edu; sboyd1@stanford.edu	Bonsignori, Mattia/AAE-7678-2019	Bonsignori, Mattia/0000-0003-2973-2101; Joshi, Shilpa/0000-0002-8014-1529; Moody, Tony/0000-0002-3890-5855; Jackson, Katherine/0000-0002-9952-7069; Hwang, Kwan-Ki/0000-0002-3903-6997; Borrow, Persephone/0000-0002-3877-9780; Fire, Andrew/0000-0001-6217-8312	National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS; UM-1 grant for the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery [AI100645]; National Institutes of Health [R21-AI100696, CHAVI-AI0678501, R01AI127877, R01AI130398]; MRC Programme [MR/ K012037]; MRC [MR/K012037/1] Funding Source: UKRI	National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UM-1 grant for the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge the participants who volunteered for this study. Support for this work was provided by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS; UM-1 grant for the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery AI100645; National Institutes of Health grant Nos. R21-AI100696, CHAVI-AI0678501, R01AI127877 and R01AI130398; and MRC Programme grant No. MR/ K012037.	[Anonymous], 2013, PYTH LANG REF V 2 7; Bertrand A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0455-8; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CIAFFONI S, 1992, HAEMATOLOGICA, V77, P233; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hicar MD, 2016, MOL IMMUNOL, V70, P94, DOI 10.1016/j.molimm.2015.12.002; Hoehn KB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0241; Hohler T, 2002, LANCET, V360, P991, DOI 10.1016/S0140-6736(02)11083-X; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Li YC, 1996, J MOL BIOL, V256, P577, DOI 10.1006/jmbi.1996.0110; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McKinney W., 2010, P 9 PYTH SCI C, P51, DOI [10.25080/Majora-92bf1922-00a, DOI 10.25080/MAJORA-92BF1922-00A]; Moody MA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag0851; Nielsen SCA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2004; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; PRUZANSKI W, 1986, ACTA HAEMATOL-BASEL, V75, P171, DOI 10.1159/000206113; R Core Team, 2019, R LANG ENV STAT COMP; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Roskin KM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1216; RStudio Team, 2016, RSTUDIO INT DEV ENV; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Scheepers C, 2015, J IMMUNOL, V194, P4371, DOI 10.4049/jimmunol.1500118; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	46	23	23	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					199	+		10.1038/s41590-019-0581-0	http://dx.doi.org/10.1038/s41590-019-0581-0		JAN 2020	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31959979	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000508964100005
J	Aki, D; Li, H; Zhang, W; Zheng, MK; Elly, C; Lee, JH; Zou, WG; Liu, YC				Aki, Daisuke; Li, Hui; Zhang, Wen; Zheng, Mingke; Elly, Chris; Lee, Jee H.; Zou, Weiguo; Liu, Yun-Cai			The E3 ligases Itch and WWP2 cooperate to limit T(H)2 differentiation by enhancing signaling through the TCR	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; IMMUNE-RESPONSE; MOTH-EATEN; CBL-B; ACTIVATION; EXPRESSION; MUTATIONS; SELECTION; COMPLEX; KINASE	The mechanisms by which the sensitivity of naive CD4(+) T cells to stimulation by the cognate antigen via the T cell antigen receptor (TCR) determines their differentiation into distinct helper T cell subsets remain elusive. Here we demonstrate functional collaboration of the ubiquitin E3 ligases Itch and WWP2 in regulating the strength of the TCR signal. Mice lacking both Itch and WWP2 in T cells showed spontaneous autoimmunity and lung inflammation. CD4(+) T cells deficient in Itch and WWP2 exhibited hypo-responsiveness to TCR stimulation and a bias toward differentiation into the T(H)2 subset of helper T cells. Itch and WWP2 formed a complex and cooperated to enhance TCR-proximal signaling by catalyzing the conjugation of atypical ubiquitin chains to the phosphatase SHP-1 and reducing the association of SHP-1 with the tyrosine kinase Lck. These findings indicate that targeted ubiquitination regulates the strength of the TCR signal and differentiation toward the T(H)2 lineage.	[Aki, Daisuke; Li, Hui; Zhang, Wen; Zheng, Mingke; Liu, Yun-Cai] Tsinghua Univ, Inst Immunol, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Aki, Daisuke; Elly, Chris; Lee, Jee H.; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China	Tsinghua University; La Jolla Institute for Immunology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, YC (corresponding author), Tsinghua Univ, Inst Immunol, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.; Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	yuncai_liu@mail.tsinghua.edu.cn		LIU, YUN-CAI/0000-0002-0996-7109; Zhang, Wen/0000-0002-9069-3773; zou, weiguo/0000-0003-2516-0302	Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Natural Science Foundation of China [81725010, XBD19000000]; Ministry of Science and Technology of China [YFA0505802, YFC0903900, NSFC81630041]; US National Institutes of Health [RO1AI123398, R21A1122258]; Tsinghua-Peking Center for Life Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI132765, R01AI123398, R21AI126487, R21AI122258, R56AI137017] Funding Source: NIH RePORTER	Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tsinghua-Peking Center for Life Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L.G. Glimcher (Dana -Farber Cancer the Wwp2<SUP>-/-</SUP> mouse strain; H. Deng for mass spectrometry; Z. Yang for purification of glutathione S-transferase fusion proteins; H. Li for imaging analysis, J. Greenbaum, A. Sethi and G. Tian for RNA seq analysis; and members of the Liu laboratory for discussions. Supported by the Mochida Memorial Foundation for Medical and Pharmaceutical Research (fellowship to D.A.), the National Natural Science Foundation of China (81725010 and XBD19000000 to W. Zou), the Ministry of Science and Technology of China (YFA0505802, YFC0903900, NSFC81630041), the US National Institutes of Health (RO1AI123398 and R21A1122258) and the Tsinghua-Peking Center for Life'Sciences (r - C.1..).	Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Choi S, 2017, NAT IMMUNOL, V18, P433, DOI 10.1038/ni.3692; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; HUSTAD CM, 1995, GENETICS, V140, P255; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Martin DA, 2007, J IMMUNOL, V179, P5819, DOI 10.4049/jimmunol.179.9.5819; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Mihara M, 2000, J CLIN INVEST, V106, P91, DOI 10.1172/JCI9244; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Paster W, 2015, EMBO J, V34, P393, DOI 10.15252/embj.201387725; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sasaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066468; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Tubo NJ, 2014, TRENDS IMMUNOL, V35, P591, DOI 10.1016/j.it.2014.09.008; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	47	23	23	4	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					766	+		10.1038/s41590-018-0137-8	http://dx.doi.org/10.1038/s41590-018-0137-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925997	Green Accepted			2022-12-18	WOS:000436341300021
J	Rayamajhi, M; Miao, EA				Rayamajhi, Manira; Miao, Edward A.			The RIP1-RIP3 complex initiates mitochondrial fission to fuel NLRP3	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMASOME; RNA		[Rayamajhi, Manira] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Gastrointestinal Biol Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rayamajhi, M (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu		Miao, Edward/0000-0001-7295-3490	NIAID NIH HHS [R01 AI119073, R01 AI097518] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097518, R01AI119073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Franchi L, 2014, J IMMUNOL, V193, P4214, DOI 10.4049/jimmunol.1400582; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	12	23	25	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1100	1102		10.1038/ni.3030	http://dx.doi.org/10.1038/ni.3030			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25396345	Green Accepted			2022-12-18	WOS:000344841900006
J	Milpied, PJ; McHeyzer-Williams, MG				Milpied, Pierre J.; McHeyzer-Williams, Michael G.			High-affinity IgA needs T(H)17 cell functional plasticity	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS	The conversion of cells of the T(H)17 subset of helper T cells that previously expressed interleukin 17A (IL-17A) and the transcription factor ROR gamma t into follicular helper T cells is needed to generate antigen-specific immunoglobulin A in gut mucosa, which suggests new connections in the cognate control of regional adaptive immunity.	[Milpied, Pierre J.; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Milpied, PJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Milpied, Pierre J/Q-1380-2015	Milpied, Pierre J/0000-0003-1873-5358				Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294	12	23	24	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					313	315		10.1038/ni.2567	http://dx.doi.org/10.1038/ni.2567			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23507637				2022-12-18	WOS:000316648700004
J	Wynn, TA				Wynn, Thomas A.			Myeloid-cell differentiation redefined in cancer	NATURE IMMUNOLOGY			English	Editorial Material							IDENTIFICATION	The differentiation of monocytes is altered in cancer, which results in the unexpected conversion of a large proportion of monocytic myeloid-derived suppressor cells into polymorphonuclear myeloid-derived suppressor cells.	[Wynn, Thomas A.] NIAID, Immunopathogenesis Sect, Program Tissue Immun & Repair, NIH, Bethesda, MD 20892 USA; [Wynn, Thomas A.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wynn, TA (corresponding author), NIAID, Immunopathogenesis Sect, Program Tissue Immun & Repair, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731	Intramural NIH HHS [ZIA AI001019-06] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Gabrilovich D.I., 2013, NAT IMMUNOL, V14, P211; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055	12	23	24	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					197	199		10.1038/ni.2539	http://dx.doi.org/10.1038/ni.2539			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416669	Green Accepted			2022-12-18	WOS:000315065400006
J	Alon, R; Nourshargh, S				Alon, Ronen; Nourshargh, Sussan			Learning in motion: pericytes instruct migrating innate leukocytes	NATURE IMMUNOLOGY			English	Editorial Material							VENULAR WALLS; INFLAMMATION	During sterile inflammation, emigrating leukocytes sequentially engage subsets of pericytes associated with blood vessels and acquire adhesive, migratory and survival signals.	[Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Nourshargh, Sussan] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England	Weizmann Institute of Science; University of London; Queen Mary University London	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il; s.nourshargh@qmul.ac.uk	ALON, RONEN/GRX-6987-2022	Nourshargh, Sussan/0000-0001-5677-1806; Alon, Ronen/0000-0001-9161-6369				Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477	10	23	24	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					14	15						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23238752				2022-12-18	WOS:000312433800004
J	Hori, S				Hori, Shohei			The Foxp3 interactome: a network perspective of T-reg cells	NATURE IMMUNOLOGY			English	Editorial Material							TARGET GENES; DIFFERENTIATION; EXPRESSION; LINEAGE; KEY	Foxp3 protein complexes orchestrate the transcriptional network of regulatory T cells. The Foxp3 interactome is now identified and may act as a genetic switch that controls the differentiation of regulatory T cells.	RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Yokohama, Kanagawa, Japan	RIKEN	Hori, S (corresponding author), RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Yokohama, Kanagawa, Japan.	shohei@rcai.riken.jp	Hori, Shohei/O-6163-2019	Hori, Shohei/0000-0001-8770-4593				Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	12	23	28	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					943	945		10.1038/ni.2424	http://dx.doi.org/10.1038/ni.2424			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990900				2022-12-18	WOS:000309038600009
J	Hassan, GS; Mourad, W				Hassan, Ghada S.; Mourad, Walid			An unexpected role for MHC class II	NATURE IMMUNOLOGY			English	Editorial Material							CYTOKINE GENE-EXPRESSION; INNATE IMMUNE-RESPONSES; HUMAN B-CELLS; MOLECULES; CD40; SUPERANTIGEN; REQUIREMENT; ACTIVATION	In addition to their classical function in antigen presentation and their lesser known ability to act as signal transducers, major histocompatibility complex class II molecules are now shown to promote Toll-like receptor signaling. This intriguing role requires intracellular association with the kinase Btk and the costimulatory molecule CD40.	[Hassan, Ghada S.; Mourad, Walid] Hop St Luc, Dept Med, Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 1P1, Canada	Universite de Montreal	Hassan, GS (corresponding author), Hop St Luc, Dept Med, Ctr Hosp Univ Montreal, Ctr Rech, 264 Rene Levesque Blvd E, Montreal, PQ H2X 1P1, Canada.	mw.mourad@umontreal.ca		Hassan, Ghada S./0000-0002-1391-5248; Mourad, Walid/0000-0002-1859-9387				Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006; Frei R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008808; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Leveille C, 1999, EUR J IMMUNOL, V29, P3516, DOI 10.1002/(SICI)1521-4141(199911)29:11<3516::AID-IMMU3516>3.3.CO;2-4; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mehindate K, 1996, EUR J IMMUNOL, V26, P2075, DOI 10.1002/eji.1830260917; MEHINDATE K, 1995, J EXP MED, V182, P1573, DOI 10.1084/jem.182.5.1573; Piani A, 2000, EUR J IMMUNOL, V30, P3140, DOI 10.1002/1521-4141(200011)30:11<3140::AID-IMMU3140>3.0.CO;2-O; Sanchez PJ, 2007, J IMMUNOL, V178, P1564, DOI 10.4049/jimmunol.178.3.1564; Wagner M, 2004, J IMMUNOL, V172, P954, DOI 10.4049/jimmunol.172.2.954; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005	12	23	25	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					375	376		10.1038/ni.2023	http://dx.doi.org/10.1038/ni.2023			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21502988				2022-12-18	WOS:000289666600005
J	Blattman, JN; Greenberg, PD				Blattman, JN; Greenberg, PD			PD-1 blockade: rescue from a near-death experience	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; PERSISTENCE; B7-H1; B7-DC		Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Blattman, JN (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	pgreen@u.washington.edu						Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; BARBER D, 2005, NATURE ADV ONLINE PU, DOI DOI 10.1038/NATURE0444; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Dong HD, 1999, NAT MED, V5, P1365; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	12	23	28	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					227	228		10.1038/ni0306-227	http://dx.doi.org/10.1038/ni0306-227			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482167				2022-12-18	WOS:000235360400004
J	Sen, GC; Sarkar, SN				Sen, GC; Sarkar, SN			Hitching RIG to action	NATURE IMMUNOLOGY			English	Editorial Material							DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; PROTEIN; HELICASE; EVASION; TLR3		Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sen, GC (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	seng@ccf.org	Sarkar, Saumendra N/B-5038-2011	Sarkar, Saumendra N/0000-0002-2850-6121				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; MEYLAN E, 2005, NATURE          0921; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	12	23	24	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1074	1076		10.1038/ni1105-1074	http://dx.doi.org/10.1038/ni1105-1074			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239922				2022-12-18	WOS:000232833300007
J	Bird, A				Bird, A			II2 transcription unleashed by active DNA demethylation	NATURE IMMUNOLOGY			English	Editorial Material							GENE; MEMORY	The idea that genes are transcriptionally activated by rapid CpG demethylation has been controversial. New data provides the most compelling evidence yet, implicating a mysterious enzyme activity that can actively demethylate DNA.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.			Bird, Adrian/0000-0002-8600-0372				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; WILKS A, 1984, NUCLEIC ACIDS RES, V12, P1163, DOI 10.1093/nar/12.2.1163	13	23	23	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					208	209		10.1038/ni0303-208	http://dx.doi.org/10.1038/ni0303-208			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605226				2022-12-18	WOS:000181201000005
J	Nekrep, N; Jabrane-Ferrat, N; Wolf, HM; Eibl, MM; Geyer, M; Peterlin, BM				Nekrep, N; Jabrane-Ferrat, N; Wolf, HM; Eibl, MM; Geyer, M; Peterlin, BM			Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome	NATURE IMMUNOLOGY			English	Article							CLASS-II DEFICIENCY; COMBINED IMMUNODEFICIENCY; COOPERATIVE BINDING; REGULATORY FACTOR; COMPLEX; PROTEIN; CIITA; RFX; EXPRESSION; TRANSACTIVATOR	Bare lymphocyte syndrome (BLS) is an autosomal recessive severe-combined immunodeficiency that can result from mutations in four different transcription factors that regulate the expression of major histocompatibility complex (MHC) class II genes. We have identified here the defective gene that is responsible for the phenotype of the putative fifth BLS complementation group. The mutation was found in the regulatory factor that binds X-box 5 (RFXS) and was mapped to one of the arginines in a DNA-binding surface of this protein. Its wild-type counterpart restored binding of the RFX complex to DNA, transcription of all MHC class II genes and the appearance of these determinants on the surface of BLS cells.	Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA; Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; Immunol Outpatient Clin, Vienna, Austria; Max Planck Inst Med Res, Heidelberg, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Ljubljana; Max Planck Society	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA.	matija@itsa.ucsf.edu	Jabrane-Ferrat, Nabila/K-1224-2014	Jabrane-Ferrat, Nabila/0000-0003-4809-7836; Geyer, Matthias/0000-0002-7718-5002				BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Clausen BE, 1998, IMMUNITY, V8, P143, DOI 10.1016/S1074-7613(00)80467-7; COGSWELL JP, 1991, CRIT REV IMMUNOL, V11, P87; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DeSandro AM, 2000, MOL CELL BIOL, V20, P6587, DOI 10.1128/MCB.20.17.6587-6599.2000; Douhan J, 1996, J EXP MED, V183, P1063, DOI 10.1084/jem.183.3.1063; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Fontes JD, 1997, J MOL BIOL, V270, P336, DOI 10.1006/jmbi.1997.1121; Fontes JD, 1999, MICROBES INFECT, V1, P863, DOI 10.1016/S1286-4579(99)80529-2; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; HAUBER I, 1995, J EXP MED, V181, P1411, DOI 10.1084/jem.181.4.1411; Jabrane-Ferrat N, 2002, MOL CELL BIOL, V22, P5616, DOI 10.1128/MCB.22.15.5616-5625.2002; JabraneFerrat N, 1996, MOL CELL BIOL, V16, P4683; Kelly PF, 2000, BLOOD, V96, P1206, DOI 10.1182/blood.V96.4.1206.h8001206_1206_1214; KOBR M, 1990, MOL CELL BIOL, V10, P965, DOI 10.1128/MCB.10.3.965; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; MACH B, 1994, IMMUNOL REV, V138, P207, DOI 10.1111/j.1600-065X.1994.tb00853.x; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Masternak K, 2002, EMBO J, V21, P1379, DOI 10.1093/emboj/21.6.1379; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Nekrep N, 2000, MOL CELL BIOL, V20, P4455, DOI 10.1128/MCB.20.12.4455-4461.2000; Nekrep N, 2001, MOL CELL BIOL, V21, P5566, DOI 10.1128/MCB.21.16.5566-5576.2001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Peretti M, 2001, MOL CELL BIOL, V21, P5699, DOI 10.1128/MCB.21.17.5699-5709.2001; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; REITH W, 1994, J BIOL CHEM, V269, P20020; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Tosi G, 2000, EUR J IMMUNOL, V30, P19, DOI 10.1002/1521-4141(200001)30:1<19::AID-IMMU19>3.0.CO;2-9; Villard J, 2000, MOL CELL BIOL, V20, P3364, DOI 10.1128/MCB.20.10.3364-3376.2000; Villard J, 2001, MEDICINE, V80, P405, DOI 10.1097/00005792-200111000-00006; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000	43	23	26	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1075	1081		10.1038/ni840	http://dx.doi.org/10.1038/ni840			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12368908				2022-12-18	WOS:000179073000015
J	Fearon, DT				Fearon, DT			Innate immunity - beginning to fulfill its promise?	NATURE IMMUNOLOGY			English	News Item								Much vaccine research is directed toward the generation of more effective vaccines. By combining DNA vaccines with the innate immune system, a flu vaccine was designed that required only a single immunization.	Univ Cambridge, Sch Clin Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England	University of Cambridge	Fearon, DT (corresponding author), Univ Cambridge, Sch Clin Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England.							COX V, 2000, 3 ANN C VACC RES ABS, P52; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Nossal GJV, 2000, NAT IMMUNOL, V1, P5, DOI 10.1038/76852; ROSS TM, NATURE IMMUNOL, V2, P127; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352	7	23	25	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					102	103		10.1038/77773	http://dx.doi.org/10.1038/77773			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248799				2022-12-18	WOS:000089814900008
J	Tahtinen, S; Tong, AJ; Himmels, P; Oh, J; Paler-Martinez, A; Kim, L; Wichner, S; Oei, Y; McCarron, MJ; Freund, EC; Amir, ZA; de la Cruz, CC; Haley, B; Blanchette, C; Schartner, JM; Ye, WL; Yadav, M; Sahin, U; Delamarre, L; Mellman, I				Tahtinen, Siri; Tong, Ann-Jay; Himmels, Patricia; Oh, Jaehak; Paler-Martinez, Andres; Kim, Leesun; Wichner, Sara; Oei, Yoko; McCarron, Mark J.; Freund, Emily C.; Amir, Zhainib Adel; de la Cruz, Cecile C.; Haley, Benjamin; Blanchette, Craig; Schartner, Jill M.; Ye, Weilan; Yadav, Mahesh; Sahin, Ugur; Delamarre, Lelia; Mellman, Ira			IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; RECEPTOR; EXPRESSION; RELEASE	The use of lipid-formulated RNA vaccines for cancer or COVID-19 is associated with dose-limiting systemic inflammatory responses in humans that were not predicted from preclinical studies. Here, we show that the 'interleukin 1 (IL-1)-interleukin 1 receptor antagonist (IL-1ra)' axis regulates vaccine-mediated systemic inflammation in a host-specific manner. In human immune cells, RNA vaccines induce production of IL-1 cytokines, predominantly IL-1 beta, which is dependent on both the RNA and lipid formulation. IL-1 in turn triggers the induction of the broad spectrum of pro-inflammatory cytokines (including IL-6). Unlike humans, murine leukocytes respond to RNA vaccines by upregulating anti-inflammatory IL-1ra relative to IL-1 (predominantly IL-1 alpha), protecting mice from cytokine-mediated toxicities at >1,000-fold higher vaccine doses. Thus, the IL-1 pathway plays a key role in triggering RNA vaccine-associated innate signaling, an effect that was unexpectedly amplified by certain lipids used in vaccine formulations incorporating N1-methyl-pseudouridine-modified RNA to reduce activation of Toll-like receptor signaling. RNA vaccines have been associated with high reactogenicity. Mellman and colleagues demonstrate that lipid-formulated RNA vaccines trigger IL-1 production and inflammation in humans but this pathway is dampened in mice.	[Tahtinen, Siri; Tong, Ann-Jay; Himmels, Patricia; Oh, Jaehak; Paler-Martinez, Andres; Kim, Leesun; Wichner, Sara; Oei, Yoko; McCarron, Mark J.; Freund, Emily C.; Amir, Zhainib Adel; de la Cruz, Cecile C.; Haley, Benjamin; Blanchette, Craig; Schartner, Jill M.; Ye, Weilan; Yadav, Mahesh; Delamarre, Lelia; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Sahin, Ugur] BioNTech SE, Mainz, Germany	Roche Holding; Genentech; BioNTech SE	Mellman, I (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	mellman.ira@gene.com						Anandasabapathy N, 2015, BONE MARROW TRANSPL, V50, P924, DOI 10.1038/bmt.2015.74; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Bonow RO, 2020, JAMA CARDIOL, V5, P751, DOI 10.1001/jamacardio.2020.1105; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; Braiteh F., 2020, CANCER RES, V80; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Buschmann MD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010065; Cafri G, 2020, J CLIN INVEST, V130, P5976, DOI 10.1172/JCI134915; Cagigi A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010061; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Cauchois R, 2020, P NATL ACAD SCI USA, V117, P18951, DOI 10.1073/pnas.2009017117; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gaidt MM, 2017, CURR OPIN IMMUNOL, V44, P7, DOI 10.1016/j.coi.2016.10.007; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; Hawash MBF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015855118; Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Ji DX, 2019, NAT MICROBIOL, V4, P2128, DOI 10.1038/s41564-019-0578-3; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Krienke Christina, 2021, Science, V371, P145, DOI 10.1126/science.aay3638; Li JZ, 2019, SUSTAINABILITY-BASEL, V11, DOI [10.1126/scitranslmed.aax8861, 10.3390/su11185015]; Lo AA, 2021, MOL CANCER THER, V20, P716, DOI 10.1158/1535-7163.MCT-20-0490; Lonez C, 2014, NANOMED-NANOTECHNOL, V10, P775, DOI 10.1016/j.nano.2013.12.003; Lopez JS, 2020, CANCER RES, V80, DOI 10.1158/1538-7445.AM2020-CT301; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao L, 2019, NAT BIOTECHNOL, V37, P1174, DOI 10.1038/s41587-019-0247-3; Mitchell WM, 2014, AM J PATHOL, V184, P1062, DOI 10.1016/j.ajpath.2013.12.006; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Nalle SC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238484; Ndeupen S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103479; Nelson J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6893; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Sabnis S, 2018, MOL THER, V26, P1509, DOI 10.1016/j.ymthe.2018.03.010; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Sahin U, 2020, NATURE, V585, P107, DOI 10.1038/s41586-020-2537-9; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Van den Eeckhout B, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.621931; Vormehr M, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1758004; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang HX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005191118; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608	50	22	22	17	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					532	+		10.1038/s41590-022-01160-y	http://dx.doi.org/10.1038/s41590-022-01160-y		MAR 2022	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35332327	Bronze			2022-12-18	WOS:000774648300001
J	Brewer, RC; Ramadoss, NS; Lahey, LJ; Jahanbani, S; Robinson, WH; Lanz, TV				Brewer, R. Camille; Ramadoss, Nitya S.; Lahey, Lauren J.; Jahanbani, Shaghayegh; Robinson, William H.; Lanz, Tobias, V			BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2	NATURE IMMUNOLOGY			English	Article							RECEPTOR-BINDING DOMAIN; MEMORY B; PLASMA-CELLS; SPIKE	The first ever US Food and Drug Administration-approved messenger RNA vaccines are highly protective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1-3). However, the contribution of each dose to the generation of antibodies against SARS-CoV-2 spike (S) protein and the degree of protection against novel variants warrant further study. Here, we investigated the B cell response to the BNT162b2 vaccine by integrating B cell repertoire analysis with single-cell transcriptomics pre- and post-vaccination. The first vaccine dose elicits a recall response of IgA(+) plasmablasts targeting the S subunit S2. Three weeks after the first dose, we observed an influx of minimally mutated IgG(+) memory B cells that targeted the receptor binding domain on the S subunit S1 and likely developed from the naive B cell pool. This response was strongly boosted by the second dose and delivers potently neutralizing antibodies against SARS-CoV-2 and several of its variants.	[Brewer, R. Camille; Ramadoss, Nitya S.; Jahanbani, Shaghayegh; Robinson, William H.; Lanz, Tobias, V] Stanford Univ, Dept Med, Div Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA; [Brewer, R. Camille; Ramadoss, Nitya S.; Jahanbani, Shaghayegh; Robinson, William H.; Lanz, Tobias, V] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Lahey, Lauren J.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Lanz, Tobias, V] Heidelberg Univ, Med Fac Mannheim, Mannheim Ctr Translat Neurosci MCTN, Dept Neurol, Mannheim, Germany	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Ruprecht Karls University Heidelberg	Robinson, WH; Lanz, TV (corresponding author), Stanford Univ, Dept Med, Div Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA.; Robinson, WH; Lanz, TV (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.; Lanz, TV (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mannheim Ctr Translat Neurosci MCTN, Dept Neurol, Mannheim, Germany.	w.robinson@stanford.edu; tlanz@stanford.edu		Robinson, William/0000-0003-4385-704X; Brewer, Camille/0000-0002-0342-1826	Foundation for the National Institutes of Health [T32 AI007290-35, R01 AR078268, U19 AI057229, U01 AI101981]; National Science Foundation [DGE-1656518]; German Research Foundation [LA3657/1]	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG))	We thank all study participants who devoted time to our research. We thank D. Burton at Scripps Research Institute for providing ACE2-HeLa cells. We thank M. Baker at Stanford University for key discussions. This work was supported by a Foundation for the National Institutes of Health training grant (T32 AI007290-35) and National Science Foundation Graduate Research Fellowship (DGE-1656518) to R.C.B.; the German Research Foundation (LA3657/1) to T.V.L.; and Foundation for the National Institutes of Health R01 AR078268, U19 AI057229 and U01 AI101981 to W.H.R.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Amanat F., CELL, DOI [10.1016/j.cell.2021.06.005(2021, DOI 10.1016/J.CELL.2021.06.005(2021]; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bortnick A, 2013, J IMMUNOL, V190, P5913, DOI 10.4049/jimmunol.1300161; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Combes AJ, 2021, NATURE, V596, pE8, DOI 10.1038/s41586-021-03718-6; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Dugan HL, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3601; Ellebedy AH, 2020, P NATL ACAD SCI USA, V117, P17957, DOI 10.1073/pnas.1906613117; Fink K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00078; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Khodadadi L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00721; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Krzyzak L, 2016, J IMMUNOL, V196, P3581, DOI 10.4049/jimmunol.1502163; Ladner JT, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2020.100189; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Li X, 2018, IMMUNITY, V48, P530, DOI 10.1016/j.immuni.2018.03.006; Maddur MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5092; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Palm AKE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01787; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Roltgen Katharina, 2021, medRxiv, DOI 10.1101/2021.04.05.21254952; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Shah P, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.637651; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2020, NATURE, V586, P127, DOI 10.1038/s41586-020-2711-0; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yang AC, 2021, NATURE, V598, pE4, DOI 10.1038/s41586-021-04080-3; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	42	22	22	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					33	+		10.1038/s41590-021-01088-9	http://dx.doi.org/10.1038/s41590-021-01088-9		NOV 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34848871	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000723985200001
J	Mayer, JU; Hilligan, KL; Chandler, JS; Eccles, DA; Old, SI; Domingues, RG; Yang, JP; Webb, GR; Munoz-Erazo, L; Hyde, EJ; Wakelin, KA; Tang, SC; Chappell, SC; Von Daake, S; Brombacher, F; Mackay, CR; Sher, A; Tussiwand, R; Connor, LM; Gallego-Ortega, D; Jankovic, D; Le Gros, G; Hepworth, MR; Lamiable, O; Ronchese, F				Mayer, Johannes U.; Hilligan, Kerry L.; Chandler, Jodie S.; Eccles, David A.; Old, Samuel, I; Domingues, Rita G.; Yang, Jianping; Webb, Greta R.; Munoz-Erazo, Luis; Hyde, Evelyn J.; Wakelin, Kirsty A.; Tang, Shiau-Choot; Chappell, Sally C.; von Daake, Sventja; Brombacher, Frank; Mackay, Charles R.; Sher, Alan; Tussiwand, Roxane; Connor, Lisa M.; Gallego-Ortega, David; Jankovic, Dragana; Le Gros, Graham; Hepworth, Matthew R.; Lamiable, Olivier; Ronchese, Franca			Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote T(H)2 and inhibit T(H)17 cell polarization	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; THYMIC STROMAL LYMPHOPOIETIN; CD4(+) T-CELLS; EXPRESSION; PROGENITORS; ENRICHMENT; FILAGGRIN; IMMUNITY; INTEGRIN	Ronchese and colleagues show that IL-13 secreted homeostatically by dermal ILCs contributes to the differentiation of a CD11b(lo) type 2 dendritic cell subset, which supports the development of T(H)2 cells and curtails the development of T(H)17 cells in the skin of mice and humans. The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11b(lo) migratory DC2s-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11b(hi) and showed defective activation in response to allergens, with diminished ability to support the development of IL-4(+)GATA3(+) helper T cells (T-H), whereas antifungal IL-17(+)ROR gamma t(+) T-H cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.	[Mayer, Johannes U.; Hilligan, Kerry L.; Chandler, Jodie S.; Eccles, David A.; Old, Samuel, I; Yang, Jianping; Webb, Greta R.; Munoz-Erazo, Luis; Hyde, Evelyn J.; Wakelin, Kirsty A.; Tang, Shiau-Choot; Chappell, Sally C.; von Daake, Sventja; Connor, Lisa M.; Le Gros, Graham; Lamiable, Olivier; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand; [Hilligan, Kerry L.; Sher, Alan] NIAID, Immunobiol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Domingues, Rita G.; Hepworth, Matthew R.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Lydia Becker Inst Immunol & Inflammat, Manchester Collaborat Ctr Inflammat Res,Fac Biol, Manchester, Lancs, England; [Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol ICGEB, Cape Town Component, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Inst Infect Dis & Mol Med IDM, Div Immunol, Hlth Sci Fac, Cape Town, South Africa; [Mackay, Charles R.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [Tussiwand, Roxane] Univ Basel, Dept Biomed, Basel, Switzerland; [Tussiwand, Roxane] Natl Inst Dent & Craniofacial Res, Immune Regulat Unit, NIH, Bethesda, MD USA; [Gallego-Ortega, David] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Gallego-Ortega, David] Univ Technol Sydney, Fac Engn & IT, Ctr Single Cell Technol, Sch Biomed Engn, Ultimo, NSW, Australia; [Jankovic, Dragana] NIAID, Immunoparasitol Unit, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mayer, Johannes U.] Phillips Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany; [Connor, Lisa M.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Manchester; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; Monash University; University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Garvan Institute of Medical Research; University of Technology Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Philipps University Marburg; Victoria University Wellington	Ronchese, F (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	fronchese@malaghan.org.nz		Webb, Greta/0000-0003-0348-3119; Le Gros, Graham/0000-0002-5721-0442; Wakelin, Kirsty/0000-0002-2819-0315; Gallego Ortega, David/0000-0002-2347-7835; Hilligan, Kerry/0000-0003-1238-1552; Eccles, David/0000-0003-4634-4995; Munoz-Erazo, Luis/0000-0003-4202-1515	Independent Research Organization grant from the Health Research Council of New Zealand (HRC) [18-1003, 18-510]; Marjorie Barclay Trust; Malaghan Institute Postdoctoral Fellowship; Intramural Research Program of the NIAID, NIH; Sir Henry Dale Fellowship - Wellcome Trust [105644/Z/14/Z]; Sir Henry Dale Fellowship - Royal Society [105644/Z/14/Z]; Lister Institute of Preventative Medicine Prize; EMBO long-term fellowship [ALTF 1209-2019]	Independent Research Organization grant from the Health Research Council of New Zealand (HRC); Marjorie Barclay Trust; Malaghan Institute Postdoctoral Fellowship; Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; Lister Institute of Preventative Medicine Prize; EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	We wish to thank G. Ogg, Oxford University, for sharing raw data of the scRNA-seq analysis of human skin blisters; P.M. Brunner and V. Vorstandlechner, Medical University of Vienna, for their advice on single-cell QC filtering and data analysis of scRNA-seq data of human skin biopsies and blisters cells; Y. Wang, Google, for developing the Shiny browser for scRNA-seq data and providing debugging help; M. Brewerton, Auckland DHB; A. Livingstone and T. Mosmann, University of Rochester; A. MacDonald, University of Manchester; S. Nutt, Walter and Eliza Hall Institute; and all colleagues at the Malaghan Institute of Medical Research for discussion and suggestions. The MR1 tetramer technology was developed jointly by J. McCluskey, J. Rossjohn and D. Fairlie, and the material was produced by the NIH Tetramer Core Facility as permitted to be distributed by the University of Melbourne, Australia. We also gratefully acknowledge the flow cytometry support of the members of the Hugh Green Cytometry Centre and the expert animal husbandry of the Biomedical Research Unit at the Malaghan Institute. This work was funded by an Independent Research Organization grant from the Health Research Council of New Zealand (HRC) to the Malaghan Institute (18-1003), an HRC Project grant to F.R. (18-510), and the Marjorie Barclay Trust. K.L.H. was supported by a Malaghan Institute Postdoctoral Fellowship and the Intramural Research Program of the NIAID, NIH. M.R.H. was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant no. 105644/Z/14/Z), and a Lister Institute of Preventative Medicine Prize. R. G.D. was supported by an EMBO long-term fellowship (ALTF 1209-2019).	Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Alpan O, 2004, NAT IMMUNOL, V5, P615, DOI 10.1038/ni1077; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Bielecki P, 2021, NATURE, V592, P128, DOI 10.1038/s41586-021-03188-w; Blecher-Gonen R, 2019, CELL SYST, V8, P109, DOI 10.1016/j.cels.2019.01.001; Bojang E, 2021, J FUNGI, V7, DOI 10.3390/jof7020119; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chen YL, 2020, J EXP MED, V217, DOI 10.1084/jem.20190811; Connor LM, 2017, J EXP MED, V214, P125, DOI 10.1084/jem.20160470; Connor LM, 2014, J IMMUNOL, V193, P2709, DOI 10.4049/jimmunol.1400374; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Guerin A, 2018, ELIFE, V7, DOI 10.7554/eLife.32340; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hamada M, 2011, BIOINFORMATICS, V27, P3085, DOI 10.1093/bioinformatics/btr537; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Harris NL, 1999, EUR J IMMUNOL, V29, P311, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;311::AID-IMMU311&gt;3.0.CO;2-B; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Heidkamp GF, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7677; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hilligan KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19463-9; Hilligan KL, 2020, CELL MOL IMMUNOL, V17, P587, DOI 10.1038/s41423-020-0465-0; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Lamiable O, 2020, IMMUNOL CELL BIOL, V98, P807, DOI 10.1111/imcb.12387; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; McCormick SM, 2015, CYTOKINE, V75, P38, DOI 10.1016/j.cyto.2015.05.023; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ochiai S, 2014, J IMMUNOL, V193, P2504, DOI 10.4049/jimmunol.1400536; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pellefigues C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01575; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Rojahn TB, 2020, J ALLERGY CLIN IMMUN, V146, P1056, DOI 10.1016/j.jaci.2020.03.041; Ronchese F, 2020, CURR OPIN IMMUNOL, V64, P56, DOI 10.1016/j.coi.2020.03.006; Schapiro D, 2017, NAT METHODS, V14, P873, DOI [10.1038/NMETH.4391, 10.1038/nmeth.4391]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Sichien D, 2017, MUCOSAL IMMUNOL, V10, P831, DOI 10.1038/mi.2017.8; Srivastava A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1670-y; Strid J, 2016, J INVEST DERMATOL, V136, P561, DOI 10.1016/j.jid.2015.12.025; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zhou XY, 2021, J EXP MED, V218, DOI 10.1084/jem.20201793; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	69	22	22	7	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1538	+		10.1038/s41590-021-01067-0	http://dx.doi.org/10.1038/s41590-021-01067-0		NOV 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34795444				2022-12-18	WOS:000720214500004
J	Munnur, D; Teo, QW; Eggermont, D; Lee, HHY; Thery, F; Ho, JL; van Leur, SW; Ng, WWS; Siu, LYL; Beling, A; Ploegh, H; Pinto-Fernandez, A; Damianou, A; Kessler, B; Impens, F; Mok, CKP; Sanyal, S				Munnur, Deeksha; Teo, Qiwen; Eggermont, Denzel; Lee, Horace H. Y.; Thery, Fabien; Ho, Julian; van Leur, Sophie Wilhelmina; Ng, Wilson W. S.; Siu, Lewis Y. L.; Beling, Antje; Ploegh, Hidde; Pinto-Fernandez, Adan; Damianou, Andreas; Kessler, Benedikt; Impens, Francis; Mok, Chris Ka Pun; Sanyal, Sumana			Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Article							INFLUENZA-A VIRUS; I INTERFERON; VIRAL REPLICATION; EPITHELIAL-CELLS; ISG15; PROTEIN; EXPRESSION; INDUCTION; PATHOLOGY; SEVERITY	The antiviral factor ISG15 can be conjugated to other proteins through ISGylation. Sanyal and colleagues find that viruses can modulate ISGylation, which in turn alters macrophage responses and can result in exaggerated inflammation in COVID-19. Ubiquitin-like protein ISG15 (interferon-stimulated gene 15) (ISG15) is a ubiquitin-like modifier induced during infections and involved in host defense mechanisms. Not surprisingly, many viruses encode deISGylating activities to antagonize its effect. Here we show that infection by Zika, SARS-CoV-2 and influenza viruses induce ISG15-modifying enzymes. While influenza and Zika viruses induce ISGylation, SARS-CoV-2 triggers deISGylation instead to generate free ISG15. The ratio of free versus conjugated ISG15 driven by the papain-like protease (PLpro) enzyme of SARS-CoV-2 correlates with macrophage polarization toward a pro-inflammatory phenotype and attenuated antigen presentation. In vitro characterization of purified wild-type and mutant PLpro revealed its strong deISGylating over deubiquitylating activity. Quantitative proteomic analyses of PLpro substrates and secretome from SARS-CoV-2-infected macrophages revealed several glycolytic enzymes previously implicated in the expression of inflammatory genes and pro-inflammatory cytokines, respectively. Collectively, our results indicate that altered free versus conjugated ISG15 dysregulates macrophage responses and probably contributes to the cytokine storms triggered by SARS-CoV-2.	[Munnur, Deeksha; van Leur, Sophie Wilhelmina; Sanyal, Sumana] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford, England; [Teo, Qiwen; Lee, Horace H. Y.; Ho, Julian; Ng, Wilson W. S.; Siu, Lewis Y. L.; Mok, Chris Ka Pun; Sanyal, Sumana] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China; [Eggermont, Denzel; Thery, Fabien; Impens, Francis] VIB UGent Ctr Med Biotechnol, Ghent, Belgium; [Eggermont, Denzel; Impens, Francis] Univ Ghent, Dept Biomol Med, Ghent, Belgium; [Lee, Horace H. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China; [Beling, Antje] Charite Univ Med Berlin, Berlin, Germany; [Beling, Antje] Free Univ Berlin, Berlin, Germany; [Beling, Antje] Humboldt Univ, Inst Biochem, Berlin, Germany; [Beling, Antje] Teutsches Zentrum Herz Kreislauf Forsch, Partner Site Berlin, Berlin, Germany; [Ploegh, Hidde] Boston Childrens Hosp, Boston, MA USA; [Ploegh, Hidde] Harvard Med Sch, Boston, MA 02115 USA; [Pinto-Fernandez, Adan; Damianou, Andreas; Kessler, Benedikt] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Mass Spectrometry Lab, Oxford, England; [Impens, Francis] VIB Prote Core, Ghent, Belgium; [Mok, Chris Ka Pun] Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Mok, Chris Ka Pun] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China	University of Oxford; University of Hong Kong; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Hong Kong; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Oxford; Flanders Institute for Biotechnology (VIB); Chinese University of Hong Kong; Chinese University of Hong Kong	Sanyal, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford, England.; Mok, CKP; Sanyal, S (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China.; Impens, F (corresponding author), VIB UGent Ctr Med Biotechnol, Ghent, Belgium.; Impens, F (corresponding author), Univ Ghent, Dept Biomol Med, Ghent, Belgium.; Impens, F (corresponding author), VIB Prote Core, Ghent, Belgium.; Mok, CKP (corresponding author), Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China.; Mok, CKP (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.	francis.impens@vib-ugent.be; kapunmok@cuhk.edu.hk; sumana.sanyal@path.ox.ac.uk	Mok, Chris Ka Pun/ABD-2667-2021	Beling, Antje/0000-0002-1826-5248; Eggermont, Denzel/0000-0002-3940-7583; Lee, Hok Yeung Horace/0000-0003-4360-9986; Impens, Francis/0000-0003-2886-9616; Thery, Fabien/0000-0001-5007-0371; Kessler, Benedikt/0000-0002-8160-2446; van Leur, Sophie/0000-0002-0411-6102; TEO, QI WEN/0000-0001-6749-9684	Research Grants Council of the Hong Kong Special Administrative Region [17113019]; Health and Medical Research Funds [17161202]; Medical Research Council UK [MC_PC_19063]; Wellcome Trust [220776/Z/20/Z]; Guangdong Province International Scientific and Technological Cooperation Projects [2020A0505100063]; National Research Foundation of Korea grant through the Korean government [NRF-2018M3A9H4055203]; Research Foundation Flanders [G0F8616N]; Research Foundation Flanders; Foundation for Experimental Biomedicine Zurich; Berlin University Alliance; German Research Foundation [BE 6335/2, BE 6335/4, CRC1292, CRC167, 259373024]; ERA-NET Infect-ERA BacVirISG15	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Health and Medical Research Funds; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Guangdong Province International Scientific and Technological Cooperation Projects; National Research Foundation of Korea grant through the Korean government(National Research Foundation of Korea); Research Foundation Flanders(FWO); Research Foundation Flanders(FWO); Foundation for Experimental Biomedicine Zurich; Berlin University Alliance; German Research Foundation(German Research Foundation (DFG)); ERA-NET Infect-ERA BacVirISG15	We thank the Faculty Core Facility and Centre for Genomic Sciences of the LKS Faculty of Medicine of the University of Hoing Kong for providing tools and technical support; we also acknowledge the support of the clinicians who facilitated this study, including O. T.-Y. Tsang, W. S. Leung, J. M. C. Chan, T. S. H. Chik, C. Y. C. Choi, J. Y. H. Chan, D. P.-L. Lau and Y. M. Ho, the dedicated clinical team at the Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, the patients who kindly consented to participate in this investigation and the Hong Kong Red Cross Blood Transfusion Service for providing buffy coat packs for this research project. We thank R. Bruzzone for comments on the manuscript and J. S. M. Peiris for the license on the clinical experiments. This work was supported by research grants from the Research Grants Council of the Hong Kong Special Administrative Region (no. 17113019) (S.S.), Health and Medical Research Funds (no. 17161202) (S.S.), Medical Research Council UK (no. MC_PC_19063) (S.S.) and the Wellcome Trust (no. 220776/Z/20/Z) (S.S.), Guangdong Province International Scientific and Technological Cooperation Projects (no. 2020A0505100063) (C.K.P.M.) and the National Research Foundation of Korea grant funded through the Korean government (no. NRF-2018M3A9H4055203) (C.K.P.M.). F.I. acknowledges support from the Odysseus grant no. G0F8616N from Research Foundation Flanders and ERA-NET Infect-ERA BacVirISG15. D.E. is supported by a Research Foundation Flanders PhD fellowship for fundamental research. A.B. receives support from the Foundation for Experimental Biomedicine Zurich, the Berlin University Alliance and the German Research Foundation (grant nos. BE 6335/2 and BE 6335/4 and CRC1292 project 02 and CRC167 Project-ID 259373024).	Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; dos Santos PF, 2017, J INTERF CYTOK RES, V37, P246, DOI 10.1089/jir.2016.0103; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hermann M, 2017, TRENDS IMMUNOL, V38, P79, DOI 10.1016/j.it.2016.11.001; Hsiang TY, 2009, J VIROL, V83, P5971, DOI 10.1128/JVI.01667-08; Jahan AS, 2020, CELL REP, V30, P1570, DOI 10.1016/j.celrep.2020.01.015; Kespohl M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay1109; Koutsakos M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01158; Kroeker AL, 2012, J PROTEOME RES, V11, P4132, DOI 10.1021/pr300239r; Leidal AM, 2020, NAT CELL BIOL, V22, P187, DOI 10.1038/s41556-019-0450-y; Li MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19028-w; Mah AY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95128; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Morales DJ, 2015, J VIROL, V89, P337, DOI 10.1128/JVI.02110-14; Oslund KL, 2011, FUTURE VIROL, V6, P951, DOI 10.2217/FVL.11.63; Padovan E, 2002, CANCER RES, V62, P3453; Park JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12513; Perng YC, 2018, NAT REV MICROBIOL, V16, P423, DOI 10.1038/s41579-018-0020-5; Pinto-Fernandez A, 2021, BRIT J CANCER, V124, P817, DOI 10.1038/s41416-020-01167-y; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Radoshevich L, 2015, ELIFE, V4, DOI 10.7554/eLife.06848; Sanyal S, 2013, CELL HOST MICROBE, V14, P510, DOI 10.1016/j.chom.2013.10.011; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Swaim CD, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107772; Swaim CD, 2017, MOL CELL, V68, P581, DOI 10.1016/j.molcel.2017.10.003; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yan S, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144888; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zhang M, 2020, CELL, V181, P637, DOI 10.1016/j.cell.2020.03.031; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhang YF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13393-x; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	50	22	22	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1416	+		10.1038/s41590-021-01035-8	http://dx.doi.org/10.1038/s41590-021-01035-8		OCT 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34663977	Green Submitted, Bronze			2022-12-18	WOS:000708376800004
J	Tan, C; Hiwa, R; Mueller, JL; Vykunta, V; Hibiya, K; Noviski, M; Huizar, J; Brooks, JF; Garcia, J; Heyn, C; Li, ZM; Marson, A; Zikherman, J				Tan, Corey; Hiwa, Ryosuke; Mueller, James L.; Vykunta, Vivasvan; Hibiya, Kenta; Noviski, Mark; Huizar, John; Brooks, Jeremy F.; Garcia, Jose; Heyn, Cheryl; Li, Zhongmei; Marson, Alexander; Zikherman, Julie			NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSES; CUTTING EDGE; NUR77; TRANSCRIPTION; PROLIFERATION; RECOGNITION; LYMPHOCYTES; MIP-1-ALPHA; ALPHA/BETA; EXPRESSION	Antigen stimulation (signal 1) triggers B cell proliferation and primes B cells to recruit, engage and respond to T cell help (signal 2). Failure to receive signal 2 within a defined time window results in B cell apoptosis, yet the mechanisms that enforce dependence on co-stimulation are incompletely understood. Nr4a1-3 encode a small family of orphan nuclear receptors that are rapidly induced by B cell antigen receptor stimulation. Here, we show that Nr4a1 and Nr4a3 play partially redundant roles to restrain B cell responses to antigen in the absence of co-stimulation and do so, in part, by repressing the expression of BATF and, consequently, MYC. The NR4A family also restrains B cell access to T cell help by repressing expression of the T cell chemokines CCL3 and CCL4, as well as CD86 and ICAM1. Such NR4A-mediated regulation plays a role specifically under conditions of competition for limiting T cell help.	[Tan, Corey; Hiwa, Ryosuke; Mueller, James L.; Vykunta, Vivasvan; Hibiya, Kenta; Noviski, Mark; Brooks, Jeremy F.; Garcia, Jose; Heyn, Cheryl; Zikherman, Julie] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, San Francisco, CA 94143 USA; [Tan, Corey; Noviski, Mark] Univ Calif San Francisco, Biomed Sci BMS Grad Program, San Francisco, CA 94143 USA; [Huizar, John] Univ Calif San Francisco, Sch Med, HHMI Med Fellows Program, San Francisco, CA USA; [Li, Zhongmei; Marson, Alexander] J David Gladstone Inst, San Francisco, CA USA; [Li, Zhongmei; Marson, Alexander] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Li, Zhongmei; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Li, Zhongmei; Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Li, Zhongmei; Marson, Alexander] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Li, Zhongmei; Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Zikherman, J (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, San Francisco, CA 94143 USA.	julie.zikherman@ucsf.edu		Vykunta, Vivasvan/0000-0002-5409-8635; Noviski, Mark/0000-0001-8072-1059	NIAID [5T32AI007334-28]; NIAMS [R01AR069520]; Rheumatology Research Foundation Innovative Research Award; Uehara Memorial Foundation Research Fellowship; Burroughs Wellcome Fund; Cancer Research Institute Lloyd J. Old STAR grant; Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy; HHMI Medical Research Fellows program	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation Innovative Research Award; Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute Lloyd J. Old STAR grant; Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy; HHMI Medical Research Fellows program	We thank our funders: NIAID 5T32AI007334-28 (C.T.), the HHMI Medical Research Fellows program (J.H.), NIAMS R01AR069520 (J.Z.) the Rheumatology Research Foundation Innovative Research Award (J.Z.), and the Uehara Memorial Foundation Research Fellowship (R.H.). A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund, is an investigator at the Chan Zuckerberg Biohub and is a recipient of The Cancer Research Institute Lloyd J. Old STAR grant. A.M. has received funds from the Innovative Genomics Institute and Parker Institute for Cancer Immunotherapy.	Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; CALNAN BJ, 1995, IMMUNITY, V3, P273; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Damdinsuren B, 2010, IMMUNITY, V32, P355, DOI 10.1016/j.immuni.2010.02.013; Finkin S, 2019, IMMUNITY, V51, P324, DOI 10.1016/j.immuni.2019.06.013; Fowler T, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0012-x; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Huang B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32391-5; Huizar John, 2017, Immunohorizons, V1, P188, DOI 10.4049/immunohorizons.1700048; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Krzysiek R, 1999, J IMMUNOL, V162, P4455; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Ma YJ, 2017, CELL HOST MICROBE, V21, P580, DOI 10.1016/j.chom.2017.04.005; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Noviski M, 2019, J IMMUNOL, V203, P418, DOI 10.4049/jimmunol.1900175; Nowyhed HN, 2015, J IMMUNOL, V195, P3515, DOI 10.4049/jimmunol.1403027; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Tan C, 2019, J IMMUNOL, V202, P2907, DOI 10.4049/jimmunol.1801565; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Turner JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15072; Wholey WY, 2020, BIOCONJUGATE CHEM, V31, P685, DOI 10.1021/acs.bioconjchem.9b00825; Wingate AD, 2006, BIOCHEM SOC T, V34, P1107, DOI 10.1042/BST0341107; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	56	22	23	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1267	+		10.1038/s41590-020-0765-7	http://dx.doi.org/10.1038/s41590-020-0765-7		AUG 2020	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32868928	Green Accepted, Green Submitted			2022-12-18	WOS:000565239800001
J	Verdu, EF; Danska, JS				Verdu, Elena F.; Danska, Jayne S.			Common ground: shared risk factors for type 1 diabetes and celiac disease	NATURE IMMUNOLOGY			English	Review							T-CELLS; GLUTEN INTRODUCTION; GUT MICROBIOME; CESAREAN-SECTION; ISLET AUTOIMMUNITY; FREE DIET; HLA-DQ; INTRAEPITHELIAL LYMPHOCYTES; TISSUE TRANSGLUTAMINASE; INFLAMMATORY RESPONSES	Risk factors for most autoimmune diseases are multifactorial genetic variants modified by environmental risk factors. Type 1 diabetes and celiac disease share high-risk HLA haplotypes, and the prevalence of both diseases has increased in many regions during the past half century. Unknown environmental factors are suspected to have increased the disease penetrance. Celiac disease depends on immune responses to dietary gluten, whereas the environmental risk factors for type 1 diabetes are not yet clear. Here, we consider the shared heritable genetic factors and review evidence of the dietary and microbial exposures, particularly in early life, that might influence the pathogenesis of one or both diseases. A deeper mechanistic understanding of the environmental factors responsible for increased risk of these diseases should provide opportunities to manipulate exposure in children carrying defined risk markers and thus prevent and attenuate disease, as well as to identify new therapeutic strategies for patients.	[Verdu, Elena F.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Med, Div Gastroenterol, Hamilton, ON, Canada; [Danska, Jayne S.] Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Danska, Jayne S.] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada; [Danska, Jayne S.] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Danska, JS (corresponding author), Hosp Sick Children, Res Inst, Toronto, ON, Canada.; Danska, JS (corresponding author), Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada.; Danska, JS (corresponding author), Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada.	jayne.danska@sickkids.ca			Juvenile Diabetes Research Foundation; Canadian Institutes of Health Research (CIHR); Anne and Max Tanenbaum Chair in Molecular Medicine, University of Toronto; Hospital for Sick Children (SickKids) Foundation; Canada Research Chair; CIHR [142773]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Anne and Max Tanenbaum Chair in Molecular Medicine, University of Toronto; Hospital for Sick Children (SickKids) Foundation; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR))	J.S.D. is supported by the Juvenile Diabetes Research Foundation; by the Canadian Institutes of Health Research (CIHR); as the Anne and Max Tanenbaum Chair in Molecular Medicine, University of Toronto; and by the Hospital for Sick Children (SickKids) Foundation. E.F.V. is supported as a Canada Research Chair and by CIHR #142773.	Adlercreutz EH, 2014, CLIN EXP IMMUNOL, V177, P391, DOI 10.1111/cei.12340; Adlercreutz EH, 2015, ACTA PAEDIATR, V104, P178, DOI 10.1111/apa.12836; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Aronsson CA, 2015, PEDIATRICS, V135, P239, DOI 10.1542/peds.2014-1787; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Beyerlein A, 2014, DIABETES CARE, V37, pE194, DOI 10.2337/dc14-1208; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Bonifacio E, 2011, DIABETES, V60, P3300, DOI 10.2337/db11-0729; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Brorsson CA, 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dcs15-2003; Bruun SW, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2424306; Caminero A, 2016, GASTROENTEROLOGY, V151, P670, DOI 10.1053/j.gastro.2016.06.041; Castellaneta S, 2015, DIABETES CARE, V38, P760, DOI 10.2337/dc14-2890; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Chmiel R, 2015, ACTA DIABETOL, V52, P621, DOI 10.1007/s00592-014-0628-5; Ciccocioppo R, 2000, CLIN EXP IMMUNOL, V120, P235, DOI 10.1046/j.1365-2249.2000.01200.x; Clausen TD, 2016, EPIDEMIOLOGY, V27, P547, DOI 10.1097/EDE.0000000000000488; Craig ME, 2017, DIABETES CARE, V40, P1034, DOI 10.2337/dc16-2508; Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Crespo-Escobar P, 2017, AM J CLIN NUTR, V105, P890, DOI 10.3945/ajcn.116.144352; D'Argenio V, 2016, AM J GASTROENTEROL, V111, P879, DOI 10.1038/ajg.2016.95; de Beeck AO, 2016, NAT REV ENDOCRINOL, V12, P263, DOI 10.1038/nrendo.2016.30; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Elfstrom P, 2014, ALIMENT PHARM THER, V40, P1123, DOI 10.1111/apt.12973; Funda DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094530; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Galipeau HJ, 2015, AM J PATHOL, V185, P2969, DOI 10.1016/j.ajpath.2015.07.018; Galipeau HJ, 2011, J IMMUNOL, V187, P4338, DOI 10.4049/jimmunol.1100854; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gorelick J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050482; Gorman JA, 2017, NAT IMMUNOL, V18, P744, DOI 10.1038/ni.3766; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Gutierrez-Achury J, 2015, DIABETES CARE, V38, pS37, DOI 10.2337/dcs15-2007; Hagopian W, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1305; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Hyytinen M, 2017, GASTROENTEROLOGY, V153, P961, DOI 10.1053/j.gastro.2017.06.049; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Inshaw JRJ, 2018, NAT IMMUNOL, V19, P674, DOI 10.1038/s41590-018-0129-8; Iversen R, 2015, J IMMUNOL, V195, P5159, DOI 10.4049/jimmunol.1501363; Jabri B, 2017, J IMMUNOL, V198, P3005, DOI 10.4049/jimmunol.1601693; Johansen BH, 1996, IMMUNOGENETICS, V45, P142, DOI 10.1007/s002510050182; KAGNOFF MF, 1987, GUT, V28, P995, DOI 10.1136/gut.28.8.995; Karges W, 1997, DIABETES, V46, P557, DOI 10.2337/diabetes.46.4.557; Kemppainen KM, 2017, CLIN GASTROENTEROL H, V15, P694, DOI 10.1016/j.cgh.2016.10.033; Kemppainen KM, 2015, DIABETES CARE, V38, P329, DOI 10.2337/dc14-0850; Kimpimaki T, 2001, J CLIN ENDOCR METAB, V86, P4782, DOI 10.1210/jc.86.10.4782; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Kyvik KO, 2004, DIABETOLOGIA, V47, P377, DOI 10.1007/s00125-004-1331-9; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lionetti E, 2017, J PEDIATR-US, V184, P81, DOI 10.1016/j.jpeds.2017.01.023; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Macpherson AJ, 2007, SEMIN IMMUNOL, V19, P57, DOI 10.1016/j.smim.2007.04.001; Malkani S, 1997, DIABETES, V46, P1133, DOI 10.2337/diabetes.46.7.1133; Maltoni G, 2017, DIABETES CARE, V40, pE167, DOI 10.2337/dc17-1348; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Marietta EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078687; Marild K, 2015, AM J GASTROENTEROL, V110, P1475, DOI 10.1038/ajg.2015.287; Marild K, 2012, GASTROENTEROLOGY, V142, P39, DOI 10.1053/j.gastro.2011.09.047; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGinty JW, 2014, DIABETES, V63, P3033, DOI 10.2337/db13-1952; McKenzie CI, 2015, TRENDS ENDOCRIN MET, V26, P511, DOI 10.1016/j.tem.2015.07.009; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Parkkola A, 2018, PEDIATR DIABETES, V19, P305, DOI 10.1111/pedi.12563; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Paxson JA, 1997, DIABETES, V46, P1711, DOI 10.2337/diabetes.46.11.1711; Penno MAS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-124; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Phillips JE, 2017, PEDIATR DIABETES, V18, P417, DOI 10.1111/pedi.12425; Pinto-Sanchez MI, 2016, J PEDIATR-US, V168, P132, DOI 10.1016/j.jpeds.2015.09.032; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Riddle MS, 2013, DIGEST DIS SCI, V58, P3242, DOI 10.1007/s10620-013-2733-7; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Samuelsson U, 2015, DIABETOLOGIA, V58, P2517, DOI 10.1007/s00125-015-3716-3; Schuppan D, 1998, ANN NY ACAD SCI, V859, P121, DOI 10.1111/j.1749-6632.1998.tb11116.x; Setty M, 2015, GASTROENTEROLOGY, V149, P681, DOI 10.1053/j.gastro.2015.05.013; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Simonson W, 2002, METABOLISM, V51, P569, DOI 10.1053/meta.2002.31979; Singh P, 2018, CLIN GASTROENTEROL H, V16, P823, DOI 10.1016/j.cgh.2017.06.037; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; Szajewska H, 2015, ALIMENT PHARM THER, V41, P1038, DOI 10.1111/apt.13163; Tack GJ, 2010, NAT REV GASTRO HEPAT, V7, P204, DOI 10.1038/nrgastro.2010.23; TUOMILEHTO J, 1995, INT J EPIDEMIOL, V24, P984, DOI 10.1093/ije/24.5.984; Tuomilehto J, 2013, CURR DIABETES REP, V13, P795, DOI 10.1007/s11892-013-0433-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uibo R, 2011, CELL MOL IMMUNOL, V8, P150, DOI 10.1038/cmi.2010.66; van Lummel M, 2016, DIABETES, V65, P732, DOI 10.2337/db15-1031; vandeWal Y, 1997, IMMUNOGENETICS, V46, P484, DOI 10.1007/s002510050309; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Verbeek WHM, 2008, AM J GASTROENTEROL, V103, P3152, DOI 10.1111/j.1572-0241.2008.02213.x; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Verdu EF, 2007, CAN J GASTROENTEROL, V21, P453, DOI 10.1155/2007/169591; Verdu EF, 2015, NAT REV GASTRO HEPAT, V12, P497, DOI 10.1038/nrgastro.2015.90; Vriezinga SL, 2014, NEW ENGL J MED, V371, P1304, DOI 10.1056/NEJMoa1404172; Wacklin P, 2014, AM J GASTROENTEROL, V109, P1933, DOI 10.1038/ajg.2014.355; Welander A, 2014, J PEDIATR-US, V165, P326, DOI 10.1016/j.jpeds.2014.04.003; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Winkler C, 2011, DIABETES, V60, P685, DOI 10.2337/db10-1269; Witso E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027781; Yang JB, 2017, J IMMUNOL, V199, P91, DOI 10.4049/jimmunol.1601570; Yang J, 2014, P NATL ACAD SCI USA, V111, P14840, DOI 10.1073/pnas.1416864111; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zou J, 2018, CELL HOST MICROBE, V23, P41, DOI 10.1016/j.chom.2017.11.003	159	22	22	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					685	695		10.1038/s41590-018-0130-2	http://dx.doi.org/10.1038/s41590-018-0130-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925984				2022-12-18	WOS:000436341300014
J	Jain, SK; Tobin, DM; Tucker, EW; Venketaraman, V; Ordonez, AA; Jayashankar, L; Siddiqi, OK; Hammoud, DA; Prasadarao, NV; Sandor, M; Hafner, R; Fabry, Z				Jain, Sanjay K.; Tobin, David M.; Tucker, Elizabeth W.; Venketaraman, Vishwanath; Ordonez, Alvaro A.; Jayashankar, Lakshmi; Siddiqi, Omar K.; Hammoud, Dima A.; Prasadarao, Nemani V.; Sandor, Matyas; Hafner, Richard; Fabry, Zsuzsanna		NIH TB Meningitis Writing Grp	Tuberculous meningitis: a roadmap for advancing basic and translational research	NATURE IMMUNOLOGY			English	Editorial Material							BRAIN; GENOTYPE; THERAPY; ADULTS		[Jain, Sanjay K.; Tucker, Elizabeth W.; Ordonez, Alvaro A.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Jain, Sanjay K.; Tucker, Elizabeth W.; Ordonez, Alvaro A.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD 21218 USA; [Jain, Sanjay K.; Ordonez, Alvaro A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Tobin, David M.] Duke Univ, Sch Med, Dept Mol Genet, Durham, NC USA; [Tobin, David M.] Duke Univ, Sch Med, Dept Microbiol & Immunol, Durham, NC USA; [Tucker, Elizabeth W.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Venketaraman, Vishwanath] Western Univ Hlth Sci, Dept Basic Med Sci, Pomona, CA USA; [Jayashankar, Lakshmi] Columbus Technol Inc, NIAID, US Natl Inst Hlth, Bethesda, MD USA; [Siddiqi, Omar K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Global Neurol Program,Dept Neurol,Div Neuroimmuno, Boston, MA USA; [Siddiqi, Omar K.] Univ Zambia, Sch Med, Dept Internal Med, Lusaka, Zambia; [Hammoud, Dima A.] NIAID, Ctr Infect Dis Imaging, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Sabin Res Inst, Los Angeles, CA 90027 USA; [Sandor, Matyas; Fabry, Zsuzsanna] Univ Wisconsin, Madison Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Hafner, Richard] NIAID, Div Aids, 9000 Rockville Pike, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University; Duke University; Johns Hopkins University; Western University of Health Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Zambia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Children's Hospital Los Angeles; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD 21218 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.; Fabry, Z (corresponding author), Univ Wisconsin, Madison Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA.	sjain5@jhmi.edu; zfabry@wisc.edu	Hammoud, Dima A/C-2286-2015; venketaraman, Vishwanath/AAW-6945-2020; Ordonez, Alvaro/AAC-9996-2022	venketaraman, Vishwanath/0000-0002-2586-1160; Ordonez, Alvaro/0000-0002-8571-0655; Tobin, David/0000-0003-3465-5518; Jayashankar, Lakshmi/0000-0003-3607-7221; Tucker, Elizabeth W/0000-0002-0971-3635; Hammoud, Dima/0000-0001-7406-7871; Jain, Sanjay/0000-0001-9620-7070	NHLBI NIH HHS [R01 HL128778, R01 HL131829] Funding Source: Medline; NIAID NIH HHS [R01 AI130236, R01 AI127715, R01 AI125517] Funding Source: Medline; NIBIB NIH HHS [R01 EB020539] Funding Source: Medline; NINDS NIH HHS [K23 NS084054, R01 NS076946] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127715, R01AI125517, R01AI130236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS084054, R01NS076946] Funding Source: NIH RePORTER; CLINICAL CENTER [ZICCL040013] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER		Bahr NC, 2018, LANCET INFECT DIS, V18, P68, DOI [10.1016/s1473-3099(17)30474-7, 10.1016/S1473-3099(17)30474-7]; Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748; Chiang SS, 2014, LANCET INFECT DIS, V14, P947, DOI 10.1016/S1473-3099(14)70852-7; Coureuil M, 2017, NAT REV MICROBIOL, V15, P149, DOI 10.1038/nrmicro.2016.178; DeMarco VP, 2015, ANTIMICROB AGENTS CH, V59, P5768, DOI 10.1128/AAC.01146-15; Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062; Jain SK, 2006, J INFECT DIS, V193, P1287, DOI 10.1086/502631; Jullien S., 2016, SYST REV, V9; Mai NTH, 2018, ELIFE, V7, DOI [10.7554/elife.33478, 10.7554/eLife.33478]; MATYSZAK MK, 1995, NEUROSCIENCE, V64, P967, DOI 10.1016/0306-4522(94)00448-E; Morris D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00073; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Rohlwink UK, 2016, PEDIATR INFECT DIS J, V35, pE301, DOI 10.1097/INF.0000000000001236; Ruslami R, 2013, LANCET INFECT DIS, V13, P27, DOI 10.1016/S1473-3099(12)70264-5; Sanchez-Garibay C, 2018, TUBERCULOSIS, V110, P1, DOI 10.1016/j.tube.2018.02.007; Skerry C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066310; Sun F, 2014, ANTIMICROB AGENTS CH, V58, P6297, DOI 10.1128/AAC.02784-14; Thuong NTT, 2017, J INFECT DIS, V215, P1020, DOI 10.1093/infdis/jix050; Tobin D. M., 2010, CELL, V717-730; Tsenova L, 1998, J INFECT DIS, V177, P1563, DOI 10.1086/515327; Tucker EW, 2016, DIS MODEL MECH, V9, P1497, DOI 10.1242/dmm.027326; van Laarhoven A, 2018, LANCET INFECT DIS, V18, P526, DOI 10.1016/S1473-3099(18)30053-7; van Laarhoven A, 2017, J INFECT DIS, V215, P1029, DOI 10.1093/infdis/jix051; Weinstein EA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009815	25	22	24	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					521	525		10.1038/s41590-018-0119-x	http://dx.doi.org/10.1038/s41590-018-0119-x			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777209	Green Accepted			2022-12-18	WOS:000433041500018
J	Bedoui, S; Gebhardt, T; Gasteiger, G; Kastenmuller, W				Bedoui, Sammy; Gebhardt, Thomas; Gasteiger, Georg; Kastenmueller, Wolfgang			Parallels and differences between innate and adaptive lymphocytes	NATURE IMMUNOLOGY			English	Article							MEMORY CD8(+) T; LYMPHOID-CELLS; NK CELLS; ANTIGEN; TISSUE; ACTIVATION; MATURATION; INFECTION; REQUIRES; IMMUNITY	Lymphocytes are essential in innate and adaptive immunity. Recent insights suggest that some innate lymphocytes execute functions with adaptive characteristics, while adaptive lymphocytes can operate in ways reminiscent of innate cells. Rather than partitioning lymphocytes according to the type of effector function they execute, we propose that a relevant discrimination relates to the existence of conventional T cells in a naive state. The naive state can be seen as an actively repressed condition that supports T cell diversity and enables the flexible differentiation of effector cells in a manner that best addresses the antigenic challenge. We discuss these considerations in the context of the relative roles of innate lymphoid cells and antigen-experienced T cells in the immune system.	[Bedoui, Sammy; Gebhardt, Thomas] Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Gasteiger, Georg] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Med Ctr, Mainz, Germany; [Gasteiger, Georg] Johannes Gutenberg Univ Mainz, Forschungszentrum Immuntherapie, Med Ctr, Mainz, Germany; [Kastenmueller, Wolfgang] Univ Bonn, Inst Expt Immunol, Bonn, Germany	University of Melbourne; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Bonn	Bedoui, S (corresponding author), Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	sbedoui@unimelb.edu.au		Gebhardt, Thomas/0000-0002-3768-9468; Gasteiger, Georg/0000-0001-6986-127X; BEDOUI, SAMMY/0000-0002-7443-0543	National Health and Medical Research Council of Australia; Sylvia and Charles Viertel Charitable Foundation; German Research Council graduate program ('BoMeRang') [2168/1]; Emmy Noether program; Excellence Cluster ImmunoSensation in Bonn, Germany; NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation; German Research Council graduate program ('BoMeRang'); Emmy Noether program(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation in Bonn, Germany; NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia	We thank A. Brooks, N. La Gruta, B. Russ, S. Turner, D. Godfrey, D. Gray and N. Garbi for input and discussions. Supported by the National Health and Medical Research Council of Australia, the Sylvia and Charles Viertel Charitable Foundation, the German Research Council graduate program (2168/1 ('Bo&MeRang'), for S.B., T.G. and W.K.; the Emmy Noether program, for G.G.; and the Excellence Cluster ImmunoSensation in Bonn, Germany, for W.K.) and NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia (W.K.).	Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bezbradica JS, 2014, NAT IMMUNOL, V15, P333, DOI 10.1038/ni.2845; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gugasyan R, 2012, EMBO J, V31, P692, DOI 10.1038/emboj.2011.435; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Hogquist KA, 2015, J IMMUNOL, V195, P1351, DOI 10.4049/jimmunol.1501050; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Jameson SC, 2015, ADV IMMUNOL, V126, P173, DOI 10.1016/bs.ai.2014.12.001; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shimizu K, 2014, P NATL ACAD SCI USA, V111, P12474, DOI 10.1073/pnas.1406240111; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Sun JC, 2014, EMBO J, V33, P1295, DOI 10.1002/embj.201387651; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898	51	22	22	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					490	494		10.1038/ni.3432	http://dx.doi.org/10.1038/ni.3432			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092806				2022-12-18	WOS:000374323100007
J	Kagan, JC; Horng, T				Kagan, Jonathan C.; Horng, Tiffany			NLRP3 inflammasome activation: CD36 serves double duty	NATURE IMMUNOLOGY			English	Editorial Material							SCAVENGER RECEPTORS; NALP3 INFLAMMASOME; ATHEROSCLEROSIS; LIGANDS	Studies have linked the NLRP3 inflammasome pathway to the elaboration of sterile inflammation. CD36 serves a dual role by priming transcription of the gene encoding interleukin 1 beta (IL-1 beta) and inducing assembly of the NLRP3 inflammasome complex, which leads to the release of active IL-1 beta.	[Kagan, Jonathan C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Horng, Tiffany] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			NIAID NIH HHS [R56 AI103082, R01 AI093589] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R56AI103082] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608	14	22	25	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					772	774		10.1038/ni.2668	http://dx.doi.org/10.1038/ni.2668			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23867926	Green Accepted			2022-12-18	WOS:000322010600004
J	Bowie, AG				Bowie, Andrew G.			Innate sensing of bacterial cyclic dinucleotides: more than just STING	NATURE IMMUNOLOGY			English	News Item							DI-GMP	Bacterial cyclic dinucleotides are recognized by the innate immune system, and this leads to the induction of type I interferons. The mammalian helicase DDX41 directly binds cyclic dinucleotides and mediates the signaling pathway to the induction of type I interferons.	Univ Dublin Trinity Coll, Trin Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Trin Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373				Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	11	22	28	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1137	1139		10.1038/ni.2469	http://dx.doi.org/10.1038/ni.2469			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160208	Green Submitted			2022-12-18	WOS:000311217900004
J	Akdis, M; Akdis, CA				Akdis, Miibeccel; Akdis, Cezmi A.			IgE class switching and cellular memory	NATURE IMMUNOLOGY			English	Editorial Material								After class switching in naive B cells, memory B cells and plasma cells that produce immunoglobulin E (IgE(+) cells) develop through a germinal-center IgE(+) intermediate cell without an IgG1 phase. In addition, cellular IgE memory resides in IgE(+) memory B cells, and IgG1(+) memory B cells are not an important source of IgE memory.	[Akdis, Miibeccel; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	Akdis, M (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland.	akdisac@siaf.uzh.ch	Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X				Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Jabara HH, 2008, J ALLERGY CLIN IMMUN, V121, P191, DOI 10.1016/j.jaci.2007.08.008; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941	11	22	23	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					312	314						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430776				2022-12-18	WOS:000301886800003
J	Ridgway, WM; Healy, B; Smink, LJ; Rainbow, D; Wicker, LS				Ridgway, William M.; Healy, Barry; Smink, Luc J.; Rainbow, Dan; Wicker, Linda S.			New tools for defining the 'genetic background' of inbred mouse strains	NATURE IMMUNOLOGY			English	Editorial Material							MICE; POLYMORPHISM	There is general appreciation that `genetic background effects' can profoundly affect the immune phenotypes of congenic, transgenic and knockout mice. We suggest that attributing phenotypes to genetic background effects is outmoded and that new databases containing single-nucleotide polymorphisms obtained with a group of inbred mouse strains can be used to define the flanking DNA of nearly all mouse genes.	Univ Pittsburgh, Sch Med, Div Rheumatol & Immunol, Pittsburgh, PA 15218 USA; Univ Cambridge, Med Res Inst, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust, Cambridge CB2 0XY, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cambridge; Wellcome Trust Sanger Institute	Ridgway, WM (corresponding author), Univ Pittsburgh, Sch Med, Div Rheumatol & Immunol, Pittsburgh, PA 15218 USA.	ridgway2+@pitt.edu; linda.wicker@cimr.cam.ac.uk	Wicker, Linda S/F-7384-2010		NIAID NIH HHS [U19 AI056374-010002, U19 AI056374] Funding Source: Medline; NIDDK NIH HHS [R01 DK090019] Funding Source: Medline; Wellcome Trust [061859] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Cannons JL, 2005, J AUTOIMMUN, V25, P13, DOI 10.1016/j.jaut.2005.04.007; Cuppen E, 2005, TRENDS GENET, V21, P318, DOI 10.1016/j.tig.2005.03.010; Edwards SV, 1997, GENETICS, V146, P655; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Irie J, 2006, IMMUNOGENETICS, V58, P9, DOI 10.1007/s00251-005-0066-1; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Leiter EH, 2002, DIABETOLOGIA, V45, P296, DOI 10.1007/s00125-001-0743-z; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Witmer PD, 2003, GENOME RES, V13, P485, DOI 10.1101/gr.717903; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	21	22	25	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					669	673		10.1038/ni0707-669	http://dx.doi.org/10.1038/ni0707-669			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579641				2022-12-18	WOS:000247718100004
J	Smyth, MJ				Smyth, MJ			Type I interferon and cancer immunoediting	NATURE IMMUNOLOGY			English	Editorial Material							TUMOR; IMMUNOSURVEILLANCE; SURVEILLANCE; RESPONSES		Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Smyth, MJ (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia.	mark.smyth@petermac.org	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240				Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850	13	22	25	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					646	648		10.1038/ni0705-646	http://dx.doi.org/10.1038/ni0705-646			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15970935				2022-12-18	WOS:000229975500006
J	Lemay, J; Marullo, S; Jockers, R; Alizon, M; Brelot, A				Lemay, J; Marullo, S; Jockers, R; Alizon, M; Brelot, A			On the dimerization of CCR5	NATURE IMMUNOLOGY			English	Letter									CNRS, UMR 8104, INSERM, U567,Dept Cell Biol, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lemay, J (corresponding author), CNRS, UMR 8104, INSERM, U567,Dept Cell Biol, F-75014 Paris, France.	alizon@cochin.inserm.fr	Jockers, Ralf/Q-2100-2019; Jockers, Ralf/P-2272-2017; Marullo, Stefano/C-6142-2008; Brelot, Anne/P-4129-2017	Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750; Marullo, Stefano/0000-0001-9604-9973; Lemay, Julie/0000-0002-4029-9911; Serrano, Antonio/0000-0003-1993-640X; Rodriguez Frade, Jose Miguel/0000-0002-7753-1462; Brelot, Anne/0000-0002-8095-4909				Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Brelot A, 2001, AIDS, V15, pS3, DOI 10.1097/00002030-200100005-00002; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200	5	22	23	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					535	535		10.1038/ni0605-535a	http://dx.doi.org/10.1038/ni0605-535a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908929				2022-12-18	WOS:000229385900001
J	Heath, WR; Villadangos, JA				Heath, WR; Villadangos, JA			No driving without a license	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL TOLERANCE; DENDRITIC CELLS; LYMPH-NODE; ANTIGEN; IMMATURE; IMMUNITY; SELF	The definition of the physiological functions of dendritic cells is undergoing refinement, as specialization of dendritic cell labor depends on their previous encounters.	Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Heath, WR (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	heath@wehi.edu.au	Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891; Heath, William/0000-0001-9670-259X				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Alpan O, 2004, NAT IMMUNOL, V5, P615, DOI 10.1038/ni1077; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513	12	22	22	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					125	126		10.1038/ni0205-125	http://dx.doi.org/10.1038/ni0205-125			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662437				2022-12-18	WOS:000226468100005
J	Hackett, CJ; Sharma, OK				Hackett, CJ; Sharma, OK			Frontiers in peptide-MHC class II multimer technology	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL ACTIVATION; ANTIGEN; BINDING; LYMPHOCYTES; SELECTION; MOLECULES; AFFINITY		NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20817 USA; NIAID, Div Acquired Immunodeficiency Syndrome, NIH, Bethesda, MD 20817 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hackett, CJ (corresponding author), NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20817 USA.			Hackett, Charles/0000-0003-4586-9669				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Latek RR, 2000, P NATL ACAD SCI USA, V97, P11460, DOI 10.1073/pnas.210384197; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; McMichael AJ, 1998, J EXP MED, V187, P1367, DOI 10.1084/jem.187.9.1367; McMichael AJ, 1999, J CLIN INVEST, V104, P1669, DOI 10.1172/JCI8943; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Ober BT, 2000, INT IMMUNOL, V12, P1353, DOI 10.1093/intimm/12.9.1353; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Stone JD, 2001, BIOPHYS J, V81, P2547, DOI 10.1016/S0006-3495(01)75899-7	19	22	27	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					887	889		10.1038/ni1002-887	http://dx.doi.org/10.1038/ni1002-887			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352960	Green Published			2022-12-18	WOS:000178242100003
J	Dooms, H; Abbas, AK				Dooms, H; Abbas, AK			Life and death in effector T cells	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR-BETA CHAIN; MEMORY CELLS; SUBSETS		Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Dooms, H (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA.			Dooms, Hans/0000-0001-7964-0876				BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Harbertson J, 2002, J IMMUNOL, V168, P1095, DOI 10.4049/jimmunol.168.3.1095; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; REFAELI Y, 2002, IN PRESS J EXP MED; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832	13	22	23	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					797	798		10.1038/ni0902-797	http://dx.doi.org/10.1038/ni0902-797			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12205464				2022-12-18	WOS:000177694900003
J	Blattman, JN; Cheng, LE; Greenberg, PD				Blattman, JN; Cheng, LE; Greenberg, PD			CD8(+) T cell responses: it's all downhill after their prime ...	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; EFFECTOR	The resolution of an immune response was thought to coincide with the clearance of infection. However, the kinetics of CD8(+) T cell decline may be programmed far before the antigen load lightens.	Univ Washington, Sch Med, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Blattman, JN (corresponding author), Univ Washington, Sch Med, Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,POB 19028, Seattle, WA 98109 USA.	pgreen@u.washington.edu						Arch RH, 1999, ANNU REV CELL DEV BI, V15, P113, DOI 10.1146/annurev.cellbio.15.1.113; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Derby MA, 2001, EUR J IMMUNOL, V31, P2951, DOI 10.1002/1521-4141(2001010)31:10<2951::AID-IMMU2951>3.0.CO;2-Q; Ehl S, 1998, CELL IMMUNOL, V189, P67, DOI 10.1006/cimm.1998.1344; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Tan LC, 1999, J IMMUNOL, V162, P1827; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	12	22	23	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					601	602		10.1038/ni0702-601	http://dx.doi.org/10.1038/ni0702-601			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087413				2022-12-18	WOS:000176441700005
J	Kinet, JP; Launay, P				Kinet, JP; Launay, P			Fc alpha/mu R: single member or first born in the family?	NATURE IMMUNOLOGY			English	News Item							RECEPTOR; CELLS; IGM		Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.		Launay, Pierre/AAH-7076-2019					Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; NAKAMURA T, 1993, J IMMUNOL, V151, P6933; OHNO T, 1990, J EXP MED, V172, P1165, DOI 10.1084/jem.172.4.1165; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508	9	22	22	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					371	372		10.1038/80805	http://dx.doi.org/10.1038/80805			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062492				2022-12-18	WOS:000165076100006
J	Silverstein, AM				Silverstein, AM			The most elegant immunological experiment of the XIX century	NATURE IMMUNOLOGY			English	Editorial Material									Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.							ASKONAS I, 1954, J BIOCH, V56, P597; Behring EV., 1890, DEUT MED WOCHENSCHR, V49, P1113; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; DIXON FJ, 1954, J IMMUNOL, V72, P179; EHRLICH P, 1956, COLLECT PAPERS, V2, P45; EHRLICH P, 1956, COLLECT PAPERS, V2, P63; EHRLICH P, 1956, COLLECT PAPERS, V2, P48; EHRLICH P, 1956, COLLECT PAPERS, V2, P31; EHRLICH P, 1956, COLLECT PAPERS, V2, P21; EHRLICH P, 1956, COLLECT PAPERS, V2, P27; EHRLICH P, 1956, COLLECT PAPERS, V2, P35; FOURNIER E, 1905, HEREDOSYPHILIS 2 GEN; Hemmings W.A., 1976, MATERNOFOETAL TRANSM; Silverstein AM, 1996, CELL IMMUNOL, V174, P1, DOI 10.1006/cimm.1996.0286; SOLOMON JB, 1971, FOETAL NEONATAL IMMU; 1891, VIRUS, P285	16	22	22	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					93	94		10.1038/77874	http://dx.doi.org/10.1038/77874			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248794				2022-12-18	WOS:000089814900003
J	Gray, D				Gray, D			Thanks for the memory	NATURE IMMUNOLOGY			English	News Item							CD8 T-CELLS; NAIVE	Memory is generated with most T cell responses. The effectiveness and power of CD8(+) memory T cells may be due to their quicker responses and broader capabilities.	Univ Edinburgh, ICAPB, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Gray, D (corresponding author), Univ Edinburgh, ICAPB, Ashworth Labs, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Gray, David/L-8295-2013	Gray, David/0000-0003-3785-4934				Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Farber DL, 1997, EUR J IMMUNOL, V27, P2094, DOI 10.1002/eji.1830270838; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; ZHANG J, 1988, IMMUNOL LETT, V18, P297, DOI 10.1016/0165-2478(88)90178-2; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	11	22	23	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					11	12		10.1038/76862	http://dx.doi.org/10.1038/76862			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881165				2022-12-18	WOS:000089814800005
J	Corbett, KS; Werner, AP; O' Connell, S; Gagne, M; Lai, LL; Moliva, JI; Flynn, B; Choi, A; Koch, M; Foulds, KE; Andrew, SF; Flebbe, DR; Lamb, E; Nurmukhambetova, ST; Provost, SJ; Bock, KW; Minai, M; Nagata, BM; Van Ry, A; Flinchbaugh, Z; Johnston, TS; Mokhtari, EB; Mudvari, P; Henry, AR; Laboune, F; Chang, B; Porto, M; Wear, J; Alvarado, GS; Boyoglu-Barnum, S; Todd, JPM; Bart, B; Cook, A; Dodson, A; Pessaint, L; Steingrebe, K; Elbashir, S; Sriparna, M; Pekosz, A; Andersen, H; Wu, K; Edwards, DK; Kar, S; Lewis, MG; Boritz, E; Moore, IN; Carfi, A; Suthar, MS; McDermott, A; Roederer, M; Nason, MC; Sullivan, NJ; Douek, DC; Graham, BS; Seder, RA				Corbett, Kizzmekia S.; Werner, Anne P.; O' Connell, Sarah; Gagne, Matthew; Lai, Lilin; Moliva, Juan, I; Flynn, Barbara; Choi, Angela; Koch, Matthew; Foulds, Kathryn E.; Andrew, Shayne F.; Flebbe, Dillon R.; Lamb, Evan; Nurmukhambetova, Saule T.; Provost, Samantha J.; Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Van Ry, Alex; Flinchbaugh, Zackery; Johnston, Timothy S.; Mokhtari, Elham Bayat; Mudvari, Prakriti; Henry, Amy R.; Laboune, Farida; Chang, Becky; Porto, Maciel; Wear, Jaclyn; Alvarado, Gabriela S.; Boyoglu-Barnum, Seyhan; Todd, John-Paul M.; Bart, Bridget; Cook, Anthony; Dodson, Alan; Pessaint, Laurent; Steingrebe, Katelyn; Elbashir, Sayda; Sriparna, Manjari; Pekosz, Andrew; Andersen, Hanne; Wu, Kai; Edwards, Darin K.; Kar, Swagata; Lewis, Mark G.; Boritz, Eli; Moore, Ian N.; Carfi, Andrea; Suthar, Mehul S.; McDermott, Adrian; Roederer, Mario; Nason, Martha C.; Sullivan, Nancy J.; Douek, Daniel C.; Graham, Barney S.; Seder, Robert A.			mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates	NATURE IMMUNOLOGY			English	Article							RECEPTOR-BINDING DOMAIN; SPIKE; IMMUNOGENICITY; MUTATIONS; VACCINE	B.1.351 is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant most resistant to antibody neutralization. We demonstrate how the dose and number of immunizations influence protection. Nonhuman primates received two doses of 30 or 100 mu g of Moderna's mRNA-1273 vaccine, a single immunization of 30 mu g, or no vaccine. Two doses of 100 mu g of mRNA-1273 induced 50% inhibitory reciprocal serum dilution neutralizing antibody titers against live SARS-CoV-2 p.Asp614Gly and B.1.351 of 3,300 and 240, respectively. Higher neutralizing responses against B.1.617.2 were also observed after two doses compared to a single dose. After challenge with B.1.351, there was similar to 4- to 5-log(10) reduction of viral subgenomic RNA and low to undetectable replication in bronchoalveolar lavages in the two-dose vaccine groups, with a 1-log(10) reduction in nasal swabs in the 100-mu g group. These data establish that a two-dose regimen of mRNA-1273 will be critical for providing upper and lower airway protection against major variants of concern.	[Corbett, Kizzmekia S.; Werner, Anne P.; O' Connell, Sarah; Gagne, Matthew; Moliva, Juan, I; Flynn, Barbara; Foulds, Kathryn E.; Andrew, Shayne F.; Flebbe, Dillon R.; Lamb, Evan; Nurmukhambetova, Saule T.; Provost, Samantha J.; Johnston, Timothy S.; Mokhtari, Elham Bayat; Mudvari, Prakriti; Henry, Amy R.; Laboune, Farida; Alvarado, Gabriela S.; Boyoglu-Barnum, Seyhan; Todd, John-Paul M.; Sriparna, Manjari; Boritz, Eli; McDermott, Adrian; Roederer, Mario; Sullivan, Nancy J.; Douek, Daniel C.; Graham, Barney S.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lai, Lilin; Suthar, Mehul S.] Emory Univ, Ctr Childhood Infect & Vaccines, Childrens Healthcare Atlanta, Dept Pediat,Dept Microbiol & Immunol,Emory Vaccin, Atlanta, GA 30322 USA; [Choi, Angela; Koch, Matthew; Elbashir, Sayda; Wu, Kai; Edwards, Darin K.; Carfi, Andrea] Moderna, Cambridge, MA USA; [Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Moore, Ian N.] NIAID, Infect Dis Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Van Ry, Alex; Flinchbaugh, Zackery; Chang, Becky; Porto, Maciel; Wear, Jaclyn; Bart, Bridget; Cook, Anthony; Dodson, Alan; Pessaint, Laurent; Steingrebe, Katelyn; Andersen, Hanne; Kar, Swagata; Lewis, Mark G.] Bioqual, Rockville, MD USA; [Pekosz, Andrew] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Microbiol & Immunol, Baltimore, MD USA; [Suthar, Mehul S.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Baltimore, MD USA; [Corbett, Kizzmekia S.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Children's Healthcare of Atlanta (CHOA); Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); BIOQUAL Inc.; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Harvard University; Harvard T.H. Chan School of Public Health	Graham, BS; Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov; rseder@mail.nih.gov		Foulds, Kathryn/0000-0003-4418-6495; Werner, Anne/0000-0003-2322-6830; McDermott, Adrian/0000-0003-0616-9117; Johnston, Timothy/0000-0001-9246-6155	Intramural Research Program of the VRC; NIAID; NIH; Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority [75A50120C00034]; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; Emory Executive Vice President for Health Affairs Synergy Fund Award; Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta, Woodruff Health Sciences Center 2020 COVID-19 CURE Award; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400004C]	Intramural Research Program of the VRC; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; Emory Executive Vice President for Health Affairs Synergy Fund Award; Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta, Woodruff Health Sciences Center 2020 COVID-19 CURE Award; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS)	We thank any additional members of all included laboratories for critical discussions and advice pertaining to experiments included in the manuscript. We thank J. Stein and M. Young for technology transfer and administrative support, respectively. We thank members of the NIH NIAID VRC Translational Research Program, including C. Case, H. Bao, E. McCarthy, J. Noor, A. Taylor, and R. Woodward, for technical and administrative assistance with animal experiments. We thA2-overexpressing HEK293 cells. We thank A. Creanga and M. Kanekiyo for the Vero-TMPRSS2 cells. We thank the laboratory of P. Kwong for providing protein for use in ELISA assays for detection of mucosal antibodies. We thank M. Brunner and M. Whitt, from the University of Tennessee Health Science Center College of Medicine, for kind support on recombinant VSV-based SARS-CoV-2 pseudovirus production. This work was supported by the Intramural Research Program of the VRC, NIAID and NIH. mRNA-1273 has been funded in part with Federal funds from the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under contract 75A50120C00034. K.S.C.'s research fellowship was partially funded by the Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH. Virus propagation and live-virus neutralization assays were funded by Emory Executive Vice President for Health Affairs Synergy Fund Award, Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta, Woodruff Health Sciences Center 2020 COVID-19 CURE Award and NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN272201400004C (M.S.S.). M.S.S. is on the Advisory Board of Moderna.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Andreano E., 2020, SARS COV 2 ESC IN VI; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Corbett K. S., SCIENCE; Corbett KS, 2020, NATURE, V586, P567, DOI 10.1038/s41586-020-2622-0; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Deng X., CELL; Donaldson MM, 2019, CYTOM PART A, V95A, P261, DOI 10.1002/cyto.a.23670; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Emary K., LANCET; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Francica J. R., SCI TRANSL MED; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Guebre-Xabier M., 2020, VACCINE, V38, P7892, DOI [DOI 10.1038/s41586-020-2608-y, 10.1016/j.vaccine.2020.10.064, DOI 10.1016/j.vaccine.2020.10.064]; Hassett KJ, 2019, MOL THER-NUCL ACIDS, V15, P1, DOI 10.1016/j.omtn.2019.01.013; Hermanus T., 2021, NAT MED, V27, P622, DOI [10.1038/s41591-021-01285-x, DOI 10.1038/S41591-021-01285-X]; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Katzelnick LC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006862; Klasse PJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe8065; Li QQ, 2021, CELL, V184, P2362, DOI 10.1016/j.cell.2021.02.042; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Liu C., CELL; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Munster V. J., 2021, SUBTLE DIFFERENCES P; Novavax, 2021, NOV COVID 19 VACC DE; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pegu A., SCIENCE; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Radvak P., 2021, B 1 1 7 B 1 351 VARI; Sadoff J., NEW ENGL J MED; Shen XY, 2021, NEW ENGL J MED, V384, P2352, DOI 10.1056/NEJMc2103740; Shen Xiaoying, 2021, bioRxiv, DOI [10.1016/j.chom.2021.03.002, 10.1101/2021.01.27.428516]; Shinde V, 2021, NEW ENGL J MED, V384, P1899, DOI 10.1056/NEJMoa2103055; Starr T. N., CELL; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Tada T., DECREASED NEUTRALIZA; Tada T., Neutralization of viruses with European, South African and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies; Tegally H., NATURE; Tegally H., NATURE; van Doremalen N., 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, DOI 10.1038/s41586-020-2608-y]; Vanderheiden Abigail, 2020, Curr Protoc Immunol, V131, pe116, DOI 10.1002/cpim.116; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI 10.1159/000505601; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou H, 2021, MBIO, V12, DOI [10.1128/mBio.01386-21, 10.1101/2021.03.24.436620]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	62	21	21	3	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1306	+		10.1038/s41590-021-01021-0	http://dx.doi.org/10.1038/s41590-021-01021-0		AUG 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34417590	Bronze, Green Accepted			2022-12-18	WOS:000686852700001
J	Tonnerre, P; Wolski, D; Subudhi, S; Al-Jabban, J; Hoogeveen, RC; Damasio, M; Drescher, HK; Bartsch, LM; Tully, DC; Sen, DR; Bean, DJ; Brown, J; Torres-Cornejo, A; Robidoux, M; Kvistad, D; Alatrakchi, N; Cui, A; Lieb, D; Cheney, JA; Gustafson, J; Lewis-Ximenez, LL; Massenet-Regad, L; Eisenhaure, T; Aneja, J; Haining, WN; Chung, RT; Hacohen, N; Allen, TM; Kim, AY; Lauer, GM				Tonnerre, Pierre; Wolski, David; Subudhi, Sonu; Al-Jabban, Jihad; Hoogeveen, Ruben C.; Damasio, Marcos; Drescher, Hannah K.; Bartsch, Lea M.; Tully, Damien C.; Sen, Debattama R.; Bean, David J.; Brown, Joelle; Torres-Cornejo, Almudena; Robidoux, Maxwell; Kvistad, Daniel; Alatrakchi, Nadia; Cui, Ang; Lieb, David; Cheney, James A.; Gustafson, Jenna; Lewis-Ximenez, Lia L.; Massenet-Regad, Lucile; Eisenhaure, Thomas; Aneja, Jasneet; Haining, W. Nicholas; Chung, Raymond T.; Hacohen, Nir; Allen, Todd M.; Kim, Arthur Y.; Lauer, Georg M.			Differentiation of exhausted CD8(+) T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory	NATURE IMMUNOLOGY			English	Article							PD-1 EXPRESSION; RNA-SEQ; PERSISTENCE; LYMPHOCYTES; INFECTION	T cell exhaustion is associated with failure to clear chronic infections and malignant cells. Defining the molecular mechanisms of T cell exhaustion and reinvigoration is essential to improving immunotherapeutic modalities. Here we confirmed pervasive phenotypic, functional and transcriptional differences between memory and exhausted antigen-specific CD8(+) T cells in human hepatitis C virus (HCV) infection before and after treatment. After viral cure, phenotypic changes in clonally stable exhausted T cell populations suggested differentiation toward a memory-like profile. However, functionally, the cells showed little improvement, and critical transcriptional regulators remained in the exhaustion state. Notably, T cells from chronic HCV infection that were exposed to antigen for less time because of viral escape mutations were functionally and transcriptionally more similar to memory T cells from spontaneously resolved HCV infection. Thus, the duration of T cell stimulation impacts exhaustion recovery, with antigen removal after long-term exhaustion being insufficient for the development of functional T cell memory. Lauer and colleagues examine CD8(+) T cells following cure of human hepatitis C virus (HCV) infection. CD8(+) T cells exposed to chronic HCV-specific activation show durable functional, phenotypic and transcriptional exhaustion that is maintained even after antigen stimulus is removed.	[Tonnerre, Pierre; Wolski, David; Subudhi, Sonu; Al-Jabban, Jihad; Hoogeveen, Ruben C.; Damasio, Marcos; Drescher, Hannah K.; Bartsch, Lea M.; Brown, Joelle; Torres-Cornejo, Almudena; Robidoux, Maxwell; Kvistad, Daniel; Alatrakchi, Nadia; Cheney, James A.; Gustafson, Jenna; Aneja, Jasneet; Chung, Raymond T.; Lauer, Georg M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Tonnerre, Pierre; Wolski, David; Subudhi, Sonu; Al-Jabban, Jihad; Hoogeveen, Ruben C.; Damasio, Marcos; Drescher, Hannah K.; Bartsch, Lea M.; Brown, Joelle; Torres-Cornejo, Almudena; Robidoux, Maxwell; Kvistad, Daniel; Alatrakchi, Nadia; Cheney, James A.; Gustafson, Jenna; Aneja, Jasneet; Chung, Raymond T.; Kim, Arthur Y.; Lauer, Georg M.] Harvard Med Sch, Boston, MA 02115 USA; [Tonnerre, Pierre; Massenet-Regad, Lucile] Univ Paris, Inserm U976, Inst Rech St Louis, Paris, France; [Tully, Damien C.; Bean, David J.; Allen, Todd M.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA; [Sen, Debattama R.; Haining, W. Nicholas] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Sen, Debattama R.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Cui, Ang; Lieb, David; Eisenhaure, Thomas; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Cui, Ang] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lewis-Ximenez, Lia L.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Aneja, Jasneet; Kim, Arthur Y.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Fundacao Oswaldo Cruz; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Tonnerre, P; Lauer, GM (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Tonnerre, P; Lauer, GM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Tonnerre, P (corresponding author), Univ Paris, Inserm U976, Inst Rech St Louis, Paris, France.	pierre.tonnerre@inserm.fr; glauer@mgh.harvard.edu	Allen, Todd/F-5473-2011; Subudhi, Sonu/GRF-1871-2022; Subudhi, Sonu/GSM-6976-2022; Subudhi, Sonu/L-8509-2019	Allen, Todd/0000-0002-6609-1318; Subudhi, Sonu/0000-0002-5937-1880; Subudhi, Sonu/0000-0002-5937-1880; Drescher, Hannah/0000-0001-9945-1239; Tully, Damien/0000-0002-7620-9340; Tonnerre, Pierre/0000-0002-1719-9736; Lewis-Ximenez, Lia Laura/0000-0002-3447-4621				Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fisicaro P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00849; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hamid O, 2019, ANN ONCOL, V30, P582, DOI 10.1093/annonc/mdz011; Hegde PS, 2020, IMMUNITY, V52, P17, DOI 10.1016/j.immuni.2019.12.011; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Holmes JA, 2019, LANCET, V393, P1392, DOI 10.1016/S0140-6736(18)32326-2; Holmes JA, 2019, J VIRAL HEPATITIS, V26, P362, DOI 10.1111/jvh.13041; Hoogeveen RC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00401; Hoogeveen RC, 2019, GUT, V68, P893, DOI 10.1136/gutjnl-2018-316644; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kasprowicz V, 2010, J VIROL, V84, P1656, DOI 10.1128/JVI.01499-09; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kotecha N., 2010, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY1017S53; Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schuch A, 2019, GUT, V68, P905, DOI 10.1136/gutjnl-2018-316641; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Tully DC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005619; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wolski D, 2017, IMMUNITY, V47, P648, DOI 10.1016/j.immuni.2017.09.006; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4	53	21	21	2	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					1030	+		10.1038/s41590-021-00982-6	http://dx.doi.org/10.1038/s41590-021-00982-6			30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34312544	Green Accepted, Green Submitted			2022-12-18	WOS:000677755900013
J	Khoyratty, TE; Ai, ZC; Ballesteros, I; Eames, HL; Mathie, S; Martin-Salamanca, S; Wang, LH; Hemmings, A; Willemsen, N; von Werz, V; Zehrer, A; Walzog, B; van Grinsven, E; Hidalgo, A; Udalova, IA				Khoyratty, Tariq E.; Ai, Zhichao; Ballesteros, Ivan; Eames, Hayley L.; Mathie, Sara; Martin-Salamanca, Sandra; Wang, Lihui; Hemmings, Ashleigh; Willemsen, Nicola; von Werz, Valentin; Zehrer, Annette; Walzog, Barbara; van Grinsven, Erinke; Hidalgo, Andres; Udalova, Irina A.			Distinct transcription factor networks control neutrophil-driven inflammation	NATURE IMMUNOLOGY			English	Article							LINEAGE COMMITMENT; AIR-POUCH; EXPRESSION; GRANULOPOIESIS; MARROW; CELLS; HETEROGENEITY; RECRUITMENT; HOMEOSTASIS; VIVO	Neutrophils display distinct gene expression patters depending on their developmental stage, activation state and tissue microenvironment. To determine the transcription factor networks that shape these responses in a mouse model, we integrated transcriptional and chromatin analyses of neutrophils during acute inflammation. We showed active chromatin remodeling at two transition stages: bone marrow-to-blood and blood-to-tissue. Analysis of differentially accessible regions revealed distinct sets of putative transcription factors associated with control of neutrophil inflammatory responses. Using ex vivo and in vivo approaches, we confirmed that RUNX1 and KLF6 modulate neutrophil maturation, whereas RELB, IRF5 and JUNB drive neutrophil effector responses and RFX2 and RELB promote survival. Interfering with neutrophil activation by targeting one of these factors, JUNB, reduced pathological inflammation in a mouse model of myocardial infarction. Therefore, our study represents a blueprint for transcriptional control of neutrophil responses in acute inflammation and opens possibilities for stage-specific therapeutic modulation of neutrophil function in disease. Neutrophils demonstrate highly dynamic functional and transcriptional changes depending on their tissue environment. Udalova and colleagues use an inflammation model to examine neutrophils and find that the transcription factors RUNX1 and KLF6 control maturation; RELB, IRF5 and JUNB drive effector responses; and RFX2 and RELB promote survival.	[Khoyratty, Tariq E.; Ai, Zhichao; Eames, Hayley L.; Mathie, Sara; Wang, Lihui; Hemmings, Ashleigh; Willemsen, Nicola; von Werz, Valentin; van Grinsven, Erinke; Udalova, Irina A.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Ballesteros, Ivan; Martin-Salamanca, Sandra; Hidalgo, Andres] Ctr Nacl Invest Cardiovasc Carlos III, Area Cell & Dev Biol, Madrid, Spain; [Zehrer, Annette; Walzog, Barbara] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Cardiovasc Physiol & Pathophysiol, Biomed Ctr, Munich, Germany; [Zehrer, Annette; Walzog, Barbara] Ludwig Maximilians Univ Munchen, Univ Hosp, Walter Brendel Ctr Expt Med, Munich, Germany	University of Oxford; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Munich; University of Munich	Udalova, IA (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.	Irina.udalova@kennedy.ox.ac.uk	Hidalgo, Andrés/L-5643-2014	Hidalgo, Andrés/0000-0001-5513-555X; von Werz, Valentin/0000-0002-9055-1265; Khoyratty, Tariq/0000-0001-5911-0026; Udalova, Irina/0000-0002-6716-2528; Hemmings, Ashleigh/0000-0002-6365-7849; Ballesteros, Ivan/0000-0002-6246-2353	Oxford-Celgene fellowship; Chinese Science Council; Wellcome Trust [209422/Z/17/Z]; Novo Nordisk Foundation Tripartite Immunometabolism Consortium [NNF15CC0018486]; Erasmus Foundation	Oxford-Celgene fellowship(Bristol-Myers SquibbCelgene Corporation); Chinese Science Council; Wellcome Trust(Wellcome TrustEuropean Commission); Novo Nordisk Foundation Tripartite Immunometabolism Consortium; Erasmus Foundation	We are grateful to Jonathan Webber (Kennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)) for providing the cell sorting service, T. Nicol and M. Crabtree (Nuffield Department of Medicine) for help with the Seahorse assay the and Genomic core facility (Wellcome Centre for Human Genetics) for sample sequencing and technical support. We thank F. Powrie for scientific discussions and E. Thompson and D. Berthold (KIR, NDORMS) for helpful suggestions on the manuscript and assistance with figures. This work was supported by the Oxford-Celgene fellowship (T.E.K.); the Chinese Science Council (Z.A.); Wellcome Trust Investigator Award no. 209422/Z/17/Z to I.A.U., E.v.G. and H.E.; Novo Nordisk Foundation Tripartite Immunometabolism Consortium (no. NNF15CC0018486 to S.M. and L.W.); and the Erasmus Foundation (N.W. and V.v.W.).	Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Ai ZC, 2020, J LEUKOCYTE BIOL, V107, P419, DOI 10.1002/JLB.1RU1219-504RR; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Ballesteros I, 2020, CELL, V183, P1282, DOI 10.1016/j.cell.2020.10.003; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Fischer J, 2019, NAT IMMUNOL, V20, P546, DOI 10.1038/s41590-019-0343-z; Grassi L, 2018, CELL REP, V24, P2784, DOI 10.1016/j.celrep.2018.08.018; HARRIS JG, 1995, EUR J PHARMACOL, V283, P9, DOI 10.1016/0014-2999(95)00274-O; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007; Humbert M, 2011, LEUKEMIA RES, V35, P909, DOI 10.1016/j.leukres.2011.03.010; Jarvis JN, 2009, ARTHRITIS RHEUM-US, V60, P1488, DOI 10.1002/art.24450; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Lawrence SM, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00057-17; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Manley HR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02867; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Monticelli S, 2017, NAT REV IMMUNOL, V17, P595, DOI 10.1038/nri.2017.51; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ng KP, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.41; Ostuni R, 2016, SEMIN IMMUNOL, V28, P83, DOI 10.1016/j.smim.2016.04.002; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Riffelmacher T, 2017, IMMUNITY, V47, P466, DOI 10.1016/j.immuni.2017.08.005; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sagiv JY, 2016, METHODS MOL BIOL, V1458, P179, DOI 10.1007/978-1-4939-3801-8_13; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Tessier PA, 1997, J IMMUNOL, V159, P3595; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang LH, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139163; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; WILKINSON LS, 1993, INT J EXP PATHOL, V74, P113; Wu YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20435; Xie XM, 2020, NAT IMMUNOL, V21, P1119, DOI 10.1038/s41590-020-0736-z; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yvan-Charvet L, 2019, TRENDS IMMUNOL, V40, P598, DOI 10.1016/j.it.2019.05.004; Zhu YN, 2017, GENE DEV, V31, P141, DOI 10.1101/gad.293910.116	56	21	21	5	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1093	+		10.1038/s41590-021-00968-4	http://dx.doi.org/10.1038/s41590-021-00968-4		JUL 2021	42	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34282331	Green Accepted			2022-12-18	WOS:000674567000003
J	Eschweiler, S; Clarke, J; Ramirez-Suastegui, C; Panwar, B; Madrigal, A; Chee, SJ; Karydis, I; Woo, E; Alzetani, A; Elsheikh, S; Hanley, CJ; Thomas, GJ; Friedmann, PS; Sanchez-Elsner, T; Ay, F; Ottensmeier, CH; Vijayanand, P				Eschweiler, Simon; Clarke, James; Ramirez-Suastegui, Ciro; Panwar, Bharat; Madrigal, Ariel; Chee, Serena J.; Karydis, Ioannis; Woo, Edwin; Alzetani, Aiman; Elsheikh, Somaia; Hanley, C. J.; Thomas, G. J.; Friedmann, Peter S.; Sanchez-Elsner, Tilman; Ay, Ferhat; Ottensmeier, Christian H.; Vijayanand, Pandurangan			Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy	NATURE IMMUNOLOGY			English	Article							HELPER-CELLS; B-CELLS; IMMUNOTHERAPY; RESPONSES; PROMOTES; SURVIVAL; EXPRESSION; RESISTANCE; INDUCTION; LANDSCAPE	Immune-checkpoint blockade (ICB) has shown remarkable clinical success in boosting antitumor immunity. However, the breadth of its cellular targets and specific mode of action remain elusive. We find that tumor-infiltrating follicular regulatory T (T-FR) cells are prevalent in tumor tissues of several cancer types. They are primarily located within tertiary lymphoid structures and exhibit superior suppressive capacity and in vivo persistence as compared with regulatory T cells, with which they share a clonal and developmental relationship. In syngeneic tumor models, anti-PD-1 treatment increases the number of tumor-infiltrating T-FR cells. Both T-FR cell deficiency and the depletion of T-FR cells with anti-CTLA-4 before anti-PD-1 treatment improve tumor control in mice. Notably, in a cohort of 271 patients with melanoma, treatment with anti-CTLA-4 followed by anti-PD-1 at progression was associated with better a survival outcome than monotherapy with anti-PD-1 or anti-CTLA-4, anti-PD-1 followed by anti-CTLA-4 at progression or concomitant combination therapy. Vijayanand and colleagues show highly suppressive CD4(+)CTLA-4(+)PD-1(+) follicular regulatory T (T-FR) cells reside within tumor microenvironments. Depleting T-FR cells or blocking their activity with CTLA-4-depleting antibodies before anti-PD-1 checkpoint blockade therapy improved the efficacy of anti-PD-1 treatment in mouse tumor models and was also associated with better survival outcomes in a large cohort of patients with melanoma.	[Eschweiler, Simon; Clarke, James; Ramirez-Suastegui, Ciro; Panwar, Bharat; Madrigal, Ariel; Ottensmeier, Christian H.; Vijayanand, Pandurangan] La Jolla Inst Immunol, La Jolla, CA 92037 USA; [Chee, Serena J.; Karydis, Ioannis; Hanley, C. J.; Thomas, G. J.; Ottensmeier, Christian H.] Univ Southampton, Fac Med, NIHR, Southampton, Hants, England; [Chee, Serena J.; Karydis, Ioannis; Hanley, C. J.; Thomas, G. J.; Ottensmeier, Christian H.] Univ Southampton, CRUK Southampton Expt Canc Med Ctr, Southampton, Hants, England; [Chee, Serena J.; Hanley, C. J.; Thomas, G. J.; Ottensmeier, Christian H.; Vijayanand, Pandurangan] Univ Southampton, Fac Med, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Chee, Serena J.; Karydis, Ioannis; Woo, Edwin; Alzetani, Aiman; Ottensmeier, Christian H.] Southampton Univ Hosp NHS Fdn Trust, Southampton, Hants, England; [Elsheikh, Somaia] Nottingham Univ Hosp, Dept Cellular Pathol, Nottingham, England; [Elsheikh, Somaia] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Nottingham, England; [Friedmann, Peter S.; Sanchez-Elsner, Tilman; Vijayanand, Pandurangan] Univ Southampton, Clin & Expt Sci, Fac Med, Southampton, Hants, England; [Ay, Ferhat] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Vijayanand, Pandurangan] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of Southampton; University of Southampton; University of Southampton; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of Southampton; University of California System; University of California San Diego; University of California System; University of California San Diego	Vijayanand, P (corresponding author), La Jolla Inst Immunol, La Jolla, CA 92037 USA.; Vijayanand, P (corresponding author), Univ Southampton, Fac Med, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Vijayanand, P (corresponding author), Univ Southampton, Clin & Expt Sci, Fac Med, Southampton, Hants, England.; Vijayanand, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	vijay@lji.org	Ay, Ferhat/J-7800-2019; Hanley, Christopher/AAM-1961-2020; Ottensmeier, Christian/E-8131-2012	Ay, Ferhat/0000-0002-0708-6914; Hanley, Christopher/0000-0003-3816-7220; Ottensmeier, Christian/0000-0003-3619-1657; Sanchez-Elsner, Tilman/0000-0003-1915-2410; Karydis, Ioannis/0000-0002-8308-3141; ALZETANI, AIMAN/0000-0002-3373-6714; Eschweiler, Simon/0000-0002-6379-8588	FACSAria Fusion Cell Sorter [S10 RR027366]; NIH [S10OD016262]; NovaSeq6000 [S10OD025052-01]; Wessex Clinical Research Network; National Institute of Health Research, UK; William K. Bowes Jr Foundation; Whitaker Foundation; Cancer Research UK Centres Network Accelerator Award [A21998]; Faculty of Medicine of the University of Southampton; Cancer Research UK	FACSAria Fusion Cell Sorter; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NovaSeq6000; Wessex Clinical Research Network; National Institute of Health Research, UK(National Institute for Health Research (NIHR)); William K. Bowes Jr Foundation; Whitaker Foundation; Cancer Research UK Centres Network Accelerator Award; Faculty of Medicine of the University of Southampton; Cancer Research UK(Cancer Research UK)	We thank L. Chudley, K. McCann, O. Wood, M. Chamberlain, K. Amer, D. Jeffrey, M. Lane, C. Fixmer, M. Lopez, N. Graham, M. Machado, T. Mellows and B. Johnson for their assistance with the recruitment of study subjects and processing of samples. We thank M. Wheater for providing access to the clinical data from the joint practice with I.K. and C.H.O. We thank A. Upadhye for contributions to the experimental work. We thank J. B. Lilley for his help with the data collection and analysis of the survival cohort. We thank C. Kim, D. Hinz and C. Dillingham for their assistance with cell sorting (FACSAria Fusion Cell Sorter; grant no. S10 RR027366); S. Liang, A. Wang and H. Simon for assistance with library preparation, next-generation sequencing using an Illumina HiSeq 2500 (NIH grant no. S10OD016262) and NovaSeq6000 (grant no. S10OD025052-01). We thank the members of the Vijayanand laboratory for their assistance with editing the figures and manuscript. We thank J. Linden and S. Fuchs for providing B16F10-OVA and MC38-OVA tumor cell lines, respectively. This work was supported by the Wessex Clinical Research Network and the National Institute of Health Research, UK (sample collection), the William K. Bowes Jr Foundation (P.V.), Whitaker Foundation (T.S.-E. and C.H.O.), a Cancer Research UK Centres Network Accelerator Award Grant (grant no. A21998; T.S.-E. and C.H.O.), the Faculty of Medicine of the University of Southampton (T.S.-E. and C.H.O.) and Cancer Research UK (J.C. and C.H.O.). The funders have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmadzadeh M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aao4310; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Brenna E, 2020, CELL REP, V30, P137, DOI 10.1016/j.celrep.2019.12.016; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Champiat S, 2017, CLIN CANCER RES, V23, P1920, DOI 10.1158/1078-0432.CCR-16-1741; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Franckaert D, 2015, IMMUNOL CELL BIOL, V93, P417, DOI 10.1038/icb.2014.108; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Knorr DA, 2019, CLIN CANCER RES, V25, P904, DOI 10.1158/1078-0432.CCR-18-3144; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Mellone M, 2017, AGING-US, V9, P128, DOI 10.18632/aging.101127; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Ottensmeier CH, 2016, CANCER RES, V76, P4136, DOI 10.1158/0008-5472.CAN-15-3121; Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005; Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Ritvo PGG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan0368; ROMAO V, 2017, SCI IMMUNOL, V2; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sage PT, 2016, NAT IMMUNOL, V17, P1436, DOI 10.1038/ni.3578; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Singh D., CD4 FOLLICULAR HELPE, DOI 10.1101/2020.01.08.898346(2020; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Tam EM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax0720; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vanderleyden I, 2020, CELL REP, V30, P611, DOI 10.1016/j.celrep.2019.12.076; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wu H, 2016, EUR J IMMUNOL, V46, P1152, DOI 10.1002/eji.201546094; Xu LF, 2017, IMMUNITY, V47, P538, DOI 10.1016/j.immuni.2017.08.011; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	72	21	21	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					1052	+		10.1038/s41590-021-00958-6	http://dx.doi.org/10.1038/s41590-021-00958-6		JUN 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34168370	Green Accepted			2022-12-18	WOS:000665706700001
J	Consonni, FM; Bleve, A; Totaro, MG; Storto, M; Kunderfranco, P; Termanini, A; Pasqualini, F; Ali, C; Pandolfo, C; Sgambelluri, F; Grazia, G; Santinami, M; Maurichi, A; Milione, M; Erreni, M; Doni, A; Fabbri, M; Gribaldo, L; Rulli, E; Soares, MP; Torri, V; Mortarini, R; Anichini, A; Sica, A				Consonni, Francesca Maria; Bleve, Augusto; Totaro, Maria Grazia; Storto, Mariangela; Kunderfranco, Paolo; Termanini, Alberto; Pasqualini, Fabio; Ali, Chiara; Pandolfo, Chiara; Sgambelluri, Francesco; Grazia, Giulia; Santinami, Mario; Maurichi, Andrea; Milione, Massimo; Erreni, Marco; Doni, Andrea; Fabbri, Marco; Gribaldo, Laura; Rulli, Eliana; Soares, Miguel Parreira; Torri, Valter; Mortarini, Roberta; Anichini, Andrea; Sica, Antonio			Heme catabolism by tumor-associated macrophages controls metastasis formation	NATURE IMMUNOLOGY			English	Article								Although the pathological significance of tumor-associated macrophage (TAM) heterogeneity is still poorly understood, TAM reprogramming is viewed as a promising anticancer therapy. Here we show that a distinct subset of TAMs (F4/80(hi)CD115(hi)C3aR(hi)CD88(hi)), endowed with high rates of heme catabolism by the stress-responsive enzyme heme oxygenase-1 (HO-1), plays a critical role in shaping a prometastatic tumor microenvironment favoring immunosuppression, angiogenesis and epithelial-to-mesenchymal transition. This population originates from F4/80(+)HO-1(+) bone marrow (BM) precursors, accumulates in the blood of tumor bearers and preferentially localizes at the invasive margin through a mechanism dependent on the activation of Nrf2 and coordinated by the NF-kappa B1-CSF1R-C3aR axis. Inhibition of F4/80(+)HO-1(+) TAM recruitment or myeloid-specific deletion of HO-1 blocks metastasis formation and improves anticancer immunotherapy. Relative expression of HO-1 in peripheral monocyte subsets, as well as in tumor lesions, discriminates survival among metastatic melanoma patients. Overall, these results identify a distinct cancer-induced HO-1(+) myeloid subgroup as a new antimetastatic target and prognostic blood marker. Tumor-associated macrophages (TAMs) play multifaceted roles in establishing an immunosuppressive tumor microenvironment. Sica and colleagues find that macrophage-intrinsic complement signaling initiates a pathway leading to the induction of highly tumorigenic TAMs.	[Consonni, Francesca Maria; Totaro, Maria Grazia; Storto, Mariangela; Kunderfranco, Paolo; Termanini, Alberto; Pasqualini, Fabio; Erreni, Marco; Doni, Andrea; Sica, Antonio] IRCCS, Humanitas Clin & Res Ctr, Milan, Italy; [Consonni, Francesca Maria; Bleve, Augusto; Ali, Chiara; Pandolfo, Chiara; Sica, Antonio] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy; [Sgambelluri, Francesco; Grazia, Giulia; Mortarini, Roberta; Anichini, Andrea] Fdn IRCCS Ist Nazl Tumori, Dept Res, Human Tumors Immunobiol Unit, Milan, Italy; [Santinami, Mario; Maurichi, Andrea] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Melanoma & Sarcoma Unit, Milan, Italy; [Milione, Massimo] Fdn IRCCS Ist Nazl Tumori, Dept Pathol & Lab Med, Div Pathol 1, Milan, Italy; [Fabbri, Marco; Gribaldo, Laura] European Commiss, Joint Res Ctr JRC, Ispra, Italy; [Rulli, Eliana; Torri, Valter] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy; [Soares, Miguel Parreira] Inst Gulbenkian Ciencias, Oeiras, Portugal	University of Eastern Piedmont Amedeo Avogadro; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; European Commission Joint Research Centre; EC JRC ISPRA Site; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Instituto Gulbenkian de Ciencia	Sica, A (corresponding author), IRCCS, Humanitas Clin & Res Ctr, Milan, Italy.; Sica, A (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy.	antonio.sica@uniupo.it	Consonni, Francesca Maria/AAA-3504-2019; Sgambelluri, Francesco/D-6273-2017; Erreni, Marco/K-2522-2016; Doni, Andrea/AAB-6096-2022; Torri, Valter/H-7550-2015; Santinami, Mario/I-3795-2017; Pasqualini, Fabio/G-5610-2018; Kunderfranco, Paolo/ABH-9294-2020; Kunderfranco, Paolo/GUQ-8968-2022	Sgambelluri, Francesco/0000-0002-7451-1300; Erreni, Marco/0000-0002-1922-0818; Torri, Valter/0000-0001-9541-9354; Santinami, Mario/0000-0001-8436-4757; Pasqualini, Fabio/0000-0003-4852-3794; Kunderfranco, Paolo/0000-0001-7477-8710; Kunderfranco, Paolo/0000-0001-7477-8710; sica, antonio/0000-0002-8342-7442; Pandolfo, Chiara/0000-0001-9029-2534; fabbri, marco/0000-0002-7056-4691; Consonni, Francesca Maria/0000-0001-5229-0263; Bleve, Augusto/0000-0003-1585-4722	Associazione Italiana per la Ricerca sul Cancro (AIRC) IG [19885, 15860]; AIRC 5x1000 [22757]; Ministero Universita Ricerca [2017BA9LM5_001]; AIRC [19682]; Associazione "Augusto per la Vita" Novellara (RE); Associazione "Medicine Rocks", Milano; FundacAo 'la Caixa'; FundacAo para a Ciencia e Tecnologia [HR18-00502, SAICT/2017/029411]; Fondazione Cariplo	Associazione Italiana per la Ricerca sul Cancro (AIRC) IG(Fondazione AIRC per la ricerca sul cancro); AIRC 5x1000(Fondazione AIRC per la ricerca sul cancro); Ministero Universita Ricerca; AIRC(Fondazione AIRC per la ricerca sul cancro); Associazione "Augusto per la Vita" Novellara (RE); Associazione "Medicine Rocks", Milano; FundacAo 'la Caixa'; FundacAo para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) IG (nos. 19885 to A.S. and 15860 to R.M.); AIRC 5x1000 no. 22757; Fondazione Cariplo and Ministero Universita Ricerca (project no. 2017BA9LM5_001); AIRC fellowship 'Pierluigi Meneghelli' (no. 19682); Associazione "Augusto per la Vita" Novellara (RE); and Associazione "Medicine Rocks", Milano. We thank C. Vegetti and I. Bersani (Fondazione IRCCS Istituto Nazionale dei Tumori) for excellent technical help with flow cytometry analysis of human monocyte subsets and immunohistochemistry of melanoma lesions, respectively. We also thank M. Soares for critical discussions and editing of the manuscript. M.P.S. is supported by FundacAo 'la Caixa', FundacAo para a Ciencia e Tecnologia (nos. HR18-00502 and SAICT/2017/029411).	Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Blagih J, 2012, CELL METAB, V15, P793, DOI 10.1016/j.cmet.2012.05.008; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Carminati L, 2019, CARCINOGENESIS, V40, P303, DOI 10.1093/carcin/bgy177; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gordon S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01893; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Korolnek T, 2015, BLOOD, V125, P2893, DOI 10.1182/blood-2014-12-567776; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; McArdle AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161784; Mehla K, 2019, TRENDS CANCER, V5, P822, DOI 10.1016/j.trecan.2019.10.007; Nemeth Z, 2015, ONCOTARGET, V6, P33675, DOI 10.18632/oncotarget.5284; Nitti M, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020029; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Park JY, 2016, CLIN RES HEPATOL GAS, V40, P357, DOI 10.1016/j.clinre.2015.09.005; Ponka P, 1997, BLOOD, V89, P1; Porta C, 2018, CANCER IMMUNOL RES, V6, P578, DOI 10.1158/2326-6066.CIR-17-0036; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Sensi M, 2005, CANCER RES, V65, P632; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Sica A, 2019, CELL STRESS, V3, P284, DOI 10.15698/cst2019.09.197; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Strauss L, 2015, CANCER CELL, V28, P253, DOI 10.1016/j.ccell.2015.07.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Ueha S, 2011, INT IMMUNOPHARMACOL, V11, P783, DOI 10.1016/j.intimp.2011.03.003; Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Yang M, 2018, CANCER RES, V78, P5492, DOI 10.1158/0008-5472.CAN-18-1367; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhou CH, 2012, ACTA BIOCH BIOPH SIN, V44, P815, DOI 10.1093/abbs/gms064; Ziegler-Heitbrock L, 2001, J ENDOTOXIN RES, V7, P219, DOI 10.1179/096805101101532701	52	21	21	3	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					595	+		10.1038/s41590-021-00921-5	http://dx.doi.org/10.1038/s41590-021-00921-5		APR 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33903766				2022-12-18	WOS:000644337400001
J	Temba, GS; Kullaya, V; Pecht, T; Mmbaga, BT; Aschenbrenner, AC; Ulas, T; Kibiki, G; Lyamuya, F; Boahen, CK; Kumar, V; Joosten, LAB; Schultze, JL; van der Ven, AJ; Netea, MG; de Mast, Q				Temba, Godfrey S.; Kullaya, Vesla; Pecht, Tal; Mmbaga, Blandina T.; Aschenbrenner, Anna C.; Ulas, Thomas; Kibiki, Gibson; Lyamuya, Furaha; Boahen, Collins K.; Kumar, Vinod; Joosten, Leo A. B.; Schultze, Joachim L.; van der Ven, Andre J.; Netea, Mihai G.; de Mast, Quirijn			Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes	NATURE IMMUNOLOGY			English	Article							TRAINED INNATE IMMUNITY; WESTERN DIET; HIGH-THROUGHPUT; EXPRESSION; APIGENIN; MONOCYTES; URBANIZATION; ACTIVATION; INFECTION; MIGRATION	Sub-Saharan Africa currently experiences an unprecedented wave of urbanization, which has important consequences for health and disease patterns. This study aimed to investigate and integrate the immune and metabolic consequences of rural or urban lifestyles and the role of nutritional changes associated with urban living. In a cohort of 323 healthy Tanzanians, urban as compared to rural living was associated with a pro-inflammatory immune phenotype, both at the transcript and protein levels. We identified different food-derived and endogenous circulating metabolites accounting for these differences. Serum from urban dwellers induced reprogramming of innate immune cells with higher tumor necrosis factor production upon microbial re-stimulation in an in vitro model of trained immunity. These data demonstrate important shifts toward an inflammatory phenotype associated with an urban lifestyle and provide new insights into the underlying dietary and metabolic factors, which may affect disease epidemiology in sub-Sahara African countries. Rapid urbanization can be associated with adverse health implications. de Mast and colleagues compare urban and rural Tanzanian populations using multi-omics and observe that urbanization is associated with an elevated but reversible inflammatory state.	[Temba, Godfrey S.; Kullaya, Vesla; Boahen, Collins K.; Kumar, Vinod; Joosten, Leo A. B.; van der Ven, Andre J.; Netea, Mihai G.; de Mast, Quirijn] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Temba, Godfrey S.; Kullaya, Vesla] Kilimanjaro Christian Med Univ Coll, KCMUCo, Dept Med Biochem & Mol Biol, Moshi, Tanzania; [Temba, Godfrey S.; Boahen, Collins K.; Kumar, Vinod; Joosten, Leo A. B.; van der Ven, Andre J.; Netea, Mihai G.; de Mast, Quirijn] Radboud Univ Nijmegen, Radboud Ctr Infect Dis RCI, Med Ctr, Nijmegen, Netherlands; [Kullaya, Vesla; Mmbaga, Blandina T.; Kibiki, Gibson; Lyamuya, Furaha] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Pecht, Tal; Aschenbrenner, Anna C.; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Dept Genom & Immunoregulat, Bonn, Germany; [Pecht, Tal; Aschenbrenner, Anna C.; Ulas, Thomas; Schultze, Joachim L.] German Ctr Neurodegenerat Dis DZNE, Syst Med, Bonn, Germany; [Ulas, Thomas; Schultze, Joachim L.] German Ctr Neurodegenerat Dis DZNE, PRECISE Platform Single Cell Genom & Epigen, Bonn, Germany; [Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Bonn, Germany; [Kibiki, Gibson] East African Hlth & Res Commiss EAHRC, Bujumbura, Burundi; [Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Netea, Mihai G.] Univ Bonn, Life & Med Sci LIMES Inst, Dept Immunol & Metab, Bonn, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Kilimanjaro Christian Medical Centre; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Groningen; University of Bonn	Netea, MG; de Mast, Q (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands.; Netea, MG; de Mast, Q (corresponding author), Radboud Univ Nijmegen, Radboud Ctr Infect Dis RCI, Med Ctr, Nijmegen, Netherlands.; Netea, MG (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Dept Immunol & Metab, Bonn, Germany.	Mihai.Netea@radboudumc.nl; Quirijn.deMast@radboudumc.nl	Schultze, Joachim L./ABA-8176-2020; BOAHEN, COLLINS K./ABC-4365-2020; Kumar, Vinod/ABC-4866-2020	Schultze, Joachim L./0000-0003-2812-9853; Kumar, Vinod/0000-0002-2775-6049; Lyamuya, Furaha/0000-0002-2319-8246; de Mast, Quirijn/0000-0001-6056-157X; Aschenbrenner, Anna/0000-0002-9429-5457; Temba, Godfrey/0000-0002-1093-3037; Pacht, Tal/0000-0002-6442-0560	European Union's Horizon 2020 Research and Innovation Program under the ERA-Net Cofund action [727565]; Joint Programming Initiative, A Healthy Diet for a Healthy Life (JPI-HDHL) [529051018]; ZonMw (the Netherlands Organisation for Health Research and Development); Radboud Revolving Research Funds (3R-Fund); ERC Advanced grant [833247]; Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy [EXC2151, 390873048]; Spinoza Prize [NWO SPI94-212]	European Union's Horizon 2020 Research and Innovation Program under the ERA-Net Cofund action; Joint Programming Initiative, A Healthy Diet for a Healthy Life (JPI-HDHL); ZonMw (the Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development); Radboud Revolving Research Funds (3R-Fund); ERC Advanced grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); Spinoza Prize	The authors thank all volunteers in the Human Functional Genomics in Healthy Tanzanian Individuals study for their participation. We thank J. Njau, J. Kwayu and E. Kimaro for help in sample collection; H. Lemmers and H. Toenhake-Dijkstra for help in laboratory analysis; Y. Li for help in statistics; and M. Miclaus for help with metabolome data processing. We also thank M. Kraut and K. Handler for their great contribution to RNA sequencing. This study was funded by the following grants: the European Union's Horizon 2020 Research and Innovation Program under the ERA-Net Cofund action no. 727565; the Joint Programming Initiative, A Healthy Diet for a Healthy Life (JPI-HDHL; project 529051018) awarded to M.G.N., Q.d.M., A.V. and J.L.S.; ZonMw (the Netherlands Organisation for Health Research and Development) awarded to M.G.N., Q.dM. and A.V.; Radboud Revolving Research Funds (3R-Fund) awarded to G.S.T.; Spinoza Prize (NWO SPI94-212) and ERC Advanced grant (no. 833247) awarded to M.G.N.; and the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy (EXC2151) 390873048 awarded to M.G.N. and J.L.S.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arango D, 2012, BIOCHEM PHARMACOL, V84, P1571, DOI 10.1016/j.bcp.2012.09.005; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bekkering S, 2016, CLIN VACCINE IMMUNOL, V23, P926, DOI 10.1128/CVI.00349-16; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bickler SW, 2018, WORLD J SURG, V42, P1617, DOI 10.1007/s00268-017-4389-5; Branco ACCC, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9524075; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Choy KW, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01295; Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Collins J, 2018, NATURE, V553, P291, DOI 10.1038/nature25178; CONSTANTIN G, 1994, FEBS LETT, V350, P66, DOI 10.1016/0014-5793(94)00735-7; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; de Brauw A, 2014, WORLD DEV, V63, P33, DOI 10.1016/j.worlddev.2013.10.013; Deelen Patrick, 2014, BMC Res Notes, V7, P901, DOI 10.1186/1756-0500-7-901; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gruebner O, 2017, DTSCH ARZTEBL INT, V114, P121, DOI 10.3238/arztebl.2017.0121; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Haug K, 2020, NUCLEIC ACIDS RES, V48, pD440, DOI 10.1093/nar/gkz1019; Hemler EC, 2019, CURR ATHEROSCLER REP, V21, DOI 10.1007/s11883-019-0779-5; Horii Y, 2020, FASEB J, V34, P8749, DOI 10.1096/fj.202000041R; Hostetler GL, 2017, ADV NUTR, V8, P423, DOI 10.3945/an.116.012948; Kann PH, 2015, J CLIN ENDOCR METAB, V100, pE482, DOI 10.1210/jc.2014-2625; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kodaman N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162753; Koeken VACM, 2020, J CLIN INVEST, V130, P5591, DOI 10.1172/JCI133935; Lee JH, 2007, ARCH PHARM RES, V30, P1318, DOI 10.1007/BF02980273; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leentjens J, 2018, CIRC RES, V122, P664, DOI [10.1161/circresaha.117.312465, 10.1161/CIRCRESAHA.117.312465]; Marton A, 2001, INT J MOL MED, V8, P617; Mbow M, 2014, IMMUNOLOGY, V143, P569, DOI 10.1111/imm.12335; Minton K, 2018, NAT REV IMMUNOL, V18, P480, DOI 10.1038/s41577-018-0035-1; Minutoli L, 2007, SHOCK, V27, P91, DOI 10.1097/01.shk.0000235092.76292.bc; Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008; Napier BA, 2019, P NATL ACAD SCI USA, V116, P3688, DOI 10.1073/pnas.1814273116; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Onyango EM, 2018, J EPIDEMIOL GLOB HEA, V8, P1, DOI 10.2991/j.jegh.2017.11.004; Oosting M, 2016, CELL HOST MICROBE, V20, P822, DOI 10.1016/j.chom.2016.10.006; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; Ratter JM, 2018, TRENDS ENDOCRIN MET, V29, P468, DOI 10.1016/j.tem.2018.04.008; Ren K, 2018, CELL PHYSIOL BIOCHEM, V47, P2170, DOI 10.1159/000491528; Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; TIBSHIRANI R, 1988, J AM STAT ASSOC, V83, P394, DOI 10.2307/2288855; Unwin N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-272; Wang J, 2014, INFLAMMATION, V37, P2085, DOI 10.1007/s10753-014-9942-x; Wang Q, 2009, NEUROBIOL DIS, V36, P223, DOI 10.1016/j.nbd.2009.07.018; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang XX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107072, 10.1371/journal.pone.0110243]	63	21	21	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					287	+		10.1038/s41590-021-00867-8	http://dx.doi.org/10.1038/s41590-021-00867-8		FEB 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33574617	Green Submitted			2022-12-18	WOS:000617117400006
J	Lim, K; Kim, TH; Trzeciak, A; Amitrano, AM; Reilly, EC; Prizant, H; Fowell, DJ; Topham, DJ; Kim, M				Lim, Kihong; Kim, Tae-hyoun; Trzeciak, Alissa; Amitrano, Andrea M.; Reilly, Emma C.; Prizant, Hen; Fowell, Deborah J.; Topham, David J.; Kim, Minsoo			In situ neutrophil efferocytosis shapes T cell immunity to influenza infection	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; HORIZONTAL TRANSFER; STEADY-STATE; CROSS-PRESENTATION; ANTIGEN; MONOCYTES; DIFFERENTIATION; MACROPHAGES; MIGRATION; RECEPTOR	Kim and colleagues provide new insights into the function and fate of neutrophils during influenza infection and their roles in antiviral T cell responses. Early recruitment of neutrophils from the blood to sites of tissue infection is a hallmark of innate immune responses. However, little is known about the mechanisms by which apoptotic neutrophils are cleared in infected tissues during resolution and the immunological consequences of in situ efferocytosis. Using intravital multiphoton microscopy, we show previously unrecognized motility patterns of interactions between neutrophils and tissue-resident phagocytes within the influenza-infected mouse airway. Newly infiltrated inflammatory monocytes become a chief pool of phagocytes and play a key role in the clearance of highly motile apoptotic neutrophils during the resolution phase. Apoptotic neutrophils further release epidermal growth factor and promote the differentiation of monocytes into tissue-resident antigen-presenting cells for activation of antiviral T cell effector functions. Collectively, these results suggest that the presence of in situ neutrophil resolution at the infected tissue is critical for optimal CD8(+)T cell-mediated immune protection.	[Lim, Kihong; Kim, Tae-hyoun; Trzeciak, Alissa; Amitrano, Andrea M.; Reilly, Emma C.; Prizant, Hen; Fowell, Deborah J.; Topham, David J.; Kim, Minsoo] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14627 USA	University of Rochester	Lim, K; Kim, M (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	kihong_lim@urmc.rochester.edu; minsoo_kim@urmc.rochester.edu		Topham, David/0000-0002-9435-8673; Trzeciak, Alissa/0000-0002-4518-0098; Amitrano, Andrea/0000-0002-1101-872X; Kim, Minsoo/0000-0002-9566-9385	National Institute of Health [AI143182, AI147362, AI149775, AI102851, AI138415, AI070826]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Hohl and A. Rivera for CCR2-DTR mouse and F. Yan for EGFR-cKO (Egfr<SUP>flox</SUP>/LysM<SUP>Cre</SUP>) mouse. We especially thank M. Gunzer for Catchup<SUP>IVM-Red</SUP> mouse, Y. Gao for the technical assistance with IV-MPM and J. Ashton for help with transcriptomic analyses and depositing RNA-sequencing data. This project was financially supported through grants from the National Institute of Health (nos. AI143182, AI147362 and AI149775 to M.K., no. AI102851 to M.K., D.J.F. and D.J.T., no. AI138415 to H.P. and no. AI070826 to D.J.F.)	Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Broz ML, 2014, CANCER CELL, V26, P938, DOI 10.1016/j.ccell.2014.11.010; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Darzynkiewicz Z, 2011, METHODS MOL BIOL, V682, P103, DOI 10.1007/978-1-60327-409-8_9; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; DiPiazza A, 2017, SCI REP, V7; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Dzhagalov IL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001566; Garner H, 2017, SCIENCE, V358, P42, DOI 10.1126/science.aap8361; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047; Hind LE, 2018, DEV CELL, V47, P404, DOI 10.1016/j.devcel.2018.11.004; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Holmgren L, 2002, VOX SANG, V83, P305, DOI 10.1111/j.1423-0410.2002.tb05323.x; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Kaur M, 2013, J PHARMACOL EXP THER, V347, P173, DOI 10.1124/jpet.112.201855; Krummel MF, 1999, J IMMUNOL, V163, P2999; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Larson SR, 2016, CELL DEATH DIFFER, V23, P997, DOI 10.1038/cdd.2016.24; Ley Klaus, 2014, F1000Res, V3, P37, DOI 10.12688/f1000research.3-37.v1; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Lindsay RS, 2015, J IMMUNOL, V194, P522, DOI 10.4049/jimmunol.1400626; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Oshima T, 2006, BRIT J OPHTHALMOL, V90, P218, DOI 10.1136/bjo.2005.077875; Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13; Reichel CA, 2006, J LEUKOCYTE BIOL, V79, P114, DOI 10.1189/jlb.0605337; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sichien D, 2017, MUCOSAL IMMUNOL, V10, P831, DOI 10.1038/mi.2017.8; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Zhao G, 2016, J BIOL CHEM, V291, P20462, DOI 10.1074/jbc.M116.750182	53	21	21	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1046	+		10.1038/s41590-020-0746-x	http://dx.doi.org/10.1038/s41590-020-0746-x		AUG 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32747818	Green Accepted			2022-12-18	WOS:000555415800004
J	Kar, UK; Joosten, LAB				Kar, Upendra K.; Joosten, Leo A. B.			Training the trainable cells of the immune system and beyond	NATURE IMMUNOLOGY			English	Editorial Material							INNATE; MEMORY	The fourth Innate Immune Memory meeting was held in the historic city of Nijmegen, in the eastern-central part of the Netherlands, to discuss the basic and translational aspects of innate immune memory, popularly known as 'trained immunity'.	[Kar, Upendra K.] Univ Pittsburgh, Dept Surg, Pittsburgh Trauma Res Ctr, 497 Scaife Hall, Pittsburgh, PA 15260 USA; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Radboud University Nijmegen; Radboud University Nijmegen	Kar, UK (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh Trauma Res Ctr, 497 Scaife Hall, Pittsburgh, PA 15260 USA.	karuk@upmc.edu	Joosten, Leo AB/H-3138-2015	Joosten, Leo AB/0000-0001-6166-9830; Kar, Upendra/0000-0003-4065-0860; Temba, Godfrey/0000-0002-1093-3037				Bomans K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02685; Braza MS, 2018, IMMUNITY, V49, P819, DOI 10.1016/j.immuni.2018.09.008; Cirauqui C, 2018, EUR J IMMUNOL, V48, P180, DOI 10.1002/eji.201747024; Dijkman K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02479; Fanucchi S, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00002; Howard NC, 2018, NAT MICROBIOL, V3, P1099, DOI 10.1038/s41564-018-0245-0; Kamada R, 2018, P NATL ACAD SCI USA, V115, pE9162, DOI 10.1073/pnas.1720930115; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Netea MG, 2019, CELL HOST MICROBE, V25, P13, DOI 10.1016/j.chom.2018.12.006; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Paust S, 2017, J VIROL, V91, DOI 10.1128/JVI.00169-17; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Quinn SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01109; Saz-Leal P, 2018, CELL REP, V25, P1118, DOI 10.1016/j.celrep.2018.09.092; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; van den Boorn JG, 2016, IMMUNITY, V44, P1406, DOI 10.1016/j.immuni.2016.05.008; Yuan RX, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00497	19	21	21	3	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					115	119		10.1038/s41590-019-0583-y	http://dx.doi.org/10.1038/s41590-019-0583-y		JAN 2020	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31925389	Bronze			2022-12-18	WOS:000508169700001
J	Abeler-Dorner, L; Laing, AG; Lorenc, A; Ushakov, DS; Clare, S; Speak, AO; Duque-Correa, MA; White, JK; Ramirez-Solis, R; Saran, N; Bull, KR; Moron, B; Iwasaki, J; Barton, PR; Caetano, S; Hng, KI; Cambridge, E; Forman, S; Crockford, TL; Griffiths, M; Kane, L; Harcourt, K; Brandt, C; Notley, G; Babalola, KO; Warren, J; Mason, JC; Meeniga, A; Karp, NA; Melvin, D; Cawthorne, E; Weinrick, B; Rahim, A; Drissler, S; Meskas, J; Yue, A; Lux, M; Song-Zhao, GX; Chan, A; Reviriego, CB; Abeler, J; Wilson, H; Przemska-Kosicka, A; Edmans, M; Strevens, N; Pasztorek, M; Meehan, TF; Powrie, F; Brinkman, R; Dougan, G; Jacobs, W; Lloyd, CM; Cornall, RJ; Maloy, KJ; Grencis, RK; Griffiths, GM; Adams, DJ; Hayday, AC				Abeler-Dorner, Lucie; Laing, Adam G.; Lorenc, Anna; Ushakov, Dmitry S.; Clare, Simon; Speak, Anneliese O.; Duque-Correa, Maria A.; White, Jacqueline K.; Ramirez-Solis, Ramiro; Saran, Namita; Bull, Katherine R.; Moron, Belen; Iwasaki, Jua; Barton, Philippa R.; Caetano, Susana; Hng, Keng I.; Cambridge, Emma; Forman, Simon; Crockford, Tanya L.; Griffiths, Mark; Kane, Leanne; Harcourt, Katherine; Brandt, Cordelia; Notley, George; Babalola, Kolawole O.; Warren, Jonathan; Mason, Jeremy C.; Meeniga, Amrutha; Karp, Natasha A.; Melvin, David; Cawthorne, Eleanor; Weinrick, Brian; Rahim, Albina; Drissler, Sibyl; Meskas, Justin; Yue, Alice; Lux, Markus; Song-Zhao, George X.; Chan, Anna; Reviriego, Carmen Ballesteros; Abeler, Johannes; Wilson, Heather; Przemska-Kosicka, Agnieszka; Edmans, Matthew; Strevens, Natasha; Pasztorek, Markus; Meehan, Terrence F.; Powrie, Fiona; Brinkman, Ryan; Dougan, Gordon; Jacobs, William, Jr.; Lloyd, Clare M.; Cornall, Richard J.; Maloy, Kevin J.; Grencis, Richard K.; Griffiths, Gillian M.; Adams, David J.; Hayday, Adrian C.			High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE; SUSCEPTIBILITY LOCI; IDENTIFICATION; ASSOCIATION; DISEASE; BACH2; RISK; AGE; IMMUNODEFICIENCY; EPIDEMIOLOGY	By developing a high-density murine immunophenotyping platform compatible with high-throughput genetic screening, we have established profound contributions of genetics and structure to immune variation (http://www.immunophenotype.org). Specifically, high-throughput phenotyping of 530 unique mouse gene knockouts identified 140 monogenic 'hits', of which most had no previous immunologic association. Furthermore, hits were collectively enriched in genes for which humans show poor tolerance to loss of function. The immunophenotyping platform also exposed dense correlation networks linking immune parameters with each other and with specific physiologic traits. Such linkages limit freedom of movement for individual immune parameters, thereby imposing genetically regulated 'immunologic structures', the integrity of which was associated with immunocompetence. Hence, we provide an expanded genetic resource and structural perspective for understanding and monitoring immune variation in health and disease.	[Abeler-Dorner, Lucie; Laing, Adam G.; Lorenc, Anna; Ushakov, Dmitry S.; Saran, Namita; Caetano, Susana; Hng, Keng I.; Chan, Anna; Przemska-Kosicka, Agnieszka; Pasztorek, Markus; Hayday, Adrian C.] Kings Coll London, Dept Immunobiol, London, England; [Laing, Adam G.; Lorenc, Anna; Ushakov, Dmitry S.; Hayday, Adrian C.] Francis Crick Inst, London, England; [Clare, Simon; Speak, Anneliese O.; Duque-Correa, Maria A.; White, Jacqueline K.; Ramirez-Solis, Ramiro; Cambridge, Emma; Griffiths, Mark; Kane, Leanne; Harcourt, Katherine; Brandt, Cordelia; Notley, George; Melvin, David; Reviriego, Carmen Ballesteros; Wilson, Heather; Strevens, Natasha; Dougan, Gordon; Adams, David J.] Wellcome Sanger Inst, Hinxton, England; [Bull, Katherine R.; Crockford, Tanya L.; Cawthorne, Eleanor; Edmans, Matthew; Cornall, Richard J.] Univ Oxford, MRC Human Immunol Unit, Oxford, England; [Moron, Belen; Song-Zhao, George X.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Iwasaki, Jua; Lloyd, Clare M.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Barton, Philippa R.; Griffiths, Gillian M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Forman, Simon; Grencis, Richard K.] Univ Manchester, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res, Lydia Becker Inst Immunol & Inflammat, Manchester, Lancs, England; [Babalola, Kolawole O.; Warren, Jonathan; Mason, Jeremy C.; Meeniga, Amrutha; Meehan, Terrence F.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Karp, Natasha A.] AstraZeneca, R&D Biopharmaceut, Data Sci & Quantitat Biol, Discovery Sci, Cambridge, England; [Weinrick, Brian; Jacobs, William, Jr.] Albert Einstein Coll Med, Dept Mol Genet, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Rahim, Albina; Drissler, Sibyl; Meskas, Justin; Yue, Alice; Lux, Markus; Brinkman, Ryan] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Abeler, Johannes] Univ Oxford, Dept Econ, Oxford, England; [Pasztorek, Markus] Univ Appl Sci FH Campus Wien, Dept Biomed Sci, Vienna, Austria; [Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Brinkman, Ryan] Univ British Columbia, Dept Bioinformat, Vancouver, BC, Canada; [Maloy, Kevin J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of London; King's College London; Francis Crick Institute; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Imperial College London; University of Cambridge; University of Manchester; European Molecular Biology Laboratory (EMBL); AstraZeneca; Yeshiva University; Albert Einstein College of Medicine; British Columbia Cancer Agency; University of Oxford; University of Oxford; University of British Columbia; University of Glasgow	Hayday, AC (corresponding author), Kings Coll London, Dept Immunobiol, London, England.; Hayday, AC (corresponding author), Francis Crick Inst, London, England.	adrian.hayday@kcl.ac.uk	Adams, David/GMW-8541-2022; Ushakov, Dmitry/AAF-7914-2020; Lorenc, Anna/AAA-3138-2022; Brinkman, Ryan/B-1108-2008; Weinrick, Brian/F-6478-2011	Adams, David/0000-0001-9490-0306; Ushakov, Dmitry/0000-0001-7109-4217; Lorenc, Anna/0000-0002-1406-7607; Brinkman, Ryan/0000-0002-9765-2990; Weinrick, Brian/0000-0003-0880-4487; Griffiths, Gillian/0000-0003-0434-5842; Ramirez-Solis, Ramiro/0000-0003-4182-173X; /0000-0002-2796-5123; Babalola, Kola/0000-0003-1384-8433; HAYDAY, ADRIAN/0000-0002-9495-5793; Duque Correa, Maria Adelaida/0000-0002-0567-0412; Moron, Belen/0000-0003-4815-7536; Caetano, Susana/0000-0003-2755-5404; Bull, Katherine/0000-0003-0656-0917; Drissler, Sibyl/0000-0003-1686-8499; Meehan, Terrence/0000-0003-1980-3228; Speak, Anneliese/0000-0003-4890-4685; Iwasaki, Jua/0000-0002-5833-7146; Lloyd, Clare/0000-0001-8977-6726; Wilson, Heather/0000-0002-5431-2021	Wellcome Trust [100156/Z/12/Z, 102972/Z/13/Z, Z10661/Z/18/Z, Z03128/Z/16/Z, FC001093]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [656347]; National Institutes of Health (NIH) Common Fund [UM1 HG006370]; Genome BC [SOF152, 252FLO]; Natural Sciences and Engineering Research Council of Canada; International Society for Advancement of Cytometry Genome Canada; National Institute of General Medical Sciences [R01GM118417]; Canadian Institutes of Health Research; National Institute for Health Research; NIH [AI026170]; Wellcome Senior Fellowship in Basic Biomedical Science [107059/Z/15/Z]; Francis Crick Institute - Cancer Research UK [FC001093]; UK Medical Research Council [FC001093]; MRC [MC_UU_00008/6] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; National Institutes of Health (NIH) Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome BC; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); International Society for Advancement of Cytometry Genome Canada; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Senior Fellowship in Basic Biomedical Science; Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank many colleagues for advice, particularly: S. Heck of the Biomedical Research Centre of Guy's and St Thomas' Hospital and King's College London; D. Davies of the Francis Crick Institute; F. Geissmann, R. Noelle, J. Strid and O. Sobolev in the early stages of program planning; and N. Karamanis and K. Hawkins for UX testing of the website. The project was funded by a Wellcome Trust grant (no. 100156/Z/12/Z). M.D.-C. received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 656347. K.O.B., J.W. and T.M. were supported by the National Institutes of Health (NIH) Common Fund (grant no. UM1 HG006370). The development of automated flow analysis in R.B.'s group was supported by Genome BC (grant no. SOF152), the Natural Sciences and Engineering Research Council of Canada, the International Society for Advancement of Cytometry Genome Canada, Genome BC (grant no. 252FLO), the National Institute of General Medical Sciences (grant no. R01GM118417) and the Canadian Institutes of Health Research. G.D. was supported by a National Institute for Health Research grant to the Cambridge Biomedical Centre. W.J. was supported by an NIH grant (no. AI026170). C.M.L. is supported by a Wellcome Senior Fellowship in Basic Biomedical Science (no. 107059/Z/15/Z). R.J.C. is a principal investigator of the Medical Research Council's Human Immunology Unit. K.J.M. is funded by a Wellcome Trust Investigator Award (no. 102972/Z/13/Z). R.K.G. holds a Wellcome Trust Investigator Award (no. Z10661/Z/18/Z) and is part of the Wellcome Trust Centre for Cell Matrix Research funded by an award (no. Z03128/Z/16/Z). In addition, the project was supported by grants and facilities provided to A.C.H. by the Francis Crick Institute, which receives its core funding from Cancer Research UK (grant no. FC001093), the UK Medical Research Council (grant no. FC001093) and the Wellcome Trust (grant no. FC001093).	Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Jackson R, 2018, NATURE, V564, P434, DOI 10.1038/s41586-018-0794-7; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Karp NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15475; Karp NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002151; Karp NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111239; Karp NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052410; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kuijpers TW, 2017, J ALLERGY CLIN IMMUN, V140, P273, DOI 10.1016/j.jaci.2016.09.061; Kurbatova N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131274; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Liu W, 2014, HUM GENET, V133, P661, DOI 10.1007/s00439-013-1404-2; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Malek M, 2015, BIOINFORMATICS, V31, P606, DOI 10.1093/bioinformatics/btu677; Marquez A, 2017, ANN RHEUM DIS, V76, P286, DOI 10.1136/annrheumdis-2016-209436; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Narita T, 2018, INT IMMUNOL, V30, P301, DOI 10.1093/intimm/dxy030; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Olumuyiwa-Akeredolu OOO, 2015, RHEUMATOL INT, V35, P1955, DOI 10.1007/s00296-015-3300-7; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Pilling LC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203504; Rahim A, 2018, METHODS, V134, P164, DOI 10.1016/j.ymeth.2017.12.015; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Ryder E, 2013, MAMM GENOME, V24, P286, DOI 10.1007/s00335-013-9467-x; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Steri M, 2017, NEW ENGL J MED, V376, P1615, DOI 10.1056/NEJMoa1610528; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Turnbull C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1687; Wang T, 2015, P NATL ACAD SCI USA, V112, pE440, DOI 10.1073/pnas.1423216112; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Xuan C, 2013, ONCOGENE, V32, P3711, DOI 10.1038/onc.2012.386; Zalocusky KA, 2018, CELL REP, V25, P513, DOI 10.1016/j.celrep.2018.09.021; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	61	21	22	1	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					86	+		10.1038/s41590-019-0549-0	http://dx.doi.org/10.1038/s41590-019-0549-0			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31844327	Green Accepted, Green Submitted			2022-12-18	WOS:000515136500016
J	Arandjelovic, S; Perry, JSA; Lucas, CD; Penberthy, KK; Kim, TH; Zhou, M; Rosen, DA; Chuang, TY; Bettina, AM; Shankman, LS; Cohen, AH; Gaultier, A; Conrads, TP; Kim, M; Elliott, MR; Ravichandran, KS				Arandjelovic, Sanja; Perry, Justin S. A.; Lucas, Christopher D.; Penberthy, Kristen K.; Kim, Tae-Hyoun; Zhou, Ming; Rosen, Dorian A.; Chuang, Tzu-Ying; Bettina, Alexandra M.; Shankman, Laura S.; Cohen, Amanda H.; Gaultier, Alban; Conrads, Thomas P.; Kim, Minsoo; Elliott, Michael R.; Ravichandran, Kodi S.			A noncanonical role for the engulfment gene ELMO1 in neutrophils that promotes inflammatory arthritis	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; RNA-BINDING PROTEIN; RHEUMATOID-ARTHRITIS; APOPTOTIC CELLS; SYNOVIAL-FLUID; LEUKOCYTE RECRUITMENT; INTEGRIN ACTIVATION; IN-VIVO; DISEASE; MODEL	Rheumatoid arthritis is characterized by progressive joint inflammation and affects similar to 1% of the human population. We noted single-nucleotide polymorphisms (SNPs) in the apoptotic cell-engulfment genes ELMO1, DOCK2, and RAC1 linked to rheumatoid arthritis. As ELMO1 promotes cytoskeletal reorganization during engulfment, we hypothesized that ELMO1 loss would worsen inflammatory arthritis. Surprisingly, Elmo1-deficient mice showed reduced joint inflammation in acute and chronic arthritis models. Genetic and cell-biology studies revealed that ELMO1 associates with receptors linked to neutrophil function in arthritis and regulates activation and early neutrophil recruitment to the joints, without general inhibition of inflammatory responses. Further, neutrophils from the peripheral blood of human donors that carry the SNP in ELMO1 associated with arthritis display increased migratory capacity, whereas ELMO1 knockdown reduces human neutrophil migration to chemokines linked to arthritis. These data identify 'noncanonical' roles for ELMO1 as an important cytoplasmic regulator of specific neutrophil receptors and promoter of arthritis.	[Arandjelovic, Sanja; Perry, Justin S. A.; Lucas, Christopher D.; Penberthy, Kristen K.; Bettina, Alexandra M.; Shankman, Laura S.; Cohen, Amanda H.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Ctr Cell Clearance, Charlottesville, VA USA; [Lucas, Christopher D.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Kim, Tae-Hyoun; Kim, Minsoo; Elliott, Michael R.] Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY USA; [Zhou, Ming; Conrads, Thomas P.] Inova Schar Canc Inst, Inova Ctr Personalized Hlth, Fairfax, VA USA; [Rosen, Dorian A.; Chuang, Tzu-Ying; Gaultier, Alban] Univ Virginia, Ctr Brain Immunol & Glia, Dept Neurosci, Charlottesville, VA USA; [Ravichandran, Kodi S.] VIB, Inflammat Res Ctr, Ghent, Belgium; [Ravichandran, Kodi S.] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	University of Virginia; University of Edinburgh; University of Rochester; University of Virginia; Flanders Institute for Biotechnology (VIB); Ghent University	Arandjelovic, S; Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Ctr Cell Clearance, Charlottesville, VA USA.; Ravichandran, KS (corresponding author), VIB, Inflammat Res Ctr, Ghent, Belgium.; Ravichandran, KS (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	sa2h@virginia.edu; Ravi@virginia.edu		Bettina, Alexandra/0000-0003-3511-238X; Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X; Chuang, Tzu-Ying/0000-0003-3307-181X; Lucas, Christopher/0000-0002-7523-0295	NIGMS [R35GM122542]; NIMH [MH096484]; NHLBI [P01HL120840]; NICHD [HD07498]; Center for Cell Clearance/University of Virginia School of Medicine; FWO, Belgium; NIAID [AI114554, P01 AI102851, NS083542, NS101281]; Arthritis Foundation; Mark Foundation award from the Cancer Research Institute; Burroughs Wellcome; Wellcome Trust [206566/Z/17/Z]; American Cancer Society [PF-17-098-01-CSM]; NHLBI F30 award [F30 HL126385]; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120840, F30HL126385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI114554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS101281, R01NS083542] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Center for Cell Clearance/University of Virginia School of Medicine; FWO, Belgium(FWO); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Foundation; Mark Foundation award from the Cancer Research Institute; Burroughs Wellcome(Burroughs Wellcome Fund); Wellcome Trust(Wellcome TrustEuropean Commission); American Cancer Society(American Cancer Society); NHLBI F30 award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Ravichandran laboratory for discussions and critical reading of the manuscript, A. Criss and A. Smirnov for human neutrophils, S. T. Fleury for assistance with neutrophil purification, and K. Koster for assistance with bone marrow preparations. This work is supported by grants to K.S.R. from NIGMS R35GM122542, NIMH (MH096484), NHLBI (P01HL120840), NICHD (HD07498), and the Center for Cell Clearance/University of Virginia School of Medicine, and the Odysseus Award from the FWO, Belgium, to M.R.E. from NIAID (AI114554), to M.K. from NIAID (P01 AI102851), and to A.G. (NS083542 and NS101281). Additional support was provided by the Philip S. Magaram, Esq. Research Award from the Arthritis Foundation to S. A.. J.S.A.P. is supported by a Mark Foundation award from the Cancer Research Institute and a postdoctoral enrichment award from Burroughs Wellcome and was previously supported by a postdoctoral fellowship through a T32 Cancer Training Grant. C.D.L. is supported by an award from The Wellcome Trust (206566/Z/17/Z). L.S.S. is supported by the Roaring Fork Valley Postdoctoral Research Fellowship (PF-17-098-01-CSM) from the American Cancer Society, and K.K.P. is supported by an NHLBI F30 award (F30 HL126385) and was previously supported by an NIH T32 Immunology Training Grant (T32 AI007496).	Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Armaka M., 2009, PROTOC EXCH, DOI [10.1038/nprot.2009.102, DOI 10.1038/NPROT.2009.102]; Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-1; Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Cooper David N, 2010, Hum Genomics, V4, P284; Corr M, 2002, J IMMUNOL, V169, P6604, DOI 10.4049/jimmunol.169.11.6604; Cottier KE, 2014, RHEUMATOLOGY, V53, P1539, DOI 10.1093/rheumatology/ket408; Cui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072951; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; de Rooy DPC, 2014, ANN RHEUM DIS, V73, P1163, DOI 10.1136/annrheumdis-2013-203375; Delclaux C, 1996, AM J RESP CELL MOL, V14, P288, DOI 10.1165/ajrcmb.14.3.8845180; Diaz-Alvarez L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9247574; Ding J, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2014-000028; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Elsby LM, 2010, CLIN EXP RHEUMATOL, V28, P708; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Germena G, 2015, J IMMUNOL, V194, P728, DOI 10.4049/jimmunol.1401646; Gheita TA, 2014, MOD RHEUMATOL, V24, P612, DOI 10.3109/14397595.2013.851639; Gittens BR, 2017, J IMMUNOL, V198, P4458, DOI 10.4049/jimmunol.1600709; Glennon-Alty L, 2018, FREE RADICAL BIO MED, V125, P25, DOI 10.1016/j.freeradbiomed.2018.03.049; Gough RE, 2018, FEBS LETT, V592, P2108, DOI 10.1002/1873-3468.13081; Gregory CD, 2010, APOPTOSIS, V15, P1029, DOI 10.1007/s10495-010-0485-9; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hathaway CK, 2016, P NATL ACAD SCI USA, V113, P2218, DOI 10.1073/pnas.1600511113; Highton J, 2003, ANN RHEUM DIS, V62, P77, DOI 10.1136/ard.62.1.77; Hornum L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189017; Howng SL, 2011, MOL MED REP, V4, P825, DOI 10.3892/mmr.2011.505; Hu CY, 2011, CLIN RHEUMATOL, V30, P1227, DOI 10.1007/s10067-011-1741-2; Huang RY, 2014, DISCOV MED, V17, P75; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jin T, 2003, ARTHRITIS RES THER, V5, pR9, DOI 10.1186/ar606; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lewis AJ, 2016, SURG INFECT, V17, P385, DOI 10.1089/sur.2016.021; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lopez M, 2014, J BIOL CHEM, V289, P2736, DOI 10.1074/jbc.M113.508200; Maksymowych WP, 2014, CLIN EXP RHEUMATOL, V32, pS35; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; Marotte H, 2011, ARTHRITIS RHEUM-US, V63, P3253, DOI 10.1002/art.30583; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Miyabe Y, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj2195; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P753, DOI 10.1002/art.27238; Moots RJ, 2012, RHEUMATOLOGY, V51, P2252, DOI 10.1093/rheumatology/kes217; Morgan BP, 2004, CLIN EXP IMMUNOL, V138, P430, DOI 10.1111/j.1365-2249.2004.02646.x; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ohyama K, 2012, ANN RHEUM DIS, V71, P1916, DOI 10.1136/annrheumdis-2012-201305; Oikonomou KG, 2011, AUTOIMMUN REV, V10, P389, DOI 10.1016/j.autrev.2010.12.009; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park-Min KH, 2013, J BONE MINER RES, V28, P135, DOI 10.1002/jbmr.1739; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376; Perlman H, 2001, ARTHRITIS RHEUM, V44, P21, DOI 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8; Pierson ER, 2018, CLIN IMMUNOL, V189, P23, DOI 10.1016/j.clim.2016.06.017; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846; Rico MC, 2007, J CELL PHYSIOL, V211, P504, DOI 10.1002/jcp.20958; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sadik CD, 2018, SEMIN IMMUNOL, V37, P21, DOI 10.1016/j.smim.2018.03.002; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Savill J, 1997, BRIT MED BULL, V53, P491; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Szanto S, 2004, J IMMUNOL, V172, P6723, DOI 10.4049/jimmunol.172.11.6723; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Thomas DC, 2017, IMMUNOL LETT, V192, P88, DOI 10.1016/j.imlet.2017.08.016; Tsuzaka K, 2011, ARTHRITIS RHEUM-US, V63, pS134; Warchol T, 2011, DNA CELL BIOL, V30, P33, DOI 10.1089/dna.2010.1041; Whitaker JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124254; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Wyatt E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013823; Xiong HZ, 2015, INFECT IMMUN, V83, P3418, DOI 10.1128/IAI.00678-15; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoo IS, 2018, INT J RHEUM DIS, V21, P148, DOI 10.1111/1756-185X.12892; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	100	21	22	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					141	+		10.1038/s41590-018-0293-x	http://dx.doi.org/10.1038/s41590-018-0293-x			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643265	Green Accepted			2022-12-18	WOS:000456279100012
J	Jie, ZL; Yang, JY; Gu, MD; Wang, H; Xie, XP; Li, YC; Liu, T; Zhu, LL; Shi, JH; Zhang, LY; Zhou, XF; Joo, D; Brightbill, HD; Cong, YZ; Lin, D; Cheng, XH; Sun, SC				Jie, Zuliang; Yang, Jin-Young; Gu, Meidi; Wang, Hui; Xie, Xiaoping; Li, Yanchuan; Liu, Ting; Zhu, Lele; Shi, Jianhong; Zhang, Lingyun; Zhou, Xiaofei; Joo, Donghyun; Brightbill, Hans D.; Cong, Yingzi; Lin, Daniel; Cheng, Xuhong; Sun, Shao-Cong			NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis	NATURE IMMUNOLOGY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INNATE LYMPHOID-CELLS; B-INDUCING KINASE; POLYMERIC IG RECEPTOR; ACTIVATION; EXPRESSION; PATHWAY; IL-23; INFLAMMATION; PROTECTION	Dendritic cells (DCs) play an integral role in regulating mucosal immunity and homeostasis, but the signaling network mediating this function of DCs is poorly defined. We identified the noncanonical NF-kappa B-inducing kinase (NIK) as a crucial mediator of mucosal DC function. DC-specific NIK deletion impaired intestinal immunoglobulin A (IgA) secretion and microbiota homeostasis, rendering mice sensitive to an intestinal pathogen, Citrobacter rodentium. DC-specific NIK was required for expression of the IgA transporter polymeric immunoglobulin receptor (pIgR) in intestinal epithelial cells, which in turn relied on the cytokine IL-17 produced by T(H)17 cells and innate lymphoid cells (ILCs). NIK-activated noncanonical NF-kappa B induced expression of IL-23 in DCs, contributing to the maintenance of T(H)17 cells and type 3 ILCs. Consistent with the dual functions of IL-23 and IL-17 in mucosal immunity and inflammation, NIK deficiency also ameliorated colitis induction. Thus, our data suggest a pivotal role for the NIK signaling axis in regulating DC functions in intestinal immunity and homeostasis.	[Jie, Zuliang; Yang, Jin-Young; Gu, Meidi; Wang, Hui; Xie, Xiaoping; Li, Yanchuan; Liu, Ting; Zhu, Lele; Shi, Jianhong; Zhang, Lingyun; Zhou, Xiaofei; Joo, Donghyun; Lin, Daniel; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Wang, Hui] Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China; [Liu, Ting] Sichuan Univ, West China Univ Hosp 2, Dept Lab Med, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Liu, Ting] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China; [Shi, Jianhong] Hebei Univ, Cent Lab, Affiliated Hosp, Baoding, Peoples R China; [Zhang, Lingyun] Zhengzhou Univ, Ctr Reprod Med, Henan Key Lab Reprod & Genet, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Brightbill, Hans D.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Xuzhou Medical University; Sichuan University; Sichuan University; Hebei University; Zhengzhou University; Roche Holding; Genentech; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA.	ssun@mdanderson.org	ZHU, LELE/AAP-9075-2020; Li, Yanchuan/AGX-9749-2022; Shi, Jian-hong/AAF-6078-2019; Xie, Xiaoping/K-5710-2018; Shi, Jian-hong/AAP-5703-2021	ZHU, LELE/0000-0002-1732-8753; Li, Yanchuan/0000-0002-4732-864X; Xie, Xiaoping/0000-0001-6616-1059; Shi, Jian-hong/0000-0003-2232-1000; Lin, Daniel/0000-0002-6203-712X	National Institutes of Health [GM84459, AI057555, AI104519, AI64639]; NIH/NCI [P30CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057555, R37AI064639, R01AI064639, R01AI104519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Genentech, Inc. for providing the Map3k14-flox mice, Walter and Eliza Hall Institute of Medical Research for Nfkb2<SUP>Lym1</SUP> mice, and National Cancer Institute Preclinical Repository for NF-kappa B p100/p52 antibody. This work was supported by grants from the National Institutes of Health (GM84459, AI057555, AI104519, and AI64639). This study also used the NIH/NCI-supported resources under award number P30CA016672 at The MD Anderson Cancer Center.	Ajami NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02112-17, 10.1128/aac.02112-17]; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; Brightbill HD, 2015, J IMMUNOL, V195, P953, DOI 10.4049/jimmunol.1401514; Briseno CG, 2014, CURR OPIN IMMUNOL, V29, P69, DOI 10.1016/j.coi.2014.04.006; Buela KAG, 2015, CURR OPIN GASTROEN, V31, P449, DOI 10.1097/MOG.0000000000000217; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Catana CS, 2015, WORLD J GASTROENTERO, V21, P5823, DOI 10.3748/wjg.v21.i19.5823; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Davidson N J, 2000, Int Rev Immunol, V19, P91, DOI 10.3109/08830180009048392; Eberl G, 2017, MUCOSAL IMMUNOL, V10, P27, DOI 10.1038/mi.2016.86; Ericsson AC, 2014, COMPARATIVE MED, V64, P90; Gomes-Santos AC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/560817; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Jin J, 2016, NAT IMMUNOL, V17, P259, DOI 10.1038/ni.3347; Katakam AK, 2015, P NATL ACAD SCI USA, V112, P14664, DOI 10.1073/pnas.1520627112; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Neurath MF, 2017, NAT REV GASTRO HEPAT, V14, P269, DOI 10.1038/nrgastro.2016.208; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Ruane D, 2016, J EXP MED, V213, P53, DOI 10.1084/jem.20150567; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Specht S, 2006, MICROBES INFECT, V8, P694, DOI 10.1016/j.micinf.2005.09.006; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thompson CL, 2012, ENVIRON MICROBIOL, V14, P1454, DOI 10.1111/j.1462-2920.2012.02731.x; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Vedantam G, 2011, GASTROENTEROLOGY, V141, P795, DOI 10.1053/j.gastro.2011.07.022; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu JY, 2014, J IMMUNOL, V193, P422, DOI 10.4049/jimmunol.1303237; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou YL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005019	54	21	23	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1224	+		10.1038/s41590-018-0206-z	http://dx.doi.org/10.1038/s41590-018-0206-z			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30250187	Green Accepted			2022-12-18	WOS:000447632200017
J	Renner, M; Flanagan, A; Dejnirattisai, W; Puttikhunt, C; Kasinrerk, W; Supasa, P; Wongwiwat, W; Chawansuntati, K; Duangchinda, T; Cowper, A; Midgley, CM; Malasit, P; Huiskonen, JT; Mongkolsapaya, J; Screaton, GR; Grimes, JM				Renner, Max; Flanagan, Aleksandra; Dejnirattisai, Wanwisa; Puttikhunt, Chunya; Kasinrerk, Watchara; Supasa, Piyada; Wongwiwat, Wiyada; Chawansuntati, Kriangkrai; Duangchinda, Thaneeya; Cowper, Alison; Midgley, Claire M.; Malasit, Prida; Huiskonen, Juha T.; Mongkolsapaya, Juthathip; Screaton, Gavin R.; Grimes, Jonathan M.			Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus	NATURE IMMUNOLOGY			English	Article							HUMAN NEUTRALIZING ANTIBODIES; DEPENDENT ENHANCEMENT; ZIKA VIRUS; ENVELOPE PROTEIN; STRUCTURAL BASIS; INFECTION; DETERMINANTS; IDENTIFICATION; RECOGNITION; PERSPECTIVE	Dengue virus is a major pathogen, and severe infections can lead to life-threatening dengue hemorrhagic fever. Dengue virus exists as four serotypes, and dengue hemorrhagic fever is often associated with secondary heterologous infections. Antibody-dependent enhancement (ADE) may drive higher viral loads in these secondary infections and is purported to result from antibodies that recognize dengue virus but fail to fully neutralize it. Here we characterize two antibodies, 2C8 and 3H5, that bind to the envelope protein. Antibody 3H5 is highly unusual as it not only is potently neutralizing but also promotes little if any ADE, whereas antibody 2C8 has strong capacity to promote ADE. We show that 3H5 shows resilient binding in endosomal pH conditions and neutralizes at low occupancy. Immunocomplexes of 3H5 and dengue virus do not efficiently interact with Fc gamma receptors, which we propose is due to the binding mode of 3H5 and constitutes the primary mechanism of how ADE is avoided.	[Renner, Max; Flanagan, Aleksandra; Huiskonen, Juha T.; Grimes, Jonathan M.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England; [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Cowper, Alison; Midgley, Claire M.; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Puttikhunt, Chunya; Chawansuntati, Kriangkrai; Duangchinda, Thaneeya; Malasit, Prida] Mahidol Univ, Med Biotechnol Res Unit, Natl Ctr Genet Engn & Biotechnol, Fac Med,Siriraj Hosp, Bangkok, Thailand; [Puttikhunt, Chunya; Chawansuntati, Kriangkrai; Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Off Res & Dev, Dengue Hemorrhag Fever Res Unit, Fac Med,Siriraj Hosp, Bangkok, Thailand; [Kasinrerk, Watchara] Chiang Mai Univ, Biomed Technol Res Ctr, Natl Ctr Genet Engn & Biotechnol, Chiang Mai, Thailand; [Kasinrerk, Watchara] Chiang Mai Univ, Fac Associated Med Sci, Div Clin Immunol, Dept Med Technol, Chiang Mai, Thailand; [Grimes, Jonathan M.] Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University; Diamond Light Source	Grimes, JM (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England.; Mongkolsapaya, J; Screaton, GR (corresponding author), Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Off Res & Dev, Dengue Hemorrhag Fever Res Unit, Fac Med,Siriraj Hosp, Bangkok, Thailand.; Grimes, JM (corresponding author), Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England.	juthathip.mongkolsapaya@well.ox.ac.uk; gavin.screaton@medsci.ox.ac.uk; jonathan@strubi.ox.ac.uk	Huiskonen, Juha T/C-3043-2008; Wongwiwat, Wiyada/AAJ-8936-2021	Huiskonen, Juha T/0000-0002-0348-7323; Screaton, Gavin/0000-0002-3549-4309; Renner, Max/0000-0001-9885-8256; Wongwiwat, Wiyada/0000-0002-5889-0929; Grimes, Jonathan Mark/0000-0001-9698-0389	Wellcome Trust, UK; Newton-Medical Research Council, UK [MR/NO12658/2]; National Institute for Health Research Oxford Biomedical Research Centre funding scheme; Thailand National Center for Genetic Engineering; and Biotechnology; Academy of Finland; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Research Chair Grant from the National Science and Technology Development Agency (NSTDA), Thailand; Faculty of Medicine Siriraj Hospital, Mahidol University [(IO)R015936005]; Wellcome Trust [060208/Z/00/Z, 093305/Z/10/Z, 075491/Z/04, 095541/Z/11/Z, 203224/Z/16/Z, 204703/Z/16/Z, 080721/Z/06/Z]	Wellcome Trust, UK(Wellcome Trust); Newton-Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre funding scheme; Thailand National Center for Genetic Engineering; and Biotechnology; Academy of Finland(Academy of Finland); Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Research Chair Grant from the National Science and Technology Development Agency (NSTDA), Thailand; Faculty of Medicine Siriraj Hospital, Mahidol University; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, UK; the Newton-Medical Research Council, UK (MR/NO12658/2); the National Institute for Health Research Oxford Biomedical Research Centre funding scheme; the Thailand National Center for Genetic Engineering; and Biotechnology, the Academy of Finland; the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; the Research Chair Grant from the National Science and Technology Development Agency (NSTDA), Thailand; and Faculty of Medicine Siriraj Hospital, Mahidol University, Grant Number (IO)R015936005. The OPIC electron microscopy facility was founded by a Wellcome Trust JIF award (060208/Z/00/Z) and is supported by a Wellcome Trust equipment grant (093305/Z/10/Z). The Wellcome Trust is also acknowledged for providing administrative support (Grant 075491/Z/04). G.R.S. is a Wellcome Trust senior investigator (095541/Z/11/Z and 203224/Z/16/Z). M.R. and A.F. were supported by Wellcome Trust fellowships (204703/Z/16/Z and 080721/Z/06/Z). We thank A. Siebert for support with electron microscopy; T. Prommool and C. Tawilert for scale-up and purification of monoclonal antibodies; P. Keelapang for good advice on NT and ADE assays; and D. Bitto for assistance with cryo-EM sample preparation. We also thank the staff of the Diamond Light Source (proposal MX8423), and ESRF, K. Harlos, and T. Walter, for assistance with crystallization; and D. Stuart for scientific discussion.	Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Gallichotte EN, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006934; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004; LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MORENS DM, 1987, MICROB PATHOGENESIS, V3, P231, DOI 10.1016/0882-4010(87)90056-8; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nettleship JE, 2008, PROTEIN EXPRES PURIF, V62, P83, DOI 10.1016/j.pep.2008.06.017; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; SIBER GR, 1993, J PEDIATR-US, V122, P204, DOI 10.1016/S0022-3476(06)80114-9; Siegrist CA, 1998, VACCINE, V16, P1409, DOI 10.1016/S0264-410X(98)00100-5; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	63	21	21	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1248	+		10.1038/s41590-018-0227-7	http://dx.doi.org/10.1038/s41590-018-0227-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323338	Green Accepted, Green Submitted			2022-12-18	WOS:000447632200019
J	Zhou, Y; He, CX; Yan, DP; Liu, F; Liu, HP; Chen, JX; Cao, T; Zuo, MY; Wang, P; Ge, Y; Lu, HJ; Tong, QH; Qin, CF; Deng, YQ; Ge, BX				Zhou, Yilong; He, Chenxi; Yan, Dapeng; Liu, Feng; Liu, Haipeng; Chen, Jianxia; Cao, Ting; Zuo, Mianyong; Wang, Peng; Ge, Yan; Lu, Haojie; Tong, Qinghe; Qin, Chengfeng; Deng, Yongqiang; Ge, Baoxue			The kinase CK1 epsilon controls the antiviral immune response by phosphorylating the signaling adaptor TRAF3	NATURE IMMUNOLOGY			English	Article							PATTERN-RECOGNITION RECEPTORS; IFN-BETA; VIRUS; INDUCTION; DEUBIQUITINATION; UBIQUITINATION; ACTIVATION; MECHANISMS; EPSILON; PROTEIN	The signaling adaptor TRAF3 is a highly versatile regulator of both innate immunity and adaptive immunity, but how its phosphorylation is regulated is still unknown. Here we report that deficiency in or inhibition of the conserved serine-threonine kinase CK1 epsilon suppressed the production of type I interferon in response to viral infection. CK1 epsilon interacted with and phosphorylated TRAF3 at Ser349, which thereby promoted the Lys63 (K63)-linked ubiquitination of TRAF3 and subsequent recruitment of the kinase TBK1 to TRAF3. Consequently, CK1 epsilon-deficient mice were more susceptible to viral infection. Our findings establish CK1 epsilon as a regulator of antiviral innate immune responses and indicate a novel mechanism of immunoregulation that involves CK1 epsilon-mediated phosphorylation of TRAF3.	[Zhou, Yilong; He, Chenxi; Liu, Haipeng; Chen, Jianxia; Cao, Ting; Zuo, Mianyong; Wang, Peng; Ge, Yan; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab TB, Shanghai 200092, Peoples R China; [Yan, Dapeng; Liu, Feng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Yan, Dapeng; Liu, Feng] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Lu, Haojie; Tong, Qinghe] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Lu, Haojie; Tong, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Qin, Chengfeng; Deng, Yongqiang] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Fudan University; Beijing Institute of Microbiology & Epidemiology	Ge, BX (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab TB, Shanghai 200092, Peoples R China.	gebaoxue@sibs.ac.cn	Lu, Hao/GQH-3203-2022; Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Liu, Haipeng/0000-0002-3338-6291	National Basic Research Program of China (973 Program) [2012CB578100, 2011CB505000]; National Natural Science Foundation of China [81330069, 31030028]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank B. Zhao (Zhejiang University) for CK1 epsilon and CK1 epsilon(K38R) constructs, J. Yang (Tongji University) for HA-Ub(K63) and HA-Ub(K48) constructs, X. Cao (Zhejiang University) for HSV-1 and VSV; F. Shao (National Institute of Biological Sciences, Beijing) for immortalized BMDMs; G. Chen (University of California) for Traf3<SUP>-/-</SUP> MEFs; X. Wang (National Institute of Biological Sciences, Beijing) for mit-RFP; and Abclonal Biotech for assistance with the antibody to phosphorylated TRAF3. Supported by the National Basic Research Program of China (973 Programs 2012CB578100 and 2011CB505000) and the National Natural Science Foundation of China (projects 81330069 and 31030028).	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Fang DF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5513; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Goswami R, 2013, CELL RES, V23, P1025, DOI 10.1038/cr.2013.98; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Gu LL, 2013, MOL CELL BIOL, V33, P2004, DOI 10.1128/MCB.01603-12; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Huang YF, 2012, J IMMUNOL, V188, P358, DOI 10.4049/jimmunol.1102079; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Jin J, 2014, IMMUNITY, V40, P342, DOI 10.1016/j.immuni.2014.02.006; Karim R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003384; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Peng YY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004041; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saha SK, 2006, CELL CYCLE, V5, P804, DOI 10.4161/cc.5.8.2637; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Yi ZA, 2014, NAT IMMUNOL, V15, P866, DOI 10.1038/ni.2944; Zhang S, 2013, ACTA BIOCH BIOPH SIN, V45, P1021, DOI 10.1093/abbs/gmt110; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	47	21	23	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					397	+		10.1038/ni.3395	http://dx.doi.org/10.1038/ni.3395			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26928339				2022-12-18	WOS:000372508000013
J	Zeng, WH; Mortazavi, A				Zeng, Weihua; Mortazavi, Ali			Technical considerations for functional sequencing assays	NATURE IMMUNOLOGY			English	Article							RNA-SEQ DATA; DIFFERENTIAL EXPRESSION ANALYSIS; CHROMOSOME CONFORMATION; REFERENCE GENOME; CHROMATIN; GENE; CELL; ELEMENTS; REVEALS; QUANTIFICATION	Next-generation sequencing technologies need careful design of experiments and evaluation of results to meet field requirements. Here we discuss technical considerations for these high-throughput assays, together with criteria to assess the quality of the results and the necessary validation.	[Zeng, Weihua; Mortazavi, Ali] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Zeng, Weihua; Mortazavi, Ali] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Zeng, WH (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	ali.mortazavi@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM076516] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	40	21	22	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					802	807		10.1038/ni.2407	http://dx.doi.org/10.1038/ni.2407			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910383	Green Accepted			2022-12-18	WOS:000307863600004
J	Freeman, GJ; Sharpe, AH				Freeman, Gordon J.; Sharpe, Arlene H.			A new therapeutic strategy for malaria: targeting T cell exhaustion	NATURE IMMUNOLOGY			English	Editorial Material							CHRONIC VIRAL-INFECTION; PD-1; BLOCKADE; CANCER; TIM-3; LAG-3	Boosting immune responses during malaria remains a challenge. Overcoming T cell exhaustion by blocking coinhibitory receptors offers a promising lead.	[Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Freeman, GJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, 44 Binney St, Boston, MA 02115 USA.	gordon_freeman@dfci.harvard.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089955] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI089955] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	15	21	26	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					113	115		10.1038/ni.2211	http://dx.doi.org/10.1038/ni.2211			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261959	Green Accepted			2022-12-18	WOS:000299315000005
J	Belkaid, Y; Chen, WJ				Belkaid, Yasmine; Chen, WanJun			Regulatory ripples	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INFECTIOUS TOLERANCE; INDUCTION; CYTOKINE; IL-35	Regulatory T cells come in many different forms depending on their mode of action or developmental origin. Data now show that interleukin 35, an immunomodulatory cytokine secreted by regulatory T cells, and interleukin 10 induce so-called 'iT(R)35 cells', which may have an important role in the phenomenon of infectious tolerance.	[Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571	Intramural NIH HHS [Z99 DE999999, ZIA DE000101-07] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Seyer M, 2010, EUR J IMMUNOL, V40, P321, DOI 10.1002/eji.200939527; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	14	21	24	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1077	1078		10.1038/ni1210-1077	http://dx.doi.org/10.1038/ni1210-1077			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21079629	Green Accepted			2022-12-18	WOS:000284262200004
J	Means, TK; Luster, AD				Means, Terry K.; Luster, Andrew D.			Integrins limit the Toll	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION	Regulation of the inflammatory response is necessary for limiting tissue destruction and preventing autoimmunity. A recent discovery shows that CD11b activated by Toll-like receptors via inside-out signaling mediates degradation of the Toll-like receptor adaptors MyD88 and TRIF.	[Means, Terry K.; Luster, Andrew D.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Means, Terry K.; Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Means, Terry K.; Luster, Andrew D.] Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Means, TK (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084884] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI084884] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdelbaqi M, 2006, LAB INVEST, V86, P380, DOI 10.1038/labinvest.3700398; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014	12	21	23	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					691	693		10.1038/ni0810-691	http://dx.doi.org/10.1038/ni0810-691			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644576				2022-12-18	WOS:000280149400007
J	McEver, RP				McEver, Rodger P.			Rolling back neutrophil adhesion	NATURE IMMUNOLOGY			English	Editorial Material							LONG PENTRAXIN PTX3; E-SELECTIN; MICE	Neutrophils and other cells secrete the pentraxin PTX3, which promotes innate immunity by binding to pathogens and activating complement. PTX3 can also limit neutrophil recruitment by inhibiting rolling on P-selectin in inflamed venules.	Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034363] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL034363-26, R01 HL034363] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Esmon CT, 2009, J CLIN INVEST, V119, P3205, DOI 10.1172/JCI40682; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; ZHOU Q, 1991, J CELL BIOL, V115, P557, DOI 10.1083/jcb.115.2.557	13	21	21	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					282	284		10.1038/ni0410-282	http://dx.doi.org/10.1038/ni0410-282			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20300135	Green Accepted			2022-12-18	WOS:000275849500005
J	Watts, C				Watts, Colin			Location, location, location: identifying the neighborhoods of LPS signaling	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; TRIF	TLR4 somehow manages to activate both MyD88- and TRIF-dependent signaling. According to Medzhitovc and colleagues, TLR4 engages MyD88 and TRIF sequentially at the cell surface and in endosomes, respectively, thereby providing access to distinct pools of signaling proteins.	Univ Dundee, Coll Life Sci, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Watts, Colin/0000-0001-6183-2087				Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang YJ, 2007, NAT IMMUNOL, V8, P601, DOI 10.1038/ni1471; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	15	21	23	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					343	345		10.1038/ni0408-343	http://dx.doi.org/10.1038/ni0408-343			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349810				2022-12-18	WOS:000254123200006
J	Lee, BPL; Imhof, BA				Lee, Boris P-L; Imhof, Beat A.			Lymphocyte transmigration in the brain: a new way of thinking	NATURE IMMUNOLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS PATIENTS; ENDOTHELIAL-CELLS; E-SELECTIN; LOCOMOTION; ADHESION; NATALIZUMAB; LEUKOCYTES; MIGRATION; FLOW	Lymphocytes depend on endothelial adhesion molecules such as ICAM-1 and VCAM-1, upregulated with inflammation, to facilitate transmigration across junctional barriers. New data show that ALCAM replaces VCAM-1 in the CNS during the development of neuroinflammatory diseases such as multiple sclerosis.	[Lee, Boris P-L; Imhof, Beat A.] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland	University of Geneva	Lee, BPL (corresponding author), Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, CH-1211 Geneva 4, Switzerland.	beat.imhof@medecine.unige.ch						ALON R, 1994, J CELL BIOL, V127, P1485, DOI 10.1083/jcb.127.5.1485; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Leitinger B, 2002, J CELL SCI, V115, P963; Mareckova H, 2007, ANN NY ACAD SCI, V1110, P465, DOI 10.1196/annals.1423.049; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; Morgan L, 2007, NEUROSCIENCE, V147, P664, DOI 10.1016/j.neuroscience.2007.04.051; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Smith LA, 2007, BIOPHYS J, V92, P632, DOI 10.1529/biophysj.105.079418; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Wong D, 1999, J NEUROPATH EXP NEUR, V58, P138, DOI 10.1097/00005072-199902000-00004	16	21	27	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					117	118		10.1038/ni0208-117	http://dx.doi.org/10.1038/ni0208-117			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204421				2022-12-18	WOS:000252503000004
J	Zinkernagel, R				Zinkernagel, Rolf			On observing and analyzing disease versus signals	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; T-CELLS; TOLERANCE; IMMUNITY; MEMORY; LOCALIZATION	The immune system has co-evolved with microbes that cause acute infectious disease. Immune responses must be appropriate to allow survival of both the individual and the species. These responses involve complex interactions that often go unmeasured.	Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich	Zinkernagel, R (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	rolf.zinkernagel@usz.ch						Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BOS NA, 1989, EUR J IMMUNOL, V19, P1811, DOI 10.1002/eji.1830191008; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MEDAWAR PB, 1958, PROC R SOC SER B-BIO, V149, P145, DOI 10.1098/rspb.1958.0058; Mims C. A., 1987, PATHOGENESIS INFECT; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; SILVERS WK, 1975, J EXP MED, V142, P1312, DOI 10.1084/jem.142.5.1312; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Zinkernagel RM, 2004, SCAND J IMMUNOL, V60, P9, DOI 10.1111/j.0300-9475.2004.01460.x; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x	22	21	23	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					8	10		10.1038/ni0107-8	http://dx.doi.org/10.1038/ni0107-8			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179962				2022-12-18	WOS:000242934400004
J	Metcalfe, DD				Metcalfe, DD			Genetically modified crops and allergenicity	NATURE IMMUNOLOGY			English	Editorial Material							FOOD ALLERGENS; SENSITIZATION	Among the concerns surrounding genetically modified crops has been the possibility of expressing within a plant new proteins that may be allergenic. Using available technology, practical approaches have been adopted to help prevent the creation of foods that are allergenic.	NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Metcalfe, DD (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dmetcalfe@niaid.nih.gov						Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; [Anonymous], 2003, 30 ISAAA; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; BOCK SA, 1987, PEDIATRICS, V79, P683; *CODEX AL COMM FAO, 2003, 3 SESS CODEX AD HOC; Ebner C, 2001, ALLERGY, V56, P43, DOI 10.1034/j.1398-9995.2001.00913.x; Ebo DG, 2001, ACTA CLIN BELG, V56, P234, DOI 10.1179/acb.2001.035; FAO/WHO, 2001, EV ALL GEN MOD FOODS; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Goodman RE, 2005, INT ARCH ALLERGY IMM, V137, P153, DOI 10.1159/000086314; Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861; Hodgson J, 1999, NAT BIOTECHNOL, V17, P741, DOI 10.1038/11663; *I FOOD TECHN, 2001, FOOD TECHNOL, V54, P61; Julge K, 2001, CLIN EXP ALLERGY, V31, P1854, DOI 10.1046/j.1365-2222.2001.01235.x; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Metcalfe DD, 1996, CRIT REV FOOD SCI, V36, pS165, DOI 10.1080/10408399609527763; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; Taylor SL, 2002, J ALLERGY CLIN IMMUN, V109, P24, DOI 10.1067/mai.2002.120564; Vasar M, 2000, ACTA PAEDIATR, V89, P523, DOI 10.1080/080352500750027781; Wal JM, 1998, ALLERGY, V53, P1013, DOI 10.1111/j.1398-9995.1998.tb03811.x; Woods RK, 2002, EUR J CLIN NUTR, V56, P31, DOI 10.1038/sj.ejcn.1601306; Woods RK, 2002, ANN ALLERG ASTHMA IM, V88, P183, DOI 10.1016/S1081-1206(10)61994-1	24	21	21	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					857	860		10.1038/ni0905-857	http://dx.doi.org/10.1038/ni0905-857			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116460				2022-12-18	WOS:000231369800003
J	Barton, GM; Medzhitov, R				Barton, GM; Medzhitov, R			Toll signaling: RIPping off the TNF pathway	NATURE IMMUNOLOGY			English	Editorial Material							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; TRIF; ACTIVATION; APOPTOSIS; INDUCTION	Toll-like receptors (TLRs) use multiple downstream signaling pathways. New data suggest that components of the tumor necrosis factor receptor signaling pathway are involved in signal transduction by certain TLR family members.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Barton, GM (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	gregory.barton@yale.edu; ruslan.medzhitov@yale.edu		Barton, Gregory/0000-0002-3793-0100				Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	13	21	22	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					472	474		10.1038/ni0504-472	http://dx.doi.org/10.1038/ni0504-472			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116112				2022-12-18	WOS:000221101100008
J	Green, DR				Green, DR			The suicide in the thymus, a twisted trail	NATURE IMMUNOLOGY			English	Editorial Material							INDUCED APOPTOSIS; THYMOCYTES; ACTIVATION; LIGAND	How autoreactive thymocytes die remains a question that has not been fully answered. New results supporting a role for the death ligand TRAIL may take us a step closer to unraveling this mystery.	La Jolla Inst Allergy & Immunol, Dept Cell Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Dept Cell Immunol, San Diego, CA 92121 USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Herr I, 1999, CELL DEATH DIFFER, V6, P130, DOI 10.1038/sj.cdd.4400467; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Simon AK, 2001, P NATL ACAD SCI USA, V98, P5158, DOI 10.1073/pnas.091100398; WALSH CM, 1998, IMMUNITY, V12, P599; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	11	21	21	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					207	208		10.1038/ni0303-207	http://dx.doi.org/10.1038/ni0303-207			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605225				2022-12-18	WOS:000181201000004
J	Wilson, IA; Stanfield, RL				Wilson, IA; Stanfield, RL			Unraveling the mysteries of gamma delta T cell recognition	NATURE IMMUNOLOGY			English	News Item							PYROPHOSPHATE; ANTIGENS		Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.		Stanfield, Robyn/AAH-3190-2019					Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Johnson G, 2001, NUCLEIC ACIDS RES, V29, P205, DOI 10.1093/nar/29.1.205; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C	12	21	23	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					579	581		10.1038/89718	http://dx.doi.org/10.1038/89718			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429538				2022-12-18	WOS:000169682100008
J	Ugolini, S; Vivier, E				Ugolini, S; Vivier, E			Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation	NATURE IMMUNOLOGY			English	News Item							COSTIMULATORY MOLECULES; NKG2D RECEPTOR; NK CELLS; RECOGNITION; EXPRESSION; RESPONSES		CNRS, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; Univ Med, INSERM, CNRS, Ctr Immunol Marseille Luminy, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ugolini, S (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France.	vivier@ciml.vniv-mrs.fr	Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287; Ugolini, Sophie/0000-0003-4041-0103				BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chalupny J, 2000, FASEB J, V14, pA1018; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Ding Y, 1999, SCAND J IMMUNOL, V49, P459; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MAndelboim O, 1996, SCIENCE, V274, P2097, DOI 10.1126/science.274.5295.2097; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Namekawa T, 2000, J IMMUNOL, V165, P1138, DOI 10.4049/jimmunol.165.2.1138; Ugolini S, 2000, CURR OPIN IMMUNOL, V12, P295, DOI 10.1016/S0952-7915(00)00090-X; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	18	21	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					198	200		10.1038/85246	http://dx.doi.org/10.1038/85246			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224516				2022-12-18	WOS:000167413800010
J	Yokoyama, WM				Yokoyama, WM			Now you see it, now you don't!	NATURE IMMUNOLOGY			English	News Item							RETINOIC ACID; CELLS; NKG2D	NK cells become cytotoxic upon receiving a signal through their activation receptors. The orphan proteins H-60 and Rae I have now been identified as ligands for the mouse NKG2D activation receptor. Remarkably they are inducible and may be blocked by a viral protein.	Washington Univ, Div Rheumatol, Howard Hughes Med Inst, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Div Rheumatol, Howard Hughes Med Inst, St Louis, MO 63110 USA.							Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Brown MG, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P287; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chalupny J, 2000, FASEB J, V14, pA1018; Cosman D, 2000, FASEB J, V14, pA1018; DEGOS L, 1995, BLOOD, V85, P2643, DOI 10.1182/blood.V85.10.2643.bloodjournal85102643; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; HOLTERMANN OA, 1975, NATURE, V257, P228, DOI 10.1038/257228a0; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; Malarkannan S, 1998, J IMMUNOL, V161, P3501; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yokoyama W. M., 1999, FUNDAMENTAL IMMUNOLO, P575	15	21	22	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					95	97		10.1038/77878	http://dx.doi.org/10.1038/77878			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248795				2022-12-18	WOS:000089814900004
J	Li, CF; Lee, A; Grigoryan, L; Arunachalam, PS; Scott, MKD; Trisal, M; Wimmers, F; Sanyal, M; Weidenbacher, PA; Feng, YP; Adamska, JZ; Valore, E; Wang, YL; Verma, R; Reis, N; Dunham, D; O'Hara, R; Park, H; Luo, W; Gitlin, AD; Kim, P; Khatri, P; Nadeau, KC; Pulendran, B				Li, Chunfeng; Lee, Audrey; Grigoryan, Lilit; Arunachalam, Prabhu S.; Scott, Madeleine K. D.; Trisal, Meera; Wimmers, Florian; Sanyal, Mrinmoy; Weidenbacher, Payton A.; Feng, Yupeng; Adamska, Julia Z.; Valore, Erika; Wang, Yanli; Verma, Rohit; Reis, Noah; Dunham, Diane; O'Hara, Ruth; Park, Helen; Luo, Wei; Gitlin, Alexander D.; Kim, Peter; Khatri, Purvesh; Nadeau, Kari C.; Pulendran, Bali			Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine	NATURE IMMUNOLOGY			English	Article							YELLOW-FEVER VACCINE; MESSENGER-RNA VACCINES; CD8 T-CELLS; DENDRITIC CELLS; STRANDED-RNA; RECOGNITION; RESPONSES; ACTIVATION; SENSOR	Despite the success of the BNT162b2 mRNA vaccine, the immunological mechanisms that underlie its efficacy are poorly understood. Here we analyzed the innate and adaptive responses to BNT162b2 in mice, and show that immunization stimulated potent antibody and antigen-specific T cell responses, as well as strikingly enhanced innate responses after secondary immunization, which was concurrent with enhanced serum interferon (IFN)-gamma levels 1 d following secondary immunization. Notably, we found that natural killer cells and CD8(+) T cells in the draining lymph nodes are the major producers of this circulating IFN-gamma. Analysis of knockout mice revealed that induction of antibody and T cell responses to BNT162b2 was not dependent on signaling via Toll-like receptors 2, 3, 4, 5 and 7 nor inflammasome activation, nor the necroptosis or pyroptosis cell death pathways. Rather, the CD8(+) T cell response induced by BNT162b2 was dependent on type I interferon-dependent MDA5 signaling. These results provide insights into the molecular mechanisms by which the BNT162b2 vaccine stimulates immune responses. How mRNA-based coronavirus disease 2019 vaccines drive immune responses is not clear. Here the authors characterize immune responses to the BNT162b2 vaccine in mice, and show how it stimulates innate immunity, with antigen-specific CD8(+) T cell responses dependent on the RNA sensor MDA5.	[Li, Chunfeng; Lee, Audrey; Grigoryan, Lilit; Arunachalam, Prabhu S.; Scott, Madeleine K. D.; Trisal, Meera; Wimmers, Florian; Feng, Yupeng; Adamska, Julia Z.; Valore, Erika; Wang, Yanli; Verma, Rohit; Reis, Noah; Khatri, Purvesh; Pulendran, Bali] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Scott, Madeleine K. D.; Khatri, Purvesh] Stanford Univ, Dept Med, Ctr Biomed Informat, Sch Med, Stanford, CA 94305 USA; [Sanyal, Mrinmoy; Weidenbacher, Payton A.; Kim, Peter] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Sanyal, Mrinmoy; Weidenbacher, Payton A.; Kim, Peter] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Dunham, Diane; Nadeau, Kari C.] Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA USA; [O'Hara, Ruth] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Park, Helen] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Luo, Wei] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Gitlin, Alexander D.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Gitlin, Alexander D.; Pulendran, Bali] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Kim, Peter] Chan Zuckerberg Biohub, San Francisco, CA USA; [Nadeau, Kari C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Nadeau, Kari C.] Dept Med, Div Pulm Allergy & Crit Care Med, Stanford, CA USA; [Pulendran, Bali] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Indiana University System; Indiana University Bloomington; Roche Holding; Genentech; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Pulendran, B (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	bpulend@stanford.edu	Sanyal, Mrinmoy/B-5760-2008	Sanyal, Mrinmoy/0000-0002-1365-4279; Pulendran, Bali/0000-0001-6517-4333; Reis, Noah/0000-0002-7258-2463; Grigoryan, Lilit/0000-0002-9255-1453; Gitlin, Alexander/0000-0002-9229-0919; Adamska, Julia/0000-0001-8657-4141; S ARUNACHALAM, PRABHU/0000-0003-0090-5689; li, chunfeng/0000-0001-8883-9078; Khatri, Purvesh/0000-0002-4143-4708	NIH [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266, U19 AI159840]; Bill and Melinda Gates Foundation; Soffer Fund endowment and Open Philanthropy	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Soffer Fund endowment and Open Philanthropy	We thank Ed Mockarski and Pratyusha Mandal for their advice and help during the early stages of this work. We thank the technical support from the Stanford Shared FACS Facility. Sorting was performed on an instrument in the Shared FACS Facility purchased by Parker Institute for Cancer Immunotherapy (PICI). We thank D. Wagh from Stanford Functional Genomics for preparing the single-cell library construction. We thank L. Witt, B. Betts and T. Chang from Stanford Health care system for providing remnant vaccines. We thank the National Institutes of Health tetramer core facility for providing the spike-specific tetramer for CD8<SUP>+</SUP> T cell detection. We thank B. Franco from Stanford Veterinary Service Center (VSC) for technical support. The study was supported by NIH grants (R37 DK057665, R37 AI048638, U19 AI090023 and U19 AI057266 to R. Ahmed; U19 AI159840 to S. Foung), the Bill and Melinda Gates Foundation, and the Soffer Fund endowment and Open Philanthropy to B.P.	Alameh MG, 2021, IMMUNITY, V54, P2877, DOI 10.1016/j.immuni.2021.11.001; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Arunachalam PS, 2020, NAT MED, V26, P932, DOI 10.1038/s41591-020-0858-8; Bais AS, 2020, BIOINFORMATICS, V36, P1150, DOI 10.1093/bioinformatics/btz698; Bradley AJ, 1999, BBA-BIOMEMBRANES, V1418, P19, DOI 10.1016/S0005-2736(99)00013-9; Buschmann MD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010065; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1038/s41586-020-2622-0, 10.1101/2020.06.11.145920]; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Deets KA, 2021, NAT IMMUNOL, V22, P412, DOI 10.1038/s41590-021-00869-6; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Israelow B, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4509; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kalnin KV, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00324-5; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim EH, 2020, ELIFE, V9, DOI 10.7554/eLife.52687; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Lee, 2022, NAT COMMUN, V13; Lindsay KE, 2019, NAT BIOMED ENG, V3, P371, DOI 10.1038/s41551-019-0378-3; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miao L, 2019, NAT BIOTECHNOL, V37, P1174, DOI 10.1038/s41587-019-0247-3; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Painter MM, 2021, IMMUNITY, V54, P2133, DOI 10.1016/j.immuni.2021.08.001; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pulendran B, 2021, NAT REV DRUG DISCOV, V20, P454, DOI 10.1038/s41573-021-00163-y; Pulendran B, 2020, SCIENCE, V369, P1582, DOI 10.1126/science.aay4014; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang YM, 2010, J IMMUNOL, V184, P2751, DOI 10.4049/jimmunol.0903201; Warren, 2021, JAMA NETW OPEN, V4, pe2125524; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wimmers F, 2021, CELL, V184, P3915, DOI 10.1016/j.cell.2021.05.039; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xie XP, 2021, NAT MED, V27, DOI [10.1101/2021.01.27.427998, 10.1038/s41591-021-01270-4]; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005191118; Zhao YC, 2021, CELL RES, V31, P825, DOI 10.1038/s41422-021-00501-0; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x	65	20	22	12	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					543	+		10.1038/s41590-022-01163-9	http://dx.doi.org/10.1038/s41590-022-01163-9		MAR 2022	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35288714	Green Accepted, Bronze			2022-12-18	WOS:000768631400002
J	Friedrich, C; Taggenbrock, RLRE; Doucet-Ladeveze, R; Golda, G; Moenius, R; Arampatzi, P; Kragten, NAM; Kreymborg, K; de Aguero, MG; Kastenmuller, W; Saliba, AE; Grun, D; van Gisbergen, KPJM; Gasteiger, G				Friedrich, Christin; Taggenbrock, Renske L. R. E.; Doucet-Ladeveze, Remi; Golda, Gosia; Moenius, Rebekka; Arampatzi, Panagiota; Kragten, Natasja A. M.; Kreymborg, Katharina; de Agueero, Mercedes Gomez; Kastenmueller, Wolfgang; Saliba, Antoine-Emmanuel; Gruen, Dominic; van Gisbergen, Klaas P. J. M.; Gasteiger, Georg			Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; NATURAL-KILLER; NK CELLS; T-BET; MOUSE; PROGRAMS; EXPRESSION; MATURATION; RESIDENCY; INSTRUCT	Innate lymphoid cells (ILCs) participate in tissue homeostasis, inflammation, and early immunity against infection. It is unclear how ILCs acquire effector function and whether these mechanisms differ between organs. Through multiplexed single-cell mRNA sequencing, we identified cKit(+)CD127(hi)TCF-1(hi) early differentiation stages of T-bet(+) ILC1s. These cells were present across different organs and had the potential to mature toward CD127(int)TCF-1(int) and CD127(-)TCF-1(-) ILC1s. Paralleling a gradual loss of TCF-1, differentiating ILC1s forfeited their expansion potential while increasing expression of effector molecules, reminiscent of T cell differentiation in secondary lymphoid organs. The transcription factor Hobit was induced in TCF-1(hi) ILC1s and was required for their effector differentiation. These findings reveal sequential mechanisms of ILC1 lineage commitment and effector differentiation that are conserved across tissues. Our analyses suggest that ILC1s emerge as TCF-1(hi) cells in the periphery and acquire a spectrum of organ-specific effector phenotypes through a uniform Hobit-dependent differentiation pathway driven by local cues. ILCs are considered preformed effector cells. Gasteiger and colleagues report that ILC1s undergo effector differentiation after lineage commitment. Hobit(+) ILC1s emerge as cKit(+)TCF-1(hi) cells that generate tissue-specific helper- and cytotoxic-like cells along a Hobit-dependent trajectory.	[Friedrich, Christin; Doucet-Ladeveze, Remi; Moenius, Rebekka; de Agueero, Mercedes Gomez; Kastenmueller, Wolfgang; Gruen, Dominic; Gasteiger, Georg] Julius Maximilians Univ Wurzburg, Wurzburg Inst Syst Immunol WOSI, Max Planck Res Grp, Wurzburg, Germany; [Taggenbrock, Renske L. R. E.; Kragten, Natasja A. M.; van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam UMC, Amsterdam, Netherlands; [Golda, Gosia; Gruen, Dominic] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Golda, Gosia] Univ Freiburg, Fac Biol, Freiburg, Germany; [Golda, Gosia] Int Max Planck Res Sch Immunol Epigenet & Metab I, Freiburg, Germany; [Arampatzi, Panagiota] Julius Maximilians Univ Wurzburg, Core Unit Syst Med, Wurzburg, Germany; [Kreymborg, Katharina] Roche Innovat Ctr Munich, Oncol Div, Roche Pharmaceut Res & Early Dev, Penzberg, Germany; [Saliba, Antoine-Emmanuel] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany; [van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands	Max Planck Society; University of Wurzburg; University of Amsterdam; Max Planck Society; University of Freiburg; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; University of Amsterdam	Gasteiger, G (corresponding author), Julius Maximilians Univ Wurzburg, Wurzburg Inst Syst Immunol WOSI, Max Planck Res Grp, Wurzburg, Germany.	georg.gasteiger@uni-wuerzburg.de	Saliba, Antoine-Emmanuel/AAC-1252-2022	Saliba, Antoine-Emmanuel/0000-0001-8539-2784; Taggenbrock, Renske/0000-0003-4165-6877; Golda, Gosia/0000-0002-2520-7193; Gasteiger, Georg/0000-0001-6986-127X; ARAMPATZI, PANAGIOTA/0000-0001-7925-8984; Gomez de Aguero, Mercedes/0000-0002-7132-290X	German Research Foundation (DFG) priority program SPP1937 - Innate lymphoid cells [GA2129/2-2, GR4980/1-2]; European Research Council [818846, 819329, 759176]; Max Planck Society; Interdisciplinary Center for Clinical Research-IZKF [Z-6]; EMBO Young Investigator program; LSBR fellowship from Landsteiner Foundation of Blood Transfusion Research [1629]	German Research Foundation (DFG) priority program SPP1937 - Innate lymphoid cells(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Interdisciplinary Center for Clinical Research-IZKF; EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); LSBR fellowship from Landsteiner Foundation of Blood Transfusion Research	We thank C. Romagnani for critically reading the manuscript, and S. Klingler, M. Lian, S. Riedmann, L. Parga-Vidal and the IZKF FACS sorting facility Wurzburg for expert technical assistance. We thank E. Vivier (Aix Marseille Univ., CNRS, INSERM, CIML, Marseille, France) and A. Rudensky (Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, USA) for providing mice. We thank R. Naumann (MPI-CBG, Dresden) for providing Flp deleter mice and for microinjections of Hobit<SUP>KO</SUP> ES cells. This work was supported by grants through the German Research Foundation (DFG) priority program SPP1937 -Innate lymphoid cells (GA2129/2-2 to G.Gasteiger and GR4980/1-2 to D.G.), through the European Research Council (759176-TissueLymphoContexts to G.Gasteiger, 818846-ImmuNiche to D.G. and 819329-STEP2 to W.K.). G.Gasteiger and D.G. are supported by the Max Planck Society. P.A. acknowledges financial support from Interdisciplinary Center for Clinical Research-IZKF (project Z-6). A.-E.S. is supported by the EMBO Young Investigator program. K.P.J.M.v.G. was funded by a LSBR fellowship from Landsteiner Foundation of Blood Transfusion Research (1629).	Ataide MA, 2020, NAT IMMUNOL, V21, P1397, DOI 10.1038/s41590-020-0786-2; BAI L, 2021, SCIENCE, V371; Behr FM, 2020, NAT IMMUNOL, V21, P1070, DOI 10.1038/s41590-020-0723-4; Behr FM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00400; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Ducimetiere L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026271118; Escobar G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb9726; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Ghaedi M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182293; Grun D, 2020, NAT METHODS, V17, P45, DOI 10.1038/s41592-019-0632-3; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Krabbendam L, 2021, EUR J IMMUNOL, V51, P811, DOI 10.1002/eji.202048696; Krabbendam L, 2021, CURR OPIN IMMUNOL, V68, P28, DOI 10.1016/j.coi.2020.08.007; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Krishna S, 2020, SCIENCE, V370, P1328, DOI 10.1126/science.abb9847; Lim AI, 2019, EUR J IMMUNOL, V49, P11, DOI 10.1002/eji.201747294; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; McFarland AP, 2021, IMMUNITY, V54, P1320, DOI 10.1016/j.immuni.2021.03.024; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Oherle K, 2020, IMMUNITY, V52, P275, DOI [10.1016/j.immuni.7020.01.005, 10.1016/j.immuni.2020.01.005]; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Riggan L, 2019, TRENDS IMMUNOL, V40, P909, DOI 10.1016/j.it.2019.08.005; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Stokic-Trtica V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00813; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	58	20	20	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1256	+		10.1038/s41590-021-01013-0	http://dx.doi.org/10.1038/s41590-021-01013-0		AUG 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34462601	Green Accepted			2022-12-18	WOS:000691180200001
J	Kapoor, VN; Muller, S; Keerthivasan, S; Brown, M; Chalouni, C; Storm, EE; Castiglioni, A; Lane, R; Nitschke, M; Dominguez, CX; Astarita, JL; Krishnamurty, AT; Carbone, CB; Senbabaoglu, Y; Wang, AW; Wu, XM; Cremasco, V; Roose-Girma, M; Tam, L; Doerr, J; Chen, MZ; Lee, WP; Modrusan, Z; Yang, YA; Bourgon, R; Sandoval, W; Shaw, AS; de Sauvage, FJ; Mellman, I; Moussion, C; Turley, SJ				Kapoor, Varun N.; Muller, Soren; Keerthivasan, Shilpa; Brown, Markus; Chalouni, Cecile; Storm, Elaine E.; Castiglioni, Alessandra; Lane, Ryan; Nitschke, Maximilian; Dominguez, Claudia X.; Astarita, Jillian L.; Krishnamurty, Akshay T.; Carbone, Catherine B.; Senbabaoglu, Yasin; Wang, Amber W.; Wu, Xiumin; Cremasco, Viviana; Roose-Girma, Merone; Tam, Lucinda; Doerr, Jonas; Chen, Mark Z.; Lee, Wyne P.; Modrusan, Zora; Yang, Yeqing Angela; Bourgon, Richard; Sandoval, Wendy; Shaw, Andrey S.; de Sauvage, Frederic J.; Mellman, Ira; Moussion, Christine; Turley, Shannon J.			Gremlin 1(+) fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues	NATURE IMMUNOLOGY			English	Article							RETICULAR CELLS; STEADY-STATE; NODE; EXPRESSION; ROUTES; GENES; ENTRY	Fibroblastic reticular cells (FRCs) provide structural support and soluble factors necessary for proper lymph node organization and function. Turley and colleagues use scRNA-seq to identify a unique Gremlin1-expressing FRC subset that is found in T cell zones. Grem1(+) FRCs support the survival of resident cDCs and are necessary to promote T cell immunity. Fibroblastic reticular cells (FRCs) are specialized stromal cells that define tissue architecture and regulate lymphocyte compartmentalization, homeostasis, and innate and adaptive immunity in secondary lymphoid organs (SLOs). In the present study, we used single-cell RNA sequencing (scRNA-seq) of human and mouse lymph nodes (LNs) to identify a subset of T cell-zone FRCs defined by the expression of Gremlin1 (Grem1) in both species. Grem1-CreER(T2) knock-in mice enabled localization, multi-omics characterization and genetic depletion of Grem1(+) FRCs. Grem1(+) FRCs primarily localize at T-B cell junctions of SLOs, neighboring pre-dendritic cells and conventional dendritic cells (cDCs). As such, their depletion resulted in preferential loss and decreased homeostatic proliferation and survival of resident cDCs and compromised T cell immunity. Trajectory analysis of human LN scRNA-seq data revealed expression similarities to murine FRCs, with GREM1(+) cells marking the endpoint of both trajectories. These findings illuminate a new Grem1(+) fibroblastic niche in LNs that functions to maintain the homeostasis of lymphoid tissue-resident cDCs.	[Kapoor, Varun N.; Keerthivasan, Shilpa; Brown, Markus; Castiglioni, Alessandra; Lane, Ryan; Dominguez, Claudia X.; Astarita, Jillian L.; Krishnamurty, Akshay T.; Carbone, Catherine B.; Mellman, Ira; Moussion, Christine; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Muller, Soren; Senbabaoglu, Yasin; Wang, Amber W.; Bourgon, Richard] Genentech Inc, Dept Oncol Bioinformat, San Francisco, CA USA; [Chalouni, Cecile] Genentech Inc, Ctr Adv Light Microscopy, San Francisco, CA USA; [Storm, Elaine E.; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA; [Nitschke, Maximilian; Roose-Girma, Merone; Tam, Lucinda; Shaw, Andrey S.] Genentech Inc, Res Biol, San Francisco, CA USA; [Wu, Xiumin; Doerr, Jonas] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Cremasco, Viviana] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA USA; [Chen, Mark Z.; Lee, Wyne P.] Genentech Inc, Immunol & Infect Dis, San Francisco, CA USA; [Modrusan, Zora; Yang, Yeqing Angela; Sandoval, Wendy] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA USA; [Cremasco, Viviana] Novartis Inst BioMed Res, Cambridge, MA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Harvard University; Dana-Farber Cancer Institute; Roche Holding; Genentech; Roche Holding; Genentech; Novartis	Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	turley.shannon@gene.com	Muller, Soren/AFK-6577-2022; Muller, Soren/AAG-4846-2022	Muller, Soren/0000-0001-9490-5270; Yang, Angela/0000-0002-9868-7431	Genentech	Genentech(Roche HoldingGenentech)	We thank G. Ortiz-Munoz at Genentech for technical assistance with in vivo studies. We thank S. Carlisle at Genentech for assistance with bulk RNA-seq data analysis. We thank members of the Turley lab for helpful discussions. This work was supported by Genentech.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Baptista AP, 2019, IMMUNITY, V50, P1188, DOI 10.1016/j.immuni.2019.04.001; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; Brown M, 2018, SCIENCE, V359, P1408, DOI 10.1126/science.aal3662; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cabello-Aguilar S, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa183; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Cordeiro OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151848; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gao X, 2019, BIOINFORMATICS, V35, P3038, DOI 10.1093/bioinformatics/btz024; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Ghaleb AM, 2017, GENE, V611, P27, DOI 10.1016/j.gene.2017.02.025; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Hagos EG, 2011, AM J CANCER RES, V1, P85; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hughes E. D., 2011, ADV PROTOCOLS ANIMAL, P291, DOI DOI 10.1007/978-3-662-45763-4_14; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kumar V, 2015, IMMUNITY, V42, P719, DOI 10.1016/j.immuni.2015.03.015; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Laurila R, 2013, INT J CLIN EXP PATHO, V6, P1400; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leylek R, 2019, CELL REP, V29, P3736, DOI 10.1016/j.celrep.2019.11.042; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lu E, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5237; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martinez VG, 2019, CELL REP, V29, P2810, DOI 10.1016/j.celrep.2019.10.103; McCarthy N, 2020, CELL STEM CELL, V26, P391, DOI 10.1016/j.stem.2020.01.008; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Newman RJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv600; Perez-Shibayama C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb7066; Pezoldt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06423-7; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Severino P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00141; SHAO X, 2020, BRIEF BIOINFORM; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Vaahtomeri K, 2017, CELL REP, V19, P902, DOI 10.1016/j.celrep.2017.04.027; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	68	20	20	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					571	+		10.1038/s41590-021-00920-6	http://dx.doi.org/10.1038/s41590-021-00920-6		APR 2021	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33903764				2022-12-18	WOS:000644337400005
J	Nedeva, C; Menassa, J; Duan, MB; Liu, CX; Doerflinger, M; Kueh, AJ; Herold, MJ; Fonseka, P; Phan, TK; Faou, P; Rajapaksha, H; Chen, WS; Hulett, MD; Puthalakath, H				Nedeva, Christina; Menassa, Joseph; Duan, Mubing; Liu, Chuanxin; Doerflinger, Marcel; Kueh, Andrew J.; Herold, Marco J.; Fonseka, Pamali; Phan, Thanh Kha; Faou, Pierre; Rajapaksha, Harinda; Chen, Weisan; Hulett, Mark D.; Puthalakath, Hamsa			TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis	NATURE IMMUNOLOGY			English	Article							INDUCED IMMUNOSUPPRESSION; NEUTROPHILS; IDENTIFICATION; PURIFICATION; TRANSDUCTION; MACROPHAGES; DYSFUNCTION; MUTATIONS; PNEUMONIA; THERAPIES	Sepsis is a biphasic disease characterized by an initial inflammatory phase, followed by a prolonged immunosuppression phase. Puthalakath and colleagues utilize a CRISPR-mediated mutagenesis screen to identify TREML4 as a regulator of sepsis-induced immunosuppression. Sepsis is a biphasic disease characterized by an acute inflammatory response, followed by a prolonged immunosuppressive phase. Therapies aimed at controlling inflammation help to reduce the time patients with sepsis spend in intensive care units, but they do not lead to a reduction in overall mortality. Recently, the focus has been on addressing the immunosuppressive phase, often caused by apoptosis of immune cells. However, molecular triggers of these events are not yet known. Using whole-genome CRISPR screening in mice, we identified a triggering receptor expressed on myeloid cells (TREM) family receptor, TREML4, as a key regulator of inflammation and immune cell death in sepsis. Genetic ablation ofTreml4in mice demonstrated that TREML4 regulates calcium homeostasis, the inflammatory cytokine response, myeloperoxidase activation, the endoplasmic reticulum stress response and apoptotic cell death in innate immune cells, leading to an overall increase in survival rate, both during the acute and chronic phases of polymicrobial sepsis.	[Nedeva, Christina; Menassa, Joseph; Duan, Mubing; Liu, Chuanxin; Fonseka, Pamali; Phan, Thanh Kha; Faou, Pierre; Rajapaksha, Harinda; Chen, Weisan; Hulett, Mark D.; Puthalakath, Hamsa] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia; [Doerflinger, Marcel] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic, Australia; [Doerflinger, Marcel; Kueh, Andrew J.; Herold, Marco J.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Kueh, Andrew J.; Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Blood Cell & Canc Div, Melbourne, Vic, Australia	La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Puthalakath, H (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia.	h.puthalakath@latrobe.edu.au	Herold, Marco J/C-8039-2013	Herold, Marco J/0000-0001-7539-7581; Doerflinger, Marcel/0000-0001-9159-3021; Puthalakath, Hamsa/0000-0001-5178-1175; Menassa, Joseph/0000-0002-8777-5559; Phan, Thanh Kha/0000-0001-5802-1603; Fonseka, Pamali/0000-0002-7978-2361	La Trobe University; Strategic Innovation Fund	La Trobe University; Strategic Innovation Fund	We thank R. Anders and J. Goding for critically reading the manuscript. We thank A. Baxter for reagents, La Trobe University Animal Ethics Committee and the LARTF staff for facilitating mouse experiments and the La Trobe Bioimaging Platform for the maintenance of the flow cytometry facility. We also thank S. Wilcox and P. Hickey (Walter and Eliza Hall Institute) for RNA-seq and bioinformatics. H.P. and C.N. were supported by La Trobe University funding (RFA-UD) and the Strategic Innovation Fund. J.M. is supported by La Trobe University's postgraduate scholarship. The generation of Treml4<SUP>-/-</SUP> mice used in this study was supported by the Australian Phenomics Network and the Australian Government through the National Collaborative Research Infrastructure Strategy program.	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Bahar E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091558; Basu S, 2012, PAEDIATR INT CHILD H, V32, P147, DOI 10.1179/2046905512Y.0000000018; Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.27794, 10.4161/viru.26516]; Bordon J, 2013, INT J INFECT DIS, V17, pE76, DOI 10.1016/j.ijid.2012.06.006; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Caissutti C, 2018, ACTA OBSTET GYN SCAN, V97, P111, DOI 10.1111/aogs.13249; Cante-Barrett K, 2006, J IMMUNOL, V176, P3843, DOI 10.4049/jimmunol.176.6.3843-b; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen W, 2017, INT IMMUNOPHARMACOL, V52, P61, DOI [10.1016/j.intimp.2017.11.038, 10.1016/j.intimp.2017.08.024]; Cheng Hui, 2013, Methods Mol Biol, V976, P25, DOI 10.1007/978-1-62703-317-6_3; Condotta SA, 2015, J IMMUNOL, V195, P116, DOI 10.4049/jimmunol.1402473; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies Roger, 2018, J Intensive Care Soc, V19, P326, DOI 10.1177/1751143718765407; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Delgado-Rizo V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00081; Droop AP, 2016, BIOINFORMATICS, V32, P1883, DOI 10.1093/bioinformatics/btw088; Dugani S, 2017, CAN MED ASSOC J, V189, pE2, DOI 10.1503/cmaj.160798; Feterowski C, 2003, IMMUNOLOGY, V109, P426, DOI 10.1046/j.1365-2567.2003.01674.x; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R; Gorudko IV, 2018, BIOCHEM CELL BIOL, V96, P592, DOI 10.1139/bcb-2017-0290; Hampson P, 2017, ANN SURG, V265, P1241, DOI 10.1097/SLA.0000000000001807; Hann J, 2020, J LEUKOCYTE BIOL, V107, P285, DOI 10.1002/JLB.3RU0719-241R; Hatano S, 2016, VACCINE, V34, P2490, DOI 10.1016/j.vaccine.2016.03.096; Haviernik Peter, 2008, V430, P229, DOI 10.1007/978-1-59745-182-6_16; Hemmi H, 2012, J IMMUNOL, V188, P1147, DOI 10.4049/jimmunol.1102541; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Inger MD, 2016, METHODS MOL BIOL, V1491, P69, DOI 10.1007/978-1-4939-3581-9_6; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kremserova S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5219056; Luan YY, 2015, J INTERF CYTOK RES, V35, P17, DOI 10.1089/jir.2014.0069; Madsen MB, 2019, INTENS CARE MED, V45, P1241, DOI 10.1007/s00134-019-05730-x; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; Markwart R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115094; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Mazzoni A, 2019, EUR J IMMUNOL, V49, P79, DOI 10.1002/eji.201847677; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Muenzer JT, 2006, SHOCK, V26, P565, DOI 10.1097/01.shk.0000235130.82363.ed; Nedeva C, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00108; Nowill AE, 2019, J IMMUNOL, V203, P1298, DOI 10.4049/jimmunol.1900104; Ono S, 2018, ANN GASTROENT SURG, V2, P351, DOI 10.1002/ags3.12194; Osterburg AR, 2013, P NATL ACAD SCI USA, V110, pE3370, DOI 10.1073/pnas.1306033110; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roger T, 2010, NAT MED, V16, P638, DOI 10.1038/nm0610-638; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Stortz JA, 2017, ILAR J, V58, P90, DOI 10.1093/ilar/ilx007; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Warren HS, 2009, J LEUKOCYTE BIOL, V86, P199, DOI 10.1189/jlb.0309210; Yoshida T, 2014, RESP PHYSIOL NEUROBI, V191, P75, DOI 10.1016/j.resp.2013.11.008; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002	60	20	20	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1585	+		10.1038/s41590-020-0789-z	http://dx.doi.org/10.1038/s41590-020-0789-z		OCT 2020	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33020659				2022-12-18	WOS:000575347200003
J	Wu, JX; Hayes, BW; Phoenix, C; Macias, GS; Miao, YX; Choi, HW; Hughes, FM; Purves, JT; Reinhardt, RL; Abraham, SN				Wu, Jianxuan; Hayes, Byron W.; Phoenix, Cassandra; Macias, Gustavo Sosa; Miao, Yuxuan; Choi, Hae Woong; Hughes, Francis M., Jr.; Purves, J. Todd; Reinhardt, R. Lee; Abraham, Soman N.			A highly polarized T(H)2 bladder response to infection promotes epithelial repair at the expense of preventing new infections	NATURE IMMUNOLOGY			English	Article							URINARY-TRACT-INFECTION; CD4(+) T-CELLS; UROPATHOGENIC ESCHERICHIA-COLI; SERUM-ANTIBODY LEVELS; IMMUNE-RESPONSE; FOLLOW-UP; IN-VIVO; IL-4; DIFFERENTIATION; INFLAMMATION	Urinary tract infections (UTIs) typically evoke prompt and vigorous innate bladder immune responses, including extensive exfoliation of the epithelium. To explain the basis for the extraordinarily high recurrence rates of UTIs, we examined adaptive immune responses in mouse bladders. We found that, following each bladder infection, a highly T helper type 2 (T(H)2)-skewed immune response directed at bladder re-epithelialization is observed, with limited capacity to clear infection. This response is initiated by a distinct subset of CD301b(+)OX40L(+) dendritic cells, which migrate into the bladder epithelium after infection before trafficking to lymph nodes to preferentially activate T(H)2 cells. The bladder epithelial repair response is cumulative and aberrant as, after multiple infections, the epithelium was markedly thickened and bladder capacity was reduced relative to controls. Thus, recurrence of UTIs and associated bladder dysfunction are the outcome of the preferential focus of the adaptive immune response on epithelial repair at the expense of bacterial clearance. Abraham and colleagues show that a highly polarized T(H)2 bladder response to urinary tract infections promotes epithelial repair at the expense of preventing new infections and associated bladder dysfunction.	[Wu, Jianxuan; Abraham, Soman N.] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27708 USA; [Hayes, Byron W.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Phoenix, Cassandra] North Carolina Sch Sci & Math, Dept Sci, Durham, NC USA; [Macias, Gustavo Sosa] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Miao, Yuxuan; Abraham, Soman N.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27706 USA; [Choi, Hae Woong] Korea Univ, Dept Life Sci, Seoul, South Korea; [Hughes, Francis M., Jr.; Purves, J. Todd] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA; [Reinhardt, R. Lee] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Reinhardt, R. Lee] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore, Singapore; [Miao, Yuxuan] Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10021 USA	Duke University; Duke University; University of North Carolina; Duke University; Duke University; Korea University; Duke University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National University of Singapore; Howard Hughes Medical Institute; Rockefeller University	Abraham, SN (corresponding author), Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27708 USA.; Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; Abraham, SN (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27706 USA.; Abraham, SN (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore, Singapore.	soman.abraham@duke.edu	Wu, Jianxuan/GON-3871-2022	Wu, Jianxuan/0000-0002-3461-2852; Choi, Hae Woong/0000-0001-9372-1875; Hughes, Francis/0000-0003-3776-3653; Abraham, Soman/0000-0002-1662-2096	US National Institutes of Health [R01DK121032, R01DK121969]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Locksley for providing the reporter strains. We thank the Duke Light Microscopy Core Facility, especially Y. Gao, for their expertise and advice in light microscopy imaging. We thank the Flow Cytometry Shared Resource of the Duke Cancer Institute for their assistance with flow cytometry analysis. We also appreciate the help of M.-N. Huang in the design of the flow cytometry panel. The authors acknowledge the support of the US National Institutes of Health grants R01DK121032 and R01DK121969 to S.N.A.	Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Al-Badr Ahmed, 2013, Sultan Qaboos Univ Med J, V13, P359; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; [Anonymous], 2007, J EXP MED, V204, P237, DOI 10.1084/jem.2042fta; Antunes-Lopes T, 2020, EUR UROL FOCUS, V6, P361, DOI 10.1016/j.euf.2018.09.011; Arifuzzaman M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0216; BORODY TJ, 1989, MED J AUSTRALIA, V151, P431, DOI 10.5694/j.1326-5377.1989.tb101251.x; Brubaker L, 2016, CURR OPIN OBSTET GYN, V28, P407, DOI 10.1097/GCO.0000000000000298; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Cho M, 2018, J ALLERGY CLIN IMMUN, V142, P530, DOI 10.1016/j.jaci.2017.09.019; Choi HW, 2016, IMMUNITY, V45, P1258, DOI 10.1016/j.immuni.2016.11.003; CLARK H, 1971, J INFECT DIS, V123, P539, DOI 10.1093/infdis/123.5.539; Connor LM, 2014, J IMMUNOL, V193, P2709, DOI 10.4049/jimmunol.1400374; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; CROFT M, 1995, J IMMUNOL, V154, P4269; CROFT M, 1994, J IMMUNOL, V152, P2675; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Di Pilato M, 2019, NATURE, V570, P112, DOI 10.1038/s41586-019-1215-2; El Marjou A, 2000, CARCINOGENESIS, V21, P2211; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Geesala R, 2019, J LEUKOCYTE BIOL, V105, P767, DOI 10.1002/JLB.4A0718-283RR; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hughes FM, 2019, DIABETES, V68, P430, DOI 10.2337/db18-0845; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Inouye BM, 2018, RES REP UROL, V10, P219, DOI 10.2147/RRU.S177633; Jones-Carson J, 1999, J UROLOGY, V161, P338, DOI 10.1016/S0022-5347(01)62142-6; Julia V, 2000, J IMMUNOL, V165, P5637, DOI 10.4049/jimmunol.165.10.5637; KAYE MG, 1990, CHEST, V97, P788, DOI 10.1378/chest.97.4.788; Klinkert K, 2017, EUR SURG RES, V58, P109, DOI 10.1159/000451078; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEVIN RM, 1990, NEUROUROL URODYNAM, V9, P269, DOI 10.1002/nau.1930090305; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mogulkoc N, 1999, AM J RESP CRIT CARE, V160, P349, DOI 10.1164/ajrccm.160.1.9809041; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mora-Bau G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005044; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Niv Y, 2008, HELICOBACTER, V13, P56, DOI 10.1111/j.1523-5378.2008.00571.x; NORMARK S, 1983, INFECT IMMUN, V41, P942, DOI 10.1128/IAI.41.3.942-949.1983; O'Brien VP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007457; O'Brien VP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.196; PERCIVAL A, 1964, LANCET, V2, P1027; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Ramakrishnan K, 2005, AM FAM PHYSICIAN, V71, P933; Reinhardt RL, 2015, J IMMUNOL, V194, P2358, DOI 10.4049/jimmunol.1401992; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; SANFORD BA, 1978, J CLIN MICROBIOL, V8, P575; Sawicka E, 2003, J IMMUNOL, V171, P6206, DOI 10.4049/jimmunol.171.11.6206; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Shaikh N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2982; Silverman JA, 2013, CURR UROL REP, V14, P448, DOI 10.1007/s11934-013-0354-5; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Sokol CL, 2018, IMMUNITY, V49, P449, DOI 10.1016/j.immuni.2018.07.012; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Thumbikat P, 2006, J IMMUNOL, V176, P3080, DOI 10.4049/jimmunol.176.5.3080; Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072; Troyer KL, 2001, GASTROENTEROLOGY, V121, P68, DOI 10.1053/gast.2001.25478; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; WARBURTON D, 1992, DEV BIOL, V149, P123, DOI 10.1016/0012-1606(92)90269-M; Williams WB, 2018, CURR OPIN HIV AIDS, V13, P9, DOI [10.1097/COH.0000000000000423, 10.1097/coh.0000000000000423]; Wu JX, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.71; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yeung CK, 2007, BJU INT, V99, P651, DOI 10.1111/j.1464-410X.2006.06580.x; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	85	20	20	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					671	+		10.1038/s41590-020-0688-3	http://dx.doi.org/10.1038/s41590-020-0688-3		MAY 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424366	Green Accepted			2022-12-18	WOS:000533852800003
J	Chang, JE; Buechler, MB; Gressier, E; Turley, SJ; Carroll, MC				Chang, Jonathan E.; Buechler, Matthew B.; Gressier, Elise; Turley, Shannon J.; Carroll, Michael C.			Mechanosensing by Peyer's patch stroma regulates lymphocyte migration and mucosal antibody responses	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; FIBROBLASTIC RETICULAR CELLS; PRECURSOR FREQUENCY; L-SELECTIN; NODE; ANTIGEN; HOMEOSTASIS; CHEMOKINES; CONDUITS; NETWORK	Fibroblastic reticular cells (FRCs) and their specialized collagen fibers termed 'conduits' form fundamental structural units supporting lymphoid tissues. In lymph nodes, conduits are known to transport interstitial fluid and small molecules from afferent lymphatics into the nodal parenchyma. However, the immunological contributions of conduit function have remained elusive. Here, we report that intestinal Peyer's patches (PPs) contain a specialized conduit system that directs the flow of water absorbed across the intestinal epithelium. Notably, PP FRCs responded to conduit fluid flow via the mechanosensitive ion channel Piezo1. Disruption of fluid flow or genetic deficiency of Piezo1 on CCL19-expressing stroma led to profound structural alterations in perivascular FRCs and associated high endothelial venules. This in turn impaired lymphocyte entry into PPs and initiation of mucosal antibody responses. These results identify a critical role for conduit-mediated fluid flow in the maintenance of PP homeostasis and mucosal immunity.	[Chang, Jonathan E.; Carroll, Michael C.] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Chang, Jonathan E.; Gressier, Elise] Childrens Hosp, Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA; [Buechler, Matthew B.; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Carroll, Michael C.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Roche Holding; Genentech; Harvard University; Harvard Medical School	Carroll, MC (corresponding author), Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA.; Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.; Carroll, MC (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	turley.shannon@gene.com; michael.carroll@childrens.harvard.edu		Carroll, Michael C./0000-0002-3213-4295; Buechler, Matthew/0000-0003-1902-622X	Genentech; US National Institutes of Health [F31 DK1055, R33 AI110164, RO1 AI130307, RO1 DK074500, R21 CA182598]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI110164, R01AI130307] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Carroll laboratory and the Turley laboratory for comments and suggestions on the study. We thank B. Ludewig (Kantonsspital St. Gallen) for providing Ccl19Cre mice. This study was funded in part by Genentech and by the US National Institutes of Health (grant nos. F31 DK1055 to J.E.C.; R33 AI110164 and RO1 AI130307 to M.C.C.; RO1 DK074500 and R21 CA182598 to S.J.T.). We thank S. Jhunjhunwala and N. Lounsbury for management of sequencing files and data processing.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; ANDERSON AO, 1975, AM J PATHOL, V80, P387; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Degn SE, 2018, CLIN EXP IMMUNOL, V191, P151, DOI 10.1111/cei.13066; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; HENDRIKS HR, 1987, EUR J IMMUNOL, V17, P1691, DOI 10.1002/eji.1830171203; HENDRIKS HR, 1983, EUR J IMMUNOL, V13, P663, DOI 10.1002/eji.1830130811; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; MEBIUS RE, 1993, J IMMUNOL, V151, P6769; Moe R. E., 1963, AM J ANAT, V110, P217; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; SAINTEMARIE G, 1986, CELL TISSUE RES, V245, P481; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Thierry GR, 2018, J EXP MED, V215, P2972, DOI 10.1084/jem.20180344; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	41	20	21	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1506	+		10.1038/s41590-019-0505-z	http://dx.doi.org/10.1038/s41590-019-0505-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31611698	Green Accepted			2022-12-18	WOS:000492309600020
J	Burgener, AV; Bantug, GR; Meyer, BJ; Higgins, R; Ghosh, A; Bignucolo, O; Ma, EH; Loeliger, J; Unterstab, G; Geigges, M; Steiner, R; Enamorado, M; Ivanek, R; Hunziker, D; Schmidt, A; Muller-Durovic, B; Grahlert, J; Epple, R; Dimeloe, S; Lotscher, J; Sauder, U; Ebnother, M; Burger, B; Heijnen, I; Martinez-Cano, S; Cantoni, N; Brucker, R; Kahlert, CR; Sancho, D; Jones, RG; Navarini, A; Recher, M; Hess, C				Burgener, Anne-Valerie; Bantug, Glenn R.; Meyer, Benedikt J.; Higgins, Rebecca; Ghosh, Adhideb; Bignucolo, Olivier; Ma, Eric H.; Loeliger, Jordan; Unterstab, Gunhild; Geigges, Marco; Steiner, Rebekah; Enamorado, Michel; Ivanek, Robert; Hunziker, Danielle; Schmidt, Alexander; Mueller-Durovic, Bojana; Grahlert, Jasmin; Epple, Raja; Dimeloe, Sarah; Loetscher, Jonas; Sauder, Ursula; Ebnoether, Monika; Burger, Bettina; Heijnen, Ingmar; Martinez-Cano, Sarai; Cantoni, Nathan; Bruecker, Rolf; Kahlert, Christian R.; Sancho, David; Jones, Russell G.; Navarini, Alexander; Recher, Mike; Hess, Christoph			SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2	NATURE IMMUNOLOGY			English	Article							T-CELL METABOLISM; ZONE B-CELLS; ACTIVATION; NRF2; FUMARATE; SUCCINATION; EXPRESSION; MUTATIONS; CANCER; DIFFERENTIATION	Whether screening the metabolic activity of immune cells facilitates discovery of molecular pathology remains unknown. Here we prospectively screened the extracellular acidification rate as a measure of glycolysis and the oxygen consumption rate as a measure of mitochondrial respiration in B cells from patients with primary antibody deficiency. The highest oxygen consumption rate values were detected in three study participants with persistent polyclonal B cell lymphocytosis (PPBL). Exome sequencing identified germline mutations in SDHA, which encodes succinate dehydrogenase subunit A, in all three patients with PPBL. SDHA gain-of-function led to an accumulation of fumarate in PPBL B cells, which engaged the KEAP1-Nrf2 system to drive the transcription of genes encoding inflammatory cytokines. In a single patient trial, blocking the activity of the cytokine interleukin-6 in vivo prevented systemic inflammation and ameliorated clinical disease. Overall, our study has identified pathological mitochondrial retrograde signaling as a disease modifier in primary antibody deficiency.	[Burgener, Anne-Valerie; Bantug, Glenn R.; Loeliger, Jordan; Unterstab, Gunhild; Steiner, Rebekah; Hunziker, Danielle; Mueller-Durovic, Bojana; Grahlert, Jasmin; Epple, Raja; Loetscher, Jonas; Burger, Bettina; Navarini, Alexander; Recher, Mike; Hess, Christoph] Univ Basel, Dept Biomed, Immunobiol Lab, Basel, Switzerland; [Burgener, Anne-Valerie; Bantug, Glenn R.; Meyer, Benedikt J.; Higgins, Rebecca; Ghosh, Adhideb; Loeliger, Jordan; Unterstab, Gunhild; Steiner, Rebekah; Ivanek, Robert; Hunziker, Danielle; Mueller-Durovic, Bojana; Grahlert, Jasmin; Epple, Raja; Loetscher, Jonas; Hess, Christoph] Univ Hosp Basel, Basel, Switzerland; [Bantug, Glenn R.; Hess, Christoph] Univ Cambridge, Dept Med, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge, England; [Meyer, Benedikt J.; Recher, Mike] Univ Basel, Dept Biomed, Immunodeficiency Lab, Basel, Switzerland; [Higgins, Rebecca; Ghosh, Adhideb; Burger, Bettina; Navarini, Alexander] Univ Basel, Div Dermatol, Dept Biomed, Basel, Switzerland; [Higgins, Rebecca; Ghosh, Adhideb; Burger, Bettina; Navarini, Alexander] Univ Basel, Dermatol Lab, Dept Biomed, Basel, Switzerland; [Ghosh, Adhideb] Univ Zurich, ETH, Competence Ctr Personalized Med, Zurich, Switzerland; [Bignucolo, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Ma, Eric H.; Jones, Russell G.] Van Andel Inst, Ctr Canc & Cell Biol, Grand Rapids, MI USA; [Ma, Eric H.; Jones, Russell G.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Ma, Eric H.; Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Geigges, Marco] ETH, D BSSE, Epigen Grp, Basel, Switzerland; [Enamorado, Michel; Martinez-Cano, Sarai; Sancho, David] Entro Nacl Invest Cardiovasc Carlos III, Immunobiol Lab, Madrid, Spain; [Enamorado, Michel] NIAID, Mucosal Immunol Sect, Lab Parasit Dis, NIH, Washington, DC USA; [Ivanek, Robert] Univ Basel, Dept Biomed, Bioinformat Facil, Basel, Switzerland; [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, Basel, Switzerland; [Dimeloe, Sarah] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Sauder, Ursula] Univ Basel, Biozentrum, Electron Microscopy Core Facil, Basel, Switzerland; [Ebnoether, Monika] Claraspital, Div Hematol & Oncol, Basel, Switzerland; [Heijnen, Ingmar] Univ Hosp Basel, Lab Med, Div Med Immunol, Basel, Switzerland; [Cantoni, Nathan] Cantonal Hosp Aarau, Div Hematol, Aargau, Switzerland; [Bruecker, Rolf] Hosp St Anna, Div Internal Med & Rheumatol, Luzern, Switzerland; [Kahlert, Christian R.] Childrens Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland	University of Basel; University of Basel; University of Cambridge; University of Basel; University of Basel; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Lausanne; Van Andel Institute; McGill University; McGill University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centro Nacional de Investigaciones Cardiovasculares (CNIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Basel; University of Basel; University of Birmingham; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA)	Hess, C (corresponding author), Univ Basel, Dept Biomed, Immunobiol Lab, Basel, Switzerland.; Hess, C (corresponding author), Univ Hosp Basel, Basel, Switzerland.; Hess, C (corresponding author), Univ Cambridge, Dept Med, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge, England.	chess@uhbs.ch	Bignucolo, Olivier/AAP-2975-2021; Jones, Russell/AAC-2861-2022; Kahlert, Christian/B-9659-2017; Sancho, David/D-3433-2009; Jones, Russell Graham/ABD-5261-2021; Navarini, Alexander/C-5504-2014	Bignucolo, Olivier/0000-0003-4735-049X; Kahlert, Christian/0000-0002-0784-3276; Sancho, David/0000-0003-2890-3984; Jones, Russell Graham/0000-0003-2250-4675; Steiner, Rebekah/0000-0001-8921-3202; Navarini, Alexander/0000-0001-7059-632X; Muller-Durovic, Bojana/0000-0002-9672-3750; Burger, Bettina/0000-0002-7686-0176; Bantug, Glenn Robert/0000-0003-2253-6028; Ghosh, Adhideb/0000-0002-5160-4571; Enamorado Escalona, Neris Michel/0000-0001-7748-454X; Recher, Mike/0000-0002-9121-6936	Gebert Ruf Foundation [GRS-058/14]; Swiss National Science Foundation (SNSF) [31003A_ 172848, PP00P3_ 181038]; Swiss National Supercomputing Center [SM09]	Gebert Ruf Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Supercomputing Center	We thank the patients that participated in the study, the flow sorting team and the microscopy core facility of the Department of Biomedicine, University and University Hospital of Basel, the Blood Donor Center affiliated with the University Hospital of Basel, as well as G. Hoenger, U. Duthaler, C. Gasser, J. Hirsiger, C. Berger, T. Daikeler, F. Marquardsen and F. Baldin for technical support and/or help with the clinical management of patients. Funding was provided by Gebert Ruf Foundation (grant no. GRS-058/14 to C. H. and M. R.); Swiss National Science Foundation (SNSF) (grant nos. 31003A_ 172848 to C. H. and PP00P3_ 181038 to M. R.). This work was further supported by a grant from the Swiss National Supercomputing Center (project ID SM09).	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Bantug GR, 2018, IMMUNITY, V48, P542, DOI 10.1016/j.immuni.2018.02.012; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biatnik M, 2008, ANN NY ACAD SCI, V1126, P272, DOI 10.1196/annals.1433.047; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Bussi G, 2014, MOL PHYS, V112, P379, DOI 10.1080/00268976.2013.824126; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carulli G, 2015, J CLIN EXP HEMATOP, V55, P77, DOI 10.3960/jslrt.55.77; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Chen QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143937; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Dimeloe S, 2017, IMMUNOLOGY, V150, P35, DOI 10.1111/imm.12655; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; Fischer A, 2017, J ALLERGY CLIN IMMUN, V140, P1388, DOI 10.1016/j.jaci.2016.12.978; Gerstgrasser A, 2017, J CROHNS COLITIS, V11, P485, DOI 10.1093/ecco-jcc/jjw172; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hammad H, 2017, NAT IMMUNOL, V18, P313, DOI 10.1038/ni.3657; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo X, 2007, FEBS J, V274, P1524, DOI 10.1111/j.1742-4658.2007.05698.x; Inaoka DK, 2015, INT J MOL SCI, V16, P15287, DOI 10.3390/ijms160715287; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Jiang S, 2018, CELL METAB, V27, P393, DOI 10.1016/j.cmet.2017.12.007; Kinch L, 2011, CANCER CELL, V20, P418, DOI 10.1016/j.ccr.2011.10.005; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kornberg M. D, 2018, SCIENCE, V17; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; McGuirk S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-22; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Muller T, 2012, CHEM RES TOXICOL, V25, P1805, DOI 10.1021/tx300145n; Ogura M, 2017, EUR J IMMUNOL, V47, P406, DOI 10.1002/eji.201646342; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Salcedo I, 2002, BRIT J HAEMATOL, V116, P662, DOI 10.1046/j.0007-1048.2001.03327.x; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shanmugam G, 2017, REDOX BIOL, V12, P937, DOI 10.1016/j.redox.2017.04.038; Silva P, 2017, GENES IMMUN, V18, P197, DOI 10.1038/gene.2017.14; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; van Zelm MC, 2014, J ALLERGY CLIN IMMUN, V134, P135, DOI 10.1016/j.jaci.2013.11.015; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Zeileis A., 2005, J STAT SOFTW, V14, P1, DOI [10.18637/jss.v014.i06, DOI 10.18637/JSS.V014.I06]; Zhang P, 2013, J IMMUNOL, V191, P726, DOI 10.4049/jimmunol.1202134; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116	70	20	20	7	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1311	+		10.1038/s41590-019-0482-2	http://dx.doi.org/10.1038/s41590-019-0482-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31527833	Green Submitted			2022-12-18	WOS:000486615900015
J	Liarski, VM; Sibley, A; van Panhuys, N; Ai, J; Chang, A; Kennedy, D; Merolle, M; Germain, RN; Giger, ML; Clark, MR				Liarski, Vladimir M.; Sibley, Adam; van Panhuys, Nicholas; Ai, Junting; Chang, Anthony; Kennedy, Domenick; Merolle, Maria; Germain, Ronald N.; Giger, Maryellen L.; Clark, Marcus R.			Quantifying in situ adaptive immune cell cognate interactions in humans	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PRESENTATION; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; ACTIVATION; DYNAMICS; MOTILITY; CLUSTERS; POLARITY; CD43	Two-photon excitation microscopy (TPEM) has revolutionized the understanding of adaptive immunity. However, TPEM usually requires animal models and is not amenable to the study of human disease. The recognition of antigen by T cells requires cell contact and is associated with changes in T cell shape. We postulated that by capturing these features in fixed tissue samples, we could quantify in situ adaptive immunity. Therefore, we used a deep convolutional neural network to identify fundamental distance and cell-shape features associated with cognate help (cell-distance mapping (CDM)). In mice, CDM was comparable to TPEM in discriminating cognate T cell-dendritic cell (DC) interactions from non-cognate T cell-DC interactions. In human lupus nephritis, CDM confirmed that myeloid DCs present antigen to CD4(+) T cells and identified plasmacytoid DCs as an important antigen-presenting cell. These data reveal a new approach with which to study human in situ adaptive immunity broadly applicable to autoimmunity, infection, and cancer.	[Liarski, Vladimir M.; Ai, Junting; Kennedy, Domenick; Merolle, Maria; Clark, Marcus R.] Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Liarski, Vladimir M.; Ai, Junting; Kennedy, Domenick; Merolle, Maria; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Sibley, Adam; Merolle, Maria; Giger, Maryellen L.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Sibley, Adam; Merolle, Maria; Giger, Maryellen L.] Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA; [van Panhuys, Nicholas; Germain, Ronald N.] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chang, Anthony] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago	Clark, MR (corresponding author), Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Clark, MR (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA.; Giger, ML (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.; Giger, ML (corresponding author), Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA.	m-giger@uchicago.edu; mclark@uchicago.edu	van Panhuys, Nick/F-7034-2016; Germain, Ronald/ABE-7090-2020; Liarski, Vladimir M./D-6037-2017; Giger, Maryellen/AAH-1908-2021; Germain, Ronald N./Z-1945-2019	van Panhuys, Nick/0000-0003-2199-852X; Liarski, Vladimir M./0000-0001-7533-0491; Chang, Anthony/0000-0002-6877-5510; Kennedy, Domenick/0000-0002-5329-3711; Clark, Marcus/0000-0003-4747-0387; Giger, Maryellen/0000-0001-5482-9728; Merolle, Maria/0000-0002-5866-1835	National Institute of Allergy and Infectious Diseases (NIH) [U19 AI082724]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K08 AR068421]; Cancer Center Support Grant [P30 CA014599]; Argonne National Laboratory [1S10OD018495-01];  [R01 AR055646];  [T32 EB002103];  [U01 CA195564]; NATIONAL CANCER INSTITUTE [U01CA195564, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545, U19AI082724, ZIAAI000758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR068421, R01AR055646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB002103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Center Support Grant; Argonne National Laboratory(United States Department of Energy (DOE)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIH) under Award Number U19 AI082724 (M.R.C.) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases under Award Number K08 AR068421 (V.M.L.). Funding was also provided by R01 AR055646 (M.R.C.), T32 EB002103 (A.S.), and U01 CA195564 (M.L.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Computational support was provided by the SIRAF cluster, with special thanks to C.-W. Chan (Cancer Center Support Grant P30 CA014599). GPU computation was supported by the University of Chicago Research Computing Center. Computational support on the Beagle supercomputer was provided by the NIH through resources provided by the Computation Institute and the Biological Sciences Division of the University of Chicago and Argonne National Laboratory, under grant 1S10OD018495-01, with thanks to L. Pesce and J. Urbanski. All imaging was performed at the University of Chicago Integrated Light Microscopy Facility, with thanks to V. Bindokas and C. Labno. We thank R. Abraham for careful reading of this manuscript.	Abadi M, 2015, P 12 USENIX S OPERAT; Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; [Anonymous], MIDWAY2; [Anonymous], 2016, MATLAB 9 1 R2016B SI; Arazi A, 2018, BIORXIV, DOI [10.1101/363051, DOI 10.1101/363051]; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baumgartner CK, 2010, J IMMUNOL, V184, P573, DOI 10.4049/jimmunol.0902107; Martin-Cofreces NB, 2014, TRENDS CELL BIOL, V24, P61, DOI 10.1016/j.tcb.2013.09.005; Blanchard N, 2004, J IMMUNOL, V173, P3062, DOI 10.4049/jimmunol.173.5.3062; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fisher DT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10684; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/nmeth.2869, 10.1038/NMETH.2869]; Glorot X., 2010, PROC MACH LEARN RES, P249; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; HUTTON LV, 1992, J HOPKINS APL TECH D, V13, P291; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209; Lasserre R, 2012, EMBO J, V31, P4100, DOI 10.1038/emboj.2012.276; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; Masedunskas Andrius, 2012, Bioarchitecture, V2, P143, DOI 10.4161/bioa.21758; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Olson E., 2011, J GXP COMPLIANCE, V15, P85; POLLIACK A, 1973, J EXP MED, V138, P607, DOI 10.1084/jem.138.3.607; R Development Core Team, 2018, R LANG ENV STAT COMP; Razi MA, 2005, EXPERT SYST APPL, V29, P65, DOI 10.1016/j.eswa.2005.01.006; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Secklehner J, 2017, IMMUNOL CELL BIOL, V95, P506, DOI 10.1038/icb.2017.25; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tourret M, 2010, J IMMUNOL, V185, P6809, DOI 10.4049/jimmunol.1001501; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Yew E, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813300103; You SX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04470-8; Zhang QQ, 2016, J IMMUNOL, V197, P1471, DOI 10.4049/jimmunol.1600832	50	20	20	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					503	+		10.1038/s41590-019-0315-3	http://dx.doi.org/10.1038/s41590-019-0315-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30778242	Green Accepted			2022-12-18	WOS:000461904200020
J	Lui, Y; Davis, SJ				Lui, Yuan; Davis, Simon J.			LAG-3: a very singular immune checkpoint	NATURE IMMUNOLOGY			English	Editorial Material							CRYSTAL-STRUCTURE		[Lui, Yuan; Davis, Simon J.] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Davis, Simon J.] Univ Oxford, Radcliffe Dept Med, Oxford, England	University of Oxford; University of Oxford	Davis, SJ (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.; Davis, SJ (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.	simon.davis@imm.ox.ac.uk		Davis, Simon/0000-0002-2280-1170	Medical Research Council [MC_UU_00008/4, MC_UU_12010/4] Funding Source: Medline; Wellcome Trust [207547/Z/17/Z, 207547] Funding Source: Medline; MRC [MC_UU_12010/4, MC_UU_00008/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Le Mercier I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00418; Maruhashi, 2018, NAT IMMUNOL, DOI [10.1038/s41590-018-0217-9, DOI 10.1038/S41590-018-0217-9]; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; Sharma S, 2018, GENOME RES, V28, P1372, DOI 10.1101/gr.231183.117; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Wang XX, 2011, P NATL ACAD SCI USA, V108, P15960, DOI 10.1073/pnas.1109438108; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392	11	20	22	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1278	1279		10.1038/s41590-018-0257-1	http://dx.doi.org/10.1038/s41590-018-0257-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30446753	Green Accepted			2022-12-18	WOS:000452873000006
J	Kardava, L; Sohn, H; Youn, C; Austin, JW; Wang, W; Buckner, CM; Justement, JS; Melson, VA; Roth, GE; Hand, MA; Gittens, KR; Kwan, RW; Sneller, MC; Li, YX; Chun, TW; Sun, PD; Pierce, SK; Moir, S				Kardava, Lela; Sohn, Haewon; Youn, Christine; Austin, James W.; Wang, Wei; Buckner, Clarisa M.; Justement, J. Shawn; Melson, Valerie A.; Roth, Gwynne E.; Hand, Marissa A.; Gittens, Kathleen R.; Kwan, Richard W.; Sneller, Michael C.; Li, Yuxing; Chun, Tae-Wook; Sun, Peter D.; Pierce, Susan K.; Moir, Susan			IgG3 regulates tissue-like memory B cells in HIV-infected individuals	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REACTIVE PROTEIN; VIREMIC INDIVIDUALS; RESPONSES; RECEPTOR; FC; GAMMA; ANTIGEN; AUTOIMMUNITY; SUBCLASSES	Immunoglobulin G3 (IgG3) has an uncertain role in the response to infection with and vaccination against human immunodeficiency virus (HIV). Here we describe a regulatory role for IgG3 in dampening the immune system-activating effects of chronic HIV viremia on B cells. Secreted IgG3 was bound to IgM-expressing B cells in vivo in HIV-infected chronically viremic individuals but not in early-viremic or aviremic individuals. Tissue-like memory (TLM) B cells, a population expanded by persistent HIV viremia, bound large amounts of IgG3. IgG3 induced clustering of B cell antigen receptors (BCRs) on the IgM(+) B cells, which was mediated by direct interactions between soluble IgG3 and membrane IgM of the BCR (IgM-BCR). The inhibitory IgG receptor CD32b (Fc gamma RIIb), complement component C1q and inflammatory biomarker CRP contributed to the binding of secreted IgG3 onto IgM-expressing B cells of HIV-infected individuals. Notably, IgG3-bound TLM B cells were refractory to IgM-BCR stimulation, thus demonstrating that IgG3 can regulate B cells during chronic activation of the immune system.	[Kardava, Lela; Youn, Christine; Austin, James W.; Wang, Wei; Buckner, Clarisa M.; Justement, J. Shawn; Melson, Valerie A.; Hand, Marissa A.; Sneller, Michael C.; Chun, Tae-Wook; Moir, Susan] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sohn, Haewon; Roth, Gwynne E.; Sun, Peter D.; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Gittens, Kathleen R.; Kwan, Richard W.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Li, Yuxing] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Li, Yuxing] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University System of Maryland; University of Maryland Baltimore	Moir, S (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	smoir@niaid.nih.gov	Chun, Tae-Wook/W-9187-2019; Chun, Tae-Wook/AAC-3101-2020; Moir, Susan/AAC-3676-2020	Chun, Tae-Wook/0000-0001-5153-7340; Youn, Christine/0000-0002-0022-2848	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI000851, P30AI036214, R01AI102766, ZIAAI000880, ZIAAI000898] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the study volunteers for their participation in this study; C. Rehm and S. Jones for specimen procurement; A.S. Fauci for discussions and suggestions. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Brunner M, 2000, J INFECT DIS, V182, P534, DOI 10.1086/315724; Buckner CM, 2013, J VIROL, V87, P5800, DOI 10.1128/JVI.00094-13; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Clatworthy MR, 2007, P NATL ACAD SCI USA, V104, P7169, DOI 10.1073/pnas.0608889104; Davey AM, 2012, J IMMUNOL, V188, P3332, DOI 10.4049/jimmunol.1102322; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Dugast AS, 2014, EUR J IMMUNOL, V44, P2925, DOI 10.1002/eji.201344305; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008; Knox J. J., 2017, ICI INSIGHT, V2; Knox JJ, 2017, CELL IMMUNOL, V321, P26, DOI 10.1016/j.cellimm.2017.04.012; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lefranc Marie-Paule, 2012, Methods Mol Biol, V882, P635, DOI 10.1007/978-1-61779-842-9_34; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Meffre E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84610; Michaelsen TE, 2009, SCAND J IMMUNOL, V70, P553, DOI 10.1111/j.1365-3083.2009.02338.x; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2017, IMMUNOL REV, V275, P33, DOI 10.1111/imr.12502; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Molinos-Albert LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01154; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Mortensen R, 2015, J IMMUNOL, V195, P1657, DOI 10.4049/jimmunol.1500804; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Nezlin R, 2004, ADV IMMUNOL, V82, P155, DOI 10.1016/S0065-2776(04)82004-2; Noto A, 2017, CURR OPIN HIV AIDS, V12, P203, DOI 10.1097/COH.0000000000000359; Pallikkuth S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01380; Pekkarinen PT, 2015, EUR J IMMUNOL, V45, P915, DOI 10.1002/eji.201444948; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; Portugal S, 2017, CELL IMMUNOL, V321, P18, DOI 10.1016/j.cellimm.2017.07.003; Pupovac A, 2017, CURR OPIN IMMUNOL, V45, P89, DOI 10.1016/j.coi.2017.03.004; Roux KH, 1997, J IMMUNOL, V159, P3372; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Seeling M, 2017, NAT REV RHEUMATOL, V13, P621, DOI 10.1038/nrrheum.2017.146; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Son M, 2015, IMMUNOL RES, V63, P101, DOI 10.1007/s12026-015-8705-6; Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010; Ugurlar D, 2018, SCIENCE, V359, P794, DOI 10.1126/science.aao4988; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Xu LL, 2016, J EXP MED, V213, P2707, DOI 10.1084/jem.20160528; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e	53	20	20	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1001	+		10.1038/s41590-018-0180-5	http://dx.doi.org/10.1038/s41590-018-0180-5			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30104633	Green Accepted			2022-12-18	WOS:000442365100021
J	Mantovani, A				Mantovani, Alberto			Reflections on immunological nomenclature: in praise of imperfection	NATURE IMMUNOLOGY			English	Letter							INNATE LYMPHOID-CELLS; MACROPHAGE ACTIVATION; POLARIZATION; PLASTICITY		[Mantovani, Alberto] Humanitas Univ, Ist Clin Humanitas, Milan, Italy	Humanitas University; IRCCS Humanitas Research Hospital	Mantovani, A (corresponding author), Humanitas Univ, Ist Clin Humanitas, Milan, Italy.	alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022	Mantovani, Alberto/0000-0001-5578-236X				Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bruck Gabriele vom, 2009, ANTHR NAMES NAMING; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365	9	20	20	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					215	216		10.1038/ni.3354	http://dx.doi.org/10.1038/ni.3354			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26882248				2022-12-18	WOS:000370469300001
J	Chaussabel, D; Pulendran, B				Chaussabel, Damien; Pulendran, Bali			A vision and a prescription for big data-enabled medicine	NATURE IMMUNOLOGY			English	Article							YELLOW-FEVER VACCINE; GENE-EXPRESSION; SEASONAL INFLUENZA; SYSTEMS BIOLOGY; INTERFERON; BLOOD; CHILDREN; PREDICTION; TOLERANCE; SIGNATURE	Genetic, environmental and socioeconomic factors render humanity remarkably diverse. '-Omic' and sensor technologies permit the capture of this diversity with unprecedented precision. Leveraging these technologies in clinical decision making will help to bring about the long-heralded personalization of medicine.	[Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Sidra Medical & Research Center; Emory University	Chaussabel, D (corresponding author), Sidra Med & Res Ctr, Doha, Qatar.	dchaussabel@sidra.org; bpulend@emory.edu	Chaussabel, Damien/AAX-1909-2020; Pulendran, Bali/AAW-9550-2021	Chaussabel, Damien/0000-0002-6131-7242	NIAID NIH HHS [R37 AI048638, U19 AI090023] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, R37AI048638] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Chatterjee Bijoya, 2011, Ayu, V32, P141, DOI 10.4103/0974-8520.92539; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Ertin E., 2011, P 9 INT C EMB NETW S; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Hecker M, 2013, MOL NEUROBIOL, V48, P737, DOI 10.1007/s12035-013-8463-1; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Kallionpaa H, 2014, DIABETES, V63, P2402, DOI 10.2337/db13-1775; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lukaszewski RA, 2008, CLIN VACCINE IMMUNOL, V15, P1089, DOI 10.1128/CVI.00486-07; Martinez-Llordella M, 2008, J CLIN INVEST, V118, P2845, DOI 10.1172/JCI35342; Medawar P, 1959, REITH LECT; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Moal V, 2013, J INFECT DIS, V207, P125, DOI 10.1093/infdis/jis632; Mostafavi S, 2014, MOL PSYCHIATR, V19, P1267, DOI 10.1038/mp.2013.161; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Nikzad N., 2012, P C WIR HLTH WH 12 A; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Oswald M, 2015, ARTHRITIS RHEUMATOL, V67, P344, DOI 10.1002/art.38947; Panelli MC, 2002, GENOME BIOL, V3; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Rahman T., 2014, P INT C MOB SYST APP; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Smih F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020414; Stamova B, 2010, STROKE, V41, P2171, DOI 10.1161/STROKEAHA.110.588335; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198	38	20	23	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					435	439		10.1038/ni.3151	http://dx.doi.org/10.1038/ni.3151			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898187				2022-12-18	WOS:000353305200001
J	Ding, SY; Robek, MD				Ding, Siyuan; Robek, Michael D.			Peroxisomal MAVS activates IRF1-mediated IFN-lambda production	NATURE IMMUNOLOGY			English	Editorial Material							HEPATITIS-C VIRUS; INTERFERON; IMMUNITY; DEFENSE; CELLS	Infection with an RNA virus induces the interferons IFN-beta and IFN-lambda via the adaptor MAVS located in mitochondria, while peroxisomal MAVS selectively activates an IFN-lambda response.	[Ding, Siyuan; Robek, Michael D.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Ding, SY (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	michael.robek@yale.edu	Ding, Siyuan/G-2718-2017	Ding, Siyuan/0000-0002-5338-260X				Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gao SJ, 1997, ONCOGENE, V15, P1979, DOI 10.1038/sj.onc.1201571; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Ueki IF, 2013, J EXP MED, V210, P1929, DOI 10.1084/jem.20121401	16	20	20	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					700	701		10.1038/ni.2924	http://dx.doi.org/10.1038/ni.2924			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	25045870				2022-12-18	WOS:000339323000003
J	Subramaniam, S; Hsiao, G				Subramaniam, Shankar; Hsiao, Gene			Gene-expression measurement: variance-modeling considerations for robust data analysis	NATURE IMMUNOLOGY			English	Article							MICROARRAY DATA	System-wide measurements of gene expression by DNA microarray and, more recently, RNA-sequencing strategies have become de facto tools of modern biology and have led to deep understanding of biological mechanisms and pathways. However, analyses of the measurements have often ignored statistically robust methods that account for variance, resulting in misleading biological interpretations.	[Subramaniam, Shankar; Hsiao, Gene] Univ Calif San Diego, Dept Bioengn, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Subramaniam, Shankar; Hsiao, Gene] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Bioengn, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	shankar@ucsd.edu			US National Institute of Health [U19 AI090023, P01 DK074868, U54 GM069338, R33 HL087375]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hsiao for discussions. Supported by the US National Institute of Health (U19 AI090023, P01 DK074868, U54 GM069338 and R33 HL087375).	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Hsiao Albert, 2008, Syst Synth Biol, V2, P95, DOI 10.1007/s11693-009-9033-8; Hsiao G., 2011, AM J PHYSIOL, V300, P164; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhu QQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-285	17	20	20	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					199	203		10.1038/ni.2244	http://dx.doi.org/10.1038/ni.2244			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344273	Green Accepted			2022-12-18	WOS:000300510600002
J	May, MJ				May, Michael J.			IL-17R signaling: new players get in on the Act1	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE	Proinflammatory signaling by the interleukin 17 receptor requires the adaptor Act1. Two studies identify an additional function for Act1 and identify new participants that regulate the inflammatory effects of IL-17.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	May, MJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	maym@vet.upenn.edu		May, Michael/0000-0002-2485-3716	NHLBI NIH HHS [R01 HL096642] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007	10	20	21	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					813	U1		10.1038/ni.2093	http://dx.doi.org/10.1038/ni.2093			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21852777				2022-12-18	WOS:000294461200003
J	Debes, GF; Diehl, MC				Debes, Gudrun F.; Diehl, Malissa C.			CCL8 and skin T cells-an allergic attraction	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; INFLAMMATION; RECEPTORS; CCR8		[Debes, Gudrun F.; Diehl, Malissa C.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Debes, GF (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	gdebes@vet.upenn.edu		Debes, Gudrun/0000-0003-4208-7362				Brown MN, 2010, J IMMUNOL, V185, P4873, DOI 10.4049/jimmunol.1000676; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Louahed J, 2003, EUR J IMMUNOL, V33, P494, DOI 10.1002/immu.200310025; Mitsuyama E, 2006, MINI-REV MED CHEM, V6, P463, DOI 10.2174/138955706776361394; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Norman P, 2007, EXPERT OPIN THER PAT, V17, P465, DOI 10.1517/13543776.17.4.465; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208	11	20	20	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					111	112		10.1038/ni0211-111	http://dx.doi.org/10.1038/ni0211-111			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21245898				2022-12-18	WOS:000286378400001
J	Kaye, J				Kaye, Jonathan			CD160 and BTLA: LIGHTs out for CD4(+) T cells	NATURE IMMUNOLOGY			English	Editorial Material							LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE	The T cell costimulatory protein LIGHT and coinhbitory protein BTLA share a common ligand, HVEM. Now CD160 is also shown to bind HVEM and deliver a potent inhibitory signal to CD4 T cells.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Kaye, J (corresponding author), Scripps Res Inst, Dept Immunol, IMM 4, La Jolla, CA 92037 USA.	jkaye@scripps.edu		Kaye, Jonathan/0000-0002-1634-9069				Anumanthan A, 1998, J IMMUNOL, V161, P2780; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; Gavrieli M, 2006, BIOCHEM BIOPH RES CO, V345, P1440, DOI 10.1016/j.bbrc.2006.05.036; GUIFANG C, 2008, NAT IMMUNOL, V9, P176; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Hurchla MA, 2007, J IMMUNOL, V178, P6073, DOI 10.4049/jimmunol.178.10.6073; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Lepenies B, 2007, J IMMUNOL, V179, P4093, DOI 10.4049/jimmunol.179.6.4093; MAIZA H, 1993, J EXP MED, V178, P1121, DOI 10.1084/jem.178.3.1121; Rabot M, 2007, INT IMMUNOL, V19, P401, DOI 10.1093/intimm/dxm005; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Truong W, 2007, TRANSPLANTATION, V84, P1368, DOI 10.1097/01.tp.0000289995.70390.20; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wu TH, 2007, IMMUNOL CELL BIOL, V85, P590, DOI 10.1038/sj.icb.7100087	17	20	22	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					122	124		10.1038/ni0208-122	http://dx.doi.org/10.1038/ni0208-122			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204424	Bronze			2022-12-18	WOS:000252503000007
J	Lage, A				Lage, Agustin			Connecting immunology research to public health: Cuban biotechnology	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS IMPINGE; NEISSERIA-MENINGITIDIS; TUMOR IMMUNOBIOLOGY; CANCER VACCINES; PROTEIN; ADJUVANT	The close connection between immunology and public health has been successful in reducing infant mortality and infectious diseases in Cuba. The next challenge is to find treatments for chronic diseases of adulthood and to extend life expectancy.	Ctr Mol Immunol, Havana 11600, Cuba		Lage, A (corresponding author), Ctr Mol Immunol, Havana 11600, Cuba.	lage@cim.sld.cu						Alfonso M, 2002, J IMMUNOL, V168, P2523, DOI 10.4049/jimmunol.168.5.2523; Bequet-Romero Monica, 2007, Angiogenesis, V10, P23, DOI 10.1007/s10456-006-9062-9; CANO CA, 1999, GENET ANAL-TECH APPL, V3, P149; Crombet T, 2004, J CLIN ONCOL, V22, P1646, DOI 10.1200/JCO.2004.03.089; de Leon J, 2006, CANCER IMMUNOL IMMUN, V55, P443, DOI 10.1007/s00262-005-0041-6; FRANCO M, 2007, PAN AM J PUBLIC HLTH, V21, P239; Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036; Iglesias E, 2006, IMMUNOL CELL BIOL, V84, P174, DOI 10.1111/j.1440-1711.2005.01408.x; Lage A, 2005, CURR CANCER DRUG TAR, V5, P611, DOI 10.2174/156800905774932789; Leon K, 2007, J IMMUNOL, V179, P5659, DOI 10.4049/jimmunol.179.9.5659; Leon K, 2007, J THEOR BIOL, V247, P122, DOI 10.1016/j.jtbi.2007.01.029; LIMONTA M, 1989, ANN NY ACAD SCI, V569, P325, DOI 10.1111/j.1749-6632.1989.tb27380.x; Mesa C, 2004, VACCINE, V22, P3045, DOI 10.1016/j.vaccine.2004.02.010; Montero E, 2007, ANN NY ACAD SCI, V1107, P239, DOI 10.1196/annals.1381.026; Perez O, 2004, IMMUNOL CELL BIOL, V82, P603, DOI 10.1111/j.1440-1711.2004.01293.x; Schlom J, 2007, CLIN CANCER RES, V13, P3776, DOI 10.1158/1078-0432.CCR-07-0588; Uli L, 2006, PROTEOMICS, V6, P3389, DOI 10.1002/pmic.200500502; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Wick G, 2003, EXP GERONTOL, V38, P13, DOI 10.1016/S0531-5565(02)00161-4	20	20	23	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					109	112		10.1038/ni0208-109	http://dx.doi.org/10.1038/ni0208-109			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204419				2022-12-18	WOS:000252503000002
J	Boehm, T				Boehm, Thomas			Two in one: dual function of an invertebrate antigen receptor	NATURE IMMUNOLOGY			English	Editorial Material							DROSOPHILA DSCAM; DIVERSITY	Differential splicing generates thousands of isoforms of the arthropod cell surface receptor Dscam. A new study explains the ability of these receptors to simultaneously generate homophilic and heterophilic interaction surfaces.	Max Planck Inst Immunol, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunol, Dept Dev Immunol, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de						Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; MEIJERS R, 2007, NATURE, V26; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	11	20	21	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1031	1033		10.1038/ni1007-1031	http://dx.doi.org/10.1038/ni1007-1031			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878910				2022-12-18	WOS:000249691400009
J	Russell, DG; Yates, RM				Russell, David G.; Yates, Robin M.			Toll-like receptors and phagosome maturation	NATURE IMMUNOLOGY			English	Letter									Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	dgr8@cornell.edu	Yates, Robin/K-5032-2015; Russell, David G/N-5280-2019; Russell, David G/D-4533-2009	Yates, Robin/0000-0003-3122-1845; Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X				Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	5	20	20	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					217	217		10.1038/ni0307-217a	http://dx.doi.org/10.1038/ni0307-217a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304226	Bronze			2022-12-18	WOS:000244275100002
J	Kobayashi, T; Takaesu, G; Yoshimura, A				Kobayashi, T; Takaesu, G; Yoshimura, A			Mal-function of TLRs by SOCS	NATURE IMMUNOLOGY			English	Editorial Material							NEGATIVE REGULATION; CYTOKINE; KINASE	Suppressor of cytokine signaling 1 has been linked to the negative regulation of Toll-like receptor signaling. The mechanism for this seems to be suppressor of cytokine signaling 1-mediated degradation of the adaptor Mal, which is required for Toll-like receptor signaling.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan	Kyushu University	Kobayashi, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013	Takaesu, Giichi/0000-0002-1581-1055				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	10	20	23	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					123	124		10.1038/ni0206-123	http://dx.doi.org/10.1038/ni0206-123			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16424886				2022-12-18	WOS:000234801700004
J	Rudd, CE				Rudd, CE			MAPK p38: alternative and nonstressful in T cells	NATURE IMMUNOLOGY			English	Editorial Material							SIGNAL-TRANSDUCTION; ACTIVATION; KINASES; PROTEINS	The MAP kinase p38 is normally regulated by the MAPKKK-MAPKK pathway in mammalian cells. However, analysis of T cell signaling shows an alternative pathway for p38 activation exists.	Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Mol Immunol Sect, London, England	Imperial College London	Rudd, CE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Mol Immunol Sect, Hammersmith Campus, London, England.	c.rudd@imperial.ac.uk	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019				Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Ohkusu-Tsukada K, 2004, MOL CELL BIOL, V24, P6957, DOI 10.1128/MCB.24.16.6957-6966.2004; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153	14	20	21	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					368	370		10.1038/ni0405-368	http://dx.doi.org/10.1038/ni0405-368			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785766				2022-12-18	WOS:000227860000010
J	Abbas, AK; Sharpe, AH				Abbas, AK; Sharpe, AH			Dendritic cells giveth and taketh away	NATURE IMMUNOLOGY			English	Editorial Material							IN-VIVO; TOLERANCE; ENGAGEMENT; INDUCTION; RESPONSES; ANERGY	Resting dendritic cells can induce T cell tolerance. This process requires engagement of the costimulatory molecules PD-1 and CTLA-4 on T cells.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Abbas, AK (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	aabbas@itsa.ucsf.edu						Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040	12	20	21	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					227	228		10.1038/ni0305-227	http://dx.doi.org/10.1038/ni0305-227			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716967				2022-12-18	WOS:000227117400003
J	Trinchieri, G				Trinchieri, G			The choices of a natural killer	NATURE IMMUNOLOGY			English	Editorial Material							NK CELL ACTIVATION; NKG2D; LYMPHOCYTES; MOLECULE; 3-KINASE; 2B4	The ability of NKG2D to trigger costimulation in CD8(+) T cells and cytotoxicity in NK cells is thought to arise from its differential association with the intracellular signaling molecules DAP10 and DAP12, respectively. This model has now been refined to include the ability of DAP10 to mediate cytotoxic signals.	Schering Plough Res Inst, Lab Immunol Res, Dardilly, France	Merck & Company	Trinchieri, G (corresponding author), Schering Plough Res Inst, Lab Immunol Res, Dardilly, France.		Trinchieri, Giorgio/F-9369-2015; Calabrese, Massimiliano/I-6195-2012	Trinchieri, Giorgio/0000-0001-5892-7464; 				Aoukaty A, 2002, J BIOL CHEM, V277, P13331, DOI 10.1074/jbc.M112029200; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Kambayashi T, 2001, J IMMUNOL, V167, P6706, DOI 10.4049/jimmunol.167.12.6706; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Teng JMC, 1996, J IMMUNOL, V156, P3222; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	12	20	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					509	510		10.1038/ni0603-509	http://dx.doi.org/10.1038/ni0603-509			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774071				2022-12-18	WOS:000183175500006
J	Sprent, J; Surh, CD				Sprent, J; Surh, CD			Knowing one's self: central tolerance revisited	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; THYMUS; GENE	Tissue-specific antigens are expressed in the thymic medulla under the influence of the AIRE gene, suggesting that unresponsiveness to these peripheral antigens is a result of central tolerance. New data on T cell tolerance in AIRE(-/-) mice strongly support this hypothsis.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sprent, J (corresponding author), Scripps Res Inst, Dept Immunol, IMM4,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jsprent@scripps.edu						Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; HAMMERLING GJ, 1993, IMMUNOL REV, V133, P93, DOI 10.1111/j.1600-065X.1993.tb01511.x; HEATH WR, 1995, J IMMUNOL, V155, P2339; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; SPRENT J, 1993, IMMUNOL REV, V133, P151, DOI 10.1111/j.1600-065X.1993.tb01515.x; Stockinger B, 1999, Adv Immunol, V71, P229; Surh CD, 2002, MICROBES INFECT, V4, P51, DOI 10.1016/S1286-4579(01)01509-X	12	20	20	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					303	304		10.1038/ni0403-303	http://dx.doi.org/10.1038/ni0403-303			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660725				2022-12-18	WOS:000181987700004
J	Phillips, RE				Phillips, RE			Immunology taught by Darwin	NATURE IMMUNOLOGY			English	Review							CYTOTOXIC T-LYMPHOCYTES; ESCAPE VARIANTS; CELL RECOGNITION; VACCINE; POPULATION; EVOLUTION; INFECTION; SELECTION; PEPTIDES; VIRUSES	This Focus issue brings together the cornucopia of strategies that pathogens and tumors utilize to avoid immune recognition. Here Rodney Phillips discusses some general principles that emerge from this analysis.	Univ Oxford, Oxford OX1 3SY, England	University of Oxford	Phillips, RE (corresponding author), Univ Oxford, Peter Medawar Bldg Pathogen Res,S Pks Rd, Oxford OX1 3SY, England.	rodney.phillips@ndm.ox.ac.uk						Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Darwin C., 1859, ORIGIN SPECIES MEANS, DOI 10.5962/bhl.title.162283; Day NPJ, 2001, SCIENCE, V292, P114, DOI 10.1126/science.1056495; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Martin SL, 2000, VACCINE, V18, P2476, DOI 10.1016/S0264-410X(00)00047-5; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Sala M, 2000, J MOL EVOL, V51, P12, DOI 10.1007/s002390010062; THOMAS L, 1982, YALE J BIOL MED, V55, P329; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; van Loo IHM, 2002, MICROBIOL-SGM, V148, P2011, DOI 10.1099/00221287-148-7-2011; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WOOLHOUSE MEJ, 2002, IN PRESS NATURE GENE; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	24	20	21	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					987	989		10.1038/ni1102-987	http://dx.doi.org/10.1038/ni1102-987			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407405	Bronze			2022-12-18	WOS:000179073000002
J	Muegge, K				Muegge, K			Preparing the target for the bullet	NATURE IMMUNOLOGY			English	Editorial Material							CELL-DIFFERENTIATION; TRANSCRIPTION; CHROMATIN; INDUCTION		NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, SAIC, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Muegge, K (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, SAIC, Frederick, MD 21702 USA.							Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Wolffe AP., 1998, CHROMATIN STRUCTURE	12	20	20	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					16	17		10.1038/ni0102-16	http://dx.doi.org/10.1038/ni0102-16			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753404				2022-12-18	WOS:000173148700009
J	Colonna, M				Colonna, M			Can we apply the T(H)1-T(H)2 paradigm to all lymphocytes?	NATURE IMMUNOLOGY			English	News Item							HUMAN NK CELLS; DIFFERENTIATION; TRANSCRIPTION; IMMATURE; SUBSETS	The T(H)1-T(H)2 paradigm, in which CD4(+)T cells polarize into type 1 or type 2 helper cells, has been extended to other cells types. However, evidence now suggests that NK cells differentiate sequentially from immature type 2 to mature type 1 cells, a pathway that could apply to other lymphocytes.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Colonna, M (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.			Colonna, Marco/0000-0001-5222-4987				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Kadowaki N, 2001, J EXP MED, V193, P1221, DOI 10.1084/jem.193.10.1221; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; LOZA MJ, 2001, NATURE IMMUNOL, V20, pR20; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Peritt D, 1998, J IMMUNOL, V161, P5821; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Sandel PC, 2001, J IMMUNOL, V166, P5935, DOI 10.4049/jimmunol.166.10.5935; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	15	20	23	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					899	900		10.1038/ni1001-899	http://dx.doi.org/10.1038/ni1001-899			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577341				2022-12-18	WOS:000171361500005
J	Siegel, RM; Lenardo, MJ				Siegel, RM; Lenardo, MJ			To B or not to B: TNF family signaling in lymphocytes	NATURE IMMUNOLOGY			English	News Item							NECROSIS-FACTOR FAMILY; TACI; APRIL; ACTIVATION; RECEPTORS; MEMBER; BAFF; BCMA		NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siegel, RM (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000717, Z01AI000769, Z01AI000718, ZIAAI000769, Z01AI000717, ZIAAI000718] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	12	20	27	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					577	578		10.1038/89715	http://dx.doi.org/10.1038/89715			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429537				2022-12-18	WOS:000169682100007
J	Yun, TJ; Bevan, MJ				Yun, TJ; Bevan, MJ			The Goldilocks conditions applied to T cell development	NATURE IMMUNOLOGY			English	News Item							KINASE		Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Yun, TJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	tjyun@u.washington.edu; mbevan@u.washington.edu						ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094	7	20	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					13	14		10.1038/83118	http://dx.doi.org/10.1038/83118			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135570				2022-12-18	WOS:000166261500007
J	Di Conza, G; Tsai, CH; Gallart-Ayala, H; Yu, YR; Franco, F; Zaffalon, L; Xie, X; Li, XY; Xiao, ZT; Raines, LN; Falquet, M; Jalil, A; Locasale, JW; Percipalle, P; Masson, D; Huang, SCC; Martinon, F; Ivanisevic, J; Ho, PC				Di Conza, Giusy; Tsai, Chin-Hsien; Gallart-Ayala, Hector; Yu, Yi-Ru; Franco, Fabien; Zaffalon, Lea; Xie, Xin; Li, Xiaoyun; Xiao, Zhengtao; Raines, Lydia N.; Falquet, Maryline; Jalil, Antoine; Locasale, Jason W.; Percipalle, Piergiorgio; Masson, David; Huang, Stanley Ching-Cheng; Martinon, Fabio; Ivanisevic, Julijana; Ho, Ping-Chih			Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity	NATURE IMMUNOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; ACTIVATION; METABOLISM; ACCUMULATION; IRE1-ALPHA; INHIBITION; EXPRESSION; CELLS; STAT3	Tumor-associated macrophages (TAMs) display pro-tumorigenic phenotypes for supporting tumor progression in response to microenvironmental cues imposed by tumor and stromal cells. However, the underlying mechanisms by which tumor cells instruct TAM behavior remain elusive. Here, we uncover that tumor-cell-derived glucosylceramide stimulated unconventional endoplasmic reticulum (ER) stress responses by inducing reshuffling of lipid composition and saturation on the ER membrane in macrophages, which induced IRE1-mediated spliced XBP1 production and STAT3 activation. The cooperation of spliced XBP1 and STAT3 reinforced the pro-tumorigenic phenotype and expression of immunosuppressive genes. Ablation of XBP1 expression with genetic manipulation or ameliorating ER stress responses by facilitating LPCAT3-mediated incorporation of unsaturated lipids to the phosphatidylcholine hampered pro-tumorigenic phenotype and survival in TAMs. Together, we uncover the unexpected roles of tumor-cell-produced lipids that simultaneously orchestrate macrophage polarization and survival in tumors via induction of ER stress responses and reveal therapeutic targets for sustaining host antitumor immunity. Tumor-associated macrophages support an immunosuppressive tumor microenvironment. Di Conza et al. uncover how IRE1-XBP1 and IRE1-STAT3 endoplasmic reticulum stress responses pathways are engaged by tumor-derived lipids to orchestrate pro-tumorigenic features and survival in tumor-associated macrophages.	[Di Conza, Giusy; Tsai, Chin-Hsien; Yu, Yi-Ru; Franco, Fabien; Li, Xiaoyun; Falquet, Maryline; Ho, Ping-Chih] Univ Lausanne, Dept Oncol, Epalinges, Switzerland; [Di Conza, Giusy; Tsai, Chin-Hsien; Yu, Yi-Ru; Franco, Fabien; Li, Xiaoyun; Ho, Ping-Chih] Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland; [Gallart-Ayala, Hector; Ivanisevic, Julijana] Univ Lausanne, Fac Biol & Med, Metabol Platform, Lausanne, Switzerland; [Zaffalon, Lea; Martinon, Fabio] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Xie, Xin; Percipalle, Piergiorgio] New York Univ, Div Sci & Math, Program Biol, Abu Dhabi, U Arab Emirates; [Xiao, Zhengtao; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Xiao, Zhengtao] Xi An Jiao Tong Univ, Inst Infect & Immun, Translat Med Inst, Hlth Sci Ctr, Xian 710061, Shaanxi, Peoples R China; [Xiao, Zhengtao] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Hlth Sci Ctr, Xian 710061, Shaanxi, Peoples R China; [Raines, Lydia N.; Huang, Stanley Ching-Cheng] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Jalil, Antoine; Masson, David] Univ Bourgogne, Lipids Nutr Canc LNC, INSERM, Dijon, France; [Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Huang, Stanley Ching-Cheng] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA	University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; University of Lausanne; Duke University; Xi'an Jiaotong University; Xi'an Jiaotong University; Case Western Reserve University; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Stockholm University; Case Western Reserve University	Ho, PC (corresponding author), Univ Lausanne, Dept Oncol, Epalinges, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland.	ping-chih.ho@unil.ch	Di Conza, Giusy/GPP-1438-2022; MASSON, David/AAC-8896-2022; Martinon, Fabio/A-5575-2009	MASSON, David/0000-0003-1692-0699; Martinon, Fabio/0000-0002-6969-822X; Xiao, Zhengtao/0000-0002-5535-5381; Ho, Ping-Chih/0000-0003-3078-3774; Xie, Xin/0000-0002-6784-4860; Yu, Yi-Ru/0000-0002-3562-3502; JALIL, Antoine/0000-0002-6990-7343	Swiss Institute for Experiment Cancer Research [ISREC 26075483]; European Research Council Staring Grant [802773-MitoGuide]; SNSF [31003A_163204, 31003A_182470]; UNIL Interdisciplinary Grant; Cancer Research Institute (CLIP); Ludwig Cancer Research; NIH [R01CA1932556]; New York University Abu Dhabi Research Enhancement Fund Swedish Research Council (Vetenskapsradet); French government; French National Research Agency [ANR-11-LABX-0021, ANR-15-IDEX-0003, ANR-19-CE14-0020]; Cancer Research Institute CLIP Investigator Award; VeloSano Pilot Award; Case Comprehensive Cancer Center American Cancer Society Pilot Grants; Cleveland Digestive Diseases Research Core Center Pilot Grant [IRG<SUP>-</SUP>91-022-19, IRG-16-186-21, 1P30DK097948]; Immunology T32 Training Program [AI089474]; SNSF R'Equip [316030_183377]; Swiss Cancer league [KFS-4230-08-2017]; Swedish Cancer Society (Cancerfonden)	Swiss Institute for Experiment Cancer Research; European Research Council Staring Grant; SNSF(Swiss National Science Foundation (SNSF)); UNIL Interdisciplinary Grant; Cancer Research Institute (CLIP); Ludwig Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Abu Dhabi Research Enhancement Fund Swedish Research Council (Vetenskapsradet); French government; French National Research Agency(French National Research Agency (ANR)); Cancer Research Institute CLIP Investigator Award; VeloSano Pilot Award; Case Comprehensive Cancer Center American Cancer Society Pilot Grants; Cleveland Digestive Diseases Research Core Center Pilot Grant; Immunology T32 Training Program; SNSF R'Equip; Swiss Cancer league; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	We thank L. Glimcher and G. Hotamisligil for providing XBP1<SUP>flox/flox</SUP> mice and D. Sancho for providing Mincle-deficient bone marrows. We thank T. Shimizu and J.-i. Miyazaki for providing plasmid LPCAT3-pCNX2. P.-C.H. is funded by the Swiss Institute for Experiment Cancer Research (ISREC 26075483), European Research Council Staring Grant (802773-MitoGuide), SNSF project grants (31003A_163204 and 31003A_182470), UNIL Interdisciplinary Grant, the Cancer Research Institute (CLIP investigator award and Lloyd J. Old STAR award) and Ludwig Cancer Research. J.W.L. is supported by NIH R01CA1932556. P.P. is supported by the New York University Abu Dhabi Research Enhancement Fund Swedish Research Council (Vetenskapsradet), Swedish Cancer Society (Cancerfonden). D.M. is supported by French government grants managed by the French National Research Agency under the references ANR-11-LABX-0021, ANR-15-IDEX-0003 and ANR-19-CE14-0020. S.C.-C.H. is supported by Cancer Research Institute CLIP Investigator Award, the VeloSano Pilot Award, the Case Comprehensive Cancer Center American Cancer Society Pilot Grants and the Cleveland Digestive Diseases Research Core Center Pilot Grant (IRG<SUP>-</SUP>91-022-19, IRG-16-186-21, 1P30DK097948). L.N.R. is supported by Immunology T32 Training Program (AI089474). J.I. is supported by SNSF R'Equip 316030_183377. F.M. is supported by Swiss Cancer league KFS-4230-08-2017.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Anfray C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010046; Batista A, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000687; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Checa A, 2015, MULT SCLER J, V21, P1271, DOI 10.1177/1352458514561908; Chen M, 2018, NAT GENET, V50, P206, DOI 10.1038/s41588-017-0027-2; Chen X, 2021, NAT REV CANCER, V21, P71, DOI 10.1038/s41568-020-00312-2; Clement M, 2016, CIRCULATION, V134, P1039, DOI 10.1161/CIRCULATIONAHA.116.022668; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Di Conza G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030695; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Etzerodt A, 2019, J EXP MED, V216, P2394, DOI 10.1084/jem.20182124; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Heinzer S, 2008, J CELL SCI, V121, P55, DOI 10.1242/jcs.013383; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Herbeuval JP, 2004, J IMMUNOL, V172, P4630, DOI 10.4049/jimmunol.172.7.4630; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Ho PC, 2014, CANCER RES, V74, P3205, DOI 10.1158/0008-5472.CAN-13-3461; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jalil A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153787; Kast HR, 2001, J LIPID RES, V42, P1266; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Lee WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11322; Li CJ, 2020, CANCER IMMUNOL RES, V8, P1004, DOI 10.1158/2326-6066.CIR-19-0782; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Liu Y, 2015, J HEPATOL, V62, P590, DOI 10.1016/j.jhep.2014.10.022; Liu YY, 2018, CANCER CELL, V33, P480, DOI 10.1016/j.ccell.2018.02.005; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Lopez-Yrigoyen M, 2021, ANN NY ACAD SCI, V1499, P18, DOI 10.1111/nyas.14377; Ma XZ, 2019, CELL METAB, V30, P143, DOI 10.1016/j.cmet.2019.04.002; Martinez-Lopez M, 2019, IMMUNITY, V50, P446, DOI 10.1016/j.immuni.2018.12.020; Maynard A., 2019, HETEROGENEITY TARGET, DOI [10.1101/2019.12.08. 868828, DOI 10.1101/2019.12.08.868828]; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Mohamed E, 2020, IMMUNITY, V52, P668, DOI 10.1016/j.immuni.2020.03.004; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Poli V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00121; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Sanderson S. M., 2020, NA K ATPASE REGULATE, DOI [10.1101/2020.03.31.018739, DOI 10.1101/2020.03.31.018739]; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Su P, 2020, CANCER RES, V80, P1438, DOI 10.1158/0008-5472.CAN-19-2994; Tanaka M, 2020, J EXP MED, V217, DOI 10.1084/jem.20192230; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Tcyganov EN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145971; Thomas C, 2018, ATHEROSCLEROSIS, V275, P409, DOI 10.1016/j.atherosclerosis.2018.05.023; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Tsugawa H, 2014, BIOINFORMATICS, V30, P2379, DOI 10.1093/bioinformatics/btu203; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Vitale I, 2019, CELL METAB, V30, P36, DOI 10.1016/j.cmet.2019.06.001; Vriens K, 2019, NATURE, V566, P403, DOI 10.1038/s41586-019-0904-1; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008; Williams SJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01662; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035; Yu YR, 2020, NAT IMMUNOL, V21, P1540, DOI 10.1038/s41590-020-0793-3; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048	64	19	20	5	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1403	+		10.1038/s41590-021-01047-4	http://dx.doi.org/10.1038/s41590-021-01047-4		OCT 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34686867	Green Accepted			2022-12-18	WOS:000710077900002
J	Andreakos, E; Abel, L; Vinh, DC; Kaja, E; Drolet, BA; Zhang, Q; O'Farrelly, C; Novelli, G; Rodriguez-Gallego, C; Haerynck, F; Prando, C; Pujol, A; Su, HC; Casanova, JL; Spaan, AN; Bastard, P; Biggs, CM; Bigio, B; Boisson, B; Bolze, A; Bondarenko, A; Brodin, P; Chakravorty, S; Christodoulou, J; Cobat, A; Condino-Neto, A; Constantinescu, SN; Feldman, HB; Fellay, J; Halwani, R; Jouanguy, E; Lau, YL; Meyts, I; Mogensen, TH; Okada, S; Okamoto, K; Ozcelik, T; Pan-Hammarstrom, Q; Planas, AM; Puel, A; Quintana-Murci, L; Renia, L; Resnick, I; Sediva, A; Shcherbina, A; Slaby, O; Tancevski, I; Turvey, SE; Uddin, KMF; van de Beek, D; Zatz, M; Zawadzki, P; Zhang, SY				Andreakos, Evangelos; Abel, Laurent; Vinh, Donald C.; Kaja, Elzbieta; Drolet, Beth A.; Zhang, Qian; O'Farrelly, Cliona; Novelli, Giuseppe; Rodriguez-Gallego, Carlos; Haerynck, Filomeen; Prando, Carolina; Pujol, Aurora; Su, Helen C.; Casanova, Jean-Laurent; Spaan, Andras N.; Bastard, Paul; Biggs, Catherine M.; Bigio, Benedetta; Boisson, Bertrand; Bolze, Alexandre; Bondarenko, Anastasiia; Brodin, Petter; Chakravorty, Samya; Christodoulou, John; Cobat, Aurelie; Condino-Neto, Antonio; Constantinescu, Stefan N.; Feldman, Hagit Baris; Fellay, Jacques; Halwani, Rabih; Jouanguy, Emmanuelle; Lau, Yu-Lung; Meyts, Isabelle; Mogensen, Trine H.; Okada, Satoshi; Okamoto, Keisuke; Ozcelik, Tayfun; Pan-Hammarstrom, Qiang; Planas, Anna M.; Puel, Anne; Quintana-Murci, Lluis; Renia, Laurent; Resnick, Igor; Sediva, Anna; Shcherbina, Anna; Slaby, Ondrej; Tancevski, Ivan; Turvey, Stuart E.; Uddin, K. M. Furkan; van de Beek, Diederik; Zatz, Mayana; Zawadzki, Pawel; Zhang, Shen-Ying		COVID Human Genetic Effort	A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Article							INBORN-ERRORS; HIV-1 INFECTION; IMMUNITY; TUBERCULOSIS; RESTRICTION; INDIVIDUALS; DEFICIENCY; IL28B	SARS-CoV-2 infections display tremendous interindividual variability, ranging from asymptomatic infections to life-threatening disease. Inborn errors of, and autoantibodies directed against, type I interferons (IFNs) account for about 20% of critical COVID-19 cases among SARS-CoV-2-infected individuals. By contrast, the genetic and immunological determinants of resistance to infection per se remain unknown. Following the discovery that autosomal recessive deficiency in the DARC chemokine receptor confers resistance to Plasmodium vivax, autosomal recessive deficiencies of chemokine receptor 5 (CCR5) and the enzyme FUT2 were shown to underlie resistance to HIV-1 and noroviruses, respectively. Along the same lines, we propose a strategy for identifying, recruiting, and genetically analyzing individuals who are naturally resistant to SARS-CoV-2 infection.	[Andreakos, Evangelos] BioMed Res Fdn Acad Athens, Ctr Clin Expt Surg & Translat Res, Lab Immunobiol, Athens, Greece; [Abel, Laurent; Zhang, Qian; Su, Helen C.; Casanova, Jean-Laurent; Spaan, Andras N.; Bastard, Paul; Cobat, Aurelie; Jouanguy, Emmanuelle; Zhang, Shen-Ying] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY USA; [Abel, Laurent; Zhang, Qian; Su, Helen C.; Bastard, Paul; Boisson, Bertrand; Cobat, Aurelie; Jouanguy, Emmanuelle; Puel, Anne; Zhang, Shen-Ying] Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM U1163, Paris, France; [Abel, Laurent; Zhang, Qian; Su, Helen C.; Bastard, Paul; Boisson, Bertrand; Cobat, Aurelie; Jouanguy, Emmanuelle; Puel, Anne; Zhang, Shen-Ying] Univ Paris, Imagine Inst, Paris, France; [Vinh, Donald C.] McGill Univ, Dept Med, Div Infect Dis, Ctr Hlth, Quebec City, PQ, Canada; [Vinh, Donald C.] McGill Univ, Res Inst, Infect Dis Susceptibil Program, Ctr Hlth, Quebec City, PQ, Canada; [Kaja, Elzbieta] MNM Diagnost Inc, Lewes, DE USA; [Drolet, Beth A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI USA; [O'Farrelly, Cliona] Trinity Coll Dublin, Trinity BioMed Sci Inst, Sch Biochem & Immunol, Comparat Immunol Grp, Dublin, Ireland; [Novelli, Giuseppe] Univ Roma Tor Vergata, Dept BioMed & Prevent, Rome, Italy; [Rodriguez-Gallego, Carlos] Hosp Univ Gran Canaria, Dr Negrin Canarian Hlth Syst, Dept Immunol, Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain; [Rodriguez-Gallego, Carlos] Univ Fernando Pessoa Canarias, Dept Clin Sci, Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain; [Haerynck, Filomeen] Ghent Univ Hosp, Jeffrey Modell Diag & Res Ctr, PID Res Lab, Ctr Primary Immunodeficiency Ghent CPIG,Dept Pedi, Ghent, Belgium; [Prando, Carolina] Inst Pesquisa Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, Brazil; [Pujol, Aurora] Bellvitge BioMed Res Inst IDIBELL, Neurometabol Dis Lab, Barcelona, Spain; [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Pujol, Aurora] ISCIII, Ctr Biomed Res Rare Dis U759 CIBERER, Barcelona, Spain; [Su, Helen C.] NIAID, Intramural Res Program, NIH, Bethesda, MD USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Spaan, Andras N.] Univ Med Ctr Utrecht, Dept Med MicroBiol, Utrecht, Netherlands; [Su, Helen C.; Biggs, Catherine M.; Turvey, Stuart E.] Univ British Columbia, British Columbia Children's Hosp, Dept Pediat, Vancouver, BC, Canada; [Bolze, Alexandre] Helix, San Mateo, CA USA; [Bondarenko, Anastasiia] Univ Ukraine, Shupyk Natl Healthcare, Kiev, Kiev, Ukraine; [Brodin, Petter] Karolinska Inst, Dept Women's & Children's Hlth, SciLifeLab, Stockholm, Sweden; [Chakravorty, Samya] Emory Univ, Dept Pediat, Atlanta, GA USA; [Chakravorty, Samya] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA USA; [Christodoulou, John] Univ Melbourne, Murdoch Children's Res Inst, Dept Paediat, Victoria, Australia; [Condino-Neto, Antonio] Univ Sao Paulo, Inst BioMed Sci, Dept Immunol, Sao Paulo, Brazil; [Su, Helen C.; Constantinescu, Stefan N.] Catholic Univ Louvain, Duve Instute & Clin Univ St Luc, Brussels, Belgium; [Feldman, Hagit Baris] Aviv Univ, Genet Inst, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Feldman, Hagit Baris] Aviv Univ, Genet Inst, Sackler Fac Med, Tel Aviv, Israel; [Fellay, Jacques] Ecole PolyTech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Fellay, Jacques] Lausanne Univ Hosp, Precis Med Unit, Lausanne, Switzerland; [Fellay, Jacques] Univ Lausanne, Lausanne, Switzerland; [Halwani, Rabih] Univ Sharjah, Sharjah Inst Med Res, Coll Med, Sharjah, U Arab Emirates; [Lau, Yu-Lung] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China; [Meyts, Isabelle] Univ Hospitals Leuven, Jeffrey Modell Diagnost & Res Network Ctr, Dept Pediat, Leuven, Belgium; [Meyts, Isabelle] Katholieke Univ Leuven, Dept Immunol MicroBiol & Transplantat, Lab Inborn Errors Immun, Leuven, Belgium; [Mogensen, Trine H.] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Mogensen, Trine H.] Aarhus Univ, Dept BioMed, Aarhus, Denmark; [Okada, Satoshi] Hiroshima Univ, Grad Sch BioMed & Hlth Sci, Dept Pediat, Hiroshima, Japan; [Okamoto, Keisuke] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Ozcelik, Tayfun] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Pan-Hammarstrom, Qiang] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Planas, Anna M.] IIBB, CSIC, IDIBAPS, Barcelona, Spain; [Quintana-Murci, Lluis] Inst Pasteur, Human Evolutionary Genet Unit, CNRS U2000, Paris, France; [Quintana-Murci, Lluis] Coll France, Human Gen & Evolut, Paris, France; [Renia, Laurent] Agcy Sci Technol & Res, ASTAR Infect Dis Labs, Singapore, Singapore; [Renia, Laurent] Nanyang Technol Univ, Lee Kong Chian Sch Med, Nanyang, Singapore; [Resnick, Igor] Univ Hosp St Marina & Med Univ, Dept Med Genet, Varna, Bulgaria; [Sediva, Anna] Charles Univ Prague, Fac Med 2, Dept Immunol, Univ Hosp Motol, Prague, Czech Republic; [Shcherbina, Anna] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol, Dept Immunol, Oncology & Immunol, Moscow, Russia; [Slaby, Ondrej] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Slaby, Ondrej] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Tancevski, Ivan] Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria; [Uddin, K. M. Furkan] NeuroGen Children's Healthcare, Ctr Precis Therapeut, Genet & Gen Med Ctr, Dhaka, Bangladesh; [van de Beek, Diederik] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Neurol, Amsterdam Neurosci, Amsterdam, Netherlands; [Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Sao Paulo, Brazil; [Zawadzki, Pawel] Adam Mickiewicz Univ, Fac Phys, Mol BioPhys Div, Poznan, Poland	Academy of Athens; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; University of Wisconsin System; University of Wisconsin Madison; Trinity College Dublin; University of Rome Tor Vergata; Ghent University; Ghent University Hospital; Hospital Pequeno Principe; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA; Instituto de Salud Carlos III; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Utrecht University; Utrecht University Medical Center; University of British Columbia; Karolinska Institutet; SciLifeLab; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; University of Melbourne; Universidade de Sao Paulo; Universite Catholique Louvain; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Sharjah; University of Hong Kong; KU Leuven; Aarhus University; Aarhus University; Hiroshima University; Tokyo Medical & Dental University (TMDU); Ihsan Dogramaci Bilkent University; Karolinska Institutet; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Agency for Science Technology & Research (A*STAR); A*STAR Infectious Disease Labs (ID Labs); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Charles University Prague; Motol University Hospital; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Masaryk University Brno; Masaryk University Brno; Medical University of Innsbruck; University of Amsterdam; Vrije Universiteit Amsterdam; Universidade de Sao Paulo; Adam Mickiewicz University	Andreakos, E (corresponding author), BioMed Res Fdn Acad Athens, Ctr Clin Expt Surg & Translat Res, Lab Immunobiol, Athens, Greece.; Spaan, AN (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY USA.; Spaan, AN (corresponding author), Univ Med Ctr Utrecht, Dept Med MicroBiol, Utrecht, Netherlands.	vandreakos@bioacademy.gr; aspaan@rockefeller.edu	Fellay, Jacques/A-6681-2009; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; Quintana-Murci, Lluis/AAB-7468-2022; Turvey, Stuart/HGV-1191-2022; Boisson, Bertrand/AAC-6058-2019; Renia, Laurent/HCH-4853-2022; Okada, Satoshi/B-8901-2011; Boisson, Bertrand/I-2485-2017; Sediva, Anna/AAE-2774-2019; Pujol, Aurora/N-4990-2014; Tancevski, Ivan/AID-5169-2022; Bondarenko, Anastasiia/AAL-5037-2020; Novelli, Giuseppe/GQB-3329-2022; Cobat, Aurélie/H-4722-2017; Novelli, Giuseppe/T-8822-2019; Condino-Neto, Antonio/D-4762-2012; Haerynck, Filomeen/AAD-6761-2020; Puel, Anne/H-7305-2017; Lau, Yu Lung/C-4322-2009	Fellay, Jacques/0000-0002-8240-939X; Boisson, Bertrand/0000-0001-5240-3555; Renia, Laurent/0000-0003-0349-1557; Okada, Satoshi/0000-0002-4622-5657; Boisson, Bertrand/0000-0001-5240-3555; Sediva, Anna/0000-0001-7730-2304; Pujol, Aurora/0000-0002-9606-0600; Tancevski, Ivan/0000-0001-5116-8960; Bondarenko, Anastasiia/0000-0002-9737-2868; Novelli, Giuseppe/0000-0002-7781-602X; Cobat, Aurélie/0000-0001-7209-6257; Condino-Neto, Antonio/0000-0002-1069-3117; VINH, DONALD/0000-0003-1347-7767; Uddin, K M Furkan/0000-0001-7322-1988; Puel, Anne/0000-0003-2603-0323; Mogensen, Trine Hyrup/0000-0002-1853-9704; Biggs, Catherine/0000-0002-4363-2660; Kaja, Elzbieta/0000-0003-1277-6140; Haerynck, Filomeen/0000-0001-9161-7361; Lau, Yu Lung/0000-0002-4780-0289; Rodriguez-Gallego, Carlos/0000-0002-4344-8644; van de Beek, Diederik/0000-0002-4571-044X; Turvey, Stuart/0000-0003-1599-1065; O'Farrelly, Cliona/0000-0002-0616-2874	National Institutes of Health (NIH) [R01AI088364]; National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program [UL1TR001866]; Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; GSP Coordinating Center - the National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; French National Research Agency (ANR) under the Investments for the Future program [ANR-10-IAHU-01]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French Foundation for Medical Research (FRM) [EQU201903007798]; ANR GENCOVID project [ANR-20-COVI-0003]; ANRS-COV05; Fondation du Souffle; Square Foundation; Grandir -Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Howard Hughes Medical Institute; Rockefeller University; St. Giles Foundation; Institut National de la Sante et de la Recherche Medicale (INSERM); University of Paris; European Commission [779295, 767015, 848146]; Hellenic Foundation for Research and Innovation (INTERFLU) [1574]; Science Foundation Ireland COVID-19 Program; GecoBiomark [A0375-2020-36663]; Horizon 2020 program [824110, COVID-19/PID12342]; CERCA Program/Generalitat de Catalunya; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant) [789645]; FRM	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program; Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; GSP Coordinating Center - the National Human Genome Research Institute (NHGRI); Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; French National Research Agency (ANR) under the Investments for the Future program(French National Research Agency (ANR)); Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); ANR GENCOVID project(French National Research Agency (ANR)); ANRS-COV05; Fondation du Souffle; Square Foundation; Grandir -Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rockefeller University; St. Giles Foundation; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Paris; European Commission(European CommissionEuropean Commission Joint Research Centre); Hellenic Foundation for Research and Innovation (INTERFLU); Science Foundation Ireland COVID-19 Program(Science Foundation Ireland); GecoBiomark; Horizon 2020 program; CERCA Program/Generalitat de Catalunya; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant); FRM(Fondation pour la Recherche Medicale)	The Laboratory of Human Genetics of Infectious Diseases is supported by the National Institutes of Health (NIH) (R01AI088364), the National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program (UL1TR001866), a Fast Grant from Emergent Ventures, Mercatus Center at George Mason University, the Yale Center for Mendelian Genomics and the GSP Coordinating Center funded by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and U24HG008956), the Fisher Center for Alzheimer's Research Foundation, the Meyer Foundation, the French National Research Agency (ANR) under the Investments for the Future program (ANR-10-IAHU-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), the French Foundation for Medical Research (FRM) (EQU201903007798), the FRM and ANR GENCOVID project (ANR-20-COVI-0003), ANRS-COV05, the Fondation du Souffle, the Square Foundation, Grandir -Fonds de solidarite pour l'enfance, the SCOR Corporate Foundation for Science, the Howard Hughes Medical Institute, the Rockefeller University, the St. Giles Foundation, Institut National de la Sante et de la Recherche Medicale (INSERM), and the University of Paris. E.A. is supported by research grants from the European Commission's Horizon 2020 research and innovation program (IMMUNAID, grant no. 779295, CURE, grant no. 767015 and TO_AITION grant no. 848146) and the Hellenic Foundation for Research and Innovation (INTERFLU, no. 1574). C.O.F. is supported in part by the Science Foundation Ireland COVID-19 Program. G.N. is supported by a grant awarded to Regione Lazio (Research Group Projects 2020) no. A0375-2020-36663, GecoBiomark. A.P. is supported in part by the Horizon 2020 program under grant no. 824110 (EasiGenomics grant no. COVID-19/PID12342) and the CERCA Program/Generalitat de Catalunya. H.S. is supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. A.S. is supported in part by the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant no. 789645).	Abel L, 2018, LANCET INFECT DIS, V18, pE64, DOI 10.1016/S1473-3099(17)30623-0; Al-Tawfiq JA, 2020, J HOSP INFECT, V105, P111, DOI 10.1016/j.jhin.2020.04.002; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; BASTARD P, SCI IMMUNOL; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20202486; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Boisson-Dupuis S, 2020, HUM GENET, V139, P1001, DOI 10.1007/s00439-020-02126-6; Boisson-Dupuis S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau8714; Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Casanova JL, 2020, CELL, V181, P1194, DOI 10.1016/j.cell.2020.05.016; Casanova JL, 2021, ANNU REV PATHOL-MECH, V16, P23, DOI 10.1146/annurev-pathol-031920-101429; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Cerami C, 2022, CLIN INFECT DIS, V74, P1776, DOI 10.1093/cid/ciab701; Colmenero I, 2020, BRIT J DERMATOL, V183, P729, DOI 10.1111/bjd.19327; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030; de Prost N, 2021, J CLIN IMMUNOL, V41, P536, DOI 10.1007/s10875-021-00994-9; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Enard D, 2018, CELL, V175, P360, DOI 10.1016/j.cell.2018.08.034; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; Freeman EE, 2020, J AM ACAD DERMATOL, V83, P486, DOI 10.1016/j.jaad.2020.05.109; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Gupta RK, 2019, NATURE, V568, P244, DOI 10.1038/s41586-019-1027-4; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hoffmann HH, 2021, CELL, V184, P133, DOI 10.1016/j.cell.2020.12.005; Hoffmann H-Heinrich, 2021, Cell Host Microbe, V29, P267, DOI [10.1101/2020.09.11.291716, 10.1016/j.chom.2020.12.009]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horowitz J E, 2021, medRxiv, DOI 10.1101/2020.12.14.20248176; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kerner G, 2021, AM J HUM GENET, V108, P517, DOI 10.1016/j.ajhg.2021.02.009; Kerner G, 2019, P NATL ACAD SCI USA, V116, P10430, DOI 10.1073/pnas.1903561116; Koning R, 2021, INTENS CARE MED, V47, P704, DOI 10.1007/s00134-021-06392-4; Kreins AY, 2015, J EXP MED, V212, P1641, DOI 10.1084/jem.20140280; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; LURIE MB, 1952, J EXP MED, V95, P119, DOI 10.1084/jem.95.2.119; Madewell Zachary J, 2020, medRxiv, DOI 10.1101/2020.07.29.20164590; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Meyts I, 2016, J ALLERGY CLIN IMMUN, V138, P957, DOI 10.1016/j.jaci.2016.08.003; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Morens DM, 2020, CELL, V182, P1077, DOI 10.1016/j.cell.2020.08.021; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; Quintana-Murci L, 2019, CELL, V177, P184, DOI 10.1016/j.cell.2019.02.033; Rausell A, 2020, P NATL ACAD SCI USA, V117, P13626, DOI 10.1073/pnas.1917993117; Reukers DFM, 2022, CLIN INFECT DIS, V74, P52, DOI 10.1093/cid/ciab237; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Sancho-Shimizu V, 2021, J EXP MED, V218, DOI 10.1084/jem.20210446; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Schwarzkopf S., 2021, CELLULAR IMMUNITY CO, DOI 10.3201/2701.203772; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Shelton JF, 2021, NAT GENET, V53, P801, DOI 10.1038/s41588-021-00854-7; Souilmi Y, 2021, CURR BIOL, V31, P3504, DOI [10.1016/j.cub.2021.05.067, 10.1016/j.cub.2021.07.052]; Suryamohan K, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02030-3; Tan See Wei, 2021, JAAD Int, V2, P119, DOI 10.1016/j.jdin.2020.12.003; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; THOMPSON MA, 2020, PRIMARY CARE GUIDANC; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Troya J, 2021, J CLIN IMMUNOL, V41, P914, DOI 10.1007/s10875-021-01036-0; van der Wijst MGP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh2624; Vazquez SE, 2021, J CLIN IMMUNOL, V41, P1169, DOI 10.1007/s10875-021-01060-0; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang YJ, 2021, ANN HEMATOL, V100, P1123, DOI 10.1007/s00277-021-04489-w	81	19	18	3	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					159	164		10.1038/s41590-021-01030-z	http://dx.doi.org/10.1038/s41590-021-01030-z		OCT 2021	6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	34667308	Green Published, Bronze			2022-12-18	WOS:000708815900001
J	Sariol, A; Perlman, S				Sariol, Alan; Perlman, Stanley			SARS-CoV-2 takes its Toll	NATURE IMMUNOLOGY			English	Editorial Material							MOUSE HEPATITIS-VIRUS; TOPOLOGY		[Sariol, Alan] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Perlman, Stanley] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Perlman, S (corresponding author), Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA.	Stanley-perlman@uiowa.edu		Sariol, Alan/0000-0002-3127-0543	NIAID NIH HHS [R01 AI129269, P01 AI060699] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARTHOLD SW, 1984, ARCH VIROL, V81, P103, DOI 10.1007/BF01309300; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363; Duart G, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200209; Khan S., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.03.16.435700, DOI 10.1101/2021.03.16.435700]; Maeda J, 2001, VIROLOGY, V281, P163, DOI 10.1006/viro.2001.0818; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Proud PC, 2021, EBIOMEDICINE, V63, DOI 10.1016/j.ebiom.2020.103153; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zhou HX, 2010, MBIO, V1, DOI 10.1128/mBio.00219-10	14	19	19	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					801	802		10.1038/s41590-021-00962-w	http://dx.doi.org/10.1038/s41590-021-00962-w		JUN 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34103714	Green Accepted, Bronze			2022-12-18	WOS:000659017000001
J	Wypych, TP; Pattaroni, C; Perdijk, O; Yap, C; Trompette, A; Anderson, D; Creek, DJ; Harris, NL; Marsland, BJ				Wypych, Tomasz P.; Pattaroni, Celine; Perdijk, Olaf; Yap, Carmen; Trompette, Aurelien; Anderson, Dovile; Creek, Darren J.; Harris, Nicola L.; Marsland, Benjamin J.			Microbial metabolism of l-tyrosine protects against allergic airway inflammation	NATURE IMMUNOLOGY			English	Article							P-CRESYL SULFATE; HOUSE-DUST MITE; GUT MICROBIOTA; RESPONSES; MICE; BACTERIA; INNATE; CELLS; CCL20; EGFR	The constituents of the gut microbiome are determined by the local habitat, which itself is shaped by immunological pressures, such as mucosal IgA. Using a mouse model of restricted antibody repertoire, we identified a role for antibody-microbe interactions in shaping a community of bacteria with an enhanced capacity to metabolize l-tyrosine. This model led to increased concentrations of p-cresol sulfate (PCS), which protected the host against allergic airway inflammation. PCS selectively reduced CCL20 production by airway epithelial cells due to an uncoupling of epidermal growth factor receptor (EGFR) and Toll-like receptor 4 (TLR4) signaling. Together, these data reveal a gut microbe-derived metabolite pathway that acts distally on the airway epithelium to reduce allergic airway responses, such as those underpinning asthma. The microbiome can affect susceptibility to developing asthma. Marsland and colleagues show that changes in the microbial population lead to enrichment of an l-tyrosine metabolite, p-cresol sulfate, which can protect mice against allergic inflammation.	[Wypych, Tomasz P.; Pattaroni, Celine; Perdijk, Olaf; Yap, Carmen; Harris, Nicola L.; Marsland, Benjamin J.] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic, Australia; [Trompette, Aurelien] Univ Lausanne, Serv Pneumol, CHUV, Fac Biol & Med, Epalinges, Switzerland; [Anderson, Dovile; Creek, Darren J.] Monash Univ, Monash Inst Pharmaceut Sci, Monash Prote & Metab Facil, Melbourne, Vic, Australia	Monash University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Monash University	Wypych, TP; Marsland, BJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic, Australia.	tomasz.wypych@monash.edu; benjamin.marsland@monash.edu		Creek, Darren/0000-0001-7497-7082; Marsland, Benjamin/0000-0003-1457-3160; Wypych, Tomasz/0000-0003-0558-7923; Yap, Carmen/0000-0001-5272-0753	MASSIVE HPC facility; Swiss National Science Foundation; Alfred Research Trusts Major Grant [ANM20001]	MASSIVE HPC facility; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alfred Research Trusts Major Grant	We thank H. Mitchell for help with the shotgun metagenomics library preparation and M. Macowan for help with shotgun metagenomics data analysis. This work was supported by the MASSIVE HPC facility (http://www.massive.org.au).T.P.W.is supported by a Postdoc Mobility Fellowship from the Swiss National Science Foundation. B.J.M. is an NHMRC Senior Research Fellow and VESKI Innovation Fellow. This work has been supported by an Alfred Research Trusts Major Grant (ANM20001).	Dang AT, 2019, MUCOSAL IMMUNOL, V12, P843, DOI 10.1038/s41385-019-0160-6; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Bonecchi R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00224; Bunker JJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9356; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Chattopadhyay S, 2015, EMBO REP, V16, P1535, DOI 10.15252/embr.201540337; Clarke EL, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0658-x; De S, 2015, P NATL ACAD SCI USA, V112, P9680, DOI 10.1073/pnas.1511794112; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Fadlallah J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1217; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Goscinski WJ, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00030; Gryp T, 2020, KIDNEY INT, V97, P1230, DOI 10.1016/j.kint.2020.01.028; Gryp T, 2017, TOXINS, V9, DOI 10.3390/toxins9020052; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Kelly RS, 2018, CLIN EXP ALLERGY, V48, P1297, DOI 10.1111/cea.13183; Kogawa M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20384-3; Koppe L, 2013, J AM SOC NEPHROL, V24, P88, DOI 10.1681/ASN.2012050503; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lee-Sarwar KA, 2019, J ALLERGY CLIN IMMUN, V144, P442, DOI 10.1016/j.jaci.2019.02.032; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Lundy SK, 2005, J IMMUNOL, V174, P2054, DOI 10.4049/jimmunol.174.4.2054; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; Matti C, 2020, J LEUKOCYTE BIOL, V107, P1137, DOI 10.1002/JLB.2MA0420-295RRR; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Ni JW, 2014, THER APHER DIAL, V18, P637, DOI 10.1111/1744-9987.12185; Pabst O, 2020, MUCOSAL IMMUNOL, V13, P12, DOI 10.1038/s41385-019-0227-4; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Perruzza L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45724-9; Rollenske T, 2020, MUCOSAL IMMUNOL, V13, P1, DOI 10.1038/s41385-019-0223-8; Rollenske T, 2018, NAT IMMUNOL, V19, P617, DOI 10.1038/s41590-018-0106-2; Saito Y, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiyD25; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sterlin D, 2020, MUCOSAL IMMUNOL, V13, P3, DOI 10.1038/s41385-019-0192-y; Sun CY, 2015, J AM SOC NEPHROL, V26, P281, DOI 10.1681/ASN.2014010021; Tanaka H, 2015, BLOOD PURIFICAT, V40, P306, DOI 10.1159/000441578; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9; Wypych TP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060537; Yamamoto K, 2012, J IMMUNOL, V189, P2450, DOI 10.4049/jimmunol.1200634	48	19	19	5	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					279	+		10.1038/s41590-020-00856-3	http://dx.doi.org/10.1038/s41590-020-00856-3		JAN 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33495652				2022-12-18	WOS:000611466600002
J	Speir, M; Nowell, CJ; Chen, AA; O'Donnell, JA; Shamie, IS; Lakin, PR; D'Cruz, AA; Braun, RO; Babon, JJ; Lewis, RS; Bliss-Moreau, M; Shlomovitz, I; Wang, S; Cengia, LH; Stoica, AI; Hakem, R; Kelliher, MA; O'Reilly, LA; Patsiouras, H; Lawlor, KE; Weller, E; Lewis, NE; Roberts, AW; Gerlic, M; Croker, B				Speir, Mary; Nowell, Cameron J.; Chen, Alyce A.; O'Donnell, Joanne A.; Shamie, Isaac S.; Lakin, Paul R.; D'Cruz, Akshay A.; Braun, Roman O.; Babon, Jeff J.; Lewis, Rowena S.; Bliss-Moreau, Meghan; Shlomovitz, Inbar; Wang, Shu; Cengia, Louise H.; Stoica, Anca I.; Hakem, Razq; Kelliher, Michelle A.; O'Reilly, Lorraine A.; Patsiouras, Heather; Lawlor, Kate E.; Weller, Edie; Lewis, Nathan E.; Roberts, Andrew W.; Gerlic, Motti; Croker, Ben A.			Ptpn6 inhibits caspase-8-and Ripk3/Mlkl-dependent inflammation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; CELL-DEATH; MOTH-EATEN; PYODERMA-GANGRENOSUM; PSEUDOKINASE MLKL; DISTINCT ROLES; SWEET SYNDROME; RIPK1; IL-1-BETA; APOPTOSIS	Ptpn6 is a cytoplasmic phosphatase that functions to prevent autoimmune and interleukin-1 (IL-1) receptor-dependent, caspase-1-independent inflammatory disease. Conditional deletion of Ptpn6 in neutrophils (Ptpn6(Delta PMN)) is sufficient to initiate IL-1 receptor-dependent cutaneous inflammatory disease, but the source of IL-1 and the mechanisms behind IL-1 release remain unclear. Here, we investigate the mechanisms controlling IL-1 alpha/beta release from neutrophils by inhibiting caspase-8-dependent apoptosis and Ripk1-Ripk3-Mlkl-regulated necroptosis. Loss of Ripk1 accelerated disease onset, whereas combined deletion of caspase-8 and either Ripk3 or Mlkl strongly protected Ptpn6(Delta PMN) mice. Ptpn6(Delta PMN) neutrophils displayed increased p38 mitogen-activated protein kinase-dependent Ripk1-independent IL-1 and tumor necrosis factor production, and were prone to cell death. Together, these data emphasize dual functions for Ptpn6 in the negative regulation of p38 mitogen-activated protein kinase activation to control tumor necrosis factor and IL-1 alpha/beta expression, and in maintaining Ripk1 function to prevent caspase-8- and Ripk3-Mlkl-dependent cell death and concomitant IL-1 alpha/beta release.	[Speir, Mary; Chen, Alyce A.; D'Cruz, Akshay A.; Braun, Roman O.; Bliss-Moreau, Meghan; Wang, Shu; Stoica, Anca I.; Weller, Edie; Croker, Ben A.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Speir, Mary; Chen, Alyce A.; D'Cruz, Akshay A.; Braun, Roman O.; Bliss-Moreau, Meghan; Wang, Shu; Croker, Ben A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Speir, Mary; Lawlor, Kate E.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic, Australia; [Speir, Mary; Lawlor, Kate E.] Monash Univ, Dept Mol & Translat Sci, Melbourne, Vic, Australia; [Nowell, Cameron J.] Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia; [O'Donnell, Joanne A.; Babon, Jeff J.; Lewis, Rowena S.; Cengia, Louise H.; O'Reilly, Lorraine A.; Roberts, Andrew W.; Croker, Ben A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [O'Donnell, Joanne A.; Babon, Jeff J.; Lewis, Rowena S.; O'Reilly, Lorraine A.; Roberts, Andrew W.; Croker, Ben A.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Shamie, Isaac S.; Lewis, Nathan E.; Croker, Ben A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Lakin, Paul R.; Weller, Edie] Boston Childrens Hosp, Biostat & Res Design Ctr, Inst Ctr Clin Res, Boston, MA USA; [Lakin, Paul R.; Weller, Edie] Boston Childrens Hosp, Biostat & Res Design Ctr, Inst Ctr Translat Res, Boston, MA USA; [Shlomovitz, Inbar; Gerlic, Motti] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Hakem, Razq] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Patsiouras, Heather] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic, Australia; [Lewis, Nathan E.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lewis, Nathan E.] Univ Calif San Diego, Novo Nordisk Fdn Ctr Biosustainabil, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hudson Institute of Medical Research; Monash University; Walter & Eliza Hall Institute; University of Melbourne; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Tel Aviv University; Sackler Faculty of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Massachusetts System; University of Massachusetts Worcester; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of California System; University of California San Diego; Technical University of Denmark; University of California System; University of California San Diego	Croker, B (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Croker, B (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Croker, B (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.; Croker, B (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.; Croker, B (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	bcroker@health.ucsd.edu	Gerlic, Motti/U-3484-2017; babon, jeffrey j/B-9170-2013	Gerlic, Motti/0000-0001-9518-1833; babon, jeffrey j/0000-0002-5408-6239; Chen, Alyce/0000-0002-5018-8908; Lawlor, Kate/0000-0003-0471-6842; Hakem, Razqallah/0000-0001-5948-7931; O'Donnell, Joanne/0000-0002-8434-1050; D'Cruz, Akshay/0000-0003-2718-0673; Speir, Mary/0000-0003-0384-886X; Nowell, Cameron/0000-0002-8662-9840; Braun, Roman/0000-0003-4352-3939	NIH/AID [RO1 AI075118]; NIH [5RO1HL124209]; American Asthma Foundation; ISF [1416/15, 818/18]; Alpha-1 Foundation [615533]; Recanati Foundation; Varda and Boaz Dotan Research Center; United States-Israel Binational Science Foundation [2017176]; Australian National Health and Medical Research Council (NHMRC) Dora Lush Scholarship; NHMRC [637367, 1145788, 1162765]; NHMRC Independent Research Institutes Infrastructure Support Scheme grant [9000220]; Victorian State Government Operational Infrastructure Support grant; Novo Nordisk Foundation [NNF10CC1016517]; NIGMS [R35 GM119850];  [1U54HD0902565]	NIH/AID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; ISF(Israel Science Foundation); Alpha-1 Foundation; Recanati Foundation; Varda and Boaz Dotan Research Center; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Australian National Health and Medical Research Council (NHMRC) Dora Lush Scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Independent Research Institutes Infrastructure Support Scheme grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 	Mlkl<SUP>-/-</SUP> mice were provided by W. S. Alexander (Walter and Eliza Hall Institute of Medical Research). Ripk3<SUP>-/-</SUP> mice were provided by V. Dixit (Genentech). Ripk1<SUP>-/-</SUP>, conditional Ripk1<SUP>fl/fl</SUP> and Ripk1<SUP>D138N</SUP> mice were provided by M. Kelliher and M. Pasparakis, supported by NIH/AID grant RO1 AI075118. Casp8 antibody was provided by A. Strasser (Walter and Eliza Hall Institute of Medical Research). This work was supported by NIH grant 5RO1HL124209 (to B.A.C.), the American Asthma Foundation (to B.A.C.), ISF grants 1416/15 and 818/18 (to M.G.), Alpha-1 Foundation grant 615533 (to M.G.), the Recanati Foundation and Varda and Boaz Dotan Research Center (to M.G.), United States-Israel Binational Science Foundation grant 2017176 (to M.G. and B.A.C.), the Australian National Health and Medical Research Council (NHMRC) Dora Lush Scholarship (to J.A.O.) and NHMRC grants 637367, 1145788 and 1162765. This work was supported by a NHMRC Independent Research Institutes Infrastructure Support Scheme grant (9000220), and a Victorian State Government Operational Infrastructure Support grant, support from the Novo Nordisk Foundation provided to the Center for Biosustainability at the Technical University of Denmark (NNF10CC1016517 to N.E.L.) and NIGMS (R35 GM119850 to I.S.). Live-cell imaging performed at Boston Children's Hospital Intellectual Developmental Disabilities Research Center is supported by grant 1U54HD0902565.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Acquitter M, 2015, ANN INTERN MED, V163, P70, DOI 10.7326/L15-5107; Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Anderton H, 2019, CELL DEATH DIFFER, V26, P877, DOI 10.1038/s41418-018-0166-8; Andrews S., 2010, BABRAHAM BIOINFORMAT; Beynon C, 2017, JCR-J CLIN RHEUMATOL, V23, P181, DOI 10.1097/RHU.0000000000000511; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Bourke JF, 1996, BRIT J DERMATOL, V134, P705, DOI 10.1046/j.1365-2133.1996.81843.x; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; D'Cruz AA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1716; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; De Graaf CA, 2016, STEM CELL REP, V7, P571, DOI 10.1016/j.stemcr.2016.07.007; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Dowling JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08584-5; Giasuddin ASM, 1998, J AM ACAD DERMATOL, V39, P940, DOI 10.1016/S0190-9622(98)70266-X; GOING JJ, 1987, J CLIN PATHOL, V40, P175, DOI 10.1136/jcp.40.2.175; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gurung P, 2017, IMMUNITY, V46, P635, DOI 10.1016/j.immuni.2017.03.014; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kluger N, 2011, DERMATOLOGY, V222, P123, DOI 10.1159/000326112; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Lawlor KE, 2017, CELL REP, V20, P668, DOI 10.1016/j.celrep.2017.06.073; Leuenberger M, 2016, DERMATOLOGY, V232, P254, DOI 10.1159/000443648; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Matalon O, 2018, EMBO J, V37, DOI 10.15252/embj.201696264; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Moulin M, 2012, EMBO J, V31, P1679, DOI 10.1038/emboj.2012.18; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Nesterovitch AB, 2011, AM J PATHOL, V178, P1434, DOI 10.1016/j.ajpath.2010.12.035; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Prat L, 2014, CLIN DERMATOL, V32, P376, DOI 10.1016/j.clindermatol.2013.11.004; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Roderick JE, 2014, P NATL ACAD SCI USA, V111, P14436, DOI 10.1073/pnas.1409389111; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tartey S, 2018, J CLIN INVEST, V128, P2042, DOI 10.1172/JCI98446; Thrall RS, 1997, AM J PATHOL, V151, P1303; Uihlein LC, 2012, PEDIATR DERMATOL, V29, P38, DOI 10.1111/j.1525-1470.2011.01534.x; Watson HA, 2016, IMMUNOL CELL BIOL, V94, P802, DOI 10.1038/icb.2016.45; Wicki S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.311; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711; Zhang JQ, 2019, CELL REP, V27, P2679, DOI 10.1016/j.celrep.2019.04.111	65	19	20	0	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					54	+		10.1038/s41590-019-0550-7	http://dx.doi.org/10.1038/s41590-019-0550-7			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31819256	Green Accepted			2022-12-18	WOS:000515136500013
J	Twohig, JP; Figueras, AC; Andrews, R; Wiede, F; Cossins, BC; Soria, AD; Lewis, MJ; Townsend, MJ; Millrine, D; Li, J; Hill, DG; Fernandez, JU; Liu, X; Szomolay, B; Pepper, CJ; Taylor, PR; Pitzalis, C; Tiganis, T; Williams, NM; Jones, GW; Jones, SA				Twohig, Jason P.; Figueras, Ana Cardus; Andrews, Robert; Wiede, Florian; Cossins, Benjamin C.; Soria, Alicia Derrac; Lewis, Myles J.; Townsend, Michael J.; Millrine, David; Li, Jasmine; Hill, David G.; Fernandez, Javier Uceda; Liu, Xiao; Szomolay, Barbara; Pepper, Christopher J.; Taylor, Philip R.; Pitzalis, Costantino; Tiganis, Tony; Williams, Nigel M.; Jones, Gareth W.; Jones, Simon A.			Activation of naive CD4(+) T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELL; GUIDED SYNOVIAL BIOPSY; SUPER-ENHANCERS; DIFFERENTIAL RESPONSIVENESS; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; IL-6; INTERLEUKIN-6; TYROSINE; ASSOCIATION	The cytokine IL-6 controls the survival, proliferation and effector characteristics of lymphocytes through activation of the transcription factors STAT1 and STAT3. While STAT3 activity is an ever-present feature of IL-6 signaling in CD4(+) T cells, prior activation via the T cell antigen receptor limits IL-6's control of STAT1 in effector and memory populations. Here we found that phosphorylation of STAT1 in response to IL-6 was regulated by the tyrosine phosphatases PTPN2 and PTPN22 expressed in response to the activation of naive CD4(+) T cells. Transcriptomics and chromatin immunoprecipitation-sequencing (ChIP-seq) of IL-6 responses in naive and effector memory CD4(+) T cells showed how the suppression of STAT1 activation shaped the functional identity and effector characteristics of memory CD4(+) T cells. Thus, tyrosine phosphatases induced by the activation of naive T cells determine the way activated or memory CD4(+) T cells sense and interpret cytokine signals.	[Twohig, Jason P.; Figueras, Ana Cardus; Cossins, Benjamin C.; Soria, Alicia Derrac; Millrine, David; Hill, David G.; Fernandez, Javier Uceda; Liu, Xiao; Szomolay, Barbara; Taylor, Philip R.; Jones, Gareth W.; Jones, Simon A.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Twohig, Jason P.; Figueras, Ana Cardus; Andrews, Robert; Cossins, Benjamin C.; Soria, Alicia Derrac; Millrine, David; Hill, David G.; Fernandez, Javier Uceda; Liu, Xiao; Szomolay, Barbara; Taylor, Philip R.; Jones, Gareth W.; Jones, Simon A.] Cardiff Univ, Syst Immun Univ Res Inst, Cardiff, S Glam, Wales; [Wiede, Florian; Li, Jasmine; Tiganis, Tony] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Wiede, Florian; Tiganis, Tony] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Lewis, Myles J.; Pitzalis, Costantino] Barts & London Queen Marys Sch Med & Dent, Ctr Expt Med & Rheumatol, William Harvey Res Inst, London, England; [Townsend, Michael J.] Genentech Res & Early Dev, Biomarker Discovery OMNI, San Francisco, CA USA; [Li, Jasmine] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [Pepper, Christopher J.] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, S Glam, Wales; [Pepper, Christopher J.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Williams, Nigel M.] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Jones, Gareth W.] Univ Bristol, Sch Cellular & Mol Med, Biomed Sci Bldg, Bristol, Avon, England	Cardiff University; Cardiff University; Monash University; Monash University; University of London; Queen Mary University London; Roche Holding; Genentech; Monash University; Cardiff University; University of Brighton; University of Sussex; Cardiff University; University of Bristol	Jones, SA (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales.; Jones, SA (corresponding author), Cardiff Univ, Syst Immun Univ Res Inst, Cardiff, S Glam, Wales.	JonesSA@cf.ac.uk	Cardus, Anna/P-6265-2019; Lewis, Myles J/AAW-2453-2021; Tiganis, Tony/AAV-3495-2020; Jones, Simon Arnett/Q-7017-2018	Lewis, Myles J/0000-0001-9365-5345; Tiganis, Tony/0000-0002-8065-9942; Jones, Simon Arnett/0000-0001-7297-9711; Pitzalis, Costantino/0000-0003-1326-5051; Taylor, Philip/0000-0003-0163-1421; Wiede, Florian/0000-0001-5145-7180; Szomolay, Barbara/0000-0002-5375-5533; Jones, Gareth/0000-0002-0125-4841; Liu, Xiao/0000-0001-9131-8548; Cardus, Anna/0000-0003-4699-6205; Pepper, Chris/0000-0003-3603-8839; Millrine, David/0000-0002-8041-0151; Townsend, Michael/0000-0003-0240-4562	Hoffmann la Roche; Kidney Research UK; National Health and Medical Research Council of Australia; Versus Arthritis Career Development Fellowship [20305]; Systems Immunity University Research Institute at Cardiff; Rutherford Fellowship Grant; Medical Research Council [36661, 20022]; Wellcome Trust Investigator Award; UK Dementia Research Institute [107964/Z/15/Z]; Systems Immunity University Research Institute in Cardiff; MRC [UKDRI-3001, G0800648] Funding Source: UKRI	Hoffmann la Roche(Hoffmann-La Roche); Kidney Research UK(Kidney Research UK (KRUK)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Versus Arthritis Career Development Fellowship; Systems Immunity University Research Institute at Cardiff; Rutherford Fellowship Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust); UK Dementia Research Institute; Systems Immunity University Research Institute in Cardiff; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This manuscript is dedicated in fond memory of Javier Uceda Fernandez, a dearly loved friend and colleague who was tragically taken from us on August 29, 2018. Remembered forever. Versus Arthritis (Reference 19796,20770 awarded to S.A.J., N.M.W. and G.W.J.), Hoffmann la Roche (to S.A.J.), Kidney Research UK (to S.A.J.) and the National Health and Medical Research Council of Australia (to T.T.) provided grant support for this project. G.W.J. is recipient of a Versus Arthritis Career Development Fellowship (Reference 20305). J.U.F. held a la Caixa PhD Studentship administered through the British Council, and B.C.C. is supported by a PhD studentship from the Systems Immunity University Research Institute at Cardiff. J.L. is recipient of a Rutherford Fellowship Grant. Analysis of synovial tissues was conducted with support from the Medical Research Council (to C.J.P.; Reference 36661) and the Versus Arthritis-funded Experimental Arthritis Treatment Centre (to C.J.P.; Reference 20022). P.R.T. is recipient of a Wellcome Trust Investigator Award (107964/Z/15/Z) and receives funding through the UK Dementia Research Institute. Bioinformatic analysis was developed with support from the Systems Immunity University Research Institute in Cardiff. The authors would like to thank Y. Kanno, C. Hunter, S. Turner, T. Nakayama, M. Czubala, R. Errington, A. Onodera, K. Hirahara and J. O'Shea for their advice, constructive opinions and kind support.	Anderson AE, 2016, ANN RHEUM DIS, V75, P466, DOI 10.1136/annrheumdis-2014-205850; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; BEAGLEY KW, 1991, CYTOKINE, V3, P107, DOI 10.1016/1043-4666(91)90030-H; Bohmer Frank-D, 2014, JAKSTAT, V3, pe28087, DOI 10.4161/jkst.28087; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Curnow SJ, 2004, J IMMUNOL, V173, P5290, DOI 10.4049/jimmunol.173.8.5290; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fielding CA, 2014, IMMUNITY, V40, P40, DOI 10.1016/j.immuni.2013.10.022; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenhill CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0419-y; Haines CJ, 2013, CELL REP, V3, P1378, DOI 10.1016/j.celrep.2013.03.035; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong CW, 2013, CYTOKINE, V64, P532, DOI 10.1016/j.cyto.2013.08.001; Humby F, 2016, J RHEUMATOL, V43, P208, DOI 10.3899/jrheum.141199; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jones GW, 2013, ANN RHEUM DIS, V72, P1738, DOI 10.1136/annrheumdis-2013-203771; Jones GW, 2015, J EXP MED, V212, P1793, DOI 10.1084/jem.20132307; Jones GW, 2011, FASEB J, V25, P409, DOI 10.1096/fj.10-166843; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; KASAHARA Y, 1990, J EXP MED, V172, P1419, DOI 10.1084/jem.172.5.1419; Kelly S, 2015, ANN RHEUM DIS, V74, P611, DOI 10.1136/annrheumdis-2013-204603; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu D, 2015, NAT IMMUNOL, V16, P1263, DOI 10.1038/ni.3278; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mohrs M, 2003, J IMMUNOL, V170, P1870, DOI 10.4049/jimmunol.170.4.1870; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Nowell MA, 2009, J IMMUNOL, V182, P613, DOI 10.4049/jimmunol.182.1.613; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Peters A, 2015, J IMMUNOL, V195, P4144, DOI 10.4049/jimmunol.1302246; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Pratt AG, 2012, ANN RHEUM DIS, V71, P1374, DOI 10.1136/annrheumdis-2011-200968; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salmond RJ, 2014, NAT IMMUNOL, V15, P875, DOI 10.1038/ni.2958; Sharp RC, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00095; Strutt TM, 2016, J IMMUNOL, V197, P3260, DOI 10.4049/jimmunol.1600033; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wiede F, 2017, J AUTOIMMUN, V76, P85, DOI 10.1016/j.jaut.2016.09.004; Wiede F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4073; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	70	19	20	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					458	+		10.1038/s41590-019-0350-0	http://dx.doi.org/10.1038/s41590-019-0350-0			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30890796	Green Accepted, Green Submitted			2022-12-18	WOS:000461904200016
J	Napolitani, G; Kurupati, P; Teng, KWW; Gibani, MM; Rei, M; Aulicino, A; Preciado-Llanes, L; Wong, MT; Becht, E; Howson, L; de Haas, P; Salio, M; Blohmke, CJ; Olsen, LR; Pinto, DMS; Scifo, L; Jones, C; Dobinson, H; Campbell, D; Juel, HB; Thomaides-Brears, H; Pickard, D; Bumann, D; Baker, S; Dougan, G; Simmons, A; Gordon, MA; Newell, EW; Pollard, AJ; Cerundolo, V				Napolitani, Giorgio; Kurupati, Prathiba; Teng, Karen Wei Weng; Gibani, Malick M.; Rei, Margarida; Aulicino, Anna; Preciado-Llanes, Lorena; Wong, Michael Thomas; Becht, Etienne; Howson, Lauren; de Haas, Paola; Salio, Mariolina; Blohmke, Christoph J.; Olsen, Lars Ronn; Pinto, David Miguel Susano; Scifo, Laura; Jones, Claire; Dobinson, Hazel; Campbell, Danielle; Juel, Helene B.; Thomaides-Brears, Helena; Pickard, Derek; Bumann, Dirk; Baker, Stephen; Dougan, Gordon; Simmons, Alison; Gordon, Melita A.; Newell, Evan William; Pollard, Andrew J.; Cerundolo, Vincenzo			Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses	NATURE IMMUNOLOGY			English	Article							CYTOLETHAL DISTENDING TOXIN; TYPHOID-FEVER; ENTERICA; PARATYPHI; INFECTION; PATHOGENESIS; EXPRESSION; PROTEINS; SYSTEM; MODEL	To tackle the complexity of cross-reactive and pathogen-specific T cell responses against related Salmonella serovars, we used mass cytometry, unbiased single-cell cloning, live fluorescence barcoding, and T cell-receptor sequencing to reconstruct the Salmonella-specific repertoire of circulating effector CD4 T cells, isolated from volunteers challenged with Salmonella enterica serovar Typhi (S. Typhi) or Salmonella Paratyphi A (S. Paratyphi). We describe the expansion of cross-reactive responses against distantly related Salmonella serovars and of clonotypes recognizing immunodominant antigens uniquely expressed by S. Typhi or S. Paratyphi A. In addition, single-amino acid variations in two immunodominant proteins, CdtB and PhoN, lead to the accumulation of T cells that do not cross-react against the different serovars, thus demonstrating how minor sequence variations in a complex microorganism shape the pathogen-specific T cell repertoire. Our results identify immune-dominant, serovarspecific, and cross-reactive T cell antigens, which should aid in the design of T cell-vaccination strategies against Salmonella.	[Napolitani, Giorgio; Kurupati, Prathiba; Rei, Margarida; Aulicino, Anna; Preciado-Llanes, Lorena; Howson, Lauren; de Haas, Paola; Salio, Mariolina; Scifo, Laura; Simmons, Alison; Cerundolo, Vincenzo] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Teng, Karen Wei Weng; Wong, Michael Thomas; Becht, Etienne; Newell, Evan William] Singapore Immunol Network, Agcy Sci Technol & Res, Singapore, Singapore; [Gibani, Malick M.; Blohmke, Christoph J.; Jones, Claire; Dobinson, Hazel; Campbell, Danielle; Juel, Helene B.; Thomaides-Brears, Helena; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England; [Gibani, Malick M.; Blohmke, Christoph J.; Jones, Claire; Dobinson, Hazel; Campbell, Danielle; Juel, Helene B.; Thomaides-Brears, Helena; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Preciado-Llanes, Lorena; Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Olsen, Lars Ronn] Tech Univ Denmark, Dept Bio & Hlth Informat, Copenhagen, Denmark; [Pinto, David Miguel Susano] Univ Oxford, Micron Oxford, Dept Biochem, Oxford, England; [Pickard, Derek; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland; [Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Gordon, Melita A.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Oxford; University of Oxford; University of Liverpool; Technical University of Denmark; University of Oxford; Wellcome Trust Sanger Institute; University of Basel; University of Oxford; University of Malawi	Napolitani, G (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.	giorgio.napolitani@imm.ox.ac.uk	Howson, Lauren/AAP-7848-2020; Newell, Evan W/F-9711-2012; Juel, Helene/AAD-2843-2020; Gordon, Melita/F-5563-2012	Howson, Lauren/0000-0003-3522-4533; Newell, Evan W/0000-0002-2889-243X; Becht, Etienne/0000-0003-1859-9202; Aulicino, Anna/0000-0002-3407-2796; Prathiba, Kurupati/0000-0003-0633-889X; Thomaides-Brears, Helena/0000-0003-0774-6983; Juel, Helene B/0000-0002-5763-8545; Gibani, Malick/0000-0003-1781-0053; Olsen, Lars Ronn/0000-0002-6725-7850; Susano Pinto, David Miguel/0000-0003-2710-0186; Preciado-Llanes, Lorena/0000-0001-5120-3578; Dobinson, Hazel/0000-0002-1092-5715; Simmons, Alison/0000-0003-3454-0710; Gordon, Melita/0000-0002-0629-0884; Baker, Stephen/0000-0003-1308-5755; Salio, Mariolina/0000-0002-4821-3801	UK Medical Research Council [MR/K021222/ I]; Cancer Research UK (CRUX) [C3991 A2291]; NIHR Clinical Research Network Thames Valley; Oxford Biomedical Research Centre; Bill & Melinda Gates Foundation [OPP1084259]; European Vaccine Initiative (PIM); Singapore Immunology Network (SIgN); MRC [MC_UU_00008/7, MC_UU_00008/1, MC_UU_12010/7, MR/K021222/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (CRUX); NIHR Clinical Research Network Thames Valley; Oxford Biomedical Research Centre; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European Vaccine Initiative (PIM); Singapore Immunology Network (SIgN)(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council C) (MR/K021222/ I) (G.N,, M.A.G A.S., V C., M.P., P. K., L.P.-L, H.T.-B, M,M.G.), Cancer Research UK (CRUX) (C3991 A2291) (V.C.), the NIHR Clinical Research Network Thames Valley (A.J.P.), the Oxford Biomedical Research Centre (A.J.P.), the Bill & Melinda Gates Foundation (OPP1084259) (A.J.P.), the European Vaccine Initiative (PIM) (A.I.P.), and core funding from the Singapore Immunology Network (SIgN) (K.W75.T., E.B., M.T.W., and E.W.N.) and the SIgN immunomonitoring platform (ICWW.T., E.B., NI,T,W and G.D. is supported by The Wellcome Trust. We thank C. Waugh and the WIMM PACS facility for assistance with cell sorting, and T. Rostron for assistance with next generation sequencmg. The DRB4 tettamers were provided by B. Kwok and I.- Chow, from the Tetramer Core Laboratory at the Benaroya Research Institute at Virginia Mason,	Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966; Bhuiyan MS, 2014, AM J TROP MED HYG, V90, P1024, DOI 10.4269/ajtmh.13-0261; Blohmke CJ, 2016, J EXP MED, V213, P1061, DOI 10.1084/jem.20151025; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Coward C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004359; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dobinson HC, 2017, CLIN INFECT DIS, V64, P1066, DOI 10.1093/cid/cix042; Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739; Dunstan SJ, 2014, NAT GENET, V46, P1333, DOI 10.1038/ng.3143; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Gal-Mor O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00391; Galan JE, 2016, P NATL ACAD SCI USA, V113, P6338, DOI 10.1073/pnas.1606335113; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lee SJ, 2012, IMMUNOL LETT, V148, P138, DOI 10.1016/j.imlet.2012.10.009; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McCullagh D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007481; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Olsen LR, 2013, J IMMUNOL METHODS, V400, P37, DOI 10.1016/j.jim.2013.08.014; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Reynolds CJ, 2014, IMMUNOLOGY, V143, P438, DOI 10.1111/imm.12327; Rodriguez-Rivera LD, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0065-1; Sheikh A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001193; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; TRAUNECKER A, 1991, TRENDS BIOTECHNOL, V9, P109, DOI 10.1016/0167-7799(91)90038-J; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; Waddington CS, 2014, CLIN INFECT DIS, V58, P1230, DOI 10.1093/cid/ciu078; Wahid R, 2016, CLIN IMMUNOL, V173, P87, DOI 10.1016/j.clim.2016.09.006; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022	42	19	19	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					742	+		10.1038/s41590-018-0133-z	http://dx.doi.org/10.1038/s41590-018-0133-z			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925993	Green Submitted			2022-12-18	WOS:000436341300019
J	Adoro, S; Park, KH; Bettigole, SE; Lis, R; Shin, HR; Seo, H; Kim, JH; Knobeloch, KP; Shim, JH; Glimcher, LH				Adoro, Stanley; Park, Kwang Hwan; Bettigole, Sarah E.; Lis, Raphael; Shin, Hee Rae; Seo, Heewon; Kim, Ju Han; Knobeloch, Klaus-Peter; Shim, Jae-Hyuck; Glimcher, Laurie H.			Post-translational control of T cell development by the ESCRT protein CHMP5	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; NEGATIVE SELECTION; POSITIVE SELECTION; DEVELOPING THYMOCYTES; THYMIC SELECTION; TCR EXPRESSION; LATE ENDOSOME; IN-VITRO; APOPTOSIS; SIGNALS	The acquisition of a protective vertebrate immune system hinges on the efficient generation of a diverse but self-tolerant repertoire of T cells by the thymus through mechanisms that remain incompletely resolved. Here we identified the endosomal-sorting-complex-required-for-transport (ESCRT) protein CHMP5, known to be required for the formation of multivesicular bodies, as a key sensor of thresholds for signaling via the T cell antigen receptor (TCR) that was essential for T cell development. CHMP5 enabled positive selection by promoting post-selection thymocyte survival in part through stabilization of the pro-survival protein Bcl-2. Accordingly, loss of CHMP5 in thymocyte precursor cells abolished T cell development, a phenotype that was 'rescued' by genetic deletion of the pro-apoptotic protein Bim or transgenic expression of Bcl-2. Mechanistically, positive selection resulted in the stabilization of CHMP5 by inducing its interaction with the deubiquitinase USP8. Our results thus identify CHMP5 as an essential component of the post-translational machinery required for T cell development.	[Adoro, Stanley; Glimcher, Laurie H.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Adoro, Stanley; Glimcher, Laurie H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Park, Kwang Hwan] Weill Cornell Med, Dept Pathol, New York, NY USA; [Bettigole, Sarah E.; Shin, Hee Rae] Quentis Therapeut, New York, NY USA; [Lis, Raphael] Weill Cornell Med, Dept Med Genet, Ansary Stem Cell Inst, New York, NY USA; [Seo, Heewon; Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, Seoul, South Korea; [Knobeloch, Klaus-Peter] Univ Freiburg, Inst Neuropathol, Freiburg, Germany; [Shim, Jae-Hyuck] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA 01655 USA; [Park, Kwang Hwan] Yonsei Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cornell University; Cornell University; Seoul National University (SNU); University of Freiburg; University of Massachusetts System; University of Massachusetts Worcester; Yonsei University; Yonsei University Health System	Glimcher, LH (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Shim, JH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA 01655 USA.	jaehyuck.shim@umassmed.edu; laurie_glimcher@dfci.harvard.edu		Seo, Heewon/0000-0001-6218-8609; Park, Kwang Hwan/0000-0002-2110-0559; Shim, Jae-Hyuck/0000-0002-4947-3293	US National Institutes of Health [R01AR068983, R01CA112663]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Singer (US National Institutes of Health) for Bcl2-transgenic mice; S. Dimmeler (J.W. Goethe University, Frankfurt, Germany) for Bcl-2-encoding plasmids; J. Kaplan (University of Utah) for anti-LIP5; M. Greenblatt for critical reading of the manuscript; J. McCormick (Weill Cornell Medicine) for sorting by flow cytometry; L. Cohen-Gould, J. Cohen and J. Jimenez for histology and electron microscopy; and the NIH Tetramer Core Facility (Emory University) for tetramers. Supported by the US National Institutes of Health (R01AR068983 to J.H.S., and R01CA112663 to L.H.G.).	Azad N, 2010, ANN NY ACAD SCI, V1203, P1, DOI 10.1111/j.1749-6632.2010.05608.x; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BONIFACINO JS, 1990, NATURE, V344, P247, DOI 10.1038/344247a0; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chang YC, 1998, CELL GROWTH DIFFER, V9, P79; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dufner A, 2015, NAT IMMUNOL, V16, P950, DOI 10.1038/ni.3230; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finetti F, 2014, J CELL SCI, V127, P1924, DOI 10.1242/jcs.139337; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Gerondalds S, 2014, NAT IMMUNOL, V15, P15, DOI 10.1038/ni.2785; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Grimm LM, 1996, EMBO J, V15, P3835, DOI 10.1002/j.1460-2075.1996.tb00757.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jin R, 2015, IMMUNOL CELL BIOL, V93, P744, DOI 10.1038/icb.2015.36; Khoury CM, 2007, GENE, V391, P233, DOI 10.1016/j.gene.2006.12.039; Kranz A, 2001, MOL BIOL CELL, V12, P711, DOI 10.1091/mbc.12.3.711; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Luanpitpong S, 2013, MOL BIOL CELL, V24, P858, DOI 10.1091/mbc.E12-10-0747; Maseda D, 2008, CELL DEATH DIFFER, V15, P600, DOI 10.1038/sj.cdd.4402297; Matusek T, 2014, NATURE, V516, P99, DOI 10.1038/nature13847; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; Pannu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117304; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Rybakin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043191; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shahmoradgoli M, 2011, INT J CANCER, V128, P2865, DOI 10.1002/ijc.25632; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wi SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.102; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836	60	19	20	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					780	+		10.1038/ni.3764	http://dx.doi.org/10.1038/ni.3764			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28553951				2022-12-18	WOS:000403676300013
J	Quintana, FJ				Quintana, Francisco J.			Old dog, new tricks: IL-6 cluster signaling promotes pathogenic T(H)17 cell differentiation	NATURE IMMUNOLOGY			English	Editorial Material							HELPER-CELLS; INTERLEUKIN-6; GENERATION; PATHWAYS; CYTOKINE; RECEPTOR	Different cellular sources and signaling mechanisms mediate the effects of IL-6 on the generation of pathogenic T(H)17 helper T cells and the suppression of Foxp(3+) regulatory T cells.	[Quintana, Francisco J.] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Quintana, Francisco J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Quintana, FJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Quintana, FJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020					Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bottcher JP, 2014, CELL REP, V8, P1318, DOI 10.1016/j.celrep.2014.07.008; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yeste A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0612; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	15	19	20	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					8	10		10.1038/ni.3637	http://dx.doi.org/10.1038/ni.3637			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27984572				2022-12-18	WOS:000390080000003
J	Mathewson, ND; Jenq, R; Mathew, AV; Koenigsknecht, M; Hanash, A; Toubai, T; Oravecz-Wilson, K; Wu, SR; Sun, YP; Rossi, C; Fujiwara, H; Byun, J; Shono, Y; Lindemans, C; Calafiore, M; Schmidt, TM; Honda, K; Young, VB; Pennathur, S; van den Brink, M; Reddy, P				Mathewson, Nathan D.; Jenq, Robert; Mathew, Anna V.; Koenigsknecht, Mark; Hanash, Alan; Toubai, Tomomi; Oravecz-Wilson, Katherine; Wu, Shin-Rong; Sun, Yaping; Rossi, Corinne; Fujiwara, Hideaki; Byun, Jaeman; Shono, Yusuke; Lindemans, Caroline; Calafiore, Marco; Schmidt, Thomas M.; Honda, Kenya; Young, Vincent B.; Pennathur, Subramaniam; van den Brink, Marcel; Reddy, Pavan			Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease (vol 17, pg 505, 2016)	NATURE IMMUNOLOGY			English	Correction													Fujiwara, Hideaki/ABI-6034-2020; van den Brink, Marcel R. M./HGB-9434-2022; Young, Vincent B/B-3179-2009; Mathew, Anna V/V-2511-2018	Young, Vincent B/0000-0003-3687-2364; 				Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400	1	19	20	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1235	1235		10.1038/ni1016-1235b	http://dx.doi.org/10.1038/ni1016-1235b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648549	Bronze			2022-12-18	WOS:000384302900016
J	Rocha, JDB; Schlossmacher, MG; Philpott, DJ				Rocha, Juliana D. B.; Schlossmacher, Michael G.; Philpott, Dana J.			LRRK2 and Nod2 promote lysozyme sorting in Paneth cells	NATURE IMMUNOLOGY			English	Editorial Material							DISEASE; AUTOPHAGY; REGULATOR; ATG16L1; GENE	Paneth cell dysfunction has been linked to Crohn's disease. Nod2 and LRRK2, two genetic susceptibility factors for this disease, are now shown to have a role in regulating the sorting of lysozyme in Paneth cells and its secretion into the crypt space and, ultimately, in maintenance of the intestinal barrier.	[Rocha, Juliana D. B.; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Schlossmacher, Michael G.] Univ Ottawa, Div Neurosci, Ottawa, ON, Canada; [Schlossmacher, Michael G.] Univ Ottawa, Div Neurol, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Toronto; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Rocha, JDB (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	dana.philpott@utoronto.ca		Schlossmacher, Michael/0000-0002-0394-0300				Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dalfo E, 2004, J NEUROPATH EXP NEUR, V63, P302, DOI 10.1093/jnen/63.4.302; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Lewis PA, 2012, BIOCHEM SOC T, V40, P1039, DOI 10.1042/BST20120178; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Yun HJ, 2015, J BIOCHEM, V157, P485, DOI 10.1093/jb/mvv005; Zhang Q, 2015, NAT IMMUNOL, V16, P918, DOI 10.1038/ni.3233	17	19	19	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					898	900		10.1038/ni.3255	http://dx.doi.org/10.1038/ni.3255			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287588				2022-12-18	WOS:000359876900005
J	Ohnuma, K; Hatano, R; Morimoto, C				Ohnuma, Kei; Hatano, Ryo; Morimoto, Chikao			DPP4 in anti-tumor immunity: going beyond the enzyme	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL FUNCTION; CD26; CANCER; IV	Effective anti-tumor immune therapy in solid tumors relies on the presence of effector T cells. Inhibition of the dipeptidylpeptidase DPP4 (CD26) enhances chemokine CXCL10-mediated infiltration of lymphocytes into the tumor parenchyma, which results in diminished tumor growth.	[Ohnuma, Kei; Hatano, Ryo; Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan	Juntendo University	Ohnuma, K (corresponding author), Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan.	morimoto@ims.u-tokyo.ac.jp			Grants-in-Aid for Scientific Research [15H04879] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Davies S, 2015, BIOMED PHARMACOTHER, V71, P135, DOI 10.1016/j.biopha.2015.02.031; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hatano R, 2015, J IMMUNOL, V194, P960, DOI 10.4049/jimmunol.1402143; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Herrmann H, 2014, BLOOD, V123, P3951, DOI 10.1182/blood-2013-10-536078; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Shi Z, 2009, EUR J IMMUNOL, V39, P2106, DOI 10.1002/eji.200939314; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703	12	19	20	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					791	792		10.1038/ni.3210	http://dx.doi.org/10.1038/ni.3210			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26194276				2022-12-18	WOS:000358299200002
J	Ravetch, J				Ravetch, Jeffrey			In vivo veritas: the surprising roles of Fc receptors in immunity	NATURE IMMUNOLOGY			English	Article							ANTIINFLAMMATORY ACTIVITY; MONOCLONAL-ANTIBODY; DEFICIENT; COMPLEMENT; POLYMORPHISM; RESPONSES; LUPUS	Jeffrey Ravetch describes how he came to identify the in vivo function of the once mysterious Fc receptors.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, J (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@mail.rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041				Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arthus M., 1903, SEANCES MEMOIRE SOC, V55, P817; BERKEN A, 1966, J EXP MED, V123, P119, DOI 10.1084/jem.123.1.119; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; MUTA T, 1994, NATURE, V369, P340, DOI 10.1038/369340a0; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Podolanczuk A, 2009, BLOOD, V113, P3154, DOI 10.1182/blood-2008-07-166439; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; RAVETCH JV, 1980, P NATL ACAD SCI-BIOL, V77, P6734, DOI 10.1073/pnas.77.11.6734; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Travers Paul, 1994, IMMUNOBIOLOGY; Tsuchiya N, 2005, AUTOIMMUNITY, V38, P347, DOI 10.1080/08916930500123926; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Verma A, 2009, CLIN VACCINE IMMUNOL, V16, P1405, DOI 10.1128/CVI.00194-09; Walport M., 1999, IMMUNOBIOLOGY; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490	35	19	20	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					183	185		10.1038/ni0310-183	http://dx.doi.org/10.1038/ni0310-183			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20157296				2022-12-18	WOS:000274605800002
J	Loveland, BE; Cebon, J				Loveland, Bruce E.; Cebon, Jonathan			Cancer exploiting complement: a clue or an exception?	NATURE IMMUNOLOGY			English	Editorial Material							TUMOR-CELLS; IN-VIVO; EXPRESSION; ANTIBODIES; RECEPTORS; IMMUNITY	Cancer cells are more resistant to complement-mediated lysis and use this attribute to set up a locally immunosuppressive environment. However, new findings suggest that tumor-driven complement activation can also provide the tumor a growth advantage.	[Loveland, Bruce E.] Burnet Inst, Heidelberg, Vic 3084, Australia; [Cebon, Jonathan] Austin Hosp, Ludwig Inst Canc Res, Austin Hlth & Canc Vaccine Lab, Heidelberg, Vic 3084, Australia	Burnet Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research	Loveland, BE (corresponding author), Burnet Inst, Heidelberg, Vic 3084, Australia.	bloveland@burnet.edu.au	Cebon, Jonathan S/H-1643-2013	Cebon, Jonathan/0000-0002-3898-950X				Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Davis ID, 2003, J LEUKOCYTE BIOL, V73, P3, DOI 10.1189/jlb.0502261; Dechant M, 2008, CANCER RES, V68, P4998, DOI 10.1158/0008-5472.CAN-07-6226; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Manderson AP, 2001, J EXP MED, V194, P747, DOI 10.1084/jem.194.6.747; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Nauts H C, 1990, Adv Exp Med Biol, V267, P483; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Varela JC, 2008, CANCER RES, V68, P6734, DOI 10.1158/0008-5472.CAN-08-0502; Watson NFS, 2006, CANCER IMMUNOL IMMUN, V55, P973, DOI 10.1007/s00262-005-0055-0; Wu XB, 2008, J IMMUNOL, V181, P2732, DOI 10.4049/jimmunol.181.4.2732; Zell S, 2007, CLIN EXP IMMUNOL, V150, P576, DOI 10.1111/j.1365-2249.2007.03507.x	15	19	19	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1205	1206		10.1038/ni1108-1205	http://dx.doi.org/10.1038/ni1108-1205			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18936777				2022-12-18	WOS:000260248600004
J	Waldmann, H				Waldmann, Herman			Tolerance can be infectious	NATURE IMMUNOLOGY			English	Editorial Material							MONOCLONAL-ANTIBODIES; T-CELLS; TRANSPLANTATION TOLERANCE; AUTOIMMUNE-DISEASE; BONE-MARROW; THYMUS; SUPPRESSION; INDUCTION; THERAPY; MICE	Studies focused on the goal of eliciting transplant tolerance led Herman Waldmann to rejuvenate discarded ideas of 'suppressor T cells'. Such cells are now known to exist.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Waldmann, H (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	herman.waldmann@path.ox.ac.uk	waldmann, herman/F-7412-2011; waldmann, herman/W-8051-2019	Waldmann, Herman/0000-0001-7519-6720	Medical Research Council [G7904009] Funding Source: Medline; MRC [G7904009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; CHILLER JM, 1970, P NATL ACAD SCI USA, V65, P551, DOI 10.1073/pnas.65.3.551; CLAMAN HN, 1966, J IMMUNOL, V97, P828; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; COBBOLD SP, 1986, NATURE, V323, P164, DOI 10.1038/323164a0; Davies JD, 1996, J IMMUNOL, V156, P3602; DROEGE W, 1971, NATURE, V234, P549, DOI 10.1038/234549a0; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; HALE G, 1983, BLOOD, V62, P873; KONG YCM, 1989, CLIN IMMUNOL IMMUNOP, V51, P38, DOI 10.1016/0090-1229(89)90204-3; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; SAKAGUCHI S, 1988, J EXP MED, V167, P1479, DOI 10.1084/jem.167.4.1479; WALDMANN H, 1992, J AUTOIMMUN, V5, P93, DOI 10.1016/0896-8411(92)90024-K; WALDMANN H, 1988, J AUTOIMMUN, V1, P623, DOI 10.1016/0896-8411(88)90053-4; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	23	19	20	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1001	1003		10.1038/ni0908-1001	http://dx.doi.org/10.1038/ni0908-1001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711438				2022-12-18	WOS:000258559600008
J	Min, B; Paul, WE				Min, Booki; Paul, William E.			Basophils: in the spotlight at last	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; INTERLEUKIN-4; MATURATION; IL-4	Basophils have long been suspected to be potent inducers of T helper type 2 differentiation. Sokol and colleagues now demonstrate that basophils are required for adoption of the T helper type 2 fate in vivo in response to allergens with protease activity.	[Min, Booki] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Paul, William E.] NIAID, NIH, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Min, B (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wpaul@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000926, Z01AI000968] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Haisch K, 2001, PARASITE IMMUNOL, V23, P427, DOI 10.1046/j.1365-3024.2001.00392.x; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Lim LHK, 2006, J IMMUNOL, V176, P5346, DOI 10.4049/jimmunol.176.9.5346; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448	12	19	19	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					223	225		10.1038/ni0308-223	http://dx.doi.org/10.1038/ni0308-223			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285768				2022-12-18	WOS:000253406700003
J	McEver, RP; Zhu, C				McEver, Rodger P.; Zhu, Cheng			A catch to integrin activation	NATURE IMMUNOLOGY			English	Editorial Material							CELL-ADHESION; L-SELECTIN; INSIGHTS; FORCE; CHEMOKINES; DYNAMICS; PSGL-1; ARREST; HINGE; FLOW	T cells interact with chemokines displayed on cells outside and inside blood vessels of the lymph node. New work shows that these chemokines exert distinct activation effects on T cell integrins depending on their mechanical environment.	Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Georgia Inst Technol, Coutler Dept Biomed Engn, Atlanta, GA 30332 USA	Oklahoma Medical Research Foundation; University System of Georgia; Georgia Institute of Technology	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Zhu, Cheng/A-5724-2011					Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	18	19	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1035	1037		10.1038/ni1007-1035	http://dx.doi.org/10.1038/ni1007-1035			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878912				2022-12-18	WOS:000249691400011
J	Vieira, P; O'Garra, A				Vieira, Paulo; O'Garra, Anne			Regula'ten' the gut	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INTERLEUKIN-10; EXPRESSION; IL-10	Studies of genetically modified reporter mice have provided insight into the development of regulatory T cells. New work shows that regulatory T cells producing interleukin 10 arise in the periphery from Foxp3(+) and Foxp3(-) thymic progenitors.	Inst Natl Sante & Rech Med, U668, F-75724 Paris 15, France; Inst Pasteur, Unite Dev Lymphocytes, F-75724 Paris 15, France; Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; MRC National Institute for Medical Research	O'Garra, A (corresponding author), Inst Natl Sante & Rech Med, U668, F-75724 Paris 15, France.	aogarra@nimr.mrc.ac.uk	Vieira, Paulo/D-4500-2013	Vieira, Paulo/0000-0003-1307-5119; O'Garra, Anne/0000-0001-9845-6134	Medical Research Council [MC_U117565642] Funding Source: Medline; MRC [MC_U117565642] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Calado DP, 2006, J IMMUNOL, V177, P5358, DOI 10.4049/jimmunol.177.8.5358; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251	15	19	19	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					905	907		10.1038/ni0907-905	http://dx.doi.org/10.1038/ni0907-905			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17712340				2022-12-18	WOS:000248918200005
J	Cunningham, AL; Harman, AN; Donaghy, H				Cunningham, Anthony L.; Harman, Andrew N.; Donaghy, Heather			DC-SIGN 'AIDS' HIV immune evasion and infection	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; RECEPTOR; TRANSMISSION; BINDING	Human immunodeficiency virus uses many signaling pathways and cell surface receptors to infect cells. New work emphasizes the many functions of the lectin DC-SIGN expressed in dendritic cells.	Univ Sydney, Westmead Millenium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Cunningham, AL (corresponding author), Univ Sydney, Westmead Millenium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia.	tony_cunningham@wmi.usyd.edu.au	Cunningham, Tony L/B-7011-2013; Harman, Andrew N/K-5256-2012; Donaghy, Heather/G-8351-2015	Cunningham, Tony L/0000-0002-6744-5667; Harman, Andrew N/0000-0003-1535-1279; Donaghy, Heather/0000-0002-8280-5333				Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Bowie AG, 2007, CLIN EXP IMMUNOL, V147, P217, DOI 10.1111/j.1365-2249.2006.03301.x; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Harman AN, 2006, J IMMUNOL, V177, P7103, DOI 10.4049/jimmunol.177.10.7103; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182	13	19	22	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					556	558		10.1038/ni0607-556	http://dx.doi.org/10.1038/ni0607-556			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514207	Bronze			2022-12-18	WOS:000246703300007
J	Hackett, CJ; Rotrosen, D; Auchincloss, H; Fauci, AS				Hackett, Charles J.; Rotrosen, Daniel; Auchincloss, Hugh; Fauci, Anthony S.			Immunology research: challenges and opportunities in a time of budgetary constraint	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTORS; ANTIGEN; RECOGNITION; RESPONSES; BACTERIA; IMMUNITY; NAIVE	There have been enormous advances in the field of immunology over the past 3 decades, and those advances have had a positive effect on many subspecialties of medicine. Opportunities for even more notable advances remain. However, present and projected budget constraints for the National Institutes of Health have created formidable challenges. This commentary addresses the opportunities and challenges for the field of immunology during a period of restricted budgets.	NIAID, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hackett, CJ (corresponding author), NIAID, NIH, Dept Hlth & Human Serv, 9000 Rockville Pike, Bethesda, MD 20892 USA.	chackett@niaid.nih.gov		Hackett, Charles/0000-0003-4586-9669				Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BEGLEY S, 2006, WALL ST J A11; BERNASEK A, 2006, NY TIMES SECT, V3, P3; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bishop JM, 2006, SCIENCE, V312, P499, DOI 10.1126/science.1128904; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Fauci AS, 1996, LANCET, V348, P1002; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2005, IMMUNOBIOLOGY IMMUNE, P135; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MCMICHAEL AJ, 1979, EUR J IMMUNOL, V9, P205, DOI 10.1002/eji.1830090307; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Treml LS, 2006, SEMIN IMMUNOL, V18, P297, DOI 10.1016/j.smim.2006.07.001; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362	28	19	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					114	117		10.1038/ni0207-114	http://dx.doi.org/10.1038/ni0207-114			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242679				2022-12-18	WOS:000243597600003
J	Su, B				Su, B			Linking stress to immunity?	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; KINASE; INDUCTION		Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Su, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	bingsu@odin.mdacc.tmc.edu						Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597	12	19	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					541	542		10.1038/ni0605-541	http://dx.doi.org/10.1038/ni0605-541			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908931				2022-12-18	WOS:000229385900004
J	Laudanna, C				Laudanna, C			Integrin activation under flow: a local affair	NATURE IMMUNOLOGY			English	Editorial Material							CHEMOKINES; RECOGNITION; DIVERSITY; AFFINITY; ICAM-1; LFA-1	Chemokines 'trigger' the integrin LFA-1 to different conformational and affinity states. Elegant experiments provide new insights into the involvement of different LFA-1 affinity states in rapid lymphocyte arrest under flow.	Univ Verona, Dept Pathol, I-37134 Verona, Italy	University of Verona	Laudanna, C (corresponding author), Univ Verona, Dept Pathol, I-37134 Verona, Italy.	carlo.laudanna@univr.it						Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; D'Ambrosio D, 2004, TRENDS IMMUNOL, V25, P411, DOI 10.1016/j.it.2004.05.010; D'Ambrosio D, 2002, J IMMUNOL, V169, P2303, DOI 10.4049/jimmunol.169.5.2303; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; ETZIONI A, 2004, CURR OPIN ALLERGY CL, V6, P485; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922	12	19	21	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					429	430		10.1038/ni0505-429	http://dx.doi.org/10.1038/ni0505-429			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15843795				2022-12-18	WOS:000228634300004
J	O'Garra, A; Trinchieri, G				O'Garra, A; Trinchieri, G			Are dendritic cells afraid of commitment?	NATURE IMMUNOLOGY			English	Editorial Material							BONE-MARROW; PROGENITORS; PRECURSORS; ORIGIN	Dendritic cell subsets are thought to become committed to the dendritic cell lineage once they have differentiated from lymphoid or myeloid lineage precursors. However, this tenet has been challenged by data showing plasticity among the different subsets.	Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; Schering Plough Res Inst, Lab Immunol Res, F-69571 Dardilly, France	MRC National Institute for Medical Research; Merck & Company	O'Garra, A (corresponding author), Natl Inst Med Res, Div Immunoregulat, Mill Hill, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk; giorgio.trinchieri@yahoo.com	Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464; O'Garra, Anne/0000-0001-9845-6134				Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; Briere F, 2002, HUM IMMUNOL, V63, P1081, DOI 10.1016/S0198-8859(02)00746-2; CHAN S, 2004, CLIN INVEST MED, V27, pC62; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	14	19	36	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1206	1208		10.1038/ni1204-1206	http://dx.doi.org/10.1038/ni1204-1206			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549120				2022-12-18	WOS:000225353500008
J	Silverstein, AM				Silverstein, AM			Labeled antigens and antibodies: the evolution of magic markers and magic bullets	NATURE IMMUNOLOGY			English	Review							CELL-SURFACE ANTIGENS; MONOCLONAL-ANTIBODIES; RECOMBINANT IMMUNOTOXIN; ALKALINE-PHOSPHATASE; ANTICANCER PRODRUGS; PURIFIED ANTIBODY; DIPHTHERIA-TOXIN; SPECIFICITY; MICE; PROTEINS	The ability to label antigens and antibodies with simple chemicals and even with whole proteins fostered new approaches to basic studies of the immune system as well as new methods of immunodiagnosis and immunotherapy. This was especially true following the introduction of monoclonal antibodies, which enhanced the specificity of many of these applications. The uses to which these labeled immunoreagents were put were legion, and those who employed them might come from any field of biology or medicine. Many of these technical elaborations were critical to progress in immunology and in many other biomedical sciences. They illustrate also the often complex interplay between technology and theory.	Johns Hopkins Inst Hist Med, Baltimore, MD USA	Johns Hopkins University	Silverstein, AM (corresponding author), 38 Fells Rd, Falmouth, MA 02540 USA.	arts@jhmi.edu						ADA GL, 1969, NATURE, V222, P1291, DOI 10.1038/2221291a0; AVRAMEAS S, 1967, CR ACAD SCI D NAT, V265, P1149; AVRAMEAS S, 1969, IMMUNOCHEMISTRY, V6, P43, DOI 10.1016/0019-2791(69)90177-3; BAGSHAWE KD, 1987, BRIT J CANCER, V56, P531, DOI 10.1038/bjc.1987.237; BAGSHAWE KD, 1995, DRUG DEVELOP RES, V34, P220, DOI 10.1002/ddr.430340211; BAIN B, 1964, SCIENCE, V145, P1315, DOI 10.1126/science.145.3638.1315; BLAIR AH, 1983, J IMMUNOL METHODS, V59, P129; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BOORSMA DM, 1984, HISTOCHEMISTRY, V80, P103, DOI 10.1007/BF00679982; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; Breinl F., 1930, Z PHYSL CHEM, V192, P45; BRINKMANN U, 1993, P NATL ACAD SCI USA, V90, P7538, DOI 10.1073/pnas.90.16.7538; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Cambrosio, 1995, EXQUISITE SPECIFICIT; CAMBROSIO A, 1992, MED ANTHROPOL Q, V6, P362, DOI 10.1525/maq.1992.6.4.02a00040; CAMPBELL DH, 1963, ADV IMMUNOL, V3, P261, DOI 10.1016/S0065-2776(08)60814-7; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CEROTTINI JC, 1967, IMMUNOLOGY, V13, P395; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; CHESS L, 1977, ADV IMMUNOL, V25, P213; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; Coons AH, 1942, J IMMUNOL, V45, P159; COONS AH, 1955, J EXP MED, V102, P49, DOI 10.1084/jem.102.1.49; COONS AH, 1961, J IMMUNOL, V87, P499; DIXON FJ, 1952, J IMMUNOL, V68, P693; DUPONT B, 1976, ADV IMMUNOL, V23, P107, DOI 10.1016/S0065-2776(08)60320-X; EISEN HN, 1949, J AM CHEM SOC, V71, P363, DOI 10.1021/ja01169a505; Elias J.M., 1990, IMMUNOHISTOPATHOLOGY; FARR RS, 1958, J INFECT DIS, V103, P239, DOI 10.1093/infdis/103.3.239; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; FELDMAN JD, 1963, J IMMUNOL, V91, P306; FLAVELL DJ, 1995, INT J CANCER, V62, P337, DOI 10.1002/ijc.2910620318; Fr Obermayer, 1906, WIEN KLIN WCHNSCHR, V19, P327; Galfre G, 1981, Methods Enzymol, V73, P3; GHETIE MA, 1992, BLOOD, V80, P2315; GHOSE T, 1972, BMJ-BRIT MED J, V3, P495, DOI 10.1136/bmj.3.5825.495; GOHRROSENTHAL S, 1993, INVEST RADIOL, V28, P789; GOLDENBERG DM, 1995, CANC THERAPY RADIOLA; GOLDENBERG DM, 1990, CANC IMAGING RADIOLA; GREEN LL, 1994, NAT GENET, V7, P13, DOI 10.1038/ng0594-13; HAUSCHKA TS, 1952, CANCER RES, V12, P615; Heidelberger M, 1933, J EXP MED, V58, P137, DOI 10.1084/jem.58.2.137; Hericourt J, 1895, CR HEBD ACAD SCI, V121, P567; Herzenberg LA, 2000, IMMUNOL TODAY, V21, P383, DOI 10.1016/S0167-5699(00)01678-9; HIRAMOTO R, 1958, P SOC EXP BIOL MED, V97, P611; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Kabat E.A., 1968, STRUCTURAL CONCEPTS; KABAT EA, 1966, J IMMUNOL, V97, P1; KABAT EA, 1956, J IMMUNOL, V77, P377; Kahan BD, 1999, TRANSPLANTATION, V67, P276, DOI 10.1097/00007890-199901270-00016; KARUSH F, 1962, ADV IMMUNOL, V2, P1; KEATING P, 1994, J HIST BIOL, V27, P449, DOI 10.1007/BF01058994; KENDALL PA, 1965, BIOCHIM BIOPHYS ACTA, V97, P174, DOI 10.1016/0304-4165(65)90291-6; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kreitman RJ, 2003, NAT BIOTECHNOL, V21, P372, DOI 10.1038/nbt0403-372; LAMM ME, 1972, P NATL ACAD SCI USA, V69, P3732, DOI 10.1073/pnas.69.12.3732; Landsteiner K, 1938, J EXP MED, V67, P709, DOI 10.1084/jem.67.5.709; Landsteiner K., 1962, SPECIFICITY SEROLOGI; Larsson L.-I., 1988, IMMUNOCYTOCHEMISTRY; LIBBY RL, 1947, J IMMUNOL, V55, P15; Little M, 2000, IMMUNOL TODAY, V21, P364, DOI 10.1016/S0167-5699(00)01668-6; LOKEN MR, 1975, ANN NY ACAD SCI, V254, P163, DOI 10.1111/j.1749-6632.1975.tb29166.x; Marrack J, 1934, NATURE, V133, P292, DOI 10.1038/133292b0; MASON DY, 1978, J CLIN PATHOL, V31, P454, DOI 10.1136/jcp.31.5.454; MATHE G, 1958, CR HEBD ACAD SCI, V246, P1626; MCCLUSKEY RT, 1963, J IMMUNOL, V90, P466; MEW D, 1983, J IMMUNOL, V130, P1473; MOLLER G, 1961, J EXP MED, V114, P415, DOI 10.1084/jem.114.4.415; MOOLTEN FL, 1970, SCIENCE, V169, P68, DOI 10.1126/science.169.3940.68; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; NAIRN RC, 1976, FLUORESCENT PROTEIN; NAKANE PK, 1966, J HISTOCHEM CYTOCHEM, V14, P929, DOI 10.1177/14.12.929; ORTEGA LG, 1957, J EXP MED, V106, P627, DOI 10.1084/jem.106.5.627; OSEROFF AR, 1986, P NATL ACAD SCI USA, V83, P8744, DOI 10.1073/pnas.83.22.8744; OWENS RJ, 1994, J IMMUNOL METHODS, V168, P149, DOI 10.1016/0022-1759(94)90051-5; Pastan Ira, 2002, Curr Opin Investig Drugs, V3, P1089; PRENDERGAST RA, 1964, J EXP MED, V119, P377, DOI 10.1084/jem.119.3.377; PRESSMAN D, 1958, INT ARCH ALLER A IMM, V12, P125, DOI 10.1159/000228449; PRESSMAN D, 1951, J ALLERGY, V22, P387, DOI 10.1016/0021-8707(51)90142-6; PRESSMAN D, 1957, CANCER RES, V17, P845; Pressman D, 1968, STRUCTURAL BASIS ANT; RAFF MC, 1970, NATURE, V225, P553, DOI 10.1038/225553a0; Reiner L, 1930, SCIENCE, V72, P483, DOI 10.1126/science.72.1871.483; Remsen LG, 1996, AM J NEURORADIOL, V17, P411; RHEINBERGER HJ, 1992, STUD HIST PHILOS SCI, V23, P305, DOI 10.1016/0039-3681(92)90037-7; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; RIGGS JL, 1958, AM J PATHOL, V34, P1081; ROMANO EL, 1977, IMMUNOCHEMISTRY, V14, P711, DOI 10.1016/0019-2791(77)90146-X; ROTH J, 1983, J HISTOCHEM CYTOCHEM, V31, P987, DOI 10.1177/31.8.6190857; Sabin FR, 1939, J EXP MED, V70, P67, DOI 10.1084/jem.70.1.67; SCHLOSSMAN SF, 1984, B WORLD HEALTH ORGAN, V62, P809; Sela M., 1987, IMMUNOCONJUGATES ANT, P189; SENTER PD, 1988, P NATL ACAD SCI USA, V85, P4842, DOI 10.1073/pnas.85.13.4842; Senter PD, 2001, ADV DRUG DELIVER REV, V53, P247, DOI 10.1016/S0169-409X(01)00206-X; SHAW S, 1987, IMMUNOL TODAY, V8, P1, DOI 10.1016/0167-5699(87)90816-4; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Sievers EL, 2001, J CLIN ONCOL, V19, P3244, DOI 10.1200/JCO.2001.19.13.3244; SILVERSTEIN AM, 1957, J HISTOCHEM CYTOCHEM, V5, P94, DOI 10.1177/5.1.94-b; SINGER SJ, 1959, NATURE, V183, P1523, DOI 10.1038/1831523a0; Smallshaw JE, 2003, NAT BIOTECHNOL, V21, P387, DOI 10.1038/nbt800; STERNBERGER LA, 1969, J HISTOCHEM CYTOCHEM, V17, P190; STERNBERGER LA, 1965, EXP MOL PATHOL, V4, P112, DOI 10.1016/0014-4800(65)90027-4; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; THORPE PE, 1978, NATURE, V271, P752, DOI 10.1038/271752a0; Thrush GR, 1996, ANNU REV IMMUNOL, V14, P49, DOI 10.1146/annurev.immunol.14.1.49; Torchilin V P, 1994, Immunomethods, V4, P244, DOI 10.1006/immu.1994.1027; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Unanue E R, 1967, Adv Immunol, V6, P1, DOI 10.1016/S0065-2776(08)60521-0; van den Beucken T, 2003, FEBS LETT, V546, P288, DOI 10.1016/S0014-5793(03)00602-1; VARNDELL IM, 1984, IMMUNOLABELLING ELEC, P155; Villiers MB, 1999, J IMMUNOL, V162, P3647; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Viteeta E. S., 2003, FUNDAMENTAL IMMUNOLO, P1621; VITETTA ES, 1983, SCIENCE, V219, P644, DOI 10.1126/science.6218613; Vogel C.-W., 1987, IMMUNOCONJUGATES ANT; Vogel C-W, 1987, IMMUNOCONJUGATES ANT, P170; VOLKMAN DJ, 1982, J EXP MED, V156, P634, DOI 10.1084/jem.156.2.634; VOSSEN JM, 1975, ANN NY ACAD SCI, V254, P262, DOI 10.1111/j.1749-6632.1975.tb29176.x; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Wat C K, 1984, Prog Clin Biol Res, V170, P351; WINTER G, 1993, IMMUNOL TODAY, V14, P243, DOI 10.1016/0167-5699(93)90039-N; WOFSY L, 1974, J EXP MED, V140, P523, DOI 10.1084/jem.140.2.523; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; YAMAMOTO N, 1977, ACTA HISTOCHEM CYTOC, V10, P246, DOI 10.1267/ahc.10.246; YARMUSH ML, 1993, CRIT REV THER DRUG, V10, P197; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	178	19	21	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1211	1217		10.1038/ni1140	http://dx.doi.org/10.1038/ni1140			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549122				2022-12-18	WOS:000225353500009
J	Reichhart, JM				Reichhart, JM			TLR5 takes aim at bacterial propeller	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTORS; FLAGELLIN		CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Reichhart, JM (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.							Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668	10	19	23	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1159	1160		10.1038/ni1203-1159	http://dx.doi.org/10.1038/ni1203-1159			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639462				2022-12-18	WOS:000186769500005
J	Silverstein, AM				Silverstein, AM			Cellular versus humoral immunology: a century-long dispute	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOGLOBULIN	Imunology's founding fathers argued fiercely about whether Metchnikoff's phagocytes or Ehrlich's antibodies were the most important mediators of immunity. Antibodies won out, but even after lymphocytes re-established cellular immunology, the humoralist-cellularist divide persisted.	Johns Hopkins Univ, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Univ, Inst Hist Med, Baltimore, MD 21205 USA.							Arrhenius Svante, 1907, IMMUNOCHEMISTRY; ASKONAS BA, 1965, NATURE, V205, P470, DOI 10.1038/205470a0; Baxter AG, 2001, NAT REV IMMUNOL, V1, P229, DOI 10.1038/35105083; Behring E., 1892, Z HYG, V12, P45; BEHRING E, 1892, Z HYG, V12, P10; Behring EV., 1890, DEUT MED WOCHENSCHR, V49, P1113; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bordet J., 1898, ANN I PASTEUR PARIS, V12, P688; Breinl F., 1930, Z PHYSL CHEM, V192, P45; Brent Leslie, 1997, HIST TRANSPLANTATION; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM, 1949, PRODUCTION ANTIBODIE; CAMBROSIO A, 1993, ISIS, V84, P662, DOI 10.1086/356636; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DIENES L., 1929, AMER REV TUBERC, V20, P92; EDELMAN GM, 1969, ANNU REV BIOCHEM, V38, P415, DOI 10.1146/annurev.bi.38.070169.002215; EDELMAN GM, 1970, BIOCHEMISTRY-US, V9, P3197, DOI 10.1021/bi00818a012; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P979, DOI [10.1055/s-0029-1206682, DOI 10.1055/S-0029-1206682]; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P1218, DOI DOI 10.1055/S-0029-1206825; ELBERG SS, 1960, BACTERIOL REV, V24, P67, DOI 10.1128/MMBR.24.1.67-95.1960; Erlich P, 1897, KLIN JB JENA, V6, P299; FAHEY JL, 1962, ADV IMMUNOL, V2, P41; FISHMAN M, 1963, J EXP MED, V117, P595, DOI 10.1084/jem.117.4.595; FONG J, 1963, J EXP MED, V118, P391; Gell PGH, 1968, CLIN ASPECTS IMMUNOL, VSecond, P580; GRANGER GA, 1964, SCIENCE, V145, P1427, DOI 10.1126/science.145.3639.1427; Humphrey J.H., 1963, IMMUNOLOGY STUDENTS; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; JERNE NK, 1967, ANTIBODIES, V37, P591; Kabat E.A., 1968, STRUCTURAL CONCEPTS; KABAT EA, 1949, J EXP MED, V89, P395, DOI 10.1084/jem.89.4.395; KABAT EA, 1947, J EXP MED, V85, P117, DOI 10.1084/jem.85.1.117; Kabat EA, 1948, EXPT IMMUNOCHEMISTRY; KARUSH F, 1962, ADV IMMUNOL, V2, P1; Kuhn T, 2012, STRUCTURE SCI REVOLU, V4th, DOI DOI 10.7208/CHICAGO/9780226458144.001.0001; KUNKEL HENRY G., 1965, HARVEY LECT, V59, P219; LANDSTEINER, 1962, SPECIFICITY SEROLOGI; Landsteiner K, 1942, P SOC EXP BIOL MED, V49, P688, DOI 10.3181/00379727-49-13670; Lurie MB, 1942, J EXP MED, V75, P247, DOI 10.1084/jem.75.3.247; MACKANESS GB, 1967, PROG ALLERGY, V11, P89, DOI 10.1159/000287245; Mackay I.R., 1963, AUTOIMMUNE DIS; MARRACK JR, 1934, CHEM ANTIGENS ANTIBO; MAYER MM, 1972, P NATL ACAD SCI USA, V69, P2954, DOI 10.1073/pnas.69.10.2954; Metchnikoff E., 1968, LECT COMP PATHOLOGY; METCHNIKOFF E, 1968, IMMUNITY INFECT DIS; METCHNIKOFF E, 1905, IMMUNITY INFECT DIS, P306; Metchnikoff ME., 1884, VIRCHOWS ARCH PATH A, V9, P177, DOI [10.1007/BF02361555, DOI 10.1007/BF02361555]; METCHNIKOFF O, 1921, LIFE E METCHNIKOFF, P116; MOLLER G, 1978, IMMUNOL REV, V40; Muller-Eberhard H J, 1968, Adv Immunol, V8, P1, DOI 10.1016/S0065-2776(08)60464-2; MURPHY JB, 2001, MONOGRAPHS ROCKEFELL, V21, P569; Paul W., 1999, FUNDAMENTAL IMMUNOLO; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PAULING LJ, 2003, NATURE IMMUNOL, V4, P3; PFEIFFER RZ, 1895, HYG INFEKTSKR, V18, P1; Pick E.P., 1912, HDB PATHOGENEN MIKRO, V1, P685; POLJAK RJ, 1973, P NATL ACAD SCI USA, V70, P3305, DOI 10.1073/pnas.70.12.3305; POLJAK RJ, 1974, P NATL ACAD SCI USA, V71, P1427; PORTER RR, 1963, BRIT MED BULL, V19, P197, DOI 10.1093/oxfordjournals.bmb.a070056; Pressman D, 1968, STRUCTURAL BASIS ANT; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; Rivers TM, 1935, J EXP MED, V61, P689, DOI 10.1084/jem.61.5.689; ROWLEY D, 1962, ADV IMMUNOL, V2, P241; Silverstein A.M., 2002, P EHRLICHS RECEPTOR, P95; Silverstein AM, 2002, NAT IMMUNOL, V3, P105, DOI 10.1038/ni0202-105; Silverstein AM, 2001, NAT IMMUNOL, V2, P569, DOI 10.1038/89706; SILVERSTEIN AM, 1991, CELL IMMUNOL, V132, P515, DOI 10.1016/0008-8749(91)90047-F; Silverstein AM, 1989, HIST IMMUNOLOGY, P38; SUTER E, 1964, ADV IMMUNOL, V4, P117, DOI 10.1016/S0065-2776(08)60707-5; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; TAUBER AI, 1992, CELL IMMUNOL, V139, P505, DOI 10.1016/0008-8749(92)90089-8; Tauber AI, 1991, METCHNIKOFF ORIGINS; Tauber AI, 1994, IMMUNE SELF THEORY M; UNANUE ER, 1980, MACROPHAGE REGULATIO; Virchow R., 1971, CELLULAR PATHOLOGY; WAKSMAN BH, 1958, J IMMUNOL, V81, P220; Wright AE, 1904, P R SOC LONDON, V73, P128, DOI 10.1098/rspl.1904.0022; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X; [No title captured]; [No title captured]	83	19	19	1	19	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					425	428		10.1038/ni0503-425	http://dx.doi.org/10.1038/ni0503-425			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719732	Bronze			2022-12-18	WOS:000182665400006
J	Silverstein, AM				Silverstein, AM			Darwinism and immunology: from Metchnikoff to Burnet	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOGLOBULIN SUPERFAMILY		Johns Hopkins Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Silverstein, AM (corresponding author), Johns Hopkins Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.	arts@jhmi.edu						Arrhenius Svante, 1907, IMMUNOCHEMISTRY; Bordet J., 1898, ANN I PASTEUR PARIS, V12, P688; Breinl F., 1930, Z PHYSL CHEM, V192, P45; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet F. Macfarlane, 1941, PRODUCTION ANTIBODIE; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Burnet FM, 1949, PRODUCTION ANTIBODIE; Bussard A., 1982, B SOC FRAN PHILOS, V77, P1; Chernyak L., 1991, METCHNIKOFF ORIGINS, P101; CHURCHILL EB, 1976, J HIST MED, V31, P117; Cohen I. R., 2000, TENDING ADAMS GARDEN; Cohn M., 1980, PROGR IMMUNOLOGY, V4, P153; Conry Y., 1974, INTRO DARWINISME FRA, P231; CORSI P., 1985, DARWINIAN HERITAGE, P698; EDELMAN GM, 1987, IMMUNOL REV, V100, P11, DOI 10.1111/j.1600-065X.1987.tb00526.x; EHRLICH P, 1957, COLLECTED PAPERS P E, V2, P31; Ehrlich P., 1892, HYG LNFEKT KRANKH, V2, P183, DOI [10.1007/BF02284236, DOI 10.1007/BF02284236]; Erlich P, 1897, KLIN JB JENA, V6, P299; FLEMING DW, 1954, WELCH RISE MODERN ME; FRENCH R D, 1970, Journal of the History of Biology, V3, P253, DOI 10.1007/BF00137354; Geison G., 1978, M FOSTER CAMBRIDGE S, P340; Grawitz, 1881, ARCH PATHOL ANAT PHY, V84, P87, DOI [10.1007/BF01935470, DOI 10.1007/BF01935470]; Hull DL., 1985, DARWINIAN HERITAGE, P773, DOI DOI 10.1515/9781400854714.773; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JAMES C, 1974, INTRO DARWINISME FRA, P231; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Kabat E. A., 1948, QUANTITATIVE IMMUNOC; Landsteiner K., 1962, SPECIFICITY SEROLOGI; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; MATSUNAGA T, 1987, SCAND J IMMUNOL, V25, P485, DOI 10.1111/j.1365-3083.1987.tb02220.x; Mayr E., 1985, P755; Mayr E., 1980, P1; Metalnikoff Serge, 1900, ANN I PASTEUR, V14, P577; METCHNIKOFF, 1968, LECT COMP PATHOLOGY; Metchnikoff, 1900, ANN I PASTEUR, V14, P369; METCHNIKOFF E, 1968, LECT COMP PATHOLOGY, pR17; Metchnikoff I, 1884, ARCHIV PATHOLOGISCHE, V96, P177; Moulin A.-M., 1991, DERMIER LANGAGE MED, P49; OHNO S, 1976, PERSPECT BIOL MED, V19, P527, DOI 10.1353/pbm.1976.0074; OHNO S, 1980, PROG IMMUNOL, V4, P577; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Pfeiffer R., 1894, Z HYGIENE INFEKTIONS, V18, P1, DOI [10.1007/BF02216831, DOI 10.1007/BF02216831]; Silverstein A.M., 2002, P EHRLICHS RECEPTOR, P27; Silverstein AM, 2000, NAT IMMUNOL, V1, P93, DOI 10.1038/77874; Silverstein AM, 2002, NAT IMMUNOL, V3, P793, DOI 10.1038/ni0902-793; SILVERSTEIN AM, 1991, CELL IMMUNOL, V132, P515, DOI 10.1016/0008-8749(91)90047-F; Silverstein AM, 1989, HIST IMMUNOLOGY, P38; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; TAUBEC AI, 1994, IMMUNE SELF THEORY M; TAUBER AI, 1991, PROBLEM EVOLUTION ME, P68; Todes D.P., 1989, DARWIN MALTHUS STRUG, P82; von Gruber M, 1903, WIEN KLIN WOCHENSCHR, V16, P791; von Gruber M., 1901, MUNCHEN MED WOCHEN, V48, P1214; Welch W H, 1902, Br Med J, V2, P1105; WELCH WH, 2002, BRIT MED J, V2, P1109; WELCH WH, 1920, PAPERS ADDRESSES WH, V2; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; COLLECTED PAPERS P E, V2, P107; 2000, SEMINARS IMMUNOL, V12, P159; [No title captured]; 2000, P R SOC LONDON B, V66, P424; COLLECTED PAPERS, V2, P178	63	19	20	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					3	6		10.1038/ni0103-3	http://dx.doi.org/10.1038/ni0103-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496967				2022-12-18	WOS:000180053000003
